PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, SH; Zhang, Y; Wang, Y; Ye, P; Li, J; Li, HB; Ding, QQ; Xia, JH				Wang, Sihua; Zhang, Yuan; Wang, Yan; Ye, Ping; Li, Jun; Li, Huabin; Ding, Qingqing; Xia, Jiahong			Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3 beta/Foxp3 Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SYNTHASE KINASE 3-BETA; COLORECTAL-CANCER; CETUXIMAB; FOXP3; BETA; INHIBITION; IMMUNITY; PHOSPHORYLATION; DEGRADATION	Previous studies mainly focused on the role of the epidermal growth factor receptor (EGFR) in tumor cells, whereas the effects of the EGFR on immune responses has not been determined. Our study shows that the EGFR signaling pathway play a role in the regulation of regulatory T cells (Treg cells) in cancer patients. The EGF-like growth factor Amphiregulin (AREG) protein was frequently up-regulated in a tissue microarray, which was associated with worse overall survival. Additionally, in sera, tissue specimens, and effusions of lung or gastric cancer patients, up-regulated AREG protein enhanced the suppressive function of Treg cells. AREG maintained the Treg cell suppressive function via the EGFR/GSK-3 beta/Foxp3 axis in vitro and in vivo. Furthermore, inhibition of EGFR by the tyrosine kinase inhibitor gefitinib restored the activity of GSK-3 beta and attenuated Treg cell function. beta-TrCP was involved in GSK-3 beta -mediated Foxp3 degradation, and mass spectrometry identified Lys(356) as the ubiquitination site of Foxp3 by beta-TrCP. These findings demonstrate the posttranslational regulation of Foxp3 expression by AREG in cancer patients through AREG/EGFR/GSK-3 beta signaling, which could lead to Foxp3 protein degradation in Treg cells and a potential therapeutic target for cancer treatment.	[Wang, Sihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, Wuhan 430022, Peoples R China; [Zhang, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430022, Peoples R China; [Xia, Jiahong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg, Wuhan 430022, Peoples R China; [Ye, Ping; Li, Jun] Cent Hosp Wuhan, Dept Cardiovasc Surg, Wuhan 430022, Peoples R China; [Wang, Yan; Ding, Qingqing] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Surg, Shanghai 200092, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University	Ding, QQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Li, HB (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Surg, Shanghai 200092, Peoples R China.; Xia, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg,Cent Hosp Wuhan, Wuhan 430022, Peoples R China.	allergyli@163.com; qingqing_ding@hotmail.com; jiahong.xia@hust.edu.cn			National Nature Science Foundation of China [81130056, 81401323]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Nature Science Foundation of China Grants 81130056 and 81401323. The authors declare that they have no conflicts of interest with the contents of this article.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Crane CH, 2011, J CLIN ONCOL, V29, P3037, DOI 10.1200/JCO.2010.33.8038; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Ding QQ, 2011, J CLIN INVEST, V121, P4526, DOI 10.1172/JCI45008; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Garrido G, 2007, CANCER IMMUNOL IMMUN, V56, P1701, DOI 10.1007/s00262-007-0313-4; Graham JA, 2010, J BIOL CHEM, V285, P32852, DOI 10.1074/jbc.M110.150904; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; Mekori YA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00006; Morawski PA, 2013, J BIOL CHEM, V288, P24494, DOI 10.1074/jbc.M113.467704; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Qi YL, 2010, J ALLERGY CLIN IMMUN, V126, P1260, DOI 10.1016/j.jaci.2010.08.040; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Srivastava RM, 2013, CLIN CANCER RES, V19, P1858, DOI 10.1158/1078-0432.CCR-12-2426; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thienelt CD, 2005, J CLIN ONCOL, V23, P8786, DOI 10.1200/jco.2005.03.1997; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Wu XM, 2015, J ALLERGY CLIN IMMUN, V136, P1698, DOI 10.1016/j.jaci.2015.08.014; Xie AN, 2011, TRANSPLANTATION, V91, P27, DOI 10.1097/TP.0b013e3181fdd948; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yotsumoto F, 2010, CANCER SCI, V101, P2351, DOI 10.1111/j.1349-7006.2010.01671.x; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	43	74	82	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21085	21095		10.1074/jbc.M116.717892	http://dx.doi.org/10.1074/jbc.M116.717892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27432879	Green Published, hybrid			2022-12-26	WOS:000385406200024
J	Coulson-Thomas, VJ; Lauer, ME; Soleman, S; Zhao, C; Hascall, VC; Day, AJ; Fawcett, JW				Coulson-Thomas, Vivien J.; Lauer, Mark E.; Soleman, Sara; Zhao, Chao; Hascall, Vincent C.; Day, Anthony J.; Fawcett, James W.			Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glycosaminoglycan; hyaluronan; inflammation; proteoglycan; glial scar	INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; ANTIINFLAMMATORY PROTEIN TSG-6; HEAVY-CHAIN TRANSFER; HYALURONAN-BINDING PROTEINS; FIBRILLARY ACIDIC PROTEIN; HUMAN AMNIOTIC MEMBRANE; REACTIVE ASTROCYTES; EXTRACELLULAR-MATRIX; CD44 EXPRESSION	Tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) binds to hyaluronan and can reorganize/stabilize its structure, also enhancing the binding of this glycosaminoglycan to its cell surface receptor, CD44. TSG-6 is rapidly up-regulated in response to inflammatory cytokines protecting tissues from the damaging effects of inflammation. Despite TSG-6 treatment having been shown to improve outcomes in an experimental model of traumatic brain injury, TSG-6 expression has not been extensively studied in the central nervous system (CNS). We hereby analyzed the expression profile of TSG-6 in the developing CNS and following injury. We show that TSG-6 is expressed in the rat CNS by GFAP(+) and CD44(+) astrocytes, solely in the mature brain and spinal cord, and is not present during the development of the CNS. TSG-6(-/-) mice present a reduced number of GFAP(+) astrocytes when compared with the littermate TSG-6(+/-) mice. TSG-6 expression is drastically up-regulated after injury, and the TSG-6 protein is present within the glial scar, potentially coordinating and stabilizing the formation of this hyaluronan-rich matrix. This study shows that TSG-6 is expressed in the CNS, suggesting a role for TSG-6 in astrocyte activation and tissue repair. We hypothesize that within this context TSG-6 could participate in the formation of the glial scar and confer anti-inflammatory properties. Further studies are required to elucidate the therapeutic potential of targeting TSG-6 after CNS injury to promote its protective effects while reducing the inhibitory properties of the glial scar in axon regeneration.	[Coulson-Thomas, Vivien J.; Soleman, Sara; Fawcett, James W.] Univ Cambridge, John Van Geest Cambridge Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge CB2 0PY, England; [Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Zhao, Chao] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Zhao, Chao] Univ Cambridge, Dept Clin Neurosci, Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Cambridge; Cleveland Clinic Foundation; University of Cambridge; University of Cambridge; University of Manchester	Coulson-Thomas, VJ (corresponding author), Univ Houston, Coll Optometry, 505 J Davis Armistead Bldg,Rm 2103, Houston, TX 77204 USA.; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Fawcett, JW (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	vcoulsonthomas@gmail.com; anthony.day@manchester.ac.uk; jf108@cam.ac.uk	Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134	European Research Council ECMneuro; National Institutes of Health NHLBI Award [PO1HL107147]; Medical Research Council [MC_PC_12009] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER	European Research Council ECMneuro; National Institutes of Health NHLBI Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Research Council ECMneuro and National Institutes of Health NHLBI Award PO1HL107147. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asher RA, 2000, J NEUROSCI, V20, P2427; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Beltran SR, 2015, J PERIODONTOL, V86, P62, DOI 10.1902/jop.2014.140187; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bignami A, 1984, J Neurosurg Sci, V28, P127; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Buggey H, 2013, THESIS; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Coulson-Thomas VJ, 2016, OCUL SURF, V14, P121, DOI 10.1016/j.jtos.2015.11.004; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; Coulson-Thomas YA, 2008, J NEUROSCI METH, V171, P19, DOI 10.1016/j.jneumeth.2008.01.030; Cragnolini AB, 2009, GLIA, V57, P1386, DOI 10.1002/glia.20857; DAHL D, 1976, BRAIN RES, V116, P150, DOI 10.1016/0006-8993(76)90257-2; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dyer DP, 2016, J BIOL CHEM, V291, P12627, DOI 10.1074/jbc.M116.720953; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HATHCOCK KS, 1993, J IMMUNOL, V151, P6712; He H, 2014, INVEST OPHTH VIS SCI, V55, P1647, DOI 10.1167/iovs.13-13094; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; HUTTON LA, 1992, J NEUROSCI RES, V32, P375, DOI 10.1002/jnr.490320309; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; KUMAR S, 1993, MOL BRAIN RES, V17, P163, DOI 10.1016/0169-328X(93)90086-5; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lauer M. E., 2015, INT J CELL BIOL; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2015, METHODS MOL BIOL, V1229, P543, DOI 10.1007/978-1-4939-1714-3_42; Lauer ME, 2014, J BIOL CHEM, V289, P29171, DOI 10.1074/jbc.M114.600809; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; MORETTO G, 1993, J NEUROPATH EXP NEUR, V52, P419, DOI 10.1097/00005072-199307000-00009; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Niclou SP, 2006, J NEUROTRAUM, V23, P409, DOI 10.1089/neu.2006.23.409; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Oh JW, 1998, J IMMUNOL, V161, P4992; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Park Y, 2016, BIOCHEMISTRY-US, V55, P262, DOI 10.1021/acs.biochem.5b01148; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Rodriguez-Grande B, 2014, J CEREBR BLOOD F MET, V34, P480, DOI 10.1038/jcbfm.2013.224; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Scavenius C, 2016, J BIOL CHEM, V291, P4658, DOI 10.1074/jbc.M115.678748; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Spasova MS, 2014, EXP BIOL MED, V239, P724, DOI 10.1177/1535370213519195; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Wang H, 2015, EUR J PHARMACOL, V751, P42, DOI 10.1016/j.ejphar.2015.01.040; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Ye L, 1997, CIRC RES, V81, P289, DOI 10.1161/01.RES.81.3.289; YOKOYAMA M, 1993, EXP NEUROL, V124, P377, DOI 10.1006/exnr.1993.1209; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	115	40	45	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19939	19952		10.1074/jbc.M115.710673	http://dx.doi.org/10.1074/jbc.M115.710673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27435674	hybrid, Green Published			2022-12-26	WOS:000383243100018
J	Donovan, MR; Marr, MT				Donovan, Marissa R.; Marr, Michael T., II			dFOXO Activates Large and Small Heat Shock Protein Genes in Response to Oxidative Stress to Maintain Proteostasis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; INSULIN; EXPRESSION; PATHWAY; DISEASE; BINDING; DOWNSTREAM; TRANSGENES; RESISTANCE	Maintaining protein homeostasis is critical for survival at the cellular and organismal level (Morimoto, R. I. (2011) Cold Spring Harb. Symp. Quaid. Biol. 76, 91-99). Cells express a family of molecular chaperones, the heat shock proteins, during times of oxidative stress to protect against proteotoxicity. We have identified a second stress responsive transcription factor, dFOXO, that works alongside the heat shock transcription factor to activate transcription of both the small heat shock protein and the large heat shock protein genes. This expression likely protects cells from protein misfolding associated with oxidative stress. Here we identify the regions of the Hsp70 promoter essential for FOXO-dependent transcription using in vitro methods and find a physiological role for FOXO-dependent expression of heat shock proteins in vivo.	[Marr, Michael T., II] Brandeis Univ, Dept Biol, Waltham, MA 02453 USA; Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02453 USA	Brandeis University; Brandeis University	Marr, MT (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02453 USA.	mmarr@brandeis.edu			National Institutes of Health [R01GM11703, T32 GM007122]; New Scholar in Aging Award from Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM117034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Scholar in Aging Award from Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM11703 (to M. T. M.). This work was also supported by a New Scholar in Aging Award from the Ellison Medical Foundation (to M. T. M.). The authors declare that they have no conflicts of interest with the contents of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported for a portion of the work by National Institutes of Health Training Grant T32 GM007122.	Alic N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004619; Alic N, 2014, CELL REP, V6, P608, DOI 10.1016/j.celrep.2014.01.015; Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BECKER J, 1990, EUR J BIOCHEM, V189, P553, DOI 10.1111/j.1432-1033.1990.tb15522.x; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Douglas PM, 2015, CELL REP, V12, P1196, DOI 10.1016/j.celrep.2015.07.026; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fernandes M, 1995, NUCLEIC ACIDS RES, V23, P4799, DOI 10.1093/nar/23.23.4799; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giannakou ME, 2007, AGING CELL, V6, P429, DOI 10.1111/j.1474-9726.2007.00290.x; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hard F. U., 1996, NATURE, V381, P571; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; NlcColl G., 2010, CELL METAB, V12, P260; Olson CM, 2013, ELIFE, V2, DOI 10.7554/eLife.00542; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Shukla AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098886; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Spellberg MJ, 2015, P NATL ACAD SCI USA, V112, P14587, DOI 10.1073/pnas.1517124112; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wheeler JC, 1999, NEUROBIOL AGING, V20, P545, DOI 10.1016/S0197-4580(99)00088-3; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Zhang W, 2013, GENE DEV, V27, P441, DOI 10.1101/gad.201731.112; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	43	25	27	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19042	19050		10.1074/jbc.M116.723049	http://dx.doi.org/10.1074/jbc.M116.723049			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27435672	Green Published, hybrid			2022-12-26	WOS:000383242300038
J	Kalbitz, M; Karbach, M; Braumueller, S; Kellermann, P; Gebhard, F; Huber-Lang, M; Perl, M				Kalbitz, Miriam; Karbach, Michael; Braumueller, Sonja; Kellermann, Philipp; Gebhard, Florian; Huber-Lang, Markus; Perl, Mario			Role of Complement C5 in Experimental Blunt Chest Trauma-Induced Septic Acute Lung Injury (ALI)	PLOS ONE			English	Article							RESPIRATORY-DISTRESS SYNDROME; PULMONARY CONTUSION; INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CECAL LIGATION; MURINE MODEL; SEPSIS; RECEPTOR; APOPTOSIS	Background Severe blunt chest trauma is associated with high mortality. Sepsis represents a serious risk factor for mortality in acute respiratory distress syndrome (ARDS). In septic patients with ARDS complement activation products were found to be elevated in the plasma. In single models like LPS or trauma complement has been studied to some degree, however in clinically highly relevant double hit models such as the one used here little data is available. Here, we hypothesized that absence of C5 is correlated with a decreased inflammatory response in trauma induced septic acute lung injury. Methods 12 hrs after DH in mice the local and systemic cytokines and chemokines were quantified by multiplex bead array or ELISA, activated caspase-3 by western blot. Data were analyzed using one-way ANOVA followed by post-hoc Sidak's multiple comparison test (significance, p <= 0.05). Results In lung tissue interleukin (IL)-6, monocyte chemo attractant protein-1 (MCP-1) and granulocyte-colony stimulating factor (G-CSF) was elevated in both C5(-/-) mice and wildtype littermates (wt), whereas caspase-3 was reduced in lungs after DH in C5(-/-) mice. Systemically, reduced keratinocyte-derived chemokine (KC) levels were observed after DH in C5(-/-) compared to wt mice. Locally, lung myeloperoxidase (MPO), protein, IL-6, MCP-1 and G-CSF in brochoalveolar lavage fluid (BALF) were elevated after DH in C5(-/-) compared to wt. Conclusions In the complex but clinically relevant DH model the local and systemic inflammatory immune response features both, C5-dependent and C5-independent characteristics. Activation of caspase-3 in lung tissue after DH was C5-dependent whereas local inflammation in lung tissue was C5-independent.	[Kalbitz, Miriam; Karbach, Michael; Braumueller, Sonja; Kellermann, Philipp; Gebhard, Florian; Huber-Lang, Markus; Perl, Mario] Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany; [Perl, Mario] BG Trauma Ctr Murnau, Orthoped Trauma, Murnau, Germany	Ulm University	Kalbitz, M (corresponding author), Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany.	miriam.kalbitz@uniklinik-ulm.de	Huber-Lang, Markus/AAJ-2209-2020		Deutsche Forschungsgemeinschaft [KFO200, TP2, 823/3-2]; DFG [PE 908/2-1]; Centre of Musculoskeletal Research Ulm (Zmfu) research grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Centre of Musculoskeletal Research Ulm (Zmfu) research grant	This work was supported by Deutsche Forschungsgemeinschaft research grant KFO200 (TP2; 823/3-2) to M.H.-L., DFG PE 908/2-1 to M.P. and Centre of Musculoskeletal Research Ulm (Zmfu) research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Deutsche Forschungsgemeinschaft research grant KFO200 (TP2; 823/3-2) to M.H.-L., DFG PE 908/2-1 to M.P. and Centre of Musculoskeletal Research Ulm (Zmfu) research grant. We thank Sonja Braumueller and Anke Schulze for their technical assistance.	Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Flierl MA, 2008, FASEB J, V22, P3483, DOI 10.1096/fj.08-110595; Flierl MA, 2008, SHOCK, V29, P25, DOI 10.1097/shk.0b013e3180556a0b; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Guo RF, 2006, J LEUKOCYTE BIOL, V80, P1575, DOI 10.1189/jlb.0106065; Guo RF, 2001, FASEB J, V15, pA941; Hopken U, 1996, EUR J IMMUNOL, V26, P1103, DOI 10.1002/eji.1830260522; Hoth JJ, 2007, SHOCK, V28, P447, DOI 10.1097/shk.0b013e318048801a; Hoth JJ, 2014, J TRAUMA ACUTE CARE, V76, P601, DOI 10.1097/TA.0000000000000129; Hoth JJ, 2009, SHOCK, V31, P376, DOI 10.1097/SHK.0b013e3181862279; Knoferl MW, 2004, SHOCK, V22, P51, DOI 10.1097/01.shk.0000127684.64611.5c; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; LANGLOIS PF, 1988, AM REV RESPIR DIS, V138, P368, DOI 10.1164/ajrccm/138.2.368; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Lomas-Neira J, 2006, AM J PHYSIOL-LUNG C, V290, pL51, DOI 10.1152/ajplung.00028.2005; Lomas-Neira JL, 2004, J LEUKOCYTE BIOL, V76, P58, DOI 10.1189/jlb.1103541; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; PARSONS PE, 1985, AM REV RESPIR DIS, V132, P490; Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0; Perl M, 2005, CRIT CARE MED, V33, P1351, DOI 10.1097/01.CCM.0000166352.28018.A9; Perl M, 2007, AM J RESP CRIT CARE, V176, P591, DOI 10.1164/rccm.200611-1743OC; Perl M, 2012, SHOCK, V38, P98, DOI 10.1097/SHK.0b013e318254be6a; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; ROBBINS RA, 1987, AM REV RESPIR DIS, V135, P651; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Short A, 1999, BRIT J PHARMACOL, V126, P551, DOI 10.1038/sj.bjp.0702338; STELLIN G, 1991, AM SURGEON, V57, P780; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P792, DOI 10.1097/TA.0b013e31827a3655; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b	43	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159417	10.1371/journal.pone.0159417	http://dx.doi.org/10.1371/journal.pone.0159417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437704	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100045
J	Chao, TL; Wang, GZ; Wang, JM; Liu, ZH; Ji, ZB; Hou, L; Zhang, CL				Chao, Tianle; Wang, Guizhi; Wang, Jianmin; Liu, Zhaohua; Ji, Zhibin; Hou, Lei; Zhang, Chunlan			Identification and Classification of New Transcripts in Dorper and Small-Tailed Han Sheep Skeletal Muscle Transcriptomes	PLOS ONE			English	Article							NONCODING RNAS; MESSENGER-RNAS; ANNOTATION; REVEALS; DISCOVERY; DORSET; MODEL; SKIN	High-throughput mRNA sequencing enables the discovery of new transcripts and additional parts of incompletely annotated transcripts. Compared with the human and cow genomes, the reference annotation level of the sheep genome is still low. An investigation of new transcripts in sheep skeletal muscle will improve our understanding of muscle development. Therefore, applying high-throughput sequencing, two cDNA libraries from the biceps brachii of small-tailed Han sheep and Dorper sheep were constructed, and whole-transcriptome analysis was performed to determine the unknown transcript catalogue of this tissue. In this study, 40,129 transcripts were finally mapped to the sheep genome. Among them, 3,467 transcripts were determined to be unannotated in the current reference sheep genome and were defined as new transcripts. Based on protein-coding capacity prediction and comparative analysis of sequence similarity, 246 transcripts were classified as portions of unannotated genes or incompletely annotated genes. Another 1,520 transcripts were predicted with high confidence to be long non-coding RNAs. Our analysis also revealed 334 new transcripts that displayed specific expression in ruminants and uncovered a number of new transcripts without intergenus homology but with specific expression in sheep skeletal muscle. The results confirmed a complex transcript pattern of coding and non-coding RNA in sheep skeletal muscle. This study provided important information concerning the sheep genome and transcriptome annotation, which could provide a basis for further study.	[Chao, Tianle; Wang, Guizhi; Wang, Jianmin; Liu, Zhaohua; Ji, Zhibin; Hou, Lei] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China; [Zhang, Chunlan] Weifang Univ, Coll Biol & Agr Engn, Key Lab Biochem & Mol Biol Univ Shandong, Weifang 261061, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University; Weifang University	Wang, JM (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China.	wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; tianle, chao/0000-0001-9721-0634	Shandong Provincial Modern Agriculture Industry Technology System [SDAIT-0901101]; National Key Technology Support Program [2015BAD03B05]	Shandong Provincial Modern Agriculture Industry Technology System; National Key Technology Support Program(National Key Technology R&D Program)	This work was financially supported by the Shandong Provincial Modern Agriculture Industry Technology System (no. SDAIT-0901101) and National Key Technology Support Program (2015BAD03B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Jianmin Wang for revising the language and for providing valuable comments on the manuscript. This work was financially supported by the Shandong Provincial Modern Agriculture Industry Technology System (no. SDAIT-0901101) and National Key Technology Support Program (2015BAD03B05).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cloete SWP, 2000, SMALL RUMINANT RES, V36, P119, DOI 10.1016/S0921-4488(99)00156-X; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Du L., 2011, ANIMAL GENETIC RESOU; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023; Miao XY, 2013, REPRODUCTION, V145, P587, DOI 10.1530/REP-12-0507; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052275; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Trapnell C, 2012, NATURE PROTOCOLS, P7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TU YR, 1989, SMALL TAILED HAN SHE; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Yang Q, 2013, CELL PROLIFERAT, V46, P654, DOI 10.1111/cpr.12076; Yue YJ, 2015, GENET MOL RES, V14, P1371, DOI 10.4238/2015.February.13.16; Zhang CU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004509; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159638	10.1371/journal.pone.0159638	http://dx.doi.org/10.1371/journal.pone.0159638			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434270	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600078
J	Speake, C; Pichugin, A; Sahu, T; Malkov, V; Morrison, R; Pei, Y; Juompan, L; Milman, N; Zarling, S; Anderson, C; Wong-Madden, S; Wendler, J; Ishizuka, A; MacMillen, ZW; Garcia, V; Kappe, SHI; Krzych, U; Duffy, PE				Speake, Cate; Pichugin, Alexander; Sahu, Tejram; Malkov, Vlad; Morrison, Robert; Pei, Ying; Juompan, Laure; Milman, Neta; Zarling, Stasya; Anderson, Charles; Wong-Madden, Sharon; Wendler, Jason; Ishizuka, Andrew; MacMillen, Zachary W.; Garcia, Valentino; Kappe, Stefan H. I.; Krzych, Urszula; Duffy, Patrick E.			Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein	PLOS ONE			English	Article							PLASMODIUM-BERGHEI MALARIA; CD8+ T-CELLS; NAIVE ADULTS; PROTECTIVE IMMUNITY; STERILE IMMUNITY; EFFICACY; DNA; IMMUNIZATION; SPOROZOITES; PARASITES	Malaria vaccine development has been hampered by the limited availability of antigens identified through conventional discovery approaches, and improvements are needed to enhance the efficacy of the leading vaccine candidate RTS, S that targets the circumsporozoite protein (CSP) of the infective sporozoite. Here we report a transcriptome-based approach to identify novel pre-erythrocytic vaccine antigens that could potentially be used in combination with CSP. We hypothesized that stage-specific upregulated genes would enrich for protective vaccine targets, and used tiling microarray to identify P. falciparum genes transcribed at higher levels during liver stage versus sporozoite or blood stages of development. We prepared DNA vaccines for 21 genes using the predicted orthologues in P. yoelii and P. berghei and tested their efficacy using different delivery methods against pre-erythrocytic malaria in rodent models. In our primary screen using P. yoelii in BALB/c mice, we found that 16 antigens significantly reduced liver stage parasite burden. In our confirmatory screen using P. berghei in C57Bl/6 mice, we confirmed 6 antigens that were protective in both models. Two antigens, when combined with CSP, provided significantly greater protection than CSP alone in both models. Based on the observations reported here, transcriptional patterns of Plasmodium genes can be useful in identifying novel pre-erythrocytic antigens that induce protective immunity alone or in combination with CSP.	[Speake, Cate; Malkov, Vlad; Pei, Ying; Milman, Neta; Wendler, Jason; Ishizuka, Andrew; MacMillen, Zachary W.; Garcia, Valentino; Kappe, Stefan H. I.] Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA; [Pichugin, Alexander; Juompan, Laure; Zarling, Stasya; Krzych, Urszula] Walter Reed Army Inst Res, Dept Cellular Immunol, Silver Spring, MD USA; [Sahu, Tejram; Morrison, Robert; Anderson, Charles; Wong-Madden, Sharon; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Center for Infectious Disease Research; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	duffype@niaid.nih.gov		Ishizuka, Andrew/0000-0002-3024-7536	PATH Malaria Vaccine Initiative; Intramural Research Program of NIAID, NIH; Military Infectious Diseases Research Program of Walter Reed Army Institute of Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001135] Funding Source: NIH RePORTER	PATH Malaria Vaccine Initiative; Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Military Infectious Diseases Research Program of Walter Reed Army Institute of Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded in part by the PATH Malaria Vaccine Initiative, by the Intramural Research Program of NIAID, NIH and the Military Infectious Diseases Research Program of Walter Reed Army Institute of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Aly ASI, 2011, MOL MICROBIOL, V79, P929, DOI 10.1111/j.1365-2958.2010.07497.x; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bergmann-Leitner Elke S, 2013, Methods Mol Biol, V940, P269, DOI 10.1007/978-1-62703-110-3_21; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Francis SE, 2007, INFECT IMMUN, V75, P4838, DOI 10.1128/IAI.00635-07; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Haddad D, 2004, INFECT IMMUN, V72, P1594, DOI 10.1128/IAI.72.3.1594-1602.2004; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Kaiser K, 2003, J EXP MED, V197, P1045, DOI 10.1084/jem.20022100; Kester KE, 2014, VACCINE, V32, P6683, DOI 10.1016/j.vaccine.2014.06.033; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Leitner WW, 1997, J IMMUNOL, V159, P6112; Limbach K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-65; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miller JL, 2012, INFECT IMMUN, V80, P1399, DOI 10.1128/IAI.05861-11; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Richie TL, 2012, HUM VACC IMMUNOTHER, V8, P1564, DOI 10.4161/hv.22129; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sinnis Photini, 2013, Methods Mol Biol, V923, P385; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; White MT, 2011, P ROY SOC B-BIOL SCI, V278, P1298, DOI 10.1098/rspb.2010.1697; Yoshida A, 2000, VACCINE, V18, P1725, DOI 10.1016/S0264-410X(99)00432-6	60	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159449	10.1371/journal.pone.0159449	http://dx.doi.org/10.1371/journal.pone.0159449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434123	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169600053
J	Aumann, TD; Raabus, M; Tomas, D; Prijanto, A; Churilov, L; Spitzer, NC; Horne, MK				Aumann, Tim D.; Raabus, Mai; Tomas, Doris; Prijanto, Agustinus; Churilov, Leonid; Spitzer, Nicholas C.; Horne, Malcolm K.			Differences in Number of Midbrain Dopamine Neurons Associated with Summer and Winter Photoperiods in Humans	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; SUBSTANTIA-NIGRA; CATECHOLAMINE DEPLETION; TYROSINE-HYDROXYLASE; PROGENITOR CELLS; PROLIFERATION; NEUROGENESIS; MODEL; AVAILABILITY	Recent evidence indicates the number of dopaminergic neurons in the adult rodent hypothalamus and midbrain is regulated by environmental cues, including photoperiod, and that this occurs via up-or down-regulation of expression of genes and proteins that are important for dopamine (DA) synthesis in extant neurons ('DA neurotransmitter switching'). If the same occurs in humans, it may have implications for neurological symptoms associated with DA imbalances. Here we tested whether there are differences in the number of tyrosine hydroxylase (TH, the rate-limiting enzyme in DA synthesis) and DA transporter (DAT) immunoreactive neurons in the midbrain of people who died in summer (long-day photoperiod, n = 5) versus winter (short-day photoperiod, n = 5). TH and DAT immunoreactivity in neurons and their processes was qualitatively higher in summer compared with winter. The density of TH immunopositive (TH+) neurons was significantly (similar to 6-fold) higher whereas the density of TH immunonegative (TH-) neurons was significantly (similar to 2.5-fold) lower in summer compared with winter. The density of total neurons (TH+ and TH- combined) was not different. The density of DAT+ neurons was similar to 2-fold higher whereas the density of DAT-neurons was similar to 2-fold lower in summer compared with winter, although these differences were not statistically significant. In contrast, midbrain nuclear volume, the density of supposed glia (small TH- cells), and the amount of TUNEL staining were the same in summer compared with winter. This study provides the first evidence of an association between environmental stimuli (photoperiod) and the number of midbrain DA neurons in humans, and suggests DA neurotransmitter switching underlies this association.	[Aumann, Tim D.; Raabus, Mai; Tomas, Doris; Prijanto, Agustinus; Churilov, Leonid; Horne, Malcolm K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Spitzer, Nicholas C.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Spitzer, Nicholas C.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Aumann, TD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	taumann@unimelb.edu.au	Horne, Malcolm/AAL-5214-2020	Horne, Malcolm/0000-0001-9427-2100; Spitzer, Nicholas/0000-0002-3523-1103	MRC; Brain Foundation of Australia, a Crowd-funding project [34732]; National Health and Medical Research Council (NHMRC) of Australia [1022839]; Victorian Government's Operational Infrastructure Support Grant	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brain Foundation of Australia, a Crowd-funding project; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Grant	Thank you to the donors, families and MRC-funded Edinburgh University Brain Bank for supply of the brain tissue. This study was supported by the Brain Foundation of Australia, a Crowd-funding project hosted by Pozible (http://www.pozible.com/project/34732), and the National Health and Medical Research Council (NHMRC) of Australia (project 1022839). The Florey Institute of Neuroscience and Mental Health is supported by the Victorian Government's Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to the brain tissue donors and their families; and to Chris-Anne McKenzie and staff at the Medical Research Council (MRC)-funded Edinburgh University Brain Bank. This study was supported by the Brain Foundation of Australia, a Crowd-funding project hosted by Pozible (http://www.pozible.com/project/34732), and the National Health and Medical Research Council (NHMRC) of Australia (project 1022839). The Florey Institute of Neuroscience and Mental Health is supported by the Victorian Government's Operational Infrastructure Support Grant.	Aponso PM, 2008, NEUROSCIENCE, V151, P1142, DOI 10.1016/j.neuroscience.2007.11.036; Aumann TD, 2008, EXP NEUROL, V213, P419, DOI 10.1016/j.expneurol.2008.07.005; Aumann TD, 2013, BRAIN BEHAV, V3, P617, DOI 10.1002/brb3.163; Aumann TD, 2011, J NEUROCHEM, V116, P646, DOI 10.1111/j.1471-4159.2010.07151.x; BREWERTON TD, 1988, PSYCHIAT RES, V23, P257, DOI 10.1016/0165-1781(88)90016-9; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Deats SP, 2015, NEUROSCI LETT, V602, P17, DOI 10.1016/j.neulet.2015.06.038; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Eisenberg DP, 2010, J NEUROSCI, V30, P14691, DOI 10.1523/JNEUROSCI.1953-10.2010; Frielingsdorf H, 2004, P NATL ACAD SCI USA, V101, P10177, DOI 10.1073/pnas.0401229101; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; HARTIKAINEN P, 1991, J NEURAL TRANSM-GEN, V84, P103, DOI 10.1007/BF01249114; Kaasinen V, 2012, NEUROSCI LETT, V530, P80, DOI 10.1016/j.neulet.2012.09.047; KARSON CN, 1984, PSYCHIAT RES, V11, P111, DOI 10.1016/0165-1781(84)90094-5; Lam RW, 2001, NEUROPSYCHOPHARMACOL, V25, pS97, DOI 10.1016/S0893-133X(01)00337-2; Lie DC, 2002, J NEUROSCI, V22, P6639; Neumeister A, 1998, ARCH GEN PSYCHIAT, V55, P524, DOI 10.1001/archpsyc.55.6.524; Neumeister A, 2001, INT J NEUROPSYCHOPH, V4, P409, DOI 10.1017/S1461145701002644; Neumeister A, 2001, PSYCHOL MED, V31, P1467, DOI 10.1017/S003329170105434z; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Romeo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01395; Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487; Spitzer NC, 2015, NEURON, V86, P1131, DOI 10.1016/j.neuron.2015.05.028; Tomas D, 2015, JOVE-J VIS EXP, DOI 10.3791/52329; Tsai HY, 2011, PROG NEURO-PSYCHOPH, V35, P107, DOI 10.1016/j.pnpbp.2010.09.014; WOLINSKY E, 1983, J NEUROSCI, V3, P1495; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158847	10.1371/journal.pone.0158847	http://dx.doi.org/10.1371/journal.pone.0158847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428306	Green Published, gold			2022-12-26	WOS:000380169300022
J	Hu, G; Feeley, KJ; Yu, MJ				Hu, Guang; Feeley, Kenneth J.; Yu, Mingjian			Habitat Fragmentation Drives Plant Community Assembly Processes across Life Stages	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; SPECIES-DIVERSITY; COEXISTENCE; RICHNESS; PATTERNS; ISLANDS; EVOLUTIONARY; MECHANISMS; DISPERSAL; MORTALITY	Habitat fragmentation is one of the principal causes of biodiversity loss and hence understanding its impacts on community assembly and disassembly is an important topic in ecology. We studied the relationships between fragmentation and community assembly processes in the land-bridge island system of Thousand Island Lake in East China. We focused on the changes in species diversity and phylogenetic diversity that occurred between life stages of woody plants growing on these islands. The observed diversities were compared with the expected diversities from random null models to characterize assembly processes. Regression tree analysis was used to illustrate the relationships between island attributes and community assembly processes. We found that different assembly processes predominate in the seedlings-to-saplings life-stage transition (SS) vs. the saplings-to-trees transition (ST). Island area was the main attribute driving the assembly process in SS. In ST, island isolation was more important. Within a fragmented landscape, the factors driving community assembly processes were found to differ between life stage transitions. Environmental filtering had a strong effect on the seedlings-to-saplings life-stage transition. Habitat isolation and dispersal limitation influenced all plant life stages, but had a weaker effect on communities than area. These findings add to our understanding of the processes driving community assembly and species coexistence in the context of pervasive and widespread habitat loss and fragmentation.	[Hu, Guang; Yu, Mingjian] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Guang] Zhejiang Sci Tech Univ, Sch Civil Engn & Architecture, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China; [Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL USA; [Feeley, Kenneth J.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA	Zhejiang University; Zhejiang Sci-Tech University; State University System of Florida; Florida International University	Yu, MJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Hu, Guang/AAF-1689-2020	Feeley, Kenneth/0000-0002-3618-1144	National Natural Science Foundation of China [31361123001, 31200413, 31210103908]; China Postdoctoral Science Foundation [2012M521162]; National Science Foundation [DEB-1342751, DEB-1342757]; Zhejiang Postdoctoral Science Foundation [Bsh1201034]; Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Science Foundation of Zhejiang Sci-Tech University [13052168-Y]; 521 Talent Project of Zhejiang Sci-Tech University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF)); Zhejiang Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Science Foundation of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); 521 Talent Project of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University)	This work was funded by the National Natural Science Foundation of China (31361123001, 31200413, 31210103908), http://www.nsfc.gov.cn; the China Postdoctoral Science Foundation (2012M521162), http://www.chinapostdoctor.org.cn; the National Science Foundation (DEB-1342751, DEB-1342757), http://www.nsf.gov; the Zhejiang Postdoctoral Science Foundation (Bsh1201034), http://www.zjhrss.gov.cn; the Open Fund of Zhejiang Provincial Top Key Discipline of Biology (no grant number), http://sky.zstu.edu.cn/; the Science Foundation of Zhejiang Sci-Tech University (13052168-Y), http://www.zstu.edu.cn/; and the 521 Talent Project of Zhejiang Sci-Tech University (no grant number), http://www.zstu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Borges PAV, 2009, ACTA OECOL, V35, P149, DOI 10.1016/j.actao.2008.09.003; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Condit R., 1998, FIELD GUIDE LARGE FO; CONNELL J H, 1971, P298; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dodd ME, 1999, EVOLUTION, V53, P732, DOI [10.2307/2640713, 10.1111/j.1558-5646.1999.tb05367.x]; Editorial committee of development of Xin'an River Xin'an River Development Corporation., 2009, DEV XIN RIV; Editorial Committee of Flora of Zhejiang, 1993, FLOR ZHEJ; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043894; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kembel S. W., 2011, PICANTE R TOOLS INTE; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Levin S, 2009, PRINCETON GUIDE ECOL, P438; Lomolino MV, 2000, ECOLOGY, V81, P1517, DOI 10.2307/177303; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Luo ZR, 2012, OIKOS, V121, P1239, DOI 10.1111/j.1600-0706.2011.20079.x; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Nathan R, 2004, J ECOL, V92, P733, DOI 10.1111/j.0022-0477.2004.00914.x; Norden N, 2012, ECOLOGY, V93, pS70, DOI 10.1890/10-2179.1; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; Perdomo G, 2012, PHILOS T R SOC B, V367, P3042, DOI 10.1098/rstb.2012.0241; Pillon Y, 2006, BIOL CONSERV, V129, P4, DOI 10.1016/j.biocon.2005.06.036; Qian H, 2014, J SYST EVOL, V52, P423, DOI 10.1111/jse.12086; Regetz J, 2009, ECOPD ECOLOGICALLY I; RICKLEFS RE, 1992, AM NAT, V139, P1305, DOI 10.1086/285388; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Therneau T.M., 2011, RPART RECURSIVE PART; Tilman D., 1982, Monographs in Population Biology, pi; Wang YP, 2011, J BIOGEOGR, V38, P1330, DOI 10.1111/j.1365-2699.2011.02502.x; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang DS, 2009, HORTSCIENCE, V44, P1377, DOI 10.21273/HORTSCI.44.5.1377; Yeager LA, 2011, OECOLOGIA, V167, P157, DOI 10.1007/s00442-011-1959-3; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhen C, 2005, KEYS SEED PLANTS ZHE; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024	64	10	14	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159572	10.1371/journal.pone.0159572	http://dx.doi.org/10.1371/journal.pone.0159572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427960	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300077
J	Wen, YP; Pu, XY; Zheng, W; Hu, G				Wen, Yanping; Pu, Xiaoying; Zheng, Wei; Hu, Guang			High Prevalence of Plasmid-Mediated Quinolone Resistance and IncQ Plasmids Carrying qnrS2 Gene in Bacteria from Rivers near Hospitals and Aquaculture in China	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; AEROMONAS SPP.; WASTE-WATER; KLEBSIELLA-PNEUMONIAE; BETA-LACTAMASES; DETERMINANTS; FISH	Effluents from hospital and aquaculture are considered important sources of quinolone resistance. However, little information is available on the impact of this effluent on nearby rivers. In this study, 188 ciprofloxacin-resistant bacterial isolates obtained from rivers near hospitals and aquaculture were screened for plasmid-mediated quinolone resistance (PMQR) genes. Species identification, antibiotic susceptibility testing, and PMQR gene transferability assessment were conducted for PMQR-positive bacteria. Representative qnrS2-encoding plasmids were subsequently sequenced using a primer-walking approach. In total, 44 isolates (23.4%) were positive for qnr genes (16 qnrB2, 3 qnrS1, and 25 qnrS2) and 32 isolates (17.0%) were positive for aac(60)-Ib-cr. Other PMQR genes were not detected. The qnrB2 and aac(60)-Ib-cr genes had a higher prevalence in aquaculture samples than in hospital samples, and were significantly associated with Enterobacteriaceae (p < 0.05). In contrast, the prevalence of qnrS2 was not site-related, but was significantly associated with Aeromonas spp. (p < 0.05). All PMQR isolates were resistant to three or more classes of antibiotics. Eleven qnrS2-harboring plasmids from Aeromonas spp., including a novel conjugative plasmid pHP18, were selected for sequencing. These plasmids were small in size (6,388-16,197 bp) and belonged to the IncQ or IncU plasmid family, with qnrS2 being part of a mobile insertion cassette. Taken together, our findings suggest that aquaculture is a possible source for aac(60)-Ib-cr and qnrB2 dissemination, and demonstrate the ubiquity of qnrS2 in aquatic environments. Finally, Aeromonas spp. served as vectors for qnrS2 with the help of IncQ-type plasmids.	[Wen, Yanping; Pu, Xiaoying; Zheng, Wei] Hangzhou Ctr Dis Control & Prevent, Microbiol Lab, Hangzhou, Zhejiang, Peoples R China; [Hu, Guang] Zhejiang Sci Tech Univ, Sch Civil Engn & Architecture, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Hu, G (corresponding author), Zhejiang Sci Tech Univ, Sch Civil Engn & Architecture, Dept Landscape Architecture, Hangzhou, Zhejiang, Peoples R China.	hug163@163.com	Hu, Guang/AAF-1689-2020	Hu, Guang/0000-0002-4390-6166	Hangzhou Municipal Bureau of Science and Technology [20140733Q01]; Health and Family Planning Commission of Zhejiang Province [2015KYA190]; Science Foundation of Zhejiang Sci-Tech University [13052168-Y]; 521 Talent Project of Zhejiang Sci-Tech University	Hangzhou Municipal Bureau of Science and Technology; Health and Family Planning Commission of Zhejiang Province; Science Foundation of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); 521 Talent Project of Zhejiang Sci-Tech University(Zhejiang Sci-Tech University)	This work was supported by Hangzhou Municipal Bureau of Science and Technology (no. 20140733Q01, http://www.hzst.gov.cn/) and the Health and Family Planning Commission of Zhejiang Province (no. 2015KYA190, http://www.zjwst.gov.cn/). Yanping Wen received the funding mentioned above. Science Foundation of Zhejiang Sci-Tech University (no. 13052168-Y, http://www.zstu.edu.cn), 521 Talent Project of Zhejiang Sci-Tech University (http://www.zstu.edu.cn). Guang Hu received the funding mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P47, DOI 10.1093/jac/dkr457; Alouache S, 2014, MICROB DRUG RESIST, V20, P30, DOI 10.1089/mdr.2012.0264; Bonemann G, 2006, ANTIMICROB AGENTS CH, V50, P3075, DOI 10.1128/AAC.00378-06; Briales A, 2012, INT J ANTIMICROB AG, V39, P431, DOI 10.1016/j.ijantimicag.2011.12.009; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; Chandran SP, 2014, J APPL MICROBIOL, V117, P984, DOI 10.1111/jam.12591; Chen X, 2012, ANTIMICROB AGENTS CH, V56, P3423, DOI 10.1128/AAC.06191-11; Chenia HY, 2016, INT J FOOD MICROBIOL, V231, P26, DOI 10.1016/j.ijfoodmicro.2016.04.030; Cisar CR, 2014, WATER ENVIRON RES, V86, P835, DOI 10.2175/106143014X14062131177917; Devarajan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149211; Dobiasova H, 2016, ANTIMICROB AGENTS CH, V60, P653, DOI 10.1128/AAC.01773-15; Figueira V, 2011, WATER RES, V45, P5599, DOI 10.1016/j.watres.2011.08.021; Fortini D, 2011, J ANTIMICROB CHEMOTH, V66, P1269, DOI 10.1093/jac/dkr085; Galvin S, 2010, APPL ENVIRON MICROB, V76, P4772, DOI 10.1128/AEM.02898-09; Han JE, 2012, LETT APPL MICROBIOL, V55, P290, DOI 10.1111/j.1472-765X.2012.03293.x; Han JE, 2012, LETT APPL MICROBIOL, V54, P374, DOI 10.1111/j.1472-765X.2012.03208.x; Harnisz M, 2015, CHEMOSPHERE, V128, P134, DOI 10.1016/j.chemosphere.2015.01.035; Heuer OE, 2009, CLIN INFECT DIS, V49, P1248, DOI 10.1086/605667; Huddleston JR, 2013, SYST APPL MICROBIOL, V36, P224, DOI 10.1016/j.syapm.2013.01.004; Ishida Y, 2010, J VET MED SCI, V72, P727, DOI 10.1292/jvms.09-0538; Ito H, 2004, PLASMID, V51, P41, DOI 10.1016/j.plasmid.2003.10.001; Jacoby GA, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.PLAS-0006-2013, 10.1128/microbiolspec.PLAS-0006.2013]; Jiang HX, 2012, J ANTIMICROB CHEMOTH, V67, P2350, DOI 10.1093/jac/dks250; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Kulinska A, 2008, APPL ENVIRON MICROB, V74, P4119, DOI 10.1128/AEM.00229-08; Liu BT, 2011, J ANTIMICROB CHEMOTH, V66, P1638, DOI 10.1093/jac/dkr172; Loftie-Eaton W, 2012, PLASMID, V67, P15, DOI 10.1016/j.plasmid.2011.10.001; Loftie-Eaton W, 2010, J BACTERIOL, V192, P6182, DOI 10.1128/JB.00176-10; Majumdar T, 2011, PLASMID, V66, P79, DOI 10.1016/j.plasmid.2011.05.001; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; Naas T, 2013, J ANTIMICROB CHEMOTH, V68, P1757, DOI 10.1093/jac/dkt094; Pablos M, 2010, EUR J CLIN MICROBIOL, V29, P1163, DOI 10.1007/s10096-010-0982-3; Picao RC, 2013, DIAGN MICR INFEC DIS, V76, P80, DOI 10.1016/j.diagmicrobio.2013.02.001; Pico RC, 2008, J ANTIMICROB CHEMOTH, V62, P948, DOI 10.1093/jac/dkn341; Poirel L, 2005, J ANTIMICROB CHEMOTH, V56, P1118, DOI 10.1093/jac/dki371; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Poirel L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00024; Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021; Sanchez-Cespedes J, 2008, ANTIMICROB AGENTS CH, V52, P2990, DOI 10.1128/AAC.00287-08; Seo MR, 2010, CHEMOTHERAPY, V56, P46, DOI 10.1159/000290972; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tello A, 2012, ENVIRON HEALTH PERSP, V120, P1100, DOI 10.1289/ehp.1104650; Varela AR, 2016, SCI TOTAL ENVIRON, V542, P665, DOI 10.1016/j.scitotenv.2015.10.124; Varela AR, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv015; Vredenburg J, 2014, ENVIRON MICROBIOL, V16, P995, DOI 10.1111/1462-2920.12231; Xia RR, 2013, MICROB DRUG RESIST, V19, P446, DOI 10.1089/mdr.2012.0210; Yang HY, 2013, INT J ANTIMICROB AG, V42, P173, DOI 10.1016/j.ijantimicag.2013.04.026; Zhang R, 2012, MICROBES ENVIRON, V27, P158, DOI 10.1264/jsme2.ME11308; Zhao JY, 2012, MICROB ECOL, V64, P187, DOI 10.1007/s00248-012-0008-z	51	27	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159418	10.1371/journal.pone.0159418	http://dx.doi.org/10.1371/journal.pone.0159418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427763	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300064
J	Thomas, M; Lemaitre, M; Wilson, ML; Viboud, C; Yordanov, Y; Wackernagel, H; Carrat, F				Thomas, Maud; Lemaitre, Magali; Wilson, Mark L.; Viboud, Cecile; Yordanov, Youri; Wackernagel, Hans; Carrat, Fabrice			Applications of Extreme Value Theory in Public Health	PLOS ONE			English	Article								Objectives We present how Extreme Value Theory (EVT) can be used in public health to predict future extreme events. Methods We applied EVT to weekly rates of Pneumonia and Influenza (P&I) deaths over 1979-2011. We further explored the daily number of emergency department visits in a network of 37 hospitals over 2004-2014. Maxima of grouped consecutive observations were fitted to a generalized extreme value distribution. The distribution was used to estimate the probability of extreme values in specified time periods. Results An annual P&I death rate of 12 per 100,000 (the highest maximum observed) should be exceeded once over the next 30 years and each year, there should be a 3% risk that the P&I death rate will exceed this value. Over the past 10 years, the observed maximum increase in the daily number of visits from the same weekday between two consecutive weeks was 1133. We estimated at 0.37% the probability of exceeding a daily increase of 1000 on each month. Conclusion The EVT method can be applied to various topics in epidemiology thus contributing to public health planning for extreme events.	[Thomas, Maud] Chalmers Univ Technol Goteborg, Dept Math Stat, Gothenburg, Sweden; [Lemaitre, Magali; Carrat, Fabrice] Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMR S 11, F-75012 Paris, France; [Lemaitre, Magali; Viboud, Cecile] NIH, Fogarty Int Ctr, Washington, DC USA; [Wilson, Mark L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Yordanov, Youri] Hop St Antoine, AP HP, Serv Urgences, Paris, France; [Wackernagel, Hans] PSL Res Univ, MINES ParisTech, Geostat Grp, Ctr Geosci, Fontainebleau, France; [Carrat, Fabrice] St Antoine Hosp, AP HP, Publ Hlth Unit, F-75012 Paris, France	Chalmers University of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Carrat, F (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, Inst Pierre Louis Epidemiol & Sante Publ,UMR S 11, F-75012 Paris, France.; Carrat, F (corresponding author), St Antoine Hosp, AP HP, Publ Hlth Unit, F-75012 Paris, France.	fabrice.carrat@iplesp.upmc.fr	Carrat, Fabrice/AAU-8480-2020	Carrat, Fabrice/0000-0002-8672-7918; Thomas, Maud/0000-0003-1369-055X				Chen JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118521; Coles S., 2001, INTRO STAT MODELING; de Haan L., 1990, STAT NEERL, V44, P45, DOI 10.1111j.1467-9574.1990.tb01526.x////; Embrechts P., 1997, MODELLING EXTREMAL E, DOI 10.1007/978-3-642-33483-2; Guillou A, 2014, STAT MED, V33, P5015, DOI 10.1002/sim.6275; Josseran L, 2006, Euro Surveill, V11, P11, DOI 10.2807/esm.11.12.00668-en; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; Khan AS, 2014, LANCET, V384, P93, DOI 10.1016/S0140-6736(14)60260-9; Lee H. C., 2007, EXTREME VALUES ANAL; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944	10	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159312	10.1371/journal.pone.0159312	http://dx.doi.org/10.1371/journal.pone.0159312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR1JR	27419853	Green Published, Green Submitted, gold			2022-12-26	WOS:000379662300011
J	Al Dhaheri, AS; Mohamad, MN; Jarrar, AH; Ohuma, EO; Ismail, LC; Al Meqbaali, FT; Souka, U; Shah, SM				Al Dhaheri, Ayesha S.; Mohamad, Maysm N.; Jarrar, Amjad H.; Ohuma, Eric O.; Ismail, Leila Cheikh; Al Meqbaali, Fatima T.; Souka, Usama; Shah, Syed M.			A Cross-Sectional Study of the Prevalence of Metabolic Syndrome among Young Female Emirati Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OBESITY; DIETARY; DISEASE; GENDER; FAT	Introduction Metabolic syndrome (MetS) is a growing problem in the United Arab Emirates (UAE). Moreover, the prevalence of overweight and obesity is rapidly increasing in the UAE especially among young females. However, few studies have evaluated the prevalence of MetS among young female adults in the UAE. This study determined the prevalence of MetS in Emirati females aged 17-25 years and its relation to overweight and obesity. Methods In total, 555 Emirati female college students were enrolled in a cross-sectional study, conducted during 2013-2014 at United Arab Emirates University in Al Ain, UAE. Anthropometric measurements, blood pressure and biochemical measurements were collected. MetS was defined according to the harmonised International Diabetes Federation criteria. Results Of the 555 participants enrolled, 23.1% were overweight and 10.4% were classified as obese. The overall prevalence of MetS was 6.8%. MetS prevalence was highest among obese participants (34.5%), as compared with normal-weight (1.7%) and overweight (10.1%) participants. MetS was significantly associated with overweight (adjusted odds ratio [aOR] = 3.8, 95% confidence interval [CI]; 1.15-12.52) and obesity (aOR = 11.2, 95% CI; 3.1-40.9), as compared with normal-weight. Waist-hip ratio >= 0.8 (aOR = 3.04, 95% CI; 1.10-8.44) was significantly associated with MetS, as compared with waist-hip ratio <0.8. The odds of MetS were 22 fold higher in participants with glycated haemoglobin (HbA1c) >= 6.5% (aOR = 22.5, 95% CI; 6.37-79.42) compared to HbA1c < 6.5%. This difference was 9 fold higher when HbA1c between 5.6%-6.4% was compared to HbA1c < 5.6% (aOR = 8.9, 95% CI; 3.4-23.5). Conclusion The prevalence of MetS among obese Emirati female students was significantly higher than overweight and normal weight students. The high prevalence of MetS highlights the importance of regular screening and intervention programmes targeting weight reduction.	[Al Dhaheri, Ayesha S.; Mohamad, Maysm N.; Jarrar, Amjad H.; Al Meqbaali, Fatima T.; Souka, Usama] United Arab Emirates Univ, Coll Food & Agr, Nutr & Hlth Dept, Al Ain, U Arab Emirates; [Ohuma, Eric O.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Ohuma, Eric O.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Ismail, Leila Cheikh] Univ Oxford, Green Templeton Coll, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Ismail, Leila Cheikh] Univ Oxford, Green Templeton Coll, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Shah, Syed M.] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates	United Arab Emirates University; University of Oxford; University of Oxford; University of Oxford; University of Oxford; United Arab Emirates University	Al Dhaheri, AS (corresponding author), United Arab Emirates Univ, Coll Food & Agr, Nutr & Hlth Dept, Al Ain, U Arab Emirates.	ayesha_aldhaheri@uaeu.ac.ae	Mohamad, Maysm N./AAG-4203-2020; Mohamad, Maysm/W-4573-2019	Mohamad, Maysm N./0000-0002-6396-6625; Jarrar, Amjad/0000-0001-7185-6330; AL DHAHERI, AYESHA/0000-0002-7634-3531; Cheikh Ismail, Leila/0000-0003-3048-7481	United Arab Emirates University [CFA-31F038]	United Arab Emirates University	This study was supported by a research start-up grant from the United Arab Emirates University (CFA-31F038) and was given to ASA. The funding agent had no role with the study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.uaeu.ac.ae/en/; This study was supported by a research start-up grant from the United Arab Emirates University (CFA-31F038). The authors wish to thank Ms. Rahla Daneshi, Mr. Noura Alneyadi, Ms. Sara Alyousefi, Ms. Abeer Alwahedi, Ms. Moza Alkaabi, Ms. Haneen Ateya and Mr. Asma Numan for their help in recruiting study participants. We thank all UAEU female students who participated in this study.	Abolfotouh MA, 2012, INTERNATIONAL JOURNA, V2012; Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042; Al-Daghri NM, 2010, EUR J CLIN INVEST, V40, P1063, DOI 10.1111/j.1365-2362.2010.02341.x; Al-Daghri NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012159; Al-Isa A, 2010, BRIT J NUTR, V103, P77, DOI 10.1017/S0007114509991425; Al-Kaabi Juma, 2009, Rev Diabet Stud, V6, P271, DOI 10.1900/RDS.2009.6.271; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alharbi NS, 2014, DIABETES RES CLIN PR, V106, pE30, DOI 10.1016/j.diabres.2014.08.019; ALNohair S, 2014, INT J HEALTH SCI-IJH, V8, P79, DOI 10.12816/0006074; Aounallah-Skhiri H, 2015, OBESITY FACTS S1, V8; Bhalavi Vijay, 2015, Indian J Community Med, V40, P43, DOI 10.4103/0970-0218.149270; Bowling JL, 2010, LABMEDICINE, V41, P398, DOI 10.1309/LM6T8D1LKQXVNCAC; de Freitas RWF, 2013, J CLIN NURS, V22, P1291, DOI 10.1111/jocn.12015; de Vries P.G., 1986, SAMPLING THEORY FORE, P31, DOI DOI 10.1007/978-3-642-71581-5_2; DIMAGNO EP, 1989, MAYO CLIN PROC, V64, P1226, DOI 10.1016/S0025-6196(12)61285-3; dong-il Kim, 2012, Journal of Obesity & Metabolic Syndrome, V21, P99, DOI 10.7570/kjo.2012.21.2.99; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Eapen V, 2010, J TROP PEDIATRICS, V56, P325, DOI 10.1093/tropej/fmp128; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Elmagd MA, 2015, INT J PHYS ED SPORTS, V2, P92; Fernandes J, 2011, J AM COLL HEALTH, V59, P313, DOI 10.1080/07448481.2010.508084; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P233; Gonzalez-Jimenez E, 2015, EUR J NUTR, V54, P589, DOI 10.1007/s00394-014-0740-x; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Hamer M, 2014, MED SCI SPORT EXER, V46, P1946, DOI 10.1249/MSS.0000000000000317; Jain J, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000503; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; LOHMAN TG, 1981, HUM BIOL, V53, P181; Mabry RM, 2010, DIABETIC MED, V27, P593, DOI 10.1111/j.1464-5491.2010.02998.x; Malik Mahdi, 2008, Metabolic Syndrome and Related Disorders, V6, P177, DOI 10.1089/met.2008.0006; Mehairi AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056159; Musaiger AO, 2014, ENVIRON HEALTH PREV, V19, P207, DOI 10.1007/s12199-013-0377-z; Musaiger AO, 2014, APPETITE, V73, P197, DOI 10.1016/j.appet.2013.11.002; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Organization WH, 2011, WAIST CIRCUMFERENCE; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Selmi S, 2015, AVICENNA, DOI 10.5339/avi.2015.2; Smitha F, 2011, INDIAN J PHARM PRACT, V4; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Subhedar R, 2014, INT J PHYSIOTHER RES, V2, P824, DOI DOI 10.16965/IJPR.2014.700; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Xu YQ, 2008, ACTA PAEDIATR, V97, P348, DOI 10.1111/j.1651-2227.2008.00665.x	46	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159378	10.1371/journal.pone.0159378	http://dx.doi.org/10.1371/journal.pone.0159378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414402	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500124
J	Brown, JL; Paris, S; Prado-Oviedo, NA; Meehan, CL; Hogan, JN; Morfeld, KA; Carlstead, K				Brown, Janine L.; Paris, Stephen; Prado-Oviedo, Natalia A.; Meehan, Cheryl L.; Hogan, Jennifer N.; Morfeld, Kari A.; Carlstead, Kathy			Reproductive Health Assessment of Female Elephants in North American Zoos and Association of Husbandry Practices with Reproductive Dysfunction in African Elephants (Loxodonta africana)	PLOS ONE			English	Article							POSTREPRODUCTIVE LIFE-SPAN; OVARIAN ACYCLICITY; ESTROUS-CYCLE; ENVIRONMENTAL ENRICHMENT; ASIAN ELEPHANTS; SOCIAL BONDS; HYPERPROLACTINEMIA; PROLACTIN; VARIABILITY; MAXIMUS	As part of a multi-institutional study of zoo elephant welfare, we evaluated female elephants managed by zoos accredited by the Association of Zoos and Aquariums and applied epidemiological methods to determine what factors in the zoo environment are associated with reproductive problems, including ovarian acyclicity and hyperprolactinemia. Bi-weekly blood samples were collected from 95 African (Loxodonta africana) and 75 Asian (Elephas maximus) (8-55 years of age) elephants over a 12-month period for analysis of serum progestogens and prolactin. Females were categorized as normal cycling (regular 13- to 17-week cycles), irregular cycling (cycles longer or shorter than normal) or acyclic (baseline progestogens, < 0.1 ng/ml throughout), and having Low/Normal (< 14 or 18 ng/ml) or High (>= 14 or 18 ng/ml) prolactin for Asian and African elephants, respectively. Rates of normal cycling, acyclicity and irregular cycling were 73.2, 22.5 and 4.2% for Asian, and 48.4, 37.9 and 13.7% for African elephants, respectively, all of which differed between species (P < 0.05). For African elephants, univariate assessment found that social isolation decreased and higher enrichment diversity increased the chance a female would cycle normally. The strongest multi-variable models included Age (positive) and Enrichment Diversity (negative) as important factors of acyclicity among African elephants. The Asian elephant data set was not robust enough to support multi-variable analyses of cyclicity status. Additionally, only 3% of Asian elephants were found to be hyperprolactinemic as compared to 28% of Africans, so predictive analyses of prolactin status were conducted on African elephants only. The strongest multi-variable model included Age (positive), Enrichment Diversity (negative), Alternate Feeding Methods (negative) and Social Group Contact (positive) as predictors of hyperprolactinemia. In summary, the incidence of ovarian cycle problems and hyperprolactinemia predominantly affects African elephants, and increases in social stability and feeding and enrichment diversity may have positive influences on hormone status.	[Brown, Janine L.; Paris, Stephen; Prado-Oviedo, Natalia A.; Morfeld, Kari A.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Morfeld, Kari A.] Lincoln Childrens Zoo, Lincoln, NE USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Brown, JL (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.	brownjan@si.edu			Institute of Museum and Library Services [LG-25-10-0033-10]; Smithsonian National Zoological Park; Lincoln Children's Zoo; Honolulu Zoo; IMLS; AWARE Institute	Institute of Museum and Library Services; Smithsonian National Zoological Park(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Lincoln Children's Zoo; Honolulu Zoo; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park (JLB, SP, NP-O, KM); Lincoln Children's Zoo (KM); Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2003, P R SOC LOND, V273, P513; ARON DC, 1995, WESTERN J MED, V162, P340; ASSIES J, 1992, PSYCHONEUROENDOCRINO, V17, P673, DOI 10.1016/0306-4530(92)90026-4; Bachelot A, 2007, REPRODUCTION, V133, P361, DOI 10.1530/REP-06-0299; Birkett PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038363; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Brown JL, 1997, ZOO BIOL, V16, P149, DOI 10.1002/(SICI)1098-2361(1997)16:2<149::AID-ZOO5>3.0.CO;2-A; Brown JL, 1999, BIOL REPROD, V61, P1294, DOI 10.1095/biolreprod61.5.1294; BROWN JL, 1991, J ZOO WILDLIFE MED, V22, P49; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 1995, ZOO BIOL, V14, P555, DOI 10.1002/zoo.1430140608; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Cacioppo JT, 2011, ANN NY ACAD SCI, V1231, P17, DOI 10.1111/j.1749-6632.2011.06028.x; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Capitanio JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110307; Capitanio JP, 2011, AM J PRIMATOL, V73, P507, DOI 10.1002/ajp.20870; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chelini MOM, 2011, PHYSIOL BEHAV, V104, P948, DOI 10.1016/j.physbeh.2011.06.006; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; Cohen J., 2003, APPL MULTIPLE REGRES; Deis RP, 1989, J ENDOCRINOL, V110, P423; Dow TL, 2012, REPROD FERT DEVELOP, V24, P1019, DOI 10.1071/RD11302; Dow TL, 2011, ZOO BIOL, V30, P699, DOI 10.1002/zoo.20377; Dow TL, 2011, THERIOGENOLOGY, V75, P620, DOI 10.1016/j.theriogenology.2010.10.002; DRENT RH, 1980, ARDEA, V68, P225; Fanson KV, 2013, ANIM WELFARE, V22, P159, DOI 10.7120/09627286.22.2.159; Faust L., 2011, TECHNICAL REPORT ZOO; Fraser D, 2003, ANIM WELFARE, V12, P433; Frasor J, 2003, TRENDS ENDOCRIN MET, V14, P118, DOI 10.1016/S1043-2760(03)00030-4; Freeman EW, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot025; Freeman EW, 2011, BIOL CONSERV, V144, P2105, DOI 10.1016/j.biocon.2011.04.033; Freeman EW, 2009, AFR J ECOL, V47, P192, DOI 10.1111/j.1365-2028.2008.00957.x; Freeman EW, 2009, ZOO BIOL, V28, P1, DOI 10.1002/zoo.20187; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Garstang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108736; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; Glaeser SS, 2012, THERIOGENOLOGY, V78, P285, DOI 10.1016/j.theriogenology.2012.01.014; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; GOSDEN RG, 1987, HUM REPROD, V2, P617, DOI 10.1093/oxfordjournals.humrep.a136601; Gouveia A, 2004, BEHAV PROCESS, V67, P167, DOI 10.1016/j.beproc.2004.03.018; Greco BJ, 2016, PLOS ONE; Grynnerup AGA, 2012, ACTA OBSTET GYN SCAN, V91, P1252, DOI 10.1111/j.1600-0412.2012.01471.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Lahdenpera M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0054-0; Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5; Matteri RL, 2000, BIOLOGY OF ANIMAL STRESS, P43, DOI 10.1079/9780851993591.0043; Meagher RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110589; Meehan CL, 2016, PLOS ONE; Mellen J, 2005, ZOO BIOL, V10, P95; Mellen J.D., 1998, 2 NATURE ENV ENRICHM, P329; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Morfeld KA, 2014, J ZOO WILDLIFE MED, V45, P569, DOI 10.1638/2013-0254R.1; Mouttham LL, 2011, ANIM REPROD SCI, V126, P115, DOI 10.1016/j.anireprosci.2011.04.006; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Nimon AJ, 2001, ANIM WELFARE, V10, P223; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; PIANKA ER, 1976, AM ZOOL, V16, P775; Prado-Oviedo NA, 2016, PLOS ONE; Prado-Oviedo NA, 2013, GEN COMP ENDOCR, V189, P7, DOI 10.1016/j.ygcen.2013.03.035; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Rico C, 2009, BIOL REPROD, V80, P50, DOI 10.1095/biolreprod.108.072157; Roelfsema F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031305; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Serri O, 2003, CAN MED ASSOC J, V169, P575; Shepherdson D., 1994, P167; Shepherdson D.J., 1999, J ELEPHANT MANAGERS, V10, P69; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; SOBRINHO LG, 1984, OBSTET GYNECOL, V64, P465; Sobrinho Luis Goncalves, 2003, Pituitary, V6, P35, DOI 10.1023/A:1026229810876; Sonino N, 2004, EUR J ENDOCRINOL, V151, P61, DOI 10.1530/eje.0.1510061; Stansfield FJ, 2013, REPROD FERT DEVELOP, V25, P1165, DOI 10.1071/RD12296; Stoinski TS, 2000, ZOO BIOL, V19, P485, DOI 10.1002/1098-2361(2000)19:6&lt;485::AID-ZOO1&gt;3.0.CO;2-5; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; Torre Daria La, 2007, Ther Clin Risk Manag, V3, P929; Vance EA, 2009, COMPUT MATH ORGAN TH, V15, P273, DOI 10.1007/s10588-008-9045-z; Wang C., 1981, DYNAMICS OVARIAN FUN, P61; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Wiedenmayer C, 1998, APPL ANIM BEHAV SCI, V56, P77, DOI 10.1016/S0168-1591(97)00091-9; Wielebnowski N, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P130; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Wittemyer G, 2007, HORM BEHAV, V51, P346, DOI 10.1016/j.yhbeh.2006.12.013; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Yamamoto Y, 2010, J VET MED SCI, V72, P845, DOI 10.1292/jvms.09-0480; YUEN BH, 1992, CAN FAM PHYSICIAN, V38, P367; Zacur H.A., 1999, ENCY REPROD, V2, P725	92	35	37	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0145673	10.1371/journal.pone.0145673	http://dx.doi.org/10.1371/journal.pone.0145673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416141	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500002
J	Darzi, Y; Jiao, YZ; Hasegawa, M; Moon, H; Nunez, G; Inohara, N; Raes, J				Darzi, Youssef; Jiao, Yizu; Hasegawa, Mizuho; Moon, Henry; Nunez, Gabriel; Inohara, Naohiro; Raes, Jeroen			The Genomic Sequence of the Oral Pathobiont Strain NI1060 Reveals Unique Strategies for Bacterial Competition and Pathogenicity	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE RD; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; NOD1; PEPTIDOGLYCAN; ALGORITHM; GROWTH; INDUCTION; VIRULENCE; ISLAND; GENES	Strain NI1060 is an oral bacterium responsible for periodontitis in a murine ligature-induced disease model. To better understand its pathogenicity, we have determined the complete sequence of its 2,553,982 bp genome. Although closely related to Pasteurella pneumotropica, a pneumonia-associated rodent commensal based on its 16S rRNA, the NI1060 genomic content suggests that they are different species thriving on different energy sources via alternative metabolic pathways. Genomic and phylogenetic analyses showed that strain NI1060 is distinct from the genera currently described in the family Pasteurellaceae, and is likely to represent a novel species. In addition, we found putative virulence genes involved in lipooligosaccharide synthesis, adhesins and bacteriotoxic proteins. These genes are potentially important for host adaption and for the induction of dysbiosis through bacterial competition and pathogenicity. Importantly, strain NI1060 strongly stimulates Nod1, an innate immune receptor, but is defective in two peptidoglycan recycling genes due to a frameshift mutation. The in-depth analysis of its genome thus provides critical insights for the development of NI1060 as a prime model system for infectious disease.	[Darzi, Youssef; Raes, Jeroen] Vrije Univ Brussel, Microbiol Unit, Dept Bioengn Sci, Brussels, Belgium; [Darzi, Youssef; Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Darzi, Youssef; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium; [Jiao, Yizu; Hasegawa, Mizuho; Moon, Henry; Nunez, Gabriel; Inohara, Naohiro] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raes, J (corresponding author), Vrije Univ Brussel, Microbiol Unit, Dept Bioengn Sci, Brussels, Belgium.; Raes, J (corresponding author), VIB, Ctr Biol Dis, Leuven, Belgium.; Raes, J (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium.; Inohara, N (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	ino@umich.edu; jeroen.raes@med.kuleuven.be	Nuñez, Gabriel/A-7160-2014; raes, jeroen/D-7835-2018; Darzi, Youssef/I-8920-2019	raes, jeroen/0000-0002-1337-041X; Darzi, Youssef/0000-0001-7655-5764	Research Foundation Flanders (FWO); Flemish agency for Innovation by Science and Technology (IWT); KU Leuven; Rega Institute; NIH [R01DE018503]	Research Foundation Flanders (FWO)(FWO); Flemish agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven(KU Leuven); Rega Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Research Foundation Flanders (FWO) (JR); The Flemish agency for Innovation by Science and Technology (IWT) (JR); KU Leuven (JR); The Rega Institute (JR) and grant R01DE018503 from NIH (NI).	Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Bonazzi M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003087; Brenner DJ, 2006, BERGEYS MANUAL SYS B, V2, P851; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Di Bonaventura MP, 2010, MOL PHYLOGENET EVOL, V54, P950, DOI 10.1016/j.ympev.2009.08.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Gwinn ML, 1998, J BACTERIOL, V180, P746, DOI 10.1128/JB.180.3.746-748.1998; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; INZANA TJ, 1987, AM J VET RES, V48, P366; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kawai T, 2007, ORAL MICROBIOL IMMUN, V22, P208, DOI 10.1111/j.1399-302X.2007.00348.x; KLEIN RD, 1979, J GEN MICROBIOL, V113, P409, DOI 10.1099/00221287-113-2-409; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Marsh Philip D., 2000, Microbial Ecology in Health and Disease, V12, P130, DOI 10.1080/089106000750051800; Naushad HS, 2012, ANTON LEEUW INT J G, V101, P105, DOI 10.1007/s10482-011-9628-4; Nigro G, 2008, CELL MICROBIOL, V10, P682, DOI 10.1111/j.1462-5822.2007.01075.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Sasaki H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-55; Sasaki H, 2009, J BACTERIOL, V191, P3698, DOI 10.1128/JB.01527-08; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; VANHELLEMOND JJ, 1994, BIOCHEM J, V304, P321, DOI 10.1042/bj3040321; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wall Dennis P., 2007, V396, P95; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	63	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158866	10.1371/journal.pone.0158866	http://dx.doi.org/10.1371/journal.pone.0158866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409077	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300038
J	Sneddon, WB; Ruiz, GW; Gallo, LI; Xiao, KH; Zhang, QM; Rbaibi, Y; Weisz, OA; Apodaca, GL; Friedman, PA				Sneddon, W. Bruce; Ruiz, Giovanni W.; Gallo, Luciana I.; Xiao, Kunhong; Zhang, Qiangmin; Rbaibi, Youssef; Weisz, Ora A.; Apodaca, Gerard L.; Friedman, Peter A.			Convergent Signaling Pathways Regulate Parathyroid Hormone and Fibroblast Growth Factor-23 Action on NPT2A-mediated Phosphate Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PROXIMAL TUBULE; FACTOR RECEPTOR GENES; PROTEIN-KINASE-A; FGF-RECEPTOR; CALCIUM-TRANSPORT; I COTRANSPORTERS; DOWN-REGULATION; MDCK CELLS; PTH; ACTIVATION	Parathyroid hormone (PTH) and FGF23 are the primary hormones regulating acute phosphate homeostasis. Human renal proximal tubule cells (RPTECs) were used to characterize the mechanism and signaling pathways of PTH and FGF23 on phosphate transport and the role of the PDZ protein NHERF1 in mediating PTH and FGF23 effects. RPTECs express the NPT2A phosphate transporter, alpha Klotho, FGFR1, FGFR3, FGFR4, and the PTH receptor. GFGR1 isoforms are formed from alternate splicing of exon 3 and of exon 8 or 9 in Ir-like loop 3. Exon 3 was absent, but mRNA containing both exons 8 and 9 is present in cytoplasm. Using an FGFR1c-specific antibody together with mass spectrometry analysis, we show that RPTECs express FGFR-beta 1C. The data are consistent with regulated FGFR1 splicing involving a novel cytoplasmic mechanism. PTH and FGF23 inhibited phosphate transport in a concentration-dependent manner. At maximally effective concentrations, PTH and FGF23 equivalently decreased phosphate uptake and were not additive, suggesting a shared mechanism of action. Protein kinase A or C blockade prevented PTH but not FGF23 actions. Conversely, inhibiting SGK1, blocking FGFR dimerization, or knocking down Klotho expression disrupted FGF23 actions but did not interfere with PTH effects. C-terminal FGF23(180-251) competitively and selectively blocked FGF23 action without disrupting PTH effects. However, both PTH and FGF23-sensitive phosphate transport were abolished by NHERF1 shRNA knockdown. Extended treatment with PTH or FGF23 down-regulated NPT2A without affecting NHERF1. We conclude that FGFR1C and PTHR signaling pathways converge on NHERF1 to inhibit PTH- and FGF23-sensitive phosphate transport and down-regulate NPT2A.	[Sneddon, W. Bruce; Xiao, Kunhong; Zhang, Qiangmin; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Weisz, Ora A.; Apodaca, Gerard L.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Ruiz, Giovanni W.; Gallo, Luciana I.; Rbaibi, Youssef; Weisz, Ora A.; Apodaca, Gerard L.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1356 Thomas E Starzl Biomed Sci Tower, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Gallo, Luciana I/S-4451-2019; Apodaca, Gerard/HCJ-0048-2022; Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; Gallo, Luciana I./0000-0001-7050-0121	National Institutes of Health [DK069998, DK105811, DK101484, DK100357, P30 DK079307]; Imaging Core of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104287, P30DK079307, R01DK100357, R01DK105811, R01DK101484, R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Imaging Core of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK069998 and DK105811 (to P. A. F.), DK101484 and DK100357 (to O. A. W.), and P30 DK079307 (to G. A. and O. A. W.) and the Imaging Core of the Pittsburgh Center for Kidney Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amizuka N, 1997, ENDOCRINOLOGY, V138, P469, DOI 10.1210/en.138.1.469; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Belov AA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015958; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; BIBER J, 1990, METHOD ENZYMOL, V191, P494; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Buckley PT, 2014, WIRES RNA, V5, P223, DOI 10.1002/wrna.1203; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; COLE JA, 1987, AM J PHYSIOL, V253, pE221, DOI 10.1152/ajpendo.1987.253.2.E221; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Comps-Agrar L, 2015, J BIOL CHEM, V290, P24166, DOI 10.1074/jbc.M115.681395; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; Gattineni J, 2014, CURR OPIN PEDIATR, V26, P215, DOI 10.1097/MOP.0000000000000064; Gattineni J, 2014, AM J PHYSIOL-RENAL, V306, pF351, DOI 10.1152/ajprenal.00232.2013; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Gong SG, 2014, J CELL PHYSIOL, V229, P1887, DOI 10.1002/jcp.24649; Guo J, 2013, ENDOCRINOLOGY, V154, P1680, DOI 10.1210/en.2012-2240; Han XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147845; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lederer ED, 1998, AM J PHYSIOL-RENAL, V275, pF270, DOI 10.1152/ajprenal.1998.275.2.F270; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Lelliott CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112109; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; Mamonova T, 2012, BIOCHEMISTRY-US, V51, P3110, DOI 10.1021/bi201213w; Mistry N, 2003, RNA, V9, P209, DOI 10.1261/rna.2470903; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Murer H., 2008, SELDIN GIEBISCHS KID, P1979; Murer H, 2010, J NEPHROL, V23, pS145; Nagai S, 2011, J BIOL CHEM, V286, P1618, DOI 10.1074/jbc.M110.198416; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Paradis JS, 2015, P NATL ACAD SCI USA, V112, pE5160, DOI 10.1073/pnas.1508836112; Pfister MF, 1999, AM J PHYSIOL-RENAL, V276, pF720, DOI 10.1152/ajprenal.1999.276.5.F720; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Roidl A, 2010, ONCOGENE, V29, P1543, DOI 10.1038/onc.2009.432; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sneddon WB, 2007, AM J PHYSIOL-RENAL, V292, pF1028, DOI 10.1152/ajprenal.00288.2006; Sneddon WB, 2000, ENDOCRINOLOGY, V141, P4185, DOI 10.1210/en.141.11.4185; Takenaka T, 2016, J BONE MINER RES, V31, P455, DOI 10.1002/jbmr.2691; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF792, DOI 10.1152/ajprenal.2000.278.5.F792; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang EI, 2000, TRAFFIC, V1, P480, DOI 10.1034/j.1600-0854.2000.010606.x; Weinman EJ, 2012, AM J PHYSIOL-RENAL, V303, pF321, DOI 10.1152/ajprenal.00093.2012; Weinman EJ, 2012, EXP CELL RES, V318, P1027, DOI 10.1016/j.yexcr.2012.02.037; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	66	23	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18632	18642		10.1074/jbc.M116.744052	http://dx.doi.org/10.1074/jbc.M116.744052			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432882	Green Published, hybrid			2022-12-26	WOS:000383242300004
J	Ippolito, JE; Brandenburg, MW; Ge, X; Crowley, JR; Kirmess, KM; Som, A; D'Avignon, DA; Arbeit, JM; Achilefu, S; Yarasheski, KE; Milbrandt, J				Ippolito, Joseph E.; Brandenburg, Matthew W.; Ge, Xia; Crowley, Jan R.; Kirmess, Kristopher M.; Som, Avik; D'Avignon, D. Andre; Arbeit, Jeffrey M.; Achilefu, Samuel; Yarasheski, Kevin E.; Milbrandt, Jeffrey			Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BREAST-CANCER; ACIDIC PH; ACQUIRED-RESISTANCE; TUMOR-GROWTH; MICROENVIRONMENT; DIFFERENTIATION; EXPRESSION; METFORMIN; ONCOGENE	Neuroendocrine prostate cancer is a lethal variant of prostate cancer that is associated with castrate-resistant growth, metastasis, and mortality. The tumor environment of neuroendocrine prostate cancer is heterogeneous and characterized by hypoxia, necrosis, and numerous mitoses. Although acidic extracellular pH has been implicated in aggressive cancer features including metastasis and therapeutic resistance, its role in neuroendocrine prostate cancer physiology and metabolism has not yet been explored. We used the well-characterized PNEC cell line as a model to establish the effects of extracellular pH (pH 6.5, 7.4, and 8.5) on neuroendocrine prostate cancer cell metabolism. We discovered that alkalinization of extracellular pH converted cellular metabolism to a nutrient consumption-dependent state that was susceptible to glucose deprivation, glutamine deprivation, and 2-deoxyglucose (2-DG) mediated inhibition of glycolysis. Conversely, acidic pH shifted cellular metabolism toward an oxidative phosphorylation (OXPHOS)-dependent state that was susceptible to OXPHOS inhibition. Based upon this mechanistic knowledge of pH-dependent metabolism, we identified that the FDA-approved anti-helminthic niclosamide depolarized mitochondrial potential and depleted ATP levels in PNEC cells whose effects were enhanced in acidic pH. To further establish relevance of these findings, we tested the effects of extracellular pH on susceptibility to nutrient deprivation and OXPHOS inhibition in a cohort of castrate-resistant prostate cancer cell lines C4-2B, PC-3, and PC-3M. We discovered similar pH-dependent toxicity profiles among all cell lines with these treatments. These findings underscore a potential importance to acidic extracellular pH in the modulation of cell metabolism in tumors and development of an emerging paradigm that exploits the synergy of environment and therapeutic efficacy in cancer.	[Ippolito, Joseph E.; Brandenburg, Matthew W.; Ge, Xia; Som, Avik; Achilefu, Samuel] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Ippolito, Joseph E.; Brandenburg, Matthew W.; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Crowley, Jan R.; Kirmess, Kristopher M.; Yarasheski, Kevin E.] Washington Univ, Biomed Mass Spectrometry Resource, Sch Med, St Louis, MO 63130 USA; [D'Avignon, D. Andre] Sanford Burnham Prebys Med Discovery Inst, Orlando, FL USA; [Arbeit, Jeffrey M.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute; Washington University (WUSTL)	Ippolito, JE (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA.; Ippolito, JE (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	ippolitoj@wustl.edu	Yarasheski, Kevin/AAC-7450-2021; Achilefu, Samuel/AAC-2401-2019; Arbeit, Jeffrey/K-6920-2019	Yarasheski, Kevin/0000-0001-5436-2451; Achilefu, Samuel/0000-0002-3133-6717; Milbrandt, Jeffrey/0000-0002-5477-7689	Radiological Society of North America [RSD1345]; Prostate Cancer Foundation; NIH [P41-GM103422, P30-DK056341, P30-DK020579]; NATIONAL CANCER INSTITUTE [F30CA189435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579] Funding Source: NIH RePORTER	Radiological Society of North America; Prostate Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by a grant from the Radiological Society of North America (RSD1345; http://www.rsna.org), a Young Investigator Award from the Prostate Cancer Foundation (http://www.pcf.org), and NIH grants P41-GM103422, P30-DK056341, and P30-DK020579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Bental M, 1994, NMR PHYSL BIOMEDICIN; Blair H. C., 2007, V45, P539; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151718; Circu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146931; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLellis R A, 2001, Am J Clin Pathol, V115 Suppl, pS5; Denise C, 2015, ONCOTARGET, V6, P41706, DOI 10.18632/oncotarget.5991; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Epstein JI, 2014, AM J SURG PATHOL, V38, P756, DOI 10.1097/PAS.0000000000000208; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gillies Robert J, 2012, Eur J Radiol, V81 Suppl 1, pS48, DOI 10.1016/S0720-048X(12)70018-9; Goncalves RBR, 2002, MOL CELL BIOCHEM, V241, P69, DOI 10.1023/A:1020874626923; Hashim AI, 2011, CLIN EXP METASTAS, V28, P841, DOI 10.1007/s10585-011-9415-7; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Hu Y, 2004, P NATL ACAD SCI USA, V101, P5559, DOI 10.1073/pnas.0306988101; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Ippolito JE, 2005, P NATL ACAD SCI USA, V102, P9901, DOI 10.1073/pnas.0500756102; Ippolito JE, 2006, P NATL ACAD SCI USA, V103, P12505, DOI 10.1073/pnas.0605207103; Ippolito JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088667; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Ismail AHR, 2002, PROSTATE, V51, P117, DOI 10.1002/pros.10066; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976; Kennedy KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075154; Khacho M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4550; Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Leotlela PD, 2003, ENDOCR-RELAT CANCER, V10, P437, DOI 10.1677/erc.0.0100437; Li M, 2013, J BIOL CHEM, V288, P35769, DOI 10.1074/jbc.M113.511212; Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003; Li ZG, 2013, INT J MOL SCI, V14, P20236, DOI 10.3390/ijms141020236; Liu C, 2016, ONCOTARGET; Marini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep19569; Mark R, 2000, AM J CLIN PATHOL, V113, P331; Martin NK, 2011, MATH BIOSCI, V230, P1, DOI 10.1016/j.mbs.2010.12.002; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; Oliveras-Ferraros C, 2014, CELL CYCLE, V13, P1132, DOI 10.4161/cc.27982; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Robey IF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-235; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; ROSS MH, 1951, J BIOL CHEM, V192, P561; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Scherbakov AM, 2016, IUBMB LIFE, V68, P281, DOI 10.1002/iub.1481; Schornack PA, 2003, NEOPLASIA, V5, P135, DOI 10.1016/S1476-5586(03)80005-2; Som A, 2015, NANOSCALE; Som A, 2016, NANOSCALE, V8, P12639, DOI 10.1039/c5nr06162h; Taniguchi K, 2016, BIOCHEM BIOPH RES CO, V473, P174, DOI 10.1016/j.bbrc.2016.03.074; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tessem MB, 2008, MAGN RESON MED, V60, P510, DOI 10.1002/mrm.21694; Thews O, 2006, NEOPLASIA, V8, P143, DOI 10.1593/neo.05697; TISCHLER AS, 1977, NEW ENGL J MED, V296, P919; Vander Heiden MG, 1999, MOL CELL, V3, P159; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wafa LA, 2007, HUM PATHOL, V38, P161, DOI 10.1016/j.humpath.2006.07.003; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wick MR, 2000, AM J CLIN PATHOL, V113, P331, DOI 10.1309/ETJ3-QBUK-13QD-J8FP; WICK MR, 2002, CURR DIAGN PATHOL, V8, P102, DOI DOI 10.1054/CDIP.2001.0102; Wojtkowiak JW, 2012, AUTOPHAGY, V8, P1688, DOI 10.4161/auto.21501; Wojtkowiak JW, 2012, CANCER RES, V72, P3938, DOI 10.1158/0008-5472.CAN-11-3881; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Yao CH, 2016, CELL CHEM BIOL, V23, P483, DOI 10.1016/j.chembiol.2016.03.007; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043	78	29	29	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159675	10.1371/journal.pone.0159675	http://dx.doi.org/10.1371/journal.pone.0159675			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438712	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100064
J	Li, C; Chen, ZX; Yang, H; Luo, FB; Chen, LH; Cai, HW; Li, YJ; You, GY; Long, D; Li, SF; Zhang, QP; Rao, L				Li, Chen; Chen, Zhongxiu; Yang, Hao; Luo, Fangbo; Chen, Lihong; Cai, Huawei; Li, Yajiao; You, Guiying; Long, Dan; Li, Shengfu; Zhang, Qiuping; Rao, Li			Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway	PLOS ONE			English	Article							MEK INHIBITOR SELUMETINIB; LAMIN A/C GENE; PHASE-II; SIGNALING PATHWAYS; SKELETAL-MUSCLE; KINASE; ARRY-142886; MELANOMA; SURVIVAL; MUTATION	Aims Although extracellular-regulated kinases (ERK) are a well-known central mediator in cardiac hypertrophy, no clinically available ERK antagonist has been tested for preventing cardiac hypertrophy. Selumetinib is a novel oral MEK inhibitor that is currently under Phase II and Phase III clinical investigation for advanced solid tumors. In this study, we investigated whether Selumetinib could inhibit the aberrant ERK activation of the heart in response to stress as well as prevent cardiac hypertrophy. Methods and Results In an in vitro model of PE-induced cardiac hypertrophy, Selumetinib significantly inhibited the ERK activation and prevented enlargement of cardiomyocytes or reactivation of certain fetal genes. In the pathologic cardiac hypertrophy model of ascending aortic constriction, Selumetinib provided significant ERK inhibition in the stressed heart but not in the other organs. This selective ERK inhibition prevented left ventricular (LV) wall thickening, LV mass increase, fetal gene reactivation and cardiac fibrosis. In another distinct physiologic cardiac hypertrophy model of a swimming rat, Selumetinib provided a similar anti-hypertrophy effect, except that no significant fetal gene reactivation or cardiac fibrosis was observed. Conclusions Selumetinib, a novel oral anti-cancer drug with good safety records in a number of Phase II clinical trials, can inhibit ERK activity in the heart and prevent cardiac hypertrophy. These promising results indicate that Selumetinib could potentially be used to treat cardiac hypertrophy. However, this hypothesis needs to be validated in human clinical trials.	[Li, Chen; Chen, Zhongxiu; Yang, Hao; Li, Yajiao; You, Guiying; Rao, Li] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China; [Luo, Fangbo] Community Hlth Ctr Shuangnan Wuhou Dist, Dept Rehabil, Chengdu, Sichuan, Peoples R China; [Chen, Lihong] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu, Sichuan, Peoples R China; [Cai, Huawei] Sichuan Univ, West China Hosp, Dept Nucl Med, Chengdu, Sichuan, Peoples R China; [Long, Dan; Li, Shengfu] Sichuan Univ, West China Hosp, Key Lab Transplant Engn & Immunol, Chengdu, Sichuan, Peoples R China; [Zhang, Qiuping] Kings Coll London, British Heart Fdn, Cardiovasc Div, Ctr Res Excellence, London, England	Sichuan University; Sichuan University; Sichuan University; Sichuan University; University of London; King's College London; University College London	Rao, L (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	lrlz1989@163.com	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Cai, Huawei/0000-0003-1341-8417	Natural Science Foundation of China [81300169, 81270289]; Science & Technology Pillar Program of Sichuan Province [2013SZ0082]; British Heart Foundation [PG/11/58/29004] Funding Source: researchfish	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Pillar Program of Sichuan Province; British Heart Foundation(British Heart Foundation)	This study was funded by grants from Natural Science Foundation of China (grant number 81300169 and 81270289), and Science & Technology Pillar Program of Sichuan Province (grant number 2013SZ0082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Cai J, 2009, J CELL MOL MED, V13, P909, DOI 10.1111/j.1582-4934.2008.00620.x; Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096; Catalanotti F, 2013, CLIN CANCER RES, V19, P2257, DOI 10.1158/1078-0432.CCR-12-3476; Farley J, 2013, LANCET ONCOL, V14, P134, DOI 10.1016/S1470-2045(12)70572-7; Ferguson BS, 2013, P NATL ACAD SCI USA, V110, P9806, DOI 10.1073/pnas.1301509110; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hayes DN, 2012, CLIN CANCER RES, V18, P2056, DOI 10.1158/1078-0432.CCR-11-0563; Hoffmann P, 1995, CARDIOVASC RES, V30, P889, DOI 10.1016/S0008-6363(95)00133-6; Hou JL, 2012, PHARMACOL THERAPEUT, V135, P337, DOI 10.1016/j.pharmthera.2012.06.006; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jain N, 2014, CLIN CANCER RES, V20, P490, DOI 10.1158/1078-0432.CCR-13-1311; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kehat I, 2010, ANN NY ACAD SCI, V1188, P96, DOI 10.1111/j.1749-6632.2009.05088.x; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Liu YY, 2008, J IMMUNOL, V180, P7349, DOI 10.4049/jimmunol.180.11.7349; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; MORDRET G, 1993, BIOL CELL, V79, P193, DOI 10.1016/0248-4900(93)90138-5; Muchir A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-17; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Muiesan ML, 2004, HYPERTENSION, V43, P731, DOI 10.1161/01.HYP.0000121223.44837.de; Munzel F, 2005, CARDIOVASC RES, V68, P464, DOI 10.1016/j.cardiores.2005.06.020; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Prado CMM, 2012, BRIT J CANCER, V106, P1583, DOI 10.1038/bjc.2012.144; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Siu CW, 2012, AGING-US, V4, P803, DOI 10.18632/aging.100503; Vidal M, 2012, CARDIOVASC RES, V96, P255, DOI 10.1093/cvr/cvs249; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	35	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159079	10.1371/journal.pone.0159079	http://dx.doi.org/10.1371/journal.pone.0159079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438013	Green Published, gold			2022-12-26	WOS:000380170100028
J	Lui, G; Wong, CK; Ip, M; Chu, YJ; Yung, IMH; Cheung, CSK; Zheng, L; Lam, JSY; Wong, KT; Sin, WWY; Choi, KW; Lee, N				Lui, Grace; Wong, Chun Kwok; Ip, Margaret; Chu, Yi Jun; Yung, Irene M. H.; Cheung, Catherine S. K.; Zheng, Lin; Lam, Judy S. Y.; Wong, Ka Tak; Sin, Winnie W. Y.; Choi, Kin Wing; Lee, Nelson			HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MYCOBACTERIUM-TUBERCULOSIS; SOLUBLE RECEPTOR; ACTIVATION; SEVERITY; RAGE; SUSCEPTIBILITY; IMMUNOLOGY; SECRETION; RELEASE	Background We aimed to study the pathogenic roles of High-Mobility Group Box 1 (HMGB1) / Receptor-for-Advanced-Glycation-End-products (RAGE) signaling and pro-inflammatory cytokines in patients with active pulmonary tuberculosis (PTB). Methods A prospective study was conducted among non-HIV adults newly-diagnosed with active PTB at two acute-care hospitals (n = 80); age-and-sex matched asymptomatic individuals (tested for latent TB) were used for comparison (n = 45). Plasma concentrations of 8 cytokines/chemokines, HMGB1, soluble-RAGE, and transmembrane-RAGE expressed on monocytes/dendritic cells, were measured. Gene expression (mRNA) of HMGB1, RAGE, and inflammasome-NALP3 was quantified. Patients' PBMCs were stimulated with recombinant-HMGB1 and MTB-antigen (lipoarabinomannan) for cytokine induction ex vivo. Results In active PTB, plasma IL-8/CXCL8 [median(IQR), 6.0(3.6-15.1) vs 3.6(3.6-3.6) pg/ml, P<0.001] and IL-6 were elevated, which significantly correlated with mycobacterial load, extent of lung consolidation (r(s) + 0.509, P<0.001), severity-score (r(s) + 0.317, P = 0.004), and fever and hospitalization durations (r(s) + 0.407, P<0.001). IL-were independent predictors for respiratory failure, as well as for ICU admission/death. Gene expression of HMGB1, RAGE, and inflammasome-NALP3 were upregulated (1.2-2.8 fold). Transmembrane-RAGE was increased, whereas the decoy soluble-RAGE was significantly depleted. RAGE and HMGB1 gene expressions positively correlated with cytokine levels (IL-8/CXCL8, IL-6, sTNFR1) and clinico-/radiographical severity (e.g. extent of consolidation r(s) + 0.240, P = 0.034). Ex vivo, recombinant-HMGB1 potentiated cytokine release (e.g. TNF-alpha) when combined with lipoarabinomannan. Conclusion In patients with active PTB, HMGB1/RAGE signaling and pro-inflammatory cytokines may play important roles in pathogenesis and disease manifestations. Our clinico-immunological data can provide basis for the development of new strategies for disease monitoring, management and control.18 and sTNFR1 also increased. Plasma IL-8/CXCL8 (adjusted OR 1.12, 95% CI 1.02-1.23 per unit increase, P = 0.021) and HMGB1 (adjusted OR 1.42 per unit increase, 95% CI 1.08-1.87, P = 0.012) concentrations	[Lui, Grace; Yung, Irene M. H.; Cheung, Catherine S. K.; Lee, Nelson] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Wong, Chun Kwok; Chu, Yi Jun] Chinese Univ Hong Kong, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Ip, Margaret; Zheng, Lin] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lam, Judy S. Y.; Wong, Ka Tak] Prince Wales Hosp, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Sin, Winnie W. Y.; Choi, Kin Wing] Alice Ho Miu Ling Nethersole Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Alice Ho Miu Ling Nethersole Hospital; Chinese University of Hong Kong	Lee, N (corresponding author), Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	Ip, Margaret/K-1096-2013; Wong, CK/H-3256-2016; Lee, Nelson/B-6418-2008; Lui, Grace/N-4498-2019; Lui, Chung Yan Grace/N-5178-2016; Cheung, Siu King/L-5665-2016	Ip, Margaret/0000-0003-1291-6537; Wong, CK/0000-0002-5637-8331; Lee, Nelson/0000-0002-0783-6607; Lui, Chung Yan Grace/0000-0001-5242-2967; Cheung, Siu King/0000-0002-3486-489X	Research Fund for the Control of Infectious Diseases [11100272]; Food and Health Bureau of the Hong Kong Special Administrative Region Government; Departmental research fund, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong	Research Fund for the Control of Infectious Diseases; Food and Health Bureau of the Hong Kong Special Administrative Region Government; Departmental research fund, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong	This work was supported jointly by the Research Fund for the Control of Infectious Diseases (ref. no. 11100272), Food and Health Bureau of the Hong Kong Special Administrative Region Government; and a Departmental research fund, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.	Abhimanyu, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145576; Alessandri AL, 2006, INFLAMM RES, V55, P528, DOI 10.1007/s00011-006-5136-9; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Castiglioni A, 2011, CELL TISSUE RES, V343, P189, DOI 10.1007/s00441-010-1033-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144705; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Ganachari M, 2012, GENES IMMUN, V13, P605, DOI 10.1038/gene.2012.39; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Grover A, 2014, IMMUNOLOGY, V142, P111, DOI 10.1111/imm.12236; Hansel NN, 2004, CHEST, V126, P1079, DOI 10.1378/chest.126.4.1079; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hernandez-Pando R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133200; Hofner P, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/53805; Iwamoto H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-68; Johansson L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00004; Kassa D, 2012, CLIN VACCINE IMMUNOL, V19, P1907, DOI 10.1128/CVI.00482-12; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keyel PA, 2014, CYTOKINE, V69, P136, DOI 10.1016/j.cyto.2014.03.007; Kocsis AK, 2009, PANCREATOLOGY, V9, P383, DOI 10.1159/000181172; Krupa A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124762; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Lee N, 2013, INFLUENZA OTHER RESP, V7, P666, DOI 10.1111/irv.12109; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lui G, 2011, J INFECTION, V62, P440, DOI 10.1016/j.jinf.2011.04.011; Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Magrys A, 2013, IMMUNOL INVEST, V42, P49, DOI 10.3109/08820139.2012.723769; Masood KI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-13; Momonaka H, 2014, BRAIN DEV-JPN, V36, P484, DOI 10.1016/j.braindev.2013.07.001; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Santilli F, 2009, CURR MED CHEM, V16, P940, DOI 10.2174/092986709787581888; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sukkar MB, 2012, EUR RESPIR J, V39, P721, DOI 10.1183/09031936.00022011; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tuberculosis and Chest Services Centre for Health Protection Hong Kong SAR, 2006, TUBERCULOSIS MANUAL; van Zoelen MAD, 2012, MOL IMMUNOL, V52, P183, DOI 10.1016/j.molimm.2012.05.014; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Wang GZ, 2014, EUR J PHARMACOL, V726, P27, DOI 10.1016/j.ejphar.2014.01.030; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; World Health Organization, 2020, GLOBAL TUBERCULOSIS; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180	52	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159132	10.1371/journal.pone.0159132	http://dx.doi.org/10.1371/journal.pone.0159132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434276	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600035
J	Pinilla-Vera, M; Xiong, ZY; Zhao, YT; Zhao, J; Donahoe, MP; Barge, S; Horne, WT; Kolls, JK; McVerry, BJ; Birukova, A; Tighe, RM; Foster, WM; Hollingsworth, J; Ray, A; Mallampalli, R; Ray, P; Lee, JS				Pinilla-Vera, Miguel; Xiong, Zeyu; Zhao, Yutong; Zhao, Jing; Donahoe, Michael P.; Barge, Suchitra; Horne, William T.; Kolls, Jay K.; McVerry, Bryan J.; Birukova, Anastasiya; Tighe, Robert M.; Foster, W. Michael; Hollingsworth, John; Ray, Anuradha; Mallampalli, Rama; Ray, Prabir; Lee, Janet S.			Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL PNEUMONIA; IN-VIVO; RECEPTOR; IL-10; EXPRESSION; TOLERANCE; CELLS; TRIF; LIPOPOLYSACCHARIDE	Despite recent advances in understanding macrophage activation, little is known regarding how human alveolar macrophages in health calibrate its transcriptional response to canonical TLR4 activation. In this study, we examined the full spectrum of LPS activation and determined whether the transcriptomic profile of human alveolar macrophages is distinguished by a TIR-domain-containing adapter-inducing interferon-beta (TRIF)-dominant type I interferon signature. Bronchoalveolar lavage macrophages were obtained from healthy volunteers, stimulated in the presence or absence of ultrapure LPS in vitro, and whole transcriptomic profiling was performed by RNA sequencing (RNA-Seq). LPS induced a robust type I interferon transcriptional response and Ingenuity Pathway Analysis predicted interferon regulatory factor (IRF) 7 as the top upstream regulator of 89 known gene targets. Ubiquitin-specific peptidase (USP)-18, a negative regulator of interferon alpha/beta responses, was among the top up-regulated genes in addition to IL10 and USP41, a novel gene with no known biological function but with high sequence homology to USP18. We determined whether IRF-7 and USP-18 can influence downstream macrophage effector cytokine production such as IL-10. We show that IRF-7 siRNA knockdown enhanced LPS-induced IL-10 production in human monocyte-derived macrophages, and USP-18 overexpression attenuated LPS-induced production of IL-10 in RAW264.7 cells. Quantitative PCR confirmed upregulation of USP18, USP41, IL10, and IRF7. An independent cohort confirmed LPS induction of USP41 and IL10 genes. These results suggest that IRF-7 and predicted downstream target USP18, both elements of a type I interferon gene signature identified by RNA-Seq, may serve to fine-tune early cytokine response by calibrating IL-10 production in human alveolar macrophages.	[Pinilla-Vera, Miguel; Xiong, Zeyu; Zhao, Yutong; Zhao, Jing; Donahoe, Michael P.; Barge, Suchitra; McVerry, Bryan J.; Ray, Anuradha; Ray, Prabir; Lee, Janet S.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Horne, William T.; Kolls, Jay K.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Birukova, Anastasiya; Tighe, Robert M.; Foster, W. Michael; Hollingsworth, John] Duke Univ, Dept Med, Durham, NC USA; [Hollingsworth, John] Ohio State Univ, Dept Med, Div Pulm & Crit Care Med, Columbus, OH USA; [Mallampalli, Rama] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA; [Zhao, Yutong; Zhao, Jing; Lee, Janet S.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, JS (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Lee, JS (corresponding author), Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA.	leejs3@upmc.edu	McVerry, Bryan/AAS-7790-2021; Kolls, Jay/AAH-1829-2019	McVerry, Bryan/0000-0002-1175-4874; Kolls, Jay/0000-0001-5151-6304; Tighe, Robert/0000-0002-3465-9861; Pinilla-Vera, Miguel/0000-0002-2773-1570; Lee, Janet/0000-0002-6812-6043	Breathe Pennsylvania; National Institute of Health [R01 HL086884, R21AI119042, K08 HL105537, P01 HL114453]; Flight Attendant Medical Research Institute; Pilot Project Program in Hemostasis and Vascular Biology; Vascular Medicine Institute; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114453, K08HL105537, R01HL081784, R01HL086884, R01HL098174, R01HL096376, R01HL097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016126, R01ES020350] Funding Source: NIH RePORTER	Breathe Pennsylvania; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Pilot Project Program in Hemostasis and Vascular Biology; Vascular Medicine Institute; Hemophilia Center of Western Pennsylvania; Institute for Transfusion Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by Breathe Pennsylvania (JSL, MPD); National Institute of Health R01 HL086884 and R21AI119042 (JSL), K08 HL105537 (RMT), P01 HL114453 (RKM, PR); Flight Attendant Medical Research Institute (JSL); Pilot Project Program in Hemostasis and Vascular Biology, the Vascular Medicine Institute, the Hemophilia Center of Western Pennsylvania, Institute for Transfusion Medicine (JSL). The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Borzecka K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/824919; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chang EY, 2007, J IMMUNOL, V178, P6705, DOI 10.4049/jimmunol.178.11.6705; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Doyle I, 2010, MOL IMMUNOL, V47, P1058, DOI 10.1016/j.molimm.2009.11.008; Fraziano M, 1999, AIDS RES HUM RETROV, V15, P869, DOI 10.1089/088922299310575; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino Y, 2004, J IMMUNOL, V172, P6251, DOI 10.4049/jimmunol.172.10.6251; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kaakoush NO, 2015, INFECT IMMUN, V83, P832, DOI 10.1128/IAI.03012-14; Kazeros A, 2008, AM J RESP CELL MOL, V39, P747, DOI 10.1165/rcmb.2007-0306OC; Ketscher L, 2015, P NATL ACAD SCI USA, V112, P1577, DOI 10.1073/pnas.1412881112; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Njoroge JM, 2001, CYTOMETRY, V44, P38, DOI 10.1002/1097-0320(20010501)44:1<38::AID-CYTO1080>3.0.CO;2-T; Opalek Judy M, 2007, J Inflamm (Lond), V4, P19, DOI 10.1186/1476-9255-4-19; Owens BMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041050; Palmer SM, 2003, AM J RESP CRIT CARE; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Poe SL, 2013, MUCOSAL IMMUNOL, V6, P189, DOI 10.1038/mi.2012.62; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Raben D, 2005, CLIN CANCER RES, V11, P795; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rigby RE, 2015, TRENDS IMMUNOL, V36, P179, DOI 10.1016/j.it.2015.02.001; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sethi S, 2002, GERIATRICS-US, V57, P56; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Umino T, 1999, EUR RESPIR J, V13, P894, DOI 10.1034/j.1399-3003.1999.13d33.x; West JB, 2013, AM J PHYSIOL-REG I, V304, pR171, DOI 10.1152/ajpregu.00444.2012; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	59	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159329	10.1371/journal.pone.0159329	http://dx.doi.org/10.1371/journal.pone.0159329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434537	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600047
J	Torigata, K; Daisuke, O; Mukai, S; Hatanaka, A; Ohka, F; Motooka, D; Nakamura, S; Ohkawa, Y; Yabuta, N; Kondo, Y; Nojima, H				Torigata, Kosuke; Daisuke, Okuzaki; Mukai, Satomi; Hatanaka, Akira; Ohka, Fumiharu; Motooka, Daisuke; Nakamura, Shota; Ohkawa, Yasuyuki; Yabuta, Norikazu; Kondo, Yutaka; Nojima, Hiroshi			LATS2 Positively Regulates Polycomb Repressive Complex 2	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; TUMOR-SUPPRESSOR; SELECTIVE-INHIBITION; HIPPO PATHWAY; HUMAN GENOME; STEM-CELLS; EZH2; PHOSPHORYLATION; APOPTOSIS; DIFFERENTIATION	LATS2, a pivotal Ser/Thr kinase of the Hippo pathway, plays important roles in many biological processes. LATS2 also function in Hippo-independent pathway, including mitosis, DNA damage response and epithelial to mesenchymal transition. However, the physiological relevance and molecular basis of these LATS2 functions remain obscure. To understand novel functions of LATS2, we constructed a LATS2 knockout HeLa-S3 cell line using TAL-effector nuclease (TALEN). Integrated omics profiling of this cell line revealed that LATS2 knockout caused genome-wide downregulation of Polycomb repressive complex 2 (PRC2) and H3K27me3. Cell-cycle analysis revealed that downregulation of PRC2 was not due to cell cycle aberrations caused by LATS2 knockout. Not LATS1, a homolog of LATS2, but LATS2 bound PRC2 on chromatin and phosphorylated it. LATS2 positively regulates histone methyltransferase activity of PRC2 and their expression at both the mRNA and protein levels. Our findings reveal a novel signal upstream of PRC2, and provide insight into the crucial role of LATS2 in coordinating the epigenome through regulation of PRC2.	[Torigata, Kosuke; Daisuke, Okuzaki; Mukai, Satomi; Yabuta, Norikazu; Nojima, Hiroshi] Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, Suita, Osaka, Japan; [Hatanaka, Akira; Ohka, Fumiharu; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi, Japan; [Daisuke, Okuzaki; Nojima, Hiroshi] Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Dept Infect Metagen, Genome Informat Res Ctr, Microbial Dis Res Inst, Suita, Osaka, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Dept Adv Med Initiat, Grad Sch Med Sci, Fukuoka, Fukuoka, Japan	Osaka University; Nagoya City University; Osaka University; Osaka University; Kyushu University	Nojima, H (corresponding author), Osaka Univ, Dept Mol Genet, Microbial Dis Res Inst, Suita, Osaka, Japan.; Nojima, H (corresponding author), Osaka Univ, DNA Chip Dev Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka, Japan.	snj-0212@biken.osaka-u.ac.jp	Ohka, Fumiharu/A-3420-2016; Ohkawa, Yasuyuki/C-4087-2016; Nakamura, Shota/E-3033-2010; Okuzaki, Daisuke/AAN-5641-2020; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Nakamura, Shota/0000-0003-2058-5942; Okuzaki, Daisuke/0000-0002-4552-783X; Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohka, Fumiharu/0000-0002-5569-5626	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23370086, 22570185, 255951]; Project MEET, Osaka University Graduate School of Medicine	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project MEET, Osaka University Graduate School of Medicine	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Scientific Research B 23370086 [to HN], Scientific Research C 22570185 [to NY], and Research Fellowships for Young Scientists 255951 [to KT]) and by Project MEET, Osaka University Graduate School of Medicine (to DO).; We thank Dr. Patrick Hughes (Bioedit) for critically reading the manuscript. We also thank Dr. C. Oneyama, Dr. H. Fujii, and Dr. T. Fujita for valuable technical advice and discussions. This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Scientific Research B 23370086 [to HN], Scientific Research C 22570185 [to NY], and Research Fellowships for Young Scientists 255951 [to KT]), and by Project MEET, Osaka University Graduate School of Medicine (to DO).	Aylon Y, 2014, CELL DEATH DIFFER, V21, P624, DOI 10.1038/cdd.2013.188; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boulay G, 2011, BIOCHEM J, V434, P333, DOI 10.1042/BJ20100944; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Knutson SK, 2014, MOL CANCER THER, V13, P842, DOI 10.1158/1535-7163.MCT-13-0773; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kondo Y, 2014, J BIOCHEM, V156, P249, DOI 10.1093/jb/mvu054; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Okada N, 2011, J CELL SCI, V124, P57, DOI 10.1242/jcs.072918; Parrish JZ, 2007, GENE DEV, V21, P956, DOI 10.1101/gad.1514507; Powzaniuk M, 2004, MOL ENDOCRINOL, V18, P2011, DOI 10.1210/me.2004-0065; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Qin H, 2012, HUM MOL GENET, V21, P2054, DOI 10.1093/hmg/dds023; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2013, J CELL SCI, V126, P4358, DOI 10.1242/jcs.125815; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yabuta N, 2011, CELL CYCLE, V10, P2724, DOI 10.4161/cc.10.16.16873; Zeng XZ, 2011, CELL CYCLE, V10, P579, DOI 10.4161/cc.10.4.14722; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158562	10.1371/journal.pone.0158562	http://dx.doi.org/10.1371/journal.pone.0158562			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434182	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600010
J	Breshears, LM; Gillman, AN; Stach, CS; Schlievert, PM; Peterson, ML				Breshears, Laura M.; Gillman, Aaron N.; Stach, Christopher S.; Schlievert, Patrick M.; Peterson, Marnie L.			Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock Syndrome	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; EX-VIVO; EPITHELIAL-CELLS; INFLAMMATION; MODEL; DISINTEGRIN; ACTIVATION; INFECTION; ADAM10; INJURY	Secreted factors of Staphylococcus aureus can activate host signaling from the epidermal growth factor receptor (EGFR). The superantigen toxic shock syndrome toxin-1 (TSST-1) contributes to mucosal cytokine production through a disintegrin and metalloproteinase (ADAM)-mediated shedding of EGFR ligands and subsequent EGFR activation. The secreted hemolysin, alpha-toxin, can also induce EGFR signaling and directly interacts with ADAM10, a sheddase of EGFR ligands. The current work explores the role of EGFR signaling in menstrual toxic shock syndrome (mTSS), a disease mediated by TSST-1. The data presented show that TSST-1 and alpha-toxin induce ADAM- and EGFR-dependent cytokine production from human vaginal epithelial cells. TSST-1 and alpha-toxin also induce cytokine production from an ex vivo porcine vaginal mucosa (PVM) model. EGFR signaling is responsible for the majority of IL-8 production from PVM in response to secreted toxins and live S. aureus. Finally, data are presented demonstrating that inhibition of EGFR signaling with the EGFR-specific tyrosine kinase inhibitor AG1478 significantly increases survival in a rabbit model of mTSS. These data indicate that EGFR signaling is critical for progression of an S. aureus exotoxin-mediated disease and may represent an attractive host target for therapeutics.	[Breshears, Laura M.; Gillman, Aaron N.; Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Stach, Christopher S.] Univ Minnesota, Coll Biol Sci, Inst Biotechnol, Minneapolis, MN USA; [Schlievert, Patrick M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa	Peterson, ML (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	peter377@umn.edu		Schlievert, Patrick/0000-0001-8314-9369; Breshears, Laura/0000-0002-0997-1140; Gillman, Aaron/0000-0002-1210-0485	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI073366-03, R01AI074283]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI073366-03 (MP) and R01AI074283 (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2013, J APPL MICROBIOL, V115, P679, DOI 10.1111/jam.12277; Anderson MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00064; Anderson MJ, 2010, AM J INFECT CONTROL, V38, P826, DOI 10.1016/j.ajic.2010.06.022; Bajaj-Elliott M, 1998, J CLIN INVEST, V102, P1473, DOI 10.1172/JCI2792; Berasain C, 2009, EXP BIOL MED, V234, P713, DOI 10.3181/0901-MR-12; BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; Bose JL, 2013, APPL ENVIRON MICROB, V79, P2218, DOI 10.1128/AEM.00136-13; Breshears LM, 2012, J BIOL CHEM, V287, P32578, DOI 10.1074/jbc.M112.352534; Brosnahan AJ, 2009, J IMMUNOL, V182, P2364, DOI 10.4049/jimmunol.0803283; Buret A, 1999, MICROBES INFECT, V1, P1139, DOI 10.1016/S1286-4579(99)00201-4; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Davis CC, 2014, TOXICOL APPL PHARM, V274, P240, DOI 10.1016/j.taap.2013.11.021; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lin YC, 2011, BIOCHEMISTRY-US, V50, P7157, DOI 10.1021/bi200435n; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; MACDONALD KL, 1987, JAMA-J AM MED ASSOC, V257, P1053, DOI 10.1001/jama.257.8.1053; Mahipal A, 2014, CANCER CONTROL, V21, P74, DOI 10.1177/107327481402100111; Murray DL, 1996, INFECT IMMUN, V64, P371, DOI 10.1128/IAI.64.1.371-374.1996; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Parker D, 2012, SEMIN IMMUNOPATHOL, V34, P281, DOI 10.1007/s00281-011-0291-7; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Richter E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122089; Rigby KM, 2012, SEMIN IMMUNOPATHOL, V34, P237, DOI 10.1007/s00281-011-0295-3; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Salgado-Pabon W, 2013, MBIO, V4, DOI 10.1128/mBio.00494-13; Schaefers MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032813; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; SCHLIEVERT PM, 1981, J INFECT DIS, V143, P509, DOI 10.1093/infdis/143.4.509; Soong G, 2011, J BIOL CHEM, V286, P35891, DOI 10.1074/jbc.M111.295386; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Spaulding AR, 2012, VACCINE; Squier CA, 2008, J PHARM SCI-US, V97, P9, DOI 10.1002/jps.21077; Strandberg KL, 2010, J INFECT DIS, V202, P1690, DOI 10.1086/657156; Tang YW, 2010, J CLIN MICROBIOL, V48, P1974, DOI 10.1128/JCM.00224-10; Tran QT, 2012, PHYSIOL GENOMICS, V44, P455, DOI 10.1152/physiolgenomics.00176.2011; Wang WZY, 2012, CELL MOL IMMUNOL, V9, P131, DOI 10.1038/cmi.2011.65; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Xu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028216	49	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158969	10.1371/journal.pone.0158969	http://dx.doi.org/10.1371/journal.pone.0158969			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414801	gold, Green Submitted, Green Published			2022-12-26	WOS:000379579500054
J	Du, J; Wang, X; Dong, CH; Yang, JM; Yao, XJ				Du, Juan; Wang, Xue; Dong, Chun-Hai; Yang, Jian Ming; Yao, Xiao Jun			Computational Study of the Binding Mechanism of Actin-Depolymerizing Factor 1 with Actin in Arabidopsis thaliana	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; AMBER FORCE-FIELD; ADF/COFILIN FAMILY; PROTEIN-KINASE; YEAST COFILIN; FILAMENT; HOMOLOGY; COMPLEX; MODELS	Actin is a highly conserved protein. It plays important roles in cellular function and exists either in the monomeric (G-actin) or polymeric form (F-actin). Members of the actin-depolymerizing factor (ADF)/cofilin protein family bind to both G-actin and F-actin and play vital roles in actin dynamics by manipulating the rates of filament polymerization and depolymerization. It has been reported that the S6D and R98A/K100A mutants of actin-depolymerizing factor 1 (ADF1) in Arabidopsis thaliana decreased the binding affinity of ADF for the actin monomer. To investigate the binding mechanism and dynamic behavior of the ADF1-actin complex, we constructed a homology model of the AtADF1-actin complex based on the crystal structure of AtADF1 and the twinfilin C-terminal ADF-H domain in a complex with a mouse actin monomer. The model was then refined for subsequent molecular dynamics simulations. Increased binding energy of the mutated system was observed using the Molecular Mechanics Generalized Born Surface Area and Poisson-Boltzmann Surface Area (MM-GB/PBSA) methods. To determine the residues that make decisive contributions to the ADF1 actin-binding affinity, per-residue decomposition and computational alanine scanning analyses were performed, which provided more detailed information on the binding mechanism. Root-mean-square fluctuation and principal component analyses confirmed that the S6D and R98A/K100A mutants induced an increased conformational flexibility. The comprehensive molecular insight gained from this study is of great importance for understanding the binding mechanism of ADF1 and G-actin.	[Du, Juan; Wang, Xue; Dong, Chun-Hai; Yang, Jian Ming] Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Shandong Prov, Qingdao, Peoples R China; [Yao, Xiao Jun] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou, Peoples R China	Qingdao Agricultural University; Lanzhou University	Du, J (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Shandong Prov, Qingdao, Peoples R China.	dujuannx@126.com		Du, Juan/0000-0001-5993-4949	National Natural Science Foundation of China [31300599, 31571389, 21572242]; Talents of High Level Scientific Research Foundation of Qingdao Agricultural University [6631113318, 6631113326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents of High Level Scientific Research Foundation of Qingdao Agricultural University	This work was supported by the National Natural Science Foundation of China (grant numbers 31300599, 31571389 and 21572242), and the Talents of High Level Scientific Research Foundation (grant numbers 6631113318 and 6631113326) of Qingdao Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (grant numbers 31300599, 31571389 and 21572242), the Talents of High Level Scientific Research Foundation (grant numbers 6631113318 and 6631113326) of Qingdao Agricultural University.	Aalten DMFv, 1995, PROTEIN ENG, V8, P1129, DOI [10.1093/protein/8.11.1129, DOI 10.1093/PROTEIN/8.11.1129]; Allwood EG, 2002, PLANT CELL, V14, P2915, DOI 10.1105/tpc.005363; Allwood EG, 2001, FEBS LETT, V499, P97, DOI 10.1016/S0014-5793(01)02528-5; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; [Anonymous], BRYCE GROUP COMPUTIO; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bowman GD, 2000, PROTEINS, V41, P374, DOI 10.1002/1097-0134(20001115)41:3<374::AID-PROT90>3.0.CO;2-F; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Dai K, 2011, BIOMOL NMR ASSIGN, V5, P249, DOI 10.1007/s12104-011-9311-8; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong CH, 2001, PLANT MOL BIOL, V45, P517, DOI 10.1023/A:1010687911374; Dong CH, 2013, PLANT CELL REP, V32, P1715, DOI 10.1007/s00299-013-1482-6; Dong CH, 2013, J INTEGR PLANT BIOL, V55, P250, DOI 10.1111/jipb.12015; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Fedorov AA, 1997, NAT STRUCT BIOL, V4, P366, DOI 10.1038/nsb0597-366; Feng Y, 2006, J PLANT PHYSIOL, V163, P69, DOI 10.1016/j.jplph.2005.01.015; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; Genheden S, 2012, PROTEINS, V80, P1326, DOI 10.1002/prot.24029; Goroncy AK, 2009, PROTEIN SCI, V18, P2384, DOI 10.1002/pro.248; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Hellman M, 2004, FEBS LETT, V576, P91, DOI 10.1016/j.febslet.2004.08.068; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Ivetac A, 2009, J MOL BIOL, V388, P644, DOI 10.1016/j.jmb.2009.03.037; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kandasamy MK, 2015, CYTOSKELETON, V72, P80, DOI 10.1002/cm.21198; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Kim JI, 2015, PHYS CHEM CHEM PHYS, V17, P8148, DOI 10.1039/c4cp06100d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lee MR, 2000, PROTEINS, V39, P309, DOI 10.1002/(SICI)1097-0134(20000601)39:4<309::AID-PROT40>3.0.CO;2-S; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Maciver SK, 2002, GENOME BIOL, V3; Maiti S., 2013, ENCY BIOL CHEM, V2nd ed., P18, DOI [10.1016/B978-0-12-378630-2.00415-1, DOI 10.1016/B978-0-12-378630-2.00415-1]; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pathak PP, 2010, J STRUCT BIOL, V172, P219, DOI 10.1016/j.jsb.2010.07.001; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Qu XL, 2013, PLANT CELL, V25, P1803, DOI 10.1105/tpc.113.110940; Roland J, 2008, BIOPHYS J, V94, P2082, DOI 10.1529/biophysj.107.121988; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smertenko AP, 1998, PLANT J, V14, P187, DOI 10.1046/j.1365-313X.1998.00107.x; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Su H, 2012, PLANT CELL, V24, P4539, DOI 10.1105/tpc.112.099358; Sun TT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00512; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wong DY, 2011, J MOL BIOL, V413, P97, DOI 10.1016/j.jmb.2011.08.039; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; Xue WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087077; Yadav R, 2011, J STRUCT BIOL, V176, P97, DOI 10.1016/j.jsb.2011.07.011	66	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159053	10.1371/journal.pone.0159053	http://dx.doi.org/10.1371/journal.pone.0159053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414648	Green Submitted, gold, Green Published			2022-12-26	WOS:000379579500065
J	Koster, R; Seow, TX; Dolan, RJ; Duzel, E				Koster, Raphael; Seow, Tricia X.; Dolan, Raymond J.; Duezel, Emrah			Stimulus Novelty Energizes Actions in the Absence of Explicit Reward	PLOS ONE			English	Article							RISK-TAKING; DOPAMINE; HIPPOCAMPAL; PERSONALITY; EXPLORATION; CURIOSITY; BEHAVIOR; DISSOCIATION; PREFERENCE; MECHANISM	Novelty seeking has been tied to impulsive choice and biased value based choice. It has been postulated that novel stimuli should trigger more vigorous approach and exploration. However, it is unclear whether stimulus novelty can enhance simple motor actions in the absence of explicit reward, a necessary condition for energizing approach and exploration in an entirely unfamiliar situation. In this study human subjects were cued to omit or perform actions in form of button presses by novel or familiar images. We found that subjects' motor actions were faster when cued by a novel compared to a familiar image. This facilitation by novelty was strongest when the delay between cue and action was short, consistent with a link between novelty and impulsive choices. The facilitation of reaction times by novelty was correlated across subjects with trait novelty seeking as measured in the Tridimensional Personality Questionnaire. However, this li between high novelty-seeking and action facilitation was driven by trials with a long delay between cue and action. This prolonged time window of energization following novelty could hint at a mechanistic underpinning of enhanced vigour for approach and exploration frequently postulated for novelty seeking humans. In conclusion, we show that stimulus novelty enhances the speed of a cued motor action. We suggest this is likely to reflect an adaptation to changing environments but may also provide a source of maladaptive choice and impulsive behaviour.	[Koster, Raphael; Seow, Tricia X.; Duezel, Emrah] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Koster, Raphael; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Duezel, Emrah] Univ Magdeburg, Inst Cognit Neurol & Dementia Res, D-39120 Magdeburg, Germany; [Duezel, Emrah] German Ctr Neurodegenerat Dis, D-39120 Magdeburg, Germany	University of London; University College London; University of London; University College London; Otto von Guericke University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Koster, R (corresponding author), UCL, Inst Cognit Neurosci, London WC1N 3AR, England.; Koster, R (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	raphael.koster.10@ucl.ac.uk	Duzel, Emrah/A-1794-2010	Seow, Tricia/0000-0002-5930-8929; Duzel, Emrah/0000-0002-0139-5388	UCL Grand Challenge Studentship in Biomedicine; Wellcome Trust [098362/Z/12/Z, 091593/Z/10/Z]; DFG [SFB 779]	UCL Grand Challenge Studentship in Biomedicine; Wellcome Trust(Wellcome Trust); DFG(German Research Foundation (DFG))	This work was supported by a UCL Grand Challenge Studentship in Biomedicine to RK, the Wellcome Trust (Senior Investigator Award 098362/Z/12/Z to RJD) and DFG grant SFB 779 (A07) supporting ED. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a UCL Grand Challenge Studentship in Biomedicine to RK, the Wellcome Trust (Senior Investigator Award 098362/Z/12/Z to RJD) and DFG grant SFB 779 (A07) supporting ED. The Wellcome Trust Centre for Neuroimaging is supported by core funding from the Wellcome Trust 091593/Z/10/Z. The authors would like to thank Dorothea Hammerer for comments on a previous version of this manuscript.	Baranes AF, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00317; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Belin D, 2011, NEUROPSYCHOPHARMACOL, V36, P569, DOI 10.1038/npp.2010.188; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Bunzeck N, 2014, CEREB CORTEX, V24, P1351, DOI 10.1093/cercor/bhs420; Bunzeck N, 2011, J NEUROSCI, V31, P12816, DOI 10.1523/JNEUROSCI.0461-11.2011; Bunzeck N, 2010, HUM BRAIN MAPP, V31, P1380, DOI 10.1002/hbm.20939; BUTLER RA, 1954, J COMP PHYSIOL PSYCH, V47, P258, DOI 10.1037/h0054977; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Costa A, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/260896; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DELINISTULA A, 1984, PHARMACOL BIOCHEM BE, V20, P613, DOI 10.1016/0091-3057(84)90312-5; DEsposito M, 2014, PSYCHOPHARMACOLOGY B; Donohew L, 2000, PERS INDIV DIFFER, V28, P1079, DOI 10.1016/S0191-8869(99)00158-0; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Duzel E, 2010, NEUROSCI BIOBEHAV R, V34, P660, DOI 10.1016/j.neubiorev.2009.08.006; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; GLANZER M, 1958, PSYCHOL BULL, V55, P302, DOI 10.1037/h0044731; Guitart-Masip M, 2014, TRENDS COGN SCI; Guitart-Masip M, 2012, P NATL ACAD SCI USA, V109, P7511, DOI 10.1073/pnas.1202229109; Guitart-Masip M, 2011, J COGNITIVE NEUROSCI, V23, P3933, DOI 10.1162/jocn_a_00090; Guitart-Masip M, 2011, J NEUROSCI, V31, P7867, DOI 10.1523/JNEUROSCI.6376-10.2011; Howard LR, 2011, J NEUROSCI, V31, P5253, DOI 10.1523/JNEUROSCI.6055-10.2011; Howard MO, 1997, J STUD ALCOHOL, V58, P48, DOI 10.15288/jsa.1997.58.48; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Insel N, 2008, BEHAV NEUROSCI, V122, P1328, DOI 10.1037/a0012928; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Koster R, 2015, CEREB CORTEX, V25, P4908, DOI 10.1093/cercor/bhv216; Krebs RM, 2011, J NEUROSCI, V31, P9752, DOI 10.1523/JNEUROSCI.0732-11.2011; Kumaran D, 2009, TRENDS COGN SCI, V13, P47, DOI 10.1016/j.tics.2008.11.004; Lemon N, 2012, CEREB CORTEX, V22, P2131, DOI 10.1093/cercor/bhr297; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; LOEWENSTEIN G, 1994, PSYCHOL BULL, V116, P75, DOI 10.1037/0033-2909.116.1.75; Luo AH, 2011, SCIENCE, V333, P353, DOI 10.1126/science.1204622; Maass A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6547; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Molander AC, 2011, PSYCHOPHARMACOLOGY, V215, P721, DOI 10.1007/s00213-011-2167-x; Murty VP, 2013, LEARN MEMORY, V20, P229, DOI 10.1101/lm.029728.112; Pluck Graham, 2011, Depress Res Treat, V2011, P893873, DOI 10.1155/2011/893873; Rangel-Gomez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066469; Rebec GV, 1998, ALCOHOL CLIN EXP RES, V22, P32, DOI 10.1111/j.1530-0277.1998.tb03614.x; Schonberg T, 2014, NAT NEUROSCI, V17, P625, DOI 10.1038/nn.3673; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Talmi D, 2008, J NEUROSCI, V28, P360, DOI 10.1523/JNEUROSCI.4028-07.2008; VanElzakker M, 2008, LEARN MEMORY, V15, P899, DOI 10.1101/lm.1196508; VANKOV A, 1995, EUR J NEUROSCI, V7, P1180, DOI 10.1111/j.1460-9568.1995.tb01108.x; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	59	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159120	10.1371/journal.pone.0159120	http://dx.doi.org/10.1371/journal.pone.0159120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415631	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500081
J	Lutsey, PL; Norby, FL; Gottesman, RF; Mosley, T; MacLehose, RF; Punjabi, NM; Shahar, E; Jack, CR; Alonso, A				Lutsey, Pamela L.; Norby, Faye L.; Gottesman, Rebecca F.; Mosley, Thomas; MacLehose, Richard F.; Punjabi, Naresh M.; Shahar, Eyal; Jack, Clifford R., Jr.; Alonso, Alvaro			Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC)	PLOS ONE			English	Article							COGNITIVE-DECLINE; HEART HEALTH; CEREBROVASCULAR-DISEASE; INTERMITTENT HYPOXIA; STRUCTURAL-CHANGES; BLOOD-PRESSURE; OLDER WOMEN; DEMENTIA; IMPAIRMENT; STROKE	Background A growing body of literature has suggested that obstructive sleep apnea (OSA) and habitual short sleep duration are linked to poor cognitive function. Neuroimaging studies may provide insight into this relation. Objective We tested the hypotheses that OSA and habitual short sleep duration, measured at ages 54-73 years, would be associated with adverse brain morphology at ages 67-89 years. Methods Included in this analysis are 312 ARIC study participants who underwent in-home overnight polysomnography in 1996-1998 and brain MRI scans about 15 years later (2012-2013). Sleep apnea was quantified by the apnea-hypopnea index and categorized as moderate/ severe (>= 15.0 events/hour), mild (5.0-14.9 events/hour), or normal (<5.0 events/hour). Habitual sleep duration was categorized, in hours, as <7, 7 to <8, >= 8. MRI outcomes included number of infarcts (total, subcortical, and cortical) and white matter hyperintensity (WMH) and Alzheimer's disease signature region volumes. Multivariable adjusted logistic and linear regression models were used. All models incorporated inverse probability weighting, to adjust for potential selection bias. Results At the time of the sleep study participants were 61.7 (SD: 5.0) years old and 54% female; 19% had moderate/severe sleep apnea. MRI imaging took place 14.8 (SD: 1.0) years later, when participants were 76.5 (SD: 5.2) years old. In multivariable models which accounted for body mass index, neither OSA nor abnormal sleep duration were statistically significantly associated with odds of cerebral infarcts, WMH brain volumes or regional brain volumes. Conclusions In this community-based sample, mid-life OSA and habitually short sleep duration were not associated with later-life cerebral markers of vascular dementia and Alzheimer's disease. However, selection bias may have influenced our results and the modest sample size led to relatively imprecise associations.	[Lutsey, Pamela L.; Norby, Faye L.; MacLehose, Richard F.] Univ Minnesota, Minneapolis, MN 55455 USA; [Gottesman, Rebecca F.; Punjabi, Naresh M.] Johns Hopkins Univ, Baltimore, MD USA; [Mosley, Thomas] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Shahar, Eyal] Univ Arizona, Tucson, AZ USA; [Jack, Clifford R., Jr.] Mayo Clin, Rochester, MN USA; [Alonso, Alvaro] Emory Univ, Atlanta, GA 30322 USA	University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; University of Mississippi; University of Mississippi Medical Center; University of Arizona; Mayo Clinic; Emory University	Lutsey, PL (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	lutsey@umn.edu	Jack, Clifford R/F-2508-2010; Gottesman, Rebecca/ABA-8468-2020; Norby, Faye/FNA-7255-2022; Alonso, Alvaro/A-4917-2010; Punjabi, Naresh/EMH-1007-2022	Jack, Clifford R/0000-0001-7916-622X; Norby, Faye/0000-0002-1975-0405; Alonso, Alvaro/0000-0002-2225-8323; Lutsey, Pamela/0000-0002-1572-1340	National Heart, Lung, and Blood Institute [U01HL53934, U01HL64360, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [R01-HL70825];  [R21 HL121412]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096917, U01HL096812, U01HL096814, U01HL096902, U01HL096899] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The ARIC portion of the SHHS was supported by National Heart, Lung, and Blood Institute cooperative agreements U01HL53934 (University of Minnesota) and U01HL64360 (Johns Hopkins University). The ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). Neurocognitive data is collected by U01 HL096812, HL096814, HL096899, HL096902, HL096917 from the NHLBI and the National Institute of Neurological Disorders and Stroke, and with previous brain MRI examinations funded by R01-HL70825 from the NHLBI. This study was additionally supported by grant R21 HL121412 to Dr. Lutsey.	Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Alzheimer's Association Report, 2015, ALZHEIMERS DEMENT, V11, P332; Amlander C, 2009, BASICS SLEEP GUIDE; Bliwise DL, 2002, J PSYCHOSOM RES, V53, P539, DOI 10.1016/S0022-3999(02)00436-1; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Buratti L, 2014, J ALZHEIMERS DIS, V38, P445, DOI 10.3233/JAD-131046; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Eguchi K, 2005, AM J HYPERTENS, V18, P1489, DOI 10.1016/j.amjhyper.2005.05.032; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Gottesman RF, 2014, AM J EPIDEMIOL, V179, P956, DOI 10.1093/aje/kwu020; Gottlieb DJ, 2004, NEUROLOGY, V63, P664, DOI 10.1212/01.WNL.0000134671.99649.32; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Harbison J, 2003, NEUROLOGY, V61, P959, DOI 10.1212/01.WNL.0000086818.57992.B8; Hernan MA, 2008, EPIDEMIOLOGY, V19, P448, DOI 10.1097/EDE.0b013e31816bbe14; INVESTIGATORS TA, 1989, AM J EPIDEMIOL, V129, P687; Jack CR, 2001, J MAGN RESON IMAGING, V14, P668, DOI 10.1002/jmri.10011; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; Kalaria RN, 2004, RESP PHYSIOL NEUROBI, V140, P53, DOI 10.1016/j.resp.2004.01.003; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kantarci K, 2009, NEUROLOGY, V72, P1519, DOI 10.1212/WNL.0b013e3181a2e864; Knopman DS, 2015, STROKE, V46, P433, DOI 10.1161/STROKEAHA.114.007847; Logroscino G, 2004, BMJ-BRIT MED J, V328, P548, DOI 10.1136/bmj.37977.495729.EE; Lutsey PL, 2015, SLEEP, V38, P877; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Nair D, 2011, AM J RESP CRIT CARE, V184, P1305, DOI 10.1164/rccm.201107-1173OC; Nishibayashi M, 2008, J CLIN SLEEP MED, V4, P242; Ortman JM, 2014, AGING NATION OLDER P; Pathan SS, 2011, EUR J NEUROL, V18, P888, DOI 10.1111/j.1468-1331.2010.03340.x; Placidi F, 1998, J SLEEP RES, V7, P288, DOI 10.1046/j.1365-2869.1998.00120.x; Population Division Department of Economic and Social Affairs United Nations, 2013, WORLD POP AG 2013; Quan SF, 1997, SLEEP, V20, P1077; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Raz L, 2013, NEUROLOGY, V80, P911, DOI 10.1212/WNL.0b013e3182840c9f; Redline S, 1998, SLEEP, V21, P759; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Staessen JA, 2007, HYPERTENSION, V49, P389, DOI 10.1161/01.HYP.0000258151.00728.d8; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tung A, 2005, NEUROSCIENCE, V134, P721, DOI 10.1016/j.neuroscience.2005.06.008; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x	52	23	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158758	10.1371/journal.pone.0158758	http://dx.doi.org/10.1371/journal.pone.0158758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415826	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500037
J	Watson, CV; Feng, J; Valentin-Blasini, L; Stanelle, R; Watson, CH				Watson, Christina Vaughan; Feng, June; Valentin-Blasini, Liza; Stanelle, Rayman; Watson, Clifford H.			Method for the Determination of Ammonia in Mainstream Cigarette Smoke Using Ion Chromatography	PLOS ONE			English	Article							TOBACCO; NICOTINE	Ammonia in mainstream smoke is present in both the particulate and vapor phases. The presence of ammonia in the cigarette filler material and smoke is of significance because of the potential role ammonia could have in raising the "smoke pH." An increased smoke pH could shift a fraction of total nicotine to free-base nicotine, which is reportedly more rapidly absorbed by the smoker. Methods measuring ammonia in smoke typically employ acid filled impingers to trap the smoke. We developed a fast, reliable method to measure ammonia in mainstream smoke without the use of costly and time consuming impingers to examine differences in ammonia delivery. The method uses both a Cambridge filter pad and a Tedlar bag to capture particulate and vapor phases of the smoke. We quantified ammonia levels in the mainstream smoke of 50 cigarette brands from 5 manufacturers. Ammonia levels ranged from approximately 1 mu g to 23 mu g per cigarette for ISO smoking conditions and 38 mu g to 67 mu g per cigarette for Canadian intense smoking conditions and statistically significance differences were observed between brands and manufacturers. Our findings suggest that ammonia levels vary by brand and are higher under Canadian intense smoking conditions.	[Watson, Christina Vaughan; Feng, June; Valentin-Blasini, Liza; Stanelle, Rayman; Watson, Clifford H.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Tobacco & Volatiles Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Watson, CV (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Tobacco & Volatiles Branch, Atlanta, GA 30333 USA.	cvaughan@cdc.gov						[Anonymous], 33082012 ISO; [Anonymous], 34021999 ISO; Ashley David L, 2009, Handb Exp Pharmacol, P437, DOI 10.1007/978-3-540-69248-5_15; Baker RR, 2004, FOOD CHEM TOXICOL, V42, pS3, DOI 10.1016/S0278-6915(03)00189-3; Callicutt CH, 2014, BEITR TABAKFORSCH, V22, P71; Counts ME, 2006, REGUL TOXICOL PHARM, V46, P225, DOI 10.1016/j.yrtph.2006.07.002; Food and Drug Administration, HARMF POT HARMF CONS; Hammond D, 2008, TOB CONTROL, V17, pI24, DOI 10.1136/tc.2008.024778; Hind JD, 1968, Patent, Patent No. [3,386,449, 3386449]; Huang Chorng B., 2003, Beitraege zur Tabakforschung International, V20, P389; Hundall CF, FREE NICOTINE AMMONI; JOHNSON R. W., 1989, INTRAPLATE VOLCANISM, P7; Mottier N, 2011, J AGR FOOD CHEM, V59, P92, DOI 10.1021/jf103772c; Rodgman A., 2008, CHEM COMPONENTS TOBA, DOI [10.1201/9781420078848, DOI 10.1201/9781420078848]; Seeman JI, 2007, CHEM RES TOXICOL, V20, P326, DOI 10.1021/tx600290v; Seligman RB, 1969, Patent, Patent No. [3,411,515, 3411515]; Stevenson T, 2008, AM J PUBLIC HEALTH, V98, P1184, DOI 10.2105/AJPH.2007.121657; Taylor JK, 1987, QUALITY ASSURANCE CH; Watson CV, 2015, REGUL TOXICOL PHARM, V72, P266, DOI 10.1016/j.yrtph.2015.04.019; World Health Organization, STAND OP PROC INT SM	20	3	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159126	10.1371/journal.pone.0159126	http://dx.doi.org/10.1371/journal.pone.0159126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415766	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500082
J	Chen, JF; Yang, CY; Tizioto, PC; Huang, H; Lee, MOK; Payne, HR; Lawhon, SD; Schroeder, F; Taylor, JF; Womack, JE				Chen, Junfeng; Yang, Chingyuan; Tizioto, Polyana C.; Huang, Huan; Lee, Mi O. K.; Payne, Harold R.; Lawhon, Sara D.; Schroeder, Friedhelm; Taylor, Jeremy F.; Womack, James E.			Expression of the Bovine NK-Lysin Gene Family and Activity against Respiratory Pathogens	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRAL DIARRHEA VIRUS; ANTIMICROBIAL PEPTIDES; FEEDLOT CATTLE; ANTITUMOR-ACTIVITY; FEEDER CATTLE; UNITED-STATES; T-CELLS; DISEASE; GRANULYSIN	Unlike the genomes of many mammals that have a single NK-lysin gene, the cattle genome contains a family of four genes, one of which is expressed preferentially in the lung. In this study, we compared the expression of the four bovine NK-lysin genes in healthy animals to animals challenged with pathogens known to be associated with bovine respiratory disease (BRD) using transcriptome sequencing (RNA-seq). The expression of several NK-lysins, especially NK2C, was elevated in challenged relative to control animals. The effects of synthetic peptides corresponding to functional region helices 2 and 3 of each gene product were tested on both model membranes and bio-membranes. Circular dichroism spectroscopy indicated that these peptides adopted a more helical secondary structure upon binding to an anionic model membrane and liposome leakage assays suggested that these peptides disrupt membranes. Bacterial killing assays further confirmed the antimicrobial effects of these peptides on BRD-associated bacteria, including both Pasteurella multocida and Mannhemia haemolytica and an ultrastructural examination of NK-lysin-treated P. multocida cells by transmission electron microscopy revealed the lysis of target membranes. These studies demonstrate that the expanded bovine NK-lysin gene family is potentially important in host defense against pathogens involved in bovine respiratory disease.	[Chen, Junfeng; Yang, Chingyuan; Lee, Mi O. K.; Payne, Harold R.; Lawhon, Sara D.; Womack, James E.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Tizioto, Polyana C.] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Tizioto, Polyana C.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Huang, Huan; Schroeder, Friedhelm] Texas A&M Univ, Coll Vet Med, Dept Physiol & Pharmacol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Missouri System; University of Missouri Columbia; Texas A&M University System; Texas A&M University College Station	Womack, JE (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	JWOMACK@cvm.tamu.edu	Lawhon, Sara D./G-5147-2011	Lawhon, Sara D./0000-0001-9154-8909	Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food [2011-68004-30367]	Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food	This project was supported by Agriculture and Food Research Initiative competitive grant number 2011-68004-30367 from the United States Department of Agriculture National Institute of Food.	ANDERSSON M, 1995, EMBO J, V14, P1615, DOI 10.1002/j.1460-2075.1995.tb07150.x; Andreu D, 1999, BIOCHEM J, V344, P845, DOI 10.1042/0264-6021:3440845; Bermingham ML, 2014, HEREDITY, V112, P543, DOI 10.1038/hdy.2013.137; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Casas E, 2015, ANIM GENET, V46, P8, DOI 10.1111/age.12239; Cernicchiaro N, 2012, J ANIM SCI, V90, P1929, DOI 10.2527/jas.2011-4599; Cernicchiaro N, 2012, J ANIM SCI, V90, P1328, DOI 10.2527/jas.2011-4657; Chen J, 2015, P NATL ACAD IN PRESS; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Ellis JA, 2010, VET CLIN N AM-FOOD A, V26, P575, DOI 10.1016/j.cvfa.2010.08.002; Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607; Gagea MI, 2006, J VET DIAGN INVEST, V18, P18, DOI 10.1177/104063870601800104; Garcia MD, 2010, J ANIM SCI, V88, P491, DOI 10.2527/jas.2009-1874; Gershwin LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142479; Glass EJ, 2012, VET IMMUNOL IMMUNOP, V148, P90, DOI 10.1016/j.vetimm.2011.05.009; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Jacobs T, 2003, ANTIMICROB AGENTS CH, V47, P607, DOI 10.1128/AAC.47.2.607-613.2003; JONGSTRA J, 1987, J EXP MED, V165, P601, DOI 10.1084/jem.165.3.601; Klima CL, 2014, J CLIN MICROBIOL, V52, P438, DOI 10.1128/JCM.02485-13; Krensky AM, 2000, BIOCHEM PHARMACOL, V59, P317, DOI 10.1016/S0006-2952(99)00177-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee MO, 2012, P NATL ACAD SCI USA, V109, P12087, DOI 10.1073/pnas.1209161109; Linde CMA, 2005, INFECT IMMUN, V73, P6332, DOI 10.1128/IAI.73.10.6332-6339.2005; MUGGLICOCKETT NE, 1992, J ANIM SCI, V70, P2013, DOI 10.2527/1992.7072013x; Neibergs H, 2011, J ANIM SCI, V89, P907, DOI 10.2527/jas.2010-3330; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Pena SV, 1997, J IMMUNOL, V158, P2680; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; Shahriar FM, 2002, CAN VET J, V43, P863; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Taylor JD, 2010, CAN VET J, V51, P1095; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; Wang Z, 2000, J IMMUNOL, V165, P1486, DOI 10.4049/jimmunol.165.3.1486; Welsh RD, 2004, J VET DIAGN INVEST, V16, P426, DOI 10.1177/104063870401600510; Yan JX, 2012, BIOCHIMIE, V94, P184, DOI 10.1016/j.biochi.2011.10.005; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	41	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158882	10.1371/journal.pone.0158882	http://dx.doi.org/10.1371/journal.pone.0158882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409794	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300040
J	Kang, J; Ge, CY; Yu, L; Li, LL; Ma, HT				Kang, Jian; Ge, Chongyang; Yu, Lei; Li, Longlong; Ma, Haitian			Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism via Activation of PI3K/Akt-PFK-2 Signaling Pathway in Rats Fed a High-Fat Diet	PLOS ONE			English	Article							LIPID-METABOLISM PARAMETERS; ADIPOSE-TISSUE; GLUCONEOGENIC ENZYMES; ENDOCRINE FUNCTIONS; GENE-EXPRESSION; BETA-CELLS; IN-VIVO; DHEA; ANTIOBESITY; OBESITY	Dehydroepiandrosterone ( DHEA) has a fat-reducing effect, while little information is available on whether DHEA regulates glucose metabolism, which would in turn affect fat deposition. To investigate the effects of DHEA on glucose metabolism, rats were administered a high-fat diet containing either 0 (HCG), 25 (HLG), 50 (HMG), or 100 (HHG) mg.kg(-1) DHEA per day via gavage for 8 weeks. Results showed that long-term administration of DHEA inhibited body weight gain in rats on a high-fat diet. No statistical differences in serum glucose levels were observed, whereas hepatic glycogen content in HMG and HHG groups and muscle glycogen content in HLG and HMG groups were higher than those in HCG group. Glucokinase, malate dehydrogenase and phosphofructokinase-2 activities in HMG and HHG groups, pyruvate kinase and succinate dehydrogenase activities in HMG group, and pyruvate dehydrogenase activity in all DHEA treatment groups were increased compared with those in HCG group. Phosphoenolpyruvate carboxykinase and glycogen phosphorylase mRNA levels were decreased in HMG and HHG groups, whereas glycogen synthase-2 mRNA level was increased in HMG group compared with those in HCG. The abundance of Glut2 mRNA in HMG and HHG groups and Glut4 mRNA in HMG group was higher than that in HCG group. DHEA treatment increased serum leptin content in HMG and HHG groups compared with that in HCG group. Serum insulin content and insulin receptor mRNA level in HMG group and insulin receptor substrate-2 mRNA level in HMG and HHG group were increased compared with those in HCG group. Furthermore, Pi3k mRNA level in HMG and Akt mRNA level in HMG and HHG groups were significantly increased than those in HCG group. These data showed that DHEA treatment could enhance glycogen storage and accelerate glucose catabolism in rats fed a high- fat diet, and this effect may be associated with the activation of PI3K/Akt-PFK-2 signaling pathway.	[Kang, Jian; Ge, Chongyang; Yu, Lei; Li, Longlong; Ma, Haitian] Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Ma, HT (corresponding author), Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	mahaitian@njau.edu.cn			National Natural Science Foundation of China [31572483]; Natural Science Foundation of Jiangsu Province [BK20151434]; A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31572483), the Natural Science Foundation of Jiangsu Province (No. BK20151434) and A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).; This work was supported by the National Natural Science Foundation of China (No. 31572483), the Natural Science Foundation of Jiangsu Province (No. BK20151434), and A Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adeneye AA, 2010, J ETHNOPHARMACOL, V130, P307, DOI 10.1016/j.jep.2010.05.009; Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002; Bacsi Krisztian, 2007, Orvosi Hetilap, V148, P1273, DOI 10.1556/OH.2007.28102; BURCH PT, 1985, DIABETES, V34, P1014, DOI 10.2337/diabetes.34.10.1014; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chen J, 2010, COMP BIOCHEM PHYS B, V155, P380, DOI 10.1016/j.cbpb.2009.12.005; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; CLEARY MP, 1991, P SOC EXP BIOL MED, V196, P8; CLEARY MP, 1986, INT J OBESITY, V10, P193; De Pergola G, 2000, INT J OBESITY, V24, pS59, DOI 10.1038/sj.ijo.0801280; Du GX, 2015, FOOD SCI TECHNOL RES, V21, P835, DOI 10.3136/fstr.21.835; FARKAS I, 1991, J BIOL CHEM, V266, P15602; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; GANSLER TS, 1985, P SOC EXP BIOL MED, V180, P155; Goel RM, 2011, CURR OPIN ENDOCRINOL, V18, P171, DOI 10.1097/MED.0b013e3283461818; Gui SY, 2013, J CELL BIOCHEM, V114, P1488, DOI 10.1002/jcb.24490; Hagiwara H, 2003, THROMB RES, V111, P301, DOI 10.1016/j.thromres.2003.09.023; Halimi S, 2014, DIABETES METAB, V40, P167, DOI 10.1016/j.diabet.2014.03.005; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Jaimes R, 2015, PFLUGERS ARCH EUROPE, P1; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Hernandez-Morante JJ, 2011, OBES SURG, V21, P102, DOI 10.1007/s11695-009-0064-8; Karbowska J, 2005, BIOCHEM PHARMACOL, V70, P249, DOI 10.1016/j.bcp.2005.04.022; Karbowska J, 2013, HORM MOL BIOL CLIN I, V14, P65, DOI 10.1515/hmbci-2013-0009; Karbowska J, 2012, STEROIDS, V77, P1359, DOI 10.1016/j.steroids.2012.08.002; Kelly PJ, 2014, DIABETIC MED, V31, P954, DOI 10.1111/dme.12468; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Kim YJ, 2008, GENES NUTR, V2, P353, DOI 10.1007/s12263-007-0070-1; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Legrain S, 2003, DRUG AGING, V20, P949, DOI 10.2165/00002512-200320130-00001; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; MARIE S, 1993, J BIOL CHEM, V268, P23881; Mauriege P, 2003, METABOLISM, V52, P264, DOI 10.1053/meta.2003.50043; Mayer D, 1996, INT J ONCOL, V8, P1069; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Monette MCE, 2014, CAN J DIABETES, V38, P401, DOI 10.1016/j.jcjd.2014.01.014; NAKASHIMA N, 1995, METABOLISM, V44, P543, DOI 10.1016/0026-0495(95)90065-9; Naredi Nikita, 2015, Med J Armed Forces India, V71, P274, DOI 10.1016/j.mjafi.2014.12.022; Nelson DL, 2013, LEHNINGER PRINCIPLES, V32, P947; Perrini S, 2004, DIABETES, V53, P41, DOI 10.2337/diabetes.53.1.41; Rencurel F, 1996, BIOCHEM J, V314, P903, DOI 10.1042/bj3140903; Roy S, 2003, GENE EXPRESSION, V11, P251, DOI 10.3727/000000003783992289; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Safiulina D, 2006, TOXICOL SCI, V93, P348, DOI 10.1093/toxsci/kfl064; Sato K, 2008, AJP ENDOCRINOLOGY ME, V294; Sato K, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-47; Shen XH, 2012, GEN COMP ENDOCR, V177, P177, DOI 10.1016/j.ygcen.2012.03.007; Song LJ, 2010, STEROIDS, V75, P213, DOI 10.1016/j.steroids.2009.11.007; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Suge R, 2012, BRAIN RES, V1481, P97, DOI 10.1016/j.brainres.2012.08.056; Tang X, 2007, LIPIDS, V42, P1025, DOI 10.1007/s11745-007-3104-y; Tang X, 2009, BRIT J NUTR, V102, P680, DOI 10.1017/S0007114509289021; Villareal DT, 2004, JAMA-J AM MED ASSOC, V292, P2243, DOI 10.1001/jama.292.18.2243; Yamashita R, 2005, ENDOCR J, V52, P727, DOI 10.1507/endocrj.52.727; Yang NC, 2002, LIFE SCI, V70, P1979, DOI 10.1016/S0024-3205(01)01542-9; Zhang YT, 2012, J ANIM VET ADV, V11, P4332; Zhou Y, 2015, PLOS ONE, V10	60	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159077	10.1371/journal.pone.0159077	http://dx.doi.org/10.1371/journal.pone.0159077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410429	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300055
J	Terayama, Y; Matsuura, T; Ozaki, K				Terayama, Yui; Matsuura, Tetsuro; Ozaki, Kiyokazu			Lack of Correlation between Aberrant p16, RAR-beta 2, TIMP3, ERCC1, and BRCA1 Protein Expression and Promoter Methylation in Squamous Cell Carcinoma Accompanying Candida albicans-Induced Inflammation	PLOS ONE			English	Article							RAT LUNG CARCINOGENESIS; RETINOIC ACID RECEPTOR; DNA METHYLATION; P16(INK4A) OVEREXPRESSION; PRECANCEROUS LESIONS; OVARIAN-CANCER; ORAL-CANCER; GENE; HYPERMETHYLATION; BETA	Hyperplastic candidiasis is characterized by thickening of the mucosal epithelia with Candida albicans infection with occasional progression to squamous cell carcinoma (SCC). C. albicans is a critical factor in tumor development; however, the oncogenic mechanism is unclear. We have previously produced an animal model for hyperplastic candidiasis in the rat forestomach. In the present study, we investigate whether impaired DNA methylation and associated protein expression of tumor suppressor and DNA repair genes are involved in the SCC carcinogenesis process using this hyperplastic candidiasis model. Promoter methylation and protein expression were analyzed by methylation specific PCR and immunohistochemical staining, respectively, of 5 areas in the forestomachs of alloxan-induced diabetic rats with hyperplastic candidiasis: normal squamous epithelia, squamous hyperplasia, squamous hyperplasia adjacent to SCC, squamous hyperplasia transitioning to SCC, and SCC. We observed nuclear p16 overexpression despite increases in p16 gene promoter methylation during the carcinogenic process. TIMP3 and RAR-beta 2 promoter methylation progressed until the precancerous stage but disappeared upon malignant transformation. In comparison, TIMP3 protein expression was suppressed during carcinogenesis and RAR-beta 2 expression was attenuated in the cytoplasm but enhanced in nuclei. ERCC1 and BRCA1 promoters were not methylated at any stage; however, their protein expression disappeared beginning at hyperplasia and nuclear protein re-expression in SCC was observed only for ERCC1. These results suggest that aberrant p16, RAR-beta 2, TIMP3, ERCC1, and BRCA1 expression might occur that is inconsistent with the respective gene promoter methylation status, and that this overexpression might serve to promote the inflammatory carcinogenesis caused by C. albicans infection.	[Terayama, Yui; Matsuura, Tetsuro; Ozaki, Kiyokazu] Setsunan Univ, Fac Pharmaceut Sci, Pathol Lab, Osaka, Japan	Setsunan University	Ozaki, K (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Pathol Lab, Osaka, Japan.	ozaki@pharm.setsunan.ac.jp	Ozaki, Kiyokazu/AAL-8633-2021	Ozaki, Kiyokazu/0000-0003-4275-6677				Bakri M.M., 2010, J ORAL MICROBIOL, V21; Brait M, 2012, EPIGENETICS-US, V7, P710, DOI 10.4161/epi.20524; Chang S, 2012, MOL CELLS, V34, P425, DOI 10.1007/s10059-012-0118-y; Chen HY, 2010, INT J CANCER, V126, P1944, DOI 10.1002/ijc.24772; Choi Yoon Sung, 2015, J Cancer Prev, V20, P268, DOI 10.15430/JCP.2015.20.4.268; Ciaparrone M, 2015, ONCOLOGY-BASEL, V89, P227, DOI 10.1159/000430447; Diez-Perez R, 2011, ONCOL REP, V25, P1203, DOI 10.3892/or.2011.1205; Dwivedi PP, 2009, MED MYCOL, V47, P157, DOI 10.1080/13693780802165797; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Facista Alexander, 2012, Genome Integr, V3, P3, DOI 10.1186/2041-9414-3-3; Fendrich V, 2005, PANCREAS, V30, pE40, DOI 10.1097/01.mpa.0000153325.62192.8a; Friboulet L, 2013, CELL CYCLE, V12, P3298, DOI 10.4161/cc.26309; Galle F, 2013, NEW MICROBIOL, V36, P283; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052589; Ge H, 2014, PATHOL RES PRACT, V210, P656, DOI 10.1016/j.prp.2014.06.013; Guan ZY, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-110; Gump J, 2003, J BIOL CHEM, V278, P6619, DOI 10.1074/jbc.C200622200; Hoftijzer HC, 2009, EUR J ENDOCRINOL, V160, P631, DOI 10.1530/EJE-08-0812; Kang GH, 2012, KOREAN J PATHOL, V46, P1, DOI 10.4132/KoreanJPathol.2012.46.1.1; Kobayashi T, 2013, MOL CANCER RES, V11, P828, DOI 10.1158/1541-7786.MCR-13-0207; Kodama Y, 2006, CANCER SCI, V97, P1023, DOI 10.1111/j.1349-7006.2006.00279.x; Kurie JM, 2003, J NATL CANCER I, V95, P206, DOI 10.1093/jnci/95.3.206; Lai ZL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/378358; Larque AB, 2015, VIRCHOWS ARCH, V466, P375, DOI 10.1007/s00428-015-1725-8; Li MH, 2016, CANCER RES, V76, P561, DOI 10.1158/0008-5472.CAN-14-3812; Lindsey JC, 2004, CARCINOGENESIS, V25, P661, DOI 10.1093/carcin/bgh055; Liu WB, 2011, BIOCHEM BIOPH RES CO, V408, P595, DOI 10.1016/j.bbrc.2011.04.067; Liu WB, 2011, TOXICOL APPL PHARM, V251, P70, DOI 10.1016/j.taap.2010.12.002; Liu WB, 2010, BIOCHEM BIOPH RES CO, V402, P507, DOI 10.1016/j.bbrc.2010.10.061; Liu WB, 2009, TOXICOL LETT, V189, P5, DOI 10.1016/j.toxlet.2009.04.022; LIU WZ, 2016, AM J CANCER RES, V6, P1, DOI DOI 10.1038/SREP28591; Lu DW, 2003, MODERN PATHOL, V16, P692, DOI 10.1097/01.MP.0000077417.08371.CE; Masson D, 2010, EUR J CANCER, V46, P1430, DOI 10.1016/j.ejca.2010.01.009; Mauro LV, 2008, MEDICINA-BUENOS AIRE, V68, P205; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Perez-Sayans M, 2009, ONCOL REP, V22, P1277, DOI 10.3892/or_00000565; Ralhan R, 2006, INT J CANCER, V118, P1077, DOI 10.1002/ijc.21483; Richter F, 2002, J ANDROL, V23, P830; Rochaix P, 1998, HISTOPATHOLOGY, V33, P337, DOI 10.1046/j.1365-2559.1998.00486.x; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Sano T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/509325; Sano T, 2009, TOXICOL PATHOL, V37, P790, DOI 10.1177/0192623309344204; Sitheeque MAM, 2003, CRIT REV ORAL BIOL M, V14, P253, DOI 10.1177/154411130301400403; Smith E, 2008, WORLD J GASTROENTERO, V14, P203, DOI 10.3748/wjg.14.203; Virani S, 2012, ILAR J, V53, P359, DOI 10.1093/ilar.53.3-4.359; Wang JM, 2008, CANCER EPIDEM BIOMAR, V17, P118, DOI 10.1158/1055-9965.EPI-07-0733; Wang YM, 2003, CLIN CANCER RES, V9, P5257; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Williams D W, 2001, Gerodontology, V18, P73, DOI 10.1111/j.1741-2358.2001.00073.x; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Zhao P, 2006, WORLD J GASTROENTERO, V12, P6391, DOI 10.3748/wjg.v12.i39.6391	54	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159090	10.1371/journal.pone.0159090	http://dx.doi.org/10.1371/journal.pone.0159090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410681	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300056
J	Hu, YB; Sosso, D; Qu, XQ; Chen, LQ; Ma, L; Chermak, D; Zhang, DC; Frommer, WB				Hu, Yi-Bing; Sosso, Davide; Qu, Xiao-Qing; Chen, Li-Qing; Ma, Lai; Chermak, Diane; Zhang, De-Chun; Frommer, Wolf B.			Phylogenetic evidence for a fusion of archaeal and bacterial SemiSWEETs to form eukaryotic SWEETs and identification of SWEET hexose transporters in the amphibian chytrid pathogen Batrachochytrium dendrobatidis	FASEB JOURNAL			English	Article						transporter evolution; oomycete; sugar transport; gene conversion; LECA	XANTHOMONAS-ORYZAE; GENE DUPLICATION; EVOLUTION; FAMILY; ORIGIN; NUTRITION; HOMOLOGS; SEQUENCE; LIMITS	SWEETs represent a new class of sugar transporters first described in plants, animals, and humans and later in prokaryotes. Plant SWEETs play key roles in phloem loading, seed filling, and nectar secretion, whereas the role of archaeal, bacterial, and animal transporters remains elusive. Structural analyses show that eukaryotic SWEETs are composed of 2 triple-helix bundles (THBs) fused via an inversion linker helix, whereas prokaryotic SemiSWEETs contain only a single THB and require homodimerization to form transport pores. This study indicates that SWEETs retained sugar transport activity in all kingdoms of life, and that SemiSWEETs are likely their ancestral units. Fusion of oligomeric subunits into single polypeptides during evolution of eukaryotes is commonly found for transporters. Phylogenetic analyses indicate that THBs of eukaryotic SWEETs may not have evolved by tandem duplication of an open reading frame, but rather originated by fusion between an archaeal and a bacterial SemiSWEET, which potentially explains the asymmetry of eukaryotic SWEETs. Moreover, despite the ancient ancestry, SWEETs had not been identified in fungi or oomycetes. Here, we report the identification of SWEETs in oomycetes as well as SWEETs and a potential SemiSWEET in primitive fungi. BdSWEET1 and BdSWEET2 from Batrachochytrium dendrobatidis, a nonhyphal zoosporic fungus that causes global decline in amphibians, showed glucose and fructose transport activities.-Hu, Y.-B., Sosso, D., Qu, X.-Q., Chen, L.-Q., Ma, L., Chermak, D., Zhang, D.-C., Frommer, W. B. Phylogenetic evidence for a fusion of archaeal and bacterial SemiSWEETs to form eukaryotic SWEETs and identification of SWEET hexose transporters in the amphibian chytrid pathogen Batrachochytrium dendrobatidis.	[Hu, Yi-Bing; Ma, Lai] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Hu, Yi-Bing; Sosso, Davide; Qu, Xiao-Qing; Chen, Li-Qing; Chermak, Diane; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Chen, Li-Qing] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [Chen, Li-Qing] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Zhang, De-Chun] China Three Gorges Univ, Biotechnol Res Ctr, Yichang, Peoples R China	Nanjing Agricultural University; Carnegie Institution for Science; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; China Three Gorges University	Hu, YB (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.; Frommer, WB (corresponding author), Stanford Univ, Dept Plant Biol, Carnegie Inst Sci, Stanford, CA 94305 USA.	huyb@njau.edu.cn; wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Hu, Yibing/0000-0002-7835-2319	Natural Science Foundation of China [31371596]; State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences [Y412201445]; Natural Science Foundation of Jiangsu Province [BK20151424]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy [DOE DE-FG02-04ER15542]; National Science Foundation [IOS-1258018]; Division Of Integrative Organismal Systems [1258018] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Natural Science Foundation of China (31371596), State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences (Y412201445), and Natural Science Foundation of Jiangsu Province (BK20151424). Work in the laboratory of W.B.F. was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (Grant DOE DE-FG02-04ER15542) and the National Science Foundation (IOS-1258018). The authors thank Eckhard Boles (Goethe University, Frankfurt, Germany) for allowing the use of EBY4000. The authors declare no conflicts of interest.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chen HY, 2015, PLANT J, V83, P1046, DOI 10.1111/tpj.12948; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cheng Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1151; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Da Lage JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-40; de Klein N, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/734147; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng L, 2015, TRENDS BIOCHEM SCI, V40, P480, DOI 10.1016/j.tibs.2015.05.005; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Irimia M, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016071; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0333; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Koonin EV, 2010, CELL, V140, P606, DOI 10.1016/j.cell.2010.02.022; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7112; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Moitra K, 2011, BIOL CHEM, V392, P29, DOI 10.1515/BC.2011.006; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Patil G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1730-y; Penny D, 2014, J MOL EVOL, V79, P228, DOI 10.1007/s00239-014-9643-y; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Sosso D, 2015, NAT GENET, V47, P1489, DOI 10.1038/ng.3422; Sun MX, 2013, PLANT REPROD, V26, P83, DOI 10.1007/s00497-012-0208-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xiong J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16724; Xu Y, 2014, NATURE, V515, P448, DOI 10.1038/nature13670; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; [玄元虎 Xuan Yuanhu], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P676; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094210	53	23	24	1	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3644	3654		10.1096/fj.201600576R	http://dx.doi.org/10.1096/fj.201600576R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27411857				2022-12-26	WOS:000384329800031
J	Liang, SL; Zhang, JC; Zhang, SH; Fu, XP				Liang, Shuli; Zhang, Junchen; Zhang, Shaohui; Fu, Xiangping			Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients	PLOS ONE			English	Article							BRAIN-TUMORS; SEIZURE; LEVETIRACETAM; PHENYTOIN; SURVIVAL; EXPRESSION; PHASE	Aim To analyze the incidence of epilepsy in adult patients with supratentorial glioblastoma, assess the factors influencing the development of epilepsy in these cases, and evaluate patients' response to antiepileptic drugs (AEDs) in a series of 184 patients. Methods We retrospectively analyzed the 184 adult patients diagnosed with supratentorial glioblastoma. All subjects were treated within our hospital and subsequently died between 2003 and 2013. The incidence of epilepsy was assessed before and after initial resection and reexamined every 2 months thereafter. We evaluated the efficacy of prophylactic AEDs in this patient population based on the gathered incidence data. Results Of 184 patients, 43 (23.37%) were diagnosed with epilepsy before their initial resection. The total incidence of epilepsy (both pre- and postoperative) was 68.48%. The prevalence of active epilepsy reached over 80% in patients with epilepsy and survival of greater than 13 months postoperatively. Patients with glioblastoma in the frontal and/or temporal lobes had a higher prevalence of epilepsy. In the 43 patients with preoperative epilepsy, total resection of glioblastoma resulted in significantly lower seizure frequency. Patients who received epilepsy prophylaxis with AEDs for at least 6 months had significantly fewer seizures and higher Karnofsky scores than those receiving AEDs for less than one month or not at all. Conclusion The incidence of epilepsy in adult patients with glioblastoma was high and responded poorly to AEDs in the short term. However, when taken for longer periods, AEDs can reduce the frequency of seizures in patients with glioblastoma.	[Liang, Shuli] Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China; [Liang, Shuli; Zhang, Shaohui; Fu, Xiangping] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing 100048, Peoples R China; [Zhang, Junchen] Jining Med Coll, Affiliated Hosp, Dept Neurosurg, Jining 272029, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Jining Medical University	Liang, SL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China.; Liang, SL (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Neurosurg, Beijing 100048, Peoples R China.	liangsl_304@304.com	Liang, Shuli/GWC-5028-2022		Beijing Technology & Science New-star Training Project [2010B084]	Beijing Technology & Science New-star Training Project	This research was funded by Beijing Technology & Science New-star Training Project [2010B084].	Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bruna J, 2013, EXPERT REV CLIN PHAR, V6, P333, DOI [10.1586/ECP.13.12, 10.1586/ecp.13.12]; Chaichana KL, 2009, J NEUROSURG, V111, P282, DOI 10.3171/2009.2.JNS081132; Davis ME, 2011, CLIN J ONCOL NURS, V15, P291, DOI 10.1188/11.CJON.291-297; Experts Group of China Association Against Epilepsy, 2012, CHINESE J OF NEUROSU, V28, P751; Fountain NB, 2009, EPILEPSY CURR, V9, P71, DOI 10.1111/j.1535-7511.2009.01297.x; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Klimek M, 2010, CURR OPIN ANESTHESIO, V23, P564, DOI 10.1097/ACO.0b013e32833e14f2; Lee JW, 2014, EPILEPSY RES, V108, P843, DOI 10.1016/j.eplepsyres.2014.02.021; Liang SL, 2006, CHINESE J NEUROSURGI, V5, P524; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Luyken C, 2003, EPILEPSIA, V44, P822, DOI 10.1046/j.1528-1157.2003.56102.x; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; Pace A, 2013, J NEURO-ONCOL, V111, P83, DOI 10.1007/s11060-012-0993-2; Rosati A, 2013, NEURO-ONCOLOGY, V15, P618, DOI 10.1093/neuonc/nos338; Rosati A, 2009, J NEURO-ONCOL, V93, P319, DOI 10.1007/s11060-008-9794-z; Siomin V, 2005, J NEURO-ONCOL, V74, P211, DOI 10.1007/s11060-004-6912-4; Taphoorn MJB, 2010, ONCOLOGIST, V15, P618, DOI 10.1634/theoncologist.2009-0291; Tebo CC, 2014, J NEUROSURG, V120, P1415, DOI 10.3171/2014.1.JNS131694; Tremont-Lukats IW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004424.pub2; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Vecht CJ, 2014, ONCOLOGIST, V19, P751, DOI 10.1634/theoncologist.2014-0060; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang ZJ, 2008, MED CLIN RES, V25, P2186	25	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158206	10.1371/journal.pone.0158206	http://dx.doi.org/10.1371/journal.pone.0158206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438472	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100008
J	Shanmugasundaram, U; Kovarova, M; Ho, PT; Schramm, N; Wahl, A; Parniak, MA; Garcia, JV				Shanmugasundaram, Uma; Kovarova, Martina; Ho, Phong T.; Schramm, Nathaniel; Wahl, Angela; Parniak, Michael A.; Garcia, J. Victor			Efficient Inhibition of HIV Replication in the Gastrointestinal and Female Reproductive Tracts of Humanized BLT Mice by EFdA	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; T-CELL DEPLETION; IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; TYPE-1 INFECTION; POTENT ACTIVITY; IN-VIVO; CD4(+); TRANSMISSION	Background The nucleoside reverse transcriptase inhibitor (NRTI) 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) in preclinical development exhibits improved safety and antiviral activity profiles with minimal drug resistance compared to approved NRTIs. However, the systemic antiviral efficacy of EFdA has not been fully evaluated. In this study, we utilized bone marrow/liver/thymus (BLT) humanized mice to investigate the systemic effect of EFdA treatment on HIV replication and CD4+ T cell depletion in the peripheral blood (PB) and tissues. In particular, we performed a comprehensive analysis of the female reproductive tract (FRT) and gastrointestinal (GI) tract, major sites of transmission, viral replication, and CD4+ T cell depletion and where some current antiretroviral drugs have a sub-optimal effect. Results EFdA treatment resulted in reduction of HIV-RNA in PB to undetectable levels in the majority of treated mice by 3 weeks post-treatment. HIV-RNA levels in cervicovaginal lavage of EFdA-treated BLT mice also declined to undetectable levels demonstrating strong penetration of EFdA into the FRT. Our results also demonstrate a strong systemic suppression of HIV replication in all tissues analyzed. In particular, we observed more than a 2-log difference in HIV-RNA levels in the GI tract and FRT of EFdA-treated BLT mice compared to untreated HIV-infected control mice. In addition, HIV-RNA was also significantly lower in the lymph nodes, liver, lung, spleen of EFdA- treated BLT mice compared to untreated HIV-infected control mice. Furthermore, EFdA treatment prevented the depletion of CD4+ T cells in the PB, mucosal tissues and lymphoid tissues. Conclusion Our findings indicate that EFdA is highly effective in controlling viral replication and preserving CD4+ T cells in particular with high efficiency in the GI and FRT tract. Thus, EFdA represents a strong potential candidate for further development as a part of antiretroviral therapy regimens.	[Shanmugasundaram, Uma; Kovarova, Martina; Ho, Phong T.; Schramm, Nathaniel; Wahl, Angela; Garcia, J. Victor] Univ N Carolina, Sch Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Parniak, Michael A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garcia, JV (corresponding author), Univ N Carolina, Sch Med, Div Infect Dis, Ctr AIDS Res, Chapel Hill, NC 27599 USA.	victor_garcia@med.unc.edu		Kovarova, Martina/0000-0001-7152-1709	National Institutes of Health [AI073146, AI096138]; UNC Center for AIDS Research [P30 AI50410]; AIDS Research and Reagent Program [2708]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Center for AIDS Research; AIDS Research and Reagent Program	This work was supported by National Institutes of Health grants (AI073146 and AI096138) and the UNC Center for AIDS Research (P30 AI50410). The funders had no part in the study design, data collection/analysis, decision to publish, or preparation of the manuscript.; We thank I. Chen for providing pYK-JRCSF (cat# 2708) through the AIDS Research and Reagent Program. We also thank former and current members of the Garcia laboratory as well as the husbandry technicians at the UNC Division of Laboratory Animal Medicine who contributed to aspects of this work.	Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Bourry O, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-78; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Cohan D, 2005, AIDS, V19, P989, DOI 10.1097/01.aids.0000171417.84162.af; Cohen J, 2011, SCIENCE, V334, P1614, DOI 10.1126/science.334.6063.1614; Costiniuk CT, 2015, AIDS PATIENT CARE ST, V29, P55, DOI 10.1089/apc.2014.0173; Denton PW, 2012, MUCOSAL IMMUNOL, V5, P555, DOI 10.1038/mi.2012.31; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Edagwa BJ, 2014, CURR MED CHEM, V21, P4186, DOI 10.2174/0929867321666140826114135; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09; Hsu DC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-29; Kantor R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093537; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kovarova M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005075; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Long BR, 2012, J VIROL, V86, P3327, DOI 10.1128/JVI.06676-11; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Murphey-Corb M, 2012, ANTIMICROB AGENTS CH, V56, P4707, DOI 10.1128/AAC.00723-12; O'Connor JL, 2014, AIDS, V28, P919, DOI 10.1097/QAD.0000000000000165; Ohrui H, 2007, NUCLEOS NUCLEOT NUCL, V26, P1543, DOI 10.1080/15257770701545218; Olesen R, 2016, J CLIN INVEST, V126, P892, DOI 10.1172/JCI64212; Olesen R, 2011, J REPROD IMMUNOL, V88, P195, DOI 10.1016/j.jri.2010.11.005; Shanmugasundaram U, 2014, AM J REPROD IMMUNOL, V71, P95, DOI 10.1111/aji.12182; Stoddart CA, 2015, ANTIMICROB AGENTS CH, V59, P4190, DOI 10.1128/AAC.05036-14; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wahl A, 2015, J VIROL, V89, P10868, DOI 10.1128/JVI.01702-15; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44; Zoufaly A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087160	40	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159517	10.1371/journal.pone.0159517	http://dx.doi.org/10.1371/journal.pone.0159517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438728	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100052
J	Hunt, J; Murrell, J; Knazovicky, D; Harris, J; Kelly, S; Knowles, TG; Lascelles, BDX				Hunt, James; Murrell, Jo; Knazovicky, David; Harris, John; Kelly, Sara; Knowles, Toby G.; Lascelles, B. Duncan X.			Alfaxalone Anaesthesia Facilitates Electrophysiological Recordings of Nociceptive Withdrawal Reflexes in Dogs (Canis familiaris)	PLOS ONE			English	Article							SPINAL-CORD; CENTRAL SENSITIZATION; OSTEOARTHRITIS PAIN; CONSCIOUS DOGS; RATE-INFUSION; ISOFLURANE; STIMULI; LIMB; ORGANIZATION; HEAT	Naturally occurring canine osteoarthritis represents a welfare issue for affected dogs (Canis familiaris), but is also considered very similar to human osteoarthritis and has therefore been proposed as a model of disease in humans. Central sensitisation is recognized in human osteoarthritis sufferers but identification in dogs is challenging. Electromyographic measurement of responses to nociceptive stimulation represents a potential means of investigating alterations in central nociceptive processing, and has been evaluated in conscious experimental dogs, but is likely to be aversive. Development of a suitable anaesthetic protocol in experimental dogs, which facilitated electrophysiological nociceptive withdrawal reflex assessment, may increase the acceptability of using the technique in owned dogs with naturally occurring osteoarthritis. Seven purpose bred male hound dogs underwent electromyographic recording sessions in each of three states: acepromazine sedation, alfaxalone sedation, and alfaxalone anaesthesia. Electromyographic responses to escalating mechanical and electrical, and repeated electrical, stimuli were recorded. Subsequently the integral of both early and late rectified responses was calculated. Natural logarithms of the integral values were analysed within and between the three states using multi level modeling. Alfaxalone increased nociceptive thresholds and decreased the magnitude of recorded responses, but characteristics of increasing responses with increasing stimulus magnitude were preserved. Behavioural signs of anxiety were noted in two out of seven dogs during recordings in the acepromazine sedated state. There were few significant differences in response magnitude or nociceptive threshold between the two alfaxalone states. Following acepromazine premedication, induction of anaesthesia with 1-2 mg kg(-1) alfaxalone, followed by a continuous rate infusion in the range 0.075-0.1 mg kg(-1) min(-1) produced suitable conditions to enable assessment of spinal nociceptive processing in dogs, without subjecting them to potentially aversive experiences. This methodology may be appropriate for obtaining electrophysiological nociceptive withdrawal reflex data in client-owned dogs with naturally occurring osteoarthritis.	[Hunt, James; Murrell, Jo; Knowles, Toby G.] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Knazovicky, David; Lascelles, B. Duncan X.] North Carolina State Univ, Coll Vet Med, Comparat Pain Res Lab, Raleigh, NC 27695 USA; [Harris, John; Kelly, Sara] Univ Nottingham, Sch Biosci, Div Anim Sci, Sutton Bonington Campus, Loughborough, Leics, England; [Lascelles, B. Duncan X.] UNC Sch Dent, Ctr Pain Res & Innovat, Chapel Hill, NC 27599 USA; [Lascelles, B. Duncan X.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Knazovicky, David] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA	University of Bristol; University of North Carolina; North Carolina State University; University of Nottingham; University of North Carolina; North Carolina State University; Oregon State University	Lascelles, BDX (corresponding author), North Carolina State Univ, Coll Vet Med, Comparat Pain Res Lab, Raleigh, NC 27695 USA.; Lascelles, BDX (corresponding author), UNC Sch Dent, Ctr Pain Res & Innovat, Chapel Hill, NC 27599 USA.; Lascelles, BDX (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.	dxlascel@ncsu.edu	Hunt, James/AAK-2854-2020; Knowles, Toby G/A-2026-2008	Knowles, Toby G/0000-0002-3845-0942; Lascelles, B. Duncan X./0000-0002-2950-9009; Harris, John/0000-0001-7815-5385	Comparative Pain Research Laboratory, North Carolina State University; BBSRC [BB/L00240X/1]; Biotechnology and Biological Sciences Research Council [BB/L00240X/1, BB/L001349/1] Funding Source: researchfish; BBSRC [BB/L001349/1] Funding Source: UKRI	Comparative Pain Research Laboratory, North Carolina State University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was received from the Comparative Pain Research Laboratory, North Carolina State University. Travel and accommodation expenses for J. Hunt and JM, and salary costs of J. Hunt were met from BBSRC grant BB/L00240X/1, for which Zoetis is the Industry Partner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; Baron R, 2013, ANN NEUROL, V74, P630, DOI 10.1002/ana.24017; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Bergadano A, 2006, AM J VET RES, V67, P882, DOI 10.2460/ajvr.67.5.882; Bergadano A, 2007, AM J VET RES, V68, P899, DOI 10.2460/ajvr.68.8.899; Bergadano A, 2009, VET J, V182, P252, DOI 10.1016/j.tvjl.2008.06.003; Bergadano A, 2009, VET ANAESTH ANALG, V36, P261, DOI 10.1111/j.1467-2995.2009.00447.x; Briley JD, 2014, VET J, V199, P245, DOI 10.1016/j.tvjl.2013.10.025; Brydges NM, 2012, VET J, V193, P545, DOI 10.1016/j.tvjl.2012.01.019; CARSTENS E, 1993, J NEUROPHYSIOL, V70, P621, DOI 10.1152/jn.1993.70.2.621; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; du Sert NP, 2014, BRIT J PHARMACOL, V171, P2951, DOI 10.1111/bph.12645; FANSELOW MS, 1986, ANN NY ACAD SCI, V467, P40, DOI 10.1111/j.1749-6632.1986.tb14617.x; Frahm KS, 2013, BMC NEUROSCI, V14, P1; Harris J, 2003, J PHYSIOL-LONDON, V546, P251, DOI 10.1113/jphysiol.2002.025023; Harris J, 2007, BRAIN RES, V1131, P106, DOI 10.1016/j.brainres.2006.11.003; Jennings EM, 2014, PROG NEUROBIOL, V121, P1, DOI 10.1016/j.pneurobio.2014.06.003; Jinks SL, 2003, ANESTHESIOLOGY, V98, P1128, DOI 10.1097/00000542-200305000-00015; Kelly S, 2013, OSTEOARTHR CARTILAGE, V21, P1327, DOI 10.1016/j.joca.2013.07.002; Kim J, 2007, ANESTH ANALG, V105, P1020, DOI 10.1213/01.ane.0000280483.17854.56; Knazovicky D, 2015, PEERJ, V3, DOI 10.7717/peerj.772; Lascelles BDX, 2008, J VET INTERN MED, V22, P53, DOI 10.1111/j.1939-1676.2007.0014.x; Lascelles BDX, 2002, J AM VET MED ASSOC, V221, P215, DOI 10.2460/javma.2002.221.215; Lervik A, 2012, VET ANAESTH ANALG, V39, P414, DOI 10.1111/j.1467-2995.2012.00713.x; MEYER RA, 1991, BRAIN RES, V561, P252, DOI 10.1016/0006-8993(91)91601-V; Moore SA, 2013, VET J, V197, P216, DOI 10.1016/j.tvjl.2012.11.003; Morch CD, 2011, MED BIOL ENG COMPUT, V49, P385, DOI 10.1007/s11517-010-0725-8; Nijland ML, 2010, PUBLIC HEALTH NUTR, V13, P102, DOI 10.1017/S136898000999022X; PETERSENFELIX S, 1995, BRIT J ANAESTH, V75, P55, DOI 10.1093/bja/75.1.55; Rasbash J, 2009, MLWIN VERSION 21; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; SCHOUENBORG J, 1994, NEWS PHYSIOL SCI, V9, P261; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sorensen J, 1998, J RHEUMATOL, V25, P152; Spadavecchia C, 2006, AM J VET RES, V67, P762, DOI 10.2460/ajvr.67.5.762; Tomas A, 2014, VET SURG, V43, P542, DOI 10.1111/j.1532-950X.2014.12160.x; TORRING J, 1981, J NEUROL NEUROSUR PS, V44, P129, DOI 10.1136/jnnp.44.2.129; Vainio O, 2012, SCAND J PAIN, V3, P84, DOI 10.1016/j.sjpain.2011.11.007; Weerasinghe NS, 2014, EUR J PAIN, V18, P1199, DOI 10.1002/j.1532-2149.2014.00469.x; Williams MD, 2014, VET J, V199, P63, DOI 10.1016/j.tvjl.2013.11.003; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yeates J, 2014, J AWSELVA, V18, P9	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158990	10.1371/journal.pone.0158990	http://dx.doi.org/10.1371/journal.pone.0158990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433936	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600028
J	Yan, R; Friemel, M; Aloisi, C; Huynen, M; Taylor, IA; Leimkuhler, S; Pastore, A				Yan, Robert; Friemel, Martin; Aloisi, Claudia; Huynen, Martijn; Taylor, Ian A.; Leimkuehler, Silke; Pastore, Annalisa			The Eukaryotic-Specific ISD11 Is a Complex-Orphan Protein with Ability to Bind the Prokaryotic IscS	PLOS ONE			English	Article							SULFUR CLUSTER FORMATION; CYSTEINE DESULFURASE; INTERACTING PROTEIN; BACTERIAL FRATAXIN; STATISTICAL-MODEL; BIOGENESIS; DEFICIENCY; FERREDOXIN; MECHANISM; MUTATION	The eukaryotic protein Isd11 is a chaperone that binds and stabilizes the central component of the essential metabolic pathway responsible for formation of iron-sulfur clusters in mitochondria, the desulfurase Nfs1. Little is known about the exact role of Isd11. Here, we show that human Isd11 (ISD11) is a helical protein which exists in solution as an equilibrium between monomer, dimeric and tetrameric species when in the absence of human Nfs1 (NFS1). We also show that, surprisingly, recombinant ISD11 expressed in E. coli co-purifies with the bacterial orthologue of NFS1, IscS. Binding is weak but specific suggesting that, despite the absence of Isd11 sequences in bacteria, there is enough conservation between the two desulfurases to retain a similar mode of interaction. This knowledge may inform us on the conservation of the mode of binding of Isd11 to the desulfurase. We used evolutionary evidence to suggest Isd11 residues involved in the interaction.	[Yan, Robert; Aloisi, Claudia; Pastore, Annalisa] Kings Coll London, Maurice Wohl Inst, 5 Cutcombe Rd, London SE5, England; [Friemel, Martin; Leimkuehler, Silke] Univ Potsdam, Dept Mol Enzymol, Inst Biochem & Biol, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany; [Huynen, Martijn] Radboud Univ Nijmegen, Med Ctr, CMBI 260, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Taylor, Ian A.] Francis Crick Inst, Mill Hill Lab, London NW7 1AA, England	University of Potsdam; Radboud University Nijmegen; Francis Crick Institute	Pastore, A (corresponding author), Kings Coll London, Maurice Wohl Inst, 5 Cutcombe Rd, London SE5, England.	Annalisa.1.Pastore@kcl.ac.uk	Yan, Robert/GYU-0395-2022; Huynen, Martijn A/A-1530-2014; Aloisi, Claudia/Z-1680-2018	Huynen, Martijn A/0000-0001-6189-5491; Leimkuhler, Silke/0000-0003-3238-2122; Aloisi, Claudia/0000-0002-2279-7757	MRC [U117584256]; EU (SARCOSI consortium); Deutsche Forschungsgemeinschaft (DFG) [LE1171/11-1]; MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish; The Francis Crick Institute [10029, 10178] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU (SARCOSI consortium); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	The authors are indebted to the MRC NMR Centre and David Frith of LRI/NIMR Proteomics and Metabolomics Core Technology Platform (Francis Crick Institute) for technical support. This work was funded by MRC (Grant ref. U117584256) and EU (SARCOSI consortium) (AP), and by the Deutsche Forschungsgemeinschaft (DFG) grant LE1171/11-1 (SL).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Angerer H, 2013, BIOCHEM SOC T, V41, P1335, DOI 10.1042/BST20130116; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feenstra KA, 2007, NUCLEIC ACIDS RES, V35, pW495, DOI 10.1093/nar/gkm406; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fischer S, 2011, USING ORTHOMCL ASSIG, V35; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295; Maio N, 2014, CELL METAB, V19, P445, DOI 10.1016/j.cmet.2014.01.015; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Paris Z, 2010, J BIOL CHEM, V285, P22394, DOI 10.1074/jbc.M109.083774; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pastore C, 2006, STRUCTURE, V14, P857, DOI 10.1016/j.str.2006.02.010; Prischi F, 2010, PROTEIN EXPRES PURIF, V73, P161, DOI 10.1016/j.pep.2010.05.003; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Saha PP, 2015, J BIOL CHEM; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Terali K, 2013, BIOCHEM BIOPH RES CO, V440, P235, DOI 10.1016/j.bbrc.2013.09.039; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yan R, 2015, BBA-PROTEINS PROTEOM, V1854, P1113, DOI 10.1016/j.bbapap.2015.02.002; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	44	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157895	10.1371/journal.pone.0157895	http://dx.doi.org/10.1371/journal.pone.0157895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427956	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300006
J	Lee, G; Bucheli, DER; Madabhushi, A				Lee, George; Bucheli, David Edmundo Romo; Madabhushi, Anant			Adaptive Dimensionality Reduction with Semi-Supervision (AdDReSS): Classifying Multi-Attribute Biomedical Data	PLOS ONE			English	Article							FEATURE-SELECTION; CLASSIFICATION; GENE; REGRESSION; FEATURES	Medical diagnostics is often a multi-attribute problem, necessitating sophisticated tools for analyzing high-dimensional biomedical data. Mining this data often results in two crucial bottlenecks: 1) high dimensionality of features used to represent rich biological data and 2) small amounts of labelled training data due to the expense of consulting highly specific medical expertise necessary to assess each study. Currently, no approach that we are aware of has attempted to use active learning in the context of dimensionality reduction approaches for improving the construction of low dimensional representations. We present our novel methodology, AdDReSS (Adaptive Dimensionality Reduction with Semi-Supervision), to demonstrate that fewer labeled instances identified via AL in embedding space are needed for creating a more discriminative embedding representation compared to randomly selected instances. We tested our methodology on a wide variety of domains ranging from prostate gene expression, ovarian proteomic spectra, brain magnetic resonance imaging, and breast histopathology. Across these various high dimensional biomedical datasets with 100+ observations each and all parameters considered, the median classification accuracy across all experiments showed AdDReSS (88.7%) to outperform SSAGE, a SSDR method using random sampling (85.5%), and Graph Embedding (81.5%). Furthermore, we found that embeddings generated via AdDReSS achieved a mean 35.95% improvement in Raghavan efficiency, a measure of learning rate, over SSAGE. Our results demonstrate the value of AdDReSS to provide low dimensional representations of high dimensional biomedical data while achieving higher classification rates with fewer labelled examples as compared to without active learning.	[Lee, George; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Bucheli, David Edmundo Romo] Univ Nacl Colombia, CIM LAB Res Grp, Bogota, Colombia	Case Western Reserve University; Universidad Nacional de Colombia	Lee, G; Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	george.lee@case.edu; anant.madabhushi@case.edu	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399; Lee, George/0000-0002-8705-9210	National Institutes of Health [K01ES026841]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University;  [R21CA167811-01];  [R21CA179327-01];  [R21CA195152-01];  [U24CA199374-01]; NATIONAL CANCER INSTITUTE [R21CA179327, R01CA202752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GL was supported by National Institutes of Health (K01ES026841). AM was supported by R21CA167811-01, R21CA179327-01, R21CA195152-01, U24CA199374-01; the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02; the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463); the DOD Prostate Cancer Idea Development Award; the Ohio Third Frontier Technology development Grant; the CTSC Coulter Annual Pilot Grant; the Case Comprehensive Cancer Center Pilot Grant; the VelaSano Grant from the Cleveland Clinic; and the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baram Y, 2004, J MACH LEARN RES, V5, P255; Bellman R., 1961, ADAPTIVE CONTROL PRO; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chang H, 2012, INT S BIOM IM; Chen YK, 2012, J BIOMED INFORM, V45, P265, DOI 10.1016/j.jbi.2011.11.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox TFCMAA, 2001, MULTIDIMENSIONAL SCA; Dawson K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-195; Doyle S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-424; Duda R.O., 2000, PATTERN CLASSIFICATI; Freund Y, 1997, MACH LEARN, V28, P133, DOI 10.1023/A:1007330508534; Geurts P, 2005, BIOINFORMATICS, V21, P3138, DOI 10.1093/bioinformatics/bti494; Golugula A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-483; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Han YH, 2015, IEEE T NEUR NET LEAR, V26, P252, DOI 10.1109/TNNLS.2014.2314123; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hou CP, 2011, LECT NOTES ARTIF INT, V6820, P91, DOI 10.1007/978-3-642-22589-5_10; Hoyle DC, 2008, J MACH LEARN RES, V9, P2733; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Huang Y, 2012, IEEE T NEUR NET LEAR, V23, P519, DOI 10.1109/TNNLS.2011.2178037; HUGHES GF, 1968, IEEE T INFORM THEORY, V14, P55, DOI 10.1109/TIT.1968.1054102; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Lee G, 2008, IEEE ACM T COMPUT BI, V5, P368, DOI 10.1109/TCBB.2008.36; Lee G, 2010, LECT N BIOINFORMAT, V6282, P207, DOI 10.1007/978-3-642-16001-1_18; Liu MX, 2016, IEEE T CYBERNETICS, V46, P298, DOI 10.1109/TCYB.2015.2401733; Liu Y, 2004, J CHEM INF COMP SCI, V44, P1936, DOI 10.1021/ci049810a; Madabhushi A, 2005, LECT NOTES COMPUT SC, V3749, P729; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Nilsson J, 2004, BIOINFORMATICS, V20, P874, DOI 10.1093/bioinformatics/btg496; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Qian B., 2010, AAAI; Raghavan H, 2006, J MACH LEARN RES, V7, P1655; Romo D, 2014, SPIE MED IMAGING; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Schohn G., 2000, P 17 INT C MACH LEAR, P839; Scholkopf B, 1998, KERNEL PCA PATTERN R; Seung H. S., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P287, DOI 10.1145/130385.130417; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Shi XS, 2015, IEEE T IMAGE PROCESS, V24, P1341, DOI 10.1109/TIP.2015.2405474; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Sugiyama M, 2010, MACH LEARN, V78, P35, DOI 10.1007/s10994-009-5125-7; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Venna J, 2006, NEURAL NETWORKS, V19, P889, DOI 10.1016/j.neunet.2006.05.014; Verbeek JJ, 2006, PATTERN RECOGN, V39, P1864, DOI 10.1016/j.patcog.2006.04.011; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zha H., 2006, P INT C MACHINE LEAR, DOI [10.1145/1143844.1143978, DOI 10.1145/1143844.1143978]; Zhang D, 2007, SIAM INT C DAT MIN; Zhang L, 2011, IEEE T PATTERN ANAL; Zhao HT, 2006, NEUROCOMPUTING, V69, P2385, DOI 10.1016/j.neucom.2006.02.010; Zhao MB, 2012, PATTERN RECOGN, V45, P1482, DOI 10.1016/j.patcog.2011.10.008	59	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159088	10.1371/journal.pone.0159088	http://dx.doi.org/10.1371/journal.pone.0159088			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27421116	Green Published, Green Submitted, gold			2022-12-26	WOS:000379662300009
J	Schaut, RG; Ridpath, JF; Sacco, RE				Schaut, Robert G.; Ridpath, Julia F.; Sacco, Randy E.			Bovine Viral Diarrhea Virus Type 2 Impairs Macrophage Responsiveness to Toll-Like Receptor Ligation with the Exception of Toll-Like Receptor 7	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HEPATITIS-C VIRUS; INTERFERON REGULATORY FACTOR-3; MESSENGER-RNA EXPRESSION; IN-VITRO; PROTEASOMAL DEGRADATION; MUCOSAL DISEASE; ACUTE INFECTION; T-CELLS; BVDV	Bovine viral diarrhea virus (BVDV) is a member of the Flaviviridae family. BVDV isolates are classified into two biotypes based on the development of cytopathic (cp) or non-cytopathic (ncp) effects in epithelial cell culture. BVDV isolates are further separated into species, BVDV1 and 2, based on genetic differences. Symptoms of BVDV infection range from subclinical to severe, depending on strain virulence, and may involve multiple organ systems and induction of a generalized immunosuppression. During BVDV-induced immune suppression, macrophages, critical to innate immunity, may have altered pathogen recognition receptor (PRR) signaling, including signaling through toll-like receptors (TLRs). Comparison of BVDV 2 strains with different biotypes and virulence levels is valuable to determining if there are differences in host macrophage cellular responses between viral phenotypes. The current study demonstrates that cytopathic (cp), noncytopathic (ncp), high (hv) or low virulence (lv) BVDV2 infection of bovine monocyte-derived macrophages (MDMF) result in differential expression of pro-inflammatory cytokines compared to uninfected MDMF. A hallmark of cp BVDV2 infection is IL-6 production. In response to TLR2 or 4 ligation, as might be observed during secondary bacterial infection, cytokine secretion was markedly decreased in BVDV2-infected MDMF, compared to non-infected MDMF. Macrophages were hyporesponsive to viral TLR3 or TLR8 ligation. However, TLR7 stimulation of BVDV2-infected MDMF induced cytokine secretion, unlike results observed for other TLRs. Together, these data suggest that BVDV2 infection modulated mRNA responses and induced a suppression of proinflammatory cytokine protein responses to TLR ligation in MDMF with the exception of TLR7 ligation. It is likely that there are distinct differences in TLR pathways modulated following BVDV2 infection, which have implications for macrophage responses to secondary infections.	[Schaut, Robert G.; Sacco, Randy E.] Iowa State Univ, Immunobiol Grad Program, Ames, IA 50011 USA; [Schaut, Robert G.; Ridpath, Julia F.; Sacco, Randy E.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA	Iowa State University; United States Department of Agriculture (USDA)	Sacco, RE (corresponding author), Iowa State Univ, Immunobiol Grad Program, Ames, IA 50011 USA.; Sacco, RE (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	randy.sacco@ars.usda.gov		Schaut, Robert G./0000-0003-2713-9013; Ridpath, Julia/0000-0001-7182-8161				Adler H, 1996, J VIROL, V70, P2650, DOI 10.1128/JVI.70.4.2650-2653.1996; AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Ammari M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S9; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; ATLURU D, 1992, VET IMMUNOL IMMUNOP, V31, P49, DOI 10.1016/0165-2427(92)90086-6; Baigent SJ, 2002, J VIROL, V76, P8979, DOI 10.1128/JVI.76.18.8979-8988.2002; Baroth M, 2000, VIROLOGY, V278, P456, DOI 10.1006/viro.2000.0644; Bauermann FV, 2012, J VET DIAGN INVEST, V24, P253, DOI 10.1177/1040638711435144; Becher P, 2002, J VIROL, V76, P13069, DOI 10.1128/JVI.76.24.13069-13076.2002; Biasin M, 2010, J IMMUNOL, V184, P2710, DOI 10.4049/jimmunol.0902463; BROWN GB, 1991, AM J VET RES, V52, P381; Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x; Buckwold VE, 2003, ANTIVIR RES, V60, P1, DOI 10.1016/S0166-3542(03)00174-8; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Chung H, 2011, J VIRAL HEPATITIS, V18, pE561, DOI 10.1111/j.1365-2893.2011.01478.x; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Barros VED, 2009, REV INST MED TROP SP, V51, P141, DOI 10.1590/S0036-46652009000300004; DONIS RO, 1987, VIROLOGY, V158, P168, DOI 10.1016/0042-6822(87)90250-9; Duvel A, 2012, INNATE IMMUN-LONDON, V18, P886, DOI 10.1177/1753425912446954; Franchini M, 2006, VET IMMUNOL IMMUNOP, V110, P37, DOI 10.1016/j.vetimm.2005.09.002; Fulton RW, 2006, JAVMA-J AM VET MED A, V228, P578, DOI 10.2460/javma.228.4.578; Fulton RW, 2005, VET MICROBIOL, V111, P35, DOI 10.1016/j.vetmic.2005.10.002; Gibson A, 2011, J VIROL, V85, P3695, DOI 10.1128/JVI.02626-10; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Houe H, 2003, BIOLOGICALS, V31, P137, DOI 10.1016/S1045-1056(03)00030-7; JENSEN J, 1991, VET IMMUNOL IMMUNOP, V29, P251, DOI 10.1016/0165-2427(91)90018-8; KETELSEN AT, 1979, INFECT IMMUN, V25, P565, DOI 10.1128/IAI.25.2.565-568.1979; Kummerer BM, 2000, VET MICROBIOL, V77, P117, DOI 10.1016/S0378-1135(00)00268-6; Lambot M, 1998, J GEN VIROL, V79, P1745, DOI 10.1099/0022-1317-79-7-1745; Lee SR, 2008, COMP IMMUNOL MICROB, V31, P403, DOI 10.1016/j.cimid.2007.06.006; Liebler-Tenorio EM, 2004, J VET DIAGN INVEST, V16, P388, DOI 10.1177/104063870401600504; Liebler-Tenorio EM, 2003, BIOLOGICALS, V31, P119, DOI 10.1016/S1045-1056(03)00026-5; Liebler-Tenorio EM, 2003, J VET DIAGN INVEST, V15, P221, DOI 10.1177/104063870301500303; Liu BS, 2011, J LEUKOCYTE BIOL, V89, P981, DOI 10.1189/jlb.1210680; Liu L, 1999, CAN J VET RES, V63, P41; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; MING JE, 1990, CELL IMMUNOL, V130, P437, DOI 10.1016/0008-8749(90)90285-Y; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; OHMANN HB, 1988, VET PATHOL, V25, P304, DOI 10.1177/030098588802500409; OHMANN HB, 1987, J GEN VIROL, V68, P1971, DOI 10.1099/0022-1317-68-7-1971; Pedrera M, 2009, J GEN VIROL, V90, P2650, DOI 10.1099/vir.0.012021-0; Peterhans E, 2003, BIOLOGICALS, V31, P107, DOI 10.1016/S1045-1056(03)00024-1; Peterhans E, 2010, VET MICROBIOL, V142, P18, DOI 10.1016/j.vetmic.2009.09.038; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; QI FX, 1992, VIROLOGY, V189, P285, DOI 10.1016/0042-6822(92)90704-S; Raqib R, 1996, EUR J IMMUNOL, V26, P1130, DOI 10.1002/eji.1830260526; Rathinam VAK, 2010, J CLIN IMMUNOL, V30, P632, DOI 10.1007/s10875-010-9431-4; Re F, 1996, J EXP MED, V183, P1841, DOI 10.1084/jem.183.4.1841; RIDPATH JF, 1995, VIROLOGY, V212, P39, DOI 10.1006/viro.1995.1451; Ridpath JF, 2006, VIRUS RES, V118, P62, DOI 10.1016/j.virusres.2005.11.014; Ridpath JF, 2005, PREV VET MED, V72, P17, DOI 10.1016/j.prevetmed.2005.08.003; Ridpath J, 2010, VET CLIN N AM-FOOD A, V26, P335, DOI 10.1016/j.cvfa.2010.04.003; Rogez-Kreuz C, 2005, INT IMMUNOL, V17, P1047, DOI 10.1093/intimm/dxh285; ROTH JA, 1986, AM J VET RES, V47, P1139; ROTH JA, 1981, AM J VET RES, V42, P244; Ruzek MC, 1999, J IMMUNOL, V162, P3527; Schaut RG, 2015, VIRUS RES, V208, P44, DOI 10.1016/j.virusres.2015.05.017; SCHINDLER R, 1990, J BIOL CHEM, V265, P10232; Schweizer M, 2001, J VIROL, V75, P4692, DOI 10.1128/JVI.75.10.4692-4698.2001; Stott AW, 2010, VET J, V185, P138, DOI 10.1016/j.tvjl.2009.05.020; Taraktsoglou M, 2011, VET IMMUNOL IMMUNOP, V140, P130, DOI 10.1016/j.vetimm.2010.12.002; Tserel L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-642; Welsh M, 1995, VET IMMUNOL IMMUNOPA; Werling D, 2005, VET IMMUNOL IMMUNOP, V108, P157, DOI 10.1016/j.vetimm.2005.07.017; Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643; Yamane D, 2005, MICROBES INFECT, V7, P1482, DOI 10.1016/j.micinf.2005.05.006; Yonkers NL, 2007, J IMMUNOL, V178, P4436, DOI 10.4049/jimmunol.178.7.4436	69	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159491	10.1371/journal.pone.0159491	http://dx.doi.org/10.1371/journal.pone.0159491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420479	Green Published, gold, Green Submitted			2022-12-26	WOS:000379662300014
J	Homa, J; Ortmann, W; Kolaczkowska, E				Homa, Joanna; Ortmann, Weronika; Kolaczkowska, Elzbieta			Conservative Mechanisms of Extracellular Trap Formation by Annelida Eisenia andrei: Serine Protease Activity Requirement	PLOS ONE			English	Article							NEUTROPHIL ELASTASE; INVERTEBRATE IMMUNITY; NUCLEAR-LOCALIZATION; NITRIC-OXIDE; CELL-DEATH; DNA TRAPS; EARTHWORM; RELEASE; CELOMOCYTES; AUTOPHAGY	Formation of extracellular traps (ETs) capturing and immobilizing pathogens is now a well-established defense mechanism added to the repertoire of vertebrate phagocytes. These ETs are composed of extracellular DNA (extDNA), histones and antimicrobial proteins. Formation of mouse and human ETs depends on enzymes (i) facilitating decondensation of chromatin by citrullination of histones, and (ii) serine proteases degrading histones. In invertebrates, initial reports revealed existence of ETs composed of extDNA and histones, and here we document for the first time that also coelomocytes, immunocompetent cells of an earthworm Eisenia andrei, cast ETs which successfully trap bacteria in a reactive oxygen species (ROS)-dependent and -independent manner. Importantly, the formation of ETs was observed not only when coelomocytes were studied ex vivo, but also in vivo, directly in the earthworm coelom. These ETs were composed of extDNA, heat shock proteins (HSP27) and H3 histones. Furthermore, the formation of E. andrei ETs depended on activity of serine proteases, including elastase-like activity. Moreover, ETs interconnected and hold together aggregating coelomocytes, a processes proceeding encapsulation. In conclusion, the study confirms ET formation by earthworms, and unravels mechanisms leading to ET formation and encapsulation in invertebrates.	[Homa, Joanna; Ortmann, Weronika; Kolaczkowska, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunol, Gronostajowa 9, PL-30387 Krakow, Poland	Jagiellonian University	Homa, J (corresponding author), Jagiellonian Univ, Inst Zool, Dept Evolutionary Immunol, Gronostajowa 9, PL-30387 Krakow, Poland.	joanna.homa@uj.edu.pl	Homa, Joanna/AAL-8327-2020; Kolaczkowska, Elzbieta/AAC-1988-2021	Kolaczkowska, Elzbieta/0000-0002-3573-3584	National Science Centre of Poland [2014/15/B/NZ6/02519, Opus 8];  [K/ZDS/005405]	National Science Centre of Poland(National Science Centre, Poland); 	This study was supported by the National Science Centre of Poland (grant number 2014/15/B/NZ6/02519, Opus 8) and K/ZDS/005405 to Elzbieta Kolaczkowska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Science Centre of Poland (grant number 2014/15/B/NZ6/02519, Opus 8) and K/ZDS/005405.	Adamowicz A, 2005, TISSUE CELL, V37, P125, DOI 10.1016/j.tice.2004.11.002; Albini A, 2015, INT J NANOMED, V10, P6133, DOI 10.2147/IJN.S85275; Azevedo EPC, 2012, J BIOL CHEM, V287, P37206, DOI 10.1074/jbc.M112.369942; Bakshi S, 2014, APPL ENVIRON MICROB, V80, P4977, DOI 10.1128/AEM.00989-14; Bernard E, 2015, ECOTOX ENVIRON SAFE, V114, P273, DOI 10.1016/j.ecoenv.2014.04.024; Bilej M., 2010, EARTHWORM IMMUNITY, P66, DOI 10.1007/978-1-4419-8059-5_4; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bryantsev AL, 2007, EXP CELL RES, V313, P195, DOI 10.1016/j.yexcr.2006.10.004; Cho IH, 2004, J BIOCHEM MOL BIOL, V37, P199; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Cook SR, 2015, ISJ-INVERT SURVIV J, V12, P46; Cooper EL, 2002, BIOESSAYS, V24, P319, DOI 10.1002/bies.10077; Denis H, 2009, MOL CELL BIOL, V29, P4982, DOI 10.1128/MCB.00285-09; ELLIOTT JA, 1986, INFECT IMMUN, V51, P31, DOI 10.1128/IAI.51.1.31-36.1986; Engelmann P, 2005, DEV COMP IMMUNOL, V29, P599, DOI 10.1016/j.dci.2004.10.008; Engelmann P, 2004, CELL TISSUE RES, V316, P391, DOI 10.1007/s00441-004-0874-x; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; Farrera C, 2013, J IMMUNOL, V191, P2647, DOI 10.4049/jimmunol.1300436; Fierro IM, 1996, IMMUNOLOGY, V89, P295, DOI 10.1046/j.1365-2567.1996.d01-742.x; Fjosne TF, 2015, INNATE IMMUN-LONDON, V21, P161, DOI 10.1177/1753425914523056; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Golbach LA, 2015, J INNATE IMMUN, V7, P459, DOI 10.1159/000380764; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grimaldi A, 2012, ISJ-INVERT SURVIV J, V9, P153; Hara S, 2008, CLIN EXP PHARMACOL P, V35, P841, DOI 10.1111/j.1440-1681.2008.04921.x; Hirao A, 2009, APPL MICROBIOL BIOT, V84, P77, DOI 10.1007/s00253-009-1961-4; Homa J, 2016, J COMP PHYSIOL B, V186, P417, DOI 10.1007/s00360-016-0973-5; Homa J, 2008, DEV COMP IMMUNOL, V32, P9, DOI 10.1016/j.dci.2007.04.007; Homa J, 2013, J COMP PHYSIOL B, V183, P313, DOI 10.1007/s00360-012-0710-7; Kalac Yesim, 2002, Journal of Cell and Molecular Biology, V1, P7; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koiwai K, 2016, FISH SHELLFISH IMMUN, V52, P206, DOI 10.1016/j.fsi.2016.03.039; Kolaczkowska E, 2006, IMMUNOBIOLOGY, V211, P137, DOI 10.1016/j.imbio.2005.08.004; Kolaczkowska E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7673; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolaczkowska E, 2009, J LEUKOCYTE BIOL, V85, P374, DOI 10.1189/jlb.0808460; Kurek A, 2007, EUR J SOIL BIOL, V43, pS121, DOI 10.1016/j.ejsobi.2007.08.051; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mena HA, 2016, J THROMB HAEMOST, V14, P397, DOI 10.1111/jth.13223; Mills CD, 2015, J INNATE IMMUN, V7, P443, DOI 10.1159/000380910; NAKAJIMA N, 1993, BIOSCI BIOTECH BIOCH, V57, P1726, DOI 10.1271/bbb.57.1726; Nakajima N, 2000, J BIOSCI BIOENG, V90, P174, DOI 10.1016/S1389-1723(00)80106-1; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Neeli I, 2009, J INNATE IMMUN, V1, P194, DOI 10.1159/000206974; Ng TH, 2015, DEV COMP IMMUNOL, V48, P229, DOI 10.1016/j.dci.2014.10.011; Pan R, APPL ENV SOIL SCI; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pascale M, 2014, DEV COMP IMMUNOL, V47, P129, DOI 10.1016/j.dci.2014.07.009; Pijanowski L, 2013, FISH SHELLFISH IMMUN, V34, P1244, DOI 10.1016/j.fsi.2013.02.010; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Poirier AC, 2014, J BIOL CHEM, V289, P24821, DOI 10.1074/jbc.M114.576546; Popovic M, 1998, GEN PHARMACOL, V30, P795, DOI 10.1016/S0306-3623(97)00014-1; Prochazkova P, 2006, J COMP PHYSIOL B, V176, P581, DOI 10.1007/s00360-006-0081-z; Pulze L, 2016, CLIN EXP IMMUNOL, V183, P469, DOI 10.1111/cei.12730; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Robb CT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5627; Rochael NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18302; Rohrbach AS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00360; Sauter E, 2012, J ORTHOP RES, V30, P593, DOI 10.1002/jor.21552; Schorn T, 2015, CELL TISSUE RES, V359, P853, DOI 10.1007/s00441-014-2058-7; Skanta F, 2013, DEV COMP IMMUNOL, V41, P694, DOI 10.1016/j.dci.2013.08.009; Thakur S, 2015, EUR BIOPHYS J BIOPHY, V44, P337, DOI 10.1007/s00249-015-1027-8; Thomas MP, 2014, J IMMUNOL, V192, P5390, DOI 10.4049/jimmunol.1303296; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tumminello RA, 2013, ISJ-INVERT SURVIV J, V10, P50; Ng TH, 2013, DEV COMP IMMUNOL, V41, P644, DOI 10.1016/j.dci.2013.06.014; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vorobjeva NV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1286, DOI 10.1134/S0006297914120025; Wada Y, 2006, CANCER SCI, V97, P1037, DOI 10.1111/j.1349-7006.2006.00278.x; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938; Zhao J, 2007, INT J BIOL MACROMOL, V40, P67, DOI 10.1016/j.ijbiomac.2006.05.007	80	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159031	10.1371/journal.pone.0159031	http://dx.doi.org/10.1371/journal.pone.0159031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416067	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500061
J	Morfeld, KA; Meehan, CL; Hogan, JN; Brown, JL				Morfeld, Kari A.; Meehan, Cheryl L.; Hogan, Jennifer N.; Brown, Janine L.			Assessment of Body Condition in African (Loxodonta africana) and Asian (Elephas maximus) Elephants in North American Zoos and Management Practices Associated with High Body Condition Scores	PLOS ONE			English	Article							RISK-FACTORS; VETERINARY PRACTICES; PLASMA LEPTIN; DAIRY-COW; OBESITY; POPULATION; FAT; PREVALENCE; WEIGHT; HORSES	Obesity has a negative effect on health and welfare of many species, and has been speculated to be a problem for zoo elephants. To address this concern, we assessed the body condition of 240 elephants housed in North American zoos based on a set of standardized photographs using a 5-point Body Condition Score index (1 = thinnest; 5 = fattest). A multivariable regression analysis was then used to determine how demographic, management, housing, and social factors were associated with an elevated body condition score in 132 African (Loxodonta africana) and 108 Asian (Elephas maximus) elephants. The highest BCS of 5, suggestive of obesity, was observed in 34% of zoo elephants. In both species, the majority of elephants had elevated BCS, with 74% in the BCS 4 (40%) and 5 (34%) categories. Only 22% of elephants had BCS 3, and less than 5% of the population was assigned the lowest BCS categories (BCS 1 and 2). The strongest multi-variable model demonstrated that staff-directed walking exercise of 14 hours or more per week and highly unpredictable feeding schedules were associated with decreased risk of BCS 4 or 5, while increased diversity in feeding methods and being female was associated with increased risk of BCS 4 or 5. Our data suggest that high body condition is prevalent among North American zoo elephants, and management strategies that help prevent and mitigate obesity may lead to improvements in welfare of zoo elephants.	[Morfeld, Kari A.] Lincoln Childrens Zoo, Lincoln, NE USA; [Morfeld, Kari A.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Morfeld, KA (corresponding author), Lincoln Childrens Zoo, Lincoln, NE USA.; Morfeld, KA (corresponding author), Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.	karimorfeld@yahoo.com			Institute of Museum and Library Services [LG-25-10-0033-10]; Smithsonian National Zoological Park; Lincoln Children's Zoo; IMLS; AWARE Institute	Institute of Museum and Library Services; Smithsonian National Zoological Park(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Lincoln Children's Zoo; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park (JLB, KM); Lincoln Children's Zoo (KM). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; In addition, special thanks go to the AZA Elephant TAG and TAG Chair Martha Fischer for logistical support, Jackie Ogden for communications support, and Vistalogic, Inc. for technological support and software services. Thanks to the Lincoln Children's Zoo for dedicated laboratory space and support, and the Smithsonian National Zoological Park's Veterinary Pathology Laboratory for the triglyceride analyses.	Ange K, 2001, P NUTR ADV GROUP C, V4, P5; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Christie JL, 2006, CAN VET J, V47, P136; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen J., 2003, APPL MULTIPLE REGRES; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046; DiPietro L, 1999, MED SCI SPORT EXER, V31, pS542, DOI 10.1097/00005768-199911001-00009; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Foreman J, 1998, EQUINE INTERNAL MED, P135; Frazier-Wood Alexis C, 2015, Curr Nutr Rep, V4, P82; Gallagher A. J., 2014, CONSERV PHYSIOL, V2, P1; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Greco BJ, 2016, PLOS ONE; Gustine DD, 2010, RANGIFER, V27, P249; GWINUP G, 1963, AM J CLIN NUTR, V13, P209, DOI 10.1093/ajcn/13.4.209; Hajian-Tilaki KO, 2007, OBES REV, V8, P3, DOI 10.1111/j.1467-789X.2006.00235.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Hatt J. -M., 2006, International Zoo Yearbook, V40, P88, DOI 10.1111/j.1748-1090.2006.00088.x; Hawn R, 2005, VET TECH, V26, P51; Hebebrand J, 2009, CHILD ADOL PSYCH CL, V18, P83, DOI 10.1016/j.chc.2008.07.006; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Holdgate MR, 2016, PLOS ONE; Holland JL, 1996, J ANIM SCI, V74, P1252; Hong Hye-Ryun, 2014, J Exerc Nutrition Biochem, V18, P277, DOI 10.5717/jenb.2014.18.3.277; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Garcia AI, 2015, ENDOCRINOL NUTR, V62, P130, DOI 10.1016/j.endonu.2014.11.007; Ishoika K, 2002, J VET MED SCI, V64, P39; Jakicic JM, 2002, J NUTR, V132, p3826S, DOI 10.1093/jn/132.12.3826S; Jenkins DJA, 1989, NEW ENGL J MED, V321, P919; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Laflamme D, 1997, CANINE PRACT, V22, P10; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassen J, 2003, J DAIRY SCI, V86, P4123, DOI 10.3168/jds.S0022-0302(03)74026-0; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Li G, 2012, VET MED-RES REP, V3, P71, DOI 10.2147/VMRR.S34665; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Mazrier H, 2006, CAN VET J, V47, P883; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Meehan CL, 2016, PLOS ONE; Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, REPROD FERT DEVELOP, V28, P640, DOI 10.1071/RD14140; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; OTTO KL, 1991, J DAIRY SCI, V74, P852, DOI 10.3168/jds.S0022-0302(91)78234-9; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pena C, 2014, J VET MED SCI, V76, P1305, DOI 10.1292/jvms.13-0475; Phythian CJ, 2012, VET J, V193, P257, DOI 10.1016/j.tvjl.2011.12.006; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Prado-Oviedo NA, 2016, PLOS ONE; Robinson D.S., 1970, COMPREHENSIVE BIOCH, P51; Rooney D, 1998, EQUINE INTERNAL MED, P216; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Sagawa MM, 2002, AM J VET RES, V63, P7, DOI 10.2460/AJVR.2002.63.7; Sargison ND, 2010, SMALL RUMINANT RES, V92, P2, DOI 10.1016/j.smallrumres.2010.04.019; Schroder UJ, 2006, J DAIRY SCI, V89, P1, DOI 10.3168/jds.S0022-0302(06)72064-1; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Suagee JK, 2013, J VET INTERN MED, V27, P157, DOI 10.1111/jvim.12021; Taylor VJ, 1998, ZOO BIOL, V17, P311, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;311::AID-ZOO5&gt;3.0.CO;2-C; Thompson PD, 2013, PLOS ONE, V8; Wadha PS, 1986, AM J CLIN NUTR, V5, P551; WAGNER JJ, 1988, J ANIM SCI, V66, P603; Warren BS, 2011, BRIT J NUTR, V106, pS85, DOI 10.1017/S0007114511001814; Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; Wyse CA, 2008, VET REC, V162, P590, DOI 10.1136/vr.162.18.590; Yamka R. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P282; YOUNG CM, 1972, J AM DIET ASSOC, V61, P391; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	87	63	65	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0155146	10.1371/journal.pone.0155146	http://dx.doi.org/10.1371/journal.pone.0155146			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415629	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500009
J	Riew, TR; Shin, YJ; Kim, HL; Cho, JM; Pak, HJ; Lee, MY				Riew, Tae-Ryong; Shin, Yoo-Jin; Kim, Hong Lim; Cho, Jeong Min; Pak, Ha-Jin; Lee, Mun-Yong			Spatiotemporal Progression of Microcalcification in the Hippocampal CA1 Region following Transient Forebrain Ischemia in Rats: An Ultrastructural Study	PLOS ONE			English	Article							DARK COMPACTED NEURONS; CALCIUM DEPOSITS; CEREBRAL-ISCHEMIA; HYPOXIA-ISCHEMIA; CELL-DEATH; ELECTRON-MICROSCOPY; GLOBAL-ISCHEMIA; BRAIN-INJURY; MITOCHONDRIA; CALCIFICATION	Calcification in areas of neuronal degeneration is a common finding in several neuropathological disorders including ischemic insults. Here, we performed a detailed examination of the onset and spatiotemporal profile of calcification in the CA1 region of the hippocampus, where neuronal death has been observed after transient forebrain ischemia. Histopathological examinations showed very little alizarin red staining in the CA1 pyramidal cell layer until day 28 after reperfusion, while prominent alizarin red staining was detected in CA1 dendritic subfields, particularly in the stratum radiatum, by 14 days after reperfusion. Electron microscopy using the osmium/potassium dichromate method and electron probe microanalysis revealed selective calcium deposits within the mitochondria of degenerating dendrites at as early as 7 days after reperfusion, with subsequent complete mineralization occurring throughout the dendrites, which then coalesced to form larger mineral conglomerates with the adjacent calcifying neurites by 14 days after reperfusion. Large calcifying deposits were frequently observed at 28 days after reperfusion, when they were closely associated with or completely engulfed by astrocytes. In contrast, no prominent calcification was observed in the somata of CA1 pyramidal neurons showing the characteristic features of necrotic cell death after ischemia, although what appeared to be calcified mitochondria were noted in some degenerated neurons that became dark and condensed. Thus, our data indicate that intrahippocampal calcification after ischemic insults initially occurs within the mitochondria of degenerating dendrites, which leads to the extensive calcification that is associated with ischemic injuries. These findings suggest that in degenerating neurons, the calcified mitochondria in the dendrites, rather than in the somata, may serve as the nidus for further calcium precipitation in the ischemic hippocampus.	[Riew, Tae-Ryong; Shin, Yoo-Jin; Cho, Jeong Min; Pak, Ha-Jin; Lee, Mun-Yong] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Dept Anat,Catholic Neurosci Inst, Seoul 137701, South Korea; [Kim, Hong Lim] Catholic Univ Korea, Coll Med, Lab Electron Microscope, Integrat Res Support Ctr, Seoul 137701, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, MY (corresponding author), Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Dept Anat,Catholic Neurosci Inst, Seoul 137701, South Korea.	munylee@catholic.ac.kr		Riew, Tae Ryong/0000-0001-7951-8176	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A2A1A11050246]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF; http://www.nrf.re.kr) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A11050246). MYL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A11050246).	Agnew W F, 1979, Neurol Res, V1, P187; Bernal F, 2009, J NEUROSCI RES, V87, P1240, DOI 10.1002/jnr.21930; BONNEKOH P, 1992, ACTA NEUROPATHOL, V84, P400; Bueters T, 2008, EXP NEUROL, V209, P114, DOI 10.1016/j.expneurol.2007.09.005; Csordas A, 2003, ACTA NEUROPATHOL, V106, P37, DOI 10.1007/s00401-003-0694-1; Dubinsky JM, 2004, J BIOENERG BIOMEMBR, V36, P299, DOI 10.1023/B:JOBB.0000041757.68148.3c; DUX E, 1987, NEUROSCI LETT, V78, P295, DOI 10.1016/0304-3940(87)90376-4; Fairbanks SL, 2012, NEUROSCIENCE, V219, P183, DOI 10.1016/j.neuroscience.2012.05.048; Gallyas F, 2005, EXP BRAIN RES, V160, P473, DOI 10.1007/s00221-004-2037-4; Gallyas F, 2008, BRAIN RES, V1239, P207, DOI 10.1016/j.brainres.2008.08.069; Gayoso MJ, 2003, HISTOL HISTOPATHOL, V18, P855, DOI 10.14670/HH-18.855; GUTIERREZDIAZ JA, 1985, SURG NEUROL, V24, P67, DOI 10.1016/0090-3019(85)90067-9; Hasel P, 2015, BBA-MOL CELL RES, V1853, P2066, DOI 10.1016/j.bbamcr.2014.12.021; Herson PS, 2013, TRANSL STROKE RES, V4, P413, DOI 10.1007/s12975-012-0238-x; KATO H, 1995, BRAIN RES BULL, V38, P25, DOI 10.1016/0361-9230(95)00067-O; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1; Liu FD, 2012, NEUROCHEM INT, V61, P1255, DOI 10.1016/j.neuint.2012.10.003; Luebke JI, 2010, BRAIN STRUCT FUNCT, V214, P181, DOI 10.1007/s00429-010-0244-2; Maetzler W, 2009, NEUROPATH APPL NEURO, V35, P165, DOI 10.1111/j.1365-2990.2008.00970.x; Maetzler W, 2010, AM J PATHOL, V177, P829, DOI 10.2353/ajpath.2010.090798; Mahy N, 1999, ACTA NEUROPATHOL, V98, P217, DOI 10.1007/s004010051072; Manwani B, 2013, EXP NEUROL, V249, P120, DOI 10.1016/j.expneurol.2013.08.011; Mazlo M, 2004, J NEUROCYTOL, V33, P557, DOI 10.1007/s11068-004-0517-5; Mori F, 2000, NEUROPATHOLOGY, V20, P210, DOI 10.1046/j.1440-1789.2000.00341.x; NITSCH C, 1992, ACTA NEUROPATHOL, V85, P55, DOI 10.1007/BF00304634; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; Oliveira A, 2003, EXP NEUROL, V179, P127, DOI 10.1016/S0014-4886(02)00012-2; Pagnussat AD, 2007, J ANAT, V211, P589, DOI 10.1111/j.1469-7580.2007.00802.x; Park JM, 2012, J HISTOCHEM CYTOCHEM, V60, P550, DOI 10.1369/0022155412441707; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; PROBST W, 1986, HISTOCHEMISTRY, V85, P231, DOI 10.1007/BF00494809; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P31, DOI 10.1016/S0165-3806(00)00110-3; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Ramonet D, 2006, J NEUROSCI RES, V83, P147, DOI 10.1002/jnr.20711; Ramonet D, 2002, J PHYSIOLOGY-PARIS, V96, P307, DOI 10.1016/S0928-4257(02)00020-7; Riew TR, 2015, BRAIN RES, V1622, P430, DOI 10.1016/j.brainres.2015.06.048; Rodriguez MJ, 2004, J NEUROSCI RES, V77, P344, DOI 10.1002/jnr.20177; Rodriguez MJ, 2000, INT J DEV NEUROSCI, V18, P299, DOI 10.1016/S0736-5748(99)00098-2; Rodriguez MJ, 2001, NEUROBIOL DIS, V8, P59, DOI 10.1006/nbdi.2000.0332; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Sheldon RA, 2001, NEUROSCI LETT, V304, P165, DOI 10.1016/S0304-3940(01)01788-8; Shin YJ, 2012, J NEUROTRAUM, V29, P1530, DOI 10.1089/neu.2011.2078; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Winkelmann ER, 2006, ANAT EMBRYOL, V211, P423, DOI 10.1007/s00429-006-0095-z; Zeng YS, 2000, NEUROSCI RES, V37, P113, DOI 10.1016/S0168-0102(00)00107-3	50	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159229	10.1371/journal.pone.0159229	http://dx.doi.org/10.1371/journal.pone.0159229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414398	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500100
J	Wortinger, LA; Endestad, T; Melinder, AMD; Oie, MG; Sevenius, A; Wyller, VB				Wortinger, Laura Anne; Endestad, Tor; Melinder, Annika Maria D.; Oie, Merete Glenne; Sevenius, Andre; Wyller, Vegard Bruun			Aberrant Resting-State Functional Connectivity in the Salience Network of Adolescent Chronic Fatigue Syndrome	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAINS DEFAULT NETWORK; INSULAR CORTEX; PHYSIOLOGICAL CONDITION; PREFRONTAL CORTEX; WORKING-MEMORY; MODE NETWORKS; CHRONIC PAIN; STRESS; SCALE	Neural network investigations are currently absent in adolescent chronic fatigue syndrome (CFS). In this study, we examine whether the core intrinsic connectivity networks (ICNs) are altered in adolescent CFS patients. Eighteen adolescent patients with CFS and 18 aged matched healthy adolescent control subjects underwent resting-state functional magnetic resonance imaging (rfMRI). Data was analyzed using dual-regression independent components analysis, which is a data-driven approach for the identification of independent brain networks. Intrinsic connectivity was evaluated in the default mode network (DMN), salience network (SN), and central executive network (CEN). Associations between network characteristics and symptoms of CFS were also explored. Adolescent CFS patients displayed a significant decrease in SN functional connectivity to the right posterior insula compared to healthy comparison participants, which was related to fatigue symptoms. Additionally, there was an association between pain intensity and SN functional connectivity to the left middle insula and caudate that differed between adolescent patients and healthy comparison participants. Our findings of insula dysfunction and its association with fatigue severity and pain intensity in adolescent CFS demonstrate an aberration of the salience network which might play a role in CFS pathophysiology.	[Wortinger, Laura Anne; Wyller, Vegard Bruun] Akershus Univ Hosp, Dept Pediat, Nordbyhagen, Norway; [Wortinger, Laura Anne; Endestad, Tor; Oie, Merete Glenne; Sevenius, Andre] Univ Oslo, Dept Psychol, Oslo, Norway; [Melinder, Annika Maria D.] Univ Oslo, Dept Psychol, Cognit Dev Res Unit, Oslo, Norway; [Oie, Merete Glenne] Innlandet Hosp Trust, Res Dept, Lillehammer, Norway	University of Oslo; University of Oslo; University of Oslo; Innlandet Hospital Trust	Wortinger, LA (corresponding author), Akershus Univ Hosp, Dept Pediat, Nordbyhagen, Norway.; Wortinger, LA (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	l.a.w.bakke@medisin.uio.no	Melinder, Annika/L-6782-2016	Melinder, Annika/0000-0001-7773-0579; Wortinger, Laura/0000-0003-2721-3172; Endestad, Tor/0000-0002-4403-6887; Nilsen, Andre/0000-0003-2084-6663	Norwegian Research Council [228874]; Health South-East Hospital Trust; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Health South-East Hospital Trust; University of Oslo	Norwegian Research Council, http://www.forskningsradet.no/en (VBW, grant number 228874); Health South-East Hospital Trust, http://www.helse-sorost.no/fagfolk_/forskning_/forskningsmidler (VBW); and the University of Oslo, http://www.uio.no/english/ (VBW).	Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burkey AR, 1999, J NEUROSCI, V19, P4169; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Caseras X, 2008, PSYCHOL MED, V38, P941, DOI 10.1017/S0033291708003450; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chen TW, 2015, EUR J NEUROSCI, V41, P264, DOI 10.1111/ejn.12764; Connolly CG, 2013, BIOL PSYCHIAT, V74, P898, DOI 10.1016/j.biopsych.2013.05.036; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Gay CW, 2016, BRAIN CONNECT, V6, P48, DOI 10.1089/brain.2015.0366; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Goldstein DS, 2001, AUTONOMIC NERVOUS SY; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Haig-Ferguson A, 2009, ARCH DIS CHILD, V94, P757, DOI 10.1136/adc.2008.143032; Henckens MJAG, 2015, NEUROIMAGE, V105, P312, DOI 10.1016/j.neuroimage.2014.10.037; Hong JY, 2013, J NEUROSCI, V33, P11994, DOI 10.1523/JNEUROSCI.5733-12.2013; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason LA., 2006, J CHRON FATIGUE SYND, V13, P1, DOI DOI 10.1300/J092V13N02_01; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kennedy G, 2010, PEDIATRICS, V125, pE1324, DOI 10.1542/peds.2009-2644; Kim BH, 2015, PSYCHIAT RES-NEUROIM, V234, P292, DOI 10.1016/j.pscychresns.2015.10.014; Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006; Lovick TA, 2008, NEUROSCI BIOBEHAV R, V32, P852, DOI 10.1016/j.neubiorev.2008.01.003; Menon V., 2015, BRAIN MAPPING ENCY R, V2, P597, DOI DOI 10.1016/B978-0-12-397025-1.00052-X; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Missen A, 2012, CHILD CARE HLTH DEV, V38, P505, DOI 10.1111/j.1365-2214.2011.01298.x; Moran LV, 2013, BIOL PSYCHIAT, V74, P467, DOI 10.1016/j.biopsych.2013.02.029; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; *NAT I HLTH CLIN E, 2007, NICE CLINICAL GUIDEL; National Institute for Health Care and Excellent (NICE), 2021, MAN ME CHRON FAT SYN; Nijhof SL, 2011, PEDIATRICS, V127, pE1169, DOI 10.1542/peds.2010-1147; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Nisenbaum R, 2004, J PSYCHOSOM RES, V56, P171, DOI 10.1016/S0022-3999(03)00039-4; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segal TY, 2005, J PEDIATR ENDOCR MET, V18, P295; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spielberger CD, 1973, STAI MANUAL STAIT TR; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sulheim D, 2015, ARCH DIS CHILD, V100, P838, DOI 10.1136/archdischild-2014-306764; Sulheim D, 2014, JAMA PEDIATR, V168, P351, DOI 10.1001/jamapediatrics.2013.4647; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Sund AM, 2001, EUR CHILD ADOLES PSY, V10, P222, DOI 10.1007/s007870170011; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Tanaka M, 2013, REV NEUROSCIENCE, V24, P617, DOI 10.1515/revneuro-2013-0035; Tanaka M, 2008, PSYCHOL REP, V103, P682, DOI 10.2466/PR0.103.3.682-690; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; Wechsler D., 2007, NORWEGIAN MANUAL SUP; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wiech K, 2010, J NEUROSCI, V30, P16324, DOI 10.1523/JNEUROSCI.2087-10.2010; Winger A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005920; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wyller VB, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-5; Wyller VB, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-10; Wyller VB, 2008, ANN NONINVAS ELECTRO, V13, P67, DOI 10.1111/j.1542-474X.2007.00202.x; Wyller VB, 2007, PEDIATRICS, V120, pE129, DOI 10.1542/peds.2006-2759; Wyller VB, 2007, AM J CARDIOL, V99, P997, DOI 10.1016/j.amjcard.2006.10.067; Yuen GS, 2014, INT J GERIATR PSYCH, V29, P1116, DOI 10.1002/gps.4171	86	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159351	10.1371/journal.pone.0159351	http://dx.doi.org/10.1371/journal.pone.0159351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414048	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500123
J	Kojima, T; Kunitake, E; Ihara, K; Kobayashi, T; Nakano, H				Kojima, Takaaki; Kunitake, Emi; Ihara, Kunio; Kobayashi, Tetsuo; Nakano, Hideo			A Robust Analytical Pipeline for Genome-Wide Identification of the Genes Regulated by a Transcription Factor: Combinatorial Analysis Performed Using gSELEX-Seq and RNA-Seq	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; ASPERGILLUS-NIDULANS; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; AMYLASE GENES; SELEX; AMYR; NIGER; EXPRESSION; PROMOTER	For identifying the genes that are regulated by a transcription factor (TF), we have established an analytical pipeline that combines genomic systematic evolution of ligands by exponential enrichment (gSELEX)-Seq and RNA-Seq. Here, SELEX was used to select DNA fragments from an Aspergillus nidulans genomic library that bound specifically to AmyR, a TF from A. nidulans. High-throughput sequencing data were obtained for the DNAs enriched through the selection, following which various in silico analyses were performed. Mapping reads to the genome revealed the binding motifs including the canonical AmyR-binding motif, CGGN(8)CGG, as well as the candidate promoters controlled by AmyR. In parallel, differentially expressed genes related to AmyR were identified by using RNA-Seq analysis with samples from A. nidulans WT and amyR deletant. By obtaining the intersecting set of genes detected using both gSELEX-Seq and RNA-Seq, the genes directly regulated by AmyR in A. nidulans can be identified with high reliability. This analytical pipeline is a robust platform for comprehensive genome-wide identification of the genes that are regulated by a target TF.	[Kojima, Takaaki; Nakano, Hideo] Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Kunitake, Emi; Kobayashi, Tetsuo] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University	Kojima, T; Nakano, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Bioengn Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kojimat@nuagr1.agr.nagoya-u.ac.jp; hnakano@agr.nagoya-u.ac.jp	IHARA, Kunio/D-1952-2011; Kojima, Takaaki/H-6802-2017; Kobayashi, Tetsuo/I-6901-2014	Kobayashi, Tetsuo/0000-0002-4008-454X	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22760605, 23360367]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26011A]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) https://www.jsps.go.jp/english/e-grants/ 22760605 to TK, 23360367 to HN and by the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry http://www.maff.go.jp/e/index.html, 26011A to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Norihito Nakamichi of Nagoya University for helpful advice on bioinformatics analysis. This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22760605 and 23360367] and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26011A].	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Coutinho PM, 2009, FUNGAL GENET BIOL, V46, pS161, DOI 10.1016/j.fgb.2008.07.020; Cultrone A, 2005, MOL MICROBIOL, V57, P276, DOI 10.1111/j.1365-2958.2005.04686.x; DelSorbo G, 1997, MOL GEN GENET, V254, P417, DOI 10.1007/s004380050434; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Dittmar KA, 2012, MOL CELL BIOL, V32, P1468, DOI 10.1128/MCB.06536-11; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; DYER PS, 1993, PHYSIOL MOL PLANT P, V43, P403, DOI 10.1006/pmpp.1993.1068; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gu GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076109; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ito T, 2004, BIOSCI BIOTECH BIOCH, V68, P1906, DOI 10.1271/bbb.68.1906; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kojima T, 2010, J BIOSCI BIOENG, V109, P519, DOI 10.1016/j.jbiosc.2009.11.024; Levin AM, 2007, EUKARYOT CELL, V6, P2311, DOI 10.1128/EC.00244-07; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P2363, DOI 10.1271/bbb.50694; Oberegger H, 2002, APPL ENVIRON MICROB, V68, P5769, DOI 10.1128/AEM.68.11.5769-5772.2002; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PAPOULAS O, 1992, J BIOL CHEM, V267, P10470; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Rahmatallah Y, 2016, BRIEF BIOINFORM, V17, P393, DOI 10.1093/bib/bbv069; Reiss DJ, 2011, J BIOL CHEM, V286, P44726, DOI 10.1074/jbc.M111.290684; Riley TR, 2014, METHODS MOL BIOL, V1196, P255, DOI 10.1007/978-1-4939-1242-1_16; Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718; ROWLANDS RT, 1973, MOL GEN GENET, V126, P201, DOI 10.1007/BF00267531; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Tani S, 2001, BIOSCI BIOTECH BIOCH, V65, P1568, DOI 10.1271/bbb.65.1568; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Todeschini AL, 2014, TRENDS GENET, V30, P211, DOI 10.1016/j.tig.2014.04.002; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; vanKuyk PA, 2012, APPL MICROBIOL BIOT, V93, P285, DOI 10.1007/s00253-011-3550-6; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang JK, 2011, J ENDOCRINOL, V210, P15, DOI 10.1530/JOE-11-0010; Wang PH, 2012, BIOSCI BIOTECH BIOCH, V76, P1128, DOI 10.1271/bbb.110949; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	45	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159011	10.1371/journal.pone.0159011	http://dx.doi.org/10.1371/journal.pone.0159011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411092	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300048
J	Qu, YJ; Liu, XQ; Zhuang, J; Chen, GC; Mai, JZ; Guo, XL; Ou, YQ; Chen, JM; Gong, W; Gao, XM; Wu, Y; Nie, ZQ				Qu, Yanji; Liu, Xiaoqing; Zhuang, Jian; Chen, Guanchun; Mai, Jinzhuang; Guo, Xiaoling; Ou, Yanqiu; Chen, Jimei; Gong, Wei; Gao, Xiangmin; Wu, Yong; Nie, Zhiqiang			Incidence of Congenital Heart Disease: The 9-Year Experience of the Guangdong Registry of Congenital Heart Disease, China	PLOS ONE			English	Article							BIRTH-DEFECTS SURVEILLANCE; UNITED-STATES; PREVALENCE; MORTALITY; MALFORMATIONS; EPIDEMIOLOGY; CHILDREN; ENGLAND; TRENDS	There are 16.5 million newborns in China annually. However, the incidence of congenital heart disease (CHD) has not been evaluated. In 2004, we launched an active province-wide hospital-based CHD registry in the Guangdong Province of southern China. In this study, we examined the incidence of CHD and its subtypes from 2004 to 2012 and compared our findings to the literature. Our results indicate there is an increasing trend of CHD incidence. The increase in incidence occurred mainly for single lesion and the most common subtypes (e.g., ventricular or atrial septal defect, patent ductus arteriosus). There were no increases found for multiple lesions or more complex subtypes. The proportion of CHD cases that were detected early (e.g., 1 week) increased over time. The incidence of CHD stabilized in 2010-2012 with the average cumulative incidences of 9.7, 9.9, and 11.1 per 1,000 live births at 1 week, 1 month, and 1 year, respectively. The incidences of CHD subtypes were comparable with recent international results. The data did not support previous reports that Asian children have a higher incidence of pulmonary outflow obstructions and lower incidence of transposition of the great arteries. However, there was a lower incidence of left ventricular outflow tract obstructions observed in our series. The increase in CHD incidence observed over time was due to improved detection and diagnosis. The true incidence of CHD in China was approximately 11.1 per 1,000 live births, which is higher than previously reported.	[Qu, Yanji; Liu, Xiaoqing; Mai, Jinzhuang; Ou, Yanqiu; Gao, Xiangmin; Wu, Yong; Nie, Zhiqiang] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Key Lab South China Struct Heart D, Dept Cardiovasc Dis Epidemiol,Guangdong Cardiovas, Guangzhou, Guangdong, Peoples R China; [Zhuang, Jian; Chen, Jimei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Key Lab South China Struct Heart D, Dept Cardiac Surg,Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China; [Chen, Guanchun] Dongguan Houjie Hosp, Dept Ultrasound, Dongguan, Guangdong, Peoples R China; [Guo, Xiaoling] Boai Hosp Zhongshan, Dept Pediat Cardiol, Zhongshan, Guangdong, Peoples R China; [Gong, Wei] Hexian Mem Hosp, Dept Ultrasound, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Zhuang, J (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Prov Key Lab South China Struct Heart D, Dept Cardiac Surg,Guangdong Cardiovasc Inst, Guangzhou, Guangdong, Peoples R China.	drzhuangjian5413@163.com	Ou, Yanqiu/AAJ-6251-2021; Qu, Yanji/GSN-4453-2022	Zhiqiang, Nie/0000-0001-7642-3286	National 12th Five-Year Support Projects of China (Ministry of national science and technology, China) [2011BAI11B22, 2012BAI04B05]; National Natural Science Foundation of China (Ministry of national science and technology, China) [U1401255]; Guangdong International Cooperative Project, China (Science and Technology Department of Guangdong Province) [2014A050503048]	National 12th Five-Year Support Projects of China (Ministry of national science and technology, China); National Natural Science Foundation of China (Ministry of national science and technology, China); Guangdong International Cooperative Project, China (Science and Technology Department of Guangdong Province)	This research was funded by the National 12th Five-Year Support Projects of China (funder: Ministry of national science and technology, China, no. 2011BAI11B22, 2012BAI04B05, received by JZ), National Natural Science Foundation of China (funder: Ministry of national science and technology, China, no. U1401255, received by JZ), and Guangdong International Cooperative Project, China (funder: Science and Technology Department of Guangdong Province no. 2014A050503048, received by XL). All the funders had role in the study design, data collection and analysis, decision to publish.	[Anonymous], 1980, Pediatrics, V65, P375; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Billett J, 2008, HEART, V94, P342, DOI 10.1136/hrt.2006.113787; Botto LD, 2006, AM J PUBLIC HEALTH, V96, P774, DOI 10.2105/AJPH.2004.057760; Chen XH, 2011, CHINESE J EUGENICS G, V19, P101; Dadvand P, 2009, PAEDIATR PERINAT EP, V23, P58, DOI 10.1111/j.1365-3016.2008.00987.x; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dolk H, 2009, SPECIAL REPORT CONGE; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Egbe A, 2015, CONGENIT HEART DIS, V10, P43, DOI 10.1111/chd.12176; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; FIXLER DE, 1990, CIRCULATION, V81, P137, DOI 10.1161/01.CIR.81.1.137; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hoffman JI, 2013, CARDIOVASC J AFR, V24, P141, DOI 10.5830/CVJA-2013-028; Hu Z, 2014, J THORAC CARDIOV SUR, V148, P596, DOI 10.1016/j.jtcvs.2013.08.067; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Jacobs EGJ, 2000, PEDIATR CARDIOL, V21, P148, DOI 10.1007/s002469910025; Khoshnood B, 2013, J PEDIATR-US, V162, P108, DOI 10.1016/j.jpeds.2012.06.035; Leirgul E, 2014, AM HEART J, V168, P956, DOI 10.1016/j.ahj.2014.07.030; Li S, 1999, CHIN J PEDIAT, V37, P375; Liu KB, 2013, CHINESE J EUGENICS G, V21, P127; Liu WT, 1995, CHIN J PEDIAT, V33, P347; Mai CT, 2015, J PUBLIC HLTH MANAG; Mai Q, 2006, MATERN CHILD HLTH J, V21, P2715; Oyen N, 2009, AM HEART J, V157, P467, DOI 10.1016/j.ahj.2008.10.017; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Song Y, 2002, CHINESE J EUGENICS G, V10, P96; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414; Wu L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-152; Wu MH, 2010, J PEDIATR-US, V156, P782, DOI 10.1016/j.jpeds.2009.11.062; Xia JH, 2005, CHINESE J CHILD PROT, V13, P443; Yang JF, 2007, CHINESE J NEONATES, V22, P72; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Yang XY, 2009, CHINESE J EUGENICS G, V9, P416; 朱军, 2004, [四川大学学报. 医学版, Journal of West China University of Medical Sciences], V35, P875	39	59	78	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159257	10.1371/journal.pone.0159257	http://dx.doi.org/10.1371/journal.pone.0159257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409588	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300072
J	Lum, R; Ahmad, S; Hong, SJ; Chapman, DC; Kozlov, G; Williams, DB				Lum, Ronnie; Ahmad, Samar; Hong, Seo Jung; Chapman, Daniel C.; Kozlov, Guennadi; Williams, David B.			Contributions of the Lectin and Polypeptide Binding Sites of Calreticulin to Its Chaperone Functions in Vitro and in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); lectin; molecular chaperone; protein aggregation; protein folding	MAJOR HISTOCOMPATIBILITY COMPLEX; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; QUALITY-CONTROL; P-DOMAIN; STRUCTURAL BASIS; CALNEXIN; PROTEIN; PEPTIDE; ER	Calreticulin is a lectin chaperone of the endoplasmic reticulum that interacts with newly synthesized glycoproteins by binding to Glc(1)Man(9)GlcNAc(2) oligosaccharides as well as to the polypeptide chain. In vitro, the latter interaction potently suppresses the aggregation of various non-glycosylated proteins. Although the lectin-oligosaccharide association is well understood, the polypeptide-based interaction is more controversial because the binding site on calreticulin has not been identified, and its significance in the biogenesis of glycoproteins in cells remains unknown. In this study, we identified the polypeptide binding site responsible for the in vitro aggregation suppression function by mutating four candidate hydrophobic surface patches. Mutations in only one patch, P19K/I21E and Y22K/F84E, impaired the ability of calreticulin to suppress the thermally induced aggregation of non-glycosylated firefly luciferase. These mutants also failed to bind several hydrophobic peptides that act as substrate mimetics and compete in the luciferase aggregation suppression assay. To assess the relative contributions of the glycan-dependent and -independent interactions in living cells, we expressed lectin-deficient, polypeptide binding-deficient, and doubly deficient calreticulin constructs in calreticulin-negative cells and monitored the effects on the biogenesis of MHC class I molecules, the solubility of mutant forms of (1)-antitrypsin, and interactions with newly synthesized glycoproteins. In all cases, we observed a profound impairment in calreticulin function when its lectin site was inactivated. Remarkably, inactivation of the polypeptide binding site had little impact. These findings indicate that the lectin-based mode of client interaction is the predominant contributor to the chaperone functions of calreticulin within the endoplasmic reticulum.	[Lum, Ronnie; Ahmad, Samar; Hong, Seo Jung; Chapman, Daniel C.; Williams, David B.] Univ Toronto, Dept Biochem, Med Sci Bldg, Toronto, ON M5S 1A8, Canada; [Lum, Ronnie; Ahmad, Samar; Hong, Seo Jung; Chapman, Daniel C.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kozlov, Guennadi] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	University of Toronto; University of Toronto; McGill University	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca		Ahmad, Samar/0000-0001-5015-6431	Canadian Institutes of Health Research [MOP123226]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP123226 (to D. B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ARUNACHALAM B, 1995, J BIOL CHEM, V270, P2784, DOI 10.1074/jbc.270.6.2784; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; Kimura Y, 1999, EUR J BIOCHEM, V264, P168, DOI 10.1046/j.1432-1327.1999.00598.x; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; ORA A, 1995, J BIOL CHEM, V270, P26060, DOI 10.1074/jbc.270.44.26060; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SOUSA M, 1995, EMBO J, V14, P4196, DOI 10.1002/j.1460-2075.1995.tb00093.x; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; Suh WK, 1999, J IMMUNOL, V162, P1530; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Wijeyesakere SJ, 2013, J BIOL CHEM, V288, P35104, DOI 10.1074/jbc.M113.507921; Williams A, 2002, TISSUE ANTIGENS, V59, P3, DOI 10.1034/j.1399-0039.2002.590103.x; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856	50	11	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19631	19641		10.1074/jbc.M116.746321	http://dx.doi.org/10.1074/jbc.M116.746321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27413183	Green Published, hybrid			2022-12-26	WOS:000383242800036
J	Amelineau, F; Gremillet, D; Bonnet, D; Le Bot, T; Fort, J				Amelineau, Francoise; Gremillet, David; Bonnet, Delphine; Le Bot, Tangi; Fort, Jerme			Where to Forage in the Absence of Sea Ice? Bathymetry As a Key Factor for an Arctic Seabird	PLOS ONE			English	Article							AUKS ALLE-ALLE; CLIMATE-CHANGE; FEEDING ECOLOGY; ZOOPLANKTON; BEHAVIOR; DIET; ASSOCIATIONS; GREENLAND; DOVEKIES; STRATEGY	The earth is warming at an alarming rate, especially in the Arctic, where a marked decline in sea ice cover may have far-ranging consequences for endemic species. Little auks, endemic Arctic seabirds, are key bioindicators as they forage in the marginal ice zone and feed preferentially on lipid-rich Arctic copepods and ice-associated amphipods sensitive to the consequences of global warming. We tested how little auks cope with an ice-free foraging environment during the breeding season. To this end, we took advantage of natural variation in sea ice concentration along the east coast of Greenland. We compared foraging and diving behaviour, chick diet and growth and adult body condition between two years, in the presence versus nearby absence of sea ice in the vicinity of their breeding site. Moreover, we sampled zooplankton at sea when sea ice was absent to evaluate prey location and little auk dietary preferences. Little auks foraged in the same areas both years, irrespective of sea ice presence/concentration, and targeted the shelf break and the continental shelf. We confirmed that breeding little auks showed a clear preference for larger copepod species to feed their chick, but caught smaller copepods and nearly no ice-associated amphipod when sea ice was absent. Nevertheless, these dietary changes had no impact on chick growth and adult body condition. Our findings demonstrate the importance of bathymetry for profitable little auk foraging, whatever the sea-ice conditions. Our investigations, along with recent studies, also confirm more flexibility than previously predicted for this key species in a warming Arctic.	[Amelineau, Francoise; Gremillet, David; Le Bot, Tangi] Univ Montpellier 3, Univ Montpellier, EPHE, CNRS,CEFE UMR 5175, Montpellier, France; [Gremillet, David] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, Rondebosch, South Africa; [Bonnet, Delphine] Univ Montpellier, Lab MARBEC, Montpellier, France; [Fort, Jerme] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Fort, Jerme] Univ La Rochelle, CNRS, LIENSs, UMR 7266, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Universite Paul-Valery; National Research Foundation - South Africa; University of Cape Town; Ifremer; Universite de Montpellier; Aarhus University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Amelineau, F (corresponding author), Univ Montpellier 3, Univ Montpellier, EPHE, CNRS,CEFE UMR 5175, Montpellier, France.	francoise.amelineau@gmail.com	Gremillet, David/W-1946-2018; Amelineau, Francoise/AAD-4833-2019; Fort, Jerome/F-1157-2016	Gremillet, David/0000-0002-7711-9398; Amelineau, Francoise/0000-0001-9723-5858; Fort, Jerome/0000-0002-0860-6707; BONNET, Delphine/0000-0002-2040-1800	French Polar Institute (IPEV); European Commission (Marie Curie IEF) [273061]; National Geographic Society - Global Exploration Fund Northern Europe [GEFNE-4112]; (European commission Marie Curie CIG) [631203]; French Polar Institute (ADACLIM program) [388]	French Polar Institute (IPEV); European Commission (Marie Curie IEF); National Geographic Society - Global Exploration Fund Northern Europe(National Geographic Society); (European commission Marie Curie CIG); French Polar Institute (ADACLIM program)	This study was co-funded by the French Polar Institute (IPEV (http://www.institut-polaire.fr) ADACLIM program no 388 to DG and JF), the European Commission (Marie Curie IEF to JF, Project 273061) and the the National Geographic Society - Global Exploration Fund Northern Europe (GEFNE-4112 to JF). This study also represents a contribution to the ARCTOX research project (European commission Marie Curie CIG, Project 631203 to JF).	Arndt CE, 2006, ADV MAR BIOL, V51, P197, DOI 10.1016/S0065-2881(06)51004-1; BANNASCH R, 1994, J EXP BIOL, V194, P83; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; BRADSTREET MSW, 1982, ARCTIC, V35, P126; Brown ZW, 2012, J AVIAN BIOL, V43, P215, DOI 10.1111/j.1600-048X.2012.05484.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Descamps S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065374; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dunbar MJ, 1963, CONS I POUR EXPLOR M, V4; Eamer J, 2013, LIFE LINKED ICE GUID; Egevang C, 2003, POLAR BIOL, V26, P8, DOI 10.1007/s00300-002-0448-x; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Fifield DA, 2009, ENV STUD RES FUNDS R, P183; Follestad A., 1990, Polar Research, V8, P23, DOI 10.1111/j.1751-8369.1990.tb00371.x; Fort J, 2013, DIVERS DISTRIB, V19, P1322, DOI 10.1111/ddi.12105; Fort J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041194; Fort J, 2010, MAR ECOL PROG SER, V414, P293, DOI 10.3354/meps08721; Fort J, 2010, BIOL LETTERS, V6, P682, DOI 10.1098/rsbl.2010.0082; Freeman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009236; Garzke J, 2015, OECOLOGIA, V177, P849, DOI 10.1007/s00442-014-3130-4; Gaston, 1998, THE AUKS ALCIDAE; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gremillet D, 2015, GLOBAL CHANGE BIOL, V21, P1116, DOI 10.1111/gcb.12811; Gremillet D, 2012, MAR ECOL PROG SER, V454, P197, DOI 10.3354/meps09590; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Harding AMA, 2009, POLAR BIOL, V32, P785, DOI 10.1007/s00300-009-0581-x; Hargrave B, 1984, BIOLOGICAL OCEANOGRA; Hovinen JEH, 2014, ECOL EVOL, V4, P3127, DOI 10.1002/ece3.1160; Hovinen JEH, 2014, POLAR BIOL, V37, P665, DOI 10.1007/s00300-014-1466-1; Huettmann Falk, 2011, Marine Biodiversity, V41, P141, DOI 10.1007/s12526-011-0083-2; Hunt GL, 1997, ICES J MAR SCI, V54, P600; Hunt GL, 1998, MAR ECOL PROG SER, P167; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Jakubas D, 2007, WATERBIRDS, V30, P421, DOI 10.1675/1524-4695(2007)030[0421:RODTCI]2.0.CO;2; Jakubas D, 2016, J EXP MAR BIOL ECOL, V475, P89, DOI 10.1016/j.jembe.2015.11.010; Jakubas D, 2014, J AVIAN BIOL, V45, P551, DOI 10.1111/jav.00303; Jakubas D, 2013, MAR ECOL PROG SER, V489, P263, DOI 10.3354/meps10414; Jakubas D, 2012, POLAR BIOL, V35, P73, DOI 10.1007/s00300-011-1034-x; Karnovsky N, 2010, MAR ECOL PROG SER, V415, P283, DOI 10.3354/meps08749; Karnovsky NJ, 2008, MAR ECOL PROG SER, V357, P291, DOI 10.3354/meps07295; Karnovsky NJ, 2003, MAR ECOL PROG SER, V253, P289, DOI 10.3354/meps253289; Kidawa D, 2012, POLAR BIOL, V35, P909, DOI 10.1007/s00300-011-1136-5; KINDER TH, 1983, ESTUAR COAST SHELF S, V16, P309, DOI 10.1016/0272-7714(83)90148-8; Klekowski R.Z., 1991, ATLAS MARINE FAUNA 1, V2; Kwasniewski S, 2010, PROG OCEANOGR, V87, P72, DOI 10.1016/j.pocean.2010.06.004; LONNE OJ, 1992, POLAR BIOL, V12, P685; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Lovvorn JR, 2009, ECOL APPL, V19, P1596, DOI 10.1890/08-1193.1; Mehlum F, 1997, POLAR BIOL, V18, P116, DOI 10.1007/s003000050166; Mosbech A, 2012, POLAR BIOL, V35, P305, DOI 10.1007/s00300-011-1064-4; Oksanen J., 2013, PACKAGE VEGAN, V2, P1; Pedersen CE, 2001, POLAR BIOL, V24, P53, DOI 10.1007/s003000000173; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinheiro J., 2019, NLME LINEAR NONLINEA; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Prop J, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00033; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2013, LANG ENV STAT COMP; Rose M, 1933, COPEPODES PELAGIQUES; Skov H, 2000, CONT SHELF RES, V20, P169, DOI 10.1016/S0278-4343(99)00067-9; Soreide JE, 2008, DEEP-SEA RES PT II, V55, P2225, DOI 10.1016/j.dsr2.2008.05.024; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; STEMPNIEWICZ L, 1993, POLAR RES, V12, P33, DOI 10.1111/j.1751-8369.1993.tb00420.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; STRAUSS RE, 1979, T AM FISH SOC, V108, P344, DOI 10.1577/1548-8659(1979)108<344:REFIEI>2.0.CO;2; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tencati JR, 1970, DTIC DOCUMENT; Van Hemert C, 2014, FRONT ECOL ENVIRON, V12, P548, DOI 10.1890/130291; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Welcker J, 2009, J AVIAN BIOL, V40, P388, DOI 10.1111/j.1600-048X.2008.04620.x; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Zuur Alain F., 2009, P1	78	34	34	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157764	10.1371/journal.pone.0157764	http://dx.doi.org/10.1371/journal.pone.0157764			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438790	gold, Green Submitted, Green Published			2022-12-26	WOS:000380170100003
J	Gori, M; Simonelli, MC; Giannitelli, SM; Businaro, L; Trombetta, M; Rainer, A				Gori, Manuele; Simonelli, Maria Chiara; Giannitelli, Sara Maria; Businaro, Luca; Trombetta, Marcella; Rainer, Alberto			Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device	PLOS ONE			English	Article							LIPID-ACCUMULATION; CELL-CULTURE; RISK-FACTOR; HEPATOCYTE; TISSUE; ORGANS; ACID; STEATOSIS; PROGRESSION; MODEL	Background and Aim Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease worldwide, ranging from simple steatosis to nonalcoholic steatohepatitis, which may progress to cirrhosis, eventually leading to hepatocellular carcinoma (HCC). HCC ranks as the third highest cause of cancer-related death globally, requiring an early diagnosis of NAFLD as a potential risk factor. However, the molecular mechanisms underlying NAFLD are still under investigation. So far, many in vitro studies on NAFLD have been hampered by the limitations of 2D culture systems, in which cells rapidly lose tissue-specific functions. The present liver-on-a-chip approach aims at filling the gap between conventional in vitro models, often scarcely predictive of in vivo conditions, and animal models, potentially biased by their xenogeneic nature. Methods HepG2 cells were cultured into a microfluidically perfused device under free fatty acid (FFA) supplementation, namely palmitic and oleic acid, for 24h and 48h. The device mimicked the endothelial-parenchymal interface of a liver sinusoid, allowing the diffusion of nutrients and removal of waste products similar to the hepatic microvasculature. Assessment of intracellular lipid accumulation, cell viability/cytotoxicity and oxidative stress due to the FFA overload, was performed by high-content analysis methodologies using fluorescence-based functional probes. Results The chip enables gradual and lower intracellular lipid accumulation, higher hepatic cell viability and minimal oxidative stress in microfluidic dynamic vs. 2D static cultures, thus mimicking the chronic condition of steatosis observed in vivo more closely. Conclusions Overall, the liver-on-a-chip system provides a suitable culture microenvironment, representing a more reliable model compared to 2D cultures for investigating NAFLD pathogenesis. Hence, our system is amongst the first in vitro models of human NAFLD developed within a microfluidic device in a sinusoid-like fashion, endowing a more permissive tissue-like microenvironment for long-term culture of hepatic cells than conventional 2D static cultures.	[Gori, Manuele; Simonelli, Maria Chiara; Giannitelli, Sara Maria; Trombetta, Marcella; Rainer, Alberto] Tissue Engn Lab, Dept Engn, Univ Campus Biomed Roma, Rome, Italy; [Businaro, Luca; Rainer, Alberto] CNR, Inst Photon & Nanotechnol CNR IFN, Rome, Italy; [Businaro, Luca; Trombetta, Marcella; Rainer, Alberto] UCBM IFN Joint Lab Nanotechnol Life Sci, Rome, Italy	University Campus Bio-Medico - Rome Italy; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR)	Rainer, A (corresponding author), Tissue Engn Lab, Dept Engn, Univ Campus Biomed Roma, Rome, Italy.; Rainer, A (corresponding author), CNR, Inst Photon & Nanotechnol CNR IFN, Rome, Italy.; Rainer, A (corresponding author), UCBM IFN Joint Lab Nanotechnol Life Sci, Rome, Italy.	a.rainer@unicampus.it	Giannitelli, Sara Maria/AAC-1819-2019; Gori, Manuele/AAE-7052-2021; Rainer, Alberto/G-8588-2011; businaro, luca/F-9545-2012; Gori, Manuele/J-9184-2016	Giannitelli, Sara Maria/0000-0002-3616-5953; Rainer, Alberto/0000-0001-8971-551X; businaro, luca/0000-0002-5251-093X; Gori, Manuele/0000-0001-6957-2718; Trombetta, Marcella/0000-0002-1357-4885	Fondazione Umberto Veronesi Fellowship; Universita Campus Bio-Medico di Roma "Internal Grant Program"	Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi); Universita Campus Bio-Medico di Roma "Internal Grant Program"	Support was provided by Fondazione Umberto Veronesi Fellowship to MG and Universita Campus Bio-Medico di Roma "Internal Grant Program" to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Assaily W, 2011, MOL CELL, V44, P491, DOI 10.1016/j.molcel.2011.08.038; Baudoin R, 2014, J PHARM SCI-US, V103, P706, DOI 10.1002/jps.23796; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Beebe DJ, 2013, LAB CHIP, V13, P3447, DOI 10.1039/c3lc90080k; Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bhise NS, 2014, J CONTROL RELEASE, V190, P82, DOI 10.1016/j.jconrel.2014.05.004; Chavez-Tapia NC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-20; Chen WB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764981; CORLU A, 1991, J CELL BIOL, V115, P505, DOI 10.1083/jcb.115.2.505; Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Garcia-Canaveras J. C., 2015, ELECTROPHORESIS; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gori M, 2014, J CELL PHYSIOL, V229, P1182, DOI 10.1002/jcp.24550; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Hamilton G, 2001, IN VITRO CELL DEV-AN, V37, P656; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Lee J, 2013, ENZYME MICROB TECH, V53, P159, DOI 10.1016/j.enzmictec.2013.02.015; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Luni C, 2014, CURR OPIN BIOTECH, V25, P45, DOI 10.1016/j.copbio.2013.08.015; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; No DY, 2015, LAB CHIP, V15, P3822, DOI 10.1039/c5lc00611b; Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738; Perestrelo AR, 2015, SENSORS-BASEL, V15, P31142, DOI 10.3390/s151229848; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Schutte J, 2011, BIOMED MICRODEVICES, V13, P493, DOI 10.1007/s10544-011-9517-7; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Stoehr SA, 2003, HEPATOLOGY, V38, P1125, DOI 10.1053/jhep.2003.50418; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021; Vetelainen R, 2007, ANN SURG, V245, P20, DOI 10.1097/01.sla.0000225113.88433.cf; Wagner I, 2013, LAB CHIP, V13, P3538, DOI 10.1039/c3lc50234a; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yan E, 2007, NUTR REV, V65, P376, DOI [10.1301/nr.2007.aug.376-384, 10.1111/j.1753-4887.2007.tb00315.x]; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h; Zhang MY, 2008, BIOMED MICRODEVICES, V10, P117, DOI 10.1007/s10544-007-9116-9; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751	54	96	102	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159729	10.1371/journal.pone.0159729	http://dx.doi.org/10.1371/journal.pone.0159729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438262	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100071
J	Rodrigo, MB; Mojsiejczuk, LN; Torres, C; Sevic, I; Ledesma, MMGL; Perez, PS; Bouzas, MB; Galdame, O; Marciano, S; Fainboim, H; Flichman, DM; Campos, RH				Belen Rodrigo, Maria; Noelia Mojsiejczuk, Laura; Torres, Carolina; Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Soledad Perez, Paula; Belen Bouzas, Maria; Galdame, Omar; Marciano, Sebastian; Fainboim, Hugo; Martin Flichman, Diego; Hector Campos, Rodolfo			Analysis of the Molecular Evolution of Hepatitis B Virus Genotypes in Symptomatic Acute Infections in Argentina	PLOS ONE			English	Article							E-ANTIGEN; HISTORY	Hepatitis B virus (HBV) is a globally distributed human pathogen that leads to both self-limited and chronic infections. At least eight genotypes (A-H) with distinct geographical allocations and phylodynamic behaviors have been described. They differ substantially in many virological and probably some clinical parameters. The aim of this study was to analyze full-length HBV genome sequences from individuals with symptomatic acute HBV infections using phylogenetic and coalescent methods. The phylogenetic analysis resulted in the following subgenotype distribution: F1b (52.7%), A2 (18.2%), F4 (18.2%) and A1, B2, D3 and F2a 1.8% each. These results contrast with those previously reported from chronic infections, where subgenotypes F1b, F4, A2 and genotype D were evenly distributed. This differential distribution might be related to recent internal migrations and/or intrinsic biological features of each viral genotype that could impact on the probability of transmission. The coalescence analysis showed that after a diversification process started in the 80s, the current sequences of subgenotype F1b were grouped in at least four highly supported lineages, whereas subgenotype F4 revealed a more limited diversification pattern with most lineages without offspring in the present. In addition, the genetic characterization of the studied sequences showed that only two of them presented mutations of clinical relevance at S codifyng region and none at the polymerase catalytic domains. Finally, since the acute infections could be an expression of the genotypes currently being transmitted to new hosts, the predominance of subgenotype F1b might have epidemiological, as well as, clinical relevance due to its potential adverse disease outcome among the chronic cases.	[Belen Rodrigo, Maria; Noelia Mojsiejczuk, Laura; Torres, Carolina; Sevic, Ina; Lopez Ledesma, Maria Mora Gonzalez; Soledad Perez, Paula; Martin Flichman, Diego; Hector Campos, Rodolfo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina; [Belen Bouzas, Maria] Hosp Enfermedades Infecciosas F Muniz, Unidad Virol, Buenos Aires, DF, Argentina; [Galdame, Omar; Marciano, Sebastian] Hosp Italiano Buenos Aires, Unidad Hepatol, Buenos Aires, DF, Argentina; [Fainboim, Hugo] Hosp Enfermedades Infecciosas F Muniz, Unidad Hepatopatias Infecciosas, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar	Sevic, Ina/ABF-2898-2021	Sevic, Ina/0000-0002-4920-5096; Gonzalez Lopez Ledesma, Maria Mora/0000-0002-2189-8388; Mojsiejczuk, Laura/0000-0001-7170-8880; Torres, Carolina/0000-0001-6786-8769; Rodrigo, Maria Belen/0000-0002-5741-2554	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP2012-11220110100215]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2011-0705]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP2012-11220110100215), and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT2011-0705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayashi K, 2008, J GASTROENTEROL, V43, P558, DOI 10.1007/s00535-008-2197-2; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x; Kobayashi M, 2008, J MED VIROL, V80, P1880, DOI 10.1002/jmv.21309; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Livingston SE, 2007, GASTROENTEROLOGY, V133, P1452, DOI 10.1053/j.gastro.2007.08.010; Ledesma MMGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121436; Mayerat C, 1999, J VIRAL HEPATITIS, V6, P299, DOI 10.1046/j.1365-2893.1999.00174.x; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Mizokami M, 1997, J MOL EVOL, V44, pS83, DOI 10.1007/PL00000061; Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Sagnelli C, 2015, IMPACT VIRAL MOL DIV, V45, P137; Sanchez-Tapias JM, 2002, GASTROENTEROLOGY, V123, P1848, DOI 10.1053/gast.2002.37041; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Shi WF, 2013, INFECT GENET EVOL, V16, P355, DOI 10.1016/j.meegid.2013.03.021; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Tong Shuping, 2005, Int J Med Sci, V2, P2; Torres C, 2013, VIROLOGY, V441, P40, DOI 10.1016/j.virol.2013.02.027; Torres C, 2011, MOL PHYLOGENET EVOL, V59, P114, DOI 10.1016/j.ympev.2011.01.010; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037198; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	28	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159509	10.1371/journal.pone.0159509	http://dx.doi.org/10.1371/journal.pone.0159509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433800	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600060
J	Choe, DH; Park, H; Vo, C; Knyshov, A				Choe, Dong-Hwan; Park, Hoeun; Vo, Claudia; Knyshov, Alexander			Chemically Mediated Arrestment of the Bed Bug, Cimex lectularius, by Volatiles Associated with Exuviae of Conspecifics	PLOS ONE			English	Article							DORSAL ABDOMINAL GLANDS; ALARM PHEROMONE; AGGREGATION PHEROMONE; DEFENSIVE SECRETIONS; HEMIPTERA CIMICIDAE; HETEROPTERA; COMPONENTS; PENTATOMIDAE	Extracts of the exuviae (cast skins) of nymphal bed bugs (Cimex lectularius) were analyzed for volatile compounds that might contribute to arrestment of adult bed bugs. Four volatile aldehydes, (E)-2-hexenal, 4-oxo-(E)-2-hexenal, (E)-2-octenal, and 4-oxo-(E)-2-octenal were consistently detected in the headspace of freshly shed exuviae regardless of the developmental stages from which the exuviae were obtained. Quantification of the aldehydes in the solvent extracts of homogenized fresh, 45- or 99-d aged 5th instar exuviae indicated that the aldehydes are present in the exuviae and dissipate over time, through evaporation or degradation. Microscopic observation of the fifth instar exuviae indicated that the dorsal abdominal glands on the exuviae maintained their pocket-like structures with gland reservoirs, within which the aldehydes might be retained. Two-choice olfactometer studies with the volatiles from exuviae or a synthetic blend mimicking the volatiles indicated that adult bed bugs tend to settle close to sources of the aldehydes. Our results imply that the presence and accumulation of bed bug exuviae and the aldehydes volatilizing from the exuviae might mediate bed bugs' interaction with their microhabitats.	[Choe, Dong-Hwan; Knyshov, Alexander] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Park, Hoeun] Univ Calif Riverside, Dept Media & Cultural Studies, Riverside, CA 92521 USA; [Vo, Claudia] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Park, Hoeun] La Sierra Univ, Dept Biol, Riverside, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Choe, DH (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	donghwan.choe@ucr.edu		Park, Hoeun/0000-0002-4608-548X	Early Career Chair in Urban Entomology fund; Academic Senate Regents Fellowship from University of California, Riverside	Early Career Chair in Urban Entomology fund; Academic Senate Regents Fellowship from University of California, Riverside	This research was funded in part by Early Career Chair in Urban Entomology fund and Academic Senate Regents Fellowship from University of California, Riverside. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1991, J CHEM ECOL, V17, P2307, DOI 10.1007/BF00988010; Aldritch J. R., 1988, ACS SYM SER, P417; Analytical Software, 2008, STAT 9 US MAN; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; BORGES M, 1992, EXPERIENTIA, V48, P893, DOI 10.1007/BF02118429; COLLINS RP, 1968, ANN ENTOMOL SOC AM, V61, P1338, DOI 10.1093/aesa/61.5.1338; Domingue MJ, 2010, PHYSIOL ENTOMOL, V35, P203, DOI 10.1111/j.1365-3032.2010.00738.x; Eom IY, 2012, ANAL CHIM ACTA, V716, P2, DOI 10.1016/j.aca.2011.06.010; Feldlaufer MF, 2010, J MED ENTOMOL, V47, P140, DOI 10.1603/ME09210; Gries R, 2015, ANGEW CHEM INT EDIT, V54, P1135, DOI 10.1002/anie.201409890; Harraca V, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-121; Ho HY, 2006, ANN ENTOMOL SOC AM, V99, P859, DOI 10.1603/0013-8746(2006)99[859:VITDAG]2.0.CO;2; Hokeness K, 2014, CAN J MICROBIOL, V60, P1, DOI 10.1139/cjm-2013-0708; Inamdar AA, 2010, TOXICOL SCI, V117, P418, DOI 10.1093/toxsci/kfq222; Kemper H, 1936, Z KLEINTIERK PELZTIE, V12, P1; Kilpinen O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050981; Knckel MJ., 1886, ANN MAG NAT HIST, V18, P167, DOI [10.1080/00222938609459954, DOI 10.1080/00222938609459954]; LEVINSON HZ, 1974, NATURWISSENSCHAFTEN, V61, P684, DOI 10.1007/BF00606522; LEVINSON HZ, 1974, J INSECT PHYSIOL, V20, P1231, DOI 10.1016/0022-1910(74)90229-7; LEVINSON HZ, 1971, EXPERIENTIA, V27, P102, DOI 10.1007/BF02137766; Lewis VR, 2013, CALIF AGR, V67, P172, DOI 10.3733/ca.v067n03p172; Liedtke HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018156; Mendki MJ, 2014, J VECTOR DIS, V51, P224; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; Noge K, 2015, J PESTIC SCI, V40, P143, DOI 10.1584/jpestics.J15-03; Noge K, 2012, BIOSCI BIOTECH BIOCH, V76, P1975, DOI 10.1271/bbb.120321; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; SCHILDKNECHT H, 1964, ANGEW CHEM INT EDIT, V3, P73, DOI 10.1002/anie.196400731; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Ulrich KR, 2016, PHYSIOL ENTOMOL, V41, P103, DOI 10.1111/phen.12129; Ulrich KR, 2015, BIOCONTROL, V60, P517, DOI 10.1007/s10526-015-9667-2; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Zar JH, 1999, BIOSTATISTICAL ANAL	33	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159520	10.1371/journal.pone.0159520	http://dx.doi.org/10.1371/journal.pone.0159520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434044	gold, Green Published			2022-12-26	WOS:000380169600063
J	Iglesias, M; Augustin, JJ; Alvarez, P; Santiuste, I; Postigo, J; Merino, J; Merino, R				Iglesias, Marcos; Jesus Augustin, Juan; Alvarez, Pilar; Santiuste, Ines; Postigo, Jorge; Merino, Jesus; Merino, Ramon			Selective Impairment of T(H)17-Differentiation and Protection against Autoimmune Arthritis after Overexpression of BCL2A1 in T Lymphocytes	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; PROMYELOCYTIC LEUKEMIA-CELLS; FAMILY MEMBER BIM; DEATH IN-VIVO; RETINOIC ACID; BCL-2 FAMILY; TRANSGENIC MICE; OUTER-MEMBRANE; IMMUNE-SYSTEM; B-CELLS	The inhibition of apoptotic cell death in T cells through the dysregulated expression of BCL2 family members has been associated with the protection against the development of different autoimmune diseases. However, multiple mechanisms were proposed to be responsible for such protective effect. The purpose of this study was to explore the effect of the T-cell overexpression of BCL2A1, an anti-apoptotic BCL2 family member without an effect on cell cycle progression, in the development of collagen-induced arthritis. Our results demonstrated an attenuated development of arthritis in these transgenic mice. The protective effect was unrelated to the suppressive activity of regulatory T cells but it was associated with a defective activation of p38 mitogen-activated protein kinase in CD4(+) cells after in vitro TCR stimulation. In addition, the in vitro and in vivo T(H)17 differentiation were impaired in BCL2A1 transgenic mice. Taken together, we demonstrated here a previously unknown role for BCL2A1 controlling the activation of CD4(+) cells and their differentiation into pathogenic proinflammatory T(H)17 cells and identified BCL2A1 as a potential target in the control of autoimmune/inflammatory diseases.	[Iglesias, Marcos; Jesus Augustin, Juan; Santiuste, Ines; Postigo, Jorge; Merino, Jesus; Merino, Ramon] IDIVAL Univ Cantabria, Dept Biol Mol, Santander, Spain; [Jesus Augustin, Juan; Alvarez, Pilar; Merino, Ramon] Univ Cantabria, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient, Santander, Spain; [Iglesias, Marcos] Johns Hopkins Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Postigo, Jorge] Columbia Univ, Dept Med Sci, Columbia Ctr Translat Immunol, New York, NY USA; [Postigo, Jorge] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Johns Hopkins University; Johns Hopkins Medicine; Columbia University; Columbia University	Merino, J; Merino, R (corresponding author), IDIVAL Univ Cantabria, Dept Biol Mol, Santander, Spain.; Merino, R (corresponding author), Univ Cantabria, Inst Biomed & Biotecnol Cantabria, Consejo Super Invest Cient, Santander, Spain.	merinoj@unican.es; merinor@unican.es	Merino, Ramón/L-1310-2014	Merino, Ramón/0000-0002-5306-0635; Iglesias Lozano, Marcos/0000-0002-7523-5950	Spanish Ministerio de Economia y Competitividad [SAF2011-22463, SAF2014-55088-R, SAF2012-34059, IPT2011-1527-010000]; European Regional Development Fund; Fibrostatin SL	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund(European Commission); Fibrostatin SL	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad to RM (SAF2011-22463 and SAF2014-55088-R) and JM (SAF2012-34059), which were co-funded by the European Regional Development Fund. MI was partially supported by a grant from the Spanish Ministerio de Economia y Competitividad (IPT2011-1527-010000) associated with Fibrostatin SL.	AKAO Y, 1994, CANCER RES, V54, P2468; Andre JM, 2007, LUPUS, V16, P95, DOI 10.1177/0961203306075382; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Boldizsar F, 2010, ARTHRITIS RHEUM-US, V62, P2984, DOI 10.1002/art.27614; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chandraratna RAS, 2016, AM J TRANSL RES, V8, P1016; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Di Mitri D, 2015, IMMUNOLOGY, V146, P251, DOI 10.1111/imm.12497; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; FOSSATI L, 1995, EUR J IMMUNOL, V25, P166, DOI 10.1002/eji.1830250128; Fossati-Jimack L, 2000, J EXP MED, V191, P1293, DOI 10.1084/jem.191.8.1293; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Geboes L, 2009, ARTHRITIS RHEUM-US, V60, P390, DOI 10.1002/art.24220; Gonzalez J, 2003, BLOOD, V101, P2679, DOI 10.1182/blood-2002-04-1229; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Iglesias M, 2013, ARTHRITIS RHEUM-US, V65, P343, DOI 10.1002/art.37778; Jing YK, 2001, BLOOD, V97, P264, DOI 10.1182/blood.V97.1.264; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kathania M, 2011, INT J BIOCHEM CELL B, V43, P573, DOI 10.1016/j.biocel.2010.12.014; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Korn T, 2014, ANNU REV IMMUNOL, V32, P121; Kovacs JR, 2012, CELL DEATH DIFFER, V19, P144, DOI 10.1038/cdd.2011.78; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Liu TX, 2000, BLOOD, V96, P1496, DOI 10.1182/blood.V96.4.1496.h8001496_1496_1504; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Ludwinski MW, 2009, J CLIN INVEST, V119, P1706, DOI 10.1172/JCI37619; Marquina R, 2004, J IMMUNOL, V172, P7177, DOI 10.4049/jimmunol.172.11.7177; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Olasz K, 2012, CLIN EXP IMMUNOL, V167, P346, DOI 10.1111/j.1365-2249.2011.04506.x; Postigo J, 2016, ARTHRITIS RHEUMATOL, V68, P1551, DOI 10.1002/art.39557; Postigo J, 2011, ARTHRITIS RHEUM-US, V63, P971, DOI 10.1002/art.30220; Rasooly R, 2005, J IMMUNOL, V175, P7916, DOI 10.4049/jimmunol.175.12.7916; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharabi A, 2010, J AUTOIMMUN, V34, P87, DOI 10.1016/j.jaut.2009.06.002; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Takeuchi H, 2013, J IMMUNOL, V191, P3725, DOI 10.4049/jimmunol.1300032; Verschelde C, 2006, CELL DEATH DIFFER, V13, P1213, DOI 10.1038/sj.cdd.4401814; Wen RR, 2003, J BIOL CHEM, V278, P43654, DOI 10.1074/jbc.M307318200; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369; Yu Y, 2012, AM J BLOOD RES, V2, P77	53	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159714	10.1371/journal.pone.0159714	http://dx.doi.org/10.1371/journal.pone.0159714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433938	Green Published, gold			2022-12-26	WOS:000380169600083
J	Zhu, LC; Zhang, YH; Su, FC; Chen, L; Huang, T; Cai, YD				Zhu, Liucun; Zhang, Yu-Hang; Su, Fangchu; Chen, Lei; Huang, Tao; Cai, Yu-Dong			A Shortest-Path-Based Method for the Analysis and Prediction of Fruit-Related Genes in Arabidopsis thaliana	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE-2; AUXIN RESPONSE; CELL NUMBER; PROTEIN; NETWORK; EXPRESSION; RICE; PHOTOMORPHOGENESIS; INTERACTS; ENCODES	Biologically, fruits are defined as seed-bearing reproductive structures in angiosperms that develop from the ovary. The fertilization, development and maturation of fruits are crucial for plant reproduction and are precisely regulated by intrinsic genetic regulatory factors. In this study, we used Arabidopsis thaliana as a model organism and attempted to identify novel genes related to fruit-associated biological processes. Specifically, using validated genes, we applied a shortest-path-based method to identify several novel genes in a large network constructed using the protein-protein interactions observed in Arabidopsis thaliana. The described analyses indicate that several of the discovered genes are associated with fruit fertilization, development and maturation in Arabidopsis thaliana.	[Zhu, Liucun; Su, Fangchu; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Zhang, Yu-Hang; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Maritime University	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Zhang, Yu-Hang/AAQ-9012-2021; Chen, Lei/A-2275-2011; Zhang, Yu-Hang/O-9774-2015	Zhang, Yu-Hang/0000-0003-3825-0796; Chen, Lei/0000-0003-3068-1583; Zhang, Yu-Hang/0000-0003-3825-0796; zhu, liucun/0000-0002-8334-0216; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [31371335, 31501045]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	This study was supported by the National Natural Science Foundation of China (31371335 and 31501045), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (31371335 and 31501045), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	Adwy W, 2015, PLANT J, V84, P1231, DOI 10.1111/tpj.13084; Aloisi I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00155; Anand A, 2012, NEW PHYTOL, V195, P203, DOI 10.1111/j.1469-8137.2012.04133.x; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Bernhardt A, 2010, PLANTA, V232, P555, DOI 10.1007/s00425-010-1195-9; Bomblies K, 2010, PHILOS T R SOC B, V365, P1815, DOI 10.1098/rstb.2009.0304; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Chen L, 2015, MOL BIOSYST, V11, P2541, DOI 10.1039/c5mb00276a; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096436; Chmielowska-Bak J, 2013, J PLANT PHYSIOL, V170, P1585, DOI 10.1016/j.jplph.2013.06.019; Chung K, 2011, PLANT CELL PHYSIOL, V52, P1657, DOI 10.1093/pcp/pcr099; Clemens S, 2001, Int J Occup Med Environ Health, V14, P235; Copetti D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1762-3; Egli B, 2010, PLANT PHYSIOL, V154, P1659, DOI 10.1104/pp.110.165027; El-Sharkawy I, 2014, PLANT MOL BIOL, V84, P399, DOI 10.1007/s11103-013-0139-8; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Ferrandiz C, 2002, J EXP BOT, V53, P2031, DOI 10.1093/jxb/erf082; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fujimori N, 2014, DNA REPAIR, V21, P171, DOI 10.1016/j.dnarep.2014.05.009; Gao LY, 2015, PLANT SCI, V235, P101, DOI 10.1016/j.plantsci.2015.03.007; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Guo M, 2011, PLANT SCI, V181, P1, DOI 10.1016/j.plantsci.2011.03.010; Ha S, 2014, CRIT REV BIOTECHNOL, V34, P16, DOI 10.3109/07388551.2013.783549; Hasse D, 2013, J BIOL CHEM, V288, P35333, DOI 10.1074/jbc.M113.509976; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066578; Im YJ, 2004, J MOL BIOL, V343, P659, DOI 10.1016/j.jmb.2004.08.054; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Jiang CF, 2014, GENOME RES, V24, P1821, DOI 10.1101/gr.177659.114; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kinoshita T, 2008, SEMIN CELL DEV BIOL, V19, P574, DOI 10.1016/j.semcdb.2008.07.018; KUMARDE B, 1976, INT J VITAM NUTR RES, V46, P154; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Lasky JR, 2012, MOL ECOL, V21, P5512, DOI 10.1111/j.1365-294X.2012.05709.x; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Li Bei, 2008, Weishengwu Xuebao, V48, P739; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Li ST, 2013, PLANT J, V76, P901, DOI 10.1111/tpj.12348; Liu FQ, 2004, PLANT CELL, V16, P5, DOI 10.1105/tpc.017772; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Malinova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112468; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Oh S, 2013, J EXP BOT, V64, P5457, DOI 10.1093/jxb/ert308; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Pautler M, 2015, PLANT CELL, V27, P104, DOI 10.1105/tpc.114.132506; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Ravi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6334; Robles P, 2005, INT J DEV BIOL, V49, P633, DOI 10.1387/ijdb.052020pr; Roeder Adrienne H K, 2006, Arabidopsis Book, V4, pe0075, DOI 10.1199/tab.0075; Ronceret A, 2008, PLANT J, V53, P776, DOI 10.1111/j.1365-313X.2007.03372.x; Sadanandom A, 2015, P NATL ACAD SCI USA, V112, P11108, DOI 10.1073/pnas.1415260112; Seo KI, 2014, PLANT CELL, V26, P695, DOI 10.1105/tpc.113.119974; Seong ES, 2007, BIOCHEM BIOPH RES CO, V363, P126, DOI 10.1016/j.bbrc.2007.08.147; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen Y, 2008, BMB REP, V41, P645, DOI 10.5483/BMBRep.2008.41.9.645; SNAPE JW, 1971, HEREDITY, V27, P299, DOI 10.1038/hdy.1971.91; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Sun XQ, 2014, GENE, V546, P408, DOI 10.1016/j.gene.2014.04.060; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Wang Q, 2012, PLANT PHYSIOL, V160, P1373, DOI 10.1104/pp.112.204339; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Ye WJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0479-6; Yu H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118966; Zarate X, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-32; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zimmermann S, 1999, J BIOL CHEM, V274, P17017, DOI 10.1074/jbc.274.24.17017; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	75	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159519	10.1371/journal.pone.0159519	http://dx.doi.org/10.1371/journal.pone.0159519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434024	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169600062
J	Bandyopadhyay, M; Bishop, CP; Bidwai, AP				Bandyopadhyay, Mohna; Bishop, Clifton P.; Bidwai, Ashok P.			The Conserved MAPK Site in E(spl)-M8, an Effector of Drosophila Notch Signaling, Controls Repressor Activity during Eye Development	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; OF-SPLIT COMPLEX; CELL-CYCLE PROGRESSION; CASEIN KINASE-II; EGF RECEPTOR; GENE-COMPLEX; LATERAL-INHIBITION; NEURAL DEVELOPMENT; PATTERN-FORMATION; BHLH PROTEINS	The specification of patterned R8 photoreceptors at the onset of eye development depends on timely inhibition of Atonal (Ato) by the Enhancer of split (E(spl) repressors. Repression of Ato by E(spl)-M8 requires the kinase CK2 and is inhibited by the phosphatase PP2A. The region targeted by CK2 harbors additional conserved Ser residues, raising the prospect of regulation via multi-site phosphorylation. Here we investigate one such motif that meets the consensus for modification by MAPK, a well-known effector of Epidermal Growth Factor Receptor (EGFR) signaling. Our studies reveal an important role for the predicted MAPK site of M8 during R8 birth. Ala/Asp mutations reveal that the CK2 and MAPK sites ensure that M8 repression of Ato and the R8 fate occurs in a timely manner and at a specific stage (stage-2/3) of the morphogenetic furrow (MF). M8 repression of Ato is mitigated by halved EGFR dosage, and this effect requires an intact MAPK site. Accordingly, variants with a phosphomimetic Asp at the MAPK site exhibit earlier (inappropriate) activity against Ato even at stage-1 of the MF, where a positive feedback-loop is necessary to raise Ato levels to a threshold sufficient for the R8 fate. Analysis of deletion variants reveals that both kinase sites (CK2 and MAPK) contribute to 'cis'-inhibition of M8. This key regulation by CK2 and MAPK is bypassed by the E(spl) D mutation encoding the truncated protein M8*, which potently inhibits Ato at stage-1 of R8 birth. We also provide evidence that PP2A likely targets the MAPK site. Thus multi-site phosphorylation controls timely onset of M8 repressor activity in the eye, a regulation that appears to be dispensable in the bristle. The high conservation of the CK2 and MAPK sites in the insect E(spl) proteins M7, M5 and M., and their mammalian homologue HES6, suggest that this mode of regulation may enable E(spl)/HES proteins to orchestrate repression by distinct tissue-specific mechanisms, and is likely to have broader applicability than has been previously recognized.	[Bandyopadhyay, Mohna; Bishop, Clifton P.; Bidwai, Ashok P.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA	West Virginia University	Bidwai, AP (corresponding author), West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	abidwai@wvu.edu		Bidwai, Ashok/0000-0002-4297-5629				Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Axelrod JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145pe38; Baker NE, 2004, DEV CELL, V7, P632, DOI 10.1016/j.devcel.2004.10.010; Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; Baker RH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-354; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Blau J, 2003, NAT NEUROSCI, V6, P208, DOI 10.1038/nn0303-208; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bose A, 2006, MECH DEVELOP, V123, P649, DOI 10.1016/j.mod.2006.07.003; Bose A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101884; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bray SJ, 1997, PERSPECT DEV NEUROBI, V4, P313; Brent R, 1997, ANNU REV GENET, V31, P663, DOI 10.1146/annurev.genet.31.1.663; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; CAMPOS AR, 1987, EMBO J, V6, P425, DOI 10.1002/j.1460-2075.1987.tb04772.x; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; deCelis JF, 1996, DEVELOPMENT, V122, P2719; DELIDAKIS C, 1991, GENETICS, V129, P803; Doherty D, 1997, DEVELOPMENT, V124, P3881; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Filhol O, 2004, EMBO REP, V5, P351, DOI 10.1038/sj.embor.7400115; FISCHERVIZE JA, 1992, DEVELOPMENT, V115, P89; Freeman M, 1997, DEVELOPMENT, V124, P261; Gao XM, 2001, J CELL BIOL, V154, P1161, DOI 10.1083/jcb.200104058; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Gibert JM, 2003, INT J DEV BIOL, V47, P643; Giebel B, 1997, P NATL ACAD SCI USA, V94, P6250, DOI 10.1073/pnas.94.12.6250; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Greenwald I, 2012, GENETICS, V191, P655, DOI 10.1534/genetics.112.141812; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Housden B, 2012, G3-GENES GENOM GENET, V2, P79, DOI 10.1534/g3.111.001321; Hsiung F, 2002, HUM MOL GENET, V11, P1207, DOI 10.1093/hmg/11.10.1207; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Jones C, 2006, GENETICS, V173, P793, DOI 10.1534/genetics.106.056762; Joshi M, 2006, DEV BIOL, V293, P64, DOI 10.1016/j.ydbio.2006.01.005; Kahali B, 2010, GENESIS, V48, P44, DOI 10.1002/dvg.20581; Kahali B, 2009, GENESIS, V47, P456, DOI 10.1002/dvg.20521; Karandikar UC, 2004, MECH DEVELOP, V121, P273, DOI 10.1016/j.mod.2004.01.008; Kavaler J, 1999, DEVELOPMENT, V126, P2261; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KNUST E, 1987, DEV BIOL, V122, P262, DOI 10.1016/0012-1606(87)90351-4; KNUST E, 1992, GENETICS, V132, P505; Kumar J, 1997, GENE DEV, V11, P2023, DOI 10.1101/gad.11.16.2023; Kumar JP, 2003, DEVELOPMENT, V130, P3703, DOI 10.1242/dev.00556; Kumar JP, 1998, DEVELOPMENT, V125, P3875; Kumar JP, 2010, CURR TOP DEV BIOL, V93, P1, DOI [10.1016/B978-0-12-385044-7.00001-1, 10.1016/S0070-2153(10)93001-9]; KUNISCH M, 1994, P NATL ACAD SCI USA, V91, P10139, DOI 10.1073/pnas.91.21.10139; Kunttas-Tatli E, 2009, GENESIS, V47, P647, DOI 10.1002/dvg.20543; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Ligoxygakis P, 1998, DEVELOPMENT, V125, P2893; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lubensky DK, 2011, P NATL ACAD SCI USA, V108, P11145, DOI 10.1073/pnas.1015302108; MAIER D, 1993, P NATL ACAD SCI USA, V90, P5464, DOI 10.1073/pnas.90.12.5464; Majot AT, 2015, ADV BIOCHEM HEALTH D, V12, P81, DOI 10.1007/978-3-319-14544-0_6; Mann RS, 2016, CELL, V164, P347, DOI 10.1016/j.cell.2016.01.010; Nagel AC, 1999, DEV BIOL, V208, P406, DOI 10.1006/dbio.1999.9203; Nagel AC, 2004, GENESIS, V39, P105, DOI 10.1002/gene.20033; Nagel AC, 1999, DEV GENET, V25, P168, DOI 10.1002/(SICI)1520-6408(1999)25:2<168::AID-DVG11>3.0.CO;2-0; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pepple KL, 2008, DEVELOPMENT, V135, P4071, DOI 10.1242/dev.028951; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Powell LM, 2004, MOL CELL BIOL, V24, P9517, DOI 10.1128/MCB.24.21.9517-9526.2004; PREISS A, 1988, EMBO J, V7, P3917, DOI 10.1002/j.1460-2075.1988.tb03278.x; Quan XJ, 2016, CELL, V164, P460, DOI 10.1016/j.cell.2015.12.048; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; SCHRONS H, 1992, GENETICS, V132, P481; SCHWEISGUTH F, 1995, DEVELOPMENT, V121, P1875; Schweisguth Francois, 1997, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V191, P55; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Simpson P, 1999, DEVELOPMENT, V126, P1349; Spencer SA, 1998, DEVELOPMENT, V125, P4777; Sun Y, 1998, DEVELOPMENT, V125, P3731; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; TATA F, 1995, MECH DEVELOP, V51, P305, DOI 10.1016/0925-4773(95)00377-0; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; TIETZE K, 1992, P NATL ACAD SCI USA, V89, P6152, DOI 10.1073/pnas.89.13.6152; Trott RL, 2001, J BIOL CHEM, V276, P2159, DOI 10.1074/jbc.M005996200; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Warren I, 2007, BIOESSAYS, V29, P300, DOI 10.1002/bies.20543; Welshons WJ, 1956, DROS INFORM SERV, V30, P157; White NM, 2000, DEVELOPMENT, V127, P1681; WOLFF T, 1991, DEVELOPMENT, V113, P841; WOLFF T, 1991, DEVELOPMENT, V113, P825; Wurmbach E, 2014, HEREDITAS, V151, P159, DOI 10.1111/hrd2.00065; Yang LH, 2003, DEV CELL, V4, P359, DOI 10.1016/S1534-5807(03)00059-5; Yang LH, 2001, DEVELOPMENT, V128, P1183; ZIEMER A, 1988, GENETICS, V119, P63	110	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159508	10.1371/journal.pone.0159508	http://dx.doi.org/10.1371/journal.pone.0159508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428327	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300072
J	Cox, DTC; Gaston, KJ				Cox, Daniel T. C.; Gaston, Kevin J.			Urban Bird Feeding: Connecting People with Nature	PLOS ONE			English	Article							STRESS RECOVERY; WILD BIRDS; CONSERVATION; BIODIVERSITY; EXTINCTION; EXPERIENCE; ENVIRONMENTS; BENEFITS; ATTITUDE; CONTACT	At a time of unprecedented biodiversity loss, researchers are increasingly recognizing the broad range of benefits provided to humankind by nature. However, as people live more urbanized lifestyles there is a progressive disengagement with the natural world that diminishes these benefits and discourages positive environmental behaviour. The provision of food for garden birds is an increasing global phenomenon, and provides a readily accessible way for people to counter this trend. Yet despite its popularity, quite why people feed birds remains poorly understood. We explore three loosely defined motivations behind bird feeding: that it provides psychological benefits, is due to a concern about bird welfare, and/or is due to a more general orientation towards nature. We quantitatively surveyed households from urban towns in southern England to explore attitudes and actions towards garden bird feeding. Each household scored three Likert statements relating to each of the three motivations. We found that people who fed birds regularly felt more relaxed and connected to nature when they watched garden birds, and perceived that bird feeding is beneficial for bird welfare while investing time in minimising associated risks. Finally, feeding birds may be an expression of a wider orientation towards nature. Overall, we found that the feelings of being relaxed and connected to nature were the strongest drivers. As urban expansion continues both to threaten species conservation and to change peoples' relationship with the natural world, feeding birds may provide an important tool for engaging people with nature to the benefit of both people and conservation.	[Cox, Daniel T. C.; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England	University of Exeter	Cox, DTC (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England.	dan.t.cox@googlemail.com		Gaston, Kevin J./0000-0002-7235-7928; Cox, Daniel/0000-0003-1929-5438	Natural Environment Research Council [NE/J015237/1]; Fragments, Functions, Flows and Urban Ecosystem Services project; NERC [NE/J015237/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fragments, Functions, Flows and Urban Ecosystem Services project; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Fragments, Functions, Flows and Urban Ecosystem Services project, Natural Environment Research Council grant NE/J015237/1.	Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Barton K., 2015, MUMIN MULTIMODEL INF; Belaire JA, 2015, CONDOR, V117, P192, DOI 10.1650/CONDOR-14-128.1; Brock M, 2017, ENVIRON RESOUR ECON, V67, P127, DOI 10.1007/s10640-015-9979-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Capaldi CA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00976; Christensen RHB, ORDINAL REGRESSION M; Collado S, 2015, J ENVIRON PSYCHOL, V41, P65, DOI 10.1016/j.jenvp.2014.11.001; Cox DTC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141505; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; Eurostat, 2012, EUR FIG EUR YB; Fuller R. A., 2010, URBAN ECOL, P134, DOI [DOI 10.1017/CBO9780511778483.008, 10.1017/CBO9780511778483.008]; Fuller RA, 2008, DIVERS DISTRIB, V14, P131, DOI 10.1111/j.1472-4642.2007.00439.x; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Galbraith JA, 2014, BIOL CONSERV, V180, P64, DOI 10.1016/j.biocon.2014.09.038; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Gauthier AH, 2003, RES AGING, V25, P247, DOI 10.1177/0164027503025003003; Green Ronda J., 2000, Pacific Conservation Biology, V6, P183; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Heiberger R.M., 2015, HH STAT ANAL DATA DI; Howard Peter, 2004, P55; Irvine KN, 2010, FUTURE CITY, V2, P215, DOI 10.1007/978-1-4020-8647-2_10; Ishigame Go, 2007, Ornithological Science, V6, P11, DOI 10.2326/1347-0558(2007)6[11:PAAOSA]2.0.CO;2; JIANG B, 2014, ENVIRON BEHAV, V48, P607, DOI DOI 10.1177/0013916514552321; Jones D, 2011, EMU, V111, pI, DOI 10.1071/MUv111n2_ED; Jones DN, 2008, J AVIAN BIOL, V39, P265, DOI 10.1111/j.0908-8857.2008.04271.x; Juster FT, 2004, CHANGING TIMES AM YO; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Keniger LE, 2013, INT J ENV RES PUB HE, V10, P913, DOI 10.3390/ijerph10030913; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Louv R., 2005, LAST CHILD WOODS WHY; Martyn P, 2014, J CLEAN PRO IN PRESS, V1-10; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; PYLE RM, 1977, HORTICULTURE, V55, P65; R Development Core Team, 2015, A LANGUAGE AND ENVIR; Ratcliffe E, 2013, J ENVIRON PSYCHOL, V36, P221, DOI 10.1016/j.jenvp.2013.08.004; Restall B, 2015, J ENVIRON MANAGE, V159, P264, DOI 10.1016/j.jenvman.2015.05.022; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Rollinson Daniel J., 2003, Corella, V27, P52; Royal Society for the Protection of Birds, 2007, 2007 FEED GARD BIRDS; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Scheibe S, 2013, PSYCHOL AGING, V28, P160, DOI 10.1037/a0030561; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Sigman A, 2012, ARCH DIS CHILD, V97, P935, DOI 10.1136/archdischild-2012-302196; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Soga M, 2015, LANDSCAPE URBAN PLAN, V143, P69, DOI 10.1016/j.landurbplan.2015.06.003; Tarrant MA, 2002, ENVIRON MANAGE, V30, P692, DOI 10.1007/s00267-002-2722-7; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; U.S. Department of the Interior U.S. Fish and Wildlife Service & U.S. Department of Commerce U.S. Census Bureau, 2011, 2011 NAT SURV FISH H; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Weidensaul Scott, 2008, FEATHER BRIEF HIST A; Zelenski JM, 2014, ENVIRON BEHAV, V46, P3, DOI 10.1177/0013916512451901; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011	57	81	83	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158717	10.1371/journal.pone.0158717	http://dx.doi.org/10.1371/journal.pone.0158717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427988	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300019
J	Ma, K; Guo, L; Xu, AP; Cui, S; Wang, JH				Ma, Ke; Guo, Li; Xu, Aiping; Cui, Shan; Wang, Jin-Hui			Molecular Mechanism for Stress-Induced Depression Assessed by Sequencing miRNA and mRNA in Medial Prefrontal Cortex	PLOS ONE			English	Article							CHRONIC MILD STRESS; MAGNETIC-RESONANCE SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; BIPOLAR DISORDER; THERAPEUTIC TARGETS; INHIBITORY DEFICITS; MICRORNA EXPRESSION; GABAERGIC NEURONS	Background Major depression is a prevalent mood disorder. Chronic stress is presumably main etiology that leads to the neuron and synapse atrophies in the limbic system. However, the intermediate molecules from stresses to neuronal atrophy remain elusive, which we have studied in the medial prefrontal cortices from depression mice. Methods and Results The mice were treated by the chronic unpredictable mild stress (CUMS) until they expressed depression-like behaviors confirmed by the tests of sucrose preference, forced swimming and Y-maze. High-throughput sequencings of microRNA and mRNA in the medial prefrontal cortices were performed in CUMS-induced depression mice versus control mice to demonstrate the molecular profiles of major depression. In the medial prefrontal cortices of depression- like mice, the levels of mRNAs that translated the proteins for the GABAergic synapses, dopaminergic synapses, myelination, synaptic vesicle cycle and neuronal growth were down-regulated. miRNAs of regulating these mRNAs are upregulated. Conclusion The deteriorations of GABAergic and dopaminergic synapses as well as axonal growth are associated with CUMS-induced depression.	[Ma, Ke; Wang, Jin-Hui] Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China; [Guo, Li; Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Guo, Li; Wang, Jin-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Aiping; Wang, Jin-Hui] Univ Sci & Technol China, Coll Life Sci, Hefei, Anhui, Peoples R China	Qingdao University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, JH (corresponding author), Qingdao Univ, Sch Pharm, Qingdao, Shandong, Peoples R China.; Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Sci & Technol China, Coll Life Sci, Hefei, Anhui, Peoples R China.	jhw@sun5.ibp.ac.cn			National Basic Research Program [2013CB531304]; Natural Science Foundation China [81471123]	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC))	This study is granted by the National Basic Research Program (2013CB531304) and Natural Science Foundation China (81471123) to JHW.	Afonso-Grunz F, 2015, CELL MOL LIFE SCI, V72, P3127, DOI 10.1007/s00018-015-1922-2; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bai M, 2014, PHYSIOL BEHAV, V129, P135, DOI 10.1016/j.physbeh.2014.02.035; Banasr M, 2011, CURR OPIN CELL BIOL, V23, P730, DOI 10.1016/j.ceb.2011.09.002; Barbash S, 2014, MOL BIOL EVOL, V31, P1237, DOI 10.1093/molbev/msu090; Beilharz TH, 2010, PROG MOL SUBCELL BIO, V50, P99, DOI 10.1007/978-3-642-03103-8_7; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Berton O, 2012, SCIENCE, V338, P75, DOI 10.1126/science.1222940; Bhosale G, 2015, ANN NY ACAD SCI, V1350, P107, DOI 10.1111/nyas.12885; Biggar KK, 2011, J MOL CELL BIOL, V3, P167, DOI 10.1093/jmcb/mjq045; Booij L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0251; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Chen N, 2006, BIOCHEM BIOPH RES CO, V346, P938, DOI 10.1016/j.bbrc.2006.06.003; Croarkin PE, 2011, NEUROSCI BIOBEHAV R, V35, P818, DOI 10.1016/j.neubiorev.2010.10.002; Crowley JJ, 2005, CURR PHARM DESIGN, V11, P157, DOI 10.2174/1381612053382278; Dalmay T, 2013, ESSAYS BIOCHEM, V54, P29, DOI [10.1042/BSE0540029, 10.1042/bse0540029]; Dalton VS, 2014, J AFFECT DISORDERS, V155, P1, DOI 10.1016/j.jad.2013.10.028; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Dwivedi Y, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.175; Elhwuegi AS, 2004, PROG NEURO-PSYCHOPH, V28, P435, DOI 10.1016/j.pnpbp.2003.11.018; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Fatemi SH, 2013, TRANSL PSYCHIAT, V3, DOI [10.1038/tp.2013.64, 10.1038/tp.2013.46]; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hansen KF, 2013, NEUROPSYCH DIS TREAT, V9, P1011, DOI 10.2147/NDT.S34811; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; He J, 2016, P NATL ACAD SCI USA, V113, P584, DOI 10.1073/pnas.1521098113; He Y, 2012, DNA CELL BIOL, V31, P1499, DOI 10.1089/dna.2012.1660; Hill MN, 2012, NEUROSCI BIOBEHAV R, V36, P2085, DOI 10.1016/j.neubiorev.2012.07.001; Huang L, 2010, BIOCHEM BIOPH RES CO, V394, P709, DOI 10.1016/j.bbrc.2010.03.056; Iga JI, 2008, ANN MED, V40, P336, DOI 10.1080/07853890802082088; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Lin E, 2016, PROG NEURO-PSYCHOPH, V64, P334, DOI 10.1016/j.pnpbp.2015.02.008; Lin LC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00110; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Lopizzo N, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fpsyt.2015.0068, 10.3389/fpsyt.2015.00068]; Maheu M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.11; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; O'Connor RM, 2012, MOL PSYCHIATR, V17, P359, DOI 10.1038/mp.2011.162; Opmeer EM, 2010, PROG NEUROBIOL, V92, P112, DOI 10.1016/j.pneurobio.2010.06.003; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Price RB, 2009, BIOL PSYCHIAT, V65, P792, DOI 10.1016/j.biopsych.2008.10.025; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rajkowska G, 2015, J PSYCHIATR RES, V65, P53, DOI 10.1016/j.jpsychires.2015.04.010; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Schweizer MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004326; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Smaili S, 2009, AN ACAD BRAS CIENC, V81, P467, DOI 10.1590/S0001-37652009000300011; Smalheiser NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086469; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Strekalova T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-9; Tripp A, 2011, NEUROBIOL DIS, V42, P116, DOI 10.1016/j.nbd.2011.01.014; Urani A, 2005, NEUROSCI BIOBEHAV R, V29, P805, DOI 10.1016/j.neubiorev.2005.03.020; Veeraiah P, 2014, BIOL PSYCHIAT, V76, P231, DOI 10.1016/j.biopsych.2013.09.024; Wang J-H, 2015, BRAIN DISORDERS THER, V4, P1, DOI [10.4172/2168-975X.1000200, DOI 10.4172/2168-975X.1000200]; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wurtman RJ, 2005, METABOLISM, V54, P16, DOI 10.1016/j.metabol.2005.01.007; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zink M, 2009, NEUROCHEM RES, V34, P1584, DOI 10.1007/s11064-009-9947-2	82	58	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159093	10.1371/journal.pone.0159093	http://dx.doi.org/10.1371/journal.pone.0159093			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427907	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300035
J	Marshall, E; Rain-Taljaard, R; Tsepe, M; Monkwe, C; Hlatswayo, F; Tshabalala, S; Khela, S; Xulu, L; Xaba, D; Molomo, T; Malinga, T; Puren, A; Auvert, B				Marshall, Esaie; Rain-Taljaard, Reathe; Tsepe, Motlalepule; Monkwe, Cornelius; Hlatswayo, Florence; Tshabalala, Simphiwe; Khela, Simphiwe; Xulu, Lindo; Xaba, Dumazile; Molomo, Tebogo; Malinga, Thobile; Puren, Adrian; Auvert, Bertran			Sequential Cross-Sectional Surveys in Orange Farm, a Township of South Africa, Revealed a Constant Low Voluntary Medical Male Circumcision Uptake among Adults despite Demand Creation Campaigns and High Acceptability	PLOS ONE			English	Article							HIV PREVENTION; TRIAL; UGANDA; RAKAI; KNOWLEDGE; KENYA; MEN	Background WHO recommends a male circumcision (MC) prevalence rate higher than 80% to have a substantial impact on the HIV-AIDS epidemic in Eastern and Southern Africa. Orange Farm, a township in South Africa, has a free-for-service voluntary medical male circumcision (VMMC) clinic in operation since 2008. Following an intense campaign from 2008 to 2010, MC prevalence rate increased to 55.4% (ANRS-12126). Ongoing and past VMMC campaigns focused on youths, through school talks, and adults at a community level. The main objective of the study was to assess the change in MC prevalence rate among adults aged 18-19 and 18-49 years in the past 5 years. Methods A cross-sectional survey (ANRS-12285) was conducted among a random sample of 522 adult men in 2015. MC status and characteristics of participants were collected through a genital examination and a face-to-face questionnaire. Results MC prevalence rate among young adult men aged 18-19 years increased markedly from 61.2% (95%CI: 57.4% to 65.0%) in 2010 to 87.5% (76.0% to 94.6%) in 2015 (p<0.001). In the same period, among men aged 18-49 years, MC prevalence rate varied slightly from 55.4% (53.6% to 57.1%) to 56.7% (52.4% to 60.9%). In 2015, 84.9%(79.2% to 89.5%) of uncircumcised adult men reported that they were willing to be circumcised. However, we estimated that only 4.6% (11/237; 2.5% to 7.9%) of the uncircumcised men underwent circumcision in 2015, despite 117/185 (63.2%; 95%CI: 56.1% to 69.9%) who reported that they were definitely willing to become circumcised. Conclusions In Orange Farm, VMMC campaigns were successful among the youth and led to a sufficiently high MC prevalence rate to have a substantial impact in the future on the HIV-AIDS epidemic. However, despite high acceptability and a free VMMC service, VMMC campaigns since 2010 have failed to increase MC prevalence rate among adults to above 80%. These campaigns should be revisited.	[Marshall, Esaie; Auvert, Bertran] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Marshall, Esaie] Univ Burgundy, Fac Med, Res Unit 4184, Fac Med, Dijon, France; [Rain-Taljaard, Reathe; Tsepe, Motlalepule; Monkwe, Cornelius; Hlatswayo, Florence; Tshabalala, Simphiwe; Khela, Simphiwe; Xulu, Lindo; Xaba, Dumazile; Molomo, Tebogo; Malinga, Thobile] Progressus Res & Dev, Johannesburg, South Africa; [Puren, Adrian] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Johannesburg, South Africa; [Puren, Adrian] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Auvert, Bertran] Hop Ambroise Pare, AP HP, Boulogne, France; [Auvert, Bertran] Univ Versailles St Quentin, Fac Med, Versailles, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Bourgogne; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Auvert, B (corresponding author), INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France.; Auvert, B (corresponding author), Hop Ambroise Pare, AP HP, Boulogne, France.; Auvert, B (corresponding author), Univ Versailles St Quentin, Fac Med, Versailles, France.	bertran.auvert@uvsq.fr	Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018	Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010	French Agence Nationale de Recherches sur le Sida et les Hepatites Virales [12126, 12285]; Institut Universitaire de France; National Institute for Communicable Diseases; Progressus	French Agence Nationale de Recherches sur le Sida et les Hepatites Virales(ANRS); Institut Universitaire de France; National Institute for Communicable Diseases; Progressus	BA received funding (grant 12126 and 12285) from the French Agence Nationale de Recherches sur le Sida et les Hepatites Virales (www.anrs.fr). BA also received funding from the Institut Universitaire de France. AP received funding from the National Institute for Communicable Diseases. RRT received funding from Progressus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Liwen Vaughan, 2003, STAT METHODS INFORM; Lundahl B, 2009, J CLIN PSYCHOL, V65, P1232, DOI 10.1002/jclp.20638; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Miller WR, 2009, AM PSYCHOL, V64, P527, DOI 10.1037/a0016830; National Department of Health P, 2011, 2010 NAT ANT SENT HI, P50; R Development Core Team, 2005, R LANG ENV STAT COMP; Ssekubugu R, 2013, QUAL HEALTH RES, V23, P795, DOI 10.1177/1049732313482189; Thirumurthy H, 2014, JAMA-J AM MED ASSOC, V312, P703, DOI 10.1001/jama.2014.9087; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WESTERCAMP N, 2006, AIDS BEHAV; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; WHO/UNAIDS, 2007, TECHN CONS MAL CIRC TECHN CONS MAL CIRC; WHO-UNAIDS, 2015, WHOHIV201521 WHOUNAI; WHO-UNAIDS, 2015, UNAIDS WORLD AIDS DA	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158675	10.1371/journal.pone.0158675	http://dx.doi.org/10.1371/journal.pone.0158675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427957	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169300017
J	Hansen, HH; Fabricius, K; Barkholt, P; Kongsbak-Wismann, P; Schlumberger, C; Jelsing, J; Terwel, D; Termont, A; Pyke, C; Knudsen, LB; Vrang, N				Hansen, Henrik H.; Fabricius, Katrine; Barkholt, Pernille; Kongsbak-Wismann, Pernille; Schlumberger, Chantal; Jelsing, Jacob; Terwel, Dick; Termont, Annelies; Pyke, Charles; Knudsen, Lotte Bjerre; Vrang, Niels			Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on beta-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA; SYNAPTIC PLASTICITY; OBJECT RECOGNITION; COGNITIVE DEFICITS; BEHAVIORAL-CHANGES; MEMORY IMPAIRMENT; SPATIAL MEMORY; BODY-WEIGHT; FOOD-INTAKE; BRAIN	One of the major histopathological hallmarks of Alzheimer's disease (AD) is cerebral deposits of extracellular beta-amyloid peptides. Preclinical studies have pointed to glucagon-like peptide 1 (GLP-1) receptors as a potential novel target in the treatment of AD. GLP-1 receptor agonists, including exendin-4 and liraglutide, have been shown to promote plaque-lowering and mnemonic effects of in a number of experimental models of AD. Transgenic mouse models carrying genetic mutations of amyloid protein precursor (APP) and presenilin-1 (PS1) are commonly used to assess the pharmacodynamics of potential amyloidosis-lowering and pro-cognitive compounds. In this study, effects of long-term liraglutide treatment were therefore determined in two double APP/PS1 transgenic mouse models of Alzheimer's disease carrying different clinical APP/PS1 mutations, i.e. the 'London' (hAPP(Lon)/PS1(A246E)) and 'Swedish' mutation variant (hAPP(Swe)/PS1(Delta E9)) of APP, with co-expression of distinct PS1 variants. Liraglutide was administered in 5 month-old hAPPLon/PS1A246E mice for 3 months (100 or 500 ng/kg/day, s.c.), or 7 month-old hAPP(Swe)/PS1(Delta E9) mice for 5 months (500 ng/kg/day, s.c.). In both models, regional plaque load was quantified throughout the brain using stereological methods. Vehicle-dosed hAPP(Swe)/PS1(Delta E9) mice exhibited considerably higher cerebral plaque load than hAPPLon/PS1A246E control mice. Compared to vehicle-dosed transgenic controls, liraglutide treatment had no effect on the plaque levels in hAPP(Lon)/PS1(A246E) and hAPP(Swe)/PS1(Delta E9) mice. In conclusion, long-term liraglutide treatment exhibited no effect on cerebral plaque load in two transgenic mouse models of low-and high-grade amyloidosis, which suggests differential sensitivity to long-term liraglutide treatment in various transgenic mouse models mimicking distinct pathological hallmarks of AD.	[Hansen, Henrik H.; Fabricius, Katrine; Barkholt, Pernille; Kongsbak-Wismann, Pernille; Schlumberger, Chantal; Jelsing, Jacob; Vrang, Niels] Gubra, Agern Alle 1, DK-2970 Horsholm, Denmark; [Terwel, Dick; Termont, Annelies] ReMYND NV, Gaston Greenslaan 1, B-3001 Louvain, Belgium; [Pyke, Charles; Knudsen, Lotte Bjerre] Novo Nordisk AS, Diabet Res, DK-2760 Malov, Denmark	Novo Nordisk	Hansen, HH; Vrang, N (corresponding author), Gubra, Agern Alle 1, DK-2970 Horsholm, Denmark.	hbh@gubra.dk; niels@gubra.dk		Knudsen, Lotte Bjerre/0000-0002-2439-7116; Barkholt, Pernille/0000-0002-3603-2915	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was carried out in collaboration with Novo Nordisk. Novo Nordisk funded the study, participated in the study design, data collection and analysis, as well as in decision to publish and preparation of the manuscript. The specific roles of the authors are articulated in the 'Author Contributions' section.	Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bilkei-Gorzo A, 2014, PHARMACOL THERAPEUT, V142, P244, DOI 10.1016/j.pharmthera.2013.12.009; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bomba M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.139; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Cai HY, 2014, NEUROSCIENCE, V277, P6, DOI 10.1016/j.neuroscience.2014.02.022; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; D'Amico M, 2010, EXP GERONTOL, V45, P202, DOI 10.1016/j.exger.2009.12.004; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Easton A, 2013, PSYCHOPHARMACOLOGY, V230, P279, DOI 10.1007/s00213-013-3152-3; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; Flood JF, 1996, NEUROBIOL AGING, V17, P15, DOI 10.1016/0197-4580(95)02007-1; Gengler S, 2012, NEUROBIOL AGING, V33, P265, DOI 10.1016/j.neurobiolaging.2010.02.014; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han WN, 2013, NEUROBIOL AGING, V34, P576, DOI 10.1016/j.neurobiolaging.2012.04.009; Hansen HH, 2016, BRAIN RES, V1634, P158, DOI 10.1016/j.brainres.2015.12.052; Hansen HH, 2015, J ALZHEIMERS DIS, V46, P877, DOI 10.3233/JAD-143090; Heppner KM, 2015, ENDOCRINOLOGY, V156, P255, DOI 10.1210/en.2014-1675; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Liu B, 2013, J NEUROSCI, V33, P7027, DOI 10.1523/JNEUROSCI.5924-12.2013; Long-Smith CM, 2013, NEUROMOL MED, V15, P102, DOI 10.1007/s12017-012-8199-5; Lund A, 2014, EUR J INTERN MED, V25, P407, DOI 10.1016/j.ejim.2014.03.005; Ma T, 2012, J NEUROSCI, V32, P13701, DOI 10.1523/JNEUROSCI.2107-12.2012; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Manaye KF, 2007, AGE, V29, P87, DOI 10.1007/s11357-007-9035-y; McClean PL, 2015, BEHAV BRAIN RES, V293, P96, DOI 10.1016/j.bbr.2015.07.024; McClean PL, 2014, NEUROPHARMACOLOGY, V86, P241, DOI 10.1016/j.neuropharm.2014.07.015; McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Morley JE, 2002, NEUROBIOL LEARN MEM, V78, P125, DOI 10.1006/nlme.2001.4047; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Orskov C, 1996, DIABETES, V45, P832, DOI 10.2337/diabetes.45.6.832; Park JH, 2006, J NEUROSCI, V26, P13279, DOI 10.1523/JNEUROSCI.4504-06.2006; Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Puzzo D, 2014, BIOCHEM PHARMACOL, V88, P450, DOI 10.1016/j.bcp.2014.01.011; Qin ZX, 2008, NEUROSCI LETT, V444, P217, DOI 10.1016/j.neulet.2008.08.047; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Scott L, 2012, NEUROBIOL AGING, V1481, pe1413; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Sisley S, 2014, J CLIN INVEST, V124, P2456, DOI 10.1172/JCI72434; Talbot K, 2014, NEURODEGENER DIS MAN, V4, P31, DOI [10.2217/NMT.13.73, 10.2217/nmt.13.73]; Tanghe A, 2010, INT J ALZHEIMERS DIS, P2010; Tatarkiewicz K, 2014, AM J PHYSIOL-REG I, V306, pR490, DOI 10.1152/ajpregu.00495.2013; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Velmurugan K, 2012, J NEUROCHEM, V123, P919, DOI 10.1111/jnc.12036; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	73	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158205	10.1371/journal.pone.0158205	http://dx.doi.org/10.1371/journal.pone.0158205			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27421117	gold, Green Published, Green Submitted			2022-12-26	WOS:000379662300001
J	Al Harbi, M; Khandekar, R; Kozak, I; Schatz, P				Al Harbi, Majed; Khandekar, Rajiv; Kozak, Igor; Schatz, Patrik			Association between Sickle Cell Trait and the Prevalence and Severity of Diabetic Retinopathy	PLOS ONE			English	Article							COMPLICATIONS; PROGRESSION; RISK; CANDESARTAN; KINGDOM; DISEASE; REGION; TRIAL	Purpose To determine whether Sickle cell trait (SCT) is associated with an increased severity of diabetic retinopathy. Methods This was a single center retrospective study case control study of 100 eyes of 100 patients with diabetes mellitus (DM) with SCT (SCT group) and 100 eyes of 100 age-matched patients with DM without SCT (control group). The main outcome measure was the difference in the prevalence of sight threatening DR [here defined as diabetic macular edema (DME) and/or proliferative diabetic retinopathy (PDR)], between the SCT and control groups. Secondary outcome measures included differences in visual acuity, ocular comor-bidities, intraocular pressure, glycemic control as assessed by random blood glucose measurement, diabetes duration, nephropathy, hyperlipidemia and hypertension. Results The SCT group had statistically significantly shorter duration of DM (median [25% quartile] 15 [8.3] years versus 20 [14.7] years, respectively)(P<0.001) and presented with statistically better metabolic control (mean difference 1.6 mmol/l, (95% confidence interval [CI], 0.1-3.3; P = 0.03). The prevalence of PDR and/or DME was significantly lower in the SCT group (58%) compared to the control group, (95%)(P<0.001). The absence of SCT (adjusted odds ratio [AOR] = 24; 95% CI, 8-72; P<0.001) and longer duration of DM (AOR = 1.1 [95% CI, 1.02-1.13]; P = 0.003) were independent predictors of PDR and/or DME. Conclusions SCT seems to protect against the development and progression of DR. This may have implications for monitoring and screening. Prospective studies are required to confirm this association. If true, this association may indicate an increased blood glucose buffering capacity of abnormal hemoglobin.	[Al Harbi, Majed; Khandekar, Rajiv; Kozak, Igor; Schatz, Patrik] King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh, Saudi Arabia; [Schatz, Patrik] Lund Univ, Skane Cty Univ Hosp, Clin Sci, Dept Ophthalmol, Lund, Sweden	King Khaled Eye Specialist Hospital; Lund University	Schatz, P (corresponding author), King Khalid Eye Specialist Hosp, Vitreoretinal Div, Riyadh, Saudi Arabia.; Schatz, P (corresponding author), Lund Univ, Skane Cty Univ Hosp, Clin Sci, Dept Ophthalmol, Lund, Sweden.	patrik.schatz@med.lu.se	Khandekar, Rajiv/ABE-6707-2020; Schatz, Patrik/E-3739-2018; Kozak, Igor/AAC-4645-2019; Schatz, Patrik/K-9894-2019	Khandekar, Rajiv/0000-0002-3925-1005; Schatz, Patrik/0000-0002-1747-0928; Schatz, Patrik/0000-0002-1747-0928	Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired; Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired	Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired; Cronqvist Foundation of the Swedish Society of Medicine; Eye Foundation; Foundation for the visually impaired in the Skane County; Crownprincess Margareta's Board for the visually impaired	Grants from the Cronqvist Foundation of the Swedish Society of Medicine, the Eye Foundation, the Foundation for the visually impaired in the Skane County and the Crownprincess Margareta's Board for the visually impaired. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, DIABETES, V44, P968; Bleyer AJ, 2010, CLIN J AM SOC NEPHRO, V5, P1015, DOI 10.2215/CJN.08841209; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Diaw M, 2015, DIABETES CARE, V38, P2120, DOI 10.2337/dc15-0699; El-Bab MF, 2012, CLIN OPHTHALMOL, V6, P269, DOI 10.2147/OPTH.S27363; Galvez-Ruiz A, 2016, J NEURO-OPHTHALMOL, V36, P131, DOI 10.1097/WNO.0000000000000329; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Han SZ, 2006, INT J IMMUNOGENET, V33, P281, DOI 10.1111/j.1744-313X.2006.00614.x; JACKSON H, 1995, EYE, V9, P589, DOI 10.1038/eye.1995.145; Jastaniah W, 2011, ANN SAUDI MED, V31, P289, DOI 10.4103/0256-4947.81540; Khan AR, 2010, MIDDLE EAST AFR J OP, V17, P257, DOI 10.4103/0974-9233.65502; Kopplin LJ, 2010, GENES IMMUN, V11, P609, DOI 10.1038/gene.2010.39; Lee Bao-Shiang, 2011, J Biomol Tech, V22, P90; Lemaire C, 2013, CLIN HEMORHEOL MICRO, V55, P205, DOI 10.3233/CH-2012-1622; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275	24	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159215	10.1371/journal.pone.0159215	http://dx.doi.org/10.1371/journal.pone.0159215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414024	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500099
J	Avila, EE; Salaiza, N; Pulido, J; Rodriguez, MC; Diaz-Godinez, C; Laclette, JP; Becker, I; Carrero, JC				Avila, Eva E.; Salaiza, Norma; Pulido, Julieta; Rodriguez, Mayra C.; Diaz-Godinez, Cesar; Laclette, Juan P.; Becker, Ingeborg; Carrero, Julio C.			Entamoeba histolytica Trophozoites and Lipopeptidophosphoglycan Trigger Human Neutrophil Extracellular Traps	PLOS ONE			English	Article							AMEBIC LIVER-ABSCESS; INNATE IMMUNE-RESPONSE; HEPATIC AMEBIASIS; INTESTINAL AMEBIASIS; HUMAN CATHELICIDIN; ESCAPE; STREPTOCOCCUS; PATHOGENESIS; RESISTANCE; INFECTION	Neutrophil defense mechanisms include phagocytosis, degranulation and the formation of extracellular traps (NET). These networks of DNA are triggered by several immune and microbial factors, representing a defense strategy to prevent microbial spread by trapping/killing pathogens. This may be important against Entamoeba histolytica, since its large size hinders its phagocytosis. The aim of this study was to determine whether E. histolytica and their lipopeptidophosphoglycan (EhLPPG) induce the formation of NETs and the outcome of their interaction with the parasite. Our data show that live amoebae and EhLPPG, but not fixed trophozoites, induced NET formation in a time and dose dependent manner, starting at 5 min of co-incubation. Although immunofluorescence studies showed that the NETs contain cathelicidin LL-37 in close proximity to amoebae, the trophozoite growth was only affected when ethylene glycol tetra-acetic acid (EGTA) was present during contact with NETs, suggesting that the activity of enzymes requiring calcium, such as DNases, may be important for amoeba survival. In conclusion, E. histolytica trophozoites and EhLPPG induce in vitro formation of human NETs, which did not affect the parasite growth unless a chelating agent was present. These results suggest that NETs may be an important factor of the innate immune response during infection with E. histolytica.	[Avila, Eva E.; Pulido, Julieta; Rodriguez, Mayra C.] Univ Guanajuato, Dept Biol, Div Exact & Nat Sci, Guanajuato 36050, Mexico; [Salaiza, Norma; Becker, Ingeborg] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Diaz-Godinez, Cesar; Laclette, Juan P.; Carrero, Julio C.] Univ Nacl Autonoma Mexico, Dept Immunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico	Universidad de Guanajuato; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Becker, I (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico.; Carrero, JC (corresponding author), Univ Nacl Autonoma Mexico, Dept Immunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	ingeborg_becker@hotmail.com; carrero@unam.mx		Avila, Eva E./0000-0003-2011-688X; Carrero, Julio/0000-0003-1055-5774	CONACYT [167788, 182671]; DGAPA-UNAM-PAPIIT grant [IN213611]; Universidad de Guanajuato [977/2016]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA-UNAM-PAPIIT grant; Universidad de Guanajuato	This work was funded by 1. CONACYT grant 167788, granted to JCC (http://www.conacyt.mx); 2. DGAPA-UNAM-PAPIIT grant IN213611, granted to JCC (http://dgapa.unam.mx); 3. CONACYT grant 182671, granted to EEA (http://www.conacyt.mx); and 4. Universidad de Guanajuato grant 977/2016, granted to EEA (www.ugto.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2012, INFECT IMMUN, V80, P768, DOI 10.1128/IAI.05730-11; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Asgharpour A, 2005, INFECT IMMUN, V73, P4522, DOI 10.1128/IAI.73.8.4522-4529.2005; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Becker I, 2003, MOL BIOCHEM PARASIT, V130, P65, DOI 10.1016/S0166-6851(03)00160-9; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Burgess SL, 2014, MBIO, V5, DOI 10.1128/mBio.01817-14; CAMPOSRODRIGUEZ R, 1986, ARCH INVEST MED, V17, P353; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; de Buhr N, 2015, MICROBIOL-SGM, V161, P838, DOI 10.1099/mic.0.000040; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dickson-Gonzalez SM, 2009, SURG INFECT, V10, P91, DOI 10.1089/sur.2008.011; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Espinosa-Cantellano M, 2000, CLIN MICROBIOL REV, V13, P318, DOI 10.1128/CMR.13.2.318-331.2000; Estrada-Figueroa LA, 2011, PARASITE IMMUNOL, V33, P661, DOI 10.1111/j.1365-3024.2011.01333.x; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Guimaraes-Costa AB, 2014, INFECT IMMUN, V82, P1732, DOI 10.1128/IAI.01232-13; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hahn S, 2013, SEMIN IMMUNOPATHOL, V35, P439, DOI 10.1007/s00281-013-0380-x; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; ISIBASI A, 1982, ARCH INVEST MED, V13, P51; Jarillo-Luna RA, 2002, EXP PARASITOL, V101, P40, DOI 10.1016/S0014-4894(02)00021-8; Juneau RA, 2015, J INFECT DIS, V212, P316, DOI 10.1093/infdis/jiv031; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maldonado-Bernal C, 2005, PARASITE IMMUNOL, V27, P127, DOI 10.1111/j.1365-3024.2005.00754.x; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; Naylor C, 2014, MBIO, V5, DOI 10.1128/mBio.02046-14; Olivos-Garcia A, 2007, EXP MOL PATHOL, V82, P310, DOI 10.1016/j.yexmp.2006.09.005; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Perez-Tamayo R, 2006, ARCH MED RES, V37, P203, DOI 10.1016/j.arcmed.2005.10.007; PEREZTAMAYO R, 1991, J PARASITOL, V77, P982, DOI 10.2307/3282753; PRATHAP K, 1970, AM J PATHOL, V60, P229; Quintanar-Quintanar ME, 2004, MED SCI MONITOR, V10, pBR317; Rico-Mata R, 2013, EXP PARASITOL, V133, P300, DOI 10.1016/j.exppara.2012.12.009; SALATA RA, 1986, J INFECT DIS, V154, P19, DOI 10.1093/infdis/154.1.19; Seper A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003614; Seydel KB, 1998, GASTROENTEROLOGY, V115, P1446, DOI 10.1016/S0016-5085(98)70023-X; Seydel KB, 1997, INFECT IMMUN, V65, P3951, DOI 10.1128/IAI.65.9.3951-3953.1997; Silva LMR, 2014, PARASITOL RES, V113, P2797, DOI 10.1007/s00436-014-3939-0; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sousa-Rocha D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139569; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; TSUTSUMI V, 1984, AM J PATHOL, V117, P81; TSUTSUMI V, 1988, AM J PATHOL, V130, P112; Velazquez C, 1998, PARASITE IMMUNOL, V20, P255, DOI 10.1046/j.1365-3024.1998.00128.x; Verkerke HP, 2012, SEMIN IMMUNOPATHOL, V34, P771, DOI 10.1007/s00281-012-0349-1; Vivanco-Cid H, 2007, PARASITE IMMUNOL, V29, P467, DOI 10.1111/j.1365-3024.2007.00963.x; Vorobjeva NV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1286, DOI 10.1134/S0006297914120025; WALSH JA, 1986, REV INFECT DIS, V8, P228; Yadav VP, 2009, FEBS J, V276, P7070, DOI 10.1111/j.1742-4658.2009.07419.x; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Zhu LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070363	61	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158979	10.1371/journal.pone.0158979	http://dx.doi.org/10.1371/journal.pone.0158979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415627	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500057
J	Ge, XP; Ritter, SY; Tsang, K; Shi, RR; Takei, K; Aliprantis, AO				Ge, Xianpeng; Ritter, Susan Y.; Tsang, Kelly; Shi, Ruirui; Takei, Kohtaro; Aliprantis, Antonios O.			Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1	PLOS ONE			English	Article							MURINE OSTEOARTHRITIS; EXTRACELLULAR-MATRIX; ALTERNATIVE CLEAVAGE; GAIT ANALYSIS; MOUSE MODELS; PATHOGENESIS; EXPRESSION; CYTOKINES; INTERLEUKIN-1-BETA; DESTABILIZATION	Cartilage acidic protein 1 (CRTAC1) was recently identified as an elevated protein in the synovial fluid of patients with osteoarthritis (OA) by a proteomic analysis. This gene is also upregulated in both human and mouse OA by transcriptomic analysis. The objective of this study was to characterize the expression and function of CRTAC1 in OA. Here, we first confirm the increase of CRTAC1 in cartilage biopsies from OA patients undergoing joint replacement by real-time PCR and immunohistochemistry. Furthermore, we report that proinflammatory cytokines interleukin-1beta and tumor necrosis factor alpha upregulate CRTAC1 expression in primary human articular chondrocytes and synovial fibroblasts. Genetic deletion of Crtac1 in mice significantly inhibited cartilage degradation, osteophyte formation and gait abnormalities of post-traumatic OA in female, but not male, animals undergoing the destabilization of medial meniscus (DMM) surgery. Taken together, CRTAC1 is upregulated in the osteoarthritic joint and directly induced in chondrocytes and synovial fibroblasts by pro-inflammatory cytokines. This molecule is necessary for the progression of OA in female mice after DMM surgery and thus represents a potential therapy for this prevalent disease, especially for women who demonstrate higher rates and more severe OA.	[Ge, Xianpeng; Ritter, Susan Y.; Tsang, Kelly; Aliprantis, Antonios O.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Ge, Xianpeng; Ritter, Susan Y.; Tsang, Kelly; Aliprantis, Antonios O.] Harvard Med Sch, Boston, MA 02115 USA; [Ge, Xianpeng; Shi, Ruirui] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China; [Shi, Ruirui] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA; [Takei, Kohtaro] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa, Japan; [Ge, Xianpeng] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT USA; [Aliprantis, Antonios O.] Merck Res Labs, 33 Ave Louis Pasteur, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Peking University; Harvard University; Harvard School of Dental Medicine; Yokohama City University; Yale University; Merck & Company	Aliprantis, AO (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Aliprantis, AO (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Aliprantis, AO (corresponding author), Merck Res Labs, 33 Ave Louis Pasteur, Boston, MA USA.	aaliprantis@partners.org	Ge, Xianpeng/H-7782-2019		NIH [R01AR060363]; Career Award for Medical Scientists from the Burroughs Wellcome Fund; National Natural Science Foundation of China [81100767]; Ministry of Education of China [2092808]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	The work was supported by NIH R01AR060363 (AOA) and a Career Award for Medical Scientists from the Burroughs Wellcome Fund (AOA). XG was fund by National Natural Science Foundation of China (project 81100767) and Ministry of Education of China (project 2092808).	Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bateman JF, 2013, ARTHRITIS RHEUM-US, V65, P1547, DOI 10.1002/art.37900; Boyan BD, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-4; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Chambers MG, 1997, OSTEOARTHR CARTILAGE, V5, P301, DOI 10.1016/S1063-4584(97)80034-9; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; Culley KL, 2015, METHODS MOL BIOL, V1226, P143, DOI 10.1007/978-1-4939-1619-1_12; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Greenblatt MB, 2013, P NATL ACAD SCI USA, V110, P19914, DOI 10.1073/pnas.1320036110; Hinkle KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-25; Hui AY, 2012, WIRES SYST BIOL MED, V4, P15, DOI 10.1002/wsbm.157; Ijiri K, 2008, ARTHRITIS RHEUM-US, V58, P2075, DOI 10.1002/art.23504; Jacobs BY, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0456-x; Kaneko H, 2013, MATRIX BIOL, V32, P178, DOI 10.1016/j.matbio.2013.01.004; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kim BJ, 2013, OSTEOARTHR CARTILAGE, V21, P2013, DOI 10.1016/j.joca.2013.09.012; Kim JH, 2015, P NATL ACAD SCI USA, V112, P9424, DOI 10.1073/pnas.1505700112; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Kurihara Y, 2014, MOL CELL NEUROSCI, V61, P211, DOI 10.1016/j.mcn.2014.07.001; Kurihara Y, 2012, BIOCHEM BIOPH RES CO, V418, P390, DOI 10.1016/j.bbrc.2012.01.033; Lee Y, 2012, J BONE MINER RES, V27, P1043, DOI 10.1002/jbmr.1561; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Maldonado M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/284873; Maleki-Fischbach M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3091; Malfait AM, 2016, OSTEOARTHR CARTILAGE, V24, P21, DOI 10.1016/j.joca.2015.09.010; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Onuora Sarah, 2015, Nat Rev Rheumatol, V11, P504, DOI 10.1038/nrrheum.2015.107; Park Jae-Yeo, 2014, Evid Based Complement Alternat Med, V2014, P895272, DOI 10.1155/2014/895272; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Ritter SY, 2013, ARTHRITIS RHEUM-US, V65, P981, DOI 10.1002/art.37823; Roos EM, 2016, NAT REV RHEUMATOL, V12, P92, DOI 10.1038/nrrheum.2015.135; Ruan MZC, 2013, OSTEOARTHR CARTILAGE, V21, P1355, DOI 10.1016/j.joca.2013.06.016; Saha N, 1999, ARTHRITIS RHEUM, V42, P1577, DOI 10.1002/1529-0131(199908)42:8<1577::AID-ANR3>3.0.CO;2-Z; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Steck E, 2001, BIOCHEM J, V353, P169, DOI 10.1042/0264-6021:3530169; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Vincelette J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2331; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Westacott CI, 2000, OSTEOARTHR CARTILAGE, V8, P213, DOI 10.1053/joca.1999.0292; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459	52	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159157	10.1371/journal.pone.0159157	http://dx.doi.org/10.1371/journal.pone.0159157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415616	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500093
J	Yang, Q; Lu, H; Song, XD; Li, SF; Wei, WB				Yang, Qiong; Lu, Hai; Song, Xudong; Li, Songfeng; Wei, Wenbin			iTRAQ-Based Proteomics Investigation of Aqueous Humor from Patients with Coats' Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL LASER PHOTOCOAGULATION; TRABECULAR MESHWORK; HUMAN LENS; IDENTIFICATION; PROTEINS; BEVACIZUMAB; BIOMARKERS; MANAGEMENT; RESISTANCE	Background Coats' disease is an uncommon form of retinal telangiectasis, and the identification of novel proteins that contribute to the development of Coats' disease is useful for improving treatment efficacy. Proteomic techniques have been used to study many eye diseases; however, few studies have used proteomics to study the development of Coats' disease. Methods Isobaric tagging for relative and absolute protein quantification (iTRAQ) was employed to screen differentially expressed proteins (DEPs) in the aqueous humor (AH) between stage 3A patients (n = 8), stage 3B patients (n = 14), stage 4 patients (n = 2) and control patients (n = 20). Differentially co-expressed proteins (DCPs) were present in all three stages of Coats' disease and were considered disease-specific proteins. These proteins were further analyzed using Gene Ontology (GO) functional annotations. Results A total of 819 proteins were identified in the AH, 222 of which were significantly differentially expressed (fold change > 2 and P < 0.05) in the samples from at least one stage of Coats' disease. Of the DEPs, 46 were found among all three stages of Coats' disease and the controls; therefore, they were considered Coats' disease-specific proteins (DCPs). A GO classification analysis indicated that the DCPs were closely related to structural molecule activity, cell adhesion molecule binding and receptor binding. Western blotting confirmed the expression levels of haptoglobin and apolipoprotein C-I were significantly up-regulated in Coats' disease. Conclusions The 46 Coats' disease-specific proteins may provide additional insights into the mechanism of Coats' disease and represent potential biomarkers for identifying individuals with Coats' disease.	[Yang, Qiong; Lu, Hai; Song, Xudong; Li, Songfeng; Wei, Wenbin] Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing 100730, Peoples R China	Capital Medical University	Wei, WB (corresponding author), Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing 100730, Peoples R China.	wbweitongren@163.com	wei, wei/HHR-8613-2022		Science & Technology Project of Beijing Municipal Science & Technology Commission [Z151100001615052]; National Natural Science Foundation of China [81570891, 81272981]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [ZYLX201307]; Beijing Natural Science Foundation [7151003]; Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau [2014-2-003]; Beijing Municipal Administration of Hospitals' Ascent Plan [DFL20150201]	Science & Technology Project of Beijing Municipal Science & Technology Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau; Beijing Municipal Administration of Hospitals' Ascent Plan	This study was supported by the Science & Technology Project of Beijing Municipal Science & Technology Commission (code: Z151100001615052), the National Natural Science Foundation of China (No. 81570891), the Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307), the National Natural Science Foundation of China (No. 81272981), the Beijing Natural Science Foundation (No. 7151003), the Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003) and the Beijing Municipal Administration of Hospitals' Ascent Plan (Code: DFL20150201).; This study was supported by the Science & Technology Project of Beijing Municipal Science & Technology Commission (code: Z151100001615052), the National Natural Science Foundation of China (No. 81570891), the Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (code: ZYLX201307), the National Natural Science Foundation of China (No. 81272981), the Beijing Natural Science Foundation (No. 7151003), the Advanced Health Care Professionals Development Project of Beijing Municipal Health Bureau (No. 2014-2-003) and the Beijing Municipal Administration of Hospitals' Ascent Plan (Code: DFL20150201). We also thank Dr. Xiang Jin from the Proteomics Center of Chinese Academy of Tropical Agricultural Sciences for kindly help on processing the iTRAQ data.	Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Chan MP, 2008, BIOCHEMISTRY-US, V47, P11062, DOI 10.1021/bi8012438; Chatterjee A, 2014, J OCUL PHARMACOL TH, V30, P447, DOI 10.1089/jop.2014.0013; Chiang SY, 2012, J PROTEOMICS, V75, P2950, DOI 10.1016/j.jprot.2011.12.006; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Devi RR, 2008, MOL VIS, V14, P1157; Elsobky Sherif, 2014, World J Biol Chem, V5, P106, DOI 10.4331/wjbc.v5.i2.106; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Hadjistilianou T, 2012, CLIN EXP OPHTHALMOL, V40, pE8, DOI 10.1111/j.1442-9071.2011.02711.x; He YG, 2010, GRAEF ARCH CLIN EXP, V248, P1519, DOI 10.1007/s00417-010-1366-1; HELLER J, 1975, J BIOL CHEM, V250, P3613; Jin GZ, 2011, J PROTEOME RES, V10, P3418, DOI 10.1021/pr200482t; Kaul S, 2010, INDIAN J OPHTHALMOL, V58, P76, DOI 10.4103/0301-4738.58480; Kodama A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-36; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Maatta M, 2005, J GLAUCOMA, V14, P64; Monteiro JP, 2015, PROTEOM CLIN APPL, V9, P187, DOI 10.1002/prca.201400133; Morris B, 2010, EYE, V24, P1797, DOI 10.1038/eye.2010.126; Muurling M, 2004, J LIPID RES, V45, P9, DOI 10.1194/jlr.M300240-JLR200; Ogata Masafumi, 2014, Tokai J Exp Clin Med, V39, P25; Ozcan Altan Atakan, 2004, International Ophthalmology, V25, P19, DOI 10.1023/B:INTE.0000018524.48581.79; RASK L, 1976, J BIOL CHEM, V251, P6360; RIDLEY ME, 1982, OPHTHALMOLOGY, V89, P1381; SEILER T, 1985, GRAEF ARCH CLIN EXP, V223, P88, DOI 10.1007/BF02150951; Shields JA, 2001, AM J OPHTHALMOL, V131, P561, DOI 10.1016/S0002-9394(00)00883-7; Shields JA, 2001, AM J OPHTHALMOL, V131, P572, DOI 10.1016/S0002-9394(01)00896-0; Skinner NEB, 2015, DIABETES THER, V6, P395, DOI 10.1007/s13300-015-0123-1; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Tawara A, 2000, CURR EYE RES, V21, P934, DOI 10.1076/ceyr.21.6.934.6988; Theoulakis PE, 2012, KLIN MONATSBL AUGENH, V229, P447, DOI 10.1055/s-0031-1299216; To Chi-ho, 2002, Clin Exp Optom, V85, P335; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xu DD, 2014, PROTEOMICS, V14, P322, DOI 10.1002/pmic.201300383; Yang Z, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P463; Zhang H, 2012, J OCUL PHARMACOL TH, V28, P397, DOI 10.1089/jop.2011.0168; [赵斌 Zhao Bin], 2003, [中华神经科杂志, Chinese Journal of Neurology], V36, P450; Zhao Q, 2014, ACTA OPHTHALMOL, V92, pE225, DOI 10.1111/aos.12158; Zhou HY, 2015, PROTEOM CLIN APPL, V9, P776, DOI 10.1002/prca.201400061; Zhu L, 2013, INVEST OPHTH VIS SCI, V54, P5675, DOI 10.1167/iovs.13-12050	44	18	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158611	10.1371/journal.pone.0158611	http://dx.doi.org/10.1371/journal.pone.0158611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416065	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500026
J	Zhang, HJ; Lamon, BD; Moran, G; Sun, T; Gotto, AM; Hajjar, DP				Zhang, Haijun; Lamon, Brian D.; Moran, George; Sun, Tao; Gotto, Antonio M., Jr.; Hajjar, David P.			Pitavastatin Differentially Modulates MicroRNA-Associated Cholesterol Transport Proteins in Macrophages	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR; EXPRESSION; EFFLUX; ATHEROSCLEROSIS; INDUCTION; STATINS; AGENTS; CELLS; ABCA1	There is emerging evidence identifying microRNAs (miRNAs) as mediators of statin-induced cholesterol efflux, notably through the ATP-binding cassette transporter A1 (ABCA1) in macrophages. The objective of this study was to assess the impact of an HMG-CoA reductase inhibitor, pitavastatin, on macrophage miRNAs in the presence and absence of oxidized-LDL, a hallmark of a pro-atherogenic milieu. Treatment of human THP-1 cells with pitavastatin prevented the oxLDL-mediated suppression of miR-33a, -33b and -758 mRNA in these cells, an effect which was not uniquely attributable to induction of SREBP2. Induction of ABCA1 mRNA and protein by oxLDL was inhibited (30%) by pitavastatin, while oxLDL or pitavastatin alone significantly induced and repressed ABCA1 expression, respectively. These findings are consistent with previous reports in macrophages. miRNA profiling was also performed using a miRNA array. We identified specific miRNAs which were up-regulated (122) and down-regulated (107) in THP-1 cells treated with oxLDL plus pitavastatin versus oxLDL alone, indicating distinct regulatory networks in these cells. Moreover, several of the differentially expressed miRNAs identified are functionally associated with cholesterol trafficking (six miRNAs in cells treated with oxLDL versus oxLDL plus pitavastatin). Our findings indicate that pitavastatin can differentially modulate miRNA in the presence of oxLDL; and, our results provide evidence that the net effect on cholesterol homeostasis is mediated by a network of miRNAs.	[Zhang, Haijun; Sun, Tao] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10065 USA; [Zhang, Haijun] Cornell Univ, Weill Med Coll, Dept Med Genet, 1300 York Ave, New York, NY 10065 USA; [Lamon, Brian D.; Moran, George; Hajjar, David P.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA; [Lamon, Brian D.; Moran, George; Hajjar, David P.] Cornell Univ, Weill Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Med Coll, Dept Med, 1300 York Ave, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Hajjar, DP (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, 1300 York Ave, New York, NY 10065 USA.; Hajjar, DP (corresponding author), Cornell Univ, Weill Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	dphajjar@med.cornell.edu	MIZEKA, PANU/A-3952-2017		KOWA Co, Ltd, Tokyo, Japan; NIH/NIMH [R01-MH083680-07]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083680] Funding Source: NIH RePORTER	KOWA Co, Ltd, Tokyo, Japan; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a sponsored research agreement with KOWA Co, Ltd, Tokyo, Japan, and in part, by an R01-MH083680-07 grant from the NIH/NIMH (T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a sponsored research agreement with KOWA Co, Ltd, Tokyo, Japan, and in part, by an R01-MH083680-08 grant from the NIH/NIMH (T.S.). Drs. David P. Hajjar and Antonio M. Gotto Jr. are consultants to KOWA Pharmaceuticals, Japan.	Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Cerda Alvaro, 2012, Drug Metabolism and Drug Interactions, V27, P101, DOI 10.1515/dmdi-2012-0007; Davignon J, 2012, BRIT J CLIN PHARMACO, V73, P518, DOI 10.1111/j.1365-2125.2011.04139.x; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Han JH, 2004, CIRCULATION, V110, P3472, DOI 10.1161/01.CIR.0000148368.79202.F1; Han JH, 2004, CIRCULATION, V109, P790, DOI 10.1161/01.CIR.0000112576.40815.13; Horie T, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003376; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109722; Markle RA, 2003, J CELL BIOCHEM, V90, P23, DOI 10.1002/jcb.10602; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Niesor EJ, 2015, CARDIOVASC DRUG THER, V29, P7, DOI 10.1007/s10557-015-6570-0; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Wong J, 2008, ATHEROSCLEROSIS, V196, P180, DOI 10.1016/j.atherosclerosis.2007.03.030; Xu QL, 2014, CARDIOVASC THER, V32, P193, DOI 10.1111/1755-5922.12081	21	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159130	10.1371/journal.pone.0159130	http://dx.doi.org/10.1371/journal.pone.0159130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415822	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500084
J	Oliver, KH; Duvernay, MT; Hamm, HE; Carneiro, AMD				Oliver, Kendra H.; Duvernay, Matthew T.; Hamm, Heidi E.; Carneiro, Ana M. D.			Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein alpha II beta 3 Activation through Dysregulation of the 5-HT2A Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; platelet; receptor regulation; selective serotonin reuptake inhibitor (SSRI); serotonin; serotonin transporter; bleeding	EXTRACELLULAR-REGULATED KINASE; C6 GLIOMA-CELLS; PLATELET-AGGREGATION; PERIPHERAL SEROTONIN; REUPTAKE INHIBITOR; IN-VIVO; PLASMA SEROTONIN; 2A RECEPTOR; PC12 CELLS; ADULT RATS	Reduced platelet aggregation and a mild bleeding phenotype have been observed in patients chronically taking selective serotonin reuptake inhibitors (SSRIs). However, it remains unclear how SSRIs, which inhibit the plasma membrane serotonin transporter (SERT), modulate hemostasis. Here, we examine how sustained inhibition of SERT activity alters serotonergic signaling and influences platelet activation and hemostasis. Pharmaceutical blockade (citalopram dosing) or genetic ablation (SERT-/-) of SERT function in vivo led to reduced serotonin (5-hydroxytryptamine (5-HT)) blood levels that paralleled a mild bleeding phenotype in mice. Transfusion of wild-type platelets to SERT-/- mice normalized bleeding times to wild-type levels, suggesting that loss of SERTs causes a deficiency in platelet activation. Although SERT-/- platelets displayed no difference in P-selectin or IIb3 activation upon stimulation with thrombin, ADP-mediated IIb3 activation is reduced in SERT-/- platelets. Additionally, synergistic potentiation of IIb3 activation by ADP and 5-HT is lost in SERT-/- platelets. Acute treatment of wild-type platelets with 5-HT2A receptor (5-HT2AR) antagonists or SSRIs revealed that functional 5-HT(2A)Rs, not SERTs, are necessary for the synergistic activation of IIb3 by dual 5-HT/ADP stimulation. Pharmacological studies using radiolabeled guanosine 5-3-O-([S-35]thio)triphosphate and [H-3]ketanserin revealed that platelets isolated from SERT-/- or citalopram-treated mice have reduced activation of G-proteins coupled to 5-HT(2A)Rs and receptor surface expression. Taken together, these data demonstrate that sustained SERT loss of function reduces 5-HT2AR surface expression that is critical for the synergistic activation of IIb3 by 5-HT and ADP. These results highlight an antiplatelet strategy centered on blocking or desensitizing 5-HT2AR to attenuate ADP-mediated IIb3 activation.	[Oliver, Kendra H.; Duvernay, Matthew T.; Hamm, Heidi E.; Carneiro, Ana M. D.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, 442 Robinson Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.; Carneiro, AMD (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, 461 Preston Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.	heidi.hamm@vanderbilt.edu; ana.carneiro@vanderbilt.edu		Oliver, Kendra/0000-0003-3142-5186; Marin Dias Carneiro, Ana/0000-0002-1204-9202; MD Carneiro, Ana/0000-0002-7470-7047	National Institutes of Health [MH090256]; Clinical and Translational Science Awards [UL1TR000445, KL2TR000446, TL1TR000447]; Molecular Libraries Probe Production Centers Network Grant [U54MH084659]; American Heart Association Predoctoral Fellowship Award [14PRE19640007]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000446, UL1TR000445, TL1TR000447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090256, U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Probe Production Centers Network Grant; American Heart Association Predoctoral Fellowship Award(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant MH090256 (to A. M. D. C.); Clinical and Translational Science Awards UL1TR000445, KL2TR000446, and TL1TR000447 (to Vanderbilt); and Molecular Libraries Probe Production Centers Network Grant U54MH084659 (to H. E. H.) and by American Heart Association Predoctoral Fellowship Award 14PRE19640007 (to K. H. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalik N, 2008, J THROMB HAEMOST, V6, P2168, DOI 10.1111/j.1538-7836.2008.03196.x; Adams JW, 2009, J PHARMACOL EXP THER, V331, P96, DOI 10.1124/jpet.109.153189; Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Anderson GM, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0086-8; Anderson GM, 2005, PSYCHOPHARMACOLOGY, V178, P339, DOI 10.1007/s00213-004-2011-7; Andrade C, 2010, J CLIN PSYCHIAT, V71, P1565, DOI 10.4088/JCP.09r05786blu; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Beikmann BS, 2013, ACS CHEM NEUROSCI, V4, P161, DOI 10.1021/cn300146w; Berger JS, 2013, THROMB HAEMOSTASIS, V109, P85, DOI 10.1160/TH12-03-0202; Bismuth-Evenzal Y, 2012, J AFFECT DISORDERS, V136, P99, DOI 10.1016/j.jad.2011.08.013; Blazevic S, 2015, J PHYSIOL PHARMACOL, V66, P529; Bohn LM, 2010, CRIT REV BIOCHEM MOL, V45, P555, DOI 10.3109/10409238.2010.516741; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Carneiro AMD, 2008, J CLIN INVEST, V118, P1544, DOI 10.1172/JCI33374; CERRITO F, 1993, LIFE SCI, V53, P209; GARTSIDE SE, 1995, BRIT J PHARMACOL, V115, P1064, DOI 10.1111/j.1476-5381.1995.tb15919.x; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Hirsh-Rokach B, 2015, PHARMACOTHERAPY, V35, P140, DOI 10.1002/phar.1542; Hranilovic D, 2011, NEUROCHEM INT, V59, P202, DOI 10.1016/j.neuint.2011.05.003; Hummerich R, 2010, NEUROCHEM INT, V57, P67, DOI 10.1016/j.neuint.2010.04.020; Jernej B, 2002, HEADACHE, V42, P588, DOI 10.1046/j.1526-4610.2002.02145.x; Jirouskova M, 2007, J THROMB HAEMOST, V5, P661, DOI 10.1111/j.1538-7836.2007.02407.x; Johnson-Farley NN, 2005, J NEUROCHEM, V92, P72, DOI 10.1111/j.1471-4159.2004.02832.x; Lau WKW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031617; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; MALYSZKO J, 1994, THROMB RES, V75, P569, DOI 10.1016/0049-3848(94)90231-3; Matondo RB, 2009, AM J PHYSIOL-GASTR L, V296, pG963, DOI 10.1152/ajpgi.90709.2008; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mercado CP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02795; Miller KJ, 1997, LIFE SCI, V61, P1819, DOI 10.1016/S0024-3205(97)00806-0; MOORE TC, 1966, SURGERY, V59, P765; Namkung J, 2015, MOL CELLS, V38, P1023, DOI 10.14348/molcells.2015.0258; Oliver KH, 2014, MOL PHARMACOL, V85, P921, DOI 10.1124/mol.114.091736; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Schaff M, 2012, THROMB HAEMOSTASIS, V107, P735, DOI 10.1160/TH11-06-0430; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Singh Preeti, 2013, Health (Irvine Calif), V5, P31; Stahl EL, 2015, MOL PHARMACOL, V87, P866, DOI 10.1124/mol.114.096503; THOMPSON NT, 1986, EUR J BIOCHEM, V161, P399, DOI 10.1111/j.1432-1033.1986.tb10459.x; Tseng YL, 2010, THROMB RES, V126, P517, DOI 10.1016/j.thromres.2010.09.017; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yamauchi M, 2006, BRAIN RES, V1067, P164, DOI 10.1016/j.brainres.2005.10.075	48	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20210	20219		10.1074/jbc.M116.736983	http://dx.doi.org/10.1074/jbc.M116.736983			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27422820	Green Published, hybrid			2022-12-26	WOS:000383243100040
J	Zhang, WY; Li, HF; Su, M; Lin, RF; Chen, XX; Zhang, P; Zou, CL				Zhang, Wen-Yi; Li, Hui-Fang; Su, Meng; Lin, Rui-Fang; Chen, Xing-Xing; Zhang, Ping; Zou, Chang-Lin			A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT	PLOS ONE			English	Article							SPINAL-CORD COMPRESSION; PROGNOSTIC SCORE; CANCER; CHEMOTHERAPY; RADIOTHERAPY; THERAPY	Objectives This study aimed to develop a scoring system to predict the survival time of patients with bone metastases after radiation therapy (RT). The scoring system can guide physicians to a better selection of appropriate treatment regimens. Materials and Methods The medical records of 125 patients with bone metastases treated with RT between January 2007 and September 2010 were reviewed retrospectively. Fifteen potential prognostic factors were investigated: sex, age, Karnofsky performance score (KPS), type of primary tumor, resection of tumor before bone metastases, interval between primary tumor diagnosis and diagnosis of bone metastases, Carcinoembryonic Antigen(CEA), lung metastases before bone metastases, liver metastases before bone metastases, brain metastases before bone metastases, stage, T, N, M, and degree of cellular differentiation. Results In an univariate analysis, 10 factors were significantly associated with survival time after bone metastasis: sex, KPS, breast cancer, esophageal cancer, colorectal cancer, interval between tumor diagnosis and diagnosis of bone metastases, CEA, lung metastases before bone metastases, T-staging, and differentiation. In a multivariate analysis, 7 factors were found to be significant: sex, KPS, esophageal cancer, colorectal cancer, interval between tumor diagnosis and diagnosis of bone metastases, T-staging, and differentiation. The median survival of all patients with bone metastases after RT was 14.1 months. There were significant differences in the median survival of patients with bone metastases after RT of 4.9 months, 10.5 months, and 29.7 months in groups 1, 2, and 3, respectively (P<0.001). Conclusion According to this scoring system, the survival time of patients after bone metastasis can be estimated.	[Zhang, Wen-Yi; Li, Hui-Fang; Su, Meng; Lin, Rui-Fang; Chen, Xing-Xing; Zhang, Ping; Zou, Chang-Lin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiotherapy & Chemotherapy, Wenzhou, Peoples R China	Wenzhou Medical University	Zou, CL (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiotherapy & Chemotherapy, Wenzhou, Peoples R China.	zcl19670115@163.com						Byun WM, 2002, AM J NEURORADIOL, V23, P906; Chao ST, 2012, INT J RADIAT ONCOL, V82, P1738, DOI 10.1016/j.ijrobp.2011.02.019; Choi J, 2012, CANCER CONTROL, V19, P102, DOI 10.1177/107327481201900204; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; HOSKIN PJ, 1995, PAIN, V63, P137, DOI 10.1016/0304-3959(95)00044-S; Lee YJ, 2014, SUPPORT CARE CANCER, V22, P1941, DOI 10.1007/s00520-014-2173-8; Li QQ, 2014, ASIAN PAC J CANCER P, V15, P945, DOI 10.7314/APJCP.2014.15.2.945; Lutz S, 2011, INT J RADIAT ONCOL, V79, P965, DOI 10.1016/j.ijrobp.2010.11.026; Nakayama M, 2015, HEAD NECK-J SCI SPEC, V37, P1745, DOI 10.1002/hed.23823; Nowicki A, 2015, WSPOLCZESNA ONKOL, V19, P333, DOI 10.5114/wo.2015.53249; Padhani A R, 2011, Cancer Imaging, V11 Spec No A, pS129, DOI 10.1102/1470-7330.2011.9034; Rades D, 2008, CANCER, V112, P157, DOI 10.1002/cncr.23150; Rades D, 2006, J CLIN ONCOL, V24, P3388, DOI 10.1200/JCO.2005.05.0542; Sharma K, 2008, INDIAN J PALLIAT CAR, V14, P7, DOI 10.4103/0973-1075.41924; Tassinari D, 2008, SUPPORT CARE CANCER, V16, P359, DOI 10.1007/s00520-007-0302-3; van den Hout WB, 2003, JNCI-J NATL CANCER I, V95, P222, DOI 10.1093/jnci/95.3.222; Wright AA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1219	17	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159506	10.1371/journal.pone.0159506	http://dx.doi.org/10.1371/journal.pone.0159506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438606	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100051
J	Villegas-Rodriguez, ME; Uribarri, J; Solorio-Meza, SE; Fajardo-Araujo, ME; Cai, WJ; Torres-Graciano, S; Rangel-Salazar, R; Wrobel, K; Garay-Sevilla, ME				Etzabel Villegas-Rodriguez, Ma.; Uribarri, Jaime; Solorio-Meza, Sergio E.; Fajardo-Araujo, Martha E.; Cai, Weijing; Torres-Graciano, Sofia; Rangel-Salazar, Ruben; Wrobel, Kazimierz; Eugenia Garay-Sevilla, Ma.			The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; ENDOTHELIAL FUNCTION; ARTERIAL STIFFNESS; HEART-DISEASE; SOLUBLE FORM; SERUM-LEVELS; RECEPTOR; ATHEROSCLEROSIS; BIOMARKERS	Aim The purpose of the study was the simultaneous measurement of all the different components of the AGE-RAGE axis as well as several non-invasive markers of cardiovascular disease (CVD) in a cohort of newly diagnosed diabetic patients. Materials and Methods In 80 newly diagnosed diabetic patients we measured serum carboxymethyllysine (CML), soluble RAGE (sRAGE) and peripheral mononuclear (PMNC) RAGE and AGER1 mRNA together with ICAM-1, VCAM-1, and malondialdehyde (MDA). We also assessed cardiovascular function by measurement of flow-mediated vasodilation (FMD), intima-media thickness (IMT) and arterial stiffness. Univariant correlation analysis was used to determine correlation between the variables in the study and multiple regression analysis was used to examine the association between the AGE-RAGE axis components and FMD, IMT and arterial stiffness. Results Serum CML correlated positively with sRAGE, PMNC RAGE, HOMA-IR, ICAM-1, VCAM-1 and MDA, but inversely with PMNC AGER1. sRAGE and RAGE was positively correlated with AGER; IMT was positively correlated with HOMA-IR, ICAM-1, VCAM-1, MDA, and sRAGE and arterial stiffness had correlation with HOMA-IR, ICAM-1, VCAM-1, MDA, CML, sRAGE, AGER1 and RAGE. In multivariate analysis we found a significant relationship between CML with PMNC RAGE, HOMA-IR; sRAGE with VCAM-1 and MDA; PMNC RAGE with PMNC AGER1 and CML; PMNC AGER1 with PMNC RAGE; FMD with sRAGE, CML and HbA1c; IMT with sRAGE, and arterial stiffness with sRAGE, sCML and AGER1 Conclusions We found significant and strong associations between the different components of the AGE-RAGE axis and also found significant association between AGE-RAGE axis markers, especially sRAGE with several noninvasive markers of cardiovascular disease risk. sRAGE, an easily measured parameter in blood, may potentially be used as a surrogate marker of AGEs-RAGE in patients with diabetes.	[Etzabel Villegas-Rodriguez, Ma.; Fajardo-Araujo, Martha E.; Torres-Graciano, Sofia; Rangel-Salazar, Ruben; Eugenia Garay-Sevilla, Ma.] Dept Med Sci, Div Hlth Sci, Univ Guanajuato Campus, Guanajuato, Mexico; [Uribarri, Jaime; Cai, Weijing] Icahn Sch Med Mt Sinai, Dept Medicine, New York, NY 10029 USA; [Solorio-Meza, Sergio E.] Mexican Inst Social Secur, Guanajuato, Mexico; [Wrobel, Kazimierz] Univ Guanajuato, Dept Chem, Guanajuato, Guanajuato, Mexico	Universidad de Guanajuato; Icahn School of Medicine at Mount Sinai; Instituto Mexicano del Seguro Social; Universidad de Guanajuato	Garay-Sevilla, ME (corresponding author), Dept Med Sci, Div Hlth Sci, Univ Guanajuato Campus, Guanajuato, Mexico.	marugaray_2000@yahoo.com		Wrobel, Kazimierz/0000-0003-4357-3178; Solorio, Sergio/0000-0002-7501-6088	CONACYT Mexico [FOMIXGTO-2012-C03-195211]; University of Guanajuato (DAIP)	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Guanajuato (DAIP)	This study has been supported by funds from CONACYT Mexico (FOMIXGTO-2012-C03-195211) and University of Guanajuato (DAIP 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato M, 2007, EUR HEART J, V28, P2094, DOI 10.1093/eurheartj/ehm244; Arrebola-Moreno AL, 2012, REV ESP CARDIOL, V65, P80, DOI [10.1016/j.recesp.2011.09.012, 10.1016/j.rec.2011.10.004]; Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025; Biswas SK, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/150325; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Charakida M, 2010, EUR HEART J, V31, P2854, DOI 10.1093/eurheartj/ehq340; Chiang KH, 2009, CORONARY ARTERY DIS, V20, P267, DOI 10.1097/MCA.0b013e32832c459c; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Di Pino A, 2014, DIABETES CARE, V37, P1447, DOI 10.2337/dc13-2357; Flore R, 2015, EUR REV MED PHARMACO, V19, P1430; Fujisawa K, 2013, ATHEROSCLEROSIS, V227, P425, DOI 10.1016/j.atherosclerosis.2013.01.016; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Kajikawa M, 2015, DIABETES CARE, V38, P119, DOI 10.2337/dc14-1435; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Lu B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001990; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Mackenzie IS, 2002, QJM-INT J MED, V95, P67, DOI 10.1093/qjmed/95.2.67; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Montalcini T, 2014, AM J THER, V21, P535, DOI 10.1097/MJT.0b013e318255bc26; Nakamura K, 2007, CLIN EXP MED, V7, P188, DOI 10.1007/s10238-007-0146-7; Page AV, 2013, VIRULENCE, V4, P507, DOI 10.4161/viru.24530; Pierzchalska M, 2007, J PHYSIOL PHARMACOL, V58, P207; Prasad K, 2014, INT J ANGIOL, V23, P11, DOI 10.1055/s-0033-1363423; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Ruszkowska-Ciastek B, 2015, J ZHEJIANG UNIV-SC B, V16, P355, DOI 10.1631/jzus.B1400218; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Smriti Komal, 2016, J Oral Biol Craniofac Res, V6, P41, DOI 10.1016/j.jobcr.2015.12.004; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Tam XHL, 2011, CLIN SCI, V120, P81, DOI 10.1042/CS20100256; Timmis AD, 2001, HEART, V85, P463, DOI 10.1136/heart.85.4.463; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2007, DIABETES CARE, V30, P2579, DOI 10.2337/dc07-0320; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089; Wilk G, 2013, POL ARCH MED WEWN, V123, P443, DOI 10.20452/pamw.1879	38	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159175	10.1371/journal.pone.0159175	http://dx.doi.org/10.1371/journal.pone.0159175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434539	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600037
J	Brunisholz, KD; Joy, EA; Hashibe, M; Gren, LH; Savitz, LA; Hamilton, S; Cannon, W; Kim, J				Brunisholz, Kimberly D.; Joy, Elizabeth A.; Hashibe, Mia; Gren, Lisa H.; Savitz, Lucy A.; Hamilton, Sharon; Cannon, Wayne; Kim, Jaewhan			Incidental Risk of Type 2 Diabetes Mellitus among Patients with Confirmed and Unconfirmed Prediabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; PREVENTION PROGRAM; DIAGNOSIS; PEOPLE	Objective To determine the risk of type 2 diabetes (T2DM) diagnosis among patients with confirmed and unconfirmed prediabetes (preDM) relative to an at-risk group receiving care from primary care physicians over a 5-year period. Study Design Utilizing data from the Intermountain Healthcare (IH) Enterprise Data Warehouse (EDW) from 2006-2013, we performed a prospective analysis using discrete survival analysis to estimate the time to diagnosis of T2DM among groups. Population Studied Adult patients who had at least one outpatient visit with a primary care physician during 2006-2008 at an IH clinic and subsequent visits through 2013. Patients were included for the study if they were (a) at-risk for diabetes (BMI >= 25 kg/m2 and one additional risk factor: high risk ethnicity, first degree relative with diabetes, elevated triglycerides or blood pressure, low HDL, diagnosis of gestational diabetes or polycystic ovarian syndrome, or birth of a baby weighing >9 lbs); or (b) confirmed preDM (HbA1c >= 5.7-6.49% or fasting blood glucose 100-125 mg/dL); or (c) unconfirmed preDM (documented fasting lipid panel and glucose 100-125 mg/dL on the same day). Principal Findings Of the 33,838 patients who were eligible for study, 57.0% were considered at-risk, 38.4% had unconfirmed preDM, and 4.6% had confirmed preDM. Those with unconfirmed and confirmed preDM tended to be Caucasian and a greater proportion were obese compared to those at-risk for disease. Patients with unconfirmed and confirmed preDM tended to have more prevalent high blood pressure and depression as compared to the at-risk group. Based on the discrete survival analyses, patients with unconfirmed preDM and confirmed preDM were more likely to develop T2DM when compared to at-risk patients. Conclusions Unconfirmed and confirmed preDM are strongly associated with the development of T2DM as compared to patients with only risk factors for disease.	[Brunisholz, Kimberly D.; Savitz, Lucy A.] Intermt Healthcare, Inst Healthcare Delivery Res, Salt Lake City, UT USA; [Brunisholz, Kimberly D.; Hashibe, Mia; Gren, Lisa H.; Kim, Jaewhan] Univ Utah, Sch Med, Div Publ Hlth, Salt Lake City, UT USA; [Brunisholz, Kimberly D.; Hamilton, Sharon; Cannon, Wayne] Intermt Healthcare, Primary Care Clin Program, Salt Lake City, UT USA; [Brunisholz, Kimberly D.; Joy, Elizabeth A.] Intermt Healthcare, Res Off, Salt Lake City, UT USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center	Brunisholz, KD (corresponding author), Intermt Healthcare, Inst Healthcare Delivery Res, Salt Lake City, UT USA.; Brunisholz, KD (corresponding author), Univ Utah, Sch Med, Div Publ Hlth, Salt Lake City, UT USA.; Brunisholz, KD (corresponding author), Intermt Healthcare, Primary Care Clin Program, Salt Lake City, UT USA.; Brunisholz, KD (corresponding author), Intermt Healthcare, Res Off, Salt Lake City, UT USA.	kim.brunisholz@imail.org						Ackermann RT, 2008, AM J PREV MED, V35, P357, DOI 10.1016/j.amepre.2008.06.035; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS16; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 2012, DIABETES CARE, V35, P731, DOI 10.2337/dc11-1299; Garber AJ, 2012, DIABETES OBES METAB, V14, P399, DOI 10.1111/j.1463-1326.2011.01536.x; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Healthcare Intermountain, 2001, OUTP MAN AD DIAB MEL, P1; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Herman WH, 2012, DIABETES CARE, V35, P723, DOI 10.2337/dc11-1468; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; National Audit Office, 2009, POW PREV CHRON DIS P, P1; National Center for Chronic Disease Prevention and Health Promotion, 2012, DIAB REP CARD 2012; National Committee for Quality Assurance (NCQA), 2013, HEDIS 2014 HEALTHC E, P1; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Sheehy AM, 2010, MAYO CLIN PROC, V85, P27, DOI 10.4065/mcp.2009.0289; Tuomilehto H, 2009, DIABETES CARE, V32, P1965, DOI 10.2337/dc08-1980; Utah Department of Health, 2012, UT HLTH STAT UPD UNC; Warram JH, 1996, DIABETIC MED, V13, pS40; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	22	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157729	10.1371/journal.pone.0157729	http://dx.doi.org/10.1371/journal.pone.0157729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427913	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300005
J	Ma, WSP; Pun, TC				Ma, Wai Sze Paulin; Pun, Ting Chung			Prevalence of Domestic Violence in Hong Kong Chinese Women Presenting with Urinary Symptoms	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SEXUAL-ABUSE; DETRUSOR INSTABILITY; OVERACTIVE BLADDER; GYNECOLOGY PATIENTS; TRACT SYMPTOMS; MENTAL-HEALTH; INCONTINENCE; ASSOCIATION; DYSFUNCTION	Objectives To determine the prevalence of domestic violence and its risk factors in women presenting with urinary symptoms. Methods The study was carried out in the urogynecology clinic and general gynecology clinic, Department of Obstetrics and Gynecology, Queen Mary Hospital, Hong Kong from 1st May 2013 till 31st October 2014. Two hundred and twenty-five women presenting to the urogynecology clinic with urinary symptoms were categorized according to their symptoms and were asked to complete the Modified Abuse Assessment Screen. Demographic data of the subjects and their partners were collected. Mann-Whitney U test were used for analysis of continuous variables, while Chi-square test and Fisher Exact test were used for analysis of categorical variables between the abused and non-abused group. Prevalence of domestic violence were calculated and compared. Results The prevalence of domestic violence among this group of patients (7.6%) was found to be lower when compared with other studies. Verbal abuse was the commonest form of violence in our locality. The median age of the abused group and the non-abused group were both 56 years old, with the age ranging from 40 to 64 and 29 to 70 years old respectively. The prevalence of domestic violence among patients with overactive bladder syndrome, stress urinary incontinence and mixed urinary incontinence were 19.5%, 4.2% and 5.5% respectively (Fisher Exact test for whole group, P<0.05). Conclusion The prevalence and nature of abuse in our locality was different from the quoted figures worldwide. Patients with overactive bladder syndrome were more likely to be victims of abuse than patients with other urinary symptoms. The difference in the prevalence of domestic violence among patients with different urinary symptoms could be related to their underlying pathophysiology. When encountering patients with overactive bladder syndrome, clinicians should consider this high incidence of domestic violence and provide prompt referral whenever necessary.	[Ma, Wai Sze Paulin; Pun, Ting Chung] Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Ma, WSP (corresponding author), Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China.	mawsp@hotmail.com						Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; [Anonymous], LONG TERM CONS CHILD; Ates E, 2014, NEUROUROL URODYN; Ben-Dror I, 2012, INT UROGYNECOL J, V23, P1081, DOI 10.1007/s00192-012-1738-7; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Coker A L, 2001, J Am Med Womens Assoc (1972), V56, P19; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; DeLago C, 2008, PEDIATRICS, V122, pE281, DOI 10.1542/peds.2008-0450; Elliott B A, 1995, Arch Fam Med, V4, P113; FREEMAN RM, 1985, UROL INT, V40, P257, DOI 10.1159/000281094; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Hathaway JE, 2000, AM J PREV MED, V19, P302, DOI 10.1016/S0749-3797(00)00236-1; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Heise L., 2002, WORLD REPORT VIOLENC, V1, P87, DOI DOI 10.1503/CMAJ.1150071; Hensel G, 2014, GEBURTSH FRAUENHEILK, V74, P63, DOI 10.1055/s-0033-1351073; Hsiao SM, 2014, MATURITAS, V79, P65, DOI 10.1016/j.maturitas.2014.06.001; Jewkes R, 2000, INT CLIN PSYCHOPHARM, V15, pS37; Johnson JK, 2007, EUR J OBSTET GYN R B, V133, P95, DOI 10.1016/j.ejogrb.2006.04.035; Jundt K, 2007, INT UROGYNECOL J, V18, P449, DOI 10.1007/s00192-006-0173-z; Jung SY, 1999, J UROLOGY, V162, P204, DOI 10.1097/00005392-199907000-00069; KARLSON S, 1953, Acta Obstet Gynecol Scand, V32, P285; Lai HH, 2016, NEUROUROL URODYNAM, V35, P1017, DOI 10.1002/nau.22872; Lee YS, 2014, J ELDER ABUSE NEGL, V26, P244, DOI 10.1080/08946566.2013.820656; Leithner K, 2009, EUR J OBSTET GYN R B, V144, P168, DOI 10.1016/j.ejogrb.2009.03.003; Leung TW, 2002, INT J GYNECOL OBSTET, V77, P47, DOI 10.1016/S0020-7292(01)00596-3; Leung WC, 1999, INT J GYNECOL OBSTET, V66, P23, DOI 10.1016/S0020-7292(99)00053-3; Link CL, 2007, EUR UROL, V52, P397, DOI 10.1016/j.eururo.2007.03.024; Ma PWS, 2011, HONG KONG J GYNAECOL, V11, P13; MCCAULEY J, 1995, ANN INTERN MED, V123, P737, DOI 10.7326/0003-4819-123-10-199511150-00001; Moreno CG, UNDERSTANDING ADDRES; Naved RT, 2012, J HEALTH POPUL NUTR, V30, P181, DOI 10.3329/jhpn.v30i2.11312; NORTON KRW, 1990, BRIT MED J, V301, P271, DOI 10.1136/bmj.301.6746.271; Peterman A, 2009, SOC SCI MED, V68, P971, DOI 10.1016/j.socscimed.2008.12.006; Pico-Alfonso MA, 2004, BIOL PSYCHIAT, V56, P233, DOI 10.1016/j.biopsych.2004.06.001; Pikarinen U, 2007, OBSTET GYNECOL, V109, P1116, DOI 10.1097/01.AOG.0000259906.16474.86; Romito P, 2005, SOC SCI MED, V60, P1717, DOI 10.1016/j.socscimed.2004.08.026; VEREECKEN RL, 1989, PSYCHOTHER PSYCHOSOM, V51, P128, DOI 10.1159/000288146; WALTERS MD, 1990, OBSTET GYNECOL, V75, P22; Yildirim A, 2011, UROL J, V8, P38; Yip SK, 2003, INT UROGYNECOL J, V14, P27, DOI 10.1007/s00192-002-1003-6; Yoshioka M. R., 2000, ASIAN FAMILY VIOLENC; Zhao PT, 2015, J UROLOGY, V193, P1743, DOI 10.1016/j.juro.2014.08.123	43	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159367	10.1371/journal.pone.0159367	http://dx.doi.org/10.1371/journal.pone.0159367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428060	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300058
J	Qiu, JJ; Guan, JQ; Yang, XC; Wu, J; Liu, GY; Di, GH; Chen, CM; Hou, YF; Han, QX; Shen, ZZ; Shao, ZM; Hu, Z				Qiu, Jiajia; Guan, Jiaqin; Yang, Xiaochen; Wu, Jiong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen			Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing	PLOS ONE			English	Article							IMPACT; WOMEN; DISTRESS	Background This study aims to understand the quality of life (QOL) and psychological state (PS) of Chinese breast cancer patients who received BRCA1/2 genetic testing; to examine the psychological changes between BRCA1/2 mutation carriers and non-carriers; and to further explore the psychological experience of BRCA1/2 mutation carriers. Methods This study was combined with quantitative and qualitative designs. First, we performed a quantitative investigation using FACT-B (Chinese version) and Irritability, Depression and Anxiety scale (IDA) to assess the QOL and PS in breast cancer patients who received BRCA1/2 genetic testing. Then semi-structured in-depth qualitative interviews among 13 mutation carriers were conducted in hospital. Results Results from the quantitative study showed QOL scores were relatively high and the IDA scores were relatively low among the patients, and there was no significant difference in the QOL or IDA scores between non-carriers and carriers. Based on the qualitative analysis, four main themes emerged: (1) Finding the reason for having breast cancer; (2) Negative emotions; (3) Behavioral changes; (4) Lack of information. Conclusions The present study showed that QOL and PS are good among the breast cancer patients who received genetic testing. Genetic testing itself does not cause long psychosocial effects. BRCA1/2 mutation carriers may have certain negative emotions at the first stage they knew the testing results and may initiate behavioral and lifestyle changes. The patients with a BRCA1/2 mutation desire knowledge with regard to genetic aspects in mainland China. Professional information and advice can be provided to relieve the patients' negative emotions when they were informed of gene defect.	[Qiu, Jiajia; Guan, Jiaqin] Fudan Univ, Shanghai Canc Ctr, Dept Nursing Adm, Shanghai, Peoples R China; [Yang, Xiaochen; Wu, Jiong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai, Peoples R China; [Qiu, Jiajia; Guan, Jiaqin; Yang, Xiaochen; Wu, Jiong; Liu, Guangyu; Di, Genhong; Chen, Canming; Hou, Yifeng; Han, Qixia; Shen, Zhenzhou; Shao, Zhimin; Hu, Zhen] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Hu, Z (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Breast Surg, Shanghai, Peoples R China.; Hu, Z (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	zhenhu@fudan.edu.cn		Di, Genhong/0000-0003-1171-7907	Shanghai Committee of Science and Technology Funds [14441901402]	Shanghai Committee of Science and Technology Funds(Shanghai Science & Technology Committee)	This work is supported by the Shanghai Committee of Science and Technology Funds (http://www.stcsm.gov.cn/) grant 14441901402. ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardern-Jones A, 2010, HERED CANCER CLIN PR, V8, DOI 10.1186/1897-4287-8-1; Bredart A, 2013, BRIT J CANCER, V108, P1012, DOI 10.1038/bjc.2012.599; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Colaizzi Paul, 1978, EXISTENTIAL PHENOMEN, P48; Graves KD, 2012, CANCER EPIDEM BIOMAR, V21, P445, DOI 10.1158/1055-9965.EPI-11-0991; Hamilton R, 2013, ADV NURS SCI, V36, pE41, DOI 10.1097/ANS.0b013e3182901ff1; Hooker GW, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-9; Hoskins LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087696; Kwong A, 2012, ASIAN PAC J CANCER P, V13, P2241, DOI 10.7314/APJCP.2012.13.5.2241; Meiser B, 2005, PSYCHO-ONCOL, V14, P1060, DOI 10.1002/pon.933; Roussi P, 2010, PSYCHOL HEALTH, V25, P401, DOI 10.1080/08870440802660884; Schlich-Bakker KJ, 2008, BREAST CANCER RES TR, V109, P507, DOI 10.1007/s10549-007-9680-y; Smith AW, 2008, PSYCHO-ONCOL, V17, P767, DOI 10.1002/pon.1291; SNAITH RP, 1985, BRIT J PSYCHIAT, V147, P127, DOI 10.1192/bjp.147.2.127; Song Chuan-gui, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P27; Uyei A, 2006, CANCER-AM CANCER SOC, V107, P2745, DOI 10.1002/cncr.22352; Wan C., 2002, CHINA CANC, V11, P318; [万崇华 Wan Chonghua], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P298; Xue CY, 2008, SHANGHAI ARCH PSYCHI, V20, P352; Yang XC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125571; Yuan Y., 2002, SICHUAN MENT HLTH, V15, P11	21	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158531	10.1371/journal.pone.0158531	http://dx.doi.org/10.1371/journal.pone.0158531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428375	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300012
J	Chen, LH; Huang, YN; Xu, M; Cheng, ZX; Zhang, DS; Zheng, JG				Chen, Linghua; Huang, Yining; Xu, Ming; Cheng, Zuxin; Zhang, Dasheng; Zheng, Jingui			iTRAQ-Based Quantitative Proteomics Analysis of Black Rice Grain Development Reveals Metabolic Pathways Associated with Anthocyanin Biosynthesis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SATIVA L. INDICA; ARABIDOPSIS-THALIANA; GRAPE BERRY; EXPRESSION ANALYSIS; GENE-EXPRESSION; WHEAT-GRAIN; PLANTS; SUGAR; TEMPERATURE	Background Black rice (Oryza sativa L.), whose pericarp is rich in anthocyanins (ACNs), is considered as a healthier alternative to white rice. Molecular species of ACNs in black rice have been well documented in previous studies; however, information about the metabolic mechanisms underlying ACN biosynthesis during black rice grain development is unclear. Results The aim of the present study was to determine changes in the metabolic pathways that are involved in the dynamic grain proteome during the development of black rice indica cultivar, (Oryza sativa L. indica var. SSP). Isobaric tags for relative and absolute quantification (iTRAQ) MS/MS were employed to identify statistically significant alterations in the grain proteome. Approximately 928 proteins were detected, of which 230 were differentially expressed throughout 5 successive developmental stages, starting from 3 to 20 days after flowering (DAF). The greatest number of differentially expressed proteins was observed on 7 and 10 DAF, including 76 proteins that were upregulated and 39 that were downregulated. The biological process analysis of gene ontology revealed that the 230 differentially expressed proteins could be sorted into 14 functional groups. Proteins in the largest group were related to metabolic process, which could be integrated intomultiple biochemical pathways. Specifically, proteins with a role in ACN biosynthesis, sugar synthesis, and the regulation of gene expression were upregulated, particularly from the onset of black rice grain development and during development. In contrast, the expression of proteins related to signal transduction, redox homeostasis, photosynthesis and N-metabolism decreased during grainmaturation. Finally, 8 representative genes encoding different metabolic proteins were verified via quantitative real-time polymerase chain reaction (qRT-PCR) analysis, these genes had differed in transcriptional and translational expression during grain development. Conclusions Expression analyses of metabolism-related protein groups belonging to different functional categories and subcategories indicated that significantly upregulated proteins were related to flavonoid and starch synthesis. On the other hand, the downregulated proteins were determined to be related to nitrogen metabolism, as well as other functional categories and subcategories, including photosynthesis, redox homeostasis, tocopherol biosynthetic, and signal transduction. The results provide valuable new insights into the characterization and understanding of ACN pigment production in black rice.	[Chen, Linghua; Huang, Yining; Xu, Ming; Cheng, Zuxin; Zheng, Jingui] FujianAgr & Forestry Univ, Fuzhou, Fujian, Peoples R China; [Chen, Linghua] Fujian Agr & Forestry Univ, Jinshan Coll, Fuzhou, Fujian, Peoples R China; [Huang, Yining] Zhangzhou Inst Technol, Dept Food & Biol Engn, Zhangzhou, Fujian, Peoples R China; [Xu, Ming; Cheng, Zuxin; Zheng, Jingui] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Dasheng] Chinese Acad Sci, Shanghai Chenshan Bot Garden, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Zhang, Dasheng] Shanghai Key Lab Plant Funct Genom & Resources, Shanghai, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zheng, JG (corresponding author), FujianAgr & Forestry Univ, Fuzhou, Fujian, Peoples R China.; Zheng, JG (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Fujian, Peoples R China.	jinguizheng@126.com		Zheng, Jingui/0000-0003-4976-9024	National Key Technology RD Program [2013BAD01B05]; Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University [PTJH13001, PTJH12015]	National Key Technology RD Program(National Key Technology R&D Program); Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University	This work was supported by the National Key Technology R&D Program (2013BAD01B05) and the Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University (PTJH13001, PTJH12015).; This work was supported by the National Key Technology R&D Program (2013BAD01B05) and the Science and Technology Innovation Platform Development Program of Fujian Agriculture and Forestry University (PTJH13001, PTJH12015). We gratefully acknowledge Shanghai Omicsspace Biotechnology Co. Ltd. for technical assistance with the peptide/protein identification.	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 1999, CEREAL CHEM, V76, P350, DOI 10.1094/CCHEM.1999.76.3.350; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Baier M, 2004, PLANT PHYSIOL, V134, P81, DOI 10.1104/pp.103.031674; BUDDE RJA, 1990, P NATL ACAD SCI USA, V87, P673, DOI 10.1073/pnas.87.2.673; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Calvino M, 2008, RICE, V1, P166, DOI 10.1007/s12284-008-9012-9; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Chong PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082622; CHRISTIE PJ, 1994, PLANTA, V194, P541, DOI 10.1007/BF00714468; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Ambrosio C, 2013, J PROTEOMICS, V78, P39, DOI 10.1016/j.jprot.2012.11.008; Dai SJ, 2007, MOL CELL PROTEOMICS, V6, P207, DOI 10.1074/mcp.M600146-MCP200; Di Carli M, 2011, J PROTEOME RES, V10, P429, DOI 10.1021/pr1005313; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; Dong MH, 2014, J PROTEOMICS, V109, P382, DOI 10.1016/j.jprot.2014.07.001; Du C, 2014, J PROTEOME RES, V13, P720, DOI 10.1021/pr400803w; Faurobert M, 2007, PLANT PHYSIOL, V143, P1327, DOI 10.1104/pp.106.092817; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Guo HH, 2007, PLANT FOOD HUM NUTR, V62, P1, DOI 10.1007/s11130-006-0031-7; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; He F, 2008, MOLECULES, V13, P2674, DOI 10.3390/molecules13102674; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hiemori M, 2009, J AGR FOOD CHEM, V57, P1908, DOI 10.1021/jf803153z; Hii S.L., 2012, ENZYME RES, V2012; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hou DX, 2004, J BIOMED BIOTECHNOL, P321, DOI 10.1155/S1110724304403040; Hu C, 2003, J AGR FOOD CHEM, V51, P5271, DOI 10.1021/jf034466n; Ichikawa Haruyo, 2001, J Med Food, V4, P211, DOI 10.1089/10966200152744481; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Jia LG, 2013, ANN BOT-LONDON, V111, P839, DOI 10.1093/aob/mct045; Martinez-Esteso MJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-167; Martinez-Esteso MJ, 2011, J EXP BOT, V62, P2521, DOI 10.1093/jxb/erq434; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; KEELING PL, 1988, PLANT PHYSIOL, V87, P311, DOI 10.1104/pp.87.2.311; Kim BG, 2007, J PLANT BIOL, V50, P156, DOI 10.1007/BF03030624; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kwon SH, 2007, J MED FOOD, V10, P552, DOI 10.1089/jmf.2006.147; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li Y, 2008, J INTEGR PLANT BIOL, V50, P1057, DOI 10.1111/j.1744-7909.2008.00689.x; Lin SK, 2005, PROTEOMICS, V5, P2140, DOI 10.1002/pmic.200401105; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Ma CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1029; Marondedze C, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.39; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; McClung CR, 2000, PLANT PHYSIOL, V123, P381, DOI 10.1104/pp.123.1.381; Millar AA, 1998, PLANT CELL, V10, P1889, DOI 10.1105/tpc.10.11.1889; Miron D, 2000, PLANT PHYSIOL, V123, P655, DOI 10.1104/pp.123.2.655; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Munne-Bosch S, 2005, NEW PHYTOL, V166, P363, DOI 10.1111/j.1469-8137.2005.01411.x; Nam SH, 2006, FOOD CHEM, V94, P613, DOI 10.1016/j.foodchem.2004.12.010; Nemeth K, 1998, GENE DEV, V12, P3059, DOI 10.1101/gad.12.19.3059; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Oike Y, 2009, CIRC J, V73, P2192, DOI 10.1253/circj.CJ-09-0710; Page M, 2012, PLANT CELL ENVIRON, V35, P388, DOI 10.1111/j.1365-3040.2011.02369.x; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P99, DOI 10.1006/prep.2001.1538; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpott M, 2004, J AGR FOOD CHEM, V52, P1511, DOI 10.1021/jf034593j; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ryu SN, 1998, J FOOD DRUG ANAL, V6, P729; Ryu SY, 2008, CANCER INFORM, V6, P243; Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008; Sato T, 2011, PLANT SIGNAL BEHAV, V6, P1465, DOI 10.4161/psb.6.10.17343; Seeram NP, 2004, J AGR FOOD CHEM, V52, P2512, DOI 10.1021/jf0352778; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Shao YF, 2014, FOOD CHEM, V143, P90, DOI 10.1016/j.foodchem.2013.07.042; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sompong R, 2011, FOOD CHEM, V124, P132, DOI 10.1016/j.foodchem.2010.05.115; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terrier N, 2001, J PLANT PHYSIOL, V158, P1575, DOI 10.1078/0176-1617-00566; Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036; Tschiersch H, 2011, BIOSYSTEMS, V103, P302, DOI 10.1016/j.biosystems.2010.08.007; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Vertommen A, 2011, J PROTEOMICS, V74, P1165, DOI 10.1016/j.jprot.2011.02.016; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang Q, 2007, ASIA PAC J CLIN NUTR, V16, P295; Weiss D, 2000, PHYSIOL PLANTARUM, V110, P152, DOI 10.1034/j.1399-3054.2000.110202.x; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu XL, 2006, J AGR FOOD CHEM, V54, P4069, DOI 10.1021/jf060300l; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Xia XD, 2006, J NUTR, V136, P2220, DOI 10.1093/jn/136.8.2220; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xu SB, 2010, J PROTEOME RES, V9, P4906, DOI 10.1021/pr900954p; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]; Zhao XQ, 2006, PLANT SCI, V170, P748, DOI 10.1016/j.plantsci.2005.11.006	100	14	15	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159238	10.1371/journal.pone.0159238	http://dx.doi.org/10.1371/journal.pone.0159238			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415428	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500104
J	Peron, IH; Reichert-Lima, F; Busso-Lopes, AF; Nagasako, CK; Lyra, L; Moretti, ML; Schreiber, AZ				Peron, Isabela Haddad; Reichert-Lima, Franqueline; Busso-Lopes, Ariane Fidelis; Nagasako, Cristiane Kibune; Lyra, Luzia; Moretti, Maria Luiza; Schreiber, Angelica Zaninelli			Resistance Surveillance in Candida albicans: A Five-Year Antifungal Susceptibility Evaluation in a Brazilian University Hospital	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; SPECIES DISTRIBUTION; RISK-FACTORS; SENTINEL SURVEILLANCE; INVASIVE CANDIDIASIS; AZOLE RESISTANCE; DRUG-RESISTANCE; 2009 UPDATE; EPIDEMIOLOGY	Candida albicans caused 44% of the overall candidemia episodes from 2006 to 2010 in our university tertiary care hospital. As different antifungal agents are used in therapy and also immunocompromised patients receive fluconazole prophylaxis in our institution, this study aimed to perform an antifungal susceptibility surveillance with the C. albicans bloodstream isolates and to characterize the fluconazole resistance in 2 non-blood C. albicans isolates by sequencing ERG11 gene. The study included 147 C. albicans bloodstream samples and 2 fluconazole resistant isolates: one from oral cavity (LIF 12560 fluconazole MIC: 8 mu g/mL) and one from esophageal cavity (LIF-E10 fluconazole MIC: 64 mu g/mL) of two different patients previously treated with oral fluconazole. The in vitro antifungal susceptibility to amphotericin B (AMB), 5-flucytosine (5FC), fluconazole (FLC), itraconazole (ITC), voriconazole (VRC), caspofungin (CASP) was performed by broth microdilution methodology recommended by the Clinical and Laboratory Standards Institute documents (M27-A3 and M27-S4, CLSI). All blood isolates were classified as susceptible according to CLSI guidelines for all evaluated antifungal agents (MIC range: 0,125-1.00 mu g/mL for AMB, <= 0.125-1.00 mu g/mL for 5FC, <= 0.125-0.5 mu g/mL for FLC, <= 0.015-0.125 mu g/mL for ITC, <= 0.015-0.06 mu g/mL for VRC and <= 0.015-0.125 mu g/mL for CASP). In this study, we also amplified and sequenced the ERG11 gene of LIF 12560 and LIF-E10 C. albicans isolates. Six mutations encoding distinct amino acid substitutions were found (E116D, T128K, E266D, A298V, G448V and G464S) and these mutations were previously described as associated with fluconazole resistance. Despite the large consumption of antifungals in our institution, resistant blood isolates were not found over the trial period. Further studies should be conducted, but it may be that the very prolonged direct contact with the oral antifungal agent administered to the patient from which was isolated LIF E-10, may have contributed to the development of resistance.	[Peron, Isabela Haddad; Reichert-Lima, Franqueline; Lyra, Luzia; Schreiber, Angelica Zaninelli] Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, Campinas, SP, Brazil; [Busso-Lopes, Ariane Fidelis; Nagasako, Cristiane Kibune; Moretti, Maria Luiza] Univ Estadual Campinas, Fac Med Sci, Dept Internal Med, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Peron, IH (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, Campinas, SP, Brazil.	zaninele@fcm.unicamp.br	Schreiber, Angelica/ABB-8568-2021; Schreiber, Angelica Zaninelli/C-8759-2012; Busso-Lopes, Ariane Fidelis/K-1383-2015	Schreiber, Angelica/0000-0002-5095-5054; Schreiber, Angelica Zaninelli/0000-0002-5095-5054; Busso-Lopes, Ariane Fidelis/0000-0003-2280-1848; Kibune Nagasako, Cristiane/0000-0002-8403-1677; HADDAD PERON, ISABELA/0000-0003-4760-0540	Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS); University of Campinas, Brazil [02P -29548 -09]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/08693-8]; Japan International Cooperation Agency [029-29548/2009]	Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS); University of Campinas, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Japan International Cooperation Agency	This project was supported by grants from the collaborative research project: Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS) and University of Campinas, Brazil, No. 02P -29548 -09 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant number 2014/08693-8, and 029-29548/2009 Japan International Cooperation Agency - Antifungal susceptibility supplies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alangaden GJ, 2011, INFECT DIS CLIN N AM, V25, P201, DOI 10.1016/j.idc.2010.11.003; Cortes JA, 2014, BRAZ J INFECT DIS, V18, P631, DOI 10.1016/j.bjid.2014.06.009; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021239; Arendrup MC, 2013, DAN MED J, V60; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Bustamante B, 2014, J MED MICROBIOL, V63, P855, DOI 10.1099/jmm.0.071167-0; Chau AS, 2004, ANTIMICROB AGENTS CH, V48, P2124, DOI 10.1128/AAC.48.6.2124-2131.2004; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2008, REF METH BROTH DIL A, P40; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Colombo AL, 2013, BRAZ J INFECT DIS, V17, P283, DOI 10.1016/j.bjid.2013.02.001; da Costa VG, 2014, MYCOPATHOLOGIA, V178, P243, DOI 10.1007/s11046-014-9791-z; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; Delaloye J, 2014, VIRULENCE, V5, P161, DOI 10.4161/viru.26187; Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909; Egusa H, 2008, CURR HIV RES, V6, P485, DOI 10.2174/157016208786501445; Gupta PPS, 2015, INT J CURRENT MICROB, V4, P10; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Kakati B, 2015, J CLIN DIAGN RES, V9, pDC16, DOI 10.7860/JCDR/2015/15171.6975; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kelly SL, 1999, BIOCHEM BIOPH RES CO, V262, P174, DOI 10.1006/bbrc.1999.1136; Khan PA, 2012, IRAN J MICROBIOL, V4, P204; Klepser ME, 2006, PHARMACOTHERAPY, V26, p68S, DOI 10.1592/phco.26.6part2.68S; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; MacCallum DM, 2010, ANTIMICROB AGENTS CH, V54, P1476, DOI 10.1128/AAC.01645-09; Manastir L, 2011, MYCOSES, V54, P99, DOI 10.1111/j.1439-0507.2009.01766.x; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Mokaddas EM, 2007, J MED MICROBIOL, V56, P255, DOI 10.1099/jmm.0.46817-0; Moretti ML, 2013, MED MYCOL, V51, P225, DOI 10.3109/13693786.2012.708107; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Motta AL, 2010, BRAZ J INFECT DIS, V14, P441, DOI 10.1590/S1413-86702010000500004; Nieto MC, 2015, DIAGN MICR INFEC DIS, V81, P34, DOI 10.1016/j.diagmicrobio.2014.05.021; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Peman J, 2012, J ANTIMICROB CHEMOTH, V67, P1181, DOI 10.1093/jac/dks019; Peres-Bota D, 2004, CLIN MICROBIOL INFEC, V10, P550, DOI 10.1111/j.1469-0691.2004.00873.x; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; RODRIGUES EG, 1992, REV INST MED TROP SP, V34, P159, DOI 10.1590/S0036-46651992000200012; Salari S, 2015, J MYCOL MED; SAMARANAYAKE LP, 1992, ORAL SURG ORAL MED O, V73, P171, DOI 10.1016/0030-4220(92)90191-R; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sanglard D, 2002, ENFERM INFEC MICR CL, V20, P462, DOI 10.1016/S0213-005X(02)72842-5; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Xu YH, 2008, J ANTIMICROB CHEMOTH, V61, P798, DOI 10.1093/jac/dkn015; Yapar N, 2014, THER CLIN RISK MANAG, V10, P95, DOI 10.2147/TCRM.S40160	46	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158126	10.1371/journal.pone.0158126	http://dx.doi.org/10.1371/journal.pone.0158126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414653	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500017
J	Aguirre, M; Bussolo de Souza, C; Venema, K				Aguirre, Marisol; Bussolo de Souza, Carlota; Venema, Koen			The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin	PLOS ONE			English	Article							IN-VITRO FERMENTATION; CHAIN FATTY-ACIDS; OLIGOFRUCTOSE-ENRICHED INULIN; NONSTARCH POLYSACCHARIDES; FECAL MICROBIOTA; PROPIONIC-ACID; DIETARY FIBER; BACTEROIDES-THETAIOTAOMICRON; RESISTANT STARCH; LARGE-INTESTINE	Background An aberrant metabolic activity or a compositional alteration of the gut microbiota has been proposed as a factor that makes us more prone to disease. Therefore, we explored the effect of two dietary fibers (arabinogalactan and inulin) on the microbiota from lean and obese subjects during 72 h in vitro fermentation experiments using the validated TNO dynamic in vitro model of the proximal colon: TIM-2. Metabolically, arabinogalactan fermentation showed a higher production of propionate when compared to n-butyrate in the obese microbiota fermentations. In general, lean microbiota produced more n-butyrate from the fermentation of both substrates when compared to the obese microbiota. Furthermore, the obese microbiota extracted more energy from the fermentation of both fibers. Results Compositionally, bacteria belonging to Gemmiger, Dorea, Roseburia, Alistipes, Lactobacillus and Bifidobacterium genera were found to be highly abundant or stimulated by the prebiotics in the lean microbiota suggesting a potential role in leanness. Furthermore, a significant correlation between known butyrogenic strains including B. adolescentis, an unclassified Bifidobacterium and F. prausnitzii with this metabolite in the fermentation of inulin in both microbiotas was found. Conclusions Although supplementary in vivo studies are needed, the current study provides more evidence for the consumption of specific ingredients with the aim of modulating the gut microbiota in the context of obesity.	[Aguirre, Marisol; Venema, Koen] Top Inst Food & Nutr, Wageningen, Netherlands; [Aguirre, Marisol; Venema, Koen] Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Fac Hlth Med & Life Sci, Dept Human Biol, Maastricht, Netherlands; [Aguirre, Marisol; Bussolo de Souza, Carlota] Netherlands Org Appl Sci Res TNO, Zeist, Netherlands; [Bussolo de Souza, Carlota] CNPq, Brasilia, DF, Brazil; [Bussolo de Souza, Carlota] Univ Groningen, Groningen, Netherlands; [Venema, Koen] Beneficial Microbes Consultancy, Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Netherlands Organization Applied Science Research; University of Groningen	Venema, K (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Venema, K (corresponding author), Maastricht Univ, Sch Nutr & Translat Res Metab NUTRIM, Fac Hlth Med & Life Sci, Dept Human Biol, Maastricht, Netherlands.; Venema, K (corresponding author), Beneficial Microbes Consultancy, Wageningen, Netherlands.	koen.venema@outlook.com			Top Institute Food AMP; Nutrition (TIFN, Wageningen, The Netherlands) [GH004]; CNPq (National Council for Scientific and Technological Development) - Brazil - under the Program "Science without Borders" [246027/2012-6]; TIFN	Top Institute Food AMP; Nutrition (TIFN, Wageningen, The Netherlands); CNPq (National Council for Scientific and Technological Development) - Brazil - under the Program "Science without Borders"; TIFN	This study was partly funded by the Top Institute Food & Nutrition (GH004; TIFN, Wageningen, The Netherlands). Carlota Bussolo de Souza received a scholarship from CNPq (National Council for Scientific and Technological Development) - Brazil - under the Program "Science without Borders" (grant number 246027/2012-6). Koen Venema is chief executive officer of Beneficial Microbes Consultancy. TIFN provided support in the form of salaries for authors KV and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguirre M, 2015, J MICROBIOL METH, V117, P78, DOI 10.1016/j.mimet.2015.07.019; Aguirre Marisol, 2015, Microorganisms, V3, P213, DOI 10.3390/microorganisms3020213; Aguirre M, 2014, J MICROBIOL METH, V107, P1, DOI 10.1016/j.mimet.2014.08.022; Aguirre M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113864; Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x; Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Basson MD, 1996, DIGEST DIS SCI, V41, P1986, DOI 10.1007/BF02093601; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; de Souza CB, 2014, J FUNCT FOODS, V11, P210, DOI 10.1016/j.jff.2014.09.019; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Condezo-Hoyos L, 2014, FOOD CHEM, V161, P208, DOI 10.1016/j.foodchem.2014.03.122; CROCIANI F, 1994, INT J FOOD MICROBIOL, V24, P199, DOI 10.1016/0168-1605(94)90119-8; Cummings JH, 1996, BRIT J NUTR, V75, P733, DOI 10.1079/BJN19960177; Cummings JH, 2004, CLIN NUTR, P5, DOI [10.1016/j.clnu.2004.09.003, 10.1016/j.clru.2004.09.003]; Daguet D, 2016, J FUNCT FOODS, V20, P369, DOI 10.1016/j.jff.2015.11.005; Daniel M, 1997, J NUTR, V127, P1981, DOI 10.1093/jn/127.10.1981; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; de Graaf' AA, 2008, ADV MICROB PHYSIOL, V53, P73, DOI 10.1016/S0065-2911(07)53002-X; de Graaf AA, 2010, NMR BIOMED, V23, P2, DOI 10.1002/nbm.1418; De Preter V, 2007, AM J PHYSIOL-GASTR L, V292, pG358, DOI 10.1152/ajpgi.00052.2006; De Preter V, 2010, MOL NUTR FOOD RES, V54, P1791, DOI 10.1002/mnfr.201000136; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Elli M, 2010, MED HYPOTHESES, V75, P350, DOI 10.1016/j.mehy.2010.03.022; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Grootaert C, 2009, FEMS MICROBIOL ECOL, V69, P231, DOI 10.1111/j.1574-6941.2009.00712.x; HAUER J, 1993, CANCER IMMUNOL IMMUN, V36, P237, DOI 10.1007/BF01740905; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hughes SA, 2007, J AGR FOOD CHEM, V55, P4589, DOI 10.1021/jf070293g; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Juskiewicz J, 2007, ARCH ANIM NUTR, V61, P201, DOI 10.1080/17450390701297735; Kim Linda S, 2002, Altern Med Rev, V7, P138; KNUDSEN KEB, 1994, BRIT J NUTR, V71, P471, DOI 10.1079/BJN19940156; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Korpela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090702; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lyon MR, 2012, CURR OBES REP, V1, P59, DOI 10.1007/s13679-012-0016-9; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; MACFARLANE GT, 1995, ANAEROBE, V1, P275, DOI 10.1006/anae.1995.1027; Marino PL, 2012, ICU BOOK; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Roberfroid MB, 2001, AM J CLIN NUTR, V73, p406S, DOI 10.1093/ajcn/73.2.406s; Robinson RR, 2001, J AM COLL NUTR, V20, P279, DOI 10.1080/07315724.2001.10719048; Roelofsen H, 2010, BENEF MICROBES, V1, P433, DOI 10.3920/BM2010.0028; ROYALL D, 1990, AM J GASTROENTEROL, V85, P1307; Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188; Sakaguchi E, 1998, BRIT J NUTR, V80, P469, DOI 10.1017/S0007114598001548; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Sarbini SR, 2014, BRIT J NUTR, V112, P1303, DOI 10.1017/S0007114514002177; Sarbini SR, 2013, BRIT J NUTR, V109, P1980, DOI 10.1017/S0007114512004205; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spill MK, 2011, AM J CLIN NUTR, V94, P735, DOI 10.3945/ajcn.111.015206; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Tilg H, 2010, J CLIN GASTROENTEROL, V44, pS16, DOI 10.1097/MCG.0b013e3181dd8b64; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; Van der Kamp J. W., 2010, DIETARY FIBRE NEW FR; Van Nuenen M., 2003, MICROB ECOL HEALTH D, V15, P137, DOI DOI 10.1080/08910600310018959; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Venema K, 2003, FEMS MICROBIOL LETT, V224, P143, DOI 10.1016/S0378-1097(03)00436-1; VINCE AJ, 1990, BRIT J NUTR, V63, P17, DOI 10.1079/BJN19900088; Wanders AJ, 2013, BRIT J NUTR, V109, P1330, DOI 10.1017/S0007114512003145; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Wisker E, 1997, J NUTR, V127, P108, DOI 10.1093/jn/127.1.108; Yang JY, 2013, J MED FOOD, V16, P862, DOI [10.1089/jmf.2012.0292, 10.1100/jmf.2012.0292]; Zocco MA, 2007, DIGEST LIVER DIS, V39, P707, DOI 10.1016/j.dld.2007.04.003	77	56	57	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159236	10.1371/journal.pone.0159236	http://dx.doi.org/10.1371/journal.pone.0159236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410967	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300068
J	Cox, AR; Barrandon, O; Cai, EP; Rios, JS; Chavez, J; Bonnyman, CW; Lam, CJ; Yi, P; Melton, DA; Kushner, JA				Cox, Aaron R.; Barrandon, Ornella; Cai, Erica P.; Rios, Jacqueline S.; Chavez, Julia; Bonnyman, Claire W.; Lam, Carol J.; Yi, Peng; Melton, Douglas A.; Kushner, Jake A.			Resolving Discrepant Findings on ANGPTL8 in beta-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy	PLOS ONE			English	Article							MALTOSE-BINDING-PROTEIN; METABOLISM; GENE; MICE	The beta-cell mitogenic effects of ANGPTL8 have been subjected to substantial debate. The original findings suggested that ANGPTL8 overexpression in mice induced a 17-fold increase in beta-cell proliferation. Subsequent studies in mice contested this claim, but a more recent report in rats supported the original observations. These conflicting results might be explained by variable ANGPTL8 expression and differing methods of beta-cell quantification. To resolve the controversy, three independent labs collaborated on a blinded study to test the effects of ANGPTL8 upon beta-cell proliferation. Recombinant human betatrophin (hBT) fused to maltose binding protein (MBP) was delivered to mice by intravenous injection. The results demonstrate that ANGPTL8 does not stimulate significant beta-cell proliferation. Each lab employed different methods for beta-cell identification, resulting in variable quantification of beta-cell proliferation and suggests a need for standardizing practices for beta-cell quantification. We also observed a new action of ANGPTL8 in stimulating CD45(+) hematopoietic-derived cell proliferation which may explain, in part, published discrepancies. Overall, the hypothesis that ANGPTL8 induces dramatic and specific beta-cell proliferation can no longer be supported. However, while ANGPTL8 does not stimulate robust beta-cell proliferation, the original experimental model using drug-induced (S961) insulin resistance was validated in subsequent studies, and thus still represents a robust system for studying signals that are either necessary or sufficient for beta-cell expansion. As an added note, we would like to commend collaborative group efforts, with repetition of results and procedures in multiple laboratories, as an effective method to resolve discrepancies in the literature.	[Cox, Aaron R.; Rios, Jacqueline S.; Chavez, Julia; Bonnyman, Claire W.; Lam, Carol J.; Kushner, Jake A.] Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Pediat Diabet & Endocrinol, Houston, TX 77030 USA; [Barrandon, Ornella; Cai, Erica P.; Yi, Peng; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Stem Cell & Regenerat Biol, Cambridge, MA USA; [Cai, Erica P.; Yi, Peng] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA USA	Baylor College of Medicine; Harvard University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kushner, JA (corresponding author), Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Pediat Diabet & Endocrinol, Houston, TX 77030 USA.	kushner@bcm.edu	Cai, Erica/ABE-4408-2020; Kushner, Jake A/AAF-5049-2022; Young, Richard A/F-6495-2012; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Young, Richard A/0000-0001-8855-8647; Kushner, Jake A/0000-0002-3646-1744; Bonnyman, Claire/0000-0002-6570-2623; Chavez, Julia/0000-0001-7831-7989; Cai, Erica/0000-0003-2386-5747	National Institutes of Health (NIH NIA) [1R01AG04101]; Howard Hughes Medical Institute (HHMI); Harvard Stem Cell Institute; Robert and Janice McNair Foundation; Diabetes Research Center at Baylor College of Medicine; NATIONAL INSTITUTE ON AGING [R01AG040110] Funding Source: NIH RePORTER	National Institutes of Health (NIH NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Harvard Stem Cell Institute; Robert and Janice McNair Foundation; Diabetes Research Center at Baylor College of Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH NIA - 1R01AG04101) (www.nia.nih.gov), the Howard Hughes Medical Institute (HHMI) (www.hhmi.org), the Harvard Stem Cell Institute (hsci.harvard.edu), the Robert and Janice McNair Foundation (www.mcnairfoundation.org) and the Diabetes Research Center at Baylor College of Medicine (www.bcm.edu/research/centers/diabetesresearch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JX, 2015, DIABETOLOGIA, V58, P1036, DOI 10.1007/s00125-015-3521-z; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Tuttle AH, 2010, J VIS EXP, V7; Van De Casteele M, 2013, DIABETOLOGIA, V56, P2647, DOI 10.1007/s00125-013-3049-z; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	14	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159276	10.1371/journal.pone.0159276	http://dx.doi.org/10.1371/journal.pone.0159276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410263	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300076
J	Dannenmann, M; Bimuller, C; Gschwendtner, S; Leberecht, M; Tejedor, J; Bilela, S; Gasche, R; Hanewinkel, M; Baltensweiler, A; Kogel-Knabner, I; Polle, A; Schloter, M; Simon, J; Rennenberg, H				Dannenmann, Michael; Bimueller, Carolin; Gschwendtner, Silvia; Leberecht, Martin; Tejedor, Javier; Bilela, Silvija; Gasche, Rainer; Hanewinkel, Marc; Baltensweiler, Andri; Koegel-Knabner, Ingrid; Polle, Andrea; Schloter, Michael; Simon, Judy; Rennenberg, Heinz			Climate Change Impairs Nitrogen Cycling in European Beech Forests	PLOS ONE			English	Article							PLANT-MICROBE COMPETITION; SPRUCE PICEA-ABIES; FAGUS-SYLVATICA L.; AMINO-ACIDS; SOIL-MICROORGANISMS; ANNUAL GRASSLAND; QUERCUS-PETRAEA; NET UPTAKE; TREES; ROOTS	European beech forests growing on marginal calcareous soils have been proposed to be vulnerable to decreased soil water availability. This could result in a large-scale loss of ecological services and economical value in a changing climate. In order to evaluate the potential consequences of this drought-sensitivity, we investigated potential species range shifts for European beech forests on calcareous soil in the 21st century by statistical species range distribution modelling for present day and projected future climate conditions. We found a dramatic decline by 78% until 2080. Still the physiological or biogeochemical mechanisms underlying the drought sensitivity of European beech are largely unknown. Drought sensitivity of beech is commonly attributed to plant physiological constraints. Furthermore, it has also been proposed that reduced soil water availability could promote nitrogen (N) limitation of European beech due to impaired microbial N cycling in soil, but this hypothesis has not yet been tested. Hence we investigated the influence of simulated climate change (increased temperatures, reduced soil water availability) on soil gross microbial N turnover and plant N uptake in the beech-soil interface of a typical mountainous beech forest stocking on calcareous soil in SW Germany. For this purpose, triple N-15 isotope labelling of intact beech seedling-soil-microbe systems was combined with a space-for-time climate change experiment. We found that nitrate was the dominant N source for beech natural regeneration. Reduced soil water content caused a persistent decline of ammonia oxidizing bacteria and therefore, a massive attenuation of gross nitrification rates and nitrate availability in the soil. Consequently, nitrate and total N uptake of beech seedlings were strongly reduced so that impaired growth of beech seedlings was observed already after one year of exposure to simulated climatic change. We conclude that the N cycle in this ecosystem and here specifically nitrification is vulnerable to reduced water availability, which can directly lead to nutritional limitations of beech seedlings. This tight link between reduced water availability, drought stress for nitrifiers, decreased gross nitrification rates and nitrate availability and finally nitrate uptake by beech seedlings could represent the Achilles' heel for beech under climate change stresses.	[Dannenmann, Michael; Tejedor, Javier; Gasche, Rainer] Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Environm Re, Kreuzeckbahnstr 19, D-82467 Garmisch Partenkirchen, Germany; [Dannenmann, Michael; Bilela, Silvija; Simon, Judy; Rennenberg, Heinz] Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, Georges Koehler Allee 53-54, D-79110 Freiburg, Germany; [Bimueller, Carolin; Koegel-Knabner, Ingrid] Tech Univ Munich, Wissenschaftszentrum Weihenstephan, Dept Okol Okosyst Management, Lehrstuhl Bodenkunde, D-85350 Freising Weihenstephan, Germany; [Gschwendtner, Silvia; Schloter, Michael] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Environm Genom, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Leberecht, Martin; Polle, Andrea] Univ Gottingen, Busgen Inst, Forest Bot & Tree Physiol, Busgenweg 2, D-37077 Gottingen, Germany; [Koegel-Knabner, Ingrid] Tech Univ Munich, IAS, Lichtenbergstr 2a, D-85748 Garching, Germany; [Rennenberg, Heinz] King Saud Univ, POB 2454, Riyadh 11451, Saudi Arabia; [Hanewinkel, Marc] Univ Freiburg, Chair Forestry Econ & Forest Planning, D-79110 Freiburg, Germany; [Hanewinkel, Marc; Baltensweiler, Andri] Swiss Fed Res Inst WSL, Res Unit Forest Resources & Management, Zuercherstr 111, CH-8903 Birmensdorf, Switzerland; [Simon, Judy] Univ Konstanz, Chair Plant Physiol & Biochem, Univ Str 10, D-78457 Constance, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Freiburg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen; Technical University of Munich; King Saud University; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Konstanz	Dannenmann, M (corresponding author), Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Environm Re, Kreuzeckbahnstr 19, D-82467 Garmisch Partenkirchen, Germany.; Dannenmann, M (corresponding author), Univ Freiburg, Inst Forest Sci, Chair Tree Physiol, Georges Koehler Allee 53-54, D-79110 Freiburg, Germany.	michael.dannenmann@kit.edu	Dannenmann, Michael/A-7278-2013; Schloter, 1Michael/H-9151-2013; hanewinkel, marc/E-5639-2011; Tejedor, Javier/AAA-6473-2020; Kögel-Knabner, Ingrid/A-7905-2008; Baltensweiler, Andri/V-2327-2019; Simon, Judy/C-7875-2011	hanewinkel, marc/0000-0003-4081-6621; Kögel-Knabner, Ingrid/0000-0002-7216-8326; Baltensweiler, Andri/0000-0003-1933-6535; , Javier/0000-0002-5994-0131; Polle, Andrea/0000-0001-8697-6394; Dannenmann, Michael/0000-0001-5924-7612; Leberecht, Martin/0000-0002-5672-8928; Simon, Judy/0000-0002-8879-2449	German Science Foundation (DFG) [DA 1217/2-1, KO 1035/41-1, SCHL 446/11-1, RE 515/33-1, PO 362/19-1]; Ministry of Science, Research and the Arts Baden-Wurttemberg; European Social Fund	German Science Foundation (DFG)(German Research Foundation (DFG)); Ministry of Science, Research and the Arts Baden-Wurttemberg; European Social Fund(European Social Fund (ESF))	This work has been supported by the German Science Foundation (DFG) under the contract numbers DA 1217/2-1, KO 1035/41-1, SCHL 446/11-1, RE 515/33-1 and PO 362/19-1. J.S. was financially supported by the Ministry of Science, Research and the Arts Baden-Wurttemberg and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the German Science Foundation (DFG) under the contract numbers DA 1217/2-1, KO 1035/41-1, SCHL 446/11-1, RE 515/33-1 and PO 362/19-1. J.S. was financially supported by the Ministry of Science, Research and the Arts Baden-Wurttemberg and the European Social Fund. We thank Rudi Meier (KIT/IMK-IFU-CSI), Jens Dyckmans (KOSI, Universitat Gottingen) and Franz Buegger (Helmholtz Zentrum Munchen) for isotope analyses, Thomas Klein for field work, Elisabeth Zumbusch for analysis of carbon and nitrogen in soil extracts and Allison Kolar for language correction.	Bimuller C, 2014, SOIL BIOL BIOCHEM, V68, P241, DOI 10.1016/j.soilbio.2013.10.003; Burger M, 2004, PLANT SOIL, V266, P289; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Coumou D, 2013, CLIMATIC CHANGE, V118, P771, DOI 10.1007/s10584-012-0668-1; Dannenmann M, 2008, SOIL BIOL BIOCHEM, V40, P2317, DOI 10.1016/j.soilbio.2008.05.009; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Dell CJ, 2005, SOIL SCI SOC AM J, V69, P371, DOI 10.2136/sssaj2005.0371; Ellenberg H, 1996, VEGETATION MITTELEUR; Fernandez-Martinez M, 2014, NAT CLIM CHANGE, V4, P471, DOI [10.1038/nclimate2177, 10.1038/NCLIMATE2177]; Finzi AC, 2005, ECOLOGY, V86, P3345, DOI 10.1890/04-1460; Gessler A, 2005, EUR J FOREST RES, V124, P95, DOI 10.1007/s10342-005-0055-9; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 1998, NEW PHYTOL, V138, P275, DOI 10.1046/j.1469-8137.1998.00107.x; Gessler A, 2007, TREES-STRUCT FUNCT, V21, P1, DOI 10.1007/s00468-006-0107-x; Gschwendtner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116614; Guo CJ, 2013, PLANT SOIL, V369, P657, DOI 10.1007/s11104-013-1603-6; Haas E, 2013, LANDSCAPE ECOL, V28, P615, DOI 10.1007/s10980-012-9772-x; Hanewinkel M, 2014, J ENVIRON MANAGE, V134, P153, DOI 10.1016/j.jenvman.2014.01.010; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; HART SC, 1991, BIOGEOCHEMISTRY, V12, P103; JACKSON LE, 1989, SOIL BIOL BIOCHEM, V21, P409, DOI 10.1016/0038-0717(89)90152-1; Jackson LE, 2008, ANNU REV PLANT BIOL, V59, P341, DOI 10.1146/annurev.arplant.59.032607.092932; Jaeger CH, 1999, ECOLOGY, V80, P1883, DOI 10.1890/0012-9658(1999)080[1883:SPONBP]2.0.CO;2; JOHNSON DW, 1992, J ENVIRON QUAL, V21, P1, DOI 10.2134/jeq1992.00472425002100010001x; Kohler M, 2010, EUR J FOREST RES, V129, P1109, DOI 10.1007/s10342-010-0397-9; Kreuzwieser J, 2010, TREE PHYSIOL, V30, P1221, DOI 10.1093/treephys/tpq055; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Leuschner C, 2001, FOREST ECOL MANAG, V149, P33, DOI 10.1016/S0378-1127(00)00543-0; Lipson DA, 1998, OECOLOGIA, V113, P406, DOI 10.1007/s004420050393; Liu XP, 2005, PLANT PHYSIOL BIOCH, V43, P147, DOI 10.1016/j.plaphy.2005.01.010; Michelot A, 2012, FOREST ECOL MANAG, V265, P161, DOI 10.1016/j.foreco.2011.10.024; Moosmayer H. U., 2002, LANGFRISTIGE REGIONA; Nadelhoffer KJ, 1999, ECOL APPL, V9, P72, DOI 10.1890/1051-0761(1999)009[0072:SFNEAT]2.0.CO;2; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Norton JM, 2011, METHOD ENZYMOL, V486, P343, DOI [10.1016/S0076-6879(11)86015-5, 10.1016/B978-0-12-381294-0.00015-8]; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pena R, 2010, APPL ENVIRON MICROB, V76, P1831, DOI 10.1128/AEM.01703-09; Pretzsch H, 2013, PLANT BIOLOGY, V15, P483, DOI 10.1111/j.1438-8677.2012.00670.x; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Rennenberg H, 2001, J APPL BOT-ANGEW BOT, V75, P101; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; SCHIMEL JP, 1989, SOIL BIOL BIOCHEM, V21, P1059, DOI 10.1016/0038-0717(89)90044-8; Simon J, 2010, PLANT BIOLOGY, V12, P453, DOI 10.1111/j.1438-8677.2009.00225.x; Simon J, 2011, FOREST ECOL MANAG, V262, P105, DOI 10.1016/j.foreco.2011.01.035; Smiatek G, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011353; Stoelken G, 2010, TREE PHYSIOL, V30, P1118, DOI 10.1093/treephys/tpq050; Tarp P, 2000, FOREST ECOL MANAG, V130, P187, DOI 10.1016/S0378-1127(99)00190-5; Wagner S, 2013, CLIM DYNAM, V40, P415, DOI 10.1007/s00382-012-1510-1; Weber P, 2013, TREES-STRUCT FUNCT, V27, P171, DOI 10.1007/s00468-012-0786-4; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; Wu HH, 2011, PLANT SOIL, V340, P127, DOI 10.1007/s11104-010-0575-z; ZAK DR, 1990, ECOLOGY, V71, P651, DOI 10.2307/1940319; Zimmermann J, 2015, ECOSYSTEMS IN PRESS	58	34	36	7	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158823	10.1371/journal.pone.0158823	http://dx.doi.org/10.1371/journal.pone.0158823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410969	Green Published, gold			2022-12-26	WOS:000379508300035
J	Greene, AC; Henderson, IM; Gomez, A; Paxton, WF; VanDelinder, V; Bachand, GD				Greene, Adrienne C.; Henderson, Ian M.; Gomez, Andrew; Paxton, Walter F.; VanDelinder, Virginia; Bachand, George D.			The Role of Membrane Fluidization in the Gel-Assisted Formation of Giant Polymersomes	PLOS ONE			English	Article							UNILAMELLAR VESICLES; DRUG-DELIVERY; MODEL SYSTEMS; LIPOSOMES; COPOLYMERS; NETWORKS; FILMS	Polymersomes are being widely explored as synthetic analogs of lipid vesicles based on their enhanced stability and potential uses in a wide variety of applications in (e.g., drug delivery, cell analogs, etc.). Controlled formation of giant polymersomes for use in membrane studies and cell mimetic systems, however, is currently limited by low-yield production methodologies. Here, we describe for the first time, how the size distribution of giant poly(ethylene glycol)-poly(butadiene) (PEO-PBD) polymersomes formed by gel-assisted rehydration may be controlled based on membrane fluidization. We first show that the average diameter and size distribution of PEO-PBD polymersomes may be readily increased by increasing the temperature of the rehydration solution. Further, we describe a correlative relationship between polymersome size and membrane fluidization through the addition of sucrose during rehydration, enabling the formation of PEO-PBD polymersomes with a range of diameters, including giant-sized vesicles (>100 mu m). This correlative relationship suggests that sucrose may function as a small molecule fluidizer during rehydration, enhancing polymer diffusivity during formation and increasing polymersome size. Overall the ability to easily regulate the size of PEO-PBD polymersomes based on membrane fluidity, either through temperature or fluidizers, has broadly applicability in areas including targeted therapeutic delivery and synthetic biology.	[Greene, Adrienne C.; Henderson, Ian M.; Paxton, Walter F.; VanDelinder, Virginia; Bachand, George D.] Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA; [Gomez, Andrew] Sandia Natl Labs, Ctr Mat Sci & Engn, Albuquerque, NM USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Bachand, GD (corresponding author), Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA.	gdbacha@sandia.gov	Paxton, Walter/AAP-8682-2021	Paxton, Walter/0000-0002-2438-4542; Greene, Adrienne/0000-0003-0270-3351; Bachand, George/0000-0002-3169-9980	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (BES-MSE); U.S. Department of Energy (DOE) Office of Science [RA2015A0004]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (BES-MSE); U.S. Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (BES-MSE). The funder provided support in the form of salaries for authors [ACG, AG, WFP, GDB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science (user project number RA2015A0004). The funder provided support in the form of salaries for authors [IMH and VV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000.	Amos RC, 2012, SOFT MATTER, V8, P5947, DOI 10.1039/c2sm25172h; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Dimova R, 2002, EUR PHYS J E, V7, P241, DOI 10.1140/epje/i200101032; Ding LP, 2010, LANGMUIR, V26, P5544, DOI 10.1021/la9038045; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838; Egli S, 2011, J AM CHEM SOC, V133, P4476, DOI 10.1021/ja110275f; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Hansen JS, 2013, J AM CHEM SOC, V135, P17294, DOI 10.1021/ja409708e; Henderson IM, 2014, ANGEW CHEM INT EDIT, V53, P3372, DOI 10.1002/anie.201309433; Hickey RJ, 2014, ACS NANO, V8, P495, DOI 10.1021/nn405012h; Horger KS, 2009, J AM CHEM SOC, V131, P1810, DOI 10.1021/ja805625u; Howse JR, 2009, NAT MATER, V8, P507, DOI [10.1038/NMAT2446, 10.1038/nmat2446]; Jang WS, 2016, SOFT MATTER, V12, P1014, DOI 10.1039/c5sm01881a; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Kim KT, 2009, ADV MATER, V21, P2787, DOI 10.1002/adma.200900300; Lee JCM, 2002, MACROMOLECULES, V35, P323, DOI 10.1021/ma0112063; Liu GY, 2012, SOFT MATTER, V8, P8811, DOI 10.1039/c2sm25721a; Mabrouk E, 2009, SOFT MATTER, V5, P1870, DOI 10.1039/b815817g; Marquardt D, 2015, MEMBRANES, V5, P180, DOI 10.3390/membranes5020180; Moodley K, 2012, INT J MOL SCI, V13, P18, DOI 10.3390/ijms13010018; Najer A, 2016, CHIMIA, V70, P288, DOI 10.2533/chimia.2016.288; Pata V, 2003, BIOPHYS J, V85, P2111, DOI 10.1016/S0006-3495(03)74639-6; Paxton WF, 2015, NANOSCALE, V7, P10998, DOI 10.1039/c5nr00826c; Paxton WF, 2013, SOFT MATTER, V9, P11295, DOI 10.1039/c3sm51575c; Rodriguez-Garcia R, 2011, SOFT MATTER, V7, P1532, DOI 10.1039/c0sm00823k; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Tsai FC, 2011, LANGMUIR, V27, P10061, DOI 10.1021/la201604z; Tsumoto K, 2009, COLLOID SURFACE B, V68, P98, DOI 10.1016/j.colsurfb.2008.09.023; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Weinberger A, 2013, BIOPHYS J, V105, P154, DOI 10.1016/j.bpj.2013.05.024; Wesolowska O, 2009, ACTA BIOCHIM POL, V56, P33	37	22	22	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158729	10.1371/journal.pone.0158729	http://dx.doi.org/10.1371/journal.pone.0158729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410487	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300033
J	Serebryany, E; Woodard, JC; Adkar, BV; Shabab, M; King, JA; Shakhnovich, EI				Serebryany, Eugene; Woodard, Jaie C.; Adkar, Bharat V.; Shabab, Mohammed; King, Jonathan A.; Shakhnovich, Eugene I.			An Internal Disulfide Locks a Misfolded Aggregation-prone Intermediate in Cataract-linked Mutants of Human gamma D-Crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN AGGREGATION; IN-VITRO; HUMAN LENS; DEAMIDATION DESTABILIZES; HYDROPHOBIC INTERIOR; NUCLEAR CATARACT; FIBRIL FORMATION; ALPHA-SYNUCLEIN; KINETIC TRAP	Considerable mechanistic insight has been gained into amyloid aggregation; however, a large number of non-amyloid protein aggregates are considered "amorphous," and in most cases, little is known about their mechanisms. Amorphous aggregation of gamma-crystallins in the eye lens causes cataract, a widespread disease of aging. We combined simulations and experiments to study the mechanism of aggregation of two gamma D-crystallin mutants, W42R and W42Q: the former a congenital cataract mutation, and the latter a mimic of age-related oxidative damage. We found that formation of an internal disulfide was necessary and sufficient for aggregation under physiological conditions. Two-chain all-atom simulations predicted that one non-native disulfide in particular, between Cys(32) and Cys(41), was likely to stabilize an unfolding intermediate prone to intermolecular interactions. Mass spectrometry and mutagenesis experiments confirmed the presence of this bond in the aggregates and its necessity for oxidative aggregation under physiological conditions in vitro. Mining the simulation data linked formation of this disulfide to extrusion of the N-terminal beta-hairpin and rearrangement of the native beta-sheet topology. Specific binding between the extruded hairpin and a distal beta-sheet, in an intermolecular chain reaction similar to domain swapping, is the most probable mechanism of aggregate propagation.	[Serebryany, Eugene; Shabab, Mohammed; King, Jonathan A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Woodard, Jaie C.; Adkar, Bharat V.; Shakhnovich, Eugene I.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shakhnovich, EI (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jaking@mit.edu; shakhnovich@chemistry.harvard.edu	Serebryany, Eugene/E-4595-2017; Adkar, Bharat Vighnahar/AAP-2634-2021	Adkar, Bharat Vighnahar/0000-0002-9168-051X	National Institutes of Health [R01 GM111955, R01 EY015834]; National Institutes of Health Biophysics Training Grant; MIT Biology; Whitehead Institute for Biomedical Research; NATIONAL EYE INSTITUTE [R01EY015834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111955, T32GM008313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Biology; Whitehead Institute for Biomedical Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM111955 (to E. I. S.); a National Institutes of Health Biophysics Training Grant (to J. C. W.); National Institutes of Health Grant R01 EY015834 (to J. A. K.); and fellowships from MIT Biology and the Whitehead Institute for Biomedical Research (to E. S.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Borgia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9861; Borgia MB, 2013, J AM CHEM SOC, V135, P6456, DOI 10.1021/ja308852b; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Chang JY, 2001, J BIOL CHEM, V276, P4845, DOI 10.1074/jbc.M005160200; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cutler TA, 2009, J MOL BIOL, V386, P854, DOI 10.1016/j.jmb.2008.10.090; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Das P, 2010, PROTEIN SCI, V19, P131, DOI 10.1002/pro.296; de Graff AMR, 2016, STRUCTURE, V24, P329, DOI 10.1016/j.str.2015.11.006; Dima RI, 2002, PROTEIN SCI, V11, P1036, DOI 10.1110/ps.4220102; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Fan XJ, 2015, MOL CELL PROTEOMICS, V14, P3211, DOI 10.1074/mcp.M115.050948; Flaugh SL, 2006, J BIOL CHEM, V281, P30782, DOI 10.1074/jbc.M603882200; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Fraga H, 2014, J BIOL CHEM, V289, P9852, DOI 10.1074/jbc.M114.553479; FRIEDBURG D, 1973, EXP EYE RES, V15, P173, DOI 10.1016/0014-4835(73)90116-4; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Garcia-Manyes S, 2016, J BIOL CHEM, V291, P4226, DOI 10.1074/jbc.M115.673871; Hains PG, 2010, INVEST OPHTH VIS SCI, V51, P3107, DOI 10.1167/iovs.09-4308; Hains PG, 2008, BBA-PROTEINS PROTEOM, V1784, P1959, DOI 10.1016/j.bbapap.2008.07.016; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jung J., 2013, J BIOL CHEM, V288, P99; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 2014, PROG BIOPHYS MOL BIO, V115, P21, DOI 10.1016/j.pbiomolbio.2014.02.004; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Levy Y, 2004, P NATL ACAD SCI USA, V101, P511, DOI 10.1073/pnas.2534828100; Mahler B, 2011, J MOL BIOL, V405, P840, DOI 10.1016/j.jmb.2010.11.005; Maisonneuve P, 2016, J BIOL CHEM, V291, P16699, DOI 10.1074/jbc.M115.707208; Metlapally S, 2008, EXP EYE RES, V86, P434, DOI 10.1016/j.exer.2007.11.018; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; OZAKI Y, 1987, J BIOL CHEM, V262, P15445; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Quintanar L, 2016, ACS CHEM BIOL, V11, P263, DOI 10.1021/acschembio.5b00919; Rains P. G., 2007, J PROTEOME RES, V6, P3935; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Reddy G, 2009, J PHYS CHEM B, V113, P1162, DOI 10.1021/jp808914c; Robinson AC, 2014, P NATL ACAD SCI USA, V111, P11685, DOI 10.1073/pnas.1402900111; Robrnan L., 2005, EYE, V19, P1074; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Serebryany E, 2016, PROTEIN SCI, V25, P1115, DOI 10.1002/pro.2924; Serebryany E, 2015, J BIOL CHEM, V290, P11491, DOI 10.1074/jbc.M114.621581; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; Shu M, 2013, P NATL ACAD SCI USA, V110, pE1669, DOI 10.1073/pnas.1305475110; SPECTOR A, 1978, P NATL ACAD SCI USA, V75, P3244, DOI 10.1073/pnas.75.7.3244; Takata T, 2008, PROTEIN SCI, V17, P1565, DOI 10.1110/ps.035410.108; Tian J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004207; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Truscott RE, 2007, PROTEIN MISFOLDING A, P435; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Wommack AJ, 2014, J AM CHEM SOC, V136, P13494, DOI 10.1021/ja505957w; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Xu JB, 2011, PROTEINS, V79, P1704, DOI 10.1002/prot.22993; Yang JS, 2008, P NATL ACAD SCI USA, V105, P895, DOI 10.1073/pnas.0707284105; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; Zhang J, 2012, INVEST OPHTH VIS SCI, V53, P7276, DOI 10.1167/iovs.12-10482; Zhao L, 2015, NATURE, V523, P607, DOI 10.1038/nature14650	78	39	39	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19172	19183		10.1074/jbc.M116.735977	http://dx.doi.org/10.1074/jbc.M116.735977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417136	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000383242300048
J	Gomez-Gonzalez, S; Ojeda, F; Torres-Morales, P; Palma, JE				Gomez-Gonzalez, Susana; Ojeda, Fernando; Torres-Morales, Patricio; Palma, Jazmin E.			Seed Pubescence and Shape Modulate Adaptive Responses to Fire Cues	PLOS ONE			English	Article							ANTHROPOGENIC FIRE; SAVANNA VEGETATION; PLANT; EVOLUTION; GERMINATION; TRAITS; RAINFALL; ECOLOGY; HISTORY; SMOKE	Post-fire recruitment by seeds is regarded as an adaptive response in fire-prone ecosystems. Nevertheless, little is known about which heritable seed traits are functional to the main signals of fire (heat and smoke), thus having the potential to evolve. Here, we explored whether three seed traits (pubescence, dormancy and shape) and fire regime modulate seed response to fire cues(heat and smoke). As a model study system, we used Helenium aromaticum (Asteraceae), a native annual forb from the Chilean matorral, where fires are anthropogenic. We related seed trait values with fitness responses (germination and survival) after exposure to heat-shock and smoke experimental treatments on seeds from 10 H. aromaticum wild populations. We performed a phenotypic selection experiment to examine the relationship of seed traits with post-treatment fitness within a population (adaptive hypothesis). We then explored whether fire frequency in natural habitats was associated with trait expression across populations, and with germination and survival responses to experimental fire-cues. We found that populations subjected to higher fire frequency had, in average, more rounded and pubescent seeds than populations from rarely burned areas. Populations with more rounded and pubescent seeds were more resistant to 80 degrees C heat-shock and smoke treatments. There was correlated selection on seed traits: pubescent-rounded or glabrouscent-elongated seeds had the highest probability of germinating after heat-shock treatments. Seed pubescence and shape in H. aromaticum are heritable traits that modulate adaptive responses to fire. Our results provide new insights into the process of plant adaptation to fire and highlight the relevance of human-made fires as a strong evolutionary agent in the Anthropocene.	[Gomez-Gonzalez, Susana; Palma, Jazmin E.] Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile; [Gomez-Gonzalez, Susana; Ojeda, Fernando] Univ Cadiz, Dept Biol, IVAGRO, Campus Rio San Pedro, Puerto Real, Spain; [Torres-Morales, Patricio] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Universidad de Chile; Universidad de Cadiz; Universidad Austral de Chile	Gomez-Gonzalez, S (corresponding author), Univ Chile, Ctr Sci & Resilience Res CR2, Santiago, Chile.; Gomez-Gonzalez, S (corresponding author), Univ Cadiz, Dept Biol, IVAGRO, Campus Rio San Pedro, Puerto Real, Spain.	sgomezgo@gmail.com	Gómez-González, Susana/AAL-2631-2021; Ojeda, Fernando/L-1626-2014	Gómez-González, Susana/0000-0002-3779-8701; Ojeda, Fernando/0000-0001-5480-0925	CONICYT-FONDECYT INICIACION [11121264]; CONICYT-FONDAP [15110009]	CONICYT-FONDECYT INICIACION(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	CONICYT-FONDECYT INICIACION #11121264 financed the equipment, reagents, materials, fieldwork travels and publication expenses. CONICYT-FONDAP #15110009 financed the travels for meetings. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarzua AM, 2016, PALAEOGEOGR PALAEOCL, V459, P76, DOI 10.1016/j.palaeo.2016.06.036; Aravena JC, 2003, ECOL STU AN, V160, P343; Austin DF., 1998, DIVERSITY TAXONOMY T, P201; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BIERNER MW, 1978, SYST BOT, V3, P277, DOI 10.2307/2418298; Bond WJ, 2010, NEW PHYTOL, V188, P1137, DOI 10.1111/j.1469-8137.2010.03418.x; BOND WJ, 1995, OIKOS, V73, P79, DOI 10.2307/3545728; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradshaw SD, 2011, TRENDS PLANT SCI, V16, P69, DOI 10.1016/j.tplants.2010.10.007; BROWN NAC, 1993, NEW PHYTOL, V123, P575, DOI 10.1111/j.1469-8137.1993.tb03770.x; Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001; Climent J, 2004, PLANT ECOL, V171, P185, DOI 10.1023/B:VEGE.0000029374.64778.68; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Cowling RM, 2005, GLOBAL ECOL BIOGEOGR, V14, P509, DOI 10.1111/j.1466-822x.2005.00166.x; Crisp MD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1191; Di Castri F, 1976, BIOCLIMATOLOGIA CHIL; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; Endler J. A., 1986, NATURAL SELECTION WI; Ghermandi L, 2013, J ARID ENVIRON, V97, P9, DOI 10.1016/j.jaridenv.2013.05.005; Gomez-Gonzalez S, 2008, FOREST ECOL MANAG, V255, P1510, DOI 10.1016/j.foreco.2007.11.006; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Gomez-Gonzalez S, 2011, DIVERS DISTRIB, V17, P58, DOI 10.1111/j.1472-4642.2010.00728.x; Gomez-Gonzalez S, 2009, INT J WILDLAND FIRE, V18, P213, DOI 10.1071/WF07074; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; He TH, 2011, NEW PHYTOL, V191, P184, DOI 10.1111/j.1469-8137.2011.03663.x; Hernandez-Serrano A, 2013, AM J BOT, V100, P2349, DOI 10.3732/ajb.1300182; HEUSSER CJ, 1994, REV CHIL HIST NAT, V67, P435; JANZEN DH, 1977, ECOLOGY, V58, P921, DOI 10.2307/1936229; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Keeley J. E., 2000, Seeds: the ecology of regeneration in plant communities, P311, DOI 10.1079/9780851994321.0311; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; Lamont BB, 2011, PLANT ECOL, V212, P1945, DOI 10.1007/s11258-011-9982-3; Le Stradic S, 2015, AUSTRAL ECOL, V40, P537, DOI 10.1111/aec.12221; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; Moreira B, 2014, MOL ECOL, V23, P1213, DOI 10.1111/mec.12665; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; Moreira B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051523; MUNOZ MR, 1989, OIKOS, V56, P177, DOI 10.2307/3565333; Ojeda F, 2005, NEW PHYTOL, V168, P155, DOI 10.1111/j.1469-8137.2005.01486.x; Ojeda F, 2010, OECOLOGIA, V163, P729, DOI 10.1007/s00442-009-1550-3; Pausas JG, 2006, J ECOL, V94, P31, DOI 10.1111/j.1365-2745.2005.01092.x; Pausas JG, 2015, TRENDS PLANT SCI, V20, P318, DOI 10.1016/j.tplants.2015.03.001; Pausas JG, 2012, NEW PHYTOL, V193, P301, DOI 10.1111/j.1469-8137.2011.04010.x; Pausas JG, 2012, NEW PHYTOL, V193, P18, DOI 10.1111/j.1469-8137.2011.03945.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ruprecht E, 2015, PERSPECT PLANT ECOL, V17, P397, DOI 10.1016/j.ppees.2015.07.001; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sheuyange A, 2005, J ENVIRON MANAGE, V75, P189, DOI 10.1016/j.jenvman.2004.11.004; Shryock DF, 2014, ECOL EVOL, V4, P3046, DOI 10.1002/ece3.1159; Stephens SL, 2006, J BIOGEOGR, V33, P648, DOI 10.1111/j.1365-2699.2005.01387.x; Verdu M, 2007, J ECOL, V95, P1316, DOI 10.1111/j.1365-2745.2007.01300.x; Villa-Martinez R, 2003, QUATERNARY RES, V60, P284, DOI 10.1016/j.yqres.2003.07.007; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Willis CG, 2014, NEW PHYTOL, V203, P300, DOI 10.1111/nph.12782	64	7	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159655	10.1371/journal.pone.0159655	http://dx.doi.org/10.1371/journal.pone.0159655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438267	gold, Green Submitted, Green Published			2022-12-26	WOS:000380170100061
J	Kulakowski, D; Veblen, TT; Bebi, P				Kulakowski, Dominik; Veblen, Thomas T.; Bebi, Peter			Fire Severity Controlled Susceptibility to a 1940s Spruce Beetle Outbreak in Colorado, USA	PLOS ONE			English	Article							SUB-ALPINE FORESTS; MOUNTAIN PINE-BEETLE; WESTERN COLORADO; DISTURBANCE REGIME; TREE REGENERATION; UNITED-STATES; BARK BEETLES; WILDFIRE; HISTORY; FUELS	The frequency, magnitude, and size of forest disturbances are increasing globally. Much recent research has focused on how the occurrence of one disturbance may affect susceptibility to subsequent disturbances. While much has been learned about such linked disturbances, the strength of the interactions is likely to be contingent on the severity of disturbances as well as climatic conditions, both of which can affect disturbance intensity and tree resistance to disturbances. Subalpine forests in western Colorado were affected by extensive and severe wildfires in the late 19th century and an extensive and severe outbreak of spruce beetle (Dendroctonus rufipennis) in the 1940s. Previous research found that most, but not all, of the stands that burned and established following the late 19th century fires were not susceptible to the 1940s outbreak as beetles preferentially attack larger trees and stands in advanced stages of development. However, previous research also left open the possibility that some stands that burned and established following the 19th century fires may have been attacked during the 1940s outbreak. Understanding how strongly stand structure, as shaped by disturbances of varying severity, affected susceptibility to past outbreaks is important to provide a baseline for assessing the degree to which recent climate change may be relaxing the preferences of beetles for larger trees and for stands in latter stages of structural development and thereby changing the nature of linked disturbances. Here, dendroecological methods were used to study disturbance history and tree age of stands in the White River National Forest in Western Colorado that were identified in historical documents or remotely-sensed images as having burned in the 19th century and having been attacked by spruce beetle in the 1940s. Dendroecological reconstructions indicate that in young post-fire stands only old remnant trees that survived the otherwise stand-replacing fires were killed in the 1940s outbreak. No young post-fire trees (< ca. 128 years) were susceptible to the 1940s outbreak, implying that under the relatively cool and wet conditions of the mid-20th century, susceptibility to and spatial patterns of spruce beetle outbreak were most likely controlled by variations in severity of prior disturbance by fire. This study provides a baseline for comparing linked disturbances under the relatively warmer and drier conditions of recent (e.g. post-1990) outbreaks in order to assess how climate mitigates the degree to which pre-disturbance history and structure affect susceptibility to disturbances.	[Kulakowski, Dominik] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Kulakowski, Dominik; Bebi, Peter] WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland; [Veblen, Thomas T.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA	Clark University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Colorado System; University of Colorado Boulder	Kulakowski, D (corresponding author), Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA.; Kulakowski, D (corresponding author), WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland.	dkulakowski@clarku.edu	Veblen, Thomas T./U-6461-2018		National Science Foundation [1262691, 1262687]	National Science Foundation(National Science Foundation (NSF))	This material was supported by Awards 1262691 and 1262687 from the National Science Foundation.	Andrus RA, 2016, ECOL APPL, V26, P700, DOI 10.1890/15-1121; Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Black SH, 2013, NAT AREA J, V33, P59, DOI 10.3375/043.033.0107; Cybis Elektronik, 2014, CDENDRO COORECORDER; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; DeRose RJ, 2013, FOREST ECOL MANAG, V308, P198, DOI 10.1016/j.foreco.2013.07.061; DeRose RJ, 2012, CAN J FOREST RES, V42, P1649, DOI [10.1139/X2012-102, 10.1139/x2012-102]; DUNCAN R P, 1989, New Zealand Natural Sciences, V16, P31; Eisenhart KS, 2000, CAN J FOREST RES, V30, P1788, DOI 10.1139/cjfr-30-11-1788; Hansen EM, 2003, CAN ENTOMOL, V135, P697; Hart SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127975; Hart SJ, 2014, FOREST ECOL MANAG, V318, P44, DOI 10.1016/j.foreco.2013.12.035; Hart SJ, 2014, ECOLOGY, V95, P930, DOI 10.1890/13-0230.1; Harvey BJ, 2014, P NATL ACAD SCI USA, V111, P15120, DOI 10.1073/pnas.1411346111; Harvey BJ, 2014, ECOL APPL, V24, P1608, DOI 10.1890/13-1851.1; Hebertson EG, 2008, ENVIRON ENTOMOL, V37, P281; Herring SC, 2015, B AM METEOROLOGICAL, V96, P1; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; HINDS THOMAS E., 1965, J FOREST, V63, P536; Jarvis DS, 2015, J BIOGEOGR, V42, P1029, DOI 10.1111/jbi.12489; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; Jenkins MJ, 2012, FOREST ECOL MANAG, V275, P23, DOI 10.1016/j.foreco.2012.02.036; Kipfmueller KF, 1998, FOREST ECOL MANAG, V104, P171, DOI 10.1016/S0378-1127(97)00245-4; Kulakowski D, 2003, J BIOGEOGR, V30, P1445, DOI 10.1046/j.1365-2699.2003.00912.x; Kulakowski D, 2002, J ECOL, V90, P806, DOI 10.1046/j.1365-2745.2002.00722.x; Kulakowski D., 2015, MIXED HIGH SEVERITY, P149, DOI DOI 10.1016/B978-0-12-802749-3.00006-2; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Kulakowski D, 2006, CAN J FOREST RES, V36, P2974, DOI 10.1139/X06-182; Kulakowski D, 2013, J VEG SCI, V24, P168, DOI 10.1111/j.1654-1103.2012.01437.x; Kulakowski D, 2012, J BIOGEOGR, V39, P2052, DOI 10.1111/j.1365-2699.2012.02748.x; Lukas J., 2014, CLIMATE CHANGE COLOR; MAST JN, 1994, PHYS GEOGR, V15, P529, DOI 10.1080/02723646.1994.10642533; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Meigs GW, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00037.1; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; ROMME WH, 1989, BIOSCIENCE, V39, P695, DOI 10.2307/1311000; Schmid J., 1974, RM131 USDA FOR SERV; Schmid J. M., 1977, USDA Forest Service General Technical Report, Rocky Mountain Forest and Range Experiment Station; Schoennagel T, 2007, ECOLOGY, V88, P2891, DOI 10.1890/06-1860.1; Sibold JS, 2006, J BIOGEOGR, V33, P631, DOI 10.1111/j.1365-2699.2005.01404.x; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Stokes M.A., 1968, INTRO TREE RING DATI; SUDWORTH GB, 2000, 20 ANN REPORT US G 5, P117; Temperli C, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00394.1; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; VEBLEN TT, 1991, ECOLOGY, V72, P213, DOI 10.2307/1938916; VEBLEN TT, 1994, J ECOL, V82, P125, DOI 10.2307/2261392	49	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158138	10.1371/journal.pone.0158138	http://dx.doi.org/10.1371/journal.pone.0158138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438289	Green Published, gold			2022-12-26	WOS:000380170100007
J	Mari-Sanchis, A; Gea, A; Basterra-Gortari, FJ; Martinez-Gonzalez, MA; Beunza, JJ; Bes-Rastrollo, M				Mari-Sanchis, A.; Gea, A.; Basterra-Gortari, F. J.; Martinez-Gonzalez, M. A.; Beunza, J. J.; Bes-Rastrollo, M.			Meat Consumption and Risk of Developing Type 2 Diabetes in the SUN Project: A Highly Educated Middle-Class Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; FOOD-FREQUENCY QUESTIONNAIRE; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; SEGUIMIENTO-UNIVERSIDAD; UNPROCESSED RED; PROCESSED MEATS; PUBLIC-HEALTH; HEART-DISEASE; WEIGHT-GAIN	Background Meat consumption has been consistently associated with the risk of diabetes in different populations. The aim of our study was to investigate the incidence of type 2 diabetes according to baseline total meat consumption in a longitudinal assessment of a middle-aged Mediterranean population. Methods We followed 18,527 participants (mean age: 38 years, 61% women) in the SUN Project, an open-enrolment cohort of a highly educated population of middle-class Spanish graduate students. All participants were initially free of diabetes. Diet was assessed at baseline using a semi-quantitative food frequency questionnaire of 136-items previously validated. Incident diabetes was defined according to the American Diabetes Association's criteria. Results We identified 146 incident cases of diabetes after a maximum of 14 years of follow-up period (mean: 8.7 years). In the fully adjusted model, the consumption of >= 3 servings/day of all types of meat was significantly associated with a higher risk of diabetes (HR: 1.85; 95% CI: 1.03-3.31; p for trend = 0.031) in comparison with the reference category (<2 servings/day). When we separated processed from non-processed meat, we observed a non-significant higher risk associated with greater consumption of processed meat and a non-significant lower risk associated with non-processed meat consumption (p for trend = 0.123 and 0.487, respectively). No significant difference was found between the two types of meat (p = 0.594). Conclusions Our results suggest that meat consumption, especially processed meat, was associated with a higher risk of developing diabetes in our young Mediterranean cohort.	[Mari-Sanchis, A.; Gea, A.; Basterra-Gortari, F. J.; Martinez-Gonzalez, M. A.; Bes-Rastrollo, M.] Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain; [Mari-Sanchis, A.] Hosp Navarra, Dept Endocrinol & Nutr, Nutr Unit, Pamplona, Spain; [Gea, A.; Martinez-Gonzalez, M. A.; Bes-Rastrollo, M.] Inst Salud Carlos III, CIBERobn, Madrid, Spain; [Gea, A.; Basterra-Gortari, F. J.; Martinez-Gonzalez, M. A.; Bes-Rastrollo, M.] Navarras Res Hlth Inst, IDISNA, Pamplona, Spain; [Basterra-Gortari, F. J.] Hosp Reina Sofia, Dept Internal Med, Endocrinol Unit, Tudela, Spain; [Beunza, J. J.] Univ Europea Madrid, Laureate Int Univ, Sch Biomed & Hlth Sci, Dept Clin Sci, Madrid, Spain	University of Navarra; Servicio Navarro de Salud - Osasunbidea; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Servicio Navarro de Salud - Osasunbidea; European University of Madrid	Bes-Rastrollo, M (corresponding author), Univ Navarra, Dept Prevent Med & Publ Hlth, Pamplona, Spain.; Bes-Rastrollo, M (corresponding author), Inst Salud Carlos III, CIBERobn, Madrid, Spain.; Bes-Rastrollo, M (corresponding author), Navarras Res Hlth Inst, IDISNA, Pamplona, Spain.	mbes@unav.es	Beunza, Juan-Jose/ABF-4650-2020; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Bes-Rastrollo, Maira/A-1329-2009	Bes-Rastrollo, Maira/0000-0002-9139-4206; Beunza, Juan-Jose/0000-0001-8192-2952; Gea, Alfredo/0000-0002-2229-4690; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Spanish Government-Instituto de Salud Carlos III; European Regional Development Fund (FEDER) [RD 06/0045]; Navarra Regional Government [45/2011, 122/2014]; University of Navarra; European Regional Development Fund (FEDER) (CIBER-OBN) [PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, G03/140]	Spanish Government-Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (FEDER)(European Commission); Navarra Regional Government; University of Navarra; European Regional Development Fund (FEDER) (CIBER-OBN)	The SUN Project has received funding from the Spanish Government-Instituto de Salud Carlos III, and the European Regional Development Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, and G03/140), the Navarra Regional Government (45/2011, 122/2014), and the University of Navarra.	Alemany M, 2012, NUTR RES REV, V25, P18, DOI 10.1017/S0954422411000163; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2013, DIABETOLOGIA, V56, P47, DOI [10.1007/s00125-012-2718-7, DOI 10.1007/S00125-012-2718-7]; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Fernandez-Cao JC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1042; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; de la Fuente-Arrillaga C, 2010, PUBLIC HEALTH NUTR, V13, P1364, DOI 10.1017/S1368980009993065; Dominguez LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106627; Ericson U, 2013, BRIT J NUTR, V109, P1143, DOI 10.1017/S0007114512003017; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Feskens EJM, 2013, CURR DIABETES REP, V13, P298, DOI 10.1007/s11892-013-0365-0; FESKENS EJM, 1990, INT J EPIDEMIOL, V19, P953, DOI 10.1093/ije/19.4.953; FESKENS EJM, 1994, AM J EPIDEMIOL, V140, P350, DOI 10.1093/oxfordjournals.aje.a117257; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Fretts AM, 2015, AM J CLIN NUTR, V102, P1266, DOI 10.3945/ajcn.114.101238; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Hodge AM, 2007, AM J EPIDEMIOL, V165, P603, DOI 10.1093/aje/kwk061; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; International Diabetes Federation, 2013, IDF DIABETES ATLAS; KEYS A, 1995, AM J CLIN NUTR, V61, p1321S, DOI 10.1093/ajcn/61.6.1321S; Kim Y, 2015, METABOLISM, V64, P768, DOI 10.1016/j.metabol.2015.03.008; Kurotani K, 2013, BRIT J NUTR, V110, P1910, DOI 10.1017/S0007114513001128; Lajous M, 2012, DIABETES CARE, V35, P128, DOI 10.2337/dc11-1518; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Mannisto S, 2010, BRIT J NUTR, V103, P1817, DOI 10.1017/S0007114510000073; MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094; Moreiras O., 2007, TABLA COMPOSICION AL, P37; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Peppa M, 2002, DIABETES CARE, V25, P1898, DOI 10.2337/diacare.25.10.1898; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Sanchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P285, DOI 10.1038/sj.ejcn.1601528; Sanchez-Villegas A, 2002, EUR J NUTR, V41, P249, DOI 10.1007/s00394-002-0382-2; Schulze MB, 2003, DIABETOLOGIA, V46, P1465, DOI 10.1007/s00125-003-1220-7; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SNOWDON DA, 1985, AM J PUBLIC HEALTH, V75, P507, DOI 10.2105/AJPH.75.5.507; Song Y, 2004, DIABETES CARE, V27, P2108, DOI 10.2337/diacare.27.9.2108; Steinbrecher A, 2011, PUBLIC HEALTH NUTR, V14, P568, DOI 10.1017/S1368980010002004; Swaminathan S, 2007, DIABETES CARE, V30, P1926, DOI 10.2337/dc06-2625; Takata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056963; Tong M, 2009, J ALZHEIMERS DIS, V17, P827, DOI 10.3233/JAD-2009-1115; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vang A, 2008, ANN NUTR METAB, V52, P96, DOI 10.1159/000121365; Villegas Raquel, 2006, Int J Med Sci, V3, P152; Zhao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041641	63	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157990	10.1371/journal.pone.0157990	http://dx.doi.org/10.1371/journal.pone.0157990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437689	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100005
J	Meneses, ME; Martinez-Carrera, D; Torres, N; Sanchez-Tapia, M; Aguilar-Lopez, M; Morales, P; Sobal, M; Bernabe, T; Escudero, H; Granados-Portillo, O; Tovar, AR				Meneses, Maria E.; Martinez-Carrera, Daniel; Torres, Nimbe; Sanchez-Tapia, Monica; Aguilar-Lopez, Miriam; Morales, Porfirio; Sobal, Mercedes; Bernabe, Teodoro; Escudero, Helios; Granados-Portillo, Omar; Tovar, Armando R.			Hypocholesterolemic Properties and Prebiotic Effects of Mexican Ganoderma lucidum in C57BL/6 Mice	PLOS ONE			English	Article							BETA-GLUCANS; CHOLESTEROL; GUT; SUPPLEMENTATION; MODULATION; MICROBIOTA; MUSHROOMS; STEROLS; OBESITY; FIBER	Edible and medicinal mushrooms contain bioactive compounds with promising effects on several cardiovascular risk biomarkers. However, strains of Ganoderma lucidum of Mexican origin have not yet been studied. Standardized extracts of G. lucidum (Gl) were given to C57BL/6 mice fed a high-cholesterol diet compared with the drug simvastatin. The effects of the extracts on serum biochemical parameters, liver lipid content, cholesterol metabolism, and the composition of gut microbiota were assessed. Acetylsalicylic acid (10 mM) added to the cultivation substrate modulated properties of Gl extracts obtained from mature basidiomata. Compared to the high-cholesterol diet group, the consumption of Gl extracts significantly reduced total serum cholesterol (by 19.2% to 27.1%), LDL-C (by 4.5% to 35.1%), triglyceride concentration (by 16.3% to 46.6%), hepatic cholesterol (by 28.7% to 52%) and hepatic triglycerides (by 43.8% to 56.6%). These effects were associated with a significant reduction in the expression of lipogenic genes (Hmgcr, Srebp1c, Fasn, and Acaca) and genes involved in reverse cholesterol transport (Abcg5 and Abcg8), as well as an increase in Ldlr gene expression in the liver. No significant changes were observed in the gene expression of Srebp2, Abca1 or Cyp7a1. In several cases, Gl-1 or Gl-2 extracts showed better effects on lipid metabolism than the drug simvastatin. A proposed mechanism of action for the reduction in cholesterol levels is mediated by alpha-glucans and beta-glucans from Gl, which promoted decreased absorption of cholesterol in the gut, as well as greater excretion of fecal bile acids and cholesterol. The prebiotic effects of Gl-1 and Gl-2 extracts modulated the composition of gut microbiota and produced an increase in the Lactobacillaceae family and Lactobacillus genus level compared to the control group, high-cholesterol diet group and group supplemented with simvastatin. Mexican genetic resources of Gl represent a new source of bioactive compounds showing hypocholesterolemic properties and prebiotic effects.	[Meneses, Maria E.] CONACYT Colegio Postgrad, Campus Puebla, Puebla, Puebla, Mexico; [Martinez-Carrera, Daniel; Morales, Porfirio; Sobal, Mercedes; Bernabe, Teodoro; Escudero, Helios] CP, Biotecnol Hongos Comestibles Func & Med, Campus Puebla, Puebla, Puebla, Mexico; [Torres, Nimbe; Sanchez-Tapia, Monica; Aguilar-Lopez, Miriam; Granados-Portillo, Omar; Tovar, Armando R.] INCMNSZ, Dept Fisiol Nutr, Ciudad De Mexico, Mexico		Martinez-Carrera, D (corresponding author), CP, Biotecnol Hongos Comestibles Func & Med, Campus Puebla, Puebla, Puebla, Mexico.; Tovar, AR (corresponding author), INCMNSZ, Dept Fisiol Nutr, Ciudad De Mexico, Mexico.	dcarrera@colpos.mx; tovar.ar@gmail.com	Aguilar-Lopez, Miriam/CJH-4026-2022; González, Teodoro Bernabé/AAQ-4183-2020; Torres, Nimbe/AAY-8821-2020; Meneses, María E./HHN-1339-2022; Torres, Nimbe/AAI-4340-2020	Aguilar-Lopez, Miriam/0000-0003-2010-1653; González, Teodoro Bernabé/0000-0003-1428-7332; Torres, Nimbe/0000-0002-1741-0984; Meneses, María E./0000-0002-7689-7024; Sanchez-Tapia, Monica/0000-0001-9748-5734	National Council of Science and Technology (CONACYT) in Mexico, through Research Project "105 Genomica de las Propiedades Funcionales y Medicinales de los Hongos Comestibles de Mexico"; CONACYT [290754]; Dannon Institute of Mexico	National Council of Science and Technology (CONACYT) in Mexico, through Research Project "105 Genomica de las Propiedades Funcionales y Medicinales de los Hongos Comestibles de Mexico"; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Dannon Institute of Mexico	The research work was supported by the National Council of Science and Technology (CONACYT; www.conacyt.mx) in Mexico, through the Research Project "105 Genomica de las Propiedades Funcionales y Medicinales de los Hongos Comestibles de Mexico," directed by DMC; CONACYT also supported the Postdoctoral Position for MEM (agreement no. 290754). A grant from Dannon Institute of Mexico was received by NT. The funders had no role in study design, data collection	Batta AK, 1999, J LIPID RES, V40, P1148; Berger A, 2004, Lipids Health Dis, V3, P2, DOI 10.1186/1476-511X-3-2; Brownawell AM, 2010, NUTR REV, V68, P355, DOI 10.1111/j.1753-4887.2010.00294.x; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Caz V, 2015, J AGR FOOD CHEM, V63, P7371, DOI 10.1021/acs.jafc.5b02942; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freckmann G, 2014, DIABETES TECHNOL THE, V16, P113, DOI 10.1089/dia.2013.0208; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guillamon E, 2010, FITOTERAPIA, V81, P715, DOI 10.1016/j.fitote.2010.06.005; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jones ML, 2012, BRIT J NUTR, V107, P1505, DOI 10.1017/S0007114511004703; Keller S, 2004, J CHROMATOGR B, V813, P199, DOI 10.1016/j.jchromb.2004.09.046; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Nicolosi R, 1999, AM J CLIN NUTR, V70, P208; Pagidipati NJ, 2013, CIRCULATION, V127, P749, DOI 10.1161/CIRCULATIONAHA.112.128413; Pan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068332; Ramuirez JuuYrez J., 2016, CIENCIA TECNOLOGIA I; Reeves PG, 1997, J NUTR, V127, pS838; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rop O, 2009, NUTR REV, V67, P624, DOI 10.1111/j.1753-4887.2009.00230.x; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; Theuwissen E, 2008, PHYSIOL BEHAV, V94, P285, DOI 10.1016/j.physbeh.2008.01.001; Torres N, 2015, ARCH MED RES, V46, P408, DOI 10.1016/j.arcmed.2015.05.010; Vetvicka V, 2009, J IMMUNOTOXICOL, V6, P30, DOI 10.1080/15476910802604317; Wachtel-Galor S, 2004, INT J FOOD SCI NUTR, V55, P75, DOI 10.1080/09637480310001642510; Wang CD, 2012, BRIT J NUTR, V108, P2014, DOI 10.1017/S0007114512000153; Wang LX, 2013, WORLD J GASTROENTERO, V19, P3150, DOI 10.3748/wjg.v19.i20.3150; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65	37	36	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159631	10.1371/journal.pone.0159631	http://dx.doi.org/10.1371/journal.pone.0159631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438015	gold, Green Submitted, Green Published			2022-12-26	WOS:000380170100058
J	Hill, LJB; Coats, RO; Mushtaq, F; Williams, JHG; Aucott, LS; Mon-Williams, M				Hill, Liam J. B.; Coats, Rachel O.; Mushtaq, Faisal; Williams, Justin H. G.; Aucott, Lorna S.; Mon-Williams, Mark			Moving to Capture Children's Attention: Developing a Methodology for Measuring Visuomotor Attention	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME VARIABILITY; FEATURE-INTEGRATION-THEORY; PARENT RATING-SCALE; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; POSTURAL STABILITY; EXECUTIVE FUNCTION; ACADEMIC-ACHIEVEMENT; SUSTAINED ATTENTION	Attention underpins many activities integral to a child's development. However, methodological limitations currently make large-scale assessment of children's attentional skill impractical, costly and lacking in ecological validity. Consequently we developed a measure of 'Visual Motor Attention' (VMA)-a construct defined as the ability to sustain and adapt visuomotor behaviour in response to task-relevant visual information. In a series of experiments, we evaluated the capability of our method to measure attentional processes and their contributions in guiding visuomotor behaviour. Experiment 1 established the method's core features (ability to track stimuli moving on a tablet-computer screen with a hand-held stylus) and demonstrated its sensitivity to principled manipulations in adults' attentional load. Experiment 2 standardised a format suitable for use with children and showed construct validity by capturing developmental changes in executive attention processes. Experiment 3 tested the hypothesis that children with and without coordination difficulties would show qualitatively different response patterns, finding an interaction between the cognitive and motor factors underpinning responses. Experiment 4 identified associations between VMA performance and existing standardised attention assessments and thereby confirmed convergent validity. These results establish a novel approach to measuring childhood attention that can produce meaningful functional assessments that capture how attention operates in an ecologically valid context (i.e. attention's specific contribution to visuomanual action).	[Hill, Liam J. B.; Coats, Rachel O.; Mushtaq, Faisal; Mon-Williams, Mark] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Williams, Justin H. G.; Aucott, Lorna S.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Leeds; University of Aberdeen	Hill, LJB (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.	paclab@leeds.ac.uk	Mushtaq, Faisal/H-4800-2019; Williams, Justin/AAE-5903-2020; Coats, Rachel/AAH-6980-2019	Mushtaq, Faisal/0000-0001-7881-1127; Coats, Rachel/0000-0003-4415-408X; Aucott, Lorna/0000-0001-6277-7972; Mon-Williams, Mark/0000-0001-7595-8545; Hill, Liam/0000-0002-4069-5121	Medical Research Council (MRC) scholarship; MRC Centenary Early Career Award; Waterloo Foundation (TWF) [1285/1986]	Medical Research Council (MRC) scholarship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Waterloo Foundation (TWF)	Authors LH and MMW are part of the Healthy Children, Healthy Families Theme of the National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Yorkshire and Humber (www.clahrc-yh.nihr.ac.uk/). Please note, the views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR and the Department of Health. At different points in time this programme of research has been supported by a Medical Research Council (MRC; www.mrc.ac.uk) scholarship, an MRC Centenary Early Career Award and a grant from The Waterloo Foundation (TWF reference: 1285/1986; www. waterloofoundation.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo N, 2014, J ATTEN DISORD, V18, P434, DOI 10.1177/1087054712439419; Altman D.G., 1991, PRACTICAL STATISTIC; AMMONS RB, 1955, J EXP PSYCHOL, V49, P127, DOI 10.1037/h0044345; Antonini TN, 2013, NEUROPSYCHOLOGY, V27, P201, DOI 10.1037/a0032071; Aylward GP, 1997, ASSESSMENT, V4, P325, DOI 10.1177/107319119700400403; Bard DE, 2013, J DEV BEHAV PEDIATR, V34, P72, DOI 10.1097/DBP.0b013e31827a3a22; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bernardi M, 2016, CHILD NEUROPSYCHOL, V22, P627, DOI 10.1080/09297049.2015.1014898; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Boiteau TW, 2014, J EXP PSYCHOL GEN, V143, P295, DOI 10.1037/a0031858; Boonyong S, 2012, GAIT POSTURE, V35, P428, DOI 10.1016/j.gaitpost.2011.11.002; Breckenridge K, 2013, BRIT J DEV PSYCHOL, V31, P271, DOI 10.1111/bjdp.12004; Brockmole JR, 2013, CURR DIR PSYCHOL SCI, V22, P38, DOI 10.1177/0963721412465065; Brogan E, 2014, ARCH DIS CHILD, V99, P834, DOI 10.1136/archdischild-2013-305532; Brossard-Racine M, 2011, RES DEV DISABIL, V32, P2927, DOI 10.1016/j.ridd.2011.05.010; Brown JD, 2006, AMBUL PEDIATR, V6, P347, DOI 10.1016/j.ambp.2006.09.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cairney J, 2010, CURR OPIN PSYCHIATR, V23, P324, DOI 10.1097/YCO.0b013e32833aa0aa; Carter L, 2013, BRAIN COGNITION, V82, P35, DOI 10.1016/j.bandc.2013.02.002; Clark A, 1999, TRENDS COGN SCI, V3, P345, DOI 10.1016/S1364-6613(99)01361-3; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Danna J, 2012, J EXP CHILD PSYCHOL, V111, P37, DOI 10.1016/j.jecp.2011.07.005; Davies SC, 2013, LANCET, V382, P1383, DOI 10.1016/S0140-6736(13)62004-8; Desjardins JL, 2013, EAR HEARING, V34, P261, DOI 10.1097/AUD.0b013e31826d0ba4; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Dickerson MS, 2001, CHILD NEUROPSYCHOL, V7, P32, DOI DOI 10.1076/CHIN.7.1.32.3151; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Finley JR, 2014, J EXP PSYCHOL-APPL, V20, P158, DOI 10.1037/xap0000010; Flatters I, 2014, EXP BRAIN RES, V232, P2907, DOI 10.1007/s00221-014-3947-4; Flatters I, 2014, EXP BRAIN RES, V232, P1953, DOI 10.1007/s00221-014-3886-0; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Forbes GB, 1998, J CLIN PSYCHOL, V54, P461, DOI 10.1002/(SICI)1097-4679(199806)54:4<461::AID-JCLP8>3.3.CO;2-S; Forns J, 2014, NEUROPSYCHOLOGY, V28, P519, DOI 10.1037/neu0000085; Freund AM, 1998, PSYCHOL AGING, V13, P531, DOI 10.1037/0882-7974.13.4.531; Fuentes CT, 2009, NEUROLOGY, V73, P1532, DOI 10.1212/WNL.0b013e3181c0d48c; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gilden DL, 2007, PSYCHOL SCI, V18, P796, DOI 10.1111/j.1467-9280.2007.01982.x; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; GORDON M, 1988, Journal of Clinical Psychology, V44, P682, DOI 10.1002/1097-4679(198809)44:5<682::AID-JCLP2270440504>3.0.CO;2-E; GORDON M, 1996, GORDON DIAGNOSTIC SY; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Helps SK, 2011, NEUROPSYCHOLOGY, V25, P711, DOI 10.1037/a0024479; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Herwig A, 2015, NEUROSCI BIOBEHAV R, V52, P105, DOI 10.1016/j.neubiorev.2015.02.013; Hill LJB, 2016, EUR CHILD ADOLES PSY, V25, P283, DOI 10.1007/s00787-015-0732-2; HOLLERBACH JM, 1981, BIOL CYBERN, V39, P139, DOI 10.1007/BF00336740; Irwin-Chase H, 2000, J EXP CHILD PSYCHOL, V77, P61, DOI 10.1006/jecp.1999.2557; Jacobi-Polishook T, 2009, J NEUROL SCI, V280, P15, DOI 10.1016/j.jns.2009.01.007; Jaekel J, 2013, PSYCHOL MED, V43, P183, DOI 10.1017/S0033291712001031; Jans B, 2010, PSYCHOL REV, V117, P637, DOI 10.1037/a0019082; Johnson S, 2014, DEV MED CHILD NEUROL, V56, P453, DOI 10.1111/dmcn.12360; Kahneman D, 1973, ATTENTION EFFORT; Kane MJ, 2006, J EXP PSYCHOL LEARN, V32, P749, DOI 10.1037/0278-7393.32.4.749; Kelly TP, 2000, CHILD NEUROPSYCHOL, V6, P24, DOI 10.1076/0929-7049(200003)6:1;1-B;FT024; Kemper S, 2010, PSYCHOL AGING, V25, P949, DOI 10.1037/a0020000; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Korkman M, 2001, DEV NEUROPSYCHOL, V20, P331, DOI 10.1207/S15326942DN2001_2; Krampe RT, 2011, GAIT POSTURE, V33, P401, DOI 10.1016/j.gaitpost.2010.12.012; Leitner Y, 2007, J NEUROL, V254, P1330, DOI 10.1007/s00415-006-0522-3; Leslie LK, 2004, PEDIATRICS, V114, P129, DOI 10.1542/peds.114.1.129; Marmot M, 2010, FAIR SOC HLTH LIVES; Martin NC, 2010, HUM MOVEMENT SCI, V29, P799, DOI 10.1016/j.humov.2009.09.005; Mayes SD, 2007, CHILD NEUROPSYCHOL, V13, P469, DOI 10.1080/09297040601112773; Mayes SD, 2009, J ATTEN DISORD, V12, P540, DOI 10.1177/1087054708320402; McClelland MM, 2013, EARLY CHILD RES Q, V28, P314, DOI 10.1016/j.ecresq.2012.07.008; McDermott PA, 2014, PSYCHOL ASSESSMENT, V26, P207, DOI 10.1037/a0034832; Medwell J, 2014, LANG EDUC-UK, V28, P34, DOI 10.1080/09500782.2013.763819; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Ogundele MO, 2011, PROG NEUROL PSYCHIAT, V15, P8, DOI 10.1002/pnp.198; Papaioannou S, 2016, EDUC PSYCHOL-UK, V36, P138, DOI 10.1080/01443410.2014.915931; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Pieters S, 2012, CHILD CARE HLTH DEV, V38, P139, DOI 10.1111/j.1365-2214.2011.01225.x; Piper BJ, 2011, J NEUROSCI METH, V195, P88, DOI 10.1016/j.jneumeth.2010.11.018; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Quinlan PT, 2003, PSYCHOL BULL, V129, P643, DOI 10.1037/0033-2909.129.5.643; Racine MB, 2008, J CHILD NEUROL, V23, P399, DOI 10.1177/0883073807309244; Rapp MA, 2006, AM J GERIAT PSYCHIAT, V14, P52, DOI 10.1097/01.JGP.0000192490.43179.e7; Reilly DS, 2008, J MOTOR BEHAV, V40, P90, DOI 10.3200/JMBR.40.2.90-102; Ren XZ, 2013, ACTA PSYCHOL, V142, P195, DOI 10.1016/j.actpsy.2012.12.007; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Russell G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080247; Schaefer S, 2008, DEV PSYCHOL, V44, P747, DOI 10.1037/0012-1649.44.3.747; Shalev L, 2011, NEUROPSYCHOLOGIA, V49, P2584, DOI 10.1016/j.neuropsychologia.2011.05.006; Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99; Sjowall D, 2014, DEV NEUROPSYCHOL, V39, P187, DOI 10.1080/87565641.2014.886691; Skogsberg K, 2015, J EXP PSYCHOL HUMAN, V41, P761, DOI 10.1037/a0039000; Stirling LA, 2013, J GERONTOL A-BIOL, V68, P938, DOI 10.1093/gerona/glt003; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; Tarantino V, 2013, J INT NEUROPSYCH SOC, V19, P820, DOI 10.1017/S1355617713000623; Teicher MH, 2004, J CHILD ADOL PSYCHOP, V14, P219, DOI 10.1089/1044546041648995; Thelen E., 1994, DYNAMIC SYSTEMS APPR; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tseng MH, 2004, DEV MED CHILD NEUROL, V46, P381, DOI 10.1017/S0012162204000623; Ullebo AK, 2011, EUR CHILD ADOLES PSY, V20, P451, DOI 10.1007/s00787-011-0198-9; Westendorp M, 2011, RES DEV DISABIL, V32, P2773, DOI 10.1016/j.ridd.2011.05.032; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Wu SY, 2013, RES DEV DISABIL, V34, P505, DOI 10.1016/j.ridd.2012.09.004; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	106	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159543	10.1371/journal.pone.0159543	http://dx.doi.org/10.1371/journal.pone.0159543			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434198	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600066
J	Soriano, LC; Soriano-Gabarro, M; Rodriguez, LAG				Cea Soriano, Lucia; Soriano-Gabarro, Montse; Garcia Rodriguez, Luis A.			The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice	PLOS ONE			English	Article							HEALTH IMPROVEMENT NETWORK; TRIALS; PREVENTION; VALIDATION; DATABASE; RISK	Background We conducted three differently designed nested case-control studies to evaluate whether the protective effect of low-dose aspirin against colorectal cancer (CRC) is explained by selection bias. Methods Using a large validated UK primary care database, we followed different cohorts of patients, who varied in their demographic and clinical characteristics, to identify first ever cases of CRC. In Studies 1 and 2, two cohorts were followed, i) new users of low-dose aspirin at start of follow-up (N = 170,336 in Study 1, N = 171,527 in Study 2) and either ii) non-users of low-dose aspirin (Study 1, N = 170,336) or new users of paracetamol (Study 2, N = 149,597) at start of follow-up. In Study 3 a single cohort of individuals naive to low-dose aspirin at the start of observation was followed. Controls were selected using incidence sampling and logistic regression used to obtain an unbiased estimate of the incidence rate ratio (RR) with 95% confidence intervals (CIs). Low-dose aspirin exposure was analyzed 'as-treated' before the index date (CRC date for cases, random date for controls). Results In the three studies, median (maximum) follow-up was 5.1 (12), 5.8 (12) and 7.5 (13) years, respectively. 3033 incident CRC cases were identified in Study 1, 3174 in Study 2, and 12,333 in Study 3. Current use of low-dose aspirin was associated with a significantly reduced risk of 34%, 29% and 31% in the three studies, respectively; corresponding RRs (95% CIs) were 0.66 (0.60-0.73), 0.71 (0.63-0.80) and 0.69 (0.64-0.74). In each study, significantly reduced risks of CRC were seen when low-dose aspirin was used for primary or secondary cardiovascular disease prevention, in both sexes, and across all age groups evaluated. Conclusion Low-dose aspirin is associated with a significantly reduced risk of CRC. The consistency of our findings across different studies makes selection bias an unlikely explanation.	[Cea Soriano, Lucia; Garcia Rodriguez, Luis A.] Spanish Ctr Pharmacoepidemiol Res, Madrid, Spain; [Soriano-Gabarro, Montse] Bayer Pharma AG, Epidemiol, Berlin, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals	Rodriguez, LAG (corresponding author), Spanish Ctr Pharmacoepidemiol Res, Madrid, Spain.	lagarcia@ceife.es	Soriano, Lucia Cea/D-4380-2018; rodriguez, luis a garcia/B-1980-2010	Soriano, Lucia Cea/0000-0002-7051-0730; 	Bayer Pharma AG	Bayer Pharma AG	This study was funded by Bayer Pharma AG. The funder provided support in the form of salaries for MS-G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Susan Bromley of EpiMed Communications Ltd for medical writing assistance funded by Bayer Pharma AG.	Blak Betina T, 2011, Inform Prim Care, V19, P251; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Soriano LC, 2016, PHARMACOEPIDEM DR S, V25, P385, DOI 10.1002/pds.3877; Soriano LC, 2016, PHARMACOEPIDEM DR S, V25, P392, DOI 10.1002/pds.3926; Soriano LC, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00126; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia Rodriguez LA, 2015, DIG DIS WEEK WASH DC; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Health IMS, THIN DAT STAT; Information Services Division Scotland, CANC STAT COL CANC; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Office for National Statistics, 2009, COLORECTAL CANC; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	19	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159179	10.1371/journal.pone.0159179	http://dx.doi.org/10.1371/journal.pone.0159179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428004	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300039
J	Ritchey, M; Tsipas, S; Loustalot, F; Wozniak, G				Ritchey, Matthew; Tsipas, Stavros; Loustalot, Fleetwood; Wozniak, Gregory			Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; IMPROVING ADHERENCE; UNITED-STATES; HEALTH; TRENDS; THERAPIES; OUTCOMES; AGENTS; ADULTS	Background Effective hypertension management often necessitates patients' adherence to the blood pressure (BP)-lowering medication regimen they are prescribed. Patients' adherence to that regimen can be affected by prescription- and payment-related factors that are typically controlled by prescribers, filling pharmacies, pharmacy benefit managers, and/or patients' health insurance plans. This study describes patterns and changes from 2009 to 2014 in factors that the literature reports are associated with increased adherence to BP-lowering medication. Methods and Findings We use a robust source of United States prescription sales data-IMS Health's National Prescription Audit-to describe BP-lowering medication fill counts and spending in 2009 compared with 2014. Moreover, we describe patterns and changes in adherence-promoting factors across age groups, payment sources, and medication classes. From 2009 to 2014, the BP-lowering medication prescription fill count increased from 613.7 million to 653.0 million. Encouraging changes in adherence-promoting factors included: the share of generic fills increased from 82.5% to 95.0%; average days' supply per fill increased from 45.9 to 51.8 days; and average total (patient contribution) spending per years' supply decreased from $359 ($54) to $311 ($37). Possibly undesirable changes included: the percentage of fills for fixed-dose combinations decreased from 17.1% to 14.2% and acquired via mail order decreased from 10.7% to 8.2%. In 2014: 653.0 million fills occurred accounting for $28.81B in spending; adults aged 45-64 years had the highest percentage of fixed-dose combinations fills (16.9%); and fills with Medicaid as the payment source had the lowest average patient spending per fill ($1.19). Conclusions We identified both encouraging and possibly undesirable patterns and changes from 2009 to 2014 in factors that promote adherence to BP-lowering medications during this period. Continued tracking of these metrics using pharmacy sales data can help identify areas that can be addressed by clinical and policy interventions to improve adherence for medications commonly used to treat hypertension.	[Ritchey, Matthew; Loustalot, Fleetwood] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Tsipas, Stavros; Wozniak, Gregory] Amer Med Assoc, Hlth Outcomes Grp, 515 N State St, Chicago, IL 60610 USA	Centers for Disease Control & Prevention - USA; American Medical Association	Ritchey, M (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	hha7@cdc.gov			Centers for Disease Control and Prevention; American Medical Association	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Medical Association	This study was entirely supported by the Centers for Disease Control and Prevention and American Medical Association.	American Medical Association, IMPR HLTH OUTC; Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Bitton A, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.09.004; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chernew M, 2008, J GEN INTERN MED, V23, P1131, DOI 10.1007/s11606-008-0614-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Domino FJ, 2005, AM FAM PHYSICIAN, V71, P2089; Dragomir A, 2010, MED CARE, V48, P418, DOI 10.1097/MLR.0b013e3181d567bd; Duru OK, 2010, AM J MANAG CARE, V16, P33; El Azizi GB, 2012, PHARMACOEPIDEM DR S, V21, P1067, DOI 10.1002/pds.3288; Frieden TR, 2014, JAMA-J AM MED ASSOC, V311, P21, DOI 10.1001/jama.2013.282615; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Gellad WF, 2009, REV BARRIERS MED ADH; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Gu Qiuping, 2010, NCHS Data Brief, P1; Guide to Community Preventive Services, 2019, CARD DIS PREV CONTR; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Hill SC, 2014, HEALTH AFFAIR, V33, P691, DOI 10.1377/hlthaff.2013.0743; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; IMS Institute for Healthcare Informatics, HSRN DAT BRIEF NAT P; Iskedjian M, 2002, CLIN THER, V24, P302, DOI 10.1016/S0149-2918(02)85026-3; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Kettani FZ, 2009, STROKE, V40, P213, DOI 10.1161/STROKEAHA.108.522193; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; National Conference of State Legislatures, 2009, 4 FREE DRUG PROM LAR; Neal B, 2000, LANCET, V356, P1955; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Paulozzi LJ, 2014, J SAFETY RES, V51, P125, DOI 10.1016/j.jsr.2014.09.001; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; PWC, 2013, MED COST TREND NUMBE; SabatU E., 2003, ADHERENCE LONG TERM; Schmittdiel JA, 2011, J GEN INTERN MED, V26, P1396, DOI 10.1007/s11606-011-1805-7; Schroeder K, 2004, Cochrane Database Syst Rev, pCD004804; Sherrill B, 2011, J CLIN HYPERTENS, V13, P898, DOI 10.1111/j.1751-7176.2011.00550.x; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Walker RL, 2011, CAN J CARDIOL, V27, P461, DOI 10.1016/j.cjca.2010.12.071; Wozniak G, 2016, J CLIN HYPERTENS, V18, P232, DOI 10.1111/jch.12654; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	46	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159366	10.1371/journal.pone.0159366	http://dx.doi.org/10.1371/journal.pone.0159366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428008	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169300057
J	Roncalli, V; Jungbluth, MJ; Lenz, PH				Roncalli, Vittoria; Jungbluth, Michelle J.; Lenz, Petra H.			Glutathione S-Transferase Regulation in Calanus finmarchicus Feeding on the Toxic Dinoflagellate Alexandrium fundyense	PLOS ONE			English	Article							DIATOM SKELETONEMA-MARINOI; GENE-EXPRESSION LEVELS; REAL-TIME PCR; INSECTICIDE RESISTANCE; GST GENES; HELGOLANDICUS; REPRODUCTION; PUBLICATION; RESPONSES; COPEPODS	The effect of the dinoflagellate, Alexandrium fundyense, on relative expression of glutathione S-transferase (GST) transcripts was examined in the copepod Calanus finmarchicus. Adult females were fed for 5-days on one of three experimental diets: control (100% Rhodomonas spp.), low dose of A. fundyense (25% by volume, 75% Rhodomonas spp.), and high dose (100% A. fundyense). Relative expression of three GST genes was measured using RT-qPCR on days 0.5, 1, 2 and 5 in two independent experiments. Differential regulation was found for the Delta and the Sigma GSTs between 0.5 to 2 days, but not on day 5 in both experiments. The third GST, a microsomal, was not differentially expressed in either treatment or day. RT-qPCR results from the two experiments were similar, even though experimental females were collected from the Gulf of Maine on different dates and their reproductive output differed. In the second experiment, expression of 39 GSTs was determined on days 2 and 5 using RNA-Seq. Global gene expression analyses agreed with the RT-qPCR results. Furthermore, the RNA-Seq measurements indicated that only four GSTs were differentially expressed under the experimental conditions, and the response was small in amplitude. In summary, the A. fundyense diet led to a rapid and transient response in C. finmarchicus in three cytosolic GSTs, while a fourth GST (Omega I) was significantly up-regulated on day 5. Although there was some regulation of GSTs in response the toxic dinoflagellate, the tolerance to A. fundyense by C. finmarchicus is not dependent on the long-term up-regulation of specific GSTs.	[Roncalli, Vittoria; Lenz, Petra H.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, 1993 East West Rd, Honolulu, HI 96822 USA; [Jungbluth, Michelle J.] Univ Hawaii Manoa, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Roncalli, V (corresponding author), Univ Hawaii Manoa, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, 1993 East West Rd, Honolulu, HI 96822 USA.	roncalli@hawaii.edu	Lenz, Petra H/ABE-4940-2021	Roncalli, Vittoria/0000-0003-3024-7568; Jungbluth, Michelle/0000-0001-9339-7497	National Science Foundation [OCE-1040597, OCE-1235549]; Cades Foundation of Honolulu; Mount Desert Island Biological Laboratory's David W. Towle Fellowship	National Science Foundation(National Science Foundation (NSF)); Cades Foundation of Honolulu; Mount Desert Island Biological Laboratory's David W. Towle Fellowship	This work was supported by the National Science Foundation [grant numbers OCE-1040597, OCE-1235549] to PHL, the Cades Foundation of Honolulu to Daniel K. Hartline and Mount Desert Island Biological Laboratory's David W. Towle Fellowship 2012 to VR. The views expressed herein are those of the authors and do not reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson DM, 2014, DEEP-SEA RES PT II, V103, P264, DOI 10.1016/j.dsr2.2013.09.018; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; Asselman J, 2012, ENVIRON SCI TECHNOL, V46, P8448, DOI 10.1021/es301100j; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carotenuto Y, 2014, HARMFUL ALGAE, V31, P153, DOI 10.1016/j.hal.2013.11.002; Che-Mendoza A, 2009, AFR J BIOTECHNOL, V8, P1386; da Fonseca RR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-281; Darbyson E, 2003, J FISH BIOL, V63, P1235, DOI 10.1046/j.1095-8649.2003.00247.x; Davis C.S., 1987, P256; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gallardo-Escarate C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092239; Han J, 2015, AQUAT TOXICOL, V165, P136, DOI 10.1016/j.aquatox.2015.05.022; Hansen BH, 2011, SCI TOTAL ENVIRON, V409, P704, DOI 10.1016/j.scitotenv.2010.10.035; Hansen BH, 2010, AQUAT TOXICOL, V99, P212, DOI 10.1016/j.aquatox.2010.04.018; Hansen BH, 2009, J TOXICOL ENV HEAL A, V72, P131, DOI 10.1080/15287390802537313; Harris RP, 2000, ICES J MAR SCI, V57, P1708, DOI 10.1006/jmsc.2000.0959; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauritano C, 2016, HARMFUL ALGAE, V55, P221, DOI 10.1016/j.hal.2016.03.015; Lauritano C, 2015, MAR GENOM, V24, P89, DOI 10.1016/j.margen.2015.01.007; Lauritano C, 2013, HARMFUL ALGAE, V28, P23, DOI 10.1016/j.hal.2013.05.004; Lauritano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047262; Lauritano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026850; Lauritano C, 2011, J EXP MAR BIOL ECOL, V404, P79, DOI 10.1016/j.jembe.2011.05.009; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Lenz PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088589; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Melle W, 2014, PROG OCEANOGR, V129, P244, DOI 10.1016/j.pocean.2014.04.026; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roncalli V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25708; Roncalli V, 2016, HARMFUL ALGAE, V51, P56, DOI 10.1016/j.hal.2015.11.003; Roncalli V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123322; Schoville SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-170; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sherman K., 1987, P268; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Starr M, 1999, SARSIA, V84, P379, DOI 10.1080/00364827.1999.10807345; Turner JT, 2014, HARMFUL ALGAE, V32, P81, DOI 10.1016/j.hal.2013.12.001; Willoughby L, 2006, INSECT BIOCHEM MOLEC, V36, P934, DOI 10.1016/j.ibmb.2006.09.004	47	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159563	10.1371/journal.pone.0159563	http://dx.doi.org/10.1371/journal.pone.0159563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427938	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300076
J	Schneider, AD				Schneider, Adam D.			Model Vestibular Nuclei Neurons Can Exhibit a Boosting Nonlinearity Due to an Adaptation Current Regulated by Spike-Triggered Calcium and Calcium-Activated Potassium Channels	PLOS ONE			English	Article							DYNAMICS	In vitro studies have previously found a class of vestibular nuclei neurons to exhibit a bidirectional afterhyperpolarization (AHP) in their membrane potential, due to calcium and calcium-activated potassium conductances. More recently in vivo studies of such vestibular neurons were found to exhibit a boosting nonlinearity in their input-output tuning curves. In this paper, a Hodgkin-Huxley (HH) type neuron model, originally developed to reproduce the in vitro AHP, is shown to produce a boosting nonlinearity similar to that seen in vivo for increased the calcium conductance. Indicative of a bifurcation, the HH model is reduced to a generalized integrate-and-fire (IF) model that preserves the bifurcation structure and boosting nonlinearity. By then projecting the neuron model's phase space trajectories into 2D, the underlying geometric mechanism relating the AHP and boosting nonlinearity is revealed. Further simplifications and approximations are made to derive analytic expressions for the steady steady state firing rate as a function of bias current, mu, as well as the gain (i.e. its slope) and the position of its peak at mu = mu*. Finally, although the boosting nonlinearity has not yet been experimentally observed in vitro, testable predictions indicate how it might be found.	[Schneider, Adam D.] McGill Univ, Phys, Montreal, PQ, Canada	McGill University	Schneider, AD (corresponding author), McGill Univ, Phys, Montreal, PQ, Canada.	adam.schneider@mail.mcgill.ca						Av-Ron E, 1999, BIOL CYBERN, V80, P383, DOI 10.1007/s004220050533; Badel L, 2008, J NEUROPHYSIOL, V99, P656, DOI 10.1152/jn.01107.2007; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; Fourcaud-Trocme N, 2003, J NEUROSCIENCE; Hertag L, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00116; Hertag L, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00062; Izhikevich E. M., 2010, DYNAMICAL SYSTEMS NE; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Massot C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001365; Naud R, 2008, BIOL CYBERN, V99, P335, DOI 10.1007/s00422-008-0264-7; Richardson MJE, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021928; Rieke F., 1997, SPIKES EXPLORING NEU; Sadeghi S, 2007, J NEUROPHYSIOLOGY; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Schneider AD, 2015, J NEUROSCI, V35, P5522, DOI 10.1523/JNEUROSCI.3841-14.2015; Schneider AD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002120; Shlizerman E, 2012, NEURAL COMPUT, V24, P2078, DOI 10.1162/NECO_a_00308; Touboul J, 2008, BIOL CYBERN, V99, P319, DOI 10.1007/s00422-008-0267-4	19	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159300	10.1371/journal.pone.0159300	http://dx.doi.org/10.1371/journal.pone.0159300			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427914	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300045
J	Breuer, A; Haj, CG; Fogaca, MV; Gomes, FV; Silva, NR; Pedrazzi, JF; Del Bel, EA; Hallak, JC; Crippa, JA; Zuardi, AW; Mechoulam, R; Guimaraes, FS				Breuer, Aviva; Haj, Christeene G.; Fogaca, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Pedrazzi, Joao Francisco; Del Bel, Elaine A.; Hallak, Jaime C.; Crippa, Jose A.; Zuardi, Antonio W.; Mechoulam, Raphael; Guimaraes, Francisco S.			Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects	PLOS ONE			English	Article							MARBLE-BURYING BEHAVIOR; ELEVATED PLUS-MAZE; PREPULSE INHIBITION; ANIMAL-MODELS; ENDOCANNABINOID SYSTEM; ANXIETY DISORDERS; 5-HT1A RECEPTORS; HASHISH; INVOLVEMENT; DISRUPTION	Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in a numerous pharmacological assays, including mice tests for anxiety, obsessive-compulsive disorder, depression and schizophrenia. In human trials the doses of CBD needed to achieve effects in anxiety and schizophrenia are high. We report now the synthesis of 3 fluorinated CBD derivatives, one of which, 4'-F-CBD (HUF-101) (1), is considerably more potent than CBD in behavioral assays in mice predictive of anxiolytic, antidepressant, antipsychotic and anti-compulsive activity. Similar to CBD, the anti-compulsive effects of HUF-101 depend on cannabinoid receptors.	[Breuer, Aviva; Haj, Christeene G.; Mechoulam, Raphael] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Jerusalem, Israel; [Fogaca, Manoela V.; Gomes, Felipe V.; Silva, Nicole Rodrigues; Guimaraes, Francisco S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Pedrazzi, Joao Francisco; Hallak, Jaime C.; Crippa, Jose A.; Zuardi, Antonio W.] Univ Sao Paulo, Med Sch Ribeirao Preto, Neurosci & Behav, Sao Paulo, Brazil; [Del Bel, Elaine A.] Univ Sao Paulo, Sch Odontol Ribeirao Preto, Dept Morphol Physiol & Pathol, Sao Paulo, Brazil	Hebrew University of Jerusalem; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Mechoulam, R (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Jerusalem, Israel.; Guimaraes, FS (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil.	mechou@cc.huji.ac.il; fsguimar@uol.com.br	de Souza Crippa, José Alexandre/A-1215-2008; Del Bel, Elaine A/E-2308-2012; Guimaraes, Francisco Silveira/C-1059-2012; Del Bel, Elaine/ABH-1331-2020; Gomes, Felipe/Q-3153-2019; Zuardi, Antonio W/B-6078-2016; Silva, Nicole NRS/E-8267-2018; Pedrazzi, João Francisco/A-4559-2019	Del Bel, Elaine A/0000-0002-4158-7376; Guimaraes, Francisco Silveira/0000-0003-4092-7778; Del Bel, Elaine/0000-0003-3483-8074; Gomes, Felipe/0000-0003-1033-1850; Rodrigues, Nicole/0000-0002-1149-0776	Kessler Foundation, Boston; CNPq; Capes; Fapesp	Kessler Foundation, Boston; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The research in Israel was supported by the Kessler Foundation, Boston.; The research in Brazil was supported by grants from CNPq, Capes, Fapesp. The research in Israel was supported by the Kessler Foundation, Boston.	Adams R, 1940, J AM CHEM SOC, V62, P196, DOI 10.1021/ja01858a058; Begue J.-P., 2008, BIOORGANIC AND MEDIC; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Bisogno T, 2009, BBA-MOL CELL BIOL L, V1791, P53, DOI 10.1016/j.bbalip.2008.10.007; Blessing EM, 2015, NEUROTHERAPEUTICS, V12, P825, DOI 10.1007/s13311-015-0387-1; Boukerb A, 1998, J FLUORINE CHEM, V88, P23, DOI 10.1016/S0022-1139(98)00115-8; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Campos AC, 2013, INT J NEUROPSYCHOPH, V16, P1407, DOI 10.1017/S1461145712001502; Campos AC, 2012, PHILOS T R SOC B, V367, P3364, DOI 10.1098/rstb.2011.0389; Casarotto PC, 2010, BEHAV PHARMACOL, V21, P353, DOI 10.1097/FBP.0b013e32833b33c5; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Detyniecki K, 2016, LANCET NEUROL, V15, P235, DOI 10.1016/S1474-4422(16)00002-8; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Fernandez-Ruiz J, 2013, BRIT J CLIN PHARMACO, V75, P323, DOI 10.1111/j.1365-2125.2012.04341.x; FILE SE, 1992, BIOL COUN S, P25; GAONI Y, 1971, J AM CHEM SOC, V93, P217, DOI 10.1021/ja00730a036; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Gomes FV, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu041; Gomes FV, 2011, PROG NEURO-PSYCHOPH, V35, P434, DOI 10.1016/j.pnpbp.2010.11.027; GUIMARAES FS, 1990, PSYCHOPHARMACOLOGY, V100, P558, DOI 10.1007/BF02244012; GUIMARAES FS, 1994, GEN PHARMACOL, V25, P161, DOI 10.1016/0306-3623(94)90027-2; HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983; Jacob A, 1940, J CHEM SOC, P649, DOI 10.1039/jr9400000649; JORAPUR VS, 1984, SYNTHETIC COMMUN, V14, P655, DOI 10.1080/00397918408063751; Kozela E, 2016, CHEM BIOL DRUG DES, V87, P143, DOI 10.1111/cbdd.12637; Leweke FM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.15; Linge R, 2016, NEUROPHARMACOLOGY, V103, P16, DOI 10.1016/j.neuropharm.2015.12.017; Long LE, 2006, NEUROPSYCHOPHARMACOL, V31, P795, DOI 10.1038/sj.npp.1300838; Mechoulam R, 2002, J CLIN PHARMACOL, V42, p11S, DOI 10.1002/j.1552-4604.2002.tb05998.x; MECHOULAM R, 1967, TETRAHEDRON LETT, P1109; MECHOULAM R, 1963, TETRAHEDRON, V19, P2073, DOI 10.1016/0040-4020(63)85022-X; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; Meuth SG, 2015, EXPERT REV NEUROTHER, V15, P909, DOI 10.1586/14737175.2015.1067607; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Pedrazzi JFC, 2015, PSYCHOPHARMACOLOGY, V232, P3057, DOI 10.1007/s00213-015-3945-7; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Renard J, 2016, J NEUROSCI, V36, P5160, DOI 10.1523/JNEUROSCI.3387-15.2016; Stern CAJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2132, DOI 10.1038/npp.2012.63; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tzadok M, 2016, SEIZURE-EUR J EPILEP, V35, P41, DOI 10.1016/j.seizure.2016.01.004; UMEMOTO T, 1990, J AM CHEM SOC, V112, P8563, DOI 10.1021/ja00179a047; Viveros MP, 2005, PHARMACOL BIOCHEM BE, V81, P331, DOI 10.1016/j.pbb.2005.01.029; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; Zhornitsky S, 2012, PHARMACEUTICALS, V5, P529, DOI 10.3390/ph5050529; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967; ZUARDI AW, 1991, PSYCHOPHARMACOLOGY, V104, P260, DOI 10.1007/BF02244189; ZUARDI AW, 1982, PSYCHOPHARMACOLOGY, V76, P245, DOI 10.1007/BF00432554; ZUARDI AW, 1995, J CLIN PSYCHIAT, V56, P485	52	27	29	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158779	10.1371/journal.pone.0158779	http://dx.doi.org/10.1371/journal.pone.0158779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416026	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500038
J	Dutriaux, L; Gyselinck, V				Dutriaux, Leo; Gyselinck, Valerie			Learning Is Better with the Hands Free: The Role of Posture in the Memory of Manipulable Objects	PLOS ONE			English	Article							MOTOR SIMULATION; MENTAL ROTATION; WORKING-MEMORY; KNOWLEDGE; IMAGERY; WORDS; REPRESENTATIONS; CATEGORIZATION; RECOGNITION; AFFORDANCE	Grounded cognition proposes that memory shares processing resources with sensorimotor systems. The aim of the present study was to show that motor simulation participates in the conceptual representation of manipulable objects in long-term memory. In two experiments, lists of manipulable and nonmanipulable objects were presented. Participants were instructed to memorize the items while adopting different postures. In the control condition, they had to keep their hands at rest in front of them. In the interference condition, participants had to keep their hands crossed behind their back to make their hands less free for action. After each list, participants had to perform first a distractive task, and then an oral free recall. The results showed that the interfering posture produced a specific decrease in the recall of manipulable objects, but not of nonmanipulable ones. This decrease was similar when the items were presented as pictures (Experiment 1) or as words (Experiment 2), thus excluding a purely visual effect. These results provide strong evidence that the motor simulation plays a role in the memory trace of the object.	[Dutriaux, Leo; Gyselinck, Valerie] Univ Paris 05, Sorbonne Paris Cite, Lab Memoire & Cognit, Paris, France; [Dutriaux, Leo; Gyselinck, Valerie] Ctr Henri Pieron, Inst Psychol, Boulogne Billancourt, France; [Dutriaux, Leo; Gyselinck, Valerie] INSERM U894, Ctr Psychiatr & Neurosci, Paris, France; [Gyselinck, Valerie] IFSTTAR LPC, Versailles, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel	Dutriaux, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Lab Memoire & Cognit, Paris, France.; Dutriaux, L (corresponding author), Ctr Henri Pieron, Inst Psychol, Boulogne Billancourt, France.; Dutriaux, L (corresponding author), INSERM U894, Ctr Psychiatr & Neurosci, Paris, France.	leo.dutriaux@parisdescartes.fr		Gyselinck, Valerie/0000-0001-9715-6148; Dutriaux, Leo/0000-0001-6304-8691	French National Research Agency (ANR) [ANR-13-APPR-0009]	French National Research Agency (ANR)(French National Research Agency (ANR))	The work was supported by Grant ANR-13-APPR-0009 from the French National Research Agency (ANR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Alix Seigneuric and Jane Oakhill for fruitful comments on an earlier version of the manuscript. The work was supported by Grant ANR-13-APPR-0009 from the French National Research Agency (ANR).	[Anonymous], 1983, CANADIAN PSYCHOL; Apel JK, 2012, EXP BRAIN RES, V223, P199, DOI 10.1007/s00221-012-3251-0; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bonin P, 2011, ANN PSYCHOL, V111, P327; Bub DN, 2008, COGNITION, V106, P27, DOI 10.1016/j.cognition.2006.12.010; Bub DN, 2013, PSYCHOL SCI, V24, P1269, DOI 10.1177/0956797612472909; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Buxbaum LJ, 2010, ANN NY ACAD SCI, V1191, P201, DOI 10.1111/j.1749-6632.2010.05447.x; Buxbaum LJ, 2002, BRAIN LANG, V82, P179, DOI 10.1016/S0093-934X(02)00014-7; Campanella F, 2011, EXP BRAIN RES, V208, P369, DOI 10.1007/s00221-010-2489-7; Cardellicchio P, 2011, NEUROPSYCHOLOGIA, V49, P1369, DOI 10.1016/j.neuropsychologia.2011.01.021; Carota F, 2012, J COGNITIVE NEUROSCI, V24, P1492, DOI 10.1162/jocn_a_00219; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; de Vega M., 2012, MENTAL IMAGERY SPATI, P177; Desrochers A, 2000, CAN J EXP PSYCHOL, V54, P274, DOI 10.1037/h0087347; Desrochers A, 2009, BEHAV RES METHODS, V41, P546, DOI 10.3758/BRM.41.2.546; Downing-Doucet F, 2014, PSYCHON B REV, V21, P1033, DOI 10.3758/s13423-013-0570-5; Franzen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037359; Funk M, 2005, DEVELOPMENTAL SCI, V8, P402, DOI 10.1111/j.1467-7687.2005.00428.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Garcea Frank E, 2013, Front Hum Neurosci, V7, P120, DOI 10.3389/fnhum.2013.00120; Gerlach C, 2002, J COGNITIVE NEUROSCI, V14, P1230, DOI 10.1162/089892902760807221; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Iachini T, 2008, BRAIN COGNITION, V67, P31, DOI 10.1016/j.bandc.2007.11.002; Iachini T, 2014, ACTA PSYCHOL, V153, P20, DOI 10.1016/j.actpsy.2014.09.001; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Lagace S, 2015, ACTA PSYCHOL, V157, P65, DOI 10.1016/j.actpsy.2015.02.009; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Masson MEJ, 2008, J MEM LANG, V59, P256, DOI 10.1016/j.jml.2008.05.003; Matheson HE, 2014, ACTA PSYCHOL, V145, P33, DOI 10.1016/j.actpsy.2013.10.012; Morlino G, 2015, COGNITIVE SCI, V39, P39, DOI 10.1111/cogs.12130; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Myung JY, 2010, BRAIN LANG, V112, P101, DOI 10.1016/j.bandl.2009.12.003; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; New B, 2001, ANN PSYCHOL, V101, P447; PAIVIO A, 1969, J EXP PSYCHOL, V80, P279, DOI 10.1037/h0027273; Pecher D, 2013, J COGN PSYCHOL, V25, P107, DOI 10.1080/20445911.2012.750324; Pecher D, 2013, J EXP PSYCHOL LEARN, V39, P2, DOI 10.1037/a0028642; Pezzulo G, 2010, BRAIN COGNITION, V73, P68, DOI 10.1016/j.bandc.2010.03.002; Phillips JC, 2002, VIS COGN, V9, P540, DOI 10.1080/13506280143000575; Pobric G, 2010, CURR BIOL, V20, P964, DOI 10.1016/j.cub.2010.03.070; Pulvermuller F, 1999, BEHAV BRAIN SCI, V22, P253, DOI 10.1017/S0140525X9900182X; Quak M, 2014, ATTEN PERCEPT PSYCHO, V76, P2063, DOI 10.3758/s13414-014-0654-y; Rueschemeyer SA, 2010, J COGNITIVE NEUROSCI, V22, P1844, DOI 10.1162/jocn.2009.21310; Rueschemeyer SA, 2010, NEUROPSYCHOLOGIA, V48, P774, DOI 10.1016/j.neuropsychologia.2009.09.019; Shebani Z, 2013, CORTEX, V49, P222, DOI 10.1016/j.cortex.2011.10.005; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Versace R, 2014, J COGN PSYCHOL, V26, P280, DOI 10.1080/20445911.2014.892113; Witt JK, 2010, PSYCHOL SCI, V21, P1215, DOI 10.1177/0956797610378307; Yee E, 2013, PSYCHOL SCI, V24, P909, DOI 10.1177/0956797612464658; Zeelenberg R, 2016, PSYCHOL LEARN MOTIV, V64, P161, DOI 10.1016/bs.plm.2015.09.005; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	63	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159108	10.1371/journal.pone.0159108	http://dx.doi.org/10.1371/journal.pone.0159108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414407	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500076
J	Gebremedhin, B; Flagstad, O; Bekele, A; Chala, D; Bakkestuen, V; Boessenkool, S; Popp, M; Gussarova, G; Schroder-Nielsen, A; Nemomissa, S; Brochmann, C; Stenseth, NC; Epp, LS				Gebremedhin, Berihun; Flagstad, Oystein; Bekele, Afework; Chala, Desalegn; Bakkestuen, Vegar; Boessenkool, Sanne; Popp, Magnus; Gussarova, Galina; Schroder-Nielsen, Audun; Nemomissa, Sileshi; Brochmann, Christian; Stenseth, Nils Chr.; Epp, Laura S.			DNA Metabarcoding Reveals Diet Overlap between the Endangered Walia Ibex and Domestic Goats - Implications for Conservation	PLOS ONE			English	Article							MOUNTAINS NATIONAL-PARK; LARGE HERBIVORES; CAPRA-HIRCUS; WILD; LIVESTOCK; CLIMATE; SHEEP; COMPETITION; VEGETATION; FUTURE	Human population expansion and associated degradation of the habitat of many wildlife species cause loss of biodiversity and species extinctions. The small Simen Mountains National Park in Ethiopia is one of the last strongholds for the preservation of a number of afro-alpine mammals, plants and birds, and it is home to the rare endemic Walia ibex, Capra walie. The narrow distribution range of this species as well as potential competition for resources with livestock, especially with domestic goat, Capra hircus, may compromise its future survival. Based on a curated afro-alpine taxonomic reference library constructed for plant taxon identification, we investigated the diet of the Walia ibex and addressed the dietary overlap with domestic goat using DNA metabarcoding of faecal samples. Faeces of both species were collected from different localities in the National Park. We show that both species are browsers, with forbs, shrubs and trees comprising the largest proportion of their diet, supplemented by grasses. There was a considerable overlap in dietary preferences. Several of the preferred diet items of the Walia ibex (Alchemilla sp., Hypericum revolutum, Erica arborea and Rumex sp.) were also among the most preferred diet items of the domestic goat. These results indicate that there is potential for competition between the two species, especially during the dry season, when resources are limited. Our findings, in combination with the expected increase in domestic herbivores, suggest that management plans should consider the potential threat posed by domestic goats to ensure future survival of the endangered Walia ibex.	[Gebremedhin, Berihun; Stenseth, Nils Chr.] Univ Oslo, Dept Biosci, CEES, Oslo, Norway; [Flagstad, Oystein; Bakkestuen, Vegar] Norwegian Inst Nat Res, Trondheim, Norway; [Bekele, Afework] Univ Addis Ababa, Dept Zool Sci, Addis Ababa, Ethiopia; [Chala, Desalegn; Bakkestuen, Vegar; Boessenkool, Sanne; Popp, Magnus; Gussarova, Galina; Schroder-Nielsen, Audun; Brochmann, Christian; Epp, Laura S.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Nemomissa, Sileshi] Univ Addis Ababa, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia; [Epp, Laura S.] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Periglacial Res, Potsdam, Germany	University of Oslo; Norwegian Institute Nature Research; Addis Ababa University; University of Oslo; Addis Ababa University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Epp, LS (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.; Epp, LS (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Periglacial Res, Potsdam, Germany.	laura.saskia.epp@gmail.com	Brochmann, Christian/A-4105-2009; Boessenkool, Sanne/K-4274-2017; Gussarova, Galina/E-4758-2015; Chala, Desalegn/AAA-8024-2020; Nemomissa, Sileshi/AAB-7270-2022; Epp, Laura/AFS-1695-2022; Gussarova, Galina/ABC-8696-2021; Epp, Laura Saskia/J-5301-2016	Boessenkool, Sanne/0000-0001-8033-1165; Gussarova, Galina/0000-0001-5388-7491; Chala, Desalegn/0000-0002-8045-6950; Gussarova, Galina/0000-0001-5388-7491; Gebremedhin, Berihun/0000-0002-2585-7743; Bakkestuen, Vegar/0000-0003-2573-6615; Popp, Magnus/0000-0001-6745-3301; Epp, Laura Saskia/0000-0002-2230-9477	Research Council of Norway [191627/V40]; Center for Ecology and Evolutionary Synthesis (CEES) at the University of Oslo; Mohamed Bin Zyad Species Conservation Foundation Fund [11052467]; Norwegian Programme for Development, Research and Higher Education (NUFU) [2007/10058]; Conservation des Especes et des Populations Animals, CEPA; Conservation des Especes et des Populations Animals (CEPA)	Research Council of Norway(Research Council of Norway); Center for Ecology and Evolutionary Synthesis (CEES) at the University of Oslo; Mohamed Bin Zyad Species Conservation Foundation Fund; Norwegian Programme for Development, Research and Higher Education (NUFU); Conservation des Especes et des Populations Animals, CEPA; Conservation des Especes et des Populations Animals (CEPA)	The laboratory analyses were funded by the Research Council of Norway [http://www.forskningsradet.no], grant no. 191627/V40 to CB, the Center for Ecology and Evolutionary Synthesis (CEES, [http://www.mn.uio.no/cees/]) at the University of Oslo, the Mohamed Bin Zyad Species Conservation Foundation Fund [http://www.speciesconservation.org], Project ID. 11052467, and the Norwegian Programme for Development, Research and Higher Education (NUFU, [http://siu.no/eng/Programme-information/Developmentcooperation/NUFU]; project 2007/10058 to SN and CB). Field work and sample collection was funded by the Conservation des Especes et des Populations Animals [http://www.cepa-association.org], CEPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The laboratory analyses were funded by the Research Council of Norway (grant no. 191627/V40 to C.B.), the Center for Ecology and Evolutionary Synthesis (CEES) at the University of Oslo, the Mohamed Bin Zyad Species Conservation Foundation Fund (Project ID. 11052467), and the Norwegian Programme for Development, Research and Higher Education (NUFU; project 2007/10058 to S.N. and C.B.). Field work and sample collection was funded by the Conservation des Especes et des Populations Animals (CEPA). B.G. is grateful for the assistance from Pierre Taberlet and Mebrahtu Ateweberhan.	Acevedo P, 2007, BIODIVERS CONSERV, V16, P3361, DOI 10.1007/s10531-006-9032-y; Alemayehu K, 2011, AFR J AGR RES, V6, P856; Alemayehu K, 2011, AFR J ECOL, V49, P292, DOI 10.1111/j.1365-2028.2011.01264.x; Amhara National Regional State Parks Development and Protection Authority, 2007, GRAZ PRESS RED STRAT; [Anonymous], 2000, FLORA ETHIOPIA ERITR; Baamrane MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035643; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; Bellemain E, 2013, ENVIRON MICROBIOL, V15, P1176, DOI 10.1111/1462-2920.12020; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Boessenkool S, 2014, CONSERV BIOL, V28, P446, DOI 10.1111/cobi.12195; Boessenkool S, 2012, MOL ECOL, V21, P1806, DOI 10.1111/j.1365-294X.2011.05306.x; Bogale B., 2014, ACTA PARASITOL GLOB, V5, P19, DOI 10.5829/idosi.apg.2014.5.1.8346; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Braak Ter C., 1998, CANOCO REFERENCE MAN; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Burnand J., 1998, SURVEY FLORA FAUNA S, P24; Chynoweth MW, 2013, PAC SCI, V67, P141, DOI 10.2984/67.2.1; COBLENTZ BE, 1977, J RANGE MANAGE, V30, P415, DOI 10.2307/3897801; DEBOER WF, 1990, OECOLOGIA, V82, P264, DOI 10.1007/BF00323544; DUNBAR RIM, 1978, E AFR WILDL J, V16, P183; Ejigu D., 2012, THESIS; [Ethiopian Wildlife Conservation Authority Simien Mountains National Park], 2013, CHALL CONS PROT AR M; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gebremedhin B, 2009, ANIM CONSERV, V12, P89, DOI 10.1111/j.1469-1795.2009.00238.x; Gebremedhin B, 2008, IUCN RED LIST THREAT; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Gottelli D, 2013, ANIM CONSERV, V16, P234, DOI 10.1111/j.1469-1795.2012.00591.x; Grunenfelder J., 2005, THESIS; Hagedorn F, 2010, BIOGEOCHEMISTRY, V97, P1, DOI 10.1007/s10533-009-9386-9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hedberg I, 2006, FLORA ETHIOPIA ERITR, V5; Hedberg I., 2003, FLORA ETHIOPIA ERITR, V4, P1; Hedberg I, 1997, FLORA ETHIOPIA ERITR, V7; Hibert F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060799; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hurni H, 1986, MANAGEMENT PLAN SIME; Hurni H., 2010, GLOBAL CHANGE SUSTAI, P187, DOI DOI 10.13140/2.1.3976.5449; Hurni H, 2000, RECONCILING CONSERVA; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jongman RHG, 1995, DATA ANAL COMMUNITY; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; LANGTON RW, 1982, FISH B-NOAA, V80, P745; Li ZQ, 2008, J WILDLIFE MANAGE, V72, P944, DOI 10.2193/2007-233; Liu BM, 2008, HYDROL PROCESS, V22, P1059, DOI 10.1002/hyp.7022; Mason THE, 2014, GLOBAL CHANGE BIOL, V20, P3872, DOI 10.1111/gcb.12641; Mendelsohn R, 2007, CLIMATE CHANGE IMPAC; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Nievergelt B., 1981, IBEXES AFRICAN ENV E; Nyssen J, 2014, SCI TOTAL ENVIRON, V485, P164, DOI 10.1016/j.scitotenv.2014.03.052; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Phillips S., 1995, FLORA ETHIOPIA ERITR, V7; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Puff C., 2005, PLANTS SIMEN FLORA S; Putman R. J., 1996, COMPETITION RESOURCE; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; SCHOENER TW, 1974, THEOR POPUL BIOL, V6, P265, DOI 10.1016/0040-5809(74)90013-6; Shrestha R, 2005, J ZOOL, V266, P111, DOI 10.1017/S0952836905006527; Shrestha R, 2008, ENVIRON CONSERV, V35, P125, DOI 10.1017/S0376892908004724; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Verdcourt B., 1989, FLORA ETHIOPIA ERITR, P511; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	72	25	27	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159133	10.1371/journal.pone.0159133	http://dx.doi.org/10.1371/journal.pone.0159133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416020	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500085
J	Korona-Glowniak, I; Maj, M; Siwiec, R; Niedzielski, A; Malm, A				Korona-Glowniak, Izabela; Maj, Maciej; Siwiec, Radoslaw; Niedzielski, Artur; Malm, Anna			Molecular Epidemiology of Streptococcus pneumoniae Isolates from Children with Recurrent Upper Respiratory Tract Infections	PLOS ONE			English	Article							SEROTYPE 19A; CLONAL COMPLEX; RESISTANCE; ELEMENTS; PNEUMOCOCCI; MECHANISMS; DIVERSITY; TRANSPOSONS; ASSOCIATION; EVOLUTION	A total of 125 isolates were recovered from adenoids and/or nasopharynx of 170 children aged 2 to 5 from south-east Poland; they had undergone adenoidectomy for recurrent and/or persistent symptoms of upper respiratory tract infections. Pneumococcal isolates were analyzed by phenotyping (serotyping and antimicrobial resistance tests) and genotyping together with the clonality of the pneumococcal isolates based on resistance determinants, transposon distribution and multilocus sequence typing (MLST). Serotypes 19F, 6B and 23F constituted 44.8% of the isolates. Among all of the strains, 44.8% showed decreased susceptibility to penicillin and resistance to co-trimoxazole (52.8%), tetracycline (38.4%), erythromycin (53.6%), clindamycin (52.8%) and chloramphenicol (27.2%) was observed. Tn6002 was found in 34.8% of erythromycin-resistant isolates while composite Tn2010-in 16.7% of erm(B)-carrying isolates that harboured also mef(E) gene. Tn3872-related elements were detected in 27.3% of erythromycin-resistant strains. In the majority of chloramphenicol-resistant cat(pC194)-carrying isolates (79.4%), ICESp23FST81-family elements were detected. The genotyping showed that pneumococcal population was very heterogeneous; 82 sequence types (STs) were identified, and the most frequent contributed to not more than 8% of the isolates. Nearly 44% STs were novel, each of them was recovered only from one child. Four STs belonged to one of the 43 worldwide spread resistant pneumococcal clones currently accepted by Pneumococcal Molecular Epidemiology Network (PMEN), i.e. Spain 9V-3, Spain 23F-1, Norway NT-42 and Poland 6B-20, accounting for 12 (16.7%) of the 75 nonususceptible isolates, and five STs were single-locus variants of PMEN resistant clones (England 14-9, Spain 9V-3, Spain 23F-1, Greece 21-30, Denmark 14-32), accounting 9 (12%) of nonsusceptible isolates. A few MDR clones belonging to 6B and 19F serotypes found among preschool children emphasizes rather the role of clonal dissemination of local strains in the community than international clones spreading in the increase of resistance among pneumococcal strains.	[Korona-Glowniak, Izabela; Siwiec, Radoslaw; Malm, Anna] Med Univ Lublin, Dept Pharmaceut Microbiol, Lab Microbiol Diagnost, Lublin, Poland; [Maj, Maciej] Med Univ Lublin, Dept Clin Immunol, Lublin, Poland; [Niedzielski, Artur] Med Univ Lublin, Otoneurol Lab 3, Chair Paediat, Lublin, Poland; [Niedzielski, Artur] Med Univ Lublin, Dept Pediat Otolaryngol Phoniatr & Audiol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Korona-Glowniak, I (corresponding author), Med Univ Lublin, Dept Pharmaceut Microbiol, Lab Microbiol Diagnost, Lublin, Poland.	iza.glowniak@umlub.pl		Korona-Glowniak, Izabela/0000-0003-1634-0387; Malm, Anna/0000-0003-1503-7634; Maj, Maciej/0000-0002-3435-2544; Siwiec, Radoslaw/0000-0002-2959-5015; Niedzielski, Artur/0000-0001-9062-0403				Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Calatayud L, 2007, ANTIMICROB AGENTS CH, V51, P3240, DOI 10.1128/AAC.00157-07; Calatayud L, 2010, J CLIN MICROBIOL, V48, P1310, DOI 10.1128/JCM.01868-09; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Cochetti I, 2008, ANTIMICROB AGENTS CH, V52, P1285, DOI 10.1128/AAC.01457-07; Cochetti I, 2007, J ANTIMICROB CHEMOTH, V60, P127, DOI 10.1093/jac/dkm120; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Del Grosso M, 2007, ANTIMICROB AGENTS CH, V51, P4184, DOI 10.1128/AAC.00598-07; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Geng Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093752; Henderson-Begg SK, 2009, INT J ANTIMICROB AG, V33, P364, DOI 10.1016/j.ijantimicag.2008.10.002; Isaacman D. J., 2010, INT J INFECT DIS, V14, pE197, DOI DOI 10.1016/j.ijid.2009.05.010; Izdebski R, 2007, ANTIMICROB AGENTS CH, V51, P1155, DOI 10.1128/AAC.01384-06; Jacobs MR, 2008, J CLIN MICROBIOL, V46, P982, DOI 10.1128/JCM.02321-07; Korona-Glowniak I, 2015, EPIDEMIOL INFECT, V143, P821, DOI 10.1017/S0950268814001460; Korona-Glowniak I, 2013, POL J MICROBIOL, V62, P385; Li Y, 2011, J APPL MICROBIOL, V110, P254, DOI 10.1111/j.1365-2672.2010.04875.x; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Mingoia M, 2011, ANTIMICROB AGENTS CH, V55, P1453, DOI 10.1128/AAC.01087-10; Montanari MP, 2003, J CLIN MICROBIOL, V41, P428, DOI 10.1128/JCM.41.1.428-431.2003; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642; Quintero B, 2011, ANTIMICROB AGENTS CH, V55, P4930, DOI 10.1128/AAC.00242-11; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Sadowy E, 2007, ANTIMICROB AGENTS CH, V51, P40, DOI 10.1128/AAC.01072-06; Sadowy E, 2010, ANTIMICROB AGENTS CH, V54, P1720, DOI 10.1128/AAC.01340-09; Siira L, 2012, EUR J CLIN MICROBIOL, V31, P867, DOI 10.1007/s10096-011-1386-8; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Vestrheim DF, 2008, J CLIN MICROBIOL, V46, P2508, DOI 10.1128/JCM.02296-07; Widdowson CA, 2000, ANTIMICROB AGENTS CH, V44, P393, DOI 10.1128/AAC.44.2.393-395.2000; Xu XP, 2010, ANTIMICROB AGENTS CH, V54, P1152, DOI 10.1128/AAC.01268-09; Zhou L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-228	37	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158909	10.1371/journal.pone.0158909	http://dx.doi.org/10.1371/journal.pone.0158909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415833	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500049
J	Li, J; Tang, Y; Huang, L; Yu, QQ; Hu, GY; Yuan, XL				Li, Jing; Tang, Yang; Huang, Liu; Yu, Qianqian; Hu, Guangyuan; Yuan, Xianglin			Genetic Variants in the p14ARF/MDM2/TP53 Pathway Are Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated with Radical Resection	PLOS ONE			English	Article							P53; POLYMORPHISMS	The p14ARF/MDM2/TP53 pathway is known to play an important role in tumor progression by cell cycle control, although the association between this pathway and the prognosis of esophageal squamous cell carcinoma (ESCC) is unclear. In this study, we explored the association between genetic variants in the p14ARF/MDM2/TP53 pathway and prognosis in ESCC patients with radical resection. 124 ESCC patients with radical resection were included in this retrospective study and genotyped using the MassArray method. According to multivariate Cox hazard analysis and multiple testing, the TC/CC genotype of p14ARF rs3814960 was shown to be strongly related to a decreased overall survival (OS) (HR = 2.77, 95% CI: 1.33-5.75, P = 0.006, Pc = 0.030) and disease-free survival (DFS) (HR = 2.45, 95% CI: 1.30-4.61, P = 0.005, Pc = 0.025). Moreover, patients with the DEL/A + AA genotype of MDM2 rs34886328 had a notably increased OS (HR = 0.27, 95% CI: 0.13-0.56, P = 4.7x10(-4), Pc = 0.003) and DFS (HR = 0.22, 95% CI: 0.11-0.43, P = 1.1x10(-5), Pc = 6.6x10(-5)). We also found that these two SNPs had a cumulative effect on the prognosis of ESCC, with the OS (P < 0.001) and DFS (P < 0.001) being shortest for patients carrying both of these unfavorable genotypes. In conclusion, genetic variants of the p14ARF/MDM2/TP53 pathway are significantly related to OS and DFS, and may be predictors of the prognosis of ESCC after surgery. We speculate the individuals with the TC/CC genotype of p14ARF rs3814960 and/or the DEL/DEL genotype of MDMD2 rs34886328 should have more aggressive treatment and may greatly benefit from early prediction and prevention of an unfavorable prognosis by genotyping before the initiation of therapy. These findings should be further validated in a larger population.	[Li, Jing; Tang, Yang; Huang, Liu; Yu, Qianqian; Hu, Guangyuan; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Hubei Province, Peoples R China.	YXL@medmail.com.cn			Merck Serono Oncology Rearch Fund of Chinese Society of Clinical Oncology [Y-MT2014-001]	Merck Serono Oncology Rearch Fund of Chinese Society of Clinical Oncology	This work was supported by the Merck Serono Oncology Rearch Fund of Chinese Society of Clinical Oncology (Y-MT2014-001) [http://www.csco.org.cn/cat/158/show/6961.html] to XLY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2000, CANCER, V89, P946; Ajani JA, 2005, J CLIN ONCOL, V23, P4256, DOI 10.1200/JCO.2005.12.911; Ando N, 2000, ANN SURG, V232, P225, DOI 10.1097/00000658-200008000-00013; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng TH, 2009, J CANCER RES CLIN, V135, P1577, DOI 10.1007/s00432-009-0605-5; Gryshchenko I, 2008, J CLIN ONCOL, V26, P2252, DOI 10.1200/JCO.2007.11.5212; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kleinberg L, 2007, J CLIN ONCOL, V25, P4110, DOI 10.1200/JCO.2007.12.0881; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwon JM, 2000, ALCOHOL RES HEALTH, V24, P164; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Prives C, 1999, J PATHOL, V187, P112; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang J, 2013, CANCER EPIDEMIOL, V37, P629, DOI 10.1016/j.canep.2013.06.001; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099255; Zhang Y, 2011, CANCER-AM CANCER SOC, V117, P1227, DOI 10.1002/cncr.25605	25	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158613	10.1371/journal.pone.0158613	http://dx.doi.org/10.1371/journal.pone.0158613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414035	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500027
J	Sasakawa, K				Sasakawa, Koji			Notes on the Reproductive Ecology and Description of the Preimaginal Morphology of Elaphrus sugai Nakane, the Most Endangered Species of Elaphrus Fabricius (Coleoptera: Carabidae) Ground Beetle Worldwide	PLOS ONE			English	Article							LARVAL DEVELOPMENT; LIFE-CYCLE; DIET; FECUNDITY; CHAUDOIR; CARABUS; KEY	Elucidating the basic life-history of endangered species is the first important step in the conservation of such species. This study examined the reproductive ecology and the preimaginal morphology of the endangered ground beetle Elaphrus sugai Nakane (Coleoptera: Carabidae); currently, the Watarase wetland of the central Kanto Plain, Japan is the only confirmed locality of this beetle species. Laboratory rearing of reproductive adults collected in early April revealed that females can lay more than 131 eggs. Eggs were laid in mud, without an egg chamber. Larvae reached adulthood when fed a diet of mealworms, indicating that E. sugai larvae are insect larvae feeders. An earthworm diet, the optimal diet for larvae of a congeneric species (E. punctatus Motschulsky), was lethal to E. sugai larvae. The egg stage was 3-4 days in duration under a 16L8D cycle (22 degrees C). The duration from hatching to adult eclosion was 23-42 days at various temperatures simulating those of the reproductive period. Larval morphology was similar to that of consubgeneric species described previously. The pupa is unusual, in that the setae on the abdominal tergites are long (twice as long as those of the abdominal segment) and have somewhat "coiled" apices. Finally, the current endangered status of E. sugai was compared to that of E. viridis Horn, which has been regarded as the most endangered species of the genus worldwide.	[Sasakawa, Koji] Chiba Univ, Fac Educ, Dept Sci Educ, Zool Lab,Inage Ku, Yayoi Cho, Chiba, Japan; [Sasakawa, Koji] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan	Chiba University; University of Tokyo	Sasakawa, K (corresponding author), Chiba Univ, Fac Educ, Dept Sci Educ, Zool Lab,Inage Ku, Yayoi Cho, Chiba, Japan.; Sasakawa, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo, Japan.	ksasa@chiba-u.jp			Japan Society for the Promotion of Science [25830150]; Grants-in-Aid for Scientific Research [25830150] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (no. 25830150), https://kaken.nii.ac.jp/d/p/25830150.en.html.; I thank Dr. D.H. Kavanaugh (California Academy of Sciences, CA, U.S.A.) and Dr. T. Kishimoto (Museum of Natural and Environmental History, Shizuoka, Japan) for recent information of E. viridis and E. sugai, respectively. The present study was partly supported by a grantin-aid from the Japan Society for the Promotion of Science (no. 25830150).	BALL GE, 1969, CAN J ZOOLOG, V47, P877, DOI 10.1139/z69-146; BOUSQUET Y, 1986, SYST ENTOMOL, V11, P25, DOI 10.1111/j.1365-3113.1986.tb00160.x; BOUSQUET Y, 1984, CAN J ZOOL, V62, P573, DOI 10.1139/z84-085; Bousquet Y., 1985, REV ECOLOGIE SYSTEMA, V112, P191; BURAKOWSKI B, 1989, Annales Zoologici (Warsaw), V42, P181; Busato E, 2012, ZOOTAXA, P1; Busato E, 2014, ZOOTAXA, V3866, P451, DOI 10.11646/zootaxa.3866.4.1; Cardenas Talaveron AM, 1993, ELYTRON, V7, P123; Costa C, 2011, ZOOTAXA, P30; Dajoz Roger, 2005, Nouvelle Revue d'Entomologie, V22, P283; Fish Sacramento & Office Wildlife, 2006, DELT GREEN GROUND BE; GOULET H, 1983, Quaestiones Entomologicae, V19, P219; Huk T, 1999, OECOLOGIA, V121, P348, DOI 10.1007/s004420050938; Ikeda H, 2010, ECOL ENTOMOL, V35, P307, DOI 10.1111/j.1365-2311.2010.01182.x; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jorgensen HB, 1997, PEDOBIOLOGIA, V41, P307; Jorgensen HB, 1997, ECOL ENTOMOL, V22, P7, DOI 10.1046/j.1365-2311.1997.00045.x; Kishimoto T, 2015, RED DATA BOOK 2014 T, V5, P91; Kleinwachter M, 2008, ECOL ENTOMOL, V33, P286, DOI 10.1111/j.1365-2311.2007.00963.x; Kurata K., 2012, JAPAN RURIBOSHI, V41, P87; MAKAROV KV, 1994, SERIES ENTOM, V51, P177; Monitoring Committee for Wetland Conservation and Restoration in the Watarase Flood Control Basin, 2012, C MAT 7 5 M RES INS; Monitoring Committee for Wetland Conservation and Restoration in the Watarase Flood Control Basin, 2014, C MAT 6 9 M ANN REP; Monitoring Committee for Wetland Conservation and Restoration in the Watarase Flood Control Basin, 2014, C MAT 6 7 M ANN REP; Okuzaki Y, 2010, ENTOMOL EXP APPL, V135, P263, DOI 10.1111/j.1570-7458.2010.00987.x; Pavel VR, 2002, COLEOPT B, V56, P310; Sasakawa K., 2016, ZOOKEYS IN PRESS; Sasakawa K., 2015, DRYAD DIGITAL REPOSI; Sasakawa K, 2009, ENTOMOL EXP APPL, V130, P106, DOI 10.1111/j.1570-7458.2008.00799.x; Sasakawa K, 2016, BIOL J LINN SOC, V118, P394, DOI 10.1111/bij.12727; Sasakawa K, 2011, APPL ENTOMOL ZOOL, V46, P511, DOI 10.1007/s13355-011-0070-x; Sasakawa K, 2011, ZOOL STUD, V50, P264; Sasakawa K, 2009, ECOL ENTOMOL, V34, P406, DOI 10.1111/j.1365-2311.2009.01092.x; Sota, 1998, NATURE INSECTS, V33, P38; Sota T., 2000, CARABUS 4 SEASONS LI; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; ZANGGER A, 1994, SERIES ENTOM, V51, P469	37	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159164	10.1371/journal.pone.0159164	http://dx.doi.org/10.1371/journal.pone.0159164			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415755	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500094
J	Yan, IK; Wang, X; Asmann, YW; Haga, H; Patel, T				Yan, Irene K.; Wang, Xue; Asmann, Yan W.; Haga, Hiroaki; Patel, Tushar			Circulating Extracellular RNA Markers of Liver Regeneration	PLOS ONE			English	Article							HEPATOCELLULAR CANCER; PARTIAL-HEPATECTOMY; MICRORNAS; MODULATION; TARGETS; GROWTH	Background and Aims Although a key determinant of hepatic recovery after injury is active liver regeneration, the ability to detect ongoing regeneration is lacking. The restoration of liver mass after hepatectomy involves systemic changes with coordinated changes in gene expression guiding regenerative responses, activation of progenitor cells, and proliferation of quiescent hepatocytes. We postulated that these responses involve intercellular communication involving extracellular RNA and that these could represent biomarkers of active regenerative responses. Methods RNA sequencing was performed to identify temporal changes in serum extracellular non-coding RNA after partial hepatectomy in C57BL/6 male mice. Tissue expression of selected RNA was performed by microarray analysis and validated using qRT-PCR. Digital PCR was used to detect and quantify serum expression of selected RNA. Results A peak increase in extracellular RNA content occurred six hours after hepatectomy. RNA sequencing identified alterations in several small non-coding RNA including known and novel microRNAs, snoRNAs, tRNA, antisense and repeat elements after partial hepatectomy. Combinatorial effects and network analyses identified signal regulation, protein complex assembly, and signal transduction as the most common biological processes targeted by miRNA that altered. miR-1A and miR-181 were most significantly altered microRNA in both serum and in hepatic tissues, and their presence in serum was quantitated using digital PCR. Conclusions Extracellular RNA selectively enriched during acute regeneration can be detected within serum and represent biomarkers of ongoing liver regeneration in mice. The ability to detect ongoing active regeneration would improve the assessment of hepatic recovery from liver injury.	[Yan, Irene K.; Haga, Hiroaki; Patel, Tushar] Mayo Clin, Dept Transplantat, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA; [Yan, Irene K.; Haga, Hiroaki; Patel, Tushar] Dept Canc Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA; [Wang, Xue; Asmann, Yan W.] Dept Hlth Sci Res, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA	Mayo Clinic	Patel, T (corresponding author), Mayo Clin, Dept Transplantat, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.; Patel, T (corresponding author), Dept Canc Biol, 4500 San Pablo Rd South, Jacksonville, FL 32224 USA.	patel.tushar@mayo.edu			Office of the Director, National Institutes of Health and NCATS [R01DK069370, UH3TR000884]; Mayo Clinic Center for Regenerative Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health and NCATS; Mayo Clinic Center for Regenerative Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants R01DK069370 and UH3TR000884 from the Office of the Director, National Institutes of Health and NCATS, and the Mayo Clinic Center for Regenerative Medicine.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Castro RE, 2010, AM J PHYSIOL-GASTR L, V299, pG887, DOI 10.1152/ajpgi.00216.2010; Chiba M, 2013, BIOMED REP, V1, P383, DOI [10.3892/br.2013.80, 10.3892/br.2012.15]; Elfimova N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00476; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kren BT, 2009, AM J PHYSIOL-GASTR L, V297, pG1181, DOI 10.1152/ajpgi.90636.2008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sabin K, 2014, TRANSL RES, V163, P286, DOI 10.1016/j.trsl.2013.10.005; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schug J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-264; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Takahashi K, 2014, MOL CANCER RES, V12, P1377, DOI 10.1158/1541-7786.MCR-13-0636; Takahashi K, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00129; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Wei W, 2015, EUR SURG RES, V54, P97, DOI 10.1159/000368573	27	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0155888	10.1371/journal.pone.0155888	http://dx.doi.org/10.1371/journal.pone.0155888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415797	Green Submitted, gold, Green Published			2022-12-26	WOS:000379579500011
J	Zeng, CY; Yu, FL; Yang, Y; Cheng, XH; Liu, Y; Zhang, H; Zhao, SQ; Yang, ZB; Li, MY; Li, ZP; Mei, XG				Zeng, Chunying; Yu, Fanglin; Yang, Yang; Cheng, Xiaohui; Liu, Yan; Zhang, Hui; Zhao, Shiqing; Yang, Zhenbo; Li, Mingyuan; Li, Zhiping; Mei, Xingguo			Preparation and Evaluation of Oxaliplatin Thermosensitive Liposomes with Rapid Release and High Stability	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; IN-VITRO; TUMOR; DOXORUBICIN; TEMPERATURE; EFFICACY; CANCER; PHARMACOKINETICS; CYTOTOXICITY; HYPERTHERMIA	Oxaliplatin (OXP) was reported to show low anti-tumor activity when used alone and to display side effects; this low activity was attributed to high partitioning to erythrocytes and low accumulation in tumors. Thermosensitive liposomes (TSL) were considered able to specifically deliver drugs to heated tumors and to resolve the OXP distribution problem. Regretfully, TSL encapsulating doxorubicin did not demonstrate significant improvement in progression-free survival. Drug release below 41 degrees C and significant leakage were considered major reasons for the failure. The purpose of this study was to acquire OXP TSL with rapid release at the triggered temperature and high stability at body temperature and at storage temperatures. A small quantity of poloxamer 188 was introduced into the TSL formulation to stabilize the encapsulated drug. It was shown that the addition of poloxamer 188 had no influence on the TSL characteristics. More than 90% of OXP was released within 10 min at 42 degrees C, and less than 15% was released within 60 min at temperatures below 39 degrees C. TSL were stable at 37 degrees C for 96 h and at 4 degrees C for 6 months. The anti-tumor activity of TSL at the dose of 2.5 mg/kg was certified to be equal to those of OXP injection and non-thermosensitive liposomes (NTSL) at the dose of 5 mg/kg, and significant improvement of tumor inhibition was observed in TSL compared with injection and NTSL at the same dose. It was also shown from the histological transmutation of tumors that TSL had stronger anti-tumor activity. Therefore, it could be concluded that TSL composed of a proper amount of poloxamer had rapid release and high stability, and OXP TSL would be anticipated to exert prominent anti-tumor activity in the clinic.	[Zeng, Chunying] Capital Med Univ, Fu Xing Hosp, Dept Pharm, Beijing, Peoples R China; [Yu, Fanglin; Yang, Yang; Cheng, Xiaohui; Liu, Yan; Zhang, Hui; Zhao, Shiqing; Li, Mingyuan; Li, Zhiping; Mei, Xingguo] Beijing Inst Pharmacol & Toxicol, Dept Pharmaceut, Beijing, Peoples R China; [Yang, Zhenbo] 261 Hosp PLA, Dept Pharm, Beijing, Peoples R China	Capital Medical University; Academy of Military Medical Sciences - China	Li, ZP; Mei, XG (corresponding author), Beijing Inst Pharmacol & Toxicol, Dept Pharmaceut, Beijing, Peoples R China.	dearwood2010@126.com; newdds@126.com			Natural Science Foundation of China [81502675]; National Key Technologies R&D Program for New Drugs [2012ZX09301003-001-009]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program for New Drugs(National Key Technology R&D Program)	This work was supported by Natural Science Foundation of China (No. 81502675; Zhiping Li; http://www.nsfc.gov.cn/) and the National Key Technologies R&D Program for New Drugs (No. 2012ZX09301003-001-009; Xingguo Mei, Zhiping Li, Yang Yang, Fanglin Yu).	Abu Lila AS, 2012, INT J PHARMACEUT, V438, P176, DOI 10.1016/j.ijpharm.2012.08.030; Abu-Lila A, 2009, J CONTROL RELEASE, V134, P18, DOI 10.1016/j.jconrel.2008.10.018; Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001; Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006; Chen D, 2013, INT J PHARMACEUT, V449, P1, DOI 10.1016/j.ijpharm.2013.04.002; Chen J, 2014, INT J PHARMACEUT, V475, P408, DOI 10.1016/j.ijpharm.2014.09.009; Church Jeffrey W., 2014, 2014 AM SOC IN PRESS, V5, P16; Dewhirst MW, 1997, SEMIN ONCOL, V24, P616; Di Francesco AM, 2002, CELL MOL LIFE SCI, V59, P1914, DOI 10.1007/PL00012514; Dicheva BM, 2015, PHARM RES-DORDR, V32, P3862, DOI 10.1007/s11095-015-1746-7; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Franzena U, 2010, J PHARM BIOMED ANAL, V55, P16; Judson I, 2001, EUR J CANCER, V37, P870, DOI 10.1016/S0959-8049(01)00050-8; Kong G, 2000, CANCER RES, V60, P6950; Kwon HJ, 2015, J CONTROL RELEASE, V216, P132, DOI 10.1016/j.jconrel.2015.08.002; Li Y, 2015, BIOMATERIALS, V41, P1, DOI 10.1016/j.biomaterials.2014.11.010; Lu T, 2015, J CONTROL RELEASE, V220, P425, DOI 10.1016/j.jconrel.2015.10.056; Mady MM, 2012, PHYS MEDICA, V28, P48, DOI 10.1016/j.ejmp.2011.02.003; May JP, 2013, MOL PHARMACEUT, V10, P4499, DOI 10.1021/mp400321e; Monsky WL, 1999, CANCER RES, V59, P4129; Mosquera M, 2014, FOOD CHEM, V156, P144, DOI 10.1016/j.foodchem.2014.02.011; Nie SF, 2011, INT J NANOMED, V6, P151, DOI 10.2147/IJN.S15057; PENDYALA L, 1993, CANCER RES, V53, P5970; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Quinteros D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110344; Romberg B, 2007, BBA-BIOMEMBRANES, V1768, P737, DOI 10.1016/j.bbamem.2006.12.005; Suzuki R, 2008, INT J PHARM, V346, P143, DOI 10.1016/j.ijpharm.2007.06.010; Tagami T, 2015, J PHARM SCI-US, V104, P3824, DOI 10.1002/jps.24593; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Wang M, 2014, INT J PHARMACEUT, V468, P243, DOI 10.1016/j.ijpharm.2014.04.014; Yang C, 2014, BIOMED REP, V2, P335, DOI 10.3892/br.2014.249; Yang CA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-21; Yang YF, 2014, BIOMATERIALS, V35, P4368, DOI 10.1016/j.biomaterials.2014.01.076; Yuba E, 2013, BIOMATERIALS, V34, P3042, DOI 10.1016/j.biomaterials.2012.12.031; Zalba S, 2012, EUR J PHARM BIOPHARM, V81, P273, DOI 10.1016/j.ejpb.2012.02.007; Zhang B, 2013, INT J PHARMACEUT, V455, P276, DOI 10.1016/j.ijpharm.2013.07.020; Zhang H, 2011, ANAL BIOCHEM, V417, P292, DOI 10.1016/j.ab.2011.06.025; Zhang WL, 2015, J CONTROL RELEASE, V203, P161, DOI 10.1016/j.jconrel.2015.02.026	39	21	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158517	10.1371/journal.pone.0158517	http://dx.doi.org/10.1371/journal.pone.0158517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415823	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500024
J	Keren-Rotem, T; Levy, N; Wolf, L; Bouskila, A; Geffen, E				Keren-Rotem, Tammy; Levy, Noga; Wolf, Lior; Bouskila, Amos; Geffen, Eli			Alternative Mating Tactics in Male Chameleons (Chamaeleo chamaeleon) Are Evident in Both Long-Term Body Color and Short-Term Courtship Pattern	PLOS ONE			English	Article							MALE COMMON CHAMELEONS; MALE REPRODUCTIVE STRATEGIES; FEMALE MATE CHOICE; MALE TREE LIZARDS; SELECTION; EVOLUTION; BEHAVIOR; ADJUST; SIZE; COMMUNICATION	Alternative mating tactics in males of various taxa are associated with body color, body size, and social status. Chameleons are known for their ability to change body color following immediate environmental or social stimuli. In this study, we examined whether the differential appearance of male common chameleon during the breeding season is indeed an expression of alternative mating tactics. We documented body color of males and used computer vision techniques to classify images of individuals into discrete color patterns associated with seasons, individual characteristics, and social contexts. Our findings revealed no differences in body color and color patterns among males during the non-breeding season. However, during the breeding season males appeared in several color displays, which reflected body size, social status, and behavioral patterns. Furthermore, smaller and younger males resembled the appearance of small females. Consequently, we suggest that long-term color change in males during the breeding season reflects male alternative mating tactics. Upon encounter with a receptive female, males rapidly alter their appearance to that of a specific brief courtship display, which reflects their social status. The females, however, copulated indiscriminately in respect to male color patterns. Thus, we suggest that the differential color patterns displayed by males during the breeding season are largely aimed at inter-male signaling.	[Keren-Rotem, Tammy; Geffen, Eli] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Levy, Noga; Wolf, Lior] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Bouskila, Amos] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Bouskila, Amos] Ben Gurion Univ Negev, Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84105 Beer Sheva, Israel	Tel Aviv University; Tel Aviv University; Ben Gurion University; Ben Gurion University	Geffen, E (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	geffene@post.tau.ac.il	Bouskila, Amos/B-4847-2010	Bouskila, Amos/0000-0002-6995-5070				Ancona S, 2010, ANIM BEHAV, V79, P75, DOI 10.1016/j.anbehav.2009.10.005; Andersson Malte, 1994; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bergman TJ, 2008, BIOL J LINN SOC, V94, P231, DOI 10.1111/j.1095-8312.2008.00981.x; Bouskila A., 2001, HDB REPTILES AMPHIBI; Bowmaker JK, 2005, J COMP PHYSIOL A, V191, P925, DOI 10.1007/s00359-005-0014-4; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Bustard HR, 1965, COPEIA, V1965, P401; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; Censky EJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P221, DOI 10.1007/s002650050336; Chih-Chung C, 2011, ACM T INTEL SYST TEC, V2; Cooper W.E. Jr, 1992, P298; COOPER WE, 1993, ANIM BEHAV, V45, P683, DOI 10.1006/anbe.1993.1083; COOPER WE, 1987, OECOLOGIA, V72, P321, DOI 10.1007/BF00377558; Corl A, 2010, EVOLUTION, V64, P79, DOI 10.1111/j.1558-5646.2009.00791.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cuadrado M, 2000, HERPETOLOGICA, V56, P387; Cuadrado M, 2001, BIOL J LINN SOC, V72, P547, DOI 10.1111/j.1095-8312.2001.tb01337.x; Cuadrado M, 1998, J ZOOL, V246, P351, DOI 10.1111/j.1469-7998.1998.tb00165.x; Cuadrado M, 1998, J ETHOL, V16, P73, DOI 10.1007/BF02769285; Cuadrado M, 2000, ETHOLOGY, V106, P79, DOI 10.1046/j.1439-0310.2000.00493.x; Cuadrado M, 2001, J ZOOL, V255, P425; Greenberg N, 2003, PHYSIOL BEHAV, V79, P429, DOI 10.1016/S0031-9384(03)00162-8; Greenberg N, 2002, INTEGR COMP BIOL, V42, P526, DOI 10.1093/icb/42.3.526; GREENBERG N, 1990, GEN COMP ENDOCR, V77, P246, DOI 10.1016/0016-6480(90)90309-A; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; GROSS MR, 1982, Z TIERPSYCHOL, V60, P1; Hews DK, 1996, PHYSIOL BEHAV, V60, P425, DOI 10.1016/S0031-9384(96)80014-X; Hodar JA, 2000, BIOL CONSERV, V94, P63, DOI 10.1016/S0006-3207(99)00163-9; How TL, 2002, J ZOOL, V257, P333, DOI 10.1017/S0952836902000936; Jenssen TA, 2005, ANIM BEHAV, V69, P1325, DOI 10.1016/j.anbehav.2004.07.023; Kano Y, 2006, J ETHOL, V24, P1, DOI 10.1007/s10164-005-0153-7; Kelso EC, 2002, ETHOLOGY, V108, P495, DOI 10.1046/j.1439-0310.2002.00789.x; Keren T., 2001, THESIS; Keren-Rotem T, 2006, BEHAV ECOL SOCIOBIOL, V59, P723, DOI 10.1007/s00265-005-0102-z; Knapp R, 2003, HORM BEHAV, V43, P83, DOI 10.1016/S0018-506X(02)00018-1; Lebas NR, 2001, BEHAVIOUR, V138, P965, DOI 10.1163/156853901753286515; Lengagne T, P ROYAL SOC B, V266, P1623; Ligon RA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1007, DOI 10.1007/s00265-014-1713-z; Ligon RA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0892; LUCAS JR, 1995, AM NAT, V146, P365, DOI 10.1086/285805; Martin J, 1999, BEHAV ECOL, V10, P396, DOI 10.1093/beheco/10.4.396; Martin J., 1992, CHAMELEONS NATURES M; Maynard Smith J., 1982, pi; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; MOORE MC, 1991, HORM BEHAV, V25, P154, DOI 10.1016/0018-506X(91)90048-M; Norman MD, 1999, P ROY SOC B-BIOL SCI, V266, P1347, DOI 10.1098/rspb.1999.0786; OLSSON M, 1995, BEHAV ECOL SOCIOBIOL, V36, P179, DOI 10.1007/BF00177794; Ord TJ, 2002, BIOL J LINN SOC, V77, P127, DOI 10.1046/j.1095-8312.2002.00100.x; de Lanuza GPI, 2013, BEHAV ECOL, V24, P273, DOI 10.1093/beheco/ars164; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Price JJ, 2013, BEHAVIOUR, V150, P995, DOI 10.1163/1568539X-00003051; RADWAN J, 1993, BEHAV ECOL SOCIOBIOL, V33, P201, DOI 10.1007/BF00216601; RAND MS, 1992, GEN COMP ENDOCR, V88, P461, DOI 10.1016/0016-6480(92)90241-B; REYNOLDS JD, 1993, ANIM BEHAV, V45, P145, DOI 10.1006/anbe.1993.1013; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shine R, 2003, BEHAVIOUR, V140, P1509, DOI 10.1163/156853903771980693; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Sinervo B, 2000, HORM BEHAV, V38, P222, DOI 10.1006/hbeh.2000.1622; Smith JM, 1997, J HERPETOL, V31, P179, DOI 10.2307/1565385; Stamps J.A., 1977, P265; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Stuart-Fox D, 2007, AM NAT, V170, P916, DOI 10.1086/522835; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Stuart-Fox DM, 2005, BIOL LETTERS, V1, P231, DOI 10.1098/rsbl.2005.0299; Sullivan BK, 2007, FUNCT ECOL, V21, P666, DOI 10.1111/j.1365-2435.2007.01244.x; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; THOMPSON CW, 1991, ANIM BEHAV, V42, P745, DOI 10.1016/S0003-3472(05)80120-4; THURMAN CL, 1988, COMP BIOCHEM PHYS C, V91, P171, DOI 10.1016/0742-8413(88)90184-3; TOKARZ RR, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P17, DOI 10.2307/1466994; Tolley KA, 2014, AFR J HERPETOL, V63, P47, DOI 10.1080/21564574.2013.872701; Vercken E, 2007, J EVOLUTION BIOL, V20, P221, DOI 10.1111/j.1420-9101.2006.01208.x; Whiting MJ, 2009, P ROY SOC B-BIOL SCI, V276, P1585, DOI 10.1098/rspb.2008.1822; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Zhang J, 2012, ECCV 2012	77	8	8	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159032	10.1371/journal.pone.0159032	http://dx.doi.org/10.1371/journal.pone.0159032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409771	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300051
J	Yu, C; Wang, J				Yu, Chong; Wang, Jin			A Physical Mechanism and Global Quantification of Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; P53; LANDSCAPE; PATHWAY; BRCA1; ROBUSTNESS; CELLS; HER2	Initiation and progression of cancer depend on many factors. Those on the genetic level are often considered crucial. To gain insight into the physical mechanisms of breast cancer, we construct a gene regulatory network (GRN) which reflects both genetic and environmental aspects of breast cancer. The construction of the GRN is based on available experimental data. Three basins of attraction, representing the normal, premalignant and cancer states respectively, were found on the phenotypic landscape. The progression of breast cancer can be seen as switching transitions between different state basins. We quantified the stabilities and kinetic paths of the three state basins to uncover the biological process of breast cancer formation. The gene expression levels at each state were obtained, which can be tested directly in experiments. Furthermore, by performing global sensitivity analysis on the landscape topography, six key genes (HER2, MDM2, TP53, BRCA1, ATM, CDK2) and four regulations (HER2aTP53, CDK2aBRCA1, ATM -> MDM2, TP53 -> ATM) were identified as being critical for breast cancer. Interestingly, HER2 and MDM2 are the most popular targets for treating breast cancer. BRCA1 and TP53 are the most important oncogene of breast cancer and tumor suppressor gene, respectively. This further validates the feasibility of our model and the reliability of our prediction results. The regulation ATM -> MDM2 has been extensive studied on DNA damage but not on breast cancer. We notice the importance of ATM -> MDM2 on breast cancer. Previous studies of breast cancer have often focused on individual genes and the anti-cancer drugs are mainly used to target the individual genes. Our results show that the network-based strategy is more effective on treating breast cancer. The landscape approach serves as a new strategy for analyzing breast cancer on both the genetic and epigenetic levels and can help on designing network based medicine for breast cancer.	[Yu, Chong; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] Jilin Univ, Coll Phys, Changchun 130012, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem Phys & Appl Math, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Jilin University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.; Wang, J (corresponding author), Jilin Univ, Coll Phys, Changchun 130012, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem Phys & Appl Math, Stony Brook, NY 11794 USA.	jin.wang.1@stonybrook.edu		Yu, Chong/0000-0003-1289-8578	Natural Science Foundation of China (NSFC) [91430217]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (NSFC Grant No. 91430217).	Al-Mulla F, 2005, J HISTOCHEM CYTOCHEM, V53, P621, DOI 10.1369/jhc.4A6544.2005; Amar D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002955; [Anonymous], 2012, MORTALITY STAT; [Anonymous], 2010, INTRO CANC BIOL; Ao P, 2008, MED HYPOTHESES, V70, P678, DOI 10.1016/j.mehy.2007.03.043; Blagosklonny MV, 2000, J CLIN INVEST, V105, P533, DOI 10.1172/JCI8625; Brekman A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3130; Burga LN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2850; Chen GC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003666; Chou WW, 2009, J CELL BIOCHEM, V107, P408, DOI 10.1002/jcb.22137; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Flobak A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004426; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garner E, 2007, CANCER RES, V67, P7631, DOI 10.1158/0008-5472.CAN-07-0334; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Li CH, 2015, CANCER RES, V75, P2607, DOI 10.1158/0008-5472.CAN-15-0079; Li CH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0774; Li CH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003165; Lin WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068578; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Molina MA, 2001, CANCER RES, V61, P4744; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Papanikolaou V, 2009, INT J ONCOL, V35, P1141, DOI 10.3892/ijo_00000430; Parikh AP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003713; PIERCE GB, 1971, CANCER RES, V31, P127; Reznik E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004176; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; Scata KA, 2007, ADV EXP MED BIOL, V608, P70; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; Wang H, 2001, CLIN CANCER RES, V7, P3613; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527	44	12	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157422	10.1371/journal.pone.0157422	http://dx.doi.org/10.1371/journal.pone.0157422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410227	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300009
J	Bender, G; Schexnaydre, EE; Murphy, RC; Uhlson, C; Newcomer, ME				Bender, Gunes; Schexnaydre, Erin E.; Murphy, Robert C.; Uhlson, Charis; Newcomer, Marcia E.			Membrane-dependent Activities of Human 15-LOX-2 and Its Murine Counterpart IMPLICATIONS FOR MURINE MODELS OF ATHEROSCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arachidonic acid (AA) (ARA); eicosanoid; lipid signaling; lipoxygenase pathway; phospholipid	CYTOSOLIC PHOSPHOLIPASE A(2); 5-LIPOXYGENASE-ACTIVATING PROTEIN; INTERFACIAL CATALYSIS; SUBSTRATE-INHIBITION; CRYSTAL-STRUCTURE; NUCLEAR-MEMBRANE; ARACHIDONIC-ACID; 15-LIPOXYGENASE; LIPOXYGENASE; DOMAIN	The enzyme encoded by the ALOX15B gene has been linked to the development of atherosclerotic plaques in humans and in a mouse model of hypercholesterolemia. In vitro, these enzymes, which share 78% sequence identity, generate distinct products from their substrate arachidonic acid: the human enzyme, a 15-S-hydroperoxy product; and the murine enzyme, an 8-S-product. We probed the activities of these enzymes with nanodiscs as membrane mimics to determine whether they can access substrate esterified in a bilayer and characterized their activities at the membrane interface. We observed that both enzymes transform phospholipid-esterified arachidonic acid to a 15-S-product. Moreover, when expressed in transfected HEK cells, both enzymes result in significant increases in the amounts of 15-hydroxyderivatives of eicosanoids detected. In addition, we show that 15-LOX-2 is distributed at the plasma membrane when the HEK293 cells are stimulated by the addition Ca2+ ionophore and that cellular localization is dependent upon the presence of a putative membrane insertion loop. We also report that sequence differences between the human and mouse enzymes in this loop appear to confer distinct mechanisms of enzyme-membrane interaction for the homologues.	[Bender, Gunes; Schexnaydre, Erin E.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Murphy, Robert C.; Uhlson, Charis] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA	Louisiana State University System; Louisiana State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu	Murphy, Robert/AAO-5349-2020; Schexnaydre, Erin/X-3790-2019	Murphy, Robert/0000-0002-9430-6515; Schexnaydre, Erin/0000-0002-2993-8647	National Institutes of Health [HL107887, HL117798]; American Heart Association [16GRNT31000010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887, U54HL117798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by National Institutes of Health Grants HL107887 (to M. E. N.) and HL117798 (to R. C. M.) and American Heart Association Grant 16GRNT31000010 (to M. E. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bocan TMA, 1998, ATHEROSCLEROSIS, V136, P203, DOI 10.1016/S0021-9150(97)00204-9; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; Brinckmann R, 1998, BLOOD, V91, P64, DOI 10.1182/blood.V91.1.64.64_64_74; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Demetz E, 2014, CELL METAB, V20, P787, DOI 10.1016/j.cmet.2014.09.004; Dewal MB, 2013, BIOCHEMISTRY-US, V52, P6559, DOI 10.1021/bi400444y; Garreta A, 2013, FASEB J, V27, P4811, DOI 10.1096/fj.13-235952; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hauser H., 2004, LIPID STRUCTURE STRU, P1; HAVIV F, 1987, J MED CHEM, V30, P254, DOI 10.1021/jm00385a005; Hutchins PM, 2012, J LIPID RES, V53, P1588, DOI 10.1194/jlr.M026799; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; Jisaka M, 1997, J BIOL CHEM, V272, P24410, DOI 10.1074/jbc.272.39.24410; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kawajiri H, 2005, BIOCHEM BIOPH RES CO, V338, P144, DOI 10.1016/j.bbrc.2005.08.099; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; Kotla S, 2014, FREE RADICAL BIO MED, V76, P147, DOI 10.1016/j.freeradbiomed.2014.08.007; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; LiCata VJ, 1997, BIOPHYS CHEM, V64, P225, DOI 10.1016/S0301-4622(96)02204-1; LUDWIG P, 1987, EUR J BIOCHEM, V168, P325, DOI 10.1111/j.1432-1033.1987.tb13424.x; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; Neau DB, 2014, J BIOL CHEM, V289, P31905, DOI 10.1074/jbc.M114.599662; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Noguchi N, 2002, BIOL CHEM, V383, P619, DOI 10.1515/BC.2002.064; Petrich K, 1996, BIOCHEM J, V314, P911, DOI 10.1042/bj3140911; Pouliot M, 1996, EUR J BIOCHEM, V238, P250, DOI 10.1111/j.1432-1033.1996.0250q.x; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; RAMIS I, 1989, J CHROMATOGR-BIOMED, V496, P416, DOI 10.1016/S0378-4347(00)82589-X; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; Willemoes M, 2003, ARCH BIOCHEM BIOPHYS, V413, P17, DOI 10.1016/S0003-9861(03)00085-7; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003	53	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19413	19424		10.1074/jbc.M116.741454	http://dx.doi.org/10.1074/jbc.M116.741454			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27435673	hybrid, Green Published			2022-12-26	WOS:000383242800020
J	Crepin, A; Santabarbara, S; Caffarri, S				Crepin, Aurelie; Santabarbara, Stefano; Caffarri, Stefano			Biochemical and Spectroscopic Characterization of Highly Stable Photosystem II Supercomplexes from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; OXYGEN-EVOLVING COMPLEX; SUPRAMOLECULAR ORGANIZATION; CRYSTAL-STRUCTURE; EXTRINSIC PROTEINS; THYLAKOID MEMBRANE; ANTENNA COMPLEX; BINDING-SITE; SPINACH; LHCII	Photosystem II (PSII) is a large membrane supercomplex involved in the first step of oxygenic photosynthesis. It is organized as a dimer, with each monomer consisting of more than 20 subunits as well as several cofactors, including chlorophyll and carotenoid pigments, lipids, and ions. The isolation of stable and homogeneous PSII supercomplexes from plants has been a hindrance for their deep structural and functional characterization. In recent years, purification of complexes with different antenna sizes was achieved with mild detergent solubilization of photosynthetic membranes and fractionation on a sucrose gradient, but these preparations were only stable in the cold for a few hours. In this work, we present an improved protocol to obtain plant PSII supercomplexes that are stable for several hours/days at a wide range of temperatures and can be concentrated without degradation. Biochemical and spectroscopic properties of the purified PSII are presented, as well as a study of the complex solubility in the presence of salts. We also tested the impact of a large panel of detergents on PSII stability and found that very few are able to maintain the integrity of PSII. Such new PSII preparation opens the possibility of performing experiments that require room temperature conditions and/or high protein concentrations, and thus it will allow more detailed investigations into the structure and molecular mechanisms that underlie plant PSII function.	[Crepin, Aurelie; Caffarri, Stefano] Aix Marseille Univ, CNRS, CEA, Lab Genet & Biophys Plantes,BIAM, F-13009 Marseille, France; [Santabarbara, Stefano] CNR, Ist Biofis, I-20133 Milan, Italy	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Caffarri, S (corresponding author), Aix Marseille Univ, CNRS, CEA, Lab Genet & Biophys Plantes,BIAM, F-13009 Marseille, France.	stefano.caffarri@univ-amu.fr	Crepin, Aurélie/AAB-2789-2022; Caffarri, Stefano/AAX-8913-2021	Crepin, Aurélie/0000-0002-4754-6823; Caffarri, Stefano/0000-0002-4729-7679; Santabarbara, Stefano/0000-0002-7993-2614	French National Research Agency through the "Investments for the Future" program (France-BioImaging) [ANR-10-INSB-04]	French National Research Agency through the "Investments for the Future" program (France-BioImaging)(French National Research Agency (ANR))	We thank Fabrice Richard and Aicha Aouane (Institut de Biologie du Developpement de Marseille (IBDM)) for technical help with electron microscopy. Pascal Arnoux (Laboratoire de Bioeneretique Cellulaire (LBC)) is thanked for providing the detergent kit. Ben Field (Laboratoire de Genetique et Biophysique des Plantes) is thanked for manuscript revision. Electron microscopy work was supported by the French National Research Agency through the "Investments for the Future" program (France-BioImaging, ANR-10-INSB-04) and was performed at the PiCSL-FBI core facility (Institut de Biologie du Developpement de Marseille, AMU-Marseille UMR 7288).	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Allahverdiyeva Y, 2013, PLANT J, V75, P671, DOI 10.1111/tpj.12230; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Barera S, 2012, PHILOS T R SOC B, V367, P3389, DOI 10.1098/rstb.2012.0056; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Broess K, 2008, BBA-BIOENERGETICS, V1777, P404, DOI 10.1016/j.bbabio.2008.02.003; Buchel C, 2005, PHOTOSYNTH RES, V85, P3, DOI 10.1007/s11120-004-3195-8; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Caffarri S, 2014, CURR PROTEIN PEPT SC, V15, P296, DOI 10.2174/1389203715666140327102218; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Campoli C, 2009, PLANT MOL BIOL, V71, P173, DOI 10.1007/s11103-009-9516-8; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; ENAMI I, 1989, BIOCHIM BIOPHYS ACTA, V977, P33, DOI 10.1016/S0005-2728(89)80006-4; Engelmann ECM, 2005, BBA-BIOENERGETICS, V1706, P276, DOI 10.1016/j.bbabio.2004.11.009; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Grisshammer R, 2006, CURR OPIN BIOTECH, V17, P337, DOI 10.1016/j.copbio.2006.06.001; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; HOMANN PH, 1988, BIOCHIM BIOPHYS ACTA, V934, P1, DOI 10.1016/0005-2728(88)90113-2; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Ifuku K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00084; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MILLER M, 1985, FEBS LETT, V189, P355, DOI 10.1016/0014-5793(85)81055-3; Nield J, 2002, J BIOL CHEM, V277, P15006, DOI 10.1074/jbc.M110549200; Nogales E, 2016, NAT METHODS, V13, P24, DOI 10.1038/nmeth.3694; Pagliano C, 2014, BBA-BIOENERGETICS, V1837, P1454, DOI 10.1016/j.bbabio.2013.11.004; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PETER GF, 1991, J BIOL CHEM, V266, P16745; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2016, PLANTA, V243, P889, DOI 10.1007/s00425-015-2462-6; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmidt-Krey I, 2007, METHODS, V41, P417, DOI 10.1016/j.ymeth.2006.07.011; SHEN JR, 1988, BIOCHIM BIOPHYS ACTA, V936, P386, DOI 10.1016/0005-2728(88)90015-1; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tibiletti T., 2016, PLANT PHYSIOL, DOI [10.1104/pp.16.00572, DOI 10.1104/PP.16.00572]; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; Tumino G, 2008, BIOCHEMISTRY-US, V47, P10449, DOI 10.1021/bi800831j; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yakushevska AE, 2001, EUR J BIOCHEM, V268, P6020, DOI 10.1046/j.0014-2956.2001.02505.x	60	14	14	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19157	19171		10.1074/jbc.M116.738054	http://dx.doi.org/10.1074/jbc.M116.738054			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432883	Green Published, hybrid			2022-12-26	WOS:000383242300047
J	Huls, A; Kramer, U; Gappa, M; Muller-Brandes, C; Schikowski, T; von Berg, A; Hoffmann, B; Schuster, A; Wisbauer, M; Flexeder, C; Heinrich, J; Schulz, H; Berdel, D				Huels, Anke; Kraemer, Ursula; Gappa, Monika; Mueller-Brandes, Christine; Schikowski, Tamara; von Berg, Andrea; Hoffmann, Barbara; Schuster, Antje; Wisbauer, Matthias; Flexeder, Claudia; Heinrich, Joachim; Schulz, Holger; Berdel, Dietrich			Age Dependency of GLI Reference Values Compared with Paediatric Lung Function Data in Two German Studies (GINIplus and LUNOKID)	PLOS ONE			English	Article							CONTEMPORARY AUSTRALASIAN SPIROMETRY; PUBERTAL GROWTH; EQUATIONS; CHILDREN; SAMPLE; ECZEMA	A hallmark of the newly published GLI (Global Lungs Initiative) spirometric reference values is their "all-age" (3-95yr) predictive power, accomplished by incorporating non-linear age dependencies into modelling parameters. This modelling strategy is especially promising for the age range of puberty; however, the performance of GLI-values for adolescents is currently unknown. We calculated GLI-based z-scores for children/adolescents without apparent respiratory diseases from two different German studies, LUNOKID (N = 1943, 4-19 years) and GINIplus (N = 1042, 15 years) and determined the goodness of fit for specific age groups. We defined fit sufficient if the absolute mean of z-scores was <0.5. For children (<10yr) the mean GLI-based z-scores for FEV1 and FVC reached a good fit with mean z-scores for FEV1 between -0.11 and 0.01 and mean z-scores for FVC between 0.01 and 0.16, but larger deviations were observed in adolescents, especially boys (mean z-score -0.58 for FEV1 and -0.57 for FVC in GINIplus). The fit for FEV1/FVC was sufficient. GLI reference values provided reasonable estimates for the individuals enrolled in our studies, which span the age range of lung growth and development. However, we found that GLI-predictions overestimated lung volumes, especially those for German adolescent boys, which may, left unrecognised, lead to erroneous diagnosis of lung disease. Caution should be taken when applying these reference values to epidemiologic studies.	[Huels, Anke; Kraemer, Ursula; Schikowski, Tamara; Hoffmann, Barbara] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Gappa, Monika; von Berg, Andrea; Berdel, Dietrich] Marien Hosp Wesel, Childrens Hosp & Res Inst, Wesel, Germany; [Mueller-Brandes, Christine] Med Sch Hanover, Dept Anaesthesiol & Intens Care Med, Hannover, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Schuster, Antje; Wisbauer, Matthias] Univ Dusseldorf, Univ Childrens Hosp, Dusseldorf, Germany; [Flexeder, Claudia; Heinrich, Joachim; Schulz, Holger] Helmholtz Zentrum Munchen Erman Res Ctr Environm, Inst Epidemiol 1, Munich, Germany; [Heinrich, Joachim; Schulz, Holger] CPC M, Munich, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); St. Marien Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Huls, A (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	Anke.Huels@IUF-Duesseldorf.de	Schulz, Holger/J-5643-2015; Heinrich, Joachim/N-1720-2013; Huels, Anke/J-8743-2019	Schulz, Holger/0000-0002-1157-200X; Heinrich, Joachim/0000-0002-9620-1629; Huels, Anke/0000-0002-6005-417X	GlaxoSmithKline GmbH & Co. KG, Munich, Germany; Aerocrine AB, Solna, Sweden; MSD Sharp & Dohme GmbH, Haar, Germany; AstraZeneca GmbH, Wedel, Germany; Novartis Pharma GmbH, Nuernberg, Germany; Astellas Pharma GmbH, Munich, Germany; Ndd Medizintechnik AG, Zurich, Switzerland, Lions Club Wesel; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Federal Ministry for Environment (IUF) [FKZ 20462296]; Commission of the European Communities, the 7th Framework Program (MeDALL project); Mead Johnson company; Nestle company; Leibniz Association; Deutsche Atemwegsliga	GlaxoSmithKline GmbH & Co. KG, Munich, Germany(GlaxoSmithKline); Aerocrine AB, Solna, Sweden; MSD Sharp & Dohme GmbH, Haar, Germany; AstraZeneca GmbH, Wedel, Germany(AstraZeneca); Novartis Pharma GmbH, Nuernberg, Germany; Astellas Pharma GmbH, Munich, Germany(Astellas Pharmaceuticals); Ndd Medizintechnik AG, Zurich, Switzerland, Lions Club Wesel; Federal Ministry for Education, Science, Research and Technology; Helmholtz Zentrum Munich; Federal Ministry for Environment (IUF); Commission of the European Communities, the 7th Framework Program (MeDALL project); Mead Johnson company; Nestle company(Nestle SA); Leibniz Association; Deutsche Atemwegsliga	LUNOKID was supported by GlaxoSmithKline GmbH & Co. KG, Munich, Germany; Aerocrine AB, Solna, Sweden; MSD Sharp & Dohme GmbH, Haar, Germany; AstraZeneca GmbH, Wedel, Germany; Novartis Pharma GmbH, Nuernberg, Germany; Astellas Pharma GmbH, Munich, Germany, Deutsche Atemwegsliga; Ndd Medizintechnik AG, Zurich, Switzerland, Lions Club Wesel. The GINIplus study was mainly supported for the first 3 years by the Federal Ministry for Education, Science, Research and Technology (interventional arm) and Helmholtz Zentrum Munich (former GSF) (observational arm). The 4-year, 6-year and 10-year follow-up examinations of the GINIplus study were covered from the respective budgets of the 5 study centres (Helmholtz Zentrum Munich (former GSF), Marien-Hospital Wesel, LMU Munich, TU Munich and from 6 years onward also from IUF - Leibniz Research-Institute for Environmental Medicine) and a grant from the Federal Ministry for Environment (IUF, FKZ 20462296). The 15-year follow-up examination of the GINIplus study was supported by the Commission of the European Communities, the 7th Framework Program (MeDALL project) and the Mead Johnson and Nestle companies. The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman H, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0022-2; Ben Saad H, 2013, RESP MED, V107, P2000, DOI 10.1016/j.rmed.2013.10.015; Berdel D, 2010, ATEMWEG LUNGENKRANK, P395; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Bonner R, 2013, AM J RESP CRIT CARE, V188, P515, DOI 10.1164/rccm.201212-2208LE; Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; de Muinich Keizer-Schrama SMPF, HUM REPROD UPDATE, V7, P287; DEGROODT EG, 1986, RESP PHYSIOL, V65, P139, DOI 10.1016/0034-5687(86)90046-0; DEGROODT EG, 1988, EUR RESPIR J, V1, P102; Filipiak B, 2007, J PEDIATR-US, V151, P352, DOI 10.1016/j.jpeds.2007.05.018; Fuertes E, 2015, INT J HYG ENVIR HEAL, V218, P656, DOI 10.1016/j.ijheh.2015.07.003; Hall GL, 2012, RESPIROLOGY, V17, P1150, DOI 10.1111/j.1440-1843.2012.02232.x; Huls A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157569; Huls A, 2016, EUR RESPIR J, V47, P1890, DOI 10.1183/13993003.01465-2015; Huls A, 2014, Pneumologie, V68, P393, DOI 10.1055/s-0034-1367575; Kainu A, 2016, CLIN PHYSIOL FUNCT I, V36, P346, DOI 10.1111/cpf.12237; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Muller-Brandes C, 2014, EUR RESPIR J, V43, P1347, DOI 10.1183/09031936.00058813; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; Quanjer PH, 2015, CHEST, V147, P792, DOI 10.1378/chest.14-1365; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2008, AM J RESP CRIT CARE, V178, P1262, DOI 10.1164/rccm.200805-700OC; R Development Core Team, 2014, R LANG ENV STAT COMP; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; SCHRADER PC, 1984, B EUR PHYSIOPATH RES, V20, P381; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Thompson BR, 2011, RESPIROLOGY, V16, P912, DOI 10.1111/j.1440-1843.2011.01970.x; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Zapletal A, 1987, LUNG FUNCTION CHILDR	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159678	10.1371/journal.pone.0159678	http://dx.doi.org/10.1371/journal.pone.0159678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438002	Green Submitted, gold, Green Published			2022-12-26	WOS:000380170100067
J	Yi, CH; Lei, WY; Hung, JS; Liu, TT; Orr, WC; Fabio, P; Chen, CL				Yi, Chih-Hsun; Lei, Wei-Yi; Hung, Jui-Sheng; Liu, Tso-Tsai; Orr, William C.; Fabio, Pace; Chen, Chien-Lin			Differences in the Control of Secondary Peristalsis in the Human Esophagus: Influence of the 5-HT4 Receptor versus the TRPV1 Receptor	PLOS ONE			English	Article							RED-PEPPER SAUCE; GASTROESOPHAGEAL-REFLUX DISEASE; VAGAL AFFERENT-FIBERS; GASTROINTESTINAL MOTILITY; MOSAPRIDE CITRATE; BOLUS TRANSIT; ION CHANNELS; ACID REFLUX; IN-VITRO; STIMULATION	Objective Acute administration of 5-hydroxytryptamine4 (5-HT4) receptor agonist, mosapride or esophageal infusion of the transient receptor potential vanilloid receptor-1 (TRPV1) agonist capsaicin promotes secondary peristalsis. We aimed to investigate whether acute esophageal instillation of capsaicin-containing red pepper sauce or administration of mosapride has different effects on the physiological characteristics of secondary peristalsis. Methods Secondary peristalsis was induced with mid-esophageal air injections in 14 healthy subjects. We compared the effects on secondary peristalsis subsequent to capsaicin-containing red pepper sauce (pure capsaicin, 0.84 mg) or 40 mg oral mosapride. Results The threshold volume for generating secondary peristalsis during slow air distensions was significantly decreased with capsaicin infusion compared to mosapride (11.6 +/- 1.0 vs. 14.1 +/- 0.8 mL, P = 0.02). The threshold volume required to produce secondary peristalsis during rapid air distension was also significantly decreased with capsaicin infusion (4.6 +/- 0.5 vs. 5.2 +/- 0.6 mL, P = 0.02). Secondary peristalsis was noted more frequently in response to rapid air distension after capsaicin infusion than mosapride (80% [60-100%] vs. 65% [5-100%], P = 0.04). Infusion of capsaicin or mosapride administration didn't change any parameters of primary or secondary peristalsis. Conclusions Esophageal infusion with capsaicin-containing red pepper sauce suspension does create greater mechanosensitivity as measured by secondary peristalsis than 5-HT4 receptor agonist mosapride. Capsaicin-sensitive afferents appear to be more involved in the sensory modulation of distension-induced secondary peristalsis.	[Yi, Chih-Hsun; Lei, Wei-Yi; Hung, Jui-Sheng; Liu, Tso-Tsai; Chen, Chien-Lin] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med, Hualien, Taiwan; [Yi, Chih-Hsun; Lei, Wei-Yi; Hung, Jui-Sheng; Liu, Tso-Tsai; Chen, Chien-Lin] Tzu Chi Univ, Hualien, Taiwan; [Orr, William C.] Univ Oklahoma, Hlth Sci Ctr, Lynn Inst Healthcare Res, Oklahoma City, OK USA; [Fabio, Pace] L Sacco Univ Hosp, Div Gastroenterol, Dept Clin Sci, Milan, Italy	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Milan; Luigi Sacco Hospital	Chen, CL (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med, Hualien, Taiwan.; Chen, CL (corresponding author), Tzu Chi Univ, Hualien, Taiwan.	harry.clchen@msa.hinet.net	Lei, Wei-Yi/AAW-8292-2020		National Science Council, Taiwan [NSC 101-2314-B-303-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant, NSC 101-2314-B-303-005-MY3, from National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, DRUGS FUTURE, V18, P513; Bardan E, 2000, AM J PHYSIOL-GASTR L, V279, pG255, DOI 10.1152/ajpgi.2000.279.2.G255; BASS BL, 1991, SURGERY, V110, P419; Berthoud HR, 1997, BRAIN RES, V746, P195, DOI 10.1016/S0006-8993(96)01222-X; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Chen CL, 2011, NEUROGASTROENT MOTIL, V23, P606, DOI 10.1111/j.1365-2982.2011.01714.x; Chen CL, 2010, NEUROGASTROENT MOTIL, V22, P1177, DOI 10.1111/j.1365-2982.2010.01561.x; Chen CL, 2013, DIGEST DIS SCI, V58, P1948, DOI 10.1007/s10620-013-2584-2; Chen CL, 2008, EUR J GASTROEN HEPAT, V20, P1129, DOI 10.1097/MEG.0b013e328303bff1; Cho YK, 2006, J CLIN GASTROENTEROL, V40, P286, DOI 10.1097/01.mcg.0000210103.82241.97; CLERC N, 1983, J PHYSIOL-LONDON, V336, P487, DOI 10.1113/jphysiol.1983.sp014593; Gonzalez R, 1998, DIGEST DIS SCI, V43, P1165, DOI 10.1023/A:1018831018566; Grider JR, 2003, J PHARMACOL EXP THER, V307, P460, DOI 10.1124/jpet.103.053512; HELM JF, 1984, NEW ENGL J MED, V310, P284, DOI 10.1056/NEJM198402023100503; Holzer P, 2003, CURR OPIN PHARMACOL, V3, P618, DOI 10.1016/j.coph.2003.06.008; HWANG K, 1954, J APPL PHYSIOL, V6, P781, DOI 10.1152/jappl.1954.6.12.781; Itoh H, 2001, BIOL PHARM BULL, V24, P1072, DOI 10.1248/bpb.24.1072; Kessing Boudewijn F, 2012, Curr Gastroenterol Rep, V14, P197, DOI 10.1007/s11894-012-0253-9; Kiraly A, 2001, J PHYSIOLOGY-PARIS, V95, P197, DOI 10.1016/S0928-4257(01)00025-0; KRAVITZ JJ, 1978, AM J PHYSIOL, V234, pE359, DOI 10.1152/ajpendo.1978.234.4.E359; Lang IM, 2001, AM J PHYSIOL-GASTR L, V281, pG1246, DOI 10.1152/ajpgi.2001.281.5.G1246; Lee KJ, 2003, ALIMENT PHARM THERAP, V18, P199, DOI 10.1046/j.1365-2036.2003.01605.x; Liu TT, 2014, NEUROGASTROENT MOTIL, V26, P1487, DOI 10.1111/nmo.12414; Makimoto N, 2002, JPN J PHARMACOL, V90, P28, DOI 10.1254/jjp.90.28; Mantyh PW, 1998, NEURON, V21, P644, DOI 10.1016/S0896-6273(00)80575-9; Mine Y, 1997, J PHARMACOL EXP THER, V283, P1000; Page AJ, 1998, J PHYSIOL-LONDON, V512, P907, DOI 10.1111/j.1469-7793.1998.907bd.x; Pandolfino JE, 2005, AM J PHYSIOL-GASTR L, V288, pG671, DOI 10.1152/ajpgi.00388.2004; Ruth M, 1998, ALIMENT PHARM THERAP, V12, P35; Ruth M, 2003, EUR J GASTROEN HEPAT, V15, P1115, DOI 10.1097/00042737-200310000-00009; SATCHELL PM, 1984, J PHYSIOL-LONDON, V346, P287, DOI 10.1113/jphysiol.1984.sp015022; SCHOEMAN MN, 1995, GUT, V36, P499, DOI 10.1136/gut.36.4.499; SCHOEMAN MN, 1994, GUT, V35, P1523, DOI 10.1136/gut.35.11.1523; SCHOEMAN MN, 1994, GUT, V35, P152, DOI 10.1136/gut.35.2.152; Sekizawa SI, 1999, J APPL PHYSIOL, V86, P1231, DOI 10.1152/jappl.1999.86.4.1231; Sifrim D, 1996, DIGESTION, V57, P73, DOI 10.1159/000201316; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159452	10.1371/journal.pone.0159452	http://dx.doi.org/10.1371/journal.pone.0159452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438088	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100048
J	Devlin, KL; Sanford, T; Harrison, LM; LeBourgeois, P; Lashinger, LM; Mambo, E; Hursting, SD				Devlin, Kaylyn L.; Sanford, Tiffany; Harrison, Lauren M.; LeBourgeois, Paul; Lashinger, Laura M.; Mambo, Elizabeth; Hursting, Stephen D.			Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; INDUCED MAMMARY-TUMORS; ENERGY RESTRICTION; PROMOTION PHASE; EXPRESSION; PROGRESSION; TUMORIGENESIS; PREVENTION; BIOMARKERS; PROGNOSIS	MicroRNAs have emerged as ubiquitous post-transcriptional regulators that coordinate many fundamental processes within cells, including those commonly linked to cancer when dysregulated. Profiling microRNAs across stages of cancer progression provides focus as to which microRNAs are key players in cancer development and are therefore important to manipulate with interventions to delay cancer onset and progression. Calorie restriction is one of the most effective preventive interventions across many types of cancer, although its effects on microRNAs have not been well characterized. We used the dimethylbenz[a]-anthracene-induced model of luminal mammary cancer in Sprague Dawley rats to elucidate which microRNAs are linked to progression in this type of cancer and, subsequently, to study how calorie restriction affects such microRNAs. We identified eight microRNAs (miR-10a, miR-10b, miR-21, miR-124, miR-125b, miR-126, miR-145 and miR-200a) to be associated with DMBA-induced mammary tumor progression. Calorie restriction, which greatly increased tumor-free survival and decreased the overall size of tumors that did develop, significantly decreased the expression of one microRNA, miR-200a, which was positively associated with tumor progression. We further showed that inhibition of miR-200a function, mimicking the effect of calorie restriction on this microRNA, inhibited proliferation in both rat (LA7) and human (MCF7) luminal mammary cancer cell lines. These findings present, for the first time, a stage-specific profile of microRNAs in a rodent model of luminal mammary cancer. Furthermore, we have identified the regulation of miR-200a, a microRNA that is positively associated with progression in this model, as a possible mechanism contributing to the anticancer effects of calorie restriction.	[Devlin, Kaylyn L.] Univ Texas Austin, Dept Mol Biosci, Austin, TX USA; [Sanford, Tiffany; LeBourgeois, Paul; Mambo, Elizabeth] Asuragen Inc, Austin, TX USA; [Harrison, Lauren M.; Lashinger, Laura M.; Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Sanford, Tiffany; Harrison, Lauren M.] Luminex Corp, Austin, TX USA; [LeBourgeois, Paul] Live Edge LLC, Mandeville, LA USA; [Mambo, Elizabeth] Mol Hlth, The Woodlands, TX USA; [Hursting, Stephen D.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA	University of Texas System; University of Texas Austin; Asuragen; University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill	Hursting, SD (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.; Hursting, SD (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC USA.	hursting@email.unc.edu			National Institute of Environmental Health Sciences [T32 ES07247]; Winker Family Foundation; Breast Cancer Research Foundation; National Institute of Health [R35 CA197627]; Asuragen, Inc.; NATIONAL CANCER INSTITUTE [R35CA197627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Winker Family Foundation; Breast Cancer Research Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Asuragen, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication is made possible by a predoctoral fellowship to KLD by grant T32 ES07247 from the National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/), and grants to SDH from the Winker Family Foundation, the Breast Cancer Research Foundation (http://www.bcrfcure.org/), and R35 CA197627 from the National Institute of Health (http://www.nih.gov/). Asuragen, Inc. provided support in the form of salaries for authors TS, PL, EM. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors have been clarified in the 'Author Contributions' section.	Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bertoli G, 2015, THERANOSTICS, V5, P1122, DOI 10.7150/thno.11543; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Cheung SY, 2003, INT J ONCOL, V22, P1383; Costa I, 2002, ARCH PATHOL LAB MED, V126, P915; Dunlap SM, 2012, CANCER PREV RES, V5, P930, DOI 10.1158/1940-6207.CAPR-12-0034; Ford NA, 2013, ENDOCR-RELAT CANCER, V20, P39, DOI 10.1530/ERC-12-0329; Greene SB, 2010, CURR DRUG TARGETS, V11, P1059; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harvie M, 2012, P NUTR SOC, V71, P263, DOI 10.1017/S0029665112000195; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Hursting SD, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-10; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kan CWS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-627; KLURFELD DM, 1989, J NUTR, V119, P286, DOI 10.1093/jn/119.2.286; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048; KRITCHEVSKY D, 1989, NUTR CANCER, V12, P259, DOI 10.1080/01635588909514025; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mizuno NK, 2013, CANCER PREV RES, V6, P540, DOI 10.1158/1940-6207.CAPR-13-0033; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RUGGERI BA, 1989, CANCER RES, V49, P4135; Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074; Thompson HJ, 2000, J MAMMARY GLAND BIOL, V5, P409, DOI 10.1023/A:1009582012493; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Yu SJ, 2013, CLIN CANCER RES, V19, P1389, DOI 10.1158/1078-0432.CCR-12-1959	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159686	10.1371/journal.pone.0159686	http://dx.doi.org/10.1371/journal.pone.0159686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433802	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169600082
J	Ozawa, S; Singh, S; Singh, K; Chhabra, V; Bennett, S				Ozawa, Sachiko; Singh, Suneeta; Singh, Kriti; Chhabra, Vibha; Bennett, Sara			The Avahan Transition: Effects of Transition Readiness on Program Institutionalization and Sustained Outcomes	PLOS ONE			English	Article							HIV-PREVENTION PROGRAM; PUBLIC-HEALTH PROGRAMS; SUSTAINABILITY ASSESSMENT; COUNTRY OWNERSHIP; GLOBAL HEALTH; SCALING-UP; INDIA; RECOMMENDATIONS; ORGANIZATIONS; INNOVATIONS	Background With declines in development assistance for health and growing interest in country ownership, donors are increasingly faced with the task of transitioning health programs to local actors towards a path to sustainability. Yet there is little available guidance on how to measure and evaluate the success of a transition and its subsequent effects. This study assesses the transition of the Avahan HIV/AIDS prevention program in India to investigate how preparations for transition affected continuation of program activities post-transition. Methods Two rounds of two surveys were conducted and supplemented by data from government and Avahan Computerized Management Information Systems (CMIS). Exploratory factor analysis was used to develop two measures: 1) transition readiness pre-transition, and 2) institutionalization (i.e. integration of initial program systems into organizational procedures and behaviors) post-transition. A fixed effects model was built to examine changes in key program delivery outcomes over time. An ordinary least square regression was used to assess the relationship between transition readiness and sustainability of service outcomes both directly, and indirectly through institutionalization. Results Transition readiness data revealed 3 factors (capacity, alignment and communication), on a 15-item scale with adequate internal consistency (alpha 0.73). Institutionalization was modeled as a unidimensional construct, and a 12-item scale demonstrated moderate internal consistency (alpha 0.60). Coverage of key populations and condom distribution were sustained compared to pre-transition levels (p<0.01). Transition readiness, but not institutionalization, predicted sustained outcomes post-transition. Transition readiness did not necessarily lead to institutionalization of key program elements one year after transition. Conclusion Greater preparedness prior to transition is important to achieve better service delivery outcomes post-transition. This paper illustrates a methodology to measure transition readiness pre-transition to identify less ready organizations or program components in advance, improving the likelihood of service sustainability. Further research is needed around the conceptualization and development of measures of institutionalization and its effects on long-term program sustainability.	[Ozawa, Sachiko; Bennett, Sara] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Singh, Suneeta; Singh, Kriti; Chhabra, Vibha] Amaltas Consulting Private Ltd, New Delhi, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ozawa, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	ozawa@jhu.edu	Ozawa, Sachiko/Z-4944-2019; Singh, Kriti/ABE-3814-2020	Ozawa, Sachiko/0000-0001-7608-9038; bennett, sara/0000-0001-8094-8798	Bill and Melinda Gates Foundation [OPPGH5190]; Amaltas Consulting Pvt. Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Amaltas Consulting Pvt. Ltd.	This study was funded by the Bill and Melinda Gates Foundation (OPPGH5190, http://www.gatesfoundation.org). Foundation staff advised the study team, but did not substantively affect the study design, instruments, interpretation of data, or decision to publish. The authors confirm that Amaltas Consulting Pvt. Ltd. provided support in the form of salaries for authors SS, KS, and VC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2008, BUS HIV AIDS PREV SC; [Anonymous], 2014, 360 FHI CMIS; Atun R, 2009, JAIDS-J ACQ IMM DEF, V52, pS67, DOI 10.1097/QAI.0b013e3181bbcd58; Bennett S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136177; Bennett S, 2015, EVAL PROGRAM PLANN, V52, P148, DOI 10.1016/j.evalprogplan.2015.05.003; Bennett S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0894-0; Bennett S, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7360; BREUSCH TS, 1980, REV ECON STUD, V47, P239, DOI 10.2307/2297111; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; COOK RD, 1983, BIOMETRIKA, V70, P1, DOI 10.1093/biomet/70.1.1; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Funders Concerned About AIDS, 2013, GLOB PHIL SUPP ADDR; GOODMAN RM, 1993, HEALTH EDUC QUART, V20, P161, DOI 10.1177/109019819302000208; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Hirschhorn LR, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-57; Institute of Medicine of the National Academies, 2010, PREP FUT HIV AIDS AF; Katz I, 2014, HEALTH POLICY PLANN, V29, P379, DOI 10.1093/heapol/czt024; Le Gargasson JB, 2013, VACCINE, V31, P1886, DOI 10.1016/j.vaccine.2013.02.024; Mabuchi S, 2013, INT J HEALTH PLAN M, V28, P333, DOI 10.1002/hpm.2153; National AIDS Control Organization, 2006, NAT AIDS CONTR PROGR; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Palen J, 2012, JAIDS-J ACQ IMM DEF, V60, pS113, DOI 10.1097/QAI.0b013e31825d28d7; Pickles M, 2013, LANCET GLOB HEALTH, V1, pE289, DOI 10.1016/S2214-109X(13)70083-4; Pluye P, 2004, EVAL PROGRAM PLANN, V27, P121, DOI 10.1016/j.evalprogplan.2004.01.001; Ridde V, 2006, REV EPIDEMIOL SANTE, V54, P421, DOI 10.1016/S0398-7620(06)76740-2; Rodriguez DC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1068-8; Sarriot EG, 2004, INT J HEALTH PLAN M, V19, P23, DOI 10.1002/hpm.744; Sarriot E, 2009, INT J HEALTH PLAN M, V24, P326, DOI 10.1002/hpm.1012; Saxenian H, 2015, HEALTH POLICY PLANN, V30, P197, DOI 10.1093/heapol/czu003; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; Scheirer MA, 2011, AM J PUBLIC HEALTH, V101, P2059, DOI 10.2105/AJPH.2011.300193; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Shen AK, 2015, HEALTH POLICY PLANN, V30, P687, DOI 10.1093/heapol/czu045; Slaghuis SS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-314; Smith K, KAISER UNAIDS STUDY; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; Swidler A, 2009, WORLD DEV, V37, P1182, DOI 10.1016/j.worlddev.2008.11.002; Torpey K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-19; Valentine A, 2015, DONOR FUNDING HLTH L; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158659	10.1371/journal.pone.0158659	http://dx.doi.org/10.1371/journal.pone.0158659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434542	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600013
J	Taylor, MM; Nurse-Findlay, S; Zhang, XL; Hedman, L; Kamb, ML; Broutet, N; Kiarie, J				Taylor, Melanie M.; Nurse-Findlay, Stephen; Zhang, Xiulei; Hedman, Lisa; Kamb, Mary L.; Broutet, Nathalie; Kiarie, James			Estimating Benzathine Penicillin Need for the Treatment of Pregnant Women Diagnosed with Syphilis during Antenatal Care in High-Morbidity Countries	PLOS ONE			English	Article							CONGENITAL-SYPHILIS	Background Congenital syphilis continues to be a preventable cause of global stillbirth and neonatal morbidity and mortality. Shortages of injectable penicillin, the only recommended treatment for pregnant women and infants with syphilis, have been reported by high-morbidity countries. We sought to estimate current and projected annual needs for benzathine penicillin in antenatal care settings for 30 high morbidity countries that account for approximately 33% of the global burden of congenital syphilis. Methods Proportions of antenatal care attendance, syphilis screening coverage in pregnancy, syphilis prevalence among pregnant women, and adverse pregnancy outcomes due to untreated maternal syphilis reported to WHO were applied to 2012 birth estimates for 30 high syphilis burden countries to estimate current and projected benzathine penicillin need for prevention of congenital syphilis. Results Using current antenatal care syphilis screening coverage and seroprevalence, we estimated the total number of women requiring treatment with at least one injection of 2.4 MU of benzathine penicillin in these 30 countries to be 351,016. Syphilis screening coverage at or above 95% for all 30 countries would increase the number of women requiring treatment with benzathine penicillin to 712,030. Based on WHO management guidelines, 351,016 doses of weight-based benzathine penicillin would also be needed for the live-born infants of mothers who test positive and are treated for syphilis in pregnancy. Assuming availability of penicillin and provision of treatment for all mothers diagnosed with syphilis, an estimated 95,938 adverse birth outcomes overall would be prevented including 37,822 stillbirths, 15,814 neonatal deaths, and 34,088 other congenital syphilis cases. Conclusion Penicillin need for maternal and infant syphilis treatment is high among this group of syphilis burdened countries. Initiatives to ensure a stable and adequate supply of benzathine penicillin for treatment of maternal syphilis are important for congenital syphilis prevention, and will be increasingly critical in the future as more countries move toward elimination targets.	[Taylor, Melanie M.; Kamb, Mary L.] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Taylor, Melanie M.; Nurse-Findlay, Stephen; Broutet, Nathalie; Kiarie, James] WHO, Dept Reprod Hlth, Geneva, Switzerland; [Zhang, Xiulei; Hedman, Lisa] WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland; [Zhang, Xiulei] Shandong Prov Chest Hosp, Ctr TB Control, Jinan, Peoples R China	Centers for Disease Control & Prevention - USA; World Health Organization; World Health Organization; Shandong University	Taylor, MM (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA.; Taylor, MM (corresponding author), WHO, Dept Reprod Hlth, Geneva, Switzerland.	mtaylor@who.int		kiarie, james/0000-0003-4180-7858	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, TECHN CONS PREV MAN; [Anonymous], 2003, GLOB STRAT INF YOUNG, P41; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Centers for Disease Control and Prevention (CDC), 2015, MMWR-MORBID MORTAL W, V64, P34; Galvao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056463; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; Heikkinen T, 2000, BRIT J OBSTET GYNAEC, V107, P770, DOI 10.1111/j.1471-0528.2000.tb13339.x; LANG R, 1993, CHEMOTHERAPY, V39, P77, DOI 10.1159/000239106; Lawn JE, 2016, LANCET; Nations United, 2012, WORLD FERT DAT 2012; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Qin J, 2014, PLOS ONE, V9, P1; Sandoz Novartis Company, BENZ BENZ; Watson-Jones D, 2005, TROP MED INT HEALTH, V10, P934, DOI 10.1111/j.1365-3156.2005.01473.x; Wedderburn C., 2015, INT C AIDS SEX TRANS; Wendel GD, 2002, CLIN INFECT DIS, V35, pS200, DOI 10.1086/342108; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organization, GLOB HLTH OBS; World Health Organization, 2015, REP GLOB SEX TRANSM, P52; World Health Organization, 2012, INV CAS EL MOTH CHIL, P9; World Health Organization, 2007, GLOB EL CONG SYPH RA, P33; World Health Organization, 2005, WHOFCHCAH0508; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2015, GLOB AIDS RESP PROGR, P24; World Health Organization Prequalification of In Vitro Diagnostics Programme, WHO PREQ IN VITR DIA; Zhou PY, 2007, SEX TRANSM DIS, V34, P472, DOI 10.1097/01.olq.0000246314.35047.91	28	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159483	10.1371/journal.pone.0159483	http://dx.doi.org/10.1371/journal.pone.0159483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434236	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600055
J	Wang, D; Liu, JX; Gao, YL; Yu, JG; Zheng, CH; Xu, Y				Wang, Dong; Liu, Jin-Xing; Gao, Ying-Lian; Yu, Jiguo; Zheng, Chun-Hou; Xu, Yong			An NMF-L-2,L-1-Norm Constraint Method for Characteristic Gene Selection	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; EXPRESSION DATA; CORE GENES; NOISE	Recent research has demonstrated that characteristic gene selection based on gene expression data remains faced with considerable challenges. This is primarily because gene expression data are typically high dimensional, negative, non-sparse and noisy. However, existing methods for data analysis are able to cope with only some of these challenges. In this paper, we address all of these challenges with a unified method: nonnegative matrix factorization via the L-2,L-1-norm (NMF-L-2,L-1). While L-2,L-1-norm minimization is applied to both the error function and the regularization term, our method is robust to outliers and noise in the data and generates sparse results. The application of our method to plant and tumor gene expression data demonstrates that NMF-L-2,L-1 can extract more characteristic genes than other existing state-of-the-art methods.	[Wang, Dong; Liu, Jin-Xing; Yu, Jiguo; Zheng, Chun-Hou] Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Peoples R China; [Gao, Ying-Lian] Qufu Normal Univ, Lib Qufu Normal Univ, Rizhao 276826, Peoples R China; [Liu, Jin-Xing; Xu, Yong] Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen 518055, Peoples R China	Qufu Normal University; Qufu Normal University; Harbin Institute of Technology; University Town of Shenzhen	Liu, JX (corresponding author), Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao 276826, Peoples R China.; Liu, JX (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Biocomp Res Ctr, Shenzhen 518055, Peoples R China.	sdcavell@126.com	Yu, Jiguo Albert/I-5242-2014; Liu, Jin-Xing/AAU-7257-2020	Yu, Jiguo Albert/0000-0001-6451-1158; 	NSFC [61572284, 61502272, 61370163, 61272339]; Shandong Provincial Natural Science Foundation [ZR2013FL016, BS2014DX004]; Shenzhen Municipal Science and Technology Innovation Council [JCYJ20140904154645958, JCYJ20140417172417174, CXZZ20140904154910774]	NSFC(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Shenzhen Municipal Science and Technology Innovation Council	This work was supported in part by the NSFC under grant nos. 61572284, 61502272, 61370163 and 61272339; the Shandong Provincial Natural Science Foundation, under grant nos. ZR2013FL016 and BS2014DX004; and Shenzhen Municipal Science and Technology Innovation Council (Nos. JCYJ20140904154645958, JCYJ20140417172417174 and CXZZ20140904154910774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; BALADANDAYUTHAPANI V, 2014, IEEE ACM T COMPUTATI, V1; Chen D, 2013, PROC CVPR IEEE, P3025, DOI 10.1109/CVPR.2013.389; Di L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-233; Ding H, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-203; Dinkla K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-201; Fa R, 2014, IEEE ACM T COMPUT BI, V11, P741, DOI 10.1109/TCBB.2014.2312006; Fang XZ, 2014, NEUROCOMPUTING, V128, P304, DOI 10.1016/j.neucom.2013.08.040; Feigelman J, 2014, ARXIV14072112; Ferson W, 2013, J FINANC ECON, V107, P537, DOI 10.1016/j.jfineco.2012.09.006; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Jauhari S, 2014, IEEE ACM T COMPUT BI, V11, P533, DOI 10.1109/TCBB.2014.2312002; Jenks M. A., 2008, PLANT ABIOTIC STRESS; Journee M, 2010, J MACH LEARN RES, V11, P517; Kong D, 2011, ROBUST NONNEGATIVE M, P673; Lee DD, 2001, ADV NEUR IN, V13, P556; Lin CF, 2004, PATTERN RECOGN LETT, V25, P1647, DOI 10.1016/j.patrec.2004.06.009; Liu J, 2009, MULTITASK FEATURE LE, P339; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133124; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106097; Liu JX, 2012, COMPUT BIOL MED, V42, P582, DOI 10.1016/j.compbiomed.2012.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazza T, 2015, IEEE ACM T COMPUTATI, V1; Nie F, 2010, EFFICIENT ROBUST FEA, P1813; Nie F, 2014, OPTIMAL MEAN ROBUST, P1062; Nie F, 2008, TRACE RATIO CRITERIO, P671; Nie F., 2010, ADV NEURAL INFORM PR, V2, P1813; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Nyamundanda G, 2014, J ROYAL STAT SOC C; Ortega-Martorell S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-38; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Utreras F, 2013, SIAM J SCI STAT COMP, V2; Witten Daniela M, 2009, BIOSTATISTICS; Wu M., 2013, PLOS ONE, P8; Yalavarthy PK, 2007, MED PHYS, V34, P2085, DOI 10.1118/1.2733803; Yang SZ, 2013, NEURAL COMPUT APPL, V23, P541, DOI 10.1007/s00521-013-1371-5; Zhang Y., 2006, J COMPUTER APPL, V4; Zheng CH, 2011, IEEE T NANOBIOSCI, V10, P86, DOI 10.1109/TNB.2011.2144998; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115	42	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158494	10.1371/journal.pone.0158494	http://dx.doi.org/10.1371/journal.pone.0158494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428058	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300009
J	Wongjaikam, S; Kumfu, S; Khamseekaew, J; Sripetchwandee, J; Srichairatanakool, S; Fucharoen, S; Chattipakorn, SC; Chattipakorn, N				Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Srichairatanakool, Somdet; Fucharoen, Suthat; Chattipakorn, Siriporn C.; Chattipakorn, Nipon			Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats	PLOS ONE			English	Article							BETA-THALASSEMIA MAJOR; OXIDATIVE STRESS; N-ACETYLCYSTEINE; CARDIAC IRON; MITOCHONDRIAL DYSFUNCTION; CURRENT KNOWLEDGE; CALCIUM-CHANNEL; DEFERIPRONE; DEFERASIROX; CARDIOMYOPATHY	Background Iron chelators are used to treat iron overload cardiomyopathy patients. However, a direct comparison of the benefits of three common iron chelators (deferoxamine (DFO), deferiprone (DFP) and deferasirox (DFX)) or an antioxidant (N-acetyl cysteine (NAC)) with a combined DFP and NAC treatments on left ventricular (LV) function with iron overload has not been investigated. Methods and Findings Male Wistar rats were fed with either a normal diet or a high iron diet (HFe group) for 4 months. After 2 months, the HFe-fed rats were divided into 6 groups to receive either: a vehicle, DFO (25 mg/kg/day), DFP (75 mg/kg/day), DFX (20 mg/kg/day), NAC (100 mg/kg/day) or the combined DFP and NAC for 2 months. Our results demonstrated that HFe rats had increased plasma non-transferrin bound iron (NTBI), malondialdehyde (MDA), cardiac iron and MDA levels and cardiac mitochondrial dysfunction, leading to LV dysfunction. Although DFO, DFP, DFX or NAC improved these parameters, leading to improved LV function, the combined DFP and NAC therapy caused greater improvement, leading to more extensively improved LV function. Conclusions The combined DFP and NAC treatment had greater efficacy than monotherapy in cardioprotection through the reduction of cardiac iron deposition and improved cardiac mitochondrial function in iron-overloaded rats.	[Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand; [Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Chattipakorn, Siriporn C.; Chattipakorn, Nipon] Chiang Mai Univ, Dept Physiol, Fac Med, Cardiac Electrophysiol Unit, Chiang Mai, Thailand; [Wongjaikam, Suwakon; Kumfu, Sirinart; Khamseekaew, Juthamas; Sripetchwandee, Jirapas; Chattipakorn, Nipon] Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai, Thailand; [Chattipakorn, Siriporn C.] Chiang Mai Univ, Dept Oral Biol & Diagnost Sci, Fac Dent, Chiang Mai, Thailand; [Srichairatanakool, Somdet] Chiang Mai Univ, Dept Biochem, Fac Med, Chiang Mai, Thailand; [Fucharoen, Suthat] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Nakhon Pathom, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Mahidol University	Chattipakorn, N (corresponding author), Chiang Mai Univ, Cardiac Electrophysiol Res & Training Ctr, Fac Med, Chiang Mai, Thailand.; Chattipakorn, N (corresponding author), Chiang Mai Univ, Dept Physiol, Fac Med, Cardiac Electrophysiol Unit, Chiang Mai, Thailand.; Chattipakorn, N (corresponding author), Chiang Mai Univ, Ctr Excellence Cardiac Electrophysiol Res, Chiang Mai, Thailand.	nchattip@gmail.com	Chattipakorn, Nipon/AAJ-4049-2021	Srichairatanakool, Somdet/0000-0002-5706-8781; Chattipakorn, Nipon/0000-0003-3026-718X; Sripetchwandee, Jirapas/0000-0002-4473-7018	NSTDA Research Chair Grant from National Science and Technology Development Agency Thailand; Thailand Research Fund [BRG5780016, MRG5980222, TRG5880045]; Royal Golden Jubilee PhD program; Chiang Mai University Center of Excellence Award; Faculty of Medicine Chiang Mai University Fund	NSTDA Research Chair Grant from National Science and Technology Development Agency Thailand; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee PhD program(Thailand Research Fund (TRF)); Chiang Mai University Center of Excellence Award; Faculty of Medicine Chiang Mai University Fund	This work was supported by the NSTDA Research Chair Grant from the National Science and Technology Development Agency Thailand (NC) and grants from the Thailand Research Fund BRG5780016 (SC), MRG5980222 (SK), TRG5880045 (JS), the Royal Golden Jubilee PhD program (SC and SW), Chiang Mai University Center of Excellence Award (NC), and the Faculty of Medicine Chiang Mai University Fund (SW and NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abetz L, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-73; Apaijai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102374; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Asif M, 2015, J PAK MED ASSOC, V65, P838; Aziza Samy Ali Hussein, 2014, Pak J Biol Sci, V17, P964, DOI 10.3923/pjbs.2014.964.977; BANNER W, 1986, TOXICOL APPL PHARM, V83, P142, DOI 10.1016/0041-008X(86)90331-5; Bartfay WJ, 1999, CARDIOVASC RES, V43, P892, DOI 10.1016/S0008-6363(99)00040-1; Berdoukas V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-20; Burke W, 2002, BEST PRACT RES CL HA, V15, P315, DOI 10.1053/beha.2002.0002; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chinda K, 2014, DIABETES VASC DIS RE, V11, P75, DOI 10.1177/1479164113516134; Darley-Usmar V, 2004, FREE RADICAL BIO MED, V37, P753, DOI 10.1016/j.freeradbiomed.2004.05.026; Lima AHRD, 2011, ARQ BRAS CARDIOL, V96, P498; Fibach E, 2010, ANN NY ACAD SCI, V1202, P10, DOI 10.1111/j.1749-6632.2010.05577.x; Gao XS, 2010, FREE RADICAL BIO MED, V49, P401, DOI 10.1016/j.freeradbiomed.2010.04.033; Gao XS, 2009, J BIOL CHEM, V284, P4767, DOI 10.1074/jbc.M806235200; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Glos M, 2007, P ANN INT IEEE EMBS, P263, DOI 10.1109/IEMBS.2007.4352274; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509; Hershko C, 2006, HAEMATOLOGICA, V91, P1307; Hershko C, 2010, ANN NY ACAD SCI, V1202, P1, DOI 10.1111/j.1749-6632.2010.05544.x; Hider RC, 2010, ANN NY ACAD SCI, V1202, P94, DOI 10.1111/j.1749-6632.2010.05573.x; HJORTSO E, 1990, EUR J CLIN PHARMACOL, V39, P29, DOI 10.1007/BF02657052; HOUGLUM K, 1990, J CLIN INVEST, V86, P1991, DOI 10.1172/JCI114934; Hui L, 2003, HEART, V89, P669, DOI 10.1136/heart.89.6.669; Knutson MD, 2000, J NUTR, V130, P621, DOI 10.1093/jn/130.3.621; Kramer JH, 2012, CAN J PHYSIOL PHARM, V90, P1257, DOI [10.1139/y2012-091, 10.1139/Y2012-091]; Kremastinos DT, 2011, CIRCULATION, V124, P2253, DOI 10.1161/CIRCULATIONAHA.111.050773; Kremastinos DT, 2010, CIRC-HEART FAIL, V3, P451, DOI 10.1161/CIRCHEARTFAILURE.109.913863; Kumfu S, 2012, BIOMETALS, V25, P1167, DOI 10.1007/s10534-012-9579-x; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; Latchman PL, 2011, CLIN AUTON RES, V21, P319, DOI 10.1007/s10286-011-0116-8; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Ma YM, 2014, BIOCHEM J, V463, P351, DOI 10.1042/BJ20140795; Maggio A, 2002, BLOOD CELL MOL DIS, V28, P196, DOI 10.1006/bcmd.2002.0510; Montuschi P, 1999, AM J RESP CRIT CARE, V160, P216, DOI 10.1164/ajrccm.160.1.9809140; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Morrow JD, 1996, BIOCHEM PHARMACOL, V51, P1, DOI 10.1016/0006-2952(95)02072-1; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Ozdemir ZC, 2014, HEMOGLOBIN, V15, P1; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pennell DJ, 2012, HAEMATOL-HEMATOL J, V97, P842, DOI 10.3324/haematol.2011.049957; Pepe A, 2006, EUR J HAEMATOL, V76, P183, DOI 10.1111/j.1600-0609.2005.00587.x; Pepe A, 2011, HAEMATOL-HEMATOL J, V96, P41, DOI 10.3324/haematol.2009.019042; Piga A, 2010, ANN NY ACAD SCI, V1202, P75, DOI 10.1111/j.1749-6632.2010.05586.x; Pongkan W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122503; Porter JB, 2010, ANN NY ACAD SCI, V1202, P87, DOI 10.1111/j.1749-6632.2010.05582.x; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Samniang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19749; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; SINGH S, 1990, ANAL BIOCHEM, V186, P320, DOI 10.1016/0003-2697(90)90088-Q; Sripetchwandee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085115; Surinkaew S, 2013, J CARDIOVASC PHARM, V61, P133, DOI 10.1097/FJC.0b013e318279b7b1; Tabatabaie M, 2013, IRAN J KIDNEY DIS, V7, P299; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Thummasorn S, 2011, MITOCHONDRION, V11, P457, DOI 10.1016/j.mito.2011.01.008; Walker J M, 1994, Methods Mol Biol, V32, P5; Wijarnpreecha K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130837; Wongjaikam S, 2015, EUR J PHARMACOL, V765, P86, DOI 10.1016/j.ejphar.2015.08.017; Wood JC, 2006, TRANSL RES, V148, P272, DOI 10.1016/j.trsl.2006.05.005; Wood JC, 2010, BLOOD, V116, P537, DOI 10.1182/blood-2009-11-250308; Zannos-Mariolea L, 2008, BRIT J HAEMATOL, V26, P193; Ziegler D, 2015, ACTA DIABETOL, V52, P65, DOI 10.1007/s00592-014-0601-3; ZURLO MG, 1989, LANCET, V2, P27, DOI 10.1016/S0140-6736(89)90264-X	68	34	35	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159414	10.1371/journal.pone.0159414	http://dx.doi.org/10.1371/journal.pone.0159414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428732	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169300063
J	Prado-Oviedo, NA; Bonaparte-Saller, MK; Malloy, EJ; Meehan, CL; Mench, JA; Carlstead, K; Brown, JL				Prado-Oviedo, Natalia A.; Bonaparte-Saller, Mary K.; Malloy, Elizabeth J.; Meehan, Cheryl L.; Mench, Joy A.; Carlstead, Kathy; Brown, Janine L.			Evaluation of Demographics and Social Life Events of Asian (Elephas maximus) and African Elephants (Loxodonta africana) in North American Zoos	PLOS ONE			English	Article							ARTIFICIAL-INSEMINATION; STRESS; ORGANIZATION; SENESCENCE; MANAGEMENT; DYNAMICS; BEHAVIOR; STATE; MUSTH	This study quantified social life events hypothesized to affect the welfare of zoo African and Asian elephants, focusing on animals that were part of a large multi-disciplinary, multi-institutional elephant welfare study in North America. Age was calculated based on recorded birth dates and an age-based account of life event data for each elephant was compiled. These event histories included facility transfers, births and deaths of offspring, and births and deaths of non-offspring herd mates. Each event was evaluated as a total number of events per elephant, lifetime rate of event exposure, and age at first event exposure. These were then compared across three categories: species (African vs. Asian); sex (male vs. female); and origin (imported vs. captive-born). Mean age distributions differed (p<0.05) between the categories: African elephants were 6 years younger than Asian elephants, males were 12 years younger than females, and captive-born elephants were 20 years younger than imported elephants. Overall, the number of transfers ranged from 0 to 10, with a 33% higher age-adjusted transfer rate for imported African than imported Asian elephants, and 37% lower rate for imported females than males (p<0.05). Other differences (p<0.05) included a 96% higher rate of offspring births for captive-born females than those imported from range countries, a 159% higher rate of birthing event exposures for captive-born males than for their imported counterparts, and Asian elephant females being 4 years younger than African females when they produced their first calf. In summarizing demographic and social life events of elephants in North American zoos, we found both qualitative and quantitative differences in the early lives of imported versus captive-born elephants that could have long-term welfare implications.	[Prado-Oviedo, Natalia A.; Brown, Janine L.] Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Prado-Oviedo, Natalia A.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Malloy, Elizabeth J.] American Univ, Dept Math & Stat, 4400 Massachusetts Ave NW, Washington, DC 20016 USA; [Meehan, Cheryl L.] AWARE Inst, Portland, OR USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; University of California System; University of California Davis; University of California System; University of California Davis; American University	Prado-Oviedo, NA (corresponding author), Smithsonian Natl Zool Pk, Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA.; Prado-Oviedo, NA (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.	PradoN@si.edu	Malloy, Elizabeth/AAP-6243-2021; Malloy, Elizabeth/AAV-6244-2021	Malloy, Elizabeth/0000-0002-7209-5147	Institution of Museum and Library Services [LG-25-10-0033-10]; Smithsonian National Zoological Park; Honolulu Zoo; IMLS; AWARE Institute	Institution of Museum and Library Services; Smithsonian National Zoological Park(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute); Honolulu Zoo; IMLS; AWARE Institute	Funding for this project was received from The Institution of Museum and Library Services; grant number LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Smithsonian National Zoological Park (JLB, NP-O); Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLOU J, 1985, INT STUDBOOK GOLDEN; Baranyi J, 2005, PHYSIOL BEHAV, V84, P511, DOI 10.1016/j.physbeh.2005.01.005; Bartolomucci A, 2001, PHYSIOL BEHAV, V73, P401, DOI 10.1016/S0031-9384(01)00453-X; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Brown JL, 2007, GEN COMP ENDOCR, V151, P153, DOI 10.1016/j.ygcen.2007.01.006; Brown JL, 2014, ADV EXP MED BIOL, V753, P135, DOI 10.1007/978-1-4939-0820-2_8; Brown JL, 2004, ZOO BIOL, V23, P45, DOI 10.1002/zoo.10116; Brown JL, 2016, PLOS ONE; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Christensen JW, 2011, APPL ANIM BEHAV SCI, V133, P199, DOI 10.1016/j.applanim.2011.05.013; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; COOPER KA, 1990, ZOO BIOL, V9, P297, DOI 10.1002/zoo.1430090405; Coutellier L, 2007, APPL ANIM BEHAV SCI, V105, P102, DOI 10.1016/j.applanim.2006.05.007; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Douglas-Hamilton I.O., 1975, ELEPHANTS, V113, P72; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; Faust L., 2011, TECHNICAL REPORT ZOO; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; FOOSE TJ, 1978, ACTA ZOOL PATHOL ANT, P119; Fowler M.E., 1993, ZOO WILD ANIMAL MED; FRASER D, 1978, ANIM BEHAV, V26, P22, DOI 10.1016/0003-3472(78)90004-0; Glaeser SS, 2012, THERIOGENOLOGY, V78, P285, DOI 10.1016/j.theriogenology.2012.01.014; Glatson AR, 1998, P 5 C BREED END SPEC, P53; Glatston AR, 1986, INT ZOO YB, V24, P162; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goldenberg SZ, 2014, ANIM BEHAV, V95, P111, DOI 10.1016/j.anbehav.2014.07.002; Greco BJ, 2016, PLOS ONE; Haller J, 1999, BRAIN RES BULL, V50, P33, DOI 10.1016/S0361-9230(99)00087-8; Hayward AD, 2014, J EVOLUTION BIOL, V27, P772, DOI 10.1111/jeb.12350; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hermes R, 2008, THERIOGENOLOGY, V70, P131, DOI 10.1016/j.theriogenology.2008.04.003; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Hildebrandt TB, 2012, THERIOGENOLOGY, V78, P1398, DOI 10.1016/j.theriogenology.2012.06.014; Hildebrandt TB, 2000, ZOO BIOL, V19, P333, DOI 10.1002/1098-2361(2000)19:5&lt;333::AID-ZOO5&gt;3.0.CO;2-A; Holdgate MR, 2016, PLOS ONE; IBM Corp, 2016, IBM SPSS STAT WIND V; Kleiman D. G., 1977, International Zoo Yearbook, V17, DOI 10.1111/j.1748-1090.1977.tb00923.x; KOROSI A, 2012, PLOS ONE 2016, V227, P400, DOI DOI 10.1016/J.BBR.2011.07.037; Lahdenpera M, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0054-0; Latham N.R, 2005, REFINING ROLE STEREO; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Lee Phyllis C., 1999, Symposia of the Zoological Society of London, V72, P102; Lee PC, 2016, BEHAV ECOL SOCIOBIOL, V70, P337, DOI 10.1007/s00265-015-2051-5; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Ljungberg T, 2000, PRIMATES, V41, P79, DOI 10.1007/BF02557463; Meehan CL, 2016, PLOS ONE; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Moss C, 1988, ELEPHANT MEMORIES; Moss C.J., 2011, AMBOSELI ELEPHANTS L, DOI DOI 10.7208/CHICAGO/9780226542263.001.0001; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Newberry RC, 2008, APPL ANIM BEHAV SCI, V110, P3, DOI 10.1016/j.applanim.2007.03.021; Olson D, 2000, ZOO BIOL, V19, P311, DOI 10.1002/1098-2361(2000)19:5<311::AID-ZOO3>3.3.CO;2-F; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; POOLE JH, 1989, SYM ZOOL S, V61, P111; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Rietkerk F, 1998, EEP YB 1997 98; Ryan S, 2002, ZOO BIOL, V21, P389, DOI 10.1002/zoo.10045; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Slotow R., 2001, Koedoe, V44, P85; Spinage C.A., 1994, ELEPHANTS; Stone AI, 2010, BEHAV PROCESS, V83, P8, DOI 10.1016/j.beproc.2009.08.008; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Sukumar R., 2003, LIVING EVOLUTIONARY; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sukumar Raman, 1994, ELEPHANT DAYS NIGHTS; Vidya TNC, 2005, J ETHOL, V23, P205, DOI 10.1007/s10164-005-0144-8; VISALBERGHI E, 1993, ANIM WELFARE, V2, P3; Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	78	24	25	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0154750	10.1371/journal.pone.0154750	http://dx.doi.org/10.1371/journal.pone.0154750			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415437	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500008
J	Shimono, M; Higaki, T; Kaku, H; Shibuya, N; Hasezawa, S; Day, B				Shimono, Masaki; Higaki, Takumi; Kaku, Hanae; Shibuya, Naoto; Hasezawa, Seiichiro; Day, Brad			Quantitative Evaluation of Stomatal Cytoskeletal Patterns during the Activation of Immune Signaling in Arabidopsis thaliana	PLOS ONE			English	Article							PLANT INNATE IMMUNITY; ACTIN DYNAMICS; POWDERY MILDEW; PATHWAYS; RECEPTOR; PROTEIN; RESISTANCE; FILAMENTS; NETWORK	Historically viewed as primarily functioning in the regulation of gas and water vapor exchange, it is now evident that stomata serve an important role in plant immunity. Indeed, in addition to classically defined functions related to cell architecture and movement, the actin cytoskeleton has emerged as a central component of the plant immune system, underpinning not only processes related to cell shape and movement, but also receptor activation and signaling. Using high resolution quantitative imaging techniques, the temporal and spatial changes in the actin microfilament array during diurnal cycling of stomatal guard cells has revealed a highly orchestrated transition from random arrays to ordered bundled filaments. While recent studies have demonstrated that plant stomata close in response to pathogen infection, an evaluation of stimulus-induced changes in actin cytoskeletal dynamics during immune activation in the guard cell, as well as the relationship of these changes to the function of the actin cytoskeleton and stomatal aperture, remains undefined. In the current study, we employed quantitative cell imaging and hierarchical clustering analyses to define the response of the guard cell actin cytoskeleton to pathogen infection and the elicitation of immune signaling. Using this approach, we demonstrate that stomatal-localized actin filaments respond rapidly, and specifically, to both bacterial phytopathogens and purified pathogen elicitors. Notably, we demonstrate that higher order temporal and spatial changes in the filament array show distinct patterns of organization during immune activation, and that changes in the naive diurnal oscillations of guard cell actin filaments are perturbed by pathogens, and that these changes parallel pathogen-induced stomatal gating. The data presented herein demonstrate the application of a highly tractable and quantifiable method to assign transitions in actin filament organization to the activation of immune signaling in plants.	[Shimono, Masaki; Day, Brad] Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St A286, E Lansing, MI 48824 USA; [Higaki, Takumi; Hasezawa, Seiichiro] Univ Tokyo, Dept Integrated Biosci, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778562, Japan; [Kaku, Hanae; Shibuya, Naoto] Meiji Univ, Sch Agr, Dept Life Sci, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan; [Day, Brad] Michigan State Univ, Grad Program Genet, 2240E Biomed Phys Sci, E Lansing, MI 48824 USA; [Day, Brad] Michigan State Univ, Grad Program Cell & Mol Biol, 2240A Biomed Phys Sci, E Lansing, MI 48824 USA	Michigan State University; University of Tokyo; Meiji University; Michigan State University; Michigan State University	Day, B (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St A286, E Lansing, MI 48824 USA.; Day, B (corresponding author), Michigan State Univ, Grad Program Genet, 2240E Biomed Phys Sci, E Lansing, MI 48824 USA.; Day, B (corresponding author), Michigan State Univ, Grad Program Cell & Mol Biol, 2240A Biomed Phys Sci, E Lansing, MI 48824 USA.	bday@msu.edu		Day, Brad/0000-0002-9880-4319	Ministry of Education, Science and Culture of Japan [25711017, 22248041, 26650104]; MEXT [S1411023]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Institute of Science and Technology from Meiji University; U.S. National Science Foundation [IOS-1557437];  [15H01240]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Science and Technology from Meiji University; U.S. National Science Foundation(National Science Foundation (NSF)); 	This work was supported by Grants-in-Aid to TH (25711017) and NS (22248041 and 26650104) from the Ministry of Education, Science and Culture of Japan. Research in the lab of HK is supported by Grants-in-Aid for Scientific Research on Innovative Areas (15H01240), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411023), the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Research Project Grant from the Institute of Science and Technology from Meiji University. Research in the laboratory of BD is supported the U.S. National Science Foundation (IOS-1557437).; We thank Amy Baetsen-Young, Alex Corrion, and Yi-Ju Lu for critical reading of the manuscript. This work was supported by Grants-in-Aid to TH (25711017) and NS (22248041 and 26650104) from the Ministry of Education, Science and Culture of Japan. Research in the lab of HK is supported by Grants-in-Aid for Scientific Research on Innovative Areas (15H01240), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1411023), the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Research Project Grant from the Institute of Science and Technology from Meiji University. Research in the laboratory of BD is supported the U.S. National Science Foundation (IOS-1557437).	Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Bigeard J, 2015, MOL PLANT, V8, P521, DOI 10.1016/j.molp.2014.12.022; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Day B, 2011, ANNU REV PHYTOPATHOL, V49, P483, DOI 10.1146/annurev-phyto-072910-095426; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Guo M, 2016, CELL HOST MICROBE, V19, P67, DOI 10.1016/j.chom.2015.12.007; Harries PA, 2009, P NATL ACAD SCI USA, V106, P17594, DOI 10.1073/pnas.0909239106; Hayafune M, 2014, P NATL ACAD SCI USA, V111, pE404, DOI 10.1073/pnas.1312099111; Henty-Ridilla JL, 2014, PLANT CELL, V26, P340, DOI 10.1105/tpc.113.122499; Henty-Ridilla JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003290; Higaki T, 2007, CURR OPIN PLANT BIOL, V10, P549, DOI 10.1016/j.pbi.2007.08.012; Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x; Higaki T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-80; Inada N, 2016, PLANT PHYSIOL; Inada N, 2016, J PLANT RES, V129, P103, DOI 10.1007/s10265-015-0769-9; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kang YS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004232; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Li JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8206; Liu SG, 2012, PLANT CELL REP, V31, P1219, DOI 10.1007/s00299-012-1242-z; Lozano-Duran R, 2014, NEW PHYTOL, V202, P259, DOI 10.1111/nph.12651; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Miklis M, 2007, PLANT PHYSIOL, V144, P1132, DOI 10.1104/pp.107.098897; Moes D, 2013, MOL PLANT, V6, P483, DOI 10.1093/mp/sss075; Murata Y, 2015, ANNU REV PLANT BIOL, V66, P369, DOI 10.1146/annurev-arplant-043014-114707; Ou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101587; Porter K, 2016, J INTEGR PLANT BIOL, V58, P299, DOI 10.1111/jipb.12445; Porter K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003006; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Shimono M, 2016, PLANT PHYSIOL; Shinya T, 2015, CURR OPIN PLANT BIOL, V26, P64, DOI 10.1016/j.pbi.2015.05.032; Staiger CJ, 2009, J CELL BIOL, V184, P269, DOI 10.1083/jcb.200806185; Tian MY, 2009, PLANT PHYSIOL, V150, P815, DOI 10.1104/pp.109.137604; Wang WM, 2009, PLANT CELL, V21, P2898, DOI 10.1105/tpc.109.067587; Zeng WQ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002291	39	13	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159291	10.1371/journal.pone.0159291	http://dx.doi.org/10.1371/journal.pone.0159291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415815	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500121
J	Takaya, A; Hirohashi, Y; Murai, A; Morita, R; Saijo, H; Yamamoto, E; Kubo, T; Nakatsugawa, M; Kanaseki, T; Tsukahara, T; Tamura, Y; Takemasa, I; Kondo, T; Sato, N; Torigoe, T				Takaya, Akari; Hirohashi, Yoshihiko; Murai, Aiko; Morita, Rena; Saijo, Hiroshi; Yamamoto, Eri; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Tamura, Yasuaki; Takemasa, Ichiro; Kondo, Toru; Sato, Noriyuki; Torigoe, Toshihiko			Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480	PLOS ONE			English	Article							SIDE POPULATION; STATE	Human cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) can be isolated as side population (SP) cells, aldehyde dehydrogenase high (ALDH(high)) cells or cell surface marker-positive cells including CD44(+) cells and CD133(+) cells. CSCs/CICs and non-CSCs/CICs are unstable in in vitro culture, and CSCs/CICs can differentiate into non-CSCs/CICs and some non-CSCs/CICs can dedifferentiate into CSCs/CICs. Therefore, experiments using a large amount of CSCs/CICs are technically very difficult. In this study, we isolated single cell clones from SP cells and main population (MP) cells derived from the human colon cancer cell line SW480. SP analysis revealed that SP clone cells had relatively high percentages of SP cells, whereas MP clone cells showed very few SP cells, and the phenotypes were sustainable for more than 2 months of in vitro culture. Xenograft transplantation revealed that SP clone cells have higher tumor-initiating ability than that of MP clone cells and SP clone cell showed higher chemo-resistance compared with MP clone cells. These results indicate that SP clone cells derived from SW480 cells are enriched with CSCs/CICs, whereas MP clone cells are pure non-CSCs/CICs. SP clone cells and MP clone cells are a very stable in vitro CSC/CIC-enriched and non-CSC/CIC model for further analysis.	[Takaya, Akari; Hirohashi, Yoshihiko; Murai, Aiko; Morita, Rena; Saijo, Hiroshi; Yamamoto, Eri; Kubo, Terufumi; Nakatsugawa, Munehide; Kanaseki, Takayuki; Tsukahara, Tomohide; Sato, Noriyuki; Torigoe, Toshihiko] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Saijo, Hiroshi] Sapporo Med Univ, Sch Med, Dept Resp Med & Allergol, Sapporo, Hokkaido 0608543, Japan; [Tamura, Yasuaki] Hokkaido Univ, Ctr Food & Med Innovat, Dept Mol Therapeut, Sapporo, Hokkaido 0608638, Japan; [Takemasa, Ichiro] Sapporo Med Univ, Sch Med, Dept Surg, Sapporo, Hokkaido 0608543, Japan; [Kondo, Toru] Hokkaido Univ, Inst Med Genet, Div Stem Cell Biol, Sapporo, Hokkaido 0608638, Japan	Sapporo Medical University; Sapporo Medical University; Hokkaido University; Sapporo Medical University; Hokkaido University	Hirohashi, Y; Torigoe, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022	Kanaseki, Takayuki/0000-0001-7294-6880	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research; Northern Advancement Center for Science & Technology of Hokkaido Japan; Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research(Kobayashi Foundation for Cancer Research); Northern Advancement Center for Science & Technology of Hokkaido Japan; Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. S.), program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. S.) and Takeda Science Foundation (to Y. H.), Sagawa Foundation for Promotion of Cancer Research (to Y. H.), Suharakinenzaidan Co., Ltd. (to Y.H.) and Kobayashi foundation for cancer research (to Y.H.). This study was supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan (to Y.H. and T. Torigoe). This research is supported by the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED (to T. Torigoe).	Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Inoda S, 2011, AM J PATHOL, V178, P1805, DOI 10.1016/j.ajpath.2011.01.004; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Moti N, 2015, ONCOGENE, V34, P1843, DOI 10.1038/onc.2014.112; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nakatsugawa M, 2011, J IMMUNOASS IMMUNOCH, V32, P93, DOI 10.1080/15321819.2010.543219; Nishizawa S, 2012, CANCER RES, V72, P2844, DOI 10.1158/0008-5472.CAN-11-3062; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Yasuda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068187	20	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158903	10.1371/journal.pone.0158903	http://dx.doi.org/10.1371/journal.pone.0158903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415781	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500047
J	Cardenas-Garcia, S; Dunwoody, RP; Marcano, V; Diel, DG; Williams, RJ; Gogal, RM; Brown, CC; Miller, PJ; Afonso, CL				Cardenas-Garcia, Stivalis; Dunwoody, Robert P.; Marcano, Valerie; Diel, Diego G.; Williams, Robert J.; Gogal, Robert M., Jr.; Brown, Corrie C.; Miller, Patti J.; Afonso, Claudio L.			Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity	PLOS ONE			English	Article							RECOMBINANT SUBUNIT VACCINE; IFN-GAMMA; DNA VACCINE; IMMUNE-RESPONSE; EXPRESSION; ADJUVANT; CLONING; INFECTION; EFFICACY	More effective vaccines are needed to control avian diseases. The use of chicken interferon gamma (chIFN gamma) during vaccination is a potentially important but controversial approach that may improve the immune response to antigens. In the present study, three different systems to co-deliver chIFN gamma with Newcastle disease virus (NDV) antigens were evaluated for their ability to enhance the avian immune response and their protective capacity upon challenge with virulent NDV. These systems consisted of: 1) a DNA vaccine expressing the Newcastle disease virus fusion (F) protein co-administered with a vector expressing the chIFN gamma gene for in ovo and booster vaccination, 2) a recombinant Newcastle disease virus expressing the chIFN gamma gene (rZJ1*L/IFN gamma) used as a live vaccine delivered in ovo and into juvenile chickens, and 3) the same rZJ1*L/IFN gamma virus used as an inactivated vaccine for juvenile chickens. Co-administration of chIFN gamma with a DNA vaccine expressing the F protein resulted in higher levels of morbidity and mortality, and higher amounts of virulent virus shed after challenge when compared to the group that did not receive chIFN gamma. The live vaccine system co-delivering chIFN gamma did not enhanced post-vaccination antibody response, nor improved survival after hatch, when administered in ovo, and did not affect survival after challenge when administered to juvenile chickens. The low dose of the inactivated vaccine co-delivering active chIFN gamma induced lower antibody titers than the groups that did not receive the cytokine. The high dose of this vaccine did not increase the antibody titers or antigen-specific memory response, and did not reduce the amount of challenge virus shed or mortality after challenge. In summary, regardless of the delivery system, chIFN gamma, when administered simultaneously with the vaccine antigen, did not enhance Newcastle disease virus vaccine immunogenicity.	[Cardenas-Garcia, Stivalis; Marcano, Valerie; Miller, Patti J.; Afonso, Claudio L.] USDA SEA, Southeast Poultry Res Lab, Athens, GA 30613 USA; [Cardenas-Garcia, Stivalis; Marcano, Valerie; Brown, Corrie C.] Univ Georgia, Coll Vet Med, Dept Vet Pathol, Athens, GA USA; [Dunwoody, Robert P.] Mercer Univ, Mem Univ Med Ctr, Sch Med, Savannah, GA USA; [Diel, Diego G.] South Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA; [Williams, Robert J.; Gogal, Robert M., Jr.] Univ Georgia, Coll Vet Med, Dept Biosci & Diagnost Imaging, Athens, GA USA	United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; Mercer University; South Dakota State University; University System of Georgia; University of Georgia	Afonso, CL (corresponding author), USDA SEA, Southeast Poultry Res Lab, Athens, GA 30613 USA.	claudio.afonso@ars.usda.gov	Diel, Diego G./ABC-6242-2021; Miller, Patti/T-3933-2019	Diel, Diego G./0000-0003-3237-8940; Marcano, Valerie/0000-0003-2218-7577; Cardenas Garcia, Stivalis/0000-0002-7613-8642	United States Department of Agriculture, Agricultural Research Service [CRIS 6612-32000-064-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS 6612-32000-064-00D.	Abbas AK aL, 2012, CELLULAR MOL IMMUNOL; Alexander D.J., 2008, LAB MANUAL ISOLATION, V4th, P135; Asif M, 2004, IMMUNOL CELL BIOL, V82, P638, DOI 10.1111/j.1440-1711.2004.01295.x; Cardenas-Garcia S, 2015, BIOLOGICALS, V43, P136, DOI 10.1016/j.biologicals.2014.11.003; Choi KS, 2014, TROP ANIM HEALTH PRO, V46, P271, DOI 10.1007/s11250-013-0475-3; Choi KS, 2013, VIRUS GENES, V47, P244, DOI 10.1007/s11262-013-0930-2; DIGBY MR, 1995, J INTERF CYTOK RES, V15, P939, DOI 10.1089/jir.1995.15.939; Ding XC, 2004, INFECT IMMUN, V72, P6939, DOI 10.1128/IAI.72.12.6939-6944.2004; Fringuelli E, 2010, RES VET SCI, V89, P367, DOI 10.1016/j.rvsc.2010.03.021; Gallili GE, 1998, BIOTECHNOL ADV, V16, P343, DOI 10.1016/S0734-9750(97)00081-5; Ganar K, 2014, VIRUS RES, V184, P71, DOI 10.1016/j.virusres.2014.02.016; Goossens KE, 2013, DEV COMP IMMUNOL, V41, P370, DOI 10.1016/j.dci.2013.05.020; Haq K, 2011, ANTIVIR RES, V90, P218, DOI 10.1016/j.antiviral.2011.04.001; He HQ, 2011, CYTOKINE, V53, P363, DOI 10.1016/j.cyto.2010.12.009; HEATH AW, 1989, IMMUNOLOGY, V67, P520; Jaganathan S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0537-z; Jansen T, 2005, VACCINE, V23, P1053, DOI 10.1016/j.vaccine.2004.08.023; Kaiser P, 1998, J INTERF CYTOK RES, V18, P711, DOI 10.1089/jir.1998.18.711; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kammon A, 2015, AVIAN DIS, V59, P422, DOI 10.1637/11068-032215-ResNote.1; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074022; Li HT, 2007, VET IMMUNOL IMMUNOP, V117, P67, DOI 10.1016/j.vetimm.2007.01.009; Liu YL, 2007, ARCH VIROL, V152, P1241, DOI 10.1007/s00705-007-0961-x; LOWENTHAL JW, 1995, J INTERF CYTOK RES, V15, P933, DOI 10.1089/jir.1995.15.933; Lowenthal JW, 1998, J INTERF CYTOK RES, V18, P617, DOI 10.1089/jir.1998.18.617; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; Min WG, 2001, VACCINE, V20, P267, DOI 10.1016/S0264-410X(01)00270-5; Nath B, 2015, MICROB PATHOG; Nimal S, 2005, VACCINE, V23, P3984, DOI 10.1016/j.vaccine.2005.01.160; OIE (World Organisation for Animal Health), 2012, MANUAL DIAGNOSTIC TE; Park JH, 2009, J VET SCI, V10, P131, DOI 10.4142/jvs.2009.10.2.131; QUIROGA JA, 1990, HEPATOLOGY, V12, P661, DOI 10.1002/hep.1840120407; Rautenschlein S, 1999, VACCINE, V18, P426, DOI 10.1016/S0264-410X(99)00254-6; Sawant PM, 2011, VET IMMUNOL IMMUNOP, V144, P36, DOI 10.1016/j.vetimm.2011.07.006; Schat K. A., 2013, AVIAN IMMUNOLOGY, V2nd; Schijns VECJ, 2000, VACCINE, V18, P2147, DOI 10.1016/S0264-410X(99)00537-X; Schultz UA, 1999, J VIROL, V73, P3162, DOI 10.1128/JVI.73.4.3162-3168.1999; Shabbir MZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-170; Shen SY, 2015, VET IMMUNOL IMMUNOP, V167, P200, DOI 10.1016/j.vetimm.2015.08.002; Song KD, 1997, VET IMMUNOL IMMUNOP, V58, P321, DOI 10.1016/S0165-2427(97)00034-2; Sreekumar E, 2009, INT J POULTRY SCI, V8, P122; Sun M., 2013, GENOME ANNOUNC, V1; Susta L, 2013, MICROB PATHOGENESIS, V61-62, P73, DOI 10.1016/j.micpath.2013.05.009; Weining KC, 1996, EUR J IMMUNOL, V26, P2440, DOI 10.1002/eji.1830261026; Xu JJ, 2012, J ANIM VET ADV, V11, P4394; Yeh HY, 1999, J INTERF CYTOK RES, V19, P687, DOI 10.1089/107999099313848; Yin JM, 2007, VIRAL IMMUNOL, V20, P288, DOI 10.1089/vim.2006.0108	48	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159153	10.1371/journal.pone.0159153	http://dx.doi.org/10.1371/journal.pone.0159153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409587	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300061
J	Lassale, C; Gunter, MJ; Romaguera, D; Peelen, LM; Van der Schouw, YT; Beulens, JWJ; Freisling, H; Muller, DC; Ferrari, P; Huybrechts, I; Fagherazzi, G; Boutron-Ruault, MC; Affret, A; Overvad, K; Dahm, CC; Olsen, A; Roswall, N; Tsilidis, KK; Katzke, VA; Kuhn, T; Buijsse, B; Quiros, JR; Sanchez-Cantalejo, E; Etxezarreta, N; Huerta, JM; Barricarte, A; Bonet, C; Khaw, KT; Key, TJ; Trichopoulou, A; Bamia, C; Lagiou, P; Palli, D; Agnoli, C; Tumino, R; Fasanelli, F; Panico, S; Bueno-De-Mesquita, HB; Boer, JMA; Sonestedt, E; Nilsson, LM; Renstrom, F; Weiderpass, E; Skeie, G; Lund, E; Moons, KGM; Riboli, E; Tzoulaki, I				Lassale, Camille; Gunter, Marc J.; Romaguera, Dora; Peelen, Linda M.; Van der Schouw, Yvonne T.; Beulens, Joline W. J.; Freisling, Heinz; Muller, David C.; Ferrari, Pietro; Huybrechts, Inge; Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie; Overvad, Kim; Dahm, Christina C.; Olsen, Anja; Roswall, Nina; Tsilidis, Konstantinos K.; Katzke, Verena A.; Kuehn, Tilman; Buijsse, Brian; Quiros, Jose-Ramon; Sanchez-Cantalejo, Emilio; Etxezarreta, Nerea; Maria Huerta, Jose; Barricarte, Aurelio; Bonet, Catalina; Khaw, Kay-Tee; Key, Timothy J.; Trichopoulou, Antonia; Bamia, Christina; Lagiou, Pagona; Palli, Domenico; Agnoli, Claudia; Tumino, Rosario; Fasanelli, Francesca; Panico, Salvatore; Bueno-de-Mesquita, H. Bas; Boer, Jolanda M. A.; Sonestedt, Emily; Nilsson, Lena Maria; Renstrom, Frida; Weiderpass, Elisabete; Skeie, Guri; Lund, Eiliv; Moons, Karel G. M.; Riboli, Elio; Tzoulaki, Ioanna			Diet Quality Scores and Prediction of All-Cause, Cardiovascular and Cancer Mortality in a Pan-European Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTHY EATING INDEX; POSTMENOPAUSAL WOMEN; MULTIETHNIC COHORT; MEDITERRANEAN DIET; EPIC PROJECT; LIFE-STYLE; RISK; ADHERENCE; NUTRITION	Scores of overall diet quality have received increasing attention in relation to disease aetiology; however, their value in risk prediction has been little examined. The objective was to assess and compare the association and predictive performance of 10 diet quality scores on 10-year risk of all-cause, CVD and cancer mortality in 451,256 healthy participants to the European Prospective Investigation into Cancer and Nutrition, followed-up for a median of 12.8y. All dietary scores studied showed significant inverse associations with all outcomes. The range of HRs (95% CI) in the top vs. lowest quartile of dietary scores in a composite model including non-invasive factors (age, sex, smoking, body mass index, education, physical activity and study centre) was 0.75 (0.72-0.79) to 0.88 (0.84-0.92) for all-cause, 0.76 (0.69-0.83) to 0.84 (0.76-0.92) for CVD and 0.78 (0.73-0.83) to 0.91 (0.85-0.97) for cancer mortality. Models with dietary scores alone showed low discrimination, but composite models also including age, sex and other non-invasive factors showed good discrimination and calibration, which varied little between different diet scores examined. Mean C-statistic of full models was 0.73, 0.80 and 0.71 for all-cause, CVD and cancer mortality. Dietary scores have poor predictive performance for 10-year mortality risk when used in isolation but display good predictive ability in combination with other non-invasive common risk factors.	[Lassale, Camille; Gunter, Marc J.; Romaguera, Dora; Tsilidis, Konstantinos K.; Riboli, Elio; Tzoulaki, Ioanna] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Romaguera, Dora] Inst Invest Sanit Palma IdISPa, Palma De Mallorca, Spain; [Romaguera, Dora; Sanchez-Cantalejo, Emilio; Etxezarreta, Nerea; Maria Huerta, Jose; Barricarte, Aurelio; Bonet, Catalina] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain; [Peelen, Linda M.; Van der Schouw, Yvonne T.; Beulens, Joline W. J.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Freisling, Heinz; Muller, David C.; Ferrari, Pietro; Huybrechts, Inge] Int Agcy Res Canc, Lyon, France; [Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie] Inst Natl Sante & Rech Med, Ctr Res Epidemiol & Populat, U1018, Hlth,Team 9, Villejuif, France; [Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie] Inst Gustave Roussy, Villejuif, France; [Fagherazzi, Guy; Boutron-Ruault, Marie-Christine; Affret, Aurelie] Paris South Univ, Unite Mixte Rech 1018, Villejuif, France; [Overvad, Kim; Dahm, Christina C.] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Olsen, Anja; Roswall, Nina] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Tsilidis, Konstantinos K.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Katzke, Verena A.; Kuehn, Tilman] Deutsch Inst Ernahrungsforsch Potsdam Rehbrucke, German Inst Human Nutr, Potsdam, Germany; [Buijsse, Brian] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Quiros, Jose-Ramon] Publ Hlth Directorate, Oviedo, Spain; [Sanchez-Cantalejo, Emilio] Andalusian Sch Publ Hlth, Granada, Spain; [Etxezarreta, Nerea] Publ Hlth Direct, San Sebastian, Spain; [Etxezarreta, Nerea] Biodonostia Basque Reg Hlth Dept, San Sebastian, Spain; [Maria Huerta, Jose] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Bonet, Catalina] Catalan Inst Oncol, Unit Nutr Environm & Canc, Barcelona, Spain; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England; [Key, Timothy J.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford OX1 2JD, England; [Trichopoulou, Antonia; Bamia, Christina; Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Trichopoulou, Antonia; Bamia, Christina; Lagiou, Pagona] Hellen Hlth Fdn, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Agnoli, Claudia] Fdn Carlo Besta Neurol Inst, Epidemiol & Prevent Unit, Dept Prevent & Predict Med, Milan, Italy; [Tumino, Rosario] Civic MP Arezzo Hosp, Canc Registry & Histopathol Unit, Ragusa, Italy; [Fasanelli, Francesca] Human Genet Fdn, Turin, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Bueno-de-Mesquita, H. Bas; Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Sonestedt, Emily] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Nilsson, Lena Maria; Renstrom, Frida] Umea Univ, Dept Publ Hlth & Clin Med, Nutr Res, Umea, Sweden; [Weiderpass, Elisabete; Skeie, Guri; Lund, Eiliv] Univ Tromso, Arctic Univ Norway, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland	Imperial College London; Institut Investigacio Sanitaria Illes Balears (IdISBa); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Utrecht University; Utrecht University Medical Center; World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Aarhus University; Danish Cancer Society; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Ioannina; Escuela Andaluza de Salud Publica; Murcia Regional Health Council; Public Health Institute of Navarra; Catalan Institute of Oncology; University of Cambridge; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Istituto Neurologico Besta; Civile M.P. Arezzo Hospital; University of Naples Federico II; Netherlands National Institute for Public Health & the Environment; Lund University; Umea University; UiT The Arctic University of Tromso; University of Oslo; Karolinska Institutet; Folkhalsan Research Center	Tzoulaki, I (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	i.tzoulaki@imperial.ac.uk	Dahm, Christina C/G-9787-2014; Boutron-Ruault, Marie-Christine/H-3936-2014; Affret, Aurélie/T-1297-2019; Weiderpass, Elisabete/M-4029-2016; Romaguera, Dora/AAB-2852-2020; Tzoulaki, Ioanna/ABE-6269-2020; Fagherazzi, Guy/P-3534-2017; Weiderpass, Elisabete/AAP-2747-2021; Muller, David C/V-8207-2017; Huerta, José María/N-8654-2015; Fagherazzi, Guy/ABB-2555-2020; Romaguera, Dora/ABE-7004-2020; Bonet, Catalina/AFR-7176-2022; TRICHOPOULOU, ANTONIA/ABF-8727-2021; van der Schouw, Yvonne T./F-8327-2014; Khaw, Kay-Tee/AAZ-3209-2021; Lassale, Camille/ABE-7813-2020; Gunter, Marc/AAP-8621-2020; Roswall, Nina/AAJ-6700-2020; Agnoli, Claudia/K-5916-2016	Dahm, Christina C/0000-0003-0481-2893; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Affret, Aurélie/0000-0002-6070-1197; Weiderpass, Elisabete/0000-0003-2237-0128; Tzoulaki, Ioanna/0000-0002-4275-9328; Fagherazzi, Guy/0000-0001-5033-5966; Weiderpass, Elisabete/0000-0003-2237-0128; Muller, David C/0000-0002-2350-0417; Huerta, José María/0000-0002-9637-3869; Fagherazzi, Guy/0000-0001-5033-5966; Romaguera, Dora/0000-0002-5762-8558; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; van der Schouw, Yvonne T./0000-0002-4605-435X; Lassale, Camille/0000-0002-9340-2708; Roswall, Nina/0000-0003-3071-1658; Agnoli, Claudia/0000-0003-4472-1179; Lund, Eiliv/0000-0002-8071-8711; Gunter, Marc/0000-0001-5472-6761; Bonet, Catalina/0000-0003-0259-2591; Riboli, Elio/0000-0001-6795-6080; Nilsson, Lena Maria/0000-0002-2354-7258; Olsen, Anja/0000-0003-4788-503X; Skeie, Guri/0000-0003-2476-4251; Freisling, Heinz/0000-0001-8648-4998; Tsilidis, Konstantinos/0000-0002-8452-8472; Beulens, Joline/0000-0002-4181-0937; Rasul, holem/0000-0003-0579-9029; Overvad, Kim/0000-0001-6429-7921; tumino, rosario/0000-0003-2666-414X	European Commission (D-GSANCO); International Agency for Research on Cancer; Danish Cancer Society (Denmark); Ligue Contre le Cancer (France); Institut Gustave Roussy (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ) (Germany); Federal Ministry of Education and Research (BMBF) (Germany); Deutsche Krebshilfe (Germany); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC- Italy (Italy); National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Health Research Fund (FIS) [PI13/00061]; Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra, ISCIII RETIC [RD06/0020]; Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK [14136, C570/A16491, C8221/A19170]; Medical Research Council (United Kingdom) [1000143, MR/M012190/1]; MRC [MR/N003284/1] Funding Source: UKRI; Cancer Research UK [16491] Funding Source: researchfish; Medical Research Council [G1000143, MR/N003284/1, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	European Commission (D-GSANCO)(European CommissionEuropean Commission Joint Research Centre); International Agency for Research on Cancer; Danish Cancer Society (Denmark)(Danish Cancer Society); Ligue Contre le Cancer (France); Institut Gustave Roussy (France); Mutuelle Generale de l'Education Nationale (France); Institut National de la Sante et de la Recherche Medicale (INSERM) (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Aid, German Cancer Research Center (DKFZ) (Germany); Federal Ministry of Education and Research (BMBF) (Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe (Germany)(Deutsche Krebshilfe); Deutsches Krebsforschungszentrum (Germany); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC- Italy (Italy)(Fondazione AIRC per la ricerca sul cancro); National Research Council (Italy)(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Statistics Netherlands (The Netherlands)(Netherlands Government); Health Research Fund (FIS)(Instituto de Salud Carlos III); Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra, ISCIII RETIC; Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK(Cancer Research UK); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The coordination of EPIC is financially supported by the European Commission (D-GSANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe, Deutsches Krebsforschungszentrum and Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC- Italy and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS), PI13/00061 to Granada, Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra, ISCIII RETIC (RD06/0020) (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skane and Vasterbotten (Sweden); Cancer Research UK (14136 to EPIC-Norfolk; C570/A16491 and C8221/A19170 to EPIC-Oxford), Medical Research Council (1000143 to EPIC-Norfolk, MR/M012190/1 to EPIC-Oxford) (United Kingdom).	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Berentzen NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070535; Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282; Chiuve SE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000954; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Fransen HP, 2008, CURR OPIN CLIN NUTR, V11, P559, DOI 10.1097/MCO.0b013e32830a49db; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; George SM, 2014, AM J EPIDEMIOL, V180, P616, DOI 10.1093/aje/kwu173; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Harmon BE, 2015, AM J CLIN NUTR, V101, P587, DOI 10.3945/ajcn.114.090688; Hippisley-Cox J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007825; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ireland J, 2002, EUR J CLIN NUTR, V56, pS33, DOI 10.1038/sj.ejcn.1601427; Jankovic N, 2014, AM J EPIDEMIOL, V180, P978, DOI 10.1093/aje/kwu229; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Kipnis V, 2002, PUBLIC HEALTH NUTR, V5, P915, DOI 10.1079/PHN2002383; McKenzie F, 2015, INT J CANCER, V136, P2640, DOI 10.1002/ijc.29315; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Olsen A, 2011, J NUTR, V141, P639, DOI 10.3945/jn.110.131375; Paynter NP, 2014, CIRCULATION, V130, P1466, DOI 10.1161/CIRCULATIONAHA.114.012069; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Price HC, 2011, DIABETIC MED, V28, P363, DOI 10.1111/j.1464-5491.2010.03212.x; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Roswall N, 2015, EUR J EPIDEMIOL, V30, P509, DOI 10.1007/s10654-015-0021-x; Roswall N, 2014, PUBLIC HEALTH NUTR, V17, P2650, DOI 10.1017/S1368980014000159; Rumawas ME, 2009, J NUTR, V139, P1150, DOI 10.3945/jn.108.103424; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Steyerberg E., 2009, CLIN PREDICTION MODE; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vergnaud AC, 2013, AM J CLIN NUTR, V97, P1107, DOI 10.3945/ajcn.112.049569; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WCRF/AICR, 2015, CANC LINK GREAT BOD; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; WHO, 2011, ICD 10 INT STAT CLAS, V2; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	46	60	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159025	10.1371/journal.pone.0159025	http://dx.doi.org/10.1371/journal.pone.0159025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409582	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300050
J	Grzegorzewicz, AE; de Sousa-d'Auria, C; McNeil, MR; Huc-Claustre, E; Jones, V; Petit, C; Angala, SK; Zemanova, J; Wang, QL; Belardinelli, JM; Gao, Q; Ishizaki, Y; Mikusova, K; Brennan, PJ; Ronning, DR; Chami, M; Houssin, C; Jackson, M				Grzegorzewicz, Anna E.; de Sousa-d'Auria, Celia; McNeil, Michael R.; Huc-Claustre, Emilie; Jones, Victoria; Petit, Cecile; Angala, Shiva Kumar; Zemanova, Julia; Wang, Qinglan; Belardinelli, Juan Manuel; Gao, Qian; Ishizaki, Yoshimasa; Mikusova, Katarina; Brennan, Patrick J.; Ronning, Donald R.; Chami, Mohamed; Houssin, Christine; Jackson, Mary			Assembling of the Mycobacterium tuberculosis Cell Wall Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPSA-PSR FAMILY; CORYNEBACTERIUM-GLUTAMICUM; CAPSULAR POLYSACCHARIDE; STAPHYLOCOCCUS-AUREUS; OUTER-MEMBRANE; FUNCTIONAL-ANALYSIS; ARABINOGALACTAN; STREPTOCOCCUS; BIOSYNTHESIS; PROTEIN	The unique cell wall of mycobacteria is essential to their viability and the target of many clinically used anti-tuberculosis drugs and inhibitors under development. Despite intensive efforts to identify the ligase(s) responsible for the covalent attachment of the two major heteropolysaccharides of the mycobacterial cell wall, arabinogalactan (AG) and peptidoglycan (PG), the enzyme or enzymes responsible have remained elusive. We here report on the identification of the two enzymes of Mycobacterium tuberculosis, CpsA1 (Rv3267) and CpsA2 (Rv3484), responsible for this function. CpsAl and CpsA2 belong to the widespread LytR-Cps2A-Psr (LCP) family of enzymes that has been shown to catalyze a variety of glycopolymer transfer reactions in Gram-positive bacteria, including the attachment of wall teichoic acids to PG. Although individual cpsA1 and cpsA2 knock-outs of M. tuberculosis were readily obtained, the combined inactivation of both genes appears to be lethal. In the closely related microorganism Corynebacterium glutamicum, the ortholog of cpsA1 is the only gene involved in this function, and its conditional knockdown leads to dramatic changes in the cell wall composition and morphology of the bacteria due to extensive shedding of cell wall material in the cut ture medium as a result of defective attachment of AG to PG. This work marks an important step in our understanding of the biogenesis of the unique cell envelope of mycobacteria and opens new opportunities for drug development.	[Grzegorzewicz, Anna E.; McNeil, Michael R.; Huc-Claustre, Emilie; Jones, Victoria; Angala, Shiva Kumar; Wang, Qinglan; Belardinelli, Juan Manuel; Ishizaki, Yoshimasa; Brennan, Patrick J.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [de Sousa-d'Auria, Celia; Houssin, Christine] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France; [Petit, Cecile] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA; [Zemanova, Julia; Mikusova, Katarina] Comenius Univ, Fac Nat Sci, Dept Biochem, Mlynska Dolina CH 1, Bratislava 84215, Slovakia; [Wang, Qinglan; Gao, Qian] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Shanghai Med Coll,Key Lab Med Mol Virol MOE & MOH, Shanghai 200032, Peoples R China; [Wang, Qinglan; Gao, Qian] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Ishizaki, Yoshimasa] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo 31423, Japan; [Chami, Mohamed] Univ Basel, Biozentrum, C CINA Ctr Imaging & NanoAnalyt, Mattenstr 26, CH-4058 Basel, Switzerland	Colorado State University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University System of Ohio; University of Toledo; Comenius University Bratislava; Fudan University; Fudan University; University of Basel	Houssin, C (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France.; Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	christine.houssin@u-psud.fr; Mary.Jackson@colostate.edu	Brennan, Patrick J/G-6896-2017; Claustre, Emilie Huc/M-6693-2016; Wang, Qinglan/AAM-3023-2020; McNeil, Michael/G-3325-2019; Mikusova, Katarina/I-3622-2014; Belardinelli, Juan Manuel/N-7335-2019; Jackson, Mary/D-5345-2017	Claustre, Emilie Huc/0000-0002-8856-207X; Belardinelli, Juan Manuel/0000-0003-1336-9141; Jackson, Mary/0000-0002-9212-0258; Wang, Qinglan/0000-0002-7629-5058; Mikusova, Katarina/0000-0002-0100-4877; Ronning, Donald/0000-0003-2583-8849; Sousa, Celia R/0000-0001-8988-3724; Houssin, christine/0000-0003-4319-1313	NIAID, National Institutes of Health [AI119670]; College of Veterinary Medicine and Biomedical Sciences Research Council (Colorado State University); Swiss National Science Foundation (SystemsX.ch RTD CINA); Swiss National Science Foundation (NCCR TransCure); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084, R21AI119670] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); College of Veterinary Medicine and Biomedical Sciences Research Council (Colorado State University); Swiss National Science Foundation (SystemsX.ch RTD CINA)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (NCCR TransCure)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health, Grant AI119670 and the College of Veterinary Medicine and Biomedical Sciences Research Council (Colorado State University). The electron microscopy work at C-CINA (Biozentrum) was supported in part by the Swiss National Science Foundation (SystemsX.ch RTD CINA and NCCR TransCure). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, GLYCOBIOLOGY, V16, P1073, DOI 10.1093/glycob/cwl030; Angala SK, 2014, CRIT REV BIOCHEM MOL, V49, P361, DOI 10.3109/10409238.2014.925420; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Barry Clifton E., 2007, Infectious Disorders - Drug Targets, V7, P182; Belardinelli JM, 2014, J BIOL CHEM, V289, P27952, DOI 10.1074/jbc.M114.581199; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bhamidi S, 2012, ANAL BIOCHEM, V421, P240, DOI 10.1016/j.ab.2011.10.046; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Chan YGY, 2014, J BIOL CHEM, V289, P15680, DOI 10.1074/jbc.M114.567669; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Eberhardt A, 2012, MICROB DRUG RESIST, V18, P240, DOI 10.1089/mdr.2011.0232; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hancock IC, 2002, MICROBIOL-SGM, V148, P3059, DOI 10.1099/00221287-148-10-3059; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Hubscher J, 2009, FEMS MICROBIOL LETT, V295, P251, DOI 10.1111/j.1574-6968.2009.01603.x; Ishizaki Y, 2013, J BIOL CHEM, V288, P30309, DOI 10.1074/jbc.M113.492173; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; MIKUSOVA K, 1995, ANTIMICROB AGENTS CH, V39, P2484, DOI 10.1128/AAC.39.11.2484; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Pavelka MS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0034-2013; PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x; Raad RB, 2010, J BACTERIOL, V192, P2691, DOI 10.1128/JB.00009-10; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Wang QL, 2015, INFECT IMMUN, V83, P2844, DOI 10.1128/IAI.03081-14; Wu CG, 2014, MOL MICROBIOL, V94, P1227, DOI 10.1111/mmi.12780; Yagi T, 2003, J BIOL CHEM, V278, P26497, DOI 10.1074/jbc.M302216200; Zilla ML, 2015, J BACTERIOL, V197, P3731, DOI 10.1128/JB.00656-15; Zilla ML, 2015, J BACTERIOL, V197, P343, DOI 10.1128/JB.02364-14; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	44	30	31	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18867	18879		10.1074/jbc.M116.739227	http://dx.doi.org/10.1074/jbc.M116.739227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417139	Green Published, hybrid			2022-12-26	WOS:000383242300025
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			An Oral Load of [C-13(3)]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO LIPOGENESIS; GLUCOSE-PRODUCTION; GLUCONEOGENESIS; IMPROVES; FLUXES	Drugs and other interventions for high impact hepatic diseases often target biochemical pathways such as gluconeogenesis, lipogenesis, or the metabolic response to oxidative stress. However, traditional liver function tests do not provide quantitative data about these pathways. In this study, we developed a simple method to evaluate these processes by NMR analysis of plasma metabolites. Healthy subjects ingested [U-C-13(3)]glycerol, and blood was drawn at multiple times. Each subject completed three visits under differing nutritional states. High resolution C-13 NMR spectra of plasma triacylglycerols and glucose provided new insights into a number of hepatic processes including fatty acid esterification, the pentose phosphate pathway, and gluconeogenesis through the tricarboxylic acid cycle. Fasting stimulated pentose phosphate pathway activity and metabolism of [U-C-13(3)]glycerol in the tricarboxylic acid cycle prior to gluconeogenesis or glyceroneogenesis. Fatty acid esterification was transient in the fasted state but continuous under fed conditions. We conclude that a simple NMR analysis of blood metabolites provides an important biomarker of pentose phosphate pathway activity, triacylglycerol synthesis, and flux through anaplerotic pathways in mitochondria of human liver.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] VA North Texas Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [DK099289, DK058398, EB015908, HL34557]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557, R01HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK099289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK099289 (to E. S. J.), DK058398 and EB015908 (to C. R. M.), and HL34557 (to A. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Auger C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00040; Bock G, 2008, DIABETES, V57, P50, DOI 10.2337/db07-0694; Browning JD, 2008, HEPATOLOGY, V48, P1487, DOI 10.1002/hep.22504; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Federico A, 2014, WORLD J GASTROENTERO, V20, P16841, DOI 10.3748/wjg.v20.i45.16841; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Goulet Eric D. B., 2008, Journal of Physiological Anthropology, V27, P263, DOI 10.2114/jpa2.27.263; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jin ES, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.577692; Jin ES, 2015, J CLIN ENDOCR METAB, V100, P235, DOI 10.1210/jc.2014-2404; Jin ES, 2013, J BIOL CHEM, V288, P14488, DOI 10.1074/jbc.M113.461947; Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; MAGNUSSON I, 1988, P NATL ACAD SCI USA, V85, P4682, DOI 10.1073/pnas.85.13.4682; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Massicotte D, 2006, EUR J APPL PHYSIOL, V96, P322, DOI 10.1007/s00421-005-0058-8; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Takahashi Y, 2015, WORLD J GASTROENTERO, V21, P3777, DOI 10.3748/wjg.v21.i13.3777; Ugochukwu NH, 2007, CHEM-BIOL INTERACT, V165, P45, DOI 10.1016/j.cbi.2006.10.008; Van Rosendal SP, 2012, MED SCI SPORT EXER, V44, P1780, DOI 10.1249/MSS.0b013e31825420f4	27	13	15	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19031	19041		10.1074/jbc.M116.742262	http://dx.doi.org/10.1074/jbc.M116.742262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432878	hybrid, Green Published			2022-12-26	WOS:000383242300037
J	Bouch, S; Harding, R; O'Reilly, M; Wood, LG; Sozo, F				Bouch, Sheena; Harding, Richard; O'Reilly, Megan; Wood, Lisa G.; Sozo, Foula			Impact of Dietary Tomato Juice on Changes in Pulmonary Oxidative Stress, Inflammation and Structure Induced by Neonatal Hyperoxia in Mice (Mus musculus)	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; LUNG-FUNCTION; AIRWAY INFLAMMATION; PROLONGED HYPEROXIA; EXERCISE CAPACITY; CHILDREN BORN; PRETERM BIRTH; ADULT MICE; SUPPLEMENTATION; ANTIOXIDANTS	Many preterm infants require hyperoxic gas for survival, although it can contribute to lung injury. Experimentally, neonatal hyperoxia leads to persistent alterations in lung structure and increases leukocytes in bronchoalveolar lavage fluid (BALF). These effects of hyperoxia on the lungs are considered to be caused, at least in part, by increased oxidative stress. Our objective was to determine if dietary supplementation with a known source of antioxidants (tomato juice, TJ) could protect the developing lung from injury caused by breathing hyperoxic gas. Neonatal mice (C57BL6/J) breathed either 65% O-2 (hyperoxia) or room air from birth until postnatal day 7 (P7d); some underwent necropsy at P7d and others were raised in room air until adulthood (P56d). In subsets of both groups, drinking water was replaced with TJ (diluted 50: 50 in water) from late gestation to necropsy. At P7d and P56d, we analyzed total antioxidant capacity (TAC), markers of oxidative stress (nitrotyrosine and heme oxygenase-1 expression), inflammation (interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) expression), collagen (COL) and smooth muscle in the lungs; we also assessed lung structure. We quantified macrophages in lung tissue (at P7d) and leukocytes in BALF (at P56d). At P7d, TJ increased pulmonary TAC and COL1a1 expression and attenuated the hyperoxia-induced increase in nitrotyrosine and macrophage influx; however, changes in lung structure were not affected. At P56d, TJ increased TAC, decreased oxidative stress and reversed the hyperoxia-induced increase in bronchiolar smooth muscle. Additionally, TJ alone decreased IL-1 beta expression, but following hyperoxia TJ increased TNF-alpha expression and did not alter the hyperoxia-induced increase in leukocyte number. We conclude that TJ supplementation during and after neonatal exposure to hyperoxia protects the lung from some but not all aspects of hyperoxia-induced injury, but may also have adverse side-effects. The effects of TJ are likely due to elevation of circulating antioxidant concentrations.	[Bouch, Sheena; Harding, Richard; O'Reilly, Megan; Sozo, Foula] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic, Australia; [Bouch, Sheena; Harding, Richard; O'Reilly, Megan; Sozo, Foula] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Wood, Lisa G.] Univ Newcastle, Hunter Med Res Inst, Ctr Asthma & Resp Dis, Newcastle, NSW, Australia; [Bouch, Sheena] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada; [O'Reilly, Megan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	Monash University; Monash University; Hunter Medical Research Institute; University of Newcastle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta	Bouch, S (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada.	sheena.bouch@sickkids.ca		Wood, Lisa/0000-0002-0941-9225	National Health and Medical Research Council of Australia [606789]; Monash University, Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University, Australia(Monash University)	This study was supported by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au) Program Grant #606789 and Monash University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CAN MED ASSOC J, V163, P739; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Auten RL, 2009, AM J PHYSIOL-LUNG C, V297, pL134, DOI 10.1152/ajplung.00112.2009; BAI A, 1994, J APPL PHYSIOL, V77, P1011, DOI 10.1152/jappl.1994.77.2.1011; Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; BARUA AB, 1993, J CHROMATOGR-BIOMED, V617, P257, DOI 10.1016/0378-4347(93)80496-Q; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Belik J, 2003, J APPL PHYSIOL, V94, P2303, DOI 10.1152/japplphysiol.00820.2002; Berger J, 2014, AM J PHYSL LUNG CELL; Berger TM, 1998, PEDIATR RES, V43, P719, DOI 10.1203/00006450-199806000-00002; Berkelhamer SK, 2014, ANTIOXID REDOX SIGN, V21, P1837, DOI 10.1089/ars.2013.5515; Berkelhamer SK, 2013, FREE RADICAL BIO MED, V61, P51, DOI 10.1016/j.freeradbiomed.2013.03.003; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; Bouch S, 2015, AM J PHYSIOL-LUNG C, V309, pL488, DOI 10.1152/ajplung.00359.2014; Brion LP., 2003, COCHRANE DB SYST REV, V(4), pCd003665, DOI [10.1002/14651858.CD003665, DOI 10.1002/14651858.CD003665]; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chow SW, 2013, REPORT AUSTR NZ NEON; Clark RH, 2001, J PEDIATR-US, V139, P478, DOI 10.1067/mpd.2001.118201; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Davis JM, 2010, SEMIN FETAL NEONAT M, V15, P191, DOI 10.1016/j.siny.2010.04.001; Denis K, 2001, PEDIATR RES, V50, P515, DOI 10.1203/00006450-200110000-00015; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Erdman JW, 2009, ARCH BIOCHEM BIOPHYS, V483, P229, DOI 10.1016/j.abb.2008.10.022; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; Gessner BD, 2007, THORAX, V62, P231, DOI 10.1136/thx.2005.053363; Gross SJ, 1998, J PEDIATR-US, V133, P188, DOI 10.1016/S0022-3476(98)70219-7; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hazlewood LC, 2011, J NUTR BIOCHEM, V22, P95, DOI 10.1016/j.jnutbio.2009.12.003; HERSHENSON MB, 1992, AM REV RESPIR DIS, V146, P1294, DOI 10.1164/ajrccm/146.5_Pt_1.1294; Husari Ahmad, 2014, BMC Res Notes, V7, P664, DOI 10.1186/1756-0500-7-664; James ML, 2013, AM J PHYSIOL-LUNG C, V304, pL803, DOI 10.1152/ajplung.00257.2012; Kilbride HW, 2003, J PEDIATR-US, V143, P488, DOI 10.1067/S0022-3476(03)00413-X; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Korhonen P, 2004, ACTA PAEDIATR, V93, P316, DOI 10.1080/08035250410023593; Landete JM, 2013, CRIT REV FOOD SCI, V53, P706, DOI 10.1080/10408398.2011.555018; LANGLEY SC, 1992, COMP BIOCHEM PHYS A, V103, P793, DOI 10.1016/0300-9629(92)90183-Q; Lee JW, 2011, CURR OPIN PEDIATR, V23, P161, DOI 10.1097/MOP.0b013e3283423e51; Mantell LL, 1999, ANN NY ACAD SCI, V887, P171, DOI 10.1111/j.1749-6632.1999.tb07931.x; Maritz GS, 2011, PEDIATR PULM, V46, P976, DOI 10.1002/ppul.21462; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; McGrath-Morrow SA, 2001, AM J RESP CELL MOL, V25, P150, DOI 10.1165/ajrcmb.25.2.4362; McGrath-Morrow SA, 2011, AM J RESP CELL MOL, V45, P610, DOI 10.1165/rcmb.2010-0259OC; Nagato AC, 2012, INT J EXP PATHOL, V93, P269, DOI 10.1111/j.1365-2613.2012.00823.x; O'Reilly M, 2014, ANAT REC, V297, P758, DOI 10.1002/ar.22867; O'Reilly M, 2014, NEONATOLOGY, V105, P39, DOI 10.1159/000355641; O'Reilly M, 2009, AM J PHYSIOL-LUNG C, V297, pL992, DOI 10.1152/ajplung.00099.2009; Ozdemir OM, 2014, PEDIAT NEONATOL; Poggi C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/721043; Rozycki HJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1222, DOI 10.1152/ajplung.00230.2001; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SAETTA M, 1985, AM REV RESPIR DIS, V132, P894; Shi J, 2000, CRIT REV BIOTECHNOL, V20, P293, DOI 10.1080/07388550091144212; Smith LJ, 2008, PEDIATRICS, V122, pE287, DOI 10.1542/peds.2007-3657; Speer CP, 2006, J PERINATOL, V26, pS57, DOI 10.1038/sj.jp.7211476; Sumi Yuki, 2007, Allergol Int, V56, P341, DOI 10.2332/allergolint.R-07-153; ter Horst Simone A J, 2006, BMC Pulm Med, V6, P8, DOI 10.1186/1471-2466-6-8; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Trembath A, 2012, CLIN PERINATOL, V39, P585, DOI 10.1016/j.clp.2012.06.014; Tyson JE, 1999, NEW ENGL J MED, V340, P1962, DOI 10.1056/NEJM199906243402505; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Veness-Meehan KA, 2000, PEDIATR RES, V48, P434, DOI 10.1203/00006450-200010000-00004; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Weibel ER, 1963, MORPHOMETRY OF THE H; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wood LG, 2008, FREE RADICAL RES, V42, P94, DOI 10.1080/10715760701767307; Yee M, 2009, AM J PHYSIOL-LUNG C, V297, pL641, DOI 10.1152/ajplung.00023.2009; Zuberi RI, 2004, AM J PATHOL, V165, P2045, DOI 10.1016/S0002-9440(10)63255-5	70	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159633	10.1371/journal.pone.0159633	http://dx.doi.org/10.1371/journal.pone.0159633			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438045	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100059
J	Narayanan, V; Veeramuthu, V; Ahmad-Annuar, A; Ramli, N; Waran, V; Chinna, K; Bondi, MW; Delano-Wood, L; Ganesan, D				Narayanan, Vairavan; Veeramuthu, Vigneswaran; Ahmad-Annuar, Azlina; Ramli, Norlisah; Waran, Vicknes; Chinna, Karuthan; Bondi, Mark William; Delano-Wood, Lisa; Ganesan, Dharmendra			Missense Mutation of Brain Derived Neurotrophic Factor (BDNF) Alters Neurocognitive Performance in Patients with Mild Traumatic Brain Injury: A Longitudinal Study	PLOS ONE			English	Article							FACTOR VAL66MET POLYMORPHISM; APOLIPOPROTEIN-E POLYMORPHISM; FACTOR GENE; VAL(66)MET POLYMORPHISM; HIPPOCAMPAL ACTIVITY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; MEMORY FORMATION; RAT HIPPOCAMPUS; ASSOCIATION	The predictability of neurocognitive outcomes in patients with traumatic brain injury is not straightforward. The extent and nature of recovery in patients with mild traumatic brain injury (mTBI) are usually heterogeneous and not substantially explained by the commonly known demographic and injury-related prognostic factors despite having sustained similar injuries or injury severity. Hence, this study evaluated the effects and association of the Brain Derived Neurotrophic Factor (BDNF) missense mutations in relation to neurocognitive performance among patients with mTBI. 48 patients with mTBI were prospectively recruited and MRI scans of the brain were performed within an average 10.1 (SD 4.2) hours post trauma with assessment of their neuropsychological performance post full Glasgow Coma Scale (GCS) recovery. Neurocognitive assessments were repeated again at 6 months follow-up. The paired t-test, Cohen's d effect size and repeated measure ANOVA were performed to delineate statistically significant differences between the groups [wildtype G allele (Val homozygotes) vs. minor A allele (Met carriers)] and their neuropsychological performance across the time point (T-1 = baseline/admission vs. T-2 = 6th month follow-up). Minor A allele carriers in this study generally performed more poorly on neuropsychological testing in comparison wildtype G allele group at both time points. Significant mean differences were observed among the wildtype group in the domains of memory (M = -11.44, SD = 10.0, p = .01, d = 1.22), executive function (M = -11.56, SD = 11.7, p = .02, d = 1.05) and overall performance (M = -6.89 SD = 5.3, p = .00, d = 1.39), while the minor A allele carriers showed significant mean differences in the domains of attention (M = -11.0, SD = 13.1, p = .00, d = .86) and overall cognitive performance ( M = -5.25, SD = 8.1, p = .01, d = .66). The minor A allele carriers in comparison to the wildtype G allele group, showed considerably lower scores at admission and remained impaired in most domains across the timepoints, although delayed signs of recovery were noted to be significant in the domains attention and overall cognition. In conclusion, the current study has demonstrated the role of the BDNF rs6265 Val66Met polymorphism in influencing specific neurocognitive outcomes in patients with mTBI. Findings were more detrimentally profound among Met allele carriers.	[Narayanan, Vairavan; Veeramuthu, Vigneswaran; Waran, Vicknes; Ganesan, Dharmendra] Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Wilayah Perseku, Malaysia; [Ahmad-Annuar, Azlina] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Wilayah Perseku, Malaysia; [Ramli, Norlisah] Univ Malaya, Res Imaging Ctr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Chinna, Karuthan] Univ Malaya, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Wilayah Perseku, Malaysia; [Bondi, Mark William; Delano-Wood, Lisa] VA San Diego Healthcare Syst, San Diego, CA USA; [Bondi, Mark William; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Narayanan, V; Veeramuthu, V (corresponding author), Univ Malaya, Fac Med, Dept Surg, Div Neurosurg, Kuala Lumpur, Wilayah Perseku, Malaysia.	nvairavan@um.edu.my; vicveera@gmail.com	GANESAN, DHARMENDRA/B-8437-2010; RAMLI, NORLISAH MOHD/G-5209-2010; Veeramuthu, Vigneswaran/F-2220-2015; AHMAD ANNUAR, AZLINA/B-8305-2010; NARAYANAN, VAIRAVAN/B-9191-2010; Mathaneswaran, Vickneswaran/E-5180-2010	GANESAN, DHARMENDRA/0000-0003-1595-3659; RAMLI, NORLISAH MOHD/0000-0001-7497-8093; Veeramuthu, Vigneswaran/0000-0003-2052-0858; AHMAD ANNUAR, AZLINA/0000-0001-6329-4366; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; 	University Malaya Research Grant (UMRG) [RG447-12HTM]; High Impact Research Grant of University of Malaya [HIR-UM.C/625/1/HIRMOHE/12]	University Malaya Research Grant (UMRG); High Impact Research Grant of University of Malaya	This study was partially funded by University Malaya Research Grant (UMRG; RG447-12HTM) (to VN)-Link: http://umresearch.um.edu.my/; High Impact Research Grant of University of Malaya (HIR-UM.C/625/1/HIRMOHE/12) (VW)-Link: http://hir.um.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bales James W, 2010, Open Drug Discov J, V2, P119; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bennett ER, 2016, TRANSLATIONAL RES TR; Beste C, 2010, J NEUROSCI, V30, P10727, DOI 10.1523/JNEUROSCI.2493-10.2010; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Chao HM, 2008, AM J MED GENET B, V147B, P505, DOI 10.1002/ajmg.b.30619; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Comings DE, 1996, PHARMACOGENETICS, V6, P223, DOI 10.1097/00008571-199606000-00004; Coronado V. G., 2011, SURVEILLANCE TRAUMAT; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Dennis NA, 2011, HIPPOCAMPUS, V21, P980, DOI 10.1002/hipo.20809; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dutcher SA, 2001, NEUROL RES, V23, P203, DOI 10.1179/016164101101198343; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Failla M.D., 2015, NEUROREHABIL NEURAL; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Getzmann S, 2013, NEUROIMAGE, V64, P290, DOI 10.1016/j.neuroimage.2012.08.079; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hashimoto R, 2008, NEUROSCI RES, V61, P360, DOI 10.1016/j.neures.2008.04.003; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; Horch HW, 1999, NEURON, V23, P353; Huang CC, 2014, PSYCHONEUROENDOCRINO, V39, P94, DOI 10.1016/j.psyneuen.2013.09.027; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jonsson EG, 2006, PROG NEURO-PSYCHOPH, V30, P924, DOI 10.1016/j.pnpbp.2006.02.008; Kang JI, 2010, NEUROPHARMACOLOGY, V58, P1109, DOI 10.1016/j.neuropharm.2010.02.001; Karpova NN, 2014, NEUROPHARMACOLOGY, V76, P709, DOI 10.1016/j.neuropharm.2013.04.002; Kauppi K, 2013, NEUROPSYCHOLOGIA, V51, P2462, DOI 10.1016/j.neuropsychologia.2012.11.028; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Kurowski BG, 2015, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000162, DOI 10.1097/HTR.00000000000001621545968315586465]; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laurer HL, 2001, CURR PHARM DESIGN, V7, P1505, DOI 10.2174/1381612013397285; Lin WJ, 2013, FRONT ENDOCRINOL, P4; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McAllister TW, 2014, HDB CLIN NEUROL, V128, P723; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miyajima F, 2008, GENES BRAIN BEHAV, V7, P411, DOI 10.1111/j.1601-183X.2007.00363.x; Mohajeri MH, 2012, BRAIN RES BULL, V88, P429, DOI 10.1016/j.brainresbull.2011.12.003; Morley KI, 2001, BEHAV GENET, V31, P511, DOI 10.1023/A:1013337209957; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Okada T, 2006, MOL PSYCHIATR, V11, P695, DOI 10.1038/sj.mp.4001822; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; Perkovic MN, 2014, PSYCHOPHARMACOLOGY, V231, P3757, DOI 10.1007/s00213-014-3515-4; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Pruthi N, 2010, NEUROL INDIA, V58, P264, DOI 10.4103/0028-3886.63810; Quan N, 2002, HISTOL HISTOPATHOL, V17, P273, DOI 10.14670/HH-17.273; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, MOL PSYCHIATR, V11, P122, DOI 10.1038/sj.mp.4001765; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Stam AH, 2009, J NEUROL NEUROSUR PS, V80, P1125, DOI 10.1136/jnnp.2009.177279; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; UniProt Consortium, UNIPROTKB P23560 BDN; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; van Wingen G, 2010, NEUROIMAGE, V50, P1212, DOI 10.1016/j.neuroimage.2010.01.058; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Wang HY, 2013, NEURAL REGEN RES, V8, P843, DOI 10.3969/j.issn.1673-5374.2013.09.009; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; Weese-Mayer DE, 2002, AM J MED GENET, V107, P306, DOI 10.1002/ajmg.10133; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; World Health Organization, 2013, WHO GLOB STAT REP RO; World Health Organization, 2009, GLOB STAT REP ROAD S; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; Yue JK, 2015, NEUROSURGERY, V62, P225	102	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158838	10.1371/journal.pone.0158838	http://dx.doi.org/10.1371/journal.pone.0158838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438599	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000380170100024
J	Yurist-Doutsch, S; Arrieta, MC; Tupin, A; Valdez, Y; Antunes, LCM; Yen, R; Finlay, BB				Yurist-Doutsch, Sophie; Arrieta, Marie-Claire; Tupin, Audrey; Valdez, Yanet; Antunes, L. Caetano M.; Yen, Ryan; Finlay, B. Brett			Nutrient Deprivation Affects Salmonella Invasion and Its Interaction with the Gastrointestinal Microbiota	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 2; INTESTINAL MICROBIOTA; GENE-EXPRESSION; CELLS; INFLAMMATION; COMMUNITIES; INFECTIONS; HOST; SURVIVAL	Salmonella enterica serovar Typhimurium (S. Typhimurium) is a foodborne enteric pathogen and a major cause of gastroenteritis in humans. It is known that molecules derived from the human fecal microbiota downregulate S. Typhimurium virulence gene expression and induce a starvation-like response. In this study, S. Typhimurium was cultured in minimal media to mimic starvation conditions such as that experienced by S. Typhimurium in the human intestinal tract, and the pathogen's virulence in vitro and in vivo was measured. S. Typhimurium cultured in minimal media displayed a reduced ability to invade human epithelial cells in a manner that was at least partially independent of the Salmonella Pathogenicity Island 1 (SPI-1) type III secretion system. Nutrient deprivation did not, however, alter the ability of S. Typhimurium to replicate and survive inside epithelial cells. In a murine model of S. Typhimurium-induced gastroenteritis, prior cultivation in minimal media did not alter the pathogen's ability to colonize mice, nor did it affect levels of gastrointestinal inflammation. Upon examining the post-infection fecal gastrointestinal microbiota, we found that specifically in the 129Sv/ImJ murine strain S. Typhimurium cultured in minimal media induced differential microbiota compositional shifts compared to that of S. Typhimurium cultured in rich media. Together these findings demonstrate that S. Typhimurium remains a potent pathogen even in the face of nutritional deprivation, but nevertheless that nutrient deprivation encountered in this environment elicits significant changes in the bacterium genetic programme, as well as its capacity to alter host microbiota composition.	[Yurist-Doutsch, Sophie; Arrieta, Marie-Claire; Tupin, Audrey; Valdez, Yanet; Yen, Ryan; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Yurist-Doutsch, Sophie; Arrieta, Marie-Claire; Tupin, Audrey; Valdez, Yanet; Yen, Ryan; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Antunes, L. Caetano M.] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Inst Nacl Ciencia & Tecnol Inovacao Doencas Negli, BR-21040900 Rio De Janeiro, RJ, Brazil; [Antunes, L. Caetano M.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, BR-22780194 Rio De Janeiro, RJ, Brazil; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.; Finlay, BB (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca	Antunes, Luis Caetano Martha/P-4988-2019; Arrieta, Marie-Claire/AAU-2427-2021		Canadian Institutes of Health Research [CIHR-27R18706]; Science without Borders program of the National Council of Technological and Scientific Development (CNPq-Brazil); Michael Smith Foundation for Health research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Science without Borders program of the National Council of Technological and Scientific Development (CNPq-Brazil); Michael Smith Foundation for Health research(Michael Smith Foundation for Health Research)	The work in BBF lab is funded by Canadian Institutes of Health Research (CIHR-27R18706). LCMA was supported by a fellowship from the Science without Borders program of the National Council of Technological and Scientific Development (CNPq-Brazil). YV was supported by a fellowship from the Michael Smith Foundation for Health research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1978, RES VET SCI, V25, P139; Antunes LCM, 2014, MBIO, V5, DOI 10.1128/mBio.01183-14; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Blair JMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063912; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Forbester JL, 2015, INFECT IMMUN, V83, P2926, DOI 10.1128/IAI.00161-15; GALAN JE, 1991, INFECT IMMUN, V59, P2901; GALAN JE, 1992, J BACTERIOL, V174, P4338; Gill N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049646; Grassl GA, 2008, CURR OPIN GASTROEN, V24, P22, DOI 10.1097/MOG.0b013e3282f21388; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McKenney PT, 2015, CELL, V163, P1326, DOI 10.1016/j.cell.2015.11.032; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NELSON K, 1991, P NATL ACAD SCI USA, V88, P6667, DOI 10.1073/pnas.88.15.6667; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; RICCA E, 1990, NUCLEIC ACIDS RES, V18, P1290, DOI 10.1093/nar/18.5.1290; Saito N, 2010, CURR OPIN MICROBIOL, V13, P358, DOI 10.1016/j.mib.2010.04.006; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Singh P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0109-2; SONTI RV, 1989, GENETICS, V123, P19; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Yurist-Doutsch S, 2014, ANNU REV GENET, V48, P361, DOI 10.1146/annurev-genet-120213-092421	45	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159676	10.1371/journal.pone.0159676	http://dx.doi.org/10.1371/journal.pone.0159676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437699	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100065
J	Conteduca, V; Crabb, SJ; Jones, RJ; Caffo, O; Elliott, T; Scarpi, E; Fabbri, P; Derosa, L; Massari, F; Numico, G; Zarif, S; Hanna, C; Maines, F; Joyce, H; Lolli, C; De Giorgi, U				Conteduca, Vincenza; Crabb, Simon J.; Jones, Robert J.; Caffo, Orazio; Elliott, Tony; Scarpi, Emanuela; Fabbri, Paolo; Derosa, Lisa; Massari, Francesco; Numico, Gianmauro; Zarif, Sunnya; Hanna, Catherine; Maines, Francesca; Joyce, Helen; Lolli, Cristian; De Giorgi, Ugo			Persistent Neutrophil to Lymphocyte Ratio > 3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INCREASED SURVIVAL; CHEMOTHERAPY; INFLAMMATION; ABIRATERONE; DOCETAXEL; INTERLEUKIN-6; MECHANISMS; MEN	The baseline value of neutrophil to lymphocyte ratio (NLR) has been found to be prognostic in patients with metastatic castration resistant prostate cancer (CRPC). We evaluated the impact of baseline NLR and its change in patients receiving enzalutamide. We included consecutive metastatic CRPC patients treated with enzalutamide after docetaxel and studies the change of NLR (>3 vs <= 3) after week 4 and 12 weeks. Progression-free survival (PFS), overall survival (OS) and their 95% Confidence Intervals (95% CI) were estimated by the Kaplan-Meier method and compared with the log-rank test. The impact of NLR on PFS and OS was evaluated by Cox regression analyses and on prostate-specific antigen response rates (PSA RR; PSA decline >50%) were evaluated by binary logistic regression. Data collected on 193 patients from 9 centers were evaluated. Median age was 73.1 years (range, 42.8-90.7). The median baseline NLR was 3.2. The median PFS was 3.2 months (95% CI = 2.7-4.2) in patients with baseline NLR >3 and 7.4 months (95% CI = 5.5-9.7) in those with NLR <= 3, p < 0.0001. The median OS was 10.4 months (95% CI = 6.5-14.9) in patients with baseline NLR >3 and 16.9 months (95% CI = 11.2-20.9) in those with baseline NLR <= 3, p < 0.0001. In multivariate analysis, changes in NLR at 4 weeks were significant predictors of both PFS [hazard ratio (HR) 1.24, 95% confidence interval (95% CI) 1.07-1.42, p = 0.003, and OS (HR 1.29, 95% CI 1.10-1.51, p = 0.001. A persistent NLR >3 during treatment with enzalutamide seems to have both prognostic and predictive value in CRPC patients.	[Conteduca, Vincenza; Scarpi, Emanuela; Lolli, Cristian; De Giorgi, Ugo] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy; [Crabb, Simon J.; Zarif, Sunnya] Univ Southampton, Canc Sci Unit, Southampton, Hants, England; [Jones, Robert J.; Hanna, Catherine] Univ Glasgow, Beatson West Scotland Canc Ctr, Inst Canc Sci, Glasgow, Lanark, Scotland; [Caffo, Orazio; Maines, Francesca] Santa Chiara Hosp, Dept Med Oncol, Trento, Italy; [Elliott, Tony; Joyce, Helen] Christie Hosp, Manchester, Lancs, England; [Fabbri, Paolo] Cervesi Hosp, Oncol Unit, Cattolica, Italy; [Derosa, Lisa] Santa Chiara Hosp, Dept Med Oncol, Pisa, Italy; [Massari, Francesco] Inst Gustave Roussy, Villejuif, France; [Numico, Gianmauro] Azienda USL Valle Aosta, Med Oncol & Hematol, Aosta, Italy	IRCCS Meldola (IRST); University of Southampton; Beatson Oncology Centre; University of Glasgow; Santa Chiara Hospital; Christie NHS Foundation Trust; Christie Hospital; Santa Chiara Hospital; UNICANCER; Gustave Roussy; Azienda USL della Valle d'Aosta	De Giorgi, U (corresponding author), IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy.	ugo.degiorgi@irst.emr.it	Numico, Gianmauro/AAE-4489-2020; Scarpi, Emanuela/AAD-7036-2019; Lolli, Cristian/AAC-4116-2022; DEROSA, LISA/E-6814-2015; Caffo, Orazio/AAE-5485-2020; Massari, Francesco/K-7239-2016; conteduca, vincenza/E-8640-2019	Numico, Gianmauro/0000-0003-3253-2960; Scarpi, Emanuela/0000-0001-7230-9267; Caffo, Orazio/0000-0001-7968-2531; Massari, Francesco/0000-0001-6476-6871; conteduca, vincenza/0000-0002-6921-714X; Derosa, Lisa/0000-0003-0527-2964; Crabb, Simon/0000-0003-3521-9064	ESMO Translational Research Fellowships	ESMO Translational Research Fellowships	Vincenza Conteduca acknowledges support from an ESMO Translational Research Fellowships 2014-2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Vincenza Conteduca acknowledges support from an ESMO Translational Research Fellowships 2014-2016.	Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; FAUCI AS, 1975, IMMUNOLOGY, V28, P669; Gannon PO, 2009, J IMMUNOL METHODS, V348, P9, DOI 10.1016/j.jim.2009.06.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Keizman D, 2012, ONCOLOGIST, V17, P1508, DOI 10.1634/theoncologist.2012-0125; Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Mahon KL, 2015, BRIT J CANCER, V112, P1340, DOI 10.1038/bjc.2015.74; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McDonald AC, 2014, PROSTATE, V74, P561, DOI 10.1002/pros.22782; Nuhn P, 2014, BJU INT, V114, pE11, DOI 10.1111/bju.12531; Ohno Y, 2012, J UROLOGY, V187, P411, DOI 10.1016/j.juro.2011.10.026; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ross RW, 2012, LANCET ONCOL, V13, P1105, DOI 10.1016/S1470-2045(12)70263-2; Rossi L, 2015, ANN SURG ONCOL, V22, P1377, DOI 10.1245/s10434-014-4097-4; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Stark JR, 2009, INT J CANCER, V124, P2683, DOI 10.1002/ijc.24241; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, P1, DOI [10.1093/jnci/dju124, DOI 10.1093/JNCI/DJU124]; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Zhao LL, 2009, CANCER RES, V69, P7696, DOI 10.1158/0008-5472.CAN-08-4901	36	42	43	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158952	10.1371/journal.pone.0158952	http://dx.doi.org/10.1371/journal.pone.0158952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434372	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000380169600024
J	Lin, BC; Chen, BK; Gao, YC; Tse, CK; Dong, CF; Miao, LX; Wang, BH				Lin, Benchuan; Chen, Bokui; Gao, Yachun; Tse, Chi K.; Dong, Chuanfei; Miao, Lixin; Wang, Binghong			Advanced Algorithms for Local Routing Strategy on Complex Networks	PLOS ONE			English	Article							INTELLIGENT TRAFFIC SYSTEMS; INFORMATION FEEDBACK; COMMUNICATION; BREAKDOWN	Despite the significant improvement on network performance provided by global routing strategies, their applications are still limited to small-scale networks, due to the need for acquiring global information of the network which grows and changes rapidly with time. Local routing strategies, however, need much less local information, though their transmission efficiency and network capacity are much lower than that of global routing strategies. In view of this, three algorithms are proposed and a thorough investigation is conducted in this paper. These algorithms include a node duplication avoidance algorithm, a next-nearest-neighbor algorithm and a restrictive queue length algorithm. After applying them to typical local routing strategies, the critical generation rate of information packets R-c increases by over ten-fold and the average transmission time < T > decreases by 70-90 percent, both of which are key physical quantities to assess the efficiency of routing strategies on complex networks. More importantly, in comparison with global routing strategies, the improved local routing strategies can yield better network performance under certain circumstances. This is a revolutionary leap for communication networks, because local routing strategy enjoys great superiority over global routing strategy not only in terms of the reduction of computational expense, but also in terms of the flexibility of implementation, especially for large-scale networks.	[Lin, Benchuan; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei, Peoples R China; [Chen, Bokui] Natl Univ Singapore, Sch Comp, Singapore, Singapore; [Chen, Bokui] Macau Univ Sci & Technol, Fac Informat Technol, Macau, Peoples R China; [Gao, Yachun] Univ Elect Sci & Technol China, Sch Phys Elect, Chengdu, Peoples R China; [Tse, Chi K.] Hong Kong Polytech Univ, Elect & Informat Engn Dept, Kowloon, Hong Kong, Peoples R China; [Miao, Lixin] Tsinghua Univ, Grad Sch Shenzhen, Div Logist & Transportat, Shenzhen, Peoples R China; [Miao, Lixin] Tsinghua Berkeley Shenzhen Inst, Ctr Environm Sci & New Energy Technol, Shenzhen, Peoples R China; [Dong, Chuanfei] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; National University of Singapore; Macau University of Science & Technology; University of Electronic Science & Technology of China; Hong Kong Polytechnic University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University of Michigan System; University of Michigan	Chen, BK (corresponding author), Natl Univ Singapore, Sch Comp, Singapore, Singapore.; Chen, BK (corresponding author), Macau Univ Sci & Technol, Fac Informat Technol, Macau, Peoples R China.	chenssx@mail.ustc.edu.cn	Lin, Benchuan/F-6081-2019; Dong, Chuanfei/E-6485-2010	Dong, Chuanfei/0000-0002-8990-094X; Tse, Chi/0000-0002-0462-3999; hu, xiao/0000-0001-9930-778X	Singapore Ministry of Education Research Grant [MOE2013-T2-2-033]; Hong Kong Polytechnic University Grant [G-YBAT]; National Natural Science Foundation of China [61370218]	Singapore Ministry of Education Research Grant(Ministry of Education, Singapore); Hong Kong Polytechnic University Grant(Hong Kong Polytechnic University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Singapore Ministry of Education Research Grant (Grant No. MOE2013-T2-2-033), Hong Kong Polytechnic University Grant (Grant No. G-YBAT), and the National Natural Science Foundation of China (Grant No. 61370218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Singapore Ministry of Education Research Grant (MOE2013-T2-2-033), Hong Kong Polytechnic University Grant (G-YBAT) and National Natural Science Foundation of China (61370218).	Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Arenas A, 2001, PHYS REV LETT, V86, P3196, DOI 10.1103/PhysRevLett.86.3196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Chen BK, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/14001; Chen BK, 2012, COMPUT PHYS COMMUN, V183, P2081, DOI 10.1016/j.cpc.2012.05.010; Chen BK, 2012, PHYSICA A, V391, P2730, DOI 10.1016/j.physa.2011.12.032; Chen BK, 2011, INT J MOD PHYS C, V22, P849, DOI 10.1142/S0129183111016658; Cholvi V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.035103; Guimera R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026704; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Li WT, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/64001; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Ling X, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066110; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016101; Wang WX, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066702; Wang WX, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026111; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Zhao L, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.035101	20	10	11	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0156756	10.1371/journal.pone.0156756	http://dx.doi.org/10.1371/journal.pone.0156756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434502	Green Published, gold			2022-12-26	WOS:000380169600003
J	Ehrenpreis, ED; Zhou, Y; Alexoff, A; Melitas, C				Ehrenpreis, Eli D.; Zhou, Ying; Alexoff, Aimee; Melitas, Constantine			Effect of the Diagnosis of Inflammatory Bowel Disease on Risk-Adjusted Mortality in Hospitalized Patients with Acute Myocardial Infarction, Congestive Heart Failure and Pneumonia	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RATES	Introduction Measurement of mortality in patients with acute myocardial infarction (AMI), congestive heart failure (CHF) and pneumonia (PN) is a high priority since these are common reasons for hospitalization. However, mortality in patients with inflammatory bowel disease (IBD) that are hospitalized for these common medical conditions is unknown. Methods A retrospective review of the 2005-2011 National Inpatient Sample (NIS), (approximately a 20% sample of discharges from community hospitals) was performed. A dataset for all patients with ICD-9-CM codes for primary diagnosis of acute myocardial infarction, pneumonia or congestive heart failure with a co-diagnosis of IBD, Crohn's disease (CD) or ulcerative colitis (UC). 1: 3 propensity score matching between patients with co-diagnosed disease vs. controls was performed. Continuous variables were compared between IBD and controls. Categorical variables were reported as frequency (percentage) and analyzed by Chi-square tests or Fisher's exact test for co-diagnosed disease vs. control comparisons. Propensity scores were computed through multivariable logistic regression accounting for demographic and hospital factors. In-hospital mortality between the groups was compared. Results Patients with IBD, CD and UC had improved survival after AMI compared to controls. 94/2280 (4.1%) of patients with IBD and AMI died, compared to 251/5460 (5.5%) of controls, p = 0.01. This represents a 25% improved survival in IBD patients that were hospitalized with AMI. There was a 34% improved survival in patients with CD and AMI. There was a trend toward worsening survival in patients with IBD and CHF. Patients with CD and PN had improved survival compared to controls. 87/3362 (2.59%) patients with CD and PN died, compared to 428/10076 (4.25%) of controls, p < .0001. This represents a 39% improved survival in patients with CD that are hospitalized for PN. Conclusion IBD confers a survival benefit for patients hospitalized with AMI. A diagnosis of CD benefits survival in patients that are hospitalized with PN.	[Ehrenpreis, Eli D.; Zhou, Ying; Alexoff, Aimee; Melitas, Constantine] NorthShore Univ HealthSyst, Ctr Study Complex Dis, Evanston, IL 60201 USA	NorthShore University Health System	Ehrenpreis, ED (corresponding author), NorthShore Univ HealthSyst, Ctr Study Complex Dis, Evanston, IL 60201 USA.	ehrenpreis@gipharm.net	Ehrenpreis, Eli D/F-4586-2017	Ehrenpreis, Eli D/0000-0002-7209-729X; Melitas, Constantine/0000-0002-1166-0106	Keyser Family Fund	Keyser Family Fund	This study was funded in part by a grant by the Keyser Family Fund to the Center for the Study of Complex Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2013, J CROHNS COLITIS, V7, P107, DOI 10.1016/j.crohns.2012.02.015; [Anonymous], 2012, MED HOSP QUAL CHARB; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang L, 2015, J GERIATR CARDIOL, V12, P305, DOI 10.11909/j.issn.1671-5411.2015.03.020; Fischer LM, 2004, AM J CARDIOL, V93, P198, DOI 10.1016/j.amjcard.2003.09.037; Fumery M, 2014, J CROHNS COLITIS, V8, P469, DOI 10.1016/j.crohns.2013.09.021; Hak AE, 2009, ARTHRIT CARE RES, V61, P1396, DOI 10.1002/art.24537; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Long MD, 2013, AM J GASTROENTEROL, V108, P240, DOI 10.1038/ajg.2012.406; Mohammed AM, 2009, BMJ-BRIT MED J, V338, pb780, DOI [10.1136/bmj.b780, DOI 10.1136/BMJ.B780]; Murthy SK, 2011, AM J GASTROENTEROL, V106, P713, DOI 10.1038/ajg.2011.53; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; Okafor PN, 2015, DIGEST DIS SCI, V60, P3743, DOI 10.1007/s10620-015-3796-4; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Osterman MT, 2011, CLIN GASTROENTEROL H, V9, P875, DOI 10.1016/j.cgh.2011.06.032; Owczarek D, 2014, WORLD J GASTROENTERO, V20, P53, DOI 10.3748/wjg.v20.i1.53; Sadowski M, 2011, EUROINTERVENTION, V6, P1068, DOI 10.4244/EIJV6I9A186; Shea KM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu024; Vaughan- Sarrazin M, 2011, MED MED RES REV, V1; Vester-Andersen MK, 2014, AM J GASTROENTEROL, V109, P705, DOI 10.1038/ajg.2014.45; Zakroysky P, 2015, AM J MED, V128, P303, DOI 10.1016/j.amjmed.2014.10.033	26	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158926	10.1371/journal.pone.0158926	http://dx.doi.org/10.1371/journal.pone.0158926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427905	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300025
J	Shen, MM; Qu, L; Ma, M; Dou, TC; Lu, J; Guo, J; Hu, YP; Yi, GQ; Yuan, JW; Sun, CJ; Wang, KH; Yang, N				Shen, Manman; Qu, Liang; Ma, Meng; Dou, Taocun; Lu, Jian; Guo, Jun; Hu, Yuping; Yi, Guoqiang; Yuan, Jingwei; Sun, Congjiao; Wang, Kehua; Yang, Ning			Genome-Wide Association Studies for Comb Traits in Chickens	PLOS ONE			English	Article							ANDROGEN RECEPTOR; SEXUAL SELECTION; COMPLEX TRAITS; BROILER; TESTIS; WNT; ALLOCATION; ORNAMENTS; WEIGHTS; SIGNALS	The comb, as a secondary sexual character, is an important trait in chicken. Indicators of comb length (CL), comb height (CH), and comb weight (CW) are often selected in production. DNA-based marker-assisted selection could help chicken breeders to accelerate genetic improvement for comb or related economic characters by early selection. Although a number of quantitative trait loci (QTL) and candidate genes have been identified with advances in molecular genetics, candidate genes underlying comb traits are limited. The aim of the study was to use genome-wide association (GWA) studies by 600 K Affymetrix chicken SNP arrays to detect genes that are related to comb, using an F-2 resource population. For all comb characters, comb exhibited high SNP-based heritability estimates (0.61-0.69). Chromosome 1 explained 20.80% genetic variance, while chromosome 4 explained 6.89%. Independent univariate genome-wide screens for each character identified 127, 197, and 268 novel significant SNPs with CL, CH, and CW, respectively. Three candidate genes, VPS36, AR, and WNT11B, were determined to have a plausible function in all comb characters. These genes are important to the initiation of follicle development, gonadal growth, and dermal development, respectively. The current study provides the first GWA analysis for comb traits. Identification of the genetic basis as well as promising candidate genes will help us understand the underlying genetic architecture of comb development and has practical significance in breeding programs for the selection of comb as an index for sexual maturity or reproduction.	[Shen, Manman; Qu, Liang; Ma, Meng; Dou, Taocun; Lu, Jian; Guo, Jun; Hu, Yuping; Wang, Kehua] Chinese Acad Agr Sci, Layer Breeding & Prod, Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China; [Yi, Guoqiang; Yuan, Jingwei; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Yi, Guoqiang; Yuan, Jingwei; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; China Agricultural University; China Agricultural University	Wang, KH (corresponding author), Chinese Acad Agr Sci, Layer Breeding & Prod, Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China.	sqbreeding@126.com	沈, 曼曼/AAL-5661-2021; Shen, Manman/AAC-5554-2020	Shen, Manman/0000-0003-1923-861X; Yang, Ning/0000-0001-5772-3320	National Science & Technology Pillar Program during the 12th Five-year Plan Period [2012BAD39B0401]; China Agriculture Research Systems, PR China [CARS-41-K02]	National Science & Technology Pillar Program during the 12th Five-year Plan Period; China Agriculture Research Systems, PR China	This work was supported in part by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD39B0401), and China Agriculture Research Systems (CARS-41-K02, http://119.253.58.231/), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2012BAD39B0401), and China Agriculture Research Systems (CARS-41-K02, http://119.253.58.231/), PR China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also gratefully acknowledge the staff of China Agricultural University for involvement in this program.	Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Abdollahi-Arpanahi R, 2015, J ANIM BREED GENET, V132, P218, DOI 10.1111/jbg.12131; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boije H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050890; BORIS A, 1970, P SOC EXP BIOL MED, V134, P985; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; Cornwallis CK, 2007, P ROY SOC B-BIOL SCI, V274, P583, DOI 10.1098/rspb.2006.3757; Cui XX, 2014, FRONT AGRIC SCI ENG, V1, P130, DOI 10.15302/J-FASE-2014013; Eitan Y, 1998, POULTRY SCI, V77, P1593, DOI 10.1093/ps/77.11.1593; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Huang CK, 2016, J ENDOCRINOL, V229, pR1, DOI 10.1530/JOE-15-0518; Huang SX, 2015, ARCH DERMATOL RES, V307, P835, DOI 10.1007/s00403-015-1587-6; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; JAAP RG, 1961, POULTRY SCI, V40, P354, DOI 10.3382/ps.0400354; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; JOHNSON K, 1993, BEHAV ECOL, V4, P254, DOI 10.1093/beheco/4.3.254; Johnsson M, 2014, MOL ECOL, V23, P2275, DOI 10.1111/mec.12723; Johnsson M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002914; Joseph NS, 2003, J APPL POULTRY RES, V12, P7, DOI 10.1093/japr/12.1.7; Kang L, 2012, MOL BIOL REP, V39, P3037, DOI 10.1007/s11033-011-1066-x; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moro C, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0118706, DOI 10.1371/J0URNAL.P0NE.0118706]; Mukhtar N, 2012, WORLD POULTRY SCI J, V68, P425, DOI 10.1017/S0043933912000542; Ohlsson T, 2002, P ROY SOC B-BIOL SCI, V269, P21, DOI 10.1098/rspb.2001.1848; Parker TH, 2003, EVOLUTION, V57, P2157, DOI 10.1111/j.0014-3820.2003.tb00393.x; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pizzari T, 2003, EVOLUTION, V57, P1223, DOI 10.1111/j.0014-3820.2003.tb00331.x; Podisi BK, 2011, QUANTITATIVE TRAIT L; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Sakashita S, 2011, PATHOL INT, V61, P130, DOI 10.1111/j.1440-1827.2011.02644.x; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Shanbhag BA, 1996, GEN COMP ENDOCR, V101, P76, DOI 10.1006/gcen.1996.0009; SHARP PJ, 1979, J ENDOCRINOL, V80, P51, DOI 10.1677/joe.0.0800051; Shotelersuk V, 2006, CLEFT PALATE-CRAN J, V43, P152, DOI 10.1597/05-014.1; Sun CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137145; Sun CJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1795-7; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Tufvesson M, 1999, J ANIM BREED GENET, V116, P127, DOI 10.1046/j.1439-0388.1999.00179.x; Tyler NC, 2008, S AFR J ANIM SCI, V38, P153; Van Goor A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2601-x; van Kampen M, 1971, Int J Biometeorol, V15, P244, DOI 10.1007/BF01803906; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; VONSCHANTZ T, 1995, HEREDITY, V75, P518, DOI 10.1038/hdy.1995.168; Wang WH, 2019, ANIM GENET, V50, P175, DOI 10.1111/age.12346; Wolc A, 2014, J ANIM BREED GENET, V131, P173, DOI 10.1111/jbg.12086; Wright D, 2012, REPROD DOMEST ANIM, V47, P31, DOI 10.1111/j.1439-0531.2011.01963.x; Wright D, 2008, EVOLUTION, V62, P86, DOI 10.1111/j.1558-5646.2007.00281.x; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Xu G. F., 2003, GUANGXI SANHUANG, VFirst, P114; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yi G, 2015, ANIM GENET, V46, P148, DOI 10.1111/age.12267; Yi GQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1945-y; Yoshioka K, 2010, BRIT POULTRY SCI, V51, P185, DOI 10.1080/00071661003745810; Yu G, 2015, MOL CANCER RES, V13, P348, DOI 10.1158/1541-7786.MCR-14-0384-T; Yuan JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140615; Yuan JW, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0161-1; Yuan JW, 2015, POULTRY SCI, V94, P1470, DOI 10.3382/ps/pev122; ZELLER FJ, 1971, J REPROD FERTIL, V25, P125; Zhao JH, 2007, GAP GENETIC ANAL PAC; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; ZUK M, 1990, AM NAT, V136, P459, DOI 10.1086/285107	73	17	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159081	10.1371/journal.pone.0159081	http://dx.doi.org/10.1371/journal.pone.0159081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427764	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300034
J	Delfani, P; Mellby, LD; Nordstrom, M; Holmer, A; Ohlsson, M; Borrebaeck, CAK; Wingren, C				Delfani, Payam; Mellby, Linda Dexlin; Nordstrom, Malin; Holmer, Andreas; Ohlsson, Mattias; Borrebaeck, Carl A. K.; Wingren, Christer			Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics	PLOS ONE			English	Article							DESIGN; PROTEIN; NORMALIZATION; GENERATION; PROTEOMICS	In the quest for deciphering disease-associated biomarkers, high-performing tools for multiplexed protein expression profiling of crude clinical samples will be crucial. Affinity proteomics, mainly represented by antibody-based microarrays, have during recent years been established as a proteomic tool providing unique opportunities for parallelized protein expression profiling. But despite the progress, several main technical features and assay procedures remains to be (fully) resolved. Among these issues, the handling of protein microarray data, i.e. the biostatistics parts, is one of the key features to solve. In this study, we have therefore further optimized, validated, and standardized our in-house designed recombinant antibody microarray technology platform. To this end, we addressed the main remaining technical issues (e.g. antibody quality, array production, sample labelling, and selected assay conditions) and most importantly key biostatistics subjects (e.g. array data pre-processing and biomarker panel condensation). This represents one of the first antibody array studies in which these key biostatistics subjects have been studied in detail. Here, we thus present the next generation of the recombinant antibody microarray technology platform designed for clinical immunoproteomics.	[Delfani, Payam; Mellby, Linda Dexlin; Borrebaeck, Carl A. K.; Wingren, Christer] Lund Univ, Dept Immunotechnol & CREATE Hlth, Lund, Sweden; [Mellby, Linda Dexlin; Nordstrom, Malin; Holmer, Andreas] Immunovia AB, Lund, Sweden; [Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, Lund, Sweden	Lund University; Lund University	Wingren, C (corresponding author), Lund Univ, Dept Immunotechnol & CREATE Hlth, Lund, Sweden.	christer.wingren@immun.lth.se		Ohlsson, Mattias/0000-0003-1145-4297	Swedish Research Council (VR-NT); VINNOVA; Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health; Immunovia	Swedish Research Council (VR-NT)(Swedish Research Council); VINNOVA(Vinnova); Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health; Immunovia	This study was supported by research grants from the Swedish Research Council (VR-NT) (CW), VINNOVA (CAKB), and the Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health (www.createhealth.lth.se) (CAKB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Immunovia) provided support in the form of reagents and salaries for authors (LDM, MN, AH), but did not have any additional role in the study design, data collection and analysis, and decision to publish, or preparation of the manuscript.; This study was supported by research grants from the Swedish Research Council (VR-NT) (CW), VINNOVA (CAKB), and the Foundation of Strategic Research (Strategic Center for Translational Cancer Research-CREATE Health (www.createhealth.lth.se) (CAKB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (Immunovia) provided support in the form of reagents and salaries for authors (LDM, MN, AH), but did not have any additional role in the study design, data collection and analysis, and decision to publish, or preparation of the manuscript. We would like to thank Dr. Aakash Chawade for valuable discussions about normalization approaches.	Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6; Bergeron S, 2015, ANAL BIOANAL CHEM; Bolstad B, 2010, PREPROCESSCORE COLLE; Borrebaeck CAK, 2014, METHODS MOL BIOL, V1131, P563, DOI 10.1007/978-1-62703-992-5_36; Borrebaeck CAK, 2014, METHODS MOL BIOL, V1134, P67, DOI 10.1007/978-1-4939-0326-9_6; Borrebaeck CAK, 2011, METHODS MOL BIOL, V785, P247, DOI 10.1007/978-1-61779-286-1_17; Borrebaeck CAK, 2009, J PROTEOMICS, V72, P928, DOI 10.1016/j.jprot.2009.01.027; Borrebaeck CAK, 2009, EXPERT REV PROTEOMIC, V6, P11, DOI 10.1586/14789450.6.1.11; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2015, RANDOMFOREST BREIMAN; Carlsson A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005033; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; Chiechi Antonella, 2012, Biotechniques, V0, P1, DOI 10.2144/000113926; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Dexlin-Mellby L, 2010, PROTEOM CLIN APPL, V4, P794, DOI 10.1002/prca.201000001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerdtsson Anna S, 2015, Int J Proteomics, V2015, P587250, DOI 10.1155/2015/587250; Gerdtsson AS, 2016, MICROARRAYS IN PRESS; Gustavsson E, 2011, NEW BIOTECHNOL, V28, P302, DOI 10.1016/j.nbt.2010.12.005; Hamelinck D, 2005, MOL CELL PROTEOMICS, V4, P773, DOI 10.1074/mcp.M400180-MCP200; Hoheisel JD, 2013, PROTEOM CLIN APPL, V7, P8, DOI 10.1002/prca.201200114; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ingvarsson J, 2008, PROTEOMICS, V8, P2211, DOI 10.1002/pmic.200701167; Ingvarsson J, 2007, J PROTEOME RES, V6, P3527, DOI 10.1021/pr070204f; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kristensson M, 2012, PROTEOM CLIN APPL, V6, P291, DOI 10.1002/prca.201100055; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Olsson N, 2012, PROTEIN SCI, V21, P1897, DOI 10.1002/pro.2173; Pauly F, 2013, J PROTEOME RES, V12, P5943, DOI 10.1021/pr4003245; Pernemalm M, 2014, EXPERT REV PROTEOMIC, V11, P431, DOI 10.1586/14789450.2014.901157; Petersson L, 2014, BBA-PROTEINS PROTEOM, V1844, P2164, DOI 10.1016/j.bbapap.2014.08.010; Rimini R, 2009, J PROTEOMICS, V73, P252, DOI 10.1016/j.jprot.2009.09.009; Risso D, 2009, BIOINFORMATICS, V25, P2685, DOI 10.1093/bioinformatics/btp443; Rotter A, 2008, OMICS, V12, P171, DOI 10.1089/omi.2008.0032; Sanchez-Carbayo M, 2006, AM J PATHOL, V168, P93, DOI 10.2353/ajpath.2006.050601; Sanchez-Carbayo M, 2011, METHODS MOL BIOL, V785, P159, DOI 10.1007/978-1-61779-286-1_11; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; Seurynck-Servoss SL, 2007, FRONT BIOSCI-LANDMRK, V12, P3956, DOI 10.2741/2362; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; Willem T, 2009, GENE EXPRESSION STUD, p[76, 37]; Wingren C, 2007, PROTEOMICS, V7, P3055, DOI 10.1002/pmic.200700025; Wingren C, 2012, CANCER RES, V72, P2481, DOI 10.1158/0008-5472.CAN-11-2883; Wu YWB, 2005, NURS RES, V54, P212; Yauk CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-266; Zhang AH, 2013, APPL BIOCHEM BIOTECH, V170, P774, DOI 10.1007/s12010-013-0238-7	46	25	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159138	10.1371/journal.pone.0159138	http://dx.doi.org/10.1371/journal.pone.0159138			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414037	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500087
J	Drepper, VJ; Kihm, LP; Kalble, F; Diekmann, C; Seckinger, J; Sommerer, C; Zeier, M; Schwenger, V				Drepper, Valerie Jotterand; Kihm, Lars P.; Kaelble, Florian; Diekmann, Christian; Seckinger, Joerg; Sommerer, Claudia; Zeier, Martin; Schwenger, Vedat			Overhydration Is a Strong Predictor of Mortality in Peritoneal Dialysis Patients-Independently of Cardiac Failure	PLOS ONE			English	Article							WHOLE-BODY BIOIMPEDANCE; RESIDUAL RENAL-FUNCTION; HEMODIALYSIS-PATIENTS; INCIDENT PERITONEAL; NATRIURETIC PEPTIDE; TROPONIN-T; SPECTROSCOPY; SURVIVAL; RISK; INFLAMMATION	Background Overhydration is a common problem in peritoneal dialysis patients and has been shown to be associated with mortality. However, it still remains unclear whether overhydration per se is predictive of mortality or whether it is mainly a reflection of underlying comorbidities. The purpose of our study was to assess overhydration in peritoneal dialysis patients using bioimpedance spectroscopy and to investigate whether overhydration is an independent predictor of mortality. Methods We analyzed and followed 54 peritoneal dialysis patients between June 2008 and December 2014. All patients underwent bioimpedance spectroscopy measurement once and were allocated to normohydrated and overhydrated groups. Overhydration was defined as an absolute overhydration/extracellular volume ratio > 15%. Simultaneously, clinical, echocardiographic and laboratory data were assessed. Heart failure was defined either on echocardiography, as a reduced left ventricular ejection fraction, or clinically according to the New York Heart Association functional classification. Patient survival was documented up until December 31st 2014. Factors associated with mortality were identified and a multivariable Cox regression model was used to identify independent predictors of mortality. Results Apart from higher daily peritoneal ultrafiltration rate and cumulative diuretic dose in overhydrated patients, there were no significant differences between the 2 groups, in particular with respect to gender, body mass index, comorbidity and cardiac medication. Mortality was higher in overhydrated than in euvolemic patients. In the univariate analysis, increased age, overhydration, low diastolic blood pressure, raised troponin and NTproBNP, hypoalbuminemia, heart failure but not CRP were predictive of mortality. After adjustment, only overhydration, increased age and low diastolic blood pressure remained statistically significant in the multivariate analysis. Conclusions Overhydration remains an independent predictor of mortality even after adjustment for heart failure in peritoneal dialysis patients and should therefore be actively sought and managed in order to improve survival in this population.	[Drepper, Valerie Jotterand] Univ Hosp Geneva, Dept Nephrol, Geneva, Switzerland; [Drepper, Valerie Jotterand; Kihm, Lars P.; Kaelble, Florian; Diekmann, Christian; Seckinger, Joerg; Sommerer, Claudia; Zeier, Martin; Schwenger, Vedat] Univ Heidelberg Hosp, Dept Nephrol, Heidelberg, Germany; [Seckinger, Joerg] Zug Cantonal Hosp, Dept Nephrol, Zug, Switzerland; [Schwenger, Vedat] Klinikum Stuttgart, Dept Nephrol, Stuttgart, Germany	University of Geneva; Ruprecht Karls University Heidelberg; Klinikum Stuttgart	Drepper, VJ (corresponding author), Univ Hosp Geneva, Dept Nephrol, Geneva, Switzerland.; Drepper, VJ (corresponding author), Univ Heidelberg Hosp, Dept Nephrol, Heidelberg, Germany.	Valerie.JotterandDrepper@hcuge.ch						Afshinnia F, 2015, PERIT DIAL INT; Chamney PW, 2002, KIDNEY INT, V61, P2250, DOI 10.1046/j.1523-1755.2002.00377.x; Chung SH, 2003, NEPHROL DIAL TRANSPL, V18, P590, DOI 10.1093/ndt/18.3.590; Cox-Reijven PL, 2001, AM J KIDNEY DIS, V38, P832, DOI 10.1053/ajkd.2001.27703; Devolder I, 2010, PERITON DIALYSIS INT, V30, P208, DOI 10.3747/pdi.2008.00284; Duman D, 2005, NEPHROL DIAL TRANSPL, V20, P962, DOI 10.1093/ndt/gfh741; Ellis KJ, 1998, J APPL PHYSIOL, V85, P1056, DOI 10.1152/jappl.1998.85.3.1056; Fahim MA, 2015, CLIN J AM SOC NEPHRO, V10, P620, DOI 10.2215/CJN.09060914; Franklin SS, 1997, CIRCULATION; Heaf JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090119; Hickman PE, 2015, AM J CARDIOL, V115, P1601, DOI 10.1016/j.amjcard.2015.02.066; Jovanovic DB, 2015, RENAL FAILURE, V37, P230, DOI 10.3109/0886022X.2014.982478; Kang SH, 2012, RENAL FAILURE, V34, P149, DOI 10.3109/0886022X.2011.646808; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; Kumar VA, 2014, KIDNEY INT, V86, P1016, DOI 10.1038/ki.2014.224; Leinig CE, 2011, J RENAL NUTR, V21, P176, DOI 10.1053/j.jrn.2010.06.026; Mathew S, 2015, RENAL FAILURE, V37, P66, DOI 10.3109/0886022X.2014.964147; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Noh H, 1998, PERITON DIALYSIS INT, V18, P387; O'Lone EL, 2014, NEPHROL DIAL TRANSPL, V29, P1430, DOI 10.1093/ndt/gfu049; Paniagua R, 2008, CLIN J AM SOC NEPHRO, V3, P407, DOI 10.2215/CJN.03820907; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Ronco C, 2015, NEPHROL DIAL TRANSPL, V30, P849, DOI 10.1093/ndt/gfv013; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wang AYM, 2007, CLIN CHEM, V53, P882, DOI 10.1373/clinchem.2006.078378; Wang AYM, 2007, J AM SOC NEPHROL, V18, P321, DOI 10.1681/ASN.2005121299; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Xie Q, 2015, PERIT DIAL INT	30	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158741	10.1371/journal.pone.0158741	http://dx.doi.org/10.1371/journal.pone.0158741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415758	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500034
J	Hodgson, EE; Essington, TE; Kaplan, IC				Hodgson, Emma E.; Essington, Timothy E.; Kaplan, Isaac C.			Extending Vulnerability Assessment to Include Life Stages Considerations	PLOS ONE			English	Article							QUALITATIVE RISK-ASSESSMENT; LOGGERHEAD SEA-TURTLES; OCEAN ACIDIFICATION; POPULATION BIOLOGY; CLIMATE-CHANGE; FISHERIES; IMPACTS; SUSTAINABILITY; ADAPTATION; ELASTICITY	Species are experiencing a suite of novel stressors from anthropogenic activities that have impacts at multiple scales. Vulnerability assessment is one tool to evaluate the likely impacts that these stressors pose to species so that high-vulnerability cases can be identified and prioritized for monitoring, protection, or mitigation. Commonly used semi-quantitative methods lack a framework to explicitly account for differences in exposure to stressors and organism responses across life stages. Here we propose a modification to commonly used spatial vulnerability assessment methods that includes such an approach, using ocean acidification in the California Current as an illustrative case study. Life stage considerations were included by assessing vulnerability of each life stage to ocean acidification and were used to estimate population vulnerability in two ways. We set population vulnerability equal to: (1) the maximum stage vulnerability and (2) a weighted mean across all stages, with weights calculated using Lefkovitch matrix models. Vulnerability was found to vary across life stages for the six species explored in this case study: two krill-Euphausia pacifica and Thysanoessa spinifera, pteropod-Limacina helicina, pink shrimp-Pandalus jordani, Dungeness crab-Metacarcinus magister and Pacific hake-Merluccius productus. The maximum vulnerability estimates ranged from larval to subadult and adult stages with no consistent stage having maximum vulnerability across species. Similarly, integrated vulnerability metrics varied greatly across species. A comparison showed that some species had vulnerabilities that were similar between the two metrics, while other species' vulnerabilities varied substantially between the two metrics. These differences primarily resulted from cases where the most vulnerable stage had a low relative weight. We compare these methods and explore circumstances where each method may be appropriate.	[Hodgson, Emma E.; Essington, Timothy E.] Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA; [Kaplan, Isaac C.] Natl Marine Fisheries Serv NOAA, Northwest Fisheries Sci Ctr, Conservat Biol Div, 2725 Montlake Blvd, Seattle, WA 98112 USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Hodgson, EE (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	hodgsone@uw.edu			National Science Foundation Graduate Research Fellowship Program [DGE-1256082]; National Centers for Coastal Ocean Science; NOAA Ocean Acidification Program [NA12NOS4780147]; University of Washington Graduate School Top Scholar Award	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Centers for Coastal Ocean Science(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Ocean Acidification Program; University of Washington Graduate School Top Scholar Award	This work was supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1256082 to EEH and by the National Centers for Coastal Ocean Science, and NOAA Ocean Acidification Program, grant No. NA12NOS4780147 to EEH, TEE and ICK. Additional funding was provided to EEH through the University of Washington Graduate School Top Scholar Award (no grant number associated with this funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 2009, 310001 ISO; Arnberg M, 2013, MAR BIOL, V160, P2037, DOI 10.1007/s00227-012-2072-9; Astles KL, 2006, FISH RES, V82, P290, DOI 10.1016/j.fishres.2006.05.013; Barnthouse LW, 1992, ENV TOXICOLOGY CHEM, V11; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Bi HS, 2011, J PLANKTON RES, V33, P751, DOI 10.1093/plankt/fbq138; Bolten AB, 1998, ECOL APPL, V8, P1; Breitburg DL, 2003, ESTUARIES, V26, P280, DOI 10.1007/BF02695967; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 1996, DEMOGRAPHY MEETS ECO, V2, P255; Chambers RC, 2014, BIOGEOSCIENCES, V11, P1613, DOI 10.5194/bg-11-1613-2014; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chaumot A, 2002, ECOL APPL, V12, P1771, DOI 10.1890/1051-0761(2002)012[1771:UAMTAT]2.0.CO;2; Cheung WWL, 2016, ICES J MAR SCI, V73, P1283, DOI 10.1093/icesjms/fsv250; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Fletcher WJ, 2005, ICES J MAR SCI, V62, P1576, DOI 10.1016/j.icesjms.2005.06.005; Froehlich HE, 2014, ESTUAR COAST, V37, P449, DOI 10.1007/s12237-013-9676-2; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Grantham BA, 2003, ECOL APPL, V13, pS108; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Haidvogel DB, 2008, J COMPUT PHYS, V227, P3595, DOI 10.1016/j.jcp.2007.06.016; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Harvey HR, 2010, DEEP-SEA RES PT II, V57, P663, DOI 10.1016/j.dsr2.2009.10.015; Hatton IA, 2006, ECOL APPL, V16, P1238, DOI 10.1890/1051-0761(2006)016[1238:ADATER]2.0.CO;2; Heppell S, 2000, ECOLOGY, V81, P605, DOI 10.1890/0012-9658(2000)081[0605:EAIPBM]2.0.CO;2; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hofmann GE, 2014, BIOGEOSCIENCES, V11, P1053, DOI 10.5194/bg-11-1053-2014; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hurst TP, 2013, ICES J MAR SCI, V70, P812, DOI 10.1093/icesjms/fst053; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Mastrandrea M.D., 2010, GUIDANCE NOTE LEAD A; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Metzger MJ, 2005, INT J APPL EARTH OBS, V7, P253, DOI 10.1016/j.jag.2005.06.011; Miller JJ, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2883-1; Miller TW, 2010, MAR ECOL PROG SER, V420, P15, DOI 10.3354/meps08876; Morris W. F., 2002, QUANTITATIVE CONSERV; Moyle PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063883; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Pinsky ML, 2014, OCEANOGRAPHY, V27, P146, DOI 10.5670/oceanog.2014.93; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Schindler DE, 2015, SCIENCE, V347, P953, DOI 10.1126/science.1261824; Small-Lorenz SL, 2013, NAT CLIM CHANGE, V3, P91, DOI 10.1038/nclimate1810; Smith PE, 1995, CAL COOP OCEAN FISH, V36, P144; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stobutzki I, 2001, ENVIRON CONSERV, V28, P167, DOI 10.1017/S0376892901000170; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; U. S. EPA, 1998, GUID EC RISK ASS; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	77	13	13	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158917	10.1371/journal.pone.0158917	http://dx.doi.org/10.1371/journal.pone.0158917			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416031	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500050
J	Shi, C; Song, KK; Zhang, XR; Sun, Y; Sui, Y; Chen, YF; Jia, ZY; Sun, HH; Sun, Z; Xia, XD				Shi, Chao; Song, Kaikuo; Zhang, Xiaorong; Sun, Yi; Sui, Yue; Chen, Yifei; Jia, Zhenyu; Sun, Huihui; Sun, Zheng; Xia, Xiaodong			Antimicrobial Activity and Possible Mechanism of Action of Citral against Cronobacter sakazakii	PLOS ONE			English	Article							RECONSTITUTED INFANT FORMULA; ENTEROBACTER-SAKAZAKII; ESSENTIAL OILS; ESCHERICHIA-COLI; ACID; FOOD; INACTIVATION; COMBINATION; COMPONENTS; LEMON	Citral is a flavor component that is commonly used in food, beverage and fragrance industries. Cronobacter sakazakii is a food-borne pathogen associated with severe illness and high mortality in neonates and infants. The objective of the present study was to evaluate antimicrobial effect of citral against C. sakazakii strains. The minimum inhibitory concentration (MIC) of citral against C. sakazakii was determined via agar dilution method, then Gompertz models were used to quantitate the effect of citral on microbial growth kinetics. Changes in intracellular pH (pH(in)), membrane potential, intracellular ATP concentration, and membrane integrity were measured to elucidate the possible antimicrobial mechanism. Cell morphology changes were also examined using a field emission scanning electron microscope. The MICs of citral against C. sakazakii strains ranged from 0.27 to 0.54 mg/mL, and citral resulted in a longer lag phase and lower growth rate of C. sakazakii compared to the control. Citral affected the cell membrane of C. sakazakii, as evidenced by decreased intracellular ATP concentration, reduced pHin, and cell membrane hyperpolarization. Scanning electron microscopy analysis further confirmed that C. sakazakii cell membranes were damaged by citral. These findings suggest that citral exhibits antimicrobial effect against C. sakazakii strains and could be potentially used to control C. sakazakii in foods. However, how it works in food systems where many other components may interfere with its efficacy should be tested in future research before its real application.	[Shi, Chao; Song, Kaikuo; Zhang, Xiaorong; Sun, Yi; Sui, Yue; Chen, Yifei; Jia, Zhenyu; Sun, Huihui; Sun, Zheng; Xia, Xiaodong] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China; [Xia, Xiaodong] Sino US Joint Res Ctr Food Safety, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Xia, XD (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China.; Xia, XD (corresponding author), Sino US Joint Res Ctr Food Safety, Yangling, Shaanxi, Peoples R China.	foodscixiaodong@yahoo.com	Xia, Xiaodong/R-9279-2019; Chen, Yi/HIR-2608-2022		New Century Excellent Talent Support Plan [NCET-13-0488]; Twelve-five Science and Technology Support Program [2015BAD16B08]; National Natural Science Foundation of China [31301498]; International Collaboration Partner Plan in Northwest AF University [A213021203]; Special Fund for Sino-US Joint Research Center for Food Safety [A200021501]	New Century Excellent Talent Support Plan; Twelve-five Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Collaboration Partner Plan in Northwest AF University; Special Fund for Sino-US Joint Research Center for Food Safety	This work was supported in part by New Century Excellent Talent Support Plan (NCET-13-0488), the Twelve-five Science and Technology Support Program (No. 2015BAD16B08), National Natural Science Foundation of China (31301498), International Collaboration Partner Plan (A213021203) in Northwest A&F University and Special Fund for Sino-US Joint Research Center for Food Safety (A200021501).	Bajpai VK, 2013, FOOD CONTROL, V32, P582, DOI 10.1016/j.foodcont.2013.01.032; Benvenuti F, 2001, J SUPERCRIT FLUID, V20, P29, DOI 10.1016/S0896-8446(01)00058-4; Bot C, 2009, EUR BIOPHYS J BIOPHY, V38, P1049, DOI 10.1007/s00249-009-0507-0; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Choi SJ, 2010, FOOD CHEM, V122, P111, DOI 10.1016/j.foodchem.2010.02.025; da Silva CD, 2008, BRAZ J INFECT DIS, V12, P63, DOI 10.1590/S1413-86702008000100014; Di Pasqua R, 2007, J AGR FOOD CHEM, V55, P4863, DOI 10.1021/jf0636465; EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570; Fisher K, 2006, J APPL MICROBIOL, V101, P1232, DOI 10.1111/j.1365-2672.2006.03035.x; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; Gyawali R, 2014, FOOD CONTROL, V46, P412, DOI 10.1016/j.foodcont.2014.05.047; Hayes M, 2009, J FOOD PROTECT, V72, P340, DOI 10.4315/0362-028X-72.2.340; Healy B, 2010, FOODBORNE PATHOG DIS, V7, P339, DOI 10.1089/fpd.2009.0379; Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006; Holyoak CD, 1996, APPL ENVIRON MICROB, V62, P3158, DOI 10.1128/AEM.62.9.3158-3164.1996; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2003, TRENDS FOOD SCI TECH, V14, P443, DOI 10.1016/S0924-2244(03)00155-9; Koluman A, 2013, CRIT REV MICROBIOL, V39, P57, DOI 10.3109/1040841X.2012.691458; Korenblum E, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-44; Lee SY, 2008, LETT APPL MICROBIOL, V47, P315, DOI 10.1111/j.1472-765X.2008.02432.x; Li GH, 2014, EUR FOOD RES TECHNOL, V238, P589, DOI 10.1007/s00217-013-2140-5; Li R, 2016, J DAIRY SCI, V99, P1019, DOI 10.3168/jds.2015-10039; MATES SM, 1982, P NATL ACAD SCI-BIOL, V79, P6693, DOI 10.1073/pnas.79.21.6693; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; MUYTJENS HL, 1990, PEDIATR INFECT DIS J, V9, P372, DOI 10.1097/00006454-199005000-00016; Nair MKM, 2004, J FOOD PROTECT, V67, P2815, DOI 10.4315/0362-028X-67.12.2815; Ortiz MI, 2010, PHYTOMEDICINE, V18, P74, DOI 10.1016/j.phymed.2010.05.009; Rhayour K, 2003, J ESSENT OIL RES, V15, P356, DOI 10.1080/10412905.2003.9698611; Sanchez E, 2010, APPL ENVIRON MICROB, V76, P6888, DOI 10.1128/AEM.03052-09; Shi C, 2015, J APPL MICROBIOL, V119, P1700, DOI 10.1111/jam.12964; Shi C, 2016, FOOD CONTROL, V59, P352, DOI 10.1016/j.foodcont.2015.05.041; Silva-Angulo AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114026; Somolinos M, 2008, INT J FOOD MICROBIOL, V124, P260, DOI 10.1016/j.ijfoodmicro.2008.03.021; Suzuki H, 2003, ANAL SCI, V19, P1239, DOI 10.2116/analsci.19.1239; Tajkarimi MM, 2010, FOOD CONTROL, V21, P1199, DOI 10.1016/j.foodcont.2010.02.003; Turgis M, 2009, FOOD CONTROL, V20, P1073, DOI 10.1016/j.foodcont.2009.02.001; Whiteaker KL, 2001, J BIOMOL SCREEN, V6, P305, DOI 10.1177/108705710100600504	38	106	119	15	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159006	10.1371/journal.pone.0159006	http://dx.doi.org/10.1371/journal.pone.0159006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415761	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500058
J	Chizzali, C; Swiddan, AK; Abdelaziz, S; Gaid, M; Richter, K; Fischer, TC; Liu, B; Beerhues, L				Chizzali, Cornelia; Swiddan, Asya K.; Abdelaziz, Sahar; Gaid, Mariam; Richter, Klaus; Fischer, Thilo C.; Liu, Benye; Beerhues, Ludger			Expression of Biphenyl Synthase Genes and Formation of Phytoalexin Compounds in Three Fire Blight-Infected Pyrus communis Cultivars	PLOS ONE			English	Article							AUCUPARIA CELL-CULTURES; SORBUS-AUCUPARIA; VENTURIA-INAEQUALIS; PHENOL COUPLINGS; HOLSTEINER COX; CV CONFERENCE; BIOSYNTHESIS; APPLE; DIBENZOFURANS; PROTEINS	Pear (Pyrus communis) is an economically important fruit crop. Drops in yield and even losses of whole plantations are caused by diseases, most importantly fire blight which is triggered by the bacterial pathogen Erwinia amylovora. In response to the infection, biphenyls and dibenzofurans are formed as phytoalexins, biosynthesis of which is initiated by biphenyl synthase (BIS). Two PcBIS transcripts were cloned from fire blight-infected leaves and the encoded enzymes were characterized regarding substrate specificities and kinetic parameters. Expression of PcBIS1 and PcBIS2 was studied in three pear cultivars after inoculation with E. amylovora. Both PcBIS1 and PcBIS2 were expressed in 'Harrow Sweet', while only PcBIS2 transcripts were detected in 'Alexander Lucas' and 'Conference'. Expression of the PcBIS genes was observed in both leaves and the transition zone of the stem; however, biphenyls and dibenzofurans were only detected in stems. The maximum phytoalexin level (similar to 110 mu g/g dry weight) was observed in the transition zone of 'Harrow Sweet', whereas the concentrations were ten times lower in 'Conference' and not even detectable in 'Alexander Lucas'. In 'Harrow Sweet', the accumulation of the maximum phytoalexin level correlated with the halt of migration of the transition zone, whereby the residual part of the shoot survived. In contrast, the transition zones of 'Alexander Lucas' and 'Conference' advanced down to the rootstock, resulting in necrosis of the entire shoots.	[Chizzali, Cornelia; Swiddan, Asya K.; Abdelaziz, Sahar; Gaid, Mariam; Liu, Benye; Beerhues, Ludger] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Mendelssohnstr 1, D-38106 Braunschweig, Germany; [Richter, Klaus] Inst Resistance Res & Stress Tolerance, Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Erwin Baur Str 27, D-06484 Quedlinburg, Germany; [Fischer, Thilo C.] Tech Univ Munich, Life Sci Ctr Weihenstephan, Biotechnol Nat Prod, Liesel Beckmann Str 1, D-85354 Freising Weihenstephan, Germany; [Abdelaziz, Sahar] Zagazig Univ, Fac Pharm, Dept Pharmacognosy, Zagazig 44519, Egypt	Braunschweig University of Technology; Julius Kuhn-Institut; Technical University of Munich; Egyptian Knowledge Bank (EKB); Zagazig University	Beerhues, L (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Mendelssohnstr 1, D-38106 Braunschweig, Germany.	l.beerhues@tu-bs.de	Abdelaziz, Sahar/HHZ-9560-2022; Gaid, Mariam/AAF-9512-2019; Liu, Benye/AAF-4840-2020	Gaid, Mariam/0000-0002-7290-0628; Abdelaziz, Sahar/0000-0001-9475-6121; Liu, Benye/0000-0001-8527-565X; Beerhues, Ludger/0000-0002-2147-2731	Deutsche Forschungsgemeinschaft [BE 1174]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by BE 1174 (LB); www.dfg.de; Deutsche Forschungsgemeinschaft.	Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Chizzali C, 2012, BEILSTEIN J ORG CHEM, V8, P613, DOI 10.3762/bjoc.8.68; Chizzali C, 2012, PHYTOCHEMISTRY, V77, P179, DOI 10.1016/j.phytochem.2012.01.023; Chizzali C, 2012, PLANT PHYSIOL, V158, P864, DOI 10.1104/pp.111.190918; Coyne S, 2013, ANGEW CHEM INT EDIT, V52, P10564, DOI 10.1002/anie.201305595; Deckers T, 2008, ACTA HORTIC, P95, DOI 10.17660/ActaHortic.2008.800.8; El-Awaad I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11472; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Hrazdina G, 1997, PHYTOPATHOLOGY, V87, P868, DOI 10.1094/PHYTO.1997.87.8.868; Huttner C, 2010, J AGR FOOD CHEM, V58, P11977, DOI 10.1021/jf1026857; Khalil MNA, 2015, PLANT J, V83, P263, DOI 10.1111/tpj.12885; Khalil MNA, 2013, PHYTOCHEMISTRY, V96, P101, DOI 10.1016/j.phytochem.2013.09.003; KOKUBUN T, 1995, PHYTOCHEMISTRY, V40, P1649, DOI 10.1016/0031-9422(95)00443-B; Konarska A, 2013, SCI WORLD J, DOI 10.1155/2013/846796; Liu B, 2007, PLANTA, V225, P1495, DOI 10.1007/s00425-006-0435-5; Liu BY, 2010, PLANT MOL BIOL, V72, P17, DOI 10.1007/s11103-009-9548-0; Liu BY, 2004, PLANTA, V218, P492, DOI 10.1007/s00425-003-1144-y; MIYAKODO M, 1985, J PESTIC SCI, V10, P101; Paris R, 2009, TREE GENET GENOMES, V5, P81, DOI 10.1007/s11295-008-0177-6; Peters S, 1998, PLANTA, V204, P64, DOI 10.1007/s004250050230; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reiland Holly, 2015, Nutr Today, V50, P301, DOI 10.1097/NT.0000000000000112; Sircar D, 2015, PLANT PHYSIOL, V168, P428, DOI 10.1104/pp.15.00074; Teotia D, 2016, J CHROMATOGR SCI, V54, P918, DOI 10.1093/chromsci/bmw019; Vrancken K, 2013, PLANT PHYSIOL BIOCH, V72, P134, DOI 10.1016/j.plaphy.2013.03.010; Yakovin NA, 2011, RUSS J GENET+, V47, P564, DOI 10.1134/S1022795411040156	26	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158713	10.1371/journal.pone.0158713	http://dx.doi.org/10.1371/journal.pone.0158713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410389	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300032
J	Erb, SJ; Schappi, JM; Rasenick, MM				Erb, Samuel J.; Schappi, Jeffrey M.; Rasenick, Mark M.			Antidepressants Accumulate in Lipid Rafts Independent of Monoamine Transporters to Modulate Redistribution of the G Protein, G alpha(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); depression; drug action; G protein; gas chromatography-mass spectrometry (GC-MS); glial cell; intracellular trafficking; lipid raft; monoamine transporter; selective serotonin reuptake inhibitor (SSRI); G protein-coupled receptor (GPCR); glia; heterotrimeric G protein; lipid; mass spectrometry (MS); membrane trafficking; plasma membrane; protein-drug interaction; protein translocation; protein-lipid interaction; serotonin; serotonin transporter	C6 GLIOMA-CELLS; MAJOR DEPRESSIVE DISORDER; BETA-ADRENERGIC-RECEPTOR; ADENYLYL-CYCLASE; PLASMA-MEMBRANE; GLIAL-CELLS; MICROTUBULE DYNAMICS; DRUGS INCREASES; DOMAINS; ALPHA	Depression is a significant public health problem for which currently available medications, if effective, require weeks to months of treatment before patients respond. Previous studies have shown that the G protein responsible for increasing cAMP (G(s)) is increasingly localized to lipid rafts in depressed subjects and that chronic antidepressant treatment translocates G(s) from lipid rafts. Translocation of G(s), which shows delayed onset after chronic antidepressant treatment of rats or of C6 glioma cells, tracks with the delayed onset of therapeutic action of antidepressants. Because antidepressants appear to specifically modify G(s) localized to lipid rafts, we sought to determine whether structurally diverse antidepressants accumulate in lipid rafts. Sustained treatment of C6 glioma cells, which lack 5-hydroxytryptamine transporters, showed marked concentration of several antidepressants in raft fractions, as revealed by increased absorbance and by mass fingerprint. Closely related molecules without antidepressant activity did not concentrate in raft fractions. Thus, at least two classes of antidepressants accumulate in lipid rafts and effect translocation of G(s) to the non-raft membrane fraction, where it activates the cAMP-signaling cascade. Analysis of the structural determinants of raft localization may both help to explain the hysteresis of antidepressant action and lead to design and development of novel substrates for depression therapeutics.	[Erb, Samuel J.; Rasenick, Mark M.] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [Schappi, Jeffrey M.; Rasenick, Mark M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Rasenick, Mark M.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Rasenick, Mark M.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rasenick, MM (corresponding author), Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA.; Rasenick, MM (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA.; Rasenick, MM (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.; Rasenick, MM (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.	raz@uic.edu			Veterans Administration Merit Award [BX001149]; National Institutes of Health [R01AT009169, T32 MH067631]; Eli Lilly; Lundbeck, Inc.; National Center for Complementary & Integrative Health [R01AT009169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067631] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001149] Funding Source: NIH RePORTER	Veterans Administration Merit Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); Lundbeck, Inc.(Lundbeck Corporation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Administration Merit Award BX001149 and National Institutes of Health Grants R01AT009169 and T32 MH067631. M. M. R. has received research support from Eli Lilly and Lundbeck, Inc. and is a consultant to Otsuka Pharmaceuticals. He also has ownership in Pax Neuroscience. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chen GA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001754; CHEN JA, 1995, J NEUROCHEM, V64, P724; CHIOU CT, 1981, J PHARM SCI, V70, P1176, DOI 10.1002/jps.2600701027; Czysz AH, 2015, NEUROPSYCHOPHARMACOL, V40, P766, DOI 10.1038/npp.2014.256; Di Benedetto B, 2013, CURR DRUG TARGETS, V14, P1329; Donati RJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1238, DOI 10.1038/sj.npp.1300697; Donati RJ, 2001, MOL PHARMACOL, V59, P1426, DOI 10.1124/mol.59.6.1426; Donati RJ, 2008, J NEUROSCI, V28, P3042, DOI 10.1523/JNEUROSCI.5713-07.2008; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Eisensamer B, 2005, J NEUROSCI, V25, P10198, DOI 10.1523/JNEUROSCI.2460-05.2005; Eshleman AJ, 1997, J NEUROCHEM, V69, P1459; Fujita M, 2012, BIOL PSYCHIAT, V72, P548, DOI 10.1016/j.biopsych.2012.04.030; Golan M, 2011, INT J NEUROPSYCHOPH, V14, P1289, DOI 10.1017/S1461145710001550; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Kalinowska M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121464; Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; MENKES DB, 1983, SCIENCE, V219, P65, DOI 10.1126/science.6849117; Nelson JC, 2009, AM J PSYCHIAT, V166, P980, DOI 10.1176/appi.ajp.2009.09030312; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; OZAWA H, 1991, J NEUROCHEM, V56, P330, DOI 10.1111/j.1471-4159.1991.tb02599.x; Rothschild AJ, 1999, J CLIN PSYCHIAT, V60, P116, DOI 10.4088/JCP.v60n0208; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sarma T, 2015, J BIOL CHEM, V290, P10045, DOI 10.1074/jbc.M114.630632; Toki S, 1999, J NEUROCHEM, V73, P1114, DOI 10.1046/j.1471-4159.1999.0731114.x; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; VETULANI J, 1975, NATURE, V257, P495, DOI 10.1038/257495a0; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Winecker RE, 2010, METHODS MOL BIOL, V603, P45, DOI 10.1007/978-1-60761-459-3_5; Yan K, 2001, J NEUROCHEM, V76, P182, DOI 10.1046/j.1471-4159.2001.00013.x; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zhang LQ, 2010, J PHARMACOL EXP THER, V332, P977, DOI 10.1124/jpet.109.162644	42	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19725	19733		10.1074/jbc.M116.727263	http://dx.doi.org/10.1074/jbc.M116.727263			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27432886	Green Published, hybrid			2022-12-26	WOS:000383243100001
J	Wirth, N; Gross, J; Roth, HM; Buechner, CN; Kisker, C; Tessmer, I				Wirth, Nicolas; Gross, Jonas; Roth, Heide M.; Buechner, Claudia N.; Kisker, Caroline; Tessmer, Ingrid			Conservation and Divergence in Nucleotide Excision Repair Lesion Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; UVRAB PROTEIN COMPLEX; GROUP D HELICASE; DNA-REPAIR; DAMAGE RECOGNITION; GENERAL TRANSCRIPTION; STRUCTURAL INSIGHTS; PREINCISION COMPLEX; CRYSTAL-STRUCTURE; ATPASE ACTIVITY	Nucleotide excision repair is an important and highly conserved DNA repair mechanism with an exceptionally large range of chemically and structurally unrelated targets. Lesion verification is believed to be achieved by the helicases UvrB and XPD in the prokaryotic and eukaryotic processes, respectively. Using single molecule atomic force microscopy analyses, we demonstrate that UvrB and XPD are able to load onto DNA and pursue lesion verification in the absence of the initial lesion detection proteins. Interestingly, our studies show different lesion recognition strategies for the two functionally homologous helicases, as apparent from their distinct DNA strand preferences, which can be rationalized from the different structural features and interactions with other nucleotide excision repair protein factors of the two enzymes.	[Wirth, Nicolas; Gross, Jonas; Roth, Heide M.; Buechner, Claudia N.; Kisker, Caroline; Tessmer, Ingrid] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Roth, Heide M.] NanoTemper Technol, Floessergasse 4, Wurzburg, Germany	University of Wurzburg	Tessmer, I (corresponding author), Rudolf Virchow Ctr Expt Biomed, Struct Biol, Josef Schneider Str 2 D15-00-015, D-97080 Wurzburg, Germany.	ingrid.tessmer@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019; Tessmer, Ingrid/O-2810-2013	Resch, Heide Marie/0000-0001-9635-6340; Kisker, Caroline/0000-0002-0216-6026; Tessmer, Ingrid/0000-0002-8353-6315; Wirth, Nicolas Thilo/0000-0003-0799-1321	Deutsche Forschungsgemeinschaft (DFG) [KI-562/7-1, Forschungszentrurn FZ82, TE-671/4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants KI-562/7-1, Forschungszentrurn FZ82, and TE-671/4 (to C. K. and I. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Buechner CN, 2014, J BIOL CHEM, V289, P3613, DOI 10.1074/jbc.M113.523001; Buechner CN, 2013, J MOL RECOGNIT, V26, P605, DOI 10.1002/jmr.2311; CARON PR, 1988, NUCLEIC ACIDS RES, V16, P10891, DOI 10.1093/nar/16.22.10891; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; de Jesus BMB, 2008, MOL CELL BIOL, V28, P7225, DOI 10.1128/MCB.00781-08; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gordienko I, 1997, EMBO J, V16, P889, DOI 10.1093/emboj/16.4.889; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hou EW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm639; Hughes CD, 2013, NUCLEIC ACIDS RES, V41, P4901, DOI 10.1093/nar/gkt177; Jaciuk M, 2011, NAT STRUCT MOL BIOL, V18, P191, DOI 10.1038/nsmb.1973; Jia L, 2009, BIOCHEMISTRY-US, V48, P8948, DOI 10.1021/bi9010072; Jiang GH, 2006, BIOCHEMISTRY-US, V45, P7834, DOI 10.1021/bi052515e; Koch SC, 2015, P NATL ACAD SCI USA, V112, P8272, DOI 10.1073/pnas.1508509112; Kuper J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001954; Kuper J, 2012, CURR OPIN STRUC BIOL, V22, P88, DOI 10.1016/j.sbi.2011.12.002; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Li CL, 2015, MOL CELL, V59, P1025, DOI 10.1016/j.molcel.2015.08.012; Li XM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000876; Liu Y, 2011, DNA REPAIR, V10, P684, DOI 10.1016/j.dnarep.2011.04.020; Luo J, 2015, MOL CELL, V59, P794, DOI 10.1016/j.molcel.2015.07.016; Maillard O, 2008, MUTAT RES-REV MUTAT, V658, P271, DOI 10.1016/j.mrrev.2008.01.007; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Mathieu N, 2010, P NATL ACAD SCI USA, V107, P17545, DOI 10.1073/pnas.1004339107; Moolenaar GF, 1998, J BIOL CHEM, V273, P34896, DOI 10.1074/jbc.273.52.34896; Moolenaar GF, 2000, J BIOL CHEM, V275, P8038, DOI 10.1074/jbc.275.11.8038; Moolenaar GF, 1997, MUTAT RES-DNA REPAIR, V385, P195, DOI 10.1016/S0921-8777(97)00042-6; Moolenaar GF, 1995, J BIOL CHEM, V270, P30508, DOI 10.1074/jbc.270.51.30508; Moolenaar GF, 2001, EMBO J, V20, P6140, DOI 10.1093/emboj/20.21.6140; OH EY, 1989, J BIOL CHEM, V264, P1336; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200; Roth HM, 2012, DNA REPAIR, V11, P286, DOI 10.1016/j.dnarep.2011.12.002; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SCHENDEL PF, 1982, J BACTERIOL, V150, P676, DOI 10.1128/JB.150.2.676-685.1982; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sohi M, 2000, FEBS LETT, V465, P161, DOI 10.1016/S0014-5793(99)01690-7; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugasawa K, 2009, MOL CELL, V36, P642, DOI 10.1016/j.molcel.2009.09.035; Tessmer I, 2012, NUCLEIC ACIDS RES, V40, P8296, DOI 10.1093/nar/gks574; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Theis K, 2000, MUTAT RES-DNA REPAIR, V460, P277, DOI 10.1016/S0921-8777(00)00032-X; Truglio JJ, 2006, NAT STRUCT MOL BIOL, V13, P360, DOI 10.1038/nsmb1072; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; Verhoeven EEA, 2001, EMBO J, V20, P601, DOI 10.1093/emboj/20.3.601; Wang H, 2008, NANO LETT, V8, P1631, DOI 10.1021/nl080316l; Wang H, 2006, J BIOL CHEM, V281, P15227, DOI 10.1074/jbc.M601476200; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Zou Y, 1999, EMBO J, V18, P4889, DOI 10.1093/emboj/18.17.4889; Zou Y, 1997, J BIOL CHEM, V272, P4820, DOI 10.1074/jbc.272.8.4820; Zou Y, 2004, BIOCHEMISTRY-US, V43, P4196, DOI 10.1021/bi035992a	63	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18932	18946		10.1074/jbc.M116.739425	http://dx.doi.org/10.1074/jbc.M116.739425			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405761	hybrid, Green Published			2022-12-26	WOS:000383242300029
J	Pozzi, N; Bystranowska, D; Zuo, XB; Di Cera, E				Pozzi, Nicola; Bystranowska, Dominika; Zuo, Xiaobing; Di Cera, Enrico			Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; prothrombin; single-molecule biophysics; structure-function; thrombin	ALTERNATING-LASER EXCITATION; TRYPSIN-LIKE PROTEASES; RAY CRYSTAL-STRUCTURE; BLOOD-COAGULATION; CONFORMATIONAL SELECTION; SOLUTION SCATTERING; FRET; ACTIVATION; EVOLUTION; THROMBIN	The coagulation factor prothrombin has a complex spatial organization of its modular assembly that comprises the N-terminal Gla domain, kringle-1, kringle-2, and the C-terminal protease domain connected by three intervening linkers. Here we use single molecule Forster resonance energy transfer to access the conformational landscape of prothrombin in solution and uncover structural features of functional significance that extend recent x-ray crystallographic analysis. Prothrombin exists in equilibrium between two alternative conformations, open and closed. The closed conformation predominates (70%) and features an unanticipated intramolecular collapse of Tyr(93) in kringle-1 onto Trp(547) in the protease domain that obliterates access to the active site and protects the zymogen from autoproteolytic conversion to thrombin. The open conformation (30%) is more susceptible to chymotrypsin digestion and autoactivation, and features a shape consistent with recent x-ray crystal structures. Small angle x-ray scattering measurements of prothrombin wild type stabilized 70% in the closed conformation and of the mutant Y93A stabilized 80% in the open conformation directly document two envelopes that differ 50 in length. These findings reveal important new details on the conformational plasticity of prothrombin in solution and the drastic structural difference between its alternative conformations. Prothrombin uses the intramolecular collapse of kringle-1 onto the active site in the closed form to prevent autoactivation. The open-closed equilibrium also defines a new structural framework for the mechanism of activation of prothrombin by prothrombinase.	[Pozzi, Nicola; Bystranowska, Dominika; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Bystranowska, Dominika] Wroclaw Univ Technol, Dept Biochem, PL-50370 Wroclaw, Poland	Saint Louis University; United States Department of Energy (DOE); Argonne National Laboratory; Wroclaw University of Science & Technology	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAV-4876-2021; Pozzi, Nicola/AAE-4910-2020	Pozzi, Nicola/0000-0003-2309-7100; Bystranowska, Dominika/0000-0002-6745-5355; Zuo, Xiaobing/0000-0002-0134-4804	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R01HL049413, R29HL049413, R01HL073813] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge Dr. David Gohara and Zhiwei Chen for their assistance with the model of the closed conformation of prothrombin, Daniel Shropshire and Leslie Pelc for expression and labeling of several constructs for smFRET measurements, and Dr. Tomasz Heyduk and Rachel Hickey for providing double-stranded DNA constructs used for calibration of the Micro-Time instrument and control experiments. This research used resources of the Advanced Photon Source, a U. S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Barranco-Medina S, 2013, J BIOL CHEM, V288, P35749, DOI 10.1074/jbc.M113.509786; BODE W, 1992, PROTEIN SCI, V1, P426; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Chung HS, 2013, CHEM PHYS, V422, P229, DOI 10.1016/j.chemphys.2012.08.005; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Flick MJ, 2011, BLOOD, V117, P6326, DOI 10.1182/blood-2010-08-304915; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gould TJ, 2015, J THROMB HAEMOST, V13, pS82, DOI 10.1111/jth.12977; Huang YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015809; Juette MF, 2014, CURR OPIN CHEM BIOL, V20, P103, DOI 10.1016/j.cbpa.2014.05.010; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Kudryavtsev V, 2012, CHEMPHYSCHEM, V13, P1060, DOI 10.1002/cphc.201100822; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5; Pozzi N, 2016, J BIOL CHEM, V291, P6071, DOI 10.1074/jbc.M115.700401; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; ROSING J, 1980, J BIOL CHEM, V255, P274; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tomescu AI, 2014, P NATL ACAD SCI USA, V111, pE3335, DOI 10.1073/pnas.1406056111; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wang SZ, 2016, NAT STRUCT MOL BIOL, V23, P31, DOI 10.1038/nsmb.3138; Xue JC, 1998, P NATL ACAD SCI USA, V95, P7603, DOI 10.1073/pnas.95.13.7603	49	15	16	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18107	18116		10.1074/jbc.M116.738310	http://dx.doi.org/10.1074/jbc.M116.738310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27435675	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000383241800005
J	Coria, RA; Currie, PJ				Coria, Rodolfo A.; Currie, Philip J.			A New Megaraptoran Dinosaur (Dinosauria, Theropoda, Megaraptoridae) from the Late Cretaceous of Patagonia	PLOS ONE			English	Article							CARNIVOROUS DINOSAUR; CARNOSAUR DINOSAURIA; EVOLUTION; SPECIMEN; ABELISAURIDAE; NAMUNHUAIQUII; NEUQUEN; ANATOMY; ORIGIN; GEN.	A skeleton discovered in the Upper Cretaceous Sierra Barrosa Formation (Turonian-Coniacian) of Neuquen Province, Argentina represents a new species of theropod dinosaur related to the long snouted, highly pneumatized Megaraptoridae. The holotype specimen of Murusraptor barrosaensis n.gen et n.sp. (MCF-PVPH-411) includes much of the skull, axial skeleton, pelvis and tibia. Murusraptor is unique in having several diagnostic features that include anterodorsal process of lacrimal longer than height of preorbital process, and a thick, shelf-like thickening on the lateral surface of surangular ventral to the groove between the anterior surangular foramen and the insert for the uppermost intramandibular process of the dentary. Other characteristic features of Murusraptor barrosaensis n.gen. et n.sp. include a large mandibular fenestra, distal ends of caudal neural spines laterally thickened into lateral knob-like processes, short ischia distally flattened and slightly expanded dorsoventrally. Murusraptor belongs to a Patagonian radiation of megaraptorids together with Aerosteon, Megaraptor and Orkoraptor. In spite being immature, it is a larger but more gracile animal than existing specimens of Megaraptor, and is comparable in size with Aerosteon and Orkoraptor. The controversial phylogeny of the Megaraptoridae as members of the Allosauroidea or a clade of Coelurosauria is considered analyzing two alternative data sets.	[Coria, Rodolfo A.] Consejo Nacl Invest Cient & Tecn, Gral Roca, Argentina; [Coria, Rodolfo A.] Univ Nacl Rio Negro, Gral Roca, Argentina; [Coria, Rodolfo A.] Museo Carmen Funes, Secretaria Estado Cultura Neuquen, Plaza Huincul, Neuquen, Argentina; [Currie, Philip J.] Univ Alberta, Edmonton, AB, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Alberta	Coria, RA (corresponding author), Consejo Nacl Invest Cient & Tecn, Gral Roca, Argentina.; Coria, RA (corresponding author), Univ Nacl Rio Negro, Gral Roca, Argentina.; Coria, RA (corresponding author), Museo Carmen Funes, Secretaria Estado Cultura Neuquen, Plaza Huincul, Neuquen, Argentina.	rcoria@unrn.edu.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-0233]; National Sciences and Engineering Reserach Council [203091-06]; Troodon Resources; Municipalidad de Plaza Huincul; NSERC [203091-06]; Dinosaur Research Institute; Troodon Resources (Calgary, Canada); Dinosaur Research Institute (Calgary, Canada)	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Sciences and Engineering Reserach Council; Troodon Resources; Municipalidad de Plaza Huincul; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dinosaur Research Institute; Troodon Resources (Calgary, Canada); Dinosaur Research Institute (Calgary, Canada)	Funding was provided by Consejo Nacional de Investigaciones Cientificas y Tecnicas, PIP-0233, RAC National Sciences and Engineering Reserach Council grant #203091-06, PJC, Troodon Resources, Dinosaur Research Institute and Municipalidad de Plaza Huincul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The specimen was found by S. Saldivia (MCF). The authors also thanks to the many people involved in the fieldwork of 2001-2002 in Sierra Barrosa (L. Filippi, A. Garrido, M. Getty, D. Hernandez, A. Paulina Carabajal, M. Ryan, S. Saldivia and W. Sloboda) that participated in collecting MCF-PVPH-411. Thanks are extended for funding support to P.J. Currie, NSERC grant (Grant #203091-06), Troodon Resources (Calgary, Canada), the Dinosaur Research Institute (Calgary, Canada), and Municipalidad de Plaza Huincul for travel and fieldwork assistance. E. Snively (University of Calgary) for photography and A. Paulina Carabajal (MCF) for preparation of braincase of MCF-PVPH-411. E. Koppelhus (UofA) for photography, picture setup, field assistance and logistics. To A. Gerez (MCF) for pencil drawings for Figs 2, 4, 5, 14, 15 and 22. Other figures were done by first author. To K. Kamra for helping in the editing of reviewed version of the manuscript. We thank to the reviewers F. Novas and S. Brusatte, and the PLoSOne Editor L. Claessens whose comments and suggestions greately improved the manuscript. J. Calvo and J. Porfiri (Universidad Nacional del Comahue) gave us access to specimens under their care. F. Novas (Museo Argentino de Ciencias Naturales, Buenos Aires) for access to unpublished information about Megaraptor and Orkoraptor. We also thank the docents and students of School number 291 of Sierra Barrosa, for their hospitality during our stay.	Arcucci AB, 2003, AMEGHINIANA, V40, P217; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Bell PR, 2016, GONDWANA RES, V36, P473, DOI 10.1016/j.gr.2015.08.004; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bonaparte J.F., 1985, Ameghiniana, V21, P259; BONAPARTE J F, 1986, Annales de Paleontologie, V72, P247; Bonaparte J. F., 1990, NATURAL HIST MUSEUM, V416, P1; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Calvo JO, 2004, AMEGHINIANA, V41, P565; Calvo JO, 2002, 1 C LAT PAL VERT RES, P20; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Colbert E. H., 1969, American Museum Novitates, VNo. 2380, P1; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Coria RA, 2006, GEODIVERSITAS, V28, P71; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P802, DOI 10.1671/0272-4634(2002)022[0802:TBOGCD]2.0.CO;2; Coria RA, 2002, AMEGHINIANA, V39, P453; Coria RA, 2002, J VERTEBR PALEONTOL, V22, P460, DOI 10.1671/0272-4634(2002)022[0460:ANCROC]2.0.CO;2; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Coria RA, 1998, GAIA, V15, P89; Coria RA, 2006, CAN J EARTH SCI, V43, P1283, DOI 10.1139/E06-025; Coria Rodolfo A., 2001, P3; Currie Philip J., 2000, Geodiversitas, V22, P207; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra M. D., 2016, CONTRIBUCIONES MUSEO, V6, P139; Ezcurra M.D., 2006, HIST BIOL, V19, P185; Forasiepi AM, 2012, AMEGHINIANA, V49, P497, DOI 10.5710/AMGH.8.8.2012.581; Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Goloboff P.A., 2003, TREE ANAL USING NEW; Hasiotis ST, 1997, COMB ROCK MOUNT SOUT, V29, p13A; Heaton M.J., 1979, OKLAHOMA GEOL SURV B, V127, P1; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Lamanna M, 2004, J VERTEBR PALEONTOL, V64, p252A; Lambe LM, 1904, GEOLOGICAL SURVEY CA, V3, P1; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Martinelli AG, 2013, RIV ITAL PALEONTOL S, V119, P205, DOI 10.13130/2039-4942/6035; Martinez R, 2004, AMEGHINIANA, V41, P577; Martinez R., 1986, 4 C ARG PAL BIOESTR, V2, P23; Mendez AH, 2012, CR PALEVOL, V11, P251, DOI 10.1016/j.crpv.2011.12.007; Molnar R.E., 1990, P169; MOLNAR R E, 1991, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V217, P137; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Novas FE, 2005, NATURE, V433, P858, DOI 10.1038/nature03285; Novas FE, 1997, ENCY DINOSAURS; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Novas Fernando E., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P61; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Ortega-Colonga F, 2012, AMEGHINIANA, V49, pR33; Osborn H. F., 1912, Memoirs of the American Museum of Natural History New York, V1; Ostrom JH, 1969, OSTEOLOGY DEINONYCHU, V30, P1; Poblete F, 2003, AMEGHINIANA, V40, p66R; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; RICH TH, 2000, GAIA, V15, P111; Rogers R.R., 1992, Journal of Vertebrate Paleontology, V12, P528; Salgado L, 2009, ZOOTAXA, P1; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Smith JB, 2007, J VERTEBR PALEONTOL, V27, P103, DOI 10.1671/0272-4634(2007)27[103:DMAVIM]2.0.CO;2; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; Veralli C., 2003, AMEGHINIANA, V40, p74R; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; White MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1512; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827	78	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157973	10.1371/journal.pone.0157973	http://dx.doi.org/10.1371/journal.pone.0157973			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27439002	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100004
J	Kanninen, O; Karhula, A				Kanninen, Ohto; Karhula, Aleksi			Changes in Income at Macro Level Predict Sex Ratio at Birth in OECD Countries	PLOS ONE			English	Article							TRIVERS-WILLARD; OFFSPRING SEX; POPULATION; HYPOTHESIS; SELECTION; DECLINE; HUMANS; WAR	The human sex ratio at birth (SRB) is approximately 107 boys for every 100 girls. SRB was rising until the World War II and has been declining slightly after the 1950s in several industrial countries. Recent studies have shown that SRB varies according to exposure to disasters and socioeconomic conditions. However, it remains unknown whether changes in SRB can be explained by observable macro-level socioeconomic variables across multiple years and countries. Here we show that changes in disposable income at the macro level positively predict SRB in OECD countries. A one standard deviation increase in the change of disposable income is associated with an increase of 1.03 male births per 1000 female births. The relationship is possibly nonlinear and driven by extreme changes. The association varies from country to country being particular strong in Estonia. This is the first evidence to show that economic and social conditions are connected to SRB across countries at the macro level. This calls for further research on the effects of societal conditions on general characteristics at birth.	[Kanninen, Ohto] Labour Inst Econ Res, Helsinki, Finland; [Karhula, Aleksi] Univ Turku, Dept Social Res, Turku, Finland	University of Turku	Karhula, A (corresponding author), Univ Turku, Dept Social Res, Turku, Finland.	aleksi.karhula@utu.fi		Karhula, Aleksi/0000-0002-2396-7084				Acemoglu D., 2012, FOREIGN POLICY, P85; Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; [Anonymous], 2008, SOCIOECONOMIC STATUS; Catalano R, 2006, HUM REPROD, V21, P3127, DOI 10.1093/humrep/del283; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; Catalano R, 2008, P NATL ACAD SCI USA, V105, P2244, DOI 10.1073/pnas.0710711104; Catalano R, 2010, AM J HUM BIOL, V22, P396, DOI 10.1002/ajhb.21011; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Deaton A., 2013, GREAT ESCAPE HLTH WE; Frederick S, 1999, WELL BEING FDN HEDON, P302; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Graffelman J, 2000, HUM BIOL, V72, P433; Grech V., 2015, EUR J SPORTS MED, V2; Grech V, 2012, SCAND J PUBLIC HEALT, V40, P761, DOI 10.1177/1403494812464447; Irgens A, 1999, NOR EPIDEMIOL, V9; Johns SE, 2004, P ROY SOC B-BIOL SCI, V271, pS474, DOI 10.1098/rsbl.2004.0220; Kanazawa S, 2005, J THEOR BIOL, V235, P583, DOI 10.1016/j.jtbi.2005.02.010; Khashan AS, 2009, HUM REPROD, V24, P1754, DOI 10.1093/humrep/dep082; Kolk M, 2016, AM J HUM BIOL, V28, P67, DOI 10.1002/ajhb.22756; LYSTER WR, 1974, J OBSTET GYN BR COMM, V81, P626; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; MEALEY L, 1990, ETHOL SOCIOBIOL, V11, P83, DOI 10.1016/0162-3095(90)90030-A; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; Piketty T., 2014, CAPITAL 21 CENTURY; Polasek O, 2005, HUM REPROD, V20, P2489, DOI 10.1093/humrep/dei097; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Rueness J, 2012, HUM REPROD, V27, P283, DOI 10.1093/humrep/der347; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173	30	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158943	10.1371/journal.pone.0158943	http://dx.doi.org/10.1371/journal.pone.0158943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437701	Green Submitted, Green Published, gold			2022-12-26	WOS:000380170100025
J	Chowdhury, A; Kalurupalle, S; Tharun, S				Chowdhury, Ashis; Kalurupalle, Swathi; Tharun, Sundaresan			Mutagenic Analysis of the C-Terminal Extension of Lsm1	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; SM-LIKE PROTEINS; LSM1-7-PAT1 COMPLEX; SACCHAROMYCES-CEREVISIAE; LSM1P-7P-PAT1P COMPLEX; YEAST; MUTATIONS; DECAY; DEADENYLATION; ASSOCIATION	The Sm-like proteins (also known as Lsm proteins) are ubiquitous in nature and exist as hexa or heptameric RNA binding complexes. They are characterized by the presence of the Sm-domain. The Lsm1 through Lsm7 proteins are highly conserved in eukaryotes and they form a hetero-octameric complex together with the protein Pat1. The Lsm1-7-Pat1 complex plays a key role in mRNA decapping and 3'-end protection and therefore is required for normal mRNA decay rates in vivo. Lsm1 is a key subunit that is critical for the unique RNA binding properties of this complex. We showed earlier that unlike most Sm-like proteins, Lsm1 uniquely requires both its Sm domain and its C-terminal extension to contribute to the function of the Lsm1-7-Pat1 complex and that the C-terminal segment can associate with the rest of the complex and support the function even in trans. The studies presented here identify a set of residues at the very C-terminal end of Lsm1 to be functionally important and suggest that these residues support the function of the Lsm1-7-Pat1 complex by facilitating RNA binding either directly or indirectly.	[Chowdhury, Ashis; Kalurupalle, Swathi; Tharun, Sundaresan] Uniformed Serv Univ Hlth Sci, Dept Biochem, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Tharun, S (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	tharun.sundaresan@usuhs.edu			National Institutes of Health (NIH) [GM072718]; Uniformed Services University of the Health Sciences (USUHS) [RO71JX, BIO-71-3020]; NIH RO1 grant [GM072718]; USUHS [RO71JX, BIO-71-3020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University of the Health Sciences (USUHS); NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USUHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant# GM072718 to ST; Uniformed Services University of the Health Sciences (USUHS) exploratory grant# RO71JX to ST; and Uniformed Services University of the Health Sciences (USUHS) standard grant# BIO-71-3020 to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funds from NIH RO1 grant (GM072718) and USUHS exploratory (RO71JX) and standard (BIO-71-3020) grants to S.T.	Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Chowdhury A, 2008, RNA, V14, P2149, DOI 10.1261/rna.1094208; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Chowdhury A, 2012, RNA, V18, P936, DOI 10.1261/rna.029876.111; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; He WH, 2001, GENETICS, V158, P1445; Jungfleisch J, 2015, RNA, V21, P1469, DOI 10.1261/rna.052209.115; Ling SHM, 2011, WIRES RNA, V2, P193, DOI 10.1002/wrna.44; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Sharif H, 2013, CELL REP, V5, P283, DOI 10.1016/j.celrep.2013.10.004; Tharun S, 2005, GENETICS, V170, P33, DOI 10.1534/genetics.104.034322; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tharun S, 2009, RNA BIOL, V6, P228, DOI 10.4161/rna.6.3.8282; Tharun S, 2009, INT REV CEL MOL BIO, V272, P149, DOI 10.1016/S1937-6448(08)01604-3; Totaro A, 2011, NUCLEIC ACIDS RES, V39, P635, DOI 10.1093/nar/gkq797; Wilusz CJ, 2005, NAT STRUCT MOL BIOL, V12, P1031, DOI 10.1038/nsmb1037; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Zhou L, 2014, CELL RES	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158876	10.1371/journal.pone.0158876	http://dx.doi.org/10.1371/journal.pone.0158876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434131	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600021
J	Lee, JH; Chun, JL; Kim, KJ; Kim, EY; Kim, DH; Lee, BM; Han, KW; Park, KS; Lee, KB; Kim, MK				Lee, Ji Hye; Chun, Ju Lan; Kim, Keun Jung; Kim, Eun Young; Kim, Dong-hee; Lee, Bo Myeong; Han, Kil Woo; Park, Kang-Sun; Lee, Kyung-Bon; Kim, Min Kyu			Effect of Acteoside as a Cell Protector to Produce a Cloned Dog	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; INSULIN-TRANSFERRIN-SELENIUM; DONOR SOMATIC-CELLS; OXYGEN SPECIES ROS; NUCLEAR TRANSFER; CYCLE SYNCHRONIZATION; OXIDATIVE STRESS; CULTURE-MEDIUM; DEVELOPMENTAL ABILITY; FOLLICULAR-FLUID	Somatic cell nuclear transfer (SCNT) is a well-known laboratory technique. The principle of the SCNT involves the reprogramming a somatic nucleus by injecting a somatic cell into a recipient oocyte whose nucleus has been removed. Therefore, the nucleus donor cells are considered as a crucial factor in SCNT. Cell cycle synchronization of nucleus donor cells at G0/G1 stage can be induced by contact inhibition or serum starvation. In this study, acteoside, a phenylpropanoid glycoside compound, was investigated to determine whether it is applicable for inducing cell cycle synchronization, cytoprotection, and improving SCNT efficiency in canine fetal fibroblasts. Primary canine fetal fibroblasts were treated with acteoside (10, 30, 50 mu M) for various time periods (24, 48 and 72 hours). Cell cycle synchronization at G0/G1 stage did not differ significantly with the method of induction: acteoside treatment, contact inhibition or serum starvation. However, of these three treatments, serum starvation resulted in significantly increased level of reactive oxygen species (ROS) (99.5 +/- 0.3%) and apoptosis. The results also revealed that acteoside reduced ROS and apoptosis processes including necrosis in canine fetal fibroblasts, and improved the cell survival. Canine fetal fibroblasts treated with acteoside were successfully arrested at the G0/G1 stage. Moreover, the reconstructed embryos using nucleus donor cells treated with acteoside produced a healthy cloned dog, but not the embryos produced using nucleus donor cells subjected to contact inhibition. In conclusion, acteoside induced cell cycle synchronization of nucleus donor cells would be an alternative method to improve the efficiency of canine SCNT because of its cytoprotective effects.	[Lee, Ji Hye; Chun, Ju Lan; Kim, Keun Jung; Kim, Eun Young; Kim, Dong-hee; Lee, Bo Myeong; Han, Kil Woo; Park, Kang-Sun; Kim, Min Kyu] Chungnam Natl Univ, Coll Agr & Life Sci, Div Anim & Dairy Sci, Daejeon, South Korea; [Lee, Kyung-Bon] Chonnam Natl Univ, Dept Biol Educ, Coll Educ, Gwangju, South Korea	Chungnam National University; Chonnam National University	Kim, MK (corresponding author), Chungnam Natl Univ, Coll Agr & Life Sci, Div Anim & Dairy Sci, Daejeon, South Korea.	kminkyu@cnu.ac.kr		Kim, Keun Jung/0000-0003-2340-8319; KIM, MINKYU/0000-0001-7099-9735	Korea Research institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program [KGM4611613]	Korea Research institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program	This work was supported by a grant from Korea Research institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program (KGM4611613), http://www.kribb.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Arruda ALA, 2011, J MED FOOD, V14, P1604, DOI 10.1089/jmf.2010.0251; Avila JG, 1999, J ETHNOPHARMACOL, V66, P75, DOI 10.1016/S0378-8741(98)00203-7; Boquest AC, 1999, BIOL REPROD, V60, P1013, DOI 10.1095/biolreprod60.4.1013; Campbell K H, 1999, Cloning, V1, P3, DOI 10.1089/15204559950020058; Cho JK, 2002, THERIOGENOLOGY, V57, P1819, DOI 10.1016/S0093-691X(01)00699-9; Cho SR, 2005, REPROD DOMEST ANIM, V40, P171, DOI 10.1111/j.1439-0531.2005.00577.x; Choi YH, 2002, THERIOGENOLOGY, V58, P1187, DOI 10.1016/S0093-691X(02)00946-9; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Das ZC, 2014, ZYGOTE, V22, P411, DOI 10.1017/S0967199412000731; Goissis MD, 2007, REPROD DOMEST ANIM, V42, P660, DOI 10.1111/j.1439-0531.2006.00839.x; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hase M, 2000, J VET MED SCI, V62, P243, DOI 10.1292/jvms.62.243; Hashem MA, 2006, CELL BIOL INT, V30, P698, DOI 10.1016/j.cellbi.2006.04.008; Jang G, 2004, THERIOGENOLOGY, V62, P512, DOI 10.1016/j.theriogenology.2003.11.022; Jang G, 2010, THERIOGENOLOGY, V74, P1311, DOI 10.1016/j.theriogenology.2010.05.036; Jeong YW, 2008, ANIM REPROD SCI, V106, P13, DOI 10.1016/j.anireprosci.2007.03.021; Kang EJ, 2014, NATURE, V509, P101, DOI 10.1038/nature13134; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Kasinathan P, 2001, NAT BIOTECHNOL, V19, P1176, DOI 10.1038/nbt1201-1176; Khammanit R, 2008, THERIOGENOLOGY, V70, P27, DOI 10.1016/j.theriogenology.2008.02.015; Kim EY, 2013, J REPROD DEVELOP, V59, P536, DOI 10.1262/jrd.2013-047; Kim KS, 2001, GENES GENET SYST, V76, P243, DOI 10.1266/ggs.76.243; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Koo OJ, 2009, ZYGOTE, V17, P37, DOI 10.1017/S096719940800498X; Kues Wilfried A., 2002, Cloning and Stem Cells, V4, P231, DOI 10.1089/15362300260339511; Lai LX, 2002, MOL REPROD DEV, V62, P300, DOI 10.1002/mrd.10146; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Lee KW, 2007, CARCINOGENESIS, V28, P1928, DOI 10.1093/carcin/bgm126; Mastromonaco GF, 2007, REPROD FERT DEVELOP, V19, P748, DOI 10.1071/RD07034; Miyamoto K, 2007, J REPROD DEVELOP, V53, P237, DOI 10.1262/jrd.18085; Oback Bjorn, 2002, Cloning and Stem Cells, V4, P147, DOI 10.1089/153623002320253328; Ozawa M, 2006, MOL REPROD DEV, V73, P998, DOI 10.1002/mrd.20533; Park ES, 2004, MOL REPROD DEV, V68, P65, DOI 10.1002/mrd.20046; Park SH, 2014, REPROD DOMEST ANIM, V49, P370, DOI 10.1111/rda.12281; Pendota SC, 2013, J ETHNOPHARMACOL, V148, P515, DOI 10.1016/j.jep.2013.04.047; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Shimatsu Y, 2013, XENOTRANSPLANTATION, V20, P157, DOI 10.1111/xen.12031; Shufaro Y, 2011, METHODS MOL BIOL, V761, P239, DOI 10.1007/978-1-61779-182-6_16; Uhm SJ, 2007, MOL REPROD DEV, V74, P1386, DOI 10.1002/mrd.20701; Umeyama K, 2013, J REPROD DEVELOP, V59, P599, DOI 10.1262/jrd.2013-069; Urakawa M, 2004, THERIOGENOLOGY, V62, P714, DOI 10.1016/j.theriogenology.2003.11.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu SC, 2007, AM J EMERG MED, V25, DOI [10.1016/j.ajem.2007.02.039, DOI 10.1016/J.AJEM.2007.02.039]; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yoneda A, 2004, J REPROD DEVELOP, V50, P287, DOI 10.1262/jrd.50.287; You J, 2012, THERIOGENOLOGY, V78, P235, DOI 10.1016/j.theriogenology.2012.02.027; You J, 2010, THERIOGENOLOGY, V74, P777, DOI 10.1016/j.theriogenology.2010.04.002; Zhang FX, 2002, PLANTA MED, V68, P115, DOI 10.1055/s-2002-20255	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159330	10.1371/journal.pone.0159330	http://dx.doi.org/10.1371/journal.pone.0159330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428333	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169300050
J	McTaggart, LR; Brown, EM; Richardson, SE				McTaggart, Lisa R.; Brown, Elizabeth M.; Richardson, Susan E.			Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; HISTOPLASMA-CAPSULATUM; ASPERGILLUS-FUMIGATUS; COCCIDIOIDES-IMMITIS; PHYLOGENETIC TREES; NATURAL SITES; WISCONSIN; EPIDEMIOLOGY; FUNGUS	Blastomyces dermatitidis and Blastomyces gilchristii are dimorphic fungal pathogens that cause serious pulmonary and systemic infections in humans. Although their natural habitat is in the environment, little is known about their specific ecologic niche(s). Here, we analyzed 25 microsatellite loci from 169 strains collected from various regions throughout their known endemic range in North America, representing the largest and most geographically diverse collection of isolates studied to date. Genetic analysis of multilocus microsatellite data divided the strains into four populations of B. dermatitidis and four populations of B. gilchristii. B. dermatitidis isolates were recovered from areas throughout North America, while the B. gilchristii strains were restricted to Canada and some northern US states. Furthermore, the populations of both species were associated with major freshwater drainage basins. The four B. dermatitidis populations were partitioned among (1) the Nelson River drainage basin, (2) the St. Lawrence River and northeast Atlantic Ocean Seaboard drainage basins, (3) the Mississippi River System drainage basin, and (4) the Gulf of Mexico Seaboard and southeast Atlantic Ocean Seaboard drainage basins. A similar partitioning of the B. gilchristii populations was observed among the more northerly drainage basins only. These associations suggest that the ecologic niche where the sexual reproduction, growth, and dispersal of B. dermatitidis and B. gilchristii occur is intimately linked to freshwater systems. For most populations, sexual reproduction was rare enough to produce significant linkage disequilibrium among loci but frequent enough that mating-type idiomorphic ratios were not skewed from 1:1. Furthermore, the evolutionary divergence of B. dermatitidis and B. gilchristii was estimated at 1.9 MYA during the Pleistocene epoch. We suggest that repeated glaciations during the Pleistocene period and resulting biotic refugia may have provided the impetus for speciation as theorized for other species associated with temperate freshwater systems.	[McTaggart, Lisa R.; Brown, Elizabeth M.; Richardson, Susan E.] Publ Hlth Ontario, Publ Hlth Labs Toronto, Toronto, ON, Canada; [Brown, Elizabeth M.; Richardson, Susan E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Richardson, Susan E.] Hosp Sick Children, Div Microbiol, Dept Paediat Lab Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McTaggart, LR (corresponding author), Publ Hlth Ontario, Publ Hlth Labs Toronto, Toronto, ON, Canada.	lisa.mctaggart@oahpp.ca	Brown, Elizabeth M./AAI-2537-2019	Brown, Elizabeth M./0000-0003-1411-5792				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2014, R LANG ENV STAT COMP; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Arceneaux KA, 1998, J AM VET MED ASSOC, V213, P658; BAILY GG, 1991, REV INFECT DIS, V13, P1005; BAKERSPIGEL A, 1986, J CLIN MICROBIOL, V24, P890, DOI 10.1128/JCM.24.5.890-891.1986; Barres B, 2012, HEREDITY, V109, P269, DOI 10.1038/hdy.2012.37; Baumgardner D J, 1998, WMJ, V97, P44; Baumgardner DJ, 2006, MYCOPATHOLOGIA, V161, P275, DOI 10.1007/s11046-006-0018-9; Baumgardner DJ, 2005, MED MYCOL, V43, P117, DOI 10.1080/13693780410001731529; Baumgardner DJ, 1999, MED MYCOL, V37, P163, DOI 10.1046/j.1365-280X.1999.00214.x; Benedict K, 2012, CURR FUNGAL INFECT R, V6, P327, DOI 10.1007/s12281-012-0110-1; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BRADSHER RW, 1987, AM REV RESPIR DIS, V136, P1324, DOI 10.1164/ajrccm/136.6.1324; Brisse S, 2009, EUKARYOT CELL, V8, P287, DOI 10.1128/EC.00215-08; Brown EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059237; Cano MV, 2003, EPIDEMIOL INFECT, V131, P907, DOI 10.1017/S0950268803008987; Chapman S W, 1997, Semin Respir Infect, V12, P219; DENTON JF, 1961, SCIENCE, V133, P1126, DOI 10.1126/science.133.3459.1126; DENTON JF, 1964, AM J TROP MED HYG, V13, P716, DOI 10.4269/ajtmh.1964.13.716; DENTON JF, 1979, AM J TROP MED HYG, V28, P697, DOI 10.4269/ajtmh.1979.28.697; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Disalvo Arthur F., 1992, P43; DIXON DM, 1977, MYCOLOGIA, V69, P1193, DOI 10.2307/3758943; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dutech C, 2010, HEREDITY, V105, P220, DOI 10.1038/hdy.2009.164; DUTTERA J, 1969, SOUTHERN MED J, V62, P295; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fisher MC, 2005, PLOS PATHOG, V1, P159, DOI 10.1371/journal.ppat.0010020; Fisher MC, 2002, P NATL ACAD SCI USA, V99, P9067, DOI 10.1073/pnas.132178099; Fisher MC, 2001, P NATL ACAD SCI USA, V98, P4558, DOI 10.1073/pnas.071406098; Fisher MC, 2000, J CLIN MICROBIOL, V38, P807, DOI 10.1128/JCM.38.2.807-813.2000; FREAN JA, 1989, S AFR MED J, V76, P13; Garcia-Cunchillos I, 2014, MYCORRHIZA, V24, pS89, DOI 10.1007/s00572-013-0540-9; Geml J, 2008, MOL PHYLOGENET EVOL, V48, P694, DOI 10.1016/j.ympev.2008.04.029; Gueho E, 1997, MYCOSES, V40, P69, DOI 10.1111/j.1439-0507.1997.tb00191.x; Hagen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071148; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; HARVEY RP, 1978, AM REV RESPIR DIS, V117, P695; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Henk DA, 2011, MOL ECOL, V20, P4288, DOI 10.1111/j.1365-294X.2011.05244.x; Henk DA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002851; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Institute Broad, 2010, B DERM GEN IND; KANE J, 1984, J CLIN MICROBIOL, V20, P594, DOI 10.1128/JCM.20.3.594-596.1984; Kasuga T, 2003, MOL ECOL, V12, P3383, DOI 10.1046/j.1365-294X.2003.01995.x; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; KLEIN BS, 1987, AM REV RESPIR DIS, V136, P1333, DOI 10.1164/ajrccm/136.6.1333; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; LOWRY PW, 1989, AM J EPIDEMIOL, V130, P151, DOI 10.1093/oxfordjournals.aje.a115307; McCullough MJ, 2000, CLIN INFECT DIS, V30, P328, DOI 10.1086/313649; MCDONOUG.ES, 1967, SCIENCE, V156, P528, DOI 10.1126/science.156.3774.528; MCDONOUGH ES, 1970, MYCOPATH MYCOL APPL, V41, P195, DOI 10.1007/BF02051495; MCDONOUGH ES, 1976, SABOURAUDIA, V14, P199; Meece JK, 2013, J INFECT DIS, V207, P814, DOI 10.1093/infdis/jis756; Meece JK, 2011, APPL ENVIRON MICROB, V77, P5123, DOI 10.1128/AEM.00258-11; MENGES RW, 1965, AM J EPIDEMIOL, V81, P164, DOI 10.1093/oxfordjournals.aje.a120505; Munoz JF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005493; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pan WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032868; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pfister JR, 2011, CLIN MED RES, V9, P57, DOI 10.3121/cmr.2010.958; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Pritchard JK, 2000, GENETICS, V155, P945; Randhawa HS, 2013, MED MYCOL, V51, P185, DOI 10.3109/13693786.2012.685960; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Saccente M, 2010, CLIN MICROBIOL REV, V23, P367, DOI 10.1128/CMR.00056-09; SAROSI GA, 1976, AM REV RESPIR DIS, V114, P1179; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Swofford DL, 2003, PAUP PHYLOGENETIC AN, V4; Takezaki N, 1996, GENETICS, V144, P389; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Weir B. S., 1996, GENETIC DATA ANAL; Zhao TM, 2011, CHINESE MED J-PEKING, V124, P4368, DOI 10.3760/cma.j.issn.0366-6999.2011.24.044	87	24	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159396	10.1371/journal.pone.0159396	http://dx.doi.org/10.1371/journal.pone.0159396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428521	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300061
J	Petit, O; Merunka, D; Anton, JL; Nazarian, B; Spence, C; Cheok, AD; Raccah, D; Oullier, O				Petit, Olivia; Merunka, Dwight; Anton, Jean-Luc; Nazarian, Bruno; Spence, Charles; Cheok, Adrian David; Raccah, Denis; Oullier, Olivier			Health and Pleasure in Consumers' Dietary Food Choices: Individual Differences in the Brain's Value System	PLOS ONE			English	Article							DECISION-MAKING; SELF-CONTROL; ORBITOFRONTAL CORTEX; TASTY INTUITION; GOAL VALUES; VALUATION; UNHEALTHY; VMPFC; COMPUTATION; TEMPTATION	Taking into account how people value the healthiness and tastiness of food at both the behavioral and brain levels may help to better understand and address overweight and obesity-related issues. Here, we investigate whether brain activity in those areas involved in self-control may increase significantly when individuals with a high body-mass index (BMI) focus their attention on the taste rather than on the health benefits related to healthy food choices. Under such conditions, BMI is positively correlated with both the neural responses to healthy food choices in those brain areas associated with gustation (insula), reward value (orbitofrontal cortex), and self-control (inferior frontal gyrus), and with the percent of healthy food choices. By contrast, when attention is directed towards health benefits, BMI is negatively correlated with neural activity in gustatory and reward-related brain areas (insula, inferior frontal operculum). Taken together, these findings suggest that those individuals with a high BMI do not necessarily have reduced capacities for self-control but that they may be facilitated by external cues that direct their attention toward the tastiness of healthy food. Thus, promoting the taste of healthy food in communication campaigns and/or food packaging may lead to more successful self-control and healthy food behaviors for consumers with a higher BMI, an issue which needs to be further researched.	[Petit, Olivia; Cheok, Adrian David] Imagineering Inst, Iskandar Puteri, Malaysia; [Petit, Olivia; Cheok, Adrian David] City Univ London, London, England; [Petit, Olivia; Merunka, Dwight] Aix Marseille Univ, Aix Marseille Grad Sch Management IAE, CERGAM EA 4225, Aix En Provence, France; [Petit, Olivia; Oullier, Olivier] Aix Marseille Univ, FR-3512 Marseille, France; [Petit, Olivia; Oullier, Olivier] CNRS, Behav Brain & Cognit Inst, LPC, FED 3C,UMR 7290, FR-3512 Marseille, France; [Merunka, Dwight] Kedge Business Sch, Marseille, France; [Anton, Jean-Luc; Nazarian, Bruno] Aix Marseille Univ, CNRS, Ctr IRMf, INT UMR 7289, Marseille, France; [Spence, Charles] Univ Oxford, Crossmodal Res Lab, Oxford, England; [Raccah, Denis] Univ Hosp St Marguerite, Dept Diabetol, Marseille, France	City University London; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Kedge Business School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite	Petit, O (corresponding author), Imagineering Inst, Iskandar Puteri, Malaysia.; Petit, O (corresponding author), City Univ London, London, England.; Petit, O (corresponding author), Aix Marseille Univ, Aix Marseille Grad Sch Management IAE, CERGAM EA 4225, Aix En Provence, France.; Petit, O (corresponding author), Aix Marseille Univ, FR-3512 Marseille, France.; Petit, O (corresponding author), CNRS, Behav Brain & Cognit Inst, LPC, FED 3C,UMR 7290, FR-3512 Marseille, France.	oliviapetit@imagineeringinstitute.org	Cheok, Adrian David/AAT-6141-2021; Petit, Olivia/Y-2937-2018	Cheok, Adrian David/0000-0001-6316-2339; Petit, Olivia/0000-0001-9340-5370				Basso F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100368; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Block LG, 2011, J PUBLIC POLICY MARK, V30, P5, DOI 10.1509/jppm.30.1.5; Booth SL, 2001, NUTR REV, V59, pS21, DOI 10.1111/j.1753-4887.2001.tb06983.x; Brooks SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060393; Bublitz MG, 2010, J CONSUM PSYCHOL, V20, P239, DOI 10.1016/j.jcps.2010.06.008; Fishbach A, 2009, J CONSUM PSYCHOL, V19, P129, DOI 10.1016/j.jcps.2009.02.005; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hofmann W, 2007, J EXP SOC PSYCHOL, V43, P497, DOI 10.1016/j.jesp.2006.05.004; Hollmann M, 2012, INT J OBESITY, V36, P648, DOI 10.1038/ijo.2011.125; Hutcherson CA, 2012, J NEUROSCI, V32, P13543, DOI 10.1523/JNEUROSCI.6387-11.2012; Lallukka T, 2007, EUR J CLIN NUTR, V61, P701, DOI 10.1038/sj.ejcn.1602583; Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Litt A, 2011, CEREB CORTEX, V21, P95, DOI 10.1093/cercor/bhq065; Lurquin JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147770; Mai R, 2015, J PUBLIC POLICY MARK, V34, P63, DOI 10.1509/jppm.14.006; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Pavlicek B., 2013, THESIS, P6; Petit O, 2016, PSYCHOL MARKET, V33, P608, DOI 10.1002/mar.20903; Petit O, 2011, M S-MED SCI, V27, P1000, DOI 10.1051/medsci/201127111000; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Pursey Kirrilly M, 2014, Front Nutr, V1, P7, DOI 10.3389/fnut.2014.00007; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Rangel A, 2013, NAT NEUROSCI, V16, P1717, DOI 10.1038/nn.3561; Rudorf S, 2014, J NEUROSCI, V34, P15988, DOI 10.1523/JNEUROSCI.3192-14.2014; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sokol-Hessner P, 2012, EUR J NEUROSCI, V35, P1065, DOI 10.1111/j.1460-9568.2012.08076.x; Spence C, 2016, BRAIN COGNITION, V110, P53, DOI 10.1016/j.bandc.2015.08.006; Sullivan N, 2015, PSYCHOL SCI, V26, P122, DOI 10.1177/0956797614559543; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Tuulari JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116640; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; van der Laan LN, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00308; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Werle COC, 2013, FOOD QUAL PREFER, V28, P116, DOI 10.1016/j.foodqual.2012.07.007	42	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0156333	10.1371/journal.pone.0156333	http://dx.doi.org/10.1371/journal.pone.0156333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428267	Green Published, gold, Green Accepted			2022-12-26	WOS:000380169300001
J	Yao, ZX; Yuan, Y; Buchanan, TW; Zhang, K; Zhang, L; Wu, JH				Yao, Zhuxi; Yuan, Yi; Buchanan, Tony W.; Zhang, Kan; Zhang, Liang; Wu, Jianhui			Greater Heart Rate Responses to Acute Stress Are Associated with Better Post-Error Adjustment in Special Police Cadets	PLOS ONE			English	Article							COGNITIVE CONTROL; MENTAL FATIGUE; PERFORMANCE; BRAIN; CONTROLLABILITY; DISORDER; BEHAVIOR; FITNESS; SYSTEM; THREAT	High-stress jobs require both appropriate physiological regulation and behavioral adjustment to meet the demands of emergencies. Here, we investigated the relationship between the autonomic stress response and behavioral adjustment after errors in special police cadets. Sixty-eight healthy male special police cadets were randomly assigned to perform a first-time walk on an aerial rope bridge to induce stress responses or a walk on a cushion on the ground serving as a control condition. Subsequently, the participants completed a Go/No-go task to assess behavioral adjustment after false alarm responses. Heart rate measurements and subjective reports confirmed that stress responses were successfully elicited by the aerial rope bridge task in the stress group. In addition, greater heart rate increases during the rope bridge task were positively correlated with post-error slowing and had a trend of negative correlation with post-error miss rate increase in the subsequent Go/No-go task. These results suggested that stronger autonomic stress responses are related to better post-error adjustment under acute stress in this highly selected population and demonstrate that, under certain conditions, individuals with high-stress jobs might show cognitive benefits from a stronger physiological stress response.	[Yao, Zhuxi; Yuan, Yi; Zhang, Kan; Zhang, Liang; Wu, Jianhui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China; [Yao, Zhuxi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yuan, Yi] Special Police Acad, Beijing, Peoples R China; [Buchanan, Tony W.] St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Saint Louis University	Wu, JH (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China.	wujh@psych.ac.cn			National Natural Science Foundation of China [81371203, 31100734, 91124003]; China Postdoctoral Science Foundation [2012M520425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81371203) received by JW, the National Natural Science Foundation of China (31100734) received by LZ, the National Natural Science Foundation of China (91124003) received by KZ, and a China Postdoctoral Science Foundation Grant (2012M520425) received by YY. The National Natural Science Foundation of China (81371203) supported study design, decision to publish, and preparation of the manuscript. The National Natural Science Foundation of China (31100734) supported data collection and analysis, decision to publish, and preparation of the manuscript. The National Natural Science Foundation of China (91124003) supported decision to publish, and preparation of the manuscript. The China Postdoctoral Science Foundation Grant (2012M520425) supported data collection and analysis.	Akinola M, 2012, BEHAV NEUROSCI, V126, P167, DOI 10.1037/a0026657; Alpers GW, 2008, J ANXIETY DISORD, V22, P591, DOI 10.1016/j.janxdis.2007.05.008; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bratzke D, 2008, INT J PSYCHOL, V43, P712; Cavanagh JF, 2008, PSYCHONEUROENDOCRINO, V33, P41, DOI 10.1016/j.psyneuen.2007.09.007; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Dishman RK, 2003, PSYCHOPHYSIOLOGY, V40, P370, DOI 10.1111/1469-8986.00040; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Henderson RK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00179; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Jentzsch I, 2006, Q J EXP PSYCHOL, V59, P1329, DOI 10.1080/17470210600674394; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Laming DR, 1968, INFORM THEORY CHOICE; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Murphy TI, 2006, J SLEEP RES, V15, P15, DOI 10.1111/j.1365-2869.2006.00503.x; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Regev S, 2014, ACTA PSYCHOL, V152, P10, DOI 10.1016/j.actpsy.2014.07.006; Schommer NC, 2003, PSYCHOSOM MED, V65, P450, DOI 10.1097/01.PSY.0000035721.12441.17; Themanson JR, 2006, NEUROSCIENCE, V141, P757, DOI 10.1016/j.neuroscience.2006.04.004; Themanson JR, 2012, BRAIN COGNITION, V80, P257, DOI 10.1016/j.bandc.2012.07.003; Tops M, 2011, PSYCHOPHYSIOLOGY, V48, P723, DOI 10.1111/j.1469-8986.2010.01131.x; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Van De Voorde S, 2010, BIOL PSYCHOL, V84, P176, DOI 10.1016/j.biopsycho.2010.01.011; van Meel CS, 2007, PSYCHIAT RES, V151, P211, DOI 10.1016/j.psychres.2006.05.011; van Westerloo DJ, 2011, MOL MED, V17, P180, DOI 10.2119/molmed.2010.00204; Vandewalle G, 2007, J SLEEP RES, V16, P148, DOI 10.1111/j.1365-2869.2007.00581.x; Wessel JR, 2014, CORTEX, V50, P45, DOI 10.1016/j.cortex.2013.09.002; Wu JH, 2014, BIOL PSYCHOL, V99, P77, DOI 10.1016/j.biopsycho.2014.03.002; [张金凤 Zhang Jinfeng], 2012, [中国心理卫生杂志, Chinese Mental Health Journal], V26, P357; Zhang L, 2015, STRESS, V18, P561, DOI 10.3109/10253890.2015.1058356	40	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159322	10.1371/journal.pone.0159322	http://dx.doi.org/10.1371/journal.pone.0159322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428280	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300049
J	Zhao, ZY; Zou, J; Zhao, LL; Cheng, Y; Cai, HQ; Li, M; Liu, EW; Yu, LP; Liu, Y				Zhao, Zhiyuan; Zou, Jing; Zhao, Lingling; Cheng, Yan; Cai, Hanqing; Li, Mo; Liu, Edwin; Yu, Liping; Liu, Yu			Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population	PLOS ONE			English	Article							AT-RISK; TYPE-1; AUTOANTIBODIES; PREVALENCE; MECHANISMS	The prevalence of celiac disease autoimmunity or tissue transglutaminase autoantibodies (TGA) amongst patients with type 1 diabetes (T1D) and autoimmune thyroid disease (AITD) in the Chinese population remains unknown. This study examined the rate of celiac disease autoimmunity amongst patients with T1D and AITD in the Chinese population. The study included 178 patients with type 1 diabetes and 119 with AITD where 36 had both T1D and AITD, classified as autoimmune polyglandular syndrome type 3 variant (APS3v). The study also included 145 patients with type 2 diabetes (T2D), 97 patients with non-autoimmune thyroid disease (NAITD), and 102 healthy controls. Serum islet autoantibodies, thyroid autoantibodies and TGA were measured by radioimmunoassay. TGA positivity was found in 22% of patients with either type 1 diabetes or AITD, much higher than that in patients with T2D (3.4%; p < 0.0001) or NAITD (3.1%; P < 0.0001) or healthy controls (1%; p < 0.0001). The patients with APS3v having both T1D and AITD were 36% positive for TGA, significantly higher than patients with T1D alone (p = 0.040) or with AITD alone (p = 0.017). T1D and AITD were found to have a 20% and 30% frequency of overlap respectively at diagnosis. In conclusion, TGA positivity was high in the Chinese population having existing T1D and/or AITD, and even higher when both diseases were present. Routine TGA screening in patients with T1D or AITD will be important to early identify celiac disease autoimmunity for better clinical care of patients.	[Zhao, Zhiyuan; Zou, Jing; Zhao, Lingling; Cheng, Yan; Cai, Hanqing; Li, Mo; Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun, Jilin, Peoples R China; [Liu, Edwin; Yu, Liping] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	Jilin University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, Y (corresponding author), Jilin Univ, Hosp 2, Dept Endocrinol, Changchun, Jilin, Peoples R China.	drliuyu@jlu.edu.cn						Agardh D, 2001, Pediatr Diabetes, V2, P58, DOI 10.1034/j.1399-5448.2001.002002058.x; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Ch'ng CL, 2007, CLIN MED RES, V5, P184, DOI 10.3121/cmr.2007.738; Ciclitira Paul J., 2005, Molecular Aspects of Medicine, V26, P421, DOI 10.1016/j.mam.2005.05.001; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Guariso G, 2007, ALIMENT PHARM THER, V26, P1409, DOI 10.1111/j.1365-2036.2007.03526.x; Horie I, 2012, J CLIN ENDOCR METAB, V97, pE1043, DOI 10.1210/jc.2011-3109; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Norstrom F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-125; Tomer Y, 2014, ANNU REV PATHOL-MECH, V9, P147, DOI 10.1146/annurev-pathol-012513-104713; Viljamaa M, 2005, SCAND J GASTROENTERO, V40, P437, DOI 10.1080/00365520510012181; Wenzlau JM, 2008, ANN NY ACAD SCI, V1150, P256, DOI 10.1196/annals.1447.029; Yu LP, 2001, DIABETES, V50, P1735, DOI 10.2337/diabetes.50.8.1735; Yuan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081151	16	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157510	10.1371/journal.pone.0157510	http://dx.doi.org/10.1371/journal.pone.0157510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427767	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300004
J	Yun, KE; Nam, GE; Lim, J; Park, HS; Chang, Y; Jung, HS; Kim, CW; Ko, BJ; Chung, EC; Shin, H; Ryu, S				Yun, Kyung Eun; Nam, Ga Eun; Lim, Jisun; Park, Hye Soon; Chang, Yoosoo; Jung, Hyun-Suk; Kim, Chan-Won; Ko, Byung-Joon; Chung, Eun Chul; Shin, Hocheol; Ryu, Seungho			Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study	PLOS ONE			English	Article							CARDIOMETABOLIC RISK PROFILE; BODY-MASS INDEX; CARDIOVASCULAR RISK; VISCERAL ADIPOSITY; ABDOMINAL OBESITY; STEATOHEPATITIS; DIAGNOSIS; ATHEROSCLEROSIS; COMPLICATIONS; CIRCUMFERENCE	Background We examined the relationship between changes in waist circumference (WC) and the incidence of nonalcoholic fatty liver disease (NAFLD). Methods A cohort study of 37,130 men and women were followed-up annually or biennially. Differences in WC between baseline and subsequent measurements were categorized in quartiles: first (WC loss), second (no change in WC as the reference), third and highest quartiles (WC gain). The presence of fatty liver was determined using ultrasound. Parametric Cox modeling was used to estimate the adjusted hazard ratios (aHR) and 95% confidence intervals (CIs) of the incidence of NAFLD. Results During 127,324.4 person-years of follow-up, 6249 participants developed NAFLD. Despite adjusting for possible confounders, the risk of development of NAFLD increased with increasing quartiles of WC change in a dose-response manner (p for trend < 0.001). Compared with the reference, WC loss was associated with a lower risk of NAFLD (men: aHR 0.79 [95% CI: 0.73-0.87]; women: 0.72 [0.63-0.81]), and the highest quartile (WC gain) was associated with a higher risk of NAFLD (men: 1.30 [1.19-1.42]; women: 1.48 [1.31-1.67]). Conclusion Waist gain appears to increase the risk of developing NAFLD, independently of the baseline body mass index and WC.	[Yun, Kyung Eun; Chang, Yoosoo; Jung, Hyun-Suk; Kim, Chan-Won; Ko, Byung-Joon; Chung, Eun Chul; Shin, Hocheol; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Total Healthcare Ctr, Ctr Cohort Studies,Sch Med, Seoul, South Korea; [Nam, Ga Eun] Korea Univ, Ansan Hosp, Coll Med, Dept Family Med, Ansan, South Korea; [Lim, Jisun; Park, Hye Soon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Family Med, Seoul, South Korea; [Chung, Eun Chul] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Shin, Hocheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Family Med, Seoul, South Korea; [Chang, Yoosoo; Ryu, Seungho] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Total Healthcare Ctr, Ctr Cohort Studies,Sch Med, Seoul, South Korea.; Park, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Family Med, Seoul, South Korea.; Ryu, S (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Occupat & Environm Med, Seoul, South Korea.	hyesoon@amc.seoul.kr; sh703.yoo@gmail.com	Nam, Ga Eun/AAU-6055-2020; Nam, Ga Eun/AAA-1577-2021	Nam, Ga Eun/0000-0002-6739-9904; Ryu, Seungho/0000-0002-3927-8646; Chang, Yoosoo/0000-0002-6945-9050; Kim, Chan-Won/0000-0001-5836-1974	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012 R1A1A2 004869]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012 R1A1A2 004869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2012 R1A1A2 004869).	Ahmed MH, 2012, J OBES, V2012, DOI 10.1155/2012/483135; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Balkau B, 2007, CIRCULATION, V116, P1942, DOI 10.1161/CIRCULATIONAHA.106.676379; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chang Y, 2006, INT J OBESITY, V30, P800, DOI 10.1038/sj.ijo.0803210; Chang Y, 2014, J AM COLL CARDIOL, V63, P2679, DOI 10.1016/j.jacc.2014.03.042; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Foster T, 2013, DIGEST DIS SCI, V58, P2392, DOI 10.1007/s10620-013-2652-7; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Heilbronn L, 2014, INT J OBESITY, pS12; Joy D, 2003, EUR J GASTROEN HEPAT, V15, P539, DOI 10.1097/01.meg.0000059112.41030.2e; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kim D, 2016, CLIN GASTROENTEROL H, V14, P132, DOI 10.1016/j.cgh.2015.07.024; Lonardo A, 2000, J GASTROEN HEPATOL, V15, P775, DOI 10.1046/j.1440-1746.2000.02226.x; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; Nazare JA, 2015, AM J CARDIOL, V115, P307, DOI 10.1016/j.amjcard.2014.10.039; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Otgonsuren M, 2013, DIGEST DIS SCI, V58, P1132, DOI 10.1007/s10620-012-2446-3; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; Pang Q, 2015, WORLD J GASTROENTERO, V21, P1650, DOI 10.3748/wjg.v21.i5.1650; Reue K, 2011, J LIPID RES, V52, P1865, DOI 10.1194/jlr.E020602; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sung KC, 2007, DIABETES CARE, V30, P2113, DOI 10.2337/dc07-0512; Suomela E, 2015, ANN MED, V47, P40, DOI 10.3109/07853890.2014.966752; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Targher G, 2016, J HEPATOL; Tison Geoffrey H, 2015, Am J Cardiol, V116, P541, DOI 10.1016/j.amjcard.2015.05.012; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350; Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761; Zhou YJ, 2012, J DIGEST DIS, V13, P153, DOI 10.1111/j.1751-2980.2011.00571.x	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158710	10.1371/journal.pone.0158710	http://dx.doi.org/10.1371/journal.pone.0158710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420035	Green Published, Green Submitted, gold			2022-12-26	WOS:000379662300004
J	Irrgang, M; Egermann, H				Irrgang, Melanie; Egermann, Hauke			From Motion to Emotion: Accelerometer Data Predict Subjective Experience of Music	PLOS ONE			English	Article								Music is often discussed to be emotional because it reflects expressive movements in audible form. Thus, a valid approach to measure musical emotion could be to assess movement stimulated by music. In two experiments we evaluated the discriminative power of mobile-device generated acceleration data produced by free movement during music listening for the prediction of ratings on the Geneva Emotion Music Scales (GEMS-9). The quality of prediction for different dimensions of GEMS varied between experiments for tenderness (R-1(2)(first experiment) = 0.50, R-2(2)(second experiment) = 0.39), nostalgia (R-1(2) = 0.42, R-2(2) = 0.30), wonder (R-1(2) = 0.25, R-2(2) = 0.34), sadness (R-1(2) = 0.24, R-2(2) = 0.35), peacefulness (R-1(2) = 0.20, R-2(2) = 0.35) and joy (R-1(2) = 0.19, R-2(2) = 0.33) and transcendence (R-1(2) = 0.14, R-2(2) = 0.00). For others like power (R-1(2) = 0.42, R-2(2) = 0.49) and tension (R-1(2) = 0.28, R-2(2) = 0.27) results could be almost reproduced. Furthermore, we extracted two principle components from GEMS ratings, one representing arousal and the other one valence of the experienced feeling. Both qualities, arousal and valence, could be predicted by acceleration data, indicating, that they provide information on the quantity and quality of experience. On the one hand, these findings show how music-evoked movement patterns relate to music-evoked feelings. On the other hand, they contribute to integrate findings from the field of embodied music cognition into music recommender systems.	[Irrgang, Melanie; Egermann, Hauke] Tech Univ Berlin, Audio Commun Grp, Berlin, Germany; [Egermann, Hauke] Univ York, Dept Mus, York, N Yorkshire, England	Technical University of Berlin; University of York - UK	Egermann, H (corresponding author), Tech Univ Berlin, Audio Commun Grp, Berlin, Germany.; Egermann, H (corresponding author), Univ York, Dept Mus, York, N Yorkshire, England.	hauke@egermann.net		Egermann, Hauke/0000-0001-7014-7989				Amelynck D, 2012, IEEE T AFFECT COMPUT, V3, P250, DOI 10.1109/T-AFFC.2011.39; Bergold J, 2012, HIST SOC RES, V37, P191; De Bruyn L, 2011, MUSIC MED, V4; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Egermann H, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01341; Egermann H, 2013, COGN AFFECT BEHAV NE, V13, P533, DOI 10.3758/s13415-013-0161-y; Garrido S, 2011, EMPIR MUSICOL REV, V6, P214, DOI 10.18061/1811/52950; Giordano LB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115587, DOI 10.1371/J0URNAL.P0NE.0115587]; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; Hedder KM, 2010, NEW NONVERBAL MEASUR; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; LEMAN M, 2008, EMBODIED MUSIC COGNI; Lepa S, 2013, MEDIA PERSPEKTIVEN, P545; Liljestrom S, 2013, PSYCHOL MUSIC, V41, P579, DOI 10.1177/0305735612440615; Longhi E, 2008, BEHAV BRAIN SCI, V31, P586, DOI 10.1017/S0140525X08005402; Lykartsis A, 2013, MUSIC EMOTION ICME3; PARNCUTT R., 1987, ACTION PERCEPTION RH, P127; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Saarikallio S., 2007, PSYCHOL MUSIC, V35, P88, DOI DOI 10.1177/0305735607068889; Sievers B, 2013, P NATL ACAD SCI USA, V110, P70, DOI 10.1073/pnas.1209023110; Soleymani M, 2013, P MEDEIEVAL 2013 MUL; Torres-Eliard K., 2012, INTELLIGENT TECHNOLO, P252, DOI DOI 10.1007/978-3-642-30214; Trost W, 2014, NEUROIMAGE, V103, P55, DOI 10.1016/j.neuroimage.2014.09.009; Van Someren WM, 1994, THINK ALOUD METHOD P; Zentner M., 2010, HDB MUSIC EMOTION TH, P187, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0008; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	28	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0154360	10.1371/journal.pone.0154360	http://dx.doi.org/10.1371/journal.pone.0154360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415015	Green Published, gold, Green Accepted			2022-12-26	WOS:000379579500007
J	Kanata, S; Koike, S; Ando, S; Nishida, A; Usami, S; Yamasaki, S; Morimoto, Y; Toriyama, R; Fujikawa, S; Sugimoto, N; Sasaki, T; Furukawa, TA; Hiraiwa-Hasegawa, M; Kasai, K				Kanata, Sho; Koike, Shinsuke; Ando, Shuntaro; Nishida, Atsushi; Usami, Satoshi; Yamasaki, Syudo; Morimoto, Yuko; Toriyama, Rie; Fujikawa, Shinya; Sugimoto, Noriko; Sasaki, Tsukasa; Furukawa, Toshiaki A.; Hiraiwa-Hasegawa, Mariko; Kasai, Kiyoto			Enuresis and Hyperactivity-Inattention in Early Adolescence: Findings from a Population-Based Survey in Tokyo (Tokyo Early Adolescence Survey)	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PRIMARY NOCTURNAL ENURESIS; PREPULSE INHIBITION; DIFFICULTIES QUESTIONNAIRE; PROBLEM BEHAVIOR; US CHILDREN; STARTLE; INCONTINENCE; ASSOCIATION; PREVALENCE	Background Enuresis (9% at age 9.5) negatively affects children's psychosocial status. Clinically-diagnosed enuresis (2% at the age) is associated with hyperactivity-inattention, and common neural bases have been postulated to underlie this association. It is, however, unclear whether this association is applicable to enuresis overall among the general population of early adolescents when considered comorbid behavioral problems. We aimed to examine whether enuresis correlates with hyperactivity-inattention after controlling for the effects of other behavioral problems. Methods Participants were 4,478 children (mean age 10.2 +/- 0.3 years old) and their parents from the Tokyo Early Adolescence Survey (T-EAS), a population-representative cross-sectional study conducted in Tokyo, Japan conducted from 2012 to 2015. Children's enuresis and behavioral problems, including hyperactivity-inattention (as measured by the Strength and Difficulties Questionnaire), were examined using parent-reporting questionnaires. Multivariate linear regression was used to explore whether enuresis predicts hyperactivity-inattention. Results The hyperactivity-inattention score was significantly higher in the enuretic group than the non-enuretic group (enuretic: M (SD) = 3.8 (2.3), non-enuretic: M (SD) = 3.0 (2.1), Hedge's g = 0.39, p < .001). This association remained significant even after controlling for other behavioral problems and including sex, age, intelligence quotient (IQ), low birth weight and parents' education (beta = .054 [95% CI:.028-.080], p < .001). Conclusions Enuresis was independently associated with hyperactivity-inattention in early adolescents among general population even when other behavioral problems were considered. These results suggest that, as with clinically-diagnosed cases, enuresis may predict need for screening and psychosocial support for hyperactivity-inattention.	[Kanata, Sho; Koike, Shinsuke; Ando, Shuntaro; Toriyama, Rie; Fujikawa, Shinya; Sugimoto, Noriko; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kanata, Sho] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Koike, Shinsuke] Univ Tokyo, UTIDAHM, Tokyo, Japan; [Koike, Shinsuke] Univ Tokyo, Grad Sch Art & Sci, Ctr Evolutionary Cognit Sci, Tokyo, Japan; [Ando, Shuntaro; Nishida, Atsushi; Yamasaki, Syudo; Morimoto, Yuko] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo, Japan; [Usami, Satoshi] Univ Tsukuba, Div Psychol, Fac Human Sci, Tsukuba, Ibaraki, Japan; [Morimoto, Yuko; Hiraiwa-Hasegawa, Mariko] Grad Univ Adv Studies, SOKENDAI, Sch Adv Sci, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Tokyo, Japan; [Furukawa, Toshiaki A.] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Hlth Promot & Human Behav, Kyoto, Japan	University of Tokyo; Teikyo University; University of Tokyo; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Graduate University for Advanced Studies - Japan; University of Tokyo; Kyoto University	Ando, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.; Ando, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo, Japan.	ando-st@igakuken.or.jp	Furukawa, Toshi A./B-9259-2011; Andoh, Akira/AAB-9303-2022; Kanata, Sho/AAY-7770-2021; Koike, Shinsuke/AIC-4690-2022	Furukawa, Toshi A./0000-0003-2159-3776; Kasai, Kiyoto/0000-0002-4443-4535; Koike, Shinsuke/0000-0002-3375-236X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23118002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (23118002; Adolescent Mind & Self-Regulation to Kiyoto Kasai) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in the study.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2014, DIAGN STAT MAN MENT, Vfifth; Austin PF, 2016, NEUROUROL URODYNAM, V35, P471, DOI 10.1002/nau.22751; Baeyens D, 2004, J UROLOGY, V171, P2576, DOI 10.1097/01.ju.0000108665.22072.b2; Baeyens D, 2006, J UROLOGY, V176, P744, DOI 10.1016/S0022-5347(06)00295-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Bush G, 2011, BIOL PSYCHIAT, V69, P1160, DOI 10.1016/j.biopsych.2011.01.022; Butler R, 2008, CHILD CARE HLTH DEV, V34, P65, DOI 10.1111/j.1365-2214.2007.00781.x; Butler RJ, 2008, SCAND J UROL NEPHROL, V42, P257, DOI 10.1080/00365590701748054; BUTLER RJ, 1990, J CHILD PSYCHOL PSYC, V31, P447, DOI 10.1111/j.1469-7610.1990.tb01581.x; Butler RJ, 2004, CLIN PSYCHOL REV, V24, P909, DOI 10.1016/j.cpr.2004.07.001; Butler RJ, 1998, J CHILD PSYCHOL PSYC, V39, P453, DOI 10.1111/1469-7610.00342; Byrd RS, 1996, PEDIATRICS, V98, P414; Casey BJ, 2010, NEURON, V67, P749, DOI 10.1016/j.neuron.2010.08.033; Coppola G, 2011, PEDIATR NEPHROL, V26, P1829, DOI 10.1007/s00467-011-1880-3; De Bruyne E, 2009, J UROLOGY, V182, P2015, DOI 10.1016/j.juro.2009.05.102; Freitag CM, 2006, DEV MED CHILD NEUROL, V48, P278, DOI 10.1017/S0012162206000600; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hollingshead AB., 2011, YJS, V8, P21, DOI DOI 10.1016/J.MATERRESBULL.2011.04.018; Inada N., 2010, JPN J CHILD ADOLESC, V51, P11; Joinson C, 2007, PEDIATRICS, V120, pE308, DOI 10.1542/peds.2006-2891; Joinson C, 2007, J PEDIATR PSYCHOL, V32, P605, DOI 10.1093/jpepsy/jsl039; Kasai K, 2013, NEUROSCI RES, V75, P89, DOI 10.1016/j.neures.2012.12.001; Lei D, 2012, HUM BRAIN MAPP, V33, P2913, DOI 10.1002/hbm.21411; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Najman JM, 2001, SOC PSYCH PSYCH EPID, V36, P186, DOI 10.1007/s001270170062; Nappo S, 2002, BJU INT, V90, P912, DOI 10.1046/j.1464-410X.2002.03030.x; Neveus T, 2000, SCAND J UROL NEPHROL, V34, P1; OPPEL WC, 1968, PEDIATRICS, V42, P627; Ornitz EM, 1999, BIOL PSYCHIAT, V45, P1455, DOI 10.1016/S0006-3223(98)00205-4; Park S, 2013, PSYCHIAT INVEST, V10, P253, DOI 10.4306/pi.2013.10.3.253; Redsell SA, 2001, CHILD CARE HLTH DEV, V27, P149, DOI 10.1046/j.1365-2214.2001.00195.x; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Shreeram S, 2009, J AM ACAD CHILD PSY, V48, P35, DOI 10.1097/CHI.0b013e318190045c; Sullivan S, 2015, J DEV BEHAV PEDIATR, V36, P724, DOI 10.1097/DBP.0000000000000229; Van Hoecke E, 2003, J DEV BEHAV PEDIATR, V24, P109, DOI 10.1097/00004703-200304000-00006; Van Hoecke E, 2006, J PEDIATR PSYCHOL, V31, P460, DOI 10.1093/jpepsy/jsj037; von Gontard A, 2006, DEV MED CHILD NEUROL, V48, P744, DOI 10.1017/S0012162206001599; von Gontard A, 2015, EUR CHILD ADOLES PSY, V24, P127, DOI 10.1007/s00787-014-0577-0; von Gontard A, 2011, J UROLOGY, V185, P1432, DOI 10.1016/j.juro.2010.11.051; von Gontard A, 2011, EUR CHILD ADOLES PSY, V20, P83, DOI 10.1007/s00787-010-0152-2; Whalen CK, 2002, CHILD DEV, V73, P209, DOI 10.1111/1467-8624.00401; World Health Organization, 1992, 20 REV INT CLASS DIS; Zink S, 2008, J UROLOGY, V179, P295, DOI 10.1016/j.juro.2007.09.007	44	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158786	10.1371/journal.pone.0158786	http://dx.doi.org/10.1371/journal.pone.0158786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414399	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500040
J	Okami, S; Kohtake, N				Okami, Suguru; Kohtake, Naohiko			Fine-Scale Mapping by Spatial Risk Distribution Modeling for Regional Malaria Endemicity and Its Implications under the Low-to-Moderate Transmission Setting in Western Cambodia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROARTEMISININ-PIPERAQUINE; WETNESS INDEXES; ARTEMISININ; ELIMINATION; POPULATION; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; PROVINCE	The disease burden of malaria has decreased as malaria elimination efforts progress. The mapping approach that uses spatial risk distribution modeling needs some adjustment and reinvestigation in accordance with situational changes. Here we applied a mathematical modeling approach for standardized morbidity ratio (SMR) calculated by annual parasite incidence using routinely aggregated surveillance reports, environmental data such as remote sensing data, and non-environmental anthropogenic data to create fine-scale spatial risk distribution maps of western Cambodia. Furthermore, we incorporated a combination of containment status indicators into the model to demonstrate spatial heterogeneities of the relationship between containment status and risks. The explanatory model was fitted to estimate the SMR of each area (adjusted Pearson correlation coefficient R-2 = 0.774; Akaike information criterion AIC = 149.423). A Bayesian modeling framework was applied to estimate the uncertainty of the model and cross-scale predictions. Fine-scale maps were created by the spatial interpolation of estimated SMRs at each village. Compared with geocoded case data, corresponding predicted values showed conformity [Spearman's rank correlation r = 0.662 in the inverse distance weighed interpolation and 0.645 in ordinal kriging (95% confidence intervals of 0.414-0.827 and 0.368-0.813, respectively), Welch's t-test; Not significant]. The proposed approach successfully explained regional malaria risks and fine-scale risk maps were created under low-to-moderate malaria transmission settings where reinvestigations of existing risk modeling approaches were needed. Moreover, different representations of simulated outcomes of containment status indicators for respective areas provided useful insights for tailored interventional planning, considering regional malaria endemicity.	[Okami, Suguru; Kohtake, Naohiko] Keio Univ, Grad Sch Syst Design & Management, Tokyo, Kanagawa 108, Japan	Keio University	Okami, S (corresponding author), Keio Univ, Grad Sch Syst Design & Management, Tokyo, Kanagawa 108, Japan.	yiu68252@nifty.com		Okami, Suguru/0000-0003-4402-0209	Japanese Ministry of Education, Culture, Sports, Science and Technology; Space Application Promotion Program - NEC Corporation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Space Application Promotion Program - NEC Corporation	This research has been conducted as a part of the G-SPASE Program supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology, and the Space Application Promotion Program funded by NEC Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2013, EM RESP ART RES GREA; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cheng T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100465; Cianci D, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0001-0; Clements ACA, 2013, LANCET INFECT DIS, V13, P709, DOI 10.1016/S1473-3099(13)70140-3; Cohen JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-61; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-328; Cohen JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-40; Cox J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-282; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hoyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045797; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Kurshcke JK, 2014, DOING BAYESIAN DATA; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Lwin KM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0838-5; Martin C, 2002, HEALTH PLACE, V8, P227, DOI 10.1016/S1353-8292(02)00008-4; Martuzzi M, 1996, STAT MED, V15, P1867; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; McCann RS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-17; Medecins Sans Frontieres, 2005, UNPUB; Mellor S, 2013, MOVING MALARIA ELIMI; Meyer DJ, 2012, INT ARCH PHOTOGRAMM, V39-B4, P291; Moyes CL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-161; National Center for Parasitology Entomology and Malaria Control, 2005, REP CAMB NAT MAL BAS; National Center for Parasitology Entomology and Malaria Control, 2007, CAMB MAL SURV 2007 R; National Center for Parasitology Entomology and Malaria Control, 2014, BEN NAT MAL PROGR RE; National Center for Parasitology Entomology and Malaria Control, 2011, CAMB MAL B; National Center for Parasitology Entomology and Malaria Control, 2013, CAMB MAL B; National Center for Parasitology Entomology and Malaria Control, 2011, STRAT PLAN EL MAL CA; National Centre for Parasitology Entomology and Malaria Control (CNM), 2010, CAMB MAL SURV 2010; Nihei N, 2002, JPN J INFECT DIS, V55, P160; Nmor JC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-14; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Oloukoi G, 2014, HEALTH PLACE, V25, P47, DOI 10.1016/j.healthplace.2013.09.009; Smith DL, 2009, SHRINKING MALARIA MA, P108; St Laurent B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9614; Sturrock HJW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-421; Tango T., 2007, INTRO SPATIAL EPIDEM; Targett GA, 2009, PROSPECTUS MALARIA E; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tatem AJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-218; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, Q A ART RES; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 2015, UPD ART ACT RES SEP; World Health Organization, 2015, GUID TREATM MAL, Vthird	65	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158737	10.1371/journal.pone.0158737	http://dx.doi.org/10.1371/journal.pone.0158737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415623	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500033
J	Haffner-Luntzer, M; Kemmler, J; Heidler, V; Prystaz, K; Schinke, T; Amling, M; Kovtun, A; Rapp, AE; Ignatius, A; Liedert, A				Haffner-Luntzer, Melanie; Kemmler, Julia; Heidler, Verena; Prystaz, Katja; Schinke, Thorsten; Amling, Michael; Kovtun, Anna; Rapp, Anna E.; Ignatius, Anita; Liedert, Astrid			Inhibition of Midkine Augments Osteoporotic Fracture Healing	PLOS ONE			English	Article							TRABECULAR BONE-FORMATION; RETINOIC ACID; MICE LACKING; ESTROGEN; GROWTH; PROTEIN; REPAIR; PERIOD; MODEL; AGE	The heparin-binding growth and differentiation factor midkine (Mdk) is proposed to negatively regulate osteoblast activity and bone formation in the adult skeleton. As Mdk-deficient mice were protected from ovariectomy (OVX)-induced bone loss, this factor may also play a role in the pathogenesis of postmenopausal osteoporosis. We have previously demonstrated that Mdk negatively influences bone regeneration during fracture healing. Here, we investigated whether the inhibition of Mdk using an Mdk-antibody (Mdk-Ab) improves compromised bone healing in osteoporotic OVX-mice. Using a standardized femur osteotomy model, we demonstrated that Mdk serum levels were significantly enhanced after fracture in both non-OVX and OVX-mice, however, the increase was considerably greater in osteoporotic mice. Systemic treatment with the Mdk-Ab significantly improved bone healing in osteoporotic mice by increasing bone formation in the fracture callus. On the molecular level, we demonstrated that the OVX-induced reduction of the osteoanabolic beta-catenin signaling in the bony callus was abolished by Mdk-Ab treatment. Furthermore, the injection of the Mdk-Ab increased trabecular bone mass in the skeleton of the osteoporotic mice. These results implicate that antagonizing Mdk may be useful for the therapy of osteoporosis and osteoporotic fracture-healing complications.	[Haffner-Luntzer, Melanie; Kemmler, Julia; Heidler, Verena; Prystaz, Katja; Kovtun, Anna; Rapp, Anna E.; Ignatius, Anita; Liedert, Astrid] Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Liedert, A (corresponding author), Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Ulm, Germany.	astrid.liedert@uni-ulm.de	Fischer, Verena/GVU-3636-2022; Haffner-Luntzer, Melanie/L-3562-2019; Vikman, Anna/F-1115-2017; Ignatius, Anita/M-6012-2013; Rapp, Anna/L-8807-2016	Haffner-Luntzer, Melanie/0000-0002-3333-2613; Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Fischer, Verena/0000-0001-7039-8008; Vikman, Anna/0000-0001-8531-9712	German Research Foundation [IG 18-3/3, AM103/10-3]; Elsbeth Bonhoff Foundation	German Research Foundation(German Research Foundation (DFG)); Elsbeth Bonhoff Foundation	This work was supported by grants from the German Research Foundation (IG 18-3/3 and AM103/10-3) and from the Elsbeth Bonhoff Foundation. http://www.dfg.de http://www.elsbeth-bonhoff-stiftung.de.	Beil FT, 2010, J TRAUMA, V69, P1259, DOI 10.1097/TA.0b013e3181c4544d; Bindl R, 2013, J ORTHOP RES, V31, P1851, DOI 10.1002/jor.22416; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Davey DA, 1998, S AFR MED J, V88, P1419; Diamond-Stanic MK, 2011, AM J PHYSIOL-RENAL, V300, pF139, DOI 10.1152/ajprenal.00249.2010; DIDDLE AW, 1984, SOUTH MED J, V77, P868, DOI 10.1097/00007611-198407000-00020; Haffner-Luntzer M, 2016, BRIT J PHARMACOL, V173, P2237, DOI 10.1111/bph.13503; Haffner-Luntzer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116282; Histing T, 2013, J INVEST SURG, V26, P30, DOI 10.3109/08941939.2012.687435; Histing T, 2012, J SURG RES, V175, P271, DOI 10.1016/j.jss.2011.03.052; JAWORSKI ZF, 1971, ISRAEL J MED SCI, V7, P491; Kanis JA, 2007, TECHNICAL REPORT, V2007, P6; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Li CY, 2011, BONE, V49, P1178, DOI 10.1016/j.bone.2011.08.012; Liedert A, 2011, BONE, V48, P945, DOI 10.1016/j.bone.2010.12.019; Lu CY, 2008, J ORTHOP RES, V26, P1384, DOI 10.1002/jor.20667; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; McCann RM, 2008, J ORTHOP RES, V26, P384, DOI 10.1002/jor.20505; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; MITSIADIS TA, 1995, J CELL BIOL, V129, P267, DOI 10.1083/jcb.129.1.267; MURAMATSU T, 1993, INT J DEV BIOL, V37, P183; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Neunaber C, 2010, J BONE MINER RES, V25, P1724, DOI 10.1002/jbmr.75; Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035; Ohta S, 1999, J BONE MINER RES, V14, P1132, DOI 10.1359/jbmr.1999.14.7.1132; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Pang J, 2014, REJUVENATION RES; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Wehrle E, 2015, DIS MODEL MECH, V8, P93, DOI 10.1242/dmm.018622; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yukata K, 2014, BONE, V62, P79, DOI 10.1016/j.bone.2014.02.002	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159278	10.1371/journal.pone.0159278	http://dx.doi.org/10.1371/journal.pone.0159278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410432	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300077
J	Ondracka, A; Robbins, JA; Cross, FR				Ondracka, Andrej; Robbins, Jonathan A.; Cross, Frederick R.			An APC/C-Cdh1 Biosensor Reveals the Dynamics of Cdh1 Inactivation at the G1/S Transition	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; YEAST-CELL CYCLE; SACCHAROMYCES-CEREVISIAE; MULTISITE PHOSPHORYLATION; DEPENDENT DEGRADATION; MITOTIC CYCLIN; BUDDING YEAST; POLO KINASE; S-PHASE; DESTRUCTION	B-type cyclin-dependent kinase activity must be turned off for mitotic exit and G1 stabilization. B-type cyclin degradation is mediated by the anaphase-promoting complex/cyclosome (APC/C); during and after mitotic exit, APC/C is dependent on Cdh1. Cdh1 is in turn phosphorylated and inactivated by cyclin-CDK at the Start transition of the new cell cycle. We developed a biosensor to assess the cell cycle dynamics of APC/C-Cdh1. Nuclear exit of the G1 transcriptional repressor Whi5 is a known marker of Start; APC/C-Cdh1 is inactivated 12 min after Whi5 nuclear exit with little measurable cell-to-cell timing variability. Multiple phosphorylation sites on Cdh1 act in a redundant manner to repress its activity. Reducing the number of phosphorylation sites on Cdh1 can to some extent be tolerated for cell viability, but it increases variability in timing of APC/C-Cdh1 inactivation. Mutants with minimal subsets of phosphorylation sites required for viability exhibit striking stochasticity in multiple responses including budding, nuclear division, and APC/C-Cdh1 activity itself. Multiple cyclin-CDK complexes, as well as the stoichiometric inhibitor Acm1, contribute to APC/C-Cdh1 inactivation; this redundant control is likely to promote rapid and reliable APC/CCdh1 inactivation immediately following the Start transition.	[Ondracka, Andrej; Robbins, Jonathan A.; Cross, Frederick R.] Rockefeller Univ, Lab Cell Cycle Genet, New York, NY 10065 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, Lab Cell Cycle Genet, New York, NY 10065 USA.	fred.r.cross@gmail.com		Ondracka, Andrej/0000-0003-4193-6027; Robbins, Jonathan/0000-0001-9690-4976	PHS [5RO1-GM078153]; Boehringer Ingelheim Fonds predoctoral fellowship; National Institutes of Health Medical Scientist Training Program [T32GM007739]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Boehringer Ingelheim Fonds predoctoral fellowship(Boehringer Ingelheim); National Institutes of Health Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS 5RO1-GM078153 to F.C., and Boehringer Ingelheim Fonds predoctoral fellowship to A.O. J.A.R. was supported by National Institutes of Health Medical Scientist Training Program grant T32GM007739.	Amon A, 1997, EMBO J, V16, P2693, DOI 10.1093/emboj/16.10.2693; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Koivomagi M, 2011, NATURE, V480, P128, DOI 10.1038/nature10560; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Melesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103517; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Robbins JA, 2010, MOL BIOL CELL, V21, P914, DOI 10.1091/mbc.E09-10-0901; Sajman J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8075; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Visintin C, 2008, GENE DEV, V22, P79, DOI 10.1101/gad.1601308; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yeong FM, 2001, MOL CELL BIOL, V21, P5071, DOI 10.1128/MCB.21.15.5071-5081.2001; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	50	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159166	10.1371/journal.pone.0159166	http://dx.doi.org/10.1371/journal.pone.0159166			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410035	gold, Green Submitted, Green Published			2022-12-26	WOS:000379508300063
J	Milewski, D; Pradhan, A; Wang, X; Cai, Y; Le, T; Turpin, B; Kalinichenko, VV; Kalin, TV				Milewski, D.; Pradhan, A.; Wang, X.; Cai, Y.; Le, T.; Turpin, B.; Kalinichenko, V. V.; Kalin, T. V.			FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21(Cip1) CDK inhibitor	ONCOGENE			English	Article							FORKHEAD BOX F1; TO-MESENCHYMAL TRANSITION; MICE HETEROZYGOUS NULL; CHILDHOOD RHABDOMYOSARCOMA; ALVEOLAR RHABDOMYOSARCOMA; DIFFERENTIAL EXPRESSION; LUNG-CANCER; GENE; FUSION; CELLS	The role of Forkhead Box F1 (FoxF1) transcription factor in carcinogenesis is not well characterized. Depending on tissue and histological type of cancer, FoxF1 has been shown to be either an oncogene or a tumor suppressor. Alveolar rhabdomyosarcoma ( RMS) is the most aggressive pediatric soft-tissue sarcoma. Although FoxF1 is highly expressed in alveolar RMS, the functional role of FoxF1 in RMS is unknown. The present study demonstrates that expression of FoxF1 and its closely related transcription factor FoxF2 are essential for RMS tumor growth. Depletion of FoxF1 or FoxF2 in RMS cells decreased tumor growth in orthotopic mouse models of RMS. The decreased tumorigenesis was associated with reduced tumor cell proliferation. Cell cycle regulatory proteins Cdk2, Cdk4/6, Cyclin D1 and Cyclin E2 were decreased in FoxF1-and FoxF2-deficient RMS tumors. Depletion of either FoxF1 or FoxF2 delayed G1-S cell cycle progression, decreased levels of phosphorylated retinoblastoma protein (Rb) and increased protein levels of the CDK inhibitors, p21(Cip1) and p27(Kip1). Depletion of both FoxF1 and FoxF2 in tumor cells completely abrogated RMS tumor growth in mice. Overexpression of either FoxF1 or FoxF2 in tumor cells was sufficient to increase tumor growth in orthotopic RMS mouse model. FoxF1 and FoxF2 directly bound to and repressed transcriptional activity of p21Cip1 promoter through - 556/ - 545 bp region, but did not affect p27Kip1 transcription. Knockdown of p21Cip1 restored cell cycle progression in the FoxF1-or FoxF2-deficient tumor cells. Altogether, FoxF1 and FoxF2 promoted RMS tumorigenesis by inducing tumor cell proliferation via transcriptional repression of p21Cip1 gene promoter. Because of the robust oncogenic activity in RMS tumors, FoxF1 and FoxF2 may represent promising targets for anti-tumor therapy.	[Milewski, D.; Pradhan, A.; Wang, X.; Cai, Y.; Le, T.; Kalinichenko, V. V.; Kalin, T. V.] Cincinnati Childrens Hosp Res Fdn, Perinatal Inst, Div Pulm Biol, Cincinnati, OH USA; [Wang, X.] Cincinnati Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH USA; [Turpin, B.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Kalin, TV (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Tatiana.kalin@cchmc.org	Milewski, David/GPF-5870-2022	Milewski, David/0000-0002-9778-8548	American Cancer Society [125011-RSG-13-325-01-CSM]; NIH [R01 CA142724, R01 HL84151]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151, R01HL132849, R01HL123490] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Research Grant from the American Cancer Society 125011-RSG-13-325-01-CSM (to TVK), NIH grants R01 CA142724 (to TVK) and R01 HL84151 (to VVK).	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Armeanu-Ebinger S, 2011, INT J ONCOL, V38, P993, DOI 10.3892/ijo.2011.921; Balli D, 2012, ONCOGENE, V31, P3875, DOI 10.1038/onc.2011.549; Balli D, 2013, EMBO J, V32, P231, DOI 10.1038/emboj.2012.336; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Bolte C, 2015, J BIOL CHEM, V290, P7563, DOI 10.1074/jbc.M114.609487; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; DAVIS RJ, 1994, CANCER RES, V54, P2869; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Gialmanidis IP, 2013, LUNG, V191, P511, DOI 10.1007/s00408-013-9490-4; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; HOSOI H, 1992, INT J CANCER, V50, P977, DOI 10.1002/ijc.2910500626; Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, GENE EXPR PATTERNS, V3, P153, DOI 10.1016/S1567-133X(03)00010-3; Kalinichenko VV, 2003, HEPATOLOGY, V37, P107, DOI 10.1053/jhep.2003.50005; Kalinichenko VV, 2002, J BIOL CHEM, V277, P12369, DOI 10.1074/jbc.M112162200; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; Kong PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061591; Kundu ST, 2016, ONCOGENE, V35, P173, DOI 10.1038/onc.2015.71; Lae M, 2007, J PATHOL, V212, P143, DOI 10.1002/path.2170; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lo PK, 2012, CELL SIGNAL, V24, P316, DOI 10.1016/j.cellsig.2011.09.017; Lo PK, 2010, CANCER RES, V70, P6047, DOI 10.1158/0008-5472.CAN-10-1576; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; McDowell HP, 2003, ARCH DIS CHILD, V88, P354, DOI 10.1136/adc.88.4.354; Mclin VA, 2010, INT J DEV BIOL, V54, P919, DOI 10.1387/ijdb.092916vm; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Pappo I, 2004, ANN SURG ONCOL, V11, P52, DOI 10.1007/BF02524346; Peterson RS, 1997, MECH DEVELOP, V69, P53, DOI 10.1016/S0925-4773(97)00153-6; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Qualman Stephen J, 2002, Curr Oncol Rep, V4, P123, DOI 10.1007/s11912-002-0073-4; Ren XM, 2014, CIRC RES, V115, P709, DOI 10.1161/CIRCRESAHA.115.304382; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Tamura M, 2014, ONCOGENE, V33, P4837, DOI 10.1038/onc.2013.427; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Watson JEV, 2004, ONCOGENE, V23, P3487, DOI 10.1038/sj.onc.1207474; Wei HJ, 2014, ONCOTARGET, V5, P9514, DOI 10.18632/oncotarget.2413; Weigel BJ, 2003, CLIN CANCER RES, V9, P3105; Wendling DS, 2008, INT J MOL MED, V22, P787, DOI 10.3892/ijmm_00000086; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	54	40	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					850	862		10.1038/onc.2016.254	http://dx.doi.org/10.1038/onc.2016.254			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27425595	Green Accepted			2022-12-26	WOS:000394168200012
J	Holdfeldt, A; Skovbakke, SL; Winther, M; Gabl, M; Nielsen, C; Perez-Gassol, I; Larsen, CJ; Wang, JM; Karlsson, A; Dahlgren, C; Forsman, H; Franzyk, H				Holdfeldt, Andre; Skovbakke, Sarah Line; Winther, Malene; Gabl, Michael; Nielsen, Christina; Perez-Gassol, Iris; Larsen, Camilla Josephine; Wang, Ji Ming; Karlsson, Anna; Dahlgren, Claes; Forsman, Huamei; Franzyk, Henrik			The Lipidated Peptidomimetic Lau-((S)-Aoc)-(Lys-Nphe)(6)-NH2 Is a Novel Formyl Peptide Receptor 2 Agonist That Activates Both Human and Mouse Neutrophil NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); inflammation; NADPH oxidase; neutrophil; receptor structure-function; structure-function	RESPIRATORY BURST PRODUCTS; N-FORMYLPEPTIDE RECEPTOR; CHEMOATTRACTANT RECEPTORS; HOST-DEFENSE; PROFESSIONAL PHAGOCYTES; LISTERIA-MONOCYTOGENES; ANTIMICROBIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; GRANULE MOBILIZATION; MURINE NEUTROPHILS	Neutrophils expressing formyl peptide receptor 2 (FPR2) play key roles in host defense, immune regulation, and resolution of inflammation. Consequently, the search for FPR2-specific modulators has attracted much attention due to its therapeutic potential. Earlier described agonists for this receptor display potent activity for the human receptor (FPR2) but low activity for the mouse receptor orthologue (Fpr2), rendering them inapplicable in murine models of human disease. Here we describe a novel FPR2 agonist, the proteolytically stable -peptide/-peptoid hybrid Lau-((S)-Aoc)-(Lys-Nphe)(6)-NH2 (F2M2), showing comparable potency in activating human and mouse neutrophils by inducing a rise in intracellular Ca2+ concentration and assembly of the superoxide-generating NADPH oxidase. This FPR2/Fpr2 agonist contains a headgroup consisting of a 2-aminooctanoic acid (Aoc) residue acylated with lauric acid (C-12 fatty acid), which is linked to a peptide/peptoid repeat ((Lys-Nphe)(6)-NH2). Both the fatty acid moiety and the (S)-Aoc residue were required for FPR2/Fpr2 activation. This type of proteolytically stable FPR2-specific peptidomimetics may serve as valuable tools for future analysis of FPR2 signaling as well as for development of prophylactic immunomodulatory therapy. This novel class of cross-species FPR2/Fpr2 agonists should enable translation of results obtained with mouse neutrophils (and disease models) into enhanced understanding of human inflammatory and immune diseases.	[Holdfeldt, Andre; Winther, Malene; Gabl, Michael; Karlsson, Anna; Dahlgren, Claes; Forsman, Huamei] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Box 480, S-40530 Gothenburg, Sweden; [Skovbakke, Sarah Line; Nielsen, Christina; Perez-Gassol, Iris; Larsen, Camilla Josephine; Franzyk, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark; [Wang, Ji Ming] NCI Frederick, Canc & Inflammat Program, NIH, Frederick, MD 21702 USA	University of Gothenburg; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Forsman, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Box 480, S-40530 Gothenburg, Sweden.	Huamei.forsman@rheuma.gu.se		Franzyk, Henrik/0000-0002-2822-1927; de Winther, Menno/0000-0002-4038-6636; Skovbakke, Sarah Line/0000-0002-4673-4419; Karlsson, Anna/0000-0001-6796-1154	Swedish Research Council; King Gustaf V 80-Year Foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska University Hospital through the national ALF agreement; Department of Drug Design and Pharmacology (Faculty of Health and Medical Sciences, University of Copenhagen); Aase and Ejnar Danielsens Foundation; King Christian 10th Foundation; NATIONAL CANCER INSTITUTE [ZIABC010725] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V 80-Year Foundation; IngaBritt and Arne Lundbergs foundation; Sahlgrenska University Hospital through the national ALF agreement; Department of Drug Design and Pharmacology (Faculty of Health and Medical Sciences, University of Copenhagen); Aase and Ejnar Danielsens Foundation; King Christian 10th Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Swedish research group was supported by grants from the Swedish Research Council, the King Gustaf V 80-Year Foundation, the IngaBritt and Arne Lundbergs foundation, and the Sahlgrenska University Hospital through the national ALF agreement. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by grants from the Department of Drug Design and Pharmacology (Faculty of Health and Medical Sciences, University of Copenhagen), Aase and Ejnar Danielsens Foundation, and King Christian 10th Foundation.	Almkvist J, 2002, J IMMUNOL, V168, P4034, DOI 10.4049/jimmunol.168.8.4034; Bonke G, 2008, SYNTHESIS-STUTTGART, P2381, DOI 10.1055/s-2008-1067171; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2002, INFECT IMMUN, V70, P2908, DOI 10.1128/IAI.70.6.2908-2914.2002; Bylund J, 2003, J BIOL CHEM, V278, P30578, DOI 10.1074/jbc.M209202200; Bylund J, 2003, EXP CELL RES, V282, P70, DOI 10.1016/S0014-4827(02)00010-1; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Forsman H, 2013, BBA-MOL CELL RES, V1833, P1914, DOI 10.1016/j.bbamcr.2013.03.026; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Forsman H, 2012, J IMMUNOL, V189, P629, DOI 10.4049/jimmunol.1101616; Fu HM, 2004, IMMUNOLOGY, V112, P201, DOI 10.1111/j.1365-2567.2004.01884.x; Fu HM, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-50; Gabl M, 2016, BBA-MOL CELL RES, V1863, P1228, DOI 10.1016/j.bbamcr.2016.03.014; Gabl M, 2015, EXP CELL RES, V336, P242, DOI 10.1016/j.yexcr.2015.07.014; Gabl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109516; Gao JL, 1998, GENOMICS, V51, P270, DOI 10.1006/geno.1998.5376; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; He HQ, 2013, MOL PHARMACOL, V83, P389, DOI 10.1124/mol.112.081315; He R, 2000, J IMMUNOL, V165, P4598, DOI 10.4049/jimmunol.165.8.4598; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Jahnsen RD, 2013, CHEM BIOL, V20, P1286, DOI 10.1016/j.chembiol.2013.09.007; Jahnsen RD, 2012, J MED CHEM, V55, P7253, DOI 10.1021/jm300820a; Karlsson J, 2010, J IMMUNOL METHODS, V352, P45, DOI 10.1016/j.jim.2009.10.011; Karlsson J, 2009, CELL CALCIUM, V45, P431, DOI 10.1016/j.ceca.2009.02.002; KLOTZ KN, 1994, BIOESSAYS, V16, P193, DOI 10.1002/bies.950160310; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Li LZ, 2016, J LEUKOCYTE BIOL, V99, P425, DOI 10.1189/jlb.2RI0815-354RR; Liu Y, 2013, INT J ANTIMICROB AG, V41, P20, DOI 10.1016/j.ijantimicag.2012.09.014; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Olsen CA, 2010, CHEMBIOCHEM, V11, P1356, DOI 10.1002/cbic.201000232; Onnheim K, 2008, IMMUNOLOGY, V125, P591, DOI 10.1111/j.1365-2567.2008.02873.x; Onnheim K, 2014, EXP CELL RES, V323, P209, DOI 10.1016/j.yexcr.2014.01.023; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Riesselman M, 2007, J IMMUNOL, V179, P2520, DOI 10.4049/jimmunol.179.4.2520; Skovbakke SL, 2015, J MED CHEM, V58, P801, DOI 10.1021/jm501341h; Skovbakke SL, 2015, BIOCHEM PHARMACOL, V93, P182, DOI 10.1016/j.bcp.2014.11.004; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Winther M, 2015, FEBS LETT, V589, P1832, DOI 10.1016/j.febslet.2015.05.050; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang P, 2015, METHODS MOL BIOL, V1324, P191, DOI 10.1007/978-1-4939-2806-4_13	51	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19888	19899		10.1074/jbc.M116.736850	http://dx.doi.org/10.1074/jbc.M116.736850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27422818	Green Published, hybrid			2022-12-26	WOS:000383243100014
J	Panzarin, V; Toffan, A; Abbadi, M; Buratin, A; Mancin, M; Braaen, S; Olsen, CM; Bargelloni, L; Rimstad, E; Cattoli, G				Panzarin, Valentina; Toffan, Anna; Abbadi, Miriam; Buratin, Alessandra; Mancin, Marzia; Braaen, Stine; Olsen, Christel Moraeus; Bargelloni, Luca; Rimstad, Espen; Cattoli, Giovanni			Molecular Basis for Antigenic Diversity of Genus Betanodavirus	PLOS ONE			English	Article							VIRAL NERVOUS NECROSIS; HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; JACK PSEUDOCARANX-DENTEX; JUVENILE SEA BASS; DICENTRARCHUS-LABRAX; MASS MORTALITIES; LATES-CALCARIFER; SUBGENOMIC RNA3; CELL-LINE; NODAVIRUS	Betanodaviruses are the causative agents of viral nervous necrosis (VNN), a devastating disease for the Mediterranean mariculture. Four different betanodavirus species are recognized, Striped jack-, Redspotted grouper-, Tiger puffer-, and Barfin flounder nervous necrosis virus (SJNNV, RGNNV, TPNNV and BFNNV), but there is little knowledge on their antigenic properties. In order to describe the serological relationships among different betanodavirus genotypes, serum neutralization assays were performed using rabbit polyclonal antisera against eight fish nodaviruses that cover a wide species-, temporal-, spatial- and genetic range. The results indicate that the SJNNV and RGNNV are antigenically distinct, constituting serotypes A and C, respectively. The TPNNV and BFNNV, the latter representing cold-water betanodaviruses, are antigenically related and cluster within serotype B. The reassortant viruses RGNNV/SJNNV and SJNNV/RGNNV group within serotypes A and C, respectively, indicating that the coat protein encoded by RNA2 acts as major immunoreactivity determinant. Immunostaining of in vitro expressed wild type and chimeric capsid proteins between the RGNNV and the SJNNV species indicated that the C-terminal part of the capsid protein retains the immunoreactive portion. The amino acid (aa) residues determining RGNNV and SJNNV antigenic diversity were mapped to aa residues 217-256 and aa 257-341, respectively. Neutralization of reverse genetics derived chimeric viruses indicated that these areas determine the neutralizing epitopes. The data obtained are crucial for the development of targeted serological tests for the diagnosis of VNN, and informative for development of cross-protective vaccines against various betanodavirus genotypes.	[Panzarin, Valentina; Toffan, Anna; Abbadi, Miriam; Buratin, Alessandra; Mancin, Marzia; Cattoli, Giovanni] Ist Zooprofilatt Sperimentale Venezie, Dept Comparat Biomed Sci, OIE Reference Lab Viral Encephalopathy & Retinopa, Legnaro, PD, Italy; [Panzarin, Valentina; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy; [Braaen, Stine; Olsen, Christel Moraeus; Rimstad, Espen] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	IZS delle Venezie; University of Padua; Norwegian University of Life Sciences	Panzarin, V (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Dept Comparat Biomed Sci, OIE Reference Lab Viral Encephalopathy & Retinopa, Legnaro, PD, Italy.; Panzarin, V (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	vpanzarin@izsvenezie.it	TOFFAN, ANNA/AAW-8725-2020	TOFFAN, ANNA/0000-0003-4389-3489; Panzarin, Valentina/0000-0002-9376-1612; mancin, marzia/0000-0002-7260-6031	Italian Ministry of Health [IZSVE 5/11 RC, IZSVE 2/14 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the Italian Ministry of Health (http://www.salute.gov.it/), grant numbers IZSVE 5/11 RC and IZSVE 2/14 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Athanassopoulou F, 2003, J FISH DIS, V26, P361, DOI 10.1046/j.1365-2761.2003.00458.x; Azad IS, 2005, DIS AQUAT ORGAN, V63, P113, DOI 10.3354/dao063113; Beato MS, 2013, VIROLOGY, V435, P350, DOI 10.1016/j.virol.2012.09.016; Bovo G, 1999, VIRUS RES, V63, P143, DOI 10.1016/S0168-1702(99)00068-4; Chen NC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005203; Cherif N, 2009, VET RES COMMUN, V33, P345, DOI 10.1007/s11259-008-9182-3; Chi SC, 2003, DIS AQUAT ORGAN, V55, P221, DOI 10.3354/dao055221; Chi SC, 1997, J FISH DIS, V20, P185, DOI 10.1046/j.1365-2761.1997.00291.x; Costa JZ, 2007, J FISH DIS, V30, P419, DOI 10.1111/j.1365-2761.2007.00824.x; FAO, 2014, FISHSTATJ SOFTW FISH; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Frerichs GN, 1996, J GEN VIROL, V77, P2067, DOI 10.1099/0022-1317-77-9-2067; Gagne N, 2004, DIS AQUAT ORGAN, V62, P181, DOI 10.3354/dao062181; Grotmol S, 2000, DIS AQUAT ORGAN, V39, P79, DOI 10.3354/dao039079; Hellberg H, 2010, J FISH DIS, V33, P75, DOI 10.1111/j.1365-2761.2009.01092.x; Hill B. J., 1995, Annual Review of Fish Diseases, V5, P55, DOI 10.1016/0959-8030(95)00011-9; Ito Y, 2008, DIS AQUAT ORGAN, V79, P199, DOI 10.3354/dao01906; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Iwamoto T, 2004, J VIROL, V78, P1256, DOI 10.1128/JVI.78.3.1256-1262.2004; Iwamoto T, 2000, DIS AQUAT ORGAN, V43, P81, DOI 10.3354/dao043081; Iwamoto T, 2001, J GEN VIROL, V82, P2653, DOI 10.1099/0022-1317-82-11-2653; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; LeBreton A, 1997, J FISH DIS, V20, P145, DOI 10.1046/j.1365-2761.1997.00284.x; Maeno Y, 2004, JARQ-JPN AGR RES Q, V38, P69, DOI 10.6090/jarq.38.69; Mori K, 2003, DIS AQUAT ORGAN, V57, P19, DOI 10.3354/dao057019; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; MUNDAY BL, 1992, AQUACULTURE, V103, P197, DOI 10.1016/0044-8486(92)90166-I; Nishizawa T, 1999, J GEN VIROL, V80, P3023, DOI 10.1099/0022-1317-80-11-3023; Nishizawa T, 1997, APPL ENV MICROBIOL, V63; Okinaka Y, 2008, DIS AQUAT ORGAN, V80, P113, DOI 10.3354/dao01914; Olveira JG, 2009, J GEN VIROL, V90, P2940, DOI 10.1099/vir.0.013912-0; Panzarin V, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-56; Panzarin V, 2012, INFECT GENET EVOL, V12, P63, DOI 10.1016/j.meegid.2011.10.007; Parameswaran V, 2008, AQUACULTURE, V275, P366, DOI 10.1016/j.aquaculture.2008.01.023; Rigos G, 2010, REV FISH BIOL FISHER, V20, P47, DOI 10.1007/s11160-009-9120-7; Shetty M, 2012, INDIAN J VIROL, V23, P114, DOI 10.1007/s13337-012-0088-x; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Skliris GP, 2001, VIRUS RES, V75, P59, DOI 10.1016/S0168-1702(01)00225-8; Sommerset I, 2004, DIS AQUAT ORGAN, V58, P117, DOI 10.3354/dao058117; Spearman-Karber P., 1978, STAT METHODIN BIOL A, P1; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P1, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang L, 2002, J VIROL, V76, P6370, DOI 10.1128/JVI.76.12.6370-6375.2002; Thiery R, 1999, VIRUS RES, V63, P11, DOI 10.1016/S0168-1702(99)00053-2; Toffolo V, 2007, MOL PHYLOGENET EVOL, V43, P298, DOI 10.1016/j.ympev.2006.08.003; Totland GK, 1999, DIS AQUAT ORGAN, V38, P169, DOI 10.3354/dao038169; Ucko M, 2004, J FISH DIS, V27, P459, DOI 10.1111/j.1365-2761.2004.00565.x; Vendramin N, 2014, J FISH DIS, V37, P371, DOI 10.1111/jfd.12117; Vendramin N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-20; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; [No title captured]; [No title captured]	54	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158814	10.1371/journal.pone.0158814	http://dx.doi.org/10.1371/journal.pone.0158814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438093	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000380170100021
J	Soriano, S; Calap-Quintana, P; Llorens, JV; Al-Ramahi, I; Gutierrez, L; Martinez-Sebastian, MJ; Botas, J; Molto, MD				Soriano, Sirena; Calap-Quintana, Pablo; Vicente Llorens, Jose; Al-Ramahi, Ismael; Gutierrez, Lucia; Jose Martinez-Sebastian, Maria; Botas, Juan; Dolores Molto, Maria			Metal Homeostasis Regulators Suppress FRDA Phenotypes in a Drosophila Model of the Disease	PLOS ONE			English	Article							FRIEDREICHS-ATAXIA; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; FRATAXIN DEFICIENCY; COPPER HOMEOSTASIS; HYDROGEN-PEROXIDE; HYDROXYL RADICALS; DENTATE NUCLEUS; IRON CHELATION; METALLOTHIONEIN	Friedreich's ataxia (FRDA), the most commonly inherited ataxia in populations of European origin, is a neurodegenerative disorder caused by a decrease in frataxin levels. One of the hallmarks of the disease is the accumulation of iron in several tissues including the brain, and frataxin has been proposed to play a key role in iron homeostasis. We found that the levels of zinc, copper, manganese and aluminum were also increased in a Drosophila model of FRDA, and that copper and zinc chelation improve their impaired motor performance. By means of a candidate genetic screen, we identified that genes implicated in iron, zinc and copper transport and metal detoxification can restore frataxin deficiency-induced phenotypes. Taken together, these results demonstrate that the metal dysregulation in FRDA includes other metals besides iron, therefore providing a new set of potential therapeutic targets.	[Soriano, Sirena; Calap-Quintana, Pablo; Vicente Llorens, Jose; Jose Martinez-Sebastian, Maria; Dolores Molto, Maria] Univ Valencia, Dept Genet, Valencia, Spain; [Soriano, Sirena; Al-Ramahi, Ismael; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gutierrez, Lucia] CSIC, Inst Ciencia Mat Madrid, Dept Biomat & Bioinspired Mat, Madrid, Spain; [Dolores Molto, Maria] INCLIVA, CIBERSAM, CIBERSAM INCLIVA, Valencia, Spain; [Vicente Llorens, Jose] Uppsala Univ, Evolutionary Biol Ctr, Uppsala, Sweden	University of Valencia; Baylor College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Uppsala University	Molto, MD (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	dmolto@uv.es	Gutierrez, Lucia/A-4305-2008; VICENTE, LIERN/B-6112-2008; Al-Ramahi, Ismael/B-4000-2017	Gutierrez, Lucia/0000-0003-2366-3598; VICENTE, LIERN/0000-0001-5883-9640; Al-Ramahi, Ismael/0000-0002-1275-1114; Molto, Maria Dolores/0000-0001-5219-2022; Martinez-Sebastian, Maria-Jose/0000-0001-5549-7921; Soriano, Sirena/0000-0001-9967-7262; Llorens, Jose V./0000-0001-9823-6246	European Community's Seventh Framework Program FP7 [242193 EFACTS]; Fundacio la Marato TV3 of Spain [101932]; Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067]; NIH [R01-NS42179]; Ministerio de Ciencia e Innovacion of Spain; Generalitat Valenciana of Spain; AXA Research Fund	European Community's Seventh Framework Program FP7; Fundacio la Marato TV3 of Spain; Prometeo Program from Generalitat Valenciana; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana of Spain(Center for Forestry Research & Experimentation (CIEF)); AXA Research Fund(AXA Research Fund)	This work was supported by grants from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS], the Fundacio la Marato TV3 of Spain [exp 101932] and the Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067]. Work in the Botas laboratory was supported by the R01-NS42179 NIH grant. S.S. was a recipient of a fellowship from Ministerio de Ciencia e Innovacion of Spain; P.C.-Q. is a recipient of a fellowship from Generalitat Valenciana of Spain, J.V.L. was supported by a research contract from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS] and L.G. is the beneficiary of a postdoctoral grant from the AXA Research Fund.	Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Babcock M, 1997, SCIENCE, V276; Bahadorani S, 2010, NEUROBIOL AGING, V31, P1215, DOI 10.1016/j.neurobiolaging.2008.08.001; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Calap-Quintana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132376; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Fabisiak JP, 1999, ANTIOXID REDOX SIGN, V1, P349, DOI 10.1089/ars.1999.1.3-349; Gomes CM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/487534; Gonzalez-Cabo P, 2011, J BIOL CHEM, V286, P21304, DOI 10.1074/jbc.M110.211201; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Hua HQ, 2011, BIOL CHEM, V392, P919, DOI 10.1515/BC.2011.084; Jellinger KA, 2013, INT REV NEUROBIOL, V110, P1, DOI 10.1016/B978-0-12-410502-7.00002-8; Kakhlon O, 2008, BLOOD, V112, P5219, DOI 10.1182/blood-2008-06-161919; Koeppen AH, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-26; Koeppen AH, 2012, CEREBELLUM, V11, P845, DOI 10.1007/s12311-012-0383-5; Kumar V, 2014, NEUROTOXICOLOGY, V41, P154, DOI 10.1016/j.neuro.2014.02.004; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Lang ML, 2012, PLOS GENET, V8, P623, DOI 10.1371/journal.pgen.1002683; Levy F, 2004, BIOCHIMIE, V86, P607, DOI 10.1016/j.biochi.2004.07.007; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Li YJ, 2010, J STRUCT BIOL, V169, P399, DOI 10.1016/j.jsb.2009.10.012; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lye JC, 2012, J EXP BIOL, V215, P3254, DOI 10.1242/jeb.069260; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Muckenthaler M, 1998, EUR J BIOCHEM, V254, P230, DOI 10.1046/j.1432-1327.1998.2540230.x; Navarro JA, 2015, FREE RADICAL BIO MED, V85, P71, DOI 10.1016/j.freeradbiomed.2015.03.014; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Pandolfo M, 2014, ANN NEUROL, V76, P509, DOI 10.1002/ana.24248; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; SANCHEZ-CASIS G, 1976, Canadian Journal of Neurological Sciences, V3, P349; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Soragni E, 2008, NUCLEIC ACIDS RES, V36, P6056, DOI 10.1093/nar/gkn604; Soriano S, 2013, GENE, V521, P274, DOI 10.1016/j.gene.2013.02.049; Suntres ZE, 2006, TOXICOLOGY, V217, P155, DOI 10.1016/j.tox.2005.09.004; Suzuki KT, 1996, TOXICOL APPL PHARM, V141, P231; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Viarengo A, 2000, CELL MOL BIOL, V46, P407; Waldvogel D, 1999, ANN NEUROL, V46, P123, DOI 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Wu Z, 2012, NEUROBIOL AGING, V33, P1, DOI DOI 10.1016/J.NEUR0BI0LAGING.2010.06.018; Xiao GR, 2014, ELIFE, V3, DOI 10.7554/eLife.03191; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x	58	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159209	10.1371/journal.pone.0159209	http://dx.doi.org/10.1371/journal.pone.0159209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433942	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600039
J	Habets, THPM; Oth, T; Houben, AW; Huijskens, MJAJ; Senden-Gijsbers, BLMG; Schnijderberg, MCA; Brans, B; Dubois, LJ; Lambin, P; De Saint-Hubert, M; Germeraad, WTV; Tilanus, MGJ; Mottaghy, FM; Bos, GMJ; Vanderlocht, J				Habets, Thomas H. P. M.; Oth, Tammy; Houben, Ans W.; Huijskens, Mirelle J. A. J.; Senden-Gijsbers, Birgit L. M. G.; Schnijderberg, Melanie C. A.; Brans, Boudewijn; Dubois, Ludwig J.; Lambin, Philippe; De Saint-Hubert, Marijke; Germeraad, Wilfred T. V.; Tilanus, Marcel G. J.; Mottaghy, Felix M.; Bos, Gerard M. J.; Vanderlocht, Joris			Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CELL DEATH; RADIATION; REGRESSION; IMMUNOTHERAPY; COMBINATIONS; MECHANISMS; ANTIBODIES; PATIENT; GROWTH	Accumulating evidence indicates that fractionated radiotherapy (RT) can result in distant non-irradiated (abscopal) tumour regression. Although preclinical studies indicate the importance of T cells in this infrequent phenomenon, these studies do not preclude that other immune mechanisms exhibit an addition role in the abscopal effect. We therefore addressed the question whether in addition to T cell mediated responses also humoral antitumour responses are modulated after fractionated RT and whether systemic dendritic cell (DC) stimulation can enhance tumour-specific antibody production. We selected the 67NR mammary carcinoma model since this tumour showed spontaneous antibody production in all tumour-bearing mice. Fractionated RT to the primary tumour was associated with a survival benefit and a delayed growth of a non-irradiated (contralateral) secondary tumour. Notably, fractionated RT did not affect anti-tumour antibody titers and the composition of the immunoglobulin (Ig) isotypes. Likewise, we demonstrated that treatment of tumour-bearing Balb/C mice with DC stimulating growth factor Flt3-L did neither modulate the magnitude nor the composition of the humoral immune response. Finally, we evaluated the immune infiltrate and Ig isotype content of the tumour tissue using flow cytometry and found no differences between treatment groups that were indicative for local antibody production. In conclusion, we demonstrate that the 67NR mammary carcinoma in Balb/C mice is associated with a pre-existing antibody response. And, we show that in tumour-bearing Balb/C mice with abscopal tumour regression such pre-existing antibody responses are not altered upon fractionated RT and/or DC stimulation with Flt3-L. Our research indicates that evaluating the humoral immune response in the setting of abscopal tumour regression is not invariably associated with therapeutic effects.	[Habets, Thomas H. P. M.; Oth, Tammy; Houben, Ans W.; Huijskens, Mirelle J. A. J.; Senden-Gijsbers, Birgit L. M. G.; Schnijderberg, Melanie C. A.; Germeraad, Wilfred T. V.; Bos, Gerard M. J.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Div Hematol,Dept Internal Med, Maastricht, Netherlands; [Habets, Thomas H. P. M.; Tilanus, Marcel G. J.; Vanderlocht, Joris] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Tissue Typing Lab,Dept Transplantat Immunol, Maastricht, Netherlands; [Houben, Ans W.; Brans, Boudewijn; De Saint-Hubert, Marijke; Mottaghy, Felix M.] Maastricht Univ, Med Ctr, Sch NUTRIM, Div Nucl Med,Dept Internal Med, Maastricht, Netherlands; [Dubois, Ludwig J.; Lambin, Philippe] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, MaastRO Lab,Dept Radiat Oncol, Maastricht, Netherlands; [Germeraad, Wilfred T. V.; Bos, Gerard M. J.] CiMaas BV, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University	Vanderlocht, J (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Tissue Typing Lab,Dept Transplantat Immunol, Maastricht, Netherlands.	joris.vanderlocht@mumc.nl	Mottaghy, Felix/AAU-2673-2020	Mottaghy, Felix/0000-0002-7212-6521; Lambin, Philippe/0000-0001-7961-0191; De Saint-Hubert, Marijke/0000-0003-2374-3280				Abuodeh Y, 2015, CURRENT PROBLEMS CAN; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Blank CU, 2015, INT IMMUNOL, V27, P3, DOI 10.1093/intimm/dxu076; Blank CU, 2014, CURR OPIN ONCOL, V26, P204, DOI 10.1097/CCO.0000000000000054; Bramhall RJ, 2014, EJSO-EUR J SURG ONC, V40, P34, DOI 10.1016/j.ejso.2013.09.026; Chakravarty PK, 1999, CANCER RES, V59, P6028; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00153; Derer A, 2015, CANC IMMUNOLOGY IMMU; Derer A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00505; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Girit IC, 2008, COMPARATIVE MED, V58, P264; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Golden EB, 2015, SEMIN RADIAT ONCOL, V25, P11, DOI 10.1016/j.semradonc.2014.07.005; Golden EB, 2013, CANCER IMMUNOL RES, V1, P365, DOI 10.1158/2326-6066.CIR-13-0115; GREENBERG AH, 1975, IMMUNOLOGY, V29, P719; Grimaldi AM, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28780; HERLYN D, 1982, P NATL ACAD SCI-BIOL, V79, P4761, DOI 10.1073/pnas.79.15.4761; Honeychurch J, 2015, EXPERT OPIN BIOL TH, V15, P787, DOI 10.1517/14712598.2015.1036737; Ito A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605478; Kaczanowska S, 2013, J LEUKOCYTE BIOL, V93, P847, DOI 10.1189/jlb.1012501; Kaminski JM, 2005, CANCER TREAT REV, V31, P159, DOI 10.1016/j.ctrv.2005.03.004; Kono K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.207; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lakshmanagowda Preethi Bangalore, 2009, Cases J, V2, P204, DOI 10.1186/1757-1626-2-204; Liauw SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005148; Lynch DH, 1997, NAT MED, V3, P625, DOI 10.1038/nm0697-625; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; MOLE RH, 1953, BRIT J RADIOL, V26, P234, DOI 10.1259/0007-1285-26-305-234; Ohba K, 1998, GUT, V43, P575, DOI 10.1136/gut.43.4.575; Okuma Kae, 2011, J Med Case Rep, V5, P111, DOI 10.1186/1752-1947-5-111; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Siva S, 2013, CANC LETT; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; Stamell EF, 2013, INT J RADIAT ONCOL, V85, P293, DOI 10.1016/j.ijrobp.2012.03.017; Sullivan RJ, 2013, NEW ENGL J MED, V369, P173, DOI 10.1056/NEJMcpc1302332; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Vatner RE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00325; Wersall PJ, 2006, ACTA ONCOL, V45, P493, DOI 10.1080/02841860600604611	44	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159515	10.1371/journal.pone.0159515	http://dx.doi.org/10.1371/journal.pone.0159515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427766	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300074
J	Khera, P; Pandey, MK; Wang, H; Feng, SP; Qiao, LX; Culbreath, AK; Kale, S; Wang, JP; Holbrook, CC; Zhuang, WJ; Varshney, RK; Guo, BZ				Khera, Pawan; Pandey, Manish K.; Wang, Hui; Feng, Suping; Qiao, Lixian; Culbreath, Albert K.; Kale, Sandip; Wang, Jianping; Holbrook, C. Corley; Zhuang, Weijian; Varshney, Rajeev K.; Guo, Baozhu			Mapping Quantitative Trait Loci of Resistance to Tomato Spotted Wilt Virus and Leaf Spots in a Recombinant Inbred Line Population of Peanut (Arachis hypogaea L.) from SunOleic 97R and NC94022	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; RUST RESISTANCE; FIELD RESPONSE; OIL QUALITY; IDENTIFICATION; SOFTWARE; GENOMICS; QTL	Peanut is vulnerable to a range of diseases, such as Tomato spotted wilt virus (TSWV) and leaf spots which will cause significant yield loss. The most sustainable, economical and eco-friendly solution for managing peanut diseases is development of improved cultivars with high level of resistance. We developed a recombinant inbred line population from the cross between SunOleic 97R and NC94022, named as the S-population. An improved genetic linkage map was developed for the S-population with 248 marker loci and a marker density of 5.7 cM/loci. This genetic map was also compared with the physical map of diploid progenitors of tetraploid peanut, resulting in an overall co-linearity of about 60% with the average co-linearity of 68% for the A sub-genome and 47% for the B sub-genome. The analysis using the improved genetic map and multi-season (2010-2013) phenotypic data resulted in the identification of 48 quantitative trait loci (QTLs) with phenotypic variance explained (PVE) from 3.88 to 29.14%. Of the 48 QTLs, six QTLs were identified for resistance to TSWV, 22 QTLs for early leaf spot (ELS) and 20 QTLs for late leaf spot (LLS), which included four, six, and six major QTLs ( PVE larger than 10%) for each disease, respectively. A total of six major genomic regions (MGR) were found to have QTLs controlling more than one disease resistance. The identified QTLs and resistance gene-rich MGRs will facilitate further discovery of resistance genes and development of molecular markers for these important diseases.	[Khera, Pawan; Wang, Hui; Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Khera, Pawan; Pandey, Manish K.; Kale, Sandip; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Khera, Pawan; Wang, Hui; Culbreath, Albert K.; Guo, Baozhu] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Feng, Suping] Hainan Trop Marine Univ, Coll Trop Biol & Agron, Sanya, Peoples R China; [Qiao, Lixian] Qingdao Agr Univ, Coll Life Sci, Qingdao, Shandong, Peoples R China; [Wang, Jianping] Univ Florida, Dept Agron, Gainesville, FL 32611 USA; [Holbrook, C. Corley] USDA ARS, Crop Genet & Breeding Res Unit, Tifton, GA 31793 USA; [Zhuang, Weijian] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China	United States Department of Agriculture (USDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University System of Georgia; University of Georgia; Qingdao Agricultural University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); Fujian Agriculture & Forestry University	Guo, BZ (corresponding author), USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA.; Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.; Guo, BZ (corresponding author), Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA.	r.k.varshney@cgiar.org; Baozhu.Guo@ars.usda.gov	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Pandey, Manish/0000-0002-4101-6530	USDA Agricultural Research Service; Georgia Peanut Commission; Peanut Foundation; National Peanut Board of USA; World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India; ARS [ARS-0425281] Funding Source: Federal RePORTER	USDA Agricultural Research Service(United States Department of Agriculture (USDA)); Georgia Peanut Commission; Peanut Foundation; National Peanut Board of USA; World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was partially supported by funds provided by the USDA Agricultural Research Service, the Georgia Peanut Commission, Peanut Foundation and National Peanut Board of USA and World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India. This work has been also undertaken as part of the CGIAR Research Program on Grain Legumes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Billy Wilson, Jake Fountain, Stephanie Lee, Lucero Gutierrez, Sara Beth Pelham, Victoria Weaver, and Jake Weaver for technical assistance in the field and the laboratory. This research was partially supported by funds provided by the USDA Agricultural Research Service, the Georgia Peanut Commission, Peanut Foundation and National Peanut Board of USA and World Bank assisted Watershed Development Project-II (KWDP-II) by Government of Karnataka, India. This work has been also undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Baldessari J. J., 2008, THESIS; Barrientos-Priego L., 2002, Peanut Science, V29, P72, DOI 10.3146/pnut.29.1.0013; Bayer M, 2011, BIOINFORMATICS, V27, P1307, DOI 10.1093/bioinformatics/btr111; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bertioli DJ, 2014, GENETICS GENOMICS BR, P114; CHITEKA Z A, 1988, Peanut Science, V15, P25, DOI 10.3146/i0095-3679-15-1-8; Culbreath A. K., 2005, Peanut Science, V32, P20, DOI 10.3146/0095-3679(2005)32[20:HLOFRT]2.0.CO;2; Culbreath AK, 1997, PLANT DIS, V81, P1410, DOI 10.1094/PDIS.1997.81.12.1410; Food and Agriculture Organization (FAO), 2004, STAT FOOD AGR BIOT M; Gorbet DW, 2000, CROP SCI, V40, P1190, DOI 10.2135/cropsci2000.0032rcv; Gorbet DW, 1997, S400 FL AGR EXP STN; Guo Baozhu, 2013, Peanut Science, V40, P95, DOI 10.3146/PS13-03.1; Guo YF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-608; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Li Yan, 2012, Peanut Science, V39, P30, DOI 10.3146/PS11-6.1; MILLER I L, 1990, Peanut Science, V17, P52, DOI 10.3146/i0095-3679-17-2-2; NORDEN AJ, 1985, CROP SCI, V25, P1126, DOI 10.2135/cropsci1985.0011183X002500060061x; Ogwulumba SI, 2008, AFR J BIOTECHNOL, V7, P2878; Pandey MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113326; Pandey MK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00455; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pasupuleti J, 2016, PLANT BREEDING, V135, P355, DOI 10.1111/pbr.12358; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Smith AF, 1984, PLANT DIS, V64, P356; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Surbrahmayan P, 1980, P INT WORKSH GROUNDN, P193; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2009, THEOR APPL GENET, V118, P729, DOI 10.1007/s00122-008-0933-x; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang H, 2013, PLANT GENOME, V6, P3; Wang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119454; Wang S., 2011, WINDOWS QTL CARTOGRA	42	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158452	10.1371/journal.pone.0158452	http://dx.doi.org/10.1371/journal.pone.0158452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427980	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000380169300007
J	Sureshchandra, S; Rais, M; Stull, C; Grant, K; Messaoudi, I				Sureshchandra, Suhas; Rais, Maham; Stull, Cara; Grant, Kathleen; Messaoudi, Ilhem			Transcriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus Macaques	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; NATURAL-KILLER-CELLS; MESSENGER-RNA LEVELS; GENE-EXPRESSION DATA; P-SELECTIN LEVELS; ALCOHOL-CONSUMPTION; HUMAN MONOCYTES; HEART-FAILURE; CARDIOVASCULAR-DISEASE; CYTOKINE PRODUCTION	It is well established that heavy ethanol consumption interferes with the immune system and inflammatory processes, resulting in increased risk for infectious and chronic diseases. However, these processes have yet to be systematically studied in a dose and sex-dependent manner. In this study, we investigated the impact of chronic heavy ethanol consumption on gene expression using RNA-seq in peripheral blood mononuclear cells isolated from female rhesus macaques with daily consumption of 4% ethanol available 22hr/day for 12 months resulting in average ethanol consumption of 4.3 g/kg/day (considered heavy drinking). Differential gene expression analysis was performed using edgeR and gene enrichment analysis using MetaCore (TM). We identified 1106 differentially expressed genes, meeting the criterion of >= two-fold change and p-value <= 0.05 in expression (445 up-and 661 down-regulated). Pathway analysis of the 879 genes with characterized identifiers showed that the most enriched gene ontology processes were "response to wounding", "blood coagulation", "immune system process", and "regulation of signaling". Changes in gene expression were seen despite the lack of differences in the frequency of any major immune cell subtype between ethanol and controls, suggesting that heavy ethanol consumption modulates gene expression at the cellular level rather than altering the distribution of peripheral blood mononuclear cells. Collectively, these observations provide mechanisms to explain the higher incidence of infection, delay in wound healing, and increase in cardiovascular disease seen in subjects with Alcohol use disorder.	[Sureshchandra, Suhas; Messaoudi, Ilhem] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA; [Sureshchandra, Suhas; Rais, Maham; Messaoudi, Ilhem] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Stull, Cara; Grant, Kathleen; Messaoudi, Ilhem] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; Oregon Health & Science University; Oregon National Primate Research Center	Messaoudi, I (corresponding author), Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA.; Messaoudi, I (corresponding author), Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA.; Messaoudi, I (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA.	ilhem.messaoudi@ucr.edu	Sureshchandra, Suhas/AAW-4606-2021	Rais, Maham/0000-0003-2555-2111	NIAAA grant [AA021947-02, U01 AA013510, R24 AA109431]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA019431] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIAAA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIAAA grant AA021947-02, U01 AA013510, and R24 AA109431.	Amelot AA, 2007, J BIOL CHEM, V282, P710, DOI 10.1074/jbc.M606650200; An XL, 2015, CURR OPIN HEMATOL, V22, P206, DOI 10.1097/MOH.0000000000000134; Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Ashenhurst JR, 2015, PSYCHOL ADDICT BEHAV, V29, P978, DOI 10.1037/adb0000116; Asquith M, 2014, ALCOHOL CLIN EXP RES, V38, P980, DOI 10.1111/acer.12325; Baker EJ, 2014, ALCOHOL CLIN EXP RES, V38, P2835, DOI 10.1111/acer.12547; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barr T, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.09.001; Barr T, 2016, J IMMUNOL, V196, P182, DOI 10.4049/jimmunol.1501527; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Bilal Erhan, 2010, Genes Cancer, V1, P1063, DOI 10.1177/1947601910395583; Blanco-Mezquita JT, 2013, INVEST OPHTH VIS SCI, V54, P6262, DOI 10.1167/iovs.13-11710; Bonsch D, 2005, ALCOHOL CLIN EXP RES, V29, P763, DOI 10.1097/01.ALC.0000164360.43907.24; Bonsch D, 2004, BIOL PSYCHIAT, V56, P984, DOI 10.1016/j.biopsych.2004.09.016; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Bot I, 2011, THROMB HAEMOSTASIS, V106, P820, DOI 10.1160/TH11-05-0291; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Carter AM, 2003, J THROMB HAEMOST, V1, P1718, DOI 10.1046/j.1538-7836.2003.00312.x; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Cho S, 2016, J EXP MED, V213, P235, DOI 10.1084/jem.20150990; Choudhury M, 2010, ALCOHOL, V44, P531, DOI 10.1016/j.alcohol.2010.06.003; Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Corsetti JP, 2012, METABOLISM, V61, P996, DOI 10.1016/j.metabol.2011.11.010; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; DAWSON DA, 1994, ADDICTION, V89, P345, DOI 10.1111/j.1360-0443.1994.tb00901.x; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Delaguillaumie A, 2004, J CELL SCI, V117, P5269, DOI 10.1242/jcs.01380; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; Djousse L, 2008, CURR ATHEROSCLER REP, V10, P117, DOI 10.1007/s11883-008-0017-z; Djousse L, 2008, AM J CARDIOL, V102, P593, DOI 10.1016/j.amjcard.2008.04.031; Ezell SA, 2012, TRANSCR-AUSTIN, V3, P305, DOI 10.4161/trns.21904; Falati S, 1999, BLOOD, V94, P1648, DOI 10.1182/blood.V94.5.1648.417k31_1648_1656; Faucher K, 2003, BIOCHIMIE, V85, P611, DOI 10.1016/S0300-9084(03)00089-0; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Freeman WM, 2010, BIOL PSYCHIAT, V68, P219, DOI 10.1016/j.biopsych.2010.01.028; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gavala ML, 2010, J BIOL CHEM, V285, P34288, DOI 10.1074/jbc.M110.142091; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Graeme IM, 2001, ANN REV PHARM TOXICO, V41, P297, DOI [10.1146/annurev.pharmtox.41.1.297, DOI 10.1146/ANNUREV.PHARMTOX.41.1.297]; Grant KA, 2008, ALCOHOL CLIN EXP RES, V32, P1824, DOI 10.1111/j.1530-0277.2008.00765.x; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Guo Y, 2013, INFECT IMMUN, V81, P3923, DOI 10.1128/IAI.00887-13; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Harris DR, 2001, ANN INTERN MED, V134, P120, DOI 10.7326/0003-4819-134-2-200101160-00012; He Lei, 2009, Human Genomics, V3, P195; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hermann-Kleiter N, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-38; Hinks A, 2010, GENES IMMUN, V11, P194, DOI 10.1038/gene.2009.105; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez VA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00260; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee KN, 2005, IMMUNITY, V22, P195, DOI 10.1016/j.immuni.2004.12.012; Li-Saw-Hee FL, 2001, EUR HEART J, V22, P1741, DOI 10.1053/euhj.2000.2531; Liang TB, 2003, P NATL ACAD SCI USA, V100, P4690, DOI 10.1073/pnas.0737182100; Lucero CMJ, 2013, J CELL PHYSIOL, V228, P714, DOI 10.1002/jcp.24218; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1609, DOI 10.1097/01.ALC.0000036926.46632.57; Mandrekar P, 1997, ALCOHOL CLIN EXP RES, V21, P988, DOI 10.1111/j.1530-0277.1997.tb04242.x; Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494; Minagawa K, 2009, MOL CANCER RES, V7, P880, DOI 10.1158/1541-7786.MCR-08-0511; Mirabet M, 1999, J CELL SCI, V112, P491; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Mukamal KJ, 2001, ALCOHOL RES HEALTH, V25, P255; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Mun GI, 2013, BIOCHEM BIOPH RES CO, V430, P554, DOI 10.1016/j.bbrc.2012.11.114; Nachbur U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7442; Nair J, 2014, J ATHEROSCLER THROMB, V21, P329, DOI 10.5551/jat.20123; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Okazaki H, 2008, J BIOL CHEM, V283, P33357, DOI 10.1074/jbc.M802686200; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pasala S, 2015, ALCOHOL RES-CURR REV, V37, P185; Peng SL, 2008, ONCOGENE, V27, P2337, DOI 10.1038/onc.2008.26; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Reiner AP, 2002, BRIT J HAEMATOL, V116, P376, DOI 10.1046/j.1365-2141.2002.03265.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruggeri ZM, 2007, THROMB RES, V120, pS5, DOI 10.1016/j.thromres.2007.03.011; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; Saha B, 2015, J IMMUNOL, V194, P3079, DOI 10.4049/jimmunol.1402190; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Shay T, 2013, TRENDS IMMUNOL, V34, P602, DOI 10.1016/j.it.2013.03.004; Shukla SD, 2015, BIOMOLECULES, V5, P3280, DOI 10.3390/biom5043280; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Stote KS, 2016, EUR J CLIN NUTR, V70, P470, DOI 10.1038/ejcn.2015.182; Su XM, 2012, J CLIN INVEST, V122, P3579, DOI 10.1172/JCI38576; Suzuki M, 2011, INT J HEMATOL, V93, P150, DOI 10.1007/s12185-011-0770-6; Szabo G, 2010, ALCOHOL RES HEALTH, V33, P87; Szeles L, 2007, BBA-MOL CELL BIOL L, V1771, P1014, DOI 10.1016/j.bbalip.2007.02.005; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tigges J, 2013, J INVEST DERMATOL, V133, P87, DOI 10.1038/jid.2012.259; Tonnesen H, 2009, BRIT J ANAESTH, V102, P297, DOI 10.1093/bja/aen401; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Verhaar MC, 1998, J HYPERTENS, V16, P45, DOI 10.1097/00004872-199816010-00008; Walker SJ, 2006, ALCOHOL, V38, P1, DOI 10.1016/j.alcohol.2006.03.008; Wang XL, 2015, J CONTROL RELEASE, V197, P138, DOI 10.1016/j.jconrel.2014.11.001; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xia YY, 1997, AM J PATHOL, V151, P375; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Yonezawa T, 2004, BIOCHEM BIOPH RES CO, V314, P805, DOI 10.1016/j.bbrc.2003.12.175; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zisman DA, 1998, ALCOHOL CLIN EXP RES, V22, P621, DOI 10.1111/j.1530-0277.1998.tb04303.x	133	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159295	10.1371/journal.pone.0159295	http://dx.doi.org/10.1371/journal.pone.0159295			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427759	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300044
J	Van Dyke, MW; Beyer, MD; Clay, E; Hiam, KJ; McMurry, JL; Xie, Y				Van Dyke, Michael W.; Beyer, Matthew D.; Clay, Emily; Hiam, Kamir J.; McMurry, Jonathan L.; Xie, Ying			Identification of Preferred DNA-Binding Sites for the Thermus thermophilus Transcriptional Regulator SbtR by the Combinatorial Approach REPSA	PLOS ONE			English	Article							SEQUENCE SPECIFICITY; PROTEIN COMPLEXES; HB8; GENE; GENOME; EVOLUTION; SELECTION; RESOURCE; DATABASE; INTEGRATION	One of the first steps towards elucidating the biological function of a putative transcriptional regulator is to ascertain its preferred DNA-binding sequences. This may be rapidly and effectively achieved through the application of a combinatorial approach, one involving very large numbers of randomized oligonucleotides and reiterative selection and amplification steps to enrich for high-affinity nucleic acid-binding sequences. Previously, we had developed the novel combinatorial approach Restriction Endonuclease Protection, Selection and Amplification (REPSA), which relies not on the physical separation of ligand-nucleic acid complexes but instead selects on the basis of ligand-dependent inhibition of enzymatic template inactivation, specifically cleavage by type IIS restriction endonucleases. Thus, no prior knowledge of the ligand is required for REPSA, making it more amenable for discovery purposes. Here we describe using REPSA, massively parallel sequencing, and bioinformatics to identify the preferred DNA-binding sites for the transcriptional regulator SbtR, encoded by the TTHA0167 gene from the model extreme thermophile Thermus thermophilus HB8. From the resulting position weight matrix, we can identify multiple operons potentially regulated by SbtR and postulate a biological role for this protein in regulating extracellular transport processes. Our study provides a proof-of-concept for the application of REPSA for the identification of preferred DNA-binding sites for orphan transcriptional regulators and a first step towards determining their possible biological roles.	[Van Dyke, Michael W.; Beyer, Matthew D.; Clay, Emily; Hiam, Kamir J.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA; [McMurry, Jonathan L.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA USA; [Xie, Ying] Kennesaw State Univ, Dept Comp Sci, Kennesaw, GA USA	University System of Georgia; Kennesaw State University; University System of Georgia; Kennesaw State University; University System of Georgia; Kennesaw State University	Van Dyke, MW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	mvandyk2@kennesaw.edu	Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002; Hiam, Kamir/0000-0002-1956-0257	US National Institutes of Health [1R15GM104833-01]; Kennesaw State University Foundation (Foundation Fellow in Biochemistry); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104833] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kennesaw State University Foundation (Foundation Fellow in Biochemistry); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (http:www.nih.gov, Grant 1R15GM104833-01, MVD) and by the Kennesaw State University Foundation (http://www.kennesaw.edu/foundation/, Foundation Fellow in Biochemistry, MVD). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2013, PROTEINS, V81, P1166, DOI 10.1002/prot.24266; Agari Y, 2012, J BACTERIOL, V194, P4630, DOI 10.1128/JB.00668-12; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Al-Zyoud WA, 2016, NUCLEIC ACIDS RES, V44, P1411, DOI 10.1093/nar/gkv1466; Amar D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0329-9; Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Cava F, 2009, EXTREMOPHILES, V13, P213, DOI 10.1007/s00792-009-0226-6; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Gopal YNV, 2003, BIOCHEMISTRY-US, V42, P6891, DOI 10.1021/bi027373s; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Hardenbol P, 1996, P NATL ACAD SCI USA, V93, P2811, DOI 10.1073/pnas.93.7.2811; Hardenbol P, 1997, NUCLEIC ACIDS RES, V25, P3339, DOI 10.1093/nar/25.16.3339; Hardenbol P, 1997, BIOCONJUGATE CHEM, V8, P617, DOI 10.1021/bc970066s; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hu JC, 2014, NUCLEIC ACIDS RES, V42, pD677, DOI 10.1093/nar/gkt1203; Hutchison CA, 2016, SCIENCE, V351, DOI 10.1126/science.aad6253; Iino H, 2008, ACTA CRYSTALLOGR F, V64, P487, DOI 10.1107/S1744309108013572; Iwanaga N, 2014, EXTREMOPHILES, V18, P995, DOI 10.1007/s00792-014-0669-2; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Meier M, 2013, P NATL ACAD SCI USA, V110, P477, DOI 10.1073/pnas.1210634110; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sakamoto K, 2011, J BACTERIOL, V193, P4388, DOI 10.1128/JB.05203-11; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Shen J, 2001, BIOORGAN MED CHEM, V9, P2285, DOI 10.1016/S0968-0896(01)00146-8; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Solovjev V, 2011, METAGENOMICITAPP, P61; Sunavala-Dossabhoy G, 2005, BIOCHEMISTRY-US, V44, P2510, DOI 10.1021/bi047877l; Swarup A, 2014, METAB ENG, V24, P173, DOI 10.1016/j.ymben.2014.05.013; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Takano H, 2014, MICROBIOL-SGM, V160, P2650, DOI 10.1099/mic.0.082263-0; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zykovich A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp802	54	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159408	10.1371/journal.pone.0159408	http://dx.doi.org/10.1371/journal.pone.0159408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428627	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300062
J	Zhou, T; Perez, SN; Cheng, ZM; Kinney, MC; Lemieux, ME; Scott, LM; Rebel, VI				Zhou, Ting; Perez, Stephanie N.; Cheng, Ziming; Kinney, Marsha C.; Lemieux, Madeleine E.; Scott, Linda M.; Rebel, Vivienne I.			Context Matters: Distinct Disease Outcomes as a Result of Crebbp Hemizygosity in Different Mouse Bone Marrow Compartments	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELL; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDERS; MYELOMONOCYTIC LEUKEMIA; TUMOR MICROENVIRONMENT; PROGNOSTIC-FACTORS; BINDING-PROTEIN; B-CELL	Perturbations in CREB binding protein (CREBBP) are associated with hematopoietic malignancies, including myelodysplastic syndrome (MDS). Mice hemizygous for Crebbp develop myelodysplasia with proliferative features, reminiscent of human MDS/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U), and a proportion goes on to develop acute myeloid leukemia (AML). We have also shown that the Crebbp(+/-) non-hematopoietic bone marrow microenvironment induces excessive myeloproliferation of wild-type cells. We now report that transplantation of unfractionated Crebbp(+/-) bone marrow into wild-type recipients resulted in either early-onset AML or late-onset MDS and MDS/MPN-U. In contrast, purified Lin(-)Sca-1(+)c-Kit(++) cells primarily gave rise to MDS with occasional transformation to AML. Furthermore, Crebbp(+/-) common myeloid progenitors and granulocyte/macrophage progenitors could trigger skewed myelopoiesis, myelodysplasia and late-onset AML. Surprisingly, the phenotypically abnormal cells were all of wild-type origin. MDS, MPN and AML can thus all be transferred from Crebbp(+/-) BM to wild-type hosts but fractionated bone marrow does not recapitulate the full disease spectrum of whole bone marrow, indicating that not only mutational status but also cellular context contribute to disease outcome. This has important consequences for structuring and interpreting future investigations into the underlying mechanisms of myeloid malignancies as well as for their treatment.	[Zhou, Ting; Cheng, Ziming; Rebel, Vivienne I.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Zhou, Ting; Rebel, Vivienne I.] UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Perez, Stephanie N.] Texas Lutheran Univ, Dept Biol, Seguin, TX USA; [Kinney, Marsha C.] UTHSCSA, Dept Pathol, San Antonio, TX USA; [Lemieux, Madeleine E.] Bioinfo, Plantagenet, ON, Canada; [Scott, Linda M.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Scott, Linda M.] Univ Queensland, Translat Res Inst, Brisbane, Qld, Australia; [Rebel, Vivienne I.] UTHSCSA, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Queensland; University of Queensland; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Rebel, VI (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.; Rebel, VI (corresponding author), UTHSCSA, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.; Rebel, VI (corresponding author), UTHSCSA, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA.	vr@bioaffinitytech.com	Scott, Linda/D-9777-2012	Scott, Linda/0000-0003-0334-1479; Rebel, Vivienne/0000-0002-3862-3903	GCCRI; University of Texas System's Graduate Programs Initiative; Hyundai Hope Grant Award; National Cancer Institute Cancer Center Support Grant [2P30 CA054174- 17]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	GCCRI; University of Texas System's Graduate Programs Initiative; Hyundai Hope Grant Award; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research for this publication was supported by funding from the GCCRI (V.I.R.) and the University of Texas System's Graduate Programs Initiative that funded the Translational Science Training Across Disciplines program (T.Z.) at the University of Texas Health Science Center at San Antonio. T.Z. was also supported by a Hyundai Hope Grant Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Karla Moncada and Ben Daniel of the UTHSCSA Flow Cytometry Core (supported by National Cancer Institute Cancer Center Support Grant 2P30 CA054174- 17) and Jennifer Rebeles of the GCCRI Shared Instrumentation Facility for assistance with flow cytometry, Lisa White and her staff (Genomic and RNA Profiling Core, Baylor College of Medicine, Houston TX) for conducting the NanoString experiments and David Rodriguez for help with preparing the images for publication.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Beer PA, 2010, BLOOD, V115, P2891, DOI 10.1182/blood-2009-08-236596; BEHRENS WEV, 1973, AUSTRALAS RADIOL, V17, P440, DOI 10.1111/j.1440-1673.1973.tb01482.x; Brumbaugh CD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-479; Brunning RD, 2008, WHO CLASSIFICATION T; Campbell PJ, 2006, BLOOD, V108, P3548, DOI 10.1182/blood-2005-12-013748; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dupriez B, 1996, BLOOD, V88, P1013; Elpek KG, 2014, CANCER IMMUNOL RES, V2, P655, DOI 10.1158/2326-6066.CIR-13-0209; Finazzi G, 2005, BLOOD, V105, P2664, DOI 10.1182/blood-2004-09-3426; Greeneltch KM, 2007, CANCER RES, V67, P10406, DOI 10.1158/0008-5472.CAN-07-1228; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Imamura T, 2003, GENE CHROMOSOME CANC, V36, P413, DOI 10.1002/gcc.10172; Inthal A, 2012, LEUKEMIA, V26, P1797, DOI 10.1038/leu.2012.60; Itzykson R, 2011, ED BOOK, V31, P251; Kennedy JA, 2006, P NATL ACAD SCI USA, V103, P16930, DOI 10.1073/pnas.0604902103; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kojima K, 2003, BRIT J HAEMATOL, V120, P271, DOI 10.1046/j.1365-2141.2003.04059.x; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kung AL, 2000, GENE DEV, V14, P272; Lemieux ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANOHARAN A, 1988, PATHOLOGY, V20, P7, DOI 10.3109/00313028809085188; Mattei F, 2012, NEOPLASIA, V14, P1223, DOI 10.1593/neo.121444; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Muntion S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146722; OHSAKA A, 1989, BRIT J HAEMATOL, V73, P568, DOI 10.1111/j.1365-2141.1989.tb00301.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rebel V I, 1995, Biol Blood Marrow Transplant, V1, P32; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rizzuti AE, 2008, ARCH OPHTHALMOL-CHIC, V126, P862, DOI 10.1001/archopht.126.6.862; Rowley JD, 1997, BLOOD, V90, P535; Satake N, 1997, GENE CHROMOSOME CANC, V20, P60, DOI 10.1002/(SICI)1098-2264(199709)20:1<60::AID-GCC9>3.3.CO;2-O; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stewart TJ, 2009, J IMMUNOL, V183, P117, DOI 10.4049/jimmunol.0804132; Suggs JL, 2007, EXP MOL PATHOL, V83, P471, DOI 10.1016/j.yexmp.2007.08.012; Taki T, 1997, BLOOD, V89, P3945, DOI 10.1182/blood.V89.11.3945; Theocharides A, 2007, BLOOD, V110, P375, DOI 10.1182/blood-2006-12-062125; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; VERFAILLIE CM, 1992, J CLIN INVEST, V90, P1232, DOI 10.1172/JCI115985; Vinante F, 1999, BLOOD, V93, P1715, DOI 10.1182/blood.V93.5.1715.405k26_1715_1723; Wolanskyj AP, 2006, MAYO CLIN PROC, V81, P159, DOI 10.4065/81.2.159; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Zimmer SN, 2012, EXP HEMATOL, V40, P295, DOI 10.1016/j.exphem.2011.12.004; Zimmer SN, 2011, BLOOD, V118, P69, DOI 10.1182/blood-2010-09-307942	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158649	10.1371/journal.pone.0158649	http://dx.doi.org/10.1371/journal.pone.0158649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427906	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300015
J	Kussman, BD; Aasted, CM; Yucel, MA; Steele, SC; Alexander, ME; Boas, DA; Borsook, D; Becerra, L				Kussman, Barry D.; Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Alexander, Mark E.; Boas, David A.; Borsook, David; Becerra, Lino			Capturing Pain in the Cortex during General Anesthesia: Near Infrared Spectroscopy Measures in Patients Undergoing Catheter Ablation of Arrhythmias	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; DIFFUSE OPTICAL TOMOGRAPHY; PULMONARY VEIN ISOLATION; FRONTAL-CORTEX; RADIOFREQUENCY ABLATION; BRAIN ACTIVATION; CENTRAL SENSITIZATION	The predictability of pain makes surgery an ideal model for the study of pain and the development of strategies for analgesia and reduction of perioperative pain. As functional near-infrared spectroscopy reproduces the known functional magnetic resonance imaging activations in response to a painful stimulus, we evaluated the feasibility of functional near-infrared spectroscopy to measure cortical responses to noxious stimulation during general anesthesia. A multichannel continuous wave near-infrared imager was used to measure somatosensory and frontal cortical activation in patients undergoing catheter ablation of arrhythmias under general anesthesia. Anesthetic technique was standardized and intra-operative NIRS signals recorded continuously with markers placed in the data set for the timing and duration of each cardiac ablation event. Frontal cortical signals only were suitable for analysis in five of eight patients studied (mean age 14 +/- 1 years, weight 66.7 +/- 17.6 kg, 2 males). Thirty ablative lesions were recorded for the five patients. Radiofrequency or cryoablation was temporally associated with a hemodynamic response function in the frontal cortex characterized by a significant decrease in oxyhemoglobin concentration (paired t-test, p<0.05) with the nadir occurring in the period 4 to 6 seconds after application of the ablative lesion. Cortical signals produced by catheter ablation of arrhythmias in patients under general anesthesia mirrored those seen with noxious stimulation in awake, healthy volunteers, during sedation for colonoscopy, and functional Magnetic Resonance Imaging activations in response to pain. This study demonstrates the feasibility and potential utility of functional near-infrared spectroscopy as an objective measure of cortical activation under general anesthesia.	[Kussman, Barry D.; Aasted, Christopher M.; Steele, Sarah C.; Borsook, David; Becerra, Lino] Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA; [Kussman, Barry D.; Aasted, Christopher M.; Steele, Sarah C.; Borsook, David; Becerra, Lino] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Kussman, Barry D.; Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Alexander, Mark E.; Boas, David A.; Borsook, David; Becerra, Lino] Harvard Med Sch, Boston, MA 02115 USA; [Aasted, Christopher M.; Yucel, Meryem A.; Steele, Sarah C.; Boas, David A.; Borsook, David; Becerra, Lino] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, 32 Fruit St, Boston, MA 02114 USA; [Alexander, Mark E.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital	Becerra, L (corresponding author), Harvard Med Sch, Ctr Pain & Brain, Boston, MA 02115 USA.; Becerra, L (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Becerra, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Becerra, L (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, 32 Fruit St, Boston, MA 02114 USA.	Lino.Becerra@childrens.harvard.edu		YUCEL, MERYEM/0000-0002-4291-2847	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health [R01GM104986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104986] Funding Source: NIH RePORTER	Mayday Foundation; Anesthesia Research Distinguished Trailblazer Award; National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this article was supported by the Mayday Foundation, the Anesthesia Research Distinguished Trailblazer Award, and the National Institute of General Medical Science of the National Institutes of Health under award number R01GM104986. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Azawy M, 2015, APPL NURS RES, V28, P268, DOI 10.1016/j.apnr.2015.01.011; Alaeddini J, 2007, PACE, V30, P1210, DOI 10.1111/j.1540-8159.2007.00842.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; An X, 1998, J COMP NEUROL, V401, P455; [Anonymous], 2015, EUR HEART J, V36, P140; Aryana A, 2008, J CARDIOVASC ELECTR, V19, P32, DOI 10.1111/j.1540-8167.2007.00975.x; Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011; Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; Bayle DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008207; Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008016; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Borsook D, 2013, ANN SURG, V257, P403, DOI 10.1097/SLA.0b013e3182701a7b; Borsook D, 2011, NEUROSCI BIOBEHAV R, V35, P1125, DOI 10.1016/j.neubiorev.2010.11.005; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Carnlof C, 2014, SCAND CARDIOVASC J, V48, P35, DOI 10.3109/14017431.2013.859296; Castro A, 2015, J CLIN MONIT COMPUT, V29, P561, DOI 10.1007/s10877-014-9632-0; Chen JI, 2002, J NEUROPHYSIOL, V88, P464, DOI 10.1152/jn.2002.88.1.464; Chen WG, 2002, CHINESE MED J-PEKING, V115, P84; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; Dahl JB, 2011, CURR OPIN ANESTHESIO, V24, P331, DOI 10.1097/ACO.0b013e328345afd9; Fiset P, 1999, J NEUROSCI, V19, P5506; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Foreman RD, 2015, COMPR PHYSIOL, V5, P929, DOI 10.1002/cphy.c140032; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Ghoneim MM, 2009, ANESTH ANALG, V108, P527, DOI 10.1213/ane.0b013e318193c634; Gruenewald M, 2013, BEST PRACT RES-CLIN, V27, P235, DOI 10.1016/j.bpa.2013.06.007; Hobson AR, 2003, NEWS PHYSIOL SCI, V18, P109, DOI 10.1152/nips.01428.2002; Holper L, 2014, BRAIN RES, V1557, P141, DOI 10.1016/j.brainres.2014.02.013; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Ji GC, 2011, J NEUROPHYSIOL, V106, P2642, DOI 10.1152/jn.00461.2011; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2006, ANESTH ANALG, V103, P494, DOI 10.1213/01.ANE.0000227067.35946.A2; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Leslie K, 2010, ANESTH ANALG, V110, P823, DOI 10.1213/ANE.0b013e3181b8b6ca; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Maroun M, 2013, NEUROSCIENTIST, V19, P370, DOI 10.1177/1073858412464527; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1218, DOI 10.1097/ALN.0b013e31820fc9b6; Matos SC, 2015, J NEUROSCI, V35, P13244, DOI 10.1523/JNEUROSCI.0799-15.2015; Norgaard MW, 2013, PACE, V36, P203, DOI 10.1111/pace.12032; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ridderinkhof KR, 2007, COGN AFFECT BEHAV NE, V7, P261, DOI 10.3758/CABN.7.4.261; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosen SD, 2000, ANN MED, V32, P350, DOI 10.3109/07853890008995938; Sakuma S, 2014, NEUROSCI LETT, V575, P74, DOI 10.1016/j.neulet.2014.05.040; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schlunzen L, 2012, ACTA ANAESTH SCAND, V56, P248, DOI 10.1111/j.1399-6576.2011.02561.x; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Symonds LL, 2006, J NEUROPHYSIOL, V95, P3823, DOI 10.1152/jn.01162.2005; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Untergehrer G, 2013, ANESTHESIOLOGY, V118, P308, DOI 10.1097/ALN.0b013e318279fb21; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yucel MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09469	66	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158975	10.1371/journal.pone.0158975	http://dx.doi.org/10.1371/journal.pone.0158975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415436	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500056
J	Naegele, RP; Mitchell, J; Hausbeck, MK				Naegele, Rachel P.; Mitchell, Jenna; Hausbeck, Mary K.			Genetic Diversity, Population Structure, and Heritability of Fruit Traits in Capsicum annuum	PLOS ONE			English	Article							TOMATO; SHAPE; PEPPER; RESISTANCE; LOCI; QTL; INHERITANCE; COLLECTION; GERMPLASM; THICKNESS	Cultivated pepper (Capsicum annuum) is a phenotypically diverse species grown throughout the world. Wild and landrace peppers are typically small-fruited and pungent, but contain many important traits such as insect and disease resistance. Cultivated peppers vary dramatically in size, shape, pungency, and color, and often lack resistance traits. Fruit characteristics (e.g. shape and pericarp thickness) are major determinants for cultivar selection, and their association with disease susceptibility can reduce breeding efficacy. This study evaluated a diverse collection of peppers for mature fruit phenotypic traits, correlation among fruit traits and Phytophthora fruit rot resistance, genetic diversity, population structure, and trait broad sense heritability. Significant differences within all fruit phenotype categories were detected among pepper lines. Fruit from Europe had the thickest pericarp, and fruit from Ecuador had the thinnest. For fruit shape index, fruit from Africa had the highest index, while fruit from Europe had the lowest. Five genetic clusters were detected in the pepper population and were significantly associated with fruit thickness, end shape, and fruit shape index. The genetic differentiation between clusters ranged from little to very great differentiation when grouped by the predefined categories. Broad sense heritability for fruit traits ranged from 0.56 (shoulder height) to 0.98 (pericarp thickness). When correlations among fruit phenotypes and fruit disease were evaluated, fruit shape index was negatively correlated with pericarp thickness, and positively correlated with fruit perimeter. Pepper fruit pericarp, perimeter, and width had a slight positive correlation with Phytophthora fruit rot, whereas fruit shape index had a slight negative correlation.	[Naegele, Rachel P.] ARS, USDA, San Joaquin Valley Agr Sci Ctr, 9611 South Riverbend Ave, Parlier, CA USA; [Mitchell, Jenna; Hausbeck, Mary K.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	United States Department of Agriculture (USDA); Michigan State University	Hausbeck, MK (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	hausbec1@msu.edu			ARS [ARS-0425023] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Ashrafi H, 2009, GENOME, V52, P935, DOI [10.1139/G09-065, 10.1139/g09-065]; Ben Chaim A, 2003, GENOME, V46, P1, DOI [10.1139/g02-096, 10.1139/G02-096]; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Bharath SM, 2013, HORTSCIENCE, V48, P531, DOI 10.21273/HORTSCI.48.5.531; BILES CL, 1993, PHYTOPATHOLOGY, V83, P607, DOI 10.1094/Phyto-83-607; Brewer MT, 2007, J EXP BOT, V58, P1339, DOI 10.1093/jxb/erl301; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Cheng CH, 2014, EUPHYTICA, V198, P305, DOI 10.1007/s10681-014-1107-3; Dwivedi N, 2015, J PLANT BIOCHEM BIOT, V24, P154, DOI 10.1007/s13562-013-0247-1; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fehr W.R., 1987, PRINCIPLES CULTIVAR, V2; Haggard JE, 2013, G3-GENES GENOM GENET, V3, P2131, DOI 10.1534/g3.113.007195; Hurtado M, 2013, SCI HORTIC-AMSTERDAM, V164, P625, DOI 10.1016/j.scienta.2013.10.028; Gonzalo MJ, 2009, J AM SOC HORTIC SCI, V134, P77, DOI 10.21273/JASHS.134.1.77; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Knapp SJ., 1985, CROP SCI, V25, P192, DOI [10.2135/cropsci1985.0011183X002500010046x, DOI 10.2135/cropsci1985.0011183X002500010046x]; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Ku HM, 1999, THEOR APPL GENET, V99, P844, DOI 10.1007/s001220051304; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Naegele R, 2013, PHYTOPATHOLOGY; Naegele RP, 2015, PHYTOPATHOLOGY, V105, P110, DOI 10.1094/PHYTO-02-14-0031-R; Naegele RP, 2014, PLANT DIS, V98, P885, DOI 10.1094/PDIS-03-13-0295-RE; Naegele RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095930; Nicolai M, 2013, GENET RESOUR CROP EV, V60, P2375, DOI 10.1007/s10722-013-0006-0; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Vilarinho LBO, 2015, J AM SOC HORTIC SCI, V140, P597, DOI 10.21273/JASHS.140.6.597; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Pritchard JK, 2000, GENETICS, V155, P945; Qiao Jun, 2012, Acta Horticulturae Sinica, V39, P1115; Rao GU, 2003, THEOR APPL GENET, V106, P1457, DOI 10.1007/s00122-003-1204-5; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Rodriguez JM, 1999, THEOR APPL GENET, V99, P147, DOI 10.1007/s001220051219; Sage-Palloix AM, 2007, ANAL DIVERSITY PEPER; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; *USDA, NAT GEN RES PROGR; Wahyuni Y, 2013, METABOLOMICS, V9, P130, DOI 10.1007/s11306-012-0432-6; Xiao H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-49; Xue-jun C, 2012, XIBEI ZHIWU XUEBAO, V32, P246; Zhang ShuGen, 2008, Acta Horticulturae Sinica, V35, P515; Zygier S, 2005, THEOR APPL GENET, V111, P437, DOI 10.1007/s00122-005-2015-7	45	34	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0156969	10.1371/journal.pone.0156969	http://dx.doi.org/10.1371/journal.pone.0156969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415818	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500012
J	Vidal-Castineira, JR; Lopez-Vazquez, A; Diaz-Pena, R; Diaz-Bulnes, P; Martinez-Camblor, P; Coto, E; Coto-Segura, P; Bruges-Armas, J; Pinto, JA; Blanco, FJ; Sanchez, A; Mulero, J; Queiro, R; Lopez-Larrea, C				Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Diaz-Pena, Roberto; Diaz-Bulnes, Paula; Martinez-Camblor, Pablo; Coto, Eliecer; Coto-Segura, Pablo; Bruges-Armas, Jacome; Antonio Pinto, Jose; Jose Blanco, Francisco; Sanchez, Alejandra; Mulero, Juan; Queiro, Ruben; Lopez-Larrea, Carlos			A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; POPULATION; FAMILY; RISK; PSORIASIS; RS4819554; VARIANTS; ANTIGEN; COHORT	The aim of this study was to identify new genetic variants associated with the severity of ankylosing spondylitis (AS). We sequenced the exome of eight patients diagnosed with AS, selected on the basis of the severity of their clinical parameters. We identified 27 variants in exons and regulatory regions. The contribution of candidate variants found to AS severity was validated by genotyping two Spanish cohorts consisting of 180 cases/300 controls and 419 cases/656 controls. Relationships of SNPs and clinical variables with the Bath Ankylosing Spondylitis Disease Activity and Functional Indices BASDAI and BASFI were analyzed. BASFI was standardized by adjusting for the duration of the disease since the appearance of the first symptoms. Refining the analysis of SNPs in the two cohorts, we found that the rs4819554 minor allele G in the promoter of the IL17RA gene was associated with AS (p<0.005). This variant was also associated with the BASFI score. Classifying AS patients by the severity of their functional status with respect to BASFI/disease duration of the 60th, 65th, 70th and 75th percentiles, we found the association increased from p60 to p75 (cohort 1: p<0.05 to p<0.01; cohort 2: p<0.01 to p<0.005). Our findings indicate a genetic role for the IL17/ILRA axis in the development of severe forms of AS.	[Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Diaz-Pena, Roberto; Diaz-Bulnes, Paula; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Diaz-Pena, Roberto] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile; [Martinez-Camblor, Pablo] Hosp Univ Cent Asturias, Dept Stat, Oviedo, Spain; [Martinez-Camblor, Pablo] Univ Autonoma Chile, Fac Ciencias Educ, Santiago, Chile; [Coto, Eliecer] Hosp Univ Cent Asturias, Dept Mol Genet, Oviedo, Spain; [Coto-Segura, Pablo] Hosp Univ Cent Asturias, Dept Dermatol 2, Oviedo, Spain; [Bruges-Armas, Jacome] Univ Porto, Inst Mol & Cell Biol IBMC, Oporto, Portugal; [Antonio Pinto, Jose; Jose Blanco, Francisco] UDC, CHUAC, Inst Invest Biomed Coruna INIBIC, Rheumatol Serv, A Courna, Spain; [Sanchez, Alejandra; Mulero, Juan] Puerta Hierro Univ Hosp, Rheumatol Serv, Madrid, Spain; [Queiro, Ruben] Hosp Univ Cent Asturias, Rheumatol Serv, Oviedo, Spain; [Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain	Central University Hospital Asturias; Universidad Autonoma de Chile; Central University Hospital Asturias; Universidad Autonoma de Chile; Central University Hospital Asturias; Central University Hospital Asturias; Universidade do Porto; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Hospital Puerta de Hierro-Majadahonda; Central University Hospital Asturias	Lopez-Larrea, C (corresponding author), Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain.; Lopez-Larrea, C (corresponding author), Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain.	inmuno@hca.es	Díaz-Peña, Roberto/ABF-4396-2020; Blanco, Francisco J./C-3192-2014; Sánchez, Alejandra/G-7826-2012; Camblor, Pablo Martinez/Z-4834-2019; Queiro, Rubén/D-5358-2016; Díaz-Peña, Roberto/AAB-1205-2020; Silva, Rúben/GYE-3599-2022; Coto-Segura, Pablo/AAR-4593-2021; RG, SMABSS/N-3322-2018	Díaz-Peña, Roberto/0000-0002-0114-2292; Blanco, Francisco J./0000-0001-9821-7635; Sánchez, Alejandra/0000-0003-4620-6744; Camblor, Pablo Martinez/0000-0001-7845-3905; Queiro, Rubén/0000-0002-8418-7145; Lopez-Larrea, Carlos/0000-0001-9988-1730; Armas, Jacome/0000-0001-7671-6521; RG, SMABSS/0000-0001-9944-3861; Vidal-Castineira, Jose Ramon/0000-0003-4877-3566; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Spanish Fondo de Investigaciones Sanitarias-Fondos FEDER European Union del Plan Nacional de I+D+I, Spain [FIS PI12/0287]; Red de Investigacion Renal, Spain [REDinREN RD12/0021/0018, RD12/0021/0021]; PCTI from Principado de Asturias, Spain [GRUPIN 14-030]	Spanish Fondo de Investigaciones Sanitarias-Fondos FEDER European Union del Plan Nacional de I+D+I, Spain; Red de Investigacion Renal, Spain; PCTI from Principado de Asturias, Spain	This work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias-Fondos FEDER European Union (FIS PI12/0287) del Plan Nacional de I+D+I 2008-2011, Red de Investigacion Renal (REDinREN RD12/0021/0018 and RD12/0021/0021), and the PCTI 2013-2017 (GRUPIN 14-030) from the Principado de Asturias, Spain.	Bartolome N, 2012, RHEUMATOLOGY, V51, P1471, DOI 10.1093/rheumatology/kes056; Batalla A, 2015, J DERMATOL SCI, V80, P111, DOI 10.1016/j.jdermsci.2015.06.011; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Burton PR, 2007, NAT GENET, P39; CAFFREY MFP, 1973, NATURE, V242, P121, DOI 10.1038/242121a0; Catanoso MG, 2013, RHEUMATOL INT, V33, P1165, DOI 10.1007/s00296-012-2501-6; Ciccia F, 2015, ANN RHEUM DIS; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Coto E, 2015, HUM IMMUNOL, V76, P75, DOI 10.1016/j.humimm.2015.01.027; Diaz-Pena R, 2011, ARTHRITIS RHEUM-US, V63, P3305, DOI 10.1002/art.30555; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Khan Muhammad Asim, 2010, Curr Rheumatol Rep, V12, P337, DOI 10.1007/s11926-010-0126-x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lew BL, 2012, ANN DERMATOL, V24, P61, DOI 10.5021/ad.2012.24.1.61; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Lubberts Erik, 2003, Curr Opin Investig Drugs, V4, P572; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Omrane I, 2014, IMMUNOL LETT, V158, P189, DOI 10.1016/j.imlet.2014.01.002; Pedersen SJ, 2011, ANN RHEUM DIS, V70, P1375, DOI 10.1136/ard.2010.138883; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Schiotis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043428; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Sveaas SH, 2015, SCAND J RHEUMATOL, V44, P118, DOI 10.3109/03009742.2014.956142; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wong LY, 2013, J BIOL CHEM, V288, P35170, DOI 10.1074/jbc.M113.481440; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158905	10.1371/journal.pone.0158905	http://dx.doi.org/10.1371/journal.pone.0158905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415816	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500048
J	Oroz, J; Barrera-Vilarmau, S; Alfonso, C; Rivas, G; de Alba, E				Oroz, Javier; Barrera-Vilarmau, Susana; Alfonso, Carlos; Rivas, German; de Alba, Eva			ASC Pyrin Domain Self-associates and Binds NLRP3 Protein Using Equivalent Binding Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; inflammasome; inflammation; NLRP3; nuclear magnetic resonance (NMR); ASC; pyrin	CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; PROVIDES INSIGHTS; NMR-SPECTROSCOPY; INFLAMMASOME; DEATH; APOPTOSIS; MECHANISM; REVEALS; COMPLEX	Death domain superfamily members typically act as adaptors mediating in the assembly of supramolecular complexes with critical apoptosis and inflammation functions. These modular proteins consist of death domains, death effector domains, caspase recruitment domains, and pyrin domains (PYD). Despite the high structural similarity among them, only homotypic interactions participate in complex formation, suggesting that subtle factors differentiate each interaction type. It is thus critical to identify these factors as an essential step toward the understanding of the molecular basis of apoptosis and inflammation. The proteins apoptosis-associated speck-like protein containing a CARD (ASC) and NLRP3 play key roles in the regulation of apoptosis and inflammation through self-association and protein-protein interactions mediated by their PYDs. To better understand the molecular basis of their function, we have characterized ASC and NLRP3 PYD self-association and their intermolecular interaction by solution NMR spectroscopy and analytical ultracentrifugation. We found that ASC self-associates and binds NLRP3 PYD through equivalent protein regions, with higher binding affinity for the latter. These regions are located at opposite sides of the protein allowing multimeric complex formation previously shown in ASC PYD fibril assemblies. We show that NLRP3 PYD coexists in solution as a monomer and highly populated large-order oligomerized species. Despite this, we determined its monomeric three-dimensional solution structure by NMR and characterized its binding to ASC PYD. Using our novel structural data, we propose molecular models of ASCASC and ASCNLRP3 PYD early supramolecular complexes, providing new insights into the molecular mechanisms of inflammasome and apoptosis signaling.	[Oroz, Javier; Barrera-Vilarmau, Susana] CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Ramiro de Maeztu 9, Madrid 28040, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Ramiro de Maeztu 9, Madrid 28040, Spain; [de Alba, Eva] CSIC, Ctr Nacl Biotecnol, Madrid 28040, Spain; [Oroz, Javier] Max Planck Inst Biophys Chem, German Ctr Neurodegenerat Dis DZNE, Fassberg 11, D-37077 Gottingen, Germany; [de Alba, Eva] Univ Calif Merced, Hlth Sci Res Inst, 5200 North Lake Rd, Merced, CA 95343 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of California System; University of California Merced	Oroz, J (corresponding author), Max Planck Inst Biophys Chem, German Ctr Neurodegenerat Dis DZNE, Fassberg 11, D-37077 Gottingen, Germany.; de Alba, E (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, 5200 North Lake Rd, Merced, CA 95343 USA.	jaor@nmr.mpibpc.mpg.de; edealbabastarrechea@ucmerced.edu	Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Alfonso, Carlos/K-1316-2014; Oroz, Javier/J-3297-2015; Barrera-Vilarmau, Susana/ABD-1039-2020	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Oroz, Javier/0000-0003-2687-3013; Barrera-Vilarmau, Susana/0000-0003-4868-6593	Spanish Ministry of Science and Innovation Plan Nacional I+D+i Program [BFU2008-03278, BFU2011-23797]; Programa Ingenio-CONSOLIDER Grant [CSD2009-00088]; Marie Curie Intra-European Fellowship Project [626526]	Spanish Ministry of Science and Innovation Plan Nacional I+D+i Program(Ministry of Science and Innovation, Spain (MICINN)); Programa Ingenio-CONSOLIDER Grant; Marie Curie Intra-European Fellowship Project(European Commission)	This work was supported in part by Spanish Ministry of Science and Innovation Plan Nacional I+D+i Program, Grants BFU2008-03278 and BFU2011-23797, and Programa Ingenio-2010-CONSOLIDER Grant CSD2009-00088 (to E. dA.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Marie Curie Intra-European Fellowship Project 626526. To whom correspondence may be addressed: German Center for Neurodegenerative Diseases (DZNE) %Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, Gottingen-37077, Germany. E-mail: jaor@nmr.mpibpc.mpg.de.	Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHATELIER RC, 1987, BIOPOLYMERS, V26, P507, DOI 10.1002/bip.360260405; Chu LH, 2015, APOPTOSIS, V20, P157, DOI 10.1007/s10495-014-1065-1; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cook GP, 2010, EUR J IMMUNOL, V40, P631, DOI 10.1002/eji.200940162; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Alba E., 2014, INFLAMMASOME, V1, P44; de Alba E, 2007, BIOMOL NMR ASSIGM, V1, P135, DOI 10.1007/s12104-007-9036-x; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goddard TD, 2004, SPARKY; Halff EF, 2012, J BIOL CHEM, V287, P38460, DOI 10.1074/jbc.M112.393512; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hull KM, 2003, CURR OPIN RHEUMATOL, V15, P61, DOI 10.1097/00002281-200301000-00011; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubota T, 2010, MOD RHEUMATOL, V20, P213, DOI 10.1007/s10165-009-0271-0; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Muramatsu N, 1989, J Mol Recognit, V1, P166, DOI 10.1002/jmr.300010404; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2012, APOPTOSIS, V17, P1247, DOI 10.1007/s10495-012-0775-5; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sborgi L, 2015, P NATL ACAD SCI USA, V112, P13237, DOI 10.1073/pnas.1507579112; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Su MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067843; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Touitou I, 2004, HUM MUTAT, V24, P194, DOI 10.1002/humu.20080; Vajjhala PR, 2014, J BIOL CHEM, V289, P23504, DOI 10.1074/jbc.M114.553305; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; van Holde K. E., 1986, PHYSICAL BIOCH, P110; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024	73	46	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19487	19501		10.1074/jbc.M116.741082	http://dx.doi.org/10.1074/jbc.M116.741082			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27432880	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000383242800026
J	Zhu, XQ; Dahlmans, V; Thali, R; Preisinger, C; Viollet, B; Voncken, JW; Neumann, D				Zhu, Xiaoqing; Dahlmans, Vivian; Thali, Ramon; Preisinger, Christian; Viollet, Benoit; Voncken, J. Willem; Neumann, Dietbert			AMP-activated Protein Kinase Up-regulates Mitogen-activated Protein (MAP) Kinase-interacting Serine/Threonine Kinase 1a-dependent Phosphorylation of Eukaryotic Translation Initiation Factor 4E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); eukaryotic translation initiation factor 4E (eIF4E); mitogen-activated protein kinase (MAPK); post-translational modification (PTM); protein phosphorylation; translation; MAP kinase-interacting serine; threonine protein kinase 1a (MNK1a)	CELL-GROWTH; CANCER; IDENTIFICATION; EIF4E; MNK1; COMPLEX; SUBSTRATE; PATHWAYS; VECTORS; TARGETS	AMP-activated protein kinase (AMPK) is a molecular energy sensor that acts to sustain cellular energy balance. Although AMPK is implicated in the regulation of a multitude of ATP-dependent cellular processes, exactly how these processes are controlled by AMPK as well as the identity of AMPK targets and pathways continues to evolve. Here we identify MAP kinase-interacting serine/threonine protein kinase 1a (MNK1a) as a novel AMPK target. Specifically, we show AMPK-dependent Ser(353) phosphorylation of the human MNK1a isoform in cell-free and cellular systems. We show that AMPK and MNK1a physically interact and that in vivo MNK1a-Ser(353) phosphorylation requires T-loop phosphorylation, in good agreement with a recently proposed structural regulatory model of MNK1a. Our data suggest a physiological role for MNK1a-Ser(353) phosphorylation in regulation of the MNK1a kinase, which correlates with increased eIF4E phosphorylation in vitro and in vivo.	[Zhu, Xiaoqing; Neumann, Dietbert] Maastricht Univ, Med Ctr, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Dahlmans, Vivian; Voncken, J. Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Thali, Ramon; Neumann, Dietbert] Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Preisinger, Christian] RWTH Univ Hosp Aachen, Interdisciplinary Ctr Clin Res IZKF, Prote Facil, D-52074 Aachen, Germany; [Viollet, Benoit] Inst Cochin, Dept Endocrinol Metab & Diabet, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit] CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France	Maastricht University; Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; RWTH Aachen University; RWTH Aachen University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Neumann, D (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	d.neumann@maastrichtuniversity.nl	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Neumann, Dietbert/0000-0002-4316-684X	IZKF Aachen	IZKF Aachen	We thank R. Stead (Southampton, UK) and members of the Molecular Genetics Department (Maastricht University) for helpful comments and support. The Proteomics Facility is funded by the IZKF Aachen.	Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dasgupta B, 2016, TRENDS PHARMACOL SCI, V37, P192, DOI 10.1016/j.tips.2015.11.007; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goto S, 2009, BIOCHEM J, V423, P279, DOI 10.1042/BJ20090228; Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hou JQ, 2012, ONCOTARGET, V3, P118; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Joshi Sonali, 2014, World J Biol Chem, V5, P321, DOI 10.4331/wjbc.v5.i3.321; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Klaus A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062497; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Li WD, 2015, ONCOTARGET, V6, P7365, DOI 10.18632/oncotarget.3629; Lu CW, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2015.20; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mok J, 2009, NAT PROTOC, V4, P1820, DOI 10.1038/nprot.2009.194; Moreno D, 2009, INT J BIOCHEM CELL B, V41, P2431, DOI 10.1016/j.biocel.2009.07.002; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Oligschlaeger Y, 2015, J BIOL CHEM, V290, P11715, DOI 10.1074/jbc.M114.633271; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Siddiqui N, 2015, BIOCHEM SOC T, V43, P763, DOI 10.1042/BST20150126; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thali R. F., 2010, THESIS, P84; Thali RF, 2010, BIOCHEM BIOPH RES CO, V398, P296, DOI 10.1016/j.bbrc.2010.06.084; Tuerk RD, 2007, J PROTEOME RES, V6, P3266, DOI 10.1021/pr070160a; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Viollet B, 2014, CHEM BIOL, V21, P567, DOI 10.1016/j.chembiol.2014.05.003; von Kriegsheim A, 2008, METHODS MOL BIOL, V484, P177, DOI 10.1007/978-1-59745-398-1_12; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200	43	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17020	17027		10.1074/jbc.C116.740498	http://dx.doi.org/10.1074/jbc.C116.740498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27413184	hybrid, Green Published			2022-12-26	WOS:000382643800009
J	Blumenthal, KG; Shenoy, ES; Huang, MS; Kuhlen, JL; Ware, WA; Parker, RA; Walensky, RP				Blumenthal, Kimberly G.; Shenoy, Erica S.; Huang, Mingshu; Kuhlen, James L.; Ware, Winston A.; Parker, Robert A.; Walensky, Rochelle P.			The Impact of Reporting a Prior Penicillin Allergy on the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							INFECTIOUS-DISEASE CONSULTATION; QUALITY-OF-CARE; ANTIMICROBIAL THERAPY; CLINICAL MANAGEMENT; DRUG ALLERGY; BETA-LACTAMS; CEPHALOSPORINS; OUTCOMES; GUIDELINE; HISTORY	Background Methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia is a morbid infection with mortality benefit from receipt of parenteral beta-lactam therapy. A substantial portion of MSSA bacteremia patients report penicillin allergy, but infrequently have true allergy. Objective To determine the frequency and predictors of optimal and adequate therapy in patients with MSSA bacteremia. Design Retrospective cohort. Participants Adult inpatients with MSSA bacteremia, January 2009 through October 2013. Main Measures The primary measure was a trial of optimal therapy (OT), defined as >= 3 inpatient days or discharge on any first-line agents (nafcillin, oxacillin, cefazolin, or penicillin G, if susceptible). The secondary measure was completion of adequate therapy (AT), defined as >= 10 inpatient days or discharge on an agent appropriate for MSSA bacteremia. Data were electronically gathered with key variables manually validated through chart review. Logbinomial regression models were used to determine the frequency and predictors of outcomes. Key Results Of 456 patients, 346 (76%) received a trial of OT. Patients reporting penicillin allergy (13%) were less likely to receive OT trial than those without penicillin allergy (47% vs. 80%, p<0.001). Adjusting for other factors, penicillin allergy was the largest negative predictor of OT trial (RR 0.64 [0.49, 0.83]). Infectious Disease (ID) consultation was the largest positive predictor of OT trial across all patients (RR 1.34 [1.14, 1.57]). Allergy/Immunology consultation was the single most important predictor of OT trial among patients reporting penicillin allergy (RR 2.33 [1.44, 3.77]). Of 440 patients, 391 (89%) completed AT, with ID consultation the largest positive predictor of the outcome (RR 1.28 [1.15, 1.43]). Conclusions Nearly 25% of patients with MSSA bacteremia did not receive OT trial and about 10% did not receive AT completion. Reported penicillin allergy reduced, and ID consult increased, the likelihood of OT. Allergy evaluation, coupled with ID consultation, may improve outcomes in MSSA bacteremic patients.	[Blumenthal, Kimberly G.] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Blumenthal, Kimberly G.; Shenoy, Erica S.; Huang, Mingshu; Parker, Robert A.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Blumenthal, Kimberly G.; Shenoy, Erica S.; Parker, Robert A.; Walensky, Rochelle P.] Harvard Med Sch, Boston, MA 02115 USA; [Blumenthal, Kimberly G.; Ware, Winston A.] Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA; [Shenoy, Erica S.; Walensky, Rochelle P.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Shenoy, Erica S.] Massachusetts Gen Hosp, Infect Control Unit, Boston, MA 02114 USA; [Huang, Mingshu; Parker, Robert A.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Kuhlen, James L.] Univ South Carolina, Sch Med, Dept Med, Acadia Allergy & Immunol, Greenville, SC USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.; Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Blumenthal, KG (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Edward P Lawrence Ctr Qual & Safety, Boston, MA 02114 USA.	kblumenthal1@partners.org	Shenoy, Erica/AAD-7521-2021; Blumenthal, Kimberly/AAG-8290-2019	Blumenthal, Kimberly/0000-0003-4773-9817	National Institutes of Health [T32 HL116275]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health T32 HL116275 and the Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	American Academy Of Allergy Asthma and Immunology, 2015, FIND ALL IMM; [Anonymous], 2012, RED BOOK REPORT COMM; Arroliga ME, 2000, CHEST, V118, P1106, DOI 10.1378/chest.118.4.1106; Baddour LM, 2015, CIRCULATION, V132, P1435, DOI 10.1161/CIR.0000000000000296; Bai AD, 2015, CLIN INFECT DIS, V60, P1451, DOI 10.1093/cid/civ120; Banks TA, 2015, ANN ALLERG ASTHMA IM, V115, P451, DOI 10.1016/j.anai.2015.08.008; Barr DA, 2012, INT J ANTIMICROB AG, V39, P407, DOI 10.1016/j.ijantimicag.2012.01.016; Blumenthal KG, 2015, ANN ALLERG ASTHMA IM, V115, P294, DOI 10.1016/j.anai.2015.05.011; Blumenthal KG, 2015, CLIN INFECT DIS, V61, P741, DOI 10.1093/cid/civ394; Blumenthal KG, 2014, J ALLER CL IMM-PRACT, V2, P407, DOI 10.1016/j.jaip.2014.02.003; Bourke J, 2015, J ALLER CL IMM-PRACT, V3, P365, DOI 10.1016/j.jaip.2014.11.002; Chan KE, 2012, J AM SOC NEPHROL, V23, P1551, DOI 10.1681/ASN.2012010050; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Chapman ALN, 2009, J ANTIMICROB CHEMOTH, V64, P1316, DOI 10.1093/jac/dkp343; Cox AM, 2007, J AM GERIATR SOC, V55, P645, DOI 10.1111/j.1532-5415.2007.01133.x; Daulat S, 2004, J ALLERGY CLIN IMMUN, V113, P1220, DOI 10.1016/j.jaci.2004.03.023; David MZ, 2014, CLIN INFECT DIS, V59, P798, DOI 10.1093/cid/ciu410; Davis L., 2013, E COMMUNICATION; del Real GA, 2007, ANN ALLERG ASTHMA IM, V98, P355, DOI 10.1016/S1081-1206(10)60882-4; Dodek P, 1999, CLIN INFECT DIS, V29, P1251, DOI 10.1086/313435; Forrest DM, 2001, CLIN INFECT DIS, V32, P1685, DOI 10.1086/320752; Fowler VG, 2013, UPTODATE; Gonzalez C, 1999, CLIN INFECT DIS, V29, P1171, DOI 10.1086/313440; Goodman EJ, 2001, J CLIN ANESTH, V13, P561, DOI 10.1016/S0952-8180(01)00329-4; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; Lee CE, 2000, ARCH INTERN MED, V160, P2819, DOI 10.1001/archinte.160.18.2819; Lee S, 2011, ANTIMICROB AGENTS CH, V55, P5122, DOI 10.1128/AAC.00485-11; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lopez-Cortes LE, 2013, CLIN INFECT DIS, V57, P1225, DOI 10.1093/cid/cit499; Macy E, 2015, J ALLERGY CLIN IMMUN, V135, P745, DOI 10.1016/j.jaci.2014.07.062; Macy E, 2013, J ALLER CL IMM-PRACT, V1, P258, DOI 10.1016/j.jaip.2013.02.002; McDanel JS, 2015, CLIN INFECT DIS, V61, P361, DOI 10.1093/cid/civ308; Naidoo R, 1922, PLOS ONE, V22; Paladino JA, 2010, CLIN INFECT DIS, V51, pS198, DOI 10.1086/653520; Pichichero ME, 2005, PEDIATRICS, V115, P1048, DOI 10.1542/peds.2004-1276; Pichichero ME, 2007, DIAGN MICR INFEC DIS, V57, p13S, DOI 10.1016/j.diagmicrobio.2006.12.004; Pichichero ME, 2006, J FAM PRACTICE, V55, P106; Prematta T, 2012, ALLERGY ASTHMA PROC, V33, P145, DOI 10.2500/aap.2012.33.3526; Raja AS, 2009, ANN EMERG MED, V54, P72, DOI 10.1016/j.annemergmed.2008.12.034; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Ressner RA, 2016, CLIN INFECT DIS, V62, P400, DOI 10.1093/cid/civ886; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Rimawi RH, 2013, J HOSP MED, V8, P341, DOI 10.1002/jhm.2036; Saunderson RB, 2015, CLIN MICROBIOL INFEC, V21, P779, DOI 10.1016/j.cmi.2015.05.026; Schweizer ML, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-279; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386; Tom S, 2014, CLIN MICROBIOL INFEC, V20, pO630, DOI 10.1111/1469-0691.12564; WICKERN GM, 1994, J ALLERGY CLIN IMMUN, V94, P725, DOI 10.1016/0091-6749(94)90180-5	52	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159406	10.1371/journal.pone.0159406	http://dx.doi.org/10.1371/journal.pone.0159406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438379	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100042
J	Fengler, S; Kessler, J; Timmermann, L; Zapf, A; Elben, S; Wojtecki, L; Tucha, O; Kalbe, E				Fengler, Sophie; Kessler, Josef; Timmermann, Lars; Zapf, Alexandra; Elben, Saskia; Wojtecki, Lars; Tucha, Oliver; Kalbe, Elke			Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting	PLOS ONE			English	Article							MINI-MENTAL-STATE; QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; VISUAL DYSFUNCTION; DEMENTIA; INSTRUMENTS; DEPRESSION; POPULATION; DISABILITY; DEFICITS	Background Given the high prevalence of cognitive impairment in Parkinson's disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson's disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. Methods In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the sub-tests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. Results Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. Conclusion This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA's actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system.	[Fengler, Sophie; Zapf, Alexandra; Kalbe, Elke] Univ Hosp Cologne, Dept Med Psychol Neuropsychol & Gender Studies, Cologne, Germany; [Fengler, Sophie; Kalbe, Elke] Univ Vechta, Inst Gerontol, Vechta, Germany; [Fengler, Sophie; Kalbe, Elke] Univ Vechta, Ctr Neuropsychol Diagnost & Intervent CeNDI, Vechta, Germany; [Kessler, Josef; Timmermann, Lars] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Elben, Saskia; Wojtecki, Lars] Univ Hosp Dusseldorf, Ctr Movement Disorders & Neuromodulat, Dept Neurol, Dusseldorf, Germany; [Tucha, Oliver] Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Groningen	Kalbe, E (corresponding author), Univ Hosp Cologne, Dept Med Psychol Neuropsychol & Gender Studies, Cologne, Germany.; Kalbe, E (corresponding author), Univ Vechta, Inst Gerontol, Vechta, Germany.; Kalbe, E (corresponding author), Univ Vechta, Ctr Neuropsychol Diagnost & Intervent CeNDI, Vechta, Germany.	Elke.Kalbe@uk-koeln.de	Wojtecki, Lars/AAT-6604-2021; Tucha, Oliver/AAD-1403-2019	Wojtecki, Lars/0000-0002-6205-4405; Timmermann, Lars/0000-0002-5301-3580	German Ministry for Education and Research (BMBF; Bundesministerium fur Bildung und Forschung; LANDSCAPE study project) [01GI1008c]	German Ministry for Education and Research (BMBF; Bundesministerium fur Bildung und Forschung; LANDSCAPE study project)(Federal Ministry of Education & Research (BMBF))	This study was in part supported by the German Ministry for Education and Research (BMBF; Bundesministerium fur Bildung und Forschung; LANDSCAPE study project-nr: 01GI1008c).	Aarsland D, 2004, ARCH NEUROL-CHICAGO, V61, P1906, DOI 10.1001/archneur.61.12.1906; Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; Botha H, 2012, PARKINSONISM RELAT D, V18, P742, DOI 10.1016/j.parkreldis.2012.03.004; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Caviness JN, 2007, MOVEMENT DISORD, V22, P1272, DOI 10.1002/mds.21453; Cecato JF, 2015, INT PSYCHOGERIATR, V1, P1; Chou KL, 2010, MOVEMENT DISORD, V25, P2501, DOI 10.1002/mds.23362; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; De Lau LM, 2009, PARKINSONISM RELAT D, V20, P613; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galtier I, 2009, PSICOTHEMA, V21, P21; Harting C, 2000, WECHSLER MEMORY SCAL; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Hindle JV, 2013, MOVEMENT DISORD, V28, P1034, DOI 10.1002/mds.25377; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Kalbe E, 2005, J CLIN EXP NEUROPSYC, V27, P779, DOI 10.1080/13803390490918273; Kalbe E, 2013, J ALZHEIMERS DIS, V34, P813, DOI 10.3233/JAD-122128; Kessler J., 2000, MINI MENTAL STATUS T; Koski L, 2011, INT PSYCHOGERIATR, V23, P1107, DOI 10.1017/S1041610210002450; Koski L, 2009, J GERIATR PSYCH NEUR, V22, P151, DOI 10.1177/0891988709332944; Larner AJ, 2012, INT PSYCHOGERIATR, V24, P391, DOI 10.1017/S1041610211001839; Leroi I, 2012, J GERIATR PSYCH NEUR, V25, P208, DOI 10.1177/0891988712464823; Lessig S, 2012, MOVEMENT DISORD, V27, P1125, DOI 10.1002/mds.25070; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; Markwick A, 2012, J CLIN EXP NEUROPSYC, V34, P750, DOI 10.1080/13803395.2012.672966; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Ohta K, 2014, DEMENT GER COGN D EX, V4, P147, DOI 10.1159/000362124; Pagonabarraga J, 2012, NEUROBIOL DIS, V46, P590, DOI 10.1016/j.nbd.2012.03.029; Pedersen KF, 2013, JAMA NEUROL, V70, P580, DOI 10.1001/jamaneurol.2013.2110; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Riedel O, 2010, J GERIATR PSYCH NEUR, V23, P27, DOI 10.1177/0891988709351833; Shah A, 1997, AGE AGEING, V26, P217, DOI 10.1093/ageing/26.3.217; Sollberger M, 2007, DIAGNOSTIC MANUAL FO; Sturm W., 1993, LEISTUNGSPRUFSYSTEM; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uc EY, 2005, NEUROLOGY, V65, P1907, DOI 10.1212/01.wnl.0000191565.11065.11; Velseboer DC, 2013, NEUROLOGY, V80, P627, DOI 10.1212/WNL.0b013e318281cc99; Waldron-Perrine B, 2012, INT J GERIATR PSYCH, V27, P1189, DOI 10.1002/gps.3768; Weintraub D, 2006, AM J GERIAT PSYCHIAT, V14, P169, DOI 10.1097/01.JGP.0000192488.66049.4b; Weintraub Daniel, 2004, Cogn Behav Neurol, V17, P195; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Whittington CJ, 2006, J CLIN EXP NEUROPSYC, V28, P738, DOI 10.1080/13803390590954236; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zgaljardic DJ, 2006, J CLIN EXP NEUROPSYC, V28, P1127, DOI 10.1080/13803390500246910	57	23	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159318	10.1371/journal.pone.0159318	http://dx.doi.org/10.1371/journal.pone.0159318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437705	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100035
J	Xia, F; Li, XY; Li, XZ; Zheng, DS; Sun, QX; Liu, J; Li, YX; Hua, JP; Qi, BX				Xia, Fei; Li, Xueying; Li, Xinzheng; Zheng, Desong; Sun, Quanxi; Liu, Jiang; Li, Yaxiao; Hua, Jinping; Qi, Baoxiu			Elevation of the Yields of Very Long Chain Polyunsaturated Fatty Acids via Minimal Codon Optimization of Two Key Biosynthetic Enzymes	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; ESCHERICHIA-COLI; PICHIA-PASTORIS; ARABIDOPSIS-THALIANA; TRANSGENIC OILSEEDS; ISOCHRYSIS-GALBANA; GENE; USAGE; PLANTS; TRANSFORMATION	Eicosapentaenoic acid (EPA, 20:5 Delta(5,8,11,14,17)) and Docosahexaenoic acid (DHA, 22:6 Delta(4,7,10,13,16,19)) are nutritionally beneficial to human health. Transgenic production of EPA and DHA in oilseed crops by transferring genes originating from lower eukaryotes, such as microalgae and fungi, has been attempted in recent years. However, the low yield of EPA and DHA produced in these transgenic crops is a major hurdle for the commercialization of these transgenics. Many factors can negatively affect transgene expression, leading to a low level of converted fatty acid products. Among these the codon bias between the transgene donor and the host crop is one of the major contributing factors. Therefore, we carried out codon optimization of a fatty acid delta-6 desaturase gene PinD6 from the fungus Phytophthora infestans, and a delta-9 elongase gene, IgASE1 from the microalga Isochrysis galbana for expression in Saccharomyces cerevisiae and Arabidopsis respectively. These are the two key genes encoding enzymes for driving the first catalytic steps in the Delta 6 desaturation/Delta 6 elongation and the Delta 9 elongation/Delta 8 desaturation pathways for EPA/DHA biosynthesis. Hence expression levels of these two genes are important in determining the final yield of EPA/DHA. Via PCR-based mutagenesis we optimized the least preferred codons within the first 16 codons at their N-termini, as well as the most biased CGC codons (coding for arginine) within the entire sequences of both genes. An expression study showed that transgenic Arabidopsis plants harbouring the codon-optimized IgASE1 contained 64% more elongated fatty acid products than plants expressing the native IgASE1 sequence, whilst Saccharomyces cerevisiae expressing the codon optimized PinD6 yielded 20 times more desaturated products than yeast expressing wild-type (WT) PinD6. Thus the codon optimization strategy we developed here offers a simple, effective and low-cost alternative to whole gene synthesis for high expression of foreign genes in yeast and Arabidopsis.	[Xia, Fei; Li, Xueying; Li, Xinzheng; Zheng, Desong; Sun, Quanxi; Liu, Jiang; Li, Yaxiao; Qi, Baoxiu] Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271000, Shandong, Peoples R China; [Hua, Jinping] China Agr Univ, Dept Plant Genet & Breeding, Coll Agron & Biotechnol, 2 Yuanmingyuan West Rd, Beijing 100193, Peoples R China	Shandong Agricultural University; China Agricultural University	Qi, BX (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271000, Shandong, Peoples R China.	bssbq@bath.ac.uk	Hua, Jinping/L-3221-2019	Qi, Baoxiu/0000-0002-9425-935X	National Natural Science Foundation of China [30970222]; genetically modified organisms breeding major projects of China [009ZX08005-024B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); genetically modified organisms breeding major projects of China	This work was supported to BQ by the National Natural Science Foundation of China (Grant No. 30970222) and genetically modified organisms breeding major projects of China (Grant No. 009ZX08005-024B).; This work was supported by the National Natural Science Foundation of China (Grant No. 30970222 to BQ) and Genetically Modified Organisms Breeding Major Projects of China Grant No. 009ZX08005-024B to BQ). We thank Dr. James Doughty, University of Bath, for assisting with editing the manuscript.	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; CHEN GFT, 1994, GENE DEV, V8, P2641, DOI 10.1101/gad.8.21.2641; Cheng BF, 2010, TRANSGENIC RES, V19, P221, DOI 10.1007/s11248-009-9302-z; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng TL, 1997, FEBS LETT, V409, P269, DOI 10.1016/S0014-5793(97)00522-X; Domergue F, 2005, TRENDS PLANT SCI, V10, P112, DOI 10.1016/j.tplants.2005.01.003; Eiamsa-ard P, 2013, APPL MICROBIOL BIOT, V97, P3485, DOI 10.1007/s00253-012-4556-4; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fraser TCM, 2004, PLANT PHYSIOL, V135, P859, DOI 10.1104/pp.104.038984; Frelin L, 2004, GENE THER, V11, P522, DOI 10.1038/sj.gt.3302184; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu SY, 2006, PROTEIN EXPRES PURIF, V47, P249, DOI 10.1016/j.pep.2005.11.014; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; Johansson AS, 1999, PROTEIN EXPRES PURIF, V17, P105, DOI 10.1006/prep.1999.1117; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kim MS, 2013, J SCI FOOD AGR, V93, P2683, DOI 10.1002/jsfa.6084; Kim S, 2006, PROTEIN EXPRES PURIF, V50, P49, DOI 10.1016/j.pep.2006.07.014; KINK JA, 1991, J PROTOZOOL, V38, P441, DOI 10.1111/j.1550-7408.1991.tb04814.x; Laguia-Becher M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-52; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Mirzahoseini H, 2011, YAKHTEH, V12, P453; Olivares-Trejo JJ, 2003, MOL MICROBIOL, V49, P1043, DOI 10.1046/j.1365-2958.2003.03611.x; Outchkourov NS, 2002, PROTEIN EXPRES PURIF, V24, P18, DOI 10.1006/prep.2001.1523; Petrie JR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035214, 10.1371/journal.pone.0049165]; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Qi BX, 2003, FEBS LETT, V547, P137, DOI 10.1016/S0014-5793(03)00676-8; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Ruiz-Lopez N, 2012, TRANSGENIC RES, V21, P1233, DOI 10.1007/s11248-012-9596-0; Sayanova OV, 2004, PHYTOCHEMISTRY, V65, P147, DOI 10.1016/j.phytochem.2003.10.017; Simopoulos AP, 2004, WORLD REV NUTR DIET, V93, P1; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Stenoien HK, 2005, HEREDITY, V94, P87, DOI 10.1038/sj.hdy.6800547; Sun QX, 2013, PLANT MOL BIOL, V83, P391, DOI 10.1007/s11103-013-0096-2; Sun QX, 2013, APPL MICROBIOL BIOT, V97, P7689, DOI 10.1007/s00253-012-4613-z; Teng D, 2007, APPL MICROBIOL BIOT, V74, P1074, DOI 10.1007/s00253-006-0765-z; Thangadurai C, 2008, BIOCHEM BIOPH RES CO, V376, P647, DOI 10.1016/j.bbrc.2008.09.024; Trautwein EA, 2001, EUR J LIPID SCI TECH, V103, P45, DOI 10.1002/1438-9312(200101)103:1<45::AID-EJLT45>3.0.CO;2-9; Truksa M, 2006, TRANSGENIC RES, V15, P131, DOI 10.1007/s11248-005-6069-8; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003	53	4	5	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158103	10.1371/journal.pone.0158103	http://dx.doi.org/10.1371/journal.pone.0158103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433934	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000380169600006
J	Zhang, Z; Zhao, YJ; Meng, XG; Zhao, D; Zhang, D; Wang, L; Liu, CL				Zhang, Zhe; Zhao, Yanjie; Meng, Xianggao; Zhao, Dan; Zhang, Dan; Wang, Li; Liu, Changlin			A Simple Zn2+ Complex-Based Composite System for Efficient Gene Delivery	PLOS ONE			English	Article							DNA CONDENSATION; SIRNA DELIVERY; ACID; NANOPARTICLES; LIPOPLEXES; NUCLEATION; CURVATURE; EFFICACY; SEQUENCE; BINDING	Metal complexes might become a new type of promising gene delivery systems because of their low cytotoxicity, structural diversity, controllable aqua-and lipo-solubility, and appropriate density and distribution of positive charges. In this study, Zn2+ complexes (1-10) formed with a series of ligands contained benzimidazole(bzim) were prepared and characterized. They were observed to have different affinities for DNA, dependent on their numbers of positive charges, bzim groups, and coordination structures around Zn2+. The binding induced DNA to condensate into spherical nanoparticles with similar to 50 nm in diameter. The cell transfection efficiency of the DNA nanoparticles was poor, although they were low toxic. The sequential addition of the cell-penetrating peptide (CPP) TAT(48-60) and polyethylene glycol (PEG) resulted in the large DNA condensates (similar to 100 nm in diameter) and the increased cellular uptake. The clathrin-mediated endocytosis was found to be a key cellular uptake pathway of the nanoparticles formed with or without TAT(48-60) or/and PEG. The DNA nanoparticles with TAT(48-60) and PEG was found to have the cell transfection efficiency up to 20% of the commercial carrier Lipofect. These results indicated that a simple Zn2+-bzim complex-based composite system can be developed for efficient and low toxic gene delivery through the combination with PEG and CPPs such as TAT.	[Wang, Li; Liu, Changlin] Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan 430079, Peoples R China; Cent China Normal Univ, Sch Chem, Wuhan 430079, Peoples R China	Central China Normal University; Central China Normal University	Wang, L; Liu, CL (corresponding author), Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan 430079, Peoples R China.	wl_928@mail.ccnu.edu.cn; liuchl@mail.ccnu.edu.cn		meng, xiangguang/0000-0003-4131-296X	NSFC [21271079, 21001047, 21072074]; CCNU from the colleges' basic research and operation of MOE [CCNU14A05004, CCNU14A05012, CCNU14KFY003]	NSFC(National Natural Science Foundation of China (NSFC)); CCNU from the colleges' basic research and operation of MOE(Ministry of Education, Singapore)	This study is supported by NSFC (No. 21271079, 21001047, and 21072074) and by self-determined research funds of CCNU from the colleges' basic research and operation of MOE (No. CCNU14A05004, CCNU14A05012 and CCNU14KFY003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NL, 2005, J AM CHEM SOC, V127, P11576, DOI 10.1021/ja054038t; ALLISON SA, 1981, BIOPOLYMERS, V20, P469, DOI 10.1002/bip.1981.360200305; Aytar BS, 2013, J AM CHEM SOC, V135, P9111, DOI 10.1021/ja403546b; Aytar BS, 2012, J CONTROL RELEASE, V157, P249, DOI 10.1016/j.jconrel.2011.09.074; Bhat SS, 2012, CHEM-EUR J, V18, P16383, DOI 10.1002/chem.201200407; Bhat SS, 2011, CHEM COMMUN, V47, P11068, DOI 10.1039/c1cc13863d; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Conwell CC, 2004, BIOCHEMISTRY-US, V43, P5380, DOI 10.1021/bi049872u; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Dong XD, 2010, CHEM-EUR J, V16, P14181, DOI 10.1002/chem.201001457; Draghici B, 2015, J MED CHEM, V58, P4091, DOI 10.1021/jm500330k; Golan S, 2011, LANGMUIR, V27, P6615, DOI 10.1021/la200450x; He CB, 2014, J AM CHEM SOC, V136, P5181, DOI 10.1021/ja4098862; He SQ, 2000, BIOPOLYMERS, V53, P329; Hsu CYM, 2012, BIOMATERIALS, V33, P7834, DOI 10.1016/j.biomaterials.2012.06.093; Huang XY, 2012, CHEM J CHINESE U, V33, P1151, DOI 10.3969/j.issn.0251-0790.2012.06.006; Huang XY, 2013, J INORG BIOCHEM, V129, P102, DOI 10.1016/j.jinorgbio.2013.09.009; HUD NV, 1995, P NATL ACAD SCI USA, V92, P3581, DOI 10.1073/pnas.92.8.3581; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; Jewell CM, 2008, BIOCONJUGATE CHEM, V19, P2120, DOI 10.1021/bc8002138; Jewell CM, 2006, J CONTROL RELEASE, V112, P129, DOI 10.1016/j.jconrel.2006.01.014; Jiang RW, 2013, CURR DRUG DELIV, V10, P122, DOI 10.2174/1567201811310010018; Kankia BI, 2001, NUCLEIC ACIDS RES, V29, P2795, DOI 10.1093/nar/29.13.2795; Kikuchi T, 2014, CHEM SCI, V5, P3257, DOI 10.1039/c4sc00656a; Kim HJ, 2014, ACS NANO, V8, P8979, DOI 10.1021/nn502125h; Kolate A, 2014, J CONTROL RELEASE, V192, P67, DOI 10.1016/j.jconrel.2014.06.046; Lachelt U, 2015, CHEM REV, V115, P11043, DOI 10.1021/cr5006793; Li GY, 2014, COORDIN CHEM REV, V281, P100, DOI 10.1016/j.ccr.2014.09.005; Li J, 2012, BIOMACROMOLECULES, V13, P3220, DOI 10.1021/bm3009999; Liu G, 2012, ANGEW CHEM INT EDIT, V51, P445, DOI 10.1002/anie.201105565; Liu L, 2010, BIOMATERIALS, V31, P1380, DOI 10.1016/j.biomaterials.2009.10.056; Malina J, 2014, INORG CHEM, V53, P1662, DOI 10.1021/ic402796k; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; Meng XG, 2008, INORG CHEM, V47, P6572, DOI 10.1021/ic800532q; Meng XG, 2011, DALTON T, V40, P12846, DOI 10.1039/c1dt10695c; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Pelta J, 1996, J BIOL CHEM, V271, P5656, DOI 10.1074/jbc.271.10.5656; Peng LH, 2014, BIOMATERIALS, V35, P5605, DOI 10.1016/j.biomaterials.2014.03.062; Ruvinov E, 2015, J CONTROL RELEASE, V203, P150, DOI 10.1016/j.jconrel.2015.02.029; Shen MR, 2000, J AM CHEM SOC, V122, P4833, DOI 10.1021/ja000200a; Sun B, 2009, INORG CHEM, V48, P4637, DOI 10.1021/ic900102r; Vilfan ID, 2006, BIOCHEMISTRY-US, V45, P8174, DOI 10.1021/bi060396c; WIDOM J, 1983, BIOPOLYMERS, V22, P1595, DOI 10.1002/bip.360220612; WIDOM J, 1980, J MOL BIOL, V144, P431, DOI 10.1016/0022-2836(80)90330-7; Yang CL, 2013, PROG CHEM, V25, P555; Yin J, 2012, BIOMATERIALS, V33, P7884, DOI 10.1016/j.biomaterials.2012.07.017; Yu BL, 2013, CHEM COMMUN, V49, P810, DOI 10.1039/c2cc37896e; Zhao Y. J., 2014, SCI SINICA CHIMICA, V44, P102	50	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158766	10.1371/journal.pone.0158766	http://dx.doi.org/10.1371/journal.pone.0158766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433798	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600016
J	Begum, YA; Talukder, KA; Azmi, IJ; Shahnaij, M; Sheikh, A; Sharmin, S; Svennerholm, AM; Qadri, F				Begum, Yasmin A.; Talukder, K. A.; Azmi, Ishrat J.; Shahnaij, Mohammad; Sheikh, A.; Sharmin, Salma; Svennerholm, A. -M.; Qadri, Firdausi			Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh	PLOS ONE			English	Article							SHIGELLA-DYSENTERIAE TYPE-1; COLONIZATION FACTORS; MONOCLONAL-ANTIBODIES; TRAVELERS DIARRHEA; FLUOROQUINOLONE RESISTANCE; GYRA GENE; CHOLERA; DISEASE; TOXIN; CIPROFLOXACIN	Background Enterotoxigenic Escherichia coli (ETEC) is a common cause of bacterial infection leading to acute watery diarrhea in infants and young children as well as in travellers to ETEC endemic countries. Ciprofloxacin is a broad-spectrum antimicrobial agent nowadays used for the treatment of diarrhea. This study aimed to characterize ciprofloxacin resistant ETEC strains isolated from diarrheal patients in Bangladesh. Methods A total of 8580 stool specimens from diarrheal patients attending the icddr, b Dhaka hospital was screened for ETEC between 2005 and 2009. PCR and Ganglioside GM1-Enzyme Linked Immuno sorbent Assay (ELISA) was used for detection of Heat labile (LT) and Heat stable (ST) toxins of ETEC. Antimicrobial susceptibilities for commonly used antibiotics and the minimum inhibitory concentration (MIC) of nalidixic acid, ciprofloxacin and azithromycin were examined. DNA sequencing of representative ciprofloxacin resistant strains was performed to analyze mutations of the quinolone resistance-determining region of gyrA, gyrB, parC and parE. PCR was used for the detection of qnr, a plasmid mediated ciprofloxacin resistance gene. Clonal variations among ciprofloxacin resistant (Cip(R)) and ciprofloxacin susceptible (Cip(S)) strains were determined by Pulsed-field gel electrophoresis (PFGE). Results Among 1067 (12%) ETEC isolates identified, 42% produced LT/ST, 28% ST and 30% LT alone. Forty nine percent (n = 523) of the ETEC strains expressed one or more of the 13 tested colonization factors (CFs) as determined by dot blot immunoassay. Antibiotic resistance of the ETEC strains was observed as follows: ampicillin 66%, azithromycin 27%, ciprofloxacin 27%, ceftriazone 13%, cotrimaxazole 46%, doxycycline 44%, erythromycin 96%, nalidixic acid 83%, norfloxacin 27%, streptomycin 48% and tetracycline 42%. Resistance to ciprofloxacin increased from 13% in 2005 to 34% in 2009. None of the strains was resistant to mecillinam. The MIC of the nalidixic acid and ciprofloxacin of representative Cip(R) strains were 256 mu g/ml and 32 mu g/ml respectively. A single mutation (Ser(83)-Leu) in gyrA was observed in the nalidixic acid resistant ETEC strains. In contrast, double mutation in gyrA (Ser(83)-Leu, Asp(87)-Asn) and a single mutation in parC (Glu(84)-Ly) were found in ciprofloxacin resistant strains. Mutation of gyrB was not found in either the nalidixic acid or ciprofloxacin resistant strains. None of the ciprofloxacin resistant strains was found to be positive for the qnr gene. Diverse clones were identified from all ciprofloxacin resistant strains by PFGE analysis in both CF positive and CF negative ETEC strains. Conclusion Emergence of ciprofloxacin resistant ETEC strains results in a major challenge in current treatment strategies of ETEC diarrhea.	[Begum, Yasmin A.; Talukder, K. A.; Azmi, Ishrat J.; Shahnaij, Mohammad; Sharmin, Salma; Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Sheikh, A.] Washington Univ, Div Biol & Biomed Sci, Mol Microbiol & Microbial Pathogenesis Program, St Louis, MO USA; [Svennerholm, A. -M.] Univ Gothenborg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden	International Centre for Diarrhoeal Disease Research (ICDDR); Washington University (WUSTL); University of Gothenburg	Qadri, F (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	fqadri@icddrb.org	Al, Mamun M./AAF-5850-2019; Sheikh, Alaullah/H-3125-2019; Qadri, Firdausi/AAF-4583-2019; Shahnaij, Mohammad/GMX-3978-2022	Sheikh, Alaullah/0000-0002-2972-6978; Mohammad, Shahnaij/0000-0002-3693-7239	Swedish Sida (SIDA) (grant INT-ICDDR) [B-HN-01-AV]; Swedish collaborative grant [SIDA-SWE2009-023]; Commission of the European Communities [HEALTH-F3-2010-261472]; Government of the Australia; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Swedish Sida (SIDA) (grant INT-ICDDR); Swedish collaborative grant; Commission of the European Communities(European Commission); Government of the Australia; Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research was supported by the core grants to the icddr,b, by the Governments of the Australia, Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support. This work was also supported by a Swedish Sida (SIDA) (grant INT-ICDDR, B-HN-01-AV) and Swedish collaborative grant SIDA-SWE2009-023, as well as by the Commission of the European Communities grant to STOPENTERICS (grant HEALTH-F3-2010-261472).	AGUIAR JM, 1992, J ANTIMICROB CHEMOTH, V29, P349, DOI 10.1093/jac/29.3.349; Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azmi IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102533; Begum YA, 2007, CAN J MICROBIOL, V53, P19, DOI 10.1139/W06-098; Chakraborty S, 2001, J CLIN MICROBIOL, V39, P3241, DOI 10.1128/JCM.39.9.3241-3246.2001; Das SK, 2013, J INFECT DEV COUNTR, V7, P900, DOI 10.3855/jidc.3003; Diemert DJ, 2006, CLIN MICROBIOL REV, V19, P583, DOI 10.1128/CMR.00052-05; DUPONT HL, 1981, PHARMACOL THERAPEUT, V13, P249, DOI 10.1016/0163-7258(81)90002-4; Ericsson CD, 2003, INT J ANTIMICROB AG, V21, P116, DOI 10.1016/S0924-8579(02)00282-0; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; GILL DM, 1980, J INFECT DIS, V141, P64, DOI 10.1093/infdis/141.1.64; Harris AM, 2008, AM J TROP MED HYG, V79, P708, DOI 10.4269/ajtmh.2008.79.708; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; Khan WA, 2002, LANCET, V360, P1722, DOI 10.1016/S0140-6736(02)11680-1; Matsushita S, 2001, Kansenshogaku Zasshi, V75, P785; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; MCCONNELL MM, 1989, J GEN MICROBIOL, V135, P1135; MERSON MH, 1980, J INFECT DIS, V141, P702, DOI 10.1093/infdis/141.6.702; National Committee for Clinical Laboratory Standards, 2000, PERFORMANCE STANDARD; Oethinger M, 1996, ANTIMICROB AGENTS CH, V40, P387, DOI 10.1128/AAC.40.2.387; Pichel M, 2012, FOODBORNE PATHOG DIS, V9, P418, DOI 10.1089/fpd.2011.1067; QADRI F, 1994, CLIN DIAGN LAB IMMUN, V1, P51, DOI 10.1128/CDLI.1.1.51-54.1994; Qadri F, 2000, J INFECT DIS, V181, P2071, DOI 10.1086/315507; Qadri F, 2005, EMERG INFECT DIS, V11, P1104, DOI 10.3201/eid1107.041266; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; RAHMAN M, 1987, J CLIN MICROBIOL, V25, P2204, DOI 10.1128/JCM.25.11.2204-2206.1987; RAHMAN M, 1994, ANTIMICROB AGENTS CH, V38, P2488, DOI 10.1128/AAC.38.10.2488; RAO MC, 1985, CIBA F SYMP, V112, P74; Rodas C, 2011, BRAZ J INFECT DIS, V15, P132, DOI [10.1016/S1413-8670(11)70158-1, 10.1590/S1413-86702011000200007]; SACK RB, 1975, NEW ENGL J MED, V292, P1041, DOI 10.1056/NEJM197505152922001; SACK RB, 1990, REV INFECT DIS, V12, pS59; Shaheen Hind I., 2003, International Journal of Infectious Diseases, V7, P35, DOI 10.1016/S1201-9712(03)90040-3; Sjoling A, 2007, J CLIN MICROBIOL, V45, P3295, DOI 10.1128/JCM.00471-07; SO M, 1978, INFECT IMMUN, V21, P405, DOI 10.1128/IAI.21.2.405-411.1978; STOLL BJ, 1982, BRIT MED J, V285, P1185, DOI 10.1136/bmj.285.6349.1185; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; Talukdar PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061090; Talukder KA, 2006, CURR MICROBIOL, V52, P108, DOI 10.1007/s00284-005-0140-9; Talukder KA, 2002, J CLIN MICROBIOL, V40, P2490, DOI 10.1128/JCM.40.7.2490-2497.2002; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson CJ, 1999, J ANTIMICROB CHEMOTH, V43, P31, DOI 10.1093/jac/43.suppl_1.31; Vila J, 1996, ANTIMICROB AGENTS CH, V40, P491, DOI 10.1128/AAC.40.2.491; VILA J, 1994, ANTIMICROB AGENTS CH, V38, P2477, DOI 10.1128/AAC.38.10.2477; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; WHO, 1987, PROGR CONTR DIARR DI, P9	48	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157415	10.1371/journal.pone.0157415	http://dx.doi.org/10.1371/journal.pone.0157415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428376	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300003
J	Dean, AJ; Fielding, KS; Newton, FJ				Dean, Angela J.; Fielding, Kelly S.; Newton, Fiona J.			Community Knowledge about Water: Who Has Better Knowledge and Is This Associated with Water-Related Behaviors and Support for Water-Related Policies?	PLOS ONE			English	Article							PRO-ENVIRONMENTAL BEHAVIOR; HEALTH LITERACY; PUBLIC KNOWLEDGE; DOMAIN KNOWLEDGE; INFORMATION; CONSERVATION; MANAGEMENT; ATTITUDES; PARTICIPATION; CITIZENSHIP	Sustainable approaches to water management require broad community acceptance of changes in policy, practice and technology, which in turn, requires an engaged community. A critical first step in building an engaged community is to identify community knowledge about water management, an issue rarely examined in research. To address this, we surveyed a representative sample of Australian adults (n = 5172). Knowledge was assessed using 15 questions about impact of household activities on waterways, the urban water cycle, and water management. This survey also examined demographics, psychosocial characteristics, exposure to water-related information, and water-related behaviors and policy support. Participants correctly answered a mean of 8.0 questions (Range 0-15). Most respondents knew that household actions can reduce water use and influence waterway health, whereas less than one third correctly identified that domestic wastewater is treated prior to entering waterways, urban stormwater is not treated, and that these are carried via different pipes. Higher water knowledge was associated with older age, higher education and living in non-urban areas. Poorer water knowledge was associated with speaking a language other than English in the home. Garden size, experience of water restrictions, satisfaction, waterway use for swimming, and certain information sources were also associated with knowledge. Greater water knowledge was associated with adoption of water-saving and pollution-reduction behaviors, and support for both alternative water sources and rain-gardens. These findings confirm the importance of community knowledge, and identify potential subgroups who may require additional targeting to build knowledge and support for water management initiatives.	[Dean, Angela J.; Fielding, Kelly S.] Univ Queensland, Sch Commun & Arts, St Lucia, Qld, Australia; [Dean, Angela J.; Fielding, Kelly S.; Newton, Fiona J.] Monash Univ, Cooperat Res Ctr Water Sensit Cities, Clayton, Vic, Australia; [Dean, Angela J.] Monash Univ, Monash Sustainabil Inst, BehaviourWorks, Clayton, Vic, Australia; [Newton, Fiona J.] Monash Univ, Fac Business & Econ, Caulfield, Vic, Australia	University of Queensland; Monash University; Monash University; Monash University	Dean, AJ (corresponding author), Univ Queensland, Sch Commun & Arts, St Lucia, Qld, Australia.; Dean, AJ (corresponding author), Monash Univ, Cooperat Res Ctr Water Sensit Cities, Clayton, Vic, Australia.; Dean, AJ (corresponding author), Monash Univ, Monash Sustainabil Inst, BehaviourWorks, Clayton, Vic, Australia.	a.dean@uq.edu.au	Dean, Angela/D-5618-2011	Dean, Angela/0000-0003-4017-4809; FIELDING, Kelly/0000-0001-5301-0331	Cooperative Research Centre for Water Sensitive Cities; Commonwealth of Australia; Australian Research Council [FT100100704]	Cooperative Research Centre for Water Sensitive Cities(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Commonwealth of Australia(Australian Government); Australian Research Council(Australian Research Council)	This research was supported by the Cooperative Research Centre for Water Sensitive Cities, Commonwealth of Australia and an the Australian Research Council grant FT100100704 to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Cooperative Research Centre for Water Sensitive Cities, Commonwealth of Australia and an Australian Research Council grant FT100100704 to the second author.	ABS, 2014, 31010 ABS; Ackerman PL, 1996, INTELLIGENCE, V22, P227, DOI 10.1016/S0160-2896(96)90016-1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALEXANDER PA, 1994, LEARN INDIVID DIFFER, V6, P379, DOI 10.1016/1041-6080(94)90001-9; [Anonymous], AUSTR STAT GEOGR STA; [Anonymous], 2015, ENV LIT US AG LEAD 2; [Anonymous], [No title captured]; Aslin H.J., 2013, ENGAGED ENV CITIZENS, P1; Australian Water Association, 2010, ATT WAT AUSTR COMM S; Vicente-Molina MA, 2013, J CLEAN PROD, V61, P130, DOI 10.1016/j.jclepro.2013.05.015; Baggett S, 2008, DESALINATION, V218, P132, DOI 10.1016/j.desal.2006.08.025; Beier ME, 2005, PSYCHOL AGING, V20, P341, DOI 10.1037/0882-7974.20.2.341; Beier ME, 2001, PSYCHOL AGING, V16, P615, DOI 10.1037//0882-7974.16.4.615; Bo A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1095; Brown RR, 2009, WATER SCI TECHNOL, V59, P847, DOI 10.2166/wst.2009.029; BRUVOLD WH, 1972, WATER RESOUR RES, V8, P1145, DOI 10.1029/WR008i005p01145; Buhr K, 2014, ENERGY RES SOC SCI, V3, P5, DOI 10.1016/j.erss.2014.05.004; Bureau of Meterology, CLIM DAT ONL; Carmi N, 2015, J ENVIRON EDUC, V46, P183, DOI 10.1080/00958964.2015.1028517; CH2MHILL, 2004, SO CAL WAT REC PROJ; Cockerill K, 2010, J ENVIRON EDUC, V41, P151, DOI 10.1080/00958960903295266; Daugs DR, 1984, WATER INT, V9, P84; Davies A., 2012, VALUE ROLE CITIZEN E; De Vriendt T, 2009, APPETITE, V52, P788, DOI 10.1016/j.appet.2009.02.014; de Vries G, 2014, J ENVIRON PSYCHOL, V38, P116, DOI 10.1016/j.jenvp.2014.01.003; Dean AJ, SUSTAINABLE IN PRESS; Dean AJ, 2016, ENVIRON SCI POLICY, V55, P238, DOI 10.1016/j.envsci.2015.10.016; Department of Sustainability E Water Population and Communities, 2012, NAT WAT KNOWL RES PL; Dobson A, 2007, SUSTAIN DEV, V15, P276, DOI 10.1002/sd.344; Dolnicar S, 2010, AUSTRALAS J WAT RESO, V14, P43, DOI 10.1080/13241583.2010.11465373; Dolnicar S, 2012, J ENVIRON MANAGE, V105, P44, DOI 10.1016/j.jenvman.2012.03.042; Dolnicar S, 2011, WATER RES, V45, P933, DOI 10.1016/j.watres.2010.09.030; Dolnicar S, 2010, J ENVIRON MANAGE, V91, P1288, DOI 10.1016/j.jenvman.2010.02.003; Duerden MD, 2010, J ENVIRON PSYCHOL, V30, P379, DOI 10.1016/j.jenvp.2010.03.007; Dupont DP, 2013, WATER RESOUR ECON, V4, P22, DOI 10.1016/j.wre.2013.12.003; European Social Survey, 2014, ESS 1 2002 DOC REP E; Fielding K, 2010, 152 AHURI; Fielding KS, 2014, WATER RES, V61, P86, DOI 10.1016/j.watres.2014.05.002; Frederiks ER, 2015, ENERGIES, V8, P573, DOI 10.3390/en8010573; Frisk E., 2011, J SUSTAINABILITY ED, V2, P20; Giacalone K, 2010, J CONTEMP WAT RES ED, V146, P92, DOI 10.1111/j.1936-704X.2010.00395.x; Gill R, 2011, DROUGHTS FLOODING RA; Guest H, 2015, MAR POLICY, V58, P98, DOI 10.1016/j.marpol.2015.04.007; Head BW, 2007, AUST J POLIT SCI, V42, P441, DOI 10.1080/10361140701513570; Hurlimann A, 2010, WATER RES, V44, P287, DOI 10.1016/j.watres.2009.09.020; James A, 2010, BEHAV ATTITUDES WATE; Kahlor L, 2009, SCI COMMUN, V30, P380, DOI 10.1177/1075547008328798; Kaiser FG, 2003, APPL PSYCHOL-INT REV, V52, P598, DOI 10.1111/1464-0597.00153; Larson KL, 2008, J ENVIRON MANAGE, V88, P817, DOI 10.1016/j.jenvman.2007.04.008; Leonard R, 2014, ADELAIDE SA GOYDER I; LOVRICH NP, 1984, COMMUN RES, V11, P415, DOI 10.1177/009365084011003005; Mankad A., 2010, QUALITATIVE EXPLORAT; Marlow DR, 2013, WATER RES, V47, P7150, DOI 10.1016/j.watres.2013.07.046; McDuff MM, 2008, LAKE RESERV MANAGE, V24, P47, DOI 10.1080/07438140809354050; McKenzie-Mohr D, 2014, SOCIAL MARKETING Q, V20, P35; Miller E, 2008, SOC NATUR RESOUR, V21, P244, DOI 10.1080/08941920701818258; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Otto S, 2014, J ENVIRON PSYCHOL, V40, P331, DOI 10.1016/j.jenvp.2014.08.004; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Padowski JC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104004; Pritchett J., 2009, 17 COL STAT U COL WA; Randolph B, 2008, ENVIRON SCI POLICY, V11, P441, DOI 10.1016/j.envsci.2008.03.003; Rathnayaka K, 2014, RESOUR CONSERV RECY, V92, P85, DOI 10.1016/j.resconrec.2014.08.012; Ren LJ, 2014, ENVIRON SCI POLLUT R, V21, P13646, DOI 10.1007/s11356-014-3242-8; Safford TG, 2014, ENVIRON MANAGE, V53, P757, DOI 10.1007/s00267-014-0236-8; Salvaggio M, 2014, J ENVIRON PLANN MAN, V57, P588, DOI 10.1080/09640568.2012.756806; Schewe J, 2014, P NATL ACAD SCI USA, V111, P3245, DOI 10.1073/pnas.1222460110; SPSS&REG;, 2002, LIN MIX EFF MOD SPSS; STANOVICH KE, 1993, J EDUC PSYCHOL, V85, P211, DOI 10.1037/0022-0663.85.2.211; Steel B, 2005, COAST MANAGE, V33, P37, DOI 10.1080/08920750590883105; Steg L, 2014, J ENVIRON PSYCHOL, V38, P104, DOI 10.1016/j.jenvp.2014.01.002; Suka M, 2015, PATIENT EDUC COUNS, V98, P660, DOI 10.1016/j.pec.2015.02.013; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; von Wagner C, 2011, EPIDEMIOL REV, V33, P135, DOI 10.1093/epirev/mxq018; von Wagner C, 2009, HEALTH EDUC BEHAV, V36, P860, DOI 10.1177/1090198108322819; West B. T., 2007, LINEAR MIXED MODELS; Wooden M, 2007, ECON REC, V83, P208, DOI 10.1111/j.1475-4932.2007.00395.x; Zhang HX., 2012, ENCY SUSTAINABILITY, P2061, DOI [10.1007/978-1-4419-0851-3_388, DOI 10.1007/978-1-4419-0851-3_388]; Zuur Alain F., 2009, P1	79	59	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159063	10.1371/journal.pone.0159063	http://dx.doi.org/10.1371/journal.pone.0159063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428372	gold, Green Published			2022-12-26	WOS:000380169300032
J	Margolis, EB; Fields, HL				Margolis, Elyssa B.; Fields, Howard L.			Mu Opioid Receptor Actions in the Lateral Habenula	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-GELATINOSA NEURONS; PERIAQUEDUCTAL GRAY; NUCLEUS-ACCUMBENS; GABA NEURONS; RAT; PROJECTIONS; EPITHALAMUS; CORTEX; INPUTS	Increased activity of lateral habenula (LHb) neurons is correlated with aversive states including pain, opioid abstinence, rodent models of depression, and failure to receive a predicted reward. Agonists at the mu opioid receptor (MOR) are among the most powerful rewarding and pain relieving drugs. Injection of the MOR agonist morphine directly into the habenula produces analgesia, raising the possibility that MOR acts locally within the LHb. Consequently, we examined the synaptic actions of MOR agonists in the LHb using whole cell patch clamp recording. We found that the MOR selective agonist DAMGO inhibits a subset of LHb neurons both directly and by inhibiting glutamate release onto these cells. Paradoxically, DAMGO also presynaptically inhibited GABA release onto most LHb neurons. The behavioral effect of MOR activation will thus depend upon both the level of intrinsic neuronal activity in the LHb and the balance of activity in glutamate and GABA inputs to different LHb neuronal populations.	[Margolis, Elyssa B.; Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, Wheeler Ctr Neurobiol Addict, Alcoholism & Addict Res Grp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Margolis, EB (corresponding author), Univ Calif San Francisco, Dept Neurol, Wheeler Ctr Neurobiol Addict, Alcoholism & Addict Res Grp, San Francisco, CA 94143 USA.	elyssa.margolis@ucsf.edu	Fields, Howard/ABG-9073-2020		NIDA [R01DA030529]; Wheeler Center for the Neurobiology of Addiction	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wheeler Center for the Neurobiology of Addiction	This work was supported by NIDA grant R01DA030529 to EBM and The Wheeler Center for the Neurobiology of Addiction.	Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; BENABID AL, 1989, NEUROSCI LETT, V96, P289, DOI 10.1016/0304-3940(89)90393-5; Bernard R, 2012, J COMP NEUROL, V520, P2545, DOI 10.1002/cne.23080; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; FUCHS P, 1993, NEUROREPORT, V4, P121, DOI 10.1097/00001756-199302000-00001; Goncalves L, 2012, J COMP NEUROL, V520, P1278, DOI 10.1002/cne.22787; GREATREX RM, 1982, BRAIN RES, V238, P192, DOI 10.1016/0006-8993(82)90782-X; GRUDT TJ, 1994, J NEUROSCI, V14, P1646, DOI 10.1523/JNEUROSCI.14-03-01646.1994; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Kim U, 2005, J COMP NEUROL, V483, P236, DOI 10.1002/cne.20410; Kim U, 2012, EUR J NEUROSCI, V35, P1253, DOI 10.1111/j.1460-9568.2012.08030.x; Lavezzi HN, 2012, BRAIN STRUCT FUNCT, V217, P719, DOI 10.1007/s00429-011-0368-z; LI YQ, 1993, NEUROSCI LETT, V158, P55, DOI 10.1016/0304-3940(93)90611-N; Lur G, 2015, CELL REP, V12, P326, DOI 10.1016/j.celrep.2015.06.029; MA QP, 1992, BRAIN RES, V583, P292, DOI 10.1016/S0006-8993(10)80036-8; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Navratilova E, 2015, J NEUROSCI, V35, P7264, DOI 10.1523/JNEUROSCI.3862-14.2015; Neugebauer NM, 2013, PHARMACOL BIOCHEM BE, V109, P77, DOI 10.1016/j.pbb.2013.04.015; Omelchenko N, 2009, EUR J NEUROSCI, V30, P1239, DOI 10.1111/j.1460-9568.2009.06924.x; Poller WC, 2013, BRAIN RES, V1507, P45, DOI 10.1016/j.brainres.2013.01.029; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Root DH, 2014, J NEUROSCI, V34, P13906, DOI 10.1523/JNEUROSCI.2029-14.2014; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wang LY, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00455; Weiss T, 2011, NEUROSCIENCE, V172, P74, DOI 10.1016/j.neuroscience.2010.10.047; Xie Qiang, 1998, Okajimas Folia Anatomica Japonica, V75, P167; YOSHIMURA M, 1983, NATURE, V305, P529, DOI 10.1038/305529a0; Zhang CX, 2013, NEUROSCI LETT, V555, P12, DOI 10.1016/j.neulet.2013.09.019	31	38	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159097	10.1371/journal.pone.0159097	http://dx.doi.org/10.1371/journal.pone.0159097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427945	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300036
J	Weissenbacher-Lang, C; Kureljusic, B; Nedorost, N; Matula, B; Schiessl, W; Stixenberger, D; Weissenbock, H				Weissenbacher-Lang, Christiane; Kureljusic, Branislav; Nedorost, Nora; Matula, Bettina; Schiessl, Wolfgang; Stixenberger, Daniela; Weissenboeck, Herbert			Retrospective Analysis of Bacterial and Viral Co-Infections in Pneumocystis spp. Positive Lung Samples of Austrian Pigs with Pneumonia	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; RESPIRATORY-SYNDROME VIRUS; PORCINE CIRCOVIRUS TYPE-2; TORQUE-TENO-VIRUS; CONCURRENT INFECTIONS; DUAL INFECTION; RAT MODEL; CARINII; INOCULATION; PATHOGENS	Aim of this study was the retrospective investigation of viral (porcine circovirus type 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), torque teno sus virus type 1 and 2 (TTSuV1, TTSuV2)) and bacterial (Bordetella bronchiseptica (B.b.), Mycoplasma hyopneumoniae (M. h.), and Pasteurella multocida (P. m.)) co-infections in 110 Pneumocystis spp. positive lung samples of Austrian pigs with pneumonia. Fifty-one % were positive for PCV2, 7% for PRRSV, 22% for TTSuV1, 48% for TTSuV2, 6% for B. b., 29% for M. h., and 21% for P. m. In 38.2% only viral, in 3.6% only bacterial and in 40.0% both, viral and bacterial pathogens were detected. In 29.1% of the cases a co-infection with 1 pathogen, in 28.2% with 2, in 17.3% with 3, and in 7.3% with 4 different infectious agents were observed. The exposure to Pneumocystis significantly decreased the risk of a co-infection with PRRSV in weaning piglets; all other odds ratios were not significant. Four categories of results were compared: I = P. spp. + only viral co-infectants, II = P. spp. + both viral and bacterial co-infectants, III = P. spp. + only bacterial co-infectants, and IV = P. spp. single infection. The evaluation of all samples and the age class of the weaning piglets resulted in a predomination of the categories I and II. In contrast, the suckling piglets showed more samples of category I and IV. In the group of fattening pigs, category II predominated. Suckling piglets can be infected with P. spp. early in life. With increasing age this single infections can be complicated by co-infections with other respiratory diseases.	[Weissenbacher-Lang, Christiane; Kureljusic, Branislav; Nedorost, Nora; Matula, Bettina; Schiessl, Wolfgang; Stixenberger, Daniela; Weissenboeck, Herbert] Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria; [Kureljusic, Branislav] Inst Vet Med Serbia, Dept Pathol, Belgrade, Serbia	University of Veterinary Medicine Vienna	Weissenbacher-Lang, C (corresponding author), Univ Vet Med Vienna, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria.	christiane.weissenbacher-lang@vetmeduni.ac.at		Kureljusic, Branislav/0000-0003-4281-1672; Weissenbacher-Lang, Christiane/0000-0002-1527-7593; Weissenbock, Herbert/0000-0001-8197-6379	Profile lines, University of Veterinary Medicine Vienna, Austria; Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria	Profile lines, University of Veterinary Medicine Vienna, Austria; Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria	Funding provided by Profile lines, University of Veterinary Medicine Vienna, Austria; no grant number available; recipient: CWL; https://veteasy.vetmeduni.ac.at/Bereiche/Start/FFI/Public/SitePages/Profillinien.aspx and Verein der Freunde und Forderer der Schweinemedizin, University of Veterinary Medicine Vienna, Austria; no grant number available; recipient: CWL; http://www.schweinemedizin.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Aliouat-Denis CM, 2014, REV IBEROAM MICOL, V31, P54, DOI 10.1016/j.riam.2013.10.006; Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2304; BARTLETT MS, 1988, J CLIN MICROBIOL, V26, P1100, DOI 10.1128/JCM.26.6.1100-1102.1988; Binanti D, 2014, MED MYCOL, V52, P196, DOI 10.3109/13693786.2013.809631; Blomstrom AL, 2010, VIRUS RES, V152, P59, DOI 10.1016/j.virusres.2010.06.004; Borba MR, 2011, MED MYCOL, V49, P172, DOI 10.3109/13693786.2010.510540; BOYLAN CJ, 1992, INFECT IMMUN, V60, P1589, DOI 10.1128/IAI.60.4.1589-1597.1992; Brockmeier SL, 2001, AM J VET RES, V62, P521, DOI 10.2460/ajvr.2001.62.521; Bukovsky C, 2007, VET REC, V161, P552, DOI 10.1136/vr.161.16.552; Cho JG, 2006, CAN J VET RES, V70, P297; Choi YK, 2003, CAN VET J, V44, P735; Dei-Cas E, 2000, MED MYCOL, V38, P23, DOI 10.1080/mmy.38.s1.23.32; Fablet C, 2012, RES VET SCI, V93, P627, DOI 10.1016/j.rvsc.2011.11.002; Fablet C, 2012, VET MICROBIOL, V157, P152, DOI 10.1016/j.vetmic.2011.12.015; Fablet C, 2011, VET MICROBIOL, V147, P329, DOI 10.1016/j.vetmic.2010.07.005; Farsani SMJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-323; Galeziok Michal, 2009, J Med Case Rep, V3, P76, DOI 10.1186/1752-1947-3-76; Govender S., 2008, Southern African Journal of Epidemiology & Infection, V23, P21; Harms PA, 2002, J SWINE HEALTH PROD, V10, P27; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kim KS, 2011, J VET SCI, V12, P15, DOI 10.4142/jvs.2011.12.1.15; Krakowka S, 2008, AM J VET RES, V69, P1623, DOI 10.2460/ajvr.69.12.1623; Kureljusic B, 2016, VET J, V207, P177, DOI 10.1016/j.tvjl.2015.11.003; Lang C, 2011, TIERAERZTL PRAX G N, V39, P201; Lang C, 2011, BERL MUNCH TIERARZTL, V124, P142, DOI 10.2376/0005-9366-124-142; Macy JD, 2000, COMPARATIVE MED, V50, P49; Opriessnig T, 2004, VET PATHOL, V41, P624, DOI 10.1354/vp.41-6-624; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Opriessnig T, 2012, VIRUS RES, V164, P20, DOI 10.1016/j.virusres.2011.09.014; Quintana J, 2001, VET REC, V149, P357, DOI 10.1136/vr.149.12.357; Rovira A, 2002, J VIROL, V76, P3232, DOI 10.1128/JVI.76.7.3232-3239.2002; Sanches EMC, 2006, J EUKARYOT MICROBIOL, V53, pS92, DOI 10.1111/j.1550-7408.2006.00185.x; Sorden SD, 2000, SWINE HEALTH PROD, V8, P133; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Weisbroth SH, 1999, J CLIN MICROBIOL, V37, P1441, DOI 10.1128/JCM.37.5.1441-1446.1999; Weissenbacher-Lang C, 2014, J EUKARYOT MICROBIOL, V61, P537, DOI 10.1111/jeu.12132	37	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158479	10.1371/journal.pone.0158479	http://dx.doi.org/10.1371/journal.pone.0158479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428002	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300008
J	Akimoto-Gunther, L; Bonfim-Mendonca, PD; Takahachi, G; Irie, MMT; Miyamoto, S; Consolaro, MEL; Svidzinsk, TIE				Akimoto-Gunther, Luciene; Bonfim-Mendonca, Patricia de Souza; Takahachi, Gisele; Irie, Mary Mayumi T.; Miyamoto, Sonia; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinsk, Terezinha I.			Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity	PLOS ONE			English	Article							ALBICANS; WOMEN; COLONIZATION; INFECTIONS; SYMPTOMS; IMMUNITY; GLUCOSE; DEFENSE	We studied host factors that could predispose women to develop recurrent vulvovaginal candidiasis (RVVC), including glycemia, insulin resistance, chronic stress, antioxidant capacity, overall immune status, local inflammation and vaginal microbiota. The presence of yeasts in vaginal culture was screened in 277 women, with or without signs and symptoms of VVC and RVVC. The presence of an inflammatory process and microbiota were analyzed through vaginal bacterioscopy and cervical-vaginal cytology, respectively. Fasting-blood samples were collected by standard venipuncture for biochemical analyses. Flow cytometry was employed to obtain the T helper/T cytotoxic lymphocyte ratio, and insulin resistance was assessed by the HOMA index (HI). Yeasts were isolated from 71 (26%) women: 23 (32.4%) with a positive culture but without symptoms (COL), 22 (31%) in an acute episode (VVC), and 26 (36.6%) with RVVC. C. albicans was the main yeast isolated in all clinical profiles. The control group (negative culture) comprised 206 women. Diabetes mellitus and insulin resistance were more associated with the positive-culture groups (COL, VVC and RVVC) than with negative ones. The RVVC group showed lower mean levels of cortisol than the control group and lower antioxidant capacity than all other groups. The T Helper/T cytotoxic lymphocyte ratio was similar in all groups. The RVVC group showed a similar level of vaginal inflammation to the control group, and lower than in the COL and VVC groups. Only the CVV group showed a reduction in vaginal lactobacillus microbiota. Our data suggest that both chronic stress (decreased early-morning cortisol levels) and reduced antioxidant capacity can be host predisposing factors to RVVC.	[Akimoto-Gunther, Luciene; Bonfim-Mendonca, Patricia de Souza; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinsk, Terezinha I.] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil; [Akimoto-Gunther, Luciene; Bonfim-Mendonca, Patricia de Souza; Takahachi, Gisele; Irie, Mary Mayumi T.; Miyamoto, Sonia; Lopes Consolaro, Marcia Edilaine; Estivalet Svidzinsk, Terezinha I.] Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Svidzinsk, TIE (corresponding author), Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil.; Svidzinsk, TIE (corresponding author), Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.	terezinha.svidzinski@gmail.com	Consolaro, Marcia EL/I-4932-2014	Consolaro, Marcia EL/0000-0001-9102-4865	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Government; Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government; Fundacao Araucaria de Apoio ao Desenvolvimento Tecnologico e Cientifico do Parana, Brazilian Government	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Government(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria de Apoio ao Desenvolvimento Tecnologico e Cientifico do Parana, Brazilian Government	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES) and Fundacao Araucaria de Apoio ao Desenvolvimento Tecnologico e Cientifico do Parana, Brazilian Government.	Gunther LSA, 2014, SAO PAULO MED J, V132, P116, DOI 10.1590/1516-3180.2014.1322640; Amouri I, 2013, ANN BIOL CLIN-PARIS, V71, P151, DOI 10.1684/abc.2013.0797; [Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; Bassyouni RH, 2015, J MICROBIOL BIOTECHN, V25, P1734, DOI 10.4014/jmb.1504.04009; Bonfim-Mendonca PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107805; Buchta V, 2013, Ceska Gynekol, V78, P537; Carrara MA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.011; Cassone A, 2015, BJOG-INT J OBSTET GY, V122, P785, DOI 10.1111/1471-0528.12994; Donders GGG, 2002, AM J OBSTET GYNECOL, V187, P989, DOI 10.1067/mob.2002.126285; Ehrstrom SM, 2005, AM J OBSTET GYNECOL, V193, P1376, DOI 10.1016/j.ajog.2005.03.068; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; FIDEL PL, 1995, INFECT IMMUN, V63, P2403, DOI 10.1128/IAI.63.7.2403-2408.1995; Jonsson P, 2015, PHYSIOL BEHAV, V15, P30034; Kurtzman CP, 1998, YEAST TAXONOMIC STUD; Liu MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079812; Meyer H, 2006, MYCOSES, V49, P202, DOI 10.1111/j.1439-0507.2006.01235.x; Muzny CA, 2015, CLIN INFECT DIS, V61, P601, DOI 10.1093/cid/civ353; Nayar R., 2015, BETHESDA SYSTEM REPO, V3rd; Nyirjesy P, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2650; Nyirjesy P, 2012, CURR MED RES OPIN, V28, P1173, DOI 10.1185/03007995.2012.697053; ODDS FC, 1988, J MED VET MYCOL, V26, P277; Ratti BA, 2015, CELL IMMUNOL, V293, P22, DOI 10.1016/j.cellimm.2014.11.004; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Richardson M, 2009, FRONT BIOSCI-LANDMRK, V14, P4363, DOI 10.2741/3533; Sandini S, 2011, FEMS IMMUNOL MED MIC, V62, P215, DOI 10.1111/j.1574-695X.2011.00802.x; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 2015, AM J OBSTET GYNECOL, V15, P716; Straub RH, 2011, Z RHEUMATOL, V70, P767, DOI 10.1007/s00393-011-0784-8; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Zhou X, 2009, INFECT IMMUN, V77, P4130, DOI 10.1128/IAI.00436-09	31	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158870	10.1371/journal.pone.0158870	http://dx.doi.org/10.1371/journal.pone.0158870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415762	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500046
J	Cheong, AT; Khoo, EM; Tong, SF; Liew, SM				Cheong, Ai Theng; Khoo, Ee Ming; Tong, Seng Fah; Liew, Su May			To Check or Not to Check? A Qualitative Study on How the Public Decides on Health Checks for Cardiovascular Disease Prevention	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTORS; MORTALITY; BEHAVIOR; EPIDEMIOLOGY; WILLINGNESS; POPULATIONS; MODEL; ASIA	Background More than half of the general population does not attend screening for cardiovascular diseases (CVD) hence they are unaware of their risks. The objective of this study was to explore the views and experiences of the public in deciding to undergo health checks for CVD prevention. Methods This was a qualitative study utilising the constructivist grounded theory approach. A total of 31 individuals aged 30 years and above from the community were sampled purposively. Eight interviews and six focus groups were involved, using a semi-structured topic guide. Results A conceptual framework was developed to explain the public's decision-making process on health check participation for CVD prevention. The intention to participate in health checks was influenced by the interplay between perceived relevance and the individual's readiness to face the outcome of health checks. Health checks were deemed relevant if people perceived themselves to be at risk of CVD and there was an advantage in knowing their cardiovascular status. People were ready to face the outcome of health checks if they wanted to know the results and were prepared to deal with the subsequent management. The decision to participate in health checks was also influenced by external factors such as the views of significant others, and the accessibility and availability of resources including time and finances. Conclusions The intention to screen for CVD is motivated by two internal factors: the perceived relevance of the disease and readiness to face screening outcomes. Strategies targeting the internal decision-making process may prove to be key in improving the uptake of screening.	[Cheong, Ai Theng; Khoo, Ee Ming] Univ Malaya, Fac Med, Primary Care Res Grp, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Cheong, Ai Theng] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Malaysia; [Tong, Seng Fah; Liew, Su May] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Putra Malaysia; Universiti Kebangsaan Malaysia	Khoo, EM (corresponding author), Univ Malaya, Fac Med, Primary Care Res Grp, Dept Primary Care Med, Kuala Lumpur, Malaysia.	khooem@um.edu.my	LIEW, Su May/B-8852-2010; KHOO, EE MING/B-8785-2010; Cheong, Ai Theng/H-9884-2014	LIEW, Su May/0000-0003-2865-7955; KHOO, EE MING/0000-0003-3191-1264; Cheong, Ai Theng/0000-0002-3895-530X	University of Malaya Postgraduate Research Fund [PG049-2014A]	University of Malaya Postgraduate Research Fund(Universiti Malaya)	Financial support for this study was provided by University of Malaya Postgraduate Research Fund (PG049-2014A) via EMK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas SZ, 2015, OCCUP ENVIRON MED, V72, P664, DOI 10.1136/oemed-2014-102743; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amoroso C, 2009, AUST FAM PHYSICIAN, V38, P358; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Burgess C, 2015, HEALTH EXPECT, V18, P2437, DOI 10.1111/hex.12212; Capewell S, 2000, CIRCULATION, V102; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Community Development Department (KEMAS), 2015, KOSPEN B; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Department of Health, 2009, NHS HLTH CHECK VASC; Ellis N, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0064-1; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, V2; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jenkinson CE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0244-7; Leavy Patricia Lina, 2011, PRACTICE QUALITATIVE; Members of the Expert Panel, 2011, PRACT GUID MAN DYSL; National Vascular Disease Prevention Alliance (NVDPA), 2012, GUIDELINES MANAGEMEN; Nielsen KDB, 2004, FAM PRACT, V21, P28, DOI 10.1093/fampra/cmh107; Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Tong SF, 2011, FAM PRACT, V28, P307, DOI 10.1093/fampra/cmq101; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vallis M, 2013, CAN FAM PHYSICIAN, V59, P27; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wall M, 2004, SCAND J PRIM HEALTH, V22, P248, DOI 10.1080/02813430410006611; WHO, PROJ MORT CAUS DEATH; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2004, GLOB BURD DIS 2004 U	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159438	10.1371/journal.pone.0159438	http://dx.doi.org/10.1371/journal.pone.0159438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415432	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500128
J	Pailthorpe, BA				Pailthorpe, Bernard A.			Network Analysis and Visualization of Mouse Retina Connectivity Data	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ORGANIZATION; CIRCUIT; GRAPHS	The largest available cellular level connectivity map, of a 0.1 mm sample of the mouse retina Inner Plexiform Layer, was analysed using network models and visualized using spectral graph layouts and observed cell coordinates. This allows key nodes in the network to be identified with retinal neurons. Their strongest synaptic links can trace pathways in the network, elucidating possible circuits. Modular decomposition of the network, by sampling signal flows over nodes and links using the InfoMap method, shows discrete modules of cone bipolar cells that form a tiled mosaic in the retinal plane. The highest flow nodes, calculated by InfoMap, proved to be the most useful landmarks for elucidating possible circuits. Their dominant links to high flow amacrine cells reveal possible circuits linking bipolar through to ganglion cells and show an Off-On discrimination between the Left-Right sections of the sample. Circuits suggested by this analysis confirm known roles for some cells and point to roles for others.	[Pailthorpe, Bernard A.] Univ Sydney, Sch Phys, Brain Dynam Grp, Sydney, NSW 2006, Australia	University of Sydney	Pailthorpe, BA (corresponding author), Univ Sydney, Sch Phys, Brain Dynam Grp, Sydney, NSW 2006, Australia.	bernard.pailthorpe@sydney.edu.au						Battista GD, 1998, GRAPH DRAWING ALGORI; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Civril A, 2006, LECT NOTES COMPUT SC, V3843, P512; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Cvetkovic D., 2009, INTRO THEORY GRAPH S; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; Hubel David H, 1995, EYE BRAIN VISION, P6; Koren Y, 2005, COMPUT MATH APPL, V49, P1867, DOI 10.1016/j.camwa.2004.08.015; Lambiotte R, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056107; Lauritzen JS, 2013, J COMP NEUROL, V521, P977, DOI 10.1002/cne.23244; Le Martelot E., 2012, INT J WEB BASED COMM, V9, P323; Marc RE, 2013, PROG RETIN EYE RES, V37, P141, DOI 10.1016/j.preteyeres.2013.08.002; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Masland RH, 2011, INVEST OPHTH VIS SCI, V52, P4581, DOI 10.1167/iovs.10-7083; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042822; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Purchase HC, 2002, J VISUAL LANG COMPUT, V13, P501, DOI 10.1006/S1045-926X(02)00016-2; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sohn Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001139; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158626	10.1371/journal.pone.0158626	http://dx.doi.org/10.1371/journal.pone.0158626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414405	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500028
J	Shapiro, ALB; Boyle, KE; Dabelea, D; Patinkin, ZW; De la Houssaye, B; Ringham, BM; Glueck, DH; Barbour, LA; Norris, JM; Friedman, JE				Shapiro, Allison L. B.; Boyle, Kristen E.; Dabelea, Dana; Patinkin, Zachary W.; De la Houssaye, Becky; Ringham, Brandy M.; Glueck, Deborah H.; Barbour, Linda A.; Norris, Jill M.; Friedman, Jacob E.			Nicotinamide Promotes Adipogenesis in Umbilical Cord-Derived Mesenchymal Stem Cells and Is Associated with Neonatal Adiposity: The Healthy Start BabyBUMP Project	PLOS ONE			English	Article							PPAR-GAMMA; SIRT1; DIFFERENTIATION; ADIPOCYTES; METABOLISM; SENESCENCE; OBESITY; NAMPT; GENE	The cellular mechanisms whereby excess maternal nutrition during pregnancy increases adiposity of the offspring are not well understood. However, nicotinamide (NAM), a fundamental micronutrient that is important in energy metabolism, has been shown to regulate adipogenesis through inhibition of SIRT1. Here we tested three novel hypotheses: 1) NAM increases the adipogenic response of human umbilical cord tissue-derived mesenchymal stem cells (MSCs) through a SIRT1 and PPAR gamma pathway; 2) lipid potentiates the NAM-enhanced adipogenic response; and 3) the adipogenic response to NAM is associated with increased percent fat mass (%FM) among neonates. MSCs were derived from the umbilical cord of 46 neonates born to non-obese mothers enrolled in the Healthy Start study. Neonatal %FM was measured using air displacement plethysmography (Pea Pod) shortly after birth. Adipogenic differentiation was induced for 21 days in the 46 MSC sets under four conditions, +NAM (3mM)/-lipid (200 mu M oleate/palmitate mix), +NAM/+lipid, -NAM/+lipid, and vehicle-control (-NAM/-lipid). Cells incubated in the presence of NAM had significantly higher PPAR. protein (+24%, p < 0.01), FABP4 protein (+57%, p < 0.01), and intracellular lipid content (+51%, p < 0.01). Lipid did not significantly increase either PPAR. protein (p = 0.98) or FABP4 protein content (p = 0.82). There was no evidence of an interaction between NAM and lipid on adipogenic response of PPAR gamma or FABP4 protein (p = 0.99 and p = 0.09). In a subset of 9 MSC, SIRT1 activity was measured in the +NAM/-lipid and vehicle control conditions. SIRT1 enzymatic activity was significantly lower (-70%, p < 0.05) in the +NAM/-lipid condition than in vehicle-control. In a linear model with neonatal %FM as the outcome, the percent increase in PPAR. protein in the +NAM/-lipid condition compared to vehicle-control was a significant predictor (beta = 0.04, 95% CI 0.01-0.06, p <0.001). These are the first data to support that chronic NAM exposure potentiates adipogenesis in human MSCs in-vitro, and that this process involves PPAR gamma and SIRT1.	[Shapiro, Allison L. B.; Dabelea, Dana; Norris, Jill M.] CSPH, Dept Epidemiol, Aurora, CO 80045 USA; [Boyle, Kristen E.; Patinkin, Zachary W.; De la Houssaye, Becky; Friedman, Jacob E.] UC SOM, Dept Pediat, Aurora, CO USA; [Ringham, Brandy M.; Glueck, Deborah H.] CSPH, Dept Biostat & Informat, Aurora, CO USA; [De la Houssaye, Becky; Friedman, Jacob E.] UC SOM, Dept Biochem & Mol Genet, Aurora, CO USA; [Barbour, Linda A.] UC SOM, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Barbour, Linda A.] UC SOM, Div Maternal Fetal Med, Dept Obstet & Gynecol, Aurora, CO USA		Shapiro, ALB (corresponding author), CSPH, Dept Epidemiol, Aurora, CO 80045 USA.	allison.shapiro@ucdenver.edu	Boyle, Kristen/N-7442-2018	Boyle, Kristen/0000-0001-9689-3322; Patinkin, Zachary/0000-0001-5946-6217	American Heart Association [14PRE18230008]; Colorado Nutrition and Obesity Research Center [DK048520]; parent Healthy Start study; National Institute of Diabetes and Digestive and Kidney Disease [DK076648]; NIH/NCATS Colorado CTSA Grant [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK106347, P30DK048520, R01DK076648] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Colorado Nutrition and Obesity Research Center; parent Healthy Start study; National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NCATS Colorado CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Healthy Start BabyBUMP Project is supported by grants from the American Heart Association (Pre-doctoral Fellowship 14PRE18230008, PI: A.L.B.S.) and the Colorado Nutrition and Obesity Research Center (DK048520, PI: J.E.F.), and by the parent Healthy Start study (PI: D.D.). The Healthy Start study is supported by the National Institute of Diabetes and Digestive and Kidney Disease (DK076648, PI: D.D.) and NIH/NCATS Colorado CTSA Grant Number UL1 TR001082.	Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Boyle KE, 2016, DIABETES, V65, P647, DOI 10.2337/db15-0849; Burgos ES, 2011, CURR MED CHEM, V18, P1947; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Fischer-Posovszky P, 2010, AM J CLIN NUTR, V92, P5, DOI 10.3945/ajcn.2009.28435; Goldie C, 2016, HEART, V102, P198, DOI 10.1136/heartjnl-2015-308055; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Krasnow SM, 2011, AM J PHYSIOL-ENDOC M, V301, pE1243, DOI 10.1152/ajpendo.00261.2011; Maples JM, 2015, AM J PHYSIOL-ENDOC M, V309, pE345, DOI 10.1152/ajpendo.00505.2014; Mayoral R, 2015, MOL METAB, V4, P378, DOI 10.1016/j.molmet.2015.02.007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Polidori GP, 2012, MOL CELL ENDOCRINOL, V361, P40, DOI 10.1016/j.mce.2012.03.010; Rebholz SL, 2011, AM J PHYSIOL-ENDOC M, V301, pE416, DOI 10.1152/ajpendo.00619.2010; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Song TY, 2015, BIOGERONTOLOGY, V16, P789, DOI 10.1007/s10522-015-9605-9; Starling AP, 2015, AM J CLIN NUTR, V101, P302, DOI 10.3945/ajcn.114.094946; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; U. S. National Library of Medicine, 2015, DIET SUPPL LAB DAT; Zeljkovic A, 2013, MATERN CHILD HLTH J, V17, P556, DOI 10.1007/s10995-012-1031-x; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	26	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159575	10.1371/journal.pone.0159575	http://dx.doi.org/10.1371/journal.pone.0159575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414406	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500136
J	Kripke, K; Perales, N; Lija, J; Fimbo, B; Mlanga, E; Mahler, H; Juma, JM; Baingana, E; Plotkin, M; Kakiziba, D; Semini, I; Castor, D; Njeuhmeli, E				Kripke, Katharine; Perales, Nicole; Lija, Jackson; Fimbo, Bennet; Mlanga, Eric; Mahler, Hally; Juma, James McOllogi; Baingana, Emmanuel; Plotkin, Marya; Kakiziba, Deogratias; Semini, Iris; Castor, Delivette; Njeuhmeli, Emmanuel			The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania	PLOS ONE			English	Article							YOUNG MEN; RISK; TRIAL	Background Since its launch in 2010, the Tanzania National Voluntary Medical Male Circumcision (VMMC) Program has focused efforts on males ages 10-34 in 11 priority regions. Implementers have noted that over 70% of VMMC clients are between the ages of 10 and 19, raising questions about whether additional efforts would be required to recruit men age 20 and above. This analysis uses mathematical modeling to examine the economic and epidemiological consequences of scaling up VMMC among specific age groups and priority regions in Tanzania. Methods and Findings Analyses were conducted using the Decision Makers' Program Planning Tool Version 2.0 (DMPPT 2.0), a compartmental model implemented in Microsoft Excel 2010. The model was populated with population, mortality, and HIV incidence and prevalence projections from external sources, including outputs from Spectrum/AIDS Impact Module (AIM). A separate DMPPT 2.0 model was created for each of the 11 priority regions. Tanzania can achieve the most immediate impact on HIV incidence by circumcising males ages 20-34. This strategy would also require the fewest VMMCs for each HIV infection averted. Circumcising men ages 10-24 will have the greatest impact on HIV incidence over a 15-year period. The most cost-effective approach (lowest cost per HIV infection averted) targets men ages 15-34. The model shows the VMMC program is cost saving in all 11 priority regions. VMMC program cost-effectiveness varies across regions due to differences in projected HIV incidence, with the most cost-effective programs in Njombe and Iringa. Conclusions The DMPPT 2.0 results reinforce Tanzania's current VMMC strategy, providing newfound confidence in investing in circumcising adolescents. Tanzanian policy makers and program implementers will continue to focus scale-up of VMMC on men ages 10-34 years, seeking to maximize program impact and cost-effectiveness while acknowledging trends in demand among the younger and older age groups.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA; [Perales, Nicole] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Lija, Jackson; Juma, James McOllogi] Tanzania Natl AIDS Control Program, Dar Es Salaam, Tanzania; [Fimbo, Bennet] Independent Consultant, Dar Es Salaam, Tanzania; [Mlanga, Eric; Plotkin, Marya] US Agcy Int Dev, Dar Es Salaam, Tanzania; [Mahler, Hally] Jhpiego, Dar Es Salaam, Tanzania; [Baingana, Emmanuel; Semini, Iris] Joint United Nations Programme HIV AIDS, Dar Es Salaam, Tanzania; [Kakiziba, Deogratias] US Dept Def, Dar Es Salaam, Tanzania; [Castor, Delivette] Off US Global AIDS Coordinator, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC USA	United States Agency for International Development (USAID); Jhpiego; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project [AID-OAA-A-10-00067]	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) vertical bar Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, analysis of data, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of USAID or the U.S. Government.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; CAMERON DW, 1989, LANCET, V2, P403; FRUS, 1975, COMMUNICATION 1114, V28; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Hankins C, 2015, CUTTING IT COU UNPUB; Kanagat N, 2013, AIDSTAR ONE CASE STU; Kripke K, 2015, ASSESSING PROG UNPUB; Kripke K., 2015, AGE TARGETING UNPUB; Larke Natasha, 2010, Br J Nurs, V19, P629; Liu CM, 2013, MBIO, V4, DOI 10.1128/mBio.00076-13; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; MBOERA LEG, 2009, CHALLENGES OPPORTUNI; Menon V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083925; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Plotkin M, 2011, EMBE HALIJAMENYWA UN; Plotkin M, 2013, GLOB HLTH SCI PRACT, V1; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Tanzania Commission for AIDS (TACAIDS) ZACZ National Bureau of Statistics (NBS) Office of Chief Government Statistician (OCGS) and ICF International, 2013, TANZ HIV AIDS MAL IN; The United Republic Of Tanzania MOHASW The National AIDS Control Programme, 2014, VOL MED MAL CIRC COU; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; [UNAIDS WHO], 2007, NEW DAT MAL CIRC HIV; UNAIDS, 2011, JOINT STRAT ACT FRAM; United Republic of Tanzania MoHaSW National AIDS Control Programme, 2010, NAT STRAT SCAL MAL C; Wambura M, 2009, SITUATION ANAL MALE; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0153363	10.1371/journal.pone.0153363	http://dx.doi.org/10.1371/journal.pone.0153363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410384	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300001
J	Ortega, Z; Martin-Vallejo, J; Mencia, A; Galindo-Villardon, MP; Perez-Mellado, V				Ortega, Zaida; Martin-Vallejo, Javier; Mencia, Abraham; Purificacion Galindo-Villardon, Maria; Perez-Mellado, Valentin			Introducing Meta-Partition, a Useful Methodology to Explore Factors That Influence Ecological Effect Sizes	PLOS ONE			English	Article							RANDOM-EFFECTS MODELS; REGRESSION TREES; METAANALYSIS; HETEROGENEITY; TRIALS	The study of the heterogeneity of effect sizes is a key aspect of ecological meta-analyses. Here we propose a meta-analytic methodology to study the influence of moderators in effect sizes by splitting heterogeneity: meta-partition. To introduce this methodology, we performed a meta-partition of published data about the traits that influence species sensitivity to habitat loss, that have been previously analyzed through meta-regression. Thus, here we aim to introduce meta-partition and to make an initial comparison with meta-regression. Meta-partition algorithm consists of three steps. Step 1 is to study the heterogeneity of effect sizes under the assumption of fixed effect model. If heterogeneity is found, we perform step 2, that is, to partition the heterogeneity by the moderator that minimizes heterogeneity within a subset while maximizing heterogeneity between subsets. Then, if effect sizes of the subset are still heterogeneous, we repeat step 1 and 2 until we reach final subsets. Finally, step 3 is to integrate effect sizes of final subsets, with fixed effect model if there is homogeneity, and with random effects model if there is heterogeneity. Results show that meta-partition is valuable to assess the importance of moderators in explaining heterogeneity of effect sizes, as well as to assess the directions of these relations and to detect possible interactions between moderators. With meta-partition we have been able to evaluate the importance of moderators in a more objective way than with meta-regression, and to visualize the complex relations that may exist between them. As ecological issues are often influenced by several factors interacting in complex ways, ranking the importance of possible moderators and detecting possible interactions would make meta-partition a useful exploration tool for ecological meta-analyses.	[Ortega, Zaida; Mencia, Abraham; Perez-Mellado, Valentin] Univ Salamanca, Dept Anim Biol, Salamanca, Spain; [Ortega, Zaida; Martin-Vallejo, Javier; Purificacion Galindo-Villardon, Maria] Univ Salamanca, Dept Stat, Salamanca, Spain	University of Salamanca; University of Salamanca	Ortega, Z (corresponding author), Univ Salamanca, Dept Anim Biol, Salamanca, Spain.; Ortega, Z (corresponding author), Univ Salamanca, Dept Stat, Salamanca, Spain.	zaidaortega@usal.es	Vallejo, Francisco Javier F J Martin/B-4029-2012; Ortega, Zaida/T-1466-2017; Galindo-Villardón, Purificación/E-3594-2013	Vallejo, Francisco Javier F J Martin/0000-0003-3962-7356; Ortega, Zaida/0000-0002-8167-1652; Galindo-Villardón, Purificación/0000-0001-6977-7545	University of Salamanca (FPI program); Spanish Ministry of Science and Innovation [CGL2012-39850-CO2-02]	University of Salamanca (FPI program); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support was provided to ZO and AM by predoctoral grants of the University of Salamanca (FPI program). This work was also supported by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation.; We thank Pauline Quesnelle, Kathryn Lindsay and Lenore Fahrig because we used their study to test meta-partition and compare it with meta-regression, and all authors of primary studies used in the present work. We also thank Robert B. O'Hara and two anonymous reviewers for useful suggestions that helped to improve the study, and Mary Trini Mencia and Joe McIntyre for linguistic revision. Financial support was provided to ZO and AM by predoctoral grants of the University of Salamanca (FPI program). This work was also supported by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation.	Adams DC, 2008, EVOLUTION, V62, P567, DOI 10.1111/j.1558-5646.2007.00314.x; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Berlin JA, 1994, ONLINE J CURR CLIN T, P134; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Breiman L., 1984, CLASSIFICATION REGRE; Chalmers T C, 1993, Stat Methods Med Res, V2, P161; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; EYSENCK HJ, 1978, AM PSYCHOL, V33, P517, DOI 10.1037/0003-066X.33.5.517.a; Freedman D.A., 1999, INT ENCY SOCIAL BEHA, V6, P4027; Gurevitch J, 2013, HDB METAANALYSIS ECO, P426; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillebrand H, 2013, ECOL LETT, V16, P1419, DOI 10.1111/ele.12190; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Humphrey SE, 2011, ORGAN PSYCHOL REV, V1, P99, DOI 10.1177/2041386611401273; Hunter J.E., 2004, METHODS META ANAL CO; Ioannidis JPA, 2008, BMJ-BRIT MED J, V336, P1413, DOI 10.1136/bmj.a117; Jeng GT, 1995, JAMA-J AM MED ASSOC, V247, P831; Jennions MD, 2013, HDB METAANALYSIS ECO, P381; JONES DR, 1992, J ROY SOC MED, V85, P165; Krist M, 2011, BIOL REV, V86, P692, DOI 10.1111/j.1469-185X.2010.00166.x; Lajeunesse MJ, 2009, AM NAT, V174, P369, DOI 10.1086/603628; Lortie CJ, 2015, RES SYNTH METHODS, V6, P124, DOI 10.1002/jrsm.1109; Martin-Vallejo J, 1995, THESIS; Mengersen K., 2013, HDB META ANAL ECOLOG, P89, DOI DOI 10.1515/9781400846184-010; Mezei P, 2014, FOREST ECOL MANAG, V331, P196, DOI 10.1016/j.foreco.2014.07.031; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Nakagawa S, 2012, EVOL ECOL, V26, P1253, DOI 10.1007/s10682-012-9555-5; Nakagawa S, 2012, EVOL ECOL, V26, P1085, DOI 10.1007/s10682-012-9593-z; Oakes M, 1993, Stat Methods Med Res, V2, P147; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; Quesnelle PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090926; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Sall J., 2002, MONTE CARLO CALIBRAT; Schwenk K, 2009, INTEGR COMP BIOL, V49, P7, DOI 10.1093/icb/icp034; Stewart G, 2010, BIOL LETTERS, V6, P78, DOI 10.1098/rsbl.2009.0546; Sutton AJ, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P175; Thompson S G, 1993, Stat Methods Med Res, V2, P173, DOI 10.1177/096228029300200205; THOMPSON SG, 1991, LANCET, V338, P1127, DOI 10.1016/0140-6736(91)91975-Z; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	50	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158624	10.1371/journal.pone.0158624	http://dx.doi.org/10.1371/journal.pone.0158624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409084	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300027
J	Wang, L; Zhang, P; Molkentine, DP; Chen, C; Molkentine, JM; Piao, H; Raju, U; Zhang, J; Valdecanas, DR; Tailor, RC; Thames, HD; Buchholz, TA; Chen, J; Ma, L; Mason, KA; Ang, KK; Meyn, RE; Skinner, HD				Wang, L.; Zhang, P.; Molkentine, D. P.; Chen, C.; Molkentine, J. M.; Piao, H.; Raju, U.; Zhang, J.; Valdecanas, D. R.; Tailor, R. C.; Thames, H. D.; Buchholz, T. A.; Chen, J.; Ma, L.; Mason, K. A.; Ang, K-K; Meyn, R. E.; Skinner, H. D.			TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; DOUBLE-STRAND BREAKS; DNA-DAMAGE-RESPONSE; P16 GENE; CANCER GENOMICS; POSITIVE HEAD; NUCLEAR FOCI; 53BP1; EXPRESSION; REPAIR	Patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) have better responses to radiotherapy and higher overall survival rates than do patients with HPV-negative HNSCC, but the mechanisms underlying this phenomenon are unknown. p16 is used as a surrogate marker for HPV infection. Our goal was to examine the role of p16 in HPV-related favorable treatment outcomes and to investigate the mechanisms by which p16 may regulate radiosensitivity. HNSCC cells and xenografts (HPV/p16-positive and -negative) were used. p16-overexpressing and small hairpin RNA-knockdown cells were generated, and the effect of p16 on radiosensitivity was determined by clonogenic cell survival and tumor growth delay assays. DNA double-strand breaks (DSBs) were assessed by immunofluorescence analysis of 53BP1 foci; DSB levels were determined by neutral comet assay; western blotting was used to evaluate protein changes; changes in protein half-life were tested with a cycloheximide assay; gene expression was examined by real-time polymerase chain reaction; and data from The Cancer Genome Atlas HNSCC project were analyzed. p16 overexpression led to downregulation of TRIP12, which in turn led to increased RNF168 levels, repressed DNA damage repair (DDR), increased 53BP1 foci and enhanced radioresponsiveness. Inhibition of TRIP12 expression further led to radiosensitization, and overexpression of TRIP12 was associated with poor survival in patients with HPV-positive HNSCC. These findings reveal that p16 participates in radiosensitization through influencing DDR and support the rationale of blocking TRIP12 to improve radiotherapy outcomes.	[Wang, L.; Zhang, P.; Molkentine, D. P.; Chen, C.; Molkentine, J. M.; Piao, H.; Raju, U.; Zhang, J.; Valdecanas, D. R.; Thames, H. D.; Chen, J.; Ma, L.; Mason, K. A.; Ang, K-K; Meyn, R. E.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Z7-3014,1515 Holcombe Blvd,Unit 1052, Houston, TX 77030 USA; [Piao, H.] Chinese Acad Sci, Dalian Inst Chem Phys, Div Biotechnol, Dalian, Peoples R China; [Tailor, R. C.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Buchholz, T. A.; Ang, K-K; Skinner, H. D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wang, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Z7-3014,1515 Holcombe Blvd,Unit 1052, Houston, TX 77030 USA.	Lwang6@mdanderson.org	Ma, Li/GQR-1313-2022; Skinner, Heath/A-1669-2012	Ma, Li/0000-0001-9965-989X; Buchholz, Thomas/0000-0002-7859-5572; Zhang, Peijing/0000-0003-1586-8710; Skinner, Heath/0000-0003-1836-151X; Molkentine, Jessica/0000-0002-3757-7167	National Cancer Institute [R01CA168485, R01CA181029]; Cancer Prevention Research Institute of Texas [RP150293, P30 NCI CA016672]; MD Anderson Cancer Head and Cancer SPORE Career Development Award; Center for Radiation Oncology Research Development Award; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA181029, R01CA168485] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas; MD Anderson Cancer Head and Cancer SPORE Career Development Award; Center for Radiation Oncology Research Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Jeffery Myers and Dr Peter J F Snijders for kindly sharing their cell lines. This work was supported by grants R01CA168485 and R01CA181029 from the National Cancer Institute (REM and KKA) and (LM), respectively, the Gilbert H Fletcher Chair (KKA), Cancer Center Support Grant (P30 NCI CA016672), Individual Investigator Research Award RP150293 from the Cancer Prevention Research Institute of Texas (HDS), an MD Anderson Cancer Head and Cancer SPORE Career Development Award (HDS) and a Center for Radiation Oncology Research Development Award (HDS). The content is solely the responsibility of the authors and does not represent the official views of any grant-awarding agency.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2012, SEMIN RADIAT ONCOL, V22, P128, DOI 10.1016/j.semradonc.2011.12.004; Bauer E, 1998, MUTAT RES-FUND MOL M, V398, P101, DOI 10.1016/S0027-5107(97)00246-7; Bihl MP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-173; Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DL, 2013, MOL CELL, V51, P46, DOI 10.1016/j.molcel.2013.05.006; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Collado M, 2010, CANCER CELL, V17, P317, DOI 10.1016/j.ccr.2010.03.015; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dok R, 2014, CANCER RES, V74, P1739, DOI 10.1158/0008-5472.CAN-13-2479; Duan S., 2012, ABSTRACT APPL ANAL, V2012, P1, DOI DOI 10.1109/SPC0M.2012.6290252; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; HALL M, 1995, ONCOGENE, V11, P1581; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Klussmann JP, 2003, AM J PATHOL, V162, P747, DOI 10.1016/S0002-9440(10)63871-0; Lee AWC, 2003, MOL CANCER THER, V2, P961; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lewis JS, 2010, AM J SURG PATHOL, V34, P1088, DOI 10.1097/PAS.0b013e3181e84652; Li CY, 2013, CELL CYCLE, V12, P923, DOI 10.4161/cc.23882; Li W, 2004, HEAD NECK-J SCI SPEC, V26, P1, DOI 10.1002/hed.10335; Lou-Qian Zhang, 2013, PLoS One, V8, pe54970, DOI 10.1371/journal.pone.0054970; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Matsuda K, 2011, HISTOPATHOLOGY, V59, P441, DOI 10.1111/j.1365-2559.2011.03963.x; Matsumura Y, 1997, CANCER LETT, V115, P91, DOI 10.1016/S0304-3835(97)04714-9; McLaughlin-Drubin ME, 2013, P NATL ACAD SCI USA, V110, P16175, DOI 10.1073/pnas.1310432110; Mirzayans R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951574; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rieckmann T, 2013, RADIOTHER ONCOL, V107, P242, DOI 10.1016/j.radonc.2013.03.013; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; SmithSorensen B, 1996, HUM MUTAT, V7, P294, DOI 10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Velimezi G, 2013, NAT CELL BIOL, V15, P967, DOI 10.1038/ncb2795; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Wang L, 2012, MOL MED REP, V6, P904, DOI 10.3892/mmr.2012.1001; Wang L, 2011, ANTICANCER RES, V31, P2141; Westra WH, 2011, HEAD NECK-J SCI SPEC, V34, P459; Xu RB, 2013, CANCER BIOMARK, V13, P215, DOI 10.3233/CBM-130355; Yang ZH, 2014, ASIAN PAC J CANCER P, V15, P3817, DOI 10.7314/APJCP.2014.15.8.3817	50	27	27	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					820	828		10.1038/onc.2016.250	http://dx.doi.org/10.1038/onc.2016.250			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27425591	Green Accepted			2022-12-26	WOS:000394168200009
J	Damaraju, VL; Weber, D; Kuzma, M; Cass, CE; Sawyer, MB				Damaraju, Vijaya L.; Weber, Dwayne; Kuzma, Michelle; Cass, Carol E.; Sawyer, Michael B.			Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors IDENTIFICATION OF KEY hENT1 AMINO ACID RESIDUES FOR INTERACTION WITH BCR-ABL KINASE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE; IMATINIB MESYLATE; CELLULAR UPTAKE; PHARMACOLOGICAL-PROPERTIES; SACCHAROMYCES-CEREVISIAE; PHILADELPHIA-CHROMOSOME; COMBINATION THERAPY; DRUG-RESISTANCE	Human nucleoside transporters (hNTs) mediate cellular influx of anticancer nucleoside drugs, including cytarabine, cladribine, and fludarabine. BCR-ABL tyrosine kinase inhibitors (TKIs) imatinib and dasatinib inhibit fludarabine and cytarabine uptake. We assessed interactions of bosutinib, dasatinib, imatinib, nilotinib, and ponatinib with recombinant hNTs (hENT1, 2; hCNT1, -2, and-3) produced individually in yeast Saccharomyces cerevisiae. Nilotinib inhibited hENT1-mediated uridine transport most potently (IC50 value, 0.7 mu m) followed by ponatinib > bosutinib > dasatinib > imatinib. Imatinib inhibited hCNI2 with an IC50 value of 2.3 mu m. Ponatinib inhibited all five hNTs with the greatest effect seen for hENT1 (IC50 value, 9 gm). TKIs inhibited [H-3]uridine uptake in a competitive manner. Studies in yeast with mutants at two amino acid residues of hENT1 (L4421, L442T, M33A, M33A/L442I) previously shown to be involved in uridine and dipyridamole binding, suggested that BCR-ABL TKIs interacted with Met(33) (TM1) and Leu(442) (TM11) residues of hENT1. In cultured human CEM lymphoblastoid cells, which possess a single hNT type (hENT1), accumulation of [H-3]cytarabine, [H-3]cladribine, or [H-3]fludarabine was reduced by each of the five TKIs, and also caused a reduction in cell surface expression of hENT1 protein. In conclusion, BCR-ABL TKIs variously inhibit five different hNTs, cause a decrease in cell surface hENT1 expression, and decrease uridine accumulation when presented together with uridine or when given before uridine. In experiments with mutant hENT1, we showed for the first time interaction of Met(33) (involved in dipyridamole binding) with BCR-ABI, inhibitors and reduced interaction with M33A mutant hENT1.	Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Sawyer, MB (corresponding author), 11560 Univ Ave NW, Edmonton, AB T6G 1Z2, Canada.	michael.sawyer@albertahealthservices.ca			Alberta Cancer Foundation; Alberta Innovates Health Solutions	Alberta Cancer Foundation; Alberta Innovates Health Solutions	This work was supported by grants from the Alberta Cancer Foundation and Alberta Innovates Health Solutions (to M. B. S.). V. L D. and M. B. S. are listed on a patent "Combination treatments for cancer" held by Alberta Health Services.	Asaki T, 2006, BIOORG MED CHEM LETT, V16, P1421, DOI 10.1016/j.bmcl.2005.11.042; Breccia M, 2010, LEUKEMIA RES, V34, P129, DOI 10.1016/j.leukres.2009.08.031; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; CRAWFORD CR, 1990, BIOCHIM BIOPHYS ACTA, V1024, P289, DOI 10.1016/0005-2736(90)90357-T; Damaraju VL, 2015, CANCER CHEMOTH PHARM, V76, P1093, DOI 10.1007/s00280-015-2859-8; Damaraju VL, 2015, MOL CANCER THER, V14, P236, DOI 10.1158/1535-7163.MCT-14-0337; Damaraju VL, 2014, CLIN CANCER RES, V20, P176, DOI 10.1158/1078-0432.CCR-13-2293; Damaraju VL, 2009, NUCLEOS NUCLEOT NUCL, V28, P450, DOI 10.1080/15257770903044499; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Eck MJ, 2009, CURR OPIN CELL BIOL, V21, P288, DOI 10.1016/j.ceb.2009.01.014; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Hegedus C, 2009, BRIT J PHARMACOL, V158, P1153, DOI 10.1111/j.1476-5381.2009.00383.x; Hiwase DK, 2008, CLIN CANCER RES, V14, P3881, DOI 10.1158/1078-0432.CCR-07-5095; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Jabbour E, 2011, HEMATOL ONCOL CLIN N, V25, P981, DOI 10.1016/j.hoc.2011.09.004; JARVIS SM, 1982, J PHYSIOL-LONDON, V324, P31, DOI 10.1113/jphysiol.1982.sp014099; JARVIS SM, 1986, MOL PHARMACOL, V30, P659; Leisewitz AV, 2008, NUCLEOS NUCLEOT NUCL, V27, P779, DOI 10.1080/15257770802145892; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; Naud JS, 2012, LEUKEMIA RES, V36, P1311, DOI 10.1016/j.leukres.2012.06.012; Ohanian M, 2012, EXPERT OPIN PHARMACO, V13, P927, DOI 10.1517/14656566.2012.672974; Paproski RJ, 2008, BIOCHEM J, V414, P291, DOI 10.1042/BJ20080074; PATERSON ARP, 1980, MOL PHARMACOL, V18, P40; Ravandi F, 2011, CL LYMPH MYELOM LEUK, V11, P198, DOI 10.1016/j.clml.2011.03.002; Robak P, 2013, CANCER TREAT REV, V39, P851, DOI 10.1016/j.ctrv.2013.03.006; Robins MJ, 2010, J MED CHEM, V53, P6040, DOI 10.1021/jm100432w; Segel I.H., 1975, ENZYME KINETICS; Sen R, 2012, MOL CANCER THER, V11, P2033, DOI 10.1158/1535-7163.MCT-12-0302; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; Thielen N, 2013, ANN HEMATOL, V92, P1049, DOI 10.1007/s00277-013-1730-4; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Vickers MF, 2002, BIOCHEM CELL BIOL, V80, P639, DOI 10.1139/O02-148; Visser F, 2005, J BIOL CHEM, V280, P11025, DOI 10.1074/jbc.M410348200; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; White DL, 2006, BLOOD, V108, P697, DOI 10.1182/blood-2005-11-4687; Woodahl EL, 2008, CANCER CHEMOTH PHARM, V62, P735, DOI 10.1007/s00280-007-0629-y; Yamakawa Y, 2011, CLIN PHARMACOL THER, V90, P157, DOI 10.1038/clpt.2011.102; Yamakawa Y, 2014, BIOL PHARM BULL, V37, P1330, DOI 10.1248/bpb.b14-00254; Yang K, 2015, CRIT REV ONCOL HEMAT, V93, P277, DOI 10.1016/j.critrevonc.2014.11.001; Zhang J, 2003, MOL PHARMACOL, V64, P1512, DOI 10.1124/mol.64.6.1512; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	46	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18809	18817		10.1074/jbc.M116.741074	http://dx.doi.org/10.1074/jbc.M116.741074			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432881	Green Published, hybrid			2022-12-26	WOS:000383242300018
J	Bromley, M; Johns, A; Davies, E; Fraczek, M; Gilsenan, JM; Kurbatova, N; Keays, M; Kapushesky, M; Gut, M; Gut, I; Denning, DW; Bowyer, P				Bromley, Mike; Johns, Anna; Davies, Emma; Fraczek, Marcin; Gilsenan, Jane Mabey; Kurbatova, Natalya; Keays, Maria; Kapushesky, Misha; Gut, Marta; Gut, Ivo; Denning, David W.; Bowyer, Paul			Mitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in Fungi	PLOS ONE			English	Article							CANDIDA-ALBICANS; ASPERGILLUS-FUMIGATUS; NEUROSPORA-CRASSA; ANTIFUNGAL AGENTS; CONFERRING RESISTANCE; EFFLUX TRANSPORTER; MAJOR FACILITATOR; DRUG-RESISTANCE; FLUCONAZOLE; SUSCEPTIBILITY	Recent estimates of the global burden of fungal disease suggest that that their incidence has been drastically underestimated and that mortality may rival that of malaria or tuberculosis. Azoles are the principal class of antifungal drug and the only available oral treatment for fungal disease. Recent occurrence and increase in azole resistance is a major concern worldwide. Known azole resistance mechanisms include over-expression of efflux pumps and mutation of the gene encoding the target protein cyp51a, however, for one of the most important fungal pathogens of humans, Aspergillus fumigatus, much of the observed azole resistance does not appear to involve such mechanisms. Here we present evidence that azole resistance in A. fumigatus can arise through mutation of components of mitochondrial complex I. Gene deletions of the 29.9KD subunit of this complex are azole resistant, less virulent and exhibit dysregulation of secondary metabolite gene clusters in a manner analogous to deletion mutants of the secondary metabolism regulator, LaeA. Additionally we observe that a mutation leading to an E180D amino acid change in the 29.9 KD subunit is strongly associated with clinical azole resistant A. fumigatus isolates. Evidence presented in this paper suggests that complex I may play a role in the hypoxic response and that one possible mechanism for cell death during azole treatment is a dysfunctional hypoxic response that may be restored by dysregulation of complex I. Both deletion of the 29.9 KD subunit of complex I and azole treatment alone profoundly change expression of gene clusters involved in secondary metabolism and immunotoxin production raising potential concerns about long term azole therapy.	[Bromley, Mike; Johns, Anna; Fraczek, Marcin; Gilsenan, Jane Mabey; Bowyer, Paul] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester Fungal Infect Grp, 2-24 Core Technol Bldg,Grafton St, Manchester M13 9NT, Lancs, England; [Davies, Emma; Denning, David W.; Bowyer, Paul] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Natl Aspergillosis Ctr,Univ Hosp South Manchester, 2nd Floor Educ & Res Ctr, Manchester M23 9LT, Lancs, England; [Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Parc Cient Barcelona,Baldiri Reixac,4,PCB Tower 1, Barcelona 08028, Spain; [Kurbatova, Natalya; Keays, Maria; Kapushesky, Misha] EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England; [Kapushesky, Misha] Genestack Ltd, Salisbury House,Stn Rd, Cambridge CB1 2LA, England	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Bowyer, P (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Manchester Fungal Infect Grp, 2-24 Core Technol Bldg,Grafton St, Manchester M13 9NT, Lancs, England.; Bowyer, P (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Natl Aspergillosis Ctr,Univ Hosp South Manchester, 2nd Floor Educ & Res Ctr, Manchester M23 9LT, Lancs, England.	paul.bowyer@manchester.ac.uk	Denning, David/AAC-6931-2019; Fraczek, Marcin/AAZ-5748-2021; Gut, Ivo/ABF-3188-2020	Denning, David/0000-0001-5626-2251; Gut, Ivo/0000-0001-7219-632X; Davies, Emma/0000-0003-4704-736X; Bromley, Michael/0000-0002-7611-0201; Fraczek, Marcin/0000-0001-5134-4709; bowyer, paul/0000-0002-1083-9286; Keays, Maria/0000-0003-2034-601X	EU [242220]	EU(European Commission)	The work of the Mycology Reference Centre Manchester (ED, DWD) has been underwritten by the Fungal Research Trust since 1991. MB, MF, MKa, IG, MG and PB were funded by an EU Framework Programme 7 Collaborative Project, SYBARIS, Grant Agreement Number 242220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; [Anonymous], 1997, AGRIOS PLANT PATHOLO, pP25; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Barnes PD, 2007, BRIT J HAEMATOL, V139, P519, DOI 10.1111/j.1365-2141.2007.06812.x; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bennett J.W., 1999, ENCY BIOPROCESS TECH, P213; Bowyer P, 2012, FEMS MICROBIOL LETT, V332, P10, DOI 10.1111/j.1574-6968.2012.02575.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMBL R, 1986, P NATL ACAD SCI USA, V83, P3644, DOI 10.1073/pnas.83.11.3644; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Cheng SJ, 2007, ANTIMICROB AGENTS CH, V51, P1855, DOI 10.1128/AAC.00182-07; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Ene IV, 2013, INFECT IMMUN, V81, P238, DOI 10.1128/IAI.01092-12; Ene IV, 2012, PROTEOMICS, V12, P3164, DOI 10.1002/pmic.201200228; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Fraczek MG, 2013, J ANTIMICROB CHEMOTH, V68, P1486, DOI 10.1093/jac/dkt075; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; Gupta V, 1998, CURR GENET, V34, P192, DOI 10.1007/s002940050385; Jantunen E, 2008, TRANSPL INFECT DIS, V10, P156, DOI 10.1111/j.1399-3062.2008.00301.x; KELLY SL, 1995, BIOCHEM BIOPH RES CO, V207, P910, DOI 10.1006/bbrc.1995.1272; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khamooshi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-56; Latge JP, 2002, CURR OPIN MICROBIOL, V5, P355, DOI 10.1016/S1369-5274(02)00343-0; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Law D, 1997, ANTIMICROB AGENTS CH, V41, P2310, DOI 10.1128/AAC.41.10.2310; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Manavathu EK, 1998, ANTIMICROB AGENTS CH, V42, P3018, DOI 10.1128/AAC.42.11.3018; Marichal P, 1999, ANTIMICROB AGENTS CH, V43, P2663, DOI 10.1128/AAC.43.11.2663; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Marques I, 2005, BBA-BIOENERGETICS, V1707, P211, DOI 10.1016/j.bbabio.2004.12.003; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nolte FS, 1997, ANTIMICROB AGENTS CH, V41, P196, DOI 10.1128/AAC.41.1.196; Nout MJR, 2002, MYCOTA, V10, P23; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Oerke EC., 1994, CROP PRODUCTION CROP; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; Pfaller MA, 2006, CLIN MICROBIOL REV, V19, P435, DOI 10.1128/CMR.19.2.435-447.2006; Ronning Catherine M., 2005, Revista Iberoamericana de Micologia, V22, P223; Ruijter GJG, 2002, MYCOTA, V10, P213; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 1997, MICROBIOL-UK, V143, P405, DOI 10.1099/00221287-143-2-405; Schaller M, 1998, MOL MICROBIOL, V29, P605, DOI 10.1046/j.1365-2958.1998.00957.x; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Silveira FP, 2007, MED MYCOL, V45, P305, DOI 10.1080/13693780701200372; Sun N, 2013, ANTIMICROB AGENTS CH, V57, P532, DOI 10.1128/AAC.01520-12; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13; Thompson GR, 2008, SEMIN RESP CRIT CARE, V29, P103, DOI 10.1055/s-2008-1063849; Torres HA, 2005, LANCET INFECT DIS, V5, P775, DOI 10.1016/S1473-3099(05)70297-8; Ushakova AV, 2005, J MOL BIOL, V351, P327, DOI 10.1016/j.jmb.2005.06.005; Vanden Bossche H, 1985, Curr Top Med Mycol, V1, P313; VANDENBOSSCHE H, 1993, ANTIMICROB AGENTS CH, V37, P2101, DOI 10.1128/AAC.37.10.2101; Videira A, 2002, BBA-BIOENERGETICS, V1555, P187, DOI 10.1016/S0005-2728(02)00276-1; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; WRIGHT GD, 1990, BIOCHIM BIOPHYS ACTA, V1040, P95, DOI 10.1016/0167-4838(90)90151-5; Yang Yun-Liang, 2001, Journal of Microbiology Immunology and Infection, V34, P79; YOSHIDA Y, 1984, J BIOL CHEM, V259, P1655; YOSHIDA Y, 1987, BIOCHEM PHARMACOL, V36, P229, DOI 10.1016/0006-2952(87)90694-0	66	27	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158724	10.1371/journal.pone.0158724	http://dx.doi.org/10.1371/journal.pone.0158724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438017	Green Submitted, Green Published, gold			2022-12-26	WOS:000380170100019
J	Davies, JL; Thompson, S; Kaur-Sandhu, H; Sawcer, S; Coles, A; Ban, M; Jones, J				Davies, Jessica L.; Thompson, Sara; Kaur-Sandhu, Harpreet; Sawcer, Stephen; Coles, Alasdair; Ban, Maria; Jones, Joanne			Increased THEMIS First Exon Usage in CD4+T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis	PLOS ONE			English	Article							REGULATORY T-CELLS; THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; CELIAC-DISEASE; TRANSCRIPTION; HOMEOSTASIS; VARIANTS; PROTEIN; COMMON; RNA	Multiple sclerosis is an autoimmune disease of the central nervous system. Genome wide association studies have identified over 100 common variants associated with multiple sclerosis, the majority of which implicate immunologically relevant genes, particularly those involved in T-cell development. SNP rs13204742 at the THEMIS/PTPRK locus is one such variant. Here, we have demonstrated mutually exclusive use of exon 1 and 2 amongst 16 novel THEMIS isoforms. We also show inverse correlation between THEMIS expression in human CD4+ T-cells and dosage of the multiple sclerosis risk allele at rs13204742, driven by reduced expression of exon 1-containing isoforms. In silico analysis suggests that this may be due to cell-specific, allele-dependent binding of the transcription factors FoxP3 and/or E47. Research exploring the functional implications of GWAS variants is important for gaining an understanding of disease pathogenesis, with the ultimate aim of identifying new therapeutic targets.	[Davies, Jessica L.; Thompson, Sara; Kaur-Sandhu, Harpreet; Sawcer, Stephen; Coles, Alasdair; Ban, Maria; Jones, Joanne] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Cambridge	Davies, JL (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	jessicaldavies6@gmail.com		Sawcer, Stephen/0000-0001-7685-0974; /0000-0002-8888-1441; Jones, Joanne/0000-0003-4974-1371; Coles, Alasdair/0000-0003-4738-0760	Cambridge NIHR Biomedical Research Centre; Department of Clinical Neurosciences at University of Cambridge; Wellcome Trust Clinical Research Facility; Pattinson family; National Institute for Health Research [CL-2008-14-004] Funding Source: researchfish; Wellcome Trust [105924/Z/14/Z] Funding Source: researchfish	Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Clinical Neurosciences at University of Cambridge; Wellcome Trust Clinical Research Facility(Wellcome Trust); Pattinson family; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Cambridge NIHR Biomedical Research Centre, the Department of Clinical Neurosciences at University of Cambridge and the Wellcome Trust Clinical Research Facility. JLD was supported by the Pattinson family through personal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Cambridge BioResource for sample provision; Simon McCallum from the Cambridge NIHR BRC Cell Phenotyping Hub for advice and support in flow cytometry; and Dr Lorenzi and Julie Diboll at Newcastle University for their advice with TREC assays and providing the sjTREC plasmid. This work was supported by the Cambridge NIHR Biomedical Research Centre and the Wellcome Trust Clinical Research Facility.	Andersen M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-8; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bondar C, 2014, EUR J HUM GENET, V22, P358, DOI 10.1038/ejhg.2013.136; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Bros M, 2006, GENOMICS, V87, P463, DOI 10.1016/j.ygeno.2005.11.013; Broux B, 2010, GENES IMMUN, V11, P326, DOI 10.1038/gene.2009.106; Chabod M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002461; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duszczyszyn DA, 2010, J NEUROIMMUNOL, V221, P73, DOI 10.1016/j.jneuroim.2010.02.005; Erdenebayar N, 2009, BIOCHEM BIOPH RES CO, V390, P489, DOI 10.1016/j.bbrc.2009.09.117; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hug A, 2003, J IMMUNOL, V171, P432, DOI 10.4049/jimmunol.171.1.432; Iwata R, 2010, BIOMED RES-TOKYO, V31, P83, DOI 10.2220/biomedres.31.83; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lorenzi AR, 2008, J IMMUNOL METHODS, V339, P185, DOI 10.1016/j.jim.2008.09.013; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shabalina SA, 2010, GENOME BIOL EVOL, V2, P791, DOI 10.1093/gbe/evq058; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Stevenson WS, 2014, LEUKEMIA, V28, P787, DOI 10.1038/leu.2013.270; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158327	10.1371/journal.pone.0158327	http://dx.doi.org/10.1371/journal.pone.0158327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438997	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100011
J	Nohr, MK; Kroager, TP; Sanggaard, KW; Knudsen, AD; Stensballe, A; Enghild, JJ; Olholm, J; Richelsen, B; Pedersen, SB				Nohr, Mark K.; Kroager, Toke P.; Sanggaard, Kristian W.; Knudsen, Anders D.; Stensballe, Allan; Enghild, Jan J.; Olholm, Jens; Richelsen, Bjorn; Pedersen, Steen B.			SILAC-MS Based Characterization of LPS and Resveratrol Induced Changes in Adipocyte Proteomics - Resveratrol as Ameliorating Factor on LPS Induced Changes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; NF-KAPPA-B; TRIGLYCERIDE CLEARANCE; INDUCED ACTIVATION; GENE-EXPRESSION; INSULIN; ENDOTOXEMIA; GLYCOSYLATION; TRANSCRIPTION	Adipose tissue inflammation is believed to play a pivotal role in the development obesity-related morbidities such as insulin resistance. However, it is not known how this (low-grade) inflammatory state develops. It has been proposed that the leakage of lipopolysaccharides (LPS), originating from the gut microbiota, through the gut epithelium could drive initiation of inflammation. To get a better understanding of which proteins and intracellular pathways are affected by LPS in adipocytes, we performed SILAC proteomic analysis and identified proteins that were altered in expression. Furthermore, we tested the anti-inflammatory compound resveratrol. A total of 927 proteins were quantified by the SILAC method and of these 57- and 64 were significantly up- and downregulated by LPS, respectively. Bioinformatic analysis (GO analysis) revealed that the upregulated proteins were especially involved in the pathways of respiratory electron transport chain and inflammation. The downregulated proteins were especially involved in protein glycosylation. One of the latter proteins, GALNT2, has previously been described to regulate the expression of liver lipases such as ANGPTL3 and apoC-III affecting lipid metabolism. Furthermore, LPS treatment reduced the protein levels of the insulin sensitizing adipokine, adiponectin, and proteins participating in the final steps of triglyceride- and cholesterol synthesis. Generally, resveratrol opposed the effect induced by LPS and, as such, functioning as an ameliorating factor in disease state. Using an unbiased proteomic approach, we present novel insight of how the proteome is altered in adipocytes in response to LPS as seen in obesity. We suggest that LPS partly exerts its detrimental effects by altering glycosylation processes of the cell, which is starting to emerge as important posttranscriptional regulators of protein expression. Furthermore, resveratrol could be a prime candidate in ameliorating dysfunctioning adipose tissue induced by inflammatory stimulation.	[Nohr, Mark K.; Olholm, Jens; Richelsen, Bjorn; Pedersen, Steen B.] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Nohr, Mark K.; Olholm, Jens; Richelsen, Bjorn; Pedersen, Steen B.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Kroager, Toke P.; Sanggaard, Kristian W.; Knudsen, Anders D.; Enghild, Jan J.] Aarhus Univ, Lab Proteome Anal & Prot Characterizat, Dept Mol Biol & Genet, Aarhus, Denmark; [Kroager, Toke P.; Sanggaard, Kristian W.; Knudsen, Anders D.; Enghild, Jan J.] Aarhus Univ, iNANO, Aarhus, Denmark; [Stensballe, Allan] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aalborg University	Nohr, MK (corresponding author), Aarhus Univ, Inst Clin Med, Aarhus, Denmark.; Nohr, MK (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.	mkln@clin.au.dk	Pedersen, Steen B./AAB-3331-2019; Stensballe, Allan/K-6756-2019	Pedersen, Steen B./0000-0002-7838-8063; Stensballe, Allan/0000-0002-9888-1955; Richelsen, Bjoern/0000-0001-8886-9736; Enghild, Jan Johannes/0000-0001-9292-9172; Nohr, Mark Klitgaard/0000-0002-5536-654X	Graduate School of Health, Aarhus University; Rasmus Riisfort Foundation; Ejnar Danielsens Foundation; AP Moller Maersk Foundation; Danish Council for Strategic Research [10-093499]	Graduate School of Health, Aarhus University; Rasmus Riisfort Foundation; Ejnar Danielsens Foundation; AP Moller Maersk Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	MKN was supported by a full PhD scholarship provided by the Graduate School of Health, Aarhus University. The study was supported by the Rasmus Riisfort Foundation, Ejnar Danielsens Foundation and the AP Moller Maersk Foundation. The study is part of the research program LIRMOI Research Center (www.LIRMOI.com), which is supported by the Danish Council for Strategic Research (Grant 10-093499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cullberg KB, 2013, EUR J PHARM SCI, V49, P251, DOI 10.1016/j.ejps.2013.02.014; Dao TMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020700; Ezzati P, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00030; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Heynekamp JJ, 2006, J MED CHEM, V49, P7182, DOI 10.1021/jm060630x; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Jin WJ, 2007, CELL METAB, V6, P129, DOI 10.1016/j.cmet.2007.07.009; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laugerette F, 2011, J NUTR BIOCHEM, V22, P53, DOI 10.1016/j.jnutbio.2009.11.011; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Nohr MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146840; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Olholm J, 2010, INT J OBESITY, V34, P1546, DOI 10.1038/ijo.2010.98; Ornstrup MJ, 2014, J CLIN ENDOCR METAB, V99, P4720, DOI 10.1210/jc.2014-2799; Pedersen SB, 2008, INT J OBESITY, V32, P1250, DOI 10.1038/ijo.2008.78; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.3.CO;2-V; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vicennati V, 2002, INT J OBESITY, V26, P905, DOI 10.1038/sj.ijo.0802035; Wellhoener P, 2011, HORM METAB RES, V43, P754, DOI 10.1055/s-0031-1287854; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	56	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159747	10.1371/journal.pone.0159747	http://dx.doi.org/10.1371/journal.pone.0159747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438462	Green Submitted, Green Published, gold			2022-12-26	WOS:000380170100072
J	Verstraeten, T; Jiang, BG; Weil, JG; Lin, JH				Verstraeten, Thomas; Jiang, Baoguo; Weil, John G.; Lin, Jennifer H.			Modelling Estimates of Norovirus Disease in Patients with Chronic Medical Conditions	PLOS ONE			English	Article							GASTROENTERITIS; BURDEN; INFLUENZA; OUTBREAK; ENGLAND	Background The burden of disease due to norovirus infection has been well described in the general United States population, but studies of norovirus occurrence among persons with chronic medical conditions have been limited mostly to the immunocompromised. We assessed the impact of norovirus gastroenteritis on health care utilization in US subjects with a range of chronic medical conditions. Methods We performed a retrospective cohort study using MarketScan data from July 2002 to December 2013, comparing the rates of emergency department visits, outpatient visits and hospitalizations among patients with chronic conditions (renal, cardiovascular, respiratory, immunocompromising, gastrointestinal, hepatic/pancreatic and neurological conditions and diabetes) with those in a healthy population. We estimated the rates of these outcomes due to norovirus gastroenteritis using an indirect modelling approach whereby cases of gastroenteritis of unknown cause and not attributed to a range of other causes were assumed to be due to norovirus. Results Hospitalization rates for norovirus gastroenteritis were higher in all of the risk groups analyzed compared with data in otherwise healthy subjects, ranging from 3.2 per 10,000 person-years in persons with chronic respiratory conditions, to 23.1 per 10,000 person-years in persons with chronic renal conditions, compared to 2.1 per 10,000 among persons without chronic conditions. Over 51% of all norovirus hospitalizations occurred in the 37% of the population with some form of chronic medical condition. Outpatient visits for norovirus gastroenteritis were also increased in persons with chronic gastrointestinal or immunocompromising conditions. Conclusion Norovirus gastroenteritis leads to significantly higher rates of healthcare utilization in patients with a chronic medical condition compared to patients without any such condition.	[Verstraeten, Thomas] P95 Pharmacovigilance & Epidemiol Serv, Leuven, Belgium; [Jiang, Baoguo; Lin, Jennifer H.] Amer Inc, Takeda Dev Ctr, Deerfield, IL USA; [Weil, John G.] Takeda Pharmaceut Int, Zurich, Switzerland	Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.	Verstraeten, T (corresponding author), P95 Pharmacovigilance & Epidemiol Serv, Leuven, Belgium.	Thomas.Verstraeten@P-95.com			Takeda Development Center Americas, Inc.; Takeda Pharmaceuticals International; Takeda Vaccines Inc. Deerfield IL; Takeda	Takeda Development Center Americas, Inc.(Takeda Pharmaceutical Company Ltd); Takeda Pharmaceuticals International(Takeda Pharmaceutical Company Ltd); Takeda Vaccines Inc. Deerfield IL; Takeda(Takeda Pharmaceutical Company Ltd)	JW and BJ are employees of Takeda, a company developing a vaccine for the prevention of norovirus disease. BJ is supported by Takeda Development Center Americas, Inc. JW is supported by Takeda Pharmaceuticals International. JL, at the time of the study, was supported by Takeda Development Center Americas, Inc. TV has received consulting fees from Takeda. Takeda Vaccines Inc. Deerfield IL provided support in the form of salaries for authors [JW, BJ and JL], and played a role in the decision to publish and review of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P842; Bernard H, 2014, EPIDEMIOL INFECT, V142, P63, DOI 10.1017/S0950268813000435; Bernstein DI, 2015, J INFECT DIS, V211, P870, DOI 10.1093/infdis/jiu497; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P41; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Karve S, 2014, HUM VACC IMMUNOTHER, V10, P1544, DOI 10.4161/hv.28704; Koo HL, 2010, DISCOV MED, V10, P61; Koo HL, 2009, CLIN INFECT DIS, V49, P1069, DOI 10.1086/605558; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Lopman BA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001999; Markov PV, 2007, EPIDEMIOL INFECT, V135, P17, DOI 10.1017/S0950268806006625; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; Mullooly JP, 2007, VACCINE, V25, P846, DOI 10.1016/j.vaccine.2006.09.041; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Phillips G, 2010, AM J EPIDEMIOL, V171, P1014, DOI 10.1093/aje/kwq021; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Siebenga JJ, 2008, J INFECT DIS, V198, P994, DOI 10.1086/591627; Simon A, 2006, SCAND J GASTROENTERO, V41, P693, DOI 10.1080/00365520500421694; Treanor JJ, 2014, J INFECT DIS, V210, P1763, DOI 10.1093/infdis/jiu337; [No title captured], DOI DOI 10.5888/PCD11.130389	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158822	10.1371/journal.pone.0158822	http://dx.doi.org/10.1371/journal.pone.0158822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438335	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100022
J	de Vries, EM; Lammers, LA; Achterbergh, R; Klumpen, HJ; Mathot, RAA; Boelen, A; Romijn, JA				de Vries, E. M.; Lammers, L. A.; Achterbergh, R.; Klumpen, H-J; Mathot, R. A. A.; Boelen, A.; Romijn, J. A.			Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR	PLOS ONE			English	Article							MOUSE; EXPRESSION; MIDAZOLAM; GENES; ALPHA; LIVER; MICE; RAT	Introduction Hepatic drug metabolism by cytochrome P450 enzymes is altered by the nutritional status of patients. The expression of P450 enzymes is partly regulated by the constitutive androstane receptor (CAR). Fasting regulates the expression of both P450 enzymes and CAR and affects hepatic drug clearance. We hypothesized that the fasting-induced alterations in P450 mediated drug clearance are mediated by CAR. Methods To investigate this we used a drug cocktail validated in humans consisting of five widely prescribed drugs as probes for specific P450 enzymes: caffeine (CYP1A2), metoprolol (CYP2D6), omeprazole (CYP2C19), midazolam (CYP3A4) and s-warfarin (CYP2C9). This cocktail was administered to wild type (WT, C57Bl/6) mice or mice deficient for CAR (CAR(-/-)) that were either fed ad libitum or fasted for 24 hours. Blood was sampled at predefined intervals and drug concentrations were measured as well as hepatic mRNA expression of homologous/orthologous P450 enzymes (Cyp1a2, Cyp2d22, Cyp3a11, Cyp2c37, Cyp2c38 and Cyp2c65). Results Fasting decreased Cyp1a2 and Cyp2d22 expression and increased Cyp3a11 and Cyp2c38 expression in both WT and CAR(-/-) mice. The decrease in Cyp1a2 was diminished in CAR(-/-) comparison with WT mice. Basal Cyp2c37 expression was lower in CAR(-/-) compared to WT mice. Fasting decreased the clearance of all drugs tested in both WT and CAR(-/-) mice. The absence of CAR was associated with an decrease in the clearance of omeprazole, metoprolol and midazolam in fed mice. The fasting-induced reduction in clearance of s-warfarin was greater in WT than in CAR(-/-). The changes in drug clearance correlated with the expression pattern of the specific P450 enzymes in case of Cyp1a2-caffeine and Cyp2c37-omeprazole. Conclusion We conclude that CAR is important for hepatic clearance of several widely prescribed drugs metabolized by P450 enzymes. However the fasting-induced alterations in P450 mediated drug clearance are largely independent of CAR.	[de Vries, E. M.; Romijn, J. A.] Acad Med Ctr, Dept Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lammers, L. A.; Mathot, R. A. A.] Acad Med Ctr, Dept Hosp Pharm, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Achterbergh, R.; Klumpen, H-J] Acad Med Ctr, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Boelen, A.] Acad Med Ctr, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, EM (corresponding author), Acad Med Ctr, Dept Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.m.devries@amc.uva.nl		mathot, ron/0000-0001-8401-0879				Blume N, 2000, ARCH BIOCHEM BIOPHYS, V381, P191, DOI 10.1006/abbi.2000.1978; Buters JTM, 1996, PHARMACOGENETICS, V6, P291, DOI 10.1097/00008571-199608000-00002; Cui JY, 2016, BBA-GENE REGUL MECH, V1859, P1198, DOI 10.1016/j.bbagrm.2016.04.010; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Kumar GN, 2001, MED RES REV, V21, P397, DOI 10.1002/med.1016; Lammers LA, 2015, DRUG METAB DISPOS, V43, P819, DOI 10.1124/dmd.114.062299; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Monostory K, 2009, DRUG METAB REV, V41, P547, DOI 10.1080/03602530903112284; Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Turpault S, 2009, BRIT J CLIN PHARMACO, V68, P928, DOI 10.1111/j.1365-2125.2009.03548.x; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; Wang H, 2004, MOL PHARMACOL, V65, P1148, DOI 10.1124/mol.65.5.1148; Wieneke N, 2007, FEBS LETT, V581, P5617, DOI 10.1016/j.febslet.2007.11.011; Yanagimoto T, 1997, ARCH BIOCHEM BIOPHYS, V340, P215, DOI 10.1006/abbi.1997.9900; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159552	10.1371/journal.pone.0159552	http://dx.doi.org/10.1371/journal.pone.0159552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434302	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600068
J	Li, YX; Ren, YL; Fu, HJ; Zou, L; Yang, Y; Chen, Z				Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Yang, Ying; Chen, Zhi			Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-kappa B Pathways in an ER Stress-Dependent Manner	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SURFACE-ANTIGEN; LIVER-CANCER; X PROTEIN; SERUM INTERLEUKIN-6; OXIDATIVE STRESS; GENE-EXPRESSION; C/EBP-BETA; ACTIVATION; PROGRESSION	During hepatitis B virus (HBV) infection, three viral envelope proteins of HBV are over-expressed in the endoplasmic reticulum (ER). The large S protein (LHBs) and truncated middle S protein (MHBst) have been documented to play roles in regulating host gene expression and contribute to hepatic disease development. As a predominant protein at the ultrastructural level in biopsy samples taken from viremic patients, the role of the middle S protein (MHBs) remains to be understood despite its high immunogenicity. When we transfected hepatocytes with an enhanced green fluorescent protein (EGFP)-tagged MHBs expressing plasmid, the results showed that expression of MHBs cause an upregulation of IL-6 at the message RNA and protein levels through activating the p38 mitogen-activated protein kinase (p38 MAPK) and nuclear factor-kappa B (NF-kappa B) pathways. The use of specific inhibitors of the signaling pathways can diminish this upregulation. The use of BAPTA-AM attenuated the stimulation caused by MHBs. We further found that MHBs accumulated in the endoplasmic reticulum and increased the amount of glucose regulated protein 78 (GRP78/BiP). Our results provide a possibility that MHBs could be involved in liver disease progression.	[Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Yang, Ying; Chen, Zhi] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Inst Infect Dis, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Yang, Ying; Chen, Zhi] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Yang-Xia; Ren, Yan-Li; Fu, Hai-Jing; Zou, Ling; Chen, Zhi] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Chen, Z (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Inst Infect Dis, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, Z (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Chen, Z (corresponding author), Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China.	zjuchenzhi@zju.edu.cn			State Science and Technology Projects of 12th Five Year [2012ZX10002007]	State Science and Technology Projects of 12th Five Year	This work was supported by the State Science and Technology Projects of 12th Five Year, No. 2012ZX10002007.	Caselmann WH, 1997, J GEN VIROL, V78, P1487, DOI 10.1099/0022-1317-78-6-1487; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Chung JH, 2000, J INVEST DERMATOL, V115, P177, DOI 10.1046/j.1523-1747.2000.00009.x; DIENES HP, 1990, GASTROENTEROLOGY, V98, P1017, DOI 10.1016/0016-5085(90)90028-Y; EBLE BE, 1986, MOL CELL BIOL, V6, P1454, DOI 10.1128/MCB.6.5.1454; Ebrahim M, 2014, FUTURE VIROL, V9, P431, DOI 10.2217/fvl.14.21; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Florian PE, 2014, ROM BIOTECH LETT, V19, P9974; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Glebe D, 2007, WORLD J GASTROENTERO, V13, P8, DOI 10.3748/wjg.v13.i1.8; Gur A, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-30; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Jang JW, 2012, CYTOKINE, V60, P686, DOI 10.1016/j.cyto.2012.07.017; KAKUMU S, 1992, J CLIN PATHOL, V45, P408, DOI 10.1136/jcp.45.5.408; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P253, DOI 10.1016/j.bbrc.2006.10.028; Lee IK, 2015, WORLD J GASTROENTERO, V21, P6872, DOI 10.3748/wjg.v21.i22.6872; Lee Y, 1998, CLIN CANCER RES, V4, P1711; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; Liu XF, 2015, EXP CELL RES, V331, P223, DOI 10.1016/j.yexcr.2014.08.040; MOLNARKIMBER KL, 1988, J VIROL, V62, P407, DOI 10.1128/JVI.62.2.407-416.1988; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ohishi W, 2014, INT J CANCER, V134, P154, DOI 10.1002/ijc.28337; Pollicino T, 2014, J HEPATOLOGY; Schluter V, 2001, DIGEST DIS, V19, P352, DOI 10.1159/000050703; Sengupta S, 2007, J MED VIROL, V79, P220, DOI 10.1002/jmv.20790; Shen ML, 2010, VACCINE, V28, P7288, DOI 10.1016/j.vaccine.2010.08.081; Suhail M, 2014, WORLD J GASTROENTERO, V20, P12462, DOI 10.3748/wjg.v20.i35.12462; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Waris G, 2002, J VIROL, V76, P2721, DOI 10.1128/JVI.76.6.2721-2729.2002; Xiang WQ, 2011, J HEPATOL, V54, P26, DOI 10.1016/j.jhep.2010.08.006; Xiao WH, 2004, PROSTATE, V61, P354, DOI 10.1002/pros.20113; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	39	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159089	10.1371/journal.pone.0159089	http://dx.doi.org/10.1371/journal.pone.0159089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434097	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600032
J	Minard, LV; Corkum, A; Sketris, I; Fisher, J; Zhang, Y; Saleh, A				Minard, Laura V.; Corkum, Amber; Sketris, Ingrid; Fisher, Judith; Zhang, Ying; Saleh, Ahmed			Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PRIMARY PREVENTION; JUPITER TRIAL; CARDIOVASCULAR-DISEASE; RISK-ASSESSMENT; ROSUVASTATIN; CHOLESTEROL; THERAPY; PEOPLE; HEALTH	Purpose To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pharmacare program (NSSPP) beneficiaries over a 14-year period in response to: 1) rosuvastatin market entry in 2003, 2) JUPITER trial publication in 2008, and 3) generic atorvastatin availability in 2010. Methods All NSSPP beneficiaries who redeemed at least one prescription for a statin from April 1, 1999 to March 31, 2013 were included. Aggregated, anonymous monthly prescription counts were extracted by the Nova Scotia Department of Health and Wellness (Nova Scotia, Canada) and changes in dispensing patterns of statins were measured. Data were analyzed using descriptive analyses and interrupted time series methods. Results The percentage of NSSPP beneficiaries dispensed any statin increased from 5.3% in April 1999 to 20.7% in March 2013. In 1999, most NSSPP beneficiaries were dispensed either simvastatin (29.5%) or atorvastatin (28.7%). When rosuvastatin was added to the NSSPP Formulary in August 2003, prescriptions dispensed for simvastatin, lovastatin, pravastatin, and fluvastatin declined significantly (slope change, -0.0027; 95% confidence interval (CI), (-0.0046, -0.0009)). This significant decline continued following the publication of JUPITER (level change, -0.1974; 95% CI, (-0.2991, -0.0957)) and the availability of generic atorvastatin (level change, -0.2436; 95% CI, (-0.3314, -0.1558)). Atorvastatin was not significantly affected by any of the three interventions, although it maintained an overall decreasing trend. Only upon the availability of generic atorvastatin did the upward trend in rosuvastatin use decrease significantly (slope change, -0.0010, 95% CI, (-0.0015, -0.0005)). Conclusions The type and rate of statins dispensed to NSSPP beneficiaries changed from 1999 to 2013 in response to the availability of new agents and publication of the JUPITER trial. The overall proportion of NSSPP beneficiaries dispensed a statin increased approximately 4-fold during the study period. In 2013, rosuvastatin was the most commonly dispensed statin (44.1%) followed by atorvastatin (39.1%).	[Minard, Laura V.; Sketris, Ingrid] Dalhousie Univ, Coll Pharm, Halifax, NS, Canada; [Corkum, Amber; Zhang, Ying] Acadia Univ, Stat Consulting Unit, Wolfville, NS, Canada; [Fisher, Judith] Nova Scotia Dept Hlth & Wellness, Halifax, NS, Canada; [Saleh, Ahmed] Dalhousie Univ, Fac Med, Halifax, NS, Canada	Dalhousie University; Acadia University; Dalhousie University	Minard, LV (corresponding author), Dalhousie Univ, Coll Pharm, Halifax, NS, Canada.	lminard@dal.ca		Sketris, Ingrid/0000-0003-1820-5883; Minard, Laura/0000-0002-1545-3470	Canadian Institutes of Health Research; Drug Evaluation Alliance of Nova Scotia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Drug Evaluation Alliance of Nova Scotia	Funding for this research was provided by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to IS and though an unconditional grant from the Drug Evaluation Alliance of Nova Scotia (http://novascotia.ca/dhw/pharmacare/drug-evaluation-alliance-of-novascotia.asp) to LVM. The decision to publish and the content to be published was the decision of the research team. The data used in this report were made available by the Nova Scotia Department of Health and Wellness. Although this research is based on data obtained from the Nova Scotia Department of Health and Wellness, the observations and opinions expressed do not represent those of the Department of Health and Wellness.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; [Anonymous], NIH PUBLICATION; [Anonymous], 2013, LIP LOW PRIM PREV CA; [Anonymous], 2005, STAT CARD DIS; Barrett B, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0436-9; Brown JD, 2016, RES SOCIAL ADM PHARM; Canadian Institute of Health Information, 2014, DRUG US SEN PUBL DRU; Canadian Institute of Health Information, DRIV PRESCR DRUG SPE; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carrera M., 2016, AM EC J IN PRESS; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; de Lorgeril M, 2010, ARCH INTERN MED, V170, P1032, DOI 10.1001/archinternmed.2010.184; Dunne SS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0415-3; Fraeyman J, 2013, EXPERT REV PHARM OUT, V13, P141, DOI [10.1586/ERP.12.88, 10.1586/erp.12.88]; Galper BZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138092; Gupta M, 2012, CAN J CARDIOL, V28, P14, DOI 10.1016/j.cjca.2011.09.014; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jackevicius CA, 2001, ARCH INTERN MED, V161, P183, DOI 10.1001/archinte.161.2.183; Jackson G, 2009, INT J CLIN PRACT, V63, P347, DOI 10.1111/j.1742-1241.2009.02013.x; Kappagoda CT, 2009, AM J CARDIOL, V104, P1603, DOI 10.1016/j.amjcard.2009.07.033; Kildemoes HW, 2012, HEALTH POLICY, V108, P216, DOI 10.1016/j.healthpol.2012.08.008; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Kwon HY, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1356-z; Launer J, 2015, POSTGRAD MED J, V91, P663, DOI 10.1136/postgradmedj-2015-133766; Lindgren P, 2012, EUR J HEALTH ECON, V13, P445, DOI 10.1007/s10198-011-0315-1; Mamdani MM, 2001, CAN MED ASSOC J, V164, P1695; Manzoli L, 2015, EUR J EPIDEMIOL; Meissner B, 2006, J MANAG CARE PHARM, V12, P331, DOI 10.18553/jmcp.2006.12.4.331; Mintzes B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005699; Murphy AL, 2006, BMC NURS, V5, DOI 10.1186/1472-6955-5-5; Nanchen D, 2011, PREV MED, V52, P159, DOI 10.1016/j.ypmed.2010.11.018; Niederdeppe J, 2013, J GEN INTERN MED, V28, P886, DOI 10.1007/s11606-013-2379-3; Nissen Steven E, 2009, Curr Cardiol Rep, V11, P81; Patel MS, 2014, ANN INTERN MED, V161, pS44, DOI 10.7326/M13-3001; Pichetti S, 2013, APPL HEALTH ECON HEA, V11, P205, DOI 10.1007/s40258-013-0014-4; Polinski JM, 2008, J POPUL THER CLIN PH, V15, pE286; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, AM J CARDIOL, V100, P1659, DOI 10.1016/j.amjcard.2007.09.072; Ridker PM, 2010, AM J CARDIOL, V106, P1351, DOI 10.1016/j.amjcard.2010.08.025; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Rikala M, 2013, BASIC CLIN PHARMACOL, V113, P173, DOI 10.1111/bcpt.12075; Schneemann M, 2009, INT J CLIN PRACT, V63, P1118, DOI 10.1111/j.1742-1241.2009.02069.x; Shishehbor MH, 2009, CLEV CLIN J MED, V76, P37, DOI 10.3949/ccjm.75a.08105; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Sketris IS, 2009, J POPUL THER CLIN PH, V16, pE103; Slejko JF, 2010, CURR MED RES OPIN, V26, P2485, DOI 10.1185/03007995.2010.516994; Spatz ES, 2009, CIRC-CARDIOVASC QUAL, V2, P41, DOI 10.1161/CIRCOUTCOMES.108.832592; Statistics Canada, FOC GEOGR SER 2011 C; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Sullivan HW, 2015, J HEALTH COMMUN, V20, P1391, DOI 10.1080/10810730.2015.1018635; Teng JFT, 2014, PHARMACOTHERAPY, V34, P9, DOI 10.1002/phar.1340; Tziomalos K, 2009, CURR MED RES OPIN, V25, P133, DOI [10.1185/03007990802643557, 10.1185/03007990802643557 ]; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walley T, 2005, BRIT J CLIN PHARMACO, V60, P543, DOI 10.1111/j.1365-2125.2005.02478.x; Wieringa S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0229-x; Winkelmayer WC, 2010, WIEN KLIN WOCHENSCHR, V122, P89, DOI 10.1007/s00508-009-1292-6; Yang EY, 2009, J AM COLL CARDIOL, V54, P2388, DOI 10.1016/j.jacc.2009.10.006; Yusuf S, 2009, LANCET, V373, P1152, DOI 10.1016/S0140-6736(09)60357-3; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	59	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158608	10.1371/journal.pone.0158608	http://dx.doi.org/10.1371/journal.pone.0158608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434392	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600012
J	Mukhin, A; Palinauskas, V; Platonova, E; Kobylkov, D; Vakoliuk, I; Valkiunas, G				Mukhin, Andrey; Palinauskas, Vaidas; Platonova, Elena; Kobylkov, Dmitry; Vakoliuk, Irina; Valkiunas, Gediminas			The Strategy to Survive Primary Malaria Infection: An Experimental Study on Behavioural Changes in Parasitized Birds	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; PLASMODIUM; WILD; HAEMOPROTEUS; HOSTS; LEUCOCYTOZOON	Avian malaria parasites (Haemosporida, Plasmodium) are of cosmopolitan distribution, and they have a significant impact on vertebrate host fitness. Experimental studies show that high parasitemia often develops during primary malaria infections. However, field studies only occasionally reveal high parasitemia in free-living birds sampled using the traditional methods of mist-netting or trapping, and light chronic infections predominate. The reason for this discrepancy between field observation and experimental data remains insufficiently understood. Since mist-netting is a passive capture method, two main parameters determine its success in sampling infected birds in wildlife, i. e. the presence of parasitized birds at a study site and their mobility. In other words, the trapping probability depends on the survival rate of birds and their locomotor activity during infection. Here we test (1) the mortality rate of wild birds infected with Plasmodium relictum (the lineage pSGS1), (2) the changes in their behaviour during presence of an aerial predator, and (3) the changes in their locomotor activity at the stage of high primary parasitemia. We show that some behavioural features which might affect a bird's survival during a predator attack (time of reaction, speed of flush flight and take off angle) did not change significantly during primary infection. However, the locomotor activity of infected birds was almost halved compared to control (non-infected) birds during the peak of parasitemia. We report (1) the markedly reduced mobility and (2) the 20% mortality rate caused by P. relictum and conclude that these factors are responsible for the underrepresentation of birds in mist nets and traps during the stage of high primary parasitemia in wildlife. This study indicates that the widespread parasite, P. relictum (pSGS1) influences the behaviour of birds during primary parasitemia. Experimental studies combined with field observations are needed to better understand the mechanisms of pathogenicity of avian malaria parasites and their influence on bird populations.	[Mukhin, Andrey; Platonova, Elena] RAS, Inst Zool, Biol Stn Rybachy, Rybachy 238535, Russia; [Palinauskas, Vaidas; Valkiunas, Gediminas] Nat Res Ctr, Akad 2, LT-08412 Vilnius, Lithuania; [Platonova, Elena] St Petersburg State Univ, St Petersburg 199034, Russia; [Kobylkov, Dmitry] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Vakoliuk, Irina] Immanuel Kant Baltic Fed Univ, Kaliningrad 236041, Russia	Russian Academy of Sciences; Nature Research Center - Lithuania; Saint Petersburg State University; Carl von Ossietzky Universitat Oldenburg; Immanuel Kant Baltic Federal University	Mukhin, A (corresponding author), RAS, Inst Zool, Biol Stn Rybachy, Rybachy 238535, Russia.	a.l.mukhin@gmail.com	Mukhin, Andrey/P-6391-2015; Platonova, Elena/R-6750-2017; Palinauskas, Vaidas/J-1576-2016; Vakolyuk, Irina/E-1942-2014; Kobylkov, Dmitry/G-3162-2014	Platonova, Elena/0000-0002-9425-8998; Palinauskas, Vaidas/0000-0002-4714-0305; Vakoliuk, Irina/0000-0001-5480-1645; Mukhin, Andrey/0000-0003-1238-4163; Kobylkov, Dmitry/0000-0003-0380-5907	Russian Foundation for Basic Research [15-04-00417]; Zoological Institute RAS [01201351182]; European Social Fund under the Global Grant measure [VPI-3.1.- SMM-07-K-01-047]; Lithuanian Academy of Sciences [2014/06/17-30]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Zoological Institute RAS; European Social Fund under the Global Grant measure; Lithuanian Academy of Sciences(Research Council of Lithuania (LMTLT))	Financial support for this study was made available by the Russian Foundation for Basic Research (grant# 15-04-00417 to A.M. and E.P.) and by the Zoological Institute RAS (registered research project No 01201351182 to A.M.), by the European Social Fund under the Global Grant measure (grant # VPI-3.1.- SMM-07-K-01-047 to G.V.) and by the Lithuanian Academy of Sciences (grant # 2014/06/17-30 to V.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLANDER K, 1994, J AVIAN BIOL, V25, P69, DOI 10.2307/3677296; [Anonymous], 1998, MALARIA PARASITE BIO; Asghar M, 2011, J AVIAN BIOL, V42, P530, DOI 10.1111/j.1600-048X.2011.05281.x; Atkinson CT, 2008, PARASITIC DIS WILD B, P557, DOI [10.1002/9780813804620.fmatter, DOI 10.1002/9780813804620.FMATTER]; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; BENNETT GF, 1993, J NAT HIST, V27, P993, DOI 10.1080/00222939300770621; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Cellier-Holzem E, 2010, INT J PARASITOL, V40, P1447, DOI 10.1016/j.ijpara.2010.04.014; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; Dinhopl N, 2015, PARASITOL RES, V114, P1455, DOI 10.1007/s00436-015-4328-z; Evans M, 1998, VET REC, V143, P72, DOI 10.1136/vr.143.3.72; Ferrell ST, 2007, J ZOO WILDLIFE MED, V38, P309, DOI 10.1638/1042-7260(2007)038[0309:FHIIMA]2.0.CO;2; Frevert U, 2008, INT J PARASITOL, V38, P655, DOI 10.1016/j.ijpara.2007.09.012; Garcia-Longoria L, 2015, PARASITOL RES, V114, P4493, DOI 10.1007/s00436-015-4693-7; Garnham PCC., 1966, MALARIA PARASITES OT; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Grim KC, 2003, J ZOO WILDLIFE MED, V34, P250, DOI 10.1638/02-070; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Holmstad PR, 2006, INT J PARASITOL, V36, P735, DOI 10.1016/j.ijpara.2006.02.015; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Knowles SCL, 2010, J EVOLUTION BIOL, V23, P557, DOI 10.1111/j.1420-9101.2009.01920.x; Larcombe S, 2013, EXP PARASITOL, V135, P708, DOI 10.1016/j.exppara.2013.10.012; Lind J, 1999, BEHAV ECOL SOCIOBIOL, V46, P65, DOI 10.1007/s002650050593; Loiseau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044729; Lupianez JA, 1996, COMP BIOCHEM PHYS B, V113, P439, DOI 10.1016/0305-0491(95)02030-6; Marinov MP, 2017, ETHOL ECOL EVOL, V29, P126, DOI 10.1080/03949370.2015.1102776; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; McConkey GA, 1996, J EUKARYOT MICROBIOL, V43, P393, DOI 10.1111/j.1550-7408.1996.tb05049.x; Merino S, 2000, P ROY SOC B-BIOL SCI, V267, P2507, DOI 10.1098/rspb.2000.1312; Moore J., 2002, PARASITES BEHAV ANIM; Mouritsen KN, 2005, OIKOS, V108, P344, DOI 10.1111/j.0030-1299.2005.13507.x; Olias P, 2011, EMERG INFECT DIS, V17, P950, DOI 10.3201/eid1705.101618; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Palinauskas Vaidas, 2005, Ekologija, V4, P8; Palinauskas V, 2015, INT J PARASITOL, V45, P51, DOI 10.1016/j.ijpara.2014.08.012; Palinauskas V, 2011, EXP PARASITOL, V127, P527, DOI 10.1016/j.exppara.2010.10.007; Payevsky V., 2000, BIRD STATION MANUAL, P20; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHALL JJ, 1982, SCIENCE, V217, P1057, DOI 10.1126/science.7112113; Shurulinkov P, 2009, PARASITOL RES, V104, P1453, DOI 10.1007/s00436-009-1349-5; Vanstreels RET, 2016, J WILDLIFE DIS, V52, P734, DOI 10.7589/2015-08-219; THOMPSON JN, 1987, BIOL J LINN SOC, V32, P385, DOI 10.1111/j.1095-8312.1987.tb00439.x; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas Gediminas, 1998, Bulletin of the Scandinavian Society for Parasitology, V8, P39; Vanstreels RET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103670; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	53	37	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159216	10.1371/journal.pone.0159216	http://dx.doi.org/10.1371/journal.pone.0159216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434058	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600041
J	Schenke, KC; Wyer, NA; Bach, P				Schenke, Kimberley C.; Wyer, Natalie A.; Bach, Patric			The Things You Do: Internal Models of Others' Expected Behaviour Guide Action Observation	PLOS ONE			English	Article							REACTION-TIME-TASK; PERSON MEMORY; SOCIAL COGNITION; IMPRESSION-FORMATION; FUNCTIONAL RELATIONS; RETRIEVAL-PROCESSES; SPONTANEOUS TRAIT; MOTOR ACTIVATION; PRIOR KNOWLEDGE; PERCEPTION	Predictions allow humans to manage uncertainties within social interactions. Here, we investigate how explicit and implicit person models-how different people behave in different situations-shape these predictions. In a novel action identification task, participants judged whether actors interacted with or withdrew from objects. In two experiments, we manipulated, unbeknownst to participants, the two actors action likelihoods across situations, such that one actor typically interacted with one object and withdrew from the other, while the other actor showed the opposite behaviour. In Experiment 2, participants additionally received explicit information about the two individuals that either matched or mismatched their actual behaviours. The data revealed direct but dissociable effects of both kinds of person information on action identification. Implicit action likelihoods affected response times, speeding up the identification of typical relative to atypical actions, irrespective of the explicit knowledge about the individual's behaviour. Explicit person knowledge, in contrast, affected error rates, causing participants to respond according to expectations instead of observed behaviour, even when they were aware that the explicit information might not be valid. Together, the data show that internal models of others' behaviour are routinely re-activated during action observation. They provide first evidence of a person-specific social anticipation system, which predicts forthcoming actions from both explicit information and an individuals' prior behaviour in a situation. These data link action observation to recent models of predictive coding in the non-social domain where similar dissociations between implicit effects on stimulus identification and explicit behavioural wagers have been reported.	[Schenke, Kimberley C.; Wyer, Natalie A.; Bach, Patric] Univ Plymouth, Sch Psychol, Plymouth, Devon, England	University of Plymouth	Schenke, KC (corresponding author), Univ Plymouth, Sch Psychol, Plymouth, Devon, England.	kimberley.schenke@plymouth.ac.uk	Bach, Patric/AAP-6513-2020	Schenke, Kimberley/0000-0002-1184-4802; Bach, Patric/0000-0003-4493-2080	Economic and Social Research Council grant [ES/J019178/1]; ESRC [ES/J019178/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019178/1] Funding Source: researchfish	Economic and Social Research Council grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by an Economic and Social Research Council grant (http://www.esrc.ac.uk/; ES/J019178/1) to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2006, MOTIV EMOTION, V30, P179, DOI 10.1007/s11031-006-9020-2; Agnew ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032517; Bach P, 2005, J EXP PSYCHOL HUMAN, V31, P465, DOI 10.1037/0096-1523.31.3.465; Bach P, 2006, Q J EXP PSYCHOL, V59, P2033, DOI 10.1080/17470210600917801; Bach P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00254; Bach P, 2011, PSYCHON B REV, V18, P171, DOI 10.3758/s13423-010-0029-x; Bach P, 2010, CEREB CORTEX, V20, P2798, DOI 10.1093/cercor/bhq026; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Batterink LJ, 2015, J MEM LANG, V83, P62, DOI 10.1016/j.jml.2015.04.004; Bayliss AP, 2009, EUR J COGN PSYCHOL, V21, P1072, DOI 10.1080/09541440802553490; Beersma B, 2012, J APPL SOC PSYCHOL, V42, P2640, DOI 10.1111/j.1559-1816.2012.00956.x; BELMORE SM, 1987, J EXP PSYCHOL LEARN, V13, P480, DOI 10.1037/0278-7393.13.3.480; Brockmole JR, 2006, Q J EXP PSYCHOL, V59, P1177, DOI 10.1080/17470210600665996; Buchsbaum D, 2012, ADV CHILD DEV BEHAV, V43, P125, DOI 10.1016/B978-0-12-397919-3.00005-8; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; COHEN CE, 1981, J PERS SOC PSYCHOL, V40, P441; Coventry KR, 2013, PSYCHOL SCI, V24, P1379, DOI 10.1177/0956797612469209; Csibra G., 2007, ATTENTION AND PERFOR, VXXII; Dale R., 2009, P 31 ANN M COGN SCI, P893; Dale R, 2012, ADV COGN PSYCHOL, V8, P196, DOI [10.2478/v10053-008-0115-z, 10.5709/acp-0115-z]; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Dickter C, 2012, SOC NEUROSCI-UK, V7, P240, DOI 10.1080/17470919.2011.609906; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FREYD JJ, 1983, MEM COGNITION, V11, P342, DOI 10.3758/BF03202447; Friedman O, 2005, DEVELOPMENTAL SCI, V8, P218, DOI 10.1111/j.1467-7687.2005.00410.x; Frischen A, 2006, VIS COGN, V14, P351, DOI 10.1080/13506280544000192; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; Goodman ND, 2009, P 31 ANN C COGN SCI, P2759; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Ham J, 2003, J EXP SOC PSYCHOL, V39, P434, DOI 10.1016/S0022-1031(03)00033-7; Hamilton DL, 1996, PSYCHOL REV, V103, P336, DOI 10.1037/0033-295X.103.2.336; Hassabis D, 2014, CEREB CORTEX, V24, P1979, DOI 10.1093/cercor/bht042; HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258; HASTIE R, 1984, J PERS SOC PSYCHOL, V46, P44, DOI 10.1037/0022-3514.46.1.44; Heider JD, 2007, J EXP SOC PSYCHOL, V43, P265, DOI 10.1016/j.jesp.2006.01.004; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Hudson M, 2016, J EXP PSYCHOL GEN, V145, P1, DOI 10.1037/xge0000126; Hudson M, 2016, COGNITION, V146, P245, DOI 10.1016/j.cognition.2015.09.021; Hunnius S, 2010, DEV PSYCHOL, V46, P446, DOI 10.1037/a0016543; Iacoboni M, 2009, CURR OPIN NEUROBIOL, V19, P661, DOI 10.1016/j.conb.2009.09.008; Jamieson RK, 2009, Q J EXP PSYCHOL, V62, P1757, DOI 10.1080/17470210802557637; Johnston L, 2010, BRIT J SOC PSYCHOL, V49, P107, DOI 10.1348/014466609X412476; Joyce K, 2016, COGN NEUROSCI-UK, V7, P74, DOI 10.1080/17588928.2015.1053443; Kaiser D, 2014, P NATL ACAD SCI USA, V111, P11217, DOI 10.1073/pnas.1400559111; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Koster-Hale J, 2013, NEURON, V79, P836, DOI 10.1016/j.neuron.2013.08.020; Leslie AM, 2005, COGNITIVE PSYCHOL, V50, P45, DOI 10.1016/j.cogpsych.2004.06.002; Lindsay D.S., 2013, SAGE HDB APPL MEMORY, P292; LUPFER MB, 1990, J PERS SOC PSYCHOL, V58, P239, DOI 10.1037/0022-3514.58.2.239; Marcus DJ, 2006, MEM COGNITION, V34, P420, DOI 10.3758/BF03193419; Meltzoff A. N., 2013, UNDERSTANDING OTHER, P19; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; PARK B, 1986, J PERS SOC PSYCHOL, V51, P907, DOI 10.1037/0022-3514.51.5.907; PARK B, 1994, J PERS SOC PSYCHOL, V66, P437, DOI 10.1037/0022-3514.66.3.437; Pellicano E, 2012, TRENDS COGN SCI, V16, P574, DOI 10.1016/j.tics.2012.10.004; Pierno AC, 2006, J COGNITIVE NEUROSCI, V18, P2130, DOI 10.1162/jocn.2006.18.12.2130; Press C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051934; Queller S, 2002, J PERS SOC PSYCHOL, V82, P300, DOI 10.1037//0022-3514.82.3.300; Quinn KA, 2011, BRIT J PSYCHOL, V102, P849, DOI 10.1111/j.2044-8295.2011.02030.x; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Ruffman T, 2012, BRIT J DEV PSYCHOL, V30, P87, DOI 10.1111/j.2044-835X.2011.02045.x; Schuck NW, 2012, ADV COGN PSYCHOL, V8, P83, DOI [10.2478/v10053-008-0106-0, 10.5709/acp-0106-0]; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shanks DR, 2002, PSYCHON B REV, V9, P362, DOI 10.3758/BF03196294; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; SHERMAN JW, 1994, J EXP SOC PSYCHOL, V30, P203, DOI 10.1006/jesp.1994.1010; Silvera DH, 2001, SCAND J PSYCHOL, V42, P313, DOI 10.1111/1467-9450.00242; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SRULL TK, 1985, J EXP PSYCHOL LEARN, V11, P316, DOI 10.1037/0278-7393.11.2.316; SRULL TK, 1989, PSYCHOL REV, V96, P58, DOI 10.1037/0033-295X.96.1.58; SRULL TK, 1983, J PERS SOC PSYCHOL, V44, P1157, DOI 10.1037/0022-3514.44.6.1157; STANGOR C, 1992, PSYCHOL BULL, V111, P42, DOI 10.1037/0033-2909.111.1.42; Stapel JC, 2012, PSYCHOL RES-PSYCH FO, V76, P434, DOI 10.1007/s00426-012-0423-2; Stapel JC, 2010, SOC NEUROSCI-UK, V5, P451, DOI 10.1080/17470919.2010.490667; Stefanics G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00666; STERN LD, 1984, J PERS SOC PSYCHOL, V47, P253, DOI 10.1037/0022-3514.47.2.253; STINSON L, 1992, J PERS SOC PSYCHOL, V62, P787, DOI 10.1037/0022-3514.62.5.787; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tipper SP, 2011, J COGN PSYCHOL, V23, P45, DOI 10.1080/20445911.2011.451888; Todd AR, 2011, J EXP SOC PSYCHOL, V47, P37, DOI 10.1016/j.jesp.2010.08.006; Todorov A, 2007, NEUROPSYCHOLOGIA, V45, P163, DOI 10.1016/j.neuropsychologia.2006.04.018; Tormala ZL, 2001, PERS SOC PSYCHOL B, V27, P1599, DOI 10.1177/01461672012712004; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; Wright MJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00851; Yomogida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096534; Zaki J, 2013, PERSPECT PSYCHOL SCI, V8, P296, DOI 10.1177/1745691613475454	96	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158910	10.1371/journal.pone.0158910	http://dx.doi.org/10.1371/journal.pone.0158910			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434265	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000380169600023
J	Svennerholm, K; Rodsand, P; Hellman, U; Waldenstrom, A; Lundholm, M; Ahren, D; Biber, B; Ronquist, G; Haney, M				Svennerholm, Kristina; Rodsand, Pouria; Hellman, Urban; Waldenstrom, Anders; Lundholm, Marie; Ahren, Dag; Biber, Bjorn; Ronquist, Gunnar; Haney, Michael			DNA Content in Extracellular Vesicles Isolated from Porcine Coronary Venous Blood Directly after Myocardial Ischemic Preconditioning	PLOS ONE			English	Article							MEDIATED TRANSFER; GENOMIC DNA; EXOSOMES; PROSTASOMES; MECHANISM; CELLS; HEART; LEADS	Background Extracellular vesicles (EV) are nano-sized membranous structures released from most cells. They have the capacity to carry bioactive molecules and gene expression signals between cells, thus mediating intercellular communication. It is believed that EV confer protection after ischemic preconditioning (IPC). We hypothesize that myocardial ischemic preconditioning will lead to rapid alteration of EV DNA content in EV collected from coronary venous effluent. Materials and Methods In a porcine myocardial ischemic preconditioning model, EV were isolated from coronary venous blood before and after IPC by differential centrifugation steps culminating in preparative ultracentrifugation combined with density gradient ultracentrifugation. The EV preparation was validated, the DNA was extracted and further characterized by DNA sequencing followed by bioinformatics analysis. Results Porcine genomic DNA fragments representing each chromosome, including mitochondrial DNA sequences, were detected in EV isolated before and after IPC. There was no difference detected in the number of sequenced gene fragments (reads) or in the genomic coverage of the sequenced DNA fragments in EV isolated before and after IPC. Gene ontology analysis showed an enrichment of genes coding for ion channels, enzymes and proteins for basal metabolism and vesicle biogenesis and specific cardiac proteins. Conclusions This study demonstrates that porcine EV isolated from coronary venous blood plasma contain fragments of DNA from the entire genome, including the mitochondria. In this model we did not find specific qualitative or quantitative changes of the DNA content in EV collected immediately after an in vivo myocardial IPC provocation. This does not rule out the possibility that EV DNA content changes in response to myocardial IPC which could occur in a later time frame.	[Svennerholm, Kristina; Biber, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Anesthesiol & Intens Care Med, Gothenburg, Sweden; [Rodsand, Pouria; Haney, Michael] Umea Univ, Inst Surg & Perioperat Sci, Anesthesiol & Intens Care Med, Umea, Sweden; [Hellman, Urban; Waldenstrom, Anders] Umea Univ, Cardiol, Inst Heart Ctr, Umea, Sweden; [Hellman, Urban; Waldenstrom, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Med, Umea, Sweden; [Lundholm, Marie] Umea Univ, Inst Med Biosci, Pathol, Umea, Sweden; [Ahren, Dag] Lund Univ, Inst Biol, Natl Bioinformat Infrastruct Sweden, Lund, Sweden; [Ronquist, Gunnar] Uppsala Univ, Inst Med Sci, Clin Chem, Uppsala, Sweden	University of Gothenburg; Umea University; Umea University; Umea University; Umea University; Lund University; Uppsala University	Svennerholm, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Anesthesiol & Intens Care Med, Gothenburg, Sweden.	Kristina.svennerholm@vgregion.se	Hellman, Urban/L-7820-2019	Hellman, Urban/0000-0002-3822-0725; Waldenstrom, Anders/0000-0002-5304-0802	Goteborgs Lakarsallskap [GLS-326401]; Kungliga Hvitfeldska Stiftelsen; Elsa och Gustav Lindhs fond; University of Gothenburg, Sahlgrenska academy, ALF-LUA; Umea University; Swedish Heart-Lung Foundation [2013-0690]	Goteborgs Lakarsallskap; Kungliga Hvitfeldska Stiftelsen; Elsa och Gustav Lindhs fond; University of Gothenburg, Sahlgrenska academy, ALF-LUA; Umea University; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This work was funded by Goteborgs Lakarsallskap GLS-326401 (www.gls.se) (KS); Kungliga Hvitfeldska Stiftelsen (www.hvitfeldtskastiftelsen.se), no grant number (KS); Elsa och Gustav Lindhs fond, no grant number or URL (KS); University of Gothenburg, Sahlgrenska academy, ALF-LUA no grant number (www.fou.nu/is/alfgbg) (BB); Umea University, no grant number (www.vll.se) (MH); and Swedish Heart-Lung Foundation 2013-0690 (MH).	Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Barile L, 2014, CARDIOVASC RES, V103, P530, DOI 10.1093/cvr/cvu167; Cai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105200; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cheng JL, 2012, P NATL ACAD SCI USA, V109, P10827, DOI 10.1073/pnas.1208716109; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Feng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088685; Genneback N, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20167; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Kahlert C, 2014, J BIOL CHEM, V289, P3869, DOI 10.1074/jbc.C113.532267; Kavianipour M, 2003, ACTA PHYSIOL SCAND, V178, P129, DOI 10.1046/j.1365-201X.2003.01108.x; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lampa S, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-9; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; OLSSON I, 1990, ARCH ANDROLOGY, V24, P1; Ronquist GK, 2012, PROSTATE, V72, P1736, DOI 10.1002/pros.22526; Ronquist GK, 2011, MOL REPROD DEV, V78, P467, DOI 10.1002/mrd.21327; Ronquist KG, 2009, PROSTATE, V69, P737, DOI 10.1002/pros.20921; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Svennerholm K, 2015, IJC HEART VASC, V8, P62, DOI 10.1016/j.ijcha.2015.05.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Yamaguchi T, 2015, INT J CARDIOL, V178, P239, DOI 10.1016/j.ijcard.2014.10.144	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159105	10.1371/journal.pone.0159105	http://dx.doi.org/10.1371/journal.pone.0159105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434143	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600033
J	Yoshida, T; Sakamoto, A; Terui, Y; Takao, K; Sugita, Y; Yamamoto, K; Ishihama, A; Igarashi, K; Kashiwagi, K				Yoshida, Taketo; Sakamoto, Akihiko; Terui, Yusuke; Takao, Koichi; Sugita, Yoshiaki; Yamamoto, Kaneyoshi; Ishihama, Akira; Igarashi, Kazuei; Kashiwagi, Keiko			Effect of Spermidine Analogues on Cell Growth of Escherichia coli Polyamine Requiring Mutant MA261	PLOS ONE			English	Article							PREFERENTIAL UPTAKE SYSTEM; PROTEIN-SYNTHESIS; TRANSPORT-SYSTEM; RAT-LIVER; BINDING; POTD; RNA; HOMOSPERMIDINE; IDENTIFICATION; STIMULATION	The effects of spermidine analogues [norspermidine (NSPD, 33), spermidine (SPD, 34), homospermidine (HSPD, 44) and aminopropylcadaverine (APCAD, 35)] on cell growth were studied using Escherichia coli polyamine-requiring mutant MA261. Cell growth was compared at 32 degrees C, 37 degrees C, and 42 degrees C. All four analogues were taken up mainly by the PotABCD spermidine-preferential uptake system. The degree of stimulation of cell growth at 32 degrees C and 37 degrees C was NSPD >= SPD >= HSPD > APCAD, and SPD >= HSPD >= NSPD > APCAD, respectively. However, at 42 degrees C, it was HSPD >> SPD > NSPD > APCAD. One reason for this is HSPD was taken up effectively compared with other triamines. In addition, since natural polyamines (triamines and teteraamines) interact mainly with RNA, and the structure of RNA is more flexible at higher temperatures, HSPD probably stabilized RNA more tightly at 42 degrees C. We have thus far found that 20 kinds of protein syntheses are stimulated by polyamines at the translational level. Among them, synthesis of OppA, RpoE and StpA was more strongly stimulated by HSPD at 42 degrees C than at 37 degrees C. Stabilization of the initiation region of oppA and rpoE mRNA was tighter by HSPD at 42 degrees C than 37 degrees C determined by circular dichroism (CD). The degree of polyamine stimulation of OppA, RpoE and StpA synthesis by NSPD, SPD and APCAD was smaller than that by HSPD at 42 degrees C. Thus, the degree of stimulation of cell growth by spermidine analogues at the different temperatures is dependent on the stimulation of protein synthesis by some components of the polyamine modulon.	[Yoshida, Taketo; Sakamoto, Akihiko; Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan; [Takao, Koichi; Sugita, Yoshiaki] Josai Univ, Dept Pharmaceut Technol, Bioorgan Chem Lab, 1-1 Keyaki Dai, Sakado, Saitama 3500295, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan; [Igarashi, Kazuei] Innovat Plaza Chiba Univ, Amine Pharma Res Inst, Chuo Ku, 1-8-15 Inohana, Chiba, Chiba 2600856, Japan; [Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2608675, Japan	Josai University; Hosei University; Chiba University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan.	kkashiwagi@cis.ac.jp		Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI) [26860044]; Futaba Electronics Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Futaba Electronics Memorial Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (KAKENHI No. 26860044). T. Yoshida was supported by the Futaba Electronics Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. A. Michael for his help in preparing this manuscript. T. Yoshida was supported by the Futaba Electronics Memorial Foundation.	Antognoni F, 1999, J BIOL CHEM, V274, P1942, DOI 10.1074/jbc.274.4.1942; BEHE M, 1981, P NATL ACAD SCI-BIOL, V78, P1619, DOI 10.1073/pnas.78.3.1619; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; HAMANA K, 1992, CRIT REV MICROBIOL, V18, P261, DOI 10.3109/10408419209113518; Higashi K, 2008, J BIOL CHEM, V283, P32989, DOI 10.1074/jbc.M806027200; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1981, EUR J BIOCHEM, V114, P127; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; IGARASHI K, 1974, EUR J BIOCHEM, V48, P495, DOI 10.1111/j.1432-1033.1974.tb03790.x; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; KASHIWAGI K, 1993, J BIOL CHEM, V268, P19358; Kashiwagi K, 1996, J BIOL CHEM, V271, P12205, DOI 10.1074/jbc.271.21.12205; Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; NIITSU M, 1993, J CHROMATOGR, V641, P115, DOI 10.1016/0021-9673(93)83465-5; NIITSU M, 1986, CHEM PHARM BULL, V34, P1032; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Oshima T, 2011, METHODS MOL BIOL, V720, P81, DOI 10.1007/978-1-61779-034-8_5; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Sakamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124883; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Terui Y, 2014, AMINO ACIDS, V46, P661, DOI 10.1007/s00726-013-1517-x; Terui Y, 2009, J BACTERIOL, V191, P5348, DOI 10.1128/JB.00387-09; THOMAS T, 1995, J STEROID BIOCHEM, V54, P89, DOI 10.1016/0960-0760(95)00126-K; WATANABE S, 1991, J BIOL CHEM, V266, P20803; YAMAMOTO S, 1986, CAN J MICROBIOL, V32, P99, DOI 10.1139/m86-021; YAMAMOTO S, 1993, J BIOCHEM-TOKYO, V114, P45, DOI 10.1093/oxfordjournals.jbchem.a124137	37	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159494	10.1371/journal.pone.0159494	http://dx.doi.org/10.1371/journal.pone.0159494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434546	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600058
J	Dahl, LCM; Nasa, Z; Chung, JY; Niego, B; Tarlac, V; Ho, HD; Galle, A; Petratos, S; Lee, JY; Alderuccio, F; Medcalf, RL				Dahl, Lisa C. M.; Nasa, Zeyad; Chung, JieYu; Niego, Be'eri; Tarlac, Volga; Ho, Heidi; Galle, Adam; Petratos, Steven; Lee, Jae Young; Alderuccio, Frank; Medcalf, Robert L.			The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXTRACELLULAR PROTEOLYSIS; MATRIX METALLOPROTEINASES; DEFICIENT MICE; DEMYELINATION; INFLAMMATION; FIBRINOLYSIS; INHIBITORS	Tissue type plasminogen activator (t-PA) has been implicated in the development of multiple sclerosis (MS) and in rodent models of experimental autoimmune encephalomyelitis (EAE). We show that levels of t-PA mRNA and activity are increased similar to 4 fold in the spinal cords of wild-type mice that are mice subjected to EAE. This was also accompanied with a significant increase in the levels of pro-matrix metalloproteinase 9 (pro-MMP-9) and an influx of fibrinogen. We next compared EAE severity in wild-type mice, t-PA(-/-) mice and T4+ transgenic mice that selectively over-express (similar to 14-fold) mouse t-PA in neurons of the central nervous system. Our results confirm that t-PA deficient mice have an earlier onset and more severe form of EAE. T4+ mice, despite expressing higher levels of endogenous t-PA, manifested a similar rate of onset and neurological severity of EAE. Levels of proMMP-9, and extravasated fibrinogen in spinal cord extracts were increased in mice following EAE onset regardless of the absence or over-expression of t-PA wild-type. Interestingly, MMP-2 levels also increased in spinal cord extracts of T4+ mice following EAE, but not in the other genotypes. Hence, while the absence of t-PA confers a more deleterious form of EAE, neuronal over-expression of t-PA does not overtly protect against this condition with regards to symptom onset or severity of EAE.	[Dahl, Lisa C. M.; Niego, Be'eri; Ho, Heidi; Galle, Adam; Medcalf, Robert L.] Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic 3004, Australia; [Nasa, Zeyad; Chung, JieYu; Alderuccio, Frank] Monash Univ, Dept Immunol, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Tarlac, Volga] Monash Univ, Cent Clin Sch, Van Cleef Roet Ctr Nervous Dis, Melbourne, Vic 3004, Australia; [Petratos, Steven; Lee, Jae Young] Monash Univ, Cent Clin Sch, Dept Med, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University; Monash University	Medcalf, RL (corresponding author), Monash Univ, Cent Clin Sch, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic 3004, Australia.	robert.medcalf@monash.edu	Medcalf, Robert L/E-9632-2011; Niego, Beeri/AAG-5534-2019	Niego, Beeri/0000-0001-6714-9131; Alderuccio, Frank/0000-0003-4853-3394; Tarlac, Volga/0000-0001-5566-075X	National Health and Medical Research Council of Australia [1045756]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by a grant awarded to RLM from the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/); Grant #1045756.	Adams RA, 2004, MOL INTERV, V4, P163; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Akenami FOT, 1999, J NEUROL SCI, V165, P71, DOI 10.1016/S0022-510X(99)00080-5; Akenami FOT, 1996, J CLIN PATHOL, V49, P577, DOI 10.1136/jcp.49.7.577; Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Chan J, 2008, J IMMUNOL, V181, P7571, DOI 10.4049/jimmunol.181.11.7571; Chevilley A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00415; CLAUDIO L, 1995, ACTA NEUROPATHOL, V90, P228; Cops EJ, 2013, EXP NEUROL, V249, P8, DOI 10.1016/j.expneurol.2013.08.001; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; Defawe OD, 2005, CARDIOVASC RES, V66, P402, DOI 10.1016/j.cardiores.2004.11.025; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; East E, 2008, NEUROPATH APPL NEURO, V34, P216, DOI 10.1111/j.1365-2990.2007.00889.x; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Grierson C, 2010, ANAL BIOCHEM, V404, P232, DOI 10.1016/j.ab.2010.05.020; Gveric D, 2003, BRAIN, V126, P1590, DOI 10.1093/brain/awg167; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Inoue A, 1997, J NEUROIMMUNOL, V77, P185, DOI 10.1016/S0165-5728(97)00072-6; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Ko HJ, 2011, AUTOIMMUNITY, V44, P177, DOI 10.3109/08916934.2010.515274; Konnecke H, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/914104; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lu WQ, 2002, J NEUROSCI, V22, P10781; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; Moon LDF, 2006, J NEUROSCI RES, V84, P1245, DOI 10.1002/jnr.21019; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Niego B, 2014, J CEREBR BLOOD F MET, V34, P1283, DOI 10.1038/jcbfm.2014.99; Niimi N, 2013, NEUROPATHOLOGY, V33, P612, DOI 10.1111/neup.12039; PATERSON PY, 1987, FED PROC, V46, P91; ROMANIC AM, 1994, BRAIN PATHOL, V4, P145, DOI 10.1111/j.1750-3639.1994.tb00825.x; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Seeds NW, 2003, J NEUROSCI, V23, P7368; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Suzuki Y, 2007, J THROMB HAEMOST, V5, P1732, DOI 10.1111/j.1538-7836.2007.02628.x; Suzuki Y, 2009, BLOOD, V114, P3352, DOI 10.1182/blood-2009-02-203919; Teesalu T, 2002, BIOCHEM SOC T, V30, P183, DOI 10.1042/BST0300183; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012; Yang Y, 2011, CELL MOL NEUROBIOL, V31, P437, DOI 10.1007/s10571-010-9637-2; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	57	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158653	10.1371/journal.pone.0158653	http://dx.doi.org/10.1371/journal.pone.0158653			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427941	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300016
J	Villegas, G; Calenda, G; Ugaonkar, S; Zhang, SM; Kizima, L; Mizenina, O; Gettie, A; Blanchard, J; Cooney, ML; Robbiani, M; Fernandez-Romero, JA; Zydowsky, TM; Teleshova, N				Villegas, Guillermo; Calenda, Giulia; Ugaonkar, Shweta; Zhang, Shimin; Kizima, Larisa; Mizenina, Olga; Gettie, Agegnehu; Blanchard, James; Cooney, Michael L.; Robbiani, Melissa; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Teleshova, Natalia			A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INFECTION; HIV ACQUISITION; IN-VITRO; PREVENTION; WOMEN; GEL; HPV; PHARMACOKINETICS; PHARMACODYNAMICS; CONTRACEPTIVES	Women need multipurpose prevention products (MPTs) that protect against sexually transmitted infections (STIs) and provide contraception. The Population Council has developed a prototype intravaginal ring (IVR) releasing the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 (M), zinc acetate (ZA), carrageenan (CG) and levonorgestrel (LNG) (MZCL IVR) to protect against HIV, HSV-2, HPV and unintended pregnancy. Our objective was to evaluate the anti-SHIV-RT activity of MZCL IVR in genital mucosa. First, macaque vaginal tissues were challenged with SHIV-RT in the presence of (i) MIV-150 similar to LNG or (ii) vaginal fluids (VF); available from studies completed earlier) collected at various time points post insertion of MZCL and MZC IVRs. Then, (iii) MZCL IVRs (vs. LNG IVRs) were inserted in non-Depo Provera-treated macaques for 24h and VF, genital biopsies, and blood were collected and tissues were challenged with SHIV-RT. Infection was monitored with one step SIV gag qRT-PCR or p27 ELISA. MIV-150 (LCMS/ MS, RIA), LNG (RIA) and CG (ELISA) were measured in different compartments. Log-normal generalized mixed linear models were used for analysis. LNG did not affect the anti-SHIV-RT activity of MIV-150 in vitro. MIV-150 in VF from MZC/ MZCL IVR-treated macaques inhibited SHIV-RT in vaginal mucosa in a dose-dependent manner (p< 0.05). MIV-150 in vaginal tissue from MZCL IVRtreated animals inhibited ex vivo infection relative to baseline (96%; p< 0.0001) and post LNG IVR group (90%, p< 0.001). No MIV-150 dose-dependent protection was observed, likely because of high MIV-150 concentrations in all vaginal tissue samples. In cervical tissue, MIV-150 inhibited infection vs. baseline (99%; p< 0.05). No cervical tissue was available for MIV-150 measurement. Exposure to LNG IVR did not change tissue infection level. These observations support further development of MZCL IVR as a multipurpose prevention technology to improve women's sexual and reproductive health.	[Villegas, Guillermo; Calenda, Giulia; Ugaonkar, Shweta; Zhang, Shimin; Kizima, Larisa; Mizenina, Olga; Cooney, Michael L.; Robbiani, Melissa; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Teleshova, Natalia] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA	Population Council; Rockefeller University; Tulane University	Teleshova, N (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.	nteleshova@popcouncil.org		Cooney, Michael/0000-0001-7943-1951	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; National Institute of Allergy and Infectious Diseases (NIH) [R21 AI098645]; Tulane National Primate Research Center [Primate Center base grant] [P51 OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098645] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tulane National Primate Research Center [Primate Center base grant]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) Cooperative Agreement [GPO-A-00-04-00019-00, www.usaid.gov]; The National Institute of Allergy and Infectious Diseases (NIH) [R21 AI098645, www.niaid.nih.gov]; The Tulane National Primate Research Center [Primate Center base grant P51 OD011104, http://tulane.edu/tnprc]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles SL, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.016; [Anonymous], 1985, COMM CAR US LAB AN I; Aravantinou M, 2012, AIDS RES HUM RETROV, V28, P1467, DOI [10.1089/aid.2012.0080, 10.1089/AID.2012.0080]; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; BARBOSA I, 1990, CONTRACEPTION, V42, P51, DOI 10.1016/0010-7824(90)90092-A; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Barnable P, 2015, ANTIMICROB AGENTS CH, V59, P3829, DOI 10.1128/AAC.00073-15; Barnable P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108109; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Chen BA, 2015, JAIDS-J ACQ IMM DEF, V70, P242, DOI 10.1097/QAI.0000000000000702; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Friedland B, 2016, 1 IN HUMAN TRIAL PC; Friend DR, 2013, ANTIVIR RES, V100, pS39, DOI 10.1016/j.antiviral.2013.09.030; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Goldfien GA, 2015, REPROD SCI, V22, P814, DOI 10.1177/1933719114565035; Goode D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004567; Harrison PF, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/790154; Hild-Petito S, 1998, AIDS RES HUM RETROV, V14, pS125; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Hsu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089300; Jean-Pierre N, 2016, ANTIMICROB AGENTS CH, V60, P1141, DOI 10.1128/AAC.02468-15; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kenney J, 2012, AIDS RES HUM RETROV, V28, P1476, DOI [10.1089/aid.2012.0087, 10.1089/AID.2012.0087]; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kizima L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094547; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Lowy DR, 2012, CANCER PREV RES, V5, P18, DOI 10.1158/1940-6207.CAPR-11-0542; LUUKKAINEN T, 1995, CONTRACEPTION, V52, P269, DOI 10.1016/0010-7824(95)00210-2; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; NILSSON CG, 1980, CONTRACEPTION, V21, P225, DOI 10.1016/0010-7824(80)90003-7; Ostergaard SD, 2015, J MED PRIMATOL, V44, P97, DOI 10.1111/jmp.12157; Ouattara LA, 2014, ANTIMICROB AGENTS CH, V58, P2841, DOI 10.1128/AAC.01529-13; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Polis CB, 2014, CONTRACEPTION, V90, P360, DOI 10.1016/j.contraception.2014.07.009; Richardson-Harman N, 2012, AIDS RES HUM RETROV, V28, P1422, DOI [10.1089/aid.2012.0073, 10.1089/AID.2012.0073]; Richardson-Harman N, 2009, J CLIN MICROBIOL, V47, P3530, DOI 10.1128/JCM.00673-09; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rodriguez A, 2014, ANTIVIR RES, V108, P88, DOI 10.1016/j.antiviral.2014.05.018; Romano J, 2013, AIDS RES HUM RETROV, V29, P1418, DOI [10.1089/aid.2013.0122, 10.1089/AID.2013.0122]; Sciaranghella G, 2015, J INFECT DIS, V212, P1397, DOI 10.1093/infdis/jiv233; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Thurman AR, 2013, INT J WOMENS HEALTH, V5, P695, DOI 10.2147/IJWH.S34030; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Ugaonkar SR, 2015, J CONTROL RELEASE, V213, P57, DOI 10.1016/j.jconrel.2015.06.018	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159332	10.1371/journal.pone.0159332	http://dx.doi.org/10.1371/journal.pone.0159332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428377	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300051
J	Bi, C; Zhang, L; Qi, M; Zheng, CX; Yi, YG; Wang, JZ; Zhang, BX				Bi, Chao; Zhang, Lei; Qi, Miao; Zheng, Caixia; Yi, Yugen; Wang, Jianzhong; Zhang, Baoxue			Supervised Filter Learning for Representation Based Face Recognition	PLOS ONE			English	Article							DIMENSIONALITY REDUCTION; DISCRIMINANT-ANALYSIS; CLASSIFICATION; EIGENFACES; PATTERNS; SCALE	Representation based classification methods, such as Sparse Representation Classification (SRC) and Linear Regression Classification (LRC) have been developed for face recognition problem successfully. However, most of these methods use the original face images without any preprocessing for recognition. Thus, their performances may be affected by some problematic factors (such as illumination and expression variances) in the face images. In order to overcome this limitation, a novel supervised filter learning algorithm is proposed for representation based face recognition in this paper. The underlying idea of our algorithm is to learn a filter so that the within-class representation residuals of the faces' Local Binary Pattern (LBP) features are minimized and the between-class representation residuals of the faces' LBP features are maximized. Therefore, the LBP features of filtered face images are more discriminative for representation based classifiers. Furthermore, we also extend our algorithm for heterogeneous face recognition problem. Extensive experiments are carried out on five databases and the experimental results verify the efficacy of the proposed algorithm.	[Bi, Chao; Qi, Miao; Zheng, Caixia; Wang, Jianzhong] Northeast Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China; [Zhang, Lei] Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, Changchun, Peoples R China; [Yi, Yugen] Jiangxi Normal Univ, Sch Software, Nanchang, Peoples R China; [Zhang, Baoxue] Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; Changchun Institute of Optics, Fine Mechanics & Physics, CAS; Jiangxi Normal University; Capital University of Economics & Business	Wang, JZ (corresponding author), Northeast Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China.; Zhang, BX (corresponding author), Capital Univ Econ & Business, Sch Stat, Beijing, Peoples R China.	wangjz019@nenu.edu.cn; zhangbaoxue@cueb.edu.cn	Zhang, Bao/B-3926-2012	Zhang, Lei/0000-0002-2830-2233; Yi, Yugen/0000-0002-1049-5022	Fund of Jilin Provincial Science AMP; Technology Department [20130206042GX]; Young scientific research fund of Jilin province science and technology development project [20130522115JH]; National Natural Science Foundation of China [11271064, 61403078, 61471111]	Fund of Jilin Provincial Science AMP; Technology Department; Young scientific research fund of Jilin province science and technology development project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Fund of Jilin Provincial Science & Technology Department (20130206042GX), Young scientific research fund of Jilin province science and technology development project (No. 20130522115JH) and National Natural Science Foundation of China (No. 11271064, 61403078, 61471111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; [Anonymous], 1997, YALE FACE DATABASE; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Chen Y, 2013, NEURAL PROCESS LETT, V37, P355, DOI 10.1007/s11063-012-9252-y; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Gao SH, 2010, LECT NOTES COMPUT SC, V6314, P1; Howland P, 2004, IEEE T PATTERN ANAL, V26, P995, DOI 10.1109/TPAMI.2004.46; Huang G. B., 2007, 0749 U MASS; Huang M-W, 2010, IM SIGN PROC CISP 20; Jain A. K., 2005, HDB FACE RECOGNITION; Kang C, 2011, IM PROC ICIP 2011 18; Lee H, 2011, LECT NOTES COMPUT SC, V6513, P273, DOI 10.1007/978-3-642-17955-6_20; Lei Z., 2012, COMP VIS PATT REC CV; Lei Z, 2014, IEEE T PATTERN ANAL, V36, P289, DOI 10.1109/TPAMI.2013.112; Lei Z, 2011, IEEE T IMAGE PROCESS, V20, P247, DOI 10.1109/TIP.2010.2060207; Lu GF, 2012, KNOWL-BASED SYST, V31, P119, DOI 10.1016/j.knosys.2012.02.014; Martinez A., 1998, AR FACE DATABASE; Mi JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059430; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Min R, 2011, MULT EXP ICME 2011 I; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Penev PS, 1996, NETWORK-COMP NEURAL, V7, P477, DOI 10.1088/0954-898X/7/3/002; Pentland A, 1994, COMP VIS PATT REC 19; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Scholkopft B., 1999, NEURAL NETW SIGNAL P, V1, P1; Shan S, 2004, PATT REC 2004 ICPR 2; Sim Terence, 2002, AUT FAC GEST REC 200; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wang Jinjun, 2010, COMP VIS PATT REC CV; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Xu Y, 2011, OPTICAL ENG, V50; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang M, 2011, COMP VIS PATT REC CV; Ye JP, 2005, IEEE T PATTERN ANAL, V27, P929, DOI 10.1109/TPAMI.2005.110; Zhang BH, 2007, IEEE T IMAGE PROCESS, V16, P57, DOI 10.1109/TIP.2006.884956; Zhang W, 2005, COMP VIS 2005 ICCV 2; Zhao S, 2008, IM PROC 2008 ICIP 20; Zhu ML, 2006, IEEE T PATTERN ANAL, V28, P1274, DOI 10.1109/TPAMI.2006.172	45	2	2	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159084	10.1371/journal.pone.0159084	http://dx.doi.org/10.1371/journal.pone.0159084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416030	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500072
J	Das, K; Srivastava, M; Raghavan, SC				Das, Kohal; Srivastava, Mrinal; Raghavan, Sathees C.			GNG Motifs Can Replace a GGG Stretch during G-Quadruplex Formation in a Context Dependent Manner	PLOS ONE			English	Article							MAJOR BREAKPOINT REGION; B-DNA-STRUCTURE; CHROMOSOMAL TRANSLOCATIONS; T(14/18) TRANSLOCATION; MOLECULAR-STRUCTURE; NUCLEIC-ACIDS; HUMAN GENOME; STABILITY; PROMOTER; FRAGILITY	G-quadruplexes are one of the most commonly studied non-B DNA structures. Generally, these structures are formed using a minimum of 4, three guanine tracts, with connecting loops ranging from one to seven. Recent studies have reported deviation from this general convention. One such deviation is the involvement of bulges in the guanine tracts. In this study, guanines along with bulges, also referred to as GNG motifs have been extensively studied using recently reported HOX11 breakpoint fragile region I as a model template. By strategic mutagenesis approach we show that the contribution from continuous G-tracts may be dispensible during G-quadruplex formation when such motifs are flanked by GNGs. Importantly, the positioning and number of GNG/GNGNG can also influence the formation of G-quadruplexes. Further, we assessed three genomic regions from HIF1 alpha, VEGF and SHOX gene for G-quadruplex formation using GNG motifs. We show that HIF1 alpha sequence harbouring GNG motifs can fold into intramolecular G-quadruplex. In contrast, GNG motifs in mutant VEGF sequence could not participate in structure formation, suggesting that the usage of GNG is context dependent. Importantly, we show that when two continuous stretches of guanines are flanked by two independent GNG motifs in a naturally occurring sequence (SHOX), it can fold into an intramolecular G-quadruplex. Finally, we show the specific binding of G-quadruplex binding protein, Nucleolin and G-quadruplex antibody, BG4 to SHOX G-quadruplex. Overall, our study provides novel insights into the role of GNG motifs in G-quadruplex structure formation which may have both physiological and pathological implications.	[Das, Kohal; Srivastava, Mrinal; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	Srivastava, Mrinal/AAM-5013-2020		IISc-DBT partnership programme [DBT/BF/PR/INS/2011-12/IISc]	IISc-DBT partnership programme [DBT/BF/PR/INS/2011-12/IISc]	This work was supported by grants IISc-DBT partnership programme [DBT/BF/PR/INS/2011-12/IISc] to SCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala P, 2015, ORG BIOMOL CHEM, V13, P5570, DOI 10.1039/c4ob02681k; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cer RZ, 2013, NUCLEIC ACIDS RES, V41, pD94, DOI 10.1093/nar/gks955; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639; Hanakahi LA, 1999, J BIOL CHEM, V274, P15908, DOI 10.1074/jbc.274.22.15908; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hurley LH, 2011, GENES CANC, V1, P641; Jiang HX, 2015, SCI REP-UK, V5, DOI 10.1038/srep09255; Katapadi VK, 2012, GENOMICS, V100, P72, DOI 10.1016/j.ygeno.2012.05.008; Kumari R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119722; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lim KW, 2015, NUCL ACIDS RES; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; Mathad RI, 2011, NUCLEIC ACIDS RES, V39, P9023, DOI 10.1093/nar/gkr612; Mirkin SM, 2013, NATURE, V497, P449, DOI 10.1038/nature12244; Mukundan VT, 2013, J AM CHEM SOC, V135, P5017, DOI 10.1021/ja310251r; Naik AK, 2008, DNA REPAIR, V7, P1384, DOI 10.1016/j.dnarep.2008.04.010; Nambiar M, 2013, MOL CELL BIOL, V33, P4266, DOI 10.1128/MCB.00540-13; Nambiar M, 2012, J BIOL CHEM, V287, P8688, DOI 10.1074/jbc.M111.307363; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Oganesian L, 2007, BIOCHEMISTRY-US, V46, P11279, DOI 10.1021/bi700993q; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Tran PLT, 2011, NUCLEIC ACIDS RES, V39, P3282, DOI 10.1093/nar/gkq1292; Rachwal PA, 2007, BIOCHEMISTRY-US, V46, P3036, DOI 10.1021/bi062118j; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Raghavan SC, 2004, J BIOL CHEM, V279, P46213, DOI 10.1074/jbc.M406280200; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2015, FEBS J; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WILKINS MHF, 1953, NATURE, V171, P738, DOI 10.1038/171738a0; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	48	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158794	10.1371/journal.pone.0158794	http://dx.doi.org/10.1371/journal.pone.0158794			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414642	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500041
J	Holdgate, MR; Meehan, CL; Hogan, JN; Miller, LJ; Soltis, J; Andrews, J; Shepherdson, DJ				Holdgate, Matthew R.; Meehan, Cheryl L.; Hogan, Jennifer N.; Miller, Lance J.; Soltis, Joseph; Andrews, Jeff; Shepherdson, David J.			Walking Behavior of Zoo Elephants: Associations between GPS-Measured Daily Walking Distances and Environmental Factors, Social Factors, and Welfare Indicators	PLOS ONE			English	Article							NATIONAL-PARK; PHYSICAL-EXERCISE; ASIAN ELEPHANTS; ANIMAL-WELFARE; AFRICAN; MORTALITY; HEALTH; IMPACT; RATES; TOOL	Research with humans and other animals suggests that walking benefits physical health. Perhaps because these links have been demonstrated in other species, it has been suggested that walking is important to elephant welfare, and that zoo elephant exhibits should be designed to allow for more walking. Our study is the first to address this suggestion empirically by measuring the mean daily walking distance of elephants in North American zoos, determining the factors that are associated with variations in walking distance, and testing for associations between walking and welfare indicators. We used anklets equipped with GPS data loggers tomeasure outdoor daily walking distance in 56 adult female African (n = 33) and Asian (n = 23) elephants housed in 30 North American zoos. We collected 259 days of data and determined associations between distance walked and social, housing, management, and demographic factors. Elephants walked an average of 5.3 km/day with no significant difference between species. In our multivariable model, more diverse feeding regimens were correlated with increased walking, and elephants who were fed on a temporally unpredictable feeding schedule walked 1.29 km/daymore than elephants fed on a predictable schedule. Distance walked was also positively correlated with an increase in the number of social groupings and negatively correlated with age. We found a small but significant negative correlation between distance walked and nighttime Space Experience, but no other associations between walking distances and exhibit size were found. Finally, distance walked was not related to health or behavioral outcomes including foot health, joint health, body condition, and the performance of stereotypic behavior, suggesting that more research is necessary to determine explicitly how differences in walking may impact elephant welfare.	[Holdgate, Matthew R.; Shepherdson, David J.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Holdgate, Matthew R.; Shepherdson, David J.] Oregon Zoo, Conservat Res Div, Portland, OR USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Miller, Lance J.] Chicago Zool Soc, Brookfield Zoo, Brookfield, IL USA; [Soltis, Joseph] Disneys Anim Kingdom, Dept Educ & Sci, Lake Buena Vista, FL USA; [Andrews, Jeff] Busch Gardens, Zool Operat, Tampa, FL USA	Portland State University; Walt Disney Company	Holdgate, MR (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.; Holdgate, MR (corresponding author), Oregon Zoo, Conservat Res Div, Portland, OR USA.	mholdgate@gmail.com			Institute of Museum and Library Services [LG-25-10-0033-10]; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Institute of Museum and Library Services; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. This paper was completed while MRH was undertaking a Ph.D. in Biology at Portland State University and in receipt of funding from the Forbes-Lea Research Grant, Marie Brown Award, and Student Education Travel Grant. Employers provided financial support in the form of authors' salaries as follows: Oregon Zoo (DS and MH); Disney's Animal Kingdom (JS); Chicago Zoological Society-Brookfield Zoo (LM); Busch Gardens (JA). After the IMLS-funded period of performance (November 2010 December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Brown JL, 2000, ZOO BIOL, V19, P347, DOI 10.1002/1098-2361(2000)19:5&lt;347::AID-ZOO6&gt;3.0.CO;2-V; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Brown JL, 2016, PLOS ONE; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Franks B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083578; Gadd ME, 2002, AFR J ECOL, V40, P328, DOI 10.1046/j.1365-2028.2002.00385.x; Greco BJ, 2016, PLOS ONE; Hacker CE, 2015, APPL ANIM BEHAV SCI, V163, P175, DOI 10.1016/j.applanim.2014.12.005; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597; Holdgate MR, 2016, PLOS ONE; Hutchins M, 2006, ZOO BIOL, V25, P161, DOI 10.1002/zoo.20087; Jones B, 2007, J VET BEHAV, V2, P185, DOI 10.1016/j.jveb.2007.06.001; Kopp M, 2012, DIABETES RES CLIN PR, V95, P25, DOI 10.1016/j.diabres.2011.09.017; Langley R. B., 1999, GPS WORLD, P52; Lee J, 2011, APPL ANIM BEHAV SCI, V130, P91, DOI 10.1016/j.applanim.2011.01.001; Leighty KA, 2010, ZOO BIOL, V29, P210, DOI 10.1002/zoo.20250; Leighty KA, 2009, ZOO BIOL, V28, P16, DOI 10.1002/zoo.20199; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Loarie SR, 2009, BIOL CONSERV, V142, P3099, DOI 10.1016/j.biocon.2009.08.021; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Meehan CL, 2016, PLOS ONE; Mench Joy A., 1998, P30; Menor-Campos DJ, 2011, VET REC, V169, P388, DOI 10.1136/vr.d4757; Mikota S.K., 1994, W BLOOMFIELD; Miller LJ, 2012, ANIM WELFARE, V21, P577, DOI 10.7120/09627286.21.4.577; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Moss Cynthia J., 2011, P205; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Popescu S, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-43; Prado-Oviedo NA, 2016, PLOS ONE; Rothwell ES, 2011, ZOO BIOL, V30, P579, DOI 10.1002/zoo.20364; Rowell Z, 2014, J ZOO AQUAR RES, V2, P130; Rushen J, 2003, APPL ANIM BEHAV SCI, V81, P199, DOI 10.1016/S0168-1591(02)00281-2; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; SHEPHERDSON DJ, 1993, ZOO BIOL, V12, P203, DOI 10.1002/zoo.1430120206; Slotow R., 2004, Koedoe, V47, P91; Soulsby KS, 2013, THESIS; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Stokke S, 2002, AFR J ECOL, V40, P360, DOI 10.1046/j.1365-2028.2002.00395.x; Sukumar R., 2003, LIVING ELEPHANTS EVO; Taylor VJ, 1998, ZOO BIOL, V17, P311, DOI 10.1002/(SICI)1098-2361(1998)17:4&lt;311::AID-ZOO5&gt;3.0.CO;2-C; Warren BS, 2011, BRIT J NUTR, V106, pS85, DOI 10.1017/S0007114511001814; WEIR JS, 1969, J ZOOL, V158, P293; WEIR JS, 1972, OIKOS, V23, P1, DOI 10.2307/3543921; Whisher L, 2011, APPL ANIM BEHAV SCI, V135, P63, DOI 10.1016/j.applanim.2011.09.001; Whitehouse AM, 2003, AFR ZOOL, V38, P95; Witte TH, 2005, J BIOMECH, V38, P1717, DOI 10.1016/j.jbiomech.2004.07.028; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	63	30	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0150331	10.1371/journal.pone.0150331	http://dx.doi.org/10.1371/journal.pone.0150331			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414411	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500004
J	Meehan, CL; Hogan, JN; Bonaparte-Saller, MK; Mench, JA				Meehan, Cheryl L.; Hogan, Jennifer N.; Bonaparte-Saller, Mary K.; Mench, Joy A.			Housing and Social Environments of African (Loxodonta africana) and Asian (Elephas maximus) Elephants in North American Zoos	PLOS ONE			English	Article							ENCLOSURE SIZE; STEREOTYPIC BEHAVIOR; CAGE SIZE; AGGRESSION; WELFARE; ACCESS; WILD; HUSBANDRY; CORTISOL; CHOICE	We evaluated 255 African (Loxodonta africana) and Asian (Elephas maximus) elephants living in 68 North American zoos over one year to quantify housing and social variables. All parameters were quantified for the both the day and the night and comparisons were made across these time periods as well as by species and sex. To assess housing, we evaluated not only total exhibit size, but also individual animals' experiences based on the time they spent in the unique environments into which the exhibits were subdivided. Variables developed to assess housing included measurements of area as a function of time (Total Space Experience), environment type (Indoor, Outdoor, In/Out Choice) and time spent on hard and soft flooring. Over the year, Total Space Experience values ranged from 1,273 square feet to 169,692 square feet, with Day values significantly greater than Night values (p<0.001). Elephants spent an average of 55.1% of their time outdoors, 28.9% indoors, and 16% in areas with a choice between being in or out. Time spent on hard flooring substrate ranged from 0% to 66.7%, with Night values significantly greater than Day (p<0.001). Social factors included number of animals functionally housed together (Social Experience) and social group characteristics such as time spent with juveniles and in mixed-sex groups. Overall Social Experience scores ranged from 1 to 11.2 and were significantly greater during the Day than at Night (p<0.001). There were few significant social or housing differences between African (N = 138) and Asian (N = 117) species or between males (N = 54) and females (N = 201). The most notable exception was Total Space Experience, with African and male elephants having larger Total Space Experience than Asian and female elephants, respectively (P-value<0.05). The housing and social variables evaluated herein have been used in a series of subsequent epidemiological analyses relating to various elephant welfare outcomes.	[Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Bonaparte-Saller, Mary K.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Meehan, CL (corresponding author), AWARE Inst, Portland, OR USA.	Cheryl.meehan@aware.institute			Institute of Museum and Library Services [LG-25-10-0033-10]; IMLS; AWARE Institute	Institute of Museum and Library Services; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; Barker ZE, 2009, J DAIRY SCI, V92, P1971, DOI 10.3168/jds.2008-1590; Brown JL, 2016, PLOS ONE; Brummer SP, 2010, APPL ANIM BEHAV SCI, V125, P171, DOI 10.1016/j.applanim.2010.04.012; Butterworth A., 2011, Animal welfare, P200, DOI 10.1079/9781845936594.0200; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; DeVries TJ, 2004, J DAIRY SCI, V87, P1432, DOI 10.3168/jds.S0022-0302(04)73293-2; Fagen RM, 1981, ANIMAL PLAY BEHAV; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; Fontenot MB, 2006, J AM ASSOC LAB ANIM, V45, P35; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Fuller G, 2013, ZOO BIOL, V32, P88, DOI 10.1002/zoo.21049; GADGIL M, 1984, P INDIAN AS-ANIM SCI, V93, P225, DOI 10.1007/BF03186282; Galindo F., 2011, Animal welfare, P228, DOI 10.1079/9781845936594.0228; Garner JP, 2012, POULTRY SCI, V91, P1522, DOI 10.3382/ps.2011-01969; Greco BJ, 2016, PLOS ONE; Haley DB, 2001, APPL ANIM BEHAV SCI, V71, P105, DOI 10.1016/S0168-1591(00)00175-1; Hansen SW, 2007, ANIM WELFARE, V16, P63; Harris M, 2008, WC05007 DEFRA U BRIS; Haufe HC, 2012, PREV VET MED, V105, P85, DOI 10.1016/j.prevetmed.2012.01.016; Hockenhull J, 2014, APPL ANIM BEHAV SCI, V155, P49, DOI 10.1016/j.applanim.2014.02.014; HOGAN ES, 1988, APPL ANIM BEHAV SCI, V21, P147, DOI 10.1016/0168-1591(88)90105-0; Holdgate MR, 2016, PLOS ONE; Johnsen PF, 2001, ACTA AGR SCAND A-AN, V51, P26, DOI 10.1080/090647001316923027; Kaufman BM, 2004, APPL ANIM BEHAV SCI, V88, P319, DOI 10.1016/j.applanim.2004.03.012; Kurtycz LM, 2014, J APPL ANIM WELF SCI, V17, P185, DOI 10.1080/10888705.2014.896213; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Nakamura K, 2011, ANIM SCI J, V82, P161, DOI 10.1111/j.1740-0929.2010.00806.x; Nielsen B. L., 2011, Animal welfare, P215, DOI 10.1079/9781845936594.0215; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Owen MA, 2005, ZOO BIOL, V24, P475, DOI 10.1002/zoo.20064; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Ross SR, 2006, BEHAV PROCESS, V73, P117, DOI 10.1016/j.beproc.2006.04.003; Schumann K, 2014, J APPL ANIM WELF SCI, V17, P111, DOI 10.1080/10888705.2014.884407; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; Thomas B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003902; Valuska AJ, 2013, APPL ANIM BEHAV SCI, V149, P72, DOI 10.1016/j.applanim.2013.10.002; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19; Wiedenmayer C, 1996, APPL ANIM BEHAV SCI, V47, P225, DOI 10.1016/0168-1591(95)00652-4	48	21	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0146703	10.1371/journal.pone.0146703	http://dx.doi.org/10.1371/journal.pone.0146703			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414034	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500003
J	Wang, TY; Santos, JH; Feng, J; Fargo, DC; Shen, L; Riadi, G; Keeley, E; Rosh, ZS; Nestler, EJ; Woychik, RP				Wang, Tianyuan; Santos, Janine H.; Feng, Jian; Fargo, David C.; Shen, Li; Riadi, Gonzalo; Keeley, Elizabeth; Rosh, Zachary S.; Nestler, Eric J.; Woychik, Richard P.			A Novel Analytical Strategy to Identify Fusion Transcripts between Repetitive Elements and Protein Coding-Exons Using RNA-Seq	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; CELLS; METHYLATION; ISOFORM; TOPHAT; BRAIN	Repetitive elements (REs) comprise 40-60% of the mammalian genome and have been shown to epigenetically influence the expression of genes through the formation of fusion transcript (FTs). We previously showed that an intracisternal A particle forms an FT with the agouti gene in mice, causing obesity/type 2 diabetes. To determine the frequency of FTs genome-wide, we developed a TopHat-Fusion-based analytical pipeline to identify FTs with high specificity. We applied it to an RNA-seq dataset from the nucleus accumbens (NAc) of mice repeatedly exposed to cocaine. Cocaine was previously shown to increase the expression of certain REs in this brain region. Using this pipeline that can be applied to single- or paired-end reads, we identified 438 genes expressing 813 different FTs in the NAc. Although all types of studied repeats were present in FTs, simple sequence repeats were underrepresented. Most importantly, reverse-transcription and quantitative PCR validated the expression of selected FTs in an independent cohort of animals, which also revealed that some FTs are the prominent isoforms expressed in the NAc by some genes. In other RNA-seq datasets, developmental expression as well as tissue specificity of some FTs differed from their corresponding non-fusion counterparts. Finally, in silico analysis predicted changes in the structure of proteins encoded by some FTs, potentially resulting in gain or loss of function. Collectively, these results indicate the robustness of our pipeline in detecting these new isoforms of genes, which we believe provides a valuable tool to aid in better understanding the broad role of REs in mammalian cellular biology.	[Wang, Tianyuan; Santos, Janine H.; Fargo, David C.; Woychik, Richard P.] NIEHS, 111 TW Alexander Dr,Bldg 101, Res Triangle Pk, NC 27709 USA; [Feng, Jian; Shen, Li; Keeley, Elizabeth; Rosh, Zachary S.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA; [Feng, Jian; Shen, Li; Keeley, Elizabeth; Rosh, Zachary S.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA; [Riadi, Gonzalo] Univ Talca, Fac Ingn, Dept Bioinformat, CBSM, Av 2 Norte 685, Talca 3465548, Chile	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Universidad de Talca	Woychik, RP (corresponding author), NIEHS, 111 TW Alexander Dr,Bldg 101, Res Triangle Pk, NC 27709 USA.; Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA.; Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, One Gustave L Levy Pl,Box 1065, New York, NY 10029 USA.	eric.nestler@mssm.edu; rick.woychik@nih.gov	Woychik, Richard P/C-8345-2019; Riadi, Gonzalo/ABG-2144-2020	Woychik, Richard P/0000-0001-8196-1732; Riadi, Gonzalo/0000-0002-7633-2365	Intramural Research Program of the NIH;  [P01DA008227];  [Fondecyt 11140869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R37DA007359] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the NIH (RPW) and by grants P01DA008227 (EJN) and Fondecyt 11140869 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Babaian A, 2016, ONCOGENE, V35, P2542, DOI 10.1038/onc.2015.308; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Bernal AJ, 2013, FASEB J, V27, P665, DOI 10.1096/fj.12-220350; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Chaya T, 2011, J BIOL CHEM, V286, P29511, DOI 10.1074/jbc.M111.236810; Criscione SW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-583; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feng J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r65; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Herquel B, 2013, NAT STRUCT MOL BIOL, V20, P339, DOI 10.1038/nsmb.2496; Jin Y, 2015, BIOINFORMATICS, P1; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21597; Lock FE, 2014, P NATL ACAD SCI USA, V111, pE3534, DOI 10.1073/pnas.1405507111; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114	36	25	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159028	10.1371/journal.pone.0159028	http://dx.doi.org/10.1371/journal.pone.0159028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415830	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500059
J	Milano, N; Nolfi, S				Milano, Nicola; Nolfi, Stefano			Robustness to Faults Promotes Evolvability: Insights from Evolving Digital Circuits	PLOS ONE			English	Article							EVOLUTION; REDUNDANCY; TOLERANT	We demonstrate how the need to cope with operational faults enables evolving circuits to find more fit solutions. The analysis of the results obtained in different experimental conditions indicates that, in absence of faults, evolution tends to select circuits that are small and have low phenotypic variability and evolvability. The need to face operation faults, instead, drives evolution toward the selection of larger circuits that are truly robust with respect to genetic variations and that have a greater level of phenotypic variability and evolvability. Overall our results indicate that the need to cope with operation faults leads to the selection of circuits that have a greater probability to generate better circuits as a result of genetic variation with respect to a control condition in which circuits are not subjected to faults.	[Milano, Nicola; Nolfi, Stefano] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Milano, Nicola] Univ Plymouth, Ctr Robot & Neural Syst, Plymouth, Devon, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Plymouth	Milano, N; Nolfi, S (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.; Milano, N (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Plymouth, Devon, England.	nicola.milano@istc.cnr.it; stefano.nolfi@istc.cnr.it		Milano, Nicola/0000-0002-1604-5161				Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Back T., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P40, DOI 10.1109/ICEC.1994.350045; Balch M., 2003, COMPLETE DIGITAL DES, V1st; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Hartmann M, 2004, IEE P-COMPUT DIG T, V151, P287, DOI 10.1049/ip-cdt:20040014; Hu T, 2012, GENET PROGRAM EVOL M, V13, P305, DOI 10.1007/s10710-012-9159-4; Hu T, 2011, LECT NOTES COMPUT SC, V6621, P13, DOI 10.1007/978-3-642-20407-4_2; Jin Y, 2005, IEEE T EVOLUT COMPUT, V9, P303, DOI 10.1109/TEVC.2005.846356; Keymeulen D, 2000, IEEE T RELIAB, V49, P305, DOI 10.1109/24.914547; Koza JR, 1992, GENETIC PROGRAMMING; Krischner M.W., 2005, PLAUSIBILITY LIFE RE; Levitan B, 1995, MOL DIVERS, V1, P53, DOI 10.1007/BF01715809; Macia J, 2009, J R SOC INTERFACE, V6, P393, DOI 10.1098/rsif.2008.0236; Miller J.F., 2000, LECT NOTES COMPUTER, V1801; Miller JF, 2001, THIRD NASA/DOD WORKSHOP ON EVOLVABLE HARDWARE, PROCEEDINGS, P116, DOI 10.1109/EH.2001.937953; Miller JF, 2000, LECT NOTES COMPUT SC, V1802, P121; Newman M.E.J., 2010, NETWORKS INTRO; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Raman K, 2011, J R SOC INTERFACE, V8, P269, DOI 10.1098/rsif.2010.0212; Rana S., 1996, Parallel Problem Solving from Nature - PPSN IV. International Conference on Evolutionary Computation - The 4th International Conference on Parallel Problem Solving from Nature. Proceedings, P198, DOI 10.1007/3-540-61723-X_984; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Sniegowsky P.D., 2006, CURR BIOL, V19, P831; Thompson A, 1999, IEEE T EVOLUT COMPUT, V3, P167, DOI 10.1109/4235.788489; Tononi G, 1999, P NATL ACAD SCI USA, V96, P3257, DOI 10.1073/pnas.96.6.3257; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A, 2011, ORIGINS OF EVOLUTIONARY INNOVATIONS: A THEORY OF TRANSFORMATIVE CHANGE IN LIVING SYSTEMS, P1, DOI 10.1093/acprof:oso/9780199692590.001.0001; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; West-Eberhard Mary Jane, 2003, pi; Wilke CO, 2001, B MATH BIOL, V63, P715, DOI 10.1006/bulm.2001.0244	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158627	10.1371/journal.pone.0158627	http://dx.doi.org/10.1371/journal.pone.0158627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409589	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300028
J	Dunkel, Y; Diao, KX; Aznar, N; Swanson, L; Liu, L; Zhu, WH; Mi, XY; Ghosh, P				Dunkel, Ying; Diao, Kexin; Aznar, Nicolas; Swanson, Lee; Liu, Lawrence; Zhu, Wenhong; Mi, Xiao-yi; Ghosh, Pradipta			Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers	FASEB JOURNAL			English	Article						prognostication biomarker; guanidine exchange factor; HER-2; neu; survival analysis; triple negative	G-PROTEINS; CLINICAL-IMPLICATIONS; EMERGING BIOMARKERS; GIRDIN EXPRESSION; GIV; ACTIVATION; THERAPY; SURVIVAL; MOTILITY; SIGNALS	G-interacting vesicle-associated protein (GIV, aka Girdin) is a guanine exchange factor (GEF) for the trimeric G protein Gi and a bona fide metastasis-related gene that serves as a platform for amplification of tyrosine-based signals via G-protein intermediates. Here we present the first exploratory biomarker study conducted on a cohort of 187 patients with breast cancer to evaluate the prognostic role of total GIV (tGIV) and tyrosine phosphorylated GIV (pYGIV) across the various molecular subtypes. A Kaplan-Meier analysis of recurrence-free survival showed that the presence of tGIV, either cytoplasmic or nuclear, carried poor prognosis, but that nuclear tGIV had a greater prognostic impact (P = 0.007 in early and P = 0.0048 in late clinical stages). Activated pYGIV in the cytoplasm had the greatest prognostic impact in late clinical stages (P = 0.006). Furthermore, we found that the prognostic impacts of cytoplasmic pYGIV and nuclear tGIV were additive (hazard ratio 19.0548; P = 0.0002). Surprisingly, this additive effect of nuclear tGIV/cytoplasmic pYGIV was observed in human epidermal growth factor receptor 2-positive tumors (hazard ratio 16.918; P = 0.0005) but not in triple-negative breast cancers. In triple-negative breast cancers, tGIV and cytoplasmic pYGIV had no prognostic impact; however, membrane-association of pYGIV carried a poor prognosis (P = 0.026). Both tGIV and pYGIV showed no correlation with clinical stage, tumor size, pathologic type, lymph node involvement, and BRCA1/2 status. We conclude that immunocytochemical detection of pYGIV and tGIV can serve as an effective prognosticator. On the basis of the differential prognostic impact of tGIV/pYGIV within each molecular subtype, we propose a diagnostic algorithm. Further studies on larger cohorts are essential to rigorously assess the effectiveness and robustness of this algorithm in prognosticating outcome among patients with breast cancer.Dunkel, Y., Diao, K., Aznar, N., Swanson, L., Liu, L., Zhu, W., Mi, X.-Y., Ghosh, P. Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.	[Dunkel, Ying; Aznar, Nicolas; Swanson, Lee; Liu, Lawrence; Ghosh, Pradipta] China Med Univ, Dept Med, Shenyang, Peoples R China; [Dunkel, Ying; Aznar, Nicolas; Swanson, Lee; Liu, Lawrence; Ghosh, Pradipta] China Med Univ, Dept Cell & Mol Med, Shenyang, Peoples R China; [Diao, Kexin; Mi, Xiao-yi] China Med Univ, Dept Pathol, Shenyang, Peoples R China; [Zhu, Wenhong] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA	China Medical University; China Medical University; China Medical University; University of California System; University of California San Diego	Mi, XY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, 77 Puhe Rd, Shenyang 110001, Liaoning Provin, Peoples R China.; Mi, XY (corresponding author), China Med Univ, Coll Basic Med Sci, 77 Puhe Rd, Shenyang 110001, Liaoning Provin, Peoples R China.; Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mixiaoyi2005@163.com; prghosh@ucsd.edu		Aznar, Nicolas/0000-0003-3338-9932	U.S. National Institutes of Health (NIH) National Cancer Institute [CA100768, CA160911]; National Natural Science Foundation of China [8157102286]; Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS) award; American Cancer Society [ACS-IRG 70-002]; University of California, San Diego Moores Cancer Center [P30CA23100]; predoctoral training award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases [T32DK0070202]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA100768, R01CA160911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS) award; American Cancer Society(American Cancer Society); University of California, San Diego Moores Cancer Center; predoctoral training award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grants CA100768 and CA160911 (to P.G), and by National Natural Science Foundation of China Grant 8157102286 (to X.M). P.G. was also supported by the Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS) award, the American Cancer Society (ACS-IRG 70-002), and the University of California, San Diego Moores Cancer Center (P30CA23100). L.S. was supported by a predoctoral training award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (T32DK0070202).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Aznar N, 2016, BIOESSAYS, V38, P379, DOI 10.1002/bies.201500133; Cao K, 2015, INT J CLIN EXP PATHO, V8, P551; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Dunkel Y, 2012, J BIOL CHEM, V287, P41667, DOI 10.1074/jbc.M112.390781; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2016, PHARMACOL RES, V105, P99, DOI 10.1016/j.phrs.2016.01.017; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Ghosh P, 2015, CELL CYCLE, V14, P2561, DOI 10.1080/15384101.2015.1066538; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiang P, 2013, TUMORI J, V99, P530, DOI 10.1700/1361.15106; Jin F, 2013, ONCOL LETT, V5, P1549, DOI 10.3892/ol.2013.1249; Jun BY, 2013, DIS COLON RECTUM, V56, P51, DOI 10.1097/DCR.0b013e31826b9b7e; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Lopez-Sanchez I, 2015, MOL BIOL CELL, V26, P4313, DOI 10.1091/mbc.E15-07-0496; Lopez-Sanchez I, 2015, BIOCHEM BIOPH RES CO, V468, P287, DOI 10.1016/j.bbrc.2015.10.111; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Ma GS, 2015, MOL BIOL CELL, V26, P4209, DOI 10.1091/mbc.E15-08-0553; Ma GS, 2015, P NATL ACAD SCI USA, V112, pE2602, DOI 10.1073/pnas.1505543112; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Nishimae K, 2015, BREAST CANCER-TOKYO, V22, P445, DOI 10.1007/s12282-013-0501-3; Peng WT, 2014, ANN SURG ONCOL, V21, pS648, DOI 10.1245/s10434-014-3746-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Song JY, 2014, ONCOL LETT, V7, P337, DOI 10.3892/ol.2013.1745; Wang AL, 2015, MOL MED REP, V11, P3635, DOI 10.3892/mmr.2015.3211; Wang CH, 2014, MOL CLIN ONCOL, V2, P425, DOI 10.3892/mco.2014.265; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Yamamura Y, 2015, CANCER RES, V75, P813, DOI 10.1158/0008-5472.CAN-14-1317	40	6	6	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3702	3713		10.1096/fj.201600500	http://dx.doi.org/10.1096/fj.201600500			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27440794	Green Published			2022-12-26	WOS:000386474700006
J	Sharma, S; Xing, F; Liu, Y; Wu, KR; Said, N; Pochampally, R; Shiozawa, Y; Lin, HK; Balaji, KC; Watabe, K				Sharma, Sambad; Xing, Fei; Liu, Yin; Wu, Kerui; Said, Neveen; Pochampally, Radhika; Shiozawa, Yusuke; Lin, Hui-Kuan; Balaji, K. C.; Watabe, Kounosuke			Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA demethylation; prostate cancer; stromal cell; tumor cell biology; tumor microenvironment; BMP7; bone metastasis; dormancy; SPARC	BREAST-CANCER; TUMOR-GROWTH; MORPHOGENETIC PROTEIN-7; RADICAL PROSTATECTOMY; PROGNOSTIC VALUE; DEFICIENT MICE; CELL DORMANCY; IN-VITRO; EXPRESSION; PROGRESSION	Prostate cancer is known to frequently recur in bone; however, how dormant cells switch its phenotype leading to recurrent tumor remains poorly understood. We have isolated two syngeneic cell lines (indolent and aggressive) through in vivo selection by implanting PC3mm stem-like cells into tibial bones. We found that indolent cells retained the dormant phenotype, whereas aggressive cells grew rapidly in bone in vivo, and the growth rates of both cells in culture were similar, suggesting a role of the tumor microenvironment in the regulation of dormancy and recurrence. Indolent cells were found to secrete a high level of secreted protein acidic and rich in cysteine (SPARC), which significantly stimulated the expression of BMP7 in bone marrow stromal cells. The secreted BMP7 then kept cancer cells in a dormant state by inducing senescence, reducing stemness, and activating dormancy-associated p38 MAPK signaling and p21 expression in cancer cells. Importantly, we found that SPARC was epigenetically silenced in aggressive cells by promoter methylation, but 5-azacytidine treatment reactivated the expression. Furthermore, high SPARC promoter methylation negatively correlated with disease-free survival of prostate cancer patients. We also found that the COX2 inhibitor NS398 down-regulated DNMTs and increased expression of SPARC, which led to tumor growth suppression in bone in vivo. These findings suggest that SPARC plays a key role in maintaining the dormancy of prostate cancer cells in the bone microenvironment.	[Sharma, Sambad; Xing, Fei; Liu, Yin; Wu, Kerui; Shiozawa, Yusuke; Lin, Hui-Kuan; Watabe, Kounosuke] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Said, Neveen] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Balaji, K. C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA; [Pochampally, Radhika] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Pochampally, Radhika] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Watabe, K (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	kwatabe@wakehealth.edu	Said, Neveen/K-1563-2019		Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health [P30CA012197]; NATIONAL CANCER INSTITUTE [R01CA185650, R01CA193437, P30CA012197, R01CA173499] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001421] Funding Source: NIH RePORTER	Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank Dr. Aya Kobayashi for help with the initial work of isolation and characterization of the clones. The Flow Cytometry Shared Resources, Cell and Viral Vector Core Lab are supported by the Comprehensive Cancer Center of Wake Forest University NCI, National Institutes of Health Grant (P30CA012197).	Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANCER LETT, V294, P139, DOI 10.1016/j.canlet.2010.03.004; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chen C, 2012, J CELL BIOCHEM, V113, P3672, DOI 10.1002/jcb.24240; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Chery L, 2014, ONCOTARGET, V5, P9939, DOI 10.18632/oncotarget.2480; Chlenski A, 2006, INT J CANCER, V118, P310, DOI 10.1002/ijc.21357; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; DeRosa CA, 2012, PROSTATE CANCER P D, V15, P150, DOI 10.1038/pcan.2011.61; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ferrario A, 2005, CANCER RES, V65, P9473, DOI 10.1158/0008-5472.CAN-05-1659; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Golembieski WA, 2008, GLIA, V56, P1061, DOI 10.1002/glia.20679; Hiraga T, 2006, CANCER RES, V66, P2067, DOI 10.1158/0008-5472.CAN-05-2012; Horwich A, 2013, ANN ONCOL, V24, P106, DOI 10.1093/annonc/mdt208; Jacob K, 1999, CANCER RES, V59, P4453; Jones MK, 1999, NAT MED, V5, P1418; Kapinas K, 2012, MATRIX BIOL, V31, P299, DOI 10.1016/j.matbio.2012.03.002; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Koblinski JE, 2005, CANCER RES, V65, P7370, DOI 10.1158/0008-5472.CAN-05-0807; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Kwabi-Addo B, 2010, CLIN CANCER RES, V16, P3539, DOI 10.1158/1078-0432.CCR-09-3342; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Leyton PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076947; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; McCabe NP, 2011, NEOPLASIA, V13, P31, DOI 10.1593/neo.10998; Mohler JL, 2013, J NATL COMPR CANC NE, V11, P1471, DOI 10.6004/jnccn.2013.0174; Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754; MORRIS VL, 1993, CLIN EXP METASTAS, V11, P103, DOI 10.1007/BF00880071; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Nagaraju GP, 2014, CARCINOGENESIS, V35, P967, DOI 10.1093/carcin/bgu072; Nishikawa M, 2004, J AM COLL SURGEONS, V199, P428, DOI 10.1016/j.jamcollsurg.2004.05.265; OSSOWSKI L, 1987, J CELL PHYSIOL, V133, P288, DOI 10.1002/jcp.1041330212; Pan MR, 2008, EXP BIOL MED, V233, P456, DOI 10.3181/0709-RM-257; Podgorski I, 2009, AM J PATHOL, V175, P1255, DOI 10.2353/ajpath.2009.080906; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2009, ONCOGENE, V28, P3487, DOI 10.1038/onc.2009.205; Said N, 2013, J CLIN INVEST, V123, P751, DOI 10.1172/JCI64782; Said NA, 2008, NEOPLASIA, V10, P1092, DOI 10.1593/neo.08672; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Sosa MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7170; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Weckermann D, 2001, J UROLOGY, V166, P699, DOI 10.1016/S0022-5347(05)66046-6; Welsh JB, 2001, CANCER RES, V61, P5974; Wong SY, 2008, CLIN EXP METASTAS, V25, P109, DOI 10.1007/s10585-007-9126-2; Wong SY, 2007, P NATL ACAD SCI USA, V104, P12784, DOI 10.1073/pnas.0705499104; Ye L, 2007, J UROLOGY, V178, P1086, DOI 10.1016/j.juro.2007.05.003; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang JL, 2014, ONCOL REP, V31, P2312, DOI 10.3892/or.2014.3118; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	68	64	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19351	19363		10.1074/jbc.M116.737379	http://dx.doi.org/10.1074/jbc.M116.737379			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27422817	hybrid, Green Published			2022-12-26	WOS:000383242800015
J	Alvarez Rojas, CA; Scheerlinck, JP; Ansell, BRE; Hall, RS; Gasser, RB; Jex, AR				Alvarez Rojas, Cristian A.; Scheerlinck, Jean-Pierre; Ansell, Brendan R. E.; Hall, Ross S.; Gasser, Robin B.; Jex, Aaron R.			Time-Course Study of the Transcriptome of Peripheral Blood Mononuclear Cells (PBMCs) from Sheep Infected with Fasciola hepatica	PLOS ONE			English	Article							IMMUNE-RESPONSE; IFN-GAMMA; TGF-BETA; ALTERNATIVE ACTIVATION; SECRETORY PRODUCTS; IN-VITRO; T-CELLS; B-CELLS; EXPRESSION; PROTEIN	Fasciola hepatica is a parasitic trematode that infects a wide range of mammalian hosts, including livestock and humans, in temperate and tropical regions globally. This trematode causes the disease fascioliasis, which consists of an acute phase (<= 12 weeks) during which juvenile parasites migrate through the host liver tissues, and a chronic phase (> 12 weeks) following the establishment of adult parasites in the liver bile ducts. Few studies have explored the progression of the host response over the course of Fasciola infection in the same animals. In this study, we characterized transcriptomic changes in peripheral blood mononuclear cells (PBMCs) collected from sheep at three time points over the first eight weeks of infection relative to uninfected controls. In total, 183 and 76 genes were found to be differentially transcribed at two and eight weeks post-infection respectively. Functional and pathway analysis of differentially transcribed genes revealed changes related to T-cell activation that may underpin a Th2-biased immune response against this parasite. This first insight into the dynamics of host responses during the early stages of infection improves the understanding of the pathogenesis of acute fascioliasis, informs vaccine development and presents a set of PBMC markers with diagnostic potential.	[Alvarez Rojas, Cristian A.; Scheerlinck, Jean-Pierre] Univ Melbourne, Fac Vet & Agr Sci, Ctr Anim Biotechnol, Parkville, Vic 3010, Australia; [Ansell, Brendan R. E.; Hall, Ross S.; Gasser, Robin B.; Jex, Aaron R.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3010, Australia; [Jex, Aaron R.] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute	Alvarez Rojas, CA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Ctr Anim Biotechnol, Parkville, Vic 3010, Australia.	alvarezc@unimelb.edu.au	Rojas, Cristian A Alvarez/AAR-1231-2020; Ansell, Brendan/O-4150-2014; Jex, Aaron/AGZ-7897-2022; Gasser, Robin/ABH-6185-2020	Rojas, Cristian A Alvarez/0000-0002-8069-7607; Ansell, Brendan/0000-0003-0297-897X; Jex, Aaron/0000-0002-1285-7947; Gasser, Robin/0000-0002-4423-1690; Scheerlinck, Jean-Pierre/0000-0002-8385-353X	Australian Research Council; ARC [DP110103175]; National Health and Medical Research Council (NHMRC) of Australia; Victorian Life Sciences Computation Initiative (VLSCI) [VR0007]; Victorian Government	Australian Research Council(Australian Research Council); ARC(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Victorian Government	This work was supported by the Australian Research Council and (ARC) grant number DP110103175 and the National Health and Medical Research Council (NHMRC) of Australia as well as by a Victorian Life Sciences Computation Initiative (VLSCI) grant number VR0007 on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government (to RB Gasser).	Akirav EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034698; Aldridge A, 2016, EUR J IMMUNOL, V46, P1180, DOI 10.1002/eji.201545905; Alvarez Rojas CA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0715-7; Ansari AW, 2006, INT IMMUNOL, V18, P1443, DOI 10.1093/intimm/dxl078; Ardia DR, 2011, FUNCT ECOL, V25, P61, DOI 10.1111/j.1365-2435.2010.01759.x; BAEZA E, 1994, VET PARASITOL, V51, P219, DOI 10.1016/0304-4017(94)90159-7; Basika T, 2012, PARASITOLOGY, V139, P271, DOI 10.1017/S003118201100179X; Behm CA, 1999, FASCIOLOSIS, P185; Boray J. C., 1969, Adv. Parasitol., V7, P95, DOI 10.1016/S0065-308X(08)60435-2; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Brown CT, REFERENCE FREE ALGOR; Chauvin A, 1996, PARASITE, V3, P209, DOI 10.1051/parasite/1996033209; CHAUVIN A, 1995, INT J PARASITOL, V25, P1227, DOI 10.1016/0020-7519(95)00039-5; Chauvin A, 2001, VET RES, V32, P87, DOI 10.1051/vetres:2001113; Chen F, 2014, NAT IMMUNOL, V15, P938, DOI 10.1038/ni.2984; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Chuah C, 2014, CELL MICROBIOL, V16, P1666, DOI 10.1111/cmi.12316; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; deSchoolmeester ML, 2003, J IMMUNOL, V170; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; Fahel JS, 2015, INFECT IMMUN, V83, P1210, DOI 10.1128/IAI.02592-14; Ferre I, 1997, VET PARASITOL, V68, P261, DOI 10.1016/S0304-4017(96)01070-9; Flynn RJ, 2008, INT J PARASITOL, V38, P1673, DOI 10.1016/j.ijpara.2008.05.008; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Golbar HM, 2013, J VET MED SCI, V75, P857, DOI 10.1292/jvms.12-0536; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Guasconi L, 2011, IMMUNOLOGY, V133, P386, DOI 10.1111/j.1365-2567.2011.03449.x; Guerfali FZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-238; Hamilton CM, 2009, INFECT IMMUN, V77, P2488, DOI 10.1128/IAI.00919-08; Hermosilla C, 2014, PARASITOLOGY, V141, P1489, DOI 10.1017/S0031182014000316; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Jefferies JR, 1997, INT J PARASITOL, V27, P1025, DOI 10.1016/S0020-7519(97)00067-2; Jefferies JR, 1996, INT J PARASITOL, V26, P409, DOI 10.1016/0020-7519(95)00136-0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Lee HW, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0855-4; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lopez-Bernad F, 2000, VET PARASITOL, V88, P1, DOI 10.1016/S0304-4017(99)00199-5; Lv K, 2013, MOL MED REP, V7, P205, DOI 10.3892/mmr.2012.1125; Machado FS, 2008, INT IMMUNOPHARMACOL, V8, P1316, DOI 10.1016/j.intimp.2008.01.001; Malissen B, 2014, NAT IMMUNOL, V15, P790, DOI 10.1038/ni.2959; Martin I, 2015, J IMMUNOL, V194, P3924, DOI 10.4049/jimmunol.1401182; Mendes EA, 2013, VET PARASITOL, V195, P177, DOI 10.1016/j.vetpar.2013.03.035; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; MONTGOMERY TD, 1986, VET PARASITOL, V19, P55, DOI 10.1016/0304-4017(86)90032-4; Moreau E, 1998, PARASITE, V5, P307, DOI 10.1051/parasite/1998054307; Nagashima T, 2011, AM J PATHOL, V178, P222, DOI 10.1016/j.ajpath.2010.11.033; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Phiri IK, 2006, VET PARASITOL, V141, P234, DOI 10.1016/j.vetpar.2006.05.019; Preston S, 2015, METHODS MOL BIOL, V1207, P371, DOI 10.1007/978-1-4939-1396-1_25; Prowse RK, 2002, PARASITE IMMUNOL, V24, P57, DOI 10.1046/j.0141-9838.2001.00438.x; Raadsma HW, 2007, VET PARASITOL, V143, P275, DOI 10.1016/j.vetpar.2006.09.008; Rabinovich GA, 2012, ANN NY ACAD SCI, V1253, P1, DOI 10.1111/j.1749-6632.2012.06492.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Richardson MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00288; Rojas-Caraballo J, 2015, GENOM DATA, V6, P89, DOI 10.1016/j.gdata.2015.08.020; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; SANTIAGO N, 1988, J PARASITOL, V74, P810, DOI 10.2307/3282259; Scheerlinck JPY, 2001, VACCINE, V19, P4053, DOI 10.1016/S0264-410X(01)00133-5; Schnoor M, 2015, J IMMUNOL, V194, P3535, DOI 10.4049/jimmunol.1403250; Schroeder H, 2009, DEV COMP IMMUNOL, V33, P5, DOI 10.1016/j.dci.2008.07.010; Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188; Shih CH, 2005, EXP HEMATOL, V33, P1101, DOI 10.1016/j.exphem.2005.06.028; Sundrud MS, 2005, BLOOD, V106, P3440, DOI 10.1182/blood-2005-03-0857; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Vukman KV, 2013, J IMMUNOL, V190, P2873, DOI 10.4049/jimmunol.1203011; Waldvogel AS, 2004, VET IMMUNOL IMMUNOP, V97, P53, DOI 10.1016/j.vetimm.2003.08.002; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Young AR, 2009, GLYCOCONJUGATE J, V26, P423, DOI 10.1007/s10719-008-9190-0; Zhang WY, 2005, EXP PARASITOL, V111, P154, DOI 10.1016/j.exppara.2005.06.005	84	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159194	10.1371/journal.pone.0159194	http://dx.doi.org/10.1371/journal.pone.0159194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438474	gold, Green Published			2022-12-26	WOS:000380170100031
J	Huang, Y; Su, LQ; Wu, J				Huang, Yan; Su, Lingqia; Wu, Jing			Pyridoxine Supplementation Improves the Activity of Recombinant Glutamate Decarboxylase and the Enzymatic Production of Gama-Aminobutyric Acid	PLOS ONE			English	Article							HYDROXYBUTYRIC ACID; BINDING-SITE; GABA; EXPRESSION; RESISTANCE; CLONING; GENE	Glutamate decarboxylase (GAD) catalyzes the irreversible decarboxylation of L-glutamate to the valuable food supplement gamma-aminobutyric acid (GABA). In this study, GAD from Escherichia coli K12, a pyridoxal phosphate (PLP)-dependent enzyme, was overexpressed in E. coli. The GAD produced in media supplemented with 0.05 mM soluble vitamin B-6 analog pyridoxine hydrochloride (GAD-V) activity was 154.8 U mL(-1), 1.8-fold higher than that of GAD obtained without supplementation (GAD-C). Purified GAD-V exhibited increased activity (193.4 U mg(-1), 1.5-fold higher than that of GAD-C), superior thermostability (2.8-fold greater than that of GAD-C), and higher k(cat)/K-m (1.6-fold higher than that of GAD-C). Under optimal conditions in reactions mixtures lacking added PLP, crude GAD-V converted 500 g L-1 monosodium glutamate (MSG) to GABA with a yield of 100%, and 750 g L-1 MSG with a yield of 88.7%. These results establish the utility of pyridoxine supplementation and lay the foundation for large-scale enzymatic production of GABA.	[Huang, Yan; Su, Lingqia; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Huang, Yan; Su, Lingqia; Wu, Jing] Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China; [Huang, Yan; Su, Lingqia; Wu, Jing] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China.	jingwu@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022		National Science Fund for Distinguished Young Scholars [31425020]; 111 Project [111-2-06]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 111 Project(Ministry of Education, China - 111 Project)	This work received financial support from the National Science Fund for Distinguished Young Scholars (No. 31425020), received by Jing Wu and the 111 Project (No. 111-2-06), received by Jing Wu.; This work received financial support from the National Science Fund for Distinguished Young Scholars (31425020), and the 111 Project (No. 111-2-06).	Ahboucha S, 2003, NEUROCHEM INT, V43, P551, DOI 10.1016/S0197-0186(03)00065-2; Chen XY, 2014, PROCESS BIOCHEM, V49, P1429, DOI 10.1016/j.procbio.2014.05.019; DEMPSEY WB, 1971, J BACTERIOL, V108, P415, DOI 10.1128/JB.108.1.415-421.1971; Dhakal R, 2012, BRAZ J MICROBIOL, V43, P1230, DOI 10.1590/S1517-83822012000400001; Fan EY, 2012, ANN MICROBIOL, V62, P689, DOI 10.1007/s13213-011-0307-5; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Hagiwara H, 2004, BIOSCI BIOTECH BIOCH, V68, P444, DOI 10.1271/bbb.68.444; Hu RQ, 2000, NEUROPHARMACOLOGY, V39, P427, DOI 10.1016/S0028-3908(99)00152-5; Ito Y, 2013, J NEUROSCI, V 33, P17166, DOI 10.1523/JNEUROSCI.0897-13.2013; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jiang DH, 2013, ANN MICROBIOL, V63, P487, DOI 10.1007/s13213-012-0493-9; Komatsuzaki N, 2005, FOOD MICROBIOL, V22, P497, DOI 10.1016/j.fm.2005.01.002; Li HX, 2010, AMINO ACIDS, V38, P1439, DOI 10.1007/s00726-009-0355-3; MANYAM BV, 1981, ANN NEUROL, V10, P35, DOI 10.1002/ana.410100107; Ho NAT, 2013, J BIOSCI BIOENG, V115, P154, DOI 10.1016/j.jbiosc.2012.09.002; Oh CH, 2004, J MED FOOD, V7, P19, DOI 10.1089/109662004322984653; Plokhov AY, 2000, APPL BIOCHEM BIOTECH, V88, P257, DOI 10.1385/ABAB:88:1-3:257; Qu KB, 1998, PROTEIN SCI, V7, P1092, DOI 10.1002/pro.5560070503; SASKIAWAN I., 2008, MICROBIOL INDONES, V2, P5; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STRAUSBA.PH, 1970, BIOCHEMISTRY-US, V9, P233, DOI 10.1021/bi00804a007; Vo TDL, 2013, BIOTECHNOL BIOPROC E, V18, P1062, DOI 10.1007/s12257-013-0282-8; Tam DLV, 2012, BIOPROC BIOSYST ENG, V35, P645, DOI 10.1007/s00449-011-0634-8; Ueno H, 2000, J MOL CATAL B-ENZYM, V10, P67, DOI 10.1016/S1381-1177(00)00114-4; Vella JG, 1980, VITAMIN B6 BIOSYNTHE; Wang Q, 2011, WORLD J MICROB BIOT, V27, P693, DOI 10.1007/s11274-010-0508-2; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Yokoyama S, 2002, J BIOSCI BIOENG, V93, P95, DOI 10.1263/jbb.93.95; Zeng Zhen, 2012, African Journal of Biotechnology, V11, P11333	29	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0157466	10.1371/journal.pone.0157466	http://dx.doi.org/10.1371/journal.pone.0157466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438707	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100002
J	Ouyang, KX; Li, JC; Zhao, XH; Que, QM; Li, P; Huang, H; Deng, XM; Singh, SK; Wu, AM; Chen, XY				Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Huang, Hao; Deng, Xiaomei; Singh, Sunil Kumar; Wu, Ai-Min; Chen, Xiaoyang			Transcriptomic Analysis of Multipurpose Timber Yielding Tree Neolamarckia cadamba during Xylogenesis Using RNA-Seq	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; VASCULAR-RELATED NAC-DOMAIN7; WOOD FORMATION; LIGNIN BIOSYNTHESIS; DIRECT TARGET; ARABIDOPSIS; GENES; PROTEIN; SND1; EXPRESSION	Neolamarckia cadamba is a fast-growing tropical hardwood tree that is used extensively for plywood and pulp production, light furniture fabrication, building materials, and as a raw material for the preparation of certain indigenous medicines. Lack of genomic resources hampers progress in the molecular breeding and genetic improvement of this multipurpose tree species. In this study, transcriptome profiling of differentiating stems was performed to understand N. cadamba xylogenesis. The N. cadamba transcriptome was sequenced using Illumina paired-end sequencing technology. This generated 42.49 G of raw data that was then de novo assembled into 55,432 UniGenes with a mean length of 803.2bp. Approximately 47.8% of the UniGenes (26,487) were annotated against publically available protein databases, among which 21,699 and 7,754 UniGenes were assigned to Gene Ontology categories (GO) and Clusters of Orthologous Groups (COG), respectively. 5,589 UniGenes could be mapped onto 116 pathways using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database. Among 6,202 UniGenes exhibiting differential expression during xylogenesis, 1,634 showed significantly higher levels of expression in the basal and middle stem segments compared to the apical stem segment. These genes included NAC and MYB transcription factors related to secondary cell wall biosynthesis, genes related to most metabolic steps of lignin biosynthesis, and CesA genes involved in cellulose biosynthesis. This study lays the foundation for further screening of key genes associated with xylogenesis in N. cadamba as well as enhancing our understanding of the mechanism of xylogenesis in fast-growing trees.	[Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Wu, Ai-Min; Chen, Xiaoyang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Deng, Xiaomei; Wu, Ai-Min; Chen, Xiaoyang] Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China; [Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Wu, Ai-Min; Chen, Xiaoyang] Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou, Guangdong, Peoples R China; [Ouyang, Kunxi; Li, Juncheng; Zhao, Xianhai; Que, Qingmin; Li, Pei; Deng, Xiaomei; Wu, Ai-Min; Chen, Xiaoyang] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Huang, Hao] Guangxi Bot Garden Med Plants, Nanning, Peoples R China; [Singh, Sunil Kumar] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Bot, Vadodara, Gujarat, India	South China Agricultural University; South China Agricultural University; Maharaja Sayajirao University Baroda	Wu, AM; Chen, XY (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.; Wu, AM; Chen, XY (corresponding author), Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China.; Wu, AM; Chen, XY (corresponding author), Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou, Guangdong, Peoples R China.; Wu, AM; Chen, XY (corresponding author), South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China.	wuaimin@scau.edu.cn; xychen@scau.edu.cn	Wu, Aimin/AAG-9747-2020; zhao, xianhai/AAT-6896-2020	Wu, Aimin/0000-0001-8322-8833; zhao, xianhai/0000-0002-2080-5629; Singh, Sunil Kumar/0000-0001-6682-1512	National Science Foundation of China [31470681]; special funds project of Forestry Public Welfare Industry Research of China [201004020]; State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources in China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); special funds project of Forestry Public Welfare Industry Research of China; State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources in China	This work was supported by the National Science Foundation of China (Grant Number 31470681), the special funds project of Forestry Public Welfare Industry Research of China (Grant Number 201004020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Science Foundation of China (Grant Number 31470681), the special funds project of Forestry Public Welfare Industry Research of China (Grant Number 201004020) and State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources in China.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATANASSOVA R, 1995, PLANT J, V8, P465, DOI 10.1046/j.1365-313X.1995.8040465.x; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bromley JR, 2013, PLANT J, V74, P423, DOI 10.1111/tpj.12135; BROWN RT, 1976, TETRAHEDRON LETT, P1629, DOI 10.1016/S0040-4039(01)91635-1; Carvalho Ana, 2013, Mol Biol Int, V2013, P974324, DOI 10.1155/2013/974324; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Dubey A, 2011, PHARMACOGNOSY J, V2, P71, DOI [10.1016/S0975-3575(11)80029-5, DOI 10.1016/S0975-3575(11)80029-5]; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HANDA SS, 1983, J NAT PROD, V46, P325, DOI 10.1021/np50027a005; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang H, 2014, PLANT BIOTECHNOL-NAR, V31, P115, DOI 10.5511/plantbiotechnology.14.0125a; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ko JH, 2009, PLANT J, V60, P649, DOI 10.1111/j.1365-313X.2009.03989.x; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lal M, 2010, TAPPI J, V9, P30; Lee CH, 2009, PLANT CELL PHYSIOL, V50, P812, DOI 10.1093/pcp/pcp025; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lin YC, 2013, PLANT CELL, V25, P4324, DOI 10.1105/tpc.113.117697; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Ohman D, 2013, PLANT J, V73, P63, DOI 10.1111/tpj.12018; Ouyang KX, 2013, GENET MOL RES, V12, P1061, DOI 10.4238/2013.April.10.2; Ouyang KX, 2014, BIOTECHNOL BIOTEC EQ, V28, P1008, DOI 10.1080/13102818.2014.981086; Pan QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043038; Paux E, 2004, PLANT MOL BIOL, V55, P263, DOI 10.1007/s11103-004-0621-4; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Schuetz M, 2013, J EXP BOT, V64, P11, DOI 10.1093/jxb/ers287; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Shi R, 2010, PLANT CELL PHYSIOL, V51, P144, DOI 10.1093/pcp/pcp175; Suzuki S, 2006, PLANT PHYSIOL, V142, P1233, DOI 10.1104/pp.106.086678; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Xu B, 2014, SCIENCE, V343, P1505, DOI 10.1126/science.1248417; Xu XY, 2011, J ASIAN NAT PROD RES, V13, P1008, DOI 10.1080/10286020.2011.606812; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yamaguchi M, 2010, PLANT PHYSIOL, V153, P906, DOI 10.1104/pp.110.154013; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105765; Zhang J, 2011, CURR OPIN BIOTECH, V22, P293, DOI 10.1016/j.copbio.2010.11.008; Zhao XH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00602; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	73	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159407	10.1371/journal.pone.0159407	http://dx.doi.org/10.1371/journal.pone.0159407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438485	Green Submitted, Green Published, gold			2022-12-26	WOS:000380170100043
J	Balzarotti, S; Colombo, B				Balzarotti, Stefania; Colombo, Barbara			Effects of Unilateral Transcranial Direct Current Stimulation of Left Prefrontal Cortex on Processing and Memory of Emotional Visual Stimuli	PLOS ONE			English	Article							MAJOR DEPRESSION; FACIAL EXPRESSIONS; HEMISPHERIC-DIFFERENCES; NEURAL MECHANISMS; DOUBLE-BLIND; BRAIN; TDCS; PERCEPTION; VALENCE; MODULATION	The dorsolateral prefrontal cortex (DLPFC) is generally thought to be involved in affect and emotional processing; however, the specific contribution of each hemisphere continues to be debated. In the present study, we employed unilateral tDCS to test the unique contribution of left DLPFC in the encoding and retrieval of emotional stimuli in healthy subjects. Forty-two right handed undergraduate students received either anodal, cathodal or sham stimulation of left DLPFC while viewing neutral, pleasant, and unpleasant pictures. After completing a filler task, participants were asked to remember as many pictures as possible. Results showed that participants were able to remember a larger amount of emotional (both pleasant and unpleasant) pictures than of neutral ones, regardless of the type of tDCS condition. Participants who received anodal stimulation recalled a significantly higher number of pleasant images than participants in the sham and cathodal conditions, while no differences emerged in the recall of neutral and unpleasant pictures. We conclude that our results provide some support to the role of left prefrontal cortex in the encoding and retrieval of pleasant stimuli.	[Balzarotti, Stefania; Colombo, Barbara] Univ Cattolica Sacro Cuore, Dept Psychol, Largo Gemelli 1, I-20123 Milan, Italy; [Colombo, Barbara] Champlain Coll, Div Educ & Human Studies, 251 South Willard St, Burlington, VT 05402 USA	Catholic University of the Sacred Heart	Colombo, B (corresponding author), Univ Cattolica Sacro Cuore, Dept Psychol, Largo Gemelli 1, I-20123 Milan, Italy.; Colombo, B (corresponding author), Champlain Coll, Div Educ & Human Studies, 251 South Willard St, Burlington, VT 05402 USA.	bcolombo@champlain.edu	Colombo, Barbara/E-9443-2019	Colombo, Barbara/0000-0002-4095-9633; BALZAROTTI, Stefania/0000-0002-9273-8496				Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; Asthana Manish, 2013, Front Psychiatry, V4, P107, DOI 10.3389/fpsyt.2013.00107; Austin A, 2015, ARXIV151002261; Berlim MT, 2013, J PSYCHIATR RES, V47, P1, DOI 10.1016/j.jpsychires.2012.09.025; Bloise SM, 2007, MEMORY, V15, P192, DOI 10.1080/09658210701204456; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Boggio PS, 2009, J AFFECT DISORDERS, V101, P91; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Griskevicius V, 2010, EMOTION, V10, P190, DOI 10.1037/a0018421; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hecht D, 2010, NEUROSCI RES, V68, P77, DOI 10.1016/j.neures.2010.06.013; Heller W, 1997, COGNITION EMOTION, V11, P637, DOI 10.1080/026999397379845a; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jansari A, 2000, COGNITION EMOTION, V14, P341, DOI 10.1080/026999300378860; Kalu UG, 2012, PSYCHOL MED, V42, P1791, DOI 10.1017/S0033291711003059; Kensinger EA, 2004, REV NEUROSCIENCE, V15, P241, DOI 10.1515/REVNEURO.2004.15.4.241; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang PJ, A6 U FLOR; LEY RG, 1979, BRAIN LANG, V7, P127, DOI 10.1016/0093-934X(79)90010-5; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Morgan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092162; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V527, P633; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nitschke JB, 2004, BIOL PSYCHOL, V67, P125, DOI 10.1016/j.biopsycho.2004.03.004; Palm U, 2012, BRAIN STIMUL, V5, P242, DOI 10.1016/j.brs.2011.08.005; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Penolazzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010623; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Quene H, 2008, J MEM LANG, V59, P413, DOI 10.1016/j.jml.2008.02.002; Rodway P, 2003, BRAIN COGNITION, V53, P452, DOI 10.1016/S0278-2626(03)00217-3; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Tamietto M, 2006, EXP BRAIN RES, V171, P389, DOI 10.1007/s00221-005-0279-4; Tremblay S, 2014, BRAIN STIMUL, V7, P773, DOI 10.1016/j.brs.2014.10.003; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Wager TD, 2003, NEUROIMAGE, V19, P513; WEDDING D, 1985, INT J NEUROSCI, V27, P277, DOI 10.3109/00207458509149773; Weigand A, 2013, EXP BRAIN RES, V227, P43, DOI 10.1007/s00221-013-3483-7; Yekta M., 2015, PRACTICE CLIN PSYCHO, V3, P185	56	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159555	10.1371/journal.pone.0159555	http://dx.doi.org/10.1371/journal.pone.0159555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433807	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600071
J	Dennison, L; Smith, EM; Bradbury, K; Galea, I				Dennison, Laura; Smith, Ellen McCloy; Bradbury, Katherine; Galea, Ian			How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study	PLOS ONE			English	Article							NATURAL-HISTORY; ADJUSTMENT	Background Disease progression in multiple sclerosis (MS) is highly variable and predicting prognosis is notoriously challenging. Patients' prognosis beliefs, responses to prognostic uncertainty and experiences of prognosis-related communication with healthcare professionals (HCPs) have received little study. These issues have implications for patients' psychological adjustment and are important in the context of the recent development of personalised prognosis forecasting tools. This study explored patient perspectives on the experience of prognostic uncertainty, the formation of expectations about personal prognosis and the nature of received and desired prognosis communication. Methods 15 MS patients participated in in-depth semi-structured interviews which were analysed using inductive thematic analysis. Results Six themes captured key aspects of the data: Experiencing unsatisfactory communication with HCPs, Appreciating and accepting prognostic uncertainty, Trying to stay present-focused, Forming and editing personal prognosis beliefs, Ambivalence towards forecasting the future, and Prognosis information delivery. MS patients report having minimal communication with HCPs about prognosis. Over time MS patients appear to develop expectations about their disease trajectories, but do so with minimal HCP input. Provision of prognosis information by HCPs seems to run counter to patients' attempts to remain present-focused. Patients are often ambivalent about prognosis forecasting and consider it emotionally dangerous and of circumscribed usefulness. Conclusions HCPs must carefully consider whether, when and how to share prognosis information with patients; specific training may be beneficial. Future research should confirm findings about limited HCP-patient communication, distinguish predictors of patients' attitudes towards prognostication and identify circumstances under which prognostic forecasting benefits patients.	[Dennison, Laura; Bradbury, Katherine] Univ Southampton, Acad Unit Psychol, Southampton, Hants, England; [Smith, Ellen McCloy] Univ Southampton, Fac Med, Southampton, Hants, England; [Galea, Ian] Univ Southampton, Fac Med, Clin & Expt Sci, Clin Neurosci, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton	Dennison, L (corresponding author), Univ Southampton, Acad Unit Psychol, Southampton, Hants, England.	l.k.dennison@soton.ac.uk	Galea, Ian/B-7997-2011	Galea, Ian/0000-0002-1268-5102; Bradbury, Katherine/0000-0001-5513-7571; Dennison, Laura/0000-0003-0122-6610	UK MS Register; MS Society	UK MS Register; MS Society	The authors would like to thank the 15 people with MS who participated and the UK MS Register and MS Society for supporting recruitment.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Buecken R, 2012, PATIENT EDUC COUNS, V88, P318, DOI 10.1016/j.pec.2012.03.010; Daumer M, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-11; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Dennison L, 2013, PSYCHOL HEALTH, V28, P973, DOI 10.1080/08870446.2013.767904; Dennison L, 2011, J HEALTH PSYCHOL, V16, P478, DOI 10.1177/1359105310384299; Dennison L, 2010, J PSYCHOSOM RES, V69, P353, DOI 10.1016/j.jpsychores.2010.04.009; Dennison L, 2009, CLIN PSYCHOL REV, V29, P141, DOI 10.1016/j.cpr.2008.12.001; Edwards RG, 2008, J EVAL CLIN PRACT, V14, P460, DOI 10.1111/j.1365-2753.2007.00902.x; Finlayson M., 2005, BRIT J OCCUPATIONAL, V68, P117, DOI DOI 10.1177/030802260506800304; Galea I, 2013, EUR J NEUROL, V20, P1107, DOI 10.1111/ene.12016; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Heesen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059042; Jopson NM, 2003, J PSYCHOSOM RES, V54, P503, DOI 10.1016/S0022-3999(02)00455-5; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Mackenzie IS, 2014, J NEUROL NEUROSUR PS, V85, P76, DOI 10.1136/jnnp-2013-305450; Malcomson KS, 2008, DISABIL REHABIL, V30, P662, DOI 10.1080/09638280701400730; Mishel M H, 1990, Image J Nurs Sch, V22, P256; Moss-Morris R, 2013, BRIT J HEALTH PSYCH, V18, P681, DOI 10.1111/bjhp.12072; Nerenz, 1980, CONTRIBUTIONS MED PS, V2, P7, DOI DOI 10.1093/GERONJ/46.4.P181; NICE, 2014, MULT SCLER AD MAN CG; Solari A, 2014, MULT SCLER J, V20, P397, DOI 10.1177/1352458514523061; Somerset Maggie, 2002, J Health Serv Res Policy, V7, P151, DOI 10.1258/135581902760082454; Synnot AJ, 2016, HEALTH EXPECT, V19, P727, DOI 10.1111/hex.12253; Tams R, 2016, NEUROREHABILITATION, V38, P257, DOI 10.3233/NRE-161317	27	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158982	10.1371/journal.pone.0158982	http://dx.doi.org/10.1371/journal.pone.0158982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434641	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000380169600026
J	Mokhtar, MM; Adawy, SS; El-Assal, SEDS; Hussein, EHA				Mokhtar, Morad M.; Adawy, Sami S.; El-Assal, Salah El-Din S.; Hussein, Ebtissam H. A.			Genic and Intergenic SSR Database Generation, SNPs Determination and Pathway Annotations, in Date Palm (Phoenix dactylifera L.)	PLOS ONE			English	Article							IN-SILICO ANALYSIS; MICROSATELLITE MARKERS; EST-SSR; SEQUENCE; GENOME; FREQUENCY; GENES	The present investigation was carried out aiming to use the bioinformatics tools in order to identify and characterize, simple sequence repeats within the third Version of the date palm genome and develop a new SSR primers database. In addition single nucleotide polymorphisms (SNPs) that are located within the SSR flanking regions were recognized. Moreover, the pathways for the sequences assigned by SSR primers, the biological functions and gene interaction were determined. A total of 172,075 SSR motifs was identified on date palm genome sequence with a frequency of 450.97 SSRs per Mb. Out of these, 130,014 SSRs (75.6%) were located within the intergenic regions with a frequency of 499 SSRs per Mb. While, only 42,061 SSRs (24.4%) were located within the genic regions with a frequency of 347.5 SSRs per Mb. A total of 111,403 of SSR primer pairs were designed, that represents 291.9 SSR primers per Mb. Out of the 111,403, only 31,380 SSR primers were in the genic regions, while 80,023 primers were in the intergenic regions. A number of 250,507 SNPs were recognized in 84,172 SSR flanking regions, which represents 75.55% of the total SSR flanking regions. Out of 12,274 genes only 463 genes comprising 896 SSR primers were mapped onto 111 pathways using KEGG data base. The most abundant enzymes were identified in the pathway related to the biosynthesis of antibiotics. We tested 1031 SSR primers using both publicly available date palm genome sequences as templates in the in silico PCR reactions. Concerning in vitro validation, 31 SSR primers among those used in the in silico PCR were synthesized and tested for their ability to detect polymorphism among six Egyptian date palm cultivars. All tested primers have successfully amplified products, but only 18 primers detected polymorphic amplicons among the studied date palm cultivars.	[Mokhtar, Morad M.; Adawy, Sami S.; Hussein, Ebtissam H. A.] ARC, Mol Genet & Genome Mapping Lab, Agr Genet Engn Res Inst, Giza, Egypt; [El-Assal, Salah El-Din S.; Hussein, Ebtissam H. A.] Cairo Univ, Dept Genet, Fac Agr, Giza, Egypt	Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Cairo University	Mokhtar, MM (corresponding author), ARC, Mol Genet & Genome Mapping Lab, Agr Genet Engn Res Inst, Giza, Egypt.	morad.mokhtar@ageri.sci.eg	Mokhtar, Morad M./H-4715-2019; Mokhtar, Morad/GWV-2705-2022	Mokhtar, Morad M./0000-0002-9540-0458; 				Adawy S.S., 2005, ARAB J BIOTECHNOL, V8, P99; Adawy S.S., 2015, INT J SCI RES, V14, P1063; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Farsi MA, 2008, CRIT REV FOOD SCI, V48, P877, DOI 10.1080/10408390701724264; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Barrow Sasha C., 1998, Kew Bulletin, V53, P513, DOI 10.2307/4110478; Beal JM, 1937, BOT GAZ, V99, P400, DOI 10.1086/334708; Billotte N, 2004, MOL ECOL NOTES, V4, P256, DOI 10.1111/j.1471-8286.2004.00634.x; Cardle L, 2000, GENETICS, V156, P847; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Elhoumaizi MA, 2002, GENET RESOUR CROP EV, V49, P483, DOI 10.1023/A:1020968513494; Elmeer K, 2011, 3 BIOTECH, V1, P91, DOI 10.1007/s13205-011-0010-z; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Hamwieh A, 2010, ACTA HORTIC, V882, P269; Hussein EHA, 2005, ARAB J BIOTECH JAN, V8, P83; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur R, 2015, TURKISH J AGR FOR, V39, P1; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Pinto LR, 2004, GENOME, V47, P795, DOI [10.1139/g04-055, 10.1139/G04-055]; Rajendrakumar Passoupathy, 2008, In Silico Biology, V8, P87; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zhang GY, 2012, PLANT MOL BIOL, V79, P521, DOI 10.1007/s11103-012-9924-z; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	36	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159268	10.1371/journal.pone.0159268	http://dx.doi.org/10.1371/journal.pone.0159268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434138	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600043
J	Deng, HY; Liu, Q; Cao, W; Gui, R; Ma, CZ; Yi, M; Yao, YG				Deng, Haiyou; Liu, Quan; Cao, Wei; Gui, Rong; Ma, Chengzhang; Yi, Ming; Yao, Yuangen			qiRNApredictor: A Novel Computational Program for the Prediction of qiRNAs in Neurospora crassa	PLOS ONE			English	Article							MICRORNA-LIKE RNAS; NONCODING RNAS; RANDOM FOREST; IDENTIFICATION; CLASSIFICATION	Recently, a new type of small interfering RNAs (qiRNAs) of typically 20 similar to 21 nucleotides was found in Neurospora crassa and rice and has been shown to regulate gene silencing in the DNA damage response. Identification of qiRNAs is fundamental for dissecting regulatory functions and molecular mechanisms. In contrast to other expensive and time-consuming experimental methods, the computational prediction of qiRNAs is a conveniently rapid method for gaining valuable information for a subsequent experimental verification. However, no tool existed to date for the prediction of qiRNAs. To this purpose, we developed the novel qiRNA prediction software package qiRNApredictor. This software demonstrates a promising sensitivity of 93.55% and a specificity of 71.61% from the leave-one-out validation. These studies might be beneficial for further experimental investigation. Furthermore, the local package of qiRNApredictor was implemented and made freely available to the academic community at Supplementary material.	[Deng, Haiyou; Liu, Quan; Cao, Wei; Gui, Rong; Ma, Chengzhang; Yi, Ming; Yao, Yuangen] Huazhong Agr Univ, Coll Sci, Dept Phys, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yao, YG (corresponding author), Huazhong Agr Univ, Coll Sci, Dept Phys, Wuhan, Hubei, Peoples R China.	yyg@mail.hzau.edu.cn	Yao, Yuangen/D-9327-2018; Yi, Ming/B-5383-2011; Yi, Ming/AAB-7928-2022	Yao, Yuangen/0000-0001-6967-2487; Yi, Ming/0000-0001-7198-5511; Yi, Ming/0000-0001-7534-3049	Innovation Fund of Huazhong Agricultural University [2662014BQ069, 2662015BQ045]	Innovation Fund of Huazhong Agricultural University	This work was supported by grants from Innovation Fund of Huazhong Agricultural University (2662014BQ069 YY; 2662015BQ045 HD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Bai YH, 2015, FUNGAL GENET BIOL, V81, P113, DOI 10.1016/j.fgb.2015.03.004; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055252; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104956; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12500; Dahlmann TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125989; Hertzberg L, 2005, J COMPUT BIOL, V12, P314, DOI 10.1089/cmb.2005.12.314; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lin YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123245; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Yang F, 2015, FUNGAL BIOL-UK, V119, P631, DOI 10.1016/j.funbio.2015.03.008; Yao YG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-117; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001	28	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159487	10.1371/journal.pone.0159487	http://dx.doi.org/10.1371/journal.pone.0159487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428111	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300071
J	Hall, ANB; Joseph, B; Brelsfoard, JM; Saatman, KE				Hall, Amanda N. Bolton; Joseph, Binoy; Brelsfoard, Jennifer M.; Saatman, Kathryn E.			Repeated Closed Head Injury in Mice Results in Sustained Motor and Memory Deficits and Chronic Cellular Changes	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MOUSE MODEL; AXONAL INJURY; COGNITIVE IMPAIRMENT; ASTROCYTE ACTIVATION; OPTIC-NERVE; MILD; NEURODEGENERATION; ENCEPHALOPATHY; EPIDEMIOLOGY	Millions of mild traumatic brain injuries (TBIs) occur every year in the United States, with many people subject to multiple head injuries that can lead to chronic behavioral dysfunction. We previously reported that mild TBI induced using closed head injuries (CHI) repeated at 24h intervals produced more acute neuron death and glial reactivity than a single CHI, and increasing the length of time between injuries to 48h reduced the cumulative acute effects of repeated CHI. To determine whether repeated CHI is associated with behavioral dysfunction or persistent cellular damage, mice receiving either five CHI at 24h intervals, five CHI at 48h intervals, or five sham injuries at 24h intervals were evaluated across a 10 week period after injury. Animals with repeated CHI exhibited motor coordination and memory deficits, but not gait abnormalities when compared to sham animals. At 10wks post-injury, no notable neuron loss or glial reactivity was observed in the cortex, hippocampus, or corpus callosum. Argyrophilic axons were found in the pyramidal tract of some injured animals, but neither silver stain accumulation nor inflammatory responses in the injury groups were statistically different from the sham group in this region. However, argyrophilic axons, microgliosis and astrogliosis were significantly increased within the optic tract of injured animals. Repeated mild CHI also resulted in microgliosis and a loss of neurofilament protein 200 in the optic nerve. Lengthening the inter-injury interval from 24h to 48h did not effectively reduce these behavioral or cellular responses. These results suggest that repeated mild CHI results in persistent behavioral dysfunction and chronic pathological changes within the visual system, neither of which was significantly attenuated by lengthening the inter-injury interval from 24h to 48h.	[Hall, Amanda N. Bolton; Joseph, Binoy; Brelsfoard, Jennifer M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA; [Hall, Amanda N. Bolton; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA; [Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky	Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40506 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40506 USA.; Saatman, KE (corresponding author), Univ Kentucky, Coll Med, Dept Neurosurg, Lexington, KY 40506 USA.	k.saatman@uky.edu			National Institute of Neurological Disorders and Stroke [T32 NS077889, F31 NS087878-02, P30 NS051220]; Kentucky Spinal Cord and Head Injury Trust [14-13A, 9-13]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Kentucky Spinal Cord and Head Injury Trust	This study was supported by the National Institute of Neurological Disorders and Stroke T32 NS077889 and National Institute of Neurological Disorders and Stroke F31 NS087878-02 (ANBH); National Institute of Neurological Disorders and Stroke P30 NS051220, Kentucky Spinal Cord and Head Injury Trust 14-13A, Kentucky Spinal Cord and Head Injury Trust 9-13 (KES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Balaratnasingam C, 2010, INVEST OPHTH VIS SCI, V51, P3019, DOI 10.1167/iovs.09-4692; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRONWALL D, 1975, LANCET, V2, P995; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Huynh T, 2006, AM SURGEON, V72, P1162; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo Jian, 2014, Front Neurol, V5, P12, DOI 10.3389/fneur.2014.00012; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Selwyn RG, 2015, J NEUROTRAUMA; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Tellier A, 1999, BRAIN INJURY, V13, P463; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Xu L, 2014, EXP NEUROL; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216	79	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159442	10.1371/journal.pone.0159442	http://dx.doi.org/10.1371/journal.pone.0159442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427961	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300067
J	Semenchenko, K; Wasylyk, C; Cheung, H; Tourrette, Y; Maas, P; Schalken, JA; van der Pluijm, G; Wasylyk, B				Semenchenko, Kostyantyn; Wasylyk, Christine; Cheung, Henry; Tourrette, Yves; Maas, Peter; Schalken, Jack A.; van der Pluijm, Gabri; Wasylyk, Bohdan			XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice	PLOS ONE			English	Article							MOUSE PROSTATE MODEL; BREAST-CANCER CELLS; COMPLEX FACTOR NET; TRANSGENIC MOUSE; GENE-EXPRESSION; CARCINOMA-CELLS; TRAMP MOUSE; ADENOCARCINOMA; PROGRESSION; KERATINOCYTES	Transcription factors have an important role in cancer but are difficult targets for the development of tumour therapies. These factors include the Ets family, and in this study Elk3 that is activated by Ras oncogene /Erk signalling, and is involved in angiogenesis, malignant progression and epithelial-mesenchymal type processes. We previously described the identification and in-vitro characterisation of an inhibitor of Ras / Erk activation of Elk3 that also affects microtubules, XRP44X. We now report an initial characterisation of the effects of XRP44X in-vivo on tumour growth and metastasis in three preclinical models mouse models, subcutaneous xenografts, intra-cardiac injection-bone metastasis and the TRAMP transgenic mouse model of prostate cancer progression. XRP44X inhibits tumour growth and metastasis, with limited toxicity. Tumours from XRP44X-treated animals have decreased expression of genes containing Elk3-like binding motifs in their promoters, Elk3 protein and phosphorylated Elk3, suggesting that perhaps XRP44X acts in part by inhibiting the activity of Elk3. Further studies are now warranted to develop XRP44X for tumour therapy.	[Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] CNRS, UMR7104, Illkirch Graffenstaden, France; [Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] INSERM, U964, Illkirch Graffenstaden, France; [Semenchenko, Kostyantyn; Wasylyk, Christine; Tourrette, Yves; Wasylyk, Bohdan] Univ Strasbourg, Illkirch Graffenstaden, France; [Cheung, Henry; van der Pluijm, Gabri] Leiden Univ, Med Ctr, Leiden, Netherlands; [Maas, Peter] SPECS, Kluyverweg 6, NL-2629 HT Delft, Netherlands; [Schalken, Jack A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 GA Nijmegen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Wasylyk, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.; Wasylyk, B (corresponding author), CNRS, UMR7104, Illkirch Graffenstaden, France.; Wasylyk, B (corresponding author), INSERM, U964, Illkirch Graffenstaden, France.; Wasylyk, B (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.	boh@igbmc.fr	Schalken, Jack A/B-1277-2014; Wasylyk, Bohdan/ABG-6778-2020	Schalken, Jack A/0000-0001-8274-7797; Wasylyk, Bohdan/0000-0002-1718-1237	sixth framework program; seventh framework program; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Association pour la Recherche contre le Cancer (ARC); Association for International Cancer Research (GB) [05-390]	sixth framework program(European Commission); seventh framework program(European Commission); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg (UdS); Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association for International Cancer Research (GB)	The authors thank for financial support the sixth framework program (https://ec.europa.eu/research/fp6/index_en.cfm, PRIMA FP6, BW), the seventh framework program (https://ec.europa.eu/research/fp7/index_en.cfm, PRO-NEST, BW, ESR for KS), the Centre National de la Recherche Scientifique (CNRS, http://www.cnrs.fr/, institutional funding, BW), the Institut National de la Sante et de la Recherche Medicale (INSERM, http://www.inserm.fr/, institutional funding, BW), the Universite de Strasbourg (UdS, http://www.en.unistra.fr/index.php?id=21304, institutional funding, BW), the Conference de Coordination Interregionale du Grand Est (CCIR-GE) de la Ligue Contre le Cancer (http://www.liguecancer-cd68.fr/CCIR_GE.html, project grants, BW), the Association pour la Recherche contre le Cancer (ARC, http://www.fondation-arc.org/, fellowship KS), and Association for International Cancer Research (GB), 05-390, Dr. Bohdan Wasylyk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa Z, 1997, J INVEST DERMATOL, V108, P886, DOI 10.1111/1523-1747.ep12292595; Ayadi A, 2001, MECH DEVELOP, V102, P205, DOI 10.1016/S0925-4773(01)00289-1; Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Beggs AE, 2012, AM J HEALTH-SYST PH, V69, P2147, DOI 10.2146/ajhp120330; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; Bohn AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110091; Boro A, 2012, INT J CANCER, V131, P2153, DOI 10.1002/ijc.27472; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Chen J, 2012, ANTI-CANCER DRUG, V23, P98, DOI 10.1097/CAD.0b013e32834bc978; Crawford J, 2004, CANCER-AM CANCER SOC, V100, P228, DOI 10.1002/cncr.11882; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Ducret C, 1999, MOL CELL BIOL, V19, P7076; Enk CD, 2006, ONCOGENE, V25, P2601, DOI 10.1038/sj.onc.1209292; Fanale D, 2015, ANAL CELL PATHOL, V2015, P1, DOI 10.1155/2015/690916; Feng FY, 2014, CLIN CANCER RES, V20, P4442, DOI 10.1158/1078-0432.CCR-13-0275; Field JJ, 2014, BIOORGAN MED CHEM, V22, P5050, DOI 10.1016/j.bmc.2014.02.035; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; Gingrich JR, 1996, CANCER RES, V56, P4096; Grabowska MM, 2014, CANCER METAST REV, V33, P377, DOI 10.1007/s10555-013-9487-8; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; GREENBERG NM, 1994, MOL ENDOCRINOL, V8, P230, DOI 10.1210/me.8.2.230; Grohar PJ, 2011, NEOPLASIA, V13, P145, DOI 10.1593/neo.101202; Gross C, 2007, MOL CELL BIOL, V27, P4133, DOI 10.1128/MCB.01867-06; Heo SH, 2015, GENE EXPRESSION, V16, P197, DOI 10.3727/105221615X14399878166276; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Herter-Sprie GS, 2013, J CLIN INVEST, V123, P3639, DOI 10.1172/JCI68340; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Kokkinakis DM, 2006, MOL CANCER RES, V4, P575, DOI 10.1158/1541-7786.MCR-05-0240; Kumar H, 2013, EUR J MED CHEM, V70, P248, DOI 10.1016/j.ejmech.2013.10.004; Lin X, 2002, UROLOGY, V60, P919, DOI 10.1016/S0090-4295(02)01863-0; Maira SM, 1996, EMBO J, V15, P5849, DOI 10.1002/j.1460-2075.1996.tb00972.x; Mentor-Marcel R, 2001, CANCER RES, V61, P6777; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Narayanan BA, 2004, CLIN CANCER RES, V10, P7727, DOI 10.1158/1078-0432.CCR-04-0732; Raina K, 2007, CANCER RES, V67, P11083, DOI 10.1158/0008-5472.CAN-07-2222; Robertson ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113050; Rogers CD, 2013, DEV BIOL, V374, P255, DOI 10.1016/j.ydbio.2012.12.009; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Serchov T, 2010, J BIOL CHEM, V285, P21223, DOI 10.1074/jbc.M110.121723; Stasevich I, 2015, BR J HAEMATOL; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suttie AW, 2005, TOXICOL PATHOL, V33, P386, DOI 10.1080/01926230590930272; Tang Y, 2009, PROSTATE, V69, P1763, DOI 10.1002/pros.21026; Tsui KH, 2012, INT J CANCER, V130, P2812, DOI 10.1002/ijc.26284; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; van der Horst G, 2011, EUR UROL, V60, P337, DOI 10.1016/j.eururo.2011.05.005; Wartha K, 2014, PHARMACOL THERAPEUT, V142, P351, DOI 10.1016/j.pharmthera.2014.01.001; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Wechter WJ, 2000, CANCER RES, V60, P2203; Weinl C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107048; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Yang H, 2015, ELIFE, V4, DOI 10.7554/eLife.10870; Zheng H, 2003, GENE DEV, V17, P2283, DOI 10.1101/gad.272503	61	13	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159531	10.1371/journal.pone.0159531	http://dx.doi.org/10.1371/journal.pone.0159531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427904	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300075
J	Ramakrishnan, M; Ceasar, SA; Duraipandiyan, V; Vinod, KK; Kalpana, K; Al-Dhabi, NA; Ignacimuthu, S				Ramakrishnan, M.; Ceasar, S. Antony; Duraipandiyan, V.; Vinod, K. K.; Kalpana, Krishnan; Al-Dhabi, N. A.; Ignacimuthu, S.			Tracing QTLs for Leaf Blast Resistance and Agronomic Performance of Finger Millet (Eleusine coracana (L.) Gaertn.) Genotypes through Association Mapping and in silico Comparative Genomics Analyses	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR MARKERS; WIDE ASSOCIATION; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; RICE; ARABIDOPSIS; PROTEIN; TRAITS; SEQUENCE	Finger millet is one of the small millets with high nutritive value. This crop is vulnerable to blast disease caused by Pyricularia grisea, which occurs annually during rainy and winter seasons. Leaf blast occurs at early crop stage and is highly damaging. Mapping of resistance genes and other quantitative trait loci (QTLs) for agronomic performance can be of great use for improving finger millet genotypes. Evaluation of one hundred and twenty-eight finger millet genotypes in natural field conditions revealed that leaf blast caused severe setback on agronomic performance for susceptible genotypes, most significant traits being plant height and root length. Plant height was reduced under disease severity while root length was increased. Among the genotypes, IE4795 showed superior response in terms of both disease resistance and better agronomic performance. A total of seven unambiguous QTLs were found to be associated with various agronomic traits including leaf blast resistance by association mapping analysis. The markers, UGEP101 and UGEP95, were strongly associated with blast resistance. UGEP98 was associated with tiller number and UGEP9 was associated with root length and seed yield. Cross species validation of markers revealed that 12 candidate genes were associated with 8 QTLs in the genomes of grass species such as rice, foxtail millet, maize, Brachypodium stacei, B. distachyon, Panicum hallii and switchgrass. Several candidate genes were found proximal to orthologous sequences of the identified QTLs such as 1,4-beta-glucanase for leaf blast resistance, cytokinin dehydrogenase (CKX) for tiller production, calmodulin (CaM) binding protein for seed yield and pectin methylesterase inhibitor (PMEI) for root growth and development. Most of these QTLs and their putatively associated candidate genes are reported for first time in finger millet. On validation, these novel QTLs may be utilized in future for marker assisted breeding for the development of fungal resistant and high yielding varieties of finger millet.	[Ramakrishnan, M.; Ceasar, S. Antony; Duraipandiyan, V.; Ignacimuthu, S.] Loyola Coll, Entomol Res Inst, Div Plant Biotechnol, Madras, Tamil Nadu, India; [Ceasar, S. Antony] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Ceasar, S. Antony] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Duraipandiyan, V.; Al-Dhabi, N. A.] King Saud Univ, Coll Sci, Addiriyah Chair Environm Studies, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Vinod, K. K.] ICAR Indian Agr Res Inst, Div Genet, Rice Breeding & Genet Res Ctr, Aduthurai, India; [Kalpana, Krishnan] Tamil Nadu Agr Univ, Reg Res Stn, Paiyur, India; [Ignacimuthu, S.] King Saud Univ, ISPP, Vice Rectorate Grad Studies & Res, Riyadh, Saudi Arabia	Loyola College - Chennai; University of Leeds; University of Leeds; King Saud University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Tamil Nadu Agricultural University; King Saud University	Duraipandiyan, V; Ignacimuthu, S (corresponding author), Loyola Coll, Entomol Res Inst, Div Plant Biotechnol, Madras, Tamil Nadu, India.; Duraipandiyan, V (corresponding author), King Saud Univ, Coll Sci, Addiriyah Chair Environm Studies, Dept Bot & Microbiol, Riyadh, Saudi Arabia.; Ignacimuthu, S (corresponding author), King Saud Univ, ISPP, Vice Rectorate Grad Studies & Res, Riyadh, Saudi Arabia.	avdpandiyan@gmail.com; eriloyola@hotmail.com	CEASAR, STANISLAUS ANTONY/P-2479-2017; Ignacimuthu, S/ABH-3983-2020; Ramakrishnan, Muthusamy/AAM-6865-2021; Veeramuthu, Duraipandiyan/D-9924-2012; K K, Vinod/H-2938-2019; krishnan, kalpana/AAP-1297-2020; Al-Dhabi, Naif/E-7305-2014	CEASAR, STANISLAUS ANTONY/0000-0003-4106-1531; Ignacimuthu, S/0000-0002-8467-789X; Ramakrishnan, Muthusamy/0000-0001-7819-339X; Veeramuthu, Duraipandiyan/0000-0002-2107-3503; K K, Vinod/0000-0001-8927-4590; Al-Dhabi, Naif/0000-0002-2663-6328	Department of Biotechnology [BT/PR15011/AGR/02/772/2010]; Deanship of Scientific Research at King Saud University, Kingdom of Saudi Arabia [RGP-VPP-213]; Department of Biotechnology, New Delhi [BT/PR15011/AGR/02/772/2010]; King Saud University, through Vice Deanship of Research Chairs	Department of Biotechnology; Deanship of Scientific Research at King Saud University, Kingdom of Saudi Arabia; Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); King Saud University, through Vice Deanship of Research Chairs	This work was supported by 1) Grant number: BT/PR15011/AGR/02/772/2010. http://www.dbtindia.nic.in/ (Department of Biotechnology) MR, SI, SAC, and 2) Grant number: RGP-VPP-213. http://ksu.edu.sa/en/ (Deanship of Scientific Research at King Saud University, Kingdom of Saudi Arabia). VD, NAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Department of Biotechnology, New Delhi, for providing financial support (BT/PR15011/AGR/02/772/2010). We thank ICRISAT, UAS (GKVK) and TNAU for supplying the finger millet seeds. We thank Dr. M. Maheswaran, Director of Research, Prof and Head and all staff members, RRS, Paiyur-TNAU for providing facilities for phenotype screening and for their encouragement. We thank Dr Ketrien Devos, University of Georgia, College of Agricultural Science, USA for sharing the target EST sequences of the SSR markers. Also we thank the mentors of this project, Dr. P. Kadirvel, Senior Scientist, Directorate of oil seed research, Indian Council of Agricultural Research, Hyderabad, India, Prof. P. Balasubramanian, Centre for Plant Molecular Biology, TNAU, Coimbatore, India for their encouragement. This project was also partially financially supported by King Saud University, through Vice Deanship of Research Chairs is also acknowledged.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Anilkumar TB, 2003, DIS FINGER MILLET, P1; Aru J., 2013, 11th African Crop Science Proceedings, Sowing innovations for sustainable food and nutrition security in Africa. Entebbe, Uganda, 14-17 October, 2013, P483; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashkani S, 2013, BIOTECHNOL LETT, V35, P799, DOI 10.1007/s10529-012-1130-1; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Babu B. K., 2014, SABRAO Journal of Breeding and Genetics, V46, P202; Babu BK, 2014, MOL BREEDING, V34, P1261, DOI 10.1007/s11032-014-0115-2; Babu BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099182; Babu BK, 2014, MOL BIOL REP, V41, P3081, DOI 10.1007/s11033-014-3168-8; Babu TK, 2013, EUR J PLANT PATHOL, V135, P299, DOI 10.1007/s10658-012-0086-2; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bennetzen JL, 1997, GENOME RES, V7, P301, DOI 10.1101/gr.7.4.301; Bharathi A., 2011, THESIS; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; De Villiers SM, 2015, ELECTRON J BIOTECHN, V18, P77, DOI 10.1016/j.ejbt.2014.12.001; Dida MM, 2007, THEOR APPL GENET, V114, P321, DOI 10.1007/s00122-006-0435-7; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Esele JP, 2008, DIS FINGER MILLET GL, P19; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 1995, FAO FOOD NUTR SER, V27, P186; Federer W, 1967, EXPT DESIGN THEORY A, P1; Fu Y, 2015, THEOR APPL GENET, V128, P1029, DOI 10.1007/s00122-015-2487-z; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Greco R, 1997, MOL GEN GENET, V253, P615, DOI 10.1007/s004380050364; Guo BH, 2011, MOL BREEDING, V27, P107, DOI 10.1007/s11032-010-9503-4; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hao ZN, 2012, PLANT PHYSIOL BIOCH, V60, P150, DOI 10.1016/j.plaphy.2012.08.006; Ignacimuthu S, 2012, J BIOSCIENCES, V37, P135, DOI 10.1007/s12038-011-9178-y; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Joel A, 2005, MADRAS AGR J, V92, P375; Joukhadar R, 2013, MOL BREEDING, V32, P943, DOI 10.1007/s11032-013-9924-y; Karandikar RL, 2006, SADHANA-ACAD P ENG S, V31, P81, DOI 10.1007/BF02719775; Kole C, 2006, CEREALS AND MILLETS; Koutroubas SD, 2009, TURK J AGRIC FOR, V33, P487, DOI 10.3906/tar-0812-15; Kumar A, 2014, APPL BIOCHEM BIOTECH, V172, P2955, DOI 10.1007/s12010-013-0714-0; Kurotani Ken-Ich, 2015, Plant Signal Behav, V10, pe1046667, DOI 10.1080/15592324.2015.1046667; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; MACKILL DJ, 1992, PHYTOPATHOLOGY, V82, P746, DOI 10.1094/Phyto-82-746; Markakis MN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-208; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; McRAE W., 1922, Agric. Res. Inst. Pusa, Scientific Reports 1921-22, P44; Mirza N, 2014, P NATL ACAD SCI IN B, P1; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Nagaraja A., 2007, Journal of Mycopathological Research, V45, P237; Nagaraja A., 2010, Crop Research (Hisar), V39, P120; Nagaraja A., 2007, COMPENDIUM SMALL MIL, P1; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Nirgude M, 2014, MOL BIOL REP, V41, P1189, DOI 10.1007/s11033-013-2825-7; Opiyo Stephen O, 2010, Int J Bioinform Res Appl, V6, P209, DOI 10.1504/IJBRA.2010.032122; Pall BS, 1977, FOOD FARMING AGR, V9, P55; Pritchard JK, 2000, GENETICS, V155, P945; Ramakrishnan M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-015-1626-y; Ramakrishnan M, 2016, GENET RESOUR CROP EV, V63, P361, DOI 10.1007/s10722-015-0255-1; RAO A N S, 1990, Mysore Journal of Agricultural Sciences, V24, P57; Singh A.K., 2015, MARKER ASSISTED PLAN, P217, DOI 10.1007/978-81-322-2316-0_8; Singh UM, 2014, ACTA PHYSIOL PLANT, V36, P2521, DOI 10.1007/s11738-014-1625-6; SOCK J, 1990, PLANT PHYSIOL, V94, P1376, DOI 10.1104/pp.94.3.1376; Tabien RE, 2002, THEOR APPL GENET, V105, P313, DOI 10.1007/s00122-002-0940-2; Takan JP, 2012, MOL BIOTECHNOL, V50, P145, DOI 10.1007/s12033-011-9429-z; Tanaka W, 2013, PLANT CELL PHYSIOL, V54, P313, DOI 10.1093/pcp/pct016; Upadhyaya HD, 2013, THEOR APPL GENET, V126, P2003, DOI 10.1007/s00122-013-2113-x; Upadhyaya HD, 2006, GENET RESOUR CROP EV, V53, P679, DOI 10.1007/s10722-004-3228-3; Vanniarajan C, 2012, J GENET, V91, P9, DOI 10.1007/s12041-012-0146-6; Venkatarayan S., 1947, MYSORE AGR J, V24, P50; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Wheeler BEJ., 1969, INTRO PLANT DIS, V2, P301; Wu JL, 2004, THEOR APPL GENET, V108, P1024, DOI 10.1007/s00122-003-1528-1; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Xu P, 2014, J EXP BOT, V65, P4285, DOI 10.1093/jxb/eru202; Yeh SY, 2015, RICE, V8, DOI 10.1186/s12284-015-0070-5; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	85	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159264	10.1371/journal.pone.0159264	http://dx.doi.org/10.1371/journal.pone.0159264			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415007	Green Submitted, gold, Green Published			2022-12-26	WOS:000379579500115
J	Romao-Dumaresq, AS; Dourado, MN; Favaro, LCD; Mendes, R; Ferreira, A; Araujo, WL				Romao-Dumaresq, Aline Silva; Dourado, Manuella Nobrega; de Lima Favaro, Leia Cecilia; Mendes, Rodrigo; Ferreira, Anderson; Araujo, Welington Luiz			Diversity of Cultivated Fungi Associated with Conventional and Transgenic Sugarcane and the Interaction between Endophytic Trichoderma virens and the Host Plant	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; BIOLOGICAL-CONTROL; MEDIATED TRANSFORMATION; BACTERIAL COMMUNITIES; GLIOCLADIUM-VIRENS; FUSARIUM-OXYSPORUM; PYTHIUM-ULTIMUM; ROOT ENDOPHYTES; MUSA-ACUMINATA; POTATO ROOTS	Plant-associated fungi are considered a vast source for biotechnological processes whose potential has been poorly explored. The interactions and diversity of sugarcane, one of the most important crops in Brazil, have been rarely studied, mainly concerning fungal communities and their interactions with transgenic plants. Taking this into consideration, the purpose of this study was, based on culture dependent strategy, to determine the structure and diversity of the fungal community (root endophytes and rhizosphere) associated with two varieties of sugarcane, a non-genetically modified (SP80-1842) variety and its genetically modified counterpart (IMI-1, expressing imazapyr herbicide resistance). For this, the sugarcane varieties were evaluated in three sampling times (3, 10 and 17 months after planting) under two crop management (weeding and herbicide treatments). In addition, a strain of Trichoderma virens, an endophyte isolated from sugarcane with great potential as a biological control, growth promotion and enzyme production agent, was selected for the fungal-plant interaction assays. The results of the isolation, characterization and evaluation of fungal community changes showed that the sugarcane fungal community is composed of at least 35 different genera, mostly in the phylum Ascomycota. Many genera are observed at very low frequencies among a few most abundant genera, some of which were isolated from specific plant sites (e.g., the roots or the rhizosphere). An assessment of the possible effects upon the fungal community showed that the plant growth stage was the only factor that significantly affected the community's structure. Moreover, if transgenic effects are present, they may be minor compared to other natural sources of variation. The results of interaction studies using the Green fluorescent protein (GFP)-expressing T. virens strain T. v.223 revealed that this fungus did not promote any phenotypic changes in the host plant and was found mostly in the roots where it formed a dense mycelial cover and was able to penetrate the intercellular spaces of the root epidermis upper layers. The ability of T. virens to colonize plant roots suggests a potential for protecting plant health, inhibiting pathogens or inducing systemic resistance.	[Romao-Dumaresq, Aline Silva; Dourado, Manuella Nobrega; de Lima Favaro, Leia Cecilia; Mendes, Rodrigo; Ferreira, Anderson; Araujo, Welington Luiz] Univ Sao Paulo, Dept Genet, ESALQ, Sao Paulo, Brazil; [Dourado, Manuella Nobrega; Araujo, Welington Luiz] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Biol & Microbial Ecol, Sao Paulo, Brazil; [de Lima Favaro, Leia Cecilia] Brazilian Agr Res Corp, Embrapa Agroenergy, Brasilia, DF, Brazil; [Mendes, Rodrigo] Brazilian Agr Res Corp, Embrapa Environm, Sao Paulo, Brazil; [Ferreira, Anderson] Brazilian Agr Res Corp, Embrapa Agrosilvopastoral, Sinop, Mato Grosso, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Araujo, WL (corresponding author), Univ Sao Paulo, Dept Genet, ESALQ, Sao Paulo, Brazil.; Araujo, WL (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Biol & Microbial Ecol, Sao Paulo, Brazil.	wlaraujo@usp.br	Araújo, Welington/G-4905-2012; Mendes, Rodrigo/F-1534-2010; DE LIMA FAVARO, LEIA CECILIA/F-7350-2012; Dourado, Manuella N/P-2337-2018; Mendes, Rodrigo/AAV-6490-2020	Araújo, Welington/0000-0002-2120-8172; Mendes, Rodrigo/0000-0002-9817-4118; DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Dourado, Manuella N/0000-0002-2152-0246; Mendes, Rodrigo/0000-0002-9817-4118	FAPESP [2002/14143-3, 2003/13834-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (http://www.fapesp.br/), grant number: 2002/14143-3 and 2003/13834-5.	ALUKO MO, 1970, T BRIT MYCOL SOC, V55, P173, DOI 10.1016/S0007-1536(70)80001-8; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Atkinson D, 2000, APPL SOIL ECOL, V15, P99, DOI 10.1016/S0929-1393(00)00084-6; ATLAS RM, 1991, MICROBIAL ECOL, V22, P249, DOI 10.1007/BF02540227; Azevedo JL, 2007, FUNGI MULTIFACETED M, P191; Baek JM, 1999, CURR GENET, V35, P41, DOI 10.1007/s002940050431; Bailey BA, 2008, BIOL CONTROL, V46, P24, DOI 10.1016/j.biocontrol.2008.01.003; de Azevedo LCB, 2014, BRAZ J MICROBIOL, V45, P995, DOI 10.1590/S1517-83822014000300032; Benhamou N, 2002, APPL ENVIRON MICROB, V68, P4044, DOI 10.1128/AEM.68.8.4044-4060.2002; Bills Gerald F., 1996, P31; Britz H, 2002, MYCOLOGIA, V94, P722, DOI 10.2307/3761722; Camatti-Sartori V, 2005, J BASIC MICROB, V45, P397, DOI 10.1002/jobm.200410547; Cao LX, 2002, WORLD J MICROB BIOT, V18, P169, DOI 10.1023/A:1014491528811; Colla G, 2015, J SCI FOOD AGR, V95, P1706, DOI 10.1002/jsfa.6875; Crozier J, 2006, PLANT PATHOL, V55, P783, DOI 10.1111/j.1365-3059.2006.01446.x; Cui JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118204; Araujo FDD, 2012, EUR J ORG CHEM, V2012, P5225, DOI 10.1002/ejoc.201200757; Dal Bello GM, 2003, INT J PEST MANAGE, V49, P313, DOI 10.1080/09670870310001603883; Dal-Bianco M, 2012, CURR OPIN BIOTECH, V23, P265, DOI 10.1016/j.copbio.2011.09.002; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Favaro LCD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036826; Favaro LCD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014828; De Souza JT, 2008, BIOL CONTROL, V46, P36, DOI 10.1016/j.biocontrol.2008.01.010; Martinez FD, 2016, J SCI FOOD AGR, V96, P1934, DOI 10.1002/jsfa.7301; Doni F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-532; dos Santos RMG, 2003, WORLD J MICROB BIOT, V19, P767, DOI 10.1023/A:1026000731189; Dunfield KE, 2001, FEMS MICROBIOL ECOL, V38, P1, DOI 10.1111/j.1574-6941.2001.tb00876.x; Dunham SM, 2007, MYCORRHIZA, V17, P633, DOI 10.1007/s00572-007-0141-6; El-Amin Al-Nur, 2007, International Journal of Botany, V3, P97; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; Fitzgerald AM, 2003, MYCOL RES, V107, P803, DOI 10.1017/S0953756203008086; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Gamboa MA, 2001, BIOTROPICA, V33, P352, DOI 10.1111/j.1744-7429.2001.tb00187.x; Girlanda M, 2008, FEMS MICROBIOL LETT, V288, P9, DOI 10.1111/j.1574-6968.2008.01306.x; Gotz M, 2006, FEMS MICROBIOL ECOL, V58, P404, DOI 10.1111/j.1574-6941.2006.00169.x; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; Harman GE, 2000, PLANT DIS, V84, P377, DOI 10.1094/PDIS.2000.84.4.377; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hart MM, 2009, PEDOBIOLOGIA, V52, P253, DOI 10.1016/j.pedobi.2008.10.005; Harvey PJ, 2002, ENVIRON SCI POLLUT R, V9, P29, DOI 10.1007/BF02987315; Hawksworth DL, 2004, STUD MYCOL, P9; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Howell CR, 2006, PHYTOPATHOLOGY, V96, P178, DOI 10.1094/PHYTO-96-0178; HOWELL CR, 1982, PHYTOPATHOLOGY, V72, P496, DOI 10.1094/Phyto-72-496; Huang J, 2014, SCI WORLD J, DOI 10.1155/2014/798683; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Iqtedar M, 2015, NAT PROD RES, V29, P1012, DOI 10.1080/14786419.2014.971320; Klein Dorothy, 1998, P57; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kumar DSS, 2004, FUNGAL DIVERS, V17, P69; Lamarche J, 2007, APPL ENVIRON MICROB, V73, P6577, DOI 10.1128/AEM.00812-07; Larran S, 2007, WORLD J MICROB BIOT, V23, P565, DOI 10.1007/s11274-006-9266-6; Lee SH, 2011, MICROB ECOL, V61, P646, DOI 10.1007/s00248-010-9776-5; Liu W, 2008, SOIL BIOL BIOCHEM, V40, P475, DOI 10.1016/j.soilbio.2007.09.017; Lo CT, 1998, PHYTOPATHOLOGY, V88, P129, DOI 10.1094/PHYTO.1998.88.2.129; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Macia-Vicente JG, 2008, FEMS MICROBIOL ECOL, V64, P90, DOI 10.1111/j.1574-6941.2007.00443.x; Martino E, 2007, CURR GENET, V52, P65, DOI 10.1007/s00294-007-0139-9; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; Metcalf DA, 2001, PLANT PATHOL, V50, P249, DOI 10.1046/j.1365-3059.2001.00549.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Orazova M. Kh., 1999, Mikrobiologiya, V68, P127; Pang SS, 1999, BIOCHEMISTRY-US, V38, P5222, DOI 10.1021/bi983013m; Pasonen HL, 2009, PLANTA, V230, P973, DOI 10.1007/s00425-009-1005-4; Paungfoo-Lonhienne C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08678; Pereira JO, 1999, WORLD J MICROB BIOT, V15, P43, DOI 10.1023/A:1008859823806; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Photita W, 2001, MYCOL RES, V105, P1508, DOI 10.1017/S0953756201004968; Powell JR, 2007, APPL ENVIRON MICROB, V73, P4365, DOI 10.1128/AEM.00594-07; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Ricaud C., 2012, DIS SUGARCANE MAJOR; Romao-Dumaresq AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047888; Rossetto PB, 2011, BRAZ J MICROBIOL, V42, P878, DOI 10.1590/S1517-83822011000300006; Rudresh DL, 2005, APPL SOIL ECOL, V28, P139, DOI 10.1016/j.apsoil.2004.07.005; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seifert KA, 2004, EUR J PLANT PATHOL, V110, P449, DOI 10.1023/B:EJPP.0000032385.41877.7a; Sessitsch A, 2004, PLANT SOIL, V266, P105; Singh AK, 2014, J APPL MICROBIOL, V117, P750, DOI 10.1111/jam.12549; Singh AK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-122; Sorensen J., 1997, Modern soil microbiology., P21; SRIDHAR KR, 1995, CURR SCI INDIA, V69, P570; Stevens R.R., 1974, MYCOLOGY GUIDEBOOK; Stuart RM, 2010, ARCH MICROBIOL, V192, P307, DOI 10.1007/s00203-010-0557-9; Suryanarayanan TS, 2001, FUNGAL DIVERS, V8, P155; Sylvia DM, 2001, ADV AGRON, V73, P1, DOI 10.1016/S0065-2113(01)73003-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan FX, 2010, PLANT SOIL, V329, P349, DOI 10.1007/s11104-009-0163-2; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Taylor JE, 1999, NEW PHYTOL, V142, P335, DOI 10.1046/j.1469-8137.1999.00391.x; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Thrane C, 1997, EUR J PLANT PATHOL, V103, P331, DOI 10.1023/A:1008679319544; Tsavkelova EA, 2005, MIKOL FITOPATOL, V39, P46; TU JC, 1980, PHYTOPATHOLOGY, V70, P670, DOI 10.1094/Phyto-70-670; Turco R. F., 1994, V35, P73; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; VIRET O, 1993, CAN J BOT, V71, P1520, DOI 10.1139/b93-184; Vujanovic V, 2007, MICROB ECOL, V54, P672, DOI 10.1007/s00248-007-9226-1; Wagner BL, 2000, APPL ENVIRON MICROB, V66, P3468, DOI 10.1128/AEM.66.8.3468-3473.2000; Wang Y, 2005, FUNGAL DIVERS, V20, P235; WARDLE DA, 1993, OECOLOGIA, V94, P165, DOI 10.1007/BF00341313; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Whipps J. M., 2001, Fungi as biocontrol agents: progress, problems and potential, P9, DOI 10.1079/9780851993560.0009; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Widmer F, 2007, ADV BIOCHEM ENG BIOT, V107, P207, DOI 10.1007/10_2007_047; Wu H, 2015, METHODS MOL BIOL, V1224, P307, DOI 10.1007/978-1-4939-1658-0_24; Wu JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098394; Wyss GS, 2004, WEED RES, V44, P469, DOI 10.1111/j.1365-3180.2004.00425.x; Yedidia I, 2001, PLANT SOIL, V235, P235, DOI 10.1023/A:1011990013955; Yedidia I, 2000, PLANT PHYSIOL BIOCH, V38, P863, DOI 10.1016/S0981-9428(00)01198-0; Zijlstra JD, 2005, STUD MYCOL, P147; Zuccaro A, 2003, MYCOL RES, V107, P1451, DOI 10.1017/S0953756203008657	125	24	27	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158974	10.1371/journal.pone.0158974	http://dx.doi.org/10.1371/journal.pone.0158974			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415014	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500055
J	Tan, XH; Zhu, Y; Chen, CA; Chen, XY; Qin, YY; Qu, B; Luo, LX; Lin, HT; Wu, MX; Chen, WR; Liu, YZ				Tan, Xuhua; Zhu, Yi; Chen, Chuan; Chen, Xiaoyun; Qin, Yingyan; Qu, Bo; Luo, Lixia; Lin, Haotian; Wu, Mingxing; Chen, Weirong; Liu, Yizhi			Sprouty2 Suppresses Epithelial-Mesenchymal Transition of Human Lens Epithelial Cells through Blockade of Smad2 and ERK1/2 Pathways	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; GROWTH-FACTOR-BETA; ANTERIOR SUBCAPSULAR CATARACT; TGF-BETA; SIGNALING PATHWAYS; INTRAOCULAR-LENS; DOWN-REGULATION; AQUEOUS-HUMOR; PROLIFERATION; EXPRESSION	Transforming growth factor beta (TGF beta)-induced epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) plays a key role in the pathogenesis of anterior subcapsular cataract (ASC) and capsule opacification. In mouse lens, Sprouty2 (Spry2) has a negative regulatory role on TGF beta signaling. However, the regulation of Spry2 during ASC development and how Spry2 modulates TGF beta signaling pathway in human LECs have not been characterized. Here, we demonstrate that Spry2 expression level is decreased in anterior capsule LECs of ASC patients. Spry2 negatively regulates TGF beta 2-induced EMT and migration of LECs through inhibition of Smad2 and ERK1/2 phosphorylation. Also, blockade of Smad2 or ERK1/2 activation suppresses EMT caused by Spry2 downregulation. Collectively, our results for the first time show in human LECs that Spry2 has an inhibitory role in TGF beta signaling pathway. Our findings in human lens tissue and epithelial cells suggest that Spry2 may become a novel therapeutic target for the prevention and treatment of ASC and capsule opacification.	[Tan, Xuhua; Zhu, Yi; Chen, Chuan; Chen, Xiaoyun; Qin, Yingyan; Qu, Bo; Luo, Lixia; Lin, Haotian; Wu, Mingxing; Chen, Weirong; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022; Chen, Chuan/I-1348-2019; Zhu, Yi/R-2283-2017; Chen, Wei/GZK-7348-2022	Chen, Chuan/0000-0001-5701-0857; Zhu, Yi/0000-0002-1778-8880; Lin, Haotian/0000-0003-4672-9721	National Natural Science Foundation of China [81270981, 81320108008]; Science and Technology Program of Guangdong Province [2013B051000029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province	This study was supported by the International Cooperation and Communication Project of the National Natural Science Foundation of China (No. 81320108008), the National Natural Science Foundation of China (No. 81270981) and the Science and Technology Program of Guangdong Province (No. 2013B051000029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnaof K, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-55; Akhurst RJ, 2012, NAT GENET, V44, P838, DOI 10.1038/ng.2366; Allen JB, 1998, GRAEF ARCH CLIN EXP, V236, P305, DOI 10.1007/s004170050083; APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3; Banh A, 2006, INVEST OPHTH VIS SCI, V47, P3450, DOI 10.1167/iovs.05-1208; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bill R, 2015, FEBS LETT, V589, P1577, DOI 10.1016/j.febslet.2015.05.002; Boros J, 2006, SEMIN CELL DEV BIOL, V17, P741, DOI 10.1016/j.semcdb.2006.10.007; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chang KC, 2015, INVEST OPHTH VIS SCI, V56, P4198, DOI 10.1167/iovs.15-16557; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Chen XY, 2014, INT J MOL MED, V33, P1664, DOI 10.3892/ijmm.2014.1723; Dawes LJ, 2009, INVEST OPHTH VIS SCI, V50, P5318, DOI 10.1167/iovs.08-3223; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding W, 2007, J CELL PHYSIOL, V212, P796, DOI 10.1002/jcp.21078; Dong N, 2015, INVEST OPHTH VIS SCI, V56, P993, DOI 10.1167/iovs.14-15860; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gadir N, 2007, CELL CYCLE, V6, P2840, DOI 10.4161/cc.6.22.4921; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Hodge WG, 1998, OPHTHALMOLOGY, V105, P943, DOI 10.1016/S0161-6420(98)96040-7; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Ishida I, 2005, J CATARACT REFR SURG, V31, P1219, DOI 10.1016/j.jcrs.2004.11.039; IWATA JL, 1995, CURR EYE RES, V14, P937, DOI 10.3109/02713689508995133; JAMPEL HD, 1990, CURR EYE RES, V9, P963, DOI 10.3109/02713689009069932; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kunath T, 2014, PLACENTA, V35, P1079, DOI 10.1016/j.placenta.2014.09.008; Kuracha MR, 2011, INVEST OPHTH VIS SCI, V52, P6887, DOI 10.1167/iovs.11-7531; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Macky TA, 2001, INT OPHTHALMOL CLIN, V41, P17, DOI 10.1097/00004397-200107000-00004; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Min Seong Hee, 2006, Korean J Ophthalmol, V20, P162; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nahomi RB, 2016, BIOCHEM J, V473, P1455, DOI 10.1042/BCJ20160128; Nalluri SM, 2015, CYTOSKELETON, DOI [10.1002/cm21263, DOI 10.1002/CM21263]; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Petric I, 2004, CROAT MED J, V45, P287; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004; Shin EH, 2015, DEV BIOL, V406, P129, DOI 10.1016/j.ydbio.2015.09.005; Shin EHH, 2012, MOL MED, V18, P861, DOI 10.2119/molmed.2012.00111; Shirai K, 2006, MOL VIS, V12, P681; Sigurdsson V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060798; Sinha R, 2013, INDIAN J OPHTHALMOL, V61, P371, DOI 10.4103/0301-4738.115787; Sun CB, 2014, COLLOID SURFACE B, V113, P33, DOI 10.1016/j.colsurfb.2013.08.024; Werner L, 2001, OPHTHALMOLOGY, V108, P1675, DOI 10.1016/S0161-6420(01)00674-1; Wertheimer C, 2015, GRAEF ARCH CLIN EXP, V253, P409, DOI 10.1007/s00417-014-2875-0; Xiao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08362; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]; Yao J, 2012, MOL MED REP, V5, P1509, DOI 10.3892/mmr.2012.827; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang Q, 2016, ONCOGENE, V35, P3151, DOI 10.1038/onc.2015.365; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao GN, 2015, EXP EYE RES, V132, P9, DOI 10.1016/j.exer.2015.01.001; Zheng DY, 2012, MOL VIS, V18, P1238	62	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159275	10.1371/journal.pone.0159275	http://dx.doi.org/10.1371/journal.pone.0159275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415760	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500118
J	Deakin, A; Browne, WJ; Hodge, JJL; Paul, ES; Mendl, M				Deakin, Amanda; Browne, William J.; Hodge, James J. L.; Paul, Elizabeth S.; Mendl, Michael			A Screen-Peck Task for Investigating Cognitive Bias in Laying Hens	PLOS ONE			English	Article							ANXIETY-DEPRESSION MODEL; JUDGMENT BIAS; DOMESTIC CHICKS; ANIMAL EMOTION; COLOR-VISION; GROUP-SIZE; WELFARE; PREFERENCES; STARLINGS; BEHAVIOR	Affect-induced cognitive judgement biases occur in both humans and animals. Animals in a more negative affective state tend to interpret ambiguous cues more negatively than animals in a more positive state and vice versa. Investigating animals' responses to ambiguous cues can therefore be used as a proxy measure of affective state. We investigated laying hens' responses to ambiguous stimuli using a novel cognitive bias task. In the 'screen-peck' task, hens were trained to peck a high/low saturation orange circle presented on a computer screen (positive cue-P) to obtain a mealworm reward, and to not peck when the oppositely saturated orange circle was presented (negative cue-N) to avoid a one second air puff. Ambiguous cues were orange circles of intermediate saturation between the P and N cue (near-positive-NP; middle-M; near-negative-NN), and were unrewarded. Cue pecking showed a clear generalisation curve from P through NP, M, NN to N suggesting that hens were able to associate colour saturation with reward or punishment, and could discriminate between stimuli that were more or less similar to learnt cues. Across six test sessions, there was no evidence for extinction of pecking responses to ambiguous cues. We manipulated affective state by changing temperature during testing to either similar to 20 degrees C or similar to 29 degrees C in a repeated measures cross-over design. Hens have been shown to prefer temperatures in the higher range and hence we assumed that exposure to the higher temperature would induce a relatively positive affective state. Hens tested under warmer conditions were significantly more likely to peck the M probe than those tested at cooler temperatures suggesting that increased temperature in the ranges tested here may have some positive effect on hens, inducing a positive cognitive bias.	[Deakin, Amanda; Paul, Elizabeth S.; Mendl, Michael] Univ Bristol, Sch Vet Sci, Langford, England; [Browne, William J.] Univ Bristol, Ctr Multilevel Modelling, Bristol, Avon, England; [Hodge, James J. L.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Deakin, A (corresponding author), Univ Bristol, Sch Vet Sci, Langford, England.	amanda.deakin@bristol.ac.uk	Browne, William J/A-8686-2010; Mendl, Michael/D-7220-2016	Browne, William J/0000-0002-6659-6885; Deakin, Amanda/0000-0001-7934-6984; Mendl, Michael/0000-0002-5302-1871; Hodge, James/0000-0003-4741-2363	Biotechnology and Biological Sciences Research Council [1363964]; BBSRC; BBSRC [BB/J017221/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017221/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (Grant number 1363964 awarded to AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the BBSRC for funding this work, Dr. Jo Edgar for running preliminary studies and the Animal Services Unit at the University of Bristol for caring for the hens for the duration of the study.	Abeyesinghe SM, 2001, APPL ANIM BEHAV SCI, V73, P199, DOI 10.1016/S0168-1591(01)00142-3; Baciadonna L, 2015, ANIM WELFARE, V24, P81, DOI 10.7120/09627286.24.1.081; Bateson L., 2007, ANIM WELFARE, P16; Bethell EJ, 2015, J APPL ANIM WELF SCI, V18, pS18, DOI 10.1080/10888705.2015.1075833; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Brilot BO, 2010, ANIM COGN, V13, P721, DOI 10.1007/s10071-010-0323-z; DAWKINS MS, 1982, APPL ANIM ETHOL, V8, P365, DOI 10.1016/0304-3762(82)90069-4; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; FISCHER GJ, 1975, J COMP PHYSIOL PSYCH, V89, P802, DOI 10.1037/h0078149; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hales CA, 2014, BRIT J PHARMACOL, V171, P4524, DOI 10.1111/bph.12603; Ham AD, 2007, P ROY SOC B-BIOL SCI, V274, P1941, DOI 10.1098/rspb.2007.0538; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hernandez CE, 2015, APPL ANIM BEHAV SCI, V163, P135, DOI 10.1016/j.applanim.2014.12.002; HESS EH, 1956, PSYCHOL REP, V2, P477; HUGHES BO, 1977, BRIT POULTRY SCI, V18, P9, DOI 10.1080/00071667708416325; Hymel KA, 2012, NEUROPHARMACOLOGY, V62, P161, DOI 10.1016/j.neuropharm.2011.06.009; Kampen MV, 1979, J AGR SCI, V92, P219; Kleitman N, 1937, AM J PHYSIOL, V83, P134; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miklosi A, 2002, J COMP PHYSIOL A, V188, P135, DOI 10.1007/s00359-002-0284-z; Nicol CJ, 2009, ANIM BEHAV, V78, P413, DOI 10.1016/j.anbehav.2009.05.016; Osorio D, 1999, J EXP BIOL, V202, P2951; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Rolls E. T., 2005, EMOTION EXPLAINED; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Seehuus B, 2013, APPL ANIM BEHAV SCI, V148, P85, DOI 10.1016/j.applanim.2013.07.008; Wichman A, 2012, APPL ANIM BEHAV SCI, V140, P62, DOI 10.1016/j.applanim.2012.05.006; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	32	20	20	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158222	10.1371/journal.pone.0158222	http://dx.doi.org/10.1371/journal.pone.0158222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410229	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300020
J	Vaughan, MM; Huffaker, A; Schmelz, EA; Dafoe, NJ; Christensen, SA; McAuslane, HJ; Alborn, HT; Allen, LH; Teal, PEA				Vaughan, Martha M.; Huffaker, Alisa; Schmelz, Eric A.; Dafoe, Nicole J.; Christensen, Shawn A.; McAuslane, Heather J.; Alborn, Hans T.; Allen, Leon Hartwell; Teal, Peter E. A.			Interactive Effects of Elevated [CO2] and Drought on the Maize Phytochemical Defense Response against Mycotoxigenic Fusarium verticillioides	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CLIMATE-CHANGE; PLANT-PATHOGENS; ABSCISIC-ACID; JASMONIC ACID; HDMBOA-GLC; RESISTANCE; INDUCTION; CORN; PHOTOSYNTHESIS	Changes in climate due to rising atmospheric carbon dioxide concentration ([CO2]) are predicted to intensify episodes of drought, but our understanding of how these combined conditions will influence crop-pathogen interactions is limited. We recently demonstrated that elevated [CO2] alone enhances maize susceptibility to the mycotoxigenic pathogen, Fusarium verticillioides (Fv) but fumonisin levels remain unaffected. In this study we show that maize simultaneously exposed to elevated [CO2] and drought are even more susceptible to Fv proliferation and also prone to higher levels of fumonisin contamination. Despite the increase in fumonisin levels, the amount of fumonisin produced in relation to pathogen biomass remained lower than corresponding plants grown at ambient [CO2]. Therefore, the increase in fumonisin contamination was likely due to even greater pathogen biomass rather than an increase in host-derived stimulants. Drought did not negate the compromising effects of elevated [CO2] on the accumulation of maize phytohormones and metabolites. However, since elevated [CO2] does not influence the drought-induced accumulation of abscisic acid (ABA) or root terpenoid phytoalexins, the effects elevated [CO2] are negated belowground, but the stifled defense response aboveground may be a consequence of resource redirection to the roots.	[Vaughan, Martha M.] ARS, Mycotoxin Prevent & Appl Microbiol Res Unit, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA; [Huffaker, Alisa; Schmelz, Eric A.; Dafoe, Nicole J.; Christensen, Shawn A.; Alborn, Hans T.; Allen, Leon Hartwell; Teal, Peter E. A.] ARS, Chem Res Unit, Ctr Med Agr & Vet Entomol, USDA, 1600 SW 23rd Dr, Gainesville, FL 32608 USA; [McAuslane, Heather J.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32610 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Vaughan, MM (corresponding author), ARS, Mycotoxin Prevent & Appl Microbiol Res Unit, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA.	Martha.vaughan@ars.usda.gov		Schmelz, Eric/0000-0002-2837-734X	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research was funded by the United States Department of Agriculture, Agricultural Research Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Allen LH, 2011, J PLANT PHYSIOL, V168, P1909, DOI 10.1016/j.jplph.2011.05.005; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Bird CB, 2002, J AOAC INT, V85, P404; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Burow GB, 1997, MOL PLANT MICROBE IN, V10, P380, DOI 10.1094/MPMI.1997.10.3.380; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Casteel C, 2012, AGR NORDESTE BRASILE, V6, P1; Casteel C. L, 2010, THESIS; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Christensen SA, 2011, FUNGAL GENET BIOL, V48, P4, DOI 10.1016/j.fgb.2010.05.005; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Driscoll SP, 2006, J EXP BOT, V57, P381, DOI 10.1093/jxb/erj030; Edenhofer O., 2014, CONTRIBUTION WORKING; Elad Y, 2014, J CROP IMPROV, V28, P99, DOI 10.1080/15427528.2014.865412; Erb M, 2011, NEW PHYTOL, V189, P308, DOI 10.1111/j.1469-8137.2010.03450.x; Erb M, 2009, PLANT SIGNAL BEHAV, V4, P636, DOI 10.1111/j.1365-313X.2009.03868.x; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Gao XQ, 2007, MOL PLANT MICROBE IN, V20, P922, DOI 10.1094/MPMI-20-8-0922; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Ghannoum O, 2000, PLANT CELL ENVIRON, V23, P931, DOI 10.1046/j.1365-3040.2000.00609.x; Glenn AE, 2002, MOL PLANT MICROBE IN, V15, P91, DOI 10.1094/MPMI.2002.15.2.91; Glenn AE, 2001, APPL ENVIRON MICROB, V67, P2973, DOI 10.1128/AEM.67.7.2973-2981.2001; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Huang J, 2002, J ECON ENTOMOL, V95, P849, DOI 10.1603/0022-0493-95.4.849; Huffaker A, 2011, PLANT PHYSIOL, V156, P2082, DOI 10.1104/pp.111.179457; Huffaker A, 2011, PLANT PHYSIOL, V155, P1325, DOI 10.1104/pp.110.166710; Kallenbach M, 2010, PLANT PHYSIOL, V152, P96, DOI 10.1104/pp.109.149013; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Leakey Andrew D. B., 2006, Plant Biology (Rockville), V2006, P106; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Marin P, 2010, FEMS MICROBIOL ECOL, V73, P303, DOI 10.1111/j.1574-6941.2010.00894.x; Medina A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00348; Miller JD, 2001, ENVIRON HEALTH PERSP, V109, P321, DOI 10.2307/3435025; Murillo-Williams A, 2008, PLANT DIS, V92, P1695, DOI 10.1094/PDIS-92-12-1695; Nicolaisen M, 2009, J MICROBIOL METH, V76, P234, DOI 10.1016/j.mimet.2008.10.016; Oikawa A, 2004, PHYTOCHEMISTRY, V65, P2995, DOI 10.1016/j.phytochem.2004.09.006; Oikawa A, 2002, PHYTOCHEMISTRY, V61, P331, DOI 10.1016/S0031-9422(02)00225-X; Parsons MW, 2010, FOOD ADDIT CONTAM A, V27, P591, DOI 10.1080/19440040903456337; Pautasso M, 2012, EUR J PLANT PATHOL, V133, P295, DOI 10.1007/s10658-012-9936-1; RICHARDSON MD, 1993, J CHEM ECOL, V19, P1613, DOI 10.1007/BF00982296; Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077; Samapundo S, 2007, INT J FOOD MICROBIOL, V113, P339, DOI 10.1016/j.ijfoodmicro.2006.09.006; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; SHELBY RA, 1994, PLANT DIS, V78, P582, DOI 10.1094/PD-78-0582; Sun YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019751, 10.1371/journal.pone.0028156]; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vaughan MM, 2014, PLANT CELL ENVIRON, V37, P2691, DOI 10.1111/pce.12337; Vaughan MM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-5; Vaughan MM, 2015, PLANT CELL ENV; Yates IE, 2003, CAN J BOT, V81, P422, DOI [10.1139/B03-034, 10.1139/b03-034]; Zavala JA, 2013, ANNU REV ENTOMOL, V58, P79, DOI 10.1146/annurev-ento-120811-153544	60	31	31	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159270	10.1371/journal.pone.0159270	http://dx.doi.org/10.1371/journal.pone.0159270			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410032	gold, Green Published			2022-12-26	WOS:000379508300074
J	Jang, JW; Kim, MK; Lee, YS; Lee, JW; Kim, DM; Song, SH; Lee, JY; Choi, BY; Min, B; Chi, XZ; Bae, SC				Jang, J-W; Kim, M-K; Lee, Y-S; Lee, J-W; Kim, D-M; Song, S-H; Lee, J-Y; Choi, B-Y; Min, B.; Chi, X-Z; Bae, S-C			RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PATHWAY; HIPPO PATHWAY; TRANSCRIPTIONAL COACTIVATOR; TEAD/TEF FAMILY; DROSOPHILA EYE; PROTEIN-KINASE; GROWTH-CONTROL; TISSUE-GROWTH; SIZE-CONTROL; CANCER	The tumor-suppressor RUNX3 has a critical role in a lineage determination, cell cycle arrest and apoptosis. Lozenge (Lz), a Drosophila homolog of mammalian RUNX family members, has integral roles in these processes and specifically in eye cell fate determination. To elucidate the genetic modifiers of Lz/RUNX3, we performed a large-scale functional screen in a fly mutant library. The screen revealed genetic interactions between the Lz, Rac and Hippo pathways. Analysis of interactions among these genes revealed that the defective phenotype resulting from activation of Yki, an end point effector of the Hippo pathway, was suppressed by Lz and enhanced by Rac-Trio. Molecular biological analysis using mammalian homologs reveled that LATS1/2-mediated YAP phosphorylation-facilitated dissociation of the YAP-TEAD4 complex and association of the YAP-RUNX3 complex. When cells were stimulated to proliferate, activated RAC-TRIO signaling inhibited LATS1/2-mediated YAP phosphorylation; consequently, YAP dissociated from RUNX3 and associated with TEAD, thereby replacing the YAP-RUNX3 complex with YAP-TEAD. RUNX3 contributed to both association and dissociation of YAP-TEAD complex, most likely through the formation of the YAP-TEAD-RUNX3 ternary complex. Ectopic expression of RUNX3 in MKN28 gastric cancer cells reduced tumorigenicity, and the tumor-suppressive activity of RUNX3 was associated with its ability to interact with YAP. These results identify a novel regulatory mechanism, mediated by the Hippo and RAC-TRIO pathways, that changes the binding partner of YAP.	[Jang, J-W; Kim, M-K; Lee, Y-S; Lee, J-W; Kim, D-M; Song, S-H; Lee, J-Y; Choi, B-Y; Min, B.; Chi, X-Z; Bae, S-C] Chungbuk Natl Univ, Dept Biochem, Coll Med, Cheongju, South Korea	Chungbuk National University	Bae, SC (corresponding author), Chungbuk Natl Univ, Dept Biochem, Sch Med, Cheongju 28644, South Korea.; Bae, SC (corresponding author), Chungbuk Natl Univ, Inst Tumor Res, Cheongju 28644, South Korea.	scbae@chungbuk.ac.kr		Bae, Sang-Cheol/0000-0003-4658-1093	National Research Foundation (NRF) of Korea [2014R1A3A2030690]; Chungbuk National University; Basic Science Research Program through the NRF - Ministry of Education of Korea [2014R1A1A2009492]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Chungbuk National University; Basic Science Research Program through the NRF - Ministry of Education of Korea	S-CB is supported by a Creative Research Grant (2014R1A3A2030690) through the National Research Foundation (NRF) of Korea and a Research Grant of Chungbuk National University in 2012. J-WJ is supported by Basic Science Research Program (2014R1A1A2009492) through the NRF funded by the Ministry of Education of Korea.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Flores GV, 1998, DEVELOPMENT, V125, P3681; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee YS, 2016, ONCOGENE, V35, P827, DOI 10.1038/onc.2015.153; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Levy D, 2008, J BIOL CHEM, V283, P27462, DOI 10.1074/jbc.M803941200; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Qiao Y, 2016, ONCOGENE, V35, P2664, DOI 10.1038/onc.2015.338; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang ZY, 2014, P NATL ACAD SCI USA, V111, pE89, DOI 10.1073/pnas.1319190110; Wildonger J, 2005, DEVELOPMENT, V132, P2263, DOI 10.1242/dev.01824; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	38	24	25	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 16	2017	36	7					999	1011		10.1038/onc.2016.266	http://dx.doi.org/10.1038/onc.2016.266			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8JG	27425596				2022-12-26	WOS:000394169100012
J	Yigit, S; Yu, HT; An, B; Hamaia, S; Farndale, RW; Kaplan, DL; Lin, YS; Brodsky, B				Yigit, Sezin; Yu, Hongtao; An, Bo; Hamaia, Samir; Farndale, Richard W.; Kaplan, David L.; Lin, Yu-Shan; Brodsky, Barbara			Mapping the Effect of Gly Mutations in Collagen on alpha 2 beta 1 Integrin Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENESIS IMPERFECTA; TRIPLE-HELIX; PRO-ALPHA-1(I) CHAIN; MOLECULAR-STRUCTURE; I COLLAGEN; SUBSTITUTION; RECOGNITION; DOMAINS; SITES; MODEL	The replacement of one Gly in the essential repeating tripeptide sequence of the type I collagen triple helix results in the dominant hereditary bone disorder osteogenesis imperfecta. The mechanism leading to pathology likely involves misfolding and autophagy, although it has been hypothesized that some mutations interfere with known collagen interactions. Here, the effect of Gly replacements within and nearby the integrin binding GFPGER sequence was investigated using a recombinant bacterial collagen system. When a six-triplet human type I collagen sequence containing GFPGER was introduced into a bacterial collagen-like protein, this chimeric protein bound to integrin. Constructs with Gly to Ser substitutions within and nearby the inserted human sequence still formed a trypsin-resistant triple helix, suggesting a small local conformational perturbation. Gly to Ser mutations within the two Gly residues in the essential GFPGER sequence prevented integrin binding and cell attachment as predicted from molecular dynamics studies of the complex. Replacement of Gly residues C-terminal to GFPGER did not affect integrin binding. In contrast, Gly replacements N-terminal to the GFPGER sequence, up to four triplets away, decreased integrin binding and cell adhesion. This pattern suggests either an involvement of the triplets N-terminal to GFPGER in initial binding or a propagation of the perturbation of the triple helix C-terminal to a mutation site. The asymmetry in biological consequences relative to the mutation site may relate to the observed pattern of osteogenesis imperfecta mutations near the integrin binding site.	[Yigit, Sezin; Yu, Hongtao; An, Bo; Kaplan, David L.; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Yigit, Sezin; Yu, Hongtao; Lin, Yu-Shan] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Hamaia, Samir; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England	Tufts University; Tufts University; University of Cambridge	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Lin, YS (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	Yu-Shan.Lin@tufts.edu; Barbara.Brodsky@tufts.edu	Lin, Yu-Shan/E-2198-2013; Yu, Hongtao/D-2277-2014	Lin, Yu-Shan/0000-0001-6460-2877; Yu, Hongtao/0000-0003-4818-872X	National Institutes of Health [EB011620, GM60048]; British Heart Foundation [RG/15/4/31268, PG/10/011/28199]; Tufts start-up fund; Knez Family Faculty Investment Fund; MRC [G0500707] Funding Source: UKRI; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Tufts start-up fund; Knez Family Faculty Investment Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants EB011620 (to B.B. and D.L.K.) and GM60048 (to B.B.), by British Heart Foundation Grants RG/15/4/31268 and PG/10/011/28199 (to R. W. F. and S. H.), and by a Tufts start-up fund and the Knez Family Faculty Investment Fund (to Y.-S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen M. P., 1989, COMPUTER SIMULATION, P64; An B, 2016, J BIOL CHEM, V291, P4343, DOI 10.1074/jbc.M115.674507; An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Carafoli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069833; Chan SWP, 2010, BIOMACROMOLECULES, V11, P1460, DOI 10.1021/bm100052y; Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Hamaia S, 2014, ADV EXP MED BIOL, V819, P127, DOI 10.1007/978-94-017-9153-3_9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li YJ, 2009, J BIOL CHEM, V284, P20660, DOI 10.1074/jbc.M109.018077; LIGHTFOOT SJ, 1994, J BIOL CHEM, V269, P30352; LIGHTFOOT SJ, 1992, J BIOL CHEM, V267, P25521; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mirigian LS, 2016, J BONE MINER RES, V31, P1608, DOI 10.1002/jbmr.2824; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Que RA, 2015, BIOMATERIALS, V53, P309, DOI 10.1016/j.biomaterials.2015.02.074; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; STOSS H, 1993, AM J MED GENET, V45, P257, DOI 10.1002/ajmg.1320450220; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; TANGEMANN K, 1995, FEBS LETT, V358, P179, DOI 10.1016/0014-5793(94)01411-S; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	52	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19196	19207		10.1074/jbc.M116.726182	http://dx.doi.org/10.1074/jbc.M116.726182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432884	hybrid, Green Published			2022-12-26	WOS:000383242300050
J	Li, K; Xiao, YZ; Yu, JJ; Xia, TT; Liu, B; Guo, YJ; Deng, JL; Chen, SH; Wang, CX; Guo, FF				Li, Kai; Xiao, Yuzhong; Yu, Junjie; Xia, Tingting; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan			Liver-specific Gene Inactivation of the Transcription Factor ATF4 Alleviates Alcoholic Liver Steatosis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); fatty acid synthase (FAS); lipid; liver injury; liver metabolism; ATF4; Alcoholic liver steatosis; CPT1; TRB3	ACTIVATED PROTEIN-KINASE; HEPATIC INSULIN-RESISTANCE; FATTY LIVER; DEFICIENCY PROTECTS; SIGNALING PATHWAY; OXIDATIVE STRESS; TRIBBLES HOMOLOG; ETHANOL; TRB3; BINDING	Although numerous biological functions of the activating transcription factor 4 (ATF4) have been identified, a direct effect of ATF4 on alcoholic liver steatosis has not been described previously. The aim of our current study is to investigate the role of ATF4 in alcoholic liver steatosis and elucidate the underlying mechanisms. Here, we showed that the expression of ATF4 is induced by ethanol in hepatocytes in vitro and in vivo, and liver-specific ATF4 knock-out mice are resistant to ethanol-induced liver steatosis, associated with stimulated hepatic AMP-activated protein kinase (AMPK) activity. Furthermore, adenovirus-mediated AMPK knockdown significantly reversed the suppressive effects of ATF4 deficiency on ethanol-induced liver steatosis in mice. In addition, ethanol-fed ATF4 knock-out mice exhibit AMPK-dependent inhibition of fatty acid synthase and stimulation of carnitine palmitoyltransferase 1 (CPT1) in the liver. Moreover, hepatic Tribbles homolog 3 (TRB3) expression was stimulated by ethanol in an ATF4-dependent manner, and adenovirus-mediated TRB3 knockdown blocked ATF4-dependent ethanol-induced AMPK inhibition and triglyceride accumulation in AML-12 cells. Finally, TRB3 directly interacted with AMPK to suppress its phosphorylation. Taken together, these results identify the ATF4-TRB3-AMPK axis as a novel pathway responsible for ethanol-induced liver steatosis.	[Li, Kai; Xiao, Yuzhong; Yu, Junjie; Xia, Tingting; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutr & Metab,Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, CX; Guo, FF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutr & Metab,Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	wangcx@sibs.ac.cn; ffguo@sibs.ac.cn		Li, Kai/0000-0002-4040-8604	National Natural Science Foundation [81130076, 81325005, 31271269, 81100615, 81390350, 81300659, 81471076]; Basic Research Project of Shanghai Science and Technology Commission [13JC1409000]; International S&T Cooperation Program of China (Singapore) [2014DFG32470]; CAS/SAFEA international partnership program for creative research teams; One Hundred Talents Program of the Chinese Academy of Sciences	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; International S&T Cooperation Program of China (Singapore); CAS/SAFEA international partnership program for creative research teams(Chinese Academy of Sciences); One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation Grants 81130076, 81325005, 31271269, 81100615, 81390350, 81300659, and 81471076; Basic Research Project of Shanghai Science and Technology Commission Grant 13JC1409000; International S&T Cooperation Program of China (Singapore Grant 2014DFG32470); and the CAS/SAFEA international partnership program for creative research teams. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the One Hundred Talents Program of the Chinese Academy of Sciences. To whom correspondence may be addressed. Tel.: 86-21-54920945; Fax: 86-21-54920291; E-mail: ffguo@sibs.ac.cn.	Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bi LJ, 2015, ALCOHOL ALCOHOLISM, V50, P146, DOI 10.1093/alcalc/agu102; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Carraro V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015716; Chen G, 2008, J NEUROSCI RES, V86, P937, DOI 10.1002/jnr.21540; Chen YP, 2013, CELL PHYSIOL BIOCHEM, V32, P743, DOI 10.1159/000354476; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708; Ji C, 2014, INT J HEPATOL, V2014, DOI 10.1155/2014/513787; Jiang ZA, 2015, ALCOHOL CLIN EXP RES, V39, P424, DOI 10.1111/acer.12641; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Li K, 2015, J BIOL CHEM, V290, P8185, DOI 10.1074/jbc.M114.633990; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V370, P44, DOI 10.1016/j.bbrc.2008.03.005; Magne L, 2011, J HEPATOL, V54, P729, DOI 10.1016/j.jhep.2010.07.023; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Rasineni K, 2012, INDIAN J PHARMACOL, V44, P299, DOI 10.4103/0253-7613.96297; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Sun Q, 2015, AM J PHYSIOL-GASTR L, V308, pG757, DOI 10.1152/ajpgi.00442.2014; Tomita K, 2005, ALCOHOL CLIN EXP RES, V29, p240S, DOI 10.1097/01.alc.0000191126.11479.69; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wang CX, 2014, J CELL MOL MED, V18, P80, DOI 10.1111/jcmm.12166; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao GZ, 2013, J BIOL CHEM, V288, P25350, DOI 10.1074/jbc.M113.470526; Xiao YZ, 2016, DIABETES, V65, P393, DOI 10.2337/db15-1024; Xu F, 2014, BIOCHEM J, V458, P159, DOI 10.1042/BJ20130986; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yao XH, 2008, AM J PHYSIOL-REG I, V294, pR1797, DOI 10.1152/ajpregu.00804.2007; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Yu JJ, 2015, DIABETES, V64, P1591, DOI 10.2337/db14-1368; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050; Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097	52	27	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18536	18546		10.1074/jbc.M116.726836	http://dx.doi.org/10.1074/jbc.M116.726836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405764	hybrid, Green Published			2022-12-26	WOS:000383241800043
J	Okuyama, Y; Umeda, K; Negishi, M; Katoh, H				Okuyama, Yusuke; Umeda, Kentaro; Negishi, Manabu; Katoh, Hironori			Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SERINE 897 PHOSPHORYLATION; SMALL GTPASE RHOG; APOPTOTIC CELLS; RAC1 ACTIVATION; EPHA2; ANOIKIS; COMPLEX; CANCER; MORPHOGENESIS	SGEF and Ephexin4 are members of the Ephexin subfamily of RhoGEFs that specifically activate the small GTPase RhoG. It is reported that Ephexin1 and Ephexin5, two well-characterized Ephexin subfamily RhoGEFs, are tyrosine-phosphorylated by Src, and that their phosphorylation affect their activities and functions. In this study, we show that SGEF, but not Ephexin4, is tyrosine-phosphorylated by Src. Tyrosine phosphorylation of SGEF suppresses its interaction with RhoG, the elevation of RhoG activity, and SGEF-mediated promotion of cell migration. We identified tyrosine 530 (Y530), which is located within the Dbl homology domain, as a major phosphorylation site of SGEF by Src, and Y530F mutation blocked the inhibitory effect of Src on SGEF. Taken together, these results suggest that the activity of SGEF is negatively regulated by tyrosine phosphorylation of the DH domain.	[Okuyama, Yusuke; Umeda, Kentaro; Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan; [Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.; Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan [15K07928, 15K07043]; Takeda Science Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (15K07928 and 15K07043) and by a grant from Takeda Science Foundation.	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Akada M, 2014, CELL SIGNAL, V26, P2879, DOI 10.1016/j.cellsig.2014.08.031; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Ensign SPF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.468686; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Gupta M, 2014, J BIOL CHEM, V289, P17195, DOI 10.1074/jbc.M114.573782; Harada K, 2015, J CELL SCI, V128, P1912, DOI 10.1242/jcs.163790; Harada K, 2011, EXP CELL RES, V317, P1701, DOI 10.1016/j.yexcr.2011.05.014; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kawai H, 2013, FEBS OPEN BIO, V3, P78, DOI 10.1016/j.fob.2013.01.002; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kuroiwa M, 2011, J CELL SCI, V124, P1726, DOI 10.1242/jcs.080291; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Lee J, 2014, BBA-MOL CELL RES, V1843, P2438, DOI 10.1016/j.bbamcr.2014.07.006; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Samson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055202; Sato K, 2014, J BIOL CHEM, V289, P10045, DOI 10.1074/jbc.M113.521880; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Wang HT, 2013, CARCINOGENESIS, V34, P1976, DOI 10.1093/carcin/bgt157; Wang HT, 2012, ONCOL REP, V28, P1468, DOI 10.3892/or.2012.1917; Wang YH, 2004, BIOCHEM BIOPH RES CO, V324, P1053, DOI 10.1016/j.bbrc.2004.09.153; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200	47	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159617	10.1371/journal.pone.0159617	http://dx.doi.org/10.1371/journal.pone.0159617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437949	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100056
J	De Santi, C; Willassen, NP; Williamson, A				De Santi, Concetta; Willassen, Nils Peder; Williamson, Adele			Biochemical Characterization of a Family 15 Carbohydrate Esterase from a Bacterial Marine Arctic Metagenome	PLOS ONE			English	Article							SALT-TOLERANT ESTERASE; GLUCURONOYL ESTERASE; COLD; MODEL; VERRUCOMICROBIA; ENVIRONMENT; DIVERSITY	Background The glucuronoyl esterase enzymes of wood-degrading fungi (Carbohydrate Esterase family 15; CE15) form part of the hemicellulolytic and cellulolytic enzyme systems that break down plant biomass, and have possible applications in biotechnology. Homologous enzymes are predicted in the genomes of several bacteria, however these have been much less studied than their fungal counterparts. Here we describe the recombinant production and biochemical characterization of a bacterial CE15 enzyme denoted MZ0003, which was identified by in silico screening of a prokaryotic metagenome library derived from marine Arctic sediment. MZ0003 has high similarity to several uncharacterized gene products of polysaccharide-degrading bacterial species, and phylogenetic analysis indicates a deep evolutionary split between these CE15s and fungal homologs. Results MZ0003 appears to differ from previously-studied CE15s in some aspects. Some glucuronoyl esterase activity could be measured by qualitative thin-layer chromatography which confirms its assignment as a CE15, however MZ0003 can also hydrolyze a range of other esters, including p-nitrophenyl acetate, which is not acted upon by some fungal homologs. The structure of MZ0003 also appears to differ as it is predicted to have several large loop regions that are absent in previously studied CE15s, and a combination of homology-based modelling and site-directed mutagenesis indicate its catalytic residues deviate from the conserved Ser-His-Glu triad of many fungal CE15s. Taken together, these results indicate that potentially unexplored diversity exists among bacterial CE15s, and this may be accessed by investigation of the microbial metagenome. The combination of low activity on typical glucuronoyl esterase substrates, and the lack of glucuronic acid esters in the marine environment suggest that the physiological substrate of MZ0003 and its homologs is likely to be different from that of related fungal enzymes.	[De Santi, Concetta; Willassen, Nils Peder; Williamson, Adele] UiT Arctic Univ Norway, Norwegian Struct Biol Ctr, Dept Chem, Tromso, Norway	UiT The Arctic University of Tromso	Williamson, A (corresponding author), UiT Arctic Univ Norway, Norwegian Struct Biol Ctr, Dept Chem, Tromso, Norway.	adele.k.williamson@uit.no	Willassen, Nils Peder/AAE-1843-2019	Willassen, Nils Peder/0000-0002-4397-8020; Williamson, Adele/0000-0001-8139-1071	Research Council of Norway [192123]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, Grant no 192123 (http://www.forskningsradet.no/en/Home_page/1177315753906). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERESS A, 1993, J NAT PROD, V56, P478, DOI 10.1021/np50094a005; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biely P, 2015, FEBS LETT, V589, P2334, DOI 10.1016/j.febslet.2015.07.019; Bjerga GEK, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0185-1; Cardman Z, 2014, APPL ENVIRON MICROB, V80, P3749, DOI 10.1128/AEM.00899-14; Charavgi MD, 2013, ACTA CRYSTALLOGR D, V69, P63, DOI 10.1107/S0907444912042400; Chouari R, 2003, APPL ENVIRON MICROB, V69, P7354, DOI 10.1128/AEM.69.12.7354-7363.2003; d'Errico C, 2015, BIOTECHNOL BIOENG, V112, P914, DOI 10.1002/bit.25508; De Santi C, 2016, EXTREMOPHILES, V20, P323, DOI 10.1007/s00792-016-0824-z; De Santi C, 2016, BMC BIOCHEM, V17, DOI 10.1186/s12858-016-0057-x; Duranova M, 2009, ARCH MICROBIOL, V191, P133, DOI 10.1007/s00203-008-0434-y; Duranova M, 2009, BIOSCI BIOTECH BIOCH, V73, P2483, DOI 10.1271/bbb.90486; Esteban-Torres M, 2014, J AGR FOOD CHEM, V62, P5126, DOI 10.1021/jf501493z; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Guo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086752; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katsimpouras C, 2014, APPL MICROBIOL BIOT, V98, P5507, DOI 10.1007/s00253-014-5542-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XL, 2007, FEBS LETT, V581, P4029, DOI 10.1016/j.febslet.2007.07.041; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; Ohta Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15105; Peng Q, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-95; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pokkuluri PR, 2011, PROTEINS, V79, P2588, DOI 10.1002/prot.23088; Redouan E, 2009, CARBOHYD RES, V344, P1670, DOI 10.1016/j.carres.2009.05.031; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Till M, 2013, PROTEINS; Topakas E, 2010, APPL MICROBIOL BIOT, V87, P1765, DOI 10.1007/s00253-010-2655-7; Vafiadi C, 2009, FEMS MICROBIOL LETT, V296, P178, DOI 10.1111/j.1574-6968.2009.01631.x; Vester JK, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-72; Wijesekara I, 2011, CARBOHYD POLYM, V84, P14, DOI 10.1016/j.carbpol.2010.10.062; Woebken D, 2007, ISME J, V1, P419, DOI 10.1038/ismej.2007.63; Wong Dominic W S, 2012, Biotechnol Res Int, V2012, P951267, DOI 10.1155/2012/951267; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085	44	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159345	10.1371/journal.pone.0159345	http://dx.doi.org/10.1371/journal.pone.0159345			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433797	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600049
J	Latvala, S; Hedberg, J; Di Bucchianico, S; Moller, L; Wallinder, IO; Elihn, K; Karlsson, HL				Latvala, Siiri; Hedberg, Jonas; Di Bucchianico, Sebastiano; Moller, Lennart; Wallinder, Inger Odnevall; Elihn, Karine; Karlsson, Hanna L.			Nickel Release, ROS Generation and Toxicity of Ni and NiO Micro- and Nanoparticles	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; LUNG EPITHELIAL-CELLS; OXIDATIVE DAMAGE; IN-VITRO; SURFACE CHARACTERISTICS; TRANSITION-METALS; REACTIVE OXYGEN; DNA-REPAIR; CANCER; ACTIVATION	Occupational exposure to airborne nickel is associated with an elevated risk for respiratory tract diseases including lung cancer. Therefore, the increased production of Ni-containing nanoparticles necessitates a thorough assessment of their physical, chemical, as well as toxicological properties. The aim of this study was to investigate and compare the characteristics of nickel metal (Ni) and nickel oxide (NiO) particles with a focus on Ni release, reactive oxygen species (ROS) generation, cellular uptake, cytotoxicity and genotoxicity. Four Ni-containing particles of both nano-size (Ni-n and NiO-n) and micron-size (Ni-m1 and Ni-m2) were tested. The released amount of Ni in solution was notably higher in artificial lysosomal fluid (e.g. 80-100 wt% for metallic Ni) than in cell medium after 24h (ca. 1-3 wt% for all particles). Each of the particles was taken up by the cells within 4 h and they remained in the cells to a high extent after 24 h post-incubation. Thus, the high dissolution in ALF appeared not to reflect the particle dissolution in the cells. Ni-m1 showed the most pronounced effect on cell viability after 48 h (alamar blue assay) whereas all particles showed increased cytotoxicity in the highest doses (20-40 mu g cm(2)) when assessed by colony forming efficiency (CFE). Interestingly an increased CFE, suggesting higher proliferation, was observed for all particles in low doses (0.1 or 1 mu g cm(-2)). Ni-m1 and NiO-n were the most potent in causing acellular ROS and DNA damage. However, no intracellular ROS was detected for any of the particles. Taken together, micron-sized Ni (Ni-m1) was more reactive and toxic compared to the nano-sized Ni. Furthermore, this study underlines that the low dose effect in terms of increased proliferation observed for all particles should be further investigated in future studies.	[Latvala, Siiri; Elihn, Karine] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Hedberg, Jonas; Wallinder, Inger Odnevall] KTH Royal Inst Technol, Div Surface & Corros Sci, Sch Chem Sci & Engn, Stockholm, Sweden; [Di Bucchianico, Sebastiano; Karlsson, Hanna L.] Karolinska Inst, Inst Environm Med, Biochem Toxicol Unit, Stockholm, Sweden; [Moller, Lennart] Karolinska Inst, Dept Biosci & Nutr, Analyt Toxicol, Huddinge, Sweden	Stockholm University; Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet	Latvala, S (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	siiri.latvala@aces.su.se	Di Bucchianico, Sebastiano/AAX-7000-2020; Di+Bucchianico, Sebastiano/AHI-8150-2022; Hedberg, Jonas/H-4226-2019; Wallinder, Inger Odnevall/Q-6875-2017	Di+Bucchianico, Sebastiano/0000-0002-6396-892X; Odnevall, Inger/0000-0003-2206-0082	Swedish Research Council FORMAS [2010-968]; Swedish Research Council for Health, Working Life and Welfare FORTE [2011-0832]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council for Health, Working Life and Welfare FORTE	This study was funded by the Swedish Research Council FORMAS (project: 2010-968, http://www.formas.se/en/) and the Swedish Research Council for Health, Working Life and Welfare FORTE (project: 2011-0832, http://forte.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, TOXICOL IN VITRO, V25, P930, DOI 10.1016/j.tiv.2011.02.015; Andersen A, 1996, OCCUP ENVIRON MED, V53, P708, DOI 10.1136/oem.53.10.708; Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Barchowsky A, 2003, FREE RADICAL BIO MED, V34, P1130, DOI 10.1016/S0891-5849(03)00059-5; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Burello E, 2011, NANOTOXICOLOGY, V5, P228, DOI 10.3109/17435390.2010.502980; Capasso L, 2014, TOXICOL LETT, V226, P28, DOI 10.1016/j.toxlet.2014.01.040; Cavallo D, 2003, TOXICOL IN VITRO, V17, P603, DOI 10.1016/S0887-2333(03)00138-3; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chiou YH, 2014, ENVIRON MOL MUTAGEN, V55, P624, DOI 10.1002/em.21867; Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810; Cronholm P, 2013, SMALL, V9, P970, DOI 10.1002/smll.201201069; Di Pietro A, 2009, INT J HYG ENVIR HEAL, V212, P196, DOI 10.1016/j.ijheh.2008.05.005; Doak SH, 2009, MUTAGENESIS, V24, P285, DOI 10.1093/mutage/gep010; Goodman JE, 2011, CRIT REV TOXICOL, V41, P142, DOI 10.3109/10408444.2010.531460; Grimsrud TK, 2002, AM J EPIDEMIOL, V156, P1123, DOI 10.1093/aje/kwf165; Hedberg Y, 2013, ENVIRON SCI-PROC IMP, V15, P381, DOI 10.1039/c2em30818e; Hedberg Y, 2011, BIOMETALS, V24, P1099, DOI 10.1007/s10534-011-9469-7; Hedberg YS, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4934628; Horie M, 2011, J OCCUP HEALTH, V53, P64, DOI 10.1539/joh.L10121; Horie M, 2009, CHEM RES TOXICOL, V22, P1415, DOI 10.1021/tx900171n; IARC, 1990, IARC MON EV CARC RIS; Kain J, 2012, MUTAGENESIS, V27, P491, DOI 10.1093/mutage/ges010; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Karlsson HL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0041-9; Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014; KASPRZAK KS, 1991, CHEM RES TOXICOL, V4, P604, DOI 10.1021/tx00024a002; Liden C, 2008, CONTACT DERMATITIS, V59, P31, DOI 10.1111/j.1600-0536.2008.01363.x; Mazinanian N, 2013, REGUL TOXICOL PHARM, V65, P135, DOI 10.1016/j.yrtph.2012.10.014; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Mohammadi-Bardbori A, 2014, CHEM-BIOL INTERACT, V224, P183, DOI 10.1016/j.cbi.2014.10.034; Munoz A, 2012, TOXICOL APPL PHARM, V260, P1, DOI 10.1016/j.taap.2011.12.014; National Toxicology Program, 1996, Natl Toxicol Program Tech Rep Ser, V451, P1; Pietruska JR, 2011, TOXICOL SCI, V124, P138, DOI 10.1093/toxsci/kfr206; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Salnikow K, 2000, CANCER RES, V60, P3375; Sun H, 2013, GENES-BASEL, V4, P583, DOI 10.3390/genes4040583; Tsao TM, 2011, J ENVIRON MONITOR, V13, P1156, DOI 10.1039/c1em10013k; Valavanidis A, 2005, FREE RADICAL RES, V39, P1071, DOI 10.1080/10715760500188671; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vogelgesang J, 1998, ACCREDIT QUAL ASSUR, V3, P242, DOI 10.1007/s007690050234; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083; Zhao JY, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2424-0	45	97	99	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159684	10.1371/journal.pone.0159684	http://dx.doi.org/10.1371/journal.pone.0159684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434640	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600081
J	Lam, Y; Westergaard, R; Kirk, G; Ahmadi, A; Genz, A; Keruly, J; Hutton, H; Surkan, PJ				Lam, Yukyan; Westergaard, Ryan; Kirk, Gregory; Ahmadi, Azal; Genz, Andrew; Keruly, Jeanne; Hutton, Heidi; Surkan, Pamela J.			Provider-Level and Other Health Systems Factors Influencing Engagement in HIV Care: A Qualitative Study of a Vulnerable Population	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ADHERENCE; RETENTION; PREDICTORS	Despite the existence of highly active antiretroviral therapy, HIV/AIDS morbidity and mortality continue to be public health burdens in the United States due to difficulties in engaging people living with HIV/AIDS (PLWHA) in continuous, effective care. In comparison to studies investigating patient-level characteristics associated with starting and remaining in care, there is relatively little research on how structural factors, such as those pertaining to healthcare providers and the infrastructure for delivery of health services, influence patients' engagement in HIV care. Our study, based in the city of Baltimore, Maryland, uses qualitative research methods with a population of predominantly African American PLWHA who have a history of drug abuse, to examine facilitators and barriers regarding adherence to antiretroviral therapy (ART) and HIV care appointment attendance. Data collection involved conducting one-on-one, in-depth interviews with 31 study participants, and data analysis entailed thematic coding of interview transcripts and writing analytic memos to develop ideas and concepts. Among other findings, factors described as influential by our study participants related to appointment reminders and scheduling, the attitudes and communication styles of HIV clinicians, and the disposition and availability of other healthcare workers on the care "team." Thus, improving quality of HIV care and means of delivering it may help mitigate the numerous points in the continuum of HIV care when a patient may disengage.	[Lam, Yukyan; Kirk, Gregory; Ahmadi, Azal; Genz, Andrew; Surkan, Pamela J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Westergaard, Ryan] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Kirk, Gregory; Keruly, Jeanne; Hutton, Heidi] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins Medicine	Lam, Y (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	yukyan@jhu.edu			National Institutes of Health/National Institute on Drug Abuse [R34DA033181, U01DA036297, K23DA032306]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI118591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA032306, R34DA033181, R01DA012568, U01DA036297] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institutes of Health/National Institute on Drug Abuse grants R34DA033181, U01DA036297 and K23DA032306. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; [Anonymous], 2013, DET TABL NAT VIT STA; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brennan A, 2014, AIDS CARE, V26, P804, DOI 10.1080/09540121.2013.869536; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Eberhart MG, 2015, JAIDS-J ACQ IMM DEF, V69, pS37, DOI 10.1097/QAI.0000000000000587; Eldred L, 2007, AIDS PATIENT CARE ST, V21, pS1, DOI 10.1089/apc.2007.9993; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; Giordano TP, 2005, AIDS CARE, V17, P773, DOI 10.1080/09540120412331336652; Hill C Jeanne, 2005, Health Mark Q, V23, P69; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Park WB, 2008, INT J STD AIDS, V19, P125, DOI 10.1258/ijsa.2007.007101; Perron NJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-79; Philbin MM, 2014, AIDS CARE, V26; Rumptz MH, 2007, AIDS PATIENT CARE ST, V21, pS30, DOI 10.1089/apc.2007.9989; Smith LR, 2012, AIDS PATIENT CARE ST, V26, P344, DOI 10.1089/apc.2011.0388; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0	27	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158759	10.1371/journal.pone.0158759	http://dx.doi.org/10.1371/journal.pone.0158759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27428012	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169300020
J	Alvarez, GG; Van Dyk, DD; Colquhoun, H; Moreau, KA; Mulpuru, S; Graham, ID				Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Colquhoun, Heather; Moreau, Katherine A.; Mulpuru, Sunita; Graham, Ian D.			Developing and Field Testing a Community Based Youth Initiative to Increase Tuberculosis Awareness in Remote Arctic Inuit Communities	PLOS ONE			English	Article							DISSEMINATION STRATEGIES; KNOWLEDGE TRANSLATION	Background Inuit in Canada have the highest reported tuberculosis (TB) incidence rate in Canada, even higher than other Canadian Indigenous groups. The aim of this study was to increase TB awareness among Inuit youth and their communities by equipping those who can best reach this population with a community based, youth focused, education initiative built on interventions adapted from a previous TB awareness study. Methods The Taima TB Youth Education Initiative was a field test case study of a knowledge translation (KT) strategy aimed at community members who provide health education in these communities. In the first stage of this study, interventions from a larger TB awareness campaign were adapted to focus on youth living in remote Inuit communities. During the second stage of the study, investigators field tested the initiative in two isolated Inuit communities. It was then applied by local implementation teams in two other communities. Evaluation criteria included feasibility, acceptability, knowledge uptake and health behavior change. Results Implementation of the adapted KT interventions resulted in participation of a total of 41 youth (19 females, 22 males) with an average age of 16 years (range 12-21 years) in four different communities in Nunavut. Community celebration events were attended by 271 community members where TB messaging were presented and discussed. All of the health care workers and community members surveyed reported that the adapted interventions were acceptable and a useful way of learning to some extent. Knowledge uptake measures indicated an average TB knowledge score of 64 out of 100. Local partners in all four communities indicated that they would use the Taima TB Youth Education Initiative again to raise awareness about TB among youth in their communities. Conclusions The TB awareness interventions adapted for the Taima TB Youth Education Initiative were acceptable to the Inuit communities involved in the study. They resulted in uptake of knowledge among participants. Implementation by local implementation teams was feasible as evidenced by the participation and attendance of youth and community members in all communities. The ability to implement the interventions by local implementation teams indicates there is potential to scale up in other remote communities in the arctic setting.	[Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Mulpuru, Sunita; Graham, Ian D.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Moreau, Katherine A.] Univ Ottawa, Fac Educ, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Ottawa	Alvarez, GG (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	galvarez@ohri.ca	Graham, Ian D./ABD-5259-2021	Graham, Ian D./0000-0002-3669-1216; Alvarez, Gonzalo G/0000-0003-1562-5305	Canadian Institutes of Health Research [147574]; Canadian Institutes of Health Research Foundation Grant Scheme, RFN [143237]; Canadian Institutes of Health Research Foundation Grant [RFN] [143237]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Foundation Grant Scheme, RFN; Canadian Institutes of Health Research Foundation Grant [RFN]	The study was funded by the Canadian Institutes of Health Research. GGA received a Knowledge Translation Supplement grant (RN#147574) for this project from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). IDG is a recipient of a Canadian Institutes of Health Research Foundation Grant Scheme, RFN #143237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like thank those who contributed to the implementation of this study, including: Steve Lapp, Jesse Mike, Catherine Carry, the Taima TB Steering committee, Beth Cowie, Joan Killulark, Malvin Wright, Igah Sangoya, Anastazia Jurkova, Sandra Finn, Johnny Kuluguqtuq, Markus Wilke, Eileen Grady, Tina Chen, and Jeannie Aulaqiaq. The study was funded by the Canadian Institutes of Health Research. Gonzalo G. Alvarez received a Knowledge Translation Supplement grant (RN#147574) for this project from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). Ian D. Graham is a recipient of an inaugural Canadian Institutes of Health Research Foundation Grant [RFN #143237].	Alvarez G, 2013, CANADIAN TUBERCULOSI; Alvarez GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100975; [Anonymous], 2014, TUB CAN 2012 PRER; Assent Guidelines, 2012, ASS GUID; ENARSON DA, 1986, CAN MED ASSOC J, V134, P1149; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grybowski S., 1976, B INTERNATION UNION, V51, P181; McShane KE, 2006, CAN J PUBLIC HEALTH, V97, P296, DOI 10.1007/BF03405607; Pufall EL, 2011, INT J CIRCUMPOL HEAL, V70, P532, DOI 10.3402/ijch.v70i5.17860; Santesso N, 2006, J CONTIN EDUC HEALTH, V26, P87, DOI 10.1002/chp.55; Stanchfield J., 2007, ART EXPT GROUP FACIL; Stewart S, 2008, J HEALTH PSYCHOL, V13, P180, DOI 10.1177/1359105307086709	12	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159241	10.1371/journal.pone.0159241	http://dx.doi.org/10.1371/journal.pone.0159241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415757	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500106
J	Jain, M; Batth, R; Kumari, S; Mustafiz, A				Jain, Muskan; Batth, Rituraj; Kumari, Sumita; Mustafiz, Ananda			Arabidopsis thaliana Contains Both Ni2+ and Zn2+ Dependent Glyoxalase I Enzymes and Ectopic Expression of the Latter Contributes More towards Abiotic Stress Tolerance in E-coli	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; METHYLGLYOXAL; PATHWAY; GLUTATHIONE; ACTIVATION; GENE	The glyoxalase pathway is ubiquitously found in all the organisms ranging from prokaryotes to eukaryotes. It acts as a major pathway for detoxification of methylglyoxal (MG), which deleteriously affects the biological system in stress conditions. The first important enzyme of this system is Glyoxalase I (GLYI). It is a metalloenzyme which requires divalent metal ions for its activity. This divalent metal ion can be either Zn2+ as found in most of eukaryotes or Ni2+ as seen in prokaryotes. In the present study, we have found three active GLYI enzymes (AtGLYI2, AtGLYI3 and AtGLYI6) belonging to different metal activation classes coexisting in Arabidopsis thaliana. These enzymes have been found to efficiently complement the GLYI yeast mutants. These three enzymes have been characterized in terms of their activity, metal dependency, kinetic parameters and their role in conferring tolerance to multiple abiotic stresses in E. coli and yeast. AtGLYI2 was found to be Zn2+ dependent whereas AtGLYI3 and AtGLYI6 were Ni2+ dependent. Enzyme activity of Zn2+ dependent enzyme, AtGLYI2, was observed to be exceptionally high (similar to 250-670 fold) as compared to Ni2+ dependent enzymes, AtGLYI3 and AtGLYI6. The activity of these GLYI enzymes correlated well to their role in stress tolerance. Heterologous expression of these enzymes in E. coli led to better tolerance against various stress conditions. This is the first report of a higher eukaryotic species having multiple active GLYI enzymes belonging to different metal activation classes.	[Jain, Muskan; Mustafiz, Ananda] South Asian Univ, Fac Life Sci & Biotechnol, Plant Mol Biol Lab, Akbar Bhawan, New Delhi 110021, India; [Batth, Rituraj; Kumari, Sumita] Sher E Kashmir Univ Agr Sci & Technol, Jammu 180009, India	South Asian University (SAU); Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu)	Mustafiz, A (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, Plant Mol Biol Lab, Akbar Bhawan, New Delhi 110021, India.	amustafiz@sau.ac.in		Batth, Rituraj/0000-0002-0205-645X	South Asian University	South Asian University	This work was supported by the South Asian University, Grant was received by AM. The funder have no role in study design and data collection.; Funding and support from South Asian University are duly acknowledged.	Bhomkar P, 2008, MOL BREEDING, V22, P169, DOI 10.1007/s11032-008-9164-8; CARRINGTON SJ, 1986, IRCS MED SCI-BIOCHEM, V14, P763; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Frickel EM, 2001, J BIOL CHEM, V276, P1845, DOI 10.1074/jbc.M005760200; Hossain D, 2005, J CROP SCI BIOTECH, V10, P21; Iozef R, 2003, FEBS LETT, V554, P284, DOI 10.1016/S0014-5793(03)01146-3; Irsch T, 2004, J BIOL CHEM, V279, P22209, DOI 10.1074/jbc.M401240200; JAGT DLV, 1973, BIOCHEMISTRY-US, V12, P5161, DOI 10.1021/bi00749a022; KALAPOS MP, 1992, BIOCHIM BIOPHYS ACTA, V1135, P159, DOI 10.1016/0167-4889(92)90132-U; Lin FY, 2010, MOL BIOL REP, V37, P729, DOI 10.1007/s11033-009-9578-3; Mustafiz A, 2014, PLANT J, V78, P951, DOI 10.1111/tpj.12521; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; Neuberg C, 1913, BIOCHEM Z, V49, P502; RACKER E, 1951, J BIOL CHEM, V190, P685; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Ridderstrom M, 1996, BIOCHEM J, V314, P463; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200; Sukdeo N, 2004, BIOCHEM J, V384, P111, DOI 10.1042/BJ20041006; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Suttisansanee U, 2011, J BIOL CHEM, V286, P38367, DOI 10.1074/jbc.M111.251603; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Veena, 1999, PLANT J, V17, P385, DOI 10.1046/j.1365-313X.1999.00390.x; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu C, 2013, J PLANT RES, V126, P415, DOI 10.1007/s10265-012-0532-4; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263	30	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159348	10.1371/journal.pone.0159348	http://dx.doi.org/10.1371/journal.pone.0159348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415831	gold, Green Submitted, Green Published			2022-12-26	WOS:000379579500122
J	Jin, H; Won, M; Park, SE; Lee, S; Park, M; Bae, J				Jin, Hanyong; Won, Miae; Park, Si Eun; Lee, Seunghwa; Park, Mira; Bae, Jeehyeon			FOXL2 Is an Essential Activator of SF-1-Induced Transcriptional Regulation of Anti-Mullerian Hormone in Human Granulosa Cells	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; INHIBITING SUBSTANCE GENE; ORPHAN NUCLEAR RECEPTOR; OVARIAN RESERVE; FOLLICLE DEVELOPMENT; EXPRESSION; SF-1; DIFFERENTIATION; PROMOTER; FACTOR-1	Anti-Mullerian hormone (AMH) is required for proper sexual differentiation by regulating the regression of the Mullerian ducts in males. Recent studies indicate that AMH could be an important factor for maintaining the ovarian reserve. However, the mechanisms of AMH regulation in the ovary are largely unknown. Here, we provide evidence that AMH is an ovarian target gene of steroidogenic factor-1 (SF-1), an orphan nuclear receptor required for proper follicle development. FOXL2 is an evolutionally conserved transcription factor, and its mutations cause blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES), wherein affected females display eyelid defects and premature ovarian failure (POF). Notably, we found that functional FOXL2 is essential for SF-1-induced AMH regulation, via protein-protein interactions between FOXL2 and SF-1. A BPES-inducing mutant of FOXL2 (290-291delCA) was unable to interact with SF-1 and failed to mediate the association between SF-1 and the AMH promoter. Therefore, this study identified a novel regulatory circuit for ovarian AMH production; specifically, through the coordinated interplay between FOXL2 and SF-1 that could control ovarian follicle development.	[Jin, Hanyong; Park, Si Eun; Park, Mira; Bae, Jeehyeon] Chung Ang Univ, Sch Pharm, Seoul, South Korea; [Won, Miae] CHA Univ, Dept Pharm, Songnam, South Korea; [Lee, Seunghwa] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chung Ang University; Pochon Cha University; Chung Ang University	Bae, J (corresponding author), Chung Ang Univ, Sch Pharm, Seoul, South Korea.	jeehyeon@cau.ac.kr	Won, Miae/AAL-9049-2020	bae, jeehyeon/0000-0003-1995-1378; Jin, Hanyong/0000-0002-5850-0791	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014R1A2A2A01006839, NRF-2015R1A2A1A15054332]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning (2014R1A2A2A01006839; NRF-2015R1A2A1A15054332) (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none).	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; BEZARD J, 1988, REPROD NUTR DEV, V28, P1105, DOI 10.1051/rnd:19880708; BLOCK E, 1952, ACTA ANAT, V14, P108; BLOCK E., 1953, ARCH GYNSKOL, V183, P294, DOI 10.1007/BF01004865; Broekmans FJ, 2008, TRENDS ENDOCRIN MET, V19, P340, DOI 10.1016/j.tem.2008.08.002; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; Conway GS, 2000, BRIT MED BULL, V56, P643, DOI 10.1258/0007142001903445; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Dolleman M, 2014, HUM REPROD, V29, P584, DOI 10.1093/humrep/det446; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Falender AE, 2003, ENDOCRINOLOGY, V144, P3598, DOI 10.1210/en.2002-0137; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; HATANO O, 1994, DEVELOPMENT, V120, P2787; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Jagannathan V, 2011, MOL CELL ENDOCRINOL, V334, P91, DOI 10.1016/j.mce.2010.06.012; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; LYNCH JP, 1993, MOL ENDOCRINOL, V7, P776, DOI 10.1210/me.7.6.776; Meduri G, 2007, HUM REPROD, V22, P117, DOI 10.1093/humrep/del346; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Park M, 2014, FERTIL STERIL, V102, P847, DOI 10.1016/j.fertnstert.2014.05.031; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Peluso C, 2014, CLIN CHIM ACTA, V437, P175, DOI 10.1016/j.cca.2014.07.029; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Seifer DB, 2002, FERTIL STERIL, V77, P468, DOI 10.1016/S0015-0282(01)03201-0; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Thackray VG, 2014, MOL CELL ENDOCRINOL, V385, P62, DOI 10.1016/j.mce.2013.09.034; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; Yu RN, 1998, MOL ENDOCRINOL, V12, P1010, DOI 10.1210/me.12.7.1010	48	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159112	10.1371/journal.pone.0159112	http://dx.doi.org/10.1371/journal.pone.0159112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414805	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500078
J	Krebs, BB; De Mesquita, JF				Krebs, Bruna Baumgarten; De Mesquita, Joelma Freire			Amyotrophic Lateral Sclerosis Type 20-In Silico Analysis and Molecular Dynamics Simulation of hnRNPA1	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SECONDARY STRUCTURE; SERVER; WEB; MUTATIONS; CONSURF; DOMAINS; REGIONS	Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease that affects the upper and lower motor neurons. 5-10% of cases are genetically inherited, including ALS type 20, which is caused by mutations in the hnRNPA1 gene. The goals of this work are to analyze the effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on hnRNPA1 protein function, to model the complete tridimensional structure of the protein using computational methods and to assess structural and functional differences between the wild type and its variants through Molecular Dynamics simulations. nsSNP, PhD-SNP, Polyphen2, SIFT, SNAP, SNPs&GO, SNPeffect and PROVEAN were used to predict the functional effects of nsSNPs. Ab initio modeling of hnRNPA1 was made using Rosetta and refined using KoBaMIN. The structure was validated by PROCHECK, Rampage, ERRAT, Verify3D, ProSA and Qmean. TM-align was used for the structural alignment. FoldIndex, DICHOT, ELM, D2P2, Disopred and DisEMBL were used to predict disordered regions within the protein. Amino acid conservation analysis was assessed by Consurf, and the molecular dynamics simulations were performed using GROMACS. Mutations D314V and D314N were predicted to increase amyloid propensity, and predicted as deleterious by at least three algorithms, while mutation N73S was predicted as neutral by all the algorithms. D314N and D314V occur in a highly conserved amino acid. The Molecular Dynamics results indicate that all mutations increase protein stability when compared to the wild type. Mutants D314N and N319S showed higher overall dimensions and accessible surface when compared to the wild type. The flexibility level of the C-terminal residues of hnRNPA1 is affected by all mutations, which may affect protein function, especially regarding the protein ability to interact with other proteins.	[Krebs, Bruna Baumgarten; De Mesquita, Joelma Freire] Fed Univ Rio de Janeiro State UNIRIO, Dept Genet & Mol Biol, Lab Bioinformat & Computat Biol, Rio De Janeiro, Brazil	Universidade Federal do Estado do Rio de Janeiro	De Mesquita, JF (corresponding author), Fed Univ Rio de Janeiro State UNIRIO, Dept Genet & Mol Biol, Lab Bioinformat & Computat Biol, Rio De Janeiro, Brazil.	joelma.mesquita@unirio.br	De Mesquita, Joelma/W-5553-2019; De Mesquita, Joelma/J-4837-2012	De Mesquita, Joelma/0000-0003-1684-3830	FAPERJ; CNPq	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPERJ and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Moreira LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081979; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Calini D, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.05.025; Capriles PVSZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-610; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; de Carvalho MDC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065558; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dorn M, 2014, COMPUT BIOL CHEM, V53, P251, DOI 10.1016/j.compbiolchem.2014.10.001; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, P1; Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Essman U, 1995, J CHEM PHYS, V102, P31; Eswar N, 2003, TOOLS COMP PROTEIN S, P31; Fernandez-Fuentes N, 2007, NUCL ACIDS RES S2, V35; Fukuchi S, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-26; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Honda H, 2015, NEUROPATHOLOGY, V35, P37, DOI 10.1111/neup.12153; Huang TT, 2015, NUCLEIC ACIDS RES, V43, pW338, DOI 10.1093/nar/gkv454; Huang Y, 2013, STEM CELLS, V31, P906, DOI 10.1002/stem.1324; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kamaraj B, 2015, J BIOMOL STRUCT DYN, V33, P834, DOI 10.1080/07391102.2014.915762; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kirubakaran P, 2013, J MOL MODEL, V19, P407, DOI 10.1007/s00894-012-1566-1; Kumar Chundi Vinay, 2014, Advances in Bioinformatics, V2014, P502618, DOI 10.1155/2014/502618; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Lima MA, 2014, BIOINFORMATICA BIOL, P1; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mancuso R, 2015, PROG NEUROBIOL, V133, P1, DOI 10.1016/j.pneurobio.2015.07.004; McGuffin LJ, 2015, NUCLEIC ACIDS RES, V43, pW169, DOI 10.1093/nar/gkv236; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Taylor P, 2013, RARE DIS, P1; Turner, 2005, XMGRACE VERSION 51 1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang JY, 2016, J MOL BIOL, V428, P693, DOI 10.1016/j.jmb.2015.09.024; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004	65	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158939	10.1371/journal.pone.0158939	http://dx.doi.org/10.1371/journal.pone.0158939			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414033	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500051
J	Oner, C; Cosan, DT; Colak, E				Oner, Cagri; Cosan, Didem Turgut; Colak, Ertugrul			Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer	PLOS ONE			English	Article							NOVO DNA METHYLATION; HUMAN GASTRIC-CANCER; CELL-LINE MCF-7; NONCODING RNAS; MESSENGER-RNA; IN-VITRO; RECEPTOR; CARCINOMA; PROLIFERATION; PIRNAS	PIWI interacting RNAs (piRNAs), a member of non-coding RNA, originate from intergenic repetitive regions of the genome. piRNA expressions increase in various cancers and it is thought that this increase could be caused by hormones. We aimed to determine the effects of hormones on piRNA expression in breast and prostate cancer. High viability and a decrease in adhesion were observed at the concentrations of the highest proliferation. Furthermore, an increase in adhesion was also observed in MDA-MB-231 cells. After hormone treatment, while piR-651 expression had increased both breast and prostate cancer cell lines, piR-823 expressions increased in prostate cancer cell lines and only in the breast cancer cell line which was malignant. Thus, it was determined that piR-823 might show different expressions in different type of cancers.	[Oner, Cagri; Cosan, Didem Turgut] Eskisehir Osmangazi Univ, Fac Med, Dept Med Biol, TR-26480 Eskisehir, Turkey; [Colak, Ertugrul] Eskisehir Osmangazi Univ, Fac Med, Dept Biostat & Med Informat, TR-26480 Eskisehir, Turkey	Eskisehir Osmangazi University; Eskisehir Osmangazi University	Oner, C (corresponding author), Eskisehir Osmangazi Univ, Fac Med, Dept Med Biol, TR-26480 Eskisehir, Turkey.	coner86@gmail.com	Coşan, Didem Turgut/ABC-1466-2020; ÖNER, ÇAĞRI/O-4220-2015; ÖNER, Çağrı/AAP-1421-2020; Çolak, Ertuğrul/AAG-2140-2020	Coşan, Didem Turgut/0000-0002-8488-6405; Çolak, Ertuğrul/0000-0003-3251-1043; ONER, Cagri/0000-0003-3771-3277	Eskisehir Osmangazi University Scientific Research Project Commission [2014-576]	Eskisehir Osmangazi University Scientific Research Project Commission(Eskisehir Osmangazi University)	This study was supported by Eskisehir Osmangazi University Scientific Research Project Commission (Project Number: 2014-576).	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Burow ME, 1999, CARCINOGENESIS, V20, P2057, DOI 10.1093/carcin/20.11.2057; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Chu H, 2015, CANCER, V0, P2044; Chu HY, 2015, CANCER LETT, V356, P561, DOI 10.1016/j.canlet.2014.10.004; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Cui L, 2011, CLIN BIOCHEM, V44, P1050, DOI 10.1016/j.clinbiochem.2011.06.004; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Evangelou A, 2002, ENDOCRINOLOGY, V143, P3897, DOI 10.1210/en.2002-220156; Falany JL, 1996, CANCER RES, V56, P1551; Fan SJ, 2000, CANCER RES, V60, P5635; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; FURUYA Y, 1989, CANCER RES, V49, P6670; GIERTHY JF, 1987, CANCER RES, V47, P6198; Ginsburg ES, 1999, J STEROID BIOCHEM, V69, P299, DOI 10.1016/S0960-0760(99)00047-3; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Hashim A, 2014, ONCOTARGET, V5, P9901, DOI 10.18632/oncotarget.2476; He W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-426; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; HENTTU P, 1992, ENDOCRINOLOGY, V130, P766, DOI 10.1210/en.130.2.766; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ipsaro JJ, 2012, NATURE, V491, P279, DOI 10.1038/nature11502; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang HJ, 2014, MOL BIOL REP, V41, P6729, DOI 10.1007/s11033-014-3558-y; KAREY KP, 1988, CANCER RES, V48, P4083; KIERSZENBAUM A. L., 2006, HISTOLOGY CELL BIOL; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Law PTY, 2013, J HEPATOL, V58, P1165, DOI 10.1016/j.jhep.2013.01.032; Le Bail JC, 1998, CANCER LETT, V130, P209, DOI 10.1016/S0304-3835(98)00141-4; LEE C, 1995, ENDOCRINOLOGY, V136, P796, DOI 10.1210/en.136.2.796; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Martinez VD, 2015, SCI REP-UK, V5, DOI 10.1038/srep10423; Mei YP, 2013, CANCER LETT, V336, P46, DOI 10.1016/j.canlet.2013.04.008; Momma T, 1997, INT J CANCER, V72, P1062; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Palmer CP, 2008, EUR BIOPHYS J BIOPHY, V37, P359, DOI 10.1007/s00249-007-0219-2; Pandya G. M., 2014, Current Trends in Biotechnology and Pharmacy, V8, P303; Przylipiak A, 1996, ARCH GYNECOL OBSTET, V258, P137, DOI 10.1007/s004040050114; Rajah TT, 2012, ANTICANCER RES, V32, P1181; SAPINO A, 1986, CANCER RES, V46, P2526; Siddiqi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033711; SIMANOWSKI UA, 1986, GUT, V27, P278, DOI 10.1136/gut.27.3.278; Singletary KW, 2001, CANCER LETT, V165, P131, DOI 10.1016/S0304-3835(01)00419-0; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Teixeira C, 1995, CANC RES, V55; THOMPSON EW, 1989, CANCER RES, V49, P6929; Trapman J, 1996, PATHOL RES PRACT, V192, P752, DOI 10.1016/S0344-0338(96)80097-5; Tsai EM, 2001, CANCER RES, V61, P8390; WANG TTY, 1995, CANCER RES, V55, P2487; Wang Y, 2012, INT J CLIN EXP PATHO, V5, P315; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; WIESE TE, 1992, IN VITRO CELL DEV-AN, V28A, P595; WOLF DA, 1993, MOL ENDOCRINOL, V7, P924, DOI 10.1210/me.7.7.924; Wu QL, 2010, BIOCHEM BIOPH RES CO, V396, P915, DOI 10.1016/j.bbrc.2010.05.022; Yamaguchi Y, 2014, CANCER MICROENVIRON, V7, P23, DOI 10.1007/s12307-013-0139-x; Yan H, 2015, LEUKEMIA, V29, P196, DOI 10.1038/leu.2014.135; Yang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066809; Zhao XY, 2000, ENDOCRINOLOGY, V141, P2548, DOI 10.1210/en.141.7.2548; Zhou HH, 2010, BIOL CELL, V102, P645, DOI 10.1042/BC20100029; Zhu ML, 2010, FASEB J, V24, P769, DOI 10.1096/fj.09-136994	71	31	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159044	10.1371/journal.pone.0159044	http://dx.doi.org/10.1371/journal.pone.0159044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414029	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500063
J	Wang, SH; Zhang, YY; Yang, MY; Ye, LP; Gong, L; Qian, QJ; Shuai, YJ; You, ZY; Chen, YY; Zhong, BX				Wang, Shaohua; Zhang, Yuyu; Yang, Mingying; Ye, Lupeng; Gong, Lu; Qian, Qiujie; Shuai, Yajun; You, Zhengying; Chen, Yuyin; Zhong, Boxiong			Characterization of Transgenic Silkworm Yielded Biomaterials with Calcium-Binding Activity	PLOS ONE			English	Article							BOMBYX-MORI SILK; PIGGYBAC TRANSPOSON; FIBROIN; PROTEIN; TRANSFORMATION; FIBRONECTIN; SCAFFOLDS; SEQUENCE; GLAND	Silk fibers have many inherent properties that are suitable for their use in biomaterials. In this study, the silk fibroin was genetically modified by including a Ca-binding sequence, [(AGSGAG)(6)ASEYDYDDDSDDDDEWD](2) from shell nacreous matrix protein. It can be produced as fibers by transgenic silkworm. The Ca-binding activity and mineralization of the transgenic silk fibroin were examined in vitro. The results showed that this transgenic silk fibroin had relatively higher Ca-binding activity than unmodified silk fibroin. The increased Ca-binding activity could promote the usage of silk fibroin as a biomaterial in the pharmaceutical industry. This study shows the possibility of using silk fibroin as a mineralization accelerating medical material by generating genetically modified transgenic silkworm.	[Wang, Shaohua; Zhang, Yuyu; Yang, Mingying; Ye, Lupeng; Qian, Qiujie; Shuai, Yajun; You, Zhengying; Chen, Yuyin; Zhong, Boxiong] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Gong, Lu] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhong, BX (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.	bxzhong@zju.edu.cn	Chen, Yu/Y-3292-2019; Gong, Lu/AAM-3697-2021; Shuai, Yajun/AAR-5168-2021; Gong, Lu/X-2715-2019; Chen, Yi/HIR-2608-2022	Gong, Lu/0000-0001-9151-0767; Shuai, Yajun/0000-0003-3313-1800; Yang, Mingying/0000-0003-1256-6514; Ye, Lupeng/0000-0003-3901-6598	Zhejiang Provincial Science and Technology Plans [2012C12910]; National Basic Research Program of China [2012CB114601]	Zhejiang Provincial Science and Technology Plans; National Basic Research Program of China(National Basic Research Program of China)	This work is supported by the Projects of Zhejiang Provincial Science and Technology Plans (No. 2012C12910), grants from the National Basic Research Program of China (No. 2012CB114601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura T, 2006, BIOMACROMOLECULES, V7, P1996, DOI 10.1021/bm060155k; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Kawakami M, 2011, BIO-MED MATER ENG, V21, P53, DOI 10.3233/BME-2011-0656; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Li Z, 2015, MOL BIOL REP, V42, P19, DOI 10.1007/s11033-014-3735-z; Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032; Shi P, 2014, INT J NANOMED, V9, P1617, DOI 10.2147/IJN.S53886; Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tanaka T, 2001, J THERM ANAL CALORIM, V64, P645, DOI 10.1023/A:1011575824042; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f; Yang M, 2008, BIOMACROMOLECULES, V9, P416, DOI 10.1021/bm700665m; Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348; Yang MY, 2012, INT J MOL SCI, V13, P7762, DOI 10.3390/ijms13067762; Ye L, 2015, SCI REP, V5; Zhong BX, 2007, ACTA BIOCH BIOPH SIN, V39, P117, DOI 10.1111/j.1745-7270.2007.00252.x; Zhou ZH, 2008, J PROTEOME RES, V7, P5103, DOI 10.1021/pr800383r	24	4	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159111	10.1371/journal.pone.0159111	http://dx.doi.org/10.1371/journal.pone.0159111			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414647	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500077
J	Wei, XR; Smith, AJ; Forrest, DW; Cardenas, GA; Beck, DW; LaLota, M; Metsch, LR; Sionean, C; Owen, SM; Johnson, JA				Wei, Xierong; Smith, Amanda J.; Forrest, David W.; Cardenas, Gabriel A.; Beck, Dano W.; LaLota, Marlene; Metsch, Lisa R.; Sionean, Catlainn; Owen, S. Michele; Johnson, Jeffrey A.			Incident Infection and Resistance Mutation Analysis of Dried Blood Spots Collected in a Field Study of HIV Risk Groups, 2007-2010	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE SYSTEM; SPECIMENS	Objective To assess the utility of cost-effective dried blood spot (DBS) field sampling for incidence and drug resistance surveillance of persons at high risk for HIV infection. Methods We evaluated DBS collected in 2007-2010 in non-clinical settings by finger-stick from HIV-positive heterosexuals at increased risk of HIV infection (n = 124), men who have sex with men (MSM, n = 110), and persons who inject drugs (PWID, n = 58). Relative proportions of recent-infection findings among risk groups were assessed at avidity index (AI) cutoffs of <= 25%, <= 30%, and <= 35%, corresponding to an infection mean duration of recency (MDR) of 220.6, 250.4, and 278.3 days, respectively. Drug resistance mutation prevalence was compared among the risk groups and avidity indices. Results HIV antibody avidity testing of all self-reported ARV-naive persons (n = 186) resulted in 9.7%, 11.3% and 14.0% with findings within the 221, 250, and 278-day MDRs, respectively. The proportion of ARV-naive MSM, heterosexuals, and PWID reporting only one risk category who had findings below the suggested 30% AI was 23.1%, 6.9% and 3.6% (p < 0.001), respectively. MSM had the highest prevalence of drug resistance and the only cases of transmitted multi-class resistance. Among the ARV-experienced, MSM had disproportionately more recent-infection results than did heterosexuals and PWID. Conclusions The disproportionately higher recent-infection findings for MSM as compared to PWID and heterosexuals increased as the MDR window increased. Unreported ARV use might explain greater recent-infection findings and drug resistance in this MSM population. DBS demonstrated utility in expanded HIV testing; however, optimal field handling is key to accurate recent-infection estimates.	[Wei, Xierong; Smith, Amanda J.; Sionean, Catlainn; Owen, S. Michele; Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA; [Forrest, David W.; Cardenas, Gabriel A.; Metsch, Lisa R.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Beck, Dano W.; LaLota, Marlene] Florida Dept Hlth, HIV AIDS Sect, Tallahassee, FL 32399 USA; [Beck, Dano W.] Oregon Hlth Author, Portland, OR USA; [Metsch, Lisa R.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Centers for Disease Control & Prevention - USA; University of Miami; Florida Department of Health; Columbia University	Johnson, JA (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30329 USA.	jjohnson1@cdc.gov			intramural CDC funds; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	intramural CDC funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by intramural CDC funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dinenno Elizabeth A, 2012, Open AIDS J, V6, P169, DOI 10.2174/1874613601206010169; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; HANNON WH, 1989, INFECT CONT HOSP EP, V10, P8, DOI 10.1086/645908; JINKS DC, 1989, HUM GENET, V81, P363, DOI 10.1007/BF00283692; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Laeyendecker O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013259; Lansky A, 2007, PUBLIC HEALTH REP, V122, P48, DOI 10.1177/00333549071220S108; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; WILCKEN B, 1983, J PEDIATR-US, V102, P383, DOI 10.1016/S0022-3476(83)80653-2; Winand R, 2015, AIDS, V29, P2045, DOI 10.1097/QAD.0000000000000811; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100	14	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159266	10.1371/journal.pone.0159266	http://dx.doi.org/10.1371/journal.pone.0159266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415433	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500116
J	Kimura, H; Tomatsu, K; Saiki, H; Arimitsu, K; Ono, M; Kawashima, H; Iwata, R; Nakanishi, H; Ozeki, E; Kuge, Y; Saji, H				Kimura, Hiroyuki; Tomatsu, Kenji; Saiki, Hidekazu; Arimitsu, Kenji; Ono, Masahiro; Kawashima, Hidekazu; Iwata, Ren; Nakanishi, Hiroaki; Ozeki, Eiichi; Kuge, Yuji; Saji, Hideo			Continuous-Flow Synthesis of N-Succinimidyl 4-[F-18]fluorobenzoate Using a Single Microfluidic Chip	PLOS ONE			English	Article							LABELING PROTEINS; PET; RADIOSYNTHESIS; REACTOR; F-18; RADIOPHARMACEUTICALS; RADIOCHEMISTRY; RADIOTRACER; CONJUGATION; TECHNOLOGY	In the field of positron emission tomography ( PET) radiochemistry, compact microreactors provide reliable and reproducible synthesis methods that reduce the use of expensive precursors for radiolabeling and make effective use of the limited space in a hot cell. To develop more compact microreactors for radiosynthesis of F-18-labeled compounds required for the multistep procedure, we attempted radiosynthesis of N-succinimidyl 4-[F-18]fluorobenzoate ([F-18]SFB) via a three-step procedure using a microreactor. We examined individual steps for [F-18]SFB using a batch reactor and microreactor and developed a new continuous-flow synthetic method with a single microfluidic chip to achieve rapid and efficient radiosynthesis of [F-18]SFB. In the synthesis of [F-18]SFB using this continuous-flow method, the three-step reaction was successfully completed within 6.5 min and the radiochemical yield was 64 +/- 2% (n = 5). In addition, it was shown that the quality of [F-18]SFB synthesized on this method was equal to that synthesized by conventional methods using a batch reactor in the radiolabeling of bovine serum albumin with [F-18]SFB.	[Kimura, Hiroyuki; Tomatsu, Kenji; Arimitsu, Kenji; Ono, Masahiro; Kawashima, Hidekazu; Kuge, Yuji; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Kyoto, Japan; [Kimura, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto, Kyoto, Japan; [Saiki, Hidekazu; Nakanishi, Hiroaki; Ozeki, Eiichi] Shimadzu Co Ltd, Technol Res Lab, Kyoto, Japan; [Arimitsu, Kenji] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo, Japan; [Kawashima, Hidekazu] Kyoto Pharmaceut Univ, Radioisotope Res Ctr, Kyoto, Kyoto, Japan; [Iwata, Ren] Tohoku Univ, CYRIC, Sendai, Miyagi, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan	Kyoto University; Kyoto Pharmaceutical University; Shimadzu Corporation; Mukogawa Women's University; Kyoto Pharmaceutical University; Tohoku University; Hokkaido University	Kimura, H; Saji, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Kyoto, Japan.; Kimura, H (corresponding author), Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto, Kyoto, Japan.	hkimura@mb.kyoto-phu.ac.jp; hsaji@pharm.kyoto-u.ac.jp		Arimitsu, Kenji/0000-0003-2844-1652	New Energy and Industrial Technology Development Organization [P08029]; Shimadzu Corporation; Grants-in-Aid for Scientific Research [15K15444] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Shimadzu Corporation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the New Energy and Industrial Technology Development Organization (P08029, H. Saji, http://www.nedo.go.jp/activities/ZZ_00259.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shimadzu Corporation provided support in the form of the salaries for authors, H. Saiki, H. Nakanishi and E. Ozeki, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arima V, 2013, LAB CHIP, V13, P2328, DOI 10.1039/c3lc00055a; Audrain H, 2007, ANGEW CHEM INT EDIT, V46, P1772, DOI 10.1002/anie.200603509; BANNWARTH W, 1991, TETRAHEDRON LETT, V32, P1157, DOI 10.1016/S0040-4039(00)92032-X; Bouvet V, 2012, BIOORG MED CHEM LETT, V22, P2291, DOI 10.1016/j.bmcl.2012.01.083; Bouvet VR, 2011, NUCL MED BIOL, V38, P235, DOI 10.1016/j.nucmedbio.2010.09.002; Chun JH, 2010, J ORG CHEM, V75, P3332, DOI 10.1021/jo100361d; Dahl K, 2012, J LABELLED COMPD RAD, V55, P455, DOI 10.1002/jlcr.2970; Elizarov AM, 2010, J NUCL MED, V51, P282, DOI 10.2967/jnumed.109.065946; Elizarov AM, 2009, LAB CHIP, V9, P1326, DOI 10.1039/b820299k; Fletcher PDI, 2002, TETRAHEDRON, V58, P4735, DOI 10.1016/S0040-4020(02)00432-5; Gillies JM, 2006, APPL RADIAT ISOTOPES, V64, P333, DOI 10.1016/j.apradiso.2005.08.009; Gillies JM, 2006, APPL RADIAT ISOTOPES, V64, P325, DOI 10.1016/j.apradiso.2005.08.007; Guenther KJ, 2006, J MED CHEM, V49, P1466, DOI 10.1021/jm0509344; Haroun S, 2013, CAN J CHEM, V91, P326, DOI 10.1139/cjc-2012-0331; Kealey S, 2011, ORG BIOMOL CHEM, V9, P3313, DOI 10.1039/c0ob00631a; Kimura H, 2014, J LABELLED COMPD RAD, V57, P680, DOI 10.1002/jlcr.3232; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Liang SH, 2014, MEDCHEMCOMM, V5, P432, DOI 10.1039/c3md00335c; Lin WY, 2009, NANO TODAY, V4, P470, DOI 10.1016/j.nantod.2009.10.007; Lu SY, 2004, LAB CHIP, V4, P523, DOI 10.1039/b407938h; Mading P, 2005, APPL RADIAT ISOTOPES, V63, P329, DOI 10.1016/j.apradiso.2005.03.005; Marik J, 2007, APPL RADIAT ISOTOPES, V65, P199, DOI 10.1016/j.apradiso.2006.06.007; Miller PW, 2007, ANGEW CHEM INT EDIT, V46, P2875, DOI 10.1002/anie.200604541; Miller PW, 2011, CHEM-EUR J, V17, P460, DOI 10.1002/chem.201002644; Miller PW, 2009, J CHEM TECHNOL BIOT, V84, P309, DOI 10.1002/jctb.2061; Mitchell P, 2001, NAT BIOTECHNOL, V19, P717, DOI 10.1038/90754; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Ramsey JM, 1999, NAT BIOTECHNOL, V17, P1061, DOI 10.1038/15044; REGENFUSS P, 1985, REV SCI INSTRUM, V56, P283, DOI 10.1063/1.1138345; Steel CJ, 2007, J LABELLED COMPD RAD, V50, P308, DOI 10.1002/jlcr.1259; Tang G, 2008, J LABELLED COMPD RAD, V51, P68, DOI 10.1002/jlcr.1481; Ungersboeck J, 2012, NUCL MED BIOL, V39, P1087, DOI 10.1016/j.nucmedbio.2012.04.004; VAIDYANATHAN G, 1992, NUCL MED BIOL, V19, P275; Vaidyanathan G, 2006, NAT PROTOC, V1, P1655, DOI 10.1038/nprot.2006.264; Watts P, 2012, J FLOW CHEM, V2, P37, DOI 10.1556/JFC-D-12-00010; Wester HJ, 1996, NUCL MED BIOL, V23, P365, DOI 10.1016/0969-8051(96)00017-0; Wong R, 2012, APPL RADIAT ISOTOPES, V70, P193, DOI 10.1016/j.apradiso.2011.09.022; Wust F, 2003, APPL RADIAT ISOTOPES, V59, P43, DOI 10.1016/S0969-8043(03)00161-1	38	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159303	10.1371/journal.pone.0159303	http://dx.doi.org/10.1371/journal.pone.0159303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410684	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300078
J	Marvibaigi, M; Amini, N; Supriyanto, E; Majid, FAA; Jaganathan, SK; Jamil, S; Almaki, JH; Nasiri, R				Marvibaigi, Mohsen; Amini, Neda; Supriyanto, Eko; Majid, Fadzilah Adibah Abdul; Jaganathan, Saravana Kumar; Jamil, Shajarahtunnur; Almaki, Javad Hamzehalipour; Nasiri, Rozita			Antioxidant Activity and ROS-Dependent Apoptotic Effect of Scurrula ferruginea (Jack) Danser Methanol Extract in Human Breast Cancer Cell MDA-MB-231	PLOS ONE			English	Article							MISTLETOE VISCUM-ALBUM; TUMOR-GROWTH STIMULATION; IN-VITRO; BIOACTIVE COMPOUNDS; CYTOTOXIC ACTIVITY; DEATH; MITOCHONDRIA; MECHANISMS; ASSAY; METASTASIS	Scurrula ferruginea (Jack) Danser is one of the mistletoe species belonging to Loranthaceae family, which grows on the branches of many deciduous trees in tropical countries. This study evaluated the antioxidant activities of S. ferruginea extracts. The cytotoxic activity of the selected extracts, which showed potent antioxidant activities, and high phenolic and flavonoid contents, were investigated in human breast cancer cell line (MDA-MB-231) and non-cancer human skin fibroblast cells (HSF-1184). The activities and characteristics varied depending on the different parts of S. ferruginea, solvent polarity, and concentrations of extracts. The stem methanol extract showed the highest amount of both phenolic (273.51 +/- 4.84 mg gallic acid/g extract) and flavonoid contents (163.41 +/- 4.62 mg catechin/g extract) and strong DPPH center dot radical scavenging (IC50 = 27.81 mu g/mL) and metal chelation activity (IC50 = 80.20 mu g/mL). The stem aqueous extract showed the highest ABTS(center dot+) scavenging ability. The stem methanol and aqueous extracts exhibited dose-dependent cytotoxic activity against MDA-MB-231 cells with IC50 of 19.27 and 50.35 mu g/mL, respectively. Furthermore, the extracts inhibited the migration and colony formation of MDA-MB-231 cells in a concentration-dependent manner. Morphological observations revealed hallmark properties of apoptosis in treated cells. The methanol extract induced an increase in ROS generation and mitochondrial depolarization in MDA-MB-231 cells, suggesting its potent apoptotic activity. The present study demonstrated that the S. ferruginea methanol extract mediated MDA-MB-231 cell growth inhibition via induction of apoptosis which was confirmed by Western blot analysis. It may be a potential anticancer agent; however, its in vivo anticancer activity needs to be investigated.	[Marvibaigi, Mohsen; Amini, Neda; Supriyanto, Eko; Jaganathan, Saravana Kumar] Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Skudai, Johor, Malaysia; [Majid, Fadzilah Adibah Abdul; Almaki, Javad Hamzehalipour; Nasiri, Rozita] Univ Teknol Malaysia, Fac Chem Engn, Bioproc Engn Dept, Skudai, Johor, Malaysia; [Jamil, Shajarahtunnur] Univ Teknol Malaysia, UTM Johor Bahru, Fac Sci, Dept Chem, Skudai, Johor, Malaysia; [Majid, Fadzilah Adibah Abdul] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu, Malaysia	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Malaysia Terengganu	Marvibaigi, M; Supriyanto, E (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, IJN UTM Cardiovasc Engn Ctr, Skudai, Johor, Malaysia.	mohsen_marvi@yahoo.com; eko.sup1950@gmail.com	Nasiri, Rozita/AAG-9484-2020; abdul majid, fadzilah adibah/AAA-1134-2022; Nasiri, Rozita/ABI-3475-2020; Jamil, Shajarahtunnur/GXG-9807-2022; Jaganathan, Saravana Kumar/N-2385-2017; Supriyanto, Eko/AAZ-1135-2021	Nasiri, Rozita/0000-0002-3897-8034; abdul majid, fadzilah adibah/0000-0001-8122-9605; Nasiri, Rozita/0000-0002-3897-8034; Jaganathan, Saravana Kumar/0000-0002-2785-137X; Amini, Neda/0000-0001-5084-1279; Marvibaigi, Mohsen/0000-0002-0640-2268; SUPRIYANTO, EKO/0000-0002-2142-8351				Abhyankar G, 2010, INNOV FOOD SCI EMERG, V11, P526, DOI 10.1016/j.ifset.2010.02.005; Ameer OZ, 2009, INT J PHARMACOL, V5, P44, DOI 10.3923/ijp.2009.44.50; Anders GT, 2002, FITOTERAPIA, V73, P400; Ashraf MF, 2013, SCI WORLD J, DOI 10.1155/2013/216894; Astley SB, 2003, TRENDS FOOD SCI TECH, V14, P93, DOI 10.1016/S0924-2244(02)00281-9; Barlow B. A., 1991, Flora Malesiana Bulletin, V10, P335; BECKER H, 1986, ONCOLOGY, V43, P2, DOI 10.1159/000226413; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; Bussing A, 2006, ARZNEIMITTEL-FORSCH, V56, P508; Bussing A., 2000, MISTLETOE GENUS VISC, P123; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Dashora N, 2011, PHARM CROPS, V2, P24, DOI [10.2174/2210290601102010024, DOI 10.2174/2210290601102010024]; DECKER EA, 1990, J AGR FOOD CHEM, V38, P674, DOI 10.1021/jf00093a019; Delanty N, 2000, ARCH NEUROL-CHICAGO, V57, P1265, DOI 10.1001/archneur.57.9.1265; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ganie SA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/792574; Gardner PT, 2000, FOOD CHEM, V68, P471, DOI 10.1016/S0308-8146(99)00225-3; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grieve M., 1994, MODERN HERBAL, P547; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harmsma M, 2006, ARZNEIMITTEL-FORSCH, V56, P474; Heinzerling L, 2006, J CLIN IMMUNOL, V26, P347, DOI 10.1007/s10875-006-9023-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YL, 2012, J AGR FOOD CHEM, V60, P852, DOI 10.1021/jf2052515; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Isa NM, 2013, J FUNCT FOODS, V5, P87, DOI 10.1016/j.jff.2012.08.008; Johansson S, 2003, CELL MOL LIFE SCI, V60, P165, DOI 10.1007/s000180300011; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Katsarou A, 2012, REC NAT PROD, V6, P394; Kelter G, 2007, ANTICANCER RES, V27, P223; Koizumi T, 1996, TOXICOLOGY, V114, P125, DOI 10.1016/S0300-483X(96)03477-4; Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuete V, 2012, PLANTA MED, V78, P193, DOI 10.1055/s-0031-1280319; Kumar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098696; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; Lohezic-Le Devehat F, 2002, Z NATURFORSCH C, V57, P1092; Maier G, 2002, ANTI-CANCER DRUG, V13, P373, DOI 10.1097/00001813-200204000-00006; Martin EJ, 2004, J PHARMACOL EXP THER, V310, P33, DOI 10.1124/jpet.104.066019; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; Massaoka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038698; Mathew S, 2006, FOOD CHEM TOXICOL, V44, P198, DOI 10.1016/j.fct.2005.06.013; Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007; Oluwaseun AA, 2008, AFR J BIOTECHNOL, V7, P3138; Onay-Ucar E, 2006, FITOTERAPIA, V77, P556, DOI 10.1016/j.fitote.2006.08.001; Osadebe PO, 2004, J ETHNOPHARMACOL, V95, P133, DOI 10.1016/j.jep.2004.06.029; Perry L, 1978, MED PLANTS E SE ASIA, P2138; Phang CW, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-243; Pieme CA, 2012, TOXICOL ENVIRON CHEM, V94, P987, DOI 10.1080/02772248.2012.674135; Ramaekers FCS, 2007, MEDICINA-BUENOS AIRE, V67, P79; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sahreen S, 2010, FOOD CHEM, V122, P1205, DOI 10.1016/j.foodchem.2010.03.120; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Shim HY, 2007, MOL CELLS, V24, P95; Singh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079242; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steiner R, 1961, VORTRAG VOM 2 4, p[312, 242]; Stevigny C., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P173, DOI 10.2174/1568011053174864; STEWART BW, 1994, JNCI-J NATL CANCER I, V86, P1286, DOI 10.1093/jnci/86.17.1286; Tian LQ, 2012, MOL MED REP, V5, P126, DOI 10.3892/mmr.2011.624; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Vicas S., 2008, Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Agriculture, V65, P327; Vicas S, 2009, NOT BOT HORTI AGROBO, V37, P112; Vicas SI, 2011, J MED PLANTS RES, V5, P2237; Vicas SI, 2011, NOT BOT HORTI AGROBO, V39, P48; Yoo KM, 2008, FOOD CHEM, V106, P929, DOI 10.1016/j.foodchem.2007.07.006; Zhao YL, 2012, Z NATURFORSCH C, V67, P129, DOI 10.5560/ZNC.2012.67c0129; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	79	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158942	10.1371/journal.pone.0158942	http://dx.doi.org/10.1371/journal.pone.0158942			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410459	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300044
J	Koo, J; Shiigi, S; Rohovie, M; Mehta, K; Swartz, JR				Koo, Jamin; Shiigi, Stacey; Rohovie, Marcus; Mehta, Kunal; Swartz, James R.			Characterization of [FeFe] Hydrogenase O-2 Sensitivity Using a New, Physiological Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inactivation; enzyme kinetics; fusion protein; hydrogenase; metalloprotein	OXIDATIVE INACTIVATION; OXYGEN-TOLERANT; H-CLUSTER; CELL; GENERATION	[FeFe] hydrogenases catalyze rapid H-2 production but are highly O-2-sensitive. Developing O-2-tolerant enzymes is needed for sustainable H-2 production technologies, but the lack of a quantitative and predictive assay for O-2 tolerance has impeded progress. We describe a new approach to provide quantitative assessment of O-2 sensitivity by using an assay employing ferredoxin NADP(+) reductase (FNR) to transfer electrons from NADPH to hydrogenase via ferredoxins (Fd). Hydrogenase inactivation is measured during H-2 production in an O-2-containing environment. An alternative assay uses dithionite (DTH) to provide reduced Fd. This second assay measures the remaining hydrogenase activity in periodic samples taken from the NADPH-driven reaction solutions. The second assay validates the more convenient NADPH-driven assay, which better mimics physiological conditions. During development of the NADPH-driven assay and while characterizing the Clostridium pasteurianum (Cp) [FeFe] hydrogenase, CpI, we detected significant rates of direct electron loss from reduced Fd to O-2. However, this loss does not interfere with measurement of first order hydrogenase inactivation, providing rate constants insensitive to initial hydrogenase concentration. We show increased activity and O-2 tolerance for a protein fusion between Cp ferredoxin (CpFd) and CpI mediated by a 15-amino acid linker but not for a longer linker. We suggest that this precise, solution phase assay for [FeFe] hydrogenase O-2 sensitivity and the insights we provide constitute an important advance toward the discovery of the O-2-tolerant [FeFe] hydrogenases required for photosynthetic, biological H-2 production.	[Koo, Jamin; Rohovie, Marcus; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Shiigi, Stacey; Mehta, Kunal; Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Swartz, JR (corresponding author), Stanford Univ, Dept Chem Engn & Bioengn, 443 Via Ortega, Stanford, CA 94305 USA.	jswartz@stanford.edu			Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U. S. Department of Energy [DE-FG02-09ER46632]; Samsung Scholarship Foundation; Stanford Bio-X program; National Science Foundation (NSF) [1264289]; Div Of Chem, Bioeng, Env, & Transp Sys [1264289] Funding Source: National Science Foundation	Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U. S. Department of Energy(United States Department of Energy (DOE)); Samsung Scholarship Foundation(Samsung); Stanford Bio-X program; National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by grants from the Division of Material Sciences and Engineering (Award DE-FG02-09ER46632) of the Office of Basic Energy Sciences of the U. S. Department of Energy (to J. R. S. and J. K.). This work was also supported by the Samsung Scholarship Foundation (to J. K.), the Stanford Bio-X program (to K. M.), and National Science Foundation (NSF) Award Number 1264289 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abou Hamdan A, 2013, NAT CHEM BIOL, V9, P15, DOI [10.1038/nchembio.1110, 10.1038/NCHEMBIO.1110]; Agapakis Christina M, 2010, J Biol Eng, V4, P3, DOI 10.1186/1754-1611-4-3; Bingham AS, 2012, INT J HYDROGEN ENERG, V37, P2965, DOI 10.1016/j.ijhydene.2011.02.048; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Cohen J, 2005, STRUCTURE, V13, P1321, DOI 10.1016/j.str.2005.05.013; Demuez M, 2007, FEMS MICROBIOL LETT, V275, P113, DOI 10.1111/j.1574-6968.2007.00868.x; Fourmond V, 2014, NAT CHEM, V6, P336, DOI [10.1038/NCHEM.1892, 10.1038/nchem.1892]; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Gulaboski R, 2012, J SOLID STATE ELECTR, V16, P2315, DOI 10.1007/s10008-011-1397-5; Hallenbeck PC, 2012, BIORESOURCE TECHNOL, V110, P1, DOI 10.1016/j.biortech.2012.01.103; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; Heidary N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143101; Kim DH, 2011, BIORESOURCE TECHNOL, V102, P8423, DOI 10.1016/j.biortech.2011.02.113; Knorzer P, 2012, J BIOL CHEM, V287, P1489, DOI 10.1074/jbc.M111.305797; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Lu F, 2015, INT J HYDROGEN ENERG, V40, P9113, DOI 10.1016/j.ijhydene.2015.05.121; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; MISRA HP, 1971, J BIOL CHEM, V246, P6886; Reisner E, 2009, J AM CHEM SOC, V131, P18457, DOI 10.1021/ja907923r; Shiigi S, 2016, THESIS STANFORD U; Smith PR, 2012, INT J HYDROGEN ENERG, V37, P2977, DOI 10.1016/j.ijhydene.2011.03.172; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Swanson KD, 2015, J AM CHEM SOC, V137, P1809, DOI 10.1021/ja510169s; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Wulff P, 2014, P NATL ACAD SCI USA, V111, P6606, DOI 10.1073/pnas.1322393111; Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108	26	13	13	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21563	21570		10.1074/jbc.M116.737122	http://dx.doi.org/10.1074/jbc.M116.737122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27435671	hybrid, Green Published			2022-12-26	WOS:000385999200023
J	Feigerlova, E; Demarquet, L; Melhem, H; Ghemrawi, R; Battaglia-Hsu, SF; Ewu, E; Alberto, JM; Helle, D; Weryha, G; Gueant, JL				Feigerlova, Eva; Demarquet, Lea; Melhem, Hassan; Ghemrawi, Rose; Battaglia-Hsu, Shyue-Fang; Ewu, Essi; Alberto, Jean-Marc; Helle, Deborah; Weryha, Georges; Gueant, Jean-Louis			Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-gamma coactivator-1 alpha-dependent vitamin D receptor pathway	FASEB JOURNAL			English	Article						osteoblast differentiation; bone development; 1,25-dihydroxyvitamin D-3; folate; vitamin B-12	HOMOCYSTEINE LEVELS; DIFFERENTIATION; PROTEINS; GROWTH; GENE; BINDING; ALPHA; CELLS; D-3; HYPERHOMOCYSTEINEMIA	Deficiency in methyl donor (folate and vitamin B-12) and in vitamin D is independently associated with altered bone development. Previously, methyl donor deficiency (MDD) was shown to weaken the activity of nuclear receptor coactivator, peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC1 alpha), for nuclear signaling in rat pups, including estrogen receptor- alpha and estrogen-related receptor-alpha; its effect on vitamin D receptor (VDR) signaling, however, is unknown. We studied bone development under MDD in rat pups and used human MG-63 preosteoblast cells to better understand the associated molecular mechanism. In young rats, MDD decreased total body bone mineral density, reduced tibia length, and impaired growth plate maturation, and in preosteoblasts, MDD slowed cellular proliferation. Mechanistic studies revealed decreased expression of VDR, estrogen receptor-alpha, PGC1, arginine methyltransferase 1, and sirtuin 1 in both rat proximal diaphysis of femur and in MG-63, as well as decreased nuclear VDR-PGC1 alpha interaction in MG-63 cells. The weaker VDR-PGC1 alpha interaction could be attributed to the reduced protein expression, imbalanced PGC1 alpha methylation/acetylation, and nuclear VDR sequestration by heat shock protein 90 (HSP90). These together compromised bone development, which is reflected by lowered bone alkaline phosphatase and increased proadipogenic peroxisome proliferator-activated receptor-gamma, adiponectin, and estrogen-related receptor-alpha expression. Of interest, under MDD, the bone development effects of 1,25-dihydroxyvitamin D-3 were ineffectual and these could be rescued by the addition of S-adenosylmethionine, which restored expression of arginine methyltransferase 1, PGC1 alpha, adiponectin, and HSP90. In conclusion, MDD inactivates vitamin D signaling via both disruption of VDR-PGC1 alpha interaction and sequestration of nuclear VDR attributable to HSP90 overexpression. These data suggest that vitamin D treatment may be ineffective under MDD.	[Feigerlova, Eva; Demarquet, Lea; Melhem, Hassan; Ghemrawi, Rose; Battaglia-Hsu, Shyue-Fang; Ewu, Essi; Alberto, Jean-Marc; Helle, Deborah; Gueant, Jean-Louis] Univ Lorraine, Fac Med, Nutr Genet & Exposit Risques Environm, INSERM,U954, Vandoeuvre Les Nancy, France; [Feigerlova, Eva; Weryha, Georges] Reg Univ Hosp Ctr Nancy, Div Endocrinol, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy	Feigerlova, E; Gueant, JL (corresponding author), INSERM, U954, Fac Med, 9 Ave Foret Haye,BP 184, F-54500 Nancy, France.	eva.feigerlova@chu-poitiers.fr; jean-louis.gueant@medecine.uhp-nancy.fr			Region Lorraine	Region Lorraine(Region Grand-Est)	Institutional grants were received from the Region Lorraine. The authors thank Dr. James Stevenin (Institut Genetique Biologie Moleculaire Cellulaire, Strasbourg, France), for providing NPM antibody. The authors declare no conflicts of interest.	Al-Tahan J, 2006, NUTR HOSP, V21, P452; Amer M, 2014, J CLIN ENDOCR METAB, V99, P633, DOI 10.1210/jc.2013-3262; Angelo G, 2008, BIOCHEM BIOPH RES CO, V367, P578, DOI 10.1016/j.bbrc.2007.12.179; Auwerx J, 1999, CELL, V97, P161; Azizi ZA, 2010, BONE, V46, P1344, DOI 10.1016/j.bone.2009.11.027; Battaglia-Hsu SF, 2009, P NATL ACAD SCI USA, V106, P21930, DOI 10.1073/pnas.0811794106; BONEWALD LF, 1992, J BIOL CHEM, V267, P8943; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; CARMEL R, 1988, NEW ENGL J MED, V319, P70, DOI 10.1056/NEJM198807143190202; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; CHANDAR N, 1992, BRIT J CANCER, V65, P208, DOI 10.1038/bjc.1992.43; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Compston J, 2002, J CLIN ENDOCR METAB, V87, P5398, DOI 10.1210/jc.2002-021420; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Dhonukshe-Rutten RAM, 2005, EUR J NUTR, V44, P341, DOI 10.1007/s00394-004-0531-x; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Finch JL, 2001, J AM SOC NEPHROL, V12, P1468, DOI 10.1681/ASN.V1271468; FRANCESCHI RT, 1985, J CELL PHYSIOL, V123, P401, DOI 10.1002/jcp.1041230316; Gacad MA, 1998, J CLIN ENDOCR METAB, V83, P1264, DOI 10.1210/jc.83.4.1264; Gacad MA, 1997, J BIOL CHEM, V272, P8433, DOI 10.1074/jbc.272.13.8433; Gallet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054837; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; GOERSS JB, 1992, J BONE MINER RES, V7, P573; Gradosova I, 2011, PHARMAZIE, V66, P606, DOI 10.1691/ph.2011.1525; Herrmann M, 2009, BONE, V44, P467, DOI 10.1016/j.bone.2008.10.051; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; Levasseur R, 2009, JOINT BONE SPINE, V76, P234, DOI 10.1016/j.jbspin.2008.11.002; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Marcinkowska E, 2010, J STEROID BIOCHEM, V121, P114, DOI 10.1016/j.jsbmb.2010.01.013; Merriman NA, 2010, GASTROENTEROLOGY, V138, P1330, DOI 10.1053/j.gastro.2009.12.007; POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315; Pons L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006325; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Pourie G, 2015, FASEB J, V29, P3713, DOI 10.1096/fj.14-264267; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Reinholz MM, 2010, BONE, V47, P12, DOI 10.1016/j.bone.2010.03.006; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; UBBINK JB, 1993, AM J CLIN NUTR, V57, P47, DOI 10.1093/ajcn/57.1.47; Vaisman DN, 2005, BIOL TRACE ELEM RES, V104, P131, DOI 10.1385/BTER:104:2:131; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Vaughn JD, 2004, J NUTR, V134, P2985, DOI 10.1093/jn/134.11.2985; Wang HB, 2013, CELL BIOL INT, V37, P1259, DOI 10.1002/cbin.10148; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Wu SX, 2000, MOL ENDOCRINOL, V14, P1387, DOI 10.1210/me.14.9.1387	58	2	2	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3598	3612		10.1096/fj.201600332R	http://dx.doi.org/10.1096/fj.201600332R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27435264				2022-12-26	WOS:000384329800028
J	Cao, Y; Bansal, GP; Merino, K; Kumar, N				Cao, Yi; Bansal, Geetha P.; Merino, Kristen; Kumar, Nirbhay			Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses	PLOS ONE			English	Article							TRANSMISSION-BLOCKING ANTIBODIES; SPECIES IMMUNITY; SURFACE-ANTIGEN; SEXUAL STAGE; PROTEIN; PFS48/45; PARASITE; FERTILITY; CANDIDATE	In general, malaria immunity has been suggested to be species specific with very little, if any, known cross-reactivity between Plasmodium vivax and P. falciparum, both of which are responsible for >90% of human malaria, and co-endemic in many countries. It is therefore believed that species-specific immunity may be needed to target different species of Plasmodium. Pfs48/45 and Pvs48/45 are well established targets in the sexual stages of the malaria parasites, and are being pursued for the development of transmission blocking vaccines. Comparison of their sequences reveals 61% and 55% identity at the DNA and protein level, respectively raising the possibility that these two target antigens might share cross-reacting epitopes. Having succeeded in expressing recombinant Pfs48/45 and Pvs48/45 proteins, we hypothesized that these proteins will not only exhibit immunological cross-reactivity but also cross-boost immune responses. Mice were immunized with purified recombinant proteins using CFA, Montanide ISA-51 and alum as adjuvants, and the sera were analyzed by ELISA, Western blotting and indirect fixed and live IFA to address the hypothesis. Our studies revealed that Pvs48/45-immune sera showed strong cross-reactivity to full length Pfs48/45 protein, and the majority of this cross reactivity was in the amino-terminal and carboxyl-terminal sub-fragments of Pfs48/45. In cross-boosting experiments Pfs48/45 and Pvs48/45 antigens were able to cross-boost each other in mouse immunization studies. Additionally we also noticed an effect of adjuvants in the overall magnitude of observed cross-reactivity. These studies may have significant implications for immunity targeting transmission of both the species of malaria parasites.	[Kumar, Nirbhay] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; Tulane Univ, Vector Borne Infect Dis Res Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	Kumar, N (corresponding author), Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA.	nkumar@tulane.edu			National Institute of Allergy and Infectious Diseases [RO1 AI47089, RO3 AI111138]; American Society of Microbiology	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Society of Microbiology	These studies were financially supported by research grants from National Institute of Allergy and Infectious Diseases, RO1 AI47089 (NK) and RO3 AI111138 (GB). KM was supported by The Robert D Watkins Graduate Research Fellowship provided by the American Society of Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KM was supported by The Robert D Watkins Graduate Research Fellowship provided by the American Society of Microbiology.	Arevalo-Herrera M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119335; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Bergmann-Leitner ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012294; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Douradinha B, 2008, INFECT IMMUN, V76, P873, DOI 10.1128/IAI.00431-07; Good MF, 2013, J CLIN INVEST, V123, P3353, DOI 10.1172/JCI66634; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; Igonet S, 2007, J MOL BIOL, V366, P1523, DOI 10.1016/j.jmb.2006.12.028; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Merino MM, 2016, IMMUNOLOGY; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Costa JDN, 2013, MEM I OSWALDO CRUZ, V108, P98, DOI 10.1590/S0074-02762013000100016; Nikolaeva D, 2015, EXPERT REV VACCINES, V14, P653, DOI 10.1586/14760584.2015.993383; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Outchkourov N, 2007, J BIOL CHEM, V282, P17148, DOI 10.1074/jbc.M700948200; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976; RILEY EM, 1990, J IMMUNOL, V144, P4810; Singh SK, 2015, VACCINE, V33, P1981, DOI 10.1016/j.vaccine.2015.02.040; Tachibana M, VACCINE; Theisen M, 2014, VACCINE; Theisen M, 2014, VACCINE, V32, P2623, DOI 10.1016/j.vaccine.2014.03.020; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Yadava A, 2012, J INFECT DIS, V205, P1456, DOI 10.1093/infdis/jis220	29	14	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158212	10.1371/journal.pone.0158212	http://dx.doi.org/10.1371/journal.pone.0158212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438603	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100009
J	Tempelaere, C; Pierrart, J; Lefevre-Colau, MM; Vuillemin, V; Cuenod, CA; Hansen, U; Mir, O; Skalli, W; Gregory, T				Tempelaere, Christine; Pierrart, Jerome; Lefevre-Colau, Marie-Martine; Vuillemin, Valerie; Cuenod, Charles-Andre; Hansen, Ulrich; Mir, Olivier; Skalli, Wafa; Gregory, Thomas			Dynamic Three-Dimensional Shoulder Mri during Active Motion for Investigation of Rotator Cuff Diseases	PLOS ONE			English	Article							GLENOHUMERAL JOINT; SUBACROMIAL SPACE; KINEMATICS; ABDUCTION; ELEVATION; WIDTH; TRANSLATION	Background MRI is the standard methodology in diagnosis of rotator cuff diseases. However, many patients continue to have pain despite treatment, and MRI of a static unloaded shoulder seems insufficient for best diagnosis and treatment. This study evaluated if Dynamic MRI provides novel kinematic data that can be used to improve the understanding, diagnosis and best treatment of rotator cuff diseases. Methods Dynamic MRI provided real-time 3D image series and was used to measure changes in the width of subacromial space, superior-inferior translation and anterior-posterior translation of the humeral head relative to the glenoid during active abduction. These measures were investigated for consistency with the rotator cuff diseases classifications from standard MRI. Results The study included: 4 shoulders with massive rotator cuff tears, 5 shoulders with an isolated full-thickness supraspinatus tear, 5 shoulders with tendinopathy and 6 normal shoulders. A change in the width of subacromial space greater than 4mm differentiated between rotator cuff diseases with tendon tears (massive cuff tears and supraspinatus tear) and without tears (tendinopathy) (p = 0.012). The range of the superior-inferior translation was higher in the massive cuff tears group (6.4mm) than in normals (3.4mm) (p = 0.02). The range of the anterior-posterior translation was higher in the massive cuff tears (9.2 mm) and supraspinatus tear (9.3 mm) shoulders compared to normals (3.5mm) and tendinopathy (4.8mm) shoulders (p = 0.05). Conclusion The Dynamic MRI enabled a novel measure; 'Looseness', i.e. the translation of the humeral head on the glenoid during an abduction cycle. Looseness was better able at differentiating different forms of rotator cuff disease than a simple static measure of relative glenohumeral position.	[Tempelaere, Christine; Pierrart, Jerome; Skalli, Wafa] ParisTech, Lab Biomech Arts & Matiers, Paris, France; [Tempelaere, Christine; Pierrart, Jerome; Gregory, Thomas] Univ Paris 05, European Hosp Georges Pompidou, AP HP, Sorbonne Paris Cite,Fac Med,Upper Limb Surg, Paris, France; [Lefevre-Colau, Marie-Martine] Univ Paris 05, Cochin Hosp, AP HP, Sorbonne Paris Cite,Phys Med & Rehabil Unit,Fac M, Sorbonne Paris Cite, Paris, France; [Vuillemin, Valerie; Cuenod, Charles-Andre] Univ Paris 05, European Hosp Georges Pompidou, AP HP, Sorbonne Paris Cite,Radiol Unit,Fac Med, Paris, France; [Hansen, Ulrich; Gregory, Thomas] Imperial Coll London, Dept Mech Engn, London, England; [Mir, Olivier; Gregory, Thomas] Univ Paris 05, Sorbonne Paris Cite, Inst MOVEO, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; UDICE-French Research Universities; Universite Paris Cite	Gregory, T (corresponding author), Univ Paris 05, European Hosp Georges Pompidou, AP HP, Sorbonne Paris Cite,Fac Med,Upper Limb Surg, Paris, France.; Gregory, T (corresponding author), Imperial Coll London, Dept Mech Engn, London, England.; Gregory, T (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Inst MOVEO, Fac Med, Paris, France.	tms.gregory@gmail.com	Mir, Olivier/GNP-7828-2022	Mir, Olivier/0000-0002-6761-4002; lefevre-colau, marie-martine/0000-0002-7493-1225; Cuenod, Charles Andre/0000-0002-6769-679X				Benoit DL, 2006, GAIT POSTURE, V24, P152, DOI 10.1016/j.gaitpost.2005.04.012; Bey MJ, 2011, AM J SPORT MED, V39, P2117, DOI 10.1177/0363546511412164; Billuart F, 2007, SURG RADIOL ANAT, V29, P291, DOI 10.1007/s00276-007-0208-2; Bodin J, 2012, AM J IND MED, V55, P605, DOI 10.1002/ajim.22002; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Deutsch A, 1996, J Shoulder Elbow Surg, V5, P186, DOI 10.1016/S1058-2746(05)80004-7; Giphart JE, 2012, J SHOULDER ELB SURG, V21, P1593, DOI 10.1016/j.jse.2011.11.023; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Graichen H, 1998, MAGN RESON MED, V40, P640, DOI 10.1002/mrm.1910400418; Graichen H, 2000, CLIN ORTHOP RELAT R, P154; Graichen H, 1999, AM J ROENTGENOL, V172, P1081, DOI 10.2214/ajr.172.4.10587151; Graichen H, 2005, J BIOMECH, V38, P755, DOI 10.1016/j.jbiomech.2004.05.020; Graichen H, 2001, J ORTHOP RES, V19, P1192, DOI 10.1016/S0736-0266(01)00035-3; Graichen H, 1999, SURG RADIOL ANAT, V21, P59, DOI 10.1007/BF01635055; Graichen H, 2000, J BIOMECH, V33, P609, DOI 10.1016/S0021-9290(99)00209-2; Hill AM, 2007, KNEE SURG SPORT TR A, V15, P1137, DOI 10.1007/s00167-007-0318-8; Illyes A, 2007, J ELECTROMYOGR KINES, V17, P355, DOI 10.1016/j.jelekin.2006.02.004; Lagace PY, 2012, COMPUT METHOD BIOMEC, V15, P221, DOI 10.1080/10255842.2010.522185; McPherson EJ, 1997, J SHOULDER ELB SURG, V6, P105, DOI 10.1016/S1058-2746(97)90030-6; Nove-Josserand L, 1999, REV CHIR ORTHOP, V85, P677; Paletta GA, 1997, J SHOULDER ELB SURG, V6, P516, DOI 10.1016/S1058-2746(97)90084-7; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Pierrart J, 2014, J MAGN RESON IMAGING, V39, P729, DOI 10.1002/jmri.24204; Sahara W, 2007, CLIN BIOMECH, V22, P304, DOI 10.1016/j.clinbiomech.2006.04.012; Sans N, 1996, J RADIOL, V77, P117; Thomazeau H, 1996, ACTA ORTHOP SCAND, V67, P264, DOI 10.3109/17453679608994685; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Yamaguchi K, 2000, J SHOULDER ELB SURG, V9, P6, DOI 10.1016/S1058-2746(00)90002-8; Zanetti M, 1998, INVEST RADIOL, V33, P163, DOI 10.1097/00004424-199803000-00006; Zhu ZL, 2012, MED ENG PHYS, V34, P1303, DOI 10.1016/j.medengphy.2011.12.021; Zumstein V, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-34	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158563	10.1371/journal.pone.0158563	http://dx.doi.org/10.1371/journal.pone.0158563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434235	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600011
J	Gharzai, L; Verma, V; Denniston, KA; Bhirud, AR; Bennion, NR; Lin, C				Gharzai, Laila; Verma, Vivek; Denniston, Kyle A.; Bhirud, Abhijeet R.; Bennion, Nathan R.; Lin, Chi			Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database	PLOS ONE			English	Article							3-DIMENSIONAL CONFORMAL RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; HEART-DISEASE; CHEMORADIATION THERAPY; CHEMORADIOTHERAPY; PROTON; RISK; VOLUME; TOXICITY; OUTCOMES	Objective Radiation therapy (RT) for esophageal cancer often results in unintended radiation doses delivered to the heart owing to anatomic proximity. Using the Surveillance, Epidemiology, and End Results (SEER) database, we examined late cardiac death in survivors of esophageal cancer that had or had not received RT. Methods 5,630 patients were identified that were diagnosed with esophageal squamous cell carcinoma (SCC) or adenocarcinoma (AC) from 1973-2012, who were followed for at least 5 years after therapy. Examined risk factors for cardiac death included age (<= 55/56-65/66-75/>75), gender, race (white/non-white), stage (local/regional/distant), histology (SCC/AC), esophageal location (<18cm/18-24cm/25-32cm/33-40cm from incisors), diagnosis year (1973-1992/1993-2002/2003-2012), and receipt of surgery and/or RT. Time to cardiac death was evaluated using the Kaplan-Meier method. A Cox model was used to evaluate risk factors for cardiac death in propensity score matched data. Results Patients who received RT were younger, diagnosed more recently, had more advanced disease, SCC histology, and no surgery. The RT group had higher risk of cardiac death than the no-RT group (log-rank p<0.0001). The median time to cardiac death in the RT group was 289 months (95% CI, 255-367) and was not reached in the no-RT group. The probability of cardiac death increased with age and decreased with diagnosis year, and this trend was more pronounced in the RT group. Multivariate analysis found RT to be associated with higher probability of cardiac death (OR 1.23, 95% CI 1.03-1.47, HR 1.961, 95% CI 1.466-2.624). Lower esophageal subsite (33-40 cm) was also associated with a higher risk of cardiac death. Other variables were not associated with cardiac death. Conclusions Recognizing the limitations of a SEER analysis including lack of comorbidity accountability, these data should prompt more definitive study as to whether a possible associative effect of RT on cardiac death could potentially be a causative effect.	[Gharzai, Laila] Univ Nebraska Med Ctr, Coll Med, Omaha, NE 68198 USA; [Verma, Vivek; Denniston, Kyle A.; Bhirud, Abhijeet R.; Bennion, Nathan R.; Lin, Chi] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA; [Denniston, Kyle A.] St Peters Hlth Partners Radiat Oncol, Albany, NY USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Gharzai, L (corresponding author), Univ Nebraska Med Ctr, Coll Med, Omaha, NE 68198 USA.	Laila@gharzai.net	Lin, Chi/AAE-2495-2019					Akutsu Y, 2012, J SURG ONCOL, V105, P750, DOI 10.1002/jso.22127; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Beukema JC, 2015, RADIOTHER ONCOL, V114, P85, DOI 10.1016/j.radonc.2014.11.037; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Chuong MD, 2016, INT J RADIAT ONCOL, V95, P488, DOI 10.1016/j.ijrobp.2015.11.043; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Eley JG, 2016, INT J RADIAT ONCOL, V95, P279, DOI 10.1016/j.ijrobp.2016.02.032; Frandsen J, 2015, J GASTROINTEST ONCOL, V6, P516, DOI 10.3978/j.issn.2078-6891.2015.040; Fukada J, 2013, INT J RADIAT ONCOL, V87, P487, DOI 10.1016/j.ijrobp.2013.07.008; Gayed I, 2009, INT J CARDIOVAS IMAG, V25, P487, DOI 10.1007/s10554-009-9440-7; Gayed IW, 2006, J NUCL MED, V47, P1756; HANCOCK SL, 1993, J CLIN ONCOL, V11, P1208, DOI 10.1200/JCO.1993.11.7.1208; Hatakenaka M, 2012, INT J RADIAT ONCOL, V83, pE67, DOI 10.1016/j.ijrobp.2011.12.018; Hayashi K, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140168; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; *INT AG RES CANC, 2012, GLOBOCAN 2012; Jingu K, 2006, INT J RADIAT ONCOL, V66, P845, DOI 10.1016/j.ijrobp.2006.06.007; Kataria T, 2014, J CANCER RES THER, V10, P871, DOI 10.4103/0973-1482.138217; Kole TP, 2012, INT J RADIAT ONCOL, V83, P1580, DOI 10.1016/j.ijrobp.2011.10.053; Konski A, 2012, RADIOTHER ONCOL, V104, P72, DOI 10.1016/j.radonc.2012.04.016; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Makishima H, 2015, J RADIAT RES, V56, P568, DOI 10.1093/jrr/rrv001; Mohammad NH, 2015, RADIOTHER ONCOL, V114, P91, DOI 10.1016/j.radonc.2014.12.005; Morota M, 2009, INT J RADIAT ONCOL, V75, P122, DOI 10.1016/j.ijrobp.2008.10.075; Mukherjee S, 2003, CLIN ONCOL-UK, V15, P115, DOI 10.1053/clon.2003.0218; National Cancer Institute, SURV EP END REPROG; Onwudiwe NC, 2014, CANCER MED-US, V3, P1342, DOI 10.1002/cam4.283; RODEMANN HP, 1995, RADIOTHER ONCOL, V35, P83, DOI 10.1016/0167-8140(95)01540-W; Rugbjerg K., 2014, JNCI-J NATL CANCER I, V106, P1; SPORN LA, 1984, BLOOD, V64, P567; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Tait LM, 2013, PRACT RADIAT ONCOL, V3, pE149, DOI 10.1016/j.prro.2013.02.001; Taylor CW, 2015, INT J RADIAT ONCOL, V93, P845, DOI 10.1016/j.ijrobp.2015.07.2292; Tripp P, 2005, DIS ESOPHAGUS, V18, P400, DOI 10.1111/j.1442-2050.2005.00523.x; Umezawa R, 2014, CLIN RADIOL, V69, P1273, DOI 10.1016/j.crad.2014.08.010; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Nimwegen FA, 2016, J CLIN ONCOL, V34, P235, DOI 10.1200/JCO.2015.63.4444; Verma V, 2016, CANCER-AM CANCER SOC, V122, P1483, DOI 10.1002/cncr.29882; VINKE B, 1962, ACTA MED SCAND, V172, P711; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Wang JY, 2013, INT J RADIAT ONCOL, V86, P885, DOI 10.1016/j.ijrobp.2013.04.006; Zhang P, 2015, RADIOTHER ONCOL, V115, P171, DOI 10.1016/j.radonc.2015.04.009	43	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158916	10.1371/journal.pone.0158916	http://dx.doi.org/10.1371/journal.pone.0158916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428362	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300023
J	Sutcliffe, AG; Dunbar, RIM; Wang, D				Sutcliffe, A. G.; Dunbar, R. I. M.; Wang, D.			Modelling the Evolution of Social Structure	PLOS ONE			English	Article							WILD FEMALE BABOONS; PREDATION RISK; NETWORK SIZE; PRIMATES; COOPERATION; FRIENDSHIP; COMMUNICATION; DETERMINANTS; ORGANIZATION; MECHANISMS	Although simple social structures are more common in animal societies, some taxa (mainly mammals) have complex, multi-level social systems, in which the levels reflect differential association. We develop a simulation model to explore the conditions under which multi-level social systems of this kind evolve. Our model focuses on the evolutionary trade-offs between foraging and social interaction, and explores the impact of alternative strategies for distributing social interaction, with fitness criteria for wellbeing, alliance formation, risk, stress and access to food resources that reward social strategies differentially. The results suggest that multi-level social structures characterised by a few strong relationships, more medium ties and large numbers of weak ties emerge only in a small part of the overall fitness landscape, namely where there are significant fitness benefits from wellbeing and alliance formation and there are high levels of social interaction. In contrast, 'favour-the-few' strategies are more competitive under a wide range of fitness conditions, including those producing homogeneous, single-level societies of the kind found in many birds and mammals. The simulations suggest that the development of complex, multi-level social structures of the kind found in many primates (including humans) depends on a capacity for high investment in social time, preferential social interaction strategies, high mortality risk and/or differential reproduction. These conditions are characteristic of only a few mammalian taxa.	[Sutcliffe, A. G.] Univ Manchester, Manchester Business Sch, Manchester, Lancs, England; [Dunbar, R. I. M.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Wang, D.] Khalifa Univ, EBTIC, Abu Dhabi, U Arab Emirates	University of Manchester; University of Oxford; Khalifa University of Science & Technology	Sutcliffe, AG (corresponding author), Univ Manchester, Manchester Business Sch, Manchester, Lancs, England.	ags@manchester.ac.uk			Engineering and Physical Sciences Research Council, UK [EP/D05088X/1]; ERC Advanced Investigator award; ESRC/EPSRC Cognitive Foresight Programme project TESS (Developing Theory for Evolving Socio-technical Systems); EPSRC [EP/D05088X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D05088X/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC Advanced Investigator award; ESRC/EPSRC Cognitive Foresight Programme project TESS (Developing Theory for Evolving Socio-technical Systems)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council, UK EP/D05088X/1. RD's research is supported by an ERC Advanced Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The preparation of this paper was supported by ESRC/EPSRC Cognitive Foresight Programme project TESS (Developing Theory for Evolving Socio-technical Systems). RD's research is supported by an ERC Advanced Investigator award.	Abbott D.H., 1986, P329; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Brown SL, 2006, PSYCHOL INQ, V17, P1, DOI 10.1207/s15327965pli1701_01; BUYS CJ, 1979, PSYCHOL REP, V45, P547, DOI 10.2466/pr0.1979.45.2.547; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; David-Barrett T, 2012, J THEOR BIOL, V308, P88, DOI 10.1016/j.jtbi.2012.05.007; Dunbar R., 1984, REPROD DECISIONS EC; Dunbar RIM, 2015, SOC NETWORKS, V43, P39, DOI 10.1016/j.socnet.2015.04.005; Dunbar RIM, 2009, BIOL REV, V84, P413, DOI 10.1111/j.1469-185X.2009.00080.x; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; DUNBAR RIM, 1980, BEHAV ECOL SOCIOBIOL, V7, P253, DOI 10.1007/BF00300665; DUNBAR RIM, 1987, INT J PRIMATOL, V8, P299, DOI 10.1007/BF02737386; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P273, DOI 10.1007/BF02734142; Dunbar RIM, 2009, SOCIAL BRAIN DISTRIB, P159; Dunbar RIM, 2016, OPEN SCI IN PRESS; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Gill SA, 2012, BEHAV ECOL SOCIOBIOL, V66, P757, DOI 10.1007/s00265-012-1323-6; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Greening BF, 2010, SCI REPORTS, V4, P3608; Grueter CC, 2010, BEHAV ECOL, V21, P63, DOI 10.1093/beheco/arp149; Hamilton MJ, 2007, P ROY SOC B-BIOL SCI, V274, P2195, DOI 10.1098/rspb.2007.0564; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; HAYS RB, 1989, J SOC PERS RELAT, V6, P21, DOI 10.1177/026540758900600102; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hewitt B R., 2003, NEXUS, V16, P27; Hill RA, 2000, BEHAV ECOL, V11, P560, DOI 10.1093/beheco/11.5.560; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hill RA, 1998, BEHAVIOUR, V135, P411; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; Hill RA, 2008, BIOL LETTERS, V4, P748, DOI 10.1098/rsbl.2008.0393; Hruschka DJ, 2006, J THEOR BIOL, V239, P1, DOI 10.1016/j.jtbi.2005.07.006; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; Krause J, 2002, LIVING GROUPS; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Lehmann J., 2014, LUCY LANGUAGE BENCHM, P245, DOI DOI 10.1093/ACPROF:OSOBL/9780199652594.003.0011; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; McPherson M, 2006, AM SOCIOL REV, V71, P353, DOI 10.1177/000312240607100301; Miritello G, 2013, SCI REPORTS, V13, P1950; Miritello G, 2013, SOC NETWORKS, V35, P89, DOI 10.1016/j.socnet.2013.01.003; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Opie C, 2014, P NATL ACAD SCI USA, V111, pE1675, DOI 10.1073/pnas.1403165111; Oswald DL, 2004, J SOC CLIN PSYCHOL, V23, P413, DOI 10.1521/jscp.23.3.413.35460; Pasquaretta C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07600; Pollet TV, 2011, J INDIVID DIFFER, V32, P161, DOI 10.1027/1614-0001/a000048; Roberts G, 2003, P ROY SOC B-BIOL SCI, V270, P2279, DOI 10.1098/rspb.2003.2491; Roberts SBG, 2015, HUM NATURE-INT BIOS, V26, P426, DOI 10.1007/s12110-015-9242-7; Rosas A, 2010, J THEOR BIOL, V264, P450, DOI 10.1016/j.jtbi.2010.02.015; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Rubenstein Daniel I., 2004, P266, DOI 10.1017/CBO9780511542459.017; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, P725, DOI 10.1098/rspb.2003.2626; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Shultz S, 2010, BEHAV ECOL, V21, P1073, DOI 10.1093/beheco/arq108; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Sutcliffe A, 2012, JASSS-J ARTIF SOC S, V15; Sutcliffe A, 2012, BRIT J PSYCHOL, V103, P149, DOI 10.1111/j.2044-8295.2011.02061.x; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; VanSchaik CP, 1997, P ROY SOC B-BIOL SCI, V264, P1687, DOI 10.1098/rspb.1997.0234; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; Wellman B., 2006, NETWORKED NEIGHBORHO; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009; Yamagishi T, 1998, AM J SOCIOL, V104, P165, DOI 10.1086/210005; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	77	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158605	10.1371/journal.pone.0158605	http://dx.doi.org/10.1371/journal.pone.0158605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427758	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300014
J	Tsekoa, TL; Lotter-Stark, T; Buthelezi, S; Chakauya, E; Stoychev, SH; Sabeta, C; Shumba, W; Phahladira, B; Hume, S; Morton, J; Rupprecht, CE; Steinkellner, H; Pauly, M; Zeitlin, L; Whaley, K; Chikwamba, R				Tsekoa, Tsepo Lebiletsa; Lotter-Stark, Therese; Buthelezi, Sindisiwe; Chakauya, Ereck; Stoychev, Stoyan H.; Sabeta, Claude; Shumba, Wonderful; Phahladira, Baby; Hume, Steve; Morton, Josh; Rupprecht, Charles E.; Steinkellner, Herta; Pauly, Michael; Zeitlin, Larry; Whaley, Kevin; Chikwamba, Rachel			Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3	PLOS ONE			English	Article							PROPHYLAXIS; GLYCOSYLATION; PREVENTION; EXPRESSION	Rabies is a neglected zoonotic disease that has no effective treatment after onset of illness. However the disease can be prevented effectively by prompt administration of post exposure prophylaxis which includes administration of passive immunizing antibodies (Rabies Immune Globulin, RIG). Currently, human RIG suffers from many restrictions including limited availability, batch-to batch inconsistencies and potential for contamination with blood-borne pathogens. Anti-rabies monoclonal antibodies (mAbs) have been identified as a promising alternative to RIG. Here, we applied a plant-based transient expression system to achieve rapid, high level production and efficacy of the two highly potent anti-rabies mAbs E559 and 62-71-3. Expression levels of up to 490 mg/kg of recombinant mAbs were obtained in Nicotiana benthamiana glycosylation mutants by using a viral based transient expression system. The plant-made E559 and 62-71-3, carrying human-type fucose-free N-glycans, assembled properly and were structurally sound as determined by mass spectrometry and calorimetric density measurements. Both mAbs efficiently neutralised diverse rabies virus variants in vitro. Importantly, E559 and 62-71-3 exhibited enhanced protection against rabies virus compared to human RIG in a hamster model post-exposure challenge trial. Collectively, our results provide the basis for the development of a multi-mAb based alternative to RIG.	[Tsekoa, Tsepo Lebiletsa; Lotter-Stark, Therese; Buthelezi, Sindisiwe; Chakauya, Ereck; Stoychev, Stoyan H.; Chikwamba, Rachel] CSIR, Biosci Unit, Pretoria, South Africa; [Sabeta, Claude; Shumba, Wonderful; Phahladira, Baby] ARC Onderstepoort Vet Inst, Onderstepoort, South Africa; [Pauly, Michael; Zeitlin, Larry; Whaley, Kevin] Mapp Biopharmaceut, San Diego, CA USA; [Hume, Steve; Morton, Josh] Kentucky Bioproc, Owensboro, KY USA; [Rupprecht, Charles E.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	Council for Scientific & Industrial Research (CSIR) - South Africa; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; The Wistar Institute; University of Natural Resources & Life Sciences, Vienna	Chikwamba, R (corresponding author), CSIR, Biosci Unit, Pretoria, South Africa.	rchikwamba@csir.co.za	Steinkellner, Herta/N-4267-2016; Rupprecht, Charles/AAI-1544-2020	Steinkellner, Herta/0000-0003-4823-1505; Tsekoa, Tsepo/0000-0002-5561-5462; Stark, Therese/0000-0002-0877-3695; Chakauya, Ereck/0000-0002-4282-1742; Stoychev, Stoyan/0000-0001-7504-4313	National Research Foundation; Technology Innovation Agency; Agricultural Research Council Rabies Diagnostic Cost Centre [15/04/P001]; Council for Scientific and Industrial Research; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	National Research Foundation; Technology Innovation Agency; Agricultural Research Council Rabies Diagnostic Cost Centre; Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LZ and KW are owners of Mapp Biopharmaceutical, a commercial company. MP is employed by Mapp Biopharmaceutical, while JM and SH are employed by Kentucky Bioprocessing, a commercial company. The authors thank the National Research Foundation (SB) (www.nrf.ac.za), Technology Innovation Agency (RC) (www.tia.org.za), the Agricultural Research Council Rabies Diagnostic Cost Centre (15/04/P001) (CS) and Council for Scientific and Industrial Research (SA) (TT, RC) (www.csir.co.za) for funding support. The funders provided support in the form of salaries for authors SB, TT and RC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Both L, 2013, FASEB J, V27, P2055, DOI 10.1096/fj.12-219964; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; DOI E, 1970, BIOCHEMISTRY-US, V9, P1066, DOI 10.1021/bi00807a003; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Gerdes CA, 2013, CLIN CANCER RES, V19, P1126, DOI 10.1158/1078-0432.CCR-12-0989; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hiatt A, 2014, P NATL ACAD SCI USA, V111, P5992, DOI 10.1073/pnas.1402458111; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Knobel D, 2005, B WORLD HEALTH ORGAN, V83, P931; Kuzmina N, 2013, J ANTIVIR ANTIRETROV, V5; Liu Y, 2007, BIOSENS BIOELECTRON, V23, P35, DOI 10.1016/j.bios.2007.03.009; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Muller T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000542; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Rybicki EP, 2012, BIOTECHNOL ADV, V30, P449, DOI 10.1016/j.biotechadv.2011.07.014; Satpathy D M, 2005, J Indian Med Assoc, V103, P241; Satpathy DM, 2005, J INDIAN MED ASSOC, V103, P41; Shantavasinkul P, 2011, ADV VIRUS RES, V79, P291, DOI 10.1016/B978-0-12-387040-7.00013-5; Smith TG, 2011, ADV VIRUS RES, V79, P345, DOI 10.1016/B978-0-12-387040-7.00016-0; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; van Dolleweerd CJ, 2014, J INFECT DIS, V210, P200, DOI 10.1093/infdis/jiu085; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727	25	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159313	10.1371/journal.pone.0159313	http://dx.doi.org/10.1371/journal.pone.0159313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427976	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300047
J	Muchova, K; Chromikova, Z; Bradshaw, N; Wilkinson, AJ; Barak, I				Muchova, Katarina; Chromikova, Zuzana; Bradshaw, Niels; Wilkinson, Anthony J.; Barak, Imrich			Morphogenic Protein RodZ Interacts with Sporulation Specific SpoIIE in Bacillus subtilis	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; WALL SYNTHETIC COMPLEXES; ESCHERICHIA-COLI; GENE-EXPRESSION; MREB HELIX; SHAPE; LOCALIZATION; FTSZ; ENGULFMENT; TRANSCRIPTION	The first landmark in sporulation of Bacillus subtilis is the formation of an asymmetric septum followed by selective activation of the transcription factor sigma(F) in the resulting smaller cell. How the morphological transformations that occur during sporulation are coupled to cell-specific activation of transcription is largely unknown. The membrane protein SpoIIE is a constituent of the asymmetric sporulation septum and is a crucial determinant of sF activation. Here we report that the morphogenic protein, RodZ, which is essential for cell shape determination, is additionally required for asymmetric septum formation and sporulation. In cells depleted of RodZ, formation of asymmetric septa is disturbed and sF activation is perturbed. During sporulation, we found that SpoIIE recruits RodZ to the asymmetric septum. Moreover, we detected a direct interaction between SpoIIE and RodZ in vitro and in vivo, indicating that SpoIIE-RodZ may form a complex to coordinate asymmetric septum formation and sF activation. We propose that RodZ could provide a link between the cell shape machinery and the coordinated morphological and developmental transitions required to form a resistant spore.	[Muchova, Katarina; Chromikova, Zuzana; Barak, Imrich] Slovak Acad Sci, Inst Mol Biol, Bratislava, Slovakia; [Bradshaw, Niels] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York, N Yorkshire, England	Slovak Academy of Sciences; Harvard University; University of York - UK	Barak, I (corresponding author), Slovak Acad Sci, Inst Mol Biol, Bratislava, Slovakia.	imrich.barak@savba.sk	Barak, Imrich/H-7285-2019	Barak, Imrich/0000-0002-3690-404X; Bradshaw, Niels/0000-0002-6845-4717; Chromikova, Zuzana/0000-0001-6478-5984	Slovak Academy of Sciences [VEGA 2/0009/13]; Research & Development Operational Programme - ERDF (ITMS) [26240220044]; Wellcome Trust [082829/Z/07/Z];  [APVV-14-0181]	Slovak Academy of Sciences(Slovak Academy of Sciences); Research & Development Operational Programme - ERDF (ITMS); Wellcome Trust(Wellcome TrustEuropean Commission); 	This work was supported by Grant VEGA 2/0009/13 from the Slovak Academy of Sciences, by grant APVV-14-0181, by the Research & Development Operational Programme funded by the ERDF (ITMS code: 26240220044) to IB and from The Wellcome Trust Project Grant 082829/Z/07/Z to AJW and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Alyahya SA, 2009, P NATL ACAD SCI USA, V106, P1239, DOI 10.1073/pnas.0810794106; Arigoni F, 1999, MOL MICROBIOL, V31, P1407, DOI 10.1046/j.1365-2958.1999.01282.x; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Aung S, 2007, MOL MICROBIOL, V65, P1534, DOI 10.1111/j.1365-2958.2007.05887.x; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Barak I, 2005, MOL MICROBIOL, V57, P611, DOI 10.1111/j.1365-2958.2005.04687.x; Barak I, 1996, J BACTERIOL, V178, P4984, DOI 10.1128/jb.178.16.4984-4989.1996; Barak I, 1996, MOL MICROBIOL, V19, P1047, DOI 10.1046/j.1365-2958.1996.433963.x; Barak I, 2008, MOL MICROBIOL, V68, P1315, DOI 10.1111/j.1365-2958.2008.06236.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Campo N, 2008, J BIOL CHEM, V283, P4975, DOI 10.1074/jbc.M708024200; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carniol K, 2005, J BACTERIOL, V187, P3511, DOI 10.1128/JB.187.10.3511-3520.2005; Chastanet A, 2007, MOL MICROBIOL, V64, P139, DOI 10.1111/j.1365-2958.2007.05652.x; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Errington J, 2015, NAT REV MICROBIOL, V13, P241, DOI 10.1038/nrmicro3398; Eswaramoorthy P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004526; Favini-Stabile S, 2013, ENVIRON MICROBIOL, V15, P3218, DOI 10.1111/1462-2920.12171; Feucht A, 2001, GENE, V264, P289, DOI 10.1016/S0378-1119(01)00338-9; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Gaballah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025129; Gerdes K, 2009, EMBO J, V28, P171, DOI 10.1038/emboj.2008.287; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hartl B, 2001, J BACTERIOL, V183, P2696, DOI 10.1128/JB.183.8.2696-2699.2001; Harwood C.R., 1990, MOL BIOL METHODS BAC; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; Jacquier N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4578; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Miller J.H., 1972, EXPT MOL GENETICS; Morgenstein RM, 2015, P NATL ACAD SCI USA, V112, P12510, DOI 10.1073/pnas.1509610112; Muchova K, 2013, ENVIRON MICROBIOL, V15, P3259, DOI 10.1111/1462-2920.12200; Rawlings AE, 2010, PROTEIN ENG DES SEL, V23, P817, DOI 10.1093/protein/gzq057; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Shiomi D, 2008, EMBO J, V27, P3081, DOI 10.1038/emboj.2008.234; Szwedziak P, 2013, CURR OPIN MICROBIOL, V16, P745, DOI 10.1016/j.mib.2013.09.003; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van den Ent F, 2014, ELIFE, V3, DOI 10.7554/eLife.02634; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; Varma A, 2009, J BACTERIOL, V191, P3526, DOI 10.1128/JB.01812-08; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Williams AH, 2014, RES MICROBIOL, V165, P60, DOI 10.1016/j.resmic.2013.11.002; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	61	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159076	10.1371/journal.pone.0159076	http://dx.doi.org/10.1371/journal.pone.0159076			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415800	Green Published, Green Accepted, gold			2022-12-26	WOS:000379579500071
J	Lowe, LC; Gaser, C; Franke, K				Loewe, Luise Christine; Gaser, Christian; Franke, Katja		Alzheimer's Dis Neuroimaging	The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; EPSILON 4 ALLELE; E TYPE-4 ALLELE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; HIPPOCAMPAL ATROPHY; NATIONAL INSTITUTE; DECLINE; ONSET; MRI	In our aging society, diseases in the elderly come more and more into focus. An important issue in research is Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) with their causes, diagnosis, treatment, and disease prediction. We applied the Brain Age Gap Estimation (BrainAGE) method to examine the impact of the Apolipoprotein E (APOE) genotype on structural brain aging, utilizing longitudinal magnetic resonance image (MRI) data of 405 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We tested for differences in neuroanatomical aging between carrier and non-carrier of APOE epsilon 4 within the diagnostic groups and for longitudinal changes in individual brain aging during about three years follow-up. We further examined whether a combination of BrainAGE and APOE status could improve prediction accuracy of conversion to AD in MCI patients. The influence of the APOE status on conversion from MCI to AD was analyzed within all allelic subgroups as well as for e4 carriers and non-carriers. The BrainAGE scores differed significantly between normal controls, stable MCI (sMCI) and progressive MCI (pMCI) as well as AD patients. Differences in BrainAGE changing rates over time were observed for APOE e4 carrier status as well as in the pMCI and AD groups. At baseline and during follow-up, BrainAGE scores correlated significantly with neuropsychological test scores in APOE e4 carriers and non-carriers, especially in pMCI and AD patients. Prediction of conversion was most accurate using the BrainAGE score as compared to neuropsychological test scores, even when the patient's APOE status was unknown. For assessing the individual risk of coming down with AD as well as predicting conversion from MCI to AD, the BrainAGE method proves to be a useful and accurate tool even if the information of the patient's APOE status is missing.	[Loewe, Luise Christine] Univ Jena, Fac Med, Jena, Germany; [Gaser, Christian; Franke, Katja] Univ Hosp Jena, Dept Neurol, Struct Brain Mapping Grp, Jena, Germany; [Gaser, Christian] Univ Hosp Jena, Dept Psychiat, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Franke, K (corresponding author), Univ Hosp Jena, Dept Neurol, Struct Brain Mapping Grp, Jena, Germany.	katja.franke@uni-jena.de	Gaser, Christian/F-5103-2010; Franke, Katja/S-7577-2017	Gaser, Christian/0000-0002-9940-099X; Franke, Katja/0000-0003-1859-5738	European Community [FB7 HEALTH Project (Brain Age)] [279281]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	European Community [FB7 HEALTH Project (Brain Age)]; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the European Community [FB7 HEALTH Project 279281 (Brain Age) to K.F.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Carlos, 2014, Front Aging Neurosci, V6, P145, DOI 10.3389/fnagi.2014.00145; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Anderson VM, 2012, NEUROBIOL AGING, V33, P1194, DOI 10.1016/j.neurobiolaging.2010.11.001; [Anonymous], 1996, Lancet, V347, P1091; Apostolova LG, 2014, NEUROIMAGE-CLIN, V4, P461, DOI 10.1016/j.nicl.2013.12.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Basso M, 2006, NEUROBIOL AGING, V27, P1416, DOI 10.1016/j.neurobiolaging.2005.08.002; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Bertram L, 2004, PHARMACOL RES, V50, P385, DOI 10.1016/j.phrs.2003.11.018; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Boissonneault GA, 2010, JAAPA-J AM ACAD PHYS, V23, P21; Boissonneault Gilbert A, 2010, JAAPA, V23, P21; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Desikan RS, 2008, NEUROLOGY, V71, P819, DOI 10.1212/01.wnl.0000320055.57329.34; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Franke K, 2012, GEROPSYCH, V25, P235, DOI 10.1024/1662-9647/a000074; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Franko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071354; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Growdon JH, 1996, NEUROLOGY, V47, P444, DOI 10.1212/WNL.47.2.444; Hinrichs C, 2009, NEUROIMAGE, V48, P138, DOI 10.1016/j.neuroimage.2009.05.056; Hirono N, 2003, J NEUROPSYCH CLIN N, V15, P354, DOI 10.1176/appi.neuropsych.15.3.354; Holmes C, 1996, J NEUROL NEUROSUR PS, V61, P580, DOI 10.1136/jnnp.61.6.580; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Hoyt BD, 2005, ARCH NEUROL-CHICAGO, V62, P454, DOI 10.1001/archneur.62.3.454; Hua X, 2009, NEUROIMAGE, V48, P668, DOI 10.1016/j.neuroimage.2009.07.011; Jack CR, 2008, NEUROLOGY, V70, P1740, DOI 10.1212/01.wnl.0000281688.77598.35; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 1998, ANN NEUROL, V43, P303, DOI 10.1002/ana.410430307; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kester Maartje I, 2009, Pract Neurol, V9, P241, DOI 10.1136/jnnp.2009.182477; Kurz A, 1996, J NEUROL, V243, P452, DOI 10.1007/BF00900498; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; Liddell MB, 2001, BRIT J PSYCHIAT, V178, P7, DOI 10.1192/bjp.178.1.7; Manning E, 2014, TECHNOL LIVED ABSTR, P1; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; MOHS RC, 1988, PSYCHOPHARMACOL BULL, V24, P627; Mori E, 2002, ANN NEUROL, V51, P209, DOI 10.1002/ana.10093; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; NALBANTOGLU J, 1994, ANN NEUROL, V36, P889, DOI 10.1002/ana.410360614; Olichney JM, 1996, NEUROLOGY, V47, P190, DOI 10.1212/WNL.47.1.190; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; ROSES AD, 1994, LANCET, V343, P1564, DOI 10.1016/S0140-6736(94)92960-2; Saunders AM, 2000, J NEUROPATH EXP NEUR, V59, P751, DOI 10.1093/jnen/59.9.751; Sluimer JD, 2009, EUR RADIOL, V19, P2826, DOI 10.1007/s00330-009-1512-5; SOBEL E, 1995, NEUROLOGY, V45, P903, DOI 10.1212/WNL.45.5.903; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spulber G, 2010, NEUROBIOL AGING, V31, P1601, DOI 10.1016/j.neurobiolaging.2008.08.018; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P691, DOI 10.1076/jcen.25.5.691.14573; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 1997, ANN NEUROL, V41, P615, DOI 10.1002/ana.410410510; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Susanto TAK, 2015, J ALZHEIMERS DIS, V45, P253, DOI 10.3233/JAD-142451; Thakkinstian A, 2006, AM J EPIDEMIOL, V164, P813, DOI 10.1093/aje/kwj279; Tipping ME, 2000, ADV NEUR IN, V12, P652; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Tsuang D, 1999, ARCH NEUROL-CHICAGO, V56, P1489, DOI 10.1001/archneur.56.12.1489; UTERMANN G, 1980, AM J HUM GENET, V32, P339; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yu L, 2013, PSYCHOL AGING, V28, P1015, DOI 10.1037/a0031642; ZANNIS VI, 1981, AM J HUM GENET, V33, P11	84	62	63	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157514	10.1371/journal.pone.0157514	http://dx.doi.org/10.1371/journal.pone.0157514			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410431	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300011
J	Pandey, S; Patel, MK; Mishra, A; Jha, B				Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath			In planta Transformed Cumin (Cuminum cyminum L.) Plants, Overexpressing the SbNHX1 Gene Showed Enhanced Salt Endurance	PLOS ONE			English	Article							VACUOLAR NA+/H+ ANTIPORTER; SALICORNIA-BRACHIATA; ARABIDOPSIS-THALIANA; EXTINCTION COEFFICIENTS; SEED TRANSFORMATION; TISSUE-CULTURE; CHLOROPHYLL-A; REGENERATION; STRESS; EXPRESSION	Cumin is an annual, herbaceous, medicinal, aromatic, spice glycophyte that contains diverse applications as a food and flavoring additive, and therapeutic agents. An efficient, less time consuming, Agrobacterium-mediated, a tissue culture-independent in planta genetic transformation method was established for the first time using cumin seeds. The SbNHX1 gene, cloned from an extreme halophyte Salicornia brachiata was transformed in cumin using optimized in planta transformation method. The SbNHX1 gene encodes a vacuolar Na+/H+ antiporter and is involved in the compartmentalization of excess Na+ ions into the vacuole and maintenance of ion homeostasis Transgenic cumin plants were confirmed by PCR using gene (SbNHX1, uidA and hptII) specific primers. The single gene integration event and overexpression of the gene were confirmed by Southern hybridization and competitive RT-PCR, respectively. Transgenic lines L3 and L13 showed high expression of the SbNHX1 gene compared to L6 whereas moderate expression was detected in L5 and L10 transgenic lines. Transgenic lines (L3, L5, L10 and L13), overexpressing the SbNHX1 gene, showed higher photosynthetic pigments (chlorophyll a, b and carotenoid), and lower electrolytic leakage, lipid peroxidation (MDA content) and proline content as compared to wild type plants under salinity stress. Though transgenic lines were also affected by salinity stress but performed better compared to WT plants. The ectopic expression of the SbNHX1 gene confirmed enhanced salinity stress tolerance in cumin as compared to wild type plants under stress condition. The present study is the first report of engineering salt tolerance in cumin, so far and the plant may be utilized for the cultivation in saline areas.	[Pandey, Sonika; Patel, Manish Kumar; Mishra, Avinash; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, GB Marg, Bhavnagar 364002, Gujarat, India; [Pandey, Sonika; Mishra, Avinash; Jha, Bhavanath] Acad Sci & Innovat Res, CSIR, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Mishra, A; Jha, B (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, GB Marg, Bhavnagar 364002, Gujarat, India.; Mishra, A; Jha, B (corresponding author), Acad Sci & Innovat Res, CSIR, New Delhi, India.	avinash@csmcri.org; bjha@csmcri.org	Mishra, Avinash/C-3210-2009; Patel, Manish Kumar/I-6335-2017; Mishra, Avinash/AAG-2961-2019	Mishra, Avinash/0000-0003-0342-010X; Patel, Manish Kumar/0000-0001-5250-1008; Mishra, Avinash/0000-0003-0342-010X	Council of Scientific and Industrial Research (CSIR); Government of India, New Delhi [BSC0107-PlaGen]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Government of India, New Delhi	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [BSC0107-PlaGen]. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	ADAMS P, 1992, PLANT CELL PHYSIOL, V33, P1215; Ahmad P., 2016, PLANT ENV INTERACTIO; Alireza Bahraminejad, 2012, Australian Journal of Crop Science, V6, P194; Bai JJ, 2013, PROTOC EXCH, DOI [10.1038/protex.2013.067, DOI 10.1038/PROTEX.2013.067]; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Bairwa RK., 2015, INT J SEED SPICES, V5, P68; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BRAUN AC, 1952, GROWTH, V16, P65; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Ebrahimie E, 2006, IN VITRO CELL DEV-PL, V42, P455, DOI 10.1079/IVP2006789; EVANS DA, 1986, BIO-TECHNOL, V4, P528, DOI 10.1038/nbt0686-528; FELDMANN KA, 1987, MOL GEN GENET, V208, P1, DOI 10.1007/BF00330414; Gordon-Kamm W, 2002, P NATL ACAD SCI USA, V99, P11975, DOI 10.1073/pnas.142409899; Hassanzadehdelouei M., 2013, Cercetari Agronomice in Moldova, V46, P89; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hunault H, 1989, BIOTECHNOLOGY AGR FO, P185; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Johri R K, 2011, Pharmacogn Rev, V5, P63, DOI 10.4103/0973-7847.79101; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Kabak B, 2017, CRIT REV FOOD SCI, V57, P18, DOI 10.1080/10408398.2013.772891; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Koocheki A., 2008, Journal of Herbs, Spices & Medicinal Plants, V14, P37, DOI 10.1080/10496470802341201; Lal R, 2011, WORLD SOIL RESOURCES; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Lin JZ, 2009, PLANT CELL REP, V28, P1065, DOI 10.1007/s00299-009-0706-2; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Mayavan S, 2013, PLANT CELL REP, V32, P1557, DOI 10.1007/s00299-013-1467-5; Meena RS, 2015, INT J SEED SPICES, V5, P99; Mishra A, 2008, MOL BIOL REP, V35, P81, DOI 10.1007/s11033-007-9056-8; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Morshedi D, 2015, J FOOD SCI, V80, pH2336, DOI 10.1111/1750-3841.13016; PADAN E, 1994, J EXP BIOL, V196, P443; Pandey S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144469; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Park BJ, 2005, PLANT CELL REP, V24, P494, DOI 10.1007/s00299-005-0973-5; Patel MK, 2015, PLANT CELL TISS ORG, V122, P477, DOI 10.1007/s11240-015-0785-4; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qadir M, 2014, NAT RESOUR FORUM, V38, P282, DOI 10.1111/1477-8947.12054; Rebey IB, 2012, J FOOD SCI, V77, pC734, DOI 10.1111/j.1750-3841.2012.02731.x; Rengasamy P, 2002, AUST J EXP AGR, V42, P351, DOI 10.1071/EA01111; SANGWAN RS, 1992, PLANTA, V188, P439, DOI 10.1007/BF00192812; Sankara Rao K, 2008, Physiol Mol Biol Plants, V14, P321, DOI 10.1007/s12298-008-0030-2; Shao HB, 2008, CR BIOL, V331, P215, DOI 10.1016/j.crvi.2008.01.002; Shoor M, 2014, RES J AGR ENV MANAGE, V3, P340; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; Sottosanto JB, 2004, PLANT J, V40, P752, DOI 10.1111/j.1365-313X.2004.02253.x; Sottosanto JB, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-18; Sowbhagya HB, 2013, CRIT REV FOOD SCI, V53, P1, DOI 10.1080/10408398.2010.500223; Subramanyam K, 2013, APPL BIOCHEM BIOTECH, V171, P450, DOI 10.1007/s12010-013-0359-z; TIWARI V, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0131567; Tiwari V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148494; Tiwari V, 2015, APPL BIOCHEM BIOTECH, V175, P436, DOI 10.1007/s12010-014-1286-3; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Udawat P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00518; Verma D, 2007, J BIOSCIENCES, V32, P621, DOI 10.1007/s12038-007-0061-9; Wei J, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/474509	68	13	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159349	10.1371/journal.pone.0159349	http://dx.doi.org/10.1371/journal.pone.0159349			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411057	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300080
J	Kim, J; Lee, HY; Ahn, J; Hyun, M; Lee, I; Min, KJ; You, YJ				Kim, Jeongho; Lee, Hye-Yeon; Ahn, Jheesoo; Hyun, Moonjung; Lee, Inhwan; Min, Kyung-Jin; You, Young-Jai			NHX-5, an Endosomal Na+/H+ Exchanger, Is Associated with Metformin Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; Caenorhabditis elegans (C; elegans); drug action; endosome; metformin; sodium-proton exchange; Type 2 diabetes; sodium-proton exchange	CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; C. ELEGANS; AUTOPHAGY; COMPLEX; APOPTOSIS; AMPK; DYSFUNCTION; MECHANISMS; SURVIVAL	Diabetes is one of the most impactful diseases worldwide. The most commonly prescribed anti-diabetic drug is metformin. In this study, we identified an endosomal Na+/H+ exchanger (NHE) as a new potential target of metformin from an unbiased screen in Caenorhabditis elegans. The same NHE homolog also exists in flies, where it too mediates the effects of metformin. Our results suggest that endosomal NHEs could be a metformin target and provide an insight into a novel mechanism of action of metformin on regulating the endocytic cycle.	[Kim, Jeongho; Lee, Hye-Yeon; Min, Kyung-Jin] Inha Univ, Dept Biol Sci, Inchon 22212, South Korea; [Ahn, Jheesoo; Hyun, Moonjung; Lee, Inhwan; You, Young-Jai] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [You, Young-Jai] Nagoya Univ, Grad Sch Sci, Nagoya Res Ctr Brain & Neural Circuits, Nagoya, Aichi 4648602, Japan	Inha University; Virginia Commonwealth University; Nagoya University	You, YJ (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.; You, YJ (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya Res Ctr Brain & Neural Circuits, Nagoya, Aichi 4648602, Japan.	yjyou@bio.nagoya-u.ac.jp	Min, Kyung-Jin/AAG-5774-2020	Min, Kyung-Jin/0000-0001-5829-6842; you, young/0000-0002-5716-5418	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; Bloomington Drosophila Stock Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; Bloomington Drosophila Stock Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. L. Avery for reviewing the manuscript and Dr. K.-C. Kim for helping with WGS analysis. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440) and the Bloomington Drosophila Stock Center.	AVERY L, 1993, GENETICS, V133, P897; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Djeddi A, 2012, J CELL SCI, V125, P685, DOI 10.1242/jcs.091702; DOMS RW, 1985, J BIOL CHEM, V260, P2973; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044720; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0128448, 10.1371/journal.pone.0136385]; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Park DB, 2015, DIABETES METAB J, V39, P518, DOI 10.4093/dmj.2015.39.6.518; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Slack C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047699; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Sulston J., 1988, NEMATODE CAENORHABDI, P594; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilson CM, 2014, CNS NEUROL DISORD-DR, V13, P226, DOI 10.2174/18715273113126660146; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	47	15	15	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18591	18599		10.1074/jbc.C116.744037	http://dx.doi.org/10.1074/jbc.C116.744037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27435670	Green Published, hybrid			2022-12-26	WOS:000383241800047
J	Chou, LM; Toh, TC; Ben Toh, K; Ng, CSL; Cabaitan, P; Tun, K; Goh, E; Afiq-Rosli, L; Taira, D; Du, RCP; Loke, HX; Khalis, A; Li, JH; Song, TC				Chou, Loke Ming; Toh, Tai Chong; Ben Toh, Kok; Ng, Chin Soon Lionel; Cabaitan, Patrick; Tun, Karenne; Goh, Eugene; Afiq-Rosli, Lutfi; Taira, Daisuke; Du, Rosa Celia Poquita; Loke, Hai Xin; Khalis, Aizat; Li, Jinghan; Song, Tiancheng			Differential Response of Coral Assemblages to Thermal Stress Underscores the Complexity in Predicting Bleaching Susceptibility	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CNIDARIA ANTHOZOA SCLERACTINIA; CLIMATE-CHANGE; TAXONOMIC CLASSIFICATION; WATER-QUALITY; SURVIVAL; TEMPERATURE; MORTALITY; SINGAPORE; ISLANDS	Coral bleaching events have been predicted to occur more frequently in the coming decades with global warming. The susceptibility of corals to bleaching during thermal stress episodes is dependent on many factors and an understanding of these underlying drivers is crucial for conservation management. In 2013, a mild bleaching episode ensued in response to elevated sea temperature on the sediment-burdened reefs in Singapore. Surveys of seven sites highlighted variable bleaching susceptibility among coral genera-Pachyseris and Podabacia were the most impacted (31% of colonies of both genera bleached). The most susceptible genera such as Acropora and Pocillopora, which were expected to bleach, did not. Susceptibility varied between less than 6% and more than 11% of the corals bleached, at four and three sites respectively. Analysis of four of the most bleached genera revealed that a statistical model that included a combination of the factors (genus, colony size and site) provided a better explanation of the observed bleaching patterns than any single factor alone. This underscored the complexity in predicting the coral susceptibility to future thermal stress events and the importance of monitoring coral bleaching episodes to facilitate more effective management of coral reefs under climate change.	[Chou, Loke Ming; Toh, Tai Chong; Ben Toh, Kok; Ng, Chin Soon Lionel; Cabaitan, Patrick; Afiq-Rosli, Lutfi; Taira, Daisuke; Du, Rosa Celia Poquita; Loke, Hai Xin] Natl Univ Singapore, Trop Marine Sci Inst, 18 Kent Ridge Rd, Singapore 119227, Singapore; [Tun, Karenne] Natl Pk Board, Natl Biodivers Ctr, 1 Cluny Rd, Singapore 259569, Singapore; [Goh, Eugene] DHI Water & Environm, 1 Cleantech Loop,03-04 CleanTech One, Singapore 637141, Singapore; [Khalis, Aizat; Li, Jinghan] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore; [Song, Tiancheng] Maritime & Port Author Singapore, 460 Alexandra Rd,PSA Bldg, Singapore 119963, Singapore	National University of Singapore; National University of Singapore	Toh, TC (corresponding author), Natl Univ Singapore, Trop Marine Sci Inst, 18 Kent Ridge Rd, Singapore 119227, Singapore.	Taichong.toh@nus.edu.sg	Ng, Lionel/AAF-5117-2020; Chou, Loke/AAE-5266-2020; Afiq-Rosli, Lutfi/AAB-9151-2019	Ng, Lionel/0000-0003-2700-3474; Chou, Loke/0000-0001-6668-399X; Afiq-Rosli, Lutfi/0000-0002-3987-4712; Toh, Kok Ben/0000-0003-1371-817X; Toh, Tai Chong/0000-0003-2961-4199	Maritime and Port Authority of Singapore [R347-000-215-490]; DHI Water and Environment	Maritime and Port Authority of Singapore; DHI Water and Environment	This work was funded by the Maritime and Port Authority of Singapore (Grant number: R347-000-215-490, http://www.mpa.gov.sg/) granted to LMC. This study is part of the project "Enhancing Singapore's Coral Reef Ecosystem in a Green Port". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors, EG is employed by a commercial company: DHI Water and Environment. The funder provided support in the form of salaries for EG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.r We would like to express our gratitude to Dr. Danwei Huang (Department of Biological Sciences, NUS) for his advice on the coral taxonomy, and Dr. Kwek Yan Chong (Department of Biological Sciences, NUS) and Dr. Alex Thiery (Department of Statistics and Applied Probablity, NUS) for their advice on statistical analyses. This study is part of the project "Enhancing Singapore's Coral Reef Ecosystem in a Green Port" supported by the Maritime and Port Authority of Singapore.	Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Bena C, 2004, B MAR SCI, V75, P115; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Browne NK, 2015, MAR ENVIRON RES, V105, P39, DOI 10.1016/j.marenvres.2015.02.002; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; CHOU L M, 1988, Galaxea, V7, P101; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Dikou A, 2006, MAR POLLUT BULL, V52, P7, DOI 10.1016/j.marpolbul.2005.07.021; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Edwards AJ, 2001, MAR POLLUT BULL, V42, P7, DOI 10.1016/S0025-326X(00)00200-9; Gittenberger A, 2011, CONTRIB ZOOL, V80, P107, DOI 10.1163/18759866-08002002; GRIGG RW, 1992, SCIENCE, V255, P172, DOI 10.1126/science.255.5041.172; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2009, CORAL REEFS, V28, P569, DOI 10.1007/s00338-009-0508-6; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoeksema BW, 2009, RAFFLES B ZOOL, P81; Huang DW, 2014, ZOOL J LINN SOC-LOND, V171, P277, DOI 10.1111/zoj12140; Huang DW, 2009, RAFFLES B ZOOL, P69; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; Nadaoka K, 2001, CORAL REEFS, V20, P373, DOI 10.1007/s00338-001-0187-4; Nakamura T, 2001, MAR ECOL PROG SER, V212, P301, DOI 10.3354/meps212301; National Oceanic and Atmospheric Administration Coral Reef Watch, 2000, NOAA COR REEF WATCH; Ng CS, 2016, REGIONAL STUDIES MAR; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Toh TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098529; Tun K, 2011, 22 PAC SCI C; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; Veron J. E., 2000, CORALS WORLD, V1; Wagner DE, 2010, MAR ECOL PROG SER, V408, P65, DOI 10.3354/meps08584; Wallace CC, 2012, MEMOIRS QUEENSLAND M	39	30	30	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159755	10.1371/journal.pone.0159755	http://dx.doi.org/10.1371/journal.pone.0159755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438593	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100073
J	Gualda, GAR; Sutton, SR				Gualda, Guilherme A. R.; Sutton, Stephen R.			The Year Leading to a Supereruption	PLOS ONE			English	Article							SILICIC MAGMA SYSTEM; X-RAY TOMOGRAPHY; BISHOP-TUFF; LONG-VALLEY; MELT INCLUSIONS; EXSOLVED GAS; TI DIFFUSION; QUARTZ; TITANIQ; PRESSURE	Supereruptions catastrophically eject 100s-1000s of km(3) of magma to the surface in a matter of days to a few months. In this study, we use zoning in quartz crystals from the Bishop Tuff (California) to assess the timescales over which a giant magma body transitions from relatively quiescent, pre-eruptive crystallization to rapid decompression and eruption. Quartz crystals in the Bishop Tuff have distinctive rims (<200 mu m thick), which are Ti-rich and bright in cathodoluminescence (CL) images, and which can be used to calculate Ti diffusional relaxation times. We use synchrotron-based x-ray microfluorescence to obtain quantitative Ti maps and profiles along rim-interior contacts in quartz at resolutions of 1-5 mu m in each linear dimension. We perform CL imaging on a scanning electron microscope (SEM) using a low-energy (5 kV) incident beam to characterize these contacts in high resolution (< 1 mu m in linear dimensions). Quartz growth times were determined using a 1D model for Ti diffusion, assuming initial step functions. Minimum quartz growth rates were calculated using these calculated growth times and measured rim thicknesses. Maximum rim growth times span from similar to 1 min to 35 years, with a median of similar to 4 days. More than 70% of rim growth times are less than 1 year, showing that quartz rims have mostly grown in the days to months prior to eruption. Minimum growth rates show distinct modes between 10-8 and 10-10 m/s (depending on sample), revealing very fast crystal growth rates (100s of nm to 10s of mu m per day). Our data show that quartz rims grew well within a year of eruption, with most of the growth happening in the weeks or days preceding eruption. Growth took place under conditions of high supersaturation, suggesting that rim growth marks the onset of decompression and the transition from pre-eruptive to syn-eruptive conditions.	[Gualda, Guilherme A. R.] Vanderbilt Univ, Earth & Environm Sci, PMB 351805, Nashville, TN 37235 USA; [Sutton, Stephen R.] Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA; [Sutton, Stephen R.] Ctr Adv Radiat Sources, Chicago, IL 60637 USA	Vanderbilt University; University of Chicago	Gualda, GAR (corresponding author), Vanderbilt Univ, Earth & Environm Sci, PMB 351805, Nashville, TN 37235 USA.	g.gualda@vanderbilt.edu			NSF [EAR-1151337]; Vanderbilt Discovery Grant; National Science Foundation-Earth Sciences [EAR-1128799]; Department of Energy-GeoSciences [DE-FG02-94ER14466]; DOE Office of Science [DE-AC02-06CH11357]	NSF(National Science Foundation (NSF)); Vanderbilt Discovery Grant; National Science Foundation-Earth Sciences(National Science Foundation (NSF)); Department of Energy-GeoSciences(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE))	The work was partly funded by NSF grant EAR-1151337 and a Vanderbilt Discovery Grant to Gualda. The synchrotron x-ray analysis portions of this work were performed at GeoSoilEnviroCARS (The University of Chicago, Sector 13), Advanced Photon Source (APS), Argonne National Laboratory. GeoSoilEnviroCARS is supported by the National Science Foundation-Earth Sciences (EAR-1128799) and Department of Energy-GeoSciences (DE-FG02-94ER14466). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Ayla Pamukcu, Mark Ghiorso, Darren Gravley, Lydia Harmon, and Samantha Tramontano for suggestions on earlier versions of the manuscript. Reviews by Naomi Matthews and an anonymous reviewer, and editorial handling by Axel Schmitt are greatly appreciated. The work was partly funded by NSF grant EAR-1151337 and a Vanderbilt Discovery Grant to Gualda. Portions of this work were performed at GeoSoilEnviroCARS (The University of Chicago, Sector 13), Advanced Photon Source (APS), Argonne National Laboratory. GeoSoilEnviroCARS is supported by the National Science Foundation-Earth Sciences (EAR-1128799) and Department of Energy-GeoSciences (DE-FG02-94ER14466). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	ANDERSON AT, 1991, AM MINERAL, V76, P530; Anderson AT, 2000, J PETROL, V41, P449, DOI 10.1093/petrology/41.3.449; BAILEY RA, 1976, J GEOPHYS RES, V81, P725, DOI 10.1029/JB081i005p00725; Begue F, 2014, J PETROL, V55, P1653, DOI 10.1093/petrology/egu038; Bindeman IN, 2002, CONTRIB MINERAL PETR, V144, P185, DOI 10.1007/s00410-002-0371-8; Blundy J, 2001, CONTRIB MINERAL PETR, V140, P631, DOI 10.1007/s004100000219; Carslaw HS, 1984, CONDUCTION OF HEAT I, DOI [10.1093/pertology/egr080, DOI 10.1093/PETROLOGY/EGR080]; Chamberlain KJ, 2015, J PETROL, V56, P605, DOI 10.1093/petrology/egv012; Chamberlain KJ, 2014, J PETROL, V55, P395, DOI 10.1093/petrology/egt072; Chamberlain KJ, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1034-2; Cherniak DJ, 2007, CHEM GEOL, V236, P65, DOI 10.1016/j.chemgeo.2006.09.001; Cooper GF, 2012, EARTH PLANET SC LETT, V313, P23, DOI 10.1016/j.epsl.2011.11.006; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; Crowley JL, 2007, GEOLOGY, V35, P1123, DOI 10.1130/G24017A.1; Davies GR, 1998, GEOCHIM COSMOCHIM AC, V62, P3561, DOI 10.1016/S0016-7037(98)00247-6; Gualda GAR, 2004, T ROY SOC EDIN-EARTH, V95, P375; Gualda GAR, 2006, J VOLCANOL GEOTH RES, V154, P48, DOI 10.1016/j.jvolgeores.2005.09.019; Gualda GAR, 2013, J GEOL, V121, P537, DOI 10.1086/671395; Gualda GAR, 2013, CONTRIB MINERAL PETR, V166, P755, DOI 10.1007/s00410-013-0901-6; Gualda GAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037492; Gualda GAR, 2012, J PETROL, V53, P875, DOI 10.1093/petrology/egr080; HALLIDAY AN, 1984, EARTH PLANET SC LETT, V68, P379, DOI 10.1016/0012-821X(84)90123-7; HERVIG RL, 1992, EARTH PLANET SC LETT, V111, P97, DOI 10.1016/0012-821X(92)90172-R; Hildreth W., 1979, GEOL SOC AM SPEC PAP, V180, P43, DOI DOI 10.1130/SPE180-P43; Hildreth W, 2007, J PETROL, V48, P951, DOI 10.1093/petrology/egm007; Holtz F, 2001, CONTRIB MINERAL PETR, V141, P347, DOI 10.1007/s004100100245; Huang RF, 2012, GEOCHIM COSMOCHIM AC, V84, P75, DOI 10.1016/j.gca.2012.01.009; Ickert RB, 2015, GEOCHIM COSMOCHIM AC, V168, P88, DOI 10.1016/j.gca.2015.07.018; Johannes W., 1996, PETROGENESIS EXPT PE, DOI 10.1007/978-3-642-61049-3_2; Leeman WP, 2012, MICROSC MICROANAL, V18, P1322, DOI 10.1017/S1431927612013426; Lowenstern JB, 2006, PHILOS T R SOC A, V364, P2055, DOI 10.1098/rsta.2006.1813; Matthews NE, 2012, J PETROL, V53, P1385, DOI 10.1093/petrology/egs020; Matthews NE, 2012, CONTRIB MINERAL PETR, V163, P87, DOI 10.1007/s00410-011-0660-1; MICHAEL PJ, 1983, GEOLOGY, V11, P31, DOI 10.1130/0091-7613(1983)11<31:CDOTBT>2.0.CO;2; Miller CF, 2008, ELEMENTS, V4, P11, DOI 10.2113/GSELEMENTS.4.1.11; Oppenheimer C, 2003, PROG PHYS GEOG, V27, P230, DOI 10.1191/0309133303pp379ra; Pamukcu AS, 2015, 2015 AGU FALL M; Pamukcu AS, 2015, GEOLOGY, V43, P947, DOI 10.1130/G37021.1; Pamukcu AS, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1122-y; Pamukcu AS, 2012, J PETROL, V53, P589, DOI 10.1093/petrology/egr072; Pamukcu AS, 2010, GEOSPHERE, V6, P775, DOI 10.1130/GES00565.1; Peppard BT, 2001, AM MINERAL, V86, P1034; Potts P.J., 1987, HDB SILICATE ROCK AN; Reid MR, 2011, CONTRIB MINERAL PETR, V161, P293, DOI 10.1007/s00410-010-0532-0; Roberge J, 2013, CONTRIB MINERAL PETR, V165, P237, DOI 10.1007/s00410-012-0807-8; Schopa A, 2013, J GEOPHYS RES-SOL EA, V118, P926, DOI 10.1002/jgrb.50127; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Sheridan MF, 1965, MINERALOGY PETROLOGY; Simon JI, 2007, GEOCHIM COSMOCHIM AC, V71, P2014, DOI 10.1016/j.gca.2007.01.023; Simon JI, 2005, EARTH PLANET SC LETT, V235, P123, DOI 10.1016/j.epsl.2005.03.013; Sutton SR, 2002, REV MINERAL GEOCHEM, V49, P429, DOI 10.2138/rmg.2002.49.8; Thomas JB, 2015, CONTRIB MINERAL PETR, V169, DOI 10.1007/s00410-015-1120-0; Thomas JB, 2012, CONTRIB MINERAL PETR, V164, P369, DOI 10.1007/s00410-012-0761-5; Thomas JB, 2010, CONTRIB MINERAL PETR, V160, P743, DOI 10.1007/s00410-010-0505-3; Tuttle O.F., 1958, GEOL SOC AM BULL, V74, P1; Wallace PJ, 1999, J GEOPHYS RES-SOL EA, V104, P20097, DOI 10.1029/1999JB900207; WALLACE PJ, 1995, NATURE, V377, P612, DOI 10.1038/377612a0; Wark DA, 2007, GEOLOGY, V35, P235, DOI 10.1130/G23316A.1; Wark DA, 2006, CONTRIB MINERAL PETR, V152, P743, DOI 10.1007/s00410-006-0132-1; Wilson CJN, 2006, J PETROL, V47, P35, DOI 10.1093/petrology/egi066; Wilson CJN, 1997, J GEOL, V105, P407, DOI 10.1086/515937; Wilson CJN, 2012, CONTRIB MINERAL PETR, V164, P359, DOI 10.1007/s00410-012-0757-1; Wood GDA, 2014, TAMBORA ERUPTION CHA	63	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159200	10.1371/journal.pone.0159200	http://dx.doi.org/10.1371/journal.pone.0159200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438605	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100032
J	Shang, SH; Li, P; Deng, MY; Jiang, Y; Chen, C; Qu, QM				Shang, Suhang; Li, Pei; Deng, Meiying; Jiang, Yu; Chen, Chen; Qu, Qiumin			The Age-Dependent Relationship between Blood Pressure and Cognitive Impairment: A Cross-Sectional Study in a Rural Area of Xi'an, China	PLOS ONE			English	Article							BETA-AMYLOID DEPOSITION; MINI-MENTAL STATE; CEREBRAL HYPOPERFUSION; INCIDENT DEMENTIA; DOUBLE-BLIND; MOUSE MODEL; LATE-LIFE; HYPERTENSION; MIDLIFE; DYSFUNCTION	Background Hypertension is a modifiable risk factor for cognitive impairment, although the relationship between hypertension and cognitive impairment is not fully understood. The objective of this study was to investigate the effect of age on the relationship between blood pressure and cognitive impairment. Methods Blood pressure and global cognitive function information was collected from 1799 participants (age 40-85) who lived in a village in the suburbs of Xi'an, China, during in-person interviews. Cognitive impairment was defined as a Mini-Mental State Examination (MMSE) score lower than the cutoff value. The effect of age on the relationship between blood pressure parameters [systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MABP), and high blood pressure (HBP, SBP >= 140 mm Hg and/or DBP >= 90 mm Hg)] and cognitive impairment was analyzed by logistic regression models using interaction and stratified analysis. Blood pressure and age were regarded as both continuous and categorical data. Results A total of 231 participants were diagnosed as having cognitive impairment based on our criteria. Interaction analysis for the total population showed that SBP (when regarded as continuous data) was positively correlated with cognitive impairment (OR = 1.130 [95% CI, 1.028-1.242] per 10mmHg, P = 0.011); however, the age by SBP interaction term was negatively correlated with cognitive impairment (OR = 0.989 [95% CI, 0.982-0.997] per 10mmHgxyear, P = 0.006), indicating that the relationship between SBP and cognitive impairment was age-dependent (OR = 1.130x0.989((age-55.5)) per 10mmHg, 40 <= age <= 85). When the blood pressure and age were considered as binary data, the results were similar to those obtained when they were considered as continuous variables. Stratified multivariate analysis revealed that the relationship between SBP (when regarded as continuous data) and cognitive impairment was positive for patients aged 40-49 years (OR = 1.349 [95% CI: 1.039-1.753] per 10mmHg, P = 0.025) and 50-59 years (OR = 1.185 [95% CI: 1.028-1.366] per 10mmHg, P = 0.019), whereas it tended to be negative for patients aged 60-69 years (OR = 0.878 [95% CI: 0.729-1.058] per 10mmHg, P = 0.171) and >= 70 years (OR = 0.927 [95% CI: 0.772-1.113] per 10mmHg, P = 0.416). Results similar to those for SBP were obtained for DBP, MABP and HBP as well. Subsequently, SBP, DBP and MABP were transformed into categorical data (SBP<140mmHg, 140mmHg <= SBP<160mmHg, and SBP >= 160mmHg; DBP<90mmHg, 90mmHg <= DBP< 100mmHg, and DBP >= 100mmHg; MABP<100mmHg, 100mmHg <= MABP<110mmHg, and MABP >= 110mmHg), and the stratified multivariate analysis was repeated. This analysis showed that the age-dependent association continued to exist and was especially prominent in the SBP >= 160 mmHg, DBP >= 90 mmHg and MABP >= 110 mmHg groups. Conclusions Elevated blood pressure is positively correlated with cognitive impairment in the middle-aged, but this positive association declines with increasing age. These results indicated that specific blood pressure management strategies for various age groups may be crucial for maintaining cognitive vitality.	[Shang, Suhang; Li, Pei; Deng, Meiying; Jiang, Yu; Chen, Chen; Qu, Qiumin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurol, 277 West Yanta Rd, Xian, Peoples R China	Xi'an Jiaotong University	Qu, QM (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurol, 277 West Yanta Rd, Xian, Peoples R China.	qiuminqu@outlook.com			National Science and Technology Major Project on Development of Major New Drugs [2012ZX09303-005-002]	National Science and Technology Major Project on Development of Major New Drugs	This work was supported by National Science and Technology Major Project on Development of Major New Drugs (NO. 2012ZX09303-005-002) URL: http://www.nmp.gov.cn/zxjs/zdxy/201012/t20101208_2128.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate and thank our study participants. This work was supported by the National Science and Technology Major Project on Development of Major New Drugs (NO. 2012ZX09303-005-002).	Bohm M, 2015, HYPERTENSION, V65, P651, DOI 10.1161/HYPERTENSIONAHA.114.04568; Budge MM, 2002, J AM GERIATR SOC, V50, P2014, DOI 10.1046/j.1532-5415.2002.50614.x; Carnevale D, 2012, HYPERTENSION, V60, P188, DOI 10.1161/HYPERTENSIONAHA.112.195511; Choi JY, 2015, NEUROSCIENCE, V303, P115, DOI 10.1016/j.neuroscience.2015.06.056; Cifuentes D, 2015, HYPERTENSION, V65, P218, DOI 10.1161/HYPERTENSIONAHA.114.04139; Elias MF, 2012, HYPERTENSION, V60, P260, DOI 10.1161/HYPERTENSIONAHA.111.186429; Faraco G, 2013, HYPERTENSION, V62, P810, DOI 10.1161/HYPERTENSIONAHA.113.01063; Firbank MJ, 2011, NEUROLOGY, V76, P1478, DOI 10.1212/WNL.0b013e318217e76a; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gentile MT, 2009, NEUROBIOL AGING, V30, P222, DOI 10.1016/j.neurobiolaging.2007.06.005; Gorelick PB, 2014, JAMA NEUROL, V71, P1211, DOI 10.1001/jamaneurol.2014.2014; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joas E, 2012, HYPERTENSION, V59, P796, DOI 10.1161/HYPERTENSIONAHA.111.182204; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kohler S, 2014, HYPERTENSION, V63, P245, DOI 10.1161/HYPERTENSIONAHA.113.02096; Kruyer A, 2015, HYPERTENSION, V66, P175, DOI 10.1161/HYPERTENSIONAHA.115.05524; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Mahoney JR, 2010, J INT NEUROPSYCH SOC, V16, P877, DOI 10.1017/S1355617710000767; Molander L, 2010, DEMENT GERIATR COGN, V29, P335, DOI 10.1159/000289821; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Ogliari G, 2015, J AM GERIATR SOC, V63, P1741, DOI 10.1111/jgs.13616; Oveisgharan S, 2010, ARCH NEUROL-CHICAGO, V67, P187, DOI 10.1001/archneurol.2009.312; Peng D, 2005, CHINESE J NEUROIMMUN, V12, P187; Peng D, 2005, CHINESE J NEUROIMMUN, V12, P211; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Richmond R, 2011, AM J HYPERTENS, V24, P299, DOI 10.1038/ajh.2010.236; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sabayan B, 2015, JAMA INTERN MED, V175, P586, DOI 10.1001/jamainternmed.2014.8202; Scuteri A, 2011, J HYPERTENS, V29, P1469, DOI 10.1097/HJH.0b013e328347cc17; Shah NS, 2012, HYPERTENSION, V59, P780, DOI 10.1161/HYPERTENSIONAHA.111.178962; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; Tzourio C, 2003, ARCH INTERN MED, V163, P1069; Yasar S., 2011, PLoS ONE, pe27976, DOI 10.1371/journal.pone.0027976; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	41	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159485	10.1371/journal.pone.0159485	http://dx.doi.org/10.1371/journal.pone.0159485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438476	Green Published, gold			2022-12-26	WOS:000380170100050
J	Wang, L; Chopp, M; Szalad, A; Lu, XR; Jia, LF; Lu, M; Zhang, RL; Zhang, ZG				Wang, Lei; Chopp, Michael; Szalad, Alexandra; Lu, XueRong; Jia, LongFei; Lu, Mei; Zhang, Rui Lan; Zhang, Zheng Gang			Tadalafil Promotes the Recovery of Peripheral Neuropathy in Type II Diabetic Mice	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SILDENAFIL; ANGIOGENESIS; ACTIVATION; BRAIN	We previously demonstrated that treatment of diabetic peripheral neuropathy with the short (4 hours) half-life phosphodiesterase 5 (PDE5) inhibitor, sildenafil, improved functional outcome in diabetic db/db mice. To further examine the effect of PDE5 inhibition on diabetic peripheral neuropathy, we investigated the effect of another potent PDE5 inhibitor, tadalafil, on diabetic peripheral neuropathy. Tadalafil is pharmacokinetically distinct from sildenafil and has a longer half-life (17+hours) than sildenafil. Diabetic mice (BKS.Cg-m+/+Lepr(db)/J, db/db) at age 20 weeks were treated with tadalafil every 48 hours for 8 consecutive weeks. Compared with diabetic mice treated with saline, tadalafil treatment significantly improved motor and sensory conduction velocities in the sciatic nerve and peripheral thermal sensitivity. Tadalafil treatment also markedly increased local blood flow and the density of FITC-dextran perfused vessels in the sciatic nerve concomitantly with increased intraepidermal nerve fiber density. Moreover, tadalafil reversed the diabetes-induced reductions of axon diameter and myelin thickness and reversed the diabetes-induced increased g-ratio in the sciatic nerve. Furthermore, tadalafil enhanced diabetes-reduced nerve growth factor (NGF) and platelet-derived growth factor-C (PDGF-C) protein levels in diabetic sciatic nerve tissue. The present study demonstrates that tadalafil increases regional blood flow in the sciatic nerve tissue, which may contribute to the improvement of peripheral nerve function and the amelioration of diabetic peripheral neuropathy.	[Wang, Lei; Chopp, Michael; Szalad, Alexandra; Lu, XueRong; Jia, LongFei; Lu, Mei; Zhang, Rui Lan; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Wang, L (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	leiwang@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		U.S. National Institutes of Health: NINDS [RO1 NS075084, RO1 NS075156]; U.S. National Institutes of Health: NIDDK [RO1 DK097519]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075084] Funding Source: NIH RePORTER	U.S. National Institutes of Health: NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Institutes of Health: NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health: NINDS grants RO1 NS075084 (LW), RO1 NS075156 (ZGZ) and NIDDK grant RO1 DK097519 (LW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfel Stuart C., 1999, American Journal of Medicine, V107, p34S; Boolell M, 1996, Int J Impot Res, V8, P47; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Chen XM, 2014, CNS NEUROSCI THER, V20, P40, DOI 10.1111/cns.12162; Coward Robert M, 2008, Ther Clin Risk Manag, V4, P1315; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Dyck PJ, 1996, LANCET, V348, P1044, DOI 10.1016/S0140-6736(05)64409-1; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Frajese GV, 2006, CLIN INTERV AGING, V1, P439, DOI 10.2147/ciia.2006.1.4.439; Hackett G, 2006, INT J CLIN PRACT, V60, P1123, DOI 10.1111/j.1742-1241.2006.01087.x; Hemnes Anna R, 2006, Expert Rev Cardiovasc Ther, V4, P293, DOI 10.1586/14779072.4.3.293; Ii M, 2005, CIRCULATION, V112, P93, DOI 10.1161/CIRCULATIONAHA.104.511964; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; Kamenov ZA, 2011, J SEX MED, V8, P851, DOI 10.1111/j.1743-6109.2010.02148.x; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; Lee C, 2013, TRENDS MOL MED, V19, P474, DOI 10.1016/j.molmed.2013.04.006; Margolis DJ, 2005, WOUND REPAIR REGEN, V13, P531, DOI 10.1111/j.1524-475X.2005.00074.x; Nichols DJ, 2002, BRIT J CLIN PHARMACO, V53, p5S, DOI 10.1046/j.0306-5251.2001.00027.x; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Patil C. S., 2006, Inflammopharmacology, V14, P22, DOI 10.1007/s10787-006-1511-y; Pittenger Gary, 2003, Exp Diabesity Res, V4, P271, DOI 10.1155/EDR.2003.271; Rosen RC, 2002, ANN REV SEX RES, V13, P36; Rosengarten B, 2006, CEREBROVASC DIS, V21, P194, DOI 10.1159/000090555; Sameni H R, 2008, Pak J Biol Sci, V11, P1994, DOI 10.3923/pjbs.2008.1994.2000; Tantini B, 2005, BASIC RES CARDIOL, V100, P131, DOI 10.1007/s00395-004-0504-5; Thippeswamy T, 2007, J NEUROCHEM, V100, P790, DOI 10.1111/j.1471-4159.2006.04243.x; Van Dam PS, 2013, EUR J PHARMACOL, V719, P180, DOI 10.1016/j.ejphar.2013.07.017; Varma A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045243; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wang L, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/173656; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118134; Wang L, 2012, NEUROBIOL DIS, V48, P546, DOI 10.1016/j.nbd.2012.08.002; Yorek Mark A, 2015, Rev Diabet Stud, V12, P13, DOI 10.1900/RDS.2015.12.13; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhang L, 2006, BRAIN RES, V1118, P192, DOI 10.1016/j.brainres.2006.08.028; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang ZG, 1999, J CEREBR BLOOD F MET, V19, P68, DOI 10.1097/00004647-199901000-00008	38	15	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159665	10.1371/journal.pone.0159665	http://dx.doi.org/10.1371/journal.pone.0159665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438594	gold, Green Submitted, Green Published			2022-12-26	WOS:000380170100063
J	Tian, J; Pinto, JM; Cui, XL; Zhang, HH; Li, L; Liu, YL; Wu, C; Wei, YX				Tian, Jun; Pinto, Jayant M.; Cui, Xiaolan; Zhang, Henghui; Li, Li; Liu, Yulong; Wu, Chan; Wei, Yongxiang			Sendai Virus Induces Persistent Olfactory Dysfunction in a Murine Model of PVOD via Effects on Apoptosis, Cell Proliferation, and Response to Odorants	PLOS ONE			English	Article							SENSORY NEURONS; RECEPTOR NEURONS; NERVOUS-SYSTEM; INFECTION; BRAIN; MICE; SELECTIVITY; AGE; IDENTIFICATION; VULNERABILITY	Background Viral infection is a common cause of olfactory dysfunction. The complexities of studying post-viral olfactory loss in humans have impaired further progress in understanding the underlying mechanism. Recently, evidence from clinical studies has implicated Parainfluenza virus 3 as a causal agent. An animal model of post viral olfactory disorders (PVOD) would allow better understanding of disease pathogenesis and represent a major advance in the field. Objective To develop a mouse model of PVOD by evaluating the effects of Sendai virus (SeV), the murine counterpart of Parainfluenza virus, on olfactory function and regenerative ability of the olfactory epithelium. Methods C57BL/6 mice (6-8 months old) were inoculated intranasally with SeV or ultraviolet (UV)-inactivated virus (UV-SeV). On days 3, 10, 15, 30 and 60 post-infection, olfactory epithelium was harvested and analyzed by histopathology and immunohistochemical detection of S-phase nuclei. We also measured apoptosis by TUNEL assay and viral load by real-time PCR. The buried food test (BFT) was used to measure olfactory function of mice at day 60. In parallel, cultured murine olfactory sensory neurons (OSNs) infected with SeV or UV-SeV were tested for odorant-mixture response by measuring changes in intracellular calcium concentrations indicated by fura-4 AM assay. Results Mice infected with SeV suffered from olfactory dysfunction, peaking on day 15, with no loss observed with UV-SeV. At 60 days, four out of 12 mice infected with SeV still had not recovered, with continued normal function in controls. Viral copies of SeV persisted in both the olfactory epithelium (OE) and the olfactory bulb (OB) for at least 60 days. At day 10 and after, both unit length labeling index (ULLI) of apoptosis and ULLI of proliferation in the SeV group was markedly less than the UV-SeV group. In primary cultured OSNs infected by SeV, the percentage of cells responding to mixed odors was markedly lower in the SeV group compared to UV-SeV (P = 0.007). Conclusion We demonstrate that SeV impairs olfaction, persists in OE and OB tissue, reduces their regenerative ability, and impairs the normal physiological function of OSNs without gross cytopathology. This mouse model shares key features of human post-viral olfactory loss, supporting its future use in studies of PVOD. Further testing and development of this model should allow us to clarify the pathophysiology of PVOD.	[Tian, Jun] Shanxi Med Univ, Hosp 1, Dept Otolaryngol Head & Neck Surg, Taiyuan, Shanxi Province, Peoples R China; [Pinto, Jayant M.] Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; [Cui, Xiaolan] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Zhang, Henghui] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing, Peoples R China; [Li, Li] Capital Med Univ, Beijing Chaoyang Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Liu, Yulong; Wu, Chan; Wei, Yongxiang] Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Shanxi Medical University; University of Chicago; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Peking University; Capital Medical University; Capital Medical University	Wei, YX (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	weiyongxianglc@126.com			National Natural Science Foundation, government of China [81271062]; Beijing Natural Science Foundation, Government of China [KZ201310025029]	National Natural Science Foundation, government of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation, Government of China	This work was funded by National Natural Science Foundation, government of China (81271062) (URL: http://www.nsfc.gov.cn) (YXW), and Beijing Natural Science Foundation, Government of China (KZ201310025029) (URL: http://www.bjnsf.org) (YXW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeanu S, 2005, J IMMUNOL, V175, P4971, DOI 10.4049/jimmunol.175.8.4971; Bauer S, 2005, J CELL BIOL, V171, P641, DOI 10.1083/jcb.200505072; Bauer S, 2003, J NEUROSCI, V23, P1792; Bitzer M, 1999, J VIROL, V73, P702, DOI 10.1128/JVI.73.1.702-708.1999; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Chen HY, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-22; Deng M, 2014, BRIT J ANAESTH, V113, P443, DOI 10.1093/bja/aet469; Duncan-Lewis CA, 2011, COMPARATIVE MED, V61, P361; Faisca P, 2007, RES VET SCI, V82, P115, DOI 10.1016/j.rvsc.2006.03.009; Gao Yong, 2009, V485, P27, DOI 10.1007/978-1-59745-170-3_3; Ge Y, 2002, CHEM SENSES, V27, P521, DOI 10.1093/chemse/27.6.521; Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971; Gong Q, 2012, CURR PROTOC NEUROSCI; GONG QZ, 1994, J COMP NEUROL, V344, P336, DOI 10.1002/cne.903440303; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Hummel T, 2011, GMS CURR TOP OTORHIN, V10, DOI [10.3205/cto000077, DOI 10.3205/CTO000077]; Ishimura R, 2008, J NEUROSCI, V28, P4938, DOI 10.1523/JNEUROSCI.0229-08.2008; IWATA H, 1990, J INFECT DIS, V162, P402, DOI 10.1093/infdis/162.2.402; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; KIMURA Y, 1979, ARCH VIROL, V61, P297, DOI 10.1007/BF01315016; Klemens JJ, 2006, LARYNGOSCOPE, V116, P1236, DOI 10.1097/01.mlg.0000224526.43698.52; Konstantinidis I, 2006, RHINOLOGY, V44, P135; KRISTENSSON K, 1984, ACTA NEUROPATHOL, V63, P89, DOI 10.1007/BF00697190; Leopold D, 2000, ARCH OTOLARYNGOL, V126, P803, DOI 10.1001/archotol.126.6.803; MERY S, 1994, TOXICOL PATHOL, V22, P353, DOI 10.1177/019262339402200402; MONTICELLO TM, 1990, TOXICOL PATHOL, V18, P24, DOI 10.1177/019262339001800104; MORI I, 1995, J GEN VIROL, V76, P1251, DOI 10.1099/0022-1317-76-5-1251; Mori I, 2004, REV MED VIROL, V14, P209, DOI 10.1002/rmv.426; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Nagai Y, 2004, CURR TOP MICROBIOL, V283, P197; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Rawson NE, 2012, NEUROBIOL AGING, V33, P1913, DOI 10.1016/j.neurobiolaging.2011.09.036; Rawson NE, 1997, J NEUROPHYSIOL, V77, P1606, DOI 10.1152/jn.1997.77.3.1606; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Schomacker H, 2012, CURR OPIN VIROL, V2, P294, DOI 10.1016/j.coviro.2012.02.001; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P583, DOI 10.1016/j.mcn.2005.06.003; Shi L, 2013, INACTIVATED SENDAI V, P205; Sugiura M, 1998, ACTA OTO-LARYNGOL, P191; Suzuki M, 2007, LARYNGOSCOPE, V117, P272, DOI 10.1097/01.mlg.0000249922.37381.1e; Thiemmara V, 2002, CELL DEATH DIFFER, V9, P1343, DOI 10.1038/sj.cdd.4401098; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Wang JH, 2007, LARYNGOSCOPE, V117, P1445, DOI 10.1097/MLG.0b013e318063e878; Wang L, 2013, CHEMOSPHERE, V93, P2639, DOI 10.1016/j.chemosphere.2013.08.044; Wiegand M, 2005, J GEN VIROL, V86, P2305, DOI 10.1099/vir.0.81022-0; Yamagishi Masuo, 1994, Rhinology (Utrecht), V32, P113; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092	51	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159033	10.1371/journal.pone.0159033	http://dx.doi.org/10.1371/journal.pone.0159033			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428110	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300030
J	Huang, CT; Chuang, YC; Tsai, YJ; Ko, WJ; Yu, CJ				Huang, Chun-Ta; Chuang, Yu-Chung; Tsai, Yi-Ju; Ko, Wen-Je; Yu, Chong-Jen			High Mortality in Severe Sepsis and Septic Shock Patients with Do-Not-Resuscitate Orders in East Asia	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; ICU ADMISSION; MULTICENTER; DECISIONS; OUTCOMES; THERAPY; DEATH; MORBIDITY; RISK; END	Background Severe sepsis is a potentially deadly illness and always requires intensive care. Do-not-resuscitate (DNR) orders remain a debated issue in critical care and limited data exist about its impact on care of septic patients, particularly in East Asia. We sought to assess outcome of severe sepsis patients with regard to DNR status in Taiwan. Methods A retrospective cohort study was conducted in intensive care units (ICUs) between 2008 and 2010. All severe sepsis patients were included for analysis. Primary outcome was association between DNR orders and ICU mortality. Volume of interventions was used as proxy indicator to indicate aggressiveness of care. Results Sixty-seven (9.4%) of 712 patients had DNR orders on ICU admission, and these patients were older and had higher disease severity compared with patients without DNR orders. Notably, DNR patients experienced high ICU mortality (90%). Multivariate analysis revealed that the presence of DNR orders was independently associated with ICU mortality (odds ratio: 6.13; 95% confidence interval: 2.66-14.10). In propensity score-matched cohort, ICU mortality rate (91%) in the DNR group was statistically higher than that (62%) in the non-DNR group (p < 0.001). Regarding ICU interventions, arterial and central venous catheterization were more commonly used in DNR patients than in non-DNR patients. Conclusions From the Asian perspective, septic patients placed on DNR orders on ICU admission had exceptionally high mortality. In contrast to Western reports, DNR patients received more ICU interventions, reflecting more aggressive approach to dealing with this patient population. The findings in some ways reflect differences between East and West cultures and suggest that DNR status is an important confounder in ICU studies involving severely septic patients.	[Huang, Chun-Ta; Chuang, Yu-Chung; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan; [Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan.; Huang, CT (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	huangct@ntu.edu.tw	; CHUANG, YU-CHUNG/F-4627-2016	HUANG, CHUN-TA/0000-0002-5234-4986; CHUANG, YU-CHUNG/0000-0003-3094-8276; Yu, Chong-Jen/0000-0001-5664-9392	National Taiwan University Hospital [105-N3262]	National Taiwan University Hospital(National Taiwan University)	This study was supported by the National Taiwan University Hospital grant number 105-N3262 (CTH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, JAMA, V265, P1868; Arabi YM, 2013, CRIT CARE, V17, DOI 10.1186/cc12680; Azoulay E, 2009, INTENS CARE MED, V35, P623, DOI 10.1007/s00134-008-1310-6; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; BEDELL SE, 1986, JAMA-J AM MED ASSOC, V256, P233, DOI 10.1001/jama.256.2.233; Bradford MA, 2014, CRIT CARE MED, V42, P2042, DOI 10.1097/CCM.0000000000000403; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Chang DW, 2014, J GEN INTERN MED, V29, P1256, DOI 10.1007/s11606-014-2906-x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dzeng E, 2015, JAMA INTERN MED, V175, P812, DOI 10.1001/jamainternmed.2015.0295; Fuchs L, 2012, INTENS CARE MED, V38, P1654, DOI 10.1007/s00134-012-2629-6; Garnacho-Montero J, 2008, J ANTIMICROB CHEMOTH, V61, P436, DOI 10.1093/jac/dkm460; Garnacho-Montero J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1000-z; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; HOLTZMAN J, 1994, J AM GERIATR SOC, V42, P275, DOI 10.1111/j.1532-5415.1994.tb01751.x; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Luo Zhehui, 2010, Med Care Res Rev, V67, P528, DOI 10.1177/1077558710361486; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; Mehter Hashim M, 2014, Ann Am Thorac Soc, V11, P1592, DOI 10.1513/AnnalsATS.201406-244BC; Meissner A, 2010, CRIT CARE MED, V38, P1060, DOI 10.1097/CCM.0b013e3181cd1110; Payne JK, 2008, J GERONTOL NURS, V34, P11, DOI 10.3928/00989134-20081001-06; Phua J, 2015, JAMA INTERN MED, V175, P363, DOI 10.1001/jamainternmed.2014.7386; Powell ES, 2013, J EMERG MED, V44, P742, DOI 10.1016/j.jemermed.2012.09.034; Quill CM, 2014, CHEST, V146, P573, DOI 10.1378/chest.13-2529; RABKIN MT, 1976, NEW ENGL J MED, V295, P364, DOI 10.1056/NEJM197608122950705; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Santonocito C, 2013, J CRIT CARE, V28, P14, DOI 10.1016/j.jcrc.2012.07.005; Shepardson LB, 1999, MED CARE, V37, P727, DOI 10.1097/00005650-199908000-00003; Stapleton RD, 2005, CHEST, V128, P525, DOI 10.1378/chest.128.2.525; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063; Yang Y, 2010, J CRIT CARE, V25, P398, DOI 10.1016/j.jcrc.2009.09.001; Zingmond DS, 2005, ARCH INTERN MED, V165, P1705, DOI 10.1001/archinte.165.15.1705	41	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159501	10.1371/journal.pone.0159501	http://dx.doi.org/10.1371/journal.pone.0159501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416064	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500133
J	Obradovic, D; Gaspersic, R; Caserman, S; Leonardi, A; Jamnik, M; Podlesek, Z; Seme, K; Anderluh, G; Krizaj, I; Macek, P; Butala, M				Obradovic, Davor; Gaspersic, Rok; Caserman, Simon; Leonardi, Adrijana; Jamnik, Maja; Podlesek, Zdravko; Seme, Katja; Anderluh, Gregor; Krizaj, Igor; Macek, Peter; Butala, Matej			A Cytolethal Distending Toxin Variant from Aggregatibacter actinomycetemcomitans with an Aberrant CdtB That Lacks the Conserved Catalytic Histidine 160	PLOS ONE			English	Article							CELL-CYCLE ARREST; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL GENOTOXIN; GENOMIC INSTABILITY; STRAND BREAKS; DNA-DAMAGE; 3 SUBUNITS; PERIODONTITIS; APOPTOSIS; GENES	The periodontopathogen Aggregatibacter actinomycetemcomitans synthesizes several virulence factors, including cytolethal distending toxin (CDT). The active CDT holoenzyme is an AB-type tripartite genotoxin that affects eukaryotic cells. Subunits CdtA and CdtC (B-components) allow binding and intracellular translocation of the active CdtB (A-component), which elicits nuclear DNA damage. Different strains of A. actinomycetemcomitans have diverse virulence genotypes, which results in varied pathogenic potential and disease progression. Here, we identified an A. actinomycetemcomitans strain isolated from two patients with advance chronic periodontitis that has a regular cdtABC operon, which, however, codes for a unique, shorter, variant of the CdtB subunit. We describe the characteristics of this CdtB Delta 116-188, which lacks the intact nuclear localisation signal and the catalytic histidine 160. We show that the A. actinomycetemcomitans DO15 isolate secretes CdtB Delta 116-188, and that this subunit cannot form a holotoxin and is also not genotoxic if expressed ectopically in HeLa cells. Furthermore, the A. actinomycetemcomitans DO15 isolate is not toxic, nor does it induce cellular distention upon infection of co-cultivated HeLa cells. Biological significance of this deletion in the cdtB remains to be explained.	[Obradovic, Davor; Podlesek, Zdravko; Macek, Peter; Butala, Matej] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Gaspersic, Rok] Univ Ljubljana, Dept Oral Med & Periodontol, Fac Med, Ljubljana, Slovenia; [Caserman, Simon; Jamnik, Maja; Anderluh, Gregor] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana, Slovenia; [Leonardi, Adrijana; Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Seme, Katja] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Krizaj, Igor] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; National Institute of Chemistry - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana	Macek, P; Butala, M (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia.	peter.macek@bf.uni-lj.si; matej.butala@bf.uni-lj.si	Maček, Peter/U-4662-2017; Anderluh, Gregor/C-6905-2014; Maček, Peter/Y-9877-2019	Maček, Peter/0000-0001-6470-7759; Anderluh, Gregor/0000-0002-9916-8465; Maček, Peter/0000-0001-6470-7759	Slovenian Research Agency [P1-0207, P3-0293, P1-0391]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency; https://www.arrs.gov.si/en/ grants P1-0207 to DO, AL, IK, PM, MB, P3-0293 to RG and P1-0391 to SC and GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065781; Alsina M, 2001, J CLIN MICROBIOL, V39, P509, DOI 10.1128/JCM.39.2.509-513.2001; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Bandhaya P, 2012, J CLIN PERIODONTOL, V39, P519, DOI 10.1111/j.1600-051X.2012.01871.x; Belibasakis G, 2002, EUR J ORAL SCI, V110, P366, DOI 10.1034/j.1600-0722.2002.21350.x; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DiRienzo JM, 2014, CELLS-BASEL, V3, P476, DOI 10.3390/cells3020476; Dixon SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143977; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Fabris AS, 2002, ORAL MICROBIOL IMMUN, V17, P231, DOI 10.1034/j.1399-302X.2002.170405.x; Fahrer J, 2014, DNA REPAIR, V18, P31, DOI 10.1016/j.dnarep.2014.03.002; Fine DH, 2007, J CLIN MICROBIOL, V45, P3859, DOI 10.1128/JCM.00653-07; Frisan T, 2016, BBA-BIOMEMBRANES, V1858, P567, DOI 10.1016/j.bbamem.2015.08.016; Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034; Haase EM, 1999, INFECT IMMUN, V67, P2901, DOI 10.1128/IAI.67.6.2901-2908.1999; Hassane DC, 2003, INFECT IMMUN, V71, P541, DOI 10.1128/IAI.71.1.541-545.2003; Henderson B, 2000, PERIODONTOL, V54, P78, DOI [10.1111/j.1600-0757.2009.00331.x, DOI 10.1111/J.1600-0757.2009.00331.X]; Herbert BA, 2016, MOL ORAL MICROBIOL, V31, P207, DOI 10.1111/omi.12119; Jentsch H, 2012, CLIN ORAL INVEST, V16, P1589, DOI 10.1007/s00784-012-0672-x; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; Kaplan JB, 2001, INFECT IMMUN, V69, P5375, DOI 10.1128/IAI.69.9.5375-5384.2001; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonardi A, 2012, J PROTEOME RES, V11, P5046, DOI 10.1021/pr3006155; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Matangkasombut O, 2010, INFECT IMMUN, V78, P783, DOI 10.1128/IAI.00857-09; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nishikubo S, 2003, J BIOL CHEM, V278, P50671, DOI 10.1074/jbc.M305062200; Obradovic D, 2014, BOZDRAVSTVENI VEST, V69, P21; Ohara M, 2011, J PERIODONTAL RES, V46, P389, DOI 10.1111/j.1600-0765.2011.01348.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro ET, 2011, J PERIODONTAL RES, V46, P310, DOI 10.1111/j.1600-0765.2011.01344.x; Rabin SDP, 2009, INFECT IMMUN, V77, P3161, DOI 10.1128/IAI.01227-08; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanz M, 2000, EUR J ORAL SCI, V108, P383, DOI 10.1034/j.1600-0722.2000.108005383.x; Schreiner H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069382; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Toth I, 2009, INFECT IMMUN, V77, P492, DOI 10.1128/IAI.00962-08; Ueno Y, 2006, INFECT IMMUN, V74, P3480, DOI 10.1128/IAI.00739-05; Wahasugui TC, 2013, DIAGN MICR INFEC DIS, V75, P366, DOI 10.1016/j.diagmicrobio.2012.12.013; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; Wang XQ, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-37; Wang Y, 2002, J BACTERIOL, V184, P3442, DOI 10.1128/JB.184.13.3442-3449.2002; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Zijnge V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041662	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159231	10.1371/journal.pone.0159231	http://dx.doi.org/10.1371/journal.pone.0159231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414641	Green Submitted, gold, Green Published			2022-12-26	WOS:000379579500101
J	Reza, MH; Shah, H; Manjrekar, J; Chattoo, BB				Reza, Md. Hashim; Shah, Hiral; Manjrekar, Johannes; Chattoo, Bharat B.			Magnesium Uptake by CorA Transporters Is Essential for Growth, Development and Infection in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							HYDROPHOBIN GENE; PLANT INFECTION; RESISTANCE; PROTEIN; IONS; MPG1; CALCIUM; GENOME; TOOL; SUSCEPTIBILITY	Magnaporthe oryzae, the causative organism of rice blast, infects cereal crops and grasses at various stages of plant development. A comprehensive understanding of its metabolism and the implications on pathogenesis is necessary for countering this devastating crop disease. We present the role of the CorA magnesium transporters, MoAlr2 and MoMnr2, in development and pathogenicity of M. oryzae. The MoALR2 and MoMNR2 genes individually complement the Mg2+ uptake defects of a S. cerevisiae CorA transporter double mutant. MoALR2 and MoMNR2 respond to extracellular Mg2+ and Ca2+ levels and their expression is elevated under Mg2+ scarce conditions. RNA silencing mediated knockdown of MoALR2 (WT+siALR2, Delta mnr2+siALR2 and ALR2+MNR2 simultaneous silencing) drastically alters intracellular cation concentrations and sensitivity to metal ions. MoALR2 silencing is detrimental to vegetative growth and surface hydrophobicity of mycelia, and the transformants display loss of cell wall integrity. MoALR2 is required for conidiogenesis and appressorium development, and is essential for infection. Investigation of knockdown transformants reveal low cAMP levels and altered expression of genes encoding proteins involved in MoMps1 cell wall integrity and cAMP MoPmk1 driven MAP Kinase signaling pathways. In contrast to MoALR2 knockdowns, the MoMNR2 deletion (Delta mnr2) shows increased sensitivity to CorA inhibitors as well as altered cation sensitivity, but has limited effect on surface hydrophobicity and severity of plant infection. Interestingly, MoALR2 expression is elevated in Delta mnr2. Impairment of development and infectivity of knockdown transformants and altered intracellular cation composition suggest that CorA transporters are essential for Mg2+ homeostasis within the cell, and are crucial to maintaining normal gene expression associated with cell structure, signal transduction and surface hydrophobicity in M. oryzae. We suggest that CorA transporters, and especially MoALR2, constitute an attractive target for the development of antifungal agents against this pathogen.	[Chattoo, Bharat B.] Maharaja Sayajirao Univ Baroda, Dept Microbiol, Genome Res Ctr, Vadodara 390002, Gujarat, India; Maharaja Sayajirao Univ Baroda, Ctr Biotechnol, Fac Sci, Vadodara 390002, Gujarat, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Chattoo, BB (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Microbiol, Genome Res Ctr, Vadodara 390002, Gujarat, India.	bharat.chattoo@bcmsu.ac.in		, Hiral Shah/0000-0002-8143-8244	Department of Biotechnology (DBT); Department of Science & Technology through J.C. Bose National Fellowship by the Government of India; University Grants Commission (UGC-NET); Council of Scientific & Industrial Research-Shyama Prasad Mukherjee Fellowship (CSIR-SPMF)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science & Technology through J.C. Bose National Fellowship by the Government of India; University Grants Commission (UGC-NET)(University Grants Commission, India); Council of Scientific & Industrial Research-Shyama Prasad Mukherjee Fellowship (CSIR-SPMF)	The work was funded by Department of Biotechnology (DBT) and Department of Science & Technology through J.C. Bose National Fellowship awarded to Bharat B. Chattoo by the Government of India. The authors thank University Grants Commission (UGC-NET) and Council of Scientific & Industrial Research-Shyama Prasad Mukherjee Fellowship (CSIR-SPMF) for providing the fellowship to Md. Hashim Reza and Hiral Shah respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; ASBELL MA, 1966, J BACTERIOL, V92, P380, DOI 10.1128/JB.92.2.380-387.1966; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; De Jong J. C., 1997, NATURE, V389, P471; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Filippi MC, 1998, J PLANT NUTR, V21, P1577, DOI 10.1080/01904169809365505; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; Inoue K, 2016, J GEN PLANT PATHOL, V82, P18, DOI 10.1007/s10327-015-0632-9; KACHROO P, 1994, MOL GEN GENET, V245, P339, DOI 10.1007/BF00290114; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lee JM, 2006, CURR GENET, V49, P7, DOI 10.1007/s00294-005-0037-y; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Lim PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020896; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Pasternak K, 2010, J ELEMENTOL, V15, P601; Patkar RN, 2006, MOL BREEDING, V17, P159, DOI 10.1007/s11032-005-4736-3; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; Pham CLL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25288; Pisat NP, 2009, GENETICS, V183, P873, DOI 10.1534/genetics.109.106419; PRESCOTT AR, 1988, J CELL SCI, V89, P321; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Raman V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-326; Reidinger S, 2012, NEW PHYTOL, V195, P699, DOI 10.1111/j.1469-8137.2012.04179.x; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; SMIT G, 1992, APPL ENVIRON MICROB, V58, P3709, DOI 10.1128/AEM.58.11.3709-3714.1992; Soanes DM, 2002, MOL PLANT MICROBE IN, V15, P1253, DOI 10.1094/MPMI.2002.15.12.1253; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Trofimova Y, 2010, FEMS MICROBIOL LETT, V308, P55, DOI 10.1111/j.1574-6968.2010.01989.x; vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9; WALKER GM, 1980, J CELL SCI, V42, P329; Walker GM, 2004, ADV APPL MICROBIOL, V54, P197, DOI 10.1016/S0065-2164(04)54008-X; WALKER GM, 1984, J GEN MICROBIOL, V130, P1941; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; ZIMELIS VM, 1973, J INFECT DIS, V127, P663, DOI 10.1093/infdis/127.6.663; Zimmermann G, 1998, J BIOL CHEM, V273, P19650, DOI 10.1074/jbc.273.31.19650	58	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159244	10.1371/journal.pone.0159244	http://dx.doi.org/10.1371/journal.pone.0159244			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416318	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500109
J	Sati, J; Mohanty, BP; Garg, ML; Koul, A				Sati, Jasmine; Mohanty, Biraja Prasad; Garg, Mohan Lal; Koul, Ashwani			Pro-Oxidant Role of Silibinin in DMBA/TPA Induced Skin Cancer: H-1 NMR Metabolomic and Biochemical Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; OXIDATIVE STRESS; AZADIRACHTA-INDICA; MOUSE SKIN; ULTRAVIOLET-RADIATION; FLAVONOID ANTIOXIDANT; LIPID-PEROXIDATION; TUMOR PROMOTION; RAT LUNG; CARCINOGENESIS	Silibinin, a major bioactive flavonolignan in Silybum marianum, has received considerable attention in view of its anticarcinogenic activity. The present study examines its anticancer potential against 7, 12-dimethylbenz(a) anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) induced skin cancer. Male LACA mice were randomly segregated into 4 groups: Control, DMBA/TPA, Silibinin and Silibinin+DMBA/TPA. Tumors in DMBA/TPA and Silibinin+DMBA/TPA groups were histologically graded as squamous cell carcinoma. In the Silibinin+DMBA/TPA group, significant reduction in tumor incidence (23%), tumor volume (64.4%), and tumor burden (84.8%) was observed when compared to the DMBA/TPA group. The underlying protective mechanism of Silibinin action was studied at pre-initiation (2 weeks), post-initiation (10 weeks) and promotion (22 weeks) stages of the skin carcinogenesis. The antioxidant nature of Silibinin was evident at the end of 2 weeks of its treatment. However, towards the end of 10 and 22 weeks, elevated lipid peroxidation (LPO) levels indicate the pro-oxidative nature of Silibinin in the cancerous tissue. TUNEL assay revealed enhanced apoptosis in the Silibinin+DMBA/TPA group with respect to the DMBA/TPA group. Therefore, it may be suggested that raised LPO could be responsible for triggering apoptosis in the Silibinin+DMBA/TPA group. H-1 Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the metabolic profile of the skin /skin tumors. Dimethylamine (DMA), glycerophosphocholine (GPC), glucose, lactic acid, taurine and guanine were identified as the major contributors for separation between the groups from the Principal Component Analysis (PCA) of the metabolite data. Enhanced DMA levels with no alteration in GPC, glucose and lactate levels reflect altered choline metabolism with no marked Warburg effect in skin tumors. However, elevated guanine levels with potent suppression of taurine and glucose levels in the Silibinin+DMBA/TPA group are suggestive of the pro-oxidative nature of Silibinin in regressing tumors. Thus, supporting the theory of augmented LPO levels resulting in increased apoptosis in the skin tumors treated with Silibinin.	[Sati, Jasmine; Mohanty, Biraja Prasad; Garg, Mohan Lal; Koul, Ashwani] Panjab Univ, Dept Biophys, Basic Med Sci Block, Chandigarh 160014, India	Panjab University	Koul, A (corresponding author), Panjab Univ, Dept Biophys, Basic Med Sci Block, Chandigarh 160014, India.	ashwanik@pu.ac.in		Koul, Ashwani/0000-0001-7522-412X	University Grants Commission, New Delhi, India; Indian Council of Medical Research; Department of Science and Technology, Ministry of Science and Technology	University Grants Commission, New Delhi, India(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Science and Technology, Ministry of Science and Technology(Department of Science & Technology (DOST), Philippines)	This work was supported by the University Grants Commission, New Delhi, India (http://www.ugc.ac.in/), the Indian Council of Medical Research (http://www.icmr.nic.in/), and the Department of Science and Technology, Ministry of Science and Technology (http://www.dst.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Ahmad MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119137; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Arora N, 2013, CELL BIOCHEM FUNCT, V31, P385, DOI 10.1002/cbf.2909; Arora N, 2011, PHYTOTHER RES, V25, P408, DOI 10.1002/ptr.3280; Bag S, 2015, BIOCHEM BIOPH RES CO, V459, P574, DOI 10.1016/j.bbrc.2015.02.149; Bilecova-Rabajdova M, 2013, CENT EUR J PUBL HEAL, V21, P213, DOI 10.21101/cejph.a3886; Boffetta P, 2014, SPRING CANC RES, P1, DOI 10.1007/978-3-319-05068-3; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; Chang H, 2010, EUR J PHARMACOL, V648, P31, DOI 10.1016/j.ejphar.2010.08.020; Chao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096969; Chhabra N., 2013, INT J NUTR PHARM NEU, V3, P206, DOI DOI 10.4103/2231-0738.114836; Chu Yang LW, 2011, CHINESE HERBAL MED, V3, P309; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Dhanalakshmi S, 2004, CARCINOGENESIS, V25, P1459, DOI 10.1093/carcin/bgh152; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Dummer R, 2011, SKIN CANC WORLD WIDE, VXI; Eisemann N, 2014, J INVEST DERMATOL, V134, P43, DOI 10.1038/jid.2013.304; El-Sayed S, 2002, HEAD NECK-J SCI SPEC, V24, P766, DOI 10.1002/hed.10125; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gangar SC, 2008, PHYTOTHER RES, V22, P1229, DOI 10.1002/ptr.2453; Gu M, 2007, CANCER RES, V67, P3483, DOI 10.1158/0008-5472.CAN-06-3955; Guleria A, 2014, MAGN RESON CHEM, V52, P475, DOI 10.1002/mrc.4094; Hadi SM, 2000, IUBMB LIFE, V50, P167, DOI 10.1080/152165400300001471; Heidari R, 2014, RES PHARM SCI, V9, P97; Kaur M, 2009, MOL CANCER THER, V8, P2366, DOI 10.1158/1535-7163.MCT-09-0304; Khan AQ, 2014, NUTR CANCER, V66, P249, DOI 10.1080/01635581.2014.863365; Khullar G, 2014, INDIAN J DERMATOPATH, V1, P55; KIM YH, 1989, J INVEST DERMATOL, V92, P210, DOI 10.1111/1523-1747.ep12276738; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Koul A, 2006, MOL CELL BIOCHEM, V283, P47, DOI 10.1007/s11010-006-2269-7; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Lahiri-Chatterjee M, 1999, CANCER RES, V59, P622; Larson SM, 2004, CLIN CANCER RES, V10, P2203, DOI 10.1158/1078-0432.CCR-0002-4; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luck H, 1963, METHODS ENZYMATIC AN, P885; [Lyon F Organization WH Cancer IAfRo Humans IWGotEoCRt], 2010, SOME NONHETEROCYCLIC; Mallikarjuna G, 2004, CANCER RES, V64, P6349, DOI 10.1158/0008-5472.CAN-04-1632; Marczynski B, 2009, ARCH TOXICOL, V83, P947, DOI 10.1007/s00204-009-0444-9; Moreno A, 1998, NMR BIOMED, V11, P93, DOI 10.1002/(SICI)1099-1492(199805)11:3<93::AID-NBM520>3.0.CO;2-H; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Narayanapillai S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1135, DOI 10.1111/j.1751-1097.2011.01050.x; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Parola M, 1999, ANTIOXID REDOX SIGN, V1, P255, DOI 10.1089/ars.1999.1.3-255; Raina K, 2009, CANCER RES, V69, P3731, DOI 10.1158/0008-5472.CAN-09-0096; Roy S, 2012, CARCINOGENESIS, V33, P629, DOI 10.1093/carcin/bgr299; Samarasinghe Venura, 2012, J Cutan Aesthet Surg, V5, P3, DOI 10.4103/0974-2077.94323; Singh RP, 2005, EUR J CANCER, V41, P1969, DOI 10.1016/j.ejca.2005.03.033; Subapriya R, 2003, Asian Pac J Cancer Prev, V4, P215; Surdu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062359; Tewari-Singh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046149; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; TRUSH MA, 1981, TOXICOL APPL PHARM, V60, P279, DOI 10.1016/0041-008X(91)90231-3; Umar A, 2012, NAT REV CANCER, V12, P835, DOI 10.1038/nrc3397; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Williams C.H., 1971, METHODS ENZYMOLOGY, V17, P503; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu JW, 2007, J PHARMACEUT BIOMED, V45, P635, DOI 10.1016/j.jpba.2007.06.026; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yang JC, 2015, AMINO ACIDS, V47, P1549, DOI 10.1007/s00726-015-1995-0; You JS, 1998, ADV EXP MED BIOL, V442, P163; Zhao J, 2000, CARCINOGENESIS, V21, P811, DOI 10.1093/carcin/21.4.811	67	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158955	10.1371/journal.pone.0158955	http://dx.doi.org/10.1371/journal.pone.0158955			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414401	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500052
J	Stepien, CC; Pfister, CA; Wootton, JT				Stepien, Courtney C.; Pfister, Catherine A.; Wootton, J. Timothy			Functional Traits for Carbon Access in Macrophytes	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INORGANIC CARBON; CONCENTRATING MECHANISMS; MARINE MACROALGAE; CORALLINE ALGAE; BOUNDARY-LAYERS; PHOTOSYNTHESIS; EVOLUTION; GROWTH; PATTERNS	Understanding functional trait distributions among organisms can inform impacts on and responses to environmental change. In marine systems, only 1% of dissolved inorganic carbon in seawater exists as CO2. Thus the majority of marine macrophytes not only passively access CO2 for photosynthesis, but also actively transport CO2 and the more common bicarbonate (HCO3-, 92% of seawater dissolved inorganic carbon) into their cells. Because species with these carbon concentrating mechanisms (CCMs) are non-randomly distributed in ecosystems, we ask whether there is a phylogenetic pattern to the distribution of CCMs among algal species. To determine macrophyte traits that influence carbon uptake, we assessed 40 common macrophyte species from the rocky intertidal community of the Northeast Pacific Ocean to a) query whether macrophytes have a CCM and b) determine the evolutionary history of CCMs, using ancestral state reconstructions and stochastic character mapping based on previously published data. Thirty-two species not only depleted CO2, but also concentrated and depleted HCO3-, indicative of a CCM. While analysis of CCMs as a continuous trait in 30 families within Phylum Rhodophyta showed a significant phylogenetic signal under a Brownian motion model, analysis of CCMs as a discrete trait (presence or absence) indicated that red algal families are more divergent than expected in their CCM presence or absence; CCMs are a labile trait within the Rhodophyta. In contrast, CCMs were present in each of 18 Ochrophyta families surveyed, indicating that CCMs are highly conserved in the brown algae. The trait of CCM presence or absence was largely conserved within Families. Fifteen of 23 species tested also changed the seawater buffering capacity, or Total Alkalinity (TA), shifting DIC composition towards increasing concentrations of HCO3- and CO2 for photosynthesis. Manipulating the external TA of the local environment may influence carbon availability in boundary layers and areas of low water mixing, offering an additional mechanism to increase CO2 availability.	[Stepien, Courtney C.; Pfister, Catherine A.; Wootton, J. Timothy] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Pfister, Catherine A.; Wootton, J. Timothy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL USA	University of Chicago; University of Chicago	Stepien, CC (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	courtney.stepien@gmail.com	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	National Science Foundation [DGE1144082, DEB1311286, OCE0928232, DEB0919240]; Department of Graduate Education [1144082]; National Science Foundation Department of Environmental Biology [1311286, 0919240, 1556874]; National Science Foundation Division of Ocean Sciences [0928232]; National Institutes of Health [T32 GM007197]; Genetics and Regulation Training Grant [T32 GM007197]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER; Direct For Biological Sciences [1556874] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Graduate Education; National Science Foundation Department of Environmental Biology; National Science Foundation Division of Ocean Sciences(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics and Regulation Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation (http://www.nsf.gov/) Department of Graduate Education (1144082 to CCS), the National Science Foundation Department of Environmental Biology (1311286 to CAP and CCS, 0919240 to JTW, and 1556874 to JTW) and the National Science Foundation Division of Ocean Sciences (0928232 to JTW). Funding was also provided by the National Institutes of Health (http://www.nih.gov/) Genetics and Regulation Training Grant (T32 GM007197 to CCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Park Service (Olympic NP) for access to Shi Shi Beach, and the Makah Tribal Nation for access to Tatoosh Island, D. and M. Hurd for providing research facilities, and T. Price and R. Ree for helpful comments. Research was supported in part by the National Science Foundation (DGE1144082 to CCS, DEB1311286 to CAP and CCS, OCE0928232 to CAP and DEB0919240 to JTW), and the National Institutes of Health (T32 GM007197).	ADEY W H, 1975, Phycologia, V14, P55, DOI 10.2216/i0031-8884-14-2-55.1; Aliscioni S, 2012, NEW PHYTOL, V193, P304, DOI 10.1111/j.1469-8137.2011.03972.x; Andersson AJ, 2014, NAT CLIM CHANGE, V4, P56, DOI 10.1038/NCLIMATE2050; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; AXELSSON L, 1988, MAR BIOL, V97, P295, DOI 10.1007/BF00391315; Bjork M, 2004, MAR ECOL PROG SER, V284, P109, DOI 10.3354/meps284109; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108, DOI 10.4319/lo.1976.21.1.0108; CHIN NKM, 1991, HYDROBIOLOGIA, V215, P1, DOI 10.1007/BF00005895; Christin PA, 2013, P NATL ACAD SCI USA, V110, P1381, DOI 10.1073/pnas.1216777110; Cornwall CE, 2015, PHOTOSYNTH RES, P1; Cornwall CE, 2015, MAR ECOL PROG SER, V525, P81, DOI 10.3354/meps11190; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Cornwall CE, 2012, J PHYCOL, V48, P137, DOI 10.1111/j.1529-8817.2011.01085.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; FABREGAS J, 1987, BRIT PHYCOL J, V22, P269, DOI 10.1080/00071618700650331; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GOLDMAN JC, 1980, LIMNOL OCEANOGR, V25, P352, DOI 10.4319/lo.1980.25.2.0352; Guidone M, 2012, J ECOL, V100, P1105, DOI 10.1111/j.1365-2745.2012.02002.x; Guiry MD, 2012, ALGAE BASE WORLD WID; Hellblom F, 2003, PHOTOSYNTH RES, V77, P173, DOI 10.1023/A:1025809415048; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; Hernandez-Ayon JM, 2007, LIMNOL OCEANOGR-METH, V5, P225; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; Hurd CL, 2000, J PHYCOL, V36; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kubler JE, 1999, PLANT CELL ENVIRON, V22, P1303, DOI 10.1046/j.1365-3040.1999.00492.x; Lapiedra O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2893; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; Laubach T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-110; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; Leonardos N, 2009, J PHYCOL, V45, P1046, DOI 10.1111/j.1529-8817.2009.00726.x; Lindstrom SC, 2011, PHYCOLOGIA, V50, P661, DOI 10.2216/10-38.1; Litsios G, 2012, P ROY SOC B-BIOL SCI, V279, P3662, DOI 10.1098/rspb.2012.1140; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; Low-Decarie E, 2014, TRENDS ECOL EVOL, V29, P223, DOI 10.1016/j.tree.2014.02.006; MABERLY SC, 1992, OECOLOGIA, V91, P481, DOI 10.1007/BF00650320; MABERLY SC, 1990, J PHYCOL, V26, P439, DOI 10.1111/j.0022-3646.1990.00439.x; Marconi M, 2011, J PHYCOL, V47, P1023, DOI 10.1111/j.1529-8817.2011.01045.x; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; McCoy SJ, 2014, ECOL LETT, V17, P475, DOI 10.1111/ele.12247; Meyer M, 2013, J EXP BOT, V64, P769, DOI 10.1093/jxb/ers390; Middelboe AL, 2007, MAR ECOL PROG SER, V338, P107, DOI 10.3354/meps338107; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; Murru M, 2004, J PHYCOL, V40, P837, DOI 10.1111/j.1529-8817.2004.03182.x; PADILLA DK, 1989, ECOLOGY, V70, P835, DOI 10.2307/1941352; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAINE RT, 1966, LIMNOL OCEANOGR, V11, P126, DOI 10.4319/lo.1966.11.1.0126; Paradis E., 2014, APE ANAL PHYLOGENETI; Pierrot D., 2006, ORNLCDIAC105A US DEP; Prasad V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1482; Rautenberger R, 2015, ECOL EVOL, V5, P874, DOI 10.1002/ece3.1382; Raven JA, 1997, EUR J PHYCOL, V32, P319, DOI 10.1017/S0967026297001388; Raven JA, 2002, ANN BOT-LONDON, V90, P525, DOI 10.1093/aob/mcf171; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Stepien CC, 2015, J ECOL, V103, P1372, DOI 10.1111/1365-2745.12451; Tilman D., 1981, MONOGR POPUL BIOL, V17, P1, DOI DOI 10.7861/CLINMEDICINE.14-3-000; Van Alstyne KL, 2015, INTEGR COMP BIOL; Verbruggen H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-16; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	66	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159062	10.1371/journal.pone.0159062	http://dx.doi.org/10.1371/journal.pone.0159062			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415005	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500067
J	Vinueza-Burgos, C; Cevallos, M; Ron-Garrido, L; Bertrand, S; De Zutter, L				Vinueza-Burgos, Christian; Cevallos, Maria; Ron-Garrido, Lenin; Bertrand, Sophie; De Zutter, Lieven			Prevalence and Diversity of Salmonella Serotypes in Ecuadorian Broilers at Slaughter Age	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; ENTERICA SEROVAR INFANTIS; FIELD GEL-ELECTROPHORESIS; SPECTRUM BETA-LACTAMASES; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; CHICKEN MEAT; FOOD ANIMALS; POULTRY; SUSCEPTIBILITY	Salmonella is frequently found in poultry and represent an important source for human gastrointestinal infections worldwide. The aim of this study was to investigate the prevalence, genotypes and antimicrobial resistance of Salmonella serotypes in broilers from Ecuador. Caeca content from 388 at random selected broiler batches were collected in 6 slaughterhouses during 1 year and analyzed by the ISO 6579/Amd1 protocol for the isolation for Salmonella. Isolates were serotyped and genotypic variation was acceded by pulsed field gel electrophoresis. MIC values for sulfamethoxazole, gentamicin, ciprofloxacin, ampicillin, cefotaxime, ceftazidime, tetracycline, streptomycin, trimethropim, chloramphenicol, colistin, florfenicol, kanamycin and nalidixic acid were obtained. Presence of bla(CTX-M), bla(TEM), bla(SHV) and bla(CMY); and mcr-1 plasmid genes was investigated in resistant strains to cefotaxime and colistin respectively. Prevalence at batch level was 16.0%. The most common serotype was S. Infantis (83.9%) followed by S. Enteritidis (14.5%) and S. Corvallis (1.6%). The pulsed field gel electrophoresis analysis showed that S. Corvallis, S. Enteritidis and S. Infantis isolates belonged to 1, 2 and 12 genotypes respectively. S. Infantis isolates showed high resistance rates to 12 antibiotics ranging from 57.7%(kanamycin) up to 98.1% (nalidixic acid and sulfamethoxazole). All S. Enteritidis isolates showed resistance to colistin. High multiresistant patterns were found for all the serotypes. The bla(CTX-M) gene was present in 33 S. Infantis isolates while mcr-1 was negative in 10 colistin resistant isolates. This study provides the first set of scientific data on prevalence and multidrug-resistant Salmonella coming from commercial poultry in Ecuador.	[Vinueza-Burgos, Christian; Cevallos, Maria; Ron-Garrido, Lenin] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [Bertrand, Sophie] Sci Inst Publ Hlth WIV ISP, Div Bacterial Dis, Natl Reference Ctr Salmonella & Shigella, Communicable & Infect Dis, Brussels, Belgium; [De Zutter, Lieven] Univ Ghent, Fac Vet, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium; [Ron-Garrido, Lenin] Ctr Int Zoonosis, Quito, Ecuador	Universidad Central del Ecuador; Ghent University	Vinueza-Burgos, C (corresponding author), Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador.	cvinueza@uce.edu.ec	Vinueza-Burgos, Christian/M-4430-2019	Ron, Lenin/0000-0001-9021-4376; Vinueza-Burgos, Christian/0000-0002-4893-502X	Secretaria de Educacion Superior Ciencia y Tecnologia del Ecuador; Programa de Becas Convocatoria Abierta Segunda Fase	Secretaria de Educacion Superior Ciencia y Tecnologia del Ecuador; Programa de Becas Convocatoria Abierta Segunda Fase	This work was supported by Secretaria de Educacion Superior Ciencia y Tecnologia del Ecuador; Programa de Becas Convocatoria Abierta 2012 Segunda Fase; http://www.educacionsuperior.gob.ec; to CVB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2012, FOODBORNE PATHOG DIS, V9, P367, DOI 10.1089/fpd.2011.1015; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; Barrett TJ, 2006, FOODBORNE PATHOG DIS, V3, P20, DOI 10.1089/fpd.2006.3.20; Bates D, 2016, PACKAGE IME4 LINEAR; Benford D, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3802, 10.2903/j.efsa.2015.4260]; Boscan-Duque LA, 2007, J FOOD PROTECT, V70, P2030, DOI 10.4315/0362-028X-70.9.2030; Brasil. Ministerio da Saude, 2014, GUID BAL NUTR IND, P1; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; CDC, 2015, STAND OP PROC PLUSEN; CLSI, 2014, PERF STAND ANT SUSC; CLSI, 2015, PERF STAND ANT SUSC; CONAVE, 2014, EST PROD AV 2013, P1; de Jong A, 2014, VET MICROBIOL, V171, P298, DOI 10.1016/j.vetmic.2014.01.030; Diarra MS, 2014, J FOOD PROTECT, V77, P40, DOI 10.4315/0362-028.JFP-13-251; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P874, DOI 10.4315/0362-028X.JFP-11-458; Donado-Godoy P, 2014, J FOOD PROTECT, V77, P227, DOI 10.4315/0362-028X.JFP-13-276; Donado-Godoy P, 2012, J FOOD PROTECT, V75, P1134, DOI 10.4315/0362-028X.JFP-11-513; Doumith M, 2016, J ANTIMICROB CHEMOTH, V71, P2300, DOI 10.1093/jac/dkw093; EUCAST, 2015, DAT EUCAST MIC DISTR; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; [FAO WHO FAO], 2002, RISH ASS SALM EGGS B; Fernandez J, 2003, J CLIN MICROBIOL, V41, P1617, DOI 10.1128/JCM.41.4.1617-1622.2003; Fitch FM, 2016, MICROB DRUG RESIST, V22, P164, DOI 10.1089/mdr.2015.0143; Franco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144802; Giombelli A, 2014, J FOOD PROTECT, V77, P1851, DOI 10.4315/0362-028X.JFP-14-200; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Hauser E, 2012, FOODBORNE PATHOG DIS, V9, P352, DOI 10.1089/fpd.2011.1038; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Herman KM, 2015, EPIDEMIOL INFECT, V143, P3011, DOI 10.1017/S0950268815000047; Hur J, 2012, FOOD RES INT, V45, P819, DOI 10.1016/j.foodres.2011.05.014; Hur J, 2011, VET J, V189, P306, DOI 10.1016/j.tvjl.2010.07.017; Kruger T, 2004, ANTIMICROB AGENTS CH, V48, P4263, DOI 10.1128/AAC.48.11.4263-4270.2004; Kuang XH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00602; Gelinski JMLN, 2014, INT J ENV RES PUB HE, V11, P11718, DOI 10.3390/ijerph111111718; Liu YF, 2015, J NANOMATER, V2015, DOI 10.1155/2015/792095; Lu Y, 2011, FOODBORNE PATHOG DIS, V8, P45, DOI 10.1089/fpd.2010.0605; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Malhotra-Kumar S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8; Mattiello SP, 2015, ANTON LEEUW INT J G, V108, P1227, DOI 10.1007/s10482-015-0577-1; Mercado M, 2012, BIOMEDICA, V32, P375, DOI [10.7705/biomedica.v32i3.697, 10.1590/S0120-41572012000300008]; Miriagou V, 2004, INT J ANTIMICROB AG, V23, P547, DOI 10.1016/j.ijantimicag.2004.03.006; Morales AS, 2012, SCI WORLD J, DOI 10.1100/2012/109795; Medeiros MAN, 2011, REV PANAM SALUD PUBL, V30, P555, DOI 10.1590/S1020-49892011001200010; Olaitan AO, 2015, INT J ANTIMICROB AG, V45, P600, DOI 10.1016/j.ijantimicag.2015.01.010; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; PAZZAGLIA G, 1992, Boletin de la Oficina Sanitaria Panamericana, V112, P395; Pulido-Landinez M, 2013, LETT APPL MICROBIOL, V57, P288, DOI 10.1111/lam.12110; Quesada A, 2016, RES VET SCI, V105, P134, DOI 10.1016/j.rvsc.2016.02.003; R Core Team, R LANG ENV STAT COMP; Rahmani M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-66; Rapoport M, 2016, ANTIMICROB AGENTS CH, V60, P4412, DOI 10.1128/AAC.00573-16; Rasschaert G, 2005, J CLIN MICROBIOL, V43, P3615, DOI 10.1128/JCM.43.8.3615-3623.2005; Reardon S, 2014, NATURE, V509, P141, DOI 10.1038/509141a; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Song W, 2007, DIAGN MICR INFEC DIS, V57, P315, DOI 10.1016/j.diagmicrobio.2006.08.023; Turki Y, 2014, J GEN APPL MICROBIOL, V60, P123, DOI 10.2323/jgam.60.123; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Velhner M, 2014, ZOONOSES PUBLIC HLTH, V61, P364, DOI 10.1111/zph.12081; Webb HE, 2016, LANCET INFECT DIS, V16, P144, DOI 10.1016/S1473-3099(15)00538-1; WHO, 2015, WORLDW CONTR SIT AN; WHO, 2015, ESS MED HLTH PROD; WHO (World Health Organization), 2015, WHO ESTIMATES GLOBAL; Winokur PL, 2001, CLIN INFECT DIS, V32, pS94, DOI 10.1086/320182; Wittum TE, 2012, APPL ENVIRON MICROB, V78, P7487, DOI 10.1128/AEM.01682-12	67	45	45	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159567	10.1371/journal.pone.0159567	http://dx.doi.org/10.1371/journal.pone.0159567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414038	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500135
J	Zonta, E; Garlan, F; Pecuchet, N; Perez-Toralla, K; Caen, O; Milbury, C; Didelot, A; Fabre, E; Blons, H; Laurent-Puig, P; Taly, V				Zonta, Eleonora; Garlan, Fanny; Pecuchet, Nicolas; Perez-Toralla, Karla; Caen, Ouriel; Milbury, Coren; Didelot, Audrey; Fabre, Elizabeth; Blons, Helene; Laurent-Puig, Pierre; Taly, Valerie			Multiplex Detection of Rare Mutations by Picoliter Droplet Based Digital PCR: Sensitivity and Specificity Considerations	PLOS ONE			English	Article							CELL LUNG-CANCER; CIRCULATING TUMOR DNA; TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; SINGLE-MOLECULE DETECTION; ANTI-EGFR THERAPY; COLORECTAL-CANCER; KRAS MUTATIONS; LIQUID BIOPSY; RESISTANCE	In cancer research, the accuracy of the technology used for biomarkers detection is remarkably important. In this context, digital PCR represents a highly sensitive and reproducible method that could serve as an appropriate tool for tumor mutational status analysis. In particular, droplet-based digital PCR approaches have been developed for detection of tumor-specific mutated alleles within plasmatic circulating DNA. Such an approach calls for the development and validation of a very significant quantity of assays, which can be extremely costly and time consuming. Herein, we evaluated assays for the detection and quantification of various mutations occurring in three genes often misregulated in cancers: the epidermal growth factor receptor (EGFR), the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) and the Tumoral Protein p53 (TP53) genes. In particular, commercial competitive allele-specific TaqMan (R) PCR (castPCR (TM)) technology, as well as TaqMan (R) and ZEN (TM) assays, have been evaluated for EGFR p.L858R, p.T790M, p.L861Q point mutations and in-frame deletions Del19. Specificity and sensitivity have been determined on cell lines DNA, plasmatic circulating DNA of lung cancer patients or Horizon Diagnostics Reference Standards. To show the multiplexing capabilities of this technology, several multiplex panels for EGFR (several three-and four-plexes) have been developed, offering new "ready-to-use" tests for lung cancer patients.	[Zonta, Eleonora; Garlan, Fanny; Pecuchet, Nicolas; Perez-Toralla, Karla; Caen, Ouriel; Didelot, Audrey; Fabre, Elizabeth; Blons, Helene; Laurent-Puig, Pierre; Taly, Valerie] USPC, INSERM UMR S1147, CNRS SNC 5014, Ctr Univ St Peres, Paris, France; [Pecuchet, Nicolas; Fabre, Elizabeth] HEGP, AP HP, Med Oncol, Paris, France; [Blons, Helene; Laurent-Puig, Pierre] HEGP, AP HP, Unit Pharmacogenet & Mol Oncol, Dept Biochem, Paris, France; [Milbury, Coren] RainDance Technol, Billerica, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Zonta, E; Taly, V (corresponding author), USPC, INSERM UMR S1147, CNRS SNC 5014, Ctr Univ St Peres, Paris, France.	eleonora.zonta@parisdescartes.fr; valerie.taly@parisdescartes.fr	Laurent-Puig, Pierre/K-3641-2019; TALY, VALERIE/N-9766-2014	Laurent-Puig, Pierre/0000-0001-8475-5459; Blons, Helene/0000-0002-0572-8426; Pecuchet, Nicolas/0000-0002-3321-5791; TALY, VALERIE/0000-0002-3116-8602; Didelot, Audrey/0000-0001-8693-1612; Fabre, Elizabeth/0000-0002-1244-873X	Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris-Descartes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National du Cancer (INCA) [2009-1-RT-03-US-1, 2009-RT-03-UP5-1]; Agence Nationale de la Recherche (ANR Nanobiotechnologies) [ANR-10-NANO-0002-09]; SIRIC CARPEM and canceropole funding [2011-1-LABEL-UP5-2]; INSERM Physicancer program [PC201423]; Fondation Servier; RainDance Technologies	Ministere de l'Enseignement Superieur et de la Recherche; Universite Paris-Descartes; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR Nanobiotechnologies)(French National Research Agency (ANR)); SIRIC CARPEM and canceropole funding(Region Grand-Est); INSERM Physicancer program; Fondation Servier; RainDance Technologies	This work was supported by the Ministere de l'Enseignement Superieur et de la Recherche, the Universite Paris-Descartes, the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Institut National du Cancer (INCA, no. 2009-1-RT-03-US-1 and 2009-RT-03-UP5-1), the Agence Nationale de la Recherche (ANR Nanobiotechnologies; no. ANR-10-NANO-0002-09), the SIRIC CARPEM and canceropole funding (no. 2011-1-LABEL-UP5-2). Eleonora Zonta receives salary through the INSERM Physicancer program (no. PC201423). Fanny Garlan thanks the Fondation Servier for a fellowship within the Frontiers in Life Science PhD program (FdV). Karla Perez-Toralla receives salary through the Merieux Institution (Merieux Institute Advanced research Grant to VT/PLP). Ouriel Caen receives salary through the the Association pour la recherche contre le cancer (ARC, no. SL220100601375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coren Milbury is employed by RainDance Technologies. RainDance Technologies provided support in the form of salary for author CM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Caen O, 2015, M S-MED SCI, V31, P180, DOI 10.1051/medsci/20153102015; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Duffy MJ, 2014, CANCER TREAT REV, V40, P1153, DOI 10.1016/j.ctrv.2014.10.004; Francis G, 2015, INT J MOL SCI, V16, P14122, DOI 10.3390/ijms160614122; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Guttery DS, 2015, CLIN CHEM, V61, P974, DOI 10.1373/clinchem.2015.238717; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Huang JQ, 2015, CLIN CHEM, V61, P1408, DOI 10.1373/clinchem.2015.238543; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Juchum M, 2015, DRUG RESIST UPDATE, V20, P12, DOI 10.1016/j.drup.2015.05.002; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Li J, 2014, HUM MUTAT, V35, P575, DOI 10.1002/humu.22528; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Massarelli E, 2013, LUNG CANCER, V80, P235, DOI 10.1016/j.lungcan.2013.01.018; Milbury Coren A, 2014, Biomol Detect Quantif, V1, P8; Nishiyama A, 2015, LUNG CANCER, V89, P301, DOI 10.1016/j.lungcan.2015.06.017; Perez-Toralla K, 2015, M S-MED SCI, V31, P84, DOI 10.1051/medsci/20153101017; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Taly V, 2012, TRENDS MOL MED, V18, P405, DOI 10.1016/j.molmed.2012.05.001; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Tsao SCH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11198; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang QS, 2015, J MOL DIAGN, V17, P515, DOI 10.1016/j.jmoldx.2015.04.002; Watanabe M, 2015, CLIN CANCER RES, V21, P3552, DOI 10.1158/1078-0432.CCR-14-2151; Yang X, 2016, ONCOTARGET, DOI [10.1039/c1ic20126c, DOI 10.1039/C1LC20126C]; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang Y, 2014, BIOCHIMIE, V99, P215, DOI 10.1016/j.biochi.2013.12.017; Zheng D, 2016, SCI REP-UK, V6, DOI 10.1038/srep20913; Zheng DF, 2016, ONCOTARGETS THER, V9, P833, DOI 10.2147/OTT.S96834; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c; Zonta E, 2015, ADV CLIN CHEM, V70, P197, DOI 10.1016/bs.acc.2015.03.002	36	65	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159094	10.1371/journal.pone.0159094	http://dx.doi.org/10.1371/journal.pone.0159094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416070	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500073
J	Chai, YJ; Yi, JW; Jee, HG; Kim, YA; Kim, JH; Xing, MZ; Lee, KE				Chai, Young Jun; Yi, Jin Wook; Jee, Hyeon-Gun; Kim, Young A.; Kim, Ju Han; Xing, Mingzhao; Lee, Kyu Eun			Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data	PLOS ONE			English	Article							BRAF(V600E) MUTATION; V600E MUTATION; IMMUNOHISTOCHEMICAL DETECTION; PROTEIN EXPRESSION; SIGNALING PATHWAY; ACTIVATION; PREDICTS; RET/PTC; RISK; MICROCARCINOMA	Background BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC), and it is associated with high-risk prognostic factors. However, the significance of the BRAF mRNA level in PTC remains unknown. We evaluated the significance of BRAF mRNA expression level by analyzing PTC data from The Cancer Genome Atlas (TCGA) database. Methods Data from 499 patients were downloaded from the TCGA database. After excluding other PTC variants, we selected 353 cases of classic PTC, including 193 cases with BRAF(V600E) and 160 cases with the wild-type BRAF. mRNA abundances were measured using RNA-Seq with the Expectation Maximization algorithm. Results The mean BRAF mRNA level was significantly higher in BRAF(V600E) patients than in patients with wild-type BRAF (197.6 vs. 179.3, p = 0.031). In wild-type BRAF patients, the mean BRAF mRNA level was higher in cases with a tumor > 2 cm than those with a tumor <= 2.0 cm (189.4 vs. 163.8, p = 0.046), and was also higher in cases with lymph node metastasis than in those without lymph node metastasis (188.5 vs. 157.9, p = 0.040). Within BRAF(V600E) patients, higher BRAF mRNA expression was associated with extrathyroidal extension (186.4 vs. 216.4, p = 0.001) and higher T stage (188.1 vs. 210.2, p = 0.016). Conclusions A higher BRAF mRNA expression level was associated with tumor aggressiveness in classic PTC regardless of BRAF mutational status. Evaluation of BRAF mRNA level may be helpful in prognostic risk stratification of PTC.	[Chai, Young Jun] Seoul Natl Univ, Boramae Med Ctr, Dept Surg, 20 Boramae Ro 5 Gil, Seoul 15670, South Korea; [Chai, Young Jun; Yi, Jin Wook; Lee, Kyu Eun] Seoul Natl Univ, Coll Med, Canc Res Inst, 101 Daehak Ro, Seoul 110744, South Korea; [Yi, Jin Wook; Lee, Kyu Eun] Seoul Natl Univ Hosp, Dept Surg, 101 Daehak Ro, Seoul 110744, South Korea; [Yi, Jin Wook; Lee, Kyu Eun] Coll Med, 101 Daehak Ro, Seoul 110744, South Korea; [Jee, Hyeon-Gun] Natl Med Ctr, Ctr Chron Dis, Res Inst, Seoul, South Korea; [Kim, Young A.] Seoul Natl Univ, Boramae Med Ctr, Dept Pathol, 20 Boramae Ro 5 Gil, Seoul 15670, South Korea; [Kim, Ju Han] Seoul Natl Univ, Coll Med, Syst Biomed Informat Res Ctr, Div Biomed Informat, 101 Daehak Ro, Seoul, South Korea; [Xing, Mingzhao] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, 1830E Monument St,Ste 333, Baltimore, MD 21287 USA	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Johns Hopkins University	Lee, KE (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, 101 Daehak Ro, Seoul 110744, South Korea.; Lee, KE (corresponding author), Seoul Natl Univ Hosp, Dept Surg, 101 Daehak Ro, Seoul 110744, South Korea.; Lee, KE (corresponding author), Coll Med, 101 Daehak Ro, Seoul 110744, South Korea.	kyu.eun.lee.md@snu.ac.kr	Chai, Young/AAW-6684-2021	Chai, Young Jun/0000-0001-8830-3433; Yi, Jin Wook/0000-0002-9296-8443	Korean Foundation for Cancer Research [CB-2011-03-01]; Korean Health Technology R&D Project, Ministry of Health and Welfare [HI13C2164]	Korean Foundation for Cancer Research; Korean Health Technology R&D Project, Ministry of Health and Welfare	This study was conducted with research grants from the Korean Foundation for Cancer Research (Grant Number: CB-2011-03-01) and the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI13C2164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Ahn D, 2012, AURIS NASUS LARYNX, V39, P198, DOI 10.1016/j.anl.2011.07.011; Ardekani GS, 2013, BRIT J DERMATOL, V169, P320, DOI 10.1111/bjd.12351; Chai YJ, 2014, SURGERY, V156, P1559, DOI 10.1016/j.surg.2014.08.050; Cheng SP, 2014, ANN SURG ONCOL, V21, pS619, DOI 10.1245/s10434-014-3723-5; Araujo PPC, 2012, PATHOL RES PRACT, V208, P489, DOI 10.1016/j.prp.2012.05.013; Crescenzi A, 2014, HORM METAB RES, V46, P370, DOI 10.1055/s-0034-1368700; Csardi G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005206; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; de Biase D, 2014, J CLIN ENDOCR METAB, V99, pE1530, DOI 10.1210/jc.2013-4389; Finkel A, 2016, J CLIN ENDOCR METAB, V101, P1407, DOI 10.1210/jc.2015-4031; Ghossein RA, 2013, J CLIN ENDOCR METAB, V98, pE1414, DOI 10.1210/jc.2013-1408; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P2333, DOI 10.1210/jc.2011-3106; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; Ilie MI, 2014, THYROID, V24, P858, DOI 10.1089/thy.2013.0302; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Kim MH, 2014, ENDOCR-RELAT CANCER, V21, P891, DOI 10.1530/ERC-14-0147; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Kimura ET, 2003, CANCER RES, V63, P1454; Kondo T, 2007, HUM PATHOL, V38, P1810, DOI 10.1016/j.humpath.2007.04.014; Koperek O, 2012, AM J SURG PATHOL, V36, P844, DOI 10.1097/PAS.0b013e318246b527; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Lang BHH, 2014, ENDOCR-RELAT CANCER, V21, P285, DOI 10.1530/ERC-13-0291; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li F, 2015, ENDOCR-RELAT CANCER, V22, P159, DOI 10.1530/ERC-14-0531; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Nam JK, 2012, AM J SURG, V203, P436, DOI 10.1016/j.amjsurg.2011.02.013; Nixon IJ, 2016, THYROID, V26, P373, DOI 10.1089/thy.2015.0315; Ouyang B, 2006, CLIN CANCER RES, V12, P1785, DOI 10.1158/1078-0432.CCR-05-1729; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steelman LS, 2010, CELL CYCLE, V9, P1629, DOI 10.4161/cc.9.8.11487; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walczyk A, 2014, CLIN ENDOCRINOL, V80, P899, DOI 10.1111/cen.12386; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2012, J CLIN ENDOCR METAB, V97, P2295, DOI 10.1210/jc.2012-2201; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Zagzag J, 2013, SURGERY, V154, P1199, DOI 10.1016/j.surg.2013.06.020; Zimmermann AK, 2014, CANCER CYTOPATHOL, V122, P48, DOI 10.1002/cncy.21352	47	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159235	10.1371/journal.pone.0159235	http://dx.doi.org/10.1371/journal.pone.0159235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410688	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300067
J	Kripke, K; Chen, PA; Vazzano, A; Thambinayagam, A; Pillay, Y; Loykissoonlal, D; Bonnecwe, C; Barron, P; Kiwango, E; Castor, D; Njeuhmeli, E				Kripke, Katharine; Chen, Ping-An; Vazzano, Andrea; Thambinayagam, Ananthy; Pillay, Yogan; Loykissoonlal, Dayanund; Bonnecwe, Collen; Barron, Peter; Kiwango, Eva; Castor, Delivette; Njeuhmeli, Emmanuel			Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces	PLOS ONE			English	Article							HIV PREVENTION; TRIAL; MEN	Background In 2012, South Africa set a goal of circumcising 4.3 million men ages 15-49 by 2016. By the end of March 2014, 1.9 million men had received voluntary medical male circumcision (VMMC). In an effort to accelerate progress, South Africa undertook a modeling exercise to determine whether circumcising specific client age groups or geographic locations would be particularly impactful or cost-effective. Results will inform South Africa's efforts to develop a national strategy and operational plan for VMMC. Methods and Findings The study team populated the Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0) with HIV incidence projections from the Spectrum/AIDS Impact Module (AIM), as well as national and provincial population and HIV prevalence estimates. We derived baseline circumcision rates from the 2012 South African National HIV Prevalence, Incidence and Behaviour Survey. The model showed that circumcising men ages 20-34 offers the most immediate impact on HIV incidence and requires the fewest circumcisions per HIV infection averted. The greatest impact over a 15-year period is achieved by circumcising men ages 15-24. When the model assumes a unit cost increase with client age, men ages 15-29 emerge as the most cost-effective group. When we assume a constant cost for all ages, the most cost-effective age range is 15-34 years. Geographically, the program is cost saving in all provinces; differences in the VMMC program's cost-effectiveness across provinces were obscured by uncertainty in HIV incidence projections. Conclusion The VMMC program's impact and cost-effectiveness vary by age-targeting strategy. A strategy focusing on men ages 15-34 will maximize program benefits. However, because clients older than 25 access VMMC services at low rates, South Africa could consider promoting demand among men ages 25-34, without denying services to those in other age groups. Uncertainty in the provincial estimates makes them insufficient to support geographic targeting.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Chen, Ping-An; Vazzano, Andrea] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Thambinayagam, Ananthy] US Agcy Int Dev, Pretoria, South Africa; [Pillay, Yogan; Loykissoonlal, Dayanund; Bonnecwe, Collen] Natl Dept Hlth, Pretoria, South Africa; [Barron, Peter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Kiwango, Eva] Joint United Nations Programme HIV AIDS, Pretoria, South Africa; [Castor, Delivette] US Off Global AIDS Coordinator, Washington, DC USA; [Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC USA	United States Agency for International Development (USAID); University of Witwatersrand; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Vazzano, Andrea/0000-0001-9653-4151	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]; USAID; PEPFAR	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); PEPFAR	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID- and PEPFAR-funded Health Policy Project. The authors gratefully acknowledge the South Africa National Department of Health for providing data and critical feedback and James Ndirangu and Jorge Quevedo of the Clinton Health Access Initiative for providing some of the compiled and cleaned historical program data. We thank Carlos Toledo and Alfred Bere of the U.S. Centers for Disease Control and Prevention in the United States and South Africa, respectively, for their thorough review of and input into the manuscript in its development stages. We thank the PEPFAR VMMC Technical Working Group, colleagues from the U.S. Centers for Disease Control and Prevention in Pretoria, Jason Reed, and Sema Sgaier for their feedback, helpful discussion, and information sharing. We also thank Carel Pretorius of Avenir Health for assisting with the provincial analyses in this manuscript. We are also grateful to Melissa Schnure for assistance with some of the analyses, figure preparation, and overall management of the manuscript preparation process. Finally, the authors would like to thank the publications staff at the Health Policy Project for their help with copy editing and formatting.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; AVAC, 2014, VOL MED MAL CIRC MOD; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2016, PLOS ONE IN PRESS; Khumalo-Sakutukwa G, 2013, CULT HEALTH SEX, V15, P1085, DOI 10.1080/13691058.2013.807519; Kripke K, 2016, PLOS ONE IN PRESS; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; National Department of Health SA, 2012, GUID PHARM SUBM; National Department of Health SA, 2012, STRAT PLAN SCAL MED; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Peltzer K, 2009, CULT HEALTH SEX, V11, P83, DOI 10.1080/13691050802389777; Shisana O, 2014, S AFRICAN NATL HIV P; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Tchuenche T, 2016, PLOS ONE IN PRESS; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV	16	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157071	10.1371/journal.pone.0157071	http://dx.doi.org/10.1371/journal.pone.0157071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409079	Green Published, gold			2022-12-26	WOS:000379508300005
J	Njeuhmeli, E; Stegman, P; Kripke, K; Mugurungi, O; Ncube, G; Xaba, S; Hatzold, K; Christensen, A; Stover, J				Njeuhmeli, Emmanuel; Stegman, Peter; Kripke, Katharine; Mugurungi, Owen; Ncube, Gertrude; Xaba, Sinokuthemba; Hatzold, Karin; Christensen, Alice; Stover, John			Modeling Costs and Impacts of Introducing Early Infant Male Circumcision for Long-Term Sustainability of the Voluntary Medical Male Circumcision Program	PLOS ONE			English	Article							HIV PREVENTION; TRIAL; MEN	Voluntary medical male circumcision (VMMC) has been shown to be an effective prevention strategy against HIV infection in males [1-3]. Since 2007, the President's Emergency Plan for AIDS Relief (PEPFAR) has supported VMMC programs in 14 priority countries in Africa. Today several of these countries are preparing to transition their VMMC programs from a scale-up and expansion phase to a maintenance phase. As they do so, they must consider the best approaches to sustain high levels of male circumcision in the population. The two alternatives under consideration are circumcising adolescents 10-14 years old over the long term or integrating early infant male circumcision (EIMC) into maternal and child health programs. The paper presents an analysis, using the Decision Makers Program Planning Tool, Version 2.0 (DMPPT 2.0), of the estimated cost and impact of introducing EIMC into existing VMMC programs in several countries in eastern and southern Africa. Limited cost data exist for the implementation of EIMC, but preliminary studies, such as the one detailed in Mangenah, et al. [4-5], suggest that the cost of EIMC may be less than that of adolescent and adult male circumcision. If this is the case, then adding EIMC to the VMMC program will increase the number of circumcisions that need to be performed but will not increase the total cost of the program over the long term. In addition, we found that a delayed or slow start-up of EIMC would not substantially reduce the impact of adding it to the program or increase cumulative long-term costs, which should make introduction of EIMC more feasible and attractive to countries contemplating such a program innovation.	[Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Stegman, Peter; Kripke, Katharine; Stover, John] Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA; [Mugurungi, Owen; Ncube, Gertrude; Xaba, Sinokuthemba] Minist Hlth & Child Care, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Christensen, Alice] AIDSFree Project, Dar Es Salaam, Tanzania	United States Agency for International Development (USAID)	Njeuhmeli, E (corresponding author), US Agcy Int Dev, Washington, DC 20523 USA.	enjeuhmeli@usaid.gov	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]; USAID	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID-funded Health Policy Project. The authors gratefully acknowledge the Zimbabwe Ministry of Health and Child Care for providing data for this analysis. We also thank the United Nations Children's Fund and the PEPFAR VMMC Technical Working Group for their feedback, helpful discussion, and information sharing. We thank Melissa Schnure for assistance with some of the analyses, figure preparation, and overall management of the manuscript preparation process. The authors are also grateful to the publications staff at AIDSFree for their assistance with copy editing and formatting.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Kripke K, 2016, PLOS ONE; Mangenah C, 2016, GLOB HLTH SCI PRA S1, V4; Mangenah C, 2015, JAIDS-J ACQ IMM DEF, V69, P560, DOI 10.1097/QAI.0000000000000699; Ministry of Health and Child Care, ACC STRAT OP PLAN 20; WHO/UNAIDS (Word Health Organization-United Nations Programme on HIV/AIDS, 2010, NEON CHILD MAL CIRC; World Health Organization (WHO)/Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, JOINT STRAT ACT FRAM; ZimStat ICF International, 2012, ZIMB DEM HLTH SURV 2	11	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159167	10.1371/journal.pone.0159167	http://dx.doi.org/10.1371/journal.pone.0159167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410233	gold, Green Published			2022-12-26	WOS:000379508300064
J	Liu, HC; Jamshidi, N; Chen, YC; Eraly, SA; Cho, SY; Bhatnagar, V; Wu, W; Bush, KT; Abagyan, R; Palsson, BO; Nigam, SK				Liu, Henry C.; Jamshidi, Neema; Chen, Yuchen; Eraly, Satish A.; Cho, Sai Yee; Bhatnagar, Vibha; Wu, Wei; Bush, Kevin T.; Abagyan, Ruben; Palsson, Bernhard O.; Nigam, Sanjay K.			An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; diabetes; kidney; microbiome; systems biology; Recon; SLC transporter; chronic kidney disease; genome-scale metabolic reconstruction; pharmacophore	REVERSE-TRANSCRIPTASE INHIBITORS; GENOME-SCALE RECONSTRUCTION; FLUX BALANCE ANALYSIS; UREMIC TOXINS; DRUG TRANSPORTERS; ANTIRETROVIRAL THERAPY; KIDNEY-DISEASE; OAT FAMILY; URIC-ACID; IN-VITRO	There has been a recent interest in the broader physiological importance of multispecific drug transporters of the SLC and ABC transporter families. Here, a novel multi-tiered systems biology approach was used to predict metabolites and signaling molecules potentially affected by the in vivo deletion of organic anion transporter 1 (Oat1, Slc22a6, originally NKT), a major kidney-expressed drug transporter. Validation of some predictions in wet-lab assays, together with re-evaluation of existing transport and knock-out metabolomics data, generated an experimentally validated, confidence ranked set of OAT1-interacting endogenous compounds enabling construction of an OAT1-centered metabolic interaction network. Pathway and enrichment analysis indicated an important role for OAT1 in metabolism involving: the TCA cycle, tryptophan and other amino acids, fatty acids, prostaglandins, cyclic nucleotides, odorants, polyamines, and vitamins. The partly validated reconstructed network is also consistent with a major role for OAT1 in modulating metabolic and signaling pathways involving uric acid, gut microbiome products, and so-called uremic toxins accumulating in chronic kidney disease. Together, the findings are compatible with the hypothesized role of drug transporters in remote inter-organ and inter-organismal communication: The Remote Sensing and Signaling Hypothesis (Nigam, S. K. (2015) Nat. Rev. Drug Disc. 14, 29). The fact that OAT1 can affect many systemic biological pathways suggests that drug-metabolite interactions need to be considered beyond simple competition for the drug transporter itself and may explain aspects of drug-induced metabolic syndrome. Our approach should provide novel mechanistic insights into the role of OAT1 and other drug transporters implicated in metabolic diseases like gout, diabetes, and chronic kidney disease.	[Liu, Henry C.; Jamshidi, Neema; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Eraly, Satish A.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cho, Sai Yee] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Bhatnagar, Vibha] Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Yuchen] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,MC0693, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Jamshidi, Neema/0000-0003-3857-9735	National Institutes of Health [R01-GM098449, RO1GM104098, U54-HD07160]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098449, R01GM104098, R01GM071872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM098449, RO1GM104098, and U54-HD07160. R. Abagyan has a significant financial interest in Molsoft or its products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SY, 2011, J BIOL CHEM, V286, P31522, DOI 10.1074/jbc.M111.272534; Ahn SY, 2009, J BIOL CHEM, V284, P31422, DOI 10.1074/jbc.M109.024489; Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Anderson PL, 2004, CLIN INFECT DIS, V38, P743, DOI 10.1086/381678; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Bhatnagar V, 2016, CLIN KIDNEY J, V9, P444, DOI 10.1093/ckj/sfw010; Bordbar A, 2012, J INTERN MED, V271, P131, DOI 10.1111/j.1365-2796.2011.02494.x; Burckhardt G, 2011, HANDB EXP PHARMACOL, V201, P29, DOI 10.1007/978-3-642-14541-4_2; Buscemi S, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-80; Bush KT, 2014, WILEY SER DRUG DISC, P25; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chen YC, 2014, FUTURE MED CHEM, V6, P1741, DOI [10.4155/fmc.14.113, 10.4155/FMC.14.113]; Duan P, 2012, MOL PHARMACEUT, V9, P3340, DOI 10.1021/mp300365t; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; ELION GB, 1989, BIOSCIENCE REP, V9, P509, DOI 10.1007/BF01119794; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gupta S, 2007, MOL DIVERS, V11, P23, DOI 10.1007/s11030-006-9054-0; Hester EK, 2012, NUTR CLIN PRACT, V27, P51, DOI 10.1177/0884533611431985; HITCHINGS GH, 1989, IN VITRO CELL DEV B, V25, P303; Hodson L, 2013, CURR OPIN CLIN NUTR, V16, P225, DOI 10.1097/MCO.0b013e32835d2edf; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Karakoc E, 2006, J CHEM INF MODEL, V46, P2167, DOI 10.1021/ci0601517; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Khanna V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S10; Knies D, 2015, METABOLITES, V5, P659, DOI 10.3390/metabo5040659; Kouznetsova VL, 2011, BIOORGAN MED CHEM, V19, P3320, DOI 10.1016/j.bmc.2011.04.045; Lee SC, 2014, WILEY SER DRUG DISC, P473; Lewis W, 2003, PROG CARDIOVASC DIS, V45, P305, DOI 10.1053/pcad.2003.3b; Liu H. C., 2016, J PHARMACOL EXP THER; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; LopezNieto CE, 1996, J AM SOC NEPHROL, V7, pA0277; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Mitrea C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00278; MOLLER JV, 1982, PHARMACOL REV, V34, P315; Monier PL, 2004, AM J MED SCI, V328, P48, DOI 10.1097/00000441-200407000-00007; Nagle MA, 2013, NEUROSCI LETT, V534, P133, DOI 10.1016/j.neulet.2012.11.027; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nigam SK, 2015, CLIN J AM SOC NEPHRO, V10, P2039, DOI 10.2215/CJN.02440314; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; O'Hagan S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00105; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; PRITCHARD JB, 1995, J PHARMACOL EXP THER, V274, P1278; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Riedmaier AE, 2012, PHARMACOL REV, V64, P421, DOI 10.1124/pr.111.004614; Saito H, 2010, PHARMACOL THERAPEUT, V125, P79, DOI 10.1016/j.pharmthera.2009.09.008; Schuetz JD, 2014, DRUG METAB DISPOS, V42, P541, DOI 10.1124/dmd.114.057539; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Sinxadi PZ, 2013, AIDS RES HUM RETROV, V29, P1031, DOI [10.1089/aid.2012.0373, 10.1089/AID.2012.0373]; Sweeney DE, 2011, MOL PHARMACOL, V80, P147, DOI 10.1124/mol.110.070680; Torres AM, 2011, J BIOL CHEM, V286, P26391, DOI 10.1074/jbc.M111.249292; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Vallon V, 2012, AM J PHYSIOL-RENAL, V302, pF1293, DOI 10.1152/ajprenal.00013.2012; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wang RS, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/105014; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wolman AT, 2013, DRUG METAB DISPOS, V41, P791, DOI 10.1124/dmd.112.049569; Wu W, 2015, DRUG METAB DISPOS, V43, P1855, DOI 10.1124/dmd.115.065250; Wu W, 2013, DRUG METAB DISPOS, V41, P1825, DOI 10.1124/dmd.113.052647; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhang YP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03426; Zhu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140569	75	34	34	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19474	19486		10.1074/jbc.M116.745216	http://dx.doi.org/10.1074/jbc.M116.745216			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27440044	Green Published, hybrid			2022-12-26	WOS:000383242800025
J	Assentoft, M; Kaptan, S; Schneider, HP; Deitmer, JW; de Groot, BL; MacAulay, N				Assentoft, Mette; Kaptan, Shreyas; Schneider, Hans-Peter; Deitmer, Joachim W.; de Groot, Bert L.; MacAulay, Nanna			Aquaporin 4 as a NH3 Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELATIVE CO2/NH3 SELECTIVITIES; XENOPUS-LAEVIS OOCYTES; THICK ASCENDING LIMB; AMMONIUM TRANSPORT; POTASSIUM CHANNELS; NH4+ CONDUCTANCE; INTRACELLULAR PH; WATER TRANSPORT; GLIAL-CELLS; PERMEABILITY	Ammonia is a biologically potent molecule, and the regulation of ammonia levels in the mammalian body is, therefore, strictly controlled. The molecular paths of ammonia permeation across plasma membranes remain ill-defined, but the structural similarity of water and NH3 has pointed to the aquaporins as putative NH3-permeable pores. Accordingly, a range of aquaporins from mammals, plants, fungi, and protozoans demonstrates ammonia permeability. Aquaporin 4 (AQP4) is highly expressed at perivascular glia end-feet in the mammalian brain and may, with this prominent localization at the bloodbrain- interface, participate in the exchange of ammonia, which is required to sustain the glutamate-glutamine cycle. Here we observe that AQP4-expressing Xenopus oocytes display a reflection coefficient <1 for NH4Cl at pH 8.0, at which pH an increased amount of the ammonia occurs in the form of NH3. Taken together with an NH4Cl-mediated intracellular alkalization (or lesser acidification) of AQP4-expressing oocytes, these data suggest that NH3 is able to permeate the pore of AQP4. Exposure to NH4Cl increased the membrane currents to a similar extent in uninjected oocytes and in oocytes expressing AQP4, indicating that the ionic NH4+ did not permeate AQP4. Molecular dynamics simulations revealed partial pore permeation events of NH3 but not of NH4+ and a reduced energy barrier for NH3 permeation through AQP4 compared with that of a cholesterol-containing lipid bilayer, suggesting AQP4 as a favored transmembrane route for NH3. Our data propose that AQP4 belongs to the growing list of NH3-permeable water channels.	[Assentoft, Mette; MacAulay, Nanna] Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3,Bldg 22-3, DK-2200 Copenhagen N, Denmark; [Kaptan, Shreyas; de Groot, Bert L.] Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany; [Schneider, Hans-Peter; Deitmer, Joachim W.] Univ Kaiserslautern, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany	University of Copenhagen; Max Planck Society; University of Kaiserslautern	MacAulay, N (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Blegdamsvej 3,Bldg 22-3, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	MacAulay, Nanna/AER-7709-2022	MacAulay, Nanna/0000-0002-7800-6600; Kaptan, Shreyas/0000-0003-1265-4557	Danish Medical Research Council; Max Planck Society; German Research Foundation [SFB 803]; Deutsche Forschungsgemeinschaft [DE 231/24-2]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Danish Medical Research Council.; Supported by the Max Planck Society and the German Research Foundation via the SFB 803 (Project A03).; Supported by the Deutsche Forschungsgemeinschaft (DE 231/24-2).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Bachmann O, 2003, J PHYSIOL-LONDON, V549, P525, DOI 10.1113/jphysiol.2002.030205; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; BLATZ AL, 1984, J GEN PHYSIOL, V84, P1, DOI 10.1085/jgp.84.1.1; Bodega G, 2012, NEUROCHEM INT, V61, P1314, DOI 10.1016/j.neuint.2012.09.008; Boldt M, 2003, PFLUG ARCH EUR J PHY, V446, P652, DOI 10.1007/s00424-003-1122-z; BORON WF, 1994, J EXP BIOL, V196, P347; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P83, DOI 10.1007/BF00378645; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535; Caner T, 2015, AM J PHYSIOL-CELL PH, V309, pC747, DOI 10.1152/ajpcell.00085.2015; CHEPILKO S, 1995, AM J PHYSIOL-CELL PH, V268, pC389, DOI 10.1152/ajpcell.1995.268.2.C389; Choe H, 2000, J GEN PHYSIOL, V115, P391, DOI 10.1085/jgp.115.4.391; Cohn RM, 2004, CLIN PEDIATR, V43, P683, DOI 10.1177/000992280404300801; Cougnon M, 1996, PFLUG ARCH EUR J PHY, V431, P658, DOI 10.1007/BF02191917; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dynowski M, 2008, FEBS LETT, V582, P2458, DOI 10.1016/j.febslet.2008.06.012; Edvinsson JM, 2011, CHANNELS, V5, P269, DOI 10.4161/chan.5.3.15827; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Flub J. S., 2010, J AM CHEM SOC, V132, P13251; Geyer RR, 2013, AM J PHYSIOL-CELL PH, V304, pC985, DOI 10.1152/ajpcell.00033.2013; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; HAMM LL, 1985, J CLIN INVEST, V75, P478, DOI 10.1172/JCI111723; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hub JS, 2008, P NATL ACAD SCI USA, V105, P1198, DOI 10.1073/pnas.0707662104; Hub JS, 2010, BIOPHYS J, V99, pL97, DOI 10.1016/j.bpj.2010.11.003; Hwang JH, 2010, FEBS LETT, V584, P4339, DOI 10.1016/j.febslet.2010.09.033; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KINNE R, 1986, J MEMBRANE BIOL, V94, P279, DOI 10.1007/BF01869723; Kirscht A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002411; KURTZ I, 1986, AM J PHYSIOL, V250, pF497, DOI 10.1152/ajprenal.1986.250.3.F497; LAURSEN H, 1980, ACTA NEUROPATHOL, V51, P65, DOI 10.1007/BF00688851; Liu K, 2006, BIOL CELL, V98, P153, DOI 10.1042/BC20050026; LOCKWOOD AH, 1993, HEPATOLOGY, V18, P1061; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; Nielsen S, 1997, J NEUROSCI, V17, P171; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; OCARROLL RE, 1991, LANCET, V337, P1250, DOI 10.1016/0140-6736(91)92920-W; Rao KVR, 2003, NEUROREPORT, V14, P2379, DOI 10.1097/01.wnr.0000099610.19426.a6; Rose C, 2006, J NEUROCHEM, V97, P11, DOI 10.1111/j.1471-4159.2006.03796.x; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; SASAKI S, 1992, BIOCHIM BIOPHYS ACTA, V1137, P45, DOI 10.1016/0167-4889(92)90098-V; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sogaard R, 2012, AM J PHYSIOL-CELL PH, V302, pC880, DOI 10.1152/ajpcell.00238.2011; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WATTS BA, 1994, J GEN PHYSIOL, V103, P917, DOI 10.1085/jgp.103.5.917; WOLBURG H, 1995, J BRAIN RES, V36, P239; YIP KP, 1995, AM J PHYSIOL-RENAL, V269, pF545, DOI 10.1152/ajprenal.1995.269.4.F545; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65; Zeuthen T, 2006, J PHYSIOL-LONDON, V570, P485, DOI 10.1113/jphysiol.2005.100933; Zeuthen T, 2006, MOL MICROBIOL, V61, P1598, DOI 10.1111/j.1365-2958.2006.05325.x; Zhang W, 2015, INT J ANTENN PROPAG, V2015, P1, DOI DOI 10.1145/2820783.2820823.10; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	74	20	20	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19184	19195		10.1074/jbc.M116.740217	http://dx.doi.org/10.1074/jbc.M116.740217			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27435677	Green Published, hybrid			2022-12-26	WOS:000383242300049
J	Rong, ZY; Ouyang, ZQ; Magin, RS; Marnnorstein, R; Yu, HT				Rong, Ziye; Ouyang, Zhuqing; Magin, Robert S.; Marnnorstein, Ronen; Yu, Hongtao			Opposing Functions of the N-terminal Acetyltransferases Naa50 and NatA in Sister-chromatid Cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CHROMOSOME SEGREGATION; SMC3 ACETYLATION; DNA-REPLICATION; MOLECULAR-BASIS; COMPLEX; WAPL; SORORIN; CENTROMERES; BINDING	During the cell cycle, sister-chromatid cohesion tethers sister chromatids together from S phase to the metaphase-anaphase transition and ensures accurate segregation of chromatids into daughter cells. N-terminal acetylation is one of the most prevalent protein covalent modifications in eukaryotes and is mediated by a family of N-terminal acetyltransferases (NAT). Naa50 (also called San) has previously been shown to play a role in sister-chromatid cohesion in metazoans. The mechanism by which Naa50 contributes to cohesion is not understood however. Here, we show that depletion of Naa50 in HeLa cells weakens the interaction between cohesin and its positive regulator sororin and causes cohesion defects in S phase, consistent with a role of Naa50 in cohesion establishment. Strikingly, co-depletion of NatA, a heterodimeric NAT complex that physically interacts with Naa50, rescues the sister-chromatid cohesion defects and the resulting mitotic arrest caused by Naa50 depletion, indicating that NatA and Naa50 play antagonistic roles in cohesion. Purified recombinant NatA and Naa50 do not affect each other's NAT activity in vitro. Because NatA and Naa50 exhibit distinct substrate specificity, we propose that they modify different effectors and regulate sister-chromatid cohesion in opposing ways.	[Rong, Ziye; Ouyang, Zhuqing; Yu, Hongtao] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Magin, Robert S.; Marnnorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Pennsylvania Medicine	Yu, HT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	ouyang, zhuqing/HHC-3950-2022	Magin, Robert/0000-0002-8480-8511	Welch Foundation [I-1441]; Cancer Prevention and Research Institute of Texas [RP110465-P3, RP120717-P2]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071339, R35GM118090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Welch Foundation (I-1441; to H.Y.) and the Cancer Prevention and Research Institute of Texas (RP110465-P3 and RP120717-P2; to H.Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Chu CW, 2011, MOL BIOL CELL, V22, P448, DOI 10.1091/mbc.E10-03-0203; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Dreier MR, 2011, J CELL SCI, V124, P2976, DOI 10.1242/jcs.085431; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hou FJ, 2007, J CELL BIOL, V177, P587, DOI 10.1083/jcb.200701043; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Ladurner R, 2014, CURR BIOL, V24, P2228, DOI 10.1016/j.cub.2014.08.011; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Liu H, 2015, MOL CELL, V59, P426, DOI 10.1016/j.molcel.2015.06.018; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Liu H, 2013, NAT CELL BIOL, V15, P40, DOI 10.1038/ncb2637; Magin RS, 2016, J BIOL CHEM, V291, P5270, DOI 10.1074/jbc.M115.709428; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nishiyama T, 2013, P NATL ACAD SCI USA, V110, P13404, DOI 10.1073/pnas.1305020110; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; Ouyang ZQ, 2013, P NATL ACAD SCI USA, V110, P11355, DOI 10.1073/pnas.1304594110; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Van Damme P, 2015, PROTEOMICS, V15, P2436, DOI 10.1002/pmic.201400575; Van Damme P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004580; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	49	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19079	19091		10.1074/jbc.M116.737585	http://dx.doi.org/10.1074/jbc.M116.737585			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422821	Green Published, hybrid			2022-12-26	WOS:000383242300041
J	Theparambil, SM; Weber, T; Schmalzle, J; Ruminot, I; Deitmer, JW				Theparambil, Shefeeq M.; Weber, Tobias; Schmalzle, Jana; Ruminot, Ivan; Deitmer, Joachim W.			Proton Fall or Bicarbonate Rise GLYCOLYTIC RATE IN MOUSE ASTROCYTES IS PAVED BY INTRACELLULAR ALKALINIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CORTICAL ASTROCYTES; ENERGY-METABOLISM; NEURONAL-ACTIVITY; SNAIL NEURONS; PH TRANSIENTS; FROG-MUSCLE; GLIAL-CELLS; LACTATE; BRAIN	Glycolysis is the primary step for major energy production in the cell. There is strong evidence suggesting that glucose consumption and rate of glycolysis are highly modulated by cytosolic pH/[H+], but those can also be stimulated by an increase in the intracellular [HCO3-]. Because proton and bicarbonate shift concomitantly, it remained unclear whether enhanced glucose consumption and glycolytic rate were mediated by the changes in intracellular [H+] or[HCO3-]. We have asked whether glucose metabolism is enhanced by either a fall in intracellular [H+] or a rise in intracellular [HCO3-], or by both, in mammalian astrocytes. We have recorded intracellular glucose in mouse astrocytes using a FRET-based nanosensor, while imposing different intracellular [H+] and [CO2]/[HCO3-]. Glucose consumption and glycolytic rate were augmented by a fall in intracellular [H+], irrespective of a concomitant rise or fall in intracellular [HCO3-]. Transport of HCO3- into and out of astrocytes by the electrogenic sodium bicarbonate cotransporter (NBCe1) played a crucial role in causing changes in intracellular pH and [HCO3-], but was not obligatory for the pH-dependent changes in glucose metabolism. Our results clearly show that it is the cytosolic pH that modulates glucose metabolism in cortical astrocytes, and possibly also in other cell types.	[Theparambil, Shefeeq M.; Weber, Tobias; Schmalzle, Jana; Ruminot, Ivan; Deitmer, Joachim W.] Univ Kaiserlautern, FB Biol, Abt Allgemeine Zool, PB 3049, D-67653 Kaiserslautern, Germany; [Ruminot, Ivan] Ctr Estudios Cient, Valdivia 5110466, Chile		Theparambil, SM; Deitmer, JW (corresponding author), Univ Kaiserlautern, FB Biol, Abt Allgemeine Zool, PB 3049, D-67653 Kaiserslautern, Germany.	theparambil@biologie.uni-kl.de; deitmer@biologie.uni-kl.de		Ruminot Moraga, Ivan/0000-0002-3985-384X	Deutsche Forschungsgemeinschaft [DE 231/24-1,2]; Priority Group of the Land Rheinland-Pfalz 'Bio-Comp' at the University of Kaiserslautern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Priority Group of the Land Rheinland-Pfalz 'Bio-Comp' at the University of Kaiserslautern	This work was supported by the Deutsche Forschungsgemeinschaft (Grant DE 231/24-1,2) and by the Priority Group of the Land Rheinland-Pfalz 'Bio-Comp' at the University of Kaiserslautern (to J. W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baeza Y., 2014, NEUROPHOTON, V1; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Brookes N, 1997, GLIA, V21, P64; Buck J, 2011, SENSORS-BASEL, V11, P2112, DOI 10.3390/s110202112; CARPENTER JF, 1986, ARCH BIOCHEM BIOPHYS, V248, P1, DOI 10.1016/0003-9861(86)90394-2; Chang JC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00042; CHESLER M, 1987, AM J PHYSIOL, V253, pR666, DOI 10.1152/ajpregu.1987.253.4.R666; CHESLER M, 1989, J NEUROSCI, V9, P2011; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Deitmer JW, 2001, RESP PHYSIOL, V129, P71, DOI 10.1016/S0034-5687(01)00283-3; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; ERECINSKA M, 1995, J NEUROCHEM, V65, P2765; FOLBERGROVA J, 1972, J NEUROCHEM, V19, P2507, DOI 10.1111/j.1471-4159.1972.tb01310.x; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; HASSEL B, 1995, NEUROCHEM RES, V20, P413, DOI 10.1007/BF00973096; Jakoby P, 2014, CEREB CORTEX, V24, P222, DOI 10.1093/cercor/bhs309; Karagiannis A, 2016, J CEREBR BLOOD F MET, V36, P1202, DOI 10.1177/0271678X15611912; Kerly M, 1933, J BIOL CHEM, V103, P161; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; PENG L, 1994, BRAIN RES, V663, P168, DOI 10.1016/0006-8993(94)90475-8; ROSE CR, 1994, J PHYSIOL-LONDON, V481, P1, DOI 10.1113/jphysiol.1994.sp020413; Ruminot I, 2011, J NEUROSCI, V31, P14264, DOI 10.1523/JNEUROSCI.2310-11.2011; San Martin A, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011004; Schneider J, 2015, J NEUROSCI RES, V93, P1067, DOI 10.1002/jnr.23590; Schrodl-Haussel M, 2015, GLIA, V63, P1226, DOI 10.1002/glia.22814; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; Theparambil SM, 2015, J PHYSIOL-LONDON, V593, P3533, DOI 10.1113/JP270086; Theparambil SM, 2015, GLIA, V63, P1581, DOI 10.1002/glia.22829; Theparambil SM, 2014, J NEUROSCI, V34, P1148, DOI 10.1523/JNEUROSCI.2377-13.2014; THOMAS RC, 1976, J PHYSIOL-LONDON, V255, P715, DOI 10.1113/jphysiol.1976.sp011305; THOMAS RC, 1974, J PHYSIOL-LONDON, V238, P159, DOI 10.1113/jphysiol.1974.sp010516; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Valdebenito R, 2016, J CEREBR BLOOD F MET, V36, P1813, DOI 10.1177/0271678X15613955; Wuttke M S, 2001, JOP, V2, P154; Zippin JH, 2013, J BIOL CHEM, V288, P33283, DOI 10.1074/jbc.M113.510073	43	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19108	19117		10.1074/jbc.M116.730143	http://dx.doi.org/10.1074/jbc.M116.730143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422823	hybrid, Green Published			2022-12-26	WOS:000383242300043
J	Kayigamba, FR; Franke, MF; Bakker, MI; Rodriguez, CA; Bagiruwigize, E; Wit, FWNM; Rich, ML; van der Loeff, MFS				Kayigamba, Felix R.; Franke, Molly F.; Bakker, Mirjam I.; Rodriguez, Carly A.; Bagiruwigize, Emmanuel; Wit, Ferdinand W. N. M.; Rich, Michael L.; van der Loeff, Maarten F. Schim			Discordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort Study	PLOS ONE			English	Article							COMMUNITY-BASED ACCOMPANIMENT; VIRUS-INFECTED PATIENTS; VIROLOGICAL RESPONSES; RURAL RWANDA; SUPPRESSION; ADHERENCE; ADULTS; MORTALITY; OUTCOMES; VIREMIA	Introduction Some antiretroviral therapy naive patients starting combination antiretroviral therapy (cART) experience a limited CD4 count rise despite virological suppression, or vice versa. We assessed the prevalence and determinants of discordant treatment responses in a Rwandan cohort. Methods A discordant immunological cART response was defined as an increase of < 100 CD4 cells/mm3 at 12 months compared to baseline despite virological suppression (viral load [VL] < 40 copies/mL). A discordant virological cART response was defined as detectable VL at 12 months with an increase in CD4 count >= 100 cells/mm(3). The prevalence of, and independent predictors for these two types of discordant responses were analysed in two cohorts nested in a 12-month prospective study of cART-naive HIV patients treated at nine rural health facilities in two regions in Rwanda. Results Among 382 patients with an undetectable VL at 12 months, 112 (29%) had a CD4 rise of < 100 cells/mm(3). Age >= 35 years and longer travel to the clinic were independent determinants of an immunological discordant response, but sex, baseline CD4 count, body mass index and WHO HIV clinical stage were not. Among 326 patients with a CD4 rise of >= 100 cells/mm3, 56 (17%) had a detectable viral load at 12 months. Male sex was associated with a virological discordant treatment response (P = 0.05), but age, baseline CD4 count, BMI, WHO HIV clinical stage, and travel time to the clinic were not. Conclusions Discordant treatment responses were common in cART-naive HIV patients in Rwanda. Small CD4 increases could be misinterpreted as a (virological) treatment failure and lead to unnecessary treatment changes.	[Kayigamba, Felix R.; Bagiruwigize, Emmanuel] CPCD, INTERACT, POB 2181, Kigali, Rwanda; [Franke, Molly F.; Rodriguez, Carly A.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Franke, Molly F.; Rich, Michael L.] Inshuti Mu Buzima, Rwinkwavu, Rwanda; [Bakker, Mirjam I.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands; [Wit, Ferdinand W. N. M.; van der Loeff, Maarten F. Schim] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Wit, Ferdinand W. N. M.; van der Loeff, Maarten F. Schim] Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [Rich, Michael L.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Amsterdam, Netherlands	Harvard University; Harvard Medical School; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Public Health Service Amsterdam	Kayigamba, FR (corresponding author), CPCD, INTERACT, POB 2181, Kigali, Rwanda.	fkaigamba@gmail.com	Wit, Ferdinand/AAC-3803-2019; Franke, Molly/AAK-7559-2020	Franke, Molly/0000-0002-4890-5728; Rodriguez, Carly A/0000-0003-0023-2111	Doris Duke Charitable Foundation; Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European Union [SANTE/2006/105-316]	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO); European Union(European Commission)	The Doris Duke Charitable Foundation provided financial support of this research. Technical support was provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) and the European Union (SANTE/2006/105-316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge and thank the Doris Duke Charitable Foundation for financial support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Technical support was provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) and the European Union (SANTE/2006/105-316). We are grateful to the study staff: Adrienne Socci, Massudi Hakizamungu, Wellars Ndayambaje, Eline Uwitonze, Albertine Mukeshimana, Ernest Nyirinkindi, Jean Damascene Uwamuhoro, Carine Dusenge, Claire Dusabe, and Jean Claude Nyiramana. We also thank Cheryl Amoroso, Benjamin Akimana, Christian Allen, Darius Jazayeri, Ellen Ball, the Rwanda-based PIH-EMR team, and Laboratory Management of the Rwanda National Reference Laboratory. We also thank Frank Cobelens for providing feedback on a draft of this manuscript.	Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Coffey S, 2012, SANDES HIV AIDS MED; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Falster K, 2009, JAIDS-J ACQ IMM DEF, V50, P307, DOI 10.1097/QAI.0b013e3181945ed4; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Franke MF, 2013, CLIN INFECT DIS, V56, P1319, DOI 10.1093/cid/cis1193; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Gupta N, 2016, AIDS BEHAV, V20, P1009, DOI 10.1007/s10461-015-1185-9; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOB AIDS EP 2013; Julg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031161; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; Podsadecki TJ, 2007, J INFECT DIS, V196, P1773, DOI 10.1086/523704; Prabhakar B, 2011, Indian J Sex Transm Dis AIDS, V32, P94, DOI 10.4103/0253-7184.85412; Saison J, 2014, J INT AIDS SOC, V17, P119, DOI 10.7448/IAS.17.4.19672; Casotti JAS, 2011, REV INST MED TROP SP, V53, P301, DOI 10.1590/S0036-46652011000600001; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; TRAC Plus Ministry of Health Rwanda, 2009, GUID PROV COMPR CAR; Tuboi SH, 2007, JAIDS-J ACQ IMM DEF, V45, P52, DOI 10.1097/QAI.0b013e318042e1c3; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; Wandeler G, 2013, AIDS LONDON ENGLAND, V27, DOI [10.1097/QAD.1090b1013e328362d328887, DOI 10.1097/QAD.1090B1013E328362D328887]; Wandeler G, 2013, AIDS, V27, P2225, DOI 10.1097/QAD.0b013e328362d887; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; Zoufaly A, 2011, J INFECT DIS, V203, P364, DOI 10.1093/jinfdis/jiq055	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159446	10.1371/journal.pone.0159446	http://dx.doi.org/10.1371/journal.pone.0159446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438000	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100047
J	Dias, DT; Ushida, M; Sousa, MC; Dorairaj, S; Biteli, LG; Leite, MT; Paranhos, A; Prata, TS				Dias, Diego T.; Ushida, Michele; Sousa, Marina C.; Dorairaj, Syril; Biteli, Luis G.; Leite, Mauro T.; Paranhos, Augusto, Jr.; Prata, Tiago S.			Eyes with Suspicious Appearance of the Optic Disc and Normal Intraocular Pressure: Using Clinical and Epidemiological Characteristics to Differentiate Those with and without Glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; OCULAR HYPERTENSION TREATMENT; PREDICTIVE FACTORS; RISK-FACTORS; DAMAGE; TRIAL; ONSET	Among all glaucoma suspects, eyes with optic nerve head features suspicious or suggestive of early glaucoma are probably those that offer the greatest challenge for clinicians. In contrast with the robust longitudinal data published on ocular hypertension, there is no specific management guideline for these patients. Therefore, evaluating eyes with suspicious optic disc appearance and normal intraocular pressure (IOP), we sought to investigate potential differences in clinical and epidemiological characteristics to differentiate those with normaltension glaucoma (NTG) from those with presumed large physiological optic disc cups (pLPC). In this observational case-control study, we consecutively enrolled individuals with pLPC and NTG. All eyes had vertical cup-to-disc ratio (VCDR)>= 0.6 and untreated IOP<21 mmHg. Glaucomatous eyes had reproducible visual field defects. Eyes with pLPC required normal visual fields and >= 30 months of follow-up with no evidence of glaucomatous neuropathy. Clinical and epidemiological parameters were compared between groups. Eighty-four individuals with pLPC and 40 NTG patients were included. Regarding our main results, NTG patients were significantly older and with a higher prevalence of Japanese descendants (p<0.01). Not only did pLPC eyes have smaller mean VCDR, but also larger optic discs (p <= 0.04). There were no significant differences for gender, central corneal thickness, and spherical equivalent (p >= 0.38). Significant odds ratios (OR) were found for race (OR = 2.42; for Japanese ancestry), age (OR = 1.05), VCDR (OR = 5.03), and disc size (OR = 0.04; p <= 0.04). In conclusion, in patients with suspicious optic disc and normal IOP, those with older age, Japanese ancestry, smaller optic discs, and larger VCDR are more likely to have NTG, and therefore, deserve deeper investigation and closer monitoring.	[Dias, Diego T.; Ushida, Michele; Sousa, Marina C.; Biteli, Luis G.; Leite, Mauro T.; Paranhos, Augusto, Jr.; Prata, Tiago S.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, SP, Brazil; [Dias, Diego T.; Ushida, Michele; Biteli, Luis G.; Prata, Tiago S.] Hosp Med Olhos, Glaucoma Unit, Osasco, SP, Brazil; [Dorairaj, Syril] Mayo Clin, Dept Ophthalmol, Jacksonville, FL 32224 USA	Universidade Federal de Sao Paulo (UNIFESP); Mayo Clinic	Dorairaj, S (corresponding author), Mayo Clin, Dept Ophthalmol, Jacksonville, FL 32224 USA.	dorairaj.syril@mayo.edu	Prata, Tiago/AAV-6676-2020; Paranhos, Augusto/A-6115-2010; Leite, Mauro Toledo/AAF-5666-2021; Paranhos Jr, Augusto/E-6297-2012	Prata, Tiago/0000-0003-1830-3766; Paranhos Jr, Augusto/0000-0001-6266-6922	Federal University of Sao Paulo	Federal University of Sao Paulo	The authors receive direct funding from the Federal University of Sao Paulo.	Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; De Moraes CGV, 2009, INVEST OPHTH VIS SCI, V50, P4727, DOI 10.1167/iovs.09-3446; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; KITAZAWA Y, 1977, ARCH OPHTHALMOL-CHIC, V95, P1180, DOI 10.1001/archopht.1977.04450070078004; KOLKER AE, 1977, ARCH OPHTHALMOL-CHIC, V95, P586; Lee J, 2012, EYE, V26, P1473, DOI 10.1038/eye.2012.204; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Martus P, 2005, AM J OPHTHALMOL, V139, P999, DOI 10.1016/j.ajo.2004.12.056; Miglior S, 2007, AM J OPHTHALMOL, V144, P266, DOI 10.1016/j.ajo.2007.04.040; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nakagami T, 2006, JPN J OPHTHALMOL, V50, P38, DOI 10.1007/s10384-005-0273-1; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; PHELPS CD, 1977, ARCH OPHTHALMOL-CHIC, V95, P588; Prata Tiago S, 2014, Med Hypothesis Discov Innov Ophthalmol, V3, P91; Prata TS, 2010, OPHTHALMOLOGY, V117, P24, DOI 10.1016/j.ophtha.2009.06.028; Sakata R, 2013, J GLAUCOMA, V22, P250, DOI 10.1097/IJG.0b013e31823298fb; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; SHAFFER R, 1977, ARCH OPHTHALMOL-CHIC, V95, P588; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P737, DOI 10.1167/iovs.10-5351; Swanson MW, 2011, OPTOMETRY VISION SCI, V88, P86, DOI 10.1097/OPX.0b013e3181fc3638; WILENSKY JT, 1974, ARCH OPHTHALMOL-CHIC, V91, P200	27	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158983	10.1371/journal.pone.0158983	http://dx.doi.org/10.1371/journal.pone.0158983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433805	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600027
J	Lown, L; Peters, BM; Walraven, CJ; Noverr, MC; Lee, SA				Lown, Livia; Peters, Brian M.; Walraven, Carla J.; Noverr, Mairi C.; Lee, Samuel A.			An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C-albicans - Staphyloccoccus aureus Biofilms	PLOS ONE			English	Article							IN-VITRO ACTIVITY; LIPOPEPTIDE ANTIFUNGAL AGENT; BLOOD-STREAM INFECTIONS; STAPHYLOCOCCUS-AUREUS; DRUG-RESISTANCE; POLYMICROBIAL BIOFILMS; FLUCONAZOLE RESISTANCE; MECHANICAL-PROPERTIES; EFFLUX PUMPS; SUSCEPTIBILITY	Candida albicans is a major cause of catheter-related bloodstream infections and is associated with high morbidity and mortality. Due to the propensity of C. albicans to form drug-resistant biofilms, the current standard of care includes catheter removal; however, reinsertion may be technically challenging or risky. Prolonged exposure of an antifungal lock solution within the catheter in conjunction with systemic therapy has been experimentally attempted for catheter salvage. Previously, we demonstrated excellent in vitro activity of micafungin, ethanol, and high-dose doxycycline as single agents for prevention and treatment of C. albicans biofilms. Thus, we sought to investigate optimal combinations of micafungin, ethanol, and/or doxycycline as a lock solution. We performed two-and three-drug checkerboard assays to determine the in vitro activity of pairwise or three agents in combination for prevention or treatment of C. albicans biofilms. Optimal lock solutions were tested for activity against C. albicans clinical isolates, reference strains and polymicrobial C. albicans-S. aureus biofilms. A solution containing 20% (v/v) ethanol, 0.01565 mu g/mL micafungin, and 800 mu g/mL doxycycline demonstrated a reduction of 98% metabolic activity and no fungal regrowth when used to prevent fungal biofilm formation; however there was no advantage over 20% ethanol alone. This solution was also successful in inhibiting the regrowth of C. albicans from mature polymicrobial biofilms, although it was not fully bactericidal. Solutions containing 5% ethanol with low concentrations of micafungin and doxycycline demonstrated synergistic activity when used to prevent monomicrobial C. albicans biofilm formation. A combined solution of micafungin, ethanol and doxycycline is highly effective for the prevention of C. albicans biofilm formation but did not demonstrate an advantage over 20% ethanol alone in these studies.	[Lown, Livia; Lee, Samuel A.] New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA; [Lown, Livia; Lee, Samuel A.] Univ New Mexico, Div Infect Dis, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Peters, Brian M.; Noverr, Mairi C.] LSU Hlth Sci Ctr, Sch Dent, Dept Prosthodont, New Orleans, LA USA; [Peters, Brian M.; Noverr, Mairi C.] LSU Hlth Sci Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Peters, Brian M.] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA; [Walraven, Carla J.] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Tennessee System; University of Tennessee Health Science Center; University of New Mexico	Lee, SA (corresponding author), New Mexico Vet Healthcare Syst, Infect Dis Sect, Albuquerque, NM 87108 USA.; Lee, SA (corresponding author), Univ New Mexico, Div Infect Dis, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	SamALee@salud.unm.edu		Noverr, Mairi/0000-0002-8812-1450	American Society of Microbiology Undergraduate Research Fellowship (ASM-URF); Astellas Pharma; Department of Veterans Affairs [5I01BX001130]; Biomedical Research Institute of New Mexico;  [R01-AI116025];  [R01-DE022069]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116025] Funding Source: NIH RePORTER	American Society of Microbiology Undergraduate Research Fellowship (ASM-URF); Astellas Pharma(Astellas Pharmaceuticals); Department of Veterans Affairs(US Department of Veterans Affairs); Biomedical Research Institute of New Mexico; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Society of Microbiology Undergraduate Research Fellowship (ASM-URF to L.L.; www.asm.org/), Astellas Pharma (Investigator-Initiated Grant to SAL; www.astellas.us/), Department of Veterans Affairs (Merit Award 5I01BX001130 to SAL; www.va.gov/), Biomedical Research Institute of New Mexico (award to SAL; www.brinm.org/), and R01-AI116025 (NIAID, to MCN; www.nih.gov/) and R01-DE022069 (NIDCR, to MCN; www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344; Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; [Anonymous], 2015, P NATL ACAD SCI US; Bell AL, 2006, CLIN NEPHROL, V65, P342; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; CARLSON E, 1982, INFECT IMMUN, V38, P921, DOI 10.1128/IAI.38.3.921-924.1982; Cateau E, 2008, J ANTIMICROB CHEMOTH, V62, P153, DOI 10.1093/jac/dkn160; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandra J, 2007, INFECT IMMUN, V75, P2612, DOI 10.1128/IAI.01841-06; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Chavez-Dozal AA, 2014, ANTIMICROB AGENTS CH, V58, P5855, DOI 10.1128/AAC.03137-14; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Crnich CJ, 2005, INFECT CONT HOSP EP, V26, P708, DOI 10.1086/502607; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; DiMondi VP, 2014, PHARMACOTHERAPY, V34, pE120, DOI 10.1002/phar.1433; El-Azizi M, 2007, J MED MICROBIOL, V56, P645, DOI 10.1099/jmm.0.46952-0; Ernst EJ, 2002, ANTIMICROB AGENTS CH, V46, P3846, DOI 10.1128/AAC.46.12.3846-3853.2002; Fiori A, 2012, ANTIMICROB AGENTS CH, V56, P3785, DOI 10.1128/AAC.06017-11; FONZI WA, 1993, GENETICS, V134, P717; Fothergill AW, 2012, INTERACTIONS OF YEASTS, MOULDS, AND ANTIFUNGAL AGENTS: HOW TO DETECT RESISTANCE, P65, DOI 10.1007/978-1-59745-134-5_2; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guenu S, 2007, RAPID COMMUN MASS SP, V21, P229, DOI 10.1002/rcm.2837; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Katragkou A, 2010, J INFECT DIS, V201, P1941, DOI 10.1086/652783; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Lamfon H, 2004, J ANTIMICROB CHEMOTH, V53, P383, DOI 10.1093/jac/dkh071; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Maiefski M, 2009, INFECT CONT HOSP EP, V30, P1096, DOI 10.1086/606162; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Mermel LA, 2014, J ANTIMICROB CHEMOTH, V69, P2611, DOI 10.1093/jac/dku182; Messer SA, 2006, J CLIN MICROBIOL, V44, P324, DOI 10.1128/JCM.44.2.324-326.2006; Metcalf SCL, 2004, J INFECTION, V49, P20, DOI 10.1016/j.jinf.2003.08.010; Miceli MH, 2009, INT J ANTIMICROB AG, V34, P326, DOI 10.1016/j.ijantimicag.2009.04.011; Mikamo H, 2000, J ANTIMICROB CHEMOTH, V46, P485, DOI 10.1093/jac/46.3.485; Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.8.4333-4340.2003; Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Nett JE, 2010, J INFECT DIS, V202, P171, DOI 10.1086/651200; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oliver BG, 2008, MICROBIOL-SGM, V154, P960, DOI 10.1099/mic.0.2007/013805-0; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pemmaraju SC, 2013, INDIAN J EXP BIOL, V51, P1032; Peters BM, 2013, ANTIMICROB AGENTS CH, V57, P74, DOI 10.1128/AAC.01599-12; Pfaller MA, 2003, ANTIMICROB AGENTS CH, V47, P1068, DOI 10.1128/AAC.47.3.1068-1071.2003; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Rane HS, 2012, ANTIMICROB AGENTS CH, V56, P4487, DOI 10.1128/AAC.00263-12; Rey-Jurado E, 2013, INT J ANTIMICROB AG, V41, P278, DOI 10.1016/j.ijantimicag.2012.11.011; Shanks RMQ, 2006, NEPHROL DIAL TRANSPL, V21, P2247, DOI 10.1093/ndt/gfl170; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Tawara S, 2000, ANTIMICROB AGENTS CH, V44, P57, DOI 10.1128/AAC.44.1.57-62.2000; Tobudic S, 2010, J ANTIMICROB CHEMOTH, V65, P271, DOI 10.1093/jac/dkp429; Uchida K, 2000, J ANTIBIOT, V53, P1175, DOI 10.7164/antibiotics.53.1175; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159225	10.1371/journal.pone.0159225	http://dx.doi.org/10.1371/journal.pone.0159225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428310	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300041
J	Fukutani, A; Misaki, J; Isaka, T				Fukutani, Atsuki; Misaki, Jun; Isaka, Tadao			Effect of Preactivation on Torque Enhancement by the Stretch-Shortening Cycle in Knee Extensors	PLOS ONE			English	Article							RESIDUAL FORCE ENHANCEMENT; IN-VIVO; MUSCLE TENDON; MOVEMENT; BEHAVIOR; PRESTRETCH; EXERCISE	The stretch-shortening cycle is one of the most interesting topics in the field of sport sciences, because the performance of human movement is enhanced by the stretch-shortening cycle (eccentric contraction). The purpose of the present study was to examine whether the influence of preactivation on the torque enhancement by stretch-shortening cycle in knee extensors. Twelve men participated in this study. The following three conditions were conducted for knee extensors: (1) concentric contraction without preactivation (CON), (2) concentric contraction with eccentric preactivation (ECC), and (3) concentric contraction with isometric preactivation (ISO). Muscle contractions were evoked by electrical stimulation to discard the influence of neural activity. The range of motion of the knee joint was set from 80 to 140 degrees (full extension = 180 degrees). Angular velocities of the concentric and eccentric contractions were set at 180 and 90 degrees/s, respectively. In the concentric contraction phase, joint torques were recorded at 85, 95, and 105 degrees, and they were compared among the three conditions. In the early phase (85 degrees) of concentric contraction, the joint torque was larger in the ECC and ISO conditions than in the CON condition. However, these clear differences disappeared in the later phase (105 degrees) of concentric contraction. The results showed that joint torque was clearly different among the three conditions in the early phase whereas this difference disappeared in the later phase. Thus, preactivation, which is prominent in the early phase of contractions, plays an important role in torque enhancement by the stretch-shortening cycle in knee extensors.	[Fukutani, Atsuki] Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan; [Fukutani, Atsuki] Japan Soc Promot Sci, Res Fellowship Young Scientists, Chiyoda Ku, Tokyo, Japan; [Misaki, Jun] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Isaka, Tadao] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan	Ritsumeikan University; Japan Society for the Promotion of Science; Ritsumeikan University; Ritsumeikan University	Fukutani, A (corresponding author), Ritsumeikan Univ, Res Org Sci & Technol, Kusatsu, Shiga, Japan.; Fukutani, A (corresponding author), Japan Soc Promot Sci, Res Fellowship Young Scientists, Chiyoda Ku, Tokyo, Japan.	atsukifukutani@gmail.com			Japanese society of biomechanics, research grant of Japanese Society of Biomechanics; Japan Society for the promotion of science [13J03159, 26750313]; Grants-in-Aid for Scientific Research [26560361] Funding Source: KAKEN	Japanese society of biomechanics, research grant of Japanese Society of Biomechanics; Japan Society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the following three funders in terms of data collection, analysis, and preparation of the manuscript: Japanese society of biomechanics, research grant of Japanese Society of Biomechanics (2014-2015) (AF) (http://biomechanics.jp/); Japan Society for the promotion of science, Grant-in-Aid for Japan Society for the Promotion of Science Fellows (13J03159) (AF) (https://www.jsps.go.jp/index.html); Japan Society for the promotion of science, Grant-in-Aid for Young Scientists B (26750313) (AF) (https://www.jsps.go.jp/index.html).	Andersen LL, 2010, SCAND J MED SCI SPOR, V20, pE162, DOI 10.1111/j.1600-0838.2009.00933.x; Bobbert MF, 2005, MED SCI SPORT EXER, V37, P440, DOI 10.1249/01.MSS.0000155389.34538.97; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Burkholder TJ, 2001, J EXP BIOL, V204, P1529; DIETZ V, 1979, J NEUROPHYSIOL, V42, P1212, DOI 10.1152/jn.1979.42.5.1212; EDMAN KAP, 1982, J GEN PHYSIOL, V80, P769, DOI 10.1085/jgp.80.5.769; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; ETTEMA GJC, 1990, J EXP BIOL, V152, P333; Finni T, 2001, ACTA PHYSIOL SCAND, V173, P369, DOI 10.1046/j.1365-201X.2001.00915.x; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Fukutani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120579; HERZOG W, 1991, MED SCI SPORT EXER, V23, P108; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hisey B, 2009, J BIOMECH, V42, P1488, DOI 10.1016/j.jbiomech.2009.03.046; Ishikawa M, 2006, J ELECTROMYOGR KINES, V16, P423, DOI 10.1016/j.jelekin.2005.08.006; Joumaa V, 2008, P ROY SOC B-BIOL SCI, V275, P1411, DOI 10.1098/rspb.2008.0142; JOYCE GC, 1969, J PHYSIOL-LONDON, V204, P475, DOI 10.1113/jphysiol.1969.sp008925; Kawakami Y, 2002, J PHYSIOL-LONDON, V540, P635, DOI 10.1113/jphysiol.2001.013459; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Maganaris CN, 2001, ACTA PHYSIOL SCAND, V172, P279, DOI 10.1046/j.1365-201x.2001.00799.x; NICHOLS TR, 1973, SCIENCE, V181, P182, DOI 10.1126/science.181.4095.182; Power GA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.4; Reeves ND, 2003, J APPL PHYSIOL, V95, P1090, DOI 10.1152/japplphysiol.01046.2002; Schachar R, 2004, J BIOMECH, V37, P917, DOI 10.1016/j.jbiomech.2003.10.006; Seiberl W, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12401; WESTING SH, 1988, EUR J APPL PHYSIOL O, V58, P100, DOI 10.1007/BF00636611	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159058	10.1371/journal.pone.0159058	http://dx.doi.org/10.1371/journal.pone.0159058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414804	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500066
J	Li, JH; Lin, XY; Teng, YY; Qi, SL; Xiao, DY; Zhang, JY; Kang, Y				Li, Jianhua; Lin, Xiaoyan; Teng, Yueyang; Qi, Shouliang; Xiao, Dayu; Zhang, Jianying; Kang, Yan			A Comprehensive Evaluation of Disease Phenotype Networks for Gene Prioritization	PLOS ONE			English	Article							WALKING; INTERACTOME; SIMILARITY	Identification of disease-causing genes is a fundamental challenge for human health studies. The phenotypic similarity among diseases may reflect the interactions at the molecular level, and phenotype comparison can be used to predict disease candidate genes. Online Mendelian Inheritance in Man (OMIM) is a database of human genetic diseases and related genes that has become an authoritative source of disease phenotypes. However, disease phenotypes have been described by free text; thus, standardization of phenotypic descriptions is needed before diseases can be compared. Several disease phenotype networks have been established in OMIM using different standardization methods. Two of these networks are important for phenotypic similarity analysis: the first and most commonly used network (mimMiner) is standardized by medical subject heading, and the other network (resnikHPO) is the first to be standardized by human phenotype ontology. This paper comprehensively evaluates for the first time the accuracy of these two networks in gene prioritization based on protein-protein interactions using large-scale, leave-one-out cross-validation experiments. The results show that both networks can effectively prioritize disease-causing genes, and the approach that relates two diseases using a logistic function improves prioritization performance. Tanimoto, one of four methods for normalizing resnikHPO, generates a symmetric network and it performs similarly to mimMiner. Furthermore, an integration of these two networks outperforms either network alone in gene prioritization, indicating that these two disease networks are complementary.	[Li, Jianhua; Lin, Xiaoyan; Zhang, Jianying] Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Dept Biomed Informat, Shenyang, Liaoning, Peoples R China; [Li, Jianhua; Qi, Shouliang; Kang, Yan] Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China; [Teng, Yueyang; Qi, Shouliang; Xiao, Dayu; Kang, Yan] Northeastern Univ, Dept Biomed Imaging, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China; [Zhang, Jianying] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Northeastern University - China; Northeastern University - China; Northeastern University - China; University of Texas System; University of Texas El Paso	Kang, Y (corresponding author), Northeastern Univ, Minist Educ, Key Lab Med Image Comp, Shenyang, Liaoning, Peoples R China.; Kang, Y (corresponding author), Northeastern Univ, Dept Biomed Imaging, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China.	kangyan@bmie.neu.edu.cn	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022		National Natural Science Foundation of China [61302013, 61372014]; Science and Technology Plan of Liaoning Province of China [2014305001]; Fundamental Research Funds for the Central Universities of China [N141008001, N130219001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Liaoning Province of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (61302013 and 61372014; http://www.nsfc.gov.cn) to YYT and YK, Science and Technology Plan of Liaoning Province of China (2014305001; http://www.lninfo.gov.cn/) to YYT and Fundamental Research Funds for the Central Universities of China (N141008001 and N130219001; http://www.moe.gov.cn) to YYT and SLQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000351; Bornigen D, 2012, BIOINFORMATICS, V28, P3081, DOI 10.1093/bioinformatics/bts581; Chen HL, 2013, SCI WORLD J, DOI 10.1155/2013/204658; Chen Y, 2015, J BIOMED INFORM, V53, P113, DOI 10.1016/j.jbi.2014.09.007; Cohen R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-65; Doncheva NT, 2012, WIRES SYST BIOL MED, V4, P429, DOI 10.1002/wsbm.1177; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Fang H, 2013, MOL BIOSYST, V9, P1686, DOI 10.1039/c3mb25495j; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Martinez V, 2015, ARTIF INTELL MED, V63, P41, DOI 10.1016/j.artmed.2014.11.003; Martinez V, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S1-S5; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Nakazato T, 2009, NUCLEIC ACIDS RES, V37, pW166, DOI 10.1093/nar/gkp483; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Snider J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156351; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wang G, 2012, THESIS; Wang ZG, 2012, CHINESE J BIOINFORMA, V10, P154; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Zhang SZ, 2012, GENE, V497, P58, DOI 10.1016/j.gene.2012.01.014; Zhang SH, 2010, FEBS LETT, V584, P3635, DOI 10.1016/j.febslet.2010.07.038; Zhang WS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S11; Zhang WS, 2010, FRONT ELECT ELECT EN, V5, P107, DOI [10.1007/s11460-010-0018-x, DOI 10.1007/S11460-010-0018-X]; Zhang X, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00075; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	36	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159457	10.1371/journal.pone.0159457	http://dx.doi.org/10.1371/journal.pone.0159457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415759	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500130
J	Amano, T; Tamari, K; Tanaka, S; Uchida, S; Ito, H; Morikawa, S; Kawamura, K				Amano, Tetsuya; Tamari, Kotaro; Tanaka, Shigeharu; Uchida, Shigehiro; Ito, Hideyuki; Morikawa, Shinya; Kawamura, Kenji			Factors for Assessing the Effectiveness of Early Rehabilitation after Minimally Invasive Total Knee Arthroplasty: A Prospective Cohort Study	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; HIP; OSTEOARTHRITIS; RECOVERY; OUTCOMES; PATHWAY; GO	The effectiveness of current rehabilitation programs is supported by high-level evidence from the results of randomized controlled trials, but an increasing number of patients are not discharged from the hospital because of the schedule of the critical path (CP). The present study aimed to determine which factors can be used to assess the effectiveness of early rehabilitation. We enrolled 123 patients with medial knee osteoarthritis (OA) who had undergone unilateral minimally invasive total knee arthroplasty for the first time. The following factors were assessed preoperatively: the maximum isometric muscle strength of the knee extensors and flexors, maximum knee and hip joint angle, pain, 5-m maximum walking speed, sex, age, body mass index, exercise habits, Kellgren-Lawrence grade, femorotibial angle, failure side (bilateral or unilateral knee OA), and functional independence measure. We re-evaluated physical function (i.e., muscle strength, joint angle, and pain) and motor function (5-m maximum walking speed) 14 days postoperatively. Changes in physical function, motor function (5-m maximum walking speed), and number of days to independent walking were used as explanatory variables. The postoperative duration of hospitalization (in days) was used as the dependent variable in multivariate analyses. These analyses were adjusted for sex, age, body mass index, exercise habits, Kellgren-Lawrence grade, femorotibial angle, failure side, and functional independence measure. The duration of hospitalization was significantly affected by the number of days to independent walking (p < 0.001, beta = 0.507) and a change in the 5-m maximum walking speed (p = 0.016, beta = -0.262). Multiple regression analysis showed that the radiographic knee grade (p = 0.029, beta = 0.239) was a significant confounding factor. Independent walking and walking speed recovery were considered to reduce the duration of hospitalization. Therefore, these indices can be used to assess the effectiveness of early rehabilitation.	[Amano, Tetsuya] Tokoha Univ, Fac Hlth & Med Sci, Dept Phys Therapy, Hamamatsu, Shizuoka, Japan; [Amano, Tetsuya; Kawamura, Kenji] KIBI Int Univ, Grad Sch Hlth Sci, Takahashi, Okayama, Japan; [Tamari, Kotaro] JICA Guatemala Off, Zona, Calle, Guatemala; [Tanaka, Shigeharu] Kawasaki Jr Coll Rehabil, Dept Phys Therapy, Kurashiki, Okayama, Japan; [Uchida, Shigehiro] Hiroshima Int Univ, Fac Rehabil, Dept Rehabil, Higashihiroshima, Hiroshima, Japan; [Ito, Hideyuki] Yamaguchi Allied Hlth Coll, Dept Phys Therapy, Yamaguchi, Yamaguchi, Japan; [Morikawa, Shinya] Hohsyasen Daiichi Hosp, Dept Rehabil, Imabari, Ehime, Japan		Amano, T (corresponding author), Tokoha Univ, Fac Hlth & Med Sci, Dept Phys Therapy, Hamamatsu, Shizuoka, Japan.	tamano@hm.tokoha-u.ac.jp			JSPS KAKENHI [25750245]; Grants-in-Aid for Scientific Research [25750245] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (grant number: 25750245). URL: http://www.jsps.go.jp/english/e-grants/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho KY, 2014, KNEE SURG SPORT TR A, V22, P1759, DOI 10.1007/s00167-013-2556-2; Chotanaphuti Thanainit, 2008, Journal of the Medical Association of Thailand, V91, P1382; Duncan CM, 2013, REGION ANESTH PAIN M, V38, P533, DOI 10.1097/AAP.0000000000000014; Katoh M, 2009, J PHYS THER SCI, V21, P37, DOI 10.1589/jpts.21.37; Kennedy DM, 2006, J ARTHROPLASTY, V21, P559, DOI 10.1016/j.arth.2005.07.010; Kim TK, 2009, KNEE SURG SPORT TR A, V17, P1152, DOI 10.1007/s00167-009-0731-2; Loftus T, 2014, J KNEE SURG, V27, P221, DOI 10.1055/s-0033-1360657; Moffet H, 2004, ARCH PHYS MED REHAB, V85, P546, DOI 10.1016/j.apmr.2003.08.080; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; Petterson SC, 2009, ARTHRIT RHEUM-ARTHR, V61, P174, DOI 10.1002/art.24167; Piva SR, 2010, PHYS THER, V90, P880, DOI 10.2522/ptj.20090150; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Sajima Y, 2001, RIGAKU RYOHOGAKU, V28, P14; Labraca NS, 2011, CLIN REHABIL, V25, P557, DOI 10.1177/0269215510393759; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Tamari K, 2009, AUST J PHYSIOTHER, V55, P201, DOI 10.1016/S0004-9514(09)70082-0; Tria AJ, 2003, CLIN ORTHOP RELAT R, P185, DOI 10.1097/01.blo.0000093030.56370.d9; Weigl M, 2006, OSTEOARTHR CARTILAGE, V14, P641, DOI 10.1016/j.joca.2006.01.001; Yoo Ju-Hyung, 2014, Knee Surg Relat Res, V26, P149, DOI 10.5792/ksrr.2014.26.3.149; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	20	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159172	10.1371/journal.pone.0159172	http://dx.doi.org/10.1371/journal.pone.0159172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410385	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300065
J	Daryabor, F; Ooi, SH; Abu Samah, A; Akbari, A				Daryabor, Farshid; Ooi, See Hai; Abu Samah, Azizan; Akbari, Abolghasem			Dynamics of the Water Circulations in the Southern South China Sea and Its Seasonal Transports	PLOS ONE			English	Article							INTEROCEAN CIRCULATION; INDONESIAN THROUGHFLOW; PENINSULAR MALAYSIA; FRESH-WATER; EAST-COAST; MODEL; OCEAN; SIMULATION; SURFACE; HEAT	A three-dimensional Regional Ocean Modeling System is used to study the seasonal water circulations and transports of the Southern South China Sea. The simulated seasonal water circulations and estimated transports show consistency with observations, e.g., satellite altimeter data set and re-analysis data of the Simple Ocean Data Assimilation. It is found that the seasonal water circulations are mainly driven by the monsoonal wind stress and influenced by the water outflow/inflow and associated currents of the entire South China Sea. The intrusion of the strong current along the East Coast of Peninsular Malaysia and the eddies at different depths in all seasons are due to the conservation of the potential vorticity as the depth increases. Results show that the water circulation patterns in the northern part of the East Coast of Peninsular Malaysia are generally dominated by the geostrophic currents while those in the southern areas are due solely to the wind stress because of negligible Coriolis force there. This study clearly shows that individual surface freshwater flux ( evaporation minus precipitation) controls the sea salinity balance in the Southern South China Sea thermohaline circulations. Analysis of climatological data from a high resolution Regional Ocean Modeling System reveals that the complex bathymetry is important not only for water exchange through the Southern South China Sea but also in regulating various transports across the main passages in the Southern South China Sea, namely the Sunda Shelf and the Strait of Malacca. Apart from the above, in comparision with the dynamics of the Sunda Shelf, the Strait of Malacca reflects an equally significant role in the annual transports into the Andaman Sea.	[Daryabor, Farshid; Ooi, See Hai; Abu Samah, Azizan] Univ Malaya, Inst Postgrad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia; [Daryabor, Farshid; Abu Samah, Azizan] Univ Malaya, Inst Postgrad Studies, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia; [Akbari, Abolghasem] Univ Malaysia Pahang, Fac Civil Engn & Earth Resources, Lebuhraya Tun Razak, Kuantan 26300, Pahang, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaysia Pahang	Daryabor, F (corresponding author), Univ Malaya, Inst Postgrad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia.; Daryabor, F (corresponding author), Univ Malaya, Inst Postgrad Studies, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia.	fdaryabor@um.edu.my	Daryabor, Farshid/A-9345-2019; ABU SAMAH, AZIZAN HJ/B-8295-2010; Akbari, Abolghasem/L-5971-2019; Daryabor, Farshid/K-6084-2015; Akbari, Abolghasem/N-1341-2014	Daryabor, Farshid/0000-0001-8217-8504; Akbari, Abolghasem/0000-0003-4394-1970; Daryabor, Farshid/0000-0001-8217-8504; Akbari, Abolghasem/0000-0003-4394-1970	Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES)	Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES)	This research study is funded by the Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES-2014a, Air-Ocean-Land Interaction).; This research study is funded by the Higher Institution Centre of Excellence (HICoE) Grant under the Institute of Ocean and Earth Sciences (IOES-2014a, Air-Ocean-Land Interaction). It is also strongly supported by the Vice-Chancellor of the University of Malaya. Above all, the authors greatly appreciate the invaluable and constructive comments and suggestions by the reviewers on this manuscript.	Akhir M.F., 2015, OPEN J MAR SCI, V5, P273, DOI [10.4236/ojms.2015.53022, DOI 10.4236/OJMS.2015.53022]; Antonov J. I., 2006, WORLD OCEAN ATLAS 20; Cai SQ, 2005, ACTA OCEANOL SIN, V24, P10; Cai SQ, 2005, ACTA OCEANOL SIN, V24, P31; Carton JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002817; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Chen GX, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007724; Daryabor F., 2015, OCEAN SCI DISCUSS, V12, P275, DOI [10.5194/osd-12-275-2015, DOI 10.5194/OSD-12-275-2015]; Daryabor F, 2010, GEOPH RES ABSTR, V12; Daryabor F, 2015, OCEAN DYNAM, V65, P93, DOI 10.1007/s10236-014-0787-5; Daryabor F, 2014, SAINS MALAYS, V43, P389; Ezer T, 2002, OCEAN MODEL, V4, P249, DOI 10.1016/S1463-5003(02)00003-3; Fang GH, 2005, ADV ATMOS SCI, V22, P946; Fang GH, 2003, SCI CHINA SER D, V46, P149, DOI 10.1360/03yd9014; Fang GH, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006225; Fang GH, 2009, DYNAM ATMOS OCEANS, V47, P55, DOI 10.1016/j.dynatmoce.2008.09.003; He ZG, 2015, CONT SHELF RES, V92, P16, DOI 10.1016/j.csr.2014.10.007; LARGE WG, 1994, REV GEOPHYS, V32, P363, DOI 10.1029/94RG01872; Li JX, 2011, OCEAN SCI, V7, P661, DOI 10.5194/os-7-661-2011; Locarnini R., 2006, NOAA ATLAS NESDIS, V1; Lonin SA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC005100; Marchesiello P, 2009, OCEAN MODEL, V26, P156, DOI 10.1016/j.ocemod.2008.09.004; MILLERO FJ, 1973, J GEOPHYS RES, V78, P4499, DOI 10.1029/JC078i021p04499; Qu TD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028350; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Schiller A, 1998, J PHYS OCEANOGR, V28, P2288, DOI 10.1175/1520-0485(1998)028<2288:SNSDAT>2.0.CO;2; Shchepetkin AF, 1998, MON WEATHER REV, V126, P1541, DOI 10.1175/1520-0493(1998)126<1541:QMASBO>2.0.CO;2; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Shchepetkin AF, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001047; Silva AM Da, 2006, TECHNICAL REPORT; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Song YT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003189; Tangang FT, 2011, OCEAN DYNAM, V61, P1317, DOI 10.1007/s10236-011-0432-5; Thyng KM, 2013, OCEAN MODEL, V72, P104, DOI 10.1016/j.ocemod.2013.08.008; Wyrtki K., 1961, TECHNICAL REPORT; Yanagi T., 2001, J OCEANOGR, V57, P461, DOI [10.1023/A:1021237721368, DOI 10.1023/A:1021237721368]; Ye J, 1998, J HYDRAUL ENG, V124, P687, DOI 10.1061/(ASCE)0733-9429(1998)124:7(687)	37	22	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158415	10.1371/journal.pone.0158415	http://dx.doi.org/10.1371/journal.pone.0158415			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410682	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300023
J	Hamrick, KS; Andrews, M				Hamrick, Karen S.; Andrews, Margaret			SNAP Participants' Eating Patterns over the Benefit Month: A Time Use Perspective	PLOS ONE			English	Article							FOOD-STAMP PARTICIPATION; WEIGHT; CYCLE; 1ST	Individuals receiving monthly benefits through the U.S. Supplemental Nutrition Assistance Program (SNAP) often fall short of food at the end of the month and some report feelings of hunger. To investigate this situation, we used time diaries from the 2006-08 American Time Use Survey and Eating & Health Module to identify the timing of days where respondents reported no eating occurrences. Analysis includes descriptive statistics, a logit model, and a simulated benefit month. We found that SNAP participants were increasingly more likely than nonparticipants to report a day with no eating occurrences over the benefit issuance cycle. This supports the view that there is a monthly cycle in food consumption associated with the SNAP monthly benefit issuance policy.	[Hamrick, Karen S.; Andrews, Margaret] USDA, Econ Res Serv, Washington, DC 20024 USA	United States Department of Agriculture (USDA)	Hamrick, KS (corresponding author), USDA, Econ Res Serv, Washington, DC 20024 USA.	khamrick@ers.usda.gov						Almada L, 2015, 21596 NAT BUR EC RES; Beatty T, 2013, SUPPLEMENTAL NUTR AS; Bickel G., 2000, J COOK GUIDE MEASURI; Bollinger CR, 2001, J BUS ECON STAT, V19, P129, DOI 10.1198/073500101316970368; Bustillo M., 2010, WALL STREET J; Calloway EE., 2015, J APPL RES CHILDREN, V6, P5; Castellari E., 2015, ONE MORE SATURDAY NI; Castner Laura, 2011, BENEFIT REDEMPTION P; Chen Z, 2005, AM J AGR ECON, V87, P1167, DOI 10.1111/j.1467-8276.2005.00803.x; Coleman-Jensen A, 2014, ERR173 USDA EC RES S; Coleman-Jensen Alisha, 2013, EC INFORM B, V113; D'Innocenzio A, 2010, WASH POST, pA8; Damon AL, 2013, FOOD POLICY, V41, P18, DOI 10.1016/j.foodpol.2013.04.005; Falk G, 2014, 75700 C RES SERV; Farzad Roben, 2011, BLOOMBERG BUSINESSWE; Hamrick KS, 2011, EC INFORM B; Hastings J, 2010, AM ECON J-ECON POLIC, V2, P142, DOI 10.1257/pol.2.2.142; Hopper J, 2011, WAITING MIDNIGHT HUN; Johnson EJ, 2012, MARKET LETT, V23, P487, DOI 10.1007/s11002-012-9186-1; Kalilani L, 2006, EPIDEMIOLOGIC PERSPE, V3, P5; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; KING G, 2001, POLITICAL ANAL, V0009; Lesser D., 2013, TASK FORCE CONSIDER; Li C., 2013, BIAS FOOD STAMPS PAR; Ponza M, 1999, 53319840025 USDA FOO; Robinson JP, 2011, MON LABOR REV, V134, P43; Robinson JP, 1997, SURPRISING WAYS AM U; Seligman HK, 2014, HEALTH AFFAIR, V33, P116, DOI 10.1377/hlthaff.2013.0096; Shapiro JM, 2005, J PUBLIC ECON, V89, P303, DOI 10.1016/j.jpubeco.2004.05.003; Tarabay J, 2010, MIDNIGHT SHOPPING BR; Tarasuk V, 2007, J NUTR, V137, P1980, DOI 10.1093/jn/137.8.1980; THOMPSON FE, 1988, AM J PUBLIC HEALTH, V78, P1298, DOI 10.2105/AJPH.78.10.1298; Todd JE, 2015, APPL ECON PERSPECT P, V37, P437, DOI 10.1093/aepp/ppu039; U.S. Census Bureau, 2004, DIFF EST FOOD STAMP; U.S. Department of Labor Bureau of Labor Statistics, 2013, AM TIM US SURV US GU; U.S. Department of Labor Bureau of Labor Statistics U.S. Department of Commerce Census Bureau, 2006, 66 US DEP LAB BUR LA; USDA Economic Research Service, 2020, RUR ED; Weinstein JL, 2009, J HUNGER ENVIRON NUT, V4, P48, DOI 10.1080/19320240802706833; Wilde P., 2006, CHANGING MONTHLY FOO; Wilde PE, 2000, AM J AGR ECON, V82, P200, DOI 10.1111/0002-9092.00016; Zagorsky JL, 2009, ECON HUM BIOL, V7, P246, DOI 10.1016/j.ehb.2009.05.003	42	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158422	10.1371/journal.pone.0158422	http://dx.doi.org/10.1371/journal.pone.0158422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410962	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300024
J	Hicar, MD; Chen, XM; Sulli, C; Barnes, T; Goodman, J; Sojar, H; Briney, B; Willis, J; Chukwuma, VU; Kalams, SA; Doranz, BJ; Spearman, P; Crowe, JE				Hicar, Mark D.; Chen, Xuemin; Sulli, Chidananda; Barnes, Trevor; Goodman, Jason; Sojar, Hakimuddin; Briney, Bryan; Willis, Jordan; Chukwuma, Valentine U.; Kalams, Spyros A.; Doranz, Benjamin J.; Spearman, Paul; Crowe, James E., Jr.			Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; ENVELOPE GLYCOPROTEIN; NONNEUTRALIZING ANTIBODIES; NEUTRALIZING ANTIBODIES; COMPARATIVE IMMUNOGENICITY; CONFORMATIONAL EPITOPE; BROAD NEUTRALIZATION; ANTI-GP41 ANTIBODIES	Numerous broadly neutralizing antibodies (Abs) target epitopes that are formed or enhanced during mature HIV envelope formation (i.e. quaternary epitopes). Generally, it is thought that Env epitopes that induce broadly neutralizing Abs are difficult to access and poorly immunogenic because of the characteristic oligomerization, conformational flexibility, sequence diversity and extensive glycosylation of Env protein. To enhance for isolation of quaternary epitope-targeting Abs (QtAbs), we previously used HIV virus-like particles (VLPs) to bind B cells from long-term non-progressor subjects to identify a panel of monoclonal Abs. When expressed as recombinant full-length Abs, a subset of these novel Abs exhibited the binding profiles of QtAbs, as they either failed to bind to monomeric Env protein or showed much higher affinity for Env trimers and VLPs. These QtAbs represented a significant proportion of the B-cell response identified with VLPs. The Ab genes of these clones were highly mutated, but they did not neutralize common HIV strains. We sought to further define the epitopes targeted by these QtAbs. Competition-binding and mapping studies revealed these Abs targeted four separate epitopes; they also failed to compete for binding by Abs to known major neutralizing epitopes. Detailed epitope mapping studies revealed that two of the four epitopes were located in the gp41 subunit of Env. These QtAbs bound pre-fusion forms of antigen and showed differential binding kinetics depending on whether oligomers were produced as recombinant gp140 trimers or as full-length Env incorporated into VLPs. Antigenic regions within gp41 present unexpectedly diverse structural epitopes, including these QtAb epitopes, which may be targeted by the naturally occurring Ab response to HIV infection.	[Hicar, Mark D.; Sojar, Hakimuddin] Univ Buffalo, Dept Pediat, Buffalo, NY USA; [Hicar, Mark D.] Univ Buffalo, Dept Microbiol, New York, NY USA; [Hicar, Mark D.] Univ Buffalo, Dept Immunol, New York, NY USA; [Chen, Xuemin; Spearman, Paul] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Chen, Xuemin; Spearman, Paul] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA USA; [Sulli, Chidananda; Barnes, Trevor; Goodman, Jason; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA USA; [Briney, Bryan; Chukwuma, Valentine U.; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Briney, Bryan; Chukwuma, Valentine U.; Kalams, Spyros A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Willis, Jordan] Vanderbilt Univ, Med Ctr, Program Chem Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kalams, Spyros A.] Vanderbilt Univ, Med Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [Spearman, Paul] Childrens Healthcare Atlanta, Atlanta, GA USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Emory University; Emory University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Children's Healthcare of Atlanta (CHOA); Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	NIAID NIH HHS [K08 AI083078, P30 AI110527, R01 AI125119] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125119, P30AI110527] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; BRIGGS WE, 1983, BIOPHYS CHEM, V18, P67, DOI 10.1016/0301-4622(83)80028-3; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gustchina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078187; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Hicar MD, 2016, MOL IMMUNOL, V70, P94, DOI 10.1016/j.molimm.2015.12.002; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Hicar MD, 2010, VACCINE, V28, pB18, DOI 10.1016/j.vaccine.2010.02.002; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Kuwata T, 2013, J VIROL, V87, P5424, DOI 10.1128/JVI.00201-13; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Lin G, 2007, CURR HIV RES, V5, P514, DOI 10.2174/157016207782418489; Louis JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104683; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Peressin M, 2011, J VIROL, V85, P1077, DOI 10.1128/JVI.01619-10; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Sellhorn G, 2009, VACCINE, V28, P430, DOI 10.1016/j.vaccine.2009.10.028; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Steimer K S, 1991, Biotechnol Ther, V2, P63; STIGLER RD, 1995, PROTEIN ENG, V8, P471, DOI 10.1093/protein/8.5.471; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; TYLER DS, 1990, J IMMUNOL, V145, P3276; VANCOTT TC, 1995, J IMMUNOL, V155, P4100; Vincent N, 2012, IMMUNOBIOLOGY, V217, P943, DOI 10.1016/j.imbio.2012.01.007; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Yuan W, 2009, AIDS RES HUM RETROV, V25, P319, DOI 10.1089/aid.2008.0213	59	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158861	10.1371/journal.pone.0158861	http://dx.doi.org/10.1371/journal.pone.0158861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411063	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300036
J	Kripke, K; Chimbwandira, F; Mwandi, Z; Matchere, F; Schnure, M; Reed, J; Castor, D; Sgaier, S; Njeuhmeli, E				Kripke, Katharine; Chimbwandira, Frank; Mwandi, Zebedee; Matchere, Faustin; Schnure, Melissa; Reed, Jason; Castor, Delivette; Sgaier, Sema; Njeuhmeli, Emmanuel			Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography	PLOS ONE			English	Article							TRIAL; HIV/AIDS; MEN	Background In 2007, the World Health Organization (WHO) recommended scaling up voluntary medical male circumcision (VMMC) in priority countries with high HIV prevalence and low male circumcision (MC) prevalence. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), an estimated 5.8 million males had undergone VMMC by the end of 2013. Implementation experience has raised questions about the need to refocus VMMC programs on specific subpopulations for the greatest epidemiological impact and programmatic effectiveness. As Malawi prepared its national operational plan for VMMC, it sought to examine the impacts of focusing on specific subpopulations by age and region. Methods We used the Decision Makers' Program Planning Toolkit, Version 2.0, to study the impact of scaling up VMMC to different target populations of Malawi. National MC prevalence by age group from the 2010 Demographic and Health Survey was scaled according to the MC prevalence for each district and then halved, to adjust for over-reporting of circumcision. In-country stakeholders advised a VMMC unit cost of $100, based on implementation experience. We derived a cost of $451 per patient-year for antiretroviral therapy from costs collected as part of a strategic planning exercise previously conducted in-country by UNAIDS. Results Over a fifteen-year period, circumcising males ages 10-29 would avert 75% of HIV infections, and circumcising males ages 10-34 would avert 88% of infections, compared to the current strategy of circumcising males ages 15-49. The Ministry of Health's South West and South East health zones had the lowest cost per HIV infection averted. Moreover, VMMC met WHO's definition of cost-effectiveness (that is, the cost per disability-adjusted life-year [DALY] saved was less than three times the per capita gross domestic product) in all health zones except Central East. Comparing urban versus rural areas in the country, we found that circumcising men in urban areas would be both cost-effective and cost-saving, with a VMMC cost per DALY saved of $120 USD and with 15 years of VMMC implementation resulting in lifetime HIV treatment costs savings of $331 million USD. Conclusions Based on the age analyses and programmatic experience, Malawi's VMMC operational plan focuses on males ages 10-34 in all districts in the South East and South West zones, as well as Lilongwe (an urban district in the Central zone). This plan covers 14 of the 28 districts in the country.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Chimbwandira, Frank] Minist Hlth, Lilongwe, Malawi; [Mwandi, Zebedee] US Agcy Int Dev, Lilongwe, Malawi; [Matchere, Faustin] US Dept Def, Lilongwe, Malawi; [Schnure, Melissa] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Reed, Jason; Castor, Delivette; Njeuhmeli, Emmanuel] USAID, Washington, DC USA; [Sgaier, Sema] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sgaier, Sema] Univ Washington, Seattle, WA USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID); Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], COST EFF STRAT PLANN; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Awad S, 2015, INVESTIGATING UNPUB; Awad S, 2015, REEVALUATION V UNPUB; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Bautista-Arredondo S, 2010, CURR OPIN HIV AIDS, V5, P232, DOI 10.1097/COH.0b013e32833860d3; BENGO JM, 2010, SITUATION ANAL MALE; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bollinger LA, 2012, RETHINKHIV: SMARTER WAYS TO INVEST IN ENDING HIV IN SUB-SAHARAN AFRICA, P74; Futures Institute, 2011, GOALS MAN MOD EST EF; Government of Malawi National AIDS Commission., 2014, NAT HIV PREV STRAT 2; Government of Malawi National AIDS Commission, 2014, VOL MED MAL CIRC STR; Government of Malawi National AIDS Commission, 2014, NAT STRAT PLAN HIV A; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Haacker M, 2016, PLOS MED IN PRESS; Kripke K., 2015, AGE TARGETING UNPUB; Malawi National Statistical Office and MEASURE DHS, 2010, MAL DEM HLTH SURV 20; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; UNAIDS, 2014, LOC EP ISS BRIEF; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; World Bank, 2012, GDP PER CAP CURR USD	27	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0156521	10.1371/journal.pone.0156521	http://dx.doi.org/10.1371/journal.pone.0156521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410474	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508300002
J	Salice, S; Esposito, R; Ciavardelli, D; Delli Pizzi, S; di Bastiano, R; Tartaro, A				Salice, Simone; Esposito, Roberto; Ciavardelli, Domenico; Delli Pizzi, Stefano; di Bastiano, Rossella; Tartaro, Armando			Combined 3 Tesla MRI Biomarkers Improve the Differentiation between Benign vs Malignant Single Ring Enhancing Brain Masses	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MR; CEREBRAL ABSCESSES; ORIGINAL REPORT; TUMORS; DIAGNOSIS; DISCRIMINATION; GLIOMAS; LESIONS; DISTINCTION; METASTASES	Purpose To evaluate whether the combination of imaging biomarkers obtained by means of different 3 Tesla (3T) Magnetic Resonance Imaging (MRI) advanced techniques can improve the diagnostic accuracy in the differentiation between benign and malignant single ring-enhancing brain masses. Materials and Methods 14 patients presenting at conventional 3T MRI single brain mass with similar appearance as regard ring enhancement, presence of peri-lesional edema and absence of hemorrhage signs were included in the study. All lesions were histologically proven: 5 pyogenic abscesses, 6 glioblastomas, and 3 metastases. MRI was performed at 3 Tesla and included Diffusion Weighted Imaging (DWI), Dynamic Susceptibility Contrast -Perfusion Weighted Imaging (DSC-PWI), Magnetic Resonance Spectroscopy (MRS), and Diffusion Tensor Imaging (DTI). Imaging biomarkers derived by those advanced techniques [Cerebral Blood Flow (CBF), relative Cerebral Blood Volume (rCBV), relative Main Transit Time (rMTT), Choline (Cho), Creatine (Cr), Succinate, N-Acetyl Aspartate (NAA), Lactate (Lac), Lipids, relative Apparent Diffusion Coefficient (rADC), and Fractional Anisotropy (FA)] were detected by two experienced neuroradiologists in joint session in 4 areas: Internal Cavity (IC), Ring Enhancement (RE), Peri-Lesional edema (PL), and Contralateral Normal Appearing White Matter (CNAWM). Significant differences between benign (n=5) and malignant (n=9) ring enhancing lesions were tested with Mann-Withney U test. The diagnostic accuracy of MRI biomarkers taken alone and MRI biomarkers ratios were tested with Receiver Operating Characteristic (ROC) analysis with an Area Under the Curve (AUC) >= 0.9 indicating a very good diagnostic accuracy of the variable. Results Five MRI biomarker ratios achieved excellent accuracy: IC-rADC/PL-NAA (AUC = 1), ICrADC/IC-FA (AUC = 0.978), RE-rCBV/RE-FA (AUC = 0.933), IC-rADC/RE-FA (AUC = 0.911), and IC-rADC/PL-FA (AUC = 0.911). Only IC-rADC achieved a very good diagnostic accuracy (AUC = 0.909) among MRI biomarkers taken alone. Conclusion Although the major limitation of the study was the small sample size, preliminary results seem to suggest that combination of multiple 3T MRI biomarkers is a feasible approach to MRI biomarkers in order to improve diagnostic accuracy in the differentiation between benign and malignant single ring enhancing brain masses. Further studies in larger cohorts are needed to reach definitive conclusions.	[Salice, Simone; Esposito, Roberto; Delli Pizzi, Stefano; di Bastiano, Rossella; Tartaro, Armando] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Esposito, Roberto] AO Osped Riuniti Marche Nord, Pesaro, Italy; [Ciavardelli, Domenico] Kore Univ Enna, Sch Human & Social Sci, Enna, Italy; [Ciavardelli, Domenico] Univ G dAnnunzio, Ctr Excellence Aging & Translat Med CeSI MeT, Mol Neurol Unit, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Universita Kore di ENNA; G d'Annunzio University of Chieti-Pescara	Tartaro, A (corresponding author), Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy.	tartaro@unich.it	Pizzi, Stefano Delli/J-3935-2016	Pizzi, Stefano Delli/0000-0003-4075-0132; Esposito, Roberto/0000-0003-4708-6860				Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bang Casper N, 2011, Ugeskr Laeger, V173, P1364; Bankier AA, 2010, RADIOLOGY, V257, P14, DOI 10.1148/radiol.10100252; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Bukte Y, 2005, CLIN RADIOL, V60, P375, DOI 10.1016/j.crad.2004.05.019; Cartes-Zumelzu FW, 2004, AM J NEURORADIOL, V25, P1310; Caulo M, 2014, RADIOLOGY, V272, P494, DOI 10.1148/radiol.14132040; Chang SC, 2002, CLIN IMAG, V26, P227, DOI 10.1016/S0899-7071(02)00436-9; Chiang IC, 2009, BRIT J RADIOL, V82, P813, DOI 10.1259/bjr/90100265; DEAN BL, 1990, RADIOLOGY, V174, P411, DOI 10.1148/radiology.174.2.2153310; DELATTRE JY, 1988, ARCH NEUROL-CHICAGO, V45, P741, DOI 10.1001/archneur.1988.00520310047016; Desbarats LN, 2003, MAGN RESON IMAGING, V21, P645, DOI 10.1016/S0730-725X(03)00084-5; Desprechins B, 1999, AM J NEURORADIOL, V20, P1252; Ebisu T, 1996, MAGN RESON IMAGING, V14, P1113, DOI 10.1016/S0730-725X(96)00237-8; Eichler AF, 2007, ONCOLOGIST, V12, P884, DOI 10.1634/theoncologist.12-7-884; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Erdogan C, 2005, J COMPUT ASSIST TOMO, V29, P663, DOI 10.1097/01.rct.0000168868.50256.55; Espeland A, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-4; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Gupta RK, 2005, AM J NEURORADIOL, V26, P1107; Guzman R, 2002, J NEUROSURG, V97, P1101, DOI 10.3171/jns.2002.97.5.1101; HAIMES AB, 1989, AM J ROENTGENOL, V152, P1073, DOI 10.2214/ajr.152.5.1073; Hakyemez B, 2006, J MAGN RESON IMAGING, V24, P817, DOI 10.1002/jmri.20707; Hartmann M, 2001, AM J NEURORADIOL, V22, P1738; Holmes TM, 2004, AM J ROENTGENOL, V183, P1247, DOI 10.2214/ajr.183.5.1831247; HSIA DY, 1958, J MENT DEFIC RES, V2, P8, DOI 10.1111/j.1365-2788.1958.tb00380.x; Jensen Todd, 2010, MAGN RESON MED, V64, P907, DOI [10.1002/mrm.22445, DOI 10.1002/MRM.22445]; Kim YJ, 1998, AM J ROENTGENOL, V171, P1487, DOI 10.2214/ajr.171.6.9843275; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Lai Ping-Hong, 2004, Acta Neurol Taiwan, V13, P107; Liu DP, 2014, BIOSTATISTICS, V15, P706, DOI 10.1093/biostatistics/kxu020; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; Muccio CF, 2008, RADIOL MED, V113, P747, DOI 10.1007/s11547-008-0254-9; Nath K, 2009, MAGN RESON IMAGING, V27, P198, DOI 10.1016/j.mri.2008.06.006; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Noguchi K, 1999, NEURORADIOLOGY, V41, P171, DOI 10.1007/s002340050726; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Park SH, 2000, NEURORADIOLOGY, V42, P716, DOI 10.1007/s002340000394; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Paul Tofts, 2004, QUANTITATIVE MRI BRA; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Petersen AK, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-120; Price SJ, 2016, J MAGN RESON IMAGING, V43, P487, DOI 10.1002/jmri.24996; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; Reiche W, 2010, CLIN NEUROL NEUROSUR, V112, P218, DOI 10.1016/j.clineuro.2009.11.016; Smith E.T.S., 2011, BRIT J RADIOL, V84, pS196, DOI [10.1259/bjr/16586938, DOI 10.1259/BJR/16586938]; Toh CH, 2011, AM J NEURORADIOL, V32, P1646, DOI 10.3174/ajnr.A2581; Tung GA, 2001, AM J ROENTGENOL, V177, P709, DOI 10.2214/ajr.177.3.1770709; Wardlaw JM, 2012, EUR RADIOL, V22, P2295, DOI 10.1007/s00330-012-2500-8; Williams FMK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2839; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; Xu XX, 2014, CLIN RADIOL, V69, P909, DOI 10.1016/j.crad.2014.04.012; Yuan Z, 2008, BIOMETRICS, V64, P431, DOI 10.1111/j.1541-0420.2007.00904.x	57	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159047	10.1371/journal.pone.0159047	http://dx.doi.org/10.1371/journal.pone.0159047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410226	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300053
J	Wu, P; Yan, Y; Ma, LL; Hou, BY; He, YY; Zhang, L; Niu, ZR; Song, JK; Pang, XC; Yang, XY; Du, GH				Wu, Ping; Yan, Yu; Ma, Lin-lin; Hou, Bi-yu; He, Yang-yang; Zhang, Li; Niu, Zi-ran; Song, Jun-ke; Pang, Xiao-cong; Yang, Xiu-ying; Du, Guan-hua			Effects of the Nrf2 Protein Modulator Salvianolic Acid A Alone or Combined with Metformin on Diabetes-associated Macrovascular and Renal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; diabetic nephropathy; metformin; Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); oxidative stress; diabetic macrovascular injury; salvianolic acid A	CHRONIC KIDNEY-DISEASE; ANTIOXIDANT GENE-EXPRESSION; INDUCED OXIDATIVE STRESS; APOE-DEFICIENT MICE; BARDOXOLONE METHYL; HIGH-GLUCOSE; MESANGIAL CELLS; ENDOTHELIAL DYSFUNCTION; VASCULAR INFLAMMATION; NADPH OXIDASE	Nuclear factor E2-related factor 2 (Nrf2) is considered a promising target against diabetic complications such as cardiovascular diseases and diabetic nephropathy. Herein, we investigated the effects of a potential Nrf2 modulator, salvianolic acid A (SAA), which is a natural polyphenol, on diabetes-associated macrovascular and renal injuries in streptozotocin-induced diabetic mice. Given that lowering glucose is the first objective of diabetic patients, we also examined the effects of SAA combined with metformin (MET) on both complications. Our results showed that SAA significantly increased the macrovascular relaxation response to acetylcholine and sodium nitroprusside in diabetic mice. Interestingly, treatment with SAA alone only provided minor protection against renal injury, as reflected by minor improvements in impaired renal function and structure, despite significantly reduced oxidative stress observed in the diabetic kidney. We demonstrated that decreased oxidative stress and NF-B p65 expression were associated with SAA-induced expression of Nrf2-responsive antioxidant enzymes heme oxygenase-1 (HO-1), NAD(P)H dehydrogenase (quinone) 1 (NQO-1), and glutathione peroxidase-1 (GPx-1) in vivo or in vitro, which suggested that SAA was a potential Nrf2 modulator. More significantly, compared with treatment with either SAA or MET alone, we found that their combination provided further protection against the macrovascular and renal injury, which was at least partly due to therapeutic activation of both MET-mediated AMP-activated protein kinase and SAA-mediated Nrf2/antioxidant-response element pathways. These findings suggested that polyphenol Nrf2 modulators, especially combined with drugs activating AMP-activated protein kinase, including hypoglycemic drugs, are worthy of further investigation to combat diabetic complications.	[Wu, Ping; Yan, Yu; Hou, Bi-yu; He, Yang-yang; Zhang, Li; Niu, Zi-ran; Song, Jun-ke; Pang, Xiao-cong; Yang, Xiu-ying; Du, Guan-hua] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Ma, Lin-lin] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100050, Peoples R China; [He, Yang-yang] Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Du, GH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.	dugh@imm.ac.cn	Song, Junke/AGG-9922-2022	Song, Junke/0000-0002-4379-0909	National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2013ZX09508104, 2013ZX09402203]; Doctoral Innovation Fund of Peking Union Medical College Grant [10023-1007-1020]; National Natural Science Foundation of China [81470159]	National Science and Technology Major Projects for "Major New Drugs Innovation and Development"; Doctoral Innovation Fund of Peking Union Medical College Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grants 2013ZX09508104 and 2013ZX09402203 (to G. D.), Doctoral Innovation Fund of Peking Union Medical College Grant 10023-1007-1020 (to P. W.), and National Natural Science Foundation of China Grant 81470159 (to X. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Cheng JT, 2006, DIABETES, V55, P819, DOI 10.2337/diabetes.55.03.06.db05-0934; Chin M, 2013, AM J PHYSIOL-RENAL, V304, pF1438, DOI 10.1152/ajprenal.00387.2012; Csiszar A., 2011, FASEB J, V25, P1093; Csiszar A, 2008, AM J PHYSIOL-HEART C, V294, pH2721, DOI 10.1152/ajpheart.00235.2008; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; Erejuwa OO, 2011, INT J BIOL SCI, V7, P244, DOI 10.7150/ijbs.7.244; Fan HY, 2010, THROMB RES, V126, pE17, DOI 10.1016/j.thromres.2010.04.006; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Guo R, 2014, DIABETES VASC DIS RE, V11, P92, DOI 10.1177/1479164113520332; Hamilton J, 2003, DIABETES CARE, V26, P138, DOI 10.2337/diacare.26.1.138; Hasko G, 2010, AM J PHYSIOL-HEART C, V299, pH10, DOI 10.1152/ajpheart.00436.2010; Huang J, 2013, CELL PROLIFERAT, V46, P595, DOI 10.1111/cpr.12056; Huang ZS, 2010, J THROMB HAEMOST, V8, P1383, DOI 10.1111/j.1538-7836.2010.03859.x; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; Kinaan M, 2015, MED PRIN PRACT, V24, P401, DOI 10.1159/000381643; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kumar H, 2014, NAT PROD REP, V31, P109, DOI 10.1039/c3np70065h; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Lin CC, 2009, J CHIN MED ASSOC, V72, P109, DOI 10.1016/S1726-4901(09)70035-8; Lin JT, 2014, EXPERT OPIN INV DRUG, V23, P1253, DOI 10.1517/13543784.2014.922951; Lin TJ, 1996, BIOCHEM PHARMACOL, V51, P1237, DOI 10.1016/0006-2952(96)00067-6; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Oelze M, 2006, HYPERTENSION, V48, P677, DOI 10.1161/01.HYP.0000239207.82326.29; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Pilmore HL, 2010, NEPHROLOGY, V15, P412, DOI 10.1111/j.1440-1797.2010.01328.x; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suzuki T, 2015, FREE RADICAL BIO MED, V88, P93, DOI 10.1016/j.freeradbiomed.2015.06.006; Taguchi K, 2014, BIOL PHARM BULL, V37, P1056, DOI 10.1248/bpb.b14-00157; Tan SM, 2014, DIABETES, V63, P3091, DOI 10.2337/db13-1743; Tan SM, 2013, INVEST OPHTH VIS SCI, V54, P555, DOI 10.1167/iovs.12-10685; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Vaziri ND, 2015, FREE RADICAL BIO MED, V86, P374, DOI 10.1016/j.freeradbiomed.2015.04.022; Vikram A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/679754; Wang SB, 2009, LIFE SCI, V85, P499, DOI 10.1016/j.lfs.2009.07.018; Xu H, 2014, DRUG METAB DISPOS, V42, P274, DOI 10.1124/dmd.113.053694; Yao F, 2016, ACTA PHARM SIN B, V6, P20, DOI 10.1016/j.apsb.2015.07.009; Zhang HA, 2012, BIOCHEM BIOPH RES CO, V421, P479, DOI 10.1016/j.bbrc.2012.04.021; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang M, 2009, DIABETES, V58, pA190; Zhang XC, 2014, J CARDIOVASC PHARM, V64, P318, DOI 10.1097/FJC.0000000000000117; Zhao JH, 2015, AM J PHYSIOL-RENAL, V308, pF1167, DOI 10.1152/ajprenal.00234.2014; Zhao QF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/231351; Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416; Zoja C, 2013, AM J PHYSIOL-RENAL, V304, pF808, DOI 10.1152/ajprenal.00376.2012	60	34	38	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22288	22301		10.1074/jbc.M115.712703	http://dx.doi.org/10.1074/jbc.M115.712703			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27417135	Green Published, hybrid			2022-12-26	WOS:000386332600039
J	Morozova, K; Clement, CC; Kaushik, S; Stiller, B; Arias, E; Ahmad, A; Rauch, JN; Chatterjee, V; Melis, C; Scharf, B; Gestwicki, JE; Cuervo, AM; Zuiderweg, ERP; Santambrogio, L				Morozova, Kateryna; Clement, Cristina C.; Kaushik, Susmita; Stiller, Barbara; Arias, Esperanza; Ahmad, Atta; Rauch, Jennifer N.; Chatterjee, Victor; Melis, Chiara; Scharf, Brian; Gestwicki, Jason E.; Cuervo, Ana-Maria; Zuiderweg, Erik R. P.; Santambrogio, Laura			Structural and Biological Interaction of hsc-70 Protein with Phosphatidylserine in Endosomal Microautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); autophagy; chaperone; endosome; phosphatidylserine	MOLECULAR CHAPERONE DNAK; E3 UBIQUITIN LIGASE; HEAT-SHOCK-PROTEIN-70 HSP70; SUBSTRATE-BINDING; HSC70; COMPLEX; ATP; DOMAIN; MEMBRANES; BILAYERS	hsc-70 (HSPA8) is a cytosolic molecular chaperone, which plays a central role in cellular proteostasis, including quality control during protein refolding and regulation of protein degradation. hsc-70 is pivotal to the process of macroautophagy, chaperone-mediated autophagy, and endosomal microautophagy. The latter requires hsc-70 interaction with negatively charged phosphatidylserine (PS) at the endosomal limiting membrane. Herein, by combining plasmon resonance, NMR spectroscopy, and amino acid mutagenesis, we mapped the C terminus of the hsc-70 LID domain as the structural interface interacting with endosomal PS, and we estimated an hsc-70/PS equilibrium dissociation constant of 4.7 +/- 0.1 m. This interaction is specific and involves a total of 4-5 lysine residues. Plasmon resonance and NMR results were further experimentally validated by hsc-70 endosomal binding experiments and endosomal microautophagy assays. The discovery of this previously unknown contact surface for hsc-70 in this work elucidates the mechanism of hsc-70 PS/membrane interaction for cytosolic cargo internalization into endosomes.	[Morozova, Kateryna; Clement, Cristina C.; Chatterjee, Victor; Melis, Chiara; Scharf, Brian; Santambrogio, Laura] Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Kaushik, Susmita; Stiller, Barbara; Arias, Esperanza; Cuervo, Ana-Maria] Albert Einstein Coll Med, Dept Dev Mol Biol, New York, NY 10461 USA; [Ahmad, Atta; Zuiderweg, Erik R. P.] Univ Michigan, Dept Biol Chem, Sch Med, 1500 Med Ctr Dr, Ann Arbor, MI 48105 USA; [Rauch, Jennifer N.; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Santambrogio, L (corresponding author), Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.; Zuiderweg, ERP (corresponding author), Univ Michigan, Dept Biol Chem, Sch Med, 1500 Med Ctr Dr, Ann Arbor, MI 48105 USA.	zuiderwe@umich.edu; laura.santambrogio@einstein.yu.edu	Kaushik, Susmita/GVS-3186-2022; Clement, Cristina/ABG-4525-2021; Rauch, Jennifer/AGI-2683-2022	Kaushik, Susmita/0000-0002-6096-5387; Clement, Cristina/0000-0003-1464-407X; Rauch, Jennifer/0000-0001-6853-5915; Cuervo, Ana Maria/0000-0002-0771-700X; Arias, Esperanza/0000-0002-7836-5072	National Institutes of Health [AG045223, AG031782, NS059690]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045223, P30AG038072, P01AG031782, R37AG021904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG045223 (to L. S.), AG031782 (to A. M. C. and L. S.), NS059690 (to E. R. P. Z. and J. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Arispe N, 2000, J BIOL CHEM, V275, P30839, DOI 10.1074/jbc.M005226200; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; BenTal N, 1996, BIOPHYS J, V70, P1803, DOI 10.1016/S0006-3495(96)79744-8; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; Guan JY, 2014, CHEMBIOCHEM, V15, P556, DOI 10.1002/cbic.201300623; Heimburg T, 1996, BIOPHYS J, V70, P84, DOI 10.1016/S0006-3495(96)79551-6; Horobin RW, 2002, BIOTECH HISTOCHEM, V77, P3; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mahalka AK, 2014, BBA-BIOMEMBRANES, V1838, P1344, DOI 10.1016/j.bbamem.2014.01.022; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; Mukherjee A., 2016, AUTOPHAGY; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Uytterhoeven V, 2015, NEURON, V88, P735, DOI 10.1016/j.neuron.2015.10.012; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	39	37	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18096	18106		10.1074/jbc.M116.736744	http://dx.doi.org/10.1074/jbc.M116.736744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405763	Green Published, hybrid			2022-12-26	WOS:000383241800004
J	Li, SZ; Zhu, YF; Zhi, LH; Han, XY; Shen, J; Liu, YL; Yao, JH; Yang, XJ				Li, Shizhao; Zhu, Yufei; Zhi, Lihui; Han, Xiaoying; Shen, Jing; Liu, Yanli; Yao, Junhu; Yang, Xiaojun			DNA Methylation Variation Trends during the Embryonic Development of Chicken	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MAMMALIAN DEVELOPMENT; MASS-SPECTROMETRY; GENE-EXPRESSION; X-CHROMOSOME; CANCER-CELLS; IGF-II; GENOME; PATTERNS; TISSUES	The embryogenesis period is critical for epigenetic reprogramming and is thus of great significance in the research field of poultry epigenetics for elucidation of the trends in DNA methylation variations during the embryonic development of birds, particularly due to differences in embryogenesis between birds and mammals. Here, we first examined the variations in genomic DNA methylation during chicken embryogenesis through high-performance liquid chromatography using broilers as the model organism. We then identified the degree of DNA methylation of the promoters and gene bodies involved in two specific genes (IGF2 and TNF-alpha) using the bisulfite sequencing polymerase chain reaction method. In addition, we measured the expression levels of IGF2, TNF-alpha and DNA methyl-transferase (DNMT) 1, 3a and 3b. Our results showed that the genomic DNA methylation levels in the liver, heart and muscle increased during embryonic development and that the methylation level of the liver was significantly higher in mid-anaphase. In both the muscle and liver, the promoter methylation levels of TNF-alpha first increased and then decreased, whereas the gene body methylation levels remained lower at embryonic ages E8, 11 and 14 before increasing notably at E17. The promoter methylation level of IGF2 decreased persistently, whereas the methylation levels in the gene body showed a continuous increase. No differences in the expression of TNF-alpha were found among E8, 11 and 14, whereas a significant increase was observed at E17. IGF2 showed increasing expression level during the examined embryonic stages. In addition, the mRNA and protein levels of DNMTs increased with increasing embryonic ages. These results suggest that chicken shows increasing genomic DNA methylation patterns during the embryonic period. Furthermore, the genomic DNA methylation levels in tissues are closely related to the genes expression levels, and gene expression may be simultaneously regulated by promoter hypomethylation and gene body hypermethylation.	[Li, Shizhao; Zhu, Yufei; Han, Xiaoying; Shen, Jing; Liu, Yanli; Yao, Junhu; Yang, Xiaojun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhi, Lihui] ShanXi Normal Univ, Sch Math & Comp Sci, Linfen, Shanxi, Peoples R China	Northwest A&F University - China; Shanxi Normal University	Yang, XJ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	yangxj@nwsuaf.edu.cn	Liu, Yanli/GPK-8077-2022; Li, Shizhao/ABV-9057-2022	Liu, Yanli/0000-0002-8966-5011; Li, Shizhao/0000-0002-3464-1450	National Natural Science Foundation of China [31272464]; Program for New Century Excellent Talents in University [NCET-12-0476]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The work was supported by the National Natural Science Foundation of China (No. 31272464, XJY, http://www.letpub.com.cn/?page=grant&name=&person=&no=31272464&company=&addcomment_s1=0&addcomment_s2=0&addcomment_s3=0&money1=&money2=&startTime=2011&endTime=2015&subcategory=&searchsubmit=true&submit.x=77&submit.y=10&submit=advSearch#fundlisttable), and the Program for New Century Excellent Talents in University (NCET-12-0476, XJY, http://www.cdpsn.org.cn/policy/dt104l36195.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Q, 2009, J ANHUI AGR SCI, V29, P9902; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burt D, 2003, SCIENCE, V300, P1669, DOI 10.1126/science.1086231; Cai DM, 2014, BRIT J NUTR, V112, P1459, DOI 10.1017/S0007114514002402; Choi SW, 2009, NUTRIENTS AND EPIGENETICS, P1, DOI 10.1201/9781420063561; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; DJEU JY, 1986, J IMMUNOL, V137, P2980; DOHERTY AS, 1994, MOL REPROD DEV, V37, P21, DOI 10.1002/mrd.1080370104; Erhardt S, 2003, DEV GENES EVOL, V213, P336, DOI 10.1007/s00427-003-0331-y; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; GEHRKE CW, 1984, J CHROMATOGR, V301, P199, DOI 10.1016/S0021-9673(01)89189-5; Gu DF, 2002, HUM GENET, V110, P173, DOI 10.1007/s00439-001-0663-5; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hemberger M, 2010, SCIENCE, V330, P598, DOI 10.1126/science.1199006; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Hyldig SMW, 2011, BIOL REPROD, V84, P1087, DOI 10.1095/biolreprod.110.086082; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee CI, 2001, PEDIATR RES, V49, P379, DOI 10.1203/00006450-200103000-00012; Li CW, 2015, POULTRY SCI, V94, P706, DOI 10.3382/ps/pev016; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MONK M, 1987, DEVELOPMENT, V99, P371; MUSTAFA MM, 1989, J CLIN INVEST, V84, P1253, DOI 10.1172/JCI114292; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; O'Neill C., 2015, Animal Frontiers, V5, P42, DOI 10.2527/af.2015-0007; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Patten BM., 2008, EARLY EMBRYOLOGY CHI; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Rosenquist TH, 2001, P NUTR SOC, V60, P53; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Turker MS, 1997, MUTAT RES-REV MUTAT, V386, P119, DOI 10.1016/S1383-5742(96)00048-8; Vanyushin BF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P488, DOI 10.1007/s10541-005-0143-y; VINCE MA, 1975, COMP BIOCHEM PHYS A, V52, P331, DOI 10.1016/S0300-9629(75)80096-X; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	59	40	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159230	10.1371/journal.pone.0159230	http://dx.doi.org/10.1371/journal.pone.0159230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438711	Green Submitted, Green Published, gold			2022-12-26	WOS:000380170100033
J	Bullard-Feibelman, KM; Fuller, BP; Geiss, BJ				Bullard-Feibelman, Kristen M.; Fuller, Benjamin P.; Geiss, Brian J.			A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; ESCHERICHIA-COLI; RNA-SYNTHESIS; IDENTIFICATION; BINDING; EXPRESSION; GUANOSINE	Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus that causes severe and debilitating disease symptoms. Alarmingly, transmission rates of CHIKV have increased dramatically over the last decade resulting in 1.7 million suspected cases in the Western hemisphere alone. There are currently no antivirals for treatment of CHIKV infection and novel anti-alphaviral compounds are badly needed. nsP1 is the alphavirus protein responsible for the methyltransferase and guanylyltransferase activities necessary for formation of the 5' type 0 cap structure added to newly formed viral RNA. Formation of this cap depends on nsP1 binding GTP and transferring a methylated GMP to nascent viral RNA. We have developed a fluorescence polarization-based assay that monitors displacement of a fluorescently-labeled GTP analog in real time. Determining the relative affinities of 15 GTP analogs for nsP1 GTP revealed important structural aspects of GTP that will inform identification of inhibitors able to outcompete GTP for the nsP1 binding site. Validation of the assay for HTS was completed and a secondary orthogonal assay that measures guanylation activity was developed in order to evaluate hits from future drug screens. This platform provides an avenue for identification of potent nsP1 inhibitors, which would potentially provide compounds capable of treating disease caused by CHIKV infection.	[Bullard-Feibelman, Kristen M.; Fuller, Benjamin P.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Geiss, BJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Geiss, BJ (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.; Geiss, BJ (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.	Brian.Geiss@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Fuller, Benjamin/0000-0001-7572-4415	US National Institutes of Health National Institute of Allergy and Infectious Disease [5R01AI114675]; National Institutes of Health (NIAID) [R01AI114675]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114675] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Allergy and Infectious Disease; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the US National Institutes of Health National Institute of Allergy and Infectious Disease as a grant (5R01AI114675) to BJG.; The authors would like to acknowledge the Metabolomics and Proteomics facility at Colorado State University for conducting the mass spectromety and analysis of protein samples. This work was supported by a grant from the National Institutes of Health (NIAID R01AI114675) to B.J.G.	AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Bougie I, 2004, J BIOL CHEM, V279, P22124, DOI 10.1074/jbc.M400908200; Bullard KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130083; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Ferron F, 2012, ANTIVIR RES, V96, P21, DOI 10.1016/j.antiviral.2012.07.007; Geiss BJ, 2011, J BIOMOL SCREEN, V16, P852, DOI 10.1177/1087057111412183; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465; Johansson MA, 2015, TRENDS PARASITOL, V31, P43, DOI 10.1016/j.pt.2014.12.008; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; LAAKKONEN P, 1994, J VIROL, V68, P7418, DOI 10.1128/JVI.68.11.7418-7425.1994; Lampio A, 1999, ANTIVIR RES, V42, P35, DOI 10.1016/S0166-3542(99)00011-X; Li CQ, 2015, J VIROL, V89, P8292, DOI 10.1128/JVI.00599-15; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; MI S, 1991, VIROLOGY, V184, P423, DOI 10.1016/0042-6822(91)90862-6; MI S, 1989, VIROLOGY, V170, P385, DOI 10.1016/0042-6822(89)90429-7; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; PETTERSSON RF, 1980, EUR J BIOCHEM, V105, P435, DOI 10.1111/j.1432-1033.1980.tb04518.x; Pfeffer Martin, 2008, Wien Klin Wochenschr, V120, P95, DOI 10.1007/s00508-008-1035-0; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Sittampalam GS, 2004, HTS ASSAY VALIDATION; Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12; Vasiljeva L, 2000, J BIOL CHEM, V275, P17281, DOI 10.1074/jbc.M910340199; Wang HL, 1996, VIROLOGY, V217, P527, DOI 10.1006/viro.1996.0147; WENGLER G, 1979, NATURE, V282, P754, DOI 10.1038/282754a0	28	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158923	10.1371/journal.pone.0158923	http://dx.doi.org/10.1371/journal.pone.0158923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427769	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300024
J	Costa, WJEM				Costa, Wilson J. E. M.			Inferring Evolution of Habitat Usage and Body Size in Endangered, Seasonal Cynopoeciline Killifishes from the South American Atlantic Forest through an Integrative Approach (Cyprinodontiformes: Rivulidae)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; HISTORICAL BIOGEOGRAPHY; FLORISTIC DIFFERENTIATION; BRAZIL CYPRINODONTIFORMES; COMPARATIVE MORPHOLOGY; LEPTOLEBIAS TELEOSTEI; CONTINUOUS CHARACTERS; EASTERN BRAZIL; GENUS; DIVERSIFICATION	Cynopoecilines comprise a diversified clade of small killifishes occurring in the Atlantic Forest, one of the most endangered biodiversity hotspots in the world. They are found in temporary pools of savannah-like and dense forest habitats, and most of them are highly threatened with extinction if not already extinct. The greatest gap in our knowledge of cynopoecilines stems from the absence of an integrative approach incorporating molecular phylogenetic data of species still found in their habitats with phylogenetic data taken from the rare and possibly extinct species without accessible molecular information. An integrative analysis combining 115 morphological characters with a multigene dataset of 2,108 bp comprising three nuclear loci (GLYT1, ENC1, Rho), provided a robust phylogeny of cynopoeciline killifishes, which was herein used to attain an accurate phylogenetic placement of nearly extinct species. The analysis indicates that the most recent common ancestor of the Cynopoecilini lived in open vegetation habitats of the Atlantic Forest of eastern Brazil and was a miniature species, reaching between 25 and 28mm of standard length. The rare cases of cynopoecilines specialized in inhabiting pools within dense forests are interpreted as derived from four independent evolutionary events. Shifts in habitat usage and biogeographic patterns are tentatively associated to Cenozoic paleogeographic events, but the evolutionary history of cynopoecilines may be partially lost by a combination of poor past sampling and recent habitat decline. A sharp evolutionary shift directed to increased body size in a clade encompassing the genera Campellole-bias and Cynopoecilus may be related to a parallel acquisition of an internally-fertilizing reproductive strategy, unique among aplocheiloid killifishes. This study reinforces the importance of adding morphological information to molecular databases as a tool to understand the biological complexity of organisms under intense pressure from loss of habitat.	[Costa, Wilson J. E. M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Systemat & Evolut Teleost Fishes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Costa, WJEM (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Lab Systemat & Evolut Teleost Fishes, Rio De Janeiro, RJ, Brazil.	wcosta@acd.ufrj.br	Costa, Wilson/A-9283-2013	Costa, Wilson/0000-0002-0428-638X	CNPq [303353/2010-4]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Grant 303353/2010-4, CNPq (BR) (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PEIXES ANUAIS BRASIL; [Anonymous], 2008, CATALOG APLOCHEILOID; Belote Drausio F., 2002, Boletim do Museu Nacional Rio de Janeiro Zoologia, P1; Belote Drausio F., 2003, Arquivos do Museu Nacional Rio de Janeiro, V61, P241; Belote Drausio F., 2004, Boletim do Museu Nacional Rio de Janeiro Zoologia, V514, P1; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Costa W.J.E.M., 1988, Revue Francaise d'Aquariologie Herpetologie, V15, P21; COSTA W J E M, 1990, Revista Brasileira de Biologia, V50, P83; COSTA W J E M, 1988, Revista Brasileira de Zoologia, V5, P557; COSTA W J E M, 1990, Revista Brasileira de Biologia, V50, P65; COSTA W. J. E. M., 2009, PEIXES APLOQUEILOIDE; Costa Wilson J.E.M., 2002, Ichthyological Exploration of Freshwaters, V13, P379; Costa WJEM, 2008, ZOOL J LINN SOC-LOND, V153, P147, DOI 10.1111/j.1096-3642.2008.00380.x; Costa Wilson J.E.M., 2004, Ichthyological Exploration of Freshwaters, V15, P105; Costa Wilson J. E. M., 1995, Cybium, V19, P349; Costa WJEM, 2006, NEOTROP ICHTHYOL, V4, P1, DOI 10.1590/S1679-62252006000100001; Costa WJEM, 2006, ZOOTAXA, P31; Costa Wilson J.E.M., 2002, Ichthyological Exploration of Freshwaters, V13, P41; Costa WJEM, 2016, MOL PHYLOGENET EVOL, V95, P94, DOI 10.1016/j.ympev.2015.11.011; Costa WJEM, 2015, ZOOL J LINN SOC-LOND, V175, P134, DOI 10.1111/zoj.12270; Costa WJEM, 2014, VERTEBR ZOOL, V64, P23; Costa WJEM, 2013, ICHTHYOL EXPLOR FRES, V24, P63; Costa WJEM, 2013, ICHTHYOL EXPLOR FRES, V23, P357; Costa WJEM, 2012, BIODIVERS CONSERV, V21, P2443, DOI 10.1007/s10531-012-0301-7; Costa WJEM, 2011, ZOOL J LINN SOC-LOND, V162, P131, DOI 10.1111/j.1096-3642.2010.00672.x; Costa Wilson J.E.M., 2001, Ichthyological Exploration of Freshwaters, V12, P333; Costa WJEM, 2010, J BIOGEOGR, V37, P1995, DOI 10.1111/j.1365-2699.2010.02339.x; Costa Wilson J.E.M., 2005, Zootaxa, V1067, P1; Costa Wilson J. E. M., 2009, Vertebrate Zoology, V59, P25; Costa Wilson J.E.M., 2002, Ichthyological Exploration of Freshwaters, V13, P11; Costa Wilson J.E.M., 1998, Journal of Comparative Biology, V3, P33; COSTA WJE, 1988, REV FRAN AQUARIOL HE, V14, P127; COSTA WJEM, 1995, COPEIA, P456; Costa WJEM, 1999, COPEIA, P1027; Costa WJEM, 1989, REV FRANCAISE AQUARI, V15, P65; Costa WJEM, 1995, PEARL KILLIFISHES CY; CRUZ C.A.G. DA, 1991, REV BRAS ZOOL, V7, P637, DOI DOI 10.1590/S0101-81751990000400017; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Fava D, 2007, J FISH BIOL, V71, P889, DOI 10.1111/j.1095-8649.2007.01572.x; Ferrer J, 2014, ZOOL J LINN SOC-LOND, V172, P846, DOI 10.1111/zoj.12190; Gamble T, 2008, MOL PHYLOGENET EVOL, V46, P269, DOI 10.1016/j.ympev.2007.08.013; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HOEDEMAN J. J., 1958, BULL AQUATIC BIOL, V1, P23; Hrbek T, 1999, EVOLUTION, V53, P1200, DOI 10.1111/j.1558-5646.1999.tb04533.x; Leary S, 2013, AVMA GUIDELINES EUTH; Ledru MP, 2009, PALAEOGEOGR PALAEOCL, V271, P140, DOI 10.1016/j.palaeo.2008.10.008; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Maddison, 2018, MESQUITE MODULAR SYS; Marques MCM, 2011, BIODIVERS CONSERV, V20, P153, DOI 10.1007/s10531-010-9952-4; Murphy WJ, 1999, MOL PHYLOGENET EVOL, V13, P289, DOI 10.1006/mpev.1999.0656; Myers G. S., 1952, Aquarium J, V23, P125; Myers George S., 1942, STANFORD ICHTHYOL BULL, V2, P89; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Near TJ, 2012, MOL PHYLOGENET EVOL, V63, P388, DOI 10.1016/j.ympev.2012.01.011; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Rambaut A, 2013, TRACER V1 5; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roncal J, 2013, BOT J LINN SOC, V171, P120, DOI 10.1111/j.1095-8339.2012.01297.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Saia SEMG, 2008, QUATERN INT, V184, P195, DOI 10.1016/j.quaint.2007.06.029; Saint-Hilaire AFC, 1851, VIAGEM CURITIBA PROV, VII; Sanciangco MD, 2016, MOL PHYLOGENET EVOL, V94, P565, DOI 10.1016/j.ympev.2015.10.006; Sanmartin I, 2008, J BIOGEOGR, V35, P428, DOI 10.1111/j.1365-2699.2008.01885.x; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; Sereno PC, 2007, CLADISTICS, V23, P565, DOI 10.1111/j.1096-0031.2007.00161.x; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavares ES, 2006, SYST BIOL, V55, P454, DOI 10.1080/10635150600697390; TAYLOR W R, 1985, Cybium, V9, P107; VAZ-FERREIRA R, 1974, Comunicaciones Zoologicas del Museo de Historia Natural de Montevideo, V10, P1; von Spix JB, 1823, VIAGEM PELO BRASIL 1, V1; WEITZMAN SH, 1988, P BIOL SOC WASH, V101, P444; Wied-Neuwied APM, 1820, VIAGEM AO BRASIL POR; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Yu Y., 2011, RASP RECONSTRUCT ANC	86	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159315	10.1371/journal.pone.0159315	http://dx.doi.org/10.1371/journal.pone.0159315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428070	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300048
J	Goh, YS; Peng, KT; Chia, WN; Siau, A; Chotivanich, K; Gruner, AC; Preiser, P; Mayxay, M; Pukrittayakamee, S; Sriprawat, K; Nosten, F; White, NJ; Renia, L				Goh, Yun Shan; Peng, Kaitian; Chia, Wan Ni; Siau, Anthony; Chotivanich, Kesinee; Gruner, Anne-Charlotte; Preiser, Peter; Mayxay, Mayfong; Pukrittayakamee, Sasithon; Sriprawat, Kanlaya; Nosten, Francois; White, Nicholas J.; Renia, Laurent			Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy	PLOS ONE			English	Article							ACQUIRED-IMMUNITY; PROTEIN-PEPTIDES; HOST IMMUNITY; IN-VITRO; MALARIA; INVASION; BINDING	An effective antibody response can assist drug treatment to contribute to better parasite clearance in malaria patients. To examine this, sera were obtained from two groups of adult patients with acute falciparum malaria, prior to drug treatment: patients who (1) have subsequent recrudescent infection, or (2) were cured by Day 28 following treatment. Using a Plasmodium falciparum antigen library, we examined the antibody specificities in these sera. While the antibody repertoire of both sera groups was extremely broad and varied, there was a differential antibody profile between the two groups of sera. The proportion of cured patients with antibodies against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 was higher than the proportion of patients with recrudescent infection. The presence of these antibodies was associated with higher odds of treatment cure. Sera containing all six antibodies impaired the invasion of P. falciparum clinical isolates into erythrocytes. These results suggest that antibodies specific against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 in P. falciparum infections could assist anti-malarial drug treatment and contribute to the resolution of the malarial infection.	[Goh, Yun Shan; Peng, Kaitian; Chia, Wan Ni; Gruner, Anne-Charlotte; Renia, Laurent] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Chia, Wan Ni] Natl Univ Singapore, Dept Microbiol & Immunol, Yong Loo Lin Sch Med, Singapore, Singapore; [Siau, Anthony; Preiser, Peter; Renia, Laurent] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Chotivanich, Kesinee; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Mayxay, Mayfong] Mahosot Hosp, Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit, Viangchan, Laos; [Sriprawat, Kanlaya; Nosten, Francois] Mahidol Univ, Shoklo Malaria Res Unit, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Mae Sot, Thailand; [Nosten, Francois; White, Nicholas J.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [White, Nicholas J.] Mahidol Univ, Mahidol Oxford Res Unit, Fac Trop Med, Bangkok, Thailand	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University	Renia, L (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.; Renia, L (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	renia_laurent@immunol.a-star.edu.sg	Nosten, Francois/AAC-5509-2019; Goh, Yun Shan/GXM-6170-2022; Preiser, Peter R/A-2201-2011; Renia, Laurent/E-2117-2011; White, Nick/AAC-6527-2019	Nosten, Francois/0000-0002-7951-0745; Renia, Laurent/0000-0003-0349-1557; White, Nick/0000-0002-1897-1978; , Peter/0000-0003-4331-7000	Singapore Immunology Network grant [07-009]; Singapore's Agency for Science, Technology and Research (A*STAR); Wellcome Trust of Great Britain; Yong Loo Lin School of Medicine, National University of Singapore (Singapore)	Singapore Immunology Network grant(Agency for Science Technology & Research (A*STAR)); Singapore's Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust of Great Britain(Wellcome Trust); Yong Loo Lin School of Medicine, National University of Singapore (Singapore)(National University of Singapore)	This work was supported by a Singapore Immunology Network grant No. 07-009 (PRR and LR) and an intramural grant from Singapore's Agency for Science, Technology and Research (A*STAR) (LR). Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, supported by the Wellcome Trust of Great Britain. Wan Ni Chia was supported by a postgraduate scholarship from the Yong Loo Lin School of Medicine, National University of Singapore (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Boyle MJ, 2014, INFECT IMMUN, V82, P924, DOI 10.1128/IAI.00866-13; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, INFECT IMMUN, V78, P737, DOI 10.1128/IAI.00960-09; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; Lisewski AM, 2014, CELL, V158, P916, DOI 10.1016/j.cell.2014.07.011; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; Payne RO, 2016, J INFECT DIS; Peng K, 2016, CELL MICROBIOL; Persson KEM, 2013, J IMMUNOL, V191, P785, DOI 10.4049/jimmunol.1300444; Pinzon CG, 2008, VACCINE, V26, P853, DOI 10.1016/j.vaccine.2007.11.086; Raj DK, 2014, SCIENCE, V344, P871, DOI 10.1126/science.1254417; Rodriguez LE, 2005, PROTEIN SCI, V14, P1778, DOI 10.1110/ps.041304505; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; WHO, 2015, MAL FACTSH	20	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159347	10.1371/journal.pone.0159347	http://dx.doi.org/10.1371/journal.pone.0159347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427762	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300054
J	Loeffen, R; van Oerle, R; Leers, MPG; Kragten, JA; Crijns, H; Spronk, HMH; ten Cate, H				Loeffen, Rinske a; van Oerle, Rene; Leers, Mathie P. G.; Kragten, Johannes A.; Crijns, Harry; Spronk, Henri M. H.; ten Cate, Hugo			Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ACTIVATED FACTOR-XI; TISSUE-FACTOR; ARTERY-DISEASE; COAGULATION-FACTORS; UNSTABLE ANGINA; HEART-DISEASE; IN-VIVO; MECHANISMS; ATHEROSCLEROSIS	Objective In acute coronary syndrome (ACS) cardiac cell damage is preceded by thrombosis. Therefore, plasma coagulation markers may have additional diagnostic relevance in ACS. By using novel coagulation assays this study aims to gain more insight into the relationship between the coagulation system and ACS. Methods We measured plasma thrombin generation, factor XIa and D-dimer levels in plasma from ACS (n = 104) and non-ACS patients (n = 42). Follow-up measurements (n = 73) were performed at 1 and 6 months. Associations between coagulation markers and recurrent cardiovascular events were calculated by logistic regression analysis. Results Thrombin generation was significantly enhanced in ACS compared to non-ACS patients: peak height 148 +/- 53 vs. 122 +/- 42 nM. There was a significantly diminished ETP reduction (32 vs. 41%) and increased intrinsic coagulation activation (25 vs. 7%) in ACS compared to non-ACS patients. Furthermore, compared to non-ACS patients factor XIa and D-dimer levels were significantly elevated in ACS patients: 1.9 +/- 1.1 vs. 1.4 +/- 0.7 pM and 495(310-885) vs. 380(235-540) mu g/L. Within the ACS spectrum, ST-elevated myocardial infarction patients had the highest prothrombotic profile. During the acute event, thrombin generation was significantly increased compared to 1 and 6 months afterwards: peak height 145 +/- 52 vs. 100 +/- 44 vs. 98 +/- 33 nM. Both peak height and factor XIa levels on admission predicted recurrent cardiovascular events (OR: 4.9 [95% CI 1.2-20.9] and 4.5 [1.1-18.9]). Conclusion ACS patients had an enhanced prothrombotic profile, demonstrated by an increased thrombin generation potential, factor XIa and D-dimer levels. This study is the first to demonstrate the positive association between factor XIa, thrombin generation and recurrent cardiovascular events.	[Loeffen, Rinske a; van Oerle, Rene; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Haemostas, Maastricht, Netherlands; [Loeffen, Rinske a; van Oerle, Rene; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Leers, Mathie P. G.] Atrium Med Ctr Parkstad, Dept Clin Chem, Heerlen, Netherlands; [Leers, Mathie P. G.] Atrium Med Ctr Parkstad, Dept Hematol, Heerlen, Netherlands; [Kragten, Johannes A.] Atrium Med Ctr Parkstad, Dept Cardiol, Heerlen, Netherlands; [Crijns, Harry] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Cardiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Atrium Medical Center; Atrium Medical Center; Atrium Medical Center; Maastricht University	Loeffen, R (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Internal Med,Lab Clin Thrombosis & Haemostas, Maastricht, Netherlands.; Loeffen, R (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	rinske.loeffen@maastrichtuniversity.nl	Leers, Mathie/AFV-8239-2022; Cate, Hugo ten/AAM-4000-2021	Leers, Mathie/0000-0001-5186-5600; Spronk, Henri/0000-0002-3858-334X; ten Cate, Hugo/0000-0001-7796-4463	project INCOAG [01C-201]; Dutch Heart Foundation	project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project INCOAG (grant 01C-201), and supported by the Dutch Heart Foundation.	Biasucci LM, 1996, AM J CARDIOL, V77, P85, DOI 10.1016/S0002-9149(97)89141-2; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Buller HR, 2015, NEW ENGL J MED, V372, P232, DOI 10.1056/NEJMoa1405760; Butenas S, 2008, THROMB HAEMOSTASIS, V99, P142, DOI 10.1160/TH07-08-0499; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Cooper JA, 2000, CIRCULATION, V102, P2816; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; FUSTER V, 1990, CIRCULATION, V82, P47; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Loeffen R, 2014, THROMB RES, V134, P1328, DOI 10.1016/j.thromres.2014.09.015; Loeffen R, 2012, J THROMB HAEMOST, V10, P2544, DOI 10.1111/jth.12012; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; Loeffen R, 2014, J GERONTOLOGY A; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1529, DOI 10.1161/01.ATV.0000135995.39488.6c; Luszczak J, 2011, BLOOD COAGUL FIBRIN, V22, P473, DOI 10.1097/MBC.0b013e328346c2bb; Manten A, 1998, CARDIOVASC RES, V40, P389, DOI 10.1016/S0008-6363(98)00130-8; MERLINI PA, 1994, CIRCULATION, V90, P61, DOI 10.1161/01.CIR.90.1.61; Minnema MC, 2000, ARTERIOSCL THROM VAS, V20, P2489, DOI 10.1161/01.ATV.20.11.2489; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Orbe J, 2008, THROMB HAEMOSTASIS, V99, P382, DOI 10.1160/TH07-07-0443; Ottani F, 2001, CLIN CHIM ACTA, V311, P33, DOI 10.1016/S0009-8981(01)00555-1; Rauch U, 2001, ANN INTERN MED, V134, P224, DOI 10.7326/0003-4819-134-3-200102060-00014; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Skeppholm M, 2011, THROMB RES, V128, P483, DOI 10.1016/j.thromres.2011.03.011; Smid M, 2011, J THROMB HAEMOST, V9, P450, DOI 10.1111/j.1538-7836.2010.04162.x; Smid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066977; Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675; Undas A, 2012, EUR J CLIN INVEST, V42, P123, DOI 10.1111/j.1365-2362.2011.02565.x; van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066; van der Putten RFM, 2006, CLIN CHIM ACTA, V371, P37, DOI 10.1016/j.cca.2006.03.005; Zabczyk M, 2010, POL ARCH MED WEWN, V120, P334, DOI 10.20452/pamw.961	35	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158355	10.1371/journal.pone.0158355	http://dx.doi.org/10.1371/journal.pone.0158355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27419389	Green Submitted, gold, Green Published			2022-12-26	WOS:000379662300002
J	Holdgate, MR; Meehan, CL; Hogan, JN; Miller, LJ; Rushen, J; de Passille, AM; Soltis, J; Andrews, J; Shepherdson, DJ				Holdgate, Matthew R.; Meehan, Cheryl L.; Hogan, Jennifer N.; Miller, Lance J.; Rushen, Jeff; de Passille, Anne Marie; Soltis, Joseph; Andrews, Jeff; Shepherdson, David J.			Recumbence Behavior in Zoo Elephants: Determination of Patterns and Frequency of Recumbent Rest and Associated Environmental and Social Factors	PLOS ONE			English	Article							CHOBE NATIONAL-PARK; SLEEP-DEPRIVATION; LYING BEHAVIOR; DAIRY-COWS; PHYLOGENETIC ANALYSIS; NOCTURNAL BEHAVIOR; LOXODONTA-AFRICANA; ASIAN ELEPHANT; TIME; LAMENESS	Resting behaviors are an essential component of animal welfare but have received little attention in zoological research. African savanna elephant (Loxodonta africana) and Asian elephant (Elephas maximus) rest includes recumbent postures, but no large-scale investigation of African and Asian zoo elephant recumbence has been previously conducted. We used anklets equipped with accelerometers to measure recumbence in 72 adult female African (n = 44) and Asian (n = 28) elephants housed in 40 North American zoos. We collected 344 days of data and determined associations between recumbence and social, housing, management, and demographic factors. African elephants were recumbent less (2.1 hours/day, S.D. = 1.1) than Asian elephants (3.2 hours/day, S.D. = 1.5; P < 0.001). Nearly one-third of elephants were non-recumbent on at least one night, suggesting this is a common behavior. Multi-variable regression models for each species showed that substrate, space, and social variables had the strongest associations with recumbence. In the African model, elephants who spent any amount of time housed on all-hard substrate were recumbent 0.6 hours less per day than those who were never on all-hard substrate, and elephants who experienced an additional acre of outdoor space at night increased their recumbence by 0.48 hours per day. In the Asian model, elephants who spent any amount of time housed on all-soft substrate were recumbent 1.1 hours more per day more than those who were never on all-soft substrate, and elephants who spent any amount of time housed alone were recumbent 0.77 hours more per day than elephants who were never housed alone. Our results draw attention to the significant interspecific difference in the amount of recumbent rest and in the factors affecting recumbence; however, in both species, the influence of flooring substrate is notably important to recumbent rest, and by extension, zoo elephant welfare.	[Holdgate, Matthew R.; Shepherdson, David J.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Holdgate, Matthew R.; Shepherdson, David J.] Oregon Zoo, Conservat Res Div, Portland, OR USA; [Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Miller, Lance J.] Chicago Zool Soc, Brookfield Zoo, Brookfield, IL USA; [Rushen, Jeff; de Passille, Anne Marie] Univ British Columbia, Dairy Educ & Res Ctr, Agassiz, BC, Canada; [Soltis, Joseph] Disneys Anim Kingdom, Dept Educ & Sci, Lake Buena Vista, FL USA; [Andrews, Jeff] Busch Gardens, Zool Operat, Tampa, FL USA	Portland State University; University of British Columbia; Walt Disney Company	Holdgate, MR (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97207 USA.; Holdgate, MR (corresponding author), Oregon Zoo, Conservat Res Div, Portland, OR USA.	mholdgate@gmail.com			Institute of Museum and Library Services [LG-25-10-0033-10]; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Pittsburgh Zoo; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Institute of Museum and Library Services; Forbes-Lea Research Grant; Marie Brown Award; Student Education Travel Grant; Pittsburgh Zoo; Oregon Zoo; Disney's Animal Kingdom; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. This paper was completed while MRH was undertaking a Ph.D. in Biology at Portland State University and in receipt of funding from the Forbes-Lea Research Grant, Marie Brown Award, and Student Education Travel Grant. This study was also funded in part by a research grant from the Pittsburgh Zoo. Employers provided financial support in the form of authors' salaries as follows: Oregon Zoo (DS and MH); Disney's Animal Kingdom (JS); Chicago Zoological Society-Brookfield Zoo (LM); Busch Gardens (JA). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1980, APPL ANIM ETHOL, V6, P257, DOI 10.1016/0304-3762(80)90027-9; Bell NJ, 2009, VET J, V180, P178, DOI 10.1016/j.tvjl.2008.05.020; Bergsten C, 1996, ACTA VET SCAND, V37, P383; Botreau R, 2007, ANIM WELFARE, V16, P225; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; Broom D.M., 2007, DOMESTIC ANIMAL BEHA, V4th; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; BURGER J, 1994, BEHAVIOUR, V131, P153, DOI 10.1163/156853994X00415; Capellini I, 2008, EVOLUTION, V62, P1764, DOI 10.1111/j.1558-5646.2008.00392.x; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Dimeo-Ediger N, 2000, THE ELEPHANTS FOOT, P153; Endres MI, 2007, J DAIRY SCI, V90, P4192, DOI 10.3168/jds.2006-751; EVERSON CA, 1995, BEHAV BRAIN RES, V69, P43, DOI 10.1016/0166-4328(95)00009-I; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Galindo F, 2000, RES VET SCI, V69, P75, DOI 10.1053/rvsc.2000.0391; Greco BJ, 2016, PLOS ONE; Guy P. R., 1976, AFR J ECOL, V14, P285; Haley DB, 2001, APPL ANIM BEHAV SCI, V71, P105, DOI 10.1016/S0168-1591(00)00175-1; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; HARTMANN E, 1968, PSYCHOPHYSIOLOGY, V4, P389; Hendrichs H., 1971, DIKDIK ELEFANTEN OKO; Holdgate MR, 2016, PLOS ONE; Ito K, 2009, J DAIRY SCI, V92, P4412, DOI 10.3168/jds.2009-2235; Jensen MB, 2005, APPL ANIM BEHAV SCI, V90, P207, DOI 10.1016/j.applanim.2004.08.006; Joubert D, 2006, AFR J ECOL, V44, P279, DOI 10.1111/j.1365-2028.2006.00626.x; Kandler C, 2010, THESIS; Kuhme W., 1963, P113; Ledgerwood DN, 2010, J DAIRY SCI, V93, P5129, DOI 10.3168/jds.2009-2945; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MCKAY GM, 1973, SMITHSONIAN CONTRIBU; MCKNIGHT BL, 1995, AFR J ECOL, V33, P242, DOI 10.1111/j.1365-2028.1995.tb00802.x; Meehan CL, 2016, PLOS ONE; Meller CL, 2007, ZOO BIOL, V26, P51, DOI 10.1002/zoo.20119; METZ JHM, 1985, APPL ANIM BEHAV SCI, V13, P301, DOI 10.1016/0168-1591(85)90010-3; Miller LJ, 2012, ANIM WELFARE, V21, P577, DOI 10.7120/09627286.21.4.577; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Mills DS, 2000, ANIM SCI, V70, P95, DOI 10.1017/S1357729800051638; Moss C., 1975, PORTRAITS WILD BEHAV; MUNKSGAARD L, 1993, CAN J ANIM SCI, V73, P847, DOI 10.4141/cjas93-087; Munksgaard L, 1999, ACTA AGR SCAND A-AN, V49, P172, DOI 10.1080/090647099424088; Munksgaard L, 2005, APPL ANIM BEHAV SCI, V92, P3, DOI 10.1016/j.applanim.2004.11.005; NOAA, 2011, QUAL CONTR LOC CLIM; Opp MR, 2015, BRAIN BEHAV IMMUN, V47, P1, DOI 10.1016/j.bbi.2015.03.011; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Pedersen GR, 2004, J EQUINE VET SCI, V24, P153, DOI 10.1016/j.jevs.2004.03.013; Posta B., 2013, INT J COMP PSYCHOL, V26, P37, DOI [DOI 10.46867/IJCP.2013.26.01.05, 10.46867/ijcp.2013.26.01.05]; Power RJ, 2009, AFR ZOOL, V44, P36, DOI 10.3377/004.044.0104; Prado-Oviedo NA, 2016, PLOS ONE; Preston BT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-7; Raabymagle P, 2006, J EQUINE VET SCI, V26, P11, DOI 10.1016/j.jevs.2005.11.015; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Rushen J, 2007, J DAIRY SCI, V90, P3647, DOI 10.3168/jds.2006-463; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Sikes S.K, 1971, NATURAL HIST AFRICAN; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; TOBLER I, 1992, SLEEP, V15, P1; TOTH LA, 1995, ADV NEUROIMMUNOL, V5, P79, DOI 10.1016/0960-5428(94)00045-P; Tucker CB, 2004, J DAIRY SCI, V87, P1208, DOI 10.3168/jds.S0022-0302(04)73271-3; Weisz Isolde, 2000, IZN (International Zoo News), V47, P228; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; WYATT J R, 1974, East African Wildlife Journal, V12, P273	67	31	32	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0153301	10.1371/journal.pone.0153301	http://dx.doi.org/10.1371/journal.pone.0153301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414809	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500006
J	Liljegren, MM; de Muinck, EJ; Trosvik, P				Liljegren, Mikkel Meyn; de Muinck, Eric Jacques; Trosvik, Pal			Microsatellite Length Scoring by Single Molecule Real Time Sequencing - Effects of Sequence Structure and PCR Regime	PLOS ONE			English	Article							ESCHERICHIA-COLI; MUTATION-RATES; INSTABILITY; POPULATION; NUMBER; DNA; EXPANSION; BACTERIA; ALLELES; CELLS	Microsatellites are DNA sequences consisting of repeated, short (1-6 bp) sequence motifs that are highly mutable by enzymatic slippage during replication. Due to their high intrinsic variability, microsatellites have important applications in population genetics, forensics, genome mapping, as well as cancer diagnostics and prognosis. The current analytical standard for microsatellites is based on length scoring by high precision electrophoresis, but due to increasing efficiency next-generation sequencing techniques may provide a viable alternative. Here, we evaluated single molecule real time (SMRT) sequencing, implemented in the PacBio series of sequencing apparatuses, as a means of microsatellite length scoring. To this end we carried out multiplexed SMRT sequencing of plasmid-carried artificial microsatellites of varying structure under different pre-sequencing PCR regimes. For each repeat structure, reads corresponding to the target length dominated. We found that pre-sequencing amplification had large effects on scoring accuracy and error distribution relative to controls, but that the effects of the number of amplification cycles were generally weak. In line with expectations enzymatic slippage decreased proportionally with microsatellite repeat unit length and increased with repetition number. Finally, we determined directional mutation trends, showing that PCR and SMRT sequencing introduced consistent but opposing error patterns in contraction and expansion of the microsatellites on the repeat motif and single nucleotide level.	[Liljegren, Mikkel Meyn; de Muinck, Eric Jacques; Trosvik, Pal] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo	Trosvik, P (corresponding author), Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway.	pal.trosvik@ibv.uio.no		de Muinck, Eric/0000-0001-5606-3172	Research Council of Norway [214285/F20]	Research Council of Norway(Research Council of Norway)	This study was funded by Research Council of Norway grant 214285/F20. URL: http://www.forskningsradet.no/.	Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bhargava A, 2010, MOL BIOTECHNOL, V44, P250, DOI 10.1007/s12033-009-9230-4; Boyer JC, 2002, HUM MOL GENET, V11, P707, DOI 10.1093/hmg/11.6.707; Chakraborty R, 1997, P NATL ACAD SCI USA, V94, P1041, DOI 10.1073/pnas.94.3.1041; COVARRUBIAS L, 1982, GENE, V17, P79, DOI 10.1016/0378-1119(82)90103-2; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eckert KA, 2000, NUCLEIC ACIDS RES, V28, P2831, DOI 10.1093/nar/28.14.2831; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gan C, 2015, GENES-BASEL, V6, P46, DOI 10.3390/genes6010046; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Grohme MA, 2013, BIOTECHNIQUES, V55, P255, DOI 10.2144/000114104; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lindstedt BA, 2005, ELECTROPHORESIS, V26, P2567, DOI 10.1002/elps.200500096; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Petit RJ, 2005, MOL ECOL, V14, P885, DOI 10.1111/j.1365-294X.2005.02446.x; R Core Team, 2013, R LANG ENV STAT COMP; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SCHWARTZ LS, 1992, AM J HUM GENET, V51, P721; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Twerdi CD, 1999, P NATL ACAD SCI USA, V96, P2875, DOI 10.1073/pnas.96.6.2875; Wang W, 2003, J HUM GENET, V48, P337, DOI 10.1007/s10038-003-0034-2; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	35	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159232	10.1371/journal.pone.0159232	http://dx.doi.org/10.1371/journal.pone.0159232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414800	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500102
J	McCarthy, KR; Johnson, WE; Kirmaier, A				McCarthy, Kevin R.; Johnson, Welkin E.; Kirmaier, Andrea			Phylogeny and History of the Lost SIV from Crab-Eating Macaques: SIVmfa	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MAURITIAN CYNOMOLGUS MACAQUES; CLASS-I ALLELES; MACACA-FASCICULARIS; RHESUS MACAQUES; HTLV-III; TRIM5-ALPHA GENOTYPE; FUNCTIONAL DIVERSITY; NONHUMAN-PRIMATES; HIV-1 INFECTION	In the 20th century, thirteen distinct human immunodeficiency viruses emerged following independent cross-species transmission events involving simian immunodeficiency viruses (SIV) from African primates. In the late 1900s, pathogenic SIV strains also emerged in the United Sates among captive Asian macaque species following their unintentional infection with SIV from African sooty mangabeys (SIVsmm). Since their discovery in the 1980s, SIVs from rhesus macaques (SIVmac) and pig-tailed macaques (SIVmne) have become invaluable models for studying HIV pathogenesis, vaccine design and the emergence of viruses. SIV isolates from captive crab-eating macaques (SIVmfa) were initially described but lost prior to any detailed molecular and genetic characterization. In order to infer the origins of the lost SIVmfa lineage, we located archived material and colony records, recovered its genomic sequence by PCR, and assessed its phylogenetic relationship to other SIV strains. We conclude that SIVmfa is the product of two cross-species transmission events. The first was the established transmission of SIVsmm to rhesus macaques, which occurred at the California National Primate Research Center in the late 1960s and the virus later emerged as SIVmac. In a second event, SIVmac was transmitted to crab-eating macaques, likely at the Laboratory for Experimental Medicine and Surgery in Primates in the early 1970s, and it was later spread to the New England Primate Research Center colony in 1973 and eventually isolated in 1986. Our analysis suggests that SIVmac had already emerged by the early 1970s and had begun to diverge into distinct lineages. Furthermore, our findings suggest that pathogenic SIV strains may have been more widely distributed than previously appreciated, raising the possibility that additional isolates may await discovery.	[McCarthy, Kevin R.] Harvard Med Sch, Program Virol, Boston, MA USA; [McCarthy, Kevin R.; Johnson, Welkin E.; Kirmaier, Andrea] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [McCarthy, Kevin R.] Boston Childrens Hosp, Boston, MA USA	Harvard University; Harvard Medical School; Boston College; Harvard University; Boston Children's Hospital	Kirmaier, A (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	kirmaier@bc.edu	Kirmaier, Andrea/H-4034-2019	Kirmaier, Andrea/0000-0001-7206-7640	National Institutes of Health/National Center for Research Resources grant [RR00168]	National Institutes of Health/National Center for Research Resources grant	This work was funded by National Institutes of Health/National Center for Research Resources grant RR00168 (to New England Primate Research Center).	Apetrei C, 2006, AIDS, V20, P317, DOI 10.1097/01.aids.0000206498.71041.0e; Apetrei C, 2005, J VIROL, V79, P8991, DOI 10.1128/JVI.79.14.8991-9005.2005; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Ayouba A, 2013, AIDS, V27, P2488, DOI 10.1097/01.aids.0000432443.22684.50; BASKIN GB, 1987, AM J PATHOL, V129, P345; BENVENISTE RE, 1986, J VIROL, V60, P483, DOI 10.1128/JVI.60.2.483-490.1986; Berry NJ, 2012, IMMUNOGENETICS, V64, P267, DOI 10.1007/s00251-011-0585-x; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DANIEL MD, 1988, INT J CANCER, V41, P601, DOI 10.1002/ijc.2910410421; de Groot NG, 2011, TISSUE ANTIGENS, V78, P256, DOI 10.1111/j.1399-0039.2011.01768.x; Dietrich EA, 2011, J VIROL, V85, P9956, DOI 10.1128/JVI.00097-11; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gao F, 2001, AIDS RES HUM RETROV, V17, P1217, DOI 10.1089/088922201316912826; Gardner MB, 1996, J MED PRIMATOL, V25, P148, DOI 10.1111/j.1600-0684.1996.tb00011.x; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Harris M, 2013, J VIROL, V87, P9353, DOI 10.1128/JVI.00909-13; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; KANKI PJ, 1985, SCIENCE, V228, P1199, DOI 10.1126/science.3873705; KESTLER HW, 1988, NATURE, V331, P619, DOI 10.1038/331619a0; KHAN AS, 1991, J VIROL, V65, P7061, DOI 10.1128/JVI.65.12.7061-7065.1991; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Krupp A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003641; Kuang YQ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-58; LETVIN NL, 1990, J ACQ IMMUN DEF SYND, V3, P1023; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; LOWENSTINE LJ, 1992, J MED PRIMATOL, V21, P1; MANSFIELD KG, 1995, J MED PRIMATOL, V24, P116, DOI 10.1111/j.1600-0684.1995.tb00156.x; Mattiuzzo G, 2013, J GEN VIROL, V94, P606, DOI 10.1099/vir.0.047795-0; MOORJANKOWSKI J, 1964, NATURE, V202, P663, DOI 10.1038/202663a0; MOORJANKOWSKI J, 1963, EXP MED SURG, V21, P147; MOORJANKOWSKI J, 1977, J MED PRIMATOL, V6, P76; MOORJANKOWSKI J, 1969, ANN NY ACAD SCI, V162, P324, DOI 10.1111/j.1749-6632.1969.tb56379.x; MURPHEYCORB M, 1986, NATURE, V321, P435, DOI 10.1038/321435a0; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11; Saito A, 2013, J GEN VIROL, V94, P1318, DOI 10.1099/vir.0.050252-0; Saito A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00314; Saito A, 2012, J GEN VIROL, V93, P594, DOI 10.1099/vir.0.038075-0; Sharp PM, 2000, BIOCHEM SOC T, V28, P275, DOI 10.1042/bst0280275; SIMON MA, 1992, AIDS RES HUM RETROV, V8, P327, DOI 10.1089/aid.1992.8.327; SOCHA WW, 1976, AM J PHYS ANTHROPOL, V45, P485, DOI 10.1002/ajpa.1330450309; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swofford DL, 2002, PAUP PHYLOGENETIC AN; ten Haaft P, 2001, J MED PRIMATOL, V30, P207, DOI 10.1034/j.1600-0684.2001.d01-54.x; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; WIENER AS, 1967, J IMMUNOL, V98, P1011; WIENER AS, 1963, SCIENCE, V142, P67, DOI 10.1126/science.142.3588.67; Wilson SJ, 2008, J VIROL, V82, P7243, DOI 10.1128/JVI.00307-08; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Wu F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003577; Yu CQ, 2013, IMMUNOGENETICS, V65, P185, DOI 10.1007/s00251-012-0670-9; Zhang GQ, 2013, AM J PRIMATOL, V75, P938, DOI 10.1002/ajp.22158; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	66	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159281	10.1371/journal.pone.0159281	http://dx.doi.org/10.1371/journal.pone.0159281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415779	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500119
J	Miller, MA; Hogan, JN; Meehan, CL				Miller, Michele A.; Hogan, Jennifer N.; Meehan, Cheryl L.			Housing and Demographic Risk Factors Impacting Foot and Musculoskeletal Health in African Elephants [Loxodonta africana] and Asian Elephants [Elephas maximus] in North American Zoos	PLOS ONE			English	Article							LOCOMOTION; DISEASE	For more than three decades, foot and musculoskeletal conditions have been documented among both Asian [Elephas maximus] and African [Loxodonta africana] elephants in zoos. Although environmental factors have been hypothesized to play a contributing role in the development of foot and musculoskeletal pathology, there is a paucity of evidence-based research assessing risk. We investigated the associations between foot and musculoskeletal health conditions with demographic characteristics, space, flooring, exercise, enrichment, and body condition for elephants housed in North American zoos during 2012. Clinical examinations and medical records were used to assess health indicators and provide scores to quantitate conditions. Using multivariable regression models, associations were found between foot health and age [P value = 0.076; Odds Ratio = 1.018], time spent on hard substrates [P value = 0.022; Odds Ratio = 1.014], space experienced during the night [P value = 0.041; Odds Ratio = 1.008], and percent of time spent in indoor/outdoor exhibits during the day [P value < 0.001; Odds Ratio = 1.003]. Similarly, the main risk factors for musculoskeletal disorders included time on hard substrate [P value = 0.002; Odds Ratio = 1.050] and space experienced in indoor/outdoor exhibits [P value = 0.039; Odds Ratio = 1.037]. These results suggest that facility and management changes that decrease time spent on hard substrates will improve elephant welfare through better foot and musculoskeletal health.	[Miller, Michele A.] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,Natl Res Fdn,Ctr Excel, MRC,Ctr Mol & Cellular Biol,Dept Sci & Technol, Cape Town, South Africa; [Hogan, Jennifer N.; Meehan, Cheryl L.] Anim Welf Assessment Res & Educ AWARE Inst, Portland, OR USA	National Research Foundation - South Africa; Stellenbosch University	Miller, MA (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet,Natl Res Fdn,Ctr Excel, MRC,Ctr Mol & Cellular Biol,Dept Sci & Technol, Cape Town, South Africa.	michelemiller128@gmail.com	Miller, Michele/ABA-1332-2020	Miller, Michele/0000-0002-5883-6076	Institute of Museum and Library Services [LG-25-10-0033-10]; IMLS; AWARE Institute	Institute of Museum and Library Services; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. After the IMLS-funded period of performance (November 2010-December 2013) AWARE Institute provided support in the form of salaries for authors (CM, JH). The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1979, J ZOOL, V189, P135, DOI 10.1111/j.1469-7998.1979.tb03956.x; Barker ZE, 2009, J DAIRY SCI, V92, P1971, DOI 10.3168/jds.2008-1590; duPlessis I., 2007, SA ANIM SCI, V8, P11; Fowler ME, 2001, ELEPHANT'S FOOT, P3; Fowler Murray E., 2006, P271, DOI 10.1002/9780470344484.ch20; Frankena K, 2009, PREV VET MED, V88, P150, DOI 10.1016/j.prevetmed.2008.08.004; Gage LJ, 1997, J ZOO WILDLIFE MED, V28, P208; Greco BJ, 2016, PLOS ONE; Haufe HC, 2012, PREV VET MED, V105, P85, DOI 10.1016/j.prevetmed.2012.01.016; Holdgate MR, 2016, PLOS ONE; Houck Richard, 1993, P453; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Little JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097329; Luikart KA, 2005, J ZOO WILDLIFE MED, V36, P684, DOI 10.1638/04088.1; Meehan CL, 2016, PLOS ONE; Mikota S.K., 1994, W BLOOMFIELD; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Panagiotopoulou O, 2012, J EXP BIOL, V215, P1584, DOI 10.1242/jeb.065862; Prado-Oviedo NA, 2016, PLOS ONE; Schwammer HM, 2001, ELEPHANT'S FOOT, P69; Spelman L, 2000, ANN C AM ASS ZOO VET, P388; Veasey J., 2006, International Zoo Yearbook, V40, P63, DOI 10.1111/j.1748-1090.2006.00063.x; von Houwald F., 1998, EAZWV SCI M, V2, P323; Weissengruber GE, 2006, J ANAT, V209, P781, DOI 10.1111/j.1469-7580.2006.00648.x; West Gary, 2006, P263, DOI 10.1002/9780470344484.ch19	25	48	49	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0155223	10.1371/journal.pone.0155223	http://dx.doi.org/10.1371/journal.pone.0155223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415763	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500010
J	Skoda, J; Hermanova, M; Loja, T; Nemec, P; Neradil, J; Karasek, P; Veselska, R				Skoda, Jan; Hermanova, Marketa; Loja, Tomas; Nemec, Pavel; Neradil, Jakub; Karasek, Petr; Veselska, Renata			Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							CYTOPLASMIC CD24 EXPRESSION; NESTIN EXPRESSION; TUMOR-GROWTH; CD133; TARGET; BREAST; LYN; FYN; DIFFERENTIATION; PROGRESSION	Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies. Its dismal prognosis is often attributed to the presence of cancer stem cells (CSCs) that have been identified in PDAC using various markers. However, the co-expression of all of these markers has not yet been evaluated. Furthermore, studies that compare the expression levels of CSC markers in PDAC tumor samples and in cell lines derived directly from those tumors are lacking. Here, we analyzed the expression of putative CSC markers-CD24, CD44, epithelial cell adhesion molecule (EpCAM), CD133, and nestin-by immunofluorescence, flow cytometry and quantitative PCR in 3 PDAC-derived cell lines and by immunohistochemistry in 3 corresponding tumor samples. We showed high expression of the examined CSC markers among all of the cell lines and tumor samples, with the exception of CD24 and CD44, which were enriched under in vitro conditions compared with tumor tissues. The proportions of cells positive for the remaining markers were comparable to those detected in the corresponding tumors. Co-expression analysis using flow cytometry revealed that CD24(+)/CD44(+)/EpCAM(+)/CD133(+) cells represented a significant population of the cells (range, 43 to 72%) among the cell lines. The highest proportion of CD24(+)/CD44(+)/EpCAM(+)/CD133(+) cells was detected in the cell line derived from the tumor of a patient with the shortest survival. Using gene expression profiling, we further identified the specific protumorigenic expression profile of this cell line compared with the profiles of the other two cell lines. Together, CD24(+)/CD44(+)/EpCAM(+)/CD133(+) cells are present in PDAC cell lines derived from primary tumors, and their increased proportion corresponds with a pro-tumorigenic gene expression profile.	[Skoda, Jan; Loja, Tomas; Nemec, Pavel; Neradil, Jakub; Veselska, Renata] Masaryk Univ, Fac Sci, Dept Expt Biol, Lab Tumor Biol, Brno, Czech Republic; [Skoda, Jan; Neradil, Jakub; Veselska, Renata] Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic; [Skoda, Jan; Hermanova, Marketa; Neradil, Jakub; Veselska, Renata] Masaryk Univ, Fac Med, Brno, Czech Republic; [Skoda, Jan; Neradil, Jakub; Veselska, Renata] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Hermanova, Marketa] St Annes Univ Hosp, Dept Pathol Anat 1, Brno, Czech Republic; [Karasek, Petr] Masaryk Mem Canc Inst, Dept Complex Oncol Care, Brno, Czech Republic	Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk Memorial Cancer Institute	Veselska, R (corresponding author), Masaryk Univ, Fac Sci, Dept Expt Biol, Lab Tumor Biol, Brno, Czech Republic.; Veselska, R (corresponding author), Univ Hosp Brno, Dept Pediat Oncol, Brno, Czech Republic.; Veselska, R (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.; Veselska, R (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	veselska@sci.muni.cz	Neradil, Jakub/GQZ-7932-2022; Neradil, Jakub/F-1580-2019; Veselska, Renata/L-7661-2016; Loja, Tomas/I-2698-2014; Skoda, Jan/L-6566-2019	Neradil, Jakub/0000-0001-6781-7099; Loja, Tomas/0000-0002-9007-266X; Skoda, Jan/0000-0002-9292-8177; Hermanova, Marketa/0000-0002-3889-0905; Veselska, Renata/0000-0002-0048-9913	European Regional Development Fund [CZ.1.05/1.1.00/02.0123, CZ.1.07/2.3.00/20.0183]; National Program of Sustainability II - Project Translational Medicine [LQ1605]	European Regional Development Fund(European Commission); National Program of Sustainability II - Project Translational Medicine	This study was supported by grants from the European Regional Development Fund - Projects FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123) and CEB (No. CZ.1.07/2.3.00/20.0183), and by National Program of Sustainability II - Project Translational Medicine LQ1605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balic A, 2012, EXP CELL RES, V318, P691, DOI 10.1016/j.yexcr.2011.11.007; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Bunger S, 2012, EUR SURG RES, V49, P88, DOI 10.1159/000341669; Cantilena S, 2011, ONCOTARGET, V2, P976, DOI 10.18632/oncotarget.410; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056878; Chen ZY, 2010, J GASTROEN HEPATOL, V25, P293, DOI 10.1111/j.1440-1746.2009.06021.x; Choi YL, 2005, GYNECOL ONCOL, V97, P379, DOI 10.1016/j.ygyno.2005.01.018; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Choi Yun La, 2006, Journal of Pathology and Translational Medicine, V40, P103; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Fernandez A, 2014, P NATL ACAD SCI USA, V111, P1409, DOI 10.1073/pnas.1323697111; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Fu YG, 2006, INT J ONCOL, V29, P1453; Hashimoto K, 2014, GASTRIC CANCER, V17, P97, DOI 10.1007/s10120-013-0255-9; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang MM, 2015, J SENSORS, V2015, DOI 10.1155/2015/685154; Huang SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054579; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Jao SW, 2012, ANN SURG ONCOL, V19, P3432, DOI 10.1245/s10434-012-2394-3; Jiang H, 2014, INT J CLIN EXP PATHO, V7, P4531; Kim HS, 2012, INT J CLIN EXP PATHO, V5, P754; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kristiansen G, 2010, LAB INVEST, V90, P1102, DOI 10.1038/labinvest.2010.70; Kure S, 2012, INT J ONCOL, V41, P1314, DOI 10.3892/ijo.2012.1565; Lee CJ, 2008, TRANSL ONCOL, V1, P14, DOI 10.1593/tlo.08013; Lenz J, 2011, J GASTROINTEST LIVER, V20, P389; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Liu WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070804; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda Y, 2012, MED MOL MORPHOL, V45, P59, DOI 10.1007/s00795-012-0571-x; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Modarressi MH, 2000, BIOCHEM BIOPH RES CO, V272, P610, DOI 10.1006/bbrc.2000.2832; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nunukova A, 2015, INT J MOL MED, V36, P65, DOI 10.3892/ijmm.2015.2210; Rostoker R, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0589-9; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sasaki A, 2010, ONCOL REP, V24, P537, DOI 10.3892/or_00000890; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimozato O, 2015, ONCOGENE, V34, P1949, DOI 10.1038/onc.2014.141; Skoda J, 2016, TUMOR BIOL, V37, P9535, DOI 10.1007/s13277-016-4837-0; Skoda J, 2014, ONCOL REP, V31, P480, DOI 10.3892/or.2013.2864; Soave DF, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-29; Su N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-43; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Vaz AP, 2014, J CANC STEM CELL RES, V2, P1, DOI [10.14343/jcscr.2014.2e1004, DOI 10.14343/JCSCR.2014.2E1004]; Veselska R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-32; Wang LZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6909; Weichert W, 2005, CLIN CANCER RES, V11, P6574, DOI 10.1158/1078-0432.CCR-05-0606; Yajima I, 2014, AM J CANCER RES, V4, P182; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zhang X, 2014, STEM CELL RES, V13, P379, DOI 10.1016/j.scr.2014.09.007	57	27	28	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159255	10.1371/journal.pone.0159255	http://dx.doi.org/10.1371/journal.pone.0159255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414409	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500112
J	Kinny-Koster, B; Bartels, M; Becker, S; Scholz, M; Thiery, J; Ceglarek, U; Kaiser, T				Kinny-Koester, Benedict; Bartels, Michael; Becker, Susen; Scholz, Markus; Thiery, Joachim; Ceglarek, Uta; Kaiser, Thorsten			Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; CIRRHOTIC-PATIENTS; SKELETAL-MUSCLE; MODEL; SURVIVAL; HYPONATREMIA; VALIDATION; METABOLISM; MATURATION; AMMONIA	Background The liver plays a key role in amino acid metabolism. In former studies, a ratio between branched-chain and aromatic amino acids (Fischer's ratio) revealed associations with hepatic encephalopathy. Furthermore, low concentrations of branched-chain amino acids were linked to sarcopenia in literature. Encephalopathy and sarcopenia are known to dramatically worsen the prognosis. Aim of this study was to investigate a complex panel of plasma amino acids in the context of mortality in patients with end-stage liver disease. Methods 166 patients evaluated for orthotopic liver transplantation were included. 19 amino acids were measured from citrated plasma samples using mass spectrometry. We performed survival analysis for plasma amino acid constellations and examined the relationship to established mortality predictors. Results 33/166 (19.9%) patients died during follow-up. Lower values of valine (p<0.001), Fischer's ratio (p<0.001) and valine to phenylalanine ratio (p<0.001) and higher values of phenylalanine (p<0.05) and tyrosine (p<0.05) were significantly associated with mortality. When divided in three groups, the tertiles discriminated cumulative survival for valine (p =0.016), phenylalanine (p = 0.024) and in particular for valine to phenylalanine ratio (p = 0.003) and Fischer's ratio (p = 0.005). Parameters were also significantly correlated with MELD and MELD-Na score. Conclusions Amino acids in plasma are valuable biomarkers to determine increased risk of mortality in patients with end-stage liver disease. In particular, valine concentrations and constellations composed of branched-chain and aromatic amino acids were strongly associated with prognosis. Due to their pathophysiological importance, the identified amino acids could be used to examine individual dietary recommendations to serve as potential therapeutic targets.	[Kinny-Koester, Benedict; Becker, Susen; Thiery, Joachim; Ceglarek, Uta; Kaiser, Thorsten] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Bartels, Michael] Univ Hosp Leipzig, Dept Visceral Vasc Thorac & Transplant Surg, Leipzig, Germany; [Becker, Susen; Scholz, Markus; Thiery, Joachim; Ceglarek, Uta] Univ Hosp Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Kaiser, T (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	thorsten.kaiser@medizin.uni-leipzig.de	Ceglarek, Uta/GOE-5561-2022		LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within excellence initiative	LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within excellence initiative	This publication is supported by LIFE - Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative.; We thank Dr. rer. nat. Sonja C. Stadler and Lars Schinkel for their substantial impact in discussions and support in measurements. This publication is supported by LIFE-Leipzig Research Center for Civilization Diseases, Universitat Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative.	Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042; Asrani SK, 2011, CLIN LIVER DIS, V15, P685, DOI 10.1016/j.cld.2011.08.009; Bobbert M, 2013, CLIN TRANSPLANT, V27, P34, DOI 10.1111/ctr.12154; Brauer R, 2011, METABOLOMICS, V7, P344, DOI 10.1007/s11306-010-0256-1; Ceglarek U, 2002, CLIN CHEM LAB MED, V40, P693, DOI 10.1515/CCLM.2002.119; Cholongitas E, 2010, NAT REV GASTRO HEPAT, V7, P659, DOI 10.1038/nrgastro.2010.169; Damink SWMO, 2007, HEPATOLOGY, V45, P560, DOI 10.1002/hep.21463; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; FISCHER JE, 1971, LANCET, V2, P75, DOI 10.1016/s0140-6736(71)92048-4; FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9; Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418; Gluud LL, 2013, J NUTR, V143, P1263, DOI 10.3945/jn.113.174375; Hamaguchi Y, 2014, LIVER TRANSPLANT, V20, P1413, DOI 10.1002/lt.23970; Holecek M, 2015, NUTRITION, V31, P14, DOI 10.1016/j.nut.2014.03.016; Holecek M, 2013, NUTRITION, V29, P1186, DOI 10.1016/j.nut.2013.01.022; Kachaamy T, 2012, CLIN GASTROENTEROL H, V10, P100, DOI 10.1016/j.cgh.2011.11.002; Kakazu E, 2007, J IMMUNOL, V179, P7137, DOI 10.4049/jimmunol.179.10.7137; Kakazu E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03459; Kakazu E, 2009, HEPATOLOGY, V50, P1936, DOI 10.1002/hep.23248; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kawaguchi T, 2014, CLIN GASTROENTEROL H, V12, P1012, DOI 10.1016/j.cgh.2013.08.050; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kawamura E, 2009, LIVER TRANSPLANT, V15, P790, DOI 10.1002/lt.21758; Kim TY, 2014, J KOREAN MED SCI, V29, P1253, DOI 10.3346/jkms.2014.29.9.1253; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Montano-Loza AJ, 2014, CURR OPIN CLIN NUTR, V17, P219, DOI 10.1097/MCO.0000000000000046; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Ney M, 2015, NUTR CLIN PRACT, V30, P530, DOI 10.1177/0884533614567716; Plauth M, 2011, CURR OPIN CLIN NUTR, V14, P61, DOI 10.1097/MCO.0b013e3283413726; Schwabl P, 2015, LIVER INT, V35, P2121, DOI 10.1111/liv.12795; Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717; Wedd J, 2014, LIVER TRANSPLANT, V20, P1193, DOI 10.1002/lt.23929; Weismuller TJ, 2009, TRANSPL INT, V22, P970, DOI 10.1111/j.1432-2277.2009.00915.x; Wong RJ, 2015, LIVER TRANSPLANT, V21, P873, DOI 10.1002/lt.24153; Yoo HY, 2003, AM J GASTROENTEROL, V98, P1395, DOI 10.1016/S0002-9270(03)00240-5	38	28	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159205	10.1371/journal.pone.0159205	http://dx.doi.org/10.1371/journal.pone.0159205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410482	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300066
J	Veluchamy, A; Jegu, T; Ariel, F; Latrasse, D; Mariappan, KG; Kim, SK; Crespi, M; Hirt, H; Bergounioux, C; Raynaud, C; Benhamed, M				Veluchamy, Alaguraj; Jegu, Teddy; Ariel, Federico; Latrasse, David; Mariappan, Kiruthiga Gayathri; Kim, Soon-Kap; Crespi, Martin; Hirt, Heribert; Bergounioux, Catherine; Raynaud, Cecile; Benhamed, Moussa			LHP1 Regulates H3K27me3 Spreading and Shapes the Three-Dimensional Conformation of the Arabidopsis Genome	PLOS ONE			English	Article							POLYCOMB REPRESSIVE COMPLEX; FLOWERING-LOCUS-C; DNA-POLYMERASE-ALPHA; EMBRYONIC STEM-CELLS; GROUP PROTEINS; HISTONE H3; CATALYTIC SUBUNIT; NONCODING RNA; GROUP GENE; TRANSCRIPTIONAL REGULATION	Precise expression patterns of genes in time and space are essential for proper development of multicellular organisms. Dynamic chromatin conformation and spatial organization of the genome constitute a major step in this regulation to modulate developmental outputs. Polycomb repressive complexes (PRCs) mediate stable or flexible gene repression in response to internal and environmental cues. In Arabidopsis thaliana, LHP1 co-localizes with H3K27me3 epigenetic marks throughout the genome and interacts with PRC1 and PRC2 members as well as with a long noncoding RNA. Here, we show that LHP1 is responsible for the spreading of H3K27me3 towards the 3' end of the gene body. We also identified a subset of LHP1-activated genes and demonstrated that LHP1 shapes local chromatin topology in order to control transcriptional co-regulation. Our work reveals a general role of LHP1 from local to higher conformation levels of chromatin configuration to determine its accessibility to define gene expression patterns.	[Veluchamy, Alaguraj; Mariappan, Kiruthiga Gayathri; Kim, Soon-Kap; Hirt, Heribert] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal 239556900, Saudi Arabia; [Jegu, Teddy; Ariel, Federico; Latrasse, David; Crespi, Martin; Bergounioux, Catherine; Raynaud, Cecile; Benhamed, Moussa] Univ Paris Saclay, Univ Paris Diderot, Univ Evry,Inst Plant Sci Paris Saclay IPS2, Univ Paris 11,Sorbonne Paris Cite,CNRS,INRA, Batiment 630, F-91405 Orsay, France	King Abdullah University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Benhamed, M (corresponding author), Univ Paris Saclay, Univ Paris Diderot, Univ Evry,Inst Plant Sci Paris Saclay IPS2, Univ Paris 11,Sorbonne Paris Cite,CNRS,INRA, Batiment 630, F-91405 Orsay, France.	moussa.benhamed@u-psud.fr	Ariel, Federico/AAU-6726-2020; Raynaud, Cécile/H-9711-2012; Crespi, Martin/AAB-1424-2020; Veluchamy, Alaguraj/AAW-1680-2020	Ariel, Federico/0000-0001-8478-8808; Raynaud, Cécile/0000-0002-5231-8120; Crespi, Martin/0000-0002-5698-9482; Veluchamy, Alaguraj/0000-0002-5349-5794; MARIAPPAN, Kiruthiga Gayathri/0000-0002-0831-8756; Benhamed, Moussa/0000-0002-4181-1702; Hirt, Heribert/0000-0003-3119-9633	LabExSaclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]	LabExSaclay Plant Sciences-SPS	TJ was Paris-Sud University PhD fellow. The IPS2 benefits from the support of the LabExSaclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).r TJ was Paris-Sud University PhD fellow. The IPS2 benefits from the support of the LabExSaclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).	Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Ariel F, 2015, TRENDS PLANT SCI, V20, P362, DOI 10.1016/j.tplants.2015.03.003; Ariel F, 2014, MOL CELL, V55, P383, DOI 10.1016/j.molcel.2014.06.011; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Berger N, 2011, PLANT CELL, V23, P4065, DOI 10.1105/tpc.111.087866; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bratzel F, 2012, MOL PLANT, V5, P260, DOI 10.1093/mp/ssr078; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Calonje M, 2008, PLANT CELL, V20, P277, DOI 10.1105/tpc.106.049957; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chen DH, 2010, CELL RES, V20, P1332, DOI 10.1038/cr.2010.151; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; del Olmo I, 2010, PLANT J, V61, P623, DOI 10.1111/j.1365-313X.2009.04093.x; Deleris A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003062; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Deng WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-593; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Derkacheva M, 2014, J EXP BOT, V65, P2769, DOI 10.1093/jxb/ert410; Derkacheva M, 2013, EMBO J, V32, P2073, DOI 10.1038/emboj.2013.145; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Feng SH, 2014, MOL CELL, V55, P694, DOI 10.1016/j.molcel.2014.07.008; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grob S, 2014, MOL CELL, V55, P678, DOI 10.1016/j.molcel.2014.07.009; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helliwell CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021513; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hyun Y, 2013, DEVELOPMENT, V140, P156, DOI 10.1242/dev.084624; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jegu T, 2014, PLANT CELL, V26, P538, DOI 10.1105/tpc.113.114454; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kim SY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002512; Kim SY, 2010, PLANT PHYSIOL, V152, P516, DOI 10.1104/pp.109.143495; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latrasse D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016592; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li H, 2011, MOL PLANT, V4, P748, DOI 10.1093/mp/ssr036; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Lodha M, 2013, GENE DEV, V27, P596, DOI 10.1101/gad.211425.112; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Makarevitch I, 2013, PLANT CELL, V25, P780, DOI 10.1105/tpc.112.106427; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mozgova I, 2015, ANNU REV PLANT BIOL, V66, P269, DOI 10.1146/annurev-arplant-043014-115627; Nakahigashi K, 2005, PLANT CELL PHYSIOL, V46, P1747, DOI 10.1093/pcp/pci195; Oh SY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000077; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rizzardi K, 2011, PLANT J, V65, P897, DOI 10.1111/j.1365-313X.2010.04470.x; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schoenfelder S, 2015, NAT GENET, V47, P1179, DOI 10.1038/ng.3393; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schwartz YB, 2014, CELL REP, V8, P321, DOI 10.1016/j.celrep.2014.07.001; Schwartz YB, 2013, NAT REV GENET, V14, P853, DOI 10.1038/nrg3603; Sequeira-Mendes J, 2014, PLANT CELL, V26, P2351, DOI 10.1105/tpc.114.124578; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Shen LS, 2014, DEVELOPMENT, V141, P1303, DOI 10.1242/dev.104513; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Terranova R, 2008, DEV CELL, V15, P668, DOI 10.1016/j.devcel.2008.08.015; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Wang YZ, 2014, DEV CELL, V28, P727, DOI 10.1016/j.devcel.2014.01.029; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Wingett Steven, 2015, F1000Res, V4, P1310, DOI 10.12688/f1000research.7334.1; Wolff P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002126; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yang C, 2013, CURR BIOL, V23, P1324, DOI 10.1016/j.cub.2013.05.050; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	94	74	76	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158936	10.1371/journal.pone.0158936	http://dx.doi.org/10.1371/journal.pone.0158936			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410265	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300043
J	Sayedyahossein, S; Li, ZG; Hedman, AC; Morgan, CJ; Sacks, DB				Sayedyahossein, Samar; Li, Zhigang; Hedman, Andrew C.; Morgan, Chase J.; Sacks, David B.			IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; Hippo pathway; protein complex; transcription factor; yes-associated protein (YAP); IQGAP1	HIPPO PATHWAY; HEPATOCELLULAR-CARCINOMA; NEURITE OUTGROWTH; GROWTH-CONTROL; BETA-CATENIN; IQ MOTIFS; TAZ; CALMODULIN; COMPLEX; CANCER	During development, the Hippo signaling pathway regulates key physiological processes, such as control of organ size, regeneration, and stem cell biology. Yes-associated protein (YAP) is a major transcriptional co-activator of the Hippo pathway. The scaffold protein IQGAP1 interacts with more than 100 binding partners to integrate diverse signaling pathways. In this study, we report that IQGAP1 binds to YAP and modulates its activity. IQGAP1 and YAP co-immunoprecipitated from cells. In vitro analysis with pure proteins demonstrated a direct interaction between IQGAP1 and YAP. Analysis with multiple fragments of each protein showed that the interaction occurs via the IQ domain of IQGAP1 and the TEAD-binding domain of YAP. The interaction between IQGAP1 and YAP has functional effects. Knock-out of endogenous IQGAP1 significantly increased the formation of nuclear YAP-TEAD complexes. Transcription assays were performed with IQGAP1-null mouse embryonic fibroblasts and HEK293 cells with IQGAP1 knockdown by CRISPR/Cas9. Quantification demonstrated that YAP-TEAD-mediated transcription in cells lacking IQGAP1 was significantly greater than in control cells. These data reveal that IQGAP1 binds to YAP and modulates its co-transcriptional function, suggesting that IQGAP1 participates in Hippo signaling.	[Sayedyahossein, Samar; Li, Zhigang; Hedman, Andrew C.; Morgan, Chase J.; Sacks, David B.] NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Sacks, DB (corresponding author), NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735; Sayedyahossein, Samar/0000-0003-1773-4740	National Institutes of Health Intramural Research Program; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brill S, 1996, MOL CELL BIOL, V16, P4869; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Goto T, 2013, J BIOL CHEM, V288, P36351, DOI 10.1074/jbc.M113.520528; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Johnson M, 2011, INT J BIOCHEM CELL B, V43, P65, DOI 10.1016/j.biocel.2010.09.014; Kim JH, 2013, ANTIOXID REDOX SIGN, V19, P89, DOI 10.1089/ars.2012.4586; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nishio M, 2012, J CLIN INVEST, V122, P4505, DOI 10.1172/JCI63735; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Sansores-Garcia L, 2013, CURR BIOL, V23, P229, DOI 10.1016/j.cub.2012.12.033; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Tan GS, 2015, ONCOTARGET, V6, P8676, DOI 10.18632/oncotarget.3254; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19261	19273		10.1074/jbc.M116.732529	http://dx.doi.org/10.1074/jbc.M116.732529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27440047	Green Published, hybrid			2022-12-26	WOS:000383242800008
J	MacDiarmid, CW; Taggart, J; Jeong, J; Kerdsomboon, K; Eide, DJ				MacDiarmid, Colin W.; Taggart, Janet; Jeong, Jeeyon; Kerdsomboon, Kittikhun; Eide, David J.			Activation of the Yeast UBI4 Polyubiquitin Gene by Zap1 Transcription Factor via an Intragenic Promoter Is Critical for Zinc-deficient Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; QUALITY-CONTROL; PHOSPHOLIPID-SYNTHESIS; UBIQUITIN LIGASE; PROTEASE COMPLEX; STRUCTURAL ZINC; GENOME-WIDE; EXPRESSION	Stability of many proteins requires zinc. Zinc deficiency disrupts their folding, and the ubiquitin-proteasome system may help manage this stress. In Saccharomyces cerevisiae, UBI4 encodes five tandem ubiquitin monomers and is essential for growth in zinc-deficient conditions. Although UBI4 is only one of four ubiquitin-encoding genes in the genome, a dramatic decrease in ubiquitin was observed in zinc-deficient ubi4 Delta cells. The three other ubiquitin genes were strongly repressed under these conditions, contributing to the decline in ubiquitin. In a screen for ubi4 Delta suppressors, a hypomorphic allele of the RPT2 proteasome regulatory subunit gene (rpt2(E301K)) suppressed the ubi4 Delta growth defect. The rpt2(E301K) mutation also increased ubiquitin accumulation in zinc-deficient cells, and by using a ubiquitin-independent proteasome substrate we found that proteasome activity was reduced. These results suggested that increased ubiquitin supply in suppressed ubi4 Delta cells was a consequence of more efficient ubiquitin release and recycling during proteasome degradation. Degradation of a ubiquitin-de pendent substrate was restored by the rpt2(E301K) mutation, indicating that ubiquitination is rate-limiting in this process. The UBI4 gene was induced similar to 5-fold in low zinc and is regulated by the zinc-responsive Zap 1 transcription factor. Surprisingly, Zap1 controls UBI4 by inducing transcription from an intragenic promoter, and the resulting truncated mRNA encodes only two of the five ubiquitin repeats. Expression of a short transcript alone complemented the ubi4 Delta mutation, indicating that it is efficiently translated. Loss of Zap1-dependent UBI4 expression caused a growth defect in zinc-deficient conditions. Thus, the intragenic UBI4 promoter is critical to preventing ubiquitin deficiency in zinc-deficient cells.	[MacDiarmid, Colin W.; Taggart, Janet; Kerdsomboon, Kittikhun; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [Jeong, Jeeyon] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	University of Wisconsin System; University of Wisconsin Madison; Amherst College	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eide@nutrisci.wisc.edu	MacDiarmid, Colin/AAV-5920-2021; Jeong, Jeeyon/U-9617-2019	Jeong, Jeeyon/0000-0002-5826-2682; MacDiarmid, Colin/0000-0001-8578-5756	National Institutes of Health [GM056285]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM056285. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Arribere JA, 2013, GENOME RES, V23, P977, DOI 10.1101/gr.150342.112; Bagola K, 2008, CURR BIOL, V18, pR1019, DOI 10.1016/j.cub.2008.09.036; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bilsland E, 2007, DNA REPAIR, V6, P1471, DOI 10.1016/j.dnarep.2007.04.010; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Birkeland SR, 2010, GENETICS, V186, P1127, DOI 10.1534/genetics.110.123232; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; ENGELS WR, 1993, TRENDS BIOCHEM SCI, V18, P448, DOI 10.1016/0968-0004(93)90148-G; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Frey AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022535; Frey AG, 2011, J BIOL CHEM, V286, P6844, DOI 10.1074/jbc.M110.203927; Gammie AE, 1999, MOL CELL BIOL, V19, P817; GANZHORN AJ, 1988, J BIOL CHEM, V263, P5446; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gauci VJ, 2009, FEMS YEAST RES, V9, P1187, DOI 10.1111/j.1567-1364.2009.00557.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; Isasa M, 2015, J PROTEOME RES, V14, P5306, DOI 10.1021/acs.jproteome.5b00802; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; JELOKOVA J, 1994, EUR J BIOCHEM, V225, P1015, DOI 10.1111/j.1432-1033.1994.1015b.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kato H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02186; Lee YJ, 2013, MOL CELL, V51, P105, DOI 10.1016/j.molcel.2013.05.005; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2013, J BIOL CHEM, V288, P31313, DOI 10.1074/jbc.M113.512384; MAGONET E, 1992, BIOCHEM J, V287, P361, DOI 10.1042/bj2870361; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Nostramo R, 2016, MOL CELL BIOL, V36, P173, DOI 10.1128/MCB.00609-15; O'Donnell AF, 2012, MOL CELL BIOL, V32, P4506, DOI 10.1128/MCB.01176-12; Olivarius S, 2009, BIOTECHNIQUES, V46, P130, DOI 10.2144/000113066; Ossareh-Nazari B, 2014, J CELL BIOL, V204, P909, DOI 10.1083/jcb.201308139; Poulsen JW, 2012, J PROTEOMICS, V75, P3886, DOI 10.1016/j.jprot.2012.04.055; RIVETT AJ, 1995, MOL BIOL REP, V21, P35, DOI 10.1007/BF00990968; SCHNALL R, 1994, YEAST, V10, P1141, DOI 10.1002/yea.320100903; Simon JR, 1999, MOL MICROBIOL, V31, P823, DOI 10.1046/j.1365-2958.1999.01220.x; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Winston F., 2008, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB1303BS82; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; WU M, 1987, J BIOL CHEM, V262, P12275; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	66	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18880	18896		10.1074/jbc.M116.743120	http://dx.doi.org/10.1074/jbc.M116.743120			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27432887	Green Published, hybrid			2022-12-26	WOS:000383242300026
J	Calderon-Dominguez, M; Sebastian, D; Fucho, R; Weber, M; Mir, JF; Garcia-Casarrubios, E; Obregon, MJ; Zorzano, A; Valverde, AM; Serra, D; Herrero, L				Calderon-Dominguez, Maria; Sebastian, David; Fucho, Raquel; Weber, Minela; Mir, Joan F.; Garcia-Casarrubios, Ester; Jesus Obregon, Maria; Zorzano, Antonio; Valverde, Angela M.; Serra, Dolors; Herrero, Laura			Carnitine Palmitoyltransferase 1 Increases Lipolysis, UCP1 Protein Expression and Mitochondrial Activity in Brown Adipocytes	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ADIPOSE-TISSUE ACTIVITY; UNCOUPLING PROTEIN-1; INSULIN SENSITIVITY; GENE-EXPRESSION; BETA-OXIDATION; MUSCLE-CELLS; MALONYL-COA; CPT-I; METABOLISM	The discovery of active brown adipose tissue (BAT) in adult humans and the fact that it is reduced in obese and diabetic patients have put a spotlight on this tissue as a key player in obesity-induced metabolic disorders. BAT regulates energy expenditure through thermogenesis; therefore, harnessing its thermogenic fat-burning power is an attractive therapeutic approach. We aimed to enhance BAT thermogenesis by increasing its fatty acid oxidation (FAO) rate. Thus, we expressed carnitine palmitoyltransferase 1AM (CPT1AM), a permanently active mutant form of CPT1A (the rate-limiting enzyme in FAO), in a rat brown adipocyte (rBA) cell line through adenoviral infection. We found that CPT1AM-expressing rBA have increased FAO, lipolysis, UCP1 protein levels and mitochondrial activity. Additionally, enhanced FAO reduced the palmitate-induced increase in triglyceride content and the expression of obese and inflammatory markers. Thus, CPT1AM-expressing rBA had enhanced fat-burning capacity and improved lipid-induced derangements. This indicates that CPT1AM-mediated increase in brown adipocytes FAO may be a new approach to the treatment of obesity-induced disorders.	[Calderon-Dominguez, Maria; Fucho, Raquel; Weber, Minela; Mir, Joan F.; Serra, Dolors; Herrero, Laura] Univ Barcelona, IBUB, Dept Biochem & Physiol, E-08028 Barcelona, Spain; [Calderon-Dominguez, Maria; Fucho, Raquel; Weber, Minela; Mir, Joan F.; Serra, Dolors; Herrero, Laura] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, E-28029 Madrid, Spain; [Sebastian, David; Zorzano, Antonio] Univ Barcelona, Inst Res Biomed IRB Barcelona, Fac Biol, E-08028 Barcelona, Spain; [Sebastian, David; Zorzano, Antonio] Univ Barcelona, Dept Bioquim & Biol Mol, Fac Biol, E-08028 Barcelona, Spain; [Sebastian, David; Zorzano, Antonio; Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, E-28029 Madrid, Spain; [Garcia-Casarrubios, Ester; Jesus Obregon, Maria; Valverde, Angela M.] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Garcia-Casarrubios, Ester; Jesus Obregon, Maria; Valverde, Angela M.] Inst Invest Sanitaria La Paz, Madrid 28029, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Herrero, L (corresponding author), Univ Barcelona, IBUB, Dept Biochem & Physiol, E-08028 Barcelona, Spain.; Herrero, L (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, E-28029 Madrid, Spain.	lherrero@ub.edu	Calderon-Dominguez, Maria/AAU-3721-2020; Sebastián, David/ABH-1574-2020; Serra, Dolors/L-3657-2014; Blattes, Minéia Weber/N-4805-2018; Herrero, Laura/D-4011-2014; Zorzano, Antonio/R-5479-2018	Calderon-Dominguez, Maria/0000-0003-1797-3450; Serra, Dolors/0000-0002-4936-4206; Blattes, Minéia Weber/0000-0001-5496-3679; Herrero, Laura/0000-0003-4244-4673; Mir, Joan Francesc/0000-0001-8501-0969; Sebastian, David/0000-0002-7260-3869; Martinez Valverde, Angela/0000-0003-1192-9045	Ministry of Spain - MINECO (Fondos Europeos de Desarrollo Regional de la Union Europea [FEDER]) [SAF2012-32491, SAF2013-40987R]; Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) [CB06/03/0001]; Centro de Investigacion Biomedica en red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Generalitat de Catalunya [2014SGR465, 2014SGR48]; Comunidad de Madrid [S2010/BMD-2423]; INTERREG IV-B-SUDOE-FEDER (DIOMED) [SOE1/P1/E178]; European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star research fellowship; ICREA-Academia (Generalitat de Catalunya); Ciencia sem Fronteiras-CNPq fellowship [237976/2012-9]; European Foundation for the Study of Diabetes (EFSD)/L'Oreal-UNESCO "For Women in Science" research fellowship; Ministry of Spain - MINECO [SAF2013-45887-R, SAF2014-52223-C2-1-R, SAF-2015-65267-R]	Ministry of Spain - MINECO (Fondos Europeos de Desarrollo Regional de la Union Europea [FEDER]); Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Centro de Investigacion Biomedica en red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM); Generalitat de Catalunya(Generalitat de Catalunya); Comunidad de Madrid(Comunidad de Madrid); INTERREG IV-B-SUDOE-FEDER (DIOMED); European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star research fellowship; ICREA-Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); Ciencia sem Fronteiras-CNPq fellowship; European Foundation for the Study of Diabetes (EFSD)/L'Oreal-UNESCO "For Women in Science" research fellowship(L'Oreal Group); Ministry of Spain - MINECO	This work was supported by the Ministry of Spain - MINECO (SAF2013-45887-R to LH, SAF2014-52223-C2-1-R to DS and SAF-2015-65267-R to AMV that were cofunded by the Fondos Europeos de Desarrollo Regional de la Union Europea [FEDER], SAF2012-32491 to MJO, SAF2013-40987R to AZ, and a doctoral fellowship to JFM), the Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) (Grant CB06/03/0001 to DS), the Centro de Investigacion Biomedica en red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), the Generalitat de Catalunya (2014SGR465 to DS, and 2014SGR48 to AZ), the Comunidad de Madrid (S2010/BMD-2423 to MJO and AMV), INTERREG IV-B-SUDOE-FEDER (DIOMED, SOE1/P1/E178) to AZ, and the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L'Oreal-UNESCO "For Women in Science" research fellowships to LH. AZ is a recipient of ICREA-Academia (Generalitat de Catalunya) and MW is a recipient of the Ciencia sem Fronteiras-CNPq fellowship (237976/2012-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Brown NF, 1997, BIOCHEM J, V327, P225, DOI 10.1042/bj3270225; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Calderon-Dominguez M, 2016, ADIPOCYTE, V5, P98, DOI 10.1080/21623945.2015.1122857; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Chondronikola M, 2016, CELL METAB, V23, P1200, DOI 10.1016/j.cmet.2016.04.029; Chondronikola M, 2014, DIABETES, V63, P4089, DOI 10.2337/db14-0746; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Divakaruni AS, 2012, J BIOL CHEM, V287, P36845, DOI 10.1074/jbc.M112.381780; Doh KO, 2005, LIFE SCI, V77, P435, DOI 10.1016/j.lfs.2004.11.032; Festuccia William T, 2011, Front Endocrinol (Lausanne), V2, P84, DOI 10.3389/fendo.2011.00084; Festuccia WT, 2009, AM J PHYSIOL-REG I, V296, pR1327, DOI 10.1152/ajpregu.91012.2008; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Heppner KM, 2015, DIABETOLOGIA, V58, P2124, DOI 10.1007/s00125-015-3651-3; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Queipo-Ortuno MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048605; JAMAL Z, 1988, BIOCHEM J, V252, P293, DOI 10.1042/bj2520293; Ji S, 2008, MOL GENET METAB, V93, P314, DOI 10.1016/j.ymgme.2007.10.006; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; Li YG, 2014, EMBO REP, V15, P1069, DOI 10.15252/embr.201438775; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; LORENZO M, 1993, J CELL BIOL, V123, P1567, DOI 10.1083/jcb.123.6.1567; Malandrino MI, 2015, AM J PHYSIOL-ENDOC M, V308, pE756, DOI 10.1152/ajpendo.00362.2014; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; Mera P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097195; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Orellana-Gavalda JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P773, DOI 10.1016/j.bbabio.2010.04.007; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Smith R., 1961, PHYSIOLOGIST, V4, P113; Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Townsend KL, 2014, TRENDS ENDOCRIN MET, V25, P168, DOI 10.1016/j.tem.2013.12.004; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; World Health Organization, 2018, OB OV FACT SHEET 311; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zhang Y, 2015, BIOMED ENVIRON SCI, V28, P97, DOI 10.3967/bes2015.012; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	57	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159399	10.1371/journal.pone.0159399	http://dx.doi.org/10.1371/journal.pone.0159399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438137	Green Published, gold			2022-12-26	WOS:000380170100041
J	Moncla, BJ; Chappell, CA; Debo, BM; Meyn, LA				Moncla, Bernard J.; Chappell, Catherine A.; Debo, Brian M.; Meyn, Leslie A.			The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid	PLOS ONE			English	Article							RAPID PRESUMPTIVE IDENTIFICATION; BETA-N-ACETYLGLUCOSAMINIDASE; BINDING LECTIN MBL; LOW-BIRTH-WEIGHT; BACTERIAL VAGINOSIS; SIALIC-ACID; INFLAMMATORY CYTOKINES; GARDNERELLA-VAGINALIS; MUCIN EXPRESSION; CELL-SURFACE	In this study, we characterized the glycome of cervical-vaginal fluid, collected with a Catamenial cup. We quantified: glycosidase levels; sialic acid and high mannose specific lectin binding; mucins, MUC1, MUC4, MUC5AC, MUC7; and albumin in the samples collected. These data were analyzed in the context of hormonal status (day of menstrual cycle, hormonal contraception use) and role, if any, of the type of the vaginal microflora present. When the Nugent score was used to stratify the subjects by microflora as normal, intermediate, or bacterial vaginosis, several important differences were observed. The activities of four of six glycosidases in the samples from women with bacterial vaginosis were significantly increased when compared to normal or intermediate women: sialidase, P = < 0.001; alpha-galactosidase, P = 0.006; beta-galactosidase, P = 0.005; alpha-glucosidase, P = 0.056. Sialic acid binding sites as measured by two lectins, Maackia amurensis and Sambucus nigra binding, were significantly lower in women with BV compared to women with normal and intermediate scores (P = < 0.0001 and 0.008 respectively). High mannose binding sites, a measure of innate immunity were also significantly lower in women with BV (P = < 0.001). Additionally, we observed significant increases in MUC1, MUC4, MUC5AC, and MUC7 concentrations in women with BV (P = < 0.001, 0.001, < 0.001, 0.02 respectively). Among normal women we found that the membrane bound mucin MUC4 and the secreted MUC5AC were decreased in postmenopausal women (P = 0.02 and 0.07 respectively), while MUC7 (secreted) was decreased in women using levonorgestrel-containing IUDs (P = 0.02). The number of sialic acid binding sites was lower in the postmenopausal group (P = 0.04), but the number of high mannose binding sites, measured with Griffithsin, was not significantly different among the 6 hormonal groups. The glycosidase levels in the cervical-vaginal mucus were rather low in the groups, with exception of alpha-glucosidase activity that was much lower in the postmenopausal group (P<0.001). These studies present compelling evidence that the vaginal ecosystem responds to the presence of different vaginal microorganisms. These effects were so influential that it required us to remove subjects with BV for data interpretation of the impact of hormones. We also suggest that certain changes occurring in vaginal/cervical proteins are due to bacteria or their products. Therefore, the quantitation of vaginal mucins and lectin binding offers a new method to monitor bacteria-host interactions in the female reproductive tract. The data suggest that some of the changes in these components are the result of host processing, such as the increases in mucin content, while the microflora is responsible for the increases in glycosidases and the decreases in lectin binding. The methods should be considered a valid marker for insult to the female genital tract.	[Moncla, Bernard J.; Chappell, Catherine A.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Moncla, Bernard J.; Chappell, Catherine A.; Meyn, Leslie A.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA; [Debo, Brian M.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Pennsylvania	Moncla, BJ (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.; Moncla, BJ (corresponding author), Magee Womens Res Inst, Pittsburgh, PA 15213 USA.	bjm4@pitt.edu			National Institutes of Health [U19AI082639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U19AI082639 @NIH.gov.	Albertsmeyer AC, 2010, EXP EYE RES, V90, P444, DOI 10.1016/j.exer.2009.12.009; Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Aplin JD, 1996, AM J REPROD IMMUNOL, V35, P261; Aplin JD, 1999, HUM REPROD, V14, P17, DOI 10.1093/humrep/14.suppl_2.17; Appelmelk BJ, 2000, TRENDS MICROBIOL, V8, P565, DOI 10.1016/S0966-842X(00)01875-8; Birse KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079505; Biswas N, 2014, ANTIMICROB AGENTS CH, V58, P6444, DOI 10.1128/AAC.03270-14; BRAHAM PH, 1992, J CLIN MICROBIOL, V30, P649, DOI 10.1128/JCM.30.3.649-654.1992; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carraway KL, 2001, BIOCHEM SOC T, V29, P162, DOI 10.1042/BST0290162; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2002, J CLIN MICROBIOL, V40, P2147, DOI 10.1128/JCM.40.6.2147-2152.2002; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Chappell CA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.045; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Corti S, 2010, BRAIN, V133, P465, DOI 10.1093/brain/awp318; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Dohrman A, 1998, BBA-MOL BASIS DIS, V1406, P251, DOI 10.1016/S0925-4439(98)00010-6; Escande F, 2001, BIOCHEM J, V358, P763, DOI 10.1042/0264-6021:3580763; Fields S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110980; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Gallego MP, 2006, COLLOID SURFACE B, V52, P154, DOI 10.1016/j.colsurfb.2006.04.013; Gipson IK, 1997, BIOL REPROD, V56, P999, DOI 10.1095/biolreprod56.4.999; Gipson IK, 1999, BIOL REPROD, V60, P58, DOI 10.1095/biolreprod60.1.58; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Gipson IK, 2001, J CLIN ENDOCR METAB, V86, P594, DOI 10.1210/jc.86.2.594; Gipson IK, 2008, BIOL REPROD, V78, P134, DOI 10.1095/biolreprod.106.058347; Hagen KT, 2014, GLYCOSCIENCE BIOL ME, P1; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HOMER KA, 1994, J MED MICROBIOL, V41, P184, DOI 10.1099/00222615-41-3-184; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Imseis HM, 1997, J SOC GYNECOL INVEST, V4, P90, DOI 10.1016/S1071-5576(97)00003-8; Jacobson JC, 2014, CONTRACEPTION, V90, P130, DOI 10.1016/j.contraception.2014.04.006; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; JONES AH, 1986, J GEN MICROBIOL, V132, P3381; Keller MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P194, DOI 10.1097/QAI.0b013e31826867ae; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Klebanoff MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/j.ajog.2004.07.017; Lehman DA, 2014, JAIDS-J ACQ IMM DEF, V66, P135, DOI 10.1097/QAI.0000000000000104; Leite B, 1989, MICROBIAL ECOLOGY IN, V2, P255, DOI [10.3109/08910608909140228, DOI 10.3109/08910608909140228]; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Li X, 2003, J DENT RES, V82, P883, DOI 10.1177/154405910308201107; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; MONCLA B J, 1986, Microbios Letters, V32, P81; Moncla BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127091; Moncla BJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-78; MONCLA BJ, 1991, J CLIN MICROBIOL, V29, P1955, DOI 10.1128/JCM.29.9.1955-1958.1991; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Moncla LH, 2016, CELL HOST MICROBE, V19, P169, DOI 10.1016/j.chom.2016.01.011; Mueller Y, 2014, THE JOURNAL OF IMMUN, V192, P185; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Pang SS, 2014, J BIOL CHEM, V289, P6332, DOI 10.1074/jbc.M113.513135; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Petricevic L, 2013, CLIMACTERIC, V16, P356, DOI 10.3109/13697137.2012.725788; Radtke AL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103366; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Roberton AM, 1999, MEDICAL IMPORTANCE OF THE NORMAL MICROFLORA, P222; Roberts G, 2001, J MED MICROBIOL, V50, P620, DOI 10.1099/0022-1317-50-7-620; Roberts G, 2000, J BACTERIOL, V182, P882, DOI 10.1128/JB.182.4.882-890.2000; Rossi EA, 1996, J BIOL CHEM, V271, P33476, DOI 10.1074/jbc.271.52.33476; Rousseau K, 2006, ANN HUM GENET, V70, P417, DOI 10.1111/j.1469-1809.2006.00250.x; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Smirnova MG, 2003, CELL IMMUNOL, V221, P42, DOI 10.1016/S0008-8749(03)00059-5; Strober W, 1982, RECENT ADV MUCOSAL I; Stute P, 2014, MENOPAUSE, V21, P1; Tvaroska I, 2008, GLYCOSCIENCE, DOI [10.1007/978-3-540-30429-6, DOI 10.1007/978-3-540-30429-6]; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Vogel I, 2003, INT J GYNECOL OBSTET, V83, P307, DOI 10.1016/S0020-7292(03)00268-6; Wang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127021; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Yanagihara K, 2001, AM J RESP CELL MOL, V24, P66, DOI 10.1165/ajrcmb.24.1.4122; Yudin MH, 2003, OBSTET GYNECOL, V102, P527, DOI 10.1016/S0029-7844(03)00566-0; YUREWICZ EC, 1982, J BIOL CHEM, V257, P2314; Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9	97	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158687	10.1371/journal.pone.0158687	http://dx.doi.org/10.1371/journal.pone.0158687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437931	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100016
J	Rogers, SL; Fay, N				Rogers, Shane L.; Fay, Nicolas			Stick or Switch: A Selection Heuristic Predicts when People Take the Perspective of Others or Communicate Egocentrically	PLOS ONE			English	Article							AUDIENCE; OVERESTIMATION; COMPREHENSION	This paper examines a cognitive mechanism that drives perspective-taking and egocentrism in interpersonal communication. Using a conceptual referential communication task, in which participants describe a range of abstract geometric shapes, Experiment 1 shows that perspective-taking and egocentric communication are frequent communication strategies. Experiment 2 tests a selection heuristic account of perspective-taking and egocentric communication. It uses participants' shape description ratings to predict their communication strategy. Participants' communication strategy was predicted by how informative they perceived the different shape descriptions to be. When participants' personal shape description was perceived to be more informative than their addressee's shape description, there was a strong bias to communicate egocentrically. By contrast, when their addressee's shape description was perceived to be more informative, there was a strong bias to take their addressee's perspective. When the shape descriptions were perceived to be equally informative, there was a moderate bias to communicate egocentrically. This simple, but powerful, selection heuristic may be critical to the cumulative cultural evolution of human communication systems, and cumulative cultural evolution more generally.	[Rogers, Shane L.] Edith Cowan Univ, Sch Psychol & Social Sci, Perth, WA, Australia; [Fay, Nicolas] Univ Western Australia, Sch Psychol, Perth, WA, Australia	Edith Cowan University; University of Western Australia	Fay, N (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA, Australia.	nicolas.fay@gmail.com	Rogers, Shane L./I-8562-2019	Rogers, Shane L./0000-0002-6869-3400; Fay, Nicolas/0000-0001-9866-2800	Australian Research Council (ARC) Discovery Project [DP120104237]; ARC Discovery grant [DP120104237]	Australian Research Council (ARC) Discovery Project(Australian Research Council); ARC Discovery grant(Australian Research Council)	This work was supported by the Australian Research Council (ARC) Discovery Project awarded to NF (DP120104237); http://www.arc.gov.au/discovery-projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Simon Garrod and Monica Tamariz for comments on an earlier draft of the manuscript, and Dale Barr and Christophe Scheepers for statistical advice. We also thank Rachel Kendal, Christine Cuskley and an anonymous reviewer for their helpful feedback on an earlier version of this paper. N.F. acknowledges support by an ARC Discovery grant (no. DP120104237).	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BELL A, 1984, LANG SOC, V13, P145, DOI 10.1017/S004740450001037X; Branigan HP, 2011, COGNITION, V121, P41, DOI 10.1016/j.cognition.2011.05.011; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Brennan SE, 2009, TOP COGN SCI, V1, P274, DOI 10.1111/j.1756-8765.2009.01019.x; Clark H.H., 1996, USING LANGUAGE; Clark HH., 1982, LANGUAGE COMPREHENSI, V9, P287, DOI [DOI 10.1016/S0166-4115(09)60059-5, 10.1016/S0166-4115(09)60059-5]; Fay N, 2008, PHILOS T R SOC B, V363, P3553, DOI 10.1098/rstb.2008.0130; Fay N, 2014, PRAGMAT COGN, V22, P244, DOI 10.1075/pc.22.2.05fay; Fay N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071781; Fay N, 2010, J EXP SOC PSYCHOL, V46, P689, DOI 10.1016/j.jesp.2010.02.012; Fay N, 2010, COGNITIVE SCI, V34, P351, DOI 10.1111/j.1551-6709.2009.01090.x; Fay N, 2008, PSYCHON B REV, V15, P1160, DOI 10.3758/PBR.15.6.1160; FUSSELL SR, 1989, J EXP SOC PSYCHOL, V25, P203, DOI 10.1016/0022-1031(89)90019-X; Garrod S, 2007, COGNITIVE SCI, V31, P961, DOI 10.1080/03640210701703659; Garrod S, 2010, INTERACT STUD, V11, P33, DOI 10.1075/is.11.1.04gar; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Horton WS, 2005, COGNITION, V96, P127, DOI 10.1016/j.cognition.2004.07.001; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keysar B, 2002, PSYCHOL SCI, V13, P207, DOI 10.1111/1467-9280.00439; Kronmuller E, 2015, J MEM LANG, V83, P1, DOI 10.1016/j.jml.2015.03.008; Levelt W., 1989, SPEAKING INTENTION A; Nuckles M, 2005, J EXP PSYCHOL-APPL, V11, P219, DOI 10.1037/1076-898X.11.4.219; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057211; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schlag KH, 1999, J MATH ECON, V31, P493, DOI 10.1016/S0304-4068(97)00068-2; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SCHOBER MF, 1989, COGNITIVE PSYCHOL, V21, P211, DOI 10.1016/0010-0285(89)90008-X; SCHOBER MF, 1993, COGNITION, V47, P1, DOI 10.1016/0010-0277(93)90060-9; Shintel H, 2009, TOP COGN SCI, V1, P260, DOI 10.1111/j.1756-8765.2009.01018.x; Tamariz M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0488; Tomasello Michael, 1999, CULTURAL ORIGINS HUM	36	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159570	10.1371/journal.pone.0159570	http://dx.doi.org/10.1371/journal.pone.0159570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437694	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100055
J	Perez-Perez, A; Saanchez-Jimeenez, F; Vilarinno-Garciia, T; de la Cruz, L; Virizuela, JA; Saanchez-Margalet, V				Perez-Perez, Antonio; Sanchez-Jimenez, Flora; Vilarino-Garcia, Teresa; de la Cruz, Luis; Virizuela, Juan A.; Sanchez-Margalet, Victor			Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; BLOOD MONONUCLEAR-CELLS; MAMMARY TUMORIGENESIS; SH3 DOMAINS; RECEPTOR; EXPRESSION; MECHANISMS; PATHWAYS; OBESITY; GROWTH	Obesity is a well-known risk factor for breast cancer development in postmenopausal women. High insulin and leptin levels seem to have a role modulating the growth of these tumours. Sam68 is an RNA-binding protein with signalling functions that has been found to be overexpressed in breast cancer. Moreover, Sam68 may be recruited to insulin and leptin signalling pathways, mediating its effects on survival, growth and proliferation in different cellular types. We aimed to study the expression of Sam68 and its phosphorylation level upon insulin and leptin stimulation, and the role of Sam68 in the proliferative effect and signalling pathways that are activated by insulin or leptin in human breast adenocarcinoma cells. In the human breast adenocarcinoma cell lines MCF7, MDA-MB-231 and BT-474, Sam68 protein quantity and gene expression were increased upon leptin or insulin stimulation, as it was checked by qPCR and immunoblot. Moreover, both insulin and leptin stimulation promoted an increase in Sam68 tyrosine phosphorylation and negatively regulated its RNA binding capacity. siRNA was used to downregulate Sam68 expression, which resulted in lower proliferative effects of both insulin and leptin, as well as a lower activation of MAPK and PI3K pathways promoted by both hormones. These effects may be partly explained by the decrease in IRS-1 expression by down-regulation of Sam68. These results suggest the participation of Sam68 in both leptin and insulin receptor signaling in human breast cancer cells, mediating the trophic effects of these hormones in proliferation and cellular growth.	[Perez-Perez, Antonio; Sanchez-Jimenez, Flora; Vilarino-Garcia, Teresa; Sanchez-Margalet, Victor] Univ Seville, Virgen Macarena Univ Hosp, UGC Clin Biochem, Dept Med Biochem & Mol Biol & Immunol, Seville, Spain; [de la Cruz, Luis; Virizuela, Juan A.] Virgen Macarena Univ Hosp, UGC Clin Oncol, Seville, Spain	Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena	Saanchez-Margalet, V (corresponding author), Univ Seville, Virgen Macarena Univ Hosp, UGC Clin Biochem, Dept Med Biochem & Mol Biol & Immunol, Seville, Spain.	margalet@us.es	Pérez -Perez, Antonio/GRF-5099-2022; de la Cruz-Merino, Luis/K-8633-2017; Sánchez-Margalet, Victor/AAB-9986-2021; Vilariño, Teresa/AAT-3552-2021	Pérez -Perez, Antonio/0000-0002-5660-735X; de la Cruz-Merino, Luis/0000-0002-5333-0535; Sánchez-Margalet, Victor/0000-0001-8638-8680; 	Real Maestranza de Caballeria de Sevilla; Real Maestranza de Caballeria de Sevilla, Spain	Real Maestranza de Caballeria de Sevilla; Real Maestranza de Caballeria de Sevilla, Spain	The manuscript has been funded by the Real Maestranza de Caballeria de Sevilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Real Maestranza de Caballeria de Sevilla, Spain.	Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Babic I, 2006, ONCOGENE, V25, P4955, DOI 10.1038/sj.onc.1209504; Babic I, 2004, ONCOGENE, V23, P3781, DOI 10.1038/sj.onc.1207484; Barlat I, 1997, J BIOL CHEM, V272, P3129, DOI 10.1074/jbc.272.6.3129; Bielli P, 2011, ENDOCR-RELAT CANCER, V18, pR91, DOI 10.1530/ERC-11-0041; Busa R, 2007, ONCOGENE, V26, P4372, DOI 10.1038/sj.onc.1210224; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chawla G, 2009, MOL CELL BIOL, V29, P201, DOI 10.1128/MCB.01349-08; Chen H, 2012, J BUON, V17, P658; Chen TP, 1997, MOL CELL BIOL, V17, P5707, DOI 10.1128/MCB.17.10.5707; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Dieudonne MN, 2002, BIOCHEM BIOPH RES CO, V293, P622, DOI 10.1016/S0006-291X(02)00205-X; Elliott DJ, 2010, J PATHOL, V222, P223, DOI 10.1002/path.2753; Frasca Francesco, 2003, Breast Dis, V17, P73; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; GROSS GE, 1984, CANCER RES, V44, P3570; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Kunkel GT, 2011, MOL CELL, V43, P157, DOI 10.1016/j.molcel.2011.07.004; Li QH, 2002, FEBS LETT, V525, P145, DOI 10.1016/S0014-5793(02)03103-4; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Locatelli A, 2012, HORM CANCER-US, V3, P14, DOI 10.1007/s12672-011-0097-z; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Najib S, 2005, CELL MOL LIFE SCI, V62, P36, DOI 10.1007/s00018-004-4309-3; Najib S, 2002, CELL IMMUNOL, V220, P143, DOI 10.1016/S0008-8749(03)00027-3; Najib S, 2002, J CELL BIOCHEM, V86, P99, DOI 10.1002/jcb.10198; Newman G, 2014, MOL CELL ENDOCRINOL, V382, P570, DOI 10.1016/j.mce.2013.03.025; Nolan MK, 1997, INT J CANCER, V72, P828, DOI 10.1002/(SICI)1097-0215(19970904)72:5<828::AID-IJC20>3.0.CO;2-3; Palacios C, 2010, CANCER LETT, V287, P207, DOI 10.1016/j.canlet.2009.06.012; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Paronetto MP, 2009, J CELL BIOL, V185, P235, DOI 10.1083/jcb.200811138; Quintana-Portillo R, 2012, BIOCHEM PHARMACOL, V83, P78, DOI 10.1016/j.bcp.2011.09.030; Revillion F, 2006, CLIN CANCER RES, V12, P2088, DOI 10.1158/1078-0432.CCR-05-1904; Richard S, 2008, ONCOGENE, V27, P548, DOI 10.1038/sj.onc.1210652; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Rose DP, 2002, INT J ONCOL, V21, P1285; Sanchez-Jimenez F, 2011, HUM REPROD, V26, P2306, DOI 10.1093/humrep/der187; Sanchez-Jimenez F, 2013, INT J MOL SCI, V14, P23402, DOI 10.3390/ijms141223402; Sanchez-Jimenez F, 2011, MOL CELL ENDOCRINOL, V332, P221, DOI 10.1016/j.mce.2010.10.014; Sanchez-Margalet V, 1999, FEBS LETT, V455, P307, DOI 10.1016/S0014-5793(99)00887-X; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sanchez-Margalet V, 2003, CELL MOL LIFE SCI, V60, P751, DOI 10.1007/s00018-003-2342-2; Sanchez-Margalet V, 2001, CELL IMMUNOL, V211, P30, DOI 10.1006/cimm.2001.1815; Sanchez-Margalet V, 2001, MOL CELL ENDOCRINOL, V183, P113, DOI 10.1016/S0303-7207(01)00587-1; Sette C, 2010, J ANDROL, V31, P66, DOI 10.2164/jandrol.109.008136; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song LB, 2010, J PATHOL, V222, P227, DOI 10.1002/path.2751; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Sulkowska M, 2006, PATHOL ONCOL RES, V12, P69, DOI 10.1007/BF02893446; Szanto I, 2000, P NATL ACAD SCI USA, V97, P2355, DOI 10.1073/pnas.050580497; Tanizawa Y, 1997, ENDOCRINOLOGY, V138, P4513, DOI 10.1210/en.138.10.4513; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Vigneri R, 1992, Cancer Treat Res, V63, P193; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WANG LL, 1995, J BIOL CHEM, V270, P2010, DOI 10.1074/jbc.270.5.2010	66	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158218	10.1371/journal.pone.0158218	http://dx.doi.org/10.1371/journal.pone.0158218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415018	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500019
J	Xu, B; O'Donnell, M; O'Donnell, J; Yu, JC; Zhang, YX; Sartor, MA; Koenig, RJ				Xu, Bin; O'Donnell, Michael; O'Donnell, Jeffrey; Yu, Jingcheng; Zhang, Yanxiao; Sartor, Maureen A.; Koenig, Ronald J.			Adipogenic Differentiation of Thyroid Cancer Cells Through the Pax8-PPAR Fusion Protein Is Regulated by Thyroid Transcription Factor 1 (TTF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; differentiation; fusion protein; gene expression; thyroid	GENE-EXPRESSION; LUNG ADENOCARCINOMA; FACTOR PAX8; PPAR-GAMMA; CARCINOMA; PROGRESSION; ONCOGENE; SURVIVAL; ENHANCER	A subset of thyroid carcinomas contains a t(2;3)(q13;p25) chromosomal translocation that fuses paired box gene 8 (PAX8) with the peroxisome proliferator-activated receptor gene (PPARG), resulting in expression of a PAX8-PPAR fusion protein, PPFP. We previously generated a transgenic mouse model of PPFP thyroid carcinoma and showed that feeding the PPAR agonist pioglitazone greatly decreased the size of the primary tumor and prevented metastatic disease in vivo. The antitumor effect correlates with the fact that pioglitazone turns PPFP into a strongly PPAR-like molecule, resulting in trans-differentiation of the thyroid cancer cells into adipocyte-like cells that lose malignant character as they become more differentiated. To further study this process, we performed cell culture experiments with thyrocytes from the PPFP mouse thyroid cancers. Our data show that pioglitazone induced cellular lipid accumulation and the expression of adipocyte marker genes in the cultured cells, and shRNA knockdown of PPFP eliminated this pioglitazone effect. In addition, we found that PPFP and thyroid transcription factor 1 (TTF-1) physically interact, and that these transcription factors bind near each other on numerous target genes. TTF-1 knockdown and overexpression studies showed that TTF-1 inhibits PPFP target gene expression and impairs adipogenic trans-differentiation. Surprisingly, pioglitazone repressed TTF-1 expression in PPFP-expressing thyrocytes. Our data indicate that TTF-1 interacts with PPFP to inhibit the pro-adipogenic response to pioglitazone, and that the ability of pioglitazone to decrease TTF-1 expression contributes to its pro-adipogenic action.	[Xu, Bin; O'Donnell, Michael; O'Donnell, Jeffrey; Yu, Jingcheng; Koenig, Ronald J.] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Zhang, Yanxiao; Sartor, Maureen A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu	Zhang, Yanxiao/Q-8263-2019; Sartor, Maureen/L-2902-2019	Zhang, Yanxiao/0000-0001-9618-637X	National Institutes of Health (NIH) [R01CA151842, R01CA166033]; NATIONAL CANCER INSTITUTE [R01CA166033, R01CA151842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants R01CA151842 and R01CA166033. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Vu-Phan D, 2013, ENDOCR-RELAT CANCER, V20, P725, DOI 10.1530/ERC-13-0058; Di Palma T, 2003, J BIOL CHEM, V278, P3395, DOI 10.1074/jbc.M205977200; Dobson ME, 2011, ENDOCRINOLOGY, V152, P4455, DOI 10.1210/en.2011-1178; Endo T, 2013, ENDOCR-RELAT CANCER, V20, P767, DOI 10.1530/ERC-13-0310; Esposito C, 1998, BIOCHEM J, V331, P37, DOI 10.1042/bj3310037; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fabbro D, 1998, J MOL ENDOCRINOL, V21, P347, DOI 10.1677/jme.0.0210347; Giordano TJ, 2006, CLIN CANCER RES, V12, P1983, DOI 10.1158/1078-0432.CCR-05-2039; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Miccadei S, 2002, MOL ENDOCRINOL, V16, P837, DOI 10.1210/me.16.4.837; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Ngan ESW, 2009, JNCI-J NATL CANCER I, V101, P162, DOI 10.1093/jnci/djn471; Ohno M, 1999, MOL CELL BIOL, V19, P2051; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stanfel MN, 2005, CELL MOL BIOL, V51, pOL785, DOI 10.1170/92; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Zhang YX, 2015, ONCOTARGET, V6, P40418, DOI 10.18632/oncotarget.6340	27	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19274	19286		10.1074/jbc.M116.740324	http://dx.doi.org/10.1074/jbc.M116.740324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27435678	Green Published, hybrid			2022-12-26	WOS:000383242800009
J	Dang, FW; Chen, L; Madura, K				Dang, Francis Wang; Chen, Li; Madura, Kiran			Catalytically Active Proteasomes Function Predominantly in the Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY CONTROL DEGRADATION; NUCLEOTIDE EXCISION-REPAIR; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; 20S PROTEASOME; SUBCELLULAR-LOCALIZATION; NUCLEAR PROTEINS; GENE-EXPRESSION; HO ENDONUCLEASE; YEAST-CELLS	The ubiquitin/proteasome pathway is a well characterized system for degrading intracellular proteins, although many aspects remain poorly understood. There is, for instance, a conspicuous lack of understanding of the site(s) where nuclear proteins are degraded because the subcellular distribution of peptidase activity has not been investigated systematically. Although nuclear proteins could be degraded by importing proteasomes into the nucleus, it is also evident that some nuclear proteins are degraded only after export to cytosolic proteasomes. Proteasomes and substrates are mobile, and consequently, the sites of degradation might not be static. We sought to identify the location of proteasomes to provide more conclusive evidence on the sites of protein degradation. We report that catalytically active proteasomes exist almost exclusively in the cytosol. The resulting lack of nuclear peptidase activity suggests that little, if any, degradation occurs in the nucleus. These and other studies suggest that the export of proteolytic substrates could define an important regulatory step in the degradation of nuclear proteins by cytosolic proteasomes.	[Dang, Francis Wang; Chen, Li; Madura, Kiran] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, SPH 383,683 Hoes Lane, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, SPH 383,683 Hoes Lane, Piscataway, NJ 08854 USA.	maduraki@rwjms.rutgers.edu			National Institutes of Health [GM104968]; National Cancer Institute [CA083875]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM104968 and Grant CA083875 from National Cancer Institute (to K. M.). K. M. is a founder of CellXplore LLC whose objectives are unrelated to the content of this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Apcher GS, 2004, FEBS LETT, V569, P211, DOI 10.1016/j.febslet.2004.05.067; Bakhrat A, 2008, CURR GENET, V54, P271, DOI 10.1007/s00294-008-0216-8; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chandra A, 2010, J BIOL CHEM, V285, P8330, DOI 10.1074/jbc.M109.076786; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen L, 2008, MOL CELL BIOL, V28, P1829, DOI 10.1128/MCB.01256-07; Chen L, 2014, J BIOL CHEM, V289, P32339, DOI 10.1074/jbc.M114.582023; Chen L, 2014, GENETICS, V197, P193, DOI 10.1534/genetics.114.163824; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dieppois G, 2010, J CELL SCI, V123, P1989, DOI 10.1242/jcs.053694; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hedhli N, 2008, CARDIOVASC RES, V77, P497, DOI 10.1093/cvr/cvm054; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kulichkova VA, 2015, MOL BIOTECHNOL, V57, P36, DOI 10.1007/s12033-014-9799-0; Lahaye F, 2010, NUCLEIC ACIDS RES, V38, P3655, DOI 10.1093/nar/gkq098; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Livinskaya VA, 2014, PROTEIN EXPRES PURIF, V97, P37, DOI 10.1016/j.pep.2014.02.011; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Niepel M, 2013, MOL BIOL CELL, V24, P3920, DOI 10.1091/mbc.E13-07-0412; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Sanchez Leticia, 2005, J Biomol Tech, V16, P235; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; Tsuchiya H, 2013, BIOCHEM BIOPH RES CO, V436, P372, DOI 10.1016/j.bbrc.2013.05.105; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; Wiehens N, 2001, CURR BIOL, V11, P18; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zang ZJ, 2009, CELL SIGNAL, V21, P34, DOI 10.1016/j.cellsig.2008.09.018	50	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18765	18777		10.1074/jbc.M115.712406	http://dx.doi.org/10.1074/jbc.M115.712406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417138	Green Published, hybrid			2022-12-26	WOS:000383242300014
J	Jimenez-Canino, R; Fernandes, MX; de la Rosa, DA				Jimenez-Canino, Ruben; Fernandes, Miguel X.; Alvarez de la Rosa, Diego			Phosphorylation of Mineralocorticoid Receptor Ligand Binding Domain Impairs Receptor Activation and Has a Dominant Negative Effect over Non-phosphorylated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; GLUCOCORTICOID-RECEPTORS; TRANSCRIPTIONAL ACTIVITY; ALDOSTERONE; HETERODIMERIZATION; IDENTIFICATION; COACTIVATOR; MECHANISMS; EXPRESSION; GENE	Post-translational modification of steroid receptors allows fine-tuning different properties of this family of proteins, including stability, activation, or interaction with co-regulators. Recently, a novel effect of phosphorylation on steroid receptor biology was described. Phosphorylation of human mineralocorticoid receptor (MR) on Ser-843, a residue placed on the ligand binding domain, lowers affinity for agonists, producing inhibition of gene transactivation. We now show that MR inhibition by phosphorylation occurs even at high agonist concentration, suggesting that phosphorylation may also impair coupling between ligand binding and receptor activation. Our results demonstrate that agonists are able to induce partial nuclear translocation of MR but fail to produce transactivation due at least in part to impaired co-activator recruitment. The inhibitory effect of phosphorylation on MR acts in a dominant-negative manner, effectively amplifying its functional effect on gene transactivation.	[Alvarez de la Rosa, Diego] Univ La Laguna, Inst Tecnol Biomed, Dept Ciencias Med Basicas, Tenerife 38071, Spain; Univ La Laguna, Ctr Invest Biomed Canarias CIBICAN, Tenerife 38071, Spain	Universidad de la Laguna; Universidad de la Laguna	de la Rosa, DA (corresponding author), Univ La Laguna, Inst Tecnol Biomed, Dept Ciencias Med Basicas, Tenerife 38071, Spain.	diego.alvarez@ull.edu.es	Fernandes, Miguel Xavier/AAP-6504-2020; Alvarez de la Rosa, Diego/H-8500-2015	Fernandes, Miguel Xavier/0000-0002-1840-616X; Alvarez de la Rosa, Diego/0000-0002-4324-2793	Ministerio de Economia y Competitividad (Spain) [BFU2013-47089-R]; European Cooperation on Science and Technology (COST) network ADMIRE [BM1301]; European Union [FP7-REGPOT-2012-CT2012-31637-IMBRAIN]; Cajacanarias (Spain); Formacion de Profesorado Universitario (FPU) Program (Ministerio de Educacion, Spain)	Ministerio de Economia y Competitividad (Spain); European Cooperation on Science and Technology (COST) network ADMIRE; European Union(European Commission); Cajacanarias (Spain); Formacion de Profesorado Universitario (FPU) Program (Ministerio de Educacion, Spain)(German Research Foundation (DFG))	This work was supported by Ministerio de Economia y Competitividad (Spain) Grant BFU2013-47089-R, European Cooperation on Science and Technology (COST) network ADMIRE BM1301, and the European Union Seventh Framework Program "Capacities" (FP7-REGPOT-2012-CT2012-31637-IMBRAIN). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by predoctoral fellowships from Cajacanarias (Spain) and Formacion de Profesorado Universitario (FPU) Program (Ministerio de Educacion, Spain).	Aguilar-Sanchez C, 2012, ENDOCRINOLOGY, V153, P3517, DOI 10.1210/en.2012-1210; Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Funder JW, 2013, CELL METAB, V18, P609, DOI 10.1016/j.cmet.2013.10.010; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gravez B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073737; Hasui T, 2011, J MED CHEM, V54, P8616, DOI 10.1021/jm2011645; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Hellal-Levy C, 2000, KIDNEY INT, V57, P1250, DOI 10.1046/j.1523-1755.2000.00958.x; Hernandez-Diaz I, 2010, ENDOCRINOLOGY, V151, P3888, DOI 10.1210/en.2010-0099; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Jimenez-Canino R, 2016, ENDOCRINOLOGY, V157, P2515, DOI 10.1210/en.2015-2055; Kino T, 2010, MOL ENDOCRINOL, V24, P941, DOI 10.1210/me.2009-0395; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; LOMBES M, 1994, ENDOCRINOLOGY, V135, P834, DOI 10.1210/en.135.3.834; Mani O, 2016, J STEROID BIOCHEM, V159, P31, DOI 10.1016/j.jsbmb.2016.02.017; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Refolio E, 2011, J CELL SCI, V124, P2488, DOI 10.1242/jcs.081711; Sever R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016709; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200	26	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19068	19078		10.1074/jbc.M116.718395	http://dx.doi.org/10.1074/jbc.M116.718395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422824	Green Published, hybrid			2022-12-26	WOS:000383242300040
J	Kanda, T; Nishida, A; Ohno, M; Imaeda, H; Shimada, T; Inatomi, O; Bamba, S; Sugimoto, M; Andoh, A				Kanda, Toshihiro; Nishida, Atsushi; Ohno, Masashi; Imaeda, Hirotsugu; Shimada, Takashi; Inatomi, Osamu; Bamba, Shigeki; Sugimoto, Mitsushige; Andoh, Akira			Enterococcus durans TN-3 Induces Regulatory T Cells and Suppresses the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN COLONIC FLORA; ULCERATIVE-COLITIS; ANIMAL-MODELS; HUMAN FECES; MICROBIOTA; BACTERIA; INDUCTION; MICE; PATHOGENESIS	Background and Aims Probiotic properties of Enterococcus strains have been reported previously. In this study, we investigated the effects of Enterococcus (E.) durans TN-3 on the development of dextran sulfate sodium (DSS) colitis. Methods BALB/c mice were fed with 4.0% DSS in normal chow. Administration of TN-3 (10mg/day) was initiated 7days before the start of DSS feeding. Mucosal cytokine expression was analyzed by real time-PCR and immunohistochemistry. The lymphocyte subpopulation were analyzed by flow cytometry. The gut microbiota profile was analyzed by a terminal-restriction fragment length polymorphism method (T-RFLP). Results The disease activity index and histological colitis score were significantly lower in the DSS plus TN-3 group than in the DSS group. The mucosal mRNA expression of proinflammatory cytokines (IL-1 beta, IL-6, IL-17A and IFN-gamma) decreased significantly in the DSS plus TN-3 group as compared to the DSS group. The proportion of regulatory T cells (Treg cells) in the mucosa increased significantly in the DSS plus TN-3 group as compared to the DSS group. Both fecal butyrate levels and the diversity of fecal microbial community were significantly higher in the TN-3 plus DSS group than in the DSS group. Conclusions E. durans TN-3 exerted an inhibitory effect on the development of DSS colitis. This action might be mediated by the induction of Treg cells and the restoration of the diversity of the gut microbiota.	[Kanda, Toshihiro; Nishida, Atsushi; Ohno, Masashi; Imaeda, Hirotsugu; Inatomi, Osamu; Bamba, Shigeki; Sugimoto, Mitsushige; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Shimada, Takashi] Nichinichi Pharmaceut Corp Ltd, Cent Res Labs, Iga, Mie, Japan	Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	atsuda@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Bamba, Shigeki/0000-0002-4108-5894; Inatomi, Osamu/0000-0002-5837-6575	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08967, 15K19322]; Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan [067]; Smoking Research Foundation [1828]; Nichinichi Pharmaceutical Corporation Ltd; Grants-in-Aid for Scientific Research [15K08948] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Smoking Research Foundation; Nichinichi Pharmaceutical Corporation Ltd; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, (15K08967, 15K19322), https://www.jsps.go.jp/english/e-grants/, the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan, 067, http://www.mhlw.go.jp/english/, Smoking Research Foundation, 1828, http://www.srf.or.jp/english/, Nichinichi Pharmaceutical Corporation Ltd provided support in the form of salaries for T.S, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nichinichi Pharmaceutical Corporation Ltd and T.S. provided E. durans (TN-3) used in this study.; Authors appreciate technical supports of TechnoSuruga Laboratory Co., Ltd. (Sizuoka, Japan) and would like to express thanks. Authors thank Dr. Masahiro Kawahara for his useful advice and technical help. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K08967, 15K19322), a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan (067), and a grant from Smoking Research Foundation (1828).	Andoh A, 2016, DIGESTION, V93, P176, DOI 10.1159/000444066; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avram-Hananel L, 2010, DIS COLON RECTUM, V53, P1676, DOI 10.1007/DCR.0b013e3181f4b148; Chassaing B, 2014, CURRENT PROTOCOLS IM; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; COOPER HS, 1993, LAB INVEST, V69, P238; DEANROSS D, 1989, APPL ENVIRON MICROB, V55, P2002, DOI 10.1128/AEM.55.8.2002-2009.1989; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kindlund B, 2016, GASTRIC CANC; Klein G, 1998, INT J FOOD MICROBIOL, V41, P103, DOI 10.1016/S0168-1605(98)00049-X; Kondoh M, 2009, BRIT J NUTR, V102, P3, DOI 10.1017/S0007114508158998; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mayer L, 2010, J GASTROENTEROL, V45, P9, DOI 10.1007/s00535-009-0138-3; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mizoguchi A, 2008, J GASTROENTEROL, V43, P1, DOI 10.1007/s00535-007-2111-3; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Nami Y, 2014, J MED MICROBIOL, V63, P1044, DOI 10.1099/jmm.0.074161-0; Nishida A, 2012, J EXP MED, V209, P2383, DOI 10.1084/jem.20112631; Nishida A, 2012, GASTROENTEROLOGY, V142, P865, DOI 10.1053/j.gastro.2011.12.036; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Raz I, 2007, BRIT J NUTR, V97, P725, DOI 10.1017/S000711450747249X; Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yin L, 2001, J BIOL CHEM, V276, P44641, DOI 10.1074/jbc.M105170200; Zeng H, 2015, TRENDS IMMUNOL, V36, P3, DOI 10.1016/j.it.2014.08.003; Zheng SG, J IMMUNOL	43	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159705	10.1371/journal.pone.0159705	http://dx.doi.org/10.1371/journal.pone.0159705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438072	gold, Green Submitted, Green Published			2022-12-26	WOS:000380170100070
J	Xu, LJ; Li, BY; Huang, MW; Xie, K; Li, D; Li, Y; Gu, H; Fang, JM				Xu, Lijun; Li, Bingyu; Huang, Mengwen; Xie, Kun; Li, Dong; Li, You; Gu, Hua; Fang, Jianmin			Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A IGA; FC-ALPHA RECEPTOR; GAMMA-CHAIN; IDENTIFICATION; PATHOGENESIS; GLYCOSYLATION; ACTIVATION; CLEARANCE; MONOCYTES; EFFICIENT	Although IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide, its etiology remains only partly understood. It is clear that the pathogenesis of IgAN involves the formation of macromolecular IgA1 complexes and increased levels of serum IgA1 and IgA1-immune complexes(IC), due to defective IgA1 clearance. Previous studies suggest that the blood and tissue myeloid cell-expressed IgA Fc receptor (FcaR/CD89) mediates IgA-IC clearance and its dysfunction, via decreased activity or excessive levels of soluble FcaR/sCD89 induces IgAN. Such a mechanism requires robust stimulation of IgAN levels via forced expression of CD89. In the absence of unequivocal evidence supporting such a mechanism to date, we attempted to test the extent of CD89-evoked IgAN by generating a transgenic mouse strain expressing human CD89 under the control of murine CD14 promotor. No deposition of IgA-CD89 complexes or glomerulonephritis was detected, however. Further studies showed that elimination of murine IgA was mediated by Kupffer cells. In patients, however, CD89/IgA complexes were detected, and injection of patient IgA induced IgAN-like features in CD89 Tg mice. In transgenic mice, IgAN pathogenesis involves impaired clearance of abnormal IgA via CD89, primarily by the Kupffer cells. Conditional IgAN progression in CD89 transgenic mice thus reveals important aspects of IgAN pathogenesis.	[Xu, Lijun; Li, Bingyu; Huang, Mengwen; Xie, Kun; Li, You; Gu, Hua; Fang, Jianmin] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Li, Dong; Fang, Jianmin] Tongji Univ, Shanghai Tongji Hosp, Shanghai, Peoples R China; [Fang, Jianmin] Tongji Univ, Suzhou Inst, Suzhou, Jiangsu, Peoples R China; [Fang, Jianmin] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China	Tongji University; Tongji University; Tongji University; Sichuan University	Gu, H; Fang, JM (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Fang, JM (corresponding author), Tongji Univ, Shanghai Tongji Hosp, Shanghai, Peoples R China.; Fang, JM (corresponding author), Tongji Univ, Suzhou Inst, Suzhou, Jiangsu, Peoples R China.; Fang, JM (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.	gu_hua@tongji.edu.cn; jfang@tongji.edu.cn	xu, li/GNH-3667-2022		National Basic Research Program of China (973 Program) [2015CB553706]; National Natural Science Foundation of China [NSFC 31470896, NSFC 81402399]; Shanghai Science & Technology Pillar Program [12431901000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Pillar Program	This work was supported by the National Basic Research Program of China (973 Program 2015CB553706), the National Natural Science Foundation of China (NSFC 31470896 and NSFC 81402399), and Shanghai Science & Technology Pillar Program 12431901000).	Abe K, 2001, NEPHRON, V87, P231, DOI 10.1159/000045920; ALLEN AC, 1995, NEPHROL DIAL TRANSPL, V10, P1121, DOI 10.1093/ndt/10.7.1121; AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; Bakema JE, 2006, J IMMUNOL, V176, P3603, DOI 10.4049/jimmunol.176.6.3603; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Barratt J, 2007, SEMIN IMMUNOPATHOL, V29, P427, DOI 10.1007/s00281-007-0089-9; BENE MC, 1983, J CLIN INVEST, V71, P1342, DOI 10.1172/JCI110886; Berthelot L, 2012, J EXP MED, V209, P793, DOI 10.1084/jem.20112005; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V85, P128; Boyd JK, 2010, KIDNEY INT, V78, P1211, DOI 10.1038/ki.2010.365; Breslin WL, 2013, J IMMUNOL METHODS, V390, P1, DOI 10.1016/j.jim.2011.03.005; D'Amico G, 2000, AM J KIDNEY DIS, V36, P227, DOI 10.1053/ajkd.2000.8966; DELACROIX DL, 1983, J CLIN INVEST, V71, P358, DOI 10.1172/JCI110777; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Floege J, 2014, SEMIN IMMUNOPATHOL, V36, P431, DOI 10.1007/s00281-013-0411-7; Geissmann F, 2001, J IMMUNOL, V166, P346, DOI 10.4049/jimmunol.166.1.346; Glassock RJ, 2011, CURR OPIN NEPHROL HY, V20, P153, DOI 10.1097/MNH.0b013e3283436f5c; Grossetete B, 1998, KIDNEY INT, V53, P1321, DOI 10.1046/j.1523-1755.1998.00885.x; Hiki Y, 1999, J AM SOC NEPHROL, V10, P760; JENNETTE JC, 1991, AM J KIDNEY DIS, V18, P466, DOI 10.1016/S0272-6386(12)80115-6; Kashem A, 1996, CLIN NEPHROL, V45, P1; Launay P, 2000, J EXP MED, V191, P1999, DOI 10.1084/jem.191.11.1999; Li PZ, 2014, IMMUNOL LETT, V158, P52, DOI 10.1016/j.imlet.2013.12.002; Martinet W, 2004, J PATHOL, V202, P382, DOI 10.1002/path.1525; Maruoka T, 2004, IMMUNOGENETICS, V55, P712, DOI 10.1007/s00251-003-0626-1; Men R, 2004, J VIROL, V78, P4665, DOI 10.1128/JVI.78.9.4665-4674.2004; Mills P, 2001, BIOCHEM J, V359, P249, DOI 10.1042/0264-6021:3590249; MOLE CM, 1995, NEPHRON, V71, P75, DOI 10.1159/000188677; MONTEIRO RC, 1993, J CLIN INVEST, V92, P1681, DOI 10.1172/JCI116754; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Monteiro RC, 2010, J CLIN IMMUNOL, V30, pS61, DOI 10.1007/s10875-010-9397-2; Morton HC, 2001, ARCH IMMUNOL THER EX, V49, P217; Rifai A, 2000, J EXP MED, V191, P2171, DOI 10.1084/jem.191.12.2171; ROSMARIN AG, 1989, BLOOD, V73, P131; STOCKERT RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6229, DOI 10.1073/pnas.79.20.6229; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2729, DOI 10.1093/ndt/gfh459; van der Boog PJM, 2004, NEPHROL DIAL TRANSPL, V19, P2487, DOI 10.1093/ndt/gfh394; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; van Egmond M, 1999, BLOOD, V93, P4387, DOI 10.1182/blood.V93.12.4387.412k08_4387_4394; van Zandbergen G, 1998, NEPHROL DIAL TRANSPL, V13, P3058, DOI 10.1093/ndt/13.12.3058; Vuong MT, 2010, KIDNEY INT, V78, P1281, DOI 10.1038/ki.2010.314; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080	43	10	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159426	10.1371/journal.pone.0159426	http://dx.doi.org/10.1371/journal.pone.0159426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437939	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100046
J	Aryal, B; Rao, VA				Aryal, Baikuntha; Rao, V. Ashutosh			Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-Lymphocytes	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; SKELETAL-MUSCLE; CANCER-CELLS; ADRIAMYCIN; APOPTOSIS; COMPLEX; HEART; METABOLISM; COMPOUND; BLOCKADE	Cardiolipin (CL) is an inner mitochondrial membrane phospholipid which plays an important role in mitochondrial function. Perturbation in CL biosynthesis alters mitochondrial bioenergetics causing a severe genetic disorder commonly known as Barth syndrome. Barth syndrome patients are known to have a reduced concentration and altered composition of CL. Cardiolipin is also known to have a high affinity for the chemotherapeutic agent doxorubicin (Dox), resulting in an extensive mitochondrial accumulation of the drug. Our results indicate that B-lymphocytes from healthy individuals are more sensitive to Dox-induced oxidative stress and cellular toxicity compared to the B-lymphocytes from Barth syndrome as indicated by greater cell death and greater level of cleaved caspase-3 following Dox treatment. Barth lymphocytes, when compared to healthy lymphocytes, showed a greater basal level of mitochondrial reactive oxygen species (mito-ROS), yet exhibited a lower level of induced mito-ROS production in response to Dox. Significantly less ATP content and slightly greater OXPHOS protein levels were detected in healthy cells compared to Barth cells after Dox treatment. Consistent with greater mitochondrial ROS, treatment with Dox induced a higher level of lipid peroxidation and protein carbonylation in healthy lymphocytes compared to Barth lymphocytes. The final remodeling of CL during CL synthesis is catalyzed by the tafazzin protein. Knockdown of tafazzin gene in H9c2 cardiomyocytes using siRNA showed decreased oxidant-induced damage, as observed in Barth lymphocytes. Our findings demonstrate that a deficiency in CL might provide a therapeutic advantage in favor of oxidant-induced anticancer activities.	[Aryal, Baikuntha; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Off Pharmaceut Qual,Ctr Drug, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Review & Res 3, Off Biotechnol Prod,Off Pharmaceut Qual,Ctr Drug, Silver Spring, MD 20993 USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049	Center for Drug Evaluation and Research Critical Path Initiative	Center for Drug Evaluation and Research Critical Path Initiative	This research was supported by the Center for Drug Evaluation and Research Critical Path Initiative. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.; We would like to thank Dr. Shen Luo (FDA) for help with MS analysis. We would like to thank Elliot Rosen (FDA) for critical reading of the manuscript. This research was supported by the Center for Drug Evaluation and Research Critical Path Initiative. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the United States Food and Drug Administration and the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.	Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Ashour AE, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/434195; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Chen YM, 2006, FREE RADICAL BIO MED, V41, P1470, DOI 10.1016/j.freeradbiomed.2006.08.006; Childs AC, 2002, CANCER RES, V62, P4592; Choi SM, 2011, BLOOD, V118, P1801, DOI 10.1182/blood-2011-03-340620; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Dorn GW, 2013, BBA-MOL CELL RES, V1833, P233, DOI 10.1016/j.bbamcr.2012.03.008; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; GOORMAGHTIGH E, 1980, BIOCHIM BIOPHYS ACTA, V597, P1, DOI 10.1016/0005-2736(80)90145-5; GOORMAGHTIGH E, 1980, BIOCHEM PHARMACOL, V29, P3003, DOI 10.1016/0006-2952(80)90050-7; GOORMAGHTIGH E, 1990, BIOPHYS CHEM, V35, P247, DOI 10.1016/0301-4622(90)80012-V; HASINOFF BB, 1988, BIOCHEM PHARMACOL, V37, P3663, DOI 10.1016/0006-2952(88)90399-1; Hasinoff Brian B, 2003, Cardiovasc Toxicol, V3, P89, DOI 10.1385/CT:3:2:89; He Q, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/654198; He Q, 2013, AM J PHYSIOL-HEART C, V305, pH1332, DOI 10.1152/ajpheart.00084.2013; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Jefferies JL, 2013, AM J MED GENET C, V163, P198, DOI 10.1002/ajmg.c.31372; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KNIGHT JA, 1988, CLIN CHEM, V34, P2433; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Lampl T, 2015, JOVE-J VIS EXP, DOI 10.3791/52076; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Malugin A, 2006, MOL PHARMACEUT, V3, P351, DOI 10.1021/mp050065e; Marques-Aleixo I, 2015, MITOCHONDRION, V20, P22, DOI 10.1016/j.mito.2014.10.008; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; NOWAK D, 1995, FREE RADICAL BIO MED, V19, P659, DOI 10.1016/0891-5849(95)00028-V; PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2; Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 1999, J LIPID RES, V40, P1585; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Strigun A, 2012, TOXICOL SCI, V125, P595, DOI 10.1093/toxsci/kfr298; Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Wong HL, 2006, J PHARMACOL EXP THER, V317, P1372, DOI 10.1124/jpet.106.101154; Yadav N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.405; Yamakawa-Karakida N, 2002, CELL DEATH DIFFER, V9, P513, DOI 10.1038/sj.cdd.4401000	50	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158376	10.1371/journal.pone.0158376	http://dx.doi.org/10.1371/journal.pone.0158376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434059	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600008
J	McCallie, BR; Parks, JC; Patton, AL; Griffin, DK; Schoolcraft, WB; Katz-Jaffe, MG				McCallie, Blair R.; Parks, Jason C.; Patton, Alyssa L.; Griffin, Darren K.; Schoolcraft, William B.; Katz-Jaffe, Mandy G.			Hypomethylation and Genetic Instability in Monosomy Blastocysts May Contribute to Decreased Implantation Potential	PLOS ONE			English	Article							DNA METHYLATION DYNAMICS; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; DOWN-SYNDROME; EXPRESSION; ANEUPLOIDY; PROTEINS; METHYLTRANSFERASES; MAINTENANCE; SEQUENCE	DNA methylation is a key epigenetic mechanism responsible for gene regulation, chromatin remodeling, and genome stability, playing a fundamental role during embryonic development. The aim of this study was to determine if these epigenetic marks are associated with chromosomal aneuploidy in human blastocysts. Surplus, cryopreserved blastocysts that were donated to research with IRB consent were chosen with varying chromosomal aneuploidies and respective implantation potential: monosomies and trisomies 7, 11, 15, 21, and 22. DNA methylation analysis was performed using the Illumina Infinium HumanMethylation450 BeadChip (similar to 485,000 CpG sites). The methylation profiles of these human blastocysts were found to be similar across all samples, independent of chromosome constitution; however, more detailed examination identified significant hypomethylation in the chromosome involved in the monosomy. Real-time PCR was also performed to determine if downstream messenger RNA (mRNA) was affected for genes on the monosomy chromosome. Gene dysregulation was observed for monosomy blastocysts within significant regions of hypo-methylation (AVEN, CYFIP1, FAM189A1, MYO9A, ADM2, PACSIN2, PARVB, and PIWIL3) (P < 0.05). Additional analysis was performed to examine the gene expression profiles of associated methylation regulators including: DNA methyltransferases (DNMT1, DNMT3A, DNMT3B, DNMT3L), chromatin modifying regulators (CSNK1E, KDM1, PRKCA), and a post-translational modifier (PRMT5). Decreased RNA transcription was confirmed for each DNMT, and the regulators that impact DNMT activity, for only monosomy blastocysts (P < 0.05). In summary, monosomy blastocysts displayed hypomethylation for the chromosome involved in the error, as well as transcription alterations of associated developmental genes. Together, these modifications may be contributing to genetic instability and therefore be responsible for the limited implantation potential observed for full monosomy blastocysts.	[McCallie, Blair R.; Parks, Jason C.; Patton, Alyssa L.; Katz-Jaffe, Mandy G.] Natl Fdn Fertil Res, Lone Tree, CO 80124 USA; [Schoolcraft, William B.; Katz-Jaffe, Mandy G.] Colorado Ctr Reprod Med, Lone Tree, CO 80124 USA; [McCallie, Blair R.; Parks, Jason C.; Griffin, Darren K.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of Kent	McCallie, BR (corresponding author), Natl Fdn Fertil Res, Lone Tree, CO 80124 USA.; McCallie, BR (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	bmccallie@fertilityresearch.org			BBSRC [BB/E024211/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [G19438/2, BB/E024211/1, BB/E010652/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Alfandari D, 2001, CURR BIOL, V11, P918, DOI 10.1016/S0960-9822(01)00263-9; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; CHAUHAN M, 2015, BIOL REPROD, V93, DOI DOI 10.1095/; Chen C, 2013, GENE CHROMOSOME CANC, V52, P564, DOI 10.1002/gcc.22054; Cousin H, 2008, DEV BIOL, V319, P86, DOI 10.1016/j.ydbio.2008.04.007; Fragouli E, 2011, MOL HUM REPROD, V17, P286, DOI 10.1093/molehr/gar024; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gorman SW, 1999, GENOMICS, V59, P150, DOI 10.1006/geno.1999.5867; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Hata K, 2002, DEVELOPMENT, V129, P1983; Jacob S, 2005, PEDIATR RES, V58, P437, DOI 10.1203/01.PDR.0000179401.17161.D3; Javerzat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007856; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Kimura M, 2010, J CELL SCI, V123, P747, DOI 10.1242/jcs.052498; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Ludwig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096090; Luthardt FW, 2001, CHROMOSOMAL SYNDROME; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Modregger J, 2000, J CELL SCI, V113, P4511; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; O'Shea LC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111880; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Robberech C, 2010, CURR GENOMICS, V11, P397, DOI 10.2174/138920210793175967; Rosenkranz D, 2015, GENOM DATA, V5, P309, DOI 10.1016/j.gdata.2015.06.026; Sanchez JM, 1999, PRENATAL DIAG, V19, P601, DOI 10.1002/(SICI)1097-0223(199907)19:7<601::AID-PD564>3.3.CO;2-S; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Treff NR, 2013, FERTIL STERIL, V99, P1049, DOI 10.1016/j.fertnstert.2012.11.007; Veitia RA, 2015, TRENDS BIOCHEM SCI, V40, P309, DOI 10.1016/j.tibs.2015.03.011; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Yin LJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-26	40	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159507	10.1371/journal.pone.0159507	http://dx.doi.org/10.1371/journal.pone.0159507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434648	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600059
J	Moe, N; Pedersen, B; Nordbo, SA; Skanke, LH; Krokstad, S; Smyrnaios, A; Dollner, H				Moe, Nina; Pedersen, Bard; Nordbo, Svein Arne; Skanke, Lars Hosoien; Krokstad, Sidsel; Smyrnaios, Anastasios; Dollner, Henrik			Respiratory Virus Detection and Clinical Diagnosis in Children Attending Day Care	PLOS ONE			English	Article							TRACT INFECTIONS; HUMAN BOCAVIRUS; VIRAL ETIOLOGY; EPIDEMIOLOGY; RNA; TRANSMISSION; PERSISTENCE; RHINOVIRUS; INFANTS; ILLNESS	Background Respiratory viruses often have been studied in children with respiratory tract infection (RTI), but less knowledge exists about viruses in asymptomatic children. We have studied the occurrence of a broad panel of respiratory viruses in apparently healthy children attending day care, taking into account the influence of possible confounding factors, such as age, clinical signs of respiratory tract infection (RTI), location (day-care section) and season. Methods We have studied 161 children in two day-care centers, each with separate sections for younger and older children, during four autumn and winter visits over a two-year period. A total of 355 clinical examinations were performed, and 343 nasopharyngeal samples (NPS) were analyzed by semi-quantitative, real-time, polymerase chain reaction (PCR) tests for 19 respiratory pathogens. Result Forty-three percent of all NPS were PCR-positive for >= 1 of 13 virus species, with high species variation during visits. Rhinovirus 26% (88/343 NPS), enterovirus 12% (40/343) and parechovirus 9% (30/343) were detected in every visit, and the rates varied in relation to age, day-care section and season. Ten other viruses were detected in <= 3% of the NPS. Generally, viruses occurred together in the NPS. In 24% (79/331) of the clinical examinations with available NPS, the children had clear signs of RTI, while in 41% (135/331) they had mild signs, and in 35% (117/331) the children had no signs of RTI. Moreover, viruses were found in 70% (55/79) of children with clear signs of RTI, in 41% (55/135) with mild signs and in 30% (35/117) without any signs of RTI (p < 0.001). Conclusions Positive PCR tests for respiratory viruses, particularly picornaviruses, were frequently detected in apparently healthy children attending day care. Virus detection rates were related to age, presence of clinical signs of RTI, location in day care and season.	[Moe, Nina; Skanke, Lars Hosoien; Smyrnaios, Anastasios; Dollner, Henrik] Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway; [Pedersen, Bard] Norwegian Inst Nat Res, Trondheim, Norway; [Nordbo, Svein Arne; Krokstad, Sidsel] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Microbiol, Trondheim, Norway; [Moe, Nina; Nordbo, Svein Arne; Skanke, Lars Hosoien; Dollner, Henrik] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moe, N (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Pediat, Trondheim, Norway.; Moe, N (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, Fac Med, Trondheim, Norway.	nina.moe@ntnu.no			St. Olavs University Hospital; University Hospital of Trondheim, Trondheim, Norway [11/8437]	St. Olavs University Hospital; University Hospital of Trondheim, Trondheim, Norway	The work was supported by a grant from St. Olavs University Hospital, The University Hospital of Trondheim, Trondheim, Norway (https://stolav.no/fag-og-forskning/forskning), grant no 11/8437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Christensen A, 2013, EMERG INFECT DIS, V19, P574, DOI 10.3201/eid1904.121775; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; Chu HY, 2013, J CLIN VIROL, V57, P343, DOI 10.1016/j.jcv.2013.04.011; Crawley MJ, 2007, R BOOK, pviii; da Silva ER, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-41; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Fairchok MP, 2010, J CLIN VIROL, V49, P16, DOI 10.1016/j.jcv.2010.06.013; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Greer RM, 2009, J CLIN VIROL, V45, P10, DOI 10.1016/j.jcv.2009.03.008; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Heinonen S, 2015, AM J RESP CRIT CARE; HOLM S, 1979, SCAND J STAT, V6, P65; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Jartti T, 2013, PAEDIATR RESPIR REV, V14, P38, DOI 10.1016/j.prrv.2012.04.002; Kristoffersen AW, 2011, PEDIATR INFECT DIS J, V30, P279, DOI 10.1097/INF.0b013e3181fcb159; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lambert SB, 2007, PEDIATRICS, V120, pe929, DOI 10.1542/peds.2006-3703; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Martin ET, 2013, J INFECT DIS, V207, P982, DOI 10.1093/infdis/jis934; Martins RB, 2014, MEM I OSWALDO CRUZ, V109, P716, DOI 10.1590/0074-0276140046; Nokso-Koivisto J, 2002, J MED VIROL, V66, P417, DOI 10.1002/jmv.2161; Patefield W. M., 1981, APPL STAT, V30, P91, DOI DOI 10.2307/2346669; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Piralla A, 2012, J MED VIROL, V84, P686, DOI 10.1002/jmv.23197; R Core Team, 2021, R LANGUAGE ENV STAT; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Skram MK, 2014, PEDIATR INFECT DIS J, V33, P1222, DOI 10.1097/INF.0000000000000456; Souza LSD, 2003, PEDIATR PULM, V35, P184, DOI 10.1002/ppul.10194; Taylor JA, 2010, PEDIATR RES, V68, P252, DOI 10.1203/00006450-201011001-00493; van den Bergh MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047711; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Wagner JC, 2016, PEDIATR INFECT DIS J, V35, P471, DOI 10.1097/INF.0000000000001058; Westerhuis B, 2013, J CLIN VIROL, V58, P211, DOI 10.1016/j.jcv.2013.06.036; Wong-Chew Rosa M, 2015, BMC Res Notes, V8, P261, DOI 10.1186/s13104-015-1239-0; Zuur Alain F., 2009, P1	42	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159196	10.1371/journal.pone.0159196	http://dx.doi.org/10.1371/journal.pone.0159196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433803	gold, Green Published, Green Accepted			2022-12-26	WOS:000380169600038
J	Byun, S; Han, JW; Kim, TH; Kim, KW				Byun, Seonjeong; Han, Ji Won; Kim, Tae Hui; Kim, Ki Woong			Test-Retest Reliability and Concurrent Validity of a Single Tri-Axial Accelerometer-Based Gait Analysis in Older Adults with Normal Cognition	PLOS ONE			English	Article							PARKINSONS-DISEASE; KOREAN VERSION; RATING-SCALE; PARAMETERS; WALKING; DEMENTIA; DECLINE	Objective We investigated the concurrent validity and test-retest reliability of spatio-temporal gait parameters measured with a single tri-axial accelerometer (TAA), determined the optimal number of steps required for obtaining acceptable levels of reliability, and compared the validity and reliability of the estimated gait parameters across the three reference axes of the TAA. Methods A total of 82 cognitively normal elderly participants walked around a 40-m long round walkway twice wearing a TAA at their center of body mass. Gait parameters such as cadence, gait velocity, step time, step length, step time variability, and step time asymmetry were estimated from the low pass-filtered signal of the TAA. The test-retest reliability and concurrent validity with the GAITRite (R) system were evaluated for the estimated gait parameters. Results Gait parameters using signals from the vertical axis showed excellent reliability for all gait parameters; the intraclass correlation coefficient (ICC) was 0.79-0.90. A minimum of 26 steps and 14 steps were needed to achieve excellent reliability in step time variability and step time asymmetry, respectively. A strong level of agreement was seen for the basic gait parameters between the TAA and GAITRite (R) (ICC = 0.91-0.96). Conclusions The measurement of gait parameters of elderly individuals with normal cognition using a TAA placed on the body's center of mass was reliable and showed superiority over the GAITRite (R) with regard to gait variability and asymmetry. The TAA system was a valid tool for measuring basic gait parameters. Considering its wearability and low price, the TAA system may be a promising alternative to the pressure sensor walkway system for measuring gait parameters.	[Byun, Seonjeong; Kim, Tae Hui; Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Byun, Seonjeong; Han, Ji Won; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Kim, Tae Hui] Yonsei Univ, Wonju Severance Christian Hosp, Dept Psychiat, Wonju, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea.; Kim, KW (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea.	kwkimmd@snu.ac.kr	Kim, Tae Hui/AAR-9213-2020	Kim, Tae Hui/0000-0003-0133-5227	Research Settlement Fund for the faculty of SNU [800-2012-0092]; SNUBH Research Fund [11-2011-030]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI09C1379(A092077)]	Research Settlement Fund for the faculty of SNU; SNUBH Research Fund; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by Research Settlement Fund for the faculty of SNU (grant number; 800-2012-0092, URL; http://www.snu.ac.kr), a grant from the SNUBH Research Fund (grand number; 11-2011-030, URL; http://www.snubh.org), and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant number; HI09C1379(A092077), URL; http://www.mw.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONSSON EK, 1985, J BIOMECH, V18, P39, DOI 10.1016/0021-9290(85)90043-0; Auvinet B, 2002, GAIT POSTURE, V16, P124, DOI 10.1016/S0966-6362(01)00203-X; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Bautmans I, 2011, GAIT POSTURE, V33, P366, DOI 10.1016/j.gaitpost.2010.12.003; Beauchet O, 2011, TEST RETEST RELIABIL; Brandes M, 2006, GAIT POSTURE, V24, P482, DOI 10.1016/j.gaitpost.2005.12.006; Del Din S, 2016, IEEE J BIOMED HEALTH, V20, P838, DOI 10.1109/JBHI.2015.2419317; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Godfrey A, 2015, MED ENG PHYS, V37, P400, DOI 10.1016/j.medengphy.2015.02.003; Hartmann A, 2009, GAIT POSTURE, V30, P351, DOI 10.1016/j.gaitpost.2009.06.008; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Hollman JH, 2010, GAIT POSTURE, V32, P23, DOI 10.1016/j.gaitpost.2010.02.017; Kim JY, 2008, PSYCHIAT INVEST, V5, P232, DOI 10.4306/pi.2008.5.4.232; Kim TH, 2010, PSYCHIAT INVEST, V7, P102, DOI 10.4306/pi.2010.7.2.102; Kim TH, 2013, ALZHEIMERS DEMENT, V9, pP626; Kressig RW, 2006, AGING CLIN EXP RES, P3; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Lewek MD, 2011, J NEUROL PHYS THER, V35, P116, DOI 10.1097/NPT.0b013e318227fe70; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Mielke MM, 2013, J GERONTOL A-BIOL, V68, P929, DOI 10.1093/gerona/gls256; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Scherder E, 2007, NEUROSCI BIOBEHAV R, V31, P485, DOI 10.1016/j.neubiorev.2006.11.007; Senden R, 2009, GAIT POSTURE, V30, P192, DOI 10.1016/j.gaitpost.2009.04.008; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Yoo S, 2006, ANXIETY MOOD, V2, P50; Zhu S, 2014, P ACM INT C MULT; Zijlstra A, 2013, GAIT POSTURE, V38, P940, DOI 10.1016/j.gaitpost.2013.04.021; Zijlstra W, 2004, EUR J APPL PHYSIOL, V92, P39, DOI 10.1007/s00421-004-1041-5; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	33	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158956	10.1371/journal.pone.0158956	http://dx.doi.org/10.1371/journal.pone.0158956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427965	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300027
J	Yeung, KR; Chiu, CL; Pears, S; Heffernan, SJ; Makris, A; Hennessy, A; Lind, JM				Yeung, Kristen R.; Chiu, Christine L.; Pears, Suzanne; Heffernan, Scott J.; Makris, Angela; Hennessy, Annemarie; Lind, Joanne M.			A Cross-Sectional Study of Ageing and Cardiovascular Function over the Baboon Lifespan	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE; QUANTITATIVE PCR; NONHUMAN PRIMATE; TELOMERE LENGTH; PAPIO-HAMADRYAS; NATIONAL-HEALTH; AGE; HYPERTENSION; ATHEROSCLEROSIS	Background Ageing is associated with changes at the molecular and cellular level that can alter cardiovascular function and ultimately lead to disease. The baboon is an ideal model for studying ageing due to the similarities in genetic, anatomical, physiological and biochemical characteristics with humans. The aim of this cross-sectional study was to investigate the changes in cardiovascular profile of baboons over the course of their lifespan. Methods Data were collected from 109 healthy baboons (Papio hamadryas) at the Australian National Baboon Colony. A linear regression model, adjusting for sex, was used to analyse the association between age and markers of ageing with P < 0.01 considered significant. Results Male (n = 49, 1.5-28.5 years) and female (n = 60, 1.8-24.6 years) baboons were included in the study. Age was significantly correlated with systolic (R-2 = 0.23, P < 0.001) and diastolic blood pressure (R-2 = 0.44, P < 0.001), with blood pressure increasing with age. Age was also highly correlated with core augmentation index (R-2 = 0.17, P < 0.001) and core pulse pressure (R-2 = 0.30, P < 0.001). Creatinine and urea were significantly higher in older animals compared to young animals (P < 0.001 for both). Older animals (>12 years) had significantly shorter telomeres when compared to younger (< 3 years) baboons (P = 0.001). Conclusion This study is the first to demonstrate that cardiovascular function alters with age in the baboon. This research identifies similarities within cardiovascular parameters between humans and baboon even though the length of life differs between the two species.	[Yeung, Kristen R.; Chiu, Christine L.; Makris, Angela; Hennessy, Annemarie; Lind, Joanne M.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Pears, Suzanne; Heffernan, Scott J.] Royal Prince Alfred Hosp, Dept Renal Med, Sydney, NSW, Australia; [Makris, Angela; Hennessy, Annemarie] Heart Res Inst, Sydney, NSW, Australia; [Makris, Angela] Liverpool Hosp, Dept Nephrol, Sydney, NSW, Australia	Western Sydney University; University of Sydney; University of Sydney; Heart Research Institute; Liverpool Hospital	Lind, JM (corresponding author), Univ Western Sydney, Sch Med, Sydney, NSW, Australia.	j.lind@westernsydney.edu.au	Hennessy, Annemarie/HGB-5049-2022	Hennessy, Annemarie/0000-0002-5975-2843; Chiu, Christine L./0000-0002-6411-9719	National Health and Medical Research Council - Enabling Capabilities Grant [1054126]; National Health and Medical Research Australian Biomedical Fellowship [457139]	National Health and Medical Research Council - Enabling Capabilities Grant; National Health and Medical Research Australian Biomedical Fellowship	This work was supported by a National Health and Medical Research Council - Enabling Capabilities Grant (1054126) awarded to AM and AH (https://www.nhmrc.gov.au/). JML was supported by a National Health and Medical Research Australian Biomedical Fellowship (457139) (https://www.nhmrc.gov.au/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerlocher GM, 2003, J LEUKOCYTE BIOL, V73, P289, DOI 10.1189/jlb.0702361; Bailey JF, 2014, OSTEOARTHR CARTILAGE, V22, P980, DOI 10.1016/j.joca.2014.04.027; Bansal N, 2012, AM J NEPHROL, V36, P405, DOI 10.1159/000343495; Beltran WA, 2007, VET OPHTHALMOL, V10, P43, DOI 10.1111/j.1463-5224.2007.00491.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOHNEN N, 1992, Z GERONTOL, V25, P339; Bourdel-Marchasson I, 2010, MATURITAS, V66, P39, DOI 10.1016/j.maturitas.2010.02.004; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cefalu WT, 1997, AGE, V20, P15, DOI 10.1007/s11357-997-0002-4; Chapman KM, 1996, J GERONTOL A-BIOL, V51, pB261, DOI 10.1093/gerona/51A.4.B261; DAHL LK, 1972, AM J CLIN NUTR, V25, P231; Darusman HS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00313; FRASER CG, 1993, DRUG AGING, V3, P246, DOI 10.2165/00002512-199303030-00006; Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; Hubbard JM, 2014, J CLIN ONCOL, V32, P2611, DOI 10.1200/JCO.2014.55.4261; Huber HF, 2015, J MED PRIMATOL, V44, P373, DOI 10.1111/jmp.12199; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, pE22, DOI 10.1161/01.ATV.0000158419.98675.d7; Lara J, 2013, MATURITAS, V76, P189, DOI 10.1016/j.maturitas.2013.07.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN F, 1961, LANCET, V1, P389; MCGILL HC, 1985, ARTERIOSCLEROSIS, V5, P481, DOI 10.1161/01.ATV.5.5.481; MURRAY CE, 1981, CLIN SCI, V61, P737, DOI 10.1042/cs0610737; O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; PAGE LB, 1974, CIRCULATION, V49, P1132, DOI 10.1161/01.CIR.49.6.1132; RODRIGUEZ BL, 1994, HYPERTENSION, V24, P779, DOI 10.1161/01.HYP.24.6.779; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; SCHAEFER EJ, 1995, AM J CLIN NUTR, V61, p726S, DOI 10.1093/ajcn/61.3.726S; Smucny DA, 2001, J MED PRIMATOL, V30, P161, DOI 10.1111/j.1600-0684.2001.tb00005.x; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Steinert S, 2002, EXP CELL RES, V272, P146, DOI 10.1006/excr.2001.5409; Stoner L, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/903107; TIETZ NW, 1992, CLIN CHEM, V38, P1167; TRUSWELL AS, 1972, AM HEART J, V84, P5, DOI 10.1016/0002-8703(72)90299-2; Ungvari Z, 2010, J MOL MED, V88, P1021, DOI 10.1007/s00109-010-0667-5; Visser M, 2005, AM J CLIN NUTR, V82, P531; Vlachopoulos C, 2000, CURR PROB CARDIOLOGY, V25, P301; Wang XL, 2004, CELL BIOCHEM BIOPHYS, V40, P371, DOI 10.1385/CBB:40:3:371; Willis EL, 2014, GEN COMP ENDOCR, V195, P21, DOI 10.1016/j.ygcen.2013.10.004; Yeung KR, 2014, J MED PRIMATOL, V43, P217, DOI 10.1111/jmp.12113; Zheng HY, 2014, EXP GERONTOL, V55, P113, DOI 10.1016/j.exger.2014.04.004	53	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159576	10.1371/journal.pone.0159576	http://dx.doi.org/10.1371/journal.pone.0159576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427971	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300078
J	Karlson, AML; Niemand, C; Savage, C; Pilditch, CA				Karlson, Agnes M. L.; Niemand, Clarisse; Savage, Candida; Pilditch, Conrad A.			Density of Key-Species Determines Efficiency of Macroalgae Detritus Uptake by Intertidal Benthic Communities	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; SPATIAL-DISTRIBUTION; FEEDING BIVALVE; STABLE-ISOTOPES; FRESH-WATER; BIODIVERSITY; DIVERSITY; MACROFAUNA; PRESERVATION; ASSEMBLAGES	Accumulating evidence shows that increased biodiversity has a positive effect on ecosystem functioning, but the mechanisms that underpin this positive relationship are contentious. Complete extinctions of regional species pools are comparatively rare whereas compositional changes and reductions in abundance and biomass are common, although seldom the focus of biodiversity-ecosystem functioning studies. We use natural, small-scale patchiness in the density of two species of large bivalves with contrasting feeding modes (the suspension-feeding Austrovenus stutchburyi and deposit-feeding Macomona liliana) to examine their influence on the uptake of nitrogen from macroalgae detritus (i.e. measure of ecosystem function and food web efficiency) by other infauna in a 10-d laboratory isotope-tracer experiment. We predicted that densities of these key bivalve species and functional group diversity (calculated as Shannons H, a density-independent measure of community composition) of the intact infaunal community will be critical factors explaining variance in macroalgal per capita uptake rates by the community members and hence determine total uptake by the community. Results show that only two species, M. liliana and a large orbiniid polychaete (Scoloplos cylindrifer) dominated macroalgal nitrogen taken up by the whole community due to their large biomass. However, their densities were mostly not important or negatively influenced per capita uptake by other species. Instead, the density of a head-down deposit-feeder (the capitellid Heteromastus filiformis), scavengers (mainly nemertines and nereids) and species and functional group diversity, best explained per capita uptake rates in community members. Our results demonstrate the importance of species identity, density and large body size for ecosystem functioning and highlight the complex interactions underlying loss of ecological functions with declining biodiversity and compositional changes.	[Karlson, Agnes M. L.] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Niemand, Clarisse; Pilditch, Conrad A.] Univ Waikato, Sch Sci, Hamilton, New Zealand; [Savage, Candida] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Savage, Candida] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa	Stockholm University; University of Waikato; University of Otago; University of Cape Town	Karlson, AML (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	agnes.karlson@aces.su.se	Karlson, Agnes/N-9230-2017; Karlson, Agnes/ABG-3861-2020	Karlson, Agnes/0000-0001-6493-9533; Karlson, Agnes/0000-0001-6493-9533	Swedish Research Council (VR) [623-2010-600]; Bay of Plenty Regional Council	Swedish Research Council (VR)(Swedish Research Council); Bay of Plenty Regional Council	This study was funded by a postdoctoral scholarship by the Swedish Research Council (VR) to AMLK (contract 623-2010-600). Performance Based Research Funds to CS for stable isotope costs and a Bay of Plenty Regional Council PhD Scholarship supported CN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2008, GUID SOFTW STAT METH; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Byren L, 2006, MAR ECOL PROG SER, V313, P135, DOI 10.3354/meps313135; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CARLTON JT, 1993, AM ZOOL, V33, P499; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; Dangles O, 2004, ECOL LETT, V7, P395, DOI 10.1111/j.1461-0248.2004.00591.x; Elahi R, 2015, CURR BIOL, V25, P1938, DOI 10.1016/j.cub.2015.05.030; Emmerson MC, 2000, OIKOS, V91, P195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Goedkoop W, 2006, FRESHWATER BIOL, V51, P878, DOI 10.1111/j.1365-2427.2006.01539.x; Greenfield BL, 2014, THESIS; Hewitt JE, 2008, J EXP MAR BIOL ECOL, V366, P116, DOI 10.1016/j.jembe.2008.07.016; Hiddink JG, 2009, OIKOS, V118, P1892, DOI 10.1111/j.1600-0706.2009.17556.x; Jones HFE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027065; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Karlson AML, 2015, SCI REP-UK, V5, DOI 10.1038/srep09715; Karlson AML, 2011, OECOLOGIA, V166, P1055, DOI 10.1007/s00442-011-1936-x; Karlson AML, 2010, ECOLOGY, V91, P1414, DOI 10.1890/09-0660.1; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lau DCP, 2012, LIMNOL OCEANOGR-METH, V10, P75, DOI 10.4319/lom.2012.10.75; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Leduc D, 2006, NEW ZEAL J MAR FRESH, V40, P615, DOI 10.1080/00288330.2006.9517450; Lohrer AM, 2010, J EXP MAR BIOL ECOL, V390, P6, DOI 10.1016/j.jembe.2010.04.035; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; McKie BG, 2008, J ANIM ECOL, V77, P495, DOI 10.1111/j.1365-2656.2008.01357.x; Naeem S, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P3; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nascimento FJA, 2011, OECOLOGIA, V166, P337, DOI 10.1007/s00442-010-1865-0; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Nordstrom MC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00515.1; Norkko A, 2001, LIMNOL OCEANOGR, V46, P2067, DOI 10.4319/lo.2001.46.8.2067; Norkko A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02646; Olafsson E, 2005, MAR ECOL PROG SER, V298, P179, DOI 10.3354/meps298179; Paavo B, 2008, NEW ZEAL J MAR FRESH, V42, P85, DOI 10.1080/00288330809509938; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Raffaelli D, 2003, J SEA RES, V49, P133, DOI 10.1016/S1385-1101(02)00200-9; Raikow DF, 2001, LIMNOL OCEANOGR, V46, P514, DOI 10.4319/lo.2001.46.3.0514; Rodil IF, 2011004 AUCKL COUNC; Rossi F, 2006, J EXP MAR BIOL ECOL, V332, P84, DOI 10.1016/j.jembe.2005.11.003; Rossi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066650; RUDNICK DT, 1989, MAR ECOL PROG SER, V50, P231, DOI 10.3354/meps050231; Sandwell DR, 2009, J EXP MAR BIOL ECOL, V373, P16, DOI 10.1016/j.jembe.2009.02.015; SEGERSTRALE S G, 1973, Commentationes Biologicae Societas Scientiarum Fennica, V67, P1; Snelgrove P, 1997, AMBIO, V26, P578; Snelgrove PVR, 2014, TRENDS ECOL EVOL, V29, P398, DOI 10.1016/j.tree.2014.05.002; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Thrush SF, 2014, ECOLOGY, V95, P1451, DOI 10.1890/13-1879.1; Thrush SF, 2012, MARINE BIODIVERSITY AND ECOSYSTEM FUNCTIONING: FRAMEWORKS, METHODOLOGIES, AND INTEGRATION, P200; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413; Volkenborn N, 2012, J MAR RES, V70, P794, DOI 10.1357/002224012806770955; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; WEINBERG JR, 1983, J MAR RES, V41, P557, DOI 10.1357/002224083788519696; Whitlatch RB, 1997, J EXP MAR BIOL ECOL, V216, P171, DOI 10.1016/S0022-0981(97)00095-6; Widdicombe S, 1998, J EXP MAR BIOL ECOL, V228, P241, DOI 10.1016/S0022-0981(98)00032-X; Widdicombe S, 1999, MAR ECOL PROG SER, V189, P181, DOI 10.3354/meps189181; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	65	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158785	10.1371/journal.pone.0158785	http://dx.doi.org/10.1371/journal.pone.0158785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414032	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500039
J	Memczak, H; Lauster, D; Kar, P; Di Lella, S; Volkmer, R; Knecht, V; Herrmann, A; Ehrentreich-Forster, E; Bier, FF; Stocklein, WFM				Memczak, Henry; Lauster, Daniel; Kar, Parimal; Di Lella, Santiago; Volkmer, Rudolf; Knecht, Volker; Herrmann, Andreas; Ehrentreich-Foerster, Eva; Bier, Frank F.; Stoecklein, Walter F. M.			Anti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus Binding	PLOS ONE			English	Article							RECEPTOR-BINDING; NEUTRALIZING ANTIBODY; ORIGIN; INFECTION; ENTRY; SITES; IDENTIFICATION; NEURAMINIDASE; RECOGNITION; ENERGETICS	Antibodies against spike proteins of influenza are used as a tool for characterization of viruses and therapeutic approaches. However, development, production and quality control of antibodies is expensive and time consuming. To circumvent these difficulties, three peptides were derived from complementarity determining regions of an antibody heavy chain against influenza A spike glycoprotein. Their binding properties were studied experimentally, and by molecular dynamics simulations. Two peptide candidates showed binding to influenza A/Aichi/2/68 H3N2. One of them, termed PeB, with the highest affinity prevented binding to and infection of target cells in the micromolar region without any cytotoxic effect. PeB matches best the conserved receptor binding site of hemagglutinin. PeB bound also to other medical relevant influenza strains, such as human-pathogenic A/California/7/2009 H1N1, and avian-pathogenic A/MuteSwan/Rostock/R901/2006 H7N1. Strategies to improve the affinity and to adapt specificity are discussed and exemplified by a double amino acid substituted peptide, obtained by substitutional analysis. The peptides and their derivatives are of great potential for drug development as well as biosensing.	[Memczak, Henry; Ehrentreich-Foerster, Eva; Stoecklein, Walter F. M.] Fraunhofer Inst Cell Therapy & Immunol Branch Bio, Dept Bioanalyt & Biosensor, Potsdam, Germany; [Memczak, Henry; Bier, Frank F.] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Lauster, Daniel; Di Lella, Santiago; Herrmann, Andreas] Humboldt Univ, Dept Biol, Berlin, Germany; [Kar, Parimal; Knecht, Volker] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Di Lella, Santiago] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Di Lella, Santiago] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Buenos Aires, DF, Argentina; [Volkmer, Rudolf] Charite, Inst Immunol, Berlin, Germany; [Bier, Frank F.] Fraunhofer Inst Cell Therapy & Immunol Branch Bio, Dept Biosystem Integrat & Automat, Potsdam, Germany; [Kar, Parimal] Indian Inst Technol Indore, Ctr Biosci & Biomed Engn, Indore, MP, India; [Knecht, Volker] Univ Freiburg, Inst Phys, Dept Biomol Dynam, Freiburg, Germany	Fraunhofer Gesellschaft; University of Potsdam; Humboldt University of Berlin; Max Planck Society; University of Buenos Aires; University of Buenos Aires; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fraunhofer Gesellschaft; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore; University of Freiburg	Stocklein, WFM (corresponding author), Fraunhofer Inst Cell Therapy & Immunol Branch Bio, Dept Bioanalyt & Biosensor, Potsdam, Germany.	walter.stoecklein@izi-bb.fraunhofer.de	Bier, Frank/AAN-2532-2020; Lauster, Daniel/AAD-5167-2022; Knecht, Volker/AAN-7337-2021	Bier, Frank/0000-0003-0375-9832; Volkmer, Rudolf/0000-0003-4710-1143; Lauster, Daniel/0000-0003-2009-633X; Kar, Parimal/0000-0001-8451-9739	German Federal Ministry of Education and Research [FKZ 03 IS2201 A]; Deutsche Forschungsgemeinschaft [SFB 765, C6]; Alexander von Humboldt foundation	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation)	This work was supported by grant FKZ 03 IS2201 A of the German Federal Ministry of Education and Research (www.bmbf.de). Additional funding was given by the Deutsche Forschungsgemeinschaft, project SFB 765, C6 (www.dfg.de). SDL is grateful for a postdoc stipend of the Alexander von Humboldt foundation (www.humboldt-foundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendolia MG, 2012, PATHOG GLOB HEALTH, V106, P12, DOI 10.1179/2047773212Y.0000000004; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BIZEBARD T, 1994, ACTA CRYSTALLOGR D, V50, P768, DOI 10.1107/S0907444994001903; Case D.A., 2014, AMBER, V14, P29; Choi SK, 1996, CHEM BIOL, V3, P97, DOI 10.1016/S1074-5521(96)90285-9; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Cross G, 2002, SEMIN AVIAN EXOT PET, V11, P15, DOI 10.1053/saep.2002.28236; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESSELBERGER U, 1975, ARCH VIROL, V49, P365, DOI 10.1007/BF01318246; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Fasting C, 2012, ANGEW CHEM INT EDIT, V51, P10472, DOI 10.1002/anie.201201114; Favre M, 1999, J AM CHEM SOC, V121, P2679, DOI 10.1021/ja984016p; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Friesen RHE, 2014, P NATL ACAD SCI USA, V111, P445, DOI 10.1073/pnas.1319058110; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Grienke U, 2012, NAT PROD REP, V29, P11, DOI 10.1039/c1np00053e; Hatano K, 2014, J MED CHEM, V57, P8332, DOI 10.1021/jm5007676; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jones JC, 2011, ANTIMICROB AGENTS CH, V55, P1810, DOI 10.1128/AAC.01428-10; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kar P, 2012, J PHYS CHEM B, V116, P6269, DOI 10.1021/jp300818c; Kar P, 2012, J PHYS CHEM B, V116, P6137, DOI 10.1021/jp3022612; Kar P, 2012, J COMPUT AID MOL DES, V26, P215, DOI 10.1007/s10822-012-9550-5; Kar P, 2012, J PHYS CHEM B, V116, P2605, DOI 10.1021/jp211768n; Kar P, 2011, J PHYS CHEM B, V115, P7661, DOI 10.1021/jp201538t; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; Laune D, 1997, J BIOL CHEM, V272, P30937, DOI 10.1074/jbc.272.49.30937; Lauster D, 2015, BEILSTEIN J ORG CHEM, V11, P589, DOI 10.3762/bjoc.11.65; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Li QL, 2011, PEPTIDES, V32, P1518, DOI 10.1016/j.peptides.2011.05.015; Lopez-Martinez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076876; MAMMEN M, 1995, J MED CHEM, V38, P4179, DOI 10.1021/jm00021a007; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Matsubara T, 2010, J MED CHEM, V53, P4441, DOI 10.1021/jm1002183; Nicol MQ, 2012, J GEN VIROL, V93, P980, DOI 10.1099/vir.0.038679-0; Papp I, 2011, CHEMBIOCHEM, V12, P887, DOI 10.1002/cbic.201000776; Papp I, 2010, SMALL, V6, P2900, DOI 10.1002/smll.201001349; Pelay-Gimeno M, 2015, ANGEW CHEM INT EDIT, V54, P8896, DOI 10.1002/anie.201412070; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rajik M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-74; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; van der Vries E, 2013, ADV PHARMACOL, V67, P217, DOI 10.1016/B978-0-12-405880-4.00006-8; Waldmann M, 2014, J AM CHEM SOC, V136, P783, DOI 10.1021/ja410918a; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023058; Yang J, 2013, VIRUSES-BASEL, V5, P352, DOI 10.3390/v5010352; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Yusuf M, 2013, J CHEM INF MODEL, V53, P2423, DOI 10.1021/ci400421e	61	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159074	10.1371/journal.pone.0159074	http://dx.doi.org/10.1371/journal.pone.0159074			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415624	gold, Green Submitted, Green Published			2022-12-26	WOS:000379579500069
J	Nymo, IH; Seppola, M; Al Dahouk, S; Bakkemo, KR; de Bagues, MPJ; Godfroid, J; Larsen, AK				Nymo, Ingebjorg Helena; Seppola, Marit; Al Dahouk, Sascha; Bakkemo, Kathrine Ryvold; Pilar Jimenez de Bagues, Maria; Godfroid, Jacques; Larsen, Anett Kristin			Experimental Challenge of Atlantic Cod (Gadus morhua) with a Brucella pinnipedialis Strain from Hooded Seal (Cystophora cristata)	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDSI; HEAD KIDNEY MACROPHAGES; CARASSIUS-AURATUS L.; MARINE-MAMMAL TYPE; MYCOBACTERIUM-MARINUM; EXPRESSION ANALYSIS; IMMUNE-RESPONSES; HARBOR SEALS; ANTIMICROBIAL RESPONSES; FRANCISELLA-NOATUNENSIS	Pathology has not been observed in true seals infected with Brucella pinnipedialis. A lack of intracellular survival and multiplication of B. pinnipedialis in hooded seal (Cystophora cristata) macrophages in vitro indicates a lack of chronic infection in hooded seals. Both epidemiology and bacteriological patterns in the hooded seal point to a transient infection of environmental origin, possibly through the food chain. To analyse the potential role of fish in the transmission of B. pinnipedialis, Atlantic cod (Gadus morhua) were injected intraperitoneally with 7.5 x 10(7) bacteria of a hooded seal field isolate. Samples of blood, liver, spleen, muscle, heart, head kidney, female gonads and feces were collected on days 1, 7, 14 and 28 post infection to assess the bacterial load, and to determine the expression of immune genes and the specific antibody response. Challenged fish showed an extended period of bacteremia through day 14 and viable bacteria were observed in all organs sampled, except muscle, until day 28. Neither gross lesions nor mortality were recorded. Anti-Brucella antibodies were detected from day 14 onwards and the expression of hepcidin, cathelicidin, interleukin (IL)-1 beta, IL-10, and interferon (IFN)-gamma genes were significantly increased in spleen at day 1 and 28. Primary mononuclear cells isolated from head kidneys of Atlantic cod were exposed to B. pinnipedialis reference (NCTC 12890) and hooded seal (17a-1) strain. Both bacterial strains invaded mononuclear cells and survived intracellularly without any major reduction in bacterial counts for at least 48 hours. Our study shows that the B. pinnipedialis strain isolated from hooded seal survives in Atlantic cod, and suggests that Atlantic cod could play a role in the transmission of B. pinnipedialis to hooded seals in the wild.	[Nymo, Ingebjorg Helena; Godfroid, Jacques; Larsen, Anett Kristin] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Infect Biol, Tromso, Norway; [Seppola, Marit] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Al Dahouk, Sascha] Fed Inst Risk Assessment, Berlin, Germany; [Al Dahouk, Sascha] Rhein Westfal TH Aachen, Dept Internal Med 3, Aachen, Germany; [Bakkemo, Kathrine Ryvold] PHARMAQ AS, Oslo, Norway; [Pilar Jimenez de Bagues, Maria] Univ Zaragoza, CITA, Inst Agroalimentario Aragon IA2, Unidad Tecnol Prod & Sanidad Anim, Zaragoza, Spain	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Federal Institute for Risk Assessment; RWTH Aachen University; University of Zaragoza	Larsen, AK (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Infect Biol, Tromso, Norway.	anett.k.larsen@uit.no	Godfroid, Jacques/HCI-7835-2022; Larsen, Anett Kristin/K-6020-2019; Godfroid, Jacques/U-3524-2017	Larsen, Anett Kristin/0000-0002-2121-2286; Godfroid, Jacques/0000-0002-0782-7858; Jimenez de Bagues, Maria Pilar/0000-0002-5490-5177; Al Dahouk, Sascha/0000-0003-3835-0818; Nymo, Ingebjorg Helena/0000-0002-4844-8344	German Federal Institute for Risk Assessment, Berlin, Germany [1329-520, 1322-578]; Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway; National Institute for Agricultural and Food Research and Technology (INIA) in Spain [RTA 2013-00065-C02-01]; PHARMAQ AS	German Federal Institute for Risk Assessment, Berlin, Germany; Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway; National Institute for Agricultural and Food Research and Technology (INIA) in Spain; PHARMAQ AS	This project was financed by the German Federal Institute for Risk Assessment, Berlin, Germany (grant no. 1329-520 and 1322-578), http://www.bfr.bund.de/en/home.html, and the Fram Centre - High North Research Centre for Climate and the Environment, Tromso, Norway, http://www.npolar.no/en/research/fram-centre.html. MPJdB was supported by the grant RTA 2013-00065-C02-01 from The National Institute for Agricultural and Food Research and Technology (INIA) in Spain, http://www.inia.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PHARMAQ AS provided support in the form of salaries for authors [KRB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Alton G G, 1975, Monogr Ser World Health Organ, P1; Bakkemo KR, 2011, FISH SHELLFISH IMMUN, V31, P993, DOI 10.1016/j.fsi.2011.08.020; Bakkemo KR, 2016, NOATUNENSIS INVADE S; BETTS M, 1993, INFECT IMMUN, V61, P1722, DOI 10.1128/IAI.61.5.1722-1729.1993; Bingham J, 2008, NEW ZEAL VET J, V56, P10, DOI 10.1080/00480169.2008.36798; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Eisenberg T, 2012, APPL ENVIRON MICROB, V78, P3753, DOI 10.1128/AEM.07509-11; El-Tras WF, 2010, VET MICROBIOL, V141, P321, DOI 10.1016/j.vetmic.2009.09.017; Ellingsen T, 2011, FISH SHELLFISH IMMUN, V31, P326, DOI 10.1016/j.fsi.2011.05.021; ESPELID S, 1991, J FISH DIS, V14, P185, DOI 10.1111/j.1365-2761.1991.tb00588.x; Fischer D, 2012, J ZOO WILDLIFE MED, V43, P625, DOI 10.1638/2011-0005R2.1; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Furnes C, 2009, FISH SHELLFISH IMMUN, V26, P285, DOI 10.1016/j.fsi.2008.12.002; Garner MM, 1997, J VET DIAGN INVEST, V9, P298, DOI 10.1177/104063879700900311; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Grayfer L, 2014, DEV COMP IMMUNOL, V43, P223, DOI 10.1016/j.dci.2013.08.003; Grayfer L, 2011, DEV COMP IMMUNOL, V35, P1146, DOI 10.1016/j.dci.2011.04.007; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Hagenaars TJ, 2004, J THEOR BIOL, V229, P349, DOI 10.1016/j.jtbi.2004.04.002; Haug T, 2007, MAR BIOL RES, V3, P123, DOI 10.1080/17451000701358531; Hodgkinson JW, 2012, DEV COMP IMMUNOL, V38, P456, DOI 10.1016/j.dci.2012.07.006; Lambourn D, 2013, J WILDLIFE DIS, V49, P802, DOI 10.7589/2012-05-137; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084861; Larsen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070186; Larsen AK, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0188-5; Lehnert K, 2010, INT J PARASITOL, V40, P845, DOI 10.1016/j.ijpara.2009.12.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund V, 2006, DEV COMP IMMUNOL, V30, P1145, DOI 10.1016/j.dci.2006.02.004; Maier VH, 2008, MOL IMMUNOL, V45, P3723, DOI 10.1016/j.molimm.2008.06.002; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; McDonald WL, 2006, J CLIN MICROBIOL, V44, P4363, DOI 10.1128/JCM.00680-06; Mikalsen J, 2009, J FISH DIS, V32, P377, DOI 10.1111/j.1365-2761.2008.00987.x; Mikkelsen H, 2013, FISH SHELLFISH IMMUN, V34, P387, DOI 10.1016/j.fsi.2012.10.010; Mikkelsen H, 2011, FISH SHELLFISH IMMUN, V30, P330, DOI 10.1016/j.fsi.2010.11.007; Nielsen K, 2002, VET MICROBIOL, V90, P447, DOI 10.1016/S0378-1135(02)00229-8; NIELSEN K, 2008, OIE MANUAL DIAGNOSTI, P634; Nymo IH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150432; Nymo IH, 2014, COMP IMMUNOL MICROB, V37, P195, DOI 10.1016/j.cimid.2014.01.005; Nymo IH, 2013, DIS AQUAT ORGAN, V106, P187, DOI 10.3354/dao02659; Nymo IH, 2013, J VET DIAGN INVEST, V25, P369, DOI 10.1177/1040638713485073; Nymo IH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-93; Olsen AB, 2006, J FISH DIS, V29, P307, DOI 10.1111/j.1365-2761.2006.00714.x; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Perrett LL, 2004, SMALL RUMINANT RES, V51, P221, DOI 10.1016/S0921-4488(03)00233-5; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rhyan JC, 2001, J VET DIAGN INVEST, V13, P379, DOI 10.1177/104063870101300502; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; ROSS HM, 1994, VET REC, V134, P359, DOI 10.1136/vr.134.14.359-b; Salem SF, 1997, VET MED-CZECH, V42, P5; Scholz HC, 2008, EMERG INFECT DIS, V14, P1316, DOI 10.3201/eid1408.080286; Schroder M. B., 1992, Fish & Shellfish Immunology, V2, P211, DOI 10.1016/S1050-4648(05)80060-9; Schroder MB, 2009, FISH SHELLFISH IMMUN, V27, P112, DOI 10.1016/j.fsi.2008.11.016; Secombes CJ, 2011, DEV COMP IMMUNOL, V35, P1336, DOI 10.1016/j.dci.2011.05.001; Seppola M, 2008, MOL IMMUNOL, V45, P887, DOI 10.1016/j.molimm.2007.08.003; Seppola M, 2007, DEV COMP IMMUNOL, V31, P156, DOI 10.1016/j.dci.2006.05.009; Seppola M, 2009, DEV COMP IMMUNOL, V33, P1205, DOI 10.1016/j.dci.2009.06.013; Solstad T, 2008, FISH SHELLFISH IMMUN, V25, P298, DOI 10.1016/j.fsi.2008.05.013; Sorensen KK, 1997, J FISH DIS, V20, P93, DOI 10.1046/j.1365-2761.1997.d01-112.x; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Steiro K, 1998, J FISH DIS, V21, P335, DOI 10.1046/j.1365-2761.1998.00110.x; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Tryland M, 2005, VET MICROBIOL, V105, P103, DOI 10.1016/j.vetmic.2004.11.001; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; Vos Q, 2000, IMMUNOL REV, V176, P154; Wang TH, 2013, FISH SHELLFISH IMMUN, V35, P1703, DOI 10.1016/j.fsi.2013.08.030; Whatmore AM., 2015, JMM CASE REPORTS, V2, P1, DOI [10.1099/jmmcr.0.000017, DOI 10.1099/JMMCR.0.000017]; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zarnke RL, 2006, J WILDLIFE DIS, V42, P290, DOI 10.7589/0090-3558-42.2.290; Zou Jun, 2016, Biology-Basel, V5, P23, DOI 10.3390/biology5020023	72	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159272	10.1371/journal.pone.0159272	http://dx.doi.org/10.1371/journal.pone.0159272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415626	Green Published, gold			2022-12-26	WOS:000379579500117
J	Fischer, M; Renevey, N; Thur, B; Hoffmann, D; Beer, M; Hoffmann, B				Fischer, Melina; Renevey, Nathalie; Thur, Barbara; Hoffmann, Donata; Beer, Martin; Hoffmann, Bernd			Efficacy Assessment of Nucleic Acid Decontamination Reagents Used in Molecular Diagnostic Laboratories	PLOS ONE			English	Article							PCR; CONTAMINATION	The occurrence of nucleic acid cross contamination in the laboratory resulting in false positive results of diagnostic samples is seriously problematic. Despite precautions to minimize or even avoid nucleic acid cross contaminations, it may appear anyway. Until now, no standardized strategy is available to evaluate the efficacy of commercially offered decontamination reagents. Therefore, a protocol for the reliable determination of nucleic acid decontamination efficacy using highly standardized solution and surface tests was established and validated. All tested sodium hypochlorite-based reagents proved to be highly efficient in nucleic acid decontamination even after short reaction times. For DNA Away, a sodium hydroxide-based decontamination product, dose- and time-dependent effectiveness was ascertained. For two other commercial decontamination reagents, the phosphoric acid-based DNA Remover and the non-enzymatic reagent DNA-ExitusPlus (TM) IF, no reduction of amplifiable DNA/RNA was observed. In conclusion, a simple test procedure for evaluation of the elimination efficacy of decontamination reagents against amplifiable nucleic acid is presented.	[Fischer, Melina; Hoffmann, Donata; Beer, Martin; Hoffmann, Bernd] Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany; [Renevey, Nathalie; Thur, Barbara] Inst Immunol & Virol, Sensemattstr 293, D-3147 Mittelhausern, Germany; [Fischer, Melina] Genolytic GmbH, Deutsch Pl 5, D-04103 Leipzig, Germany	Friedrich Loeffler Institute	Hoffmann, B (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany.	Bernd.Hoffmann@fli.bund.de		Hoffmann, Donata/0000-0003-4552-031X				[Anonymous], 2009, 1656 DIN EN; [Anonymous], 2014, 14349 DIN EN; Arena A., 2010, INVESTIG SCI J, V2, P20; BELAK S, 1993, MOL CELL PROBE, V7, P241, DOI 10.1006/mcpr.1993.1035; Cantalupo PG, 2015, J VIROL, V89, P4051, DOI 10.1128/JVI.03365-14; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Deutsche Veterinarmedizinische Gesellschaft e.V, 2000, RICHTL PRUF CHEM DES; Esser KH, 2006, BIOTECHNIQUES, V40, P238, DOI 10.2144/06402AF01; Haerinck S., 2011, J FORENSIC RES, VS2; Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Niederhauser C, 1994, PCR Methods Appl, V4, P117; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; Reybrouck G, 1998, INT BIODETER BIODEGR, V41, P269, DOI 10.1016/S0964-8305(98)00024-9; Tetzner Reimo, 2009, V507, P357, DOI 10.1007/978-1-59745-522-0_26; van Klingeren B, 1998, INT BIODETER BIODEGR, V41, P289, DOI 10.1016/S0964-8305(98)00020-1	17	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159274	10.1371/journal.pone.0159274	http://dx.doi.org/10.1371/journal.pone.0159274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410228	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300075
J	Kripke, K; Vazzano, A; Kirungi, W; Musinguzi, J; Opio, A; Ssempebwa, R; Nakawunde, S; Kyobutungi, S; Akao, JN; Magala, F; Mwidu, G; Castor, D; Njeuhmeli, E				Kripke, Katharine; Vazzano, Andrea; Kirungi, William; Musinguzi, Joshua; Opio, Alex; Ssempebwa, Rhobbinah; Nakawunde, Susan; Kyobutungi, Sheila; Akao, Juliet N.; Magala, Fred; Mwidu, George; Castor, Delivette; Njeuhmeli, Emmanuel			Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting	PLOS ONE			English	Article							HIV PREVENTION; IMPROVEMENTS; RAKAI; MEN	Background Uganda aims to provide safe male circumcision (SMC) to 80% of men ages 15-49 by 2016. To date, only 2 million men have received SMC of the 4.2 million men required. In response to age and regional trends in SMC uptake, the country sought to re-examine its targets with respect to age and subnational region, to assess the program's progress, and to refine the implementation approach. Methods and Findings The Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0), was used in conjunction with incidence projections from the Spectrum/AIDS Impact Module (AIM) to conduct this analysis. Population, births, deaths, and HIV incidence and prevalence were used to populate the model. Baseline male circumcision prevalence was derived from the 2011 AIDS Indicator Survey. Uganda can achieve the most immediate impact on HIV incidence by circumcising men ages 20-34. This group will also require the fewest circumcisions for each HIV infection averted. Focusing on men ages 10-19 will offer the greatest impact over a 15-year period, while focusing on men ages 15-34 offers the most cost-effective strategy over the same period. A regional analysis showed little variation in cost-effectiveness of scaling up SMC across eight regions. Scale-up is cost-saving in all regions. There is geographic variability in program progress, highlighting two regions with low baseline rates of circumcision where additional efforts will be needed. Conclusion Focusing SMC efforts on specific age groups and regions may help to accelerate Uganda's SMC program progress. Policy makers in Uganda have already used model outputs in planning efforts, proposing males ages 10-34 as a priority group for SMC in the 2014 application to the Global Fund's new funding model. As scale-up continues, the country should also consider a greater effort to expand SMC in regions with low MC prevalence.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Vazzano, Andrea] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Kirungi, William; Musinguzi, Joshua; Opio, Alex] Minist Hlth, Kampala, Uganda; [Ssempebwa, Rhobbinah; Nakawunde, Susan; Kyobutungi, Sheila] US Agcy Int Dev, Kampala, Uganda; [Akao, Juliet N.] US Dept Def, Kampala, Uganda; [Magala, Fred; Mwidu, George] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Castor, Delivette; Njeuhmeli, Emmanuel] USAID, Washington, DC USA	United States Agency for International Development (USAID); Makerere University; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Vazzano, Andrea/0000-0001-9653-4151	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AID-OAA-A-10-00067, AID-OAA-14-00026]; USAID	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AID-OAA-A-10-00067, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID-funded Health Policy Project. The authors gratefully acknowledge the Ugandan Ministry of Health for providing the data for this analysis. We thank the PEPFAR VMMC Technical Working Group and colleagues from the U.S. Centers for Disease Control and Prevention in Kampala for their feedback, helpful discussion, and information sharing. We thank Melissa Schnure for assistance with some of the analyses, figure preparation, and overall management of the manuscript preparation process. The authors are also grateful to the publications staff at the Health Policy Project for their assistance with copy editing and formatting.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2012, UG DEM HLTH SURV 201; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Baine SO, 2009, SITUATION ANAL DETER; Brown T, 2014, AIDS, V28, pS415, DOI 10.1097/QAD.0000000000000454; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2016, PLOS ONE IN PRESS; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Hasunira R, 2012, TOO LITTLE TOO SLOW; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; Kripke K, PLOS ONE; Kripke K, 2016, PLOS ONE IN PRESS; MOH ICF, 2012, UG AIDS IND SURV 201; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; The Joint United Nation Programme on HIV/AIDS, 2014, 90 90 90 AMB TREATM; Uganda Ministry of Health (MOH) ICF International, 2012, 2011 UG AIDS IND SUR; UNAIDS, 2013, REP GLOB AIDS EP; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO Regional Office for Africa, 2013, PROGR SCAL VOL MED M; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	25	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158693	10.1371/journal.pone.0158693	http://dx.doi.org/10.1371/journal.pone.0158693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410234	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300031
J	Khoa, LTP; Azami, T; Tsukiyama, T; Matsushita, J; Tsukiyama-Fujii, S; Takahashi, S; Ema, M				Le Tran Phuc Khoa; Azami, Takuya; Tsukiyama, Tomoyuki; Matsushita, Jun; Tsukiyama-Fujii, Setsuko; Takahashi, Satoru; Ema, Masatsugu			Visualization of the Epiblast and Visceral Endodermal Cells Using Fgf5-P2A-Venus BAC Transgenic Mice and Epiblast Stem Cells	PLOS ONE			English	Article							MOUSE EMBRYOS; GROUND-STATE; IN-VIVO; PLURIPOTENT CELLS; PRIMITIVE STREAK; CHIMERIC EMBRYO; SELF-RENEWAL; NANOG; GENE; GASTRULATION	Fibroblast growth factor 5 (Fgf5) has been widely used as a marker for the epiblast in the postimplantation embryo and epiblast stem cells (mEpiSCs) in the mouse, making it valuable for study of differentiation of various tissues and epiblast cells in vivo and in vitro. Here, we report for the first time the generation of Fgf5-P2A-Venus BAC transgenic (Tg) mice and show that the BAC Tg can recapitulate endogenous Fgf5 expression in epiblast and visceral endodermal cells of E6.5 and 7.5 embryos. We also show that Fgf5-P2A-Venus BAC Tg mEpiSCs in the undifferentiated state expressed abundant Venus, and upon reprogramming into naive state, Venus was suppressed. Furthermore, while most Tg mEpiSCs expressed Venus abundantly, surprisingly the Tg mEpiSCs contained a minor subpopulation of Venus-negative cells that were capable of conversion to Venus-positive cells, indicating that even Fgf5 expression shows dynamic heterogeneity in mEpiSCs. Taken together, Fgf5-P2A-Venus BAC Tg mice and mEpiSCs generated in this study will be useful for developmental biology as well as stem cell biology research.	[Le Tran Phuc Khoa] Univ Tsukuba, Sch Integrat & Global Majors, PhD Program Human Biol, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Azami, Takuya; Takahashi, Satoru] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Azami, Takuya; Tsukiyama, Tomoyuki; Matsushita, Jun; Tsukiyama-Fujii, Setsuko; Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Otsu, Shiga, Japan; [Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Ema, Masatsugu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tsukuba; University of Tsukuba; Shiga University of Medical Science; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Azami, T (corresponding author), Univ Tsukuba, Fac Med, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan.; Azami, T; Ema, M (corresponding author), Shiga Univ Med Sci, Res Ctr Anim Life Sci, Dept Stem Cells & Human Dis Models, Otsu, Shiga, Japan.; Ema, M (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	tazami@belle.shiga-med.ac.jp; mema@belle.shiga-med.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020; Le, Khoa/AAL-2599-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719; Ema, Masatsugu/0000-0003-0645-6183; Tran Phuc Le, Khoa/0000-0002-6076-3857; Azami, Takuya/0000-0002-3759-9710	PRESTO, Japan Science and Technology Agency (JST)	PRESTO, Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by a grant from PRESTO, Japan Science and Technology Agency (JST) (to M.E.) and a Grant-in-Aid for JSPS Fellows (to T.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ms. Keiko Amagai for preparation of BAC Tg DNA. This work was supported in part by a grant from PRESTO, Japan Science and Technology Agency (JST) (to M. E.) and a Grant-in-Aid for JSPS Fellows (to T. A.)	Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Gasnier M, 2013, NAT PROTOC, V8, P2538, DOI 10.1038/nprot.2013.160; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guzman-Ayala M, 2015, DEVELOPMENT, V142, P118, DOI 10.1242/dev.114843; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanaka H, 2014, EXP ANIM TOKYO, V63, P85, DOI 10.1538/expanim.63.85; HAUB O, 1991, DEVELOPMENT, V112, P397; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; HEBERT JM, 1990, DEV BIOL, V138, P454, DOI 10.1016/0012-1606(90)90211-Z; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Huang YL, 2012, CELL REP, V2, P1571, DOI 10.1016/j.celrep.2012.10.022; Jeon H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150715; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lawson KA, 1999, INT J DEV BIOL, V43, P773; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mason J., 1994, CELL, V79, P547; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Pelton TA, 2002, J CELL SCI, V115, P329; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Straub L, 2015, MOL METAB, V4, P605, DOI 10.1016/j.molmet.2015.06.008; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trott J, 2013, BIOL OPEN, V2, P1049, DOI 10.1242/bio.20135934; Tsakiridis A, 2014, DEVELOPMENT, V141, P1209, DOI 10.1242/dev.101014; YEOM YI, 1991, MECH DEVELOP, V35, P171; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159246	10.1371/journal.pone.0159246	http://dx.doi.org/10.1371/journal.pone.0159246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409080	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300071
J	Randremanana, RV; Razafindratsimandresy, R; Andriatahina, T; Randriamanantena, A; Ravelomanana, L; Randrianirina, F; Richard, V				Randremanana, Rindra Vatosoa; Razafindratsimandresy, Richter; Andriatahina, Todisoa; Randriamanantena, Arthur; Ravelomanana, Lovaniaina; Randrianirina, Frederique; Richard, Vincent			Etiologies, Risk Factors and Impact of Severe Diarrhea in the Under-Fives in Moramanga and Antananarivo, Madagascar	PLOS ONE			English	Article							ROTAVIRUS VACCINE; CHILDREN; BURDEN; GASTROENTERITIS; UNDERNUTRITION; INFECTIONS; NOROVIRUS; STRAINS; DISEASE; TRENDS	Background Diarrheal disease remains a leading cause of death in children in low-income countries. We investigated the etiology, risk factors and effects on nutritional status of severe diarrhea in children from two districts in Madagascar. Methods We performed a matched case-control study in 2011 to 2014, on children under the age of five years from Moramanga and Antananarivo. The cases were children hospitalized for severe diarrhea and the controls were children without diarrhea selected at random from the community. Stool samples were collected from both groups. Anthropometric measurements were made during follow-up visits about one and two months after enrolment. Results We enrolled 199 cases and 199 controls. Rotavirus infection was the most frequently detected cause of diarrhea. It was strongly associated with severe diarrhea (OR: 58.3; 95% CI: 7.7-439.9), accounting for 42.4%(95% CI: 37.6-43.1) of severe diarrhea cases. At the household level, possession of cattle (OR = 0.3; 95% CI: 0.1-0.6) and living in a house with electricity (OR = 0.4; 95% CI: 0.2-0.8) were protective factors. The presence of garbage around the house was a risk factor for severe diarrhea (OR = 3.2; 95% CI: 1.9-5.4). We found no significant association between severe diarrhea and the nutritional status of the children at follow-up visits, but evident wasting at enrolment was associated with a higher risk of severe diarrhea (OR = 9; 95% CI: 4.5-17.9). Conclusions Severe childhood diarrhea is mostly caused by rotavirus infection. An anti-rotavirus vaccine has already been introduced in Madagascar and should be promoted more widely. However, post-licensing surveillance is required. Interventions to improve the nutritional status of children, preventive measures focused on household and personal hygiene and nutritional rehabilitation during severe diarrheal disease should be reinforced.	[Randremanana, Rindra Vatosoa; Randriamanantena, Arthur] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Razafindratsimandresy, Richter] Inst Pasteur Madagascar, Virol Unit, Antananarivo, Madagascar; [Andriatahina, Todisoa] Ctr Hospitalier Dist Niveau 2, Serv Pediat, Moramanga, Madagascar; [Ravelomanana, Lovaniaina] Ctr Hosp Univ Mere Enfant Ambohimiandra, Antananarivo, Madagascar; [Randrianirina, Frederique] Inst Pasteur Madagascar, Clin Biol Ctr, Antananarivo, Madagascar; [Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Randremanana, RV (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	rrandrem@pasteur.mg		Vincent, RICHARD/0000-0002-6961-1753	TOTAL Foundation; Cellule Realisatrice de Projet of the epidemiology unit of the Institut Pasteur de Madagascar	TOTAL Foundation(Total SA); Cellule Realisatrice de Projet of the epidemiology unit of the Institut Pasteur de Madagascar	Funded by TOTAL Foundation. The funding was given to the Institut Pasteur de Madagascar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all study participants and all workers from the pediatrics departments of CHD2 Moramanga and the Centre Hospitalier Mere Enfant d'Ambohimiandra. We also thank Prof. Philippe Sansonetti from Institut Pasteur de Paris, Prof. Christophe Rogier, Marie Gousseff, Hugues Cordel, Perlinot Herindrainy, Jean Marius Rakotondramanga, Dr Patrice Piola and the Cellule Realisatrice de Projet of the epidemiology unit of the Institut Pasteur de Madagascar for their support.	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Al-Mazrou Y Y, 1995, J Family Community Med, V2, P27; Alam DS, 2000, INT J EPIDEMIOL, V29, P916, DOI 10.1093/ije/29.5.916; Banyai K, 2009, J CLIN VIROL, V46, P391, DOI 10.1016/j.jcv.2009.08.005; Boadi KO, 2005, WORLD HLTH POPULATIO; Candy DCA, 2007, PLOS MED, V4, P614, DOI 10.1371/journal.pmed.0040117; Cattaneo MD, 2007, HOUSING HLTH HAPPINE; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Groome MJ, 2014, LANCET INFECT DIS, V14, P1096, DOI 10.1016/S1473-3099(14)70940-5; Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kossmann J, 2000, EUR J CLIN NUTR, V54, P463, DOI 10.1038/sj.ejcn.1600998; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Krumkamp Ralf, 2015, PLoS Negl Trop Dis, V9, pe0003728, DOI 10.1371/journal.pntd.0003728; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luchs A, 2014, J CLIN VIROL, V59, P74, DOI 10.1016/j.jcv.2013.11.001; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Masibo PK, 2012, PUBLIC HEALTH NUTR, V15, P1715, DOI 10.1017/S1368980012002856; Muller D, 2007, APPL ENVIRON MICROB, V73, P3380, DOI 10.1128/AEM.02855-06; Mwangome MK, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-92; Nhampossa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119824; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; Papaventsis DC, 2007, EMERG INFECT DIS, V13, P908, DOI 10.3201/eid1306.070215; Randremanana R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044533; Randremanana RV, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-372; Razafindratsimandresy R, 2013, J MED VIROL, V85, P1652, DOI 10.1002/jmv.23631; Team RDC, 2019, R LANG ENV STAT COMP; Vasco G, 2014, AM J TROP MED HYG, V91, P563, DOI 10.4269/ajtmh.13-0744; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158862	10.1371/journal.pone.0158862	http://dx.doi.org/10.1371/journal.pone.0158862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411101	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300037
J	Richardson, VA; Peres, CA				Richardson, Vanessa A.; Peres, Carlos A.			Temporal Decay in Timber Species Composition and Value in Amazonian Logging Concessions	PLOS ONE			English	Article							FOREST MANAGEMENT; NATURAL-RESOURCE; SUSTAINABILITY; DEFORESTATION; EXTINCTION; ATLANTIC; FRONTIER; VULNERABILITY; EXPLOITATION; CONSERVATION	Throughout human history, slow-renewal biological resource populations have been predictably overexploited, often to the point of economic extinction. We assess whether and how this has occurred with timber resources in the Brazilian Amazon. The asynchronous advance of industrial-scale logging frontiers has left regional-scale forest landscapes with varying histories of logging. Initial harvests in unlogged forests can be highly selective, targeting slow-growing, high-grade, shade-tolerant hardwood species, while later harvests tend to focus on fast-growing, light-wooded, long-lived pioneer trees. Brazil accounts for 85% of all native neotropical forest roundlog production, and the State of Para for almost half of all timber production in Brazilian Amazonia, the largest old-growth tropical timber reserve controlled by any country. Yet the degree to which timber harvests beyond the first-cut can be financially profitable or demographically sustainable remains poorly understood. Here, we use data on legally planned logging of similar to 17.3 million cubic meters of timber across 314 species extracted from 824 authorized harvest areas in private and community-owned forests, 446 of which reported volumetric composition data by timber species. We document patterns of timber extraction by volume, species composition, and monetary value along aging eastern Amazonian logging frontiers, which are then explained on the basis of historical and environmental variables. Generalized linear models indicate that relatively recent logging operations farthest from heavy-traffic roads are the most selective, concentrating gross revenues on few high-value species. We find no evidence that the post-logging timber species composition and total value of forest stands recovers beyond the first-cut, suggesting that the commercially most valuable timber species become predictably rare or economically extinct in old logging frontiers. In avoiding even more destructive land-use patterns, managing yields of selectively-logged forests is crucial for the long-term integrity of forest biodiversity and financial viability of local industries. The logging history of eastern Amazonian old-growth forests likely mirrors unsustainable patterns of timber depletion over time in Brazil and other tropical countries.	[Richardson, Vanessa A.; Peres, Carlos A.] Univ East Anglia, Sch Environm Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Richardson, VA (corresponding author), Univ East Anglia, Sch Environm Sci, Ctr Ecol Evolut & Conservat, Norwich NR4 7TJ, Norfolk, England.	vanessa-anne.richardson@uea.ac.uk; C.Peres@uea.ac.uk	Peres, Carlos A./B-1276-2013; Peres, Carlos Augusto/N-8275-2019; Peres, Carlos A./ABE-8361-2020	Peres, Carlos A./0000-0002-1588-8765; Peres, Carlos A./0000-0002-1588-8765	NERC PhD studentship at UEA [1092538]; NERC doctoral studentship at the University of East Anglia; CAPES [PVE 004/2012]; Natural Environment Research Council [1092538] Funding Source: researchfish; The British Council [GII111] Funding Source: researchfish	NERC PhD studentship at UEA; NERC doctoral studentship at the University of East Anglia(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); The British Council	We thank the Secretaria Especial do Meio Ambiente do Estado do Para (SEMA) for making raw data on forest management plans available and IMAZON (Instituto do Homem e Ambiente da Amazonia) for discussing these data with us. VAR was funded by a NERC PhD studentship (1092538) at UEA. We thank P Amaral for insightful discussions about selective logging in the eastern Amazon.; VAR is supported by an NERC doctoral studentship (http://www.nerc.ac.uk/) at the University of East Anglia. CAP co-wrote this paper during a CAPES-funded visiting fellowship (http://www.capes.gov.br/) to Museu Goeldi, Brazil (PVE 004/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Barlow J, 2003, J TROP ECOL, V19, P291, DOI 10.1017/S0266467403003328; Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Brandt JS, 2016, LAND USE POLICY, V52, P15, DOI 10.1016/j.landusepol.2015.11.028; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busa JHM, 2013, CONSERV LETT, V6, P192, DOI 10.1111/j.1755-263X.2012.00304.x; Bacha CJC, 2007, ECOL ECON, V63, P70, DOI 10.1016/j.ecolecon.2006.09.024; Cardoso MA, 1998, MOL ECOL, V7, P601, DOI 10.1046/j.1365-294x.1998.00363.x; CLARK CW, 1973, J POLIT ECON, V81, P950, DOI 10.1086/260090; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Crawley M. J, 2002, STAT COMPUTING INTRO; de Avila AL, 2015, BIOL CONSERV, V191, P577, DOI 10.1016/j.biocon.2015.08.004; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Edwards DP, 2013, SCIENCE, V339, P646, DOI 10.1126/science.339.6120.646-b; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; FAO, 2012, STAT WORLDS FOR; Field A., 2012, DISCOVERING STAT USI; Finer M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04719; Freitas da Silva M., 1977, NOMES VULGARES PLANT; Galetti M, 1998, J APPL ECOL, V35, P294, DOI 10.1046/j.1365-2664.1998.00295.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Greenpeace, 2014, AM SIL CRIS; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; He F, 2014, ECOLOGY, V83, P1185; Higgins MA, 2004, CONSERV BIOL, V18, P799, DOI 10.1111/j.1523-1739.2004.00235.x; Holmes T, 2002, FOR ECOL, V5583, P1; Homma A. K. O., 1992, Advances in Economic Botany, V9, P23; Howard AF, 1996, FOREST ECOL MANAG, V89, P43, DOI 10.1016/S0378-1127(96)03867-4; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; IBAMA, 2008, LIST ESP AM EXT; ITTO, 2012, ANN REV ASS WORLD TR; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kammesheidt L, 2001, J APPL ECOL, V38, P756, DOI 10.1046/j.1365-2664.2001.00629.x; Kastner T, 2011, GLOBAL ENVIRON CHANG, V21, P947, DOI 10.1016/j.gloenvcha.2011.05.003; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laporte NT, 2007, SCIENCE, V316, P1451, DOI 10.1126/science.1141057; Laufer J, 2013, TROP CONSERV SCI, V6, P16, DOI 10.1177/194008291300600106; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Leao TCC, 2014, CONSERV BIOL, V28, P1349, DOI 10.1111/cobi.12286; Levi T, 2013, BIOL CONSERV, V163, P99, DOI 10.1016/j.biocon.2013.03.016; Lorenzi H, 2002, ARVORES BRASILEIRAS, V2; LORENZI H., 2016, ARVORES BRASILEIRAS, V1; LORENZI H, 1998, ARVORES BRASILEIRAS, V2; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mace GM, 1999, CONSERV BIOL, V13, P242, DOI 10.1046/j.1523-1739.1999.013002242.x; MacKenzie BR, 2009, CONSERV LETT, V2, P25, DOI 10.1111/j.1755-263X.2008.00039.x; Macpherson AJ, 2012, LAND USE POLICY, V29, P339, DOI 10.1016/j.landusepol.2011.07.004; MARTINI AMZ, 1994, ENVIRON CONSERV, V21, P152, DOI 10.1017/S0376892900024589; May PH, 2004, ECON BOT, V58, P257, DOI 10.1663/0013-0001(2004)058[0257:REITBA]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Menard S.W., 1995, APPL LOGISTIC REGRES, V2nd ed.; Merry F, 2009, ENVIRON MANAGE, V44, P395, DOI 10.1007/s00267-009-9337-1; Monteiro A, 2008, ESTADO RESUMO ESTADO; Monteiro A, 2011, 15 S, P5615; Monteiro A, 2012, TRANSPARENCY FOREST, P14; Monteiro A, 2011, B TRANSPARENCIA MANE; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Nellemann C., 2012, RAPID RESPONSE ASSES; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; PARROTTA JA, 1995, TREES TAPAJOS PHOTOG; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pearce D, 2003, FOREST ECOL MANAG, V172, P229, DOI 10.1016/S0378-1127(01)00798-8; Pena-Claros M, 2008, FOREST ECOL MANAG, V256, P1458, DOI 10.1016/j.foreco.2007.11.013; PEREIRA D., 2010, FATOS FLORESTAIS AMA, V1; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; Peres CA, 2012, BIOL CONSERV, V151, P65, DOI 10.1016/j.biocon.2011.11.011; Peres CA, 2010, CONSERVATION BIOLOGY FOR ALL, P107; Perez MR, 2005, FOREST ECOL MANAG, V214, P221, DOI 10.1016/j.foreco.2005.04.020; Phillips PD, 2004, ECOL MODEL, V173, P335, DOI 10.1016/j.ecolmodel.2003.09.023; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Plumptre AJ, 1996, FOREST ECOL MANAG, V89, P101, DOI 10.1016/S0378-1127(96)03854-6; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; REPETTO R, 1988, PUBLIC POLICIES MISU; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE, V1; Rice RE, 1997, SCI AM, V276, P44, DOI 10.1038/scientificamerican0497-44; RODAN BD, 1992, ENVIRON CONSERV, V19, P331, DOI 10.1017/S0376892900031453; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Romero C., 2015, CONTEXT NATURAL FORE; Schulze M, 2008, FOREST ECOL MANAG, V256, P1443, DOI 10.1016/j.foreco.2008.02.051; Servitho Florestal Brasileiro, 2013, FLOR BRAS RES 2013 D; SFB, 2013, PLAN AN OUT FLOR 201; Shearman P, 2012, BIOL CONSERV, DOI [10.1016/j.biocon.2011.10.036, DOI 10.1016/J.BIOCON.2011.10.]; Sist P, 2007, FOREST ECOL MANAG, V243, P199, DOI 10.1016/j.foreco.2007.02.014; Smith J, 2006, FOREST POLICY ECON, V8, P458, DOI 10.1016/j.forpol.2005.08.001; SMITH VL, 1968, AM ECON REV, V58, P409; Sorrell S, 2010, ENERG POLICY, V38, P5290, DOI 10.1016/j.enpol.2010.04.046; Southworth J, 2011, REMOTE SENS-BASEL, V3, P1047, DOI 10.3390/rs3051047; Souza CM, 2005, REMOTE SENS ENVIRON, V98, P329, DOI 10.1016/j.rse.2005.07.013; Souza Jr C, 1997, SERIE AMAZONIA, V8; Stone SW, 1998, WORLD DEV, V26, P433, DOI 10.1016/S0305-750X(97)10056-0; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; UHL C, 1991, FOREST ECOL MANAG, V46, P243, DOI 10.1016/0378-1127(91)90235-N; Uhl C, 1997, BIOSCIENCE, V47, P160, DOI 10.2307/1313035; Verissimo A, 1998, CONSERV BIOL, V12, P128, DOI 10.1046/j.1523-1739.1998.96234.x; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; Wadsworth FH, 2006, FOREST ECOL MANAG, V233, P45, DOI 10.1016/j.foreco.2006.05.072; Weinhold D, 2015, GLOBAL ENVIRON CHANG, V35, P391, DOI 10.1016/j.gloenvcha.2015.09.013; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Zarin DJ, 2007, CONSERV BIOL, V21, P916, DOI 10.1111/j.1523-1739.2007.00670.x; Zimmerman BL, 2012, BIOSCIENCE, V62, P479, DOI 10.1525/bio.2012.62.5.9; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	111	38	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159035	10.1371/journal.pone.0159035	http://dx.doi.org/10.1371/journal.pone.0159035			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410029	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300052
J	MacDonald, NJ; Nguyen, V; Shimp, R; Reiter, K; Herrera, R; Burkhardt, M; Muratova, O; Kumar, K; Aebig, J; Rausch, K; Lambert, L; Dawson, N; Sattabongkot, J; Ambroggio, X; Duffy, PE; Wu, YM; Narum, DL				MacDonald, Nicholas J.; Vu Nguyen; Shimp, Richard; Reiter, Karine; Herrera, Raul; Burkhardt, Martin; Muratova, Olga; Kumar, Krishan; Aebig, Joan; Rausch, Kelly; Lambert, Lynn; Dawson, Nikiah; Sattabongkot, Jetsumon; Ambroggio, Xavier; Duffy, Patrick E.; Wu, Yimin; Narum, David L.			Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; protein structure; recombinant protein expression; vaccine; yeast; Pfs230; Pichia pastoris; transmission blocking	TRANSMISSION-BLOCKING VACCINE; RTS,S/AS01 MALARIA VACCINE; AERUGINOSA EXOPROTEIN-A; SURFACE-ANTIGEN PFS230; ANTIBODY-RESPONSES; ESCHERICHIA-COLI; CANDIDATE; PFS48/45; IMMUNITY; TARGET	Development of a Plasmodium falciparum (Pf) transmission blocking vaccine (TBV) has the potential to significantly impact malaria control. Antibodies elicited against sexual stage proteins in the human bloodstream are taken up with the blood meal of the mosquitoes and inactivate parasite development in the mosquito. In a phase 1 trial, a leading TBV identified as Pfs25-EPA/Alhydrogel (R) appeared safe and immunogenic, however, the level of Pfs25-specific antibodies were likely too low for an effective vaccine. Pfs230, a 230-kDa sexual stage protein expressed in gametocytes is an alternative vaccine candidate. A unique 6-cysteine-rich domain structure within Pfs230 have thwarted its recombinant expression and characterization for clinical evaluation for nearly a quarter of a century. Here, we report on the identification, biochemical, biophysical, and immunological characterization of recombinant Pfs230 domains. Rabbit antibodies generated against recombinant Pfs230 domains blocked mosquito transmission of a laboratory strain and two field isolates using an ex vivo assay. A planned clinical trial of the Pfs230 vaccine is a significant step toward the potential development of a transmission blocking vaccine to eliminate malaria.	[MacDonald, Nicholas J.; Vu Nguyen; Shimp, Richard; Reiter, Karine; Herrera, Raul; Burkhardt, Martin; Muratova, Olga; Kumar, Krishan; Aebig, Joan; Rausch, Kelly; Lambert, Lynn; Dawson, Nikiah; Duffy, Patrick E.; Wu, Yimin; Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Twinbrook 1,Rm 1115, Rockville, MD 20852 USA; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok 10400, Thailand; [Ambroggio, Xavier] Rosetta Design Grp LLC, Burlington, VT 05401 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Narum, DL (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Twinbrook 1,Rm 1115, Rockville, MD 20852 USA.	dnarum@niaid.nih.gov	Prachumsri, Jetsumon/AAZ-7732-2021	Narum, David/0000-0003-3041-5402; Sattabongkot, Jetsumon/0000-0002-3938-4588	Wellcome Trust [098051, 090770]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001008, ZIAAI001009, ZIAAI001007] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Buddhadeb Mallik, Dr. Guan-Hong Song, Dr. Yanling Zhang, and Christopher Rowe for technical assistance within the Laboratory of Malaria Immunology and Vaccinology. Dr. Carl Hammer, Mark Garfield, from Research Technologies Branch, NIAID, for analytical support, and Dr. Michael Fay, from Biostatistics Research Branch, NIAID, for statistical support. Dr. Michael Nold from Waters Inc. for assistance with disulfide mapping studies, and Dr. Julian Rayner for the assistance with genotypic analysis of Pfs230 from the Wellcome Trust Sanger Institute. Finally we appreciate Dr. Louis Miller for his support and helpful discussion, This publication uses data from the MalariaGEN Pfalciparum Community Project as described in Ref. 28. Genome sequencing was performed by the Wellcome Trust Sanger Institute and the Community Projects is coordinated by the MalariaGENResource Centre with funding from the Wellcome Trust Grants 098051 and 090770.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Brooks SR, 2000, MOL BIOCHEM PARASIT, V106, P77, DOI 10.1016/S0166-6851(99)00201-7; Bustamante PJ, 2000, PARASITE IMMUNOL, V22, P373, DOI 10.1046/j.1365-3024.2000.00315.x; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Farrance CE, 2011, CLIN VACCINE IMMUNOL, V18, P1351, DOI 10.1128/CVI.05105-11; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Herrera R, 2015, INFECT IMMUN, V83, P3771, DOI 10.1128/IAI.02676-14; Jones S, 2015, J INFECTION, V71, P117, DOI 10.1016/j.jinf.2015.03.007; KOCKEN CHM, 1993, MOL BIOCHEM PARASIT, V61, P59, DOI 10.1016/0166-6851(93)90158-T; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Miura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057909; Niederwieser Igor, 2001, American Journal of Tropical Medicine and Hygiene, V64, P9; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Parker ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139407; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Qian F, 2008, VACCINE, V26, P2521, DOI 10.1016/j.vaccine.2008.03.005; Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; READ D, 1994, PARASITE IMMUNOL, V16, P511, DOI 10.1111/j.1365-3024.1994.tb00305.x; ROEFFEN W, 1995, EXP PARASITOL, V80, P15, DOI 10.1006/expr.1995.1003; ROEFFEN W, 1995, INFECT IMMUN, V63, P467, DOI 10.1128/IAI.63.2.467-471.1995; Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034; Simon N, 2016, PARASITOL INT, V65, P27, DOI 10.1016/j.parint.2015.09.007; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Strait RT, 2015, NATURE, V517, P501, DOI 10.1038/nature13868; Tachibana M, 2011, CLIN VACCINE IMMUNOL, V18, P1343, DOI 10.1128/CVI.05104-11; Templeton TJ, 1999, MOL BIOCHEM PARASIT, V101, P223, DOI 10.1016/S0166-6851(99)00066-3; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Uchime O, 2012, EUKARYOT CELL, V11, P615, DOI 10.1128/EC.00039-12; Vincent AA, 1999, PARASITE IMMUNOL, V21, P573, DOI 10.1046/j.1365-3024.1999.00255.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williamson KC, 2003, PARASITE IMMUNOL, V25, P351, DOI 10.1046/j.1365-3024.2003.00643.x; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; Wu YM, 2006, P NATL ACAD SCI USA, V103, P18243, DOI 10.1073/pnas.0608545103; Wu Yu-Huan, 2008, P3; Zhu DM, 2005, J IMMUNOL METHODS, V306, P40, DOI 10.1016/j.jim.2005.07.021	45	62	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19913	19922		10.1074/jbc.M116.732305	http://dx.doi.org/10.1074/jbc.M116.732305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27432885	hybrid, Green Published			2022-12-26	WOS:000383243100016
J	Zhang, B; Du, YL; Lu, W; Yan, XY; Yang, Q; Yang, W; Luo, JH				Zhang, Bin; Du, Yong-lan; Lu, Wen; Yan, Xun-yi; Yang, Qian; Yang, Wei; Luo, Jian-hong			Increased Activity of Src Homology 2 Domain Containing Phosphotyrosine Phosphatase 2 (Shp2) Regulates Activity-dependent AMPA Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SYNAPTIC NMDA RECEPTORS; LONG-TERM POTENTIATION; NOONAN-SYNDROME; SURFACE EXPRESSION; MEMORY FORMATION; PHOSPHORYLATION; PLASTICITY; SUBUNIT; ACTIVATION	Long term synaptic plasticity, such as long term potentiation (LTP), has been widely accepted as a cellular mechanism underlying memory. Recently, it has been unraveled that Shp2 plays a role in synaptic plasticity and memory in Drosophila and mice, revealing significant and conserved effects of Shp2 in cognitive function. However, the exact mechanism underlying this function of Shp2 in synaptic plasticity and memory still remains elusive. Here, we examine the regulation of Shp2 in hippocampal LTP and contextual tear conditioning. We find that Shp2 is rapidly recruited into spines after LTP induction. Furthermore, the phosphorylation level of Shp2 at Tyr-542 is elevated after LTP stimuli either in cultured hippocampal neurons or acute slices. Notably, contextual fear conditioning also regulates the phosphorylation level of Shp2 at Tyr-542, suggesting fine-tuned regulation of Shp2 in LTP and memory formation. By using a Shp2-specific inhibitor and adeno-associated virus-Cre mediated Shp2 knock-out in cultured neurons, we provide evidence that the phosphatase activity of Shp2 is critical for activity-dependent AMPA receptor surface trafficking. Collectively, our results have revealed a regulatory mechanism of Shp2 underlying LTP and memory, broadening our understanding of Shp2 in cognitive function.	[Zhang, Bin; Du, Yong-lan; Lu, Wen; Yan, Xun-yi; Yang, Qian; Yang, Wei; Luo, Jian-hong] Zhejiang Univ, Key Lab Med Neurobiol, Collaborat Innovat Ctr Brain Sci, Dept Neurobiol,Minist Hlth China,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Luo, JH (corresponding author), 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	Lu, Wen/AAL-8524-2020; Luo, jian/HGE-7331-2022	Yang, Qian/0000-0001-9861-2790	Natural Science Foundation of China [91232303, 81221003, 81561168022]; National Basic Research Program of China [2014CB910300]; Fundamental Research Funds for the Central Universities of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China Grants 91232303, 81221003, and 81561168022, National Basic Research Program of China Grant 2014CB910300, and the Fundamental Research Funds for the Central Universities of China. The authors declare that they have no conflict of interest with the contents of this article.	Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Barki-Harrington L, 2009, J NEUROSCI, V29, P9219, DOI 10.1523/JNEUROSCI.5667-08.2009; Bates Mark, 2013, Cold Spring Harb Protoc, V2013, P498, DOI 10.1101/pdb.top075143; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Corera AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006021; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Grosskopf S, 2015, CHEMMEDCHEM, V10, P815, DOI 10.1002/cmdc.201500015; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kusakari S, 2015, MOL CELL BIOL, V35, P1557, DOI 10.1128/MCB.01339-14; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; Lu W, 2015, EXP NEUROL, V271, P251, DOI 10.1016/j.expneurol.2015.06.016; Lu W, 2015, J BIOL CHEM, V290, P22945, DOI 10.1074/jbc.M115.663450; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Peng HY, 2012, PAIN, V153, P1042, DOI 10.1016/j.pain.2012.02.006; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Ressels H. W., 2009, NEURON, V61, P340; Saladin K. D., 2021, ANATOMY PHYSL UNITY, V9th; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shen HW, 2008, BRAIN STRUCT FUNCT, V213, P149, DOI 10.1007/s00429-008-0184-2; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V211, P950, DOI 10.1006/bbrc.1995.1904; Tang Y, 2015, NEUROSCIENCE, V304, P109, DOI 10.1016/j.neuroscience.2015.07.021; Zhang XM, 2015, CELL RES, V25, P818, DOI 10.1038/cr.2015.75; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	33	13	14	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18856	18866		10.1074/jbc.M116.714501	http://dx.doi.org/10.1074/jbc.M116.714501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27417137	Green Published, hybrid			2022-12-26	WOS:000383242300024
J	Belchior, C; Sendoya, SF; Del-Claro, K				Belchior, Ceres; Sendoya, Sebastian F.; Del-Claro, Kleber			Temporal Variation in the Abundance and Richness of Foliage-Dwelling Ants Mediated by Extrafloral Nectar	PLOS ONE			English	Article							PLANT-HERBIVORE INTERACTIONS; ECOLOGICAL COMMUNITIES; NEOTROPICAL SAVANNA; SEASONAL-VARIATION; HOST-PLANT; PROTECTION; VEGETATION; FOREST; HONEYDEW; DEFENSE	Plants bearing extrafloral nectaries (EFNs) are common in the Brazilian cerrado savanna, where climatic conditions having marked seasonality influence arboreal ant fauna organization. These ant-plant interactions have rarely been studied at community level. Here, we tested whether: 1) EFN-bearing plants are more visited by ants than EFN-lacking plants; 2) ant visitation is higher in the rainy season than in dry season; 3) plants producing young leaves are more visited than those lacking young leaves in the rainy season; 4) during the dry season, plants with old leaves and flowers are more visited than plants with young leaves and bare of leaves or flowers; 5) the composition of visiting ant fauna differs between plants with and without EFNs. Field work was done in a cerrado reserve near Uberlandia, MG State, Brazil, along ten transects (total area 3,000 m(2)), in the rainy (October-January) and dry seasons (April-July) of 2010-2011. Plants (72 species; 762 individuals) were checked three times per season for ant presence. Results showed that 21 species (29%) and 266 individuals (35%) possessed EFNs. These plants attracted 38 ant species (36 in rainy, 26 in dry season). In the rainy season, plants with EFNs had higher ant abundance/richness than plants without EFNs, but in the dry season, EFN presence did not influence ant visitation. Plant phenology affected ant richness and abundance in different ways: plants with young leaves possessed higher ant richness in the rainy season, but in the dry season ant abundance was higher on plants possessing old leaves or flowers. The species composition of plant-associated ant communities, however, did not differ between plants with and without EFNs in either season. These findings suggest that the effect of EFN presence on a community of plant-visiting ants is context dependent, being conditioned to seasonal variation.	[Belchior, Ceres; Del-Claro, Kleber] Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos, Uberlandia, MG, Brazil; [Sendoya, Sebastian F.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, BR-6109 Campinas, SP, Brazil	Universidade Federal de Uberlandia; Universidade Estadual de Campinas	Del-Claro, K (corresponding author), Univ Fed Uberlandia, Inst Biol, Programa Posgrad Ecol & Conservacao Recursos, Uberlandia, MG, Brazil.	delclaro@ufu.br	Del-Claro, K/C-5570-2013; Sendoya, Sebastian/J-9716-2012; Del-Claro, Kleber/N-3700-2019	Del-Claro, K/0000-0001-8886-9568; Sendoya, Sebastian/0000-0003-3728-9090; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CB received a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; KDC received research fellowship and grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; SFS received a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Aguirre A, 2013, FLORA, V208, P147, DOI 10.1016/j.flora.2013.02.008; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Belchior C, 2014, THESIS; Belchior C, 2012, ARTHROPOD-PLANT INTE, V6, P571, DOI 10.1007/s11829-012-9208-1; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; Bixenmann RJ, 2011, OECOLOGIA, V165, P417, DOI 10.1007/s00442-010-1787-x; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; BODINI A, 1989, BIOSYSTEMS, V22, P289, DOI 10.1016/0303-2647(89)90050-6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borges MP, 2014, FLORA, V209, P73, DOI 10.1016/j.flora.2013.10.004; Byk J, 2011, POPUL ECOL, V53, P327, DOI 10.1007/s10144-010-0240-7; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Camarota F, 2015, ECOLOGY, V96, P231, DOI 10.1890/14-0264.1; Campos RI, 2014, ARTHROPOD-PLANT INTE, V8, P507, DOI 10.1007/s11829-014-9338-8; Chamberlain SA, 2008, ECOLOGY, V89, P1364, DOI 10.1890/07-1139.1; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Damascos MA, 2005, ANN BOT-LONDON, V96, P1075, DOI 10.1093/aob/mci258; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dejean A, 2000, SOCIOBIOLOGY, V36, P227; Del-Claro K, 1999, BIOTROPICA, V31, P135, DOI 10.2307/2663967; Del-Claro K, 2004, NEOTROP ENTOMOL, V33, P665, DOI 10.1590/S1519-566X2004000600002; Del-Claro K, 2016, INSECT SOC, V63, P207, DOI 10.1007/s00040-016-0466-2; Del-Claro K, 2015, BIOTROPICA, V47, P459, DOI 10.1111/btp.12227; Del-Claro K, 2009, NEOTROP ENTOMOL, V38, P159, DOI 10.1590/S1519-566X2009000200001; Diaz-Castelazo C, 2004, ECOSCIENCE, V11, P472, DOI 10.1080/11956860.2004.11682857; Diaz-Castelazo C, 2013, ANN BOT-LONDON, V111, P1285, DOI 10.1093/aob/mct071; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Gotelli NJ, 2011, PRINCIPIOS ESTATISTI, DOI DOI 10.1007/s10533-006-9007-9; Guimaraes PR, 2011, ECOL LETT, V14, P877, DOI 10.1111/j.1461-0248.2011.01649.x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Ibarra-Isassi J, 2016, ARTHROPOD-PLANT INTE, V10, P221, DOI 10.1007/s11829-016-9429-9; JANZEN DANIEL H., 1967, UNIV KANS SCI SCI BULL, V47, P315; Junker RR, 2011, ECOL MONOGR, V81, P295, DOI 10.1890/10-1367.1; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; KISS A, 1981, OIKOS, V37, P382, DOI 10.2307/3544132; KOPPEN W, 1948, CLIMATOLOGIA CON UN; Koptur S, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P75, DOI 10.1017/CBO9780511542220.004; Korndorfer AP, 2006, BIOTROPICA, V38, P786, DOI 10.1111/j.1744-7429.2006.00200.x; Lach L, 2009, POPUL ECOL, V51, P237, DOI 10.1007/s10144-008-0132-2; Lange D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105574; Lange D, 2013, ECOL ENTOMOL, V38, P463, DOI 10.1111/een.12036; Marazzi B, 2013, ANN BOT-LONDON, V111, P1243, DOI 10.1093/aob/mct109; Melo Y, 2010, ACTA BOT BRAS, V24, P1034, DOI 10.1590/S0102-33062010000400018; Mody K, 2004, ECOL ENTOMOL, V29, P217, DOI 10.1111/j.1365-2311.2004.0588.x; Moreira VSS, 2005, NEOTROP ENTOMOL, V34, P881, DOI 10.1590/S1519-566X2005000600002; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Muniz DG, 2012, STUD NEOTROP FAUNA E, V47, P111, DOI 10.1080/01650521.2012.698932; Nahas L, 2012, BIOTROPICA, V44, P498, DOI 10.1111/j.1744-7429.2011.00850.x; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Oliveira PS, 2004, NATURWISSENSCHAFTEN, V91, P557, DOI 10.1007/s00114-004-0585-x; OLIVEIRA PS, 1987, BIOTROPICA, V19, P140, DOI 10.2307/2388736; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Powell S, 2011, J ANIM ECOL, V80, P352, DOI 10.1111/j.1365-2656.2010.01779.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ribas CR, 2003, AUSTRAL ECOL, V28, P305, DOI 10.1046/j.1442-9993.2003.01290.x; Rico-Gray V., 2008, V171, P221; Rico-Gray V, 1998, BIOTROPICA, V30, P190, DOI 10.1111/j.1744-7429.1998.tb00054.x; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; RICOGRAY V, 1993, BIOTROPICA, V25, P301, DOI 10.2307/2388788; RICOGRAY V, 1989, BIOL J LINN SOC, V38, P173, DOI 10.1111/j.1095-8312.1989.tb01572.x; Rosario-Martinez HD, 2015, PHIA POSTHOC INTERAC; Rosumek FB, 2009, OECOLOGIA, V160, P537, DOI 10.1007/s00442-009-1309-x; RUFFNER GA, 1986, AM J BOT, V73, P185, DOI 10.2307/2444171; Santos MF, 2011, ACTA BOT BRAS, V25, P793, DOI 10.1590/S0102-33062011000400007; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Sendoya SF, 2016, ARTHROPOD-PLANT INTE, V10, P183, DOI 10.1007/s11829-016-9423-2; Sendoya SF, 2015, J ANIM ECOL, V84, P442, DOI 10.1111/1365-2656.12286; Shenoy M, 2012, J CHEM ECOL, V38, P88, DOI 10.1007/s10886-011-0052-z; Silva DP, 2010, ENVIRON ENTOMOL, V39, P1903, DOI 10.1603/EN10129; Skaug H., 2013, GEN LINEAR MIXED MOD; Stefani V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131843; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Tizo-Pedroso E, 2007, INSECT SOC, V54, P124, DOI 10.1007/s00040-007-0931-z; Vasconcelos HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007762; Vilela AA, 2014, FLORA, V209, P359, DOI 10.1016/j.flora.2014.04.004; Wagner D, 2002, EVOL ECOL RES, V4, P293; Zuur Alain F., 2009, P1	87	23	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158283	10.1371/journal.pone.0158283	http://dx.doi.org/10.1371/journal.pone.0158283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438722	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100010
J	Calamia, M; Bernstein, JPK; Keller, JN				Calamia, Matthew; Bernstein, John P. K.; Keller, Jeffrey N.			I'd Do Anything for Research, But I Won't Do That: Interest in Pharmacological Interventions in Older Adults Enrolled in a Longitudinal Aging Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL STATUS RBANS; ALZHEIMERS-DISEASE PATIENTS; CLINICAL-TRIALS; REPEATABLE BATTERY; DEMENTIA RESEARCH; DECISION-MAKING; PARTICIPATION; RECRUITMENT; ATTITUDES	Alzheimer's disease (AD) ranks as the 6th leading cause of death in the United States, yet unlike other diseases in this category, there are no disease-modifying medications for AD. Currently there is significant interest in exploring the benefits of pharmacological treatment before the onset of dementia (e.g., in those with mild cognitive impairment); however, recruitment for such studies is challenging. The current study examined interest in pharmacological intervention trials relative to other types of clinical interventions. A total of 67 non-demented older adults enrolled in a longitudinal cognitive aging study completed a questionnaire assessing interest in participating in a variety of hypothetical research study designs. Consistent with past research, results showed that the opportunities for participants to advance science, receive feedback about their current health, and help themselves or others, were associated with increased interest in clinical trial participation. Some factors were not associated with change in interest (e.g., a doctor not recommending participation) while others were associated with decreased interest (e.g., having to come in for multiple visits each week). Relative to other types of interventions, pharmacological intervention trials were associated with the least interest in participation, despite pharmacological interventions being rated as more likely to result in AD treatment. Decreased interest was not predicted by subjective memory concerns, number of current medications, cardiovascular risk, or beliefs about the likely success of pharmacological treatments. These results highlight the challenges faced by researchers investigating pharmacological treatments in non-demented older individuals, and suggest future research could contribute to more effective ways of recruiting participants in AD-related clinical trials.	[Calamia, Matthew; Bernstein, John P. K.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Keller, Jeffrey N.] Pennington Biomed Res Ctr, Inst Dementia Res & Prevent, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Calamia, M (corresponding author), Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA.	mcalamia@lsu.edu	Keller, Jeffrey N/N-1975-2017	Calamia, Matthew/0000-0002-7252-7181; keller, jeffrey/0000-0002-9892-7423	NIH "Walking and Cognitive Remediation Effects on Cerebrovascular Function and Gait" [R21AG044258]	NIH "Walking and Cognitive Remediation Effects on Cerebrovascular Function and Gait"	This work was supported by NIH R21AG044258 "Walking and Cognitive Remediation Effects on Cerebrovascular Function and Gait" (JNK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Avent C, 2013, INT PSYCHOGERIATR, V25, P963, DOI 10.1017/S1041610213000252; Ayalon L, 2009, AM J GERIAT PSYCHIAT, V17, P65, DOI 10.1097/JGP.0b013e31818cd3d3; Barreira T, 2012, J SCI MED SPORT, V15, pS293; Beck CK, 1998, AM J GERIAT PSYCHIAT, V6, pS41, DOI 10.1097/00019442-199821001-00006; Black BS, 2013, AM J GERIAT PSYCHIAT, V21, P355, DOI 10.1016/j.jagp.2012.11.009; Brouillette RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065925; Brouillette RM, 2011, J ALZHEIMERS DIS, V23, P665, DOI 10.3233/JAD-2011-101455; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Carr SA, 2010, ALZ DIS ASSOC DIS, V24, P165, DOI 10.1097/WAD.0b013e3181aba927; Cary MS, 2014, ALZ DIS ASSOC DIS, V29, P70; Cohen-Mansfield J, 2001, AM J GERIAT PSYCHIAT, V9, P361, DOI 10.1176/appi.ajgp.9.4.361; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; Connell CM, 2001, ALZ DIS ASSOC DIS, V15, P137, DOI 10.1097/00002093-200107000-00005; Dunn Laura B, 2011, Narrat Inq Bioeth, V1, P107, DOI 10.1353/nib.2011.0034; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; Fitzpatrick AL, 2006, CONTEMP CLIN TRIALS, V27, P541, DOI 10.1016/j.cct.2006.06.007; Garand L, 2009, RES GERONTOL NURS, V2, P112, DOI 10.3928/19404921-20090401-04; Grill JD, 2014, ALZ DIS ASSOC DIS, V28, P1, DOI 10.1097/WAD.0000000000000016; Grill JD, 2013, ALZHEIMERS DEMENT, V9, P356, DOI 10.1016/j.jalz.2012.03.001; Grill JD, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt58; Hansen RA, 2008, CLIN INTERV AGING, V3, P211; JAGER CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI DOI 10.1002/GPS.2758; Jefferson AL, 2012, AM J GERIAT PSYCHIAT, V20, P878, DOI 10.1097/JGP.0b013e318252e5cb; Jefferson AL, 2011, J ALZHEIMERS DIS, V23, P443, DOI 10.3233/JAD-2010-101536; Karantzoulis S, 2013, ARCH CLIN NEUROPSYCH, V28, P837, DOI 10.1093/arclin/act057; Kim SYH, 2002, AM J PSYCHIAT, V159, P797, DOI 10.1176/appi.ajp.159.5.797; Lingler Jennifer Hagerty, 2010, Alzheimer Dis Assoc Disord, V24 Suppl, pS30, DOI 10.1097/WAD.0b013e3181f14ac0; MacAulay RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099436; Mastwyk M, 2002, INT PSYCHOGERIATR, V14, P39, DOI 10.1017/S1041610202008268; Montgomery SA, 2003, INT CLIN PSYCHOPHARM, V18, P61, DOI 10.1097/00004850-200303000-00001; Morrison K, 2014, J APPL GERONTOL; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reiman EM, 2015, NATURE REV NEUROLOGY; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rolison J. J., 2013, J GERONTOL B-PSYCHOL; Rollin-Sillaire A, 2013, BRIT J CLIN PHARMACO, V75, P1089, DOI 10.1111/j.1365-2125.2012.04423.x; Schuna JM, 2013, MED SCI SPORT EXER, V45, P914, DOI 10.1249/MSS.0b013e31827e47ac; Treves TA, 2000, ALZ DIS ASSOC DIS, V14, P209, DOI 10.1097/00002093-200010000-00004; Tudor-Locke C., 2012, J PHYS ACT HLTH; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Williams Monique M, 2010, Alzheimer Dis Assoc Disord, V24 Suppl, pS24, DOI 10.1097/WAD.0b013e3181f14a14	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159664	10.1371/journal.pone.0159664	http://dx.doi.org/10.1371/journal.pone.0159664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438465	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100062
J	Cattadori, IM; Sebastian, A; Hao, H; Katani, R; Albert, I; Eilertson, KE; Kapur, V; Pathak, A; Mitchell, S				Cattadori, Isabella M.; Sebastian, Aswathy; Hao, Han; Katani, Robab; Albert, Istvan; Eilertson, Kirsten E.; Kapur, Vivek; Pathak, Ashutosh; Mitchell, Susan			Impact of Helminth Infections and Nutritional Constraints on the Small Intestine Microbiota	PLOS ONE			English	Article							GUT MICROBIOTA; DENDRITIC CELLS; TRICHOSTRONGYLUS-RETORTAEFORMIS; IMMUNITY; COMMUNITIES; ACTIVATION; EXPRESSION; DIVERSITY; OBESITY; SEARCH	Helminth infections and nutrition can independently alter the composition and abundance of the gastrointestinal microbiota, however, their combined effect is poorly understood. Here, we used the T. retortaeformis-rabbit system to examine how the helminth infection and host restriction from coprophagy/ready-to-absorb nutrients affected the duodenal microbiota, and how these changes related to the acquired immune response at the site of infection. A factorial experiment was performed where the bacterial community, its functionality and the immune response were examined in four treatments (Infect, Infect+Collar, Control+Collar and Control). Helminths reduced the diversity and abundance of the microbiota while the combination of parasites and coprophagic restriction led to a more diversified and abundant microbiota than infected cases, without significantly affecting the intensity of infection. Animals restricted from coprophagy and free from parasites exhibited the richest and most abundant bacterial community. By forcing the individuals to absorb nutrients from less digested food, the coprophagic restriction appears to have facilitated the diversity and proliferation of bacteria in the duodenum. Changes in the microbiota were more clearly associated with changes in the immune response for the infected than the nutrient restricted animals. The functional and metabolic characteristics of the duodenal microbiota were not significantly different between treatments. Overall, infection and diet affect the gut microbiota but their interactions and outcome can be complex. These findings can have important implications for the development of control measures to helminth infections where poor nutrition/malnutrition can also be a concern.	[Cattadori, Isabella M.; Pathak, Ashutosh; Mitchell, Susan] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16082 USA; [Cattadori, Isabella M.; Pathak, Ashutosh; Mitchell, Susan] Penn State Univ, Dept Biol, University Pk, PA 16082 USA; [Sebastian, Aswathy; Albert, Istvan] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16082 USA; [Hao, Han; Eilertson, Kirsten E.] Penn State Univ, Dept Stat, University Pk, PA 16082 USA; [Katani, Robab; Kapur, Vivek] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16082 USA; [Pathak, Ashutosh] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia	Cattadori, IM (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16082 USA.; Cattadori, IM (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16082 USA.	imc3@psu.edu	Katani, Robab/AAS-1292-2020; Hao, Han/E-4024-2019; Albert, Istvan/J-3734-2015	Hao, Han/0000-0001-6674-1352; Cattadori, Isabella/0000-0001-6618-316X; Albert, Istvan/0000-0001-8366-984X	Pennsylvania Department of Health Tobacco Cure Funds; Pennsylvania State University, Huck Institutes of the Life Sciences; SEED grant	Pennsylvania Department of Health Tobacco Cure Funds; Pennsylvania State University, Huck Institutes of the Life Sciences; SEED grant	This study was funded by the Pennsylvania Department of Health Tobacco Cure Funds and the Pennsylvania State University, Huck Institutes of the Life Sciences with a SEED grant. IMC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2015, SOIL TRANSM HELM INF; Audebert F, 2000, J HELMINTHOL, V74, P95; Audebert F, 2003, VET PARASITOL, V112, P131, DOI 10.1016/S0304-4017(02)00386-2; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Berg JM, 2011, BIOCHEMISTRY; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Berrilli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00141; Brandt LJ, 2013, AM J GASTROENTEROL, V108, P177, DOI 10.1038/ajg.2012.450; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cattadori IM, 2005, P ROY SOC B-BIOL SCI, V272, P1163, DOI 10.1098/rspb.2004.3050; Cattadori IM, 2014, ECOLOGY, V95, P1684, DOI 10.1890/13-1538.1; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; Cornell SJ, 2008, P ROY SOC B-BIOL SCI, V275, P511, DOI 10.1098/rspb.2007.1415; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cranford JA, 1983, EFFECTS COPROPHAGY M; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; GRIFFITHS M, 1963, J NUTR, V80, P171, DOI 10.1093/jn/80.2.171; Harley ITW, 2012, MOL METAB, V1, P21, DOI 10.1016/j.molmet.2012.07.002; Hirakawa H, 2001, MAMMAL REV, V31, P61, DOI 10.1046/j.1365-2907.2001.00079.x; HOVINDHOUGEN K, 1979, INT J SYST BACTERIOL, V29, P245, DOI 10.1099/00207713-29-3-245; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kuever J R F, 2005, BERGEYS MANUAL SYSTE; KULWICH R, 1953, J NUTR, V49, P639, DOI 10.1093/jn/49.4.639; Kutner M., 2004, APPL LINEAR STAT MOD; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Lemon KP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004183; Leung JM, 2013, INT J PARASITOL, V43, P253, DOI 10.1016/j.ijpara.2012.10.015; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mavrommatis B, 2013, CURR OPIN IMMUNOL, V25, P456, DOI 10.1016/j.coi.2013.05.009; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murphy L, 2011, PARASITE IMMUNOL, V33, P287, DOI 10.1111/j.1365-3024.2011.01281.x; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Oksanen J, 2015, VEGAN COMMUNITY ECOL; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Rothman JM, 2013, NUTR ASPECTS DIET WI; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Thakar J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002345; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Van Kuren AT, 2013, PARASITOLOGY, V140, P632, DOI 10.1017/S0031182012001898; VERNAY M, 1986, REPROD NUTR DEV, V26, P1137, DOI 10.1051/rnd:19860705; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wei Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0973-1; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Yanagibashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P372, DOI 10.1271/bbb.80612; YOSHIDA T, 1968, BRIT J NUTR, V22, P723, DOI 10.1079/BJN19680082; Zeng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09342	74	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159770	10.1371/journal.pone.0159770	http://dx.doi.org/10.1371/journal.pone.0159770			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438701	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100074
J	Mathieu, S; Henrissat, B; Labre, F; Skjak-Braek, G; Helbert, W				Mathieu, Sophie; Henrissat, Bernard; Labre, Flavien; Skjak-Braek, Gudmund; Helbert, William			Functional Exploration of the Polysaccharide Lyase Family PL6	PLOS ONE			English	Article							HYDROLASE FAMILY; ALGINATE LYASE; FLAVOBACTERIUM-HEPARINUM; SUBSTRATE-SPECIFICITY; ANGSTROM RESOLUTION; DEGRADING ENZYMES; CRYSTAL-STRUCTURE; CHONDROITINASE B; PROTEIN; ACID	Alginate, the main cell-wall polysaccharide of brown algae, is composed of two residues: mannuronic acid (M-residues) and, its C5-epimer, guluronic acid (G-residues). Alginate lyases define a class of enzymes that cleave the glycosidic bond of alginate by beta-elimination. They are classified according to their ability to recognize the distribution of M- and G-residues and are named M-, G-or MG-lyases. In the CAZy database, alginate lyases have been grouped by sequence similarity into seven distinct polysaccharide lyase families. The polysaccharide lyase family PL6 is subdivided into three subfamilies. Subfamily PL6_1 includes three biochemically characterized enzymes (two alginate lyases and one dermatan sulfatase lyase). No characterized enzymes have been described in the two other subfamilies (PL6_2 and PL6_3). To improve the prediction of polysaccharide-lyase activity in the PL6 family, we re-examined the classification of the PL6 family and biochemically characterized a set of enzymes reflecting the diversity of the protein sequences. Our results show that subfamily PL6_1 includes two dermatan sulfates lyases and several alginate lyases that have various substrate specificities and modes of action. In contrast, subfamilies PL6_2 and PL6_3 were found to contain only endo-poly-MG-lyases.	[Mathieu, Sophie; Labre, Flavien; Helbert, William] CNRS, CERMAV, BP53, F-38000 Grenoble 9, France; [Mathieu, Sophie; Labre, Flavien; Helbert, William] Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France; [Henrissat, Bernard] Univ Aix Marseille, CNRS, UMR7257, F-13288 Marseille, France; [Henrissat, Bernard] INRA, USC AFMB 1408, F-13288 Marseille, France; [Skjak-Braek, Gudmund] Norwegian Univ Sci & Technol, Dept Biotechnol, NTNU Sem Saelands Vei 6-8, N-7491 Trondheim, Norway	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Norwegian University of Science & Technology (NTNU)	Helbert, W (corresponding author), CNRS, CERMAV, BP53, F-38000 Grenoble 9, France.; Helbert, W (corresponding author), Grenoble Alpes Univ, BP53, F-38000 Grenoble 9, France.	william.helbert@cermav.cnrs.fr	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588	Brittany Regional Council; OSEO, "Poly-mer" project [FUI-AAP14]	Brittany Regional Council(Region Bretagne); OSEO, "Poly-mer" project	The research leading to these results received funding from Brittany Regional Council and OSEO as part of the FUI-AAP14 "Poly-mer" project.	Aarstad OA, 2012, BIOMACROMOLECULES, V13, P106, DOI 10.1021/bm2013026; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Draget KI, 2002, BIOPOLYMERS; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Heyraud A, 1996, CARBOHYD RES, V289, P11, DOI 10.1016/0008-6215(96)00060-2; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Kraiwattanapong J, 1997, BIOSCI BIOTECH BIOCH, V61, P1853, DOI 10.1271/bbb.61.1853; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tkalec AL, 2000, APPL ENVIRON MICROB, V66, P29, DOI 10.1128/AEM.66.1.29-35.2000; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200	26	22	24	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159415	10.1371/journal.pone.0159415	http://dx.doi.org/10.1371/journal.pone.0159415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438604	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100044
J	Moore, SN; Hawley, GD; Smith, EN; Mignemi, NA; Ihejirika, RC; Yuasa, M; Cates, JMM; Liu, XL; Schoenecker, JG				Moore, Stephanie N.; Hawley, Gregory D.; Smith, Emily N.; Mignemi, Nicholas A.; Ihejirika, Rivka C.; Yuasa, Masato; Cates, Justin M. M.; Liu, Xulei; Schoenecker, Jonathan G.			Validation of a Radiography-Based Quantification Designed to Longitudinally Monitor Soft Tissue Calcification in Skeletal Muscle	PLOS ONE			English	Article							HETEROTOPIC OSSIFICATION; CARDIOTOXIN INJURY; RADIATION-THERAPY; PREVENTION; BONE; REGENERATION; INFECTION; MICE	Introduction Soft tissue calcification, including both dystrophic calcification and heterotopic ossification, may occur following injury. These lesions have variable fates as they are either resorbed or persist. Persistent soft tissue calcification may result in chronic inflammation and/or loss of function of that soft tissue. The molecular mechanisms that result in the development and maturation of calcifications are uncertain. As a result, directed therapies that prevent or resorb soft tissue calcifications remain largely unsuccessful. Animal models of post-traumatic soft tissue calcification that allow for cost-effective, serial analysis of an individual animal over time are necessary to derive and test novel therapies. We have determined that a cardiotoxin-induced injury of the muscles in the posterior compartment of the lower extremity represents a useful model in which soft tissue calcification develops remote from adjacent bones, thereby allowing for serial analysis by plain radiography. The purpose of the study was to design and validate a method for quantifying soft tissue calcifications in mice longitudinally using plain radiographic techniques and an ordinal scoring system. Methods Muscle injury was induced by injecting cardiotoxin into the posterior compartment of the lower extremity in mice susceptible to developing soft tissue calcification. Seven days following injury, radiographs were obtained under anesthesia. Multiple researchers applied methods designed to standardize post-image processing of digital radiographs (N = 4) and quantify soft tissue calcification (N = 6) in these images using an ordinal scoring system. Inter-and intra-observer agreement for both post-image processing and the scoring system used was assessed using weighted kappa statistics. Soft tissue calcification quantifications by the ordinal scale were compared to mineral volume measurements (threshold 450.7mgHA/cm(3)) determined by mu CT. Finally, sample-size calculations necessary to discriminate between a 25%, 50%, 75%, and 100% difference in STiCSS score 7 days following burn/CTX induced muscle injury were determined. Results Precision analysis demonstrated substantial to good agreement for both post-image processing (kappa = 0.73 to 0.90) and scoring (kappa = 0.88 to 0.93), with low inter-and intra-observer variability. Additionally, there was a strong correlation in quantification of soft tissue calcification between the ordinal system and by mineral volume quantification by mu CT (Spearman r = 0.83 to 0.89). The ordinal scoring system reliably quantified soft tissue calcification in a burn/CTX-induced soft tissue calcification model compared to non-injured controls (Mann-Whitney rank test: P = 0.0002, ***). Sample size calculations revealed that 6 mice per group would be required to detect a 50% difference in STiCSS score with a power of 0.8. Finally, the STiCSS was demonstrated to reliably quantify soft tissue calcification [dystrophic calcification and heterotopic ossification] by radiographic analysis, independent of the histopathological state of the mineralization. Conclusions Radiographic analysis can discriminate muscle injury-induced soft tissue calcification from adjacent bone and follow its clinical course over time without requiring the sacrifice of the animal. While the STiCSS cannot identify the specific type of soft tissue calcification present, it is still a useful and valid method by which to quantify the degree of soft tissue calcification. This methodology allows for longitudinal measurements of soft tissue calcification in a single animal, which is relatively less expensive, less time-consuming, and exposes the animal to less radiation than in vivo mu CT. Therefore, this high-throughput, longitudinal analytic method for quantifying soft tissue calcification is a viable alternative for the study of soft tissue calcification.	[Moore, Stephanie N.; Hawley, Gregory D.; Smith, Emily N.; Mignemi, Nicholas A.; Yuasa, Masato; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Med Ctr East, South Tower,Suite 4200,1215 21th Ave South, Nashville, TN 37232 USA; [Ihejirika, Rivka C.] Vanderbilt Univ, Sch Med, 2215 Garland Ave,Light Hall,Room 215, Nashville, TN 37232 USA; [Mignemi, Nicholas A.; Cates, Justin M. M.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave S, Nashville, TN 37232 USA; [Liu, Xulei] Vanderbilt Univ, Dept Biostat, 2525 West End,Ste 11000, Nashville, TN 37203 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pediat, 4202 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA; [Moore, Stephanie N.; Schoenecker, Jonathan G.] Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,Robinson Res Bldg Nashville, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthopaed & Rehabil, Med Ctr East, South Tower,Suite 4200,1215 21th Ave South, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave S, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, 4202 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.; Schoenecker, JG (corresponding author), Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,Robinson Res Bldg Nashville, Nashville, TN 37232 USA.	Jon.schoenecker@vanderbilt.edu	Cates, Justin M/D-5927-2014	Cates, Justin M/0000-0002-7336-5196; Ihejirika, Rivka/0000-0002-8858-6290	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R03AR065762-01A1]; Caitlin Lovejoy Fund; Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences; NIH [S10RR027631]; Predoctoral Training Program in Pharmacological Sciences [5T32GM007628-38]; Postdoctoral Vascular Biology Training Program [5T32HL007751]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Caitlin Lovejoy Fund; Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Program in Pharmacological Sciences; Postdoctoral Vascular Biology Training Program	Funding was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R03AR065762-01A1, JGS) and the Caitlin Lovejoy Fund (JGS). mu CT imaging and analysis were supported in part by the Center for Small Animal Imaging at the Vanderbilt University Institute of Imaging Sciences and by grant S10RR027631 from the NIH. SNM was supported by the Predoctoral Training Program in Pharmacological Sciences (5T32GM007628-38). NAM was supported by the Postdoctoral Vascular Biology Training Program (5T32HL007751).	Anthonissen J, 2015, ACTA ORTHOP TRAUMATO, V49, P197, DOI 10.3944/AOTT.2015.14.0271; AYERS DC, 1986, J BONE JOINT SURG AM, V68A, P1423, DOI 10.2106/00004623-198668090-00016; Bohannon J, 2010, J IMMUNOL, V185, P2847, DOI 10.4049/jimmunol.0903619; Bohannon JK, 2016, J LEUKOCYTE BIOL, V99, P629, DOI 10.1189/jlb.4A0815-362R; Brownley RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141432; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; Czerwinska AM, 2012, FOLIA HISTOCHEM CYTO, V50, P144, DOI [10.5603/FHC.2012.0021, 10.2478/18710]; Ebrahim MK, 2003, BURNS, V29, P461, DOI 10.1016/S0305-4179(03)00057-3; Hunt JL, 2006, J BURN CARE RES, V27, P535, DOI 10.1097/01.BCR.0000226023.58438.14; Kan LX, 2009, STEM CELLS, V27, P150, DOI 10.1634/stemcells.2008-0576; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Mignemi MY, 2016, JBMR IN PRESS; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; Parkinson J R, 1982, Hip, P211; Peterson JR, 2015, JOVE-J VIS EXP, DOI 10.3791/52880; Seegenschmiedt MH, 1997, INT J RADIAT ONCOL, V39, P161, DOI 10.1016/S0360-3016(97)00285-X; Seegenschmiedt MH, 2001, INT J RADIAT ONCOL, V51, P756, DOI 10.1016/S0360-3016(01)01640-6; Sergi C, 2001, AM J MED GENET, V103, P235, DOI 10.1002/ajmg.1541.abs; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Toliver-Kinsky TE, 2005, J IMMUNOL, V174, P404, DOI 10.4049/jimmunol.174.1.404; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Yuasa M, 2015, J CLIN INVEST, V125, P3117, DOI 10.1172/JCI80313	24	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159624	10.1371/journal.pone.0159624	http://dx.doi.org/10.1371/journal.pone.0159624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438007	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100057
J	Ershova, AI; Meshkov, AN; Rozhkova, TA; Kalinina, MV; Deev, AD; Rogoza, AN; Balakhonova, TV; Boytsov, SA				Ershova, Alexandra I.; Meshkov, Alexey N.; Rozhkova, Tatyana A.; Kalinina, Maria V.; Deev, Alexander D.; Rogoza, Anatoliy N.; Balakhonova, Tatyana V.; Boytsov, Sergey A.			Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; DENSITY-LIPOPROTEIN CHOLESTEROL; EXPERT CONSENSUS DOCUMENT; INTIMA-MEDIA THICKNESS; ARTERIAL STIFFNESS; RISK-FACTORS; AUGMENTATION INDEX; HEART-DISEASE; ATHEROSCLEROSIS; CALCIFICATION	Background The role of plasma cholesterol in impairing arterial function and elasticity remains unclear. We evaluated arterial stiffness, measured locally in the common carotid artery by high-resolution echo-tracking, and aortic stiffness, using carotid-femoral pulse wave velocity (PWV) (the "gold-standard" measurement of arterial stiffness), in treatment-naive patients with heterozygous familial hypercholesterolemia (FH). Methods The study included 66 patients with FH (10-66 years old) and 57 first-degree relatives without FH (11-61 years old). Carotid-femoral PWV was determined by SphygmoCor (AtCor, Australia). The parameters of carotid stiffness beta-index, Peterson elastic modulus and local PWV were assessed with regard to the common carotid artery at a distance of 1cm from the bifurcation (AlokaProsound Alpha7, Japan). Results FH patients showed significantly higher beta-index (6.3(4.8-8.2) vs. 5.2(4.2-6.4), p = 0.005), Ep (78(53-111) kPa vs. 62(48-79) kPa, p = 0.006), local PWV (5.4(4.5-6.4) m/c vs. 4.7 (4.2-5.4) m/c, p = 0.005), but comparable values of carotid-femoral PWV (6.76(7.0-7.92) m/c vs. 6.48(6.16-7.12) m/c, p = 0.138). Carotid arteries and the aorta stiffened with age in patients with FH, but after 30 years, carotid arteries stiffened more significantly than the aorta. Conclusions Our study demonstrated that treatment-naive patients with FH had stiffer carotid arteries than their relatives, but showed no difference in aortic stiffness. We also found out that the rate of reduction of elasticity of the aorta and carotid arteries in FH patients varies: it is observed earlier in carotid arteries than in the aorta.	[Ershova, Alexandra I.; Meshkov, Alexey N.; Boytsov, Sergey A.] Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia; [Rozhkova, Tatyana A.; Kalinina, Maria V.] Russian Cardiol Res Ctr, Dept Atherosclerosis, Moscow, Russia; [Deev, Alexander D.] Natl Res Ctr Prevent Med, Dept Epidemiol Chron Noninfect Dis, Moscow, Russia; [Rogoza, Anatoliy N.; Balakhonova, Tatyana V.] Russian Cardiol Res Ctr, Dept New Methods Diagnost, Moscow, Russia	National Medical Research Center for Therapy & Preventive Medicine; National Medical Research Center of Cardiology; National Medical Research Center for Therapy & Preventive Medicine; National Medical Research Center of Cardiology	Ershova, AI (corresponding author), Natl Res Ctr Prevent Med, Dept Clin Cardiol & Mol Genet, Moscow, Russia.	alersh@mail.ru	Ershova, Alexandra I/J-8772-2017; Meshkov, Alexey N/K-1056-2017; deev, alexander/M-7754-2014; Boytsov, Sergey/AAK-5354-2021; Stefanadis, Christodoulos/ABH-2232-2020; ROGOZA, ANATOLIY N/B-2724-2014; Tatyana, Balakhonova/AAB-4996-2020; Boytsov, Sergey A/M-4486-2014	Ershova, Alexandra I/0000-0001-7989-0760; Meshkov, Alexey N/0000-0001-5989-6233; Boytsov, Sergey/0000-0001-6998-8406; Stefanadis, Christodoulos/0000-0001-5974-6454; ROGOZA, ANATOLIY N/0000-0002-4829-0954; Boytsov, Sergey A/0000-0001-6998-8406	Ministry of Health of the Russian Federation [01201352208]	Ministry of Health of the Russian Federation	This work was supported by a Grant for Scientific Research (#01201352208) from The Ministry of Health of the Russian Federation.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Aggoun Y, 2000, ARTERIOSCL THROM VAS, V20, P2070; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dilaveris P, 2007, CURR VASC PHARMACOL, V5, P227; Ershova AI, 2012, ULTRASOUND MED BIOL, V38, P417, DOI 10.1016/j.ultrasmedbio.2011.11.014; Ferreira I, 2005, ARCH INTERN MED, V165, P875, DOI 10.1001/archinte.165.8.875; Ferrieres J, 2009, AM J CARDIOVASC DRUG, V9, P109, DOI 10.2165/00129784-200909020-00005; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; HOPKINS KD, 1993, CLIN SCI, V84, P593, DOI 10.1042/cs0840593; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; LEHMANN ED, 1992, CLIN SCI, V83, P717, DOI 10.1042/cs0830717; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Martinez LRC, 2008, ATHEROSCLEROSIS, V200, P83, DOI 10.1016/j.atherosclerosis.2007.12.014; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Odink AE, 2010, J HUM HYPERTENS, V24, P86, DOI 10.1038/jhh.2009.42; Paik DC, 1997, CONNECT TISSUE RES, V36, P241, DOI 10.3109/03008209709160224; Paini A, 2006, HYPERTENSION, V47, P371, DOI 10.1161/01.HYP.0000202052.25238.68; Pirro M, 2004, EUR J CLIN INVEST, V34, P335, DOI 10.1111/j.1365-2362.2004.01345.x; Riggio S, 2010, EUR J CLIN INVEST, V40, P250, DOI 10.1111/j.1365-2362.2010.02260.x; Shaw E., 2008, CLIN GUIDELINES EVID; SOLBERG LA, 1983, ARTERIOSCLEROSIS, V3, P187, DOI 10.1161/01.ATV.3.3.187; Soljanlahti S, 2008, VASC HEALTH RISK MAN, V4, P1103, DOI 10.2147/VHRM.S3198; STRONG JP, 1976, ATHEROSCLEROSIS, V23, P451, DOI 10.1016/0021-9150(76)90007-1; TAQUET A, 1993, EUR J EPIDEMIOL, V9, P298, DOI 10.1007/BF00146267; Toikka JO, 1999, ARTERIOSCL THROM VAS, V19, P436, DOI 10.1161/01.ATV.19.2.436; Tomochika Y, 1999, AM J CARDIOL, V83, P703, DOI 10.1016/S0002-9149(98)00974-6; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Wilkinson I, 2007, ADV CARDIOL, V44, P261, DOI 10.1159/000096747; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033; Wilkinson IB, 2002, J AM COLL CARDIOL, V39, P1005, DOI 10.1016/S0735-1097(02)01723-0; Yuan G, 2006, CAN MED ASSOC J, V174, P1124, DOI 10.1503/cmaj.051313; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	33	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158964	10.1371/journal.pone.0158964	http://dx.doi.org/10.1371/journal.pone.0158964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434535	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600025
J	Eyer, L; Vain, T; Parizkova, B; Oklestkova, J; Barbez, E; Kozubikova, H; Pospisil, T; Wierzbicka, R; Kleine-Vehn, J; Franek, M; Strnad, M; Robert, S; Novak, O				Eyer, Ludek; Vain, Thomas; Parizkova, Barbora; Oklestkova, Jana; Barbez, Elke; Kozubikova, Hana; Pospisil, Tomas; Wierzbicka, Roksana; Kleine-Vehn, Juergen; Franek, Milan; Strnad, Miroslav; Robert, Stephanie; Novak, Ondrej			2,4-D and IAA Amino Acid Conjugates Show Distinct Metabolism in Arabidopsis	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID; NAPHTHALENE-1-ACETIC ACID; BIOLOGICAL-PROPERTIES; QUECHERS EXTRACTION; AUXIN METABOLISM; PLANT HORMONES; CHROMATOGRAPHY; FAMILY; HERBICIDES; ENCODES	The herbicide 2,4-D exhibits an auxinic activity and therefore can be used as a synthetic and traceable analog to study auxin-related responses. Here we identified that not only exogenous 2,4-D but also its amide-linked metabolite 2,4-D-Glu displayed an inhibitory effect on plant growth via the TIR1/AFB auxin-mediated signaling pathway. To further investigate 2,4-D metabolite conversion, identity and activity, we have developed a novel purification procedure based on the combination of ion exchange and immuno-specific sorbents combined with a sensitive liquid chromatography-mass spectrometry method. In 2,4-D treated samples, 2,4-D-Glu and 2,4-D-Asp were detected at 100-fold lower concentrations compared to 2,4-D levels, showing that 2,4-D can be metabolized in the plant. Moreover, 2,4-D-Asp and 2,4-D-Glu were identified as reversible forms of 2,4-D homeostasis that can be converted to free 2,4-D. This work paves the way to new studies of auxin action in plant development.	[Eyer, Ludek; Wierzbicka, Roksana; Franek, Milan; Novak, Ondrej] Vet Res Inst, Dept Virol, Brno, Czech Republic; [Vain, Thomas; Robert, Stephanie] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Parizkova, Barbora; Oklestkova, Jana; Strnad, Miroslav; Novak, Ondrej] Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot CAS, Olomouc, Czech Republic; [Parizkova, Barbora; Oklestkova, Jana; Strnad, Miroslav; Novak, Ondrej] Palacky Univ, Fac Sci, Olomouc, Czech Republic; [Barbez, Elke; Kleine-Vehn, Juergen] Univ Nat Resources & Life Sci BOKU, Dept Appl Genet & Cell Biol, Vienna, Austria; [Kozubikova, Hana; Pospisil, Tomas] Palacky Univ, Dept Chem Biol & Genet, Ctr Reg Hana Biotechnol & Agr Res, Fac Sci, Olomouc, Czech Republic; [Barbez, Elke] Austrian Acad Sci, Vienna Bioctr VBC, Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Wierzbicka, Roksana] Swedish Univ Agr Sci, Dept Food Sci, Uppsala, Sweden	Czech Veterinary Research Institute; Swedish University of Agricultural Sciences; Umea University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc; University of Natural Resources & Life Sciences, Vienna; Palacky University Olomouc; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Swedish University of Agricultural Sciences	Robert, S (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, Umea, Sweden.; Novak, O (corresponding author), Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot CAS, Olomouc, Czech Republic.; Novak, O (corresponding author), Palacky Univ, Fac Sci, Olomouc, Czech Republic.	stephanie.robert@slu.se; novako@ueb.cas.cz	Pospisil, Tomas/S-5023-2016; Eyer, Ludek/U-4883-2018; Robert, Stéphanie/K-7604-2012; Strnad, Miroslav/H-1858-2014; Oklestkova, Jana/ABD-7907-2021; Kleine-Vehn, Jürgen/C-8984-2014; NOVAK, Ondrej/F-7031-2014; POSPÍŠIL, Tomáš/AAY-1379-2020; Oklešťková, Jana/G-8010-2014; Pařízková, Barbora/D-4486-2018; Pařízková, Barbora/N-6947-2019; Barbez, Elke/AAP-2131-2021	Pospisil, Tomas/0000-0003-3634-828X; Eyer, Ludek/0000-0001-7761-0702; Robert, Stéphanie/0000-0002-0013-3239; Strnad, Miroslav/0000-0002-2806-794X; Oklestkova, Jana/0000-0002-7423-5537; Kleine-Vehn, Jürgen/0000-0002-4354-3756; NOVAK, Ondrej/0000-0003-3452-0154; POSPÍŠIL, Tomáš/0000-0003-3634-828X; Oklešťková, Jana/0000-0002-7423-5537; Pařízková, Barbora/0000-0002-8125-2271; Pařízková, Barbora/0000-0002-8125-2271; Vain, Thomas/0000-0002-8153-907X; Barbez, Elke/0000-0002-5531-7916	Czech Science Foundation [GA14-34792S]; Ministry of Education, Youth and Sports of the Czech Republic - NPU I program [LO1204, LO1218]; "Navrat" program [LK21306]; Internal Grant Agency of Palacky University [IGA_PrF_2016_011]; Vetenskapsradet; VINNOVA; IWT agency for innovation by science and technology; Vienna Science and Technology Fund (WWTF) Vienna Research Group program; Austrian Science Fund (FWF) [P26568-B16, P26591-B16]; European Research Council (ERC) [639478-AuxinER]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic - NPU I program; "Navrat" program; Internal Grant Agency of Palacky University; Vetenskapsradet(Swedish Research Council); VINNOVA(Vinnova); IWT agency for innovation by science and technology; Vienna Science and Technology Fund (WWTF) Vienna Research Group program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was funded by the Czech Science Foundation (Nr. GA14-34792S; ON, JO, BP), by the Ministry of Education, Youth and Sports of the Czech Republic - NPU I program with projects LO1204 (ON, JO, HK, TP, MS) and LO1218 (LE, MF), the "Navrat" program LK21306 (ON, JO), by the Internal Grant Agency of Palacky University (Nr. IGA_PrF_2016_011; BP, HK), by Vetenskapsradet and VINNOVA (TV, SR), IWT agency for innovation by science and technology (EB), and by the Vienna Science and Technology Fund (WWTF) Vienna Research Group program (JK-V), Austrian Science Fund (FWF) (P26568-B16 and P26591-B16) (JK-V), and the European Research Council (ERC) Starting Grant 639478-AuxinER (JK-V).	Bandurski RS, 1995, PLANT HORMONES, P39, DOI [10.1007/978-94-011-0473-9_3, DOI 10.1007/978-94-011-0473-9_3]; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; COHEN JD, 1982, ANNU REV PLANT PHYS, V33, P403, DOI 10.1146/annurev.pp.33.060182.002155; DAVIDONIS GH, 1982, PLANT PHYSIOL, V70, P357, DOI 10.1104/pp.70.2.357; DAVIDONIS GH, 1980, PLANT PHYSIOL, V66, P537, DOI 10.1104/pp.66.4.537; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; De Rybel B, 2009, ACS CHEM BIOL, V4, P987, DOI 10.1021/cb9001624; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dobrev PI, 2005, J CHROMATOGR A, V1075, P159, DOI 10.1016/j.chroma.2005.02.091; FEUNG CS, 1972, PLANT PHYSIOL, V50, P80, DOI 10.1104/pp.50.1.80; FEUNG CS, 1973, J AGR FOOD CHEM, V21, P637, DOI 10.1021/jf60188a058; FEUNG CS, 1978, J AGR FOOD CHEM, V26, P1064, DOI 10.1021/jf60219a009; FEUNG CS, 1974, J AGR FOOD CHEM, V22, P307, DOI 10.1021/jf60192a040; FRANEK M, 1994, J AGR FOOD CHEM, V42, P1369, DOI 10.1021/jf00042a024; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Grossmann K, 2010, PEST MANAG SCI, V66, P113, DOI 10.1002/ps.1860; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Hamburg A, 2001, J AGR FOOD CHEM, V49, P146, DOI 10.1021/jf000120q; HANGARTER RP, 1980, PLANT PHYSIOL, V65, P761, DOI 10.1104/pp.65.5.761; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hennion MC, 2003, J CHROMATOGR A, V1000, P29, DOI 10.1016/S0021-9673(03)00529-6; Hotton SK, 2011, PLANT MOL BIOL, V75, P515, DOI 10.1007/s11103-011-9750-8; Hradecka V, 2007, J CHROMATOGR B, V847, P162, DOI 10.1016/j.jchromb.2006.09.034; KAZEMIE M, 1969, PLANTA, V89, P76, DOI 10.1007/BF00386497; Kenny DJ, 2010, J AM SOC MASS SPECTR, V21, P1061, DOI 10.1016/j.jasms.2010.02.017; Koesukwiwat U, 2008, ANAL CHIM ACTA, V626, P10, DOI 10.1016/j.aca.2008.07.034; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kowalczyk M, 2001, PLANT PHYSIOL, V127, P1845, DOI 10.1104/pp.010525; Laurent F, 2000, J AGR FOOD CHEM, V48, P5307, DOI 10.1021/jf990672c; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Liang Y, 2012, METHODS, V56, P174, DOI 10.1016/j.ymeth.2011.08.006; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Loos MA, 1975, HERBICIDES CHEM DEGR, P1; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Petersson SV, 2009, PLANT CELL, V21, P1659, DOI 10.1105/tpc.109.066480; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rampey RA, 2006, GENETICS, V174, P1841, DOI 10.1534/genetics.106.061044; Rodriguez I, 2005, ANAL CHIM ACTA, V537, P259, DOI 10.1016/j.aca.2004.12.083; Rolcik J, 2002, J CHROMATOGR B, V775, P9; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Santos-Delgado MJ, 2000, TALANTA, V53, P367, DOI 10.1016/S0039-9140(00)00498-7; Sauer M, 2013, J EXP BOT, V64, P2565, DOI 10.1093/jxb/ert139; Sauer M, 2011, PLANT CELL, V23, P2033, DOI 10.1105/tpc.111.087064; Shi XM, 2012, J AGR FOOD CHEM, V60, P60, DOI 10.1021/jf204183d; SMULDERS MJM, 1990, J PLANT GROWTH REGUL, V9, P27, DOI 10.1007/BF02041938; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Sterling T, 1997, HERBICIDE ACTIVITY T, V1, P111; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tam YY, 2000, PLANT PHYSIOL, V123, P589, DOI 10.1104/pp.123.2.589; Tarkowska D, 2014, PLANTA, V240, P55, DOI 10.1007/s00425-014-2063-9; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VIJAYARAGHAVAN SJ, 1986, PLANT PHYSIOL, V80, P315, DOI 10.1104/pp.80.2.315; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Zanella R, 2012, OPEN ACCESS BOOK IMP, P355	63	24	25	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159269	10.1371/journal.pone.0159269	http://dx.doi.org/10.1371/journal.pone.0159269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434212	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600044
J	Wein, S; Beyer, B; Gohlke, A; Blank, R; Metges, CC; Wolffram, S				Wein, Silvia; Beyer, Birgit; Gohlke, Annika; Blank, Ralf; Metges, Cornelia C.; Wolffram, Siegfried			Systemic Absorption of Catechins after Intraruminal or Intraduodenal Application of a Green Tea Extract in Cows	PLOS ONE			English	Article							DAIRY-COWS; INTESTINAL BACTERIA; BIOLOGICAL-ACTIVITY; GLUCOSE-METABOLISM; CAMELLIA-SINENSIS; POLYPHENOLS; LIVER; QUERCETIN; RATS; PERFORMANCE	Green tea catechins have various potential health benefits in humans including anti-inflammatory, anti-oxidative and hepato-protective effects. If present in the circulation, they might have similar effects in ruminants, which are exposed to oxidative stress and fatty liver disease such as dairy cows during the periparturient phase. However, the bioavailability of a substance is a prerequisite for any post absorptive effect in vivo. This study aimed to investigate the appearance of catechins from a green tea extract (GTE) in cattle plasma after intraruminal and intraduodenal administration because absorption is of major importance regarding the bioavailability of catechins. The studies were performed in 5 rumen-fistulated non-lactating heifers and 6 duodenally fistulated lactating dairy cows, respectively, equipped with indwelling catheters placed in a jugular vein. The GTE was applied intraruminally (10 and 50 mg/kg BW, heifers) or duodenally (10, 20 and 30 mg/kg BW, dairy cows) in a cross-over design with a 2 d washout period between different dosages. Blood samples were drawn following the GTE administration at various pre-defined time intervals. The concentration of the major GTE catechins (gallocatechin, epigallocatechin, catechin, epicatechin, epigallocatechin-gallate, epicatechin-gallate) in plasma samples were analysed by HPLC with electrochemical detection. Irrespective of the dose, almost none of the catechins originally contained in the GTE were detected in plasma samples after intraruminal application. In contrast, intraduodenal administration of GTE resulted in increased plasma concentrations of epicatechin, epigallocatechin, epigallocatechin gallate in a dose-dependent manner. Thus, we can conclude that intraruminally or orally administered catechins are intensively metabolized by ruminal microorganisms.	[Wein, Silvia; Beyer, Birgit; Blank, Ralf; Wolffram, Siegfried] Univ Kiel, Inst Anim Nutr & Physiol, Kiel, Germany; [Gohlke, Annika; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol, Inst Nutr Physiol, Dummerstorf, Germany	University of Kiel; Forschungsinstitut fur Nutztierbiologie (FBN)	Metges, CC (corresponding author), Leibniz Inst Farm Anim Biol, Inst Nutr Physiol, Dummerstorf, Germany.	metges@fbn-dummerstorf.de	Blank, Ralf/Q-1604-2019	Blank, Ralf/0000-0002-7439-7253	Federal Ministry of Education and Research, Germany (BMBF) [0315538A, 0315538B]; Open Access fund of Leibniz Association	Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Open Access fund of Leibniz Association	This work is part of the joint research project Food Chain Plus (FoCus) and was financially supported by the Federal Ministry of Education and Research, Germany (BMBF grant no. 0315538A and 0315538B). The publication of this article was funded by the Open Access fund of Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, BIOMED RES-TOKYO, V30, P25, DOI 10.2220/biomedres.30.25; Abrahamse SL, 2005, NUTR RES, V25, P305, DOI 10.1016/j.nutres.2004.10.013; Aron PM, 2008, MOL NUTR FOOD RES, V52, P79, DOI 10.1002/mnfr.200700137; BRAVO L, 1994, BRIT J NUTR, V71, P933, DOI 10.1079/BJN19940197; Chen JH, 2004, AM J CLIN NUTR, V80, P742; Chen X, 2005, PHARM RES-DORDR, V22, P892, DOI 10.1007/s11095-005-4584-1; Cyboran S, 2015, LIFE SCI, V126, P1, DOI 10.1016/j.lfs.2014.12.025; DAS NP, 1969, BIOCHIM BIOPHYS ACTA, V177, P668, DOI 10.1016/0304-4165(69)90340-7; Mota MAD, 2015, ACTA CIR BRAS, V30, P242, DOI 10.1590/S0102-865020150040000002; Mata-Bilbao MD, 2008, BRIT J NUTR, V100, P496, DOI 10.1017/S0007114507898692; Dube A, 2011, FOOD CHEM, V128, P7, DOI 10.1016/j.foodchem.2011.02.038; Duske K, 2009, J DAIRY SCI, V92, P1670, DOI 10.3168/jds.2008-1543; Egert S, 2013, EUR J NUTR, V52, P281, DOI 10.1007/s00394-012-0330-8; Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552; Forester SC, 2012, MOL NUTR FOOD RES, V56, P1647, DOI 10.1002/mnfr.201200206; Gesellschaft fur Ernahrungsphysiologie der Haustiere [German Society of Nutrition Physiology], 2001, AUSSCH BED GES ERN E; Gohlke A, 2013, J DAIRY SCI, V96, P6986, DOI 10.3168/jds.2013-6852; Gohlke A, 2013, J DAIRY SCI, V96, P2303, DOI 10.3168/jds.2012-6234; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Grum DE, 2002, J DAIRY SCI, V85, P3026, DOI 10.3168/jds.S0022-0302(02)74388-9; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Kutschera M, 2011, J APPL MICROBIOL, V111, P165, DOI 10.1111/j.1365-2672.2011.05025.x; Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172; Lambert JD, 2003, MUTAT RES-FUND MOL M, V523, P201, DOI 10.1016/S0027-5107(02)00336-6; Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487; Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837; Lohrke B, 2008, BRIT J NUTR, V99, P1255, DOI 10.1017/S000711450886240X; Lorz A, 2008, TIERSCHUTZGESETZ TIE, V6, P1; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Nakagawa K, 1997, BIOSCI BIOTECH BIOCH, V61, P1981, DOI 10.1271/bbb.61.1981; Naumann C, 1997, METHODENBUCH; Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133; Okushio K, 1996, BIOL PHARM BULL, V19, P326, DOI 10.1248/bpb.19.326; Pastore RL, 2006, EXPLORE-NY, V2, P531, DOI 10.1016/j.explore.2006.08.008; Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386; Sordillo LM, 2007, J DAIRY SCI, V90, P1186, DOI 10.3168/jds.S0022-0302(07)71605-3; Starp C, 2006, ANN NUTR METAB, V50, P59, DOI 10.1159/000089640; Stoldt AK, 2015, J DAIRY SCI, V98, P4509, DOI 10.3168/jds.2014-9053; Swezey RR, 2003, INT J TOXICOL, V22, P187, DOI 10.1080/10915810305101; Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Takagaki A, 2014, ARCH MICROBIOL, V196, P681, DOI 10.1007/s00203-014-1006-y; Tomaszewska E, 2015, ENVIRON TOXICOL PHAR, V40, P708, DOI 10.1016/j.etap.2015.09.002; Wang X, 2001, BIOCHEM BIOPH RES CO, V288, P1200, DOI 10.1006/bbrc.2001.5923; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511; Yuan GJ, 2006, INT J MOL SCI, V7, P204, DOI 10.3390/i7070204; Yun B, 2015, J FOOD SCI, V80, pM2925, DOI 10.1111/1750-3841.13145; Zhang X, 2015, J HUAZHONG U SCI-MED, V35, P378, DOI 10.1007/s11596-015-1441-2; Zhu QY, 1997, J AGR FOOD CHEM, V45, P4624, DOI 10.1021/jf9706080	54	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159428	10.1371/journal.pone.0159428	http://dx.doi.org/10.1371/journal.pone.0159428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427946	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169300066
J	Liu, BH; Gomez, LD; Hua, CM; Sun, LL; Ali, I; Huang, LL; Yu, CY; Simister, R; Steele-King, C; Gan, YB; McQueen-Mason, SJ				Liu, Bohan; Gomez, Leonardo D.; Hua, Cangmei; Sun, Lili; Ali, Imran; Huang, Linli; Yu, Chunyan; Simister, Rachael; Steele-King, Clare; Gan, Yinbo; McQueen-Mason, Simon J.			Linkage Mapping of Stem Saccharification Digestibility in Rice	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; TRANSCRIPTION FACTOR; LIGNOCELLULOSIC BIOMASS; L-ARABINOFURANOSIDASE; DIRECT TARGET; FERULIC ACID; EXPRESSION; GENE; LIGNIN; LIGNIFICATION	Rice is the staple food of almost half of the world population, and in excess 90% of it is grown and consumed in Asia, but the disposal of rice straw poses a problem for farmers, who often burn it in the fields, causing health and environmental problems. However, with increased focus on the development of sustainable biofuel production, rice straw has been recognized as a potential feedstock for non-food derived biofuel production. Currently, the commercial realization of rice as a biofuel feedstock is constrained by the high cost of industrial saccharification processes needed to release sugar for fermentation. This study is focused on the alteration of lignin content, and cell wall chemotypes and structures, and their effects on the saccharification potential of rice lignocellulosic biomass. A recombinant inbred lines (RILs) population derived from a cross between the lowland rice variety IR1552 and the upland rice variety Azucena with 271 molecular markers for quantitative trait SNP (QTS) analyses was used. After association analysis of 271 markers for saccharification potential, 1 locus and 4 pairs of epistatic loci were found to contribute to the enzymatic digestibility phenotype, and an inverse relationship between reducing sugar and lignin content in these recombinant inbred lines was identified. As a result of QTS analyses, several cell-wall associated candidate genes are proposed that may be useful for marker-assisted breeding and may aid breeders to produce potential high saccharification rice varieties.	[Liu, Bohan; Hua, Cangmei; Sun, Lili; Ali, Imran; Huang, Linli; Yu, Chunyan; Gan, Yinbo] Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China; [Gomez, Leonardo D.; Simister, Rachael; Steele-King, Clare; McQueen-Mason, Simon J.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England	Zhejiang University; University of York - UK	Gan, YB (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Dept Agron, Zhejiang Key Lab Crop Germplasm, Hangzhou, Zhejiang, Peoples R China.; McQueen-Mason, SJ (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	ygan@zju.edu.cn; simon.mcqueenmason@york.ac.uk	Liu, Bohan/D-4731-2015; Sun, lili/GQH-2057-2022; Gan, Yinbo/N-1480-2015; Liu, Bohan/G-4704-2017	Liu, Bohan/0000-0002-8318-9667; Liu, Bohan/0000-0002-8318-9667; Gomez, Leonardo Dario/0000-0001-6382-9447	Major State Basic Research Development Program (973 Program) [2015CB150200]; Zhejiang Provincial Natural Science Foundation of China [LZ15C020001]; National Natural Science Foundation of China [31570183, 31529001]; UK-China partnering award from BBSRC of UK [BB/H531419]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK-China partnering award from BBSRC of UK	The research was funded by Major State Basic Research Development Program (973 Program, grant no. 2015CB150200); Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ15C020001); National Natural Science Foundation of China (Grant No. 31570183; 31529001) and UK-China partnering award from BBSRC of UK (Grant No BB/H531419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was funded by Major State Basic Research Development Program (973 Program, grant no. 2015CB150200); Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ15C020001); National Natural Science Foundation of China (Grant No. 31570183; 31529001) and UK-China partnering award from BBSRC of UK (Grant No BB/H531419).	Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003; Arsovski AA, 2009, PLANT PHYSIOL, V150, P1219, DOI 10.1104/pp.109.138388; Bartley LE, 2013, PLANT PHYSIOL, V161, P1615, DOI 10.1104/pp.112.208694; BEFFA RS, 1993, P NATL ACAD SCI USA, V90, P8792, DOI 10.1073/pnas.90.19.8792; Bi YuYun, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P211; Buanafina MMDO, 2008, PLANT BIOTECHNOL J, V6, P264, DOI 10.1111/j.1467-7652.2007.00317.x; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Cao GL, 2008, CHINESE SCI BULL, V53, P784, DOI 10.1007/s11434-008-0145-4; Cao PJ, 2008, MOL PLANT, V1, P858, DOI 10.1093/mp/ssn052; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Christopher LP, 2014, FRONT ENERGY RES, DOI 10.3389/fenrg.2014.00012; CONDIT CM, 1987, MOL CELL BIOL, V7, P4273, DOI 10.1128/MCB.7.12.4273; d'Yvoire MB, 2013, PLANT J, V73, P496, DOI 10.1111/tpj.12053; DeMartini JD, 2013, ENERG ENVIRON SCI, V6, P898, DOI 10.1039/c3ee23801f; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Gadde B, 2009, BIOMASS BIOENERG, V33, P1532, DOI 10.1016/j.biombioe.2009.07.018; Gadde B, 2009, ENVIRON POLLUT, V157, P1554, DOI 10.1016/j.envpol.2009.01.004; GOLD MH, 1989, ACS SYM SER, V389, P127; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Gomez LD, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-23; Gou JY, 2012, PLANT CELL, V24, P50, DOI 10.1105/tpc.111.092411; HALL LN, 1993, PLANT J, V3, P121, DOI 10.1111/j.1365-313X.1993.tb00015.x; Harris D, 2010, PLANT BIOTECHNOL J, V8, P244, DOI 10.1111/j.1467-7652.2009.00481.x; Harris D, 2009, GCB BIOENERGY, V1, P51, DOI 10.1111/j.1757-1707.2009.01000.x; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Itai A, 2003, J EXP BOT, V54, P2615, DOI 10.1093/jxb/erg291; Jackson LA, 2008, BIOENERG RES, V1, P180, DOI 10.1007/s12155-008-9020-z; Kavousi B, 2010, PHYTOCHEMISTRY, V71, P531, DOI 10.1016/j.phytochem.2010.01.008; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; LAZAN H, 1995, PHYSIOL PLANTARUM, V95, P106, DOI 10.1034/j.1399-3054.1995.950116.x; Lin CC, 2001, J PLANT PHYSIOL, V158, P667, DOI 10.1078/0176-1617-00245; Liu ZZ, 2003, PLANTA, V216, P824, DOI 10.1007/s00425-002-0934-y; Mansfield SD, 2012, NEW PHYTOL, V194, P91, DOI 10.1111/j.1469-8137.2011.04031.x; Marriott PE, 2016, NEW PHYTOL, V209, P1366, DOI 10.1111/nph.13684; Marriott PE, 2014, P NATL ACAD SCI USA, V111, P14601, DOI 10.1073/pnas.1414020111; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mewalal R, 2014, PLANT CELL PHYSIOL, V55, P1031, DOI 10.1093/pcp/pcu050; Mika Angela, 2004, Phytochemistry Reviews, V3, P173, DOI 10.1023/B:PHYT.0000047806.21626.49; Min DY, 2012, APPL BIOCHEM BIOTECH, V168, P947, DOI 10.1007/s12010-012-9833-2; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Penning BW, 2014, PLANT PHYSIOL, V165, P1475, DOI 10.1104/pp.114.242446; Sahoo DK, 2013, PLANT BIOTECHNOL J, V11, P362, DOI 10.1111/pbi.12024; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Van Acker R, 2014, P NATL ACAD SCI USA, V111, P845, DOI 10.1073/pnas.1321673111; Vercauteren I, 2002, MOL PLANT MICROBE IN, V15, P404, DOI 10.1094/MPMI.2002.15.4.404; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang LQ, 2010, BMC PLANT BIOL, V10; XU DP, 1995, PLANT MOL BIOL, V28, P455, DOI 10.1007/BF00020394; Zhang FT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10298; Zhang HF, 2008, ATMOS ENVIRON, V42, P8432, DOI 10.1016/j.atmosenv.2008.08.015; Zhao QA, 2010, PLANT J, V63, P100, DOI 10.1111/j.1365-313X.2010.04223.x; Zheng BS, 2003, THEOR APPL GENET, V107, P1505, DOI 10.1007/s00122-003-1390-1; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2010, PLANT SIGNAL BEHAV, V5, P469, DOI 10.4161/psb.5.4.11400; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x	66	6	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159117	10.1371/journal.pone.0159117	http://dx.doi.org/10.1371/journal.pone.0159117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415441	gold, Green Published, Green Accepted			2022-12-26	WOS:000379579500080
J	Song, G; Shao, XX; Wu, QP; Xu, ZG; Liu, YL; Guo, ZY				Song, Ge; Shao, Xiao-Xia; Wu, Qing-Ping; Xu, Zeng-Guang; Liu, Ya-Li; Guo, Zhan-Yun			Novel Bioluminescent Binding Assays for Ligand-Receptor Interaction Studies of the Fibroblast Growth Factor Family	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CELLS; HORMONES; NANOLUCIFERASE; IDENTIFICATION; PROTEIN; DIMERIZATION; SPECIFICITY; EXPRESSION; PEPTIDE	We recently developed novel bioluminescent binding assays for several protein/peptide hormones to study their interactions with receptors using the so far brightest NanoLuc reporter. To validate the novel bioluminescent binding assay using a variety of protein/peptide hormones, in the present work we applied it to the fibroblast growth factor (FGF) family using the prototype member FGF2 as an example. A fully active recombinant FGF2 retaining a unique exposed cysteine (Cys) residue was chemically conjugated with an engineered NanoLuc carrying a unique exposed Cys residue at the C-terminus via formation of an intermolecular disulfide linkage. The NanoLuc-conjugated FGF2 (FGF2-Luc) retained high binding affinity to the overexpressed FGFR1 and the endogenous FGF receptor with the calculated dissociation constants of 161 +/- 21 pM (n = 3) and 25 +/- 4 pM(n = 3), respectively. In competition binding assays using FGF2-Luc as a tracer, receptor-binding potencies of wild-type or mutant FGF2s were accurately quantified. Thus, FGF2-Luc represents a novel non-radioactive tracer for the quantitative measurement of ligand-receptor interactions in the FGF family. These data suggest that the novel bioluminescent binding assay can be applied to a variety of protein/peptide hormones for ligand-receptor interaction studies.	[Song, Ge; Shao, Xiao-Xia; Wu, Qing-Ping; Xu, Zeng-Guang; Liu, Ya-Li; Guo, Zhan-Yun] Tongji Univ, Coll Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai, Peoples R China	Tongji University	Liu, YL; Guo, ZY (corresponding author), Tongji Univ, Coll Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai, Peoples R China.	yaliliuliu@163.com; zhan-yun.guo@tongji.edu.cn			National Natural Science Foundation of China [31470767, 31270824]; Fundamental Research Funds for the Central Universities [2000219098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31470767, 31270824) and the Fundamental Research Funds for the Central Universities (2000219098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; Fernandes-Freitas I, 2015, CURR OPIN PHARMACOL, V25, P30, DOI 10.1016/j.coph.2015.09.014; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; He SX, 2014, BIOCHIMIE, V106, P140, DOI 10.1016/j.biochi.2014.08.012; Hu MJ, 2016, AMINO ACIDS, V48, P2227, DOI 10.1007/s00726-016-2260-x; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; KROIHER M, 1995, BBA-PROTEIN STRUCT M, V1250, P29, DOI 10.1016/0167-4838(95)00060-8; KUROKAWA T, 1987, FEBS LETT, V213, P189, DOI 10.1016/0014-5793(87)81489-8; La Venuta G, 2015, J BIOL CHEM, V290, P27015, DOI 10.1074/jbc.R115.689257; Liu YL, 2016, AMINO ACIDS, V48, P1151, DOI 10.1007/s00726-016-2220-5; Liu Y, 2015, AMINO ACIDS, V47, P2237, DOI 10.1007/s00726-015-2009-y; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; OLWIN BB, 1986, BIOCHEMISTRY-US, V25, P3487, DOI 10.1021/bi00360a001; OLWIN BB, 1989, J CELL BIOCHEM, V39, P443, DOI 10.1002/jcb.240390410; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHARMA A, 1988, BIOMED BIOCHIM ACTA, V47, P975; Song G, 2015, J PHOTOCH PHOTOBIO B, V153, P311, DOI 10.1016/j.jphotobiol.2015.10.014; SQUIRES CH, 1988, J BIOL CHEM, V263, P16297; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wu QP, 2016, AMINO ACIDS, V48, P1099, DOI 10.1007/s00726-015-2146-3; Zhang L, 2013, BIOCHIMIE, V95, P2454, DOI 10.1016/j.biochi.2013.09.008; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	35	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159263	10.1371/journal.pone.0159263	http://dx.doi.org/10.1371/journal.pone.0159263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414797	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500114
J	Spaan, M; Hullegie, SJ; Beudeker, BJB; Kreefft, K; van Oord, GW; Groothuismink, ZMA; van Tilborg, M; Rijnders, B; de Knegt, RJ; Claassen, MAA; Boonstra, A				Spaan, Michelle; Hullegie, Sebastiaan J.; Beudeker, Boris J. B.; Kreefft, Kim; van Oord, Gertine W.; Groothuismink, Zwier M. A.; van Tilborg, Marjolein; Rijnders, Bart; de Knegt, Robert J.; Claassen, Mark A. A.; Boonstra, Andre			Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy	PLOS ONE			English	Article							INVARIANT T-CELLS; HEPATITIS-C; NK CELLS; RESPONSES; INTERFERON; ACTIVATION; EXHAUSTION; INDUCTION; INFECTION; ROLES	Objective Mucosal-associated invariant T (MAIT) cells comprise a subpopulation of T cells that can be activated by bacterial products and cytokines to produce IFN-gamma Since little is known on MAIT cells during HCV infection, we compared their phenotype and function in comparison to HIV and HCV/HIV co-infected patients, and determined the effect of IFN-alpha-based and direct-acting antiviral therapy on MAIT cells of HCV patients. Methods Blood samples from patients with chronic HCV (CHCV), virologically suppressed HIV, acute HCV/HIV co-infection (AHCV/HIV) and healthy individuals were examined by flowcytometry for phenotype and function of MAIT and NK cells. Results and Conclusions Compared to healthy individuals, the frequency of CD161(+)V alpha 7.2(+) MAIT cells was significantly decreased in patients with CHCV, HIV and AHCV/HIV co-infection. CD38 expression on MAIT cells was increased in AHCV/HIV patients. MAIT cells were responsive to IFN-alpha in vitro as evidenced by enhanced frequencies of IFN-gamma producing cells. IFN-alpha-based therapy for CHCV decreased the frequency of IFN-gamma(+) MAIT cells, which was still observed 24 weeks after successful therapy. Importantly, even after successful IFN-alpha-based as well as IFN-alpha-free therapy for CHCV, decreased frequencies of MAIT cells persisted. We show that the frequencies of MAIT cells are reduced in blood of patients with CHCV, HIV and in AHCV/HIV co-infection compared to healthy individuals. Successful therapy for CHCV did not normalize MAIT cell frequencies at 24 weeks follow up. The impact of HIV and HCV infection on the numbers and function of MAIT cells warrant further studies on the impact of viral infections and the antimicrobial function of MAIT cells.	[Spaan, Michelle; Beudeker, Boris J. B.; Kreefft, Kim; van Oord, Gertine W.; Groothuismink, Zwier M. A.; van Tilborg, Marjolein; de Knegt, Robert J.; Boonstra, Andre] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Hullegie, Sebastiaan J.; Rijnders, Bart; Claassen, Mark A. A.] Univ Med Ctr, Infect Dis Sect Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Boonstra, A (corresponding author), Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.a.boonstra@erasmusmc.nl	rijnders, bart ja/V-7527-2018; De Knegt, Robert/X-4629-2019; rijnders, bart/AAB-2868-2019	De Knegt, Robert/0000-0003-0934-6975; rijnders, bart/0000-0003-3343-9610; Boonstra, Andre/0000-0001-8607-1616	Virgo consortium - Dutch government [FES0908]	Virgo consortium - Dutch government	This study was supported by the Virgo consortium, funded by the Dutch government project number FES0908. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barathan M, 2016, EUR J CLIN INVEST, V46, P170, DOI 10.1111/eci.12581; Bosinger SE, 2015, CURR HIV-AIDS REP, V12, P41, DOI 10.1007/s11904-014-0244-6; Chua WJ, 2010, IMMUNOL CELL BIOL, V88, P767, DOI 10.1038/icb.2010.104; Claassen MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049389; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Eberhard JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111323; Fernandez CS, 2015, IMMUNOL CELL BIOL, V93, P177, DOI 10.1038/icb.2014.91; Gapin L, 2014, J IMMUNOL, V192, P4475, DOI 10.4049/jimmunol.1400119; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Hengst J, 2016, EUR J IMMUNOL, V46, P2204, DOI 10.1002/eji.201646447; Hotho DM, 2013, ANTIVIR RES, V97, P347, DOI 10.1016/j.antiviral.2012.12.025; Hullegie SJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.03.026; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Li YJ, 2014, REV MED VIROL, V24, P332, DOI 10.1002/rmv.1795; Lunemann S, 2012, DIGEST DIS, V30, P48, DOI 10.1159/000341680; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Saeidi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124659; Spaan M, 2012, BEST PRACT RES CLIN, V26, P1049; Spaan M, 2016, J INFECT DIS, V213, P216, DOI 10.1093/infdis/jiv391; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Ussher JE, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001134; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Vinton C, 2016, J VIROL, V90, P4520, DOI 10.1128/JVI.02876-15; Wong EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083474	33	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159243	10.1371/journal.pone.0159243	http://dx.doi.org/10.1371/journal.pone.0159243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416100	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500108
J	Szarmach, A; Luczkiewicz, P; Skotarczak, M; Kaszubowski, M; Winklewski, PJ; Dzierzanowski, J; Piskunowicz, M; Szurowska, E; Baczkowski, B				Szarmach, Arkadiusz; Luczkiewicz, Piotr; Skotarczak, Monika; Kaszubowski, Mariusz; Winklewski, Pawel J.; Dzierzanowski, Jaroslaw; Piskunowicz, Maciej; Szurowska, Edyta; Baczkowski, Boguslaw			Assessment of the Relationship between the Shape of the Lateral Meniscus and the Risk of Extrusion Based on MRI Examination of the Knee Joint	PLOS ONE			English	Article							CARTILAGE LOSS; ARTICULAR-CARTILAGE; MEDIAL MENISCUS; OSTEOARTHRITIS; CONTACT; DAMAGE; TEARS	Background Meniscus extrusion is a serious and relatively frequent clinical problem. For this reason the role of different risk factors for this pathology is still the subject of debate. The goal of this study was to verify the results of previous theoretical work, based on the mathematical models, regarding a relationship between the cross-section shape of the meniscus and the risk of its extrusion. Materials and Methods Knee MRI examination was performed in 77 subjects (43 men and 34 women), mean age 34.99 years (range: 18-49 years), complaining of knee pain. Patients with osteoarthritic changes (grade 3 and 4 to Kellgren classification), varus or valgus deformity and past injuries of the knee were excluded from the study. A 3-Tesla MR device was used to study the relationship between the shape of the lateral meniscus (using slope angle, meniscus-cartilage height and meniscus-bone angle) and the risk of extrusion. Results Analysis revealed that with values of slope angle and meniscus-bone angle increasing by one degree, the risk of meniscus extrusion raises by 1.157 and 1.078 respectively. Also, an increase in meniscus-cartilage height by 1 mm significantly elevates the risk of extrusion. At the same time it was demonstrated that for meniscus-bone angle values over 42 degrees and slope angle over 37 degrees the risk of extrusion increases significantly. Conclusions This was the first study to demonstrate a tight correlation between slope angle, meniscusbone angle and meniscus-cartilage height values in the assessment of the risk of lateral meniscus extrusion. Insertion of the above parameters to the radiological assessment of the knee joint allows identification of patients characterized by an elevated risk of development of this pathology.	[Szarmach, Arkadiusz; Skotarczak, Monika; Szurowska, Edyta] Med Univ Gdansk, Dept Radiol 2, Gdansk, Poland; [Luczkiewicz, Piotr; Baczkowski, Boguslaw] Med Univ Gdansk, Clin Orthopaed & Kinet Organ Traumatol 2, Gdansk, Poland; [Kaszubowski, Mariusz] Gdansk Univ Technol, Fac Econ & Management, Dept Econ Sci, Gdansk, Poland; [Winklewski, Pawel J.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Dzierzanowski, Jaroslaw] Med Univ Gdansk, Dept Neurosurg, Gdansk, Poland; [Piskunowicz, Maciej] Med Univ Gdansk, Dept Radiol 1, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Winklewski, PJ (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Luczkiewicz, Piotr/AAC-2970-2020	Luczkiewicz, Piotr/0000-0001-8988-1251; Piskunowicz, Maciej/0000-0002-3154-5463; Szarmach, Arkadiusz/0000-0003-3118-014X; Szurowska, Edyta/0000-0002-7042-4381; Winklewski, Pawel/0000-0002-1671-2163	Medical University of Gdansk	Medical University of Gdansk(Medical University Gdansk)	AS received funding from Medical University of Gdansk. The other authors received no specific funding for this work.	[Anonymous], PRACTICAL RELIABILIT; Arno S, 2012, KNEE, V19, P896, DOI 10.1016/j.knee.2012.04.005; Basu B, 2009, CERAM INT, V35, P237, DOI 10.1016/j.ceramint.2007.10.003; Bloecker K, 2015, ARTHRIT CARE RES, V67, P1545, DOI 10.1002/acr.22615; Chan WP, 2008, SKELETAL RADIOL, V37, P917, DOI 10.1007/s00256-008-0530-8; Costa CR, 2004, AM J ROENTGENOL, V183, P17, DOI 10.2214/ajr.183.1.1830017; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Gale DR, 1999, OSTEOARTHR CARTILAGE, V7, P526, DOI 10.1053/joca.1999.0256; Hudek R, 2011, CLIN ORTHOP RELAT R, V469, P2377, DOI 10.1007/s11999-011-1802-5; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hwang SH, 2012, OSTEOARTHR CARTILAGE, V20, P110, DOI 10.1016/j.joca.2011.11.005; Jang SH, 2011, ARTHROSCOPY, V27, DOI 10.1016/j.arthro.2011.02.017; Khan N, 2014, SKELETAL RADIOL, V43, P955, DOI 10.1007/s00256-014-1867-9; Lee BS, 2015, ARTHROSCOPY, V31, P699, DOI 10.1016/j.arthro.2014.10.016; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P222, DOI 10.1007/s00167-010-1274-2; Luczkiewicz P, 2015, J BIOMECH, V48, P1356, DOI 10.1016/j.jbiomech.2015.03.002; Nakamura N, 2006, MAGNETIC RESONANCE I, V24, P1143; Pollard ME, 1995, ARTHROSCOPY, V11, P684, DOI 10.1016/0749-8063(95)90110-8; Raynauld JP, 2006, ARTHRITIS RES THER, V8, P21; Rennie WJ, 2006, AM J ROENTGENOL, V186, P791, DOI 10.2214/AJR.04.1181; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Sharma L, 2008, ARTHRITIS RHEUM-US, V58, P1716, DOI 10.1002/art.23462; Sturnick DR, 2014, J ORTHOP RES, V32, P1487, DOI 10.1002/jor.22702; Sugita T, 2001, CLIN ORTHOP RELAT R, P171; Wenger A, 2013, ARTHRITIS RHEUM-US, V65, P1804, DOI 10.1002/art.37947; Wenger A, 2012, EUR RADIOL, V22, P211, DOI 10.1007/s00330-011-2234-z	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159156	10.1371/journal.pone.0159156	http://dx.doi.org/10.1371/journal.pone.0159156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415422	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500092
J	Donaubauer, EM; Law, NC; Hunzicker-Dunn, ME				Donaubauer, Elyse M.; Law, Nathan C.; Hunzicker-Dunn, Mary E.			Follicle-Stimulating Hormone (FSH)-dependent Regulation of Extracellular Regulated Kinase (ERK) Phosphorylation by the Mitogen-activated Protein (MAP) Kinase Phosphatase MKP3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dual specificity phosphoprotein phosphatase; ERK; FSH; gene expression; ovary; PKA; MAP kinase phosphatase 3 (MKP3); dual specificity phosphatase 6 (DUSP6); granulosa cells	OVARIAN GRANULOSA-CELLS; DUAL-SPECIFICITY PHOSPHATASES; NEGATIVE-FEEDBACK-REGULATION; PTP-SL; TYROSINE PHOSPHATASES; SUBSTRATE-SPECIFICITY; SIGNALING PATHWAY; INTERACTION MOTIF; MOUSE OOCYTES; CANCER-CELLS	Within the ovarian follicle, granulosa cells (GCs) surround and support immature oocytes. FSH promotes the differentiation and proliferation of GCs and is essential for fertility. We recently reported that ERK activation is necessary for FSH to induce key genes that define the preovulatory GC. This research focused on the phosphoregulation by FSH of ERK within GCs. FSH-stimulated ERK phosphorylation on Thr(202)/Tyr(204) was PKA-dependent, but MEK(Ser(217)/Ser(221)) phosphorylation was not regulated; rather, MEK was already active. However, treatment of GCs with the EGF receptor inhibitor AG1478, a dominant-negative RAS, an Src homology 2 domain-containing Tyr phosphatase inhibitor (NSC 87877), or the MEK inhibitor PD98059 blocked FSH-dependent ERK(Thr(202)/Tyr(204)) phosphorylation, demonstrating the requirement for upstream pathway components. We hypothesized that FSH via PKA enhances ERK phosphorylation by inhibiting the activity of a protein phosphatase that constitutively dephosphorylates ERK in the absence of FSH, allowing MEK-phosphorylated ERK to accumulate in the presence of FSH because of inactivation of the phosphatase. GCs treated with different phosphatase inhibitors permitted elimination of both Ser/Thr and Tyr phosphatases and implicated dual specificity phosphatases (DUSPs) in the dephosphorylation of ERK. Treatment with MAP kinase phosphatase (MKP3, DUSP6) inhibitors increased ERK(Thr(202)/Tyr(204)) phosphorylation in the absence of FSH to levels comparable with ERK phosphorylated in the presence of FSH. ERK co-immunoprecipitated with Myc-FLAG-tagged MKP3(DUSP6). GCs treated with MKP3(DUSP6) inhibitors blocked and PKA inhibitors enhanced dephosphorylation of recombinant ERK2-GST in an in vitro phosphatase assay. Together, these results suggest that FSH-stimulated ERK activation in GCs requires the PKA-dependent inactivation of MKP3(DUSP6).	[Donaubauer, Elyse M.; Law, Nathan C.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Biotechnol Life Sci Bldg,Rm 202, Pullman, WA 99164 USA.	mehd@wsu.edu			National Institutes of Health [R01HD065859, R01HD62503]; NIGMS, National Institutes of Health Training [T32GM083864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health Training; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HD065859 and R01HD62503 (to M. E. H. D.) and NIGMS, National Institutes of Health Training Grant T32GM083864 (to E. M. D). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andric N, 2006, MOL ENDOCRINOL, V20, P3308, DOI 10.1210/me.2006-0241; Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; CARR DW, 1993, J BIOL CHEM, V268, P20729; Castelli M, 2004, J BIOL CHEM, V279, P44731, DOI 10.1074/jbc.M407669200; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; CHESNEL F, 1995, MOL REPROD DEV, V40, P503, DOI 10.1002/mrd.1080400414; Choi BH, 2002, AM J PHYSIOL-CELL PH, V282, pC1461, DOI 10.1152/ajpcell.00398.2001; Cottom J, 2003, J BIOL CHEM, V278, P7167, DOI 10.1074/jbc.M203901200; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; Devi YS, 2011, J BIOL CHEM, V286, P7609, DOI 10.1074/jbc.M110.166603; Donaubauer EM, 2016, J BIOL CHEM, V291, P12145, DOI 10.1074/jbc.M115.705368; Dorfman K, 1996, ONCOGENE, V13, P925; Eblaghie MC, 2003, CURR BIOL, V13, P1009, DOI 10.1016/S0960-9822(03)00381-6; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; El-Hefnawy T, 2001, ENDOCRINOLOGY, V142, P4357, DOI 10.1210/en.142.10.4357; ERICKSON GF, 1974, J EXP ZOOL, V190, P123, DOI 10.1002/jez.1401900112; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Herndon MK, 2016, MOL CELL ENDOCRINOL, V434, P116, DOI 10.1016/j.mce.2016.06.020; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; Hunzicker-Dunn M., 2015, PHYSL REPROD, V4th, P895; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; HUNZICKERDUNN M, 1981, J BIOL CHEM, V256, P2185; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; KEMP BE, 1988, METHOD ENZYMOL, V159, P173; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lazo JS, 2001, J MED CHEM, V44, P4042, DOI 10.1021/jm0102046; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Miro F, 1996, ENDOCRINOLOGY, V137, P464, DOI 10.1210/en.137.2.464; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Muda M, 1996, J BIOL CHEM, V271, P4319; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Noordman YE, 2008, BBA-MOL CELL RES, V1783, P275, DOI 10.1016/j.bbamcr.2007.10.023; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Ogata M, 1999, BIOCHEM BIOPH RES CO, V256, P52, DOI 10.1006/bbrc.1999.0278; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pestell KE, 2000, ONCOGENE, V19, P6607, DOI 10.1038/sj.onc.1204084; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Srivastava N, 2011, J IMMUNOL, V186, P5863, DOI 10.4049/jimmunol.1003957; van den Maagdenberg AMJM, 1999, EUR J NEUROSCI, V11, P3832, DOI 10.1046/j.1460-9568.1999.00802.x; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Vogt A, 2003, CHEM BIOL, V10, P733, DOI 10.1016/S1074-5521(03)00170-4; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Woods DC, 2006, ENDOCRINOLOGY, V147, P4931, DOI 10.1210/en.2006-0194; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	80	31	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19701	19712		10.1074/jbc.M116.733972	http://dx.doi.org/10.1074/jbc.M116.733972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27422819	Green Published, hybrid			2022-12-26	WOS:000383242800042
J	Burrell, M; Henderson, SJ; Ravnefjord, A; Schweikart, F; Fowler, SB; Witt, S; Hansson, KM; Webster, CI				Burrell, Matthew; Henderson, Simon J.; Ravnefjord, Anna; Schweikart, Fritz; Fowler, Susan B.; Witt, Susanne; Hansson, Kenny M.; Webster, Carl I.			Neprilysin Inhibits Coagulation through Proteolytic Inactivation of Fibrinogen	PLOS ONE			English	Article							CEREBRAL AMYLOID ANGIOPATHY; APP TRANSGENIC MICE; ALZHEIMERS-DISEASE; HEART-FAILURE; GENE-TRANSFER; BETA; THROMBIN; BINDING; PHOSPHORAMIDON; SPECIFICITY	Neprilysin (NEP) is an endogenous protease that degrades a wide range of peptides including amyloid beta (A beta), the main pathological component of Alzheimer's disease (AD). We have engineered NEP as a potential therapeutic for AD but found in pre-clinical safety testing that this variant increased prothrombin time (PT) and activated partial thromboplastin time (APTT). The objective of the current study was to investigate the effect of wild type NEP and the engineered variant on coagulation and define the mechanism by which this effect is mediated. PT and APTT were measured in cynomolgus monkeys and rats dosed with a human serum albumin fusion with an engineered variant of NEP (HSA-NEPv) as well as in control plasma spiked with wild type or variant enzyme. The coagulation factor targeted by NEP was determined using in vitro prothrombinase, calibrated automated thrombogram (CAT) and fibrin formation assays as well as N-terminal sequencing of fibrinogen treated with the enzyme. We demonstrate that HSA-NEP wild type and HSA-NEPv unexpectedly impaired coagulation, increasing PT and APTT in plasma samples and abolishing fibrin formation from fibrinogen. This effect was mediated through cleavage of the N-termini of the A alpha- and B beta-chains of fibrinogen thereby significantly impairing initiation of fibrin formation by thrombin. Fibrinogen has therefore been identified for the first time as a substrate for NEP wild type suggesting that the enzyme may have a role in regulating fibrin formation. Reductions in NEP levels observed in AD and cerebral amyloid angiopathy may contribute to neurovascular degeneration observed in these conditions.	[Burrell, Matthew; Fowler, Susan B.; Witt, Susanne; Webster, Carl I.] MedImmune, Antibody Discovery & Prot Engn, Milstein Bldg,Granta Pk, Cambridge, England; [Henderson, Simon J.] MedImmune, Biol Safety Assessment, Aaron Klug Bldg,Granta Pk, Cambridge, England; [Ravnefjord, Anna; Hansson, Kenny M.] AstraZeneca R&D, Cardiovasc & Metab Dis iMed, SE-43183 Molndal, Sweden; [Schweikart, Fritz] AstraZeneca R&D, Pharmaceut Dev, SE-43183 Molndal, Sweden	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; AstraZeneca	Webster, CI (corresponding author), MedImmune, Antibody Discovery & Prot Engn, Milstein Bldg,Granta Pk, Cambridge, England.	websterc@medimmune.com	Schweikart, Fritz/M-6486-2019; Schweikart, Fritz/O-4560-2019	Schweikart, Fritz/0000-0002-2201-7896	MedImmune; AstraZeneca	MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca)	All work was funded by MedImmune and AstraZeneca. The funders provided support in the form of salaries for authors MB, SH, AR, FS, SBF, SW, KMH, and CIW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; BALE MD, 1985, P NATL ACAD SCI USA, V82, P1410, DOI 10.1073/pnas.82.5.1410; Bowley SR, 2009, BLOOD, V113, P4425, DOI 10.1182/blood-2008-09-178178; Carpentier M, 2002, J NEUROPATH EXP NEUR, V61, P849, DOI 10.1093/jnen/61.10.849; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Galli A, 2014, NEW ENGL J MED, V371, P2335, DOI 10.1056/NEJMc1412654; Geer CB, 2007, J THROMB HAEMOST, V5, P2344, DOI 10.1111/j.1538-7836.2007.02774.x; Goodman OB, 2006, J BIOL CHEM, V281, P33597, DOI 10.1074/jbc.M602490200; Hardy J, 2007, NEUROCHEM RES, V32, P833, DOI 10.1007/s11064-006-9221-9; Henderson SJ, 2014, BRAIN, V137, P553, DOI 10.1093/brain/awt308; Hultman K, 2013, J CEREBR BLOOD F MET, V33, P1251, DOI 10.1038/jcbfm.2013.76; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Marr RA, 2003, J NEUROSCI, V23, P1992; MARSH HC, 1982, BIOCHEMISTRY-US, V21, P6167, DOI 10.1021/bi00267a022; Marsh Jr HC, 1983, BIOCHEMISTRY-US, P22; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Miners JS, 2006, J NEUROPATH EXP NEUR, V65, P1012, DOI 10.1097/01.jnen.0000240463.87886.9a; Miners JS, 2011, BRAIN PATHOL, V21, P594, DOI 10.1111/j.1750-3639.2011.00486.x; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Webster CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104001; WEISEL JW, 1986, BIOPHYS J, V50, P1079, DOI 10.1016/S0006-3495(86)83552-4; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668	34	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158114	10.1371/journal.pone.0158114	http://dx.doi.org/10.1371/journal.pone.0158114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437944	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100006
J	Dan, S; Yuan, Y; Wang, YS; Chen, C; Gao, CX; Yu, S; Liu, Y; Song, W; Asan; Zhu, HM; Yang, L; Deng, HM; Su, Y; Yi, X				Dan, Shan; Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Yu, Song; Liu, Yan; Song, Wei; Asan; Zhu, Hongmei; Yang, Ling; Deng, Hongmei; Su, Yue; Yi, Xin			Non-Invasive Prenatal Diagnosis of Lethal Skeletal Dysplasia by Targeted Capture Sequencing of Maternal Plasma	PLOS ONE			English	Article							RARE MUTATIONS; DNA; ACHONDROPLASIA; ACCURATE	Background Since the discovery of cell-free foetal DNA in the plasma of pregnant women, many non-invasive prenatal testing assays have been developed. In the area of skeletal dysplasia diagnosis, some PCR-based non-invasive prenatal testing assays have been developed to facilitate the ultrasound diagnosis of skeletal dysplasias that are caused by de novo mutations. However, skeletal dysplasias are a group of heterogeneous genetic diseases, the PCR-based method is hard to detect multiple gene or loci simultaneously, and the diagnosis rate is highly dependent on the accuracy of the ultrasound diagnosis. In this study, we investigated the feasibility of using targeted capture sequencing to detect foetal de novo pathogenic mutations responsible for skeletal dysplasia. Methodology/Principal Findings Three families whose foetuses were affected by skeletal dysplasia and two control families whose foetuses were affected by other single gene diseases were included in this study. Sixteen genes related to some common lethal skeletal dysplasias were selected for analysis, and probes were designed to capture the coding regions of these genes. Targeted capture sequencing was performed on the maternal plasma DNA, the maternal genomic DNA, and the paternal genomic DNA. The de novo pathogenic variants in the plasma DNA data were identified using a bioinformatical process developed for low frequency mutation detection and a strict variant interpretation strategy. The causal variants could be specifically identified in the plasma, and the results were identical to those obtained by sequencing amniotic fluid samples. Furthermore, a mean of 97% foetal specific alleles, which are alleles that are not shared by maternal genomic DNA and amniotic fluid DNA, were identified successfully in plasma samples. Conclusions/Significance Our study shows that capture sequencing of maternal plasma DNA can be used to non-invasive detection of de novo pathogenic variants. This method has the potential to be used to facilitate the prenatal diagnosis of skeletal dysplasia.	[Dan, Shan; Yu, Song; Liu, Yan; Song, Wei; Deng, Hongmei; Su, Yue] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China; [Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Asan; Zhu, Hongmei; Yang, Ling; Yi, Xin] BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin, Peoples R China; [Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Asan; Zhu, Hongmei; Yang, Ling; Yi, Xin] BGI Shenzhen, BGI Tianjin, Tianjin Translat Genom Ctr, Tianjin, Peoples R China; [Yuan, Yuan; Wang, Yaoshen; Chen, Chao; Gao, Changxin; Asan; Zhu, Hongmei; Yang, Ling; Yi, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Yi, Xin] BGI Shenzhen, BGI Guangzhou, Guangzhou Key Lab Canc Trans Omics Res GZ2012, NO348, Guangzhou, Peoples R China	Capital Medical University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Dan, S; Su, Y (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Perinatal Med, Beijing, Peoples R China.	sd_bao@sina.com; yusong_bogh@sina.com		Wang, Yaoshen/0000-0003-2034-3855	Tianjin Municipal Science and Technology Special Funds for Enterprise Development [14ZXLJSY00320]; Capital Public Health Project [Z131100004013022]	Tianjin Municipal Science and Technology Special Funds for Enterprise Development; Capital Public Health Project	This work was supported by Tianjin Municipal Science and Technology Special Funds for Enterprise Development (NO. 14ZXLJSY00320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by the Capital Public Health Project(NO. Z131100004013022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ALIGNING SEQUENCE RE, DOI DOI 10.48550/ARXIV.1303.3997; Bartsch O, 2010, AM J MED GENET A, V152A, P181, DOI 10.1002/ajmg.a.33153; broadinstitute, PIC; Chen CP, 2013, TAIWAN J OBSTET GYNE, V52, P580, DOI 10.1016/j.tjog.2013.10.023; Chen SP, 2013, GENOME MED, V5, DOI 10.1186/gm422; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Chitty LS, 2013, PRENATAL DIAG, V33, P416, DOI 10.1002/pd.4066; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Goncalves LF, 2004, ULTRASOUND OBST GYN, V24, P115, DOI 10.1002/uog.1712; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2004, PRENATAL DIAG, V24, P896, DOI 10.1002/pd.1030; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Ma DY, 2014, GENE, V544, P252, DOI 10.1016/j.gene.2014.04.055; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Noel AE, 2014, INT J WOMENS HEALTH, V6, P489, DOI 10.2147/IJWH.S47073; ROSE NJ, 1994, HUM GENET, V94, P497, DOI 10.1007/BF00211014; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; You YQ, 2014, GENET MED, V16, P594, DOI 10.1038/gim.2013.197	27	11	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159355	10.1371/journal.pone.0159355	http://dx.doi.org/10.1371/journal.pone.0159355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433940	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600050
J	Kreinest, M; Reisig, G; Strobel, P; Dinter, D; Attenberger, U; Lipp, P; Schwarz, M				Kreinest, Michael; Reisig, Gregor; Stroebel, Philipp; Dinter, Dietmar; Attenberger, Ulrike; Lipp, Peter; Schwarz, Markus			A Porcine Animal Model for Early Meniscal Degeneration - Analysis of Histology, Gene Expression and Magnetic Resonance Imaging Six Months after Resection of the Anterior Cruciate Ligament	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; CANINE MENISCUS; MESSENGER-RNA; KNEE-JOINT; COLLAGEN; OSTEOARTHRITIS; CHONDROCYTES; PROFILES; STIMULATION; ARTHROSCOPY	Background/Objective The menisci of the mammalian knee joint balance the incongruence between femoral condyle and tibial plateau and thus menisci absorb and distribute high loads. Degeneration processes of the menisci lead to pain syndromes in the knee joint. The origin of such degenerative processes on meniscal tissue is rarely understood and may be described best as an imbalance of anabolic and catabolic metabolism. A standardized animal model of meniscal degeneration is needed for further studies. The aim of the current study was to develop a porcine animal model with early meniscal degeneration. Material and Methods Resection of the anterior cruciate ligament (ACLR) was performed on the left knee joints of eight Gottingen minipigs. A sham operation was carried out on the right knee joint. The grade of degeneration was determined 26 weeks after the operation using histology and magnetic resonance imaging (MRI). Furthermore, the expression of 14 genes which code for extracellular matrix proteins, catabolic matrix metalloproteinases and inflammation mediators were analyzed. Results Degenerative changes were detected by a histological analysis of the medial meniscus after ACLR. These changes were not detected by MRI. In terms of their gene expression profile, these degenerated medial menisci showed a significantly increased expression of COL1A1. Conclusion This paper describes a new animal model for early secondary meniscal degeneration in the Gottingen minipig. Histopathological evidence of the degenerative changes could be described. This early degenerative changes could not be seen by NMR imaging.	[Kreinest, Michael; Reisig, Gregor; Schwarz, Markus] Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthoped & Trauma Surg, Mannheim, Germany; [Stroebel, Philipp] Univ Med Ctr Gottingen, Dept Pathol, Gottingen, Germany; [Dinter, Dietmar; Attenberger, Ulrike] Heidelberg Univ, Med Fac Mannheim, Dept Radiol, Mannheim, Germany; [Kreinest, Michael; Lipp, Peter] Univ Saarland, Univ Med Ctr Homburg, Dept Mol Cell Biol, Homburg, Germany; [Kreinest, Michael] BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped Surg, Ludwigshafen, Germany	Ruprecht Karls University Heidelberg; University of Gottingen; Ruprecht Karls University Heidelberg; Saarland University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kreinest, M (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Expt Orthoped & Trauma Surg, Mannheim, Germany.; Kreinest, M (corresponding author), Univ Saarland, Univ Med Ctr Homburg, Dept Mol Cell Biol, Homburg, Germany.; Kreinest, M (corresponding author), BG Trauma Ctr Ludwigshafen, Dept Trauma Surg & Orthoped Surg, Ludwigshafen, Germany.	michael.kreinest@bgu-ludwigshafen.de	Attenberger, Ulrike/HDN-2286-2022; Kreinest, Michael/ABI-7282-2020; Attenberger, Ulrike/ABD-8541-2020	Attenberger, Ulrike/0000-0002-8123-5447; Attenberger, Ulrike/0000-0002-8123-5447	Medical Faculty Mannheim, Heidelberg University	Medical Faculty Mannheim, Heidelberg University	The study was financially supported by Medical Faculty Mannheim, Heidelberg University. The funding was received by MK and MS.	Aigner T, 2006, EUR CELLS MATER, V12, P49, DOI 10.22203/eCM.v012a06; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; ASPDEN RM, 1985, J ANAT, V140, P371; Biau DJ, 2008, CLIN ORTHOP RELAT R, V466, P2282, DOI 10.1007/s11999-008-0346-9; Bollen P, 1997, PHARMACOL TOXICOL, V80, P3, DOI 10.1111/j.1600-0773.1997.tb01980.x; Bydder M, 2007, J MAGN RESON IMAGING, V25, P290, DOI 10.1002/jmri.20850; Cerejo R, 2002, ARTHRITIS RHEUM, V46, P2632, DOI 10.1002/art.10530; Curt A, 2012, LEITLINIEN DIAGNOSTI; Dankof A, 2006, VIRCHOWS ARCH, V449, P230, DOI 10.1007/s00428-006-0221-6; Fan ZY, 2005, ARTHRITIS RHEUM-US, V52, P136, DOI 10.1002/art.20725; FERRERROCA O, 1980, CLIN ORTHOP RELAT R, P289; FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Guehring T, 2005, SPINE, V30, P2510, DOI 10.1097/01.brs.0000186591.17114.e9; Guehring T, 2009, ARTHRITIS RHEUM-US, V60, P1026, DOI 10.1002/art.24407; HARING F, 1963, ZBL BAKT PARASIT, V189, P521; Hauger O, 2000, RADIOLOGY, V217, P193, DOI 10.1148/radiology.217.1.r00se36193; Hsieh YS, 2004, ARTHROSCOPY, V20, P482, DOI 10.1016/j.arthro.2004.03.010; Jones ARC, 2007, EUR CELLS MATER, V13, P40, DOI 10.22203/eCM.v013a04; Jones ARC, 2009, ARTHRITIS RHEUM-US, V60, P133, DOI 10.1002/art.24143; Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x; Kambic HE, 2005, J ORTHOP RES, V23, P142, DOI 10.1016/j.orthres.2004.06.016; Kiapour AM, 2015, CLIN ORTHOP RELAT R, V473, P639, DOI 10.1007/s11999-014-3974-2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KREINEST M, 2015, COMP MED IN PRESS; Krenn V, 2010, Z RHEUMATOL, V69, P644, DOI 10.1007/s00393-010-0609-1; Krenn V, 2010, ORTHOPADE, V39, P475, DOI 10.1007/s00132-010-1606-4; Lasch P, 2001, J BIOL CHEM, V276, P9492, DOI 10.1074/jbc.M008528200; Libicher M, 2005, EUR RADIOL, V15, P390, DOI 10.1007/s00330-004-2486-y; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Lorenz H, 2005, ARTHRITIS RES THER, V7, pR156, DOI 10.1186/ar1471; McAlinden A, 2001, OSTEOARTHR CARTILAGE, V9, P33, DOI 10.1053/joca.2000.0347; Melrose J, 2005, HISTOCHEM CELL BIOL, V124, P225, DOI 10.1007/s00418-005-0005-0; Nawata K, 1999, KNEE SURG SPORT TR A, V7, P274, DOI 10.1007/s001670050163; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Ochi K, 2003, J HUM GENET, V48, P177, DOI 10.1007/s10038-003-0004-8; Papageorgiou CD, 2001, AM J SPORT MED, V29, P226, DOI 10.1177/03635465010290021801; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; RAUNEST J, 1994, ARTHROSCOPY, V10, P634, DOI 10.1016/S0749-8063(05)80061-1; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Schwarz ML, 2010, SCAND J LAB ANIM SCI, V37, P13; Stoker Aaron M, 2006, J Orthop Surg Res, V1, P8, DOI 10.1186/1749-799X-1-8; Sun YB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2968; von Engelhardt LV, 2008, ARCH ORTHOP TRAUM SU, V128, P451, DOI 10.1007/s00402-007-0485-6; Wang QG, 2009, BIOCHEM BIOPH RES CO, V379, P738, DOI 10.1016/j.bbrc.2008.12.111; Wildey GM, 2001, J ORTHOP RES, V19, P650, DOI 10.1016/S0736-0266(00)00053-X; Wimmer MA, 2007, ARTHRITIS RHEUM-US, V56, P3511, DOI 10.1002/art.22973; Wojtys Edward M, 2005, Instr Course Lect, V54, P323; Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159331	10.1371/journal.pone.0159331	http://dx.doi.org/10.1371/journal.pone.0159331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434644	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600048
J	Thakur, J; Dwivedi, MD; Sourabh, P; Uniyal, PL; Pandey, AK				Thakur, Julie; Dwivedi, Mayank D.; Sourabh, Pragya; Uniyal, Prem L.; Pandey, Arun K.			Genetic Homogeneity Revealed Using SCoT, ISSR and RAPD Markers in Micropropagated Pittosporum eriocarpum Royle- An Endemic and Endangered Medicinal Plant	PLOS ONE			English	Article							IN-VITRO PROPAGATION; IMPROVEMENT; STABILITY; CULTURES; INDIA; RARE; TREE	Pittosporum eriocarpum Royle, a medicinally important taxon, is endemic to Uttarakhand region of Himalaya. It has become endangered due to over-collection and the loss of habitats. As raising plants through seeds in this plant is problematic, a reliable protocol for micro-propagation using nodal explants has been developed. High shoot regeneration (95%) occurred in MS medium augmented with BA 0.4mg/l in combination IBA 0.6mg/l. In vitro regenerated shoots were rooted in MS medium supplemented with three auxins, of which 0.6 mg/l indole butyric acid proved to be the best for rooting (90%) with maximum number of roots per shoot. Thereafter, rooted plants were hardened and nearly 73% of rooted shoots were successfully acclimatized and established in the field. Start codon targeted (SCoT), inter simple sequence repeats (ISSR) and random amplified polymorphic DNA (RAPD) markers were used to validate the genetic homogeneity amongst nine in vitro raised plantlets with mother plant. DNA fingerprints of in vitro regenerated plantlets displayed monomorphic bands similar to mother plant, indicating homogeneity among the micropropagated plants with donor mother plant. The similarity values were calculated based on SCoT, ISSR and RAPD profiles which ranged from 0.89 to 1.00, 0.91 to 1.00 and 0.95 to 1.00 respectively. The dendrograms generated through Unweighted Pair Group Method with arithmetic mean (UPGMA) analysis revealed 97% similarity amongst micropropagated plants with donor mother plant, thus confirming genetic homogeneity of micropropagated clones. This is the first report on micropropagation and genetic homogeneity assessment of P. eriocarpum. The protocol would be useful for the conservation and large scale production of P. eriocarpum to meet the demand for medicinal formulations and also for the re-introduction of in vitro grown plants in the suitable natural habitats to restore the populations.	[Thakur, Julie; Dwivedi, Mayank D.; Sourabh, Pragya; Uniyal, Prem L.; Pandey, Arun K.] Univ Delhi, Dept Bot, Delhi, India	University of Delhi	Pandey, AK (corresponding author), Univ Delhi, Dept Bot, Delhi, India.	arunkpandey@botany.du.ac.in	Dwivedi, Mayank/V-8220-2019	Thakur, Julie/0000-0003-1077-1565	Department of Biotechnology, Government of India [BT/Env/BC/01/2010/23.3.2012]; Department of Biotechnology, Government of India, New Delhi [BT/Env/BC/01/2010/23.3.2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	Grant support from Department of Biotechnology (# BT/Env/BC/01/2010/23.3.2012), Government of India, was provided to AKP.; Grant support (# BT/Env/BC/01/2010/23.3.2012) from Department of Biotechnology, Government of India, New Delhi, is thankfully acknowledged. We thank Prof. Mala Mazumdar, CPGS Jain University, Bangalore and an anonymous reviewer for their valuable comments. We are grateful to Prof Shailendra Goel, University of Delhi for help in molecular analysis and Dr GP Sharma and Dr Pooja Jha Maity for help in statistical analysis. The authors warmly thank Dr. Randall P. Niedz for critically reading the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], PLANT BIOTECHNOL; Benmahioul B, 2012, PLANT CELL TISS ORG, V108, P353, DOI 10.1007/s11240-011-0040-6; Chalupa V, 1987, CELL TISSUE CULTURE, P224; Chandra S, 2010, BIOTECHNOL LETT, V32, P1199, DOI 10.1007/s10529-010-0290-0; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Conover CA, 1963, FLORIDA STATE HORTIC, V1781, P480; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; Dhan Singh, 1999, Annals of Forestry, V7, P185; Dhar U, 2000, PLANT CELL TISS ORG, V63, P231, DOI 10.1023/A:1010610603893; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Gaur R., 1999, FLORA DISTRICT GARHW; Gupta AK, 2014, APPL BIOCHEM BIOTECH, V173, P1481, DOI 10.1007/s12010-014-0920-4; Gupta PK, 2002, PLANT CELL TISS ORG, V70, P229, DOI 10.1023/A:1016597404454; Harish, 2014, GENE, V535, P266, DOI 10.1016/j.gene.2013.11.018; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Lakshmanan V, 2007, ELECTRON J BIOTECHN, V10, P106, DOI 10.2225/vol10-issue1-fulltext-12; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Mathur A, 2008, AFR J BIOTECHNOL, V7, P1046; McNaughton S.J., 1989, P109; Mishra J, 2011, PLANT CELL TISS ORG, V104, P181, DOI 10.1007/s11240-010-9816-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nayar M.P., 1987, RED DATA BOOK INDIAN, V1; Padalia H, 2010, J INDIAN SOC REMOT, V38, P513, DOI 10.1007/s12524-010-0036-4; Patel AK, 2014, SCI HORTIC-AMSTERDAM, V165, P175, DOI 10.1016/j.scienta.2013.10.039; Phulwaria M, 2012, ACTA PHYSIOL PLANT, V34, P299, DOI 10.1007/s11738-011-0828-3; Rai MK, 2012, PLANT CELL TISS ORG, V111, P259, DOI 10.1007/s11240-012-0190-1; Rathore NS, 2014, ACTA PHYSIOL PLANT, V36, P555, DOI 10.1007/s11738-013-1429-0; Rawat JM, 2013, ACTA PHYSIOL PLANT, V35, P2589, DOI 10.1007/s11738-013-1294-x; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; Semwal P, 2013, BTI, V6, P25; Tripathi M, 2010, ACTA PHYSIOL PLANT, V32, P1011, DOI 10.1007/s11738-010-0484-z; Velayutham P., 2006, J AGR TECHNOL, V2, P287; Wu K, PLOS ONE, V9, P1; Xiong FQ, 2011, MOL BIOL REP, V38, P3487, DOI 10.1007/s11033-010-0459-6; Yokawa K, 2013, TRENDS PLANT SCI, V18, P117, DOI 10.1016/j.tplants.2013.01.002; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460	40	42	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159050	10.1371/journal.pone.0159050	http://dx.doi.org/10.1371/journal.pone.0159050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434060	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600031
J	Hung, YC; Cheng, YC; Muo, CH; Chiu, HE; Liu, CT; Hu, WL				Hung, Yu-Chiang; Cheng, Yu-Chen; Muo, Chih-Hsin; Chiu, Hsienhsueh Elley; Liu, Chun-Ting; Hu, Wen-Long			Adjuvant Chinese Herbal Products for Preventing Ischemic Stroke in Patients with Atrial Fibrillation	PLOS ONE			English	Article							SALVIA-MILTIORRHIZA; RISK-FACTORS; WARFARIN; DANSHEN; ANTIOXIDANT; THERAPEUTICS; MEDICINE; ESTROGEN; TAIWAN; CELLS	Objective Chinese herbal products (CHPs) are widely used for atrial fibrillation (AF) in Taiwan. We investigated the effect of adjuvant CHPs in preventing ischemic stroke in patients with AF. Methods Taiwanese patients in the Health Insurance Database newly diagnosed with AF during 2000-2011 were enrolled. Medication treatment with/without CHPs was administered within 7 days after the AF diagnosis. The clinical endpoint was an ischemic stroke. The Chi-square test, Fisher's exact test, and Student t test were used to examine differences between the traditional Chinese medicine (TCM) and non-TCM cohorts. Cox proportional hazard regression was used to assess the risk for ischemic stroke between two cohorts. Results Three hundred and eleven patients underwent TCM treatment and 1715 patients did not. Compared to non-TCM users, TCM users had a lower incidence of stroke (12.59% vs. 1.93%, respectively) and lower risk of stroke [CHA(2)DS(2)-VASc score = 0-2 (hazard ratio = 0.20; 95% confidence interval = 0.06-0.65)]. Compared to non-TCM users, the stroke risk was significantly lower in TCM users with AF who were female or younger than 65 years, but not in males, people more than 65 years old, or people with comorbidities. Compared to TCM users, non-TCM users who received conventional treatment had a higher ischemic stroke risk. The risk for AF-related hospitalization was significantly lower in TCM users (0.64%) than in non-TCM users (38.1%). Conclusions Users of TCM with AF have a lower risk of new-onset ischemic stroke. Therefore, adjuvant CHP therapy may have a protective effect and may be used in AF patients to prevent ischemic stroke.	[Hung, Yu-Chiang; Cheng, Yu-Chen; Liu, Chun-Ting; Hu, Wen-Long] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Hung, Yu-Chiang; Cheng, Yu-Chen; Liu, Chun-Ting; Hu, Wen-Long] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hung, Yu-Chiang; Chiu, Hsienhsueh Elley] I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Hu, Wen-Long] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Hu, Wen-Long] Fooyin Univ, Coll Nursing, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; I Shou University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Fooyin University	Hung, YC; Hu, WL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan.; Hung, YC; Hu, WL (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Hung, YC (corresponding author), I Shou Univ, Sch Chinese Med Post Baccalaureate, Kaohsiung, Taiwan.; Hu, WL (corresponding author), Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan.; Hu, WL (corresponding author), Fooyin Univ, Coll Nursing, Kaohsiung, Taiwan.	hungyuchiang@gmail.com; oolonghu@gmail.com	Hu, Wen-Long/N-1660-2014; Liu, Chun-Ting/GWM-4693-2022; Hung, yu-chiang/ABE-7636-2020	Hu, Wen-Long/0000-0001-9549-6202; 	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW) [105TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	The use of National Health Insurance Research Database (NHIRD) was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All of the authors' contributions were independent from the study sponsors.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; [Anonymous], 2010, CHINESE PHARMACOPOEI, V1, P236; [Anonymous], 2008, TAIWAN J CLIN CHINES, V14, P308; Bonaccini L, 2015, PLANTA MED, V81, P1003, DOI 10.1055/s-0035-1546196; Cai Y, 2004, J AGR FOOD CHEM, V52, P7884, DOI 10.1021/jf0489116; Chan TYK, 2001, ANN PHARMACOTHER, V35, P501, DOI 10.1345/aph.19029; Chao TF, 2012, STROKE, V43, P2551, DOI 10.1161/STROKEAHA.112.667865; Chen Fen-yan, 2015, Zhongguo Zhong Yao Za Zhi, V40, P1649; Chen LC, 2010, INT J GYNECOL OBSTET, V109, P63, DOI 10.1016/j.ijgo.2009.10.014; Chen LY, 2001, CHINESE TRADITIONAL, V32, P134; Chen Q., 1998, PHARM CLIN BASIS REN, P382; Chen WG, 2010, J TRADIT CHIN MED, V30, P47, DOI 10.1016/S0254-6272(10)60012-X; Cheng EY, 2016, AM J CARDIOL, V117, P1021, DOI 10.1016/j.amjcard.2015.12.040; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Cheng TO, 2006, INT J CARDIOL, V113, P437, DOI 10.1016/j.ijcard.2005.10.026; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; Chinese Materia Medical Compiling Committee of the National Administration Bureau of Traditional Chinese Medicine, 1998, RAD SALV MILT, P1654; Chiu HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086351; Chu FY, 2010, CHIN J INTEGR MED, V16, P399, DOI 10.1007/s11655-010-9999-9; Chua YT, 2015, SINGAP MED J, V56, P11, DOI 10.11622/smedj.2015004; Chung JWY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/819871; Covel CL, 2014, THROMB HAEMOSTASIS, V111, P385, DOI 10.1160/TH13-04-0347; Ge BK, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/957362; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hung YC, 2010, BBA-PROTEINS PROTEOM, V1804, P1310, DOI 10.1016/j.bbapap.2010.02.001; Hung YC, 2009, J ETHNOPHARMACOL, V124, P463, DOI 10.1016/j.jep.2009.05.020; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; Lee S, 2010, AUTON NEUROSCI-BASIC, V155, P5, DOI 10.1016/j.autneu.2010.02.003; Li J, 2009, J LIAONING U TCM, V11, P83, DOI [10.13194/ j. jlunivtcm. 2009.06.84. lij. 037, DOI 10.13194/J.JLUNIVTCM.2009.06.84.LIJ.037]; Li JL, 2000, RES TRADITIONAL CHIN, V16, P57; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Liu P, 2010, PHYTOMEDICINE, V17, P794, DOI 10.1016/j.phymed.2010.01.004; Liu R, 2013, BRAIN RES, V1514, P83, DOI 10.1016/j.brainres.2013.01.023; Liu S. J., 2015, J PRACTICAL TRADITIO, V29, P7; Liu W, 2015, COMPLEMENT THER MED, V23, P100, DOI 10.1016/j.ctim.2014.12.008; Lomuscio A, 2011, J CARDIOVASC ELECTR, V22, P241, DOI 10.1111/j.1540-8167.2010.01878.x; Lu Li, 2015, Zhong Yao Cai, V38, P781; Marchlinski F, 2012, HARRISONS PRINCIPLES; Michaud GF, 2015, HARRISONS PRINCIPLES; Nagajyothi PC, 2015, J PHOTOCH PHOTOBIO B, V146, P10, DOI 10.1016/j.jphotobiol.2015.02.008; Nutescu EA, 2006, EXPERT OPIN DRUG SAF, V5, P433, DOI 10.1517/14740338.5.3.433; Pellman J, 2015, COMPR PHYSIOL, V5, P649, DOI 10.1002/cphy.c140047; Qin RA, 2014, J ETHNOPHARMACOL, V156, P190, DOI 10.1016/j.jep.2014.08.023; Qin RA, 2012, J TRADIT CHIN MED, V32, P63, DOI 10.1016/S0254-6272(12)60033-8; Qiu Zhong-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P787; Shia CS, 2011, J ETHNOPHARMACOL, V137, P1388, DOI 10.1016/j.jep.2011.08.003; Sim Y, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0922-y; Smith W, 2012, HARRISONS PRINCIPLES; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; Sze FKH, 2005, ACTA NEUROL SCAND, V111, P118, DOI 10.1111/j.1600-0404.2004.00369.x; Tang Jian-yang, 2012, Xiamen Daxue Xuebao (Ziran Kexue Ban), V51, P789; Tian HL, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/782635; Tsai CF, 2015, INT J STROKE, V10, P485, DOI 10.1111/ijs.12508; Tsai DS, 2014, J ETHNOPHARMACOL, V155, P1534, DOI 10.1016/j.jep.2014.07.047; Tsai HH, 2013, EUR J CLIN PHARMACOL, V69, P629, DOI 10.1007/s00228-012-1359-6; Wang B, 2013, J PRACT TRADIT CHIN, V29, P168; Wu Bing, 2007, Asian Journal of Ecotoxicology, V2, P18; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Xiao Y, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/936459; Xu Hong-Ke, 2007, Zhongguo Zhen Jiu, V27, P96; Xu KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep08823; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304; Zhang DY, 2013, CARBOHYD POLYM, V95, P114, DOI 10.1016/j.carbpol.2013.03.015; Zhou W, 2014, J ETHNOPHARMACOL, V151, P66, DOI 10.1016/j.jep.2013.11.007; Zhou X., 2015, CHINESE MED MODERN D, V12, P50	69	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159333	10.1371/journal.pone.0159333	http://dx.doi.org/10.1371/journal.pone.0159333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428543	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300052
J	Liang, WZ; Xu, JW; Yuan, WS; Song, X; Zhang, JY; Wei, W; Yu, XF; Yang, Y				Liang, Weizi; Xu, Jiwei; Yuan, Wensu; Song, Xuan; Zhang, Jianyong; Wei, Wei; Yu, Xiao-Fang; Yang, Ying			APOBEC3DE Inhibits LINE-1 Retrotransposition by Interacting with ORF1p and Influencing LINE Reverse Transcriptase Activity	PLOS ONE			English	Article							HIV-1 VIF; L1 RETROTRANSPOSITION; DEAMINASE APOBEC3G; ENZYME APOBEC3G; SVA ELEMENTS; 7SL RNA; PROTEINS; RESTRICTION; DISEASE; VIRUS	Human long interspersed elements 1 (LINE-1 or L1) is the only autonomous non-LTR retroelement in humans and has been associated with genome instability, inherited genetic diseases, and the development of cancer. Certain human APOBEC3 family proteins are known to have LINE-1 restriction activity. The mechanisms by which APOBEC3 affects LINE-1 retrotransposition are not all well characterized; here, we confirm that both A3B and A3DE have a strong ability to inhibit LINE-1 retrotransposition. A3DE interacts with LINE-1 ORF1p to target LINE-1 ribonucleoprotein particles in an RNA-dependent manner. Moreover, A3DE binds to LINE-1 RNA and ORF1 protein in cell culture system. Fluorescence microscopy demonstrated that A3DE co-localizes with ORF1p in cytoplasm. Furthermore, A3DE inhibits LINE-1 reverse transcriptase activity in LINE-1 ribonucleoprotein particles in a cytidine deaminase-independent manner. In contrast, A3B has less inhibitory effects on LINE-1 reverse transcriptase activity despite its strong inhibition of LINE-1 retrotransposition. This study demonstrates that different A3 proteins have been evolved to inhibit LINE-1 activity through distinct mechanisms.	[Liang, Weizi; Xu, Jiwei; Yuan, Wensu; Song, Xuan; Zhang, Jianyong; Yu, Xiao-Fang; Yang, Ying] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China; [Wei, Wei] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wei, Wei; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA	Tianjin University; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF; Yang, Y (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.; Wei, W (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.; Wei, W; Yu, XF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	wwei6@jlu.edu.cn; xyu2@jhu.edu; yangyingcn2002@163.com	Wei, Wei/ABG-9776-2021	Wei, Wei/0000-0003-4456-840X	Tianjin Municipal Science and Technology Commission [13JCYBJC40800]	Tianjin Municipal Science and Technology Commission	This work was supported by Tianjin Municipal Science and Technology Commission, Grant number: 13JCYBJC40800 (http://www.tstc.gov.cn/) to YY. The Tianjin Municipal Science and Technology Commission provided the funding for materials.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2006, P NATL ACAD SCI USA, P103; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cullen BR, 2003, MOL THER, V8, P525, DOI 10.1016/j.ymthe.2003.08.010; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Duggal NK, 2011, J VIROL, V85, P11361, DOI 10.1128/JVI.05046-11; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2013, NUCLEIC ACIDS RES, V41, P7401, DOI 10.1093/nar/gkt512; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Horn AV, 2014, NUCLEIC ACIDS RES, V42, P396, DOI 10.1093/nar/gkt898; Hu SQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005367; Khazina E, 2011, NAT STRUCT MOL BIOL, V18, P1006, DOI 10.1038/nsmb.2097; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, P409; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Li XY, 2013, J BIOL CHEM, V288, P21148, DOI 10.1074/jbc.M113.465856; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Malim MH, 2006, CR BIOL, V329, P871, DOI 10.1016/j.crvi.2006.01.012; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Moldovan JB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005121; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schumann GG, 2010, INT REV CEL MOL BIO, V285, P115, DOI 10.1016/S1937-6448(10)85003-8; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Wang T, 2008, J MOL BIOL, V375, P1098, DOI 10.1016/j.jmb.2007.11.017; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09	51	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0157220	10.1371/journal.pone.0157220	http://dx.doi.org/10.1371/journal.pone.0157220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428332	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300002
J	Li, CZ; Zhao, LH; Sun, PS; Zhao, FZ; Kang, D; Yang, GH; Han, XH; Feng, YZ; Ren, GX				Li, Changzhen; Zhao, Luhong; Sun, Pingsheng; Zhao, Fazhu; Kang, Di; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin			Deep Soil C, N, and P Stocks and Stoichiometry in Response to Land Use Patterns in the Loess Hilly Region of China	PLOS ONE			English	Article							ORGANIC-CARBON; STORAGE; NITROGEN; AFFORESTATION; PLATEAU; CONVERSION; THRESHOLD; FOREST; SEQUESTRATION; DEGRADATION	In the Loess Hilly Region of China, the widespread conversion of cropland to forestland and grassland has resulted in great increased in organic carbon (C), nitrogen (N) and phosphorus (P) stocks in the shallow soil layers. However, knowledge regarding changes in C, N, and P in deep soil is still limited. To elucidate the responses of deep soil C, N, and P stocks and stoichiometry in response to changes in land use, the soil from a 0-200 cm soil profile was collected from the following three typical land use patterns in the heartland of the region: forestland, grassland, and cropland. Compared with cropland, forestland and grassland had improved soil organic carbon (SOC) and total nitrogen (TN) contents and stocks at most soil depths but decreased total phosphorus (TP) contents and stocks. At soil depths of 0-200 cm in the forestland and grassland, the cumulative SOC stocks were improved by 34.97% and 7.61%, respectively, and the TN stocks were improved by 54.54% and 12.47%, respectively. The forestland had higher SOC, TN and TP contents and stocks compared to the grassland in almost all soil layers. The soil depths of 100-200 cm contained the highest percentages of SOC, TN and TP stocks (47.80%-49.93%, 46.08%-50.05% and 49.09%-52.98%, respectively). Additionally, the forestland and grassland showed enhanced soil C:P, N:P and C:N:P ratios, and the forestland had higher C:P, N:P and C:N:P ratios compared to the grassland. Furthermore, the SOC and TN stocks had significant impacts on the soil C:N, C:P and N:P ratios. It was concluded that afforestation was the best choice for soil nutrient restoration of degraded land, and deep soil provided an extremely important resource for evaluating soil C, N and P pools and cycling.	[Li, Changzhen; Sun, Pingsheng; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Li, Changzhen; Zhao, Luhong; Sun, Pingsheng; Kang, Di; Yang, Gaihe; Han, Xinhui; Feng, Yongzhong; Ren, Guangxin] Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Zhao, Luhong; Kang, Di] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhao, Fazhu] Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest University Xi'an	Yang, GH; Han, XH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Yang, GH; Han, XH (corresponding author), Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn; hanxinhui@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012; Zhao, Fazhu/CAG-5988-2022; Ren, Chengjie/CAF-2259-2022	Feng, Yongzhong/0000-0002-5202-4368; Zhao, Fazhu/0000-0003-4758-3277; Kang, Di/0000-0003-4255-8689	National Natural Science Foundation of China [41301601, 41571501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by National Natural Science Foundation of China (No. 41301601 and No. 41571501) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Bai ZG, 2009, AMBIO, V38, P150, DOI 10.1579/0044-7447-38.3.150; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Cao SX, 2009, P NATL ACAD SCI USA, V106, P10712, DOI 10.1073/pnas.0900197106; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Deng J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151446; Deng L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07039; Deng L, 2014, GLOBAL CHANGE BIOL, V20, P3544, DOI 10.1111/gcb.12508; Deng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071923; Deng L, 2013, CATENA, V110, P1, DOI 10.1016/j.catena.2013.06.016; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Fan HB, 2015, PLANT SOIL, V392, P127, DOI 10.1007/s11104-015-2444-2; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; FU BJ, 1989, SOIL USE MANAGE, V5, P76, DOI 10.1111/j.1475-2743.1989.tb00765.x; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gao Y, 2014, ECOL ENG, V67, P171, DOI 10.1016/j.ecoleng.2014.03.013; Gao Y, 2013, ECOL ENG, V57, P366, DOI 10.1016/j.ecoleng.2013.04.011; Gao Y, 2012, ENVIRON SCI TECHNOL, V46, P4687, DOI 10.1021/es301163u; Gao Y, 2011, J APPL ECOL, V48, P1145, DOI 10.1111/j.1365-2664.2011.02011.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; He Jin-Sheng, 2010, Chinese Journal of Plant Ecology, V34, P2, DOI 10.3773/j.issn.1005-264x.2010.01.002; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Jiao Y, 2012, J ARID LAND, V4, P420, DOI 10.3724/SP.J.1227.2012.00420; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li Y, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004399; Liao CZ, 2012, GLOBAL ECOL BIOGEOGR, V21, P318, DOI 10.1111/j.1466-8238.2011.00690.x; Michaels AF, 2003, SCIENCE, V300, P906, DOI 10.1126/science.1083140; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Paul EA., 2006, SOIL MICROBIOLOGY EC, V3rd; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Saikh H, 1998, PLANT SOIL, V198, P137, DOI 10.1023/A:1004391615003; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Scott NA, 2006, AUST J SOIL RES, V44, P85, DOI 10.1071/SR05013; Shi SW, 2013, FOREST ECOL MANAG, V296, P53, DOI 10.1016/j.foreco.2013.01.026; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Wang W, 2014, GEODERMA, V232, P459, DOI 10.1016/j.geoderma.2014.06.004; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Wei XR, 2009, BIOGEOCHEMISTRY, V96, P149, DOI 10.1007/s10533-009-9350-8; Wu HB, 2003, GLOBAL CHANGE BIOL, V9, P305, DOI 10.1046/j.1365-2486.2003.00590.x; Yimer F, 2007, FOREST ECOL MANAG, V242, P337, DOI 10.1016/j.foreco.2007.01.087; Zeng DeHui, 2005, Acta Phytoecologica Sinica, V29, P1007; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang DJ, 2014, PLANT SOIL, V376, P307, DOI 10.1007/s11104-013-1954-z; Zhang ZH, 2013, J SOIL SEDIMENT, V13, P140, DOI [10.1007/s11368-012-0571-4, 10.1007/s11368-013-0693-3]; Zhao FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10195; Zhao FZ, 2015, ECOL ENG, V74, P415, DOI 10.1016/j.ecoleng.2014.11.010; Zhao FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099657	55	73	78	11	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159075	10.1371/journal.pone.0159075	http://dx.doi.org/10.1371/journal.pone.0159075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415785	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500070
J	Liu, HT; Gao, Y; Hu, ZY; Lin, LH; Yin, XY; Wang, J; Chen, DY; Chen, F; Jiang, H; Ren, JH; Wang, W				Liu, Hongtai; Gao, Ya; Hu, Zhiyang; Lin, Linhua; Yin, Xuyang; Wang, Jun; Chen, Dayang; Chen, Fang; Jiang, Hui; Ren, Jinghui; Wang, Wei			Performance Evaluation of NIPT in Detection of Chromosomal Copy Number Variants Using Low-Coverage Whole-Genome Sequencing of Plasma DNA	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; MICRODELETION	Objectives The aim of this study was to assess the performance of noninvasively prenatal testing (NIPT) for fetal copy number variants (CNVs) in clinical samples, using a whole-genome sequencing method. Method A total of 919 archived maternal plasma samples with karyotyping/microarray results, including 33 CNVs samples and 886 normal samples from September 1, 2011 to May 31, 2013, were enrolled in this study. The samples were randomly rearranged and blindly sequenced by low-coverage (about 7M reads) whole-genome sequencing of plasma DNA. Fetal CNVs were detected by Fetal Copy-number Analysis through Maternal Plasma Sequencing (FCAPS) to compare to the karyotyping/microarray results. Sensitivity, specificity and were evaluated. Results 33 samples with deletions/duplications ranging from 1 to 129 Mb were detected with the consistent CNV size and location to karyotyping/microarray results in the study. Ten false positive results and two false negative results were obtained. The sensitivity and specificity of detection deletions/duplications were 84.21% and 98.42%, respectively. Conclusion Whole-genome sequencing-based NIPT has high performance in detecting genome-wide CNVs, in particular > 10Mb CNVs using the current FCAPS algorithm. It is possible to implement the current method in NIPT to prenatally screening for fetal CNVs.	[Liu, Hongtai; Chen, Dayang] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Peoples R China; [Liu, Hongtai; Gao, Ya; Yin, Xuyang; Wang, Jun; Chen, Dayang; Chen, Fang; Jiang, Hui; Wang, Wei] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hu, Zhiyang; Lin, Linhua; Ren, Jinghui] Jinan Univ, Sch Clin Med 2, Shenzhen Peoples Hosp, Shenzhen 518020, Peoples R China; [Chen, Fang] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Sect Mol Dis Biol, DK-2200 Copenhagen N, Denmark	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Jinan University; University of Copenhagen	Wang, W (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangw@genomics.cn		Gao, Ya/0000-0002-5094-9842	Science and Technology Plan of Guangdong Province [2013B022000005]; Guangdong Enterprise Key Laboratory of Human Disease Genomics [2011A060906007]; Shenzhen Engineering Laboratory for Birth Defects Screening [[2011]861]	Science and Technology Plan of Guangdong Province; Guangdong Enterprise Key Laboratory of Human Disease Genomics; Shenzhen Engineering Laboratory for Birth Defects Screening	The work is supported by Science and Technology Plan of Guangdong Province (no. 2013B022000005), the Guangdong Enterprise Key Laboratory of Human Disease Genomics (no. 2011A060906007), and Shenzhen Engineering Laboratory for Birth Defects Screening (no. [2011]861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Hua Y, 2015, P NATL ACAD SCI, V112; American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Brady P, 2015, CLIN GENETICS; Chen SP, 2013, PRENATAL DIAG, V33, P584, DOI 10.1002/pd.4110; Dong Z, 2016, GENET MED; Hardisty EE, 2014, CURR OPIN PEDIATR, V26, P634, DOI 10.1097/MOP.0000000000000145; Li XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085096; Litton C, 2009, MT SINAI J MED, V76, P521, DOI 10.1002/msj.20153; Lo KK, 2015, AM J HUMAN GENETICS; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Minear MA, 2015, PRENATAL DIAG, V35, P959, DOI 10.1002/pd.4637; Nevado J, 2014, GENET MOL BIOL, V37, P210, DOI 10.1590/S1415-47572014000200007; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; South ST, 2013, GENET MED, V15, P901, DOI 10.1038/gim.2013.129; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; Straver R, 2014, NUCLEIC ACIDS RES, V42, P1635; Wapner RJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.041; Wapner RJ, 2012, PRENATAL DIAG, V32, P396, DOI 10.1002/pd.3863; Weise A, 2012, J HISTOCHEM CYTOCHEM, V60, P346, DOI 10.1369/0022155412440001; Yao H, 2012, PRENATAL DIAG, V32, P1114, DOI 10.1002/pd.3946; Yu SC, 2013, PLOS ONE, V8, P392; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792; Zhou Y, 2015, REPROD SCI	26	28	40	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159233	10.1371/journal.pone.0159233	http://dx.doi.org/10.1371/journal.pone.0159233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415003	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500103
J	Udommethaporn, S; Tencomnao, T; McGowan, EM; Boonyaratanakornkit, V				Udommethaporn, Sutthirat; Tencomnao, Tewin; McGowan, Eileen M.; Boonyaratanakornkit, Viroj			Assessment of Anti-TNF-alpha Activities in Keratinocytes Expressing Inducible TNF-alpha: A Novel Tool for Anti-TNF-alpha Drug Screening	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; PSORIATIC SKIN; HACAT CELLS; IN-VITRO; INFLAMMATION; ACTIVATION; RECEPTORS; APOPTOSIS; CANCER	Tumor necrosis factor alpha (TNF-alpha) is a pro-inflammatory cytokine important in normal and pathological biological processes. Newly synthesized pro-TNF-alpha is expressed on the plasma membrane and cleaved to release soluble TNF-alpha protein: both are biologically active. Secreted TNF-alpha signals through TNF receptors and the membrane-bound TNF-alpha acts by cell contact-dependent signaling. Anti-TNF-alpha antibodies have been used effectively for treatment of chronic inflammation, however with adverse side effects. Thus, there is a need for new anti-TNF-alpha small molecule compounds. Anti-TNF-alpha activity assays involve treatment of keratinocytes with exogenous TNF-alpha before or after anti-TNF-alpha incubation. However, this model fails to address the dual signaling of TNF-alpha. Here we describe a Doxycycline (Dox)-inducible TNF-alpha (HaCaT-TNF-alpha) expression system in keratinocytes. Using this in-vitro model, we show cell inhibition and induced expression of pro-inflammatory cytokines and markers, including IL-1 beta, IL-6, IL-8, NF-kappa B1, and KRT-16, similar to cells treated with exogenous TNF-alpha. Sufficient secreted TNF-a produced also activated IL-1 beta and IL-8 expression in wt HaCaT cells. Importantly, stimulated expression of IL-1 beta and IL-8 in HaCaT-TNF-alpha were blocked by Quercetin, a flavanol shown to possess anti-TNF-alpha activities. This novel in vitro cell model provides an efficient tool to investigate the dual signaling of TNF-alpha. Importantly, this model provides an effective, fast, and simple screening for compounds with anti-TNF-alpha activities for chronic inflammatory disease therapies.	[Udommethaporn, Sutthirat; Tencomnao, Tewin; Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Fac Allied Hlth Sci, Grad Program Clin Biochem & Mol Med, Bangkok 10330, Thailand; [Tencomnao, Tewin; Boonyaratanakornkit, Viroj] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok 10330, Thailand; [McGowan, Eileen M.] Univ Technol Sydney, Chron Dis Solut Team, Sch Life Sci, Sydney, NSW 2007, Australia	Chulalongkorn University; Chulalongkorn University; University of Technology Sydney	Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Grad Program Clin Biochem & Mol Med, Bangkok 10330, Thailand.; Boonyaratanakornkit, V (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Chem, Bangkok 10330, Thailand.	Viroj.b@chula.ac.th		Boonyaratanakornkit, Viroj/0000-0003-1800-7836; McGowan, Eileen/0000-0001-6371-3751; Tencomnao, Tewin/0000-0003-4177-2165	Korea Foundation for Advanced Studies [009/2556]; Chulalongkorn University 90th Anniversary Fund [GCUGR11255725107M]; Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund) [GCUGR11255725107M]	Korea Foundation for Advanced Studies; Chulalongkorn University 90th Anniversary Fund(Chulalongkorn University); Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund)	This work was supported by grant from Korea Foundation for Advanced Studies (009/2556) and the Chulalongkorn University 90th Anniversary Fund (GCUGR11255725107M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from Korea Foundation for Advanced Studies (009/2556) to V.B., and the Chulalongkorn University 90th Anniversary Fund (Ratchadaphiseksomphot Endowment Fund) (GCUGR11255725107M) to S.U.	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Ardestani S, 2013, CANCER RES, V73, P3938, DOI 10.1158/0008-5472.CAN-13-0002; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Boonyaratanakornkit V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/140196; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Chan Chung-Yin Stanley, 2008, Dermatol Online J, V14, P12; CHENG J, 1992, GENE DEV, V6, P1444, DOI 10.1101/gad.6.8.1444; Cho JW, 2007, INT J MOL MED, V19, P469; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Corazza N, 2004, GASTROENTEROLOGY, V127, P816, DOI 10.1053/j.gastro.2004.06.036; Mackey AC, 2007, J PEDIATR GASTR NUTR, V44, P265, DOI 10.1097/MPG.0b013e31802f6424; Eissner G, 2004, CYTOKINE GROWTH F R, V15, P353, DOI 10.1016/j.cytogfr.2004.03.011; ETTEHADI P, 1994, CLIN EXP IMMUNOL, V96, P146, DOI 10.1111/j.1365-2249.1994.tb06244.x; Ganguly S, 2009, AM J CLIN DERMATOL, V10, P125, DOI 10.2165/00128071-200910020-00005; Ghazizadeh R, 2010, INT J MED SCI, V7, P284; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaplan MJ, 2008, VASC HEALTH RISK MAN, V4, P1229, DOI 10.2147/VHRM.S3461; Kim HH, 2008, BIOCHEM BIOPH RES CO, V368, P343, DOI 10.1016/j.bbrc.2008.01.062; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; KRISTENSEN M, 1993, CLIN EXP IMMUNOL, V94, P354; Kwon DJ, 2011, BIOCHEM BIOPH RES CO, V409, P780, DOI 10.1016/j.bbrc.2011.05.088; Leverkus M, 2000, CANCER RES, V60, P553; Lisby S, 2007, BIOCHEM PHARMACOL, V73, P526, DOI 10.1016/j.bcp.2006.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makol Ashima, 2008, Cases J, V1, P287, DOI 10.1186/1757-1626-1-287; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mounach A, 2008, CLIN EXP RHEUMATOL, V26, P1116; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Paul C, 1996, BRIT J DERMATOL, V134, P710, DOI 10.1111/j.1365-2133.1996.tb06976.x; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Reinartz J, 1996, EXP CELL RES, V228, P334, DOI 10.1006/excr.1996.0333; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Saelee C, 2011, MOLECULES, V16, P3908, DOI 10.3390/molecules16053908; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Vijayalakshmi A., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P269, DOI 10.1016/S2221-1691(12)60021-5; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Wermuth J, 2009, CLIN GASTROENTEROL H, V7, pXXVIII, DOI 10.1016/j.cgh.2008.08.009; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0	50	13	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159151	10.1371/journal.pone.0159151	http://dx.doi.org/10.1371/journal.pone.0159151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415000	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500091
J	Zhang, L; Wu, LH; Tian, F; Wang, Z				Zhang, Li; Wu, Lihua; Tian, Feng; Wang, Zheng			Retrospection-Simulation-Revision: Approach to the Analysis of the Composition and Characteristics of Medical Waste at a Disaster Relief Site	PLOS ONE			English	Article							MANAGEMENT; GENERATION; INCINERATION	A large amount of medical waste is produced during disaster relief, posing a potential hazard to the habitat and the environment. A comprehensive understanding of the composition and characteristics of medical waste that requires management is one of the most basic steps in the development of a plan for medical waste management. Unfortunately, limited reliable information is available in the open literature on the characteristics of the medical waste that is generated at disaster relief sites. This paper discusses the analysis of the composition and characteristics of medical waste at a disaster relief site using the retrospection-simulation-revision method. For this study, we obtained 35 medical relief records of the Wenchuan Earthquake, Sichuan, May 2008 from a field cabin hospital. We first present a retrospective analysis of the relief medical records, and then, we simulate the medical waste generated in the affected areas. We ultimately determine the composition and characteristics of medical waste in the affected areas using untreated medical waste to revise the composition of the simulated medical waste. The results from 35 cases showed that the medical waste generated from disaster relief consists of the following: plastic (43.2%), biomass (26.3%), synthetic fiber (15.3%), rubber (6.6%), liquid (6.6%), inorganic salts (0.3%) and metals (1.7%). The bulk density of medical relief waste is 249 kg/m(3), and the moisture content is 44.75%. The data should be provided to assist the collection, segregation, storage, transportation, disposal and contamination control of medical waste in affected areas. In this paper, we wish to introduce this research method of restoring the medical waste generated in disaster relief to readers and researchers. In addition, we hope more disaster relief agencies will become aware of the significance of medical case recording and storing. This may be very important for the environmental evaluation of medical waste in disaster areas, as well as for medical waste management and disposal.	[Zhang, Li; Wu, Lihua; Tian, Feng; Wang, Zheng] Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China; [Zhang, Li] Chinese Peoples Armed Police Forces, Logist Univ, Basic Courses Dept, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Wang, Z (corresponding author), Acad Mil Med Sci, Inst Med Equipment, Tianjin, Peoples R China.	wangzheng62037@163.com			National Major Projects of Infectious Diseases [2012ZX10004-801]	National Major Projects of Infectious Diseases	The work was supported by the Special Fund of National Major Projects of Infectious Diseases (2012ZX10004-801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was financially supported by the Special Fund of National Major Projects of Infectious Diseases (2012ZX10004-801). The authors thank Dr. Fan Li and Dr. Song Lin and Dr. Maoti Wei for their assistance in improving the quality of this paper. Due to confidentiality, we cannot mention the names of the staff members working at People's Liberation Army Hospital. However, we express our appreciation to the hospitals and physicians who helped with this study.	Beigl P, 2008, WASTE MANAGE, V28, P200, DOI 10.1016/j.wasman.2006.12.011; Bernstad A, 2012, WASTE MANAGE RES, V30, P200, DOI 10.1177/0734242X11410113; Caniato M, 2015, J ENVIRON MANAGE, V153, P93, DOI 10.1016/j.jenvman.2015.01.039; Carraro E, 2016, J ENVIRON MANAGE, V168, P185, DOI 10.1016/j.jenvman.2015.11.021; Cetin S, 2004, WASTE MANAGE, V24, P183, DOI 10.1016/j.wasman.2003.07.002; Chen Y, 2013, WASTE MANAGE, V33, P1165, DOI 10.1016/j.wasman.2013.01.011; Coker A, 2009, WASTE MANAGE, V29, P804, DOI 10.1016/j.wasman.2008.06.040; Diaz LF, 2008, WASTE MANAGE, V28, P1219, DOI 10.1016/j.wasman.2007.04.010; Edjabou ME, 2015, WASTE MANAGE, V36, P12, DOI 10.1016/j.wasman.2014.11.009; Gao Y, 2003, ENG ENV SANIT, V12, P77; Gautam AK, 2007, J ENVIRON MANAGE, V83, P298, DOI 10.1016/j.jenvman.2006.03.009; Hossain MS, 2011, WASTE MANAGE, V31, P754, DOI 10.1016/j.wasman.2010.11.008; [蒋旭光 JIANG Xuguang], 2009, [环境科学学报, Acta Scientiae Circumstantiae], V29, P1226; Komilis D, 2012, WASTE MANAGE, V32, P1434, DOI 10.1016/j.wasman.2012.02.015; Lee CC, 1996, J HAZARD MATER, V48, P1, DOI 10.1016/0304-3894(95)00153-0; Li YX, 2002, CHINA PREV MED, V3, P344; Ministry of Housing and Rural-Urban Development (CN), 2009, 3132009 CJT CN MIN H; Mohee R, 2005, WASTE MANAGE, V25, P575, DOI 10.1016/j.wasman.2004.10.003; Park H, 2009, J ENVIRON SCI HEAL A, V44, P995, DOI 10.1080/10934520902996898; Rajor A, 2012, J ENVIRON MANAGE, V108, P36, DOI 10.1016/j.jenvman.2012.04.031; Tan XD, 2002, CHIN HOSP MANAG, V22, P19; Townend WK, 1999, SAFE MANAGEMENT WAST, P171; Windfeld ES, 2015, J ENVIRON MANAGE, V163, P98, DOI 10.1016/j.jenvman.2015.08.013; Xin YT, 2015, J CLEAN PROD, V100, P202, DOI 10.1016/j.jclepro.2015.03.056; Zhang J, 2008, AGROENVIRONMENT DEV, V25, P41; Zhang Y, 2009, WASTE MANAGE, V29, P1376, DOI 10.1016/j.wasman.2008.10.023; Zhao LJ, 2010, J HAZARD MATER, V173, P181, DOI 10.1016/j.jhazmat.2009.08.066	27	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159261	10.1371/journal.pone.0159261	http://dx.doi.org/10.1371/journal.pone.0159261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414649	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500113
J	Zhou, P; Huang, S; Zeng, WJ; Zhang, X; Wang, LF; Fu, XL; Li, SJ				Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Fu, Xinliang; Li, Shoujun			Seroepidemiological Evidence of Subtype H3N8 Influenza Virus Infection among Pet Dogs in China	PLOS ONE			English	Article							LIVE POULTRY MARKETS; GENETIC-CHARACTERIZATION; GUANGDONG PROVINCE; CANINE H3N2; FERAL DOGS; A-VIRUS; EQUINE; TRANSMISSION; IDENTIFICATION	The H3N8 virus and the H3N2 virus are the main subtypes of canine influenza virus (CIV). H3N8 CIV mainly circulates in America, and H3N2 CIV mainly circulates in Asia. However, there was an outbreak of the Asian H3N2 virus in the United States (US) in 2015. Thus, it is important to evaluate the presence of subtype H3N8 virus in dogs in China. From May 2015 to November 2015, 600 sera from pet dogs were collected from Guangzhou, Shanghai, Beijing and Shenzhen for hemagglutination inhibition (HI) assays and microneutralization (MN) assays. Fifty-two (8.66%) of the 600 sera were positive for the subtype H3N2 virus, which matched the previous reports. Five (0.83%) of 600 sera were positive for the subtype H3N8 virus (H3N8 EIV or H3N8 AIV or H3N8 CIV), which is the first report of subtype H3N8 virus infection among dogs in China and remind us to play more attention to this subtype virus. Therefore, further serological and virological surveillance of influenza virus infection among dogs in China is imperative.	[Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Fu, Xinliang; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Li, Shoujun] Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Huang, San; Zeng, Weijie; Zhang, Xin; Wang, Lifang; Li, Shoujun] Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn			National Natural Science Foundation of China [31372448]; Special Fund for Agro-scientific Research in the Public Interest [201303042]; Natural Science Foundation of Guangdong Province [S2013020013858]; Promote Scientific and Technological Development Program [2013B040200032]; Science and Technology Planning Project of Guangdong Province [20140224, 2013B020202001]; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Promote Scientific and Technological Development Program; Science and Technology Planning Project of Guangdong Province; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases	This project was supported in part by the National Natural Science Foundation of China (31372448), the Special Fund for Agro-scientific Research in the Public Interest (201303042), the Natural Science Foundation of Guangdong Province (S2013020013858), the Promote Scientific and Technological Development Program (2013B040200032), the Science and Technology Planning Project of Guangdong Province (20140224, 2013B020202001), and the Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013).	Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Centers for Disease Control and Prevention(CDC), 2015, UPD H3N2 CAN INFL DO; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Crispe E, 2011, AUST VET J, V89, P27, DOI 10.1111/j.1751-0813.2011.00734.x; Feng HX, 2014, VET MICROBIOL, V170, P414, DOI 10.1016/j.vetmic.2014.02.040; Gonzalez G, 2014, J VIROL, V88, P9208, DOI 10.1128/JVI.00887-14; GUO YJ, 1995, J GEN VIROL, V76, P2009, DOI 10.1099/0022-1317-76-8-2009; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Kirkland PD, 2010, EMERG INFECT DIS, V16, P699, DOI 10.3201/eid1604.091489; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Li SJ, 2010, INFECT GENET EVOL, V10, P1286, DOI 10.1016/j.meegid.2010.08.010; Lin DG, 2012, J GEN VIROL, V93, P119, DOI 10.1099/vir.0.037358-0; Paul E., 2010, Animal Health Research Reviews, V11, P43, DOI 10.1017/S1466252310000046; Payungporn S, 2008, EMERG INFECT DIS, V14, P902, DOI 10.3201/eid1406.071270; Qi T, 2010, VET MICROBIOL, V144, P455, DOI 10.1016/j.vetmic.2010.01.006; Song D, 2008, EMERG INFECT DIS, V14, P741, DOI 10.3201/eid1405.071471; Song D, 2012, J GEN VIROL, V93, P551, DOI 10.1099/vir.0.037739-0; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Su S, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu345; Su S, 2014, CLIN INFECT DIS, V58, P1644, DOI 10.1093/cid/ciu154; Su S, 2014, J CLIN MICROBIOL, V52, P1762, DOI 10.1128/JCM.03522-13; Su S, 2013, INFECT GENET EVOL, V14, P444, DOI 10.1016/j.meegid.2012.11.018; Sun XX, 2013, INFECT GENET EVOL, V20, P471, DOI 10.1016/j.meegid.2013.10.012; Sun YP, 2014, VET MICROBIOL, V168, P193, DOI 10.1016/j.vetmic.2013.10.012; Sun YP, 2013, VIROLOGY, V435, P301, DOI 10.1016/j.virol.2012.09.037; Teng QY, 2013, VET MICROBIOL, V162, P345, DOI 10.1016/j.vetmic.2012.10.006; Tu JG, 2009, ARCH VIROL, V154, P887, DOI 10.1007/s00705-009-0381-1; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang XY, 2014, VIRUS GENES, V49, P342, DOI 10.1007/s11262-014-1092-6; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396; Zhang YB, 2013, J VET MED SCI, V75, P1061, DOI 10.1292/jvms.13-0022	31	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159106	10.1371/journal.pone.0159106	http://dx.doi.org/10.1371/journal.pone.0159106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414031	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500075
J	Guannel, G; Arkema, K; Ruggiero, P; Verutes, G				Guannel, Greg; Arkema, Katie; Ruggiero, Peter; Verutes, Gregory			The Power of Three: Coral Reefs, Seagrasses and Mangroves Protect Coastal Regions and Increase Their Resilience	PLOS ONE			English	Article							WAVE ATTENUATION; ECOSYSTEM SERVICES; WIDE DECLINES; DISSIPATION; DYNAMICS; WETLANDS; EROSION; MODEL; STATE	Natural habitats have the ability to protect coastal communities against the impacts of waves and storms, yet it is unclear how different habitats complement each other to reduce those impacts. Here, we investigate the individual and combined coastal protection services supplied by live corals on reefs, seagrass meadows, and mangrove forests during both non-storm and storm conditions, and under present and future sea-level conditions. Using idealized profiles of fringing and barrier reefs, we quantify the services supplied by these habitats using various metrics of inundation and erosion. We find that, together, live corals, seagrasses, and mangroves supply more protection services than any individual habitat or any combination of two habitats. Specifically, we find that, while mangroves are the most effective at protecting the coast under non-storm and storm conditions, live corals and seagrasses also moderate the impact of waves and storms, thereby further reducing the vulnerability of coastal regions. Also, in addition to structural differences, the amount of service supplied by habitats in our analysis is highly dependent on the geomorphic setting, habitat location and forcing conditions: live corals in the fringing reef profile supply more protection services than seagrasses; seagrasses in the barrier reef profile supply more protection services than live corals; and seagrasses, in our simulations, can even compensate for the long-term degradation of the barrier reef. Results of this study demonstrate the importance of taking integrated and place-based approaches when quantifying and managing for the coastal protection services supplied by ecosystems.	[Guannel, Greg; Verutes, Gregory] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA; [Arkema, Katie] Univ Washington, Nat Capital Project, Stanford Univ, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Ruggiero, Peter] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Stanford University; Stanford University; University of Washington; University of Washington Seattle; Oregon State University	Guannel, G (corresponding author), Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA.	greg.guannel@gmail.com		Verutes, Gregory/0000-0002-7667-7902	Moore Foundation; Summit Foundation; Google via Tides Foundation; National Oceanic and Atmospheric Administration [NA11OAR4310136, NA14OAR4310195]	Moore Foundation(Gordon and Betty Moore Foundation); Summit Foundation; Google via Tides Foundation(Google Incorporated); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	Greg Guannel, Katie Arkema and Gregory Verutes's research was funded in part by the Moore Foundation, the Summit Foundation and Google via the Tides Foundation. Greg Guannel was also supported by the National Oceanic and Atmospheric Administration through their grant NA11OAR4310136. Peter Ruggiero was supported by the National Oceanic and Atmospheric Administration through their grant NA14OAR4310195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2009, ENERGETICS MANGROVE; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], LOUIS COMPR MAST PLA; Anthony EJ, 2012, ECOL ENG, V47, P268, DOI 10.1016/j.ecoleng.2012.07.005; Arkema KK, 2015, P NATL ACAD SCI USA, V112, P7390, DOI 10.1073/pnas.1406483112; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; BAGNOLD R.A., 1963, SEA, V3, P507; Barbier EB, 2013, INT REV ENVIRON RESO, V7, P35, DOI 10.1561/101.00000056; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Battjes J.A., 1978, P 16 INT C COAST ENG P 16 INT C COAST ENG, P68; Becker JM, 2014, J GEOPHYS RES-OCEANS, V119, P914, DOI 10.1002/2013JC009373; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Bowler Diana E, 2010, BMC Public Health, V10, P456, DOI 10.1186/1471-2458-10-456; Bradley K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000951; Bridges T., 2013, COASTAL RISK REDUCTI; Burger B., 2005, WAVE ATTENUATION MAN; BURKE R B, 1982, Smithsonian Contributions to the Marine Sciences, P509; Carlson PR, 1985, 12TH P ANN C WETL RE, P64; Chen SN, 2007, ESTUAR COAST, V30, P296, DOI 10.1007/BF02700172; Cheong SM, 2013, NAT CLIM CHANGE, V3, P787, DOI 10.1038/NCLIMATE1854; Cherrington EA, 2010, TECHNICAL REPORT IDE; Christianen MJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062413; Cialone MA, 2008, INT WORKSH WAV HINDC; Cooper E., 2009, COASTAL CAPITAL BELI; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; DALRYMPLE RA, 1984, J WATERW PORT C-ASCE, V110, P67, DOI 10.1061/(ASCE)0733-950X(1984)110:1(67); De Vos W.J, 2004, WAVE ATTENUATION MAN; Dean R.G., 1984, ADV SER OCEAN ENG, V2, P353; Dean R.G., 2002, COASTAL PROCESSES EN; Demirbilek Z., 2009, WAVE TRANSFORMATION; Dongeren V, 2010, MODELLING INFRAGRAVI; Duncan MJ, 2014, INT J ENV RES PUB HE, V11, P3678, DOI 10.3390/ijerph110403678; FEMA, 1988, WAV HEIGHT AN FLOOD; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Filipot JF, 2012, COAST ENG, V67, P67, DOI 10.1016/j.coastaleng.2012.04.005; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gelfenbaum G, 2011, EARTH-SCI REV, V107, P12, DOI 10.1016/j.earscirev.2010.12.005; Guannel G, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4872160; Guannel G., 2014, CHANGES DELIVERY ECO; Guannel G, 2015, J GEOPHYS RES-OCEANS, V120, P324, DOI 10.1002/2014JC009821; Halide H, 2004, INDIAN J MAR SCI, V33, P220; HOLLAND GJ, 1980, MON WEATHER REV, V108, P1212, DOI 10.1175/1520-0493(1980)108<1212:AAMOTW>2.0.CO;2; Holthuijsen L. H., 2010, WAVES OCEANIC COASTA; Horstman EM, 2014, COAST ENG, V94, P47, DOI 10.1016/j.coastaleng.2014.08.005; Hsu SA, 1998, J COASTAL RES, V14, P667; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kroeger T, 2014, VALUING ECOSYSTEM SE, P464; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Lowe RJ, 2009, J PHYS OCEANOGR, V39, P873, DOI 10.1175/2008JPO3958.1; Lowe RJ, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005753; McIvor A, 2012, NATURAL COASTAL PROT; McIvor A, 2012, NATURAL COASTAL PROT; Merrifield MA, 2014, GEOPHYS RES LETT, V41, P7245, DOI 10.1002/2014GL061005; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Mumby PJ, 2006, BIOL CONSERV, V128, P215, DOI 10.1016/j.biocon.2005.09.042; Nielsen P., 1992, COASTAL BOTTOM BOUND, DOI 10.1142/1269; NOAA Hurricane Research Division (HRD), 2014, FREQ ASK QUEST; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Pinsky ML, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00080.1; Quataert E, 2015, GEOPHYS RES LETT, V42, P6407, DOI 10.1002/2015GL064861; Reniers AJHM, 1997, COAST ENG, V30, P1, DOI 10.1016/S0378-3839(96)00033-6; Ruckelshaus MH, 2016, COAST MANAG; de Alegria-Arzaburu AR, 2013, GEOMORPHOLOGY, V198, P69, DOI 10.1016/j.geomorph.2013.05.013; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Simpson M.C., 2010, QUANTIFICATION MAGNI; South Atlantic Coastal Study Main Report Final Draft, 2021, S ATL COAST STUD MAI; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Stockdon HF, 2012, 20121084 USGS; Suzuki T, 2012, COAST ENG, V59, P64, DOI 10.1016/j.coastaleng.2011.07.006; Svendsen I.A., 2006, INTRO NEARSHORE HYDR; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Thampanya U, 2006, ESTUAR COAST SHELF S, V68, P75, DOI 10.1016/j.ecss.2006.01.011; The White House, 2015, M1601 WHIT HOUS; THORNTON EB, 1983, J GEOPHYS RES-OCEANS, V88, P5925, DOI 10.1029/JC088iC10p05925; Tolman H.L., 2009, MMAB CONTRIBUTION, V276; TOMASKO DA, 1991, MAR ECOL PROG SER, V75, P9, DOI 10.3354/meps075009; Tomlinson P.B., 1995, BOT MANGROVES; URASAKI M, 1986, Plant Species Biology, V1, P19, DOI 10.1111/j.1442-1984.1986.tb00011.x; VANTUSSENBROEK BI, 1995, MAR BIOL, V122, P33, DOI 10.1007/BF00349275; Vetter O, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006455; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Watson C, 1999, ATLAS PROBABLE STORM; Young IR, 2003, MAR STRUCT, V16, P201, DOI 10.1016/S0951-8339(02)00054-0; Zeller RB, 2014, LIMNOL OCEANOGR, V59, P251, DOI 10.4319/lo.2014.59.1.0251; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021; ZIEMAN JC, 1984, MAR ECOL PROG SER, V15, P151, DOI 10.3354/meps015151	91	131	134	2	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158094	10.1371/journal.pone.0158094	http://dx.doi.org/10.1371/journal.pone.0158094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409584	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300017
J	Li, TT; Zhang, Q; Zhang, W; Wang, GC; Lu, YY; Yu, LJ; Zhang, R				Li, Tingting; Zhang, Qing; Zhang, Wen; Wang, Guocheng; Lu, Yanyu; Yu, Lijun; Zhang, Ran			Prediction CH4 Emissions from the Wetlands in the Sanjiang Plain of Northeastern China in the 21st Century	PLOS ONE			English	Article							FRESH-WATER MARSH; METHANE EMISSIONS; CLIMATE-CHANGE; NATURAL WETLANDS; CARBON STORAGE; SPATIAL-PATTERNS; MODEL; SOIL; TEMPERATURE; DYNAMICS	The Sanjiang Plain has been experienced significant wetland loss due to expanded agricultural activities, and will be potentially restored by the China National Wetland Conservation Action Plan (NWCP) in future. The objective of this study is to evaluate the impact of future climate warming and wetland restoration on wetland CH4 emissions in northeast China. We used an atmosphere-vegetation interaction model (AVIM2) to drive a modified biogeophysical model (CH4MODwetland), and projected CH4 flux variations from the Sanjiang Plain wetlands under different Representative Concentration Pathway scenarios throughout the 21st century. Model validation showed that the regressions between the observed and simulated CH4 fluxes by the modified model produced an R-2 of 0.49 with a slope of 0.87 (p < 0.001, n = 237). According to the AVIM2 simulation, the net primary productivity of the Sanjiang Plain wetlands will increase by 38.2 g m(-2) yr(-1), 116.6 g m(-2) yr(-1) and 250.4 g m(-2) yr(-1) under RCP 2.6, RCP 4.5 and RCP 8.5, respectively, by the end of this century. For RCP 2.6, 4.5 and 8.5 scenarios, the CH4 fluxes will increase by 5.7 g m(-2) yr(-1), 57.5 g m(-2) yr(-1) and 112.2 gm(-2) yr(-1). Combined with the wetland restoration, the regional emissions will increase by 0.18-1.52 Tg. The CH4 emissions will be stimulated by climate change and wetland restoration. Regional wetland restoration planning should be directed against different climate scenarios in order to suppress methane emissions.	[Li, Tingting; Zhang, Qing; Zhang, Wen; Wang, Guocheng; Yu, Lijun] Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China; [Lu, Yanyu] Anhui Climate Ctr, Hefei 230031, Peoples R China; [Zhang, Ran] Chinese Acad Sci, Inst Atmospher Phys, CCRC, Beijing 100029, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS	Zhang, W (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, LAPC, Beijing 100029, Peoples R China.	zhw@mail.iap.ac.cn	LAPC, IAP/AAI-6991-2020; WANG, YUE/GWQ-9256-2022; Zhang, Qing/AAJ-7307-2020; Wang, Yuesi/AAF-3186-2019; Li, Tingting/AAJ-7797-2020; IAP, LAPC/AAI-6390-2020; Zhang, Wen/AAH-6060-2020; Yu, Lijun/AAJ-6691-2020; Wang, Guocheng/AAJ-6674-2020	LAPC, IAP/0000-0002-0025-3484; IAP, LAPC/0000-0002-6195-7362; Zhang, Wen/0000-0001-6670-3057; Wang, Guocheng/0000-0002-4141-4395	National Natural Science Foundation of China [31000234, 41321064, 41175132]; Chinese Academy of Sciences (CAS) [XDA05050507, XDA05020204]; Climate Change Special Foundation of China Meterological Administration [CCSF201604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Climate Change Special Foundation of China Meterological Administration	Funded by 31000234, http://www.nsfc.gov.cn/, the National Natural Science Foundation of China (LTT), 41321064, http://www.nsfc.gov.cn/, the National Natural Science Foundation of China (ZW), 41175132, http://www.nsfc.gov.cn/, the National Natural Science Foundation of China (ZW), XDA05050507, http://english.cas.cn/, the Chinese Academy of Sciences (CAS) strategic pilot technology special funds (ZW, study design), XDA05020204, http://english.cas.cn/, the Chinese Academy of Sciences (CAS) strategic pilot technology special funds, (LTT, Data collection), CCSF201604, http://www.cma.gov.cn/en2014/, the Climate Change Special Foundation of China Meterological Administration, (LTT, Data collection). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arnold JG, 2012, T ASABE, V55, P1491; Basiliko N, 2007, ECOSYSTEMS, V10, P1148, DOI 10.1007/s10021-007-9083-2; Bernie D, 2014, FUTURE TEMPERATURE R; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bhullar GS, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-32; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Boon PI, 1997, HYDROBIOLOGIA, V357, P73, DOI 10.1023/A:1003126601466; Booth BBB, 2013, EARTH SYST DYNAM, V4, P95, DOI 10.5194/esd-4-95-2013; Bortoluzzi E, 2006, NEW PHYTOL, V172, P708, DOI 10.1111/j.1469-8137.2006.01859.x; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; Cai ZC, 2012, SCI CHINA EARTH SCI, V55, P173, DOI 10.1007/s11430-011-4309-8; Cao MK, 1996, J GEOPHYS RES-ATMOS, V101, P14399, DOI 10.1029/96JD00219; Cao MK, 1998, ATMOS ENVIRON, V32, P3293, DOI 10.1016/S1352-2310(98)00105-8; Chen Y, 1995, STUDIES WETLANDS CHI; CHRISTENSEN TR, 1995, TELLUS B, V47, P301, DOI 10.1034/j.1600-0889.47.issue3.2.x; Christensen TR, 2003, BIOGEOCHEMISTRY, V64, P337, DOI 10.1023/A:1024913730848; Christensen TR, 1996, TELLUS B, V48, P652, DOI 10.1034/j.1600-0889.1996.t01-4-00004.x; Cui B, 1997, SCI GEOGR SIN, V17, P93; Ding WX, 2007, PEDOSPHERE, V17, P475, DOI 10.1016/S1002-0160(07)60057-5; Ding WX, 2004, ATMOS ENVIRON, V38, P751, DOI 10.1016/j.atmosenv.2003.10.016; Ding WX, 2002, ATMOS ENVIRON, V36, P5149, DOI 10.1016/S1352-2310(02)00647-7; Fan Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004345; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FROLKING S, 1994, GLOBAL BIOGEOCHEM CY, V8, P385, DOI 10.1029/94GB01839; Grabs T, 2009, J HYDROL, V373, P15, DOI 10.1016/j.jhydrol.2009.03.031; [郭雪莲 Guo Xuelian], 2008, [生态环境, Ecology and Environment], V17, P1739; Hao Q., 2006, THESIS; He B, 2014, FLEXIBLE GLOBAL OCEA, P225; He CQ, 2001, GRASSLAND CHINA, V4; Huang Y, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004401; Huang Y, 1998, GLOBAL CHANGE BIOL, V4, P247, DOI 10.1046/j.1365-2486.1998.00129.x; Huang Y, 2010, GLOBAL CHANGE BIOL, V16, P680, DOI 10.1111/j.1365-2486.2009.01976.x; IPCC, 2007, PHYS SCI BAS SUMM PO; Jauhiainen J, 2008, ECOLOGY, V89, P3503, DOI 10.1890/07-2038.1; Ji JJ, 2008, SCI CHINA SER D, V51, P885, DOI 10.1007/s11430-008-0039-y; Ji JJ, 1999, SCI GEOGRAPHICA SIN, V4; Jin ZN, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085007; Ju WM, 2007, J ENVIRON MANAGE, V85, P538, DOI 10.1016/j.jenvman.2006.04.028; King JY, 2002, SOIL BIOL BIOCHEM, V34, P173, DOI 10.1016/S0038-0717(01)00164-X; Kleinen T, 2012, BIOGEOSCIENCES, V9, P235, DOI 10.5194/bg-9-235-2012; Li T, 2015, BIOGEOSCIENCES, V12, P6853, DOI [10.5194/bg-12-6853-2015, 10.]; Li T, 2012, BIOGEOSCIENCES, V9, P5199, DOI 10.5194/bg-9-5199-2012; Li TT, 2010, ECOL MODEL, V221, P666, DOI 10.1016/j.ecolmodel.2009.05.017; Liu H., 2004, ACTA GEOGR SINICA CH, V59, P400; Lu XL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001843; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; MOORE TR, 1993, GEOPHYS RES LETT, V20, P587, DOI 10.1029/93GL00208; Moss R.H., 2008, IPCC EXPERT M REPORT; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Ni H, 1995, B BOT RES, V16, P356; Niu ZG, 2012, CHINESE SCI BULL, V57, P2813, DOI 10.1007/s11434-012-5093-3; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Roulet NT, 2000, WETLANDS, V20, P605, DOI 10.1672/0277-5212(2000)020[0605:PCSGGA]2.0.CO;2; Shindell D. T., 2004, GEOPHYS RES LETT, V31; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Shuttleworth WJ, HDB HYDROLOGY; Song CC, 2006, ATMOS ENVIRON, V40, P6879, DOI 10.1016/j.atmosenv.2005.08.028; [宋开山 SONG Kaishan], 2008, [地理学报, Acta Geographica Sinica], V63, P93; State Forestry Administration of China, 2005, WILDL WETL RES INF; State Forestry Administration of China, 2000, CHIN NAT WETL CONS A; Stocker T. F., 2013, CLIMATE CHANGE 2013; Su FG, 2013, J CLIMATE, V26, P3187, DOI 10.1175/JCLI-D-12-00321.1; Sun G, 1998, J AM WATER RESOUR AS, V34, P843, DOI 10.1111/j.1752-1688.1998.tb01520.x; Sun L, 2008, J HYDROL, V352, P202, DOI 10.1016/j.jhydrol.2008.01.010; Thomas CR, 2009, WETLANDS, V29, P1133, DOI 10.1672/08-234.1; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Uvo CB, 2001, HYDROL EARTH SYST SC, V5, P259; Waddington JM, 2009, AMBIO, V38, P194, DOI 10.1579/0044-7447-38.4.194; Wang D, 2003, WETL SCI, V1, P63, DOI DOI 10.13248/J.CNKI.WETLANDSCI.2003.01.011; [王德宣 Wang Dexuan], 2002, [地理科学, Scientia Geographica Sinica], V22, P500; Wang L, 2014, INT J CLIMATOL, V34, P2059, DOI 10.1002/joc.3822; Wang Y, 1993, NAT RESOUR STUD, V2, P73; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Wang ZM, 2006, ENVIRON MONIT ASSESS, V112, P69, DOI 10.1007/s10661-006-0312-5; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; White A, 1999, GLOBAL ENVIRON CHANG, V9, pS21, DOI 10.1016/S0959-3780(99)00016-3; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Wieder WR, 2015, NAT GEOSCI, V8, P441, DOI 10.1038/NGEO2413; Woodward FI, 2004, BIOL REV, V79, P643, DOI 10.1017/S1464793103006419; Wu SH, 2010, INT J CLIMATOL, V30, P866, DOI 10.1002/joc.1938; Xu CH, 2012, ATMOS OCEAN SCI LETT, V5, P527, DOI 10.1080/16742834.2012.11447042; Xu XF, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003946; Xu Y, 2012, ATMOS OCEAN SCI LETT, V5, P489, DOI 10.1080/16742834.2012.11447041; Yang WY, 2006, SCI TOTAL ENVIRON, V371, P286, DOI 10.1016/j.scitotenv.2006.08.034; Yang YongXing, 2002, Grassland of China, V24, P1; Yu Y. Q., 2014, FLEXIBLE GLOBAL OCEA, P61, DOI [DOI 10.1007/978-3-642-41801-3_9, 10.1007/978-3-642-41801-3_9]; Zhang S. W., 2006, ANAL SPATIAL TEMPORA; Zhang Y, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001838; Zhao DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060849; [赵魁义 ZHAO Kui-yi], 2008, [自然资源学报, Journal of Natural Resources], V23, P790; Zheng YM, 2012, CHINESE SCI BULL, V57, P1116, DOI 10.1007/s11434-011-4942-9; Zhou TJ, 2013, ADV ATMOS SCI, V30, P638, DOI 10.1007/s00376-013-2205-1; Zhu XD, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045003; Zhuang QL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026972	98	4	4	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158872	10.1371/journal.pone.0158872	http://dx.doi.org/10.1371/journal.pone.0158872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409586	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300039
J	Aspillaga, E; Bartumeus, F; Linares, C; Starr, RM; Lopez-Sanz, A; Diaz, D; Zabala, M; Hereu, B				Aspillaga, Eneko; Bartumeus, Frederic; Linares, Cristina; Starr, Richard M.; Lopez-Sanz, Angel; Diaz, David; Zabala, Mikel; Hereu, Bernat			Ordinary and Extraordinary Movement Behaviour of Small Resident Fish within a Mediterranean Marine Protected Area	PLOS ONE			English	Article							GROUPER EPINEPHELUS-MARGINATUS; WHITE SEA BREAM; HOME-RANGE; DIPLODUS-SARGUS; SPAWNING AGGREGATIONS; DIEL ACTIVITY; HABITAT USE; REPRODUCTIVE-BIOLOGY; FISHERIES MANAGEMENT; COMMUNITY STRUCTURE	It is important to account for the movement behaviour of fishes when designing effective marine protected areas (MPAs). Fish movements occur across different spatial and temporal scales and understanding the variety of movements is essential to make correct management decisions. This study describes in detail the movement patterns of an economically and commercially important species, Diplodus sargus, within a well-enforced Mediterranean MPA. We monitored horizontal and vertical movements of 41 adult individuals using passive acoustic telemetry for up to one year. We applied novel analysis and visualization techniques to get a comprehensive view of a wide range of movements. D. sargus individuals were highly territorial, moving within small home ranges(< 1 km(2)), inside which they displayed repetitive diel activity patterns. Extraordinary movements beyond the ordinary home range were observed under two specific conditions. First, during stormy events D. sargus presented a sheltering behaviour, moving to more protected places to avoid the disturbance. Second, during the spawning season they made excursions to deep areas (> 50 m), where they aggregated to spawn. This study advances our understanding about the functioning of an established MPA and provides important insights into the biology and management of a small sedentary species, suggesting the relevance of rare but important fish behaviours.	[Aspillaga, Eneko; Linares, Cristina; Zabala, Mikel; Hereu, Bernat] Univ Barcelona, Dept Ecol, Barcelona, Spain; [Aspillaga, Eneko] Ctr Estudis Avancats Blanes CEAB CSIC, Girona, Spain; [Bartumeus, Frederic] CREAF, Cerdanyola Del Valles, Spain; [Bartumeus, Frederic] ICREA, Barcelona, Spain; [Starr, Richard M.] Univ Calif, Sea Grant Extens Program, Moss Landing Marine Labs, Moss Landing, CA USA; [Lopez-Sanz, Angel] Inst Ciencies Mar ICM CSIC, Barcelona, Spain; [Diaz, David] Inst Espanol Oceanog, Ctr Oceanog Balears, Palma de Mallorca, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); ICREA; Moss Landing Marine Laboratories; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Spanish Institute of Oceanography	Aspillaga, E (corresponding author), Univ Barcelona, Dept Ecol, Barcelona, Spain.	aspillaga@ub.edu	Linares, Cristina/A-5244-2018; Hereu, Bernat/K-9150-2015; Aspillaga, Eneko/AAH-8613-2019; DIAZ, DAVID/AAS-8722-2021	Linares, Cristina/0000-0003-3855-2743; Hereu, Bernat/0000-0001-6247-7638; Aspillaga, Eneko/0000-0002-8888-8731; DIAZ, DAVID/0000-0003-0611-2516	Spanish Ministry of Science [CGL2005-05238/BOS]; Generalitat de Catalunya [AG-2014-654]; Spanish Ministry of Education (FPU) [AP2012-0141]; ICREA Funding Source: Custom	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education (FPU)(Spanish Government); ICREA(ICREA)	This research was funded by the Spanish Ministry of Science (CGL2005-05238/BOS) and the Generalitat de Catalunya (AG-2014-654). EA was supported by the Spanish Ministry of Education (FPU scholarship No. AP2012-0141). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Abecasis D, 2013, ESTUAR COAST SHELF S, V118, P80, DOI 10.1016/j.ecss.2012.12.014; Abecasis D, 2015, MAR ECOL PROG SER, V518, P255, DOI 10.3354/meps11054; Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; Aguzzi J, 2013, MAR ECOL PROG SER, V486, P223, DOI 10.3354/meps10399; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Burger J, 2001, ENVIRON MONIT ASSESS, V66, P23, DOI 10.1023/A:1026476030728; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Claydon J, 2004, OCEANOGR MAR BIOL, V42, P265; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; DeMitcheson YS, 2012, FISH FISH SER, V35, P1, DOI 10.1007/978-94-007-1980-4; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Di Lorenzo M, 2016, MAR ENVIRON RES, V116, P1, DOI 10.1016/j.marenvres.2016.02.007; Di Lorenzo M, 2014, MAR ECOL PROG SER, V502, P245, DOI 10.3354/meps10723; Domeier ML, 1997, B MAR SCI, V60, P698; FAO, 2014, FAO SPEC FACT SHEETS; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Figueiredo M, 2005, FISH RES, V75, P107, DOI 10.1016/j.fishres.2005.04.013; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Hereu B, 2005, MAR BIOL, V146, P293, DOI 10.1007/s00227-004-1439-y; Hereu B., 2012, FONS MARI ILLES MEDE, P35; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Jadot C, 2002, AQUAT LIVING RESOUR, V15, P343, DOI 10.1016/S0990-7440(02)01193-2; Koeck B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069303; Koeck B, 2013, J EXP MAR BIOL ECOL, V440, P1, DOI 10.1016/j.jembe.2012.11.014; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LETOURNEUR Y, 1993, ENVIRON BIOL FISH, V37, P109, DOI 10.1007/BF00000586; Lino PG, 2009, REV-METHODS TECHNOL, V9, P23, DOI 10.1007/978-14020-9640-2_2; Lloret J, 2008, OCEAN COAST MANAGE, V51, P749, DOI 10.1016/j.ocecoaman.2008.07.001; Macpherson E, 1997, MAR ECOL PROG SER, V160, P135, DOI 10.3354/meps160135; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Morato T, 2003, J FISH BIOL, V63, P59, DOI 10.1046/j.1095-8649.2003.00129.x; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Nielson R. M., 2013, BBMM BROWNIAN BRIDGE; Oksanen J, 2013, PACKAGE VEGAN COMMUN, DOI [10.4135/9781412971874.n145, DOI 10.4135/9781412971874.N145]; Pages JF, 2013, MAR ECOL PROG SER, V492, P199, DOI 10.3354/meps10494; Pages JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062719; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Pascual J, 2012, FONS MARI ILLES MEDE; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; R Core Team, 2013, R LANG ENV STAT COMP; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sala E, 2001, FISHERIES, V26, P23, DOI 10.1577/1548-8446(2001)026<0023:RDONGS>2.0.CO;2; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Walsh W.J., 1983, Coral Reefs, V2, P49, DOI 10.1007/BF00304732; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zabala M, 1997, SCI MAR, V61, P65	67	33	33	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159813	10.1371/journal.pone.0159813	http://dx.doi.org/10.1371/journal.pone.0159813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437692	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100075
J	Jaffar, N; Ishikawa, Y; Mizuno, K; Okinaga, T; Maeda, T				Jaffar, Norzawani; Ishikawa, Yuya; Mizuno, Kouhei; Okinaga, Toshinori; Maeda, Toshinari			Mature Biofilm Degradation by Potential Probiotics: Aggregatibacter actinomycetemcomitans versus Lactobacillus spp.	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; HUMAN PERIODONTAL-DISEASE; LOCALIZED JUVENILE PERIODONTITIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ORAL-HEALTH; ACTINOMYCES-NAESLUNDII; STRAINS; BACTERIA; SUSCEPTIBILITY; MACROPHAGES	The biofilm degradation of Aggregatibacter actinomycetemcomitans is essential as a complete periodontal disease therapy, and here we show the effects of potential probiotic bacteria such as Lactobacillus spp. for the biofilm of several serotypes of A. actinomycetemcomitans strains. Eight of the 13 species showed the competent biofilm degradation of >= 90% reduction in biofilm values in A. actinomycetemcomitans Y4 (serotype b) as well as four of the seven species for the biofilm of A. actinomycetemcomitans OMZ 534 (serotype e). In contrast, the probiotic bacteria did not have a big impact for the degradation of A. actinomycetemcomitans SUNY 75 (serotype a) biofilm. The dispersed A. actinomycetemcomitans Y4 cells through the biofilm detachment were still viable and plausible factors for the biofilm degradation were not due to the lactic acid and low pH conditions. The three enzymes, protease, lipase, and amylase may be responsible for the biofilm degradation; in particular, lipase was the most effective enzyme for the biofilm degradation of A. actinomycetemcomitans Y4 along with the protease activity which should be also important for the other serotypes. Remarkable lipase enzyme activities were detected from some of the potential probiotics and a supporting result using a lipase inhibitor presented corroborating evidence that lipase activity is one of the contributing factors for biofilm degradation outside of the protease which is also another possible factor for the biofilm of the other serotype of A. actinomycetemcomitans strains. On the other hand, the biofilm of A. actinomycetemcomitans SUNY 75 (serotype a) was not powerfully degraded by the lipase enzyme because the lipase inhibitor was slightly functional for only two of potential probiotics.	[Jaffar, Norzawani; Ishikawa, Yuya; Maeda, Toshinari] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan; [Jaffar, Norzawani] Univ Sultan Zainal Abidin UniSZA, Fac Hlth Sci, Gong Badak Campus, Kuala Terengganu, Terengganu Daru, Malaysia; [Mizuno, Kouhei] Kitakyushu Natl Coll Technol, Dept Mat Sci & Chem Engn, Kitakyushu, Fukuoka, Japan; [Okinaga, Toshinori] Kyushu Dent Univ, Sch Oral Hlth Sci, Fac Dent, Kitakyushu, Fukuoka, Japan; [Maeda, Toshinari] Kyushu Inst Technol, Res Ctr Adv Ecofitting Technol, Kitakyushu, Fukuoka, Japan	Kyushu Institute of Technology; Universiti Sultan Zainal Abidin; Kyushu Dental University; Kyushu Institute of Technology	Maeda, T (corresponding author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan.; Maeda, T (corresponding author), Kyushu Inst Technol, Res Ctr Adv Ecofitting Technol, Kitakyushu, Fukuoka, Japan.	toshi.maeda@life.kyutech.ac.jp	Jaffar, Norzawani/AAP-6357-2021; Maeda, Toshinari/G-3302-2017	Jaffar, Norzawani/0000-0003-4560-7116; Maeda, Toshinari/0000-0002-6219-9110; Mizuno, Kouhei/0000-0002-2070-8669	Pfizer Health Research Foundation; University of Sultan Zainal Abidin (UniSZA); Grants-in-Aid for Scientific Research [15K11083] Funding Source: KAKEN	Pfizer Health Research Foundation; University of Sultan Zainal Abidin (UniSZA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Pfizer Health Research Foundation. NJ received a scholarship from the University of Sultan Zainal Abidin (UniSZA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg CH, 2015, VIRULENCE, V6, P188, DOI 10.4161/21505594.2014.982428; Amarasinghe JJ, 2009, INFECT IMMUN, V77, P2896, DOI 10.1128/IAI.00126-09; [Anonymous], 2002, EMERGING INFECT DIS, V8; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; BAKER PJ, 1995, ANTIMICROB AGENTS CH, V39, P406, DOI 10.1128/AAC.39.2.406; Boesze-Battaglia K, 2015, INFECT IMMUN, V83, P4042, DOI 10.1128/IAI.00788-15; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Caglar E, 2005, ORAL DIS, V11, P131, DOI 10.1111/j.1601-0825.2005.01109.x; Chise S, 2013, JARQ, V47, P249; Collado MC, 2007, J MICROBIOL METH, V71, P71, DOI 10.1016/j.mimet.2007.07.005; Collado MC, 2008, EUR FOOD RES TECHNOL, V226, P1065, DOI 10.1007/s00217-007-0632-x; de Toledo A, 2012, MOL ORAL MICROBIOL, V27, P295, DOI 10.1111/j.2041-1014.2012.00646.x; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; DIRIENZO JM, 1994, INFECT IMMUN, V62, P3058, DOI 10.1128/IAI.62.8.3058-3065.1994; Fine DH, 2001, J CLIN PERIODONTOL, V28, P697, DOI 10.1034/j.1600-051x.2001.028007697.x; Fine DH, 1999, ARCH ORAL BIOL, V44, P1063, DOI 10.1016/S0003-9969(99)00089-8; Free RH, 2001, ANN OTO RHINOL LARYN, V110, P946, DOI 10.1177/000348940111001010; Gilan I, 2013, FEMS MICROBIOL LETT, V342, P18, DOI 10.1111/1574-6968.12114; Haase EM, 2006, ARCH ORAL BIOL, V51, P299, DOI 10.1016/j.archoralbio.2005.09.002; Habil N, 2011, BENEF MICROBES, V2, P283, DOI 10.3920/BM2011.0027; HANDLEY PS, 1987, J GEN MICROBIOL, V133, P3207; Hansch GM, 2012, ISRN IMMUNOLOGY, V2012, P17, DOI [10.5402/2012/853123, DOI 10.5402/2012/853123]; Health ECoEo Bacteria NPoPiFiPMwLLA, 2001, HLTH NUTR PROP PROB; HOOVER CI, 1988, J DENT RES, V67, P574, DOI 10.1177/00220345880670030901; INOUYE T, 1990, FEMS MICROBIOL LETT, V69, P13, DOI 10.1016/0378-1097(90)90405-F; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Kang MS, 2006, J CLIN PERIODONTOL, V33, P226, DOI 10.1111/j.1600-051X.2006.00893.x; Kaplan JB, 2002, J CLIN MICROBIOL, V40, P1181, DOI 10.1128/JCm.40.4.1181-1187.2002; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; Karched M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0439-z; Kim JY, 2013, MOL CELLS, V35, P115, DOI 10.1007/s10059-013-2190-3; Kimizuka Ryuta, 2009, Bull Tokyo Dent Coll, V50, P23; Korhonen R, 2001, INFLAMMATION, V25, P223, DOI 10.1023/A:1010971703271; Krasse P, 2006, SWED DENT J, V30, P55; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Matangkasombut O, 2010, INFECT IMMUN, V78, P783, DOI 10.1128/IAI.00857-09; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Morou-Bermudez E, 1999, INFECT IMMUN, V67, P504, DOI 10.1128/IAI.67.2.504-512.1999; Nikawa H, 2004, INT J FOOD MICROBIOL, V95, P219, DOI 10.1016/j.ijfoodmicro.2004.03.006; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Norskov-Lauritsen N, 2006, INT J SYST EVOL MICR, V56, P2135, DOI 10.1099/ijs.0.64207-0; Paju S, 2000, J CLIN MICROBIOL, V38, P79; Paturel L, 2004, CLIN MICROBIOL INFEC, V10, P98, DOI 10.1111/j.1469-0691.2004.00794.x; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Saha S, 2012, EXPERT OPIN BIOL TH, V12, P1207, DOI 10.1517/14712598.2012.693474; Saito Takayuki, 2010, Bull Tokyo Dent Coll, V51, P145; Samot J, 2013, ANAEROBE, V19, P34, DOI 10.1016/j.anaerobe.2012.11.007; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 1999, J IMMUNOLOGY; Singh V, 2015, MICROBIOLOGY+, V84, P59, DOI 10.1134/S0026261715010130; SLOTS J, 1984, J DENT RES, V63, P412, DOI 10.1177/00220345840630031101; Sol A, 2013, INFECT IMMUN, V81, P3577, DOI 10.1128/IAI.01288-12; Takahashi N, 2007, J ANTIMICROB CHEMOTH, V59, P59, DOI 10.1093/jac/dkl452; Wang CY, 2010, J MICROBIOL IMMUNOL, V43, P491, DOI 10.1016/S1684-1182(10)60076-X; Wang PL, 2001, ORAL DIS, V7, P233, DOI 10.1034/j.1601-0825.2001.70406.x; Wilkinson SG, 1996, PROG LIPID RES, V35, P283, DOI 10.1016/S0163-7827(96)00004-5; Yusoff MZM, 2012, INT J HYDROGEN ENERG, V37, P17778, DOI 10.1016/j.ijhydene.2012.08.115; ZAMBON JJ, 1985, J CLIN PERIODONTOL, V12, P1, DOI 10.1111/j.1600-051X.1985.tb01348.x; ZAMBON JJ, 1983, INFECT IMMUN, V41, P19, DOI 10.1128/IAI.41.1.19-27.1983; Zhang YH, 2009, J MICROBIOL BIOTECHN, V19, P888, DOI 10.4014/jmb.0812.695; Zijnge V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041662	68	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159466	10.1371/journal.pone.0159466	http://dx.doi.org/10.1371/journal.pone.0159466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438340	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100049
J	Posada, IMD; Serulla, M; Zhou, Y; Oetken-Lindholm, C; Abankwa, D; Lectez, B				Posada, Itziar M. D.; Serulla, Marc; Zhou, Yong; Oetken-Lindholm, Christina; Abankwa, Daniel; Lectez, Benoit			ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold	PLOS ONE			English	Article							H-RAS; K-RAS; MEMBRANE ORIENTATION; TUMOR-SUPPRESSOR; ACTIVATE RAF-1; STEM-CELLS; P53; PROTEINS; GALECTIN-1; CANCER	Ras-induced senescence mediated through ASPP2 represents a barrier to tumour formation. It is initiated by ASPP2's interaction with Ras at the plasma membrane, which stimulates the Raf/MEK/ERK signaling cascade. Ras to Raf signalling requires Ras to be organized in nanoscale signalling complexes, called nanocluster. We therefore wanted to investigate whether ASPP2 affects Ras nanoclustering. Here we show that ASPP2 increases the nanoscale clustering of all oncogenic Ras isoforms, H-ras, K-ras and N-ras. Structure-function analysis with ASPP2 truncation mutants suggests that the nanocluster scaffolding activity of ASPP2 converges on its alpha-helical domain. While ASPP2 increased effector recruitment and stimulated ERK and AKT phosphorylation, it did not increase colony formation of RasG12V transformed NIH/3T3 cells. By contrast, ASPP2 was able to suppress the transformation enhancing ability of the nanocluster scaffold Gal-1, by competing with the specific effect of Gal-1 on H-rasG12V- and K-rasG12V-nanoclustering, thus imposing ASPP2's ERK and AKT signalling signature. Similarly, ASPP2 robustly induced senescence and strongly abrogated mammosphere formation irrespective of whether it was expressed alone or together with Gal-1, which by itself showed the opposite effect in Ras wt or H-ras mutant breast cancer cells. Our results suggest that Gal-1 and ASPP2 functionally compete in nanocluster for active Ras on the plasma membrane. ASPP2 dominates the biological outcome, thus switching from a Gal-1 supported growth-promoting setting to a senescence inducing and stemness suppressive program in cancer cells. Our results support Ras nanocluster as major integrators of tumour fate decision events.	[Posada, Itziar M. D.; Serulla, Marc; Oetken-Lindholm, Christina; Abankwa, Daniel; Lectez, Benoit] Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland; [Zhou, Yong] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX 77030 USA	Abo Akademi University; University of Texas System; University of Texas Health Science Center Houston	Abankwa, D (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	daniel.abankwa@btk.fi		Zhou, Yong/0000-0002-0214-8151; Lectez, Benoit/0000-0001-9796-1606; Abankwa, Daniel/0000-0003-2769-0745; Serulla, Marc/0000-0002-4166-1556	Academy of Finland [252381, 256440, 281497]; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration Grant; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration Grant(European Commission); Jane and Aatos Erkko Foundation	This work was supported by the Academy of Finland fellowship grant ("Targeting a new Switch in oncogenic small GTPases"; #252381, 256440, 281497), the Sigrid Juselius Foundation, the Cancer Society of Finland, the Marie-Curie Reintegration Grant and the Jane and Aatos Erkko Foundation grants to D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Amir AI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11629; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Blazevits O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24165; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ehrhardt A, 2004, MOL CELL BIOL, V24, P6311, DOI 10.1128/MCB.24.14.6311-6323.2004; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Godin-Heymann N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082022; Guzman C, 2014, J BIOL CHEM, V289, P9519, DOI 10.1074/jbc.M113.537001; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Kampa KM, 2009, CELL CYCLE, V8, P2871, DOI 10.4161/cc.8.18.9474; Kampa KM, 2009, P NATL ACAD SCI USA, V106, P4390, DOI 10.1073/pnas.0809080106; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Najumudeen AK, 2016, ONCOGENE, V35, P5248, DOI 10.1038/onc.2016.59; Najurnudeen AK, 2015, BIOCHEMISTRY-US, V54, P7212, DOI 10.1021/acs.biochem.5b00724; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior Ian A, 2003, Sci STKE, V2003, pPL9, DOI 10.1126/stke.2003.177.pl9; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rotem S, 2008, J BIOL CHEM, V283, P18990, DOI 10.1074/jbc.M708717200; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Solman M, 2015, ELIFE, V4, DOI 10.7554/eLife.08905; Tidow H, 2007, J MOL BIOL, V371, P948, DOI 10.1016/j.jmb.2007.05.024; Tordella L, 2013, P NATL ACAD SCI USA, V110, P17969, DOI 10.1073/pnas.1309362110; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Wang Y, 2013, CELL DEATH DIFFER, V20, P525, DOI 10.1038/cdd.2013.3; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Wang ZP, 2013, P NATL ACAD SCI USA, V110, P312, DOI 10.1073/pnas.1201514110; Yamashita M, 2015, CELL STEM CELL, V17, P23, DOI 10.1016/j.stem.2015.05.013; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhou Y, 2014, MOL CELL BIOL, V34, P862, DOI 10.1128/MCB.01227-13	48	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159677	10.1371/journal.pone.0159677	http://dx.doi.org/10.1371/journal.pone.0159677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437940	Green Submitted, Green Published, gold			2022-12-26	WOS:000380170100066
J	van Beek, FE; Kuling, IA; Brenner, E; Tiest, WMB; Kappers, AML				van Beek, Femke E.; Kuling, Irene A.; Brenner, Eli; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Correcting for Visuo-Haptic Biases in 3D Haptic Guidance	PLOS ONE			English	Article							SPACE; DISTANCE; HAND; POSITION; TARGETS	Visuo-haptic biases are observed when bringing your unseen hand to a visual target. The biases are different between, but consistent within participants. We investigated the usefulness of adjusting haptic guidance to these user-specific biases in aligning haptic and visual perception. By adjusting haptic guidance according to the biases, we aimed to reduce the conflict between the modalities. We first measured the biases using an adaptive procedure. Next, we measured performance in a pointing task using three conditions: 1) visual images that were adjusted to user-specific biases, without haptic guidance, 2) veridical visual images combined with haptic guidance, and 3) shifted visual images combined with haptic guidance. Adding haptic guidance increased precision. Combining haptic guidance with user-specific visual information yielded the highest accuracy and the lowest level of conflict with the guidance at the end point. These results show the potential of correcting for user-specific perceptual biases when designing haptic guidance.	[van Beek, Femke E.; Kuling, Irene A.; Brenner, Eli; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Beek, FE (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	f.e.van.beek@vu.nl	Kuling, Irene/ABC-4022-2021	Kuling, Irene/0000-0003-3556-0393; van Beek, Femke/0000-0003-4741-6196; Brenner, Eli/0000-0002-3611-2843; Kappers, Astrid/0000-0003-4101-7717	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation [12157]	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation	This work was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation, under grant number 12157.	Abbink DA, 2012, COGN TECHNOL WORK, V14, P19, DOI 10.1007/s10111-011-0192-5; Adamovich SV, 1998, J NEUROPHYSIOL, V79, P2833, DOI 10.1152/jn.1998.79.6.2833; Brenner E, 2000, VISION RES, V40, P1649, DOI 10.1016/S0042-6989(00)00062-6; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gentaz E, 2004, PSYCHON B REV, V11, P31, DOI 10.3758/BF03206457; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Hayward V., 2004, Sensor Review, V24, P16, DOI 10.1108/02602280410515770; Kuling IA, 2015, EXP BRAIN RES, V233, P61, DOI 10.1007/s00221-014-4086-7; Kuling IA, ADJUSTING HAPT UNPUB; Kuling IA, ERRORS VISUO H UNPUB; Kuling IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074236; Mon-Williams M, 1999, PERCEPTION, V28, P167, DOI 10.1068/p2737; Mugge W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150912; Pierce RM, 2012, P IEEE RAS-EMBS INT, P169, DOI 10.1109/BioRob.2012.6290927; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P582, DOI 10.1152/jn.1989.62.2.582; Sousa R, 2010, VISION RES, V50, P1786, DOI 10.1016/j.visres.2010.05.035; Sousa R, 2012, J VISION, V12, DOI 10.1167/12.10.6; TILLERY SIH, 1994, NEUROREPORT, V6, P177; van Beek FE, 2014, LECT NOTES COMPUT SC, V8618, P48, DOI 10.1007/978-3-662-44193-0_7; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; van der Kooij K, 2013, J NEUROPHYSIOL, V109, P1890, DOI 10.1152/jn.00845.2012; van der Linde RQ, 2003, IND ROBOT, V30, P515, DOI 10.1108/01439910310506783	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158709	10.1371/journal.pone.0158709	http://dx.doi.org/10.1371/journal.pone.0158709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438009	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100018
J	Pereira-Simon, S; Rubio, GA; Xia, XM; Cai, WJ; Choi, R; Striker, GE; Elliot, SJ				Pereira-Simon, Simone; Rubio, Gustavo A.; Xia, Xiaomei; Cai, Weijing; Choi, Rhea; Striker, Gary E.; Elliot, Sharon J.			Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor a Expression in Aged Female Mice	PLOS ONE			English	Article							TYPE-2 DIABETIC-NEPHROPATHY; ER-ALPHA EXPRESSION; BREAST-CANCER CELLS; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; TGF-BETA; OXIDANT STRESS; KAPPA-B; INFLAMMATORY RESPONSE; SIRT1 DEACETYLASE	Age-related increases in oxidant stress (OS) play a role in regulation of estrogen receptor (ER) expression in the kidneys. In this study, we establish that in vivo 17 beta-estradiol (E-2) replacement can no longer upregulate glomerular ER expression by 21 months of age in female mice (anestrous). We hypothesized that advanced glycation end product (AGE) accumulation, an important source of oxidant stress, contributes to these glomerular ER expression alterations. We treated 19-month old ovariectomized female mice with pyridoxamine (Pyr), a potent AGE inhibitor, in the presence or absence of E-2 replacement. Glomerular ER alpha mRNA expression was upregulated in mice treated with both Pyr and E-2 replacement and TGF beta mRNA expression decreased compared to controls. Histological sections of kidneys demonstrated decreased type IV collagen deposition in mice receiving Pyr and E-2 compared to placebo control mice. In addition, anti-AGE defenses Sirtuin1 (SIRT1) and advanced glycation receptor 1 (AGER1) were also upregulated in glomeruli following treatment with Pyr and E-2. Mesangial cells isolated from all groups of mice demonstrated similar ER alpha, SIRT1, and AGER1 expression changes to those of whole glomeruli. To demonstrate that AGE accumulation contributes to the observed age-related changes in the glomeruli of aged female mice, we treated mesangial cells from young female mice with AGE-BSA and found similar downregulation of ER alpha, SIRT1, and AGER1 expression. These results suggest that inhibition of intracellular AGE accumulation with pyridoxamine may protect glomeruli against age-related oxidant stress by preventing an increase of TGF beta production and by regulation of the estrogen receptor.	[Pereira-Simon, Simone; Rubio, Gustavo A.; Xia, Xiaomei; Elliot, Sharon J.] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Cai, Weijing; Striker, Gary E.] Mt Sinai Sch Med, Dept Geriatr & Palliat Care, Div Expt Diabet & Aging, 1 Gustave Levy Pl, New York, NY USA; [Choi, Rhea] Univ Miami, Miller Sch Med, Dept Med, Miami, FL USA	University of Miami; Icahn School of Medicine at Mount Sinai; University of Miami	Elliot, SJ (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.	selliot@med.miami.edu		Choi, Rhea/0000-0002-3173-9890	National Institute of Aging grant [RR01 AG17170-13]	National Institute of Aging grant	Author SJE was supported by the National Institute of Aging grant RR01 AG17170-13 (https://www.nia.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson NL, 2003, KIDNEY INT, V63, P2123, DOI 10.1046/j.1523-1755.2003.00027.x; Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8; Blush J, 2004, KIDNEY INT, V66, P2148, DOI 10.1111/j.1523-1755.2004.66005.x; Brands CMJ, 2000, J AGR FOOD CHEM, V48, P2271, DOI 10.1021/jf9907586; Cai W, 2012, P NATLACADSCIUSA; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Cai WJ, 2002, MOL MED, V8, P337, DOI 10.1007/BF03402014; Casalena G, 2012, SEMIN NEPHROL, V32, P295, DOI 10.1016/j.semnephrol.2012.04.009; Cohen MP, 1998, EXP NEPHROL, V6, P226; Doublier S, 2009, KIDNEY INT, V75, P1194, DOI [10.1038/ki.2009.69, DOI 10.1038/KI.2009.69]; Eikmans M, 2001, KIDNEY INT, V60, P974, DOI 10.1046/j.1523-1755.2001.060003974.x; Elliot SJ, 2007, KIDNEY INT, V72, P464, DOI 10.1038/sj.ki.5002328; Elliot SJ, 2006, J AM SOC NEPHROL, V17, P3315, DOI 10.1681/ASN.2006070799; ELLIOT SJ, 1993, ENDOCRINOLOGY, V133, P1783, DOI 10.1210/en.133.4.1783; Finot PA, 2005, ANN NY ACAD SCI, V1043, P1, DOI 10.1196/annals.1333.001; Goldberg T, 2004, J AM DIET ASSOC, V104, P1287, DOI 10.1016/j.jada.2004.05.214; Goldfarb S, 2001, Trans Am Clin Climatol Assoc, V112, P27; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Helmersson J, 2002, CLIN SCI, V102, P39, DOI 10.1042/CS20010179; Holloway JN, 2004, MOL ENDOCRINOL, V18, P1396, DOI 10.1210/me.2004-0048; KALANT N, 1977, CAN J BIOCHEM CELL B, V55, P1197, DOI 10.1139/o77-179; Kang Z, 2006, AMINO ACIDS, V30, P55, DOI 10.1007/s00726-005-0209-6; Karl M, 2006, AM J PATHOL, V169, P351, DOI 10.2353/ajpath.2006.051255; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kosch M, 2003, NEPHROL DIAL TRANSPL, V18, P1370, DOI 10.1093/ndt/gfg169; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kovacic P, 2011, J RECEPT SIG TRANSD, V31, P332, DOI 10.3109/10799893.2011.607171; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Lee HC, 2007, EXP BIOL MED, V232, P592; Lewis EJ, 2001, AM J KIDNEY DIS, V38, pS191, DOI 10.1053/ajkd.2001.27442; LOFT S, 1992, CARCINOGENESIS, V13, P2241, DOI 10.1093/carcin/13.12.2241; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Moore RL, 2012, J ENDOCRINOL, V213, P37, DOI 10.1530/JOE-11-0217; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Pereira-Simon S, 2012, ENDOCRINOLOGY, V153, P5491, DOI 10.1210/en.2012-1379; Poncelet AC, 1998, AM J PHYSIOL-RENAL, V275, pF458; Potier M, 2002, AM J PATHOL, V160, P1877, DOI 10.1016/S0002-9440(10)61134-0; Potier M, 2001, JAMSOCNEPHROL, V12; Pouillart P, 2008, ANN NY ACAD SCI, V1126, P173, DOI 10.1196/annals.1433.040; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Tanimoto M, 2007, METABOLISM, V56, P160, DOI 10.1016/j.metabol.2006.08.026; Turgut F, 2010, AM J KIDNEY DIS, V55, P928, DOI 10.1053/j.ajkd.2009.11.021; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2006, CLIN J AM SOC NEPHRO, V1, P1293, DOI 10.2215/CJN.01270406; Uribarri J, 2014, AMINO ACIDS, V46, P301, DOI 10.1007/s00726-013-1502-4; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vlassara H, 2011, NAT REV ENDOCRINOL, V7, P526, DOI 10.1038/nrendo.2011.74; Vlassara H, 2009, J CLIN ENDOCR METAB, V94, P4483, DOI 10.1210/jc.2009-0089; Wharton W, BRAIN RES; Williams ME, 2007, AM J NEPHROL, V27, P605, DOI 10.1159/000108104; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu M, 2011, J AM SOC NEPHROLOGY; Zheng F, 2004, AM J PATHOL, V165, P1789, DOI 10.1016/S0002-9440(10)63434-7; Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6	61	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159666	10.1371/journal.pone.0159666	http://dx.doi.org/10.1371/journal.pone.0159666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428057	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300080
J	Wu, W; Zhao, L; Yang, P; Zhou, W; Li, BB; Moorhead, JF; Varghese, Z; Ruan, XZ; Chen, YX				Wu, Wei; Zhao, Lei; Yang, Ping; Zhou, Wei; Li, Beibei; Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.; Chen, Yaxi			Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/- Mice	PLOS ONE			English	Article							HIGH-FAT DIET; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; MITOCHONDRIAL DYSFUNCTION; METABOLIC-DISORDERS; LIPID-PEROXIDATION; NRF2-NULL MICE; KNOCKOUT MICE; IN-VIVO; HEPATOTOXICITY	Statins, which are revolutionized cholesterol-lowing agents, have been reported to have unfavorable effects on the liver. Inflammatory stress is a susceptibility factor for drug-induced liver injury. This study investigated whether inflammatory stress sensitized the liver to statin-induced toxicity in mice and explored the underlying mechanisms. We used casein injection in ApoE-/- mice to induce inflammatory stress. Half of the mice were orally administered atorvastatin (10mg/kg/d) for 8 weeks. The results showed that casein injection increased the levels of serum pro-inflammatory cytokines (IL-6 and TNF alpha). Atorvastatin treatment increased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in casein injection mice. Moreover, atorvastatin treatment exacerbated hepatic steatosis, inflammation and fibrosis, as well as increased hepatic reactive oxygen species (ROS) and malondialdehyde in casein injection mice. However, above changes were not observed in atorvastatin treated alone mice. The protein expression of liver nuclear factor erythroid 2-related factor 2 (Nrf2) and the mRNA expressions of Nrf2 target genes were increased, together with the enhancement of activities of hepatic catalase and superoxide dismutase in atorvastatin treated alone mice, but these antioxidant responses were lost in mice treated with atorvastatin under inflammatory stress. This study demonstrates that atorvastatin exacerbates the liver injury under inflammatory stress, which may be associated with the loss of adaptive antioxidant response mediated by Nrf2.	[Wu, Wei; Zhao, Lei; Yang, Ping; Zhou, Wei; Li, Beibei; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Ctr Lipid Res, Chongqing, Peoples R China; [Wu, Wei; Zhao, Lei; Yang, Ping; Zhou, Wei; Li, Beibei; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Inst Viral Hepatitis,Dept Infect Dis,Affiliated H, Chongqing, Peoples R China; [Ruan, Xiong Z.] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Moorhead, John F.; Varghese, Zac; Ruan, Xiong Z.] UCL, Sch Med, John Moorhead Res Lab, Ctr Nephrol, Royal Free Campus, London, England	Chongqing Medical University; Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; University of London; University College London; UCL Medical School	Ruan, XZ; Chen, YX (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Chongqing, Peoples R China.; Ruan, XZ; Chen, YX (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Inst Viral Hepatitis,Dept Infect Dis,Affiliated H, Chongqing, Peoples R China.; Ruan, XZ (corresponding author), UCL, Sch Med, John Moorhead Res Lab, Ctr Nephrol, Royal Free Campus, London, England.	x.ruan@ucl.ac.uk; chenyaxi@cqmu.edu.cn	Moorhead, John/M-7404-2014; Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	Major State Basic Research Development Program of China (973 Program) [2012CB517700, 2012CB517500]; National Natural Science Foundation of China [81270789, 81390354, 81570517, 81270493]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjBX0044]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology	Major State Basic Research Development Program of China (973 Program, NO. 2012CB517700), http://www.most.gov.cn/, XZR received the funding; Major State Basic Research Development Program of China (973 Program, NO. 2012CB517500), http://www.most.gov.cn/, YC received the funding; National Natural Science Foundation of China (81270789, 81390354), http://www.nsfc.gov.cn/, XZR received the funding; National Natural Science Foundation of China (81570517, 81270493), http://www.nsfc.gov.cn/, YC received the funding; Chongqing Research Program of Basic Research and Frontier Technology (No. cstc2015jcyjBX0044), http://www.cstc.gov.cn/, YC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2014, FREE RADICAL BIO MED, V75, pS40, DOI 10.1016/j.freeradbiomed.2014.10.790; Aminzadeh MA, 2013, NEPHROL DIAL TRANSPL, V28, P2038, DOI 10.1093/ndt/gft022; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6; Bjornsson E, 2012, J HEPATOL, V56, P374, DOI [10.1016/j.jhep.2011.08.016, 10.1016/j.jhep.2011.07.023]; Bouitbir J, 2016, ANTIOXID REDOX SIGN, V24, P84, DOI 10.1089/ars.2014.6190; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Chen YX, 2014, NEPHROL DIAL TRANSPL, V29, P1864, DOI 10.1093/ndt/gfu203; Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Clarke AT, 2006, DIGEST LIVER DIS, V38, P772, DOI 10.1016/j.dld.2006.04.013; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Copple Ian M, 2010, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-00663-0_9; Deng XM, 2009, PHARMACOL REV, V61, P262, DOI 10.1124/pr.109.001727; Dworski R, 2011, FREE RADICAL BIO MED, V51, P516, DOI 10.1016/j.freeradbiomed.2011.04.040; Engelhardt JF, 1999, ANTIOXID REDOX SIGN, V1, P5, DOI 10.1089/ars.1999.1.1-5; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Ganey PE, 2004, CHEM-BIOL INTERACT, V150, P35, DOI 10.1016/j.cbi.2004.09.002; Han D, 2013, TRENDS PHARMACOL SCI, V34, P243, DOI 10.1016/j.tips.2013.01.009; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Labbe G, 2008, FUND CLIN PHARMACOL, V22, P335, DOI 10.1111/j.1472-8206.2008.00608.x; Lee J, 2015, BIOCHEM BIOPH RES CO, V464, P229, DOI 10.1016/j.bbrc.2015.06.121; Leonarduzzi G, 1997, FASEB J, V11, P851, DOI 10.1096/fasebj.11.11.9285483; Liu F, 2010, TOXICOL SCI, V115, P596, DOI 10.1093/toxsci/kfq075; Liu J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/305861; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Nieto N, 2002, HEPATOLOGY, V35, P62, DOI 10.1053/jhep.2002.30362; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Okada K, 2013, J GASTROENTEROL, V48, P620, DOI 10.1007/s00535-012-0659-z; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Pereira CV, 2012, EXPERT OPIN DRUG MET, V8, P219, DOI 10.1517/17425255.2012.645536; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rieber N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/252460; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Tariq Z, 2014, LIVER INT, V34, pE180, DOI 10.1111/liv.12523; Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160; Yuan LY, 2013, CLIN LIVER DIS, V17, P507, DOI 10.1016/j.cld.2013.07.002; Zhao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10222; Zhao L, 2011, J GASTROEN HEPATOL, V26, P875, DOI 10.1111/j.1440-1746.2010.06560.x; Zou HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040432	43	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159512	10.1371/journal.pone.0159512	http://dx.doi.org/10.1371/journal.pone.0159512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428373	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300073
J	Cameron, EZ; Ryan, SJ				Cameron, Elissa Z.; Ryan, Sadie J.			Welfare at Multiple Scales: Importance of Zoo Elephant Population Welfare in a World of Declining Wild Populations	PLOS ONE			English	Editorial Material							RELATEDNESS; IMPACTS; RISK		[Cameron, Elissa Z.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Cameron, Elissa Z.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA	University of Canterbury; University of Tasmania; State University System of Florida; University of Florida	Cameron, EZ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.; Cameron, EZ (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	elissa.cameron@canterbury.ac.nz	Ryan, Sadie Jane/H-7488-2019; Cameron, Elissa/B-8053-2014	Ryan, Sadie Jane/0000-0002-4308-6321; Cameron, Elissa/0000-0002-9243-0547				baLLou J. d., 1995, POPULATION MANAGEMEN; Bennett EL, 2015, CONSERV BIOL, V29, P54, DOI 10.1111/cobi.12377; Breuer T, 2016, CONSERV BIOL; Brown JL, 2016, PLOS ONE; Bunting E, 2013, LAND-BASEL, V2, P225, DOI 10.3390/land2020225; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; de Boer WF, 2013, BIOL CONSERV, V159, P468, DOI 10.1016/j.biocon.2012.10.015; Fiona Harvey, 2016, GUARDIAN; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Greco BJ, 2016, PLOS ONE; Holdgate MR, 2016, PLOS ONE; Ihwagi FW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139079; [IUCN T UNEP C], 2013, EL DUST THE AFR EL C; Jachowski DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031818; Jathanna D, 2015, BIOL CONSERV, V187, P212, DOI 10.1016/j.biocon.2015.04.030; Jeffery Gettleman, 2016, NY TIMES; Kerley GIH, 2006, S AFR J SCI, V102, P395; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Mackenzie CA, 2012, ECOL ECON, V75, P72, DOI 10.1016/j.ecolecon.2011.12.018; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Meehan C, PLOS ONE IN PRESS; Meehan CL, 2016, PLOS ONE; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; MILNERGULLAND EJ, 1993, P ROY SOC B-BIOL SCI, V252, P29, DOI 10.1098/rspb.1993.0042; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Mumby HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13946; Nyhus P, 2004, AGR ECOSYST ENVIRON, V104, P87, DOI 10.1016/j.agee.2004.01.009; Prado-Oviedo NA, 2016, PLOS ONE; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Rutina LP, 2005, WILDLIFE BIOL, V11, P207, DOI 10.2981/0909-6396(2005)11[207:ELADWC]2.0.CO;2; Ryan SJ, 2006, CONSERV BIOL, V20, P1321, DOI 10.1111/j.1523-1739.2006.00347.x; Ryan SJ, 2001, ZOO BIOL, V20, P89, DOI 10.1002/zoo.1009; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Sukumar R., 1992, ASIAN ELEPHANT ECOLO; Suprahman H, 1986, ECOLOGY ELEPHANT ELE; Thitaram C, 2015, APPL ANIM BEHAV SCI, V172, P52, DOI 10.1016/j.applanim.2015.09.002; van Aarde RJ, 2006, S AFR J SCI, V102, P385; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111	42	5	5	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158701	10.1371/journal.pone.0158701	http://dx.doi.org/10.1371/journal.pone.0158701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415004	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500031
J	Greco, BJ; Meehan, CL; Miller, LJ; Shepherdson, DJ; Morfeld, KA; Andrews, J; Baker, AM; Carlstead, K; Mench, JA				Greco, Brian J.; Meehan, Cheryl L.; Miller, Lance J.; Shepherdson, David J.; Morfeld, Kari A.; Andrews, Jeff; Baker, Anne M.; Carlstead, Kathy; Mench, Joy A.			Elephant Management in North American Zoos: Environmental Enrichment, Feeding, Exercise, and Training	PLOS ONE			English	Article							POSITIVE REINFORCEMENT; STEREOTYPIC BEHAVIOR; NOCTURNAL BEHAVIOR; WELFARE; CHILDREN; OBESITY; BONE; RATS	The management of African (Loxodonta africana) and Asian (Elephas maximus) elephants in zoos involves a range of practices including feeding, exercise, training, and environmental enrichment. These practices are necessary to meet the elephants' nutritional, healthcare, and husbandry needs. However, these practices are not standardized, resulting in likely variation among zoos as well as differences in the way they are applied to individual elephants within a zoo. To characterize elephant management in North America, we collected survey data from zoos accredited by the Association of Zoos and Aquariums, developed 26 variables, generated population level descriptive statistics, and analyzed them to identify differences attributable to sex and species. Sixty-seven zoos submitted surveys describing the management of 224 elephants and the training experiences of 227 elephants. Asian elephants spent more time managed (defined as interacting directly with staff) than Africans (mean time managed: Asians = 56.9%; Africans = 48.6%; p<0.001), and managed time increased by 20.2% for every year of age for both species. Enrichment, feeding, and exercise programs were evaluated using diversity indices, with mean scores across zoos in the midrange for these measures. There were an average of 7.2 feedings every 24-hour period, with only 1.2 occurring during the nighttime. Feeding schedules were predictable at 47.5% of zoos. We also calculated the relative use of rewarding and aversive techniques employed during training interactions. The population median was seven on a scale from one (representing only aversive stimuli) to nine (representing only rewarding stimuli). The results of our study provide essential information for understanding management variation that could be relevant to welfare. Furthermore, the variables we created have been used in subsequent elephant welfare analyses.	[Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Greco, Brian J.; Meehan, Cheryl L.] AWARE Inst, Portland, OR USA; [Miller, Lance J.] Chicago Zool Soc, Brookfield Zoo, Brookfield, IL USA; [Shepherdson, David J.] Oregon Zoo, Portland, OR USA; [Morfeld, Kari A.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Baker, Anne M.] CBSG North America, Apple Valley, ME USA; [Andrews, Jeff] Busch Gardens, Tampa, FL USA; [Carlstead, Kathy] Honolulu Zoo, Honolulu, HI USA	University of California System; University of California Davis; University of California System; University of California Davis; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Greco, BJ (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Greco, BJ (corresponding author), Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA.; Greco, BJ (corresponding author), AWARE Inst, Portland, OR USA.	bjgreco@ucdavis.edu			Institute of Museum and Library Services [LG-25-10-0033-10]; Oregon Zoo; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; Lincoln Children's Zoo; Smithsonian's National Zoo; Honolulu Zoo; IMLS; AWARE Institute	Institute of Museum and Library Services; Oregon Zoo; Chicago Zoological Society-Brookfield Zoo; Busch Gardens; Lincoln Children's Zoo; Smithsonian's National Zoo; Honolulu Zoo; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Oregon Zoo (DS); Chicago Zoological Society-Brookfield Zoo (LM); Busch Gardens (JA); Lincoln Children's Zoo and Smithsonian's National Zoo (KM); Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquariums AoZa, 2011, STAND EL MAN CAR; Atlantis E, 2006, INT J OBESITY, V30, P1027, DOI 10.1038/sj.ijo.0803286; Bashaw MJ, 2001, APPL ANIM BEHAV SCI, V73, P235, DOI 10.1016/S0168-1591(01)00137-X; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; BELL RR, 1995, J NUTR, V125, P2356, DOI 10.1093/jn/125.9.2356; Bennett C, 2015, J APPL ANIM WELF SCI, V18, pS43, DOI 10.1080/10888705.2015.1075835; Bollen K, 1997, J ELEPHANT MANAGERS, V8, P51; Bradshaw G. A., 2009, ELEPHANTS EDGE WHAT; Brockett RC, 1999, ZOO BIOL, V18, P101, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;101::AID-ZOO2&gt;3.0.CO;2-4; Brown JL, 2016, PLOS ONE; Buchanan-Smith HM, 2012, APPL ANIM BEHAV SCI, V137, P166, DOI 10.1016/j.applanim.2011.07.002; Butterworth A., 2011, Animal welfare, P200, DOI 10.1079/9781845936594.0200; Carlstead K, 2000, BIOLOGY OF ANIMAL STRESS, P337, DOI 10.1079/9780851993591.0337; CHANCE P, 1988, LEARNING BEHAV; Christen Catherine A., 2008, ELEPHANTS ETHICS MOR; Cohen J., 2003, APPL MULTIPLE REGRES; Degeling C, 2012, CAN J VET RES, V76, P235; DEJONG TM, 1975, OIKOS, V26, P222, DOI 10.2307/3543712; FORSYTHE WA, 1981, ATHEROSCLEROSIS, V38, P327, DOI 10.1016/0021-9150(81)90049-6; FRANKLIN CW, 1972, PSYCHOL REP, V30, P655, DOI 10.2466/pr0.1972.30.2.655; Gerber B, 2014, LEARN MEMORY, V21, P232, DOI 10.1101/lm.032995.113; Greco BJ, 2016, PLOS ONE; Green C, 1993, SHAPE ENRICHMENT, V2, P5; Greene LM, 2013, JAVMA-J AM VET MED A, V242, P1528, DOI 10.2460/javma.242.11.1528; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Henriksen EJ, 2002, J APPL PHYSIOL, V93, P778; Hiby EF, 2004, ANIM WELFARE, V13, P63; Hockenhull J, 2013, J VET BEHAV, V8, P245, DOI 10.1016/j.jveb.2012.06.002; Holdgate MR, 2016, PLOS ONE; Honda A, 2003, J APPL PHYSIOL, V95, P1032, DOI 10.1152/japplphysiol.00781.2002; Hoy JM, 2010, ZOO BIOL, V29, P303, DOI 10.1002/zoo.20254; Lambeth SP, 2006, AM J PRIMATOL, V68, P245, DOI 10.1002/ajp.20148; Laule Gail, 1998, P302; Lehnhardt John, 2008, P167; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lockhart J, 2013, APPL ANIM BEHAV SCI, V143, P128, DOI 10.1016/j.applanim.2012.10.011; Marlow AG, 1997, CHILD FAM BEHAV THER, V19, P1, DOI 10.1300/J019v19n02_01; Mason GJ, 2010, ZOO BIOL, V29, P237, DOI 10.1002/zoo.20256; Meehan CL, 2007, APPL ANIM BEHAV SCI, V102, P246, DOI 10.1016/j.applanim.2006.05.031; Meehan CL, 2016, PLOS ONE; Melfi VA, 2009, ZOO BIOL, V28, P574, DOI 10.1002/zoo.20288; Mellen J, 2001, ZOO BIOL, V20, P211, DOI 10.1002/zoo.1021; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Mikota S.K., 1994, W BLOOMFIELD; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Muths E, 1996, COMP BIOCHEM PHYS A, V114, P355, DOI 10.1016/0300-9629(96)00025-4; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Prado-Oviedo NA, 2016, PLOS ONE; Rees PA, 2009, ZOO BIOL, V28, P79, DOI 10.1002/Zoo.20200; REYNOLDS GS, 1975, PRIMER OPERANT CONDI; ROLLS BJ, 1979, PHYSIOL BEHAV, V23, P241, DOI 10.1016/0031-9384(79)90361-5; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Sambrook TD, 1997, ANIM WELFARE, V6, P207; Schneider JD, 2007, J ANIM SCI, V85, P3462, DOI 10.2527/jas.2007-0345; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; SHEPHERDSON DJ, 1993, ZOO BIOL, V12, P203, DOI 10.1002/zoo.1430120206; Shyne A, 2006, ZOO BIOL, V25, P317, DOI 10.1002/zoo.20091; Skinner BF., 1976, BEHAVIORISM; Spinage C.A., 1994, ELEPHANTS; Stoinski TS, 2000, ZOO BIOL, V19, P485, DOI 10.1002/1098-2361(2000)19:6&lt;485::AID-ZOO1&gt;3.0.CO;2-5; Sukumar R., 2003, LIVING ELEPHANTS EVO; Swaisgood R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P256, DOI 10.1079/9780851990040.0256; Under D, 2014, VET CLIN N AM-SMALL, V44, P789, DOI 10.1016/j.cvsm.2014.03.004; Veasey J., 2006, International Zoo Yearbook, V40, P63, DOI 10.1111/j.1748-1090.2006.00063.x; Walsmith J, 2002, INT J CARDIOL, V85, P89, DOI 10.1016/S0167-5273(02)00237-1; Whittaker M, 2009, ELEPHANT ROOM SCI WE; Wiedenmayer C, 1998, APPL ANIM BEHAV SCI, V56, P77, DOI 10.1016/S0168-1591(97)00091-9; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; Young RJ, 2003, ENV ENRICHMENT CAPTI, DOI DOI 10.1002/9780470751046; Zeligs JA., 2014, ANIMAL TRAINING 101	75	30	30	6	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0152490	10.1371/journal.pone.0152490	http://dx.doi.org/10.1371/journal.pone.0152490			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414654	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500005
J	Pollock, LM; Gupta, N; Chen, X; Luna, EJ; McDermott, BM				Pollock, Lana M.; Gupta, Nilay; Chen, Xi; Luna, Elizabeth J.; McDermott, Brian M., Jr.			Supervillin Is a Component of the Hair Cell's Cuticular Plate and the Head Plates of Organ of Corti Supporting Cells	PLOS ONE			English	Article							MYOSIN-II; F-ACTIN; INTERCELLULAR-JUNCTIONS; MEMBRANE SKELETON; RETICULAR LAMINA; CATION CONTENTS; GENE; COCHLEA; BINDING; PROTEIN	The organ of Corti has evolved a panoply of cells with extraordinary morphological specializations to harness, direct, and transduce mechanical energy into electrical signals. Among the cells with prominent apical specializations are hair cells and nearby supporting cells. At the apical surface of each hair cell is a mechanosensitive hair bundle of filamentous actin (F-actin)-based stereocilia, which insert rootlets into the F-actin meshwork of the underlying cuticular plate, a rigid organelle considered to hold the stereocilia in place. Little is known about the protein composition and development of the cuticular plate or the apicolateral specializations of organ of Corti supporting cells. We show that supervillin, an F-actin cross-linking protein, localizes to cuticular plates in hair cells of the mouse cochlea and vestibule and zebrafish sensory epithelia. Moreover, supervillin localizes near the apicolateral margins within the head plates of Deiters' cells and outer pillar cells, and proximal to the apicolateral margins of inner phalangeal cells, adjacent to the junctions with neighboring hair cells. Overall, supervillin localization suggests this protein may shape the surface structure of the organ of Corti.	[Pollock, Lana M.; Gupta, Nilay; Chen, Xi; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Gupta, Nilay; Chen, Xi; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44016 USA; [Luna, Elizabeth J.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01605 USA; [Chen, Xi] Loyola Univ Chicago, Stritch Sch Med, 2160 South First Ave, Maywood, IL 60153 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Massachusetts System; University of Massachusetts Worcester; Loyola University Chicago	McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.; McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA.; McDermott, BM (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44016 USA.	bmm30@case.edu			National Institutes of Health Office of Research Infrastructure Programs [S10RR017980, S10OD016164]; Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health (NIH) [DC009437, GM008056-28]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Images were generated at the Imaging Core Facility, Department of Genetics and Genome Sciences, Case Western Reserve University, supported by the National Institutes of Health Office of Research Infrastructure Programs under award numbers S10RR017980 and S10OD016164. This research was supported by the Center for Clinical Research and Technology at University Hospitals Case Medical Center (BMM) and National Institutes of Health (NIH) Grant DC009437 (BMM). LMP was supported by National Institutes of Health Training Grant GM008056-28. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Antonellis PJ, 2014, J NEUROSCI, V34, P305, DOI 10.1523/JNEUROSCI.1880-13.2014; Anttonen T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00978; Basch ML, 2016, J ANAT, V228, P233, DOI 10.1111/joa.12314; Bhuwania R, 2012, J CELL SCI, V125, P2300, DOI 10.1242/jcs.100032; Burns JC, 2013, J COMP NEUROL, V521, P1430, DOI 10.1002/cne.23250; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Chou SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014807; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285; DRENCKHAHN D, 1991, J CELL BIOL, V112, P641, DOI 10.1083/jcb.112.4.641; DUVALL AJ, 1967, ANN OTO RHINOL LARYN, V76, P688, DOI 10.1177/000348946707600312; Etournay R, 2010, DEVELOPMENT, V137, P1373, DOI 10.1242/dev.045138; Fedechkin SO, 2013, J BIOMOL STRUCT DYN, V31, P1150, DOI 10.1080/07391102.2012.726531; Fridberger A, 2002, J NEUROSCI, V22, P9850; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; HIROKAWA N, 1986, HEARING RES, V22, P41, DOI 10.1016/0378-5955(86)90076-6; Hordichok AJ, 2007, HEARING RES, V232, P1, DOI 10.1016/j.heares.2007.06.011; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; Hwang P, 2015, CELL REP, V13, P1287, DOI 10.1016/j.celrep.2015.10.003; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; KONISHI T, 1973, ACTA OTO-LARYNGOL, V76, P410, DOI 10.3109/00016487309121529; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lee JY, 2012, CURR BIOL, V22, P956, DOI 10.1016/j.cub.2012.03.068; Leonova EV, 1997, HEARING RES, V113, P14, DOI 10.1016/S0378-5955(97)00130-5; MARCUS DC, 1981, HEARING RES, V4, P149, DOI 10.1016/0378-5955(81)90002-2; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Oh SW, 2003, J CELL SCI, V116, P2261, DOI 10.1242/jcs.00422; Parker Mark, 2010, J Vis Exp, DOI 10.3791/1685; Pestonjamasp KN, 1997, J CELL BIOL, V139, P1255, DOI 10.1083/jcb.139.5.1255; Pollock LM, 2015, BIRTH DEFECTS RES C, V105, P126, DOI 10.1002/bdrc.21098; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; RAPHAEL Y, 1994, HEARING RES, V76, P173, DOI 10.1016/0378-5955(94)90098-1; Robinson-Rechavi M, 2001, GENOME RES, V11, P781, DOI 10.1101/gr.165601; Smith TC, 2013, MOL BIOL CELL, V24, P3603, DOI 10.1091/mbc.E12-10-0714; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; STOSSEL TP, 1981, COLD SPRING HARB SYM, V46, P569, DOI 10.1101/SQB.1982.046.01.053; Szarama KB, 2012, DEVELOPMENT, V139, P2187, DOI 10.1242/dev.073734; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158349	10.1371/journal.pone.0158349	http://dx.doi.org/10.1371/journal.pone.0158349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415442	Green Published, gold			2022-12-26	WOS:000379579500020
J	Wang, X; Xie, H; Cotton, AS; Duval, ER; Tamburrino, MB; Brickman, KR; Elhai, JD; Ho, SS; McLean, SA; Ferguson, EJ; Liberzon, I				Wang, Xin; Xie, Hong; Cotton, Andrew S.; Duval, Elizabeth R.; Tamburrino, Marijo B.; Brickman, Kristopher R.; Elhai, Jon D.; Ho, S. Shaun; McLean, Samuel A.; Ferguson, Eric J.; Liberzon, Israel			Preliminary Study of Acute Changes in Emotion Processing in Trauma Survivors with PTSD Symptoms	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PREFRONTAL CORTEX; BRAIN; ACTIVATION; ANXIETY; CONNECTIVITY; METAANALYSIS; EARTHQUAKE; RISK	Accumulating evidence suggests traumatic experience can rapidly alter brain activation associated with emotion processing. However, little is known about acute changes in emotion neurocircuits that underlie PTSD symptom development. To examine acute alterations in emotion circuit activation and structure that may be linked to PTSD symptoms, thirty-eight subjects performed a task of appraisal of emotional faces as their brains were functionally and structurally studied with MRI at both two weeks and three months after motor vehicle collision (MVC). As determined by symptoms reported in the PTSD Checklist at three months, sixteen survivors developed probable PTSD, whereas the remaining 22 did not meet criteria for PTSD diagnosis (non-PTSD). The probable PTSD group had greater activation than the non-PTSD group in dorsal and ventral medial prefrontal cortex (dmPFC and vmPFC) while appraising fearful faces within two weeks after MVC and in left insular cortex (IC) three months after MVC. dmPFC activation at two weeks significantly positively correlated with PTSD symptom severity at two weeks (R = 0.462, P = 0.006) and three months (R = 0.418, p = 0.012). Changes over time in dmPFC activation and in PTSD symptom severity were also significantly positively correlated in the probable PTSD group (R = 0.641, P = 0.018). A significant time by group interaction was found for volume changes in left superior frontal gyrus (SFG, F = 6.048, p = 0.019) that partially overlapped dmPFC active region. Between two weeks and three months, left SFG volume decreased in probable PTSD survivors. These findings identify alterations in frontal cortical activity and structure during the early post-trauma period that appear to be associated with development of PTSD symptoms.	[Wang, Xin; Cotton, Andrew S.; Tamburrino, Marijo B.] Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA; [Xie, Hong] Univ Toledo, Dept Neurosci, Toledo, OH USA; [Duval, Elizabeth R.; Ho, S. Shaun; Liberzon, Israel] Univ Michigan, Dept Psychiat, Ann Arbor, MI USA; [Brickman, Kristopher R.] Univ Toledo, Dept Emergency Med, Toledo, OH USA; [Elhai, Jon D.] Univ Toledo, Dept Psychol, Toledo, OH USA; [McLean, Samuel A.] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA; [Ferguson, Eric J.] ProMed Toledo Hosp, Dept Trauma Serv, Toledo, OH USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of North Carolina; University of North Carolina Chapel Hill	Wang, X (corresponding author), Univ Toledo, Dept Psychiat, 2801 W Bancroft St, Toledo, OH 43606 USA.	xin.wang2@utoledo.edu	McLean, Samuel/GPT-1213-2022; Elhai, Jon D/U-1901-2017; Duval, Elizabeth/X-3376-2019	McLean, Samuel/0000-0001-9482-3582; Elhai, Jon D/0000-0001-5205-9010; Duval, Elizabeth/0000-0002-3883-863X; Ho, Shao-Hsuan/0000-0003-2617-1628	National Institutes of Health [R21MH098198-01]; ProMedica Translational Research Stimulation Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ProMedica Translational Research Stimulation Award	The work is funded by National Institutes of Health R21MH098198-01 and by a ProMedica Translational Research Stimulation Award to XW.	Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Burgmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071289; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Cwik JC, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00049; Dickstein BD, 2015, ASSESSMENT, V22, P289, DOI 10.1177/1073191114548683; Du MY, 2015, SOC COGN AFFECT NEUR, V10, P1497, DOI 10.1093/scan/nsv040; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Felmingham KL, 2012, BIOL PSYCHOL, V90, P224, DOI 10.1016/j.biopsycho.2012.03.011; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Ke J, 2016, ACTA RADIOL, V57, P1387, DOI 10.1177/0284185115585848; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Klumpp H, 2011, DEPRESS ANXIETY, V28, P194, DOI 10.1002/da.20802; Li L, 2014, NEUROSCI BIOBEHAV R, V43, P163, DOI 10.1016/j.neubiorev.2014.04.003; Liberzon I, 2015, SOC COGN AFFECT NEUR, V10, P1596, DOI 10.1093/scan/nsv045; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Osuch EA, 2008, BIOL PSYCHIAT, V64, P327, DOI 10.1016/j.biopsych.2008.03.010; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Radley JJ, 2011, STRESS, V14, P481, DOI 10.3109/10253890.2011.604751; Ramage AE, 2013, HUM BRAIN MAPP, V34, P3392, DOI 10.1002/hbm.22155; Reynolds K, 2016, AM J GERIAT PSYCHIAT, V24, P81, DOI 10.1016/j.jagp.2015.11.001; Schmidt U, 2015, PSYCHONEUROENDOCRINO, V51, P444, DOI 10.1016/j.psyneuen.2014.08.020; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sripada RK, 2013, BIOL PSYCHIAT, V73, P1045, DOI 10.1016/j.biopsych.2012.12.008; Stark EA, 2015, NEUROSCI BIOBEHAV R, V56, P207, DOI 10.1016/j.neubiorev.2015.07.007; Sun YW, 2015, J AFFECT DISORDERS, V188, P80, DOI 10.1016/j.jad.2015.08.021; Sun YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083473; Sussman D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0247-x; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wang X, 2010, CEREB CORTEX, V20, P1513, DOI 10.1093/cercor/bhp226; Wang X, 2010, NEUROIMAGE, V49, P3075, DOI 10.1016/j.neuroimage.2009.11.018; Wolf EJ, 2009, J NERV MENT DIS, V197, P419, DOI 10.1097/NMD.0b013e3181a61c68; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	48	23	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159065	10.1371/journal.pone.0159065	http://dx.doi.org/10.1371/journal.pone.0159065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27415431	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500068
J	Laramee, ME; Smolders, K; Hu, TT; Bronchti, G; Boire, D; Arckens, L				Laramee, Marie-Eve; Smolders, Katrien; Hu, Tjing-Tjing; Bronchti, Gilles; Boire, Denis; Arckens, Lutgarde			Congenital Anophthalmia and Binocular Neonatal Enucleation Differently Affect the Proteome of Primary and Secondary Visual Cortices in Mice	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; CROSS-MODAL PLASTICITY; HEREDITARY HYPOTROPHIC AXONOPATHY; ETHYLMALEIMIDE-SENSITIVE FACTOR; GEL-ELECTROPHORESIS; CALLOSAL CONNECTIONS; MASS-SPECTROMETRY; OCULAR DOMINANCE; STRIATE CORTEX; CORTICOCORTICAL CONNECTIONS	In blind individuals, visually deprived occipital areas are activated by non-visual stimuli. The extent of this cross-modal activation depends on the age at onset of blindness. Cross-modal inputs have access to several anatomical pathways to reactivate deprived visual areas. Ectopic cross-modal subcortical connections have been shown in anophthalmic animals but not in animals deprived of sight at a later age. Direct and indirect cross-modal cortical connections toward visual areas could also be involved, yet the number of neurons implicated is similar between blind mice and sighted controls. Changes at the axon terminal, dendritic spine or synaptic level are therefore expected upon loss of visual inputs. Here, the proteome of V1, V2M and V2L from P0-enucleated, anophthalmic and sighted mice, sharing a common genetic background (C57BL/6J x ZRDCT/An), was investigated by 2-D DIGE and Western analyses to identify molecular adaptations to enucleation and/or anophthalmia. Few proteins were differentially expressed in enucleated or anophthalmic mice in comparison to sighted mice. The loss of sight affected three pathways: metabolism, synaptic transmission and morphogenesis. Most changes were detected in V1, followed by V2M. Overall, cross-modal adaptations could be promoted in both models of early blindness but not through the exact same molecular strategy. A lower metabolic activity observed in visual areas of blind mice suggests that even if cross-modal inputs reactivate visual areas, they could remain suboptimally processed.	[Laramee, Marie-Eve; Smolders, Katrien; Hu, Tjing-Tjing; Arckens, Lutgarde] Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, B-3000 Leuven, Belgium; [Bronchti, Gilles; Boire, Denis] Univ Quebec Trois Rivieres, Dept Anat, Quebec City, PQ, Canada; [Boire, Denis] Univ Montreal, Ecole Optometrie, Quebec City, PQ, Canada	KU Leuven; University of Quebec; University of Quebec Trois Rivieres; Universite de Montreal	Arckens, L (corresponding author), Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, B-3000 Leuven, Belgium.	Lut.Arckens@bio.kuleuven.be	Boire, Denis/I-4530-2019; Arckens, Lutgarde/C-3822-2016	Boire, Denis/0000-0001-5614-4976; Arckens, Lutgarde/0000-0002-2909-8449; Laramee, Marie-Eve/0000-0003-0896-6224	Alexander Graham Bell (BESC) [D3 - 378965 - 2009]; Michael Smith Foreign Study Supplements Program [2010-403534]; KU Leuven F+ postdoctoral fellowship [F+/12/006]; Fonds de Recherche du Quebec en Sante postdoctoral fellowship [FF6-14P-27498]; Agency for Innovation through Science and Technology Flanders [101421]; KU Leuven Research Council grant; National Science and Engineering Research Council of Canada (NSERC) grants; Canadian Foundation for Innovation grant	Alexander Graham Bell (BESC); Michael Smith Foreign Study Supplements Program; KU Leuven F+ postdoctoral fellowship; Fonds de Recherche du Quebec en Sante postdoctoral fellowship; Agency for Innovation through Science and Technology Flanders; KU Leuven Research Council grant; National Science and Engineering Research Council of Canada (NSERC) grants; Canadian Foundation for Innovation grant	This work was funded by an Alexander Graham Bell (BESC D3 - 378965 - 2009, http://www.nserc-crsng.gc.ca) doctoral scholarship to MEL; Michael Smith Foreign Study Supplements Program (2010-403534, http://www.nserc-crsng.gc.ca) to MEL; KU Leuven F+ postdoctoral fellowship (F+/12/006, http://www.kuleuven.be) to MEL; Fonds de Recherche du Quebec en Sante (FF6-14P-27498, http://www.frqs.gouv.qc.ca) postdoctoral fellowship to MEL; doctoral scholarship from the Agency for Innovation through Science and Technology Flanders (101421, http://www.iwt.be) to KS; KU Leuven Research Council (https://admin.kuleuven.be/raden/en/research-council) grant to LA; National Science and Engineering Research Council of Canada (NSERC) grants (http://www.nserc-crsng.gc.ca) to DB and GB; Institutional support from UQTR (www.uqtr.ca) to DB and GB; and Canadian Foundation for Innovation grant (CFI Leader, http://www.innovation.ca/en) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel PL, 1996, NEUROSCI LETT, V204, P169, DOI 10.1016/0304-3940(96)12359-4; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Allman BL, 2008, CEREB CORTEX, V18, P2066, DOI 10.1093/cercor/bhm230; Allman BL, 2007, J NEUROPHYSIOL, V98, P545, DOI 10.1152/jn.00173.2007; Allman BL, 2009, BRAIN TOPOGR, V21, P157, DOI 10.1007/s10548-009-0088-3; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beston Brett R, 2010, Front Synaptic Neurosci, V2, P138, DOI 10.3389/fnsyn.2010.00138; Bravo Hermes, 1994, Biological Research, V27, P73; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Bronchti G, 2002, EUR J NEUROSCI, V16, P311, DOI 10.1046/j.1460-9568.2002.02063.x; Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; Budinger E, 2008, BRAIN RES, V1220, P2, DOI 10.1016/j.brainres.2007.07.084; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Butts DA, 2001, J NEUROSCI, V21, P961, DOI 10.1523/JNEUROSCI.21-03-00961.2001; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; CAVINESS VS, 1975, J COMP NEUROL, V164, P247, DOI 10.1002/cne.901640207; Chabot N, 2008, NEUROSCI LETT, V433, P129, DOI 10.1016/j.neulet.2008.01.003; Chabot N, 2007, EUR J NEUROSCI, V26, P2334, DOI 10.1111/j.1460-9568.2007.05854.x; Charbonneau V, 2012, EUR J NEUROSCI, V36, P2949, DOI 10.1111/j.1460-9568.2012.08215.x; Chase HB, 1941, J MORPHOL, V68, P279, DOI 10.1002/jmor.1050680205; Chow AM, 2011, INT J DEV NEUROSCI, V29, P25, DOI 10.1016/j.ijdevneu.2010.10.002; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Cnops L, 2006, BRAIN RES, V1088, P109, DOI 10.1016/j.brainres.2006.03.028; Cohen LG, 1999, ANN NEUROL, V45, P451, DOI 10.1002/1531-8249(199904)45:4<451::AID-ANA6>3.0.CO;2-B; Dahlhaus M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005413; DORON N, 1994, NEUROREPORT, V5, P2697, DOI 10.1097/00001756-199412000-00072; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Falchier A, 2002, J NEUROSCI, V22, P5749; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Frost DO, 2000, P NATL ACAD SCI USA, V97, P11068, DOI 10.1073/pnas.190179997; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gitler D, 2008, J NEUROSCI, V28, P10835, DOI 10.1523/JNEUROSCI.0924-08.2008; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; Goshima Y, 2000, JPN J PHARMACOL, V82, P273, DOI 10.1254/jjp.82.273; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; HEIL P, 1991, NEUROREPORT, V2, P735, DOI 10.1097/00001756-199112000-00001; Heimel JA, 2008, GENES BRAIN BEHAV, V7, P915, DOI 10.1111/j.1601-183X.2008.00431.x; Henschke JU, 2014, BRAIN STRUCT FUNCT; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; Hu TT, 2011, CEREB CORTEX, V21, P2883, DOI 10.1093/cercor/bhr079; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Izraeli R, 2002, EUR J NEUROSCI, V15, P693, DOI 10.1046/j.1460-9568.2002.01902.x; JOHNSON JL, 1972, BRAIN RES, V45, P205; Kahn DM, 2000, J COMP NEUROL, V428, P337; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Laeremans A, 2013, J EXP NEUROSCI, V7, P60, DOI 10.4137/JEN.S12453; Laing RJ, 2012, J COMP NEUROL; Laramee ME, 2013, CEREB CORTEX, V23, P714, DOI 10.1093/cercor/bhs060; Laramee ME, 2011, EUR J NEUROSCI, V34, P65, DOI 10.1111/j.1460-9568.2011.07732.x; Laramee ME, 2014, BRAIN STRUCT FUNCT, V219, P2051, DOI 10.1007/s00429-013-0623-6; Larsen DD, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.030.2009; Laskowska-Macios K, 2014, CEREB CORTEX; Laskowska-Macios K, 2015, DEV NEUROBIOL UNPUB; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lequeux L, 2008, CLIN GENET, V74, P392, DOI 10.1111/j.1399-0004.2008.01078.x; Linden ML, 2009, NAT NEUROSCI, V12, P390, DOI 10.1038/nn.2284; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Macaluso E, 2006, NEUROSCIENTIST, V12, P327, DOI 10.1177/1073858406287908; Masse IO, 2014, BRAIN RES, V1588, P113, DOI 10.1016/j.brainres.2014.09.025; MIZUTANI M, 1992, J HERED, V83, P234, DOI 10.1093/oxfordjournals.jhered.a111201; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nys J, 2015, J NEUROSCI IN PRESS; Nys J, 2014, J COMP NEUROL, V522, P950, DOI 10.1002/cne.23455; OLAVARRIA J, 1988, ANAT EMBRYOL, V178, P155, DOI 10.1007/BF02463649; OLAVARRIA J, 1987, J COMP NEUROL, V260, P321, DOI 10.1002/cne.902600302; OLAVARRIA J, 1988, J COMP NEUROL, V270, P575, DOI 10.1002/cne.902700411; OLAVARRIA JF, 1995, J COMP NEUROL, V361, P138, DOI 10.1002/cne.903610111; OLAVARRIA JF, 1995, J COMP NEUROL, V363, P161, DOI 10.1002/cne.903630202; PALAIOLOGOS G, 1988, J NEUROCHEM, V51, P317, DOI 10.1111/j.1471-4159.1988.tb04872.x; PALAIOLOGOS G, 1989, NEUROCHEM RES, V14, P359, DOI 10.1007/BF01000039; PALLAS SL, 1993, J COMP NEUROL, V337, P317, DOI 10.1002/cne.903370212; PAPERNA T, 1991, J COMP NEUROL, V308, P432, DOI 10.1002/cne.903080310; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Piche M, 2007, NEUROSCIENCE, V145, P1144, DOI 10.1016/j.neuroscience.2006.12.050; Piche M, 2004, EUR J NEUROSCI, V20, P3463, DOI 10.1111/j.1460-9568.2004.03823.x; RHOADES RW, 1984, EXP BRAIN RES, V56, P92; Rittenhouse CD, 2006, J NEUROPHYSIOL, V95, P2947, DOI 10.1152/jn.01328.2005; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1992, J NEUROSCI, V12, P3651; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schousboe A, 2014, ADV NEUROBIOL, V11, P13, DOI 10.1007/978-3-319-08894-5_2; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Sheykholeslami K, 2001, HEARING RES, V159, P117, DOI 10.1016/S0378-5955(01)00326-4; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; TOLDI J, 1994, NEUROSCIENCE, V62, P105, DOI 10.1016/0306-4522(94)90318-2; TOLDI J, 1988, NEUROSCIENCE, V24, P59, DOI 10.1016/0306-4522(88)90311-9; Tucker P, 2001, GENESIS, V31, P43, DOI 10.1002/gene.10003; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Van Brussel L, 2011, CEREB CORTEX, V21, P2133, DOI 10.1093/cercor/bhq286; Van den Bergh G, 2003, ELECTROPHORESIS, V24, P1471, DOI 10.1002/elps.200390189; Van den Bergh G, 2003, J NEUROCHEM, V85, P193, DOI 10.1046/j.1471-4159.2003.01668.x; Van den Bergh G, 2006, PROTEOMICS, V6, P3821, DOI 10.1002/pmic.200500570; Van Hove I, 2015, DEV NEUROBIOL; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; Wang WF, 2005, JPN J OPHTHALMOL, V49, P6, DOI 10.1007/s10384-004-0146-z; Warland DK, 2006, J NEUROSCI, V26, P5190, DOI 10.1523/JNEUROSCI.0328-06.2006; Watkins KE, 2012, BRAIN, V135, P1566, DOI 10.1093/brain/aws067; Whitt JL, 2014, NEUROPHARMACOLOGY, V78, P45, DOI 10.1016/j.neuropharm.2013.02.016; Willems E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094902; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Wu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080073; Yaka R, 2000, EXP BRAIN RES, V131, P144, DOI 10.1007/s002219900295; Yaka R, 1999, EUR J NEUROSCI, V11, P1301, DOI 10.1046/j.1460-9568.1999.00536.x; YAMASAKI H, 1991, ACTA NEUROPATHOL, V82, P427, DOI 10.1007/BF00293376; YAMASAKI H, 1992, LAB INVEST, V66, P734	137	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159320	10.1371/journal.pone.0159320	http://dx.doi.org/10.1371/journal.pone.0159320			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410964	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300079
J	Suzuki, K; Arumugam, S; Yokoyama, J; Kawauchi, Y; Honda, Y; Sato, H; Aoyagi, Y; Terai, S; Okazaki, K; Suzuki, Y; Mizumoto, S; Sugahara, K; Atreya, R; Neurath, MF; Watanabe, K; Hashiguchi, T; Yoneyama, H; Asakura, H				Suzuki, Kenji; Arumugam, Somasundaram; Yokoyama, Junji; Kawauchi, Yusuke; Honda, Yutaka; Sato, Hiroki; Aoyagi, Yutaka; Terai, Shuji; Okazaki, Kazuichi; Suzuki, Yasuo; Mizumoto, Shuji; Sugahara, Kazuyuki; Atreya, Raja; Neurath, Markus F.; Watanabe, Kenichi; Hashiguchi, Taishi; Yoneyama, Hiroyuki; Asakura, Hitoshi			Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHONDROITIN-SULFATE-E; CROHNS-DISEASE; THERAPY; LIVER; IBD	Induction of mucosal healing (MH) is an important treatment goal in inflammatory bowel disease (IBD). Although the molecular mechanisms underlying MH in IBD is not fully explored, local fibrosis would contribute to interfere mucosal repair. Carbohydrate sulfotransferase 15 (CHST15), which catalyzes sulfation of chondroitin sulfate to produce rare E-disaccharide units, is a novel mediator to create local fibrosis. Here we have used siRNA-based approach of silencing CHST15 in dextran sulfate sodium (DSS) induced colitis in mice, human colon fibroblasts and cancer cell lines. In a DSS-induced acute colitis model, CHST15 siRNA reduced CHST15 mRNA in the colon, serum IL-6, disease activity index (DAI) and accumulation of F4/80(+) macrophages and ER-TR7(+) fibroblasts, while increased Ki-67(+) epithelial cells. In DSS-induced chronic colitis models, CHST15 siRNA reduced CHST15 mRNA in the colon, DAI, alpha-smooth muscle actin(+) fibroblasts and collagen deposition, while enhanced MH as evidenced by reduced histological and endoscopic scores. We also found that endoscopic submucosal injection achieved effective pancolonic delivery of CHST15 siRNA in mice. In human CCD-18 Co cells, CHST15 siRNA inhibited the expression of CHST15 mRNA and selectively reduced E-units, a specific product biosynthesized by CHST15, in the culture supernatant. CHST15 siRNA significantly suppressed vimentin in both TGF-beta-stimulated CCD18-Co cells and HCT116 cells while up-regulated BMP7 and Ecadherin in HCT116 cells. The present study demonstrated that blockade CHST15 represses colonic fibrosis and enhances MH partly though reversing EMT pathway, illustrating a novel therapeutic opportunity to refractory and fibrotic lesions in IBD.	[Suzuki, Kenji; Yokoyama, Junji; Kawauchi, Yusuke; Honda, Yutaka; Sato, Hiroki; Aoyagi, Yutaka; Terai, Shuji; Asakura, Hitoshi] Niigata Univ, Med & Dent Hosp, Dept Gastroenterol, Niigata, Niigata, Japan; [Arumugam, Somasundaram; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Niigata, Niigata, Japan; [Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Moriguchi, Osaka, Japan; [Suzuki, Yasuo] Toho Univ, Sakura Med Ctr, Internal Med, Sakura, Chiba, Japan; [Mizumoto, Shuji; Sugahara, Kazuyuki] Meijo Univ, Fac Pharm, Dept Pathobiochem, Nagoya, Aichi, Japan; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido, Japan; [Atreya, Raja; Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Bavaria, Germany; [Hashiguchi, Taishi; Yoneyama, Hiroyuki] Stelic Inst & Co Inc, Minato City, Tokyo, Japan	Niigata University; Niigata University; Kansai Medical University; Toho University; Meijo University; Hokkaido University; University of Erlangen Nuremberg	Suzuki, K (corresponding author), Niigata Univ, Med & Dent Hosp, Dept Gastroenterol, Niigata, Niigata, Japan.	kjsuzuki@med.niigata-u.ac.jp	Mizumoto, Shuji/F-8313-2018; Arumugam, S./AAT-7570-2020	Mizumoto, Shuji/0000-0002-4641-1505; Arumugam, Somasundaram/0000-0002-2096-2552	Japan Science and Technology Agency (JST) [AS117901G]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Japan Science and Technology Agency (JST - AS117901G). For additional experiments for revision, the authors received no specific funding.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; D'Angelo F, 2013, CLIN EXP IMMUNOL, V174, P60, DOI 10.1111/cei.12157; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; de Bruyn JR, 2015, J CROHNS COLITIS, V9, P966, DOI 10.1093/ecco-jcc/jjv133; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Habuchi O, 2002, ANAL BIOCHEM, V310, P129, DOI 10.1016/S0003-2697(02)00277-4; Hanawa T, 2006, J GENE MED, V8, P623, DOI 10.1002/jgm.880; Iacucci Marietta, 2011, Therap Adv Gastroenterol, V4, P129, DOI 10.1177/1756283X11398930; Kai Y, 2007, MED MOL MORPHOL, V40, P128, DOI 10.1007/s00795-007-0370-y; Kakushima N, 2006, ENDOSCOPY, V38, P412, DOI 10.1055/s-2006-925166; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; Levesque BG, 2015, GASTROENTEROLOGY, V148, P37, DOI 10.1053/j.gastro.2014.08.003; Mizumoto S, 2015, CURR OPIN STRUC BIOL, V34, P35, DOI 10.1016/j.sbi.2015.06.004; Mizumoto S, 2012, METHODS MOL BIOL, V836, P99, DOI 10.1007/978-1-61779-498-8_7; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Ohtake S, 2008, BBA-GEN SUBJECTS, V1780, P687, DOI 10.1016/j.bbagen.2008.01.004; Pariente B, 2011, INFLAMM BOWEL DIS, V17, P1415, DOI 10.1002/ibd.21506; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Suzuki K, 2011, PATHOL INT, V61, P228, DOI 10.1111/j.1440-1827.2011.02647.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Watanabe K, 2015, CELL SIGNAL, V27, P1517, DOI 10.1016/j.cellsig.2015.03.004; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Yu RZ, 2002, ANAL BIOCHEM, V304, P19, DOI 10.1006/abio.2002.5576	31	25	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158967	10.1371/journal.pone.0158967	http://dx.doi.org/10.1371/journal.pone.0158967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410685	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300045
J	Goyal, A; Gubbiotti, MA; Chery, DR; Han, L; Iozzo, RV				Goyal, Atul; Gubbiotti, Maria A.; Chery, Daphney R.; Han, Lin; Iozzo, Renato V.			Endorepellin-evoked Autophagy Contributes to Angiostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); angiogenesis; atomic force microscopy (AFM); Beclin-1 (BECN1); perlecan; proteoglycan	HEPARAN-SULFATE PROTEOGLYCAN; BASEMENT-MEMBRANE PROTEOGLYCANS; DENSITY-LIPOPROTEIN-RECEPTOR; ACTIVATED PROTEIN-KINASE; ATOMIC-FORCE; CELL-ADHESION; EXTRACELLULAR-MATRIX; HYALURONAN SYNTHESIS; REGULATE AUTOPHAGY; ENDOTHELIAL-CELLS	Endorepellin, the C-terminal domain of perlecan, is an angiostatic molecule that acts as a potent inducer of autophagy via its interaction with VEGFR2. In this study, we examined the effect of endorepellin on endothelial cells using atomic force microscopy. Soluble endorepellin caused morphological and biophysical changes such as an increase in cell surface roughness and cell height. Surprisingly, these changes were not accompanied by alterations in the endothelial cell elastic modulus. We discovered that endorepellin-induced autophagic flux led to co-localization of mammalian target of rapamycin with LC3-positive autophagosomes. Endorepellin functioned upstream of AMP-activated kinase , as compound C, an inhibitor of AMP-activated kinase , abrogated endorepellin-mediated activation and co-localization of Beclin 1 and LC3, thereby reducing autophagic progression. Functionally, we discovered that both endorepellin and Torin 1, a canonical autophagic inducer, blunted ex vivo angiogenesis. We conclude that autophagy is a novel mechanism by which endorepellin promotes angiostasis independent of nutrient deprivation.	[Goyal, Atul; Gubbiotti, Maria A.; Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Goyal, Atul; Gubbiotti, Maria A.; Iozzo, Renato V.] Thomas Jefferson Univ, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA; [Chery, Daphney R.; Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Jefferson University; Jefferson University; Drexel University	Iozzo, RV (corresponding author), Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336 JAH, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Lin, Han/GRF-1081-2022; Iozzo, Renato/AAS-1980-2020; Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288; Iozzo, Renato/0000-0002-5908-5112	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462, T32 AA07463]; Department of Education GAANN Program; Drexel Interdisciplinary Collaboration and Research Enterprise (iCARE); Drexel; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA164462, R01CA047282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education GAANN Program(US Department of Education); Drexel Interdisciplinary Collaboration and Research Enterprise (iCARE); Drexel; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Training Grant T32 AA07463.; Supported by the Department of Education GAANN Program and a Drexel Interdisciplinary Collaboration and Research Enterprise (iCARE) for Healthcare fellowship.; Supported by a Drexel faculty startup grant.	Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Braet F, 1998, J MICROSC-OXFORD, V190, P328, DOI 10.1046/j.1365-2818.1998.00333.x; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; CARSON DD, 1993, DEV BIOL, V155, P97, DOI 10.1006/dbio.1993.1010; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004; COHEN IR, 1994, CANCER RES, V54, P5771; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Du JH, 2012, AM J PHYSIOL-CELL PH, V302, pC383, DOI 10.1152/ajpcell.00164.2011; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grindel BJ, 2014, MATRIX BIOL, V36, P64, DOI 10.1016/j.matbio.2014.04.005; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Gustafsson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053715; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Hascall VC, 2014, MATRIX BIOL, V35, P14, DOI 10.1016/j.matbio.2014.01.014; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jochmann K, 2014, MATRIX BIOL, V34, P55, DOI 10.1016/j.matbio.2013.11.003; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Kaji T, 2006, BBA-GEN SUBJECTS, V1760, P1465, DOI 10.1016/j.bbagen.2006.06.010; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kumar S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.399; Lee J.H., 2010, INT J TISSUE REGEN, V1, P1, DOI [DOI 10.1109/IPFA.2010.5532306, DOI 10.1371/J0URNAL.P0NE.0015394]; Lekka M, 2016, BIONANOSCIENCE, V6, P65, DOI 10.1007/s12668-016-0191-3; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20639; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Lord MS, 2014, MATRIX BIOL, V35, P123, DOI 10.1016/j.matbio.2013.12.005; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mathiak M, 1997, CANCER RES, V57, P2130; Mathur AB, 2000, BIOPHYS J, V78, P1725, DOI 10.1016/S0006-3495(00)76724-5; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Nikolaev NI, 2014, J BIOMECH, V47, P625, DOI 10.1016/j.jbiomech.2013.12.004; Ning L, 2015, MATRIX BIOL, V48, P26, DOI 10.1016/j.matbio.2015.08.002; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Pan C. C., 2016, ONCOTARGET, DOI 10.18632/oncotarget.9307; Peysselon F, 2014, MATRIX BIOL, V35, P73, DOI 10.1016/j.matbio.2013.11.001; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Wang A, 2015, MATRIX BIOL, V48, P36, DOI 10.1016/j.matbio.2015.04.003; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	85	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19245	19256		10.1074/jbc.M116.740266	http://dx.doi.org/10.1074/jbc.M116.740266			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27435676	hybrid, Green Published			2022-12-26	WOS:000383242800004
J	Ayer, R; Kikuchi, K; Ghimire, M; Shibanuma, A; Pant, MR; Poudel, KC; Jimba, M				Ayer, Rakesh; Kikuchi, Kimiyo; Ghimire, Mamata; Shibanuma, Akira; Pant, Madhab Raj; Poudel, Krishna C.; Jimba, Masamine			Clinic Attendance for Antiretroviral Pills Pick-Up among HIV-Positive People in Nepal: Roles of Perceived Family Support and Associated Factors	PLOS ONE			English	Article							HEALTH-RELATED KNOWLEDGE; SELF-RATED HEALTH; INFECTED PATIENTS; MEDICATION ADHERENCE; SOCIAL SUPPORT; THERAPY; RETENTION; LITERACY; DISPARITIES; PREDICTORS	Introduction HIV-positive people's clinic attendance for medication pick-up is critical for successful HIV treatment. However, limited evidence exists on it especially in low-income settings such as Nepal. Moreover, the role of family support in clinic attendance remains under-explored. Therefore, this study was conducted to examine the association between perceived family support and regular clinic attendance and to assess factors associated with regular clinic attendance for antiretroviral pills pick-up among HIV-positive individuals in Nepal. Methods A cross-sectional study was conducted among 423 HIV-positive people in three districts of Nepal. Clinic attendance was assessed retrospectively for the period of 12 months. To assess the factors associated, an interview survey was conducted using a semi-structured questionnaire from July to August, 2015. Multiple logistic regression models were used to assess the factors associated with regular clinic attendance. Results Of 423 HIV-positive people, only 32.6% attended the clinics regularly. They were more likely to attend them regularly when they received high family support (AOR = 3.98, 95% CI = 2.29, 6.92), participated in support programs (AOR = 1.68, 95% CI = 1.00, 2.82), and had knowledge on the benefits of antiretroviral therapy (AOR = 2.62, 95% CI = 1.15, 5.99). In contrast, they were less likely to attend them regularly when they commuted more than 60 minutes to the clinics (AOR = 0.53, 95% CI = 0.30, 0.93), when they self-rated their health status as being very good (AOR = 0.13, 95% CI = 0.04, 0.44), good (AOR = 0.14, 95% CI = 0.04, 0.46), and fair (AOR = 0.21, 95% CI = 0.06, 0.70). Conclusion HIV-positive individuals are more likely to attend the clinics regularly when they receive high family support, know the benefits of antiretroviral therapy, and participate in support programs. To improve clinic attendance, family support should be incorporated with HIV care programs in resource limited settings. Service providers should also consider educating them about the benefits of antiretroviral therapy.	[Ayer, Rakesh; Kikuchi, Kimiyo; Shibanuma, Akira; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Ghimire, Mamata] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Hlth Care Policy & Management, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3018577, Japan; [Pant, Madhab Raj] Tribhuvan Univ Teaching Hosp, Antiretroviral Therapy Clin, Kathmandu, Nepal; [Poudel, Krishna C.] Univ Massachusetts, Dept Hlth Promot & Policy, Sch Publ Hlth & Hlth Sci, 316 Arnold House,715 North Pleasant St, Amherst, MA 01003 USA	University of Tokyo; University of Tsukuba; Tribhuvan University; Institute of Medicine (IoM) - Nepal; University of Massachusetts System; University of Massachusetts Amherst	Kikuchi, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kimiyo@m.u-tokyo.ac.jp	Shibanuma, Akira/C-7652-2016; Jimba, Masamine/AAF-5630-2020	Shibanuma, Akira/0000-0003-2058-1722; 	Asian Development Bank Japan Scholarship Program	Asian Development Bank Japan Scholarship Program	This study was supported by Asian Development Bank Japan Scholarship Program (http://www.adb.org/site/careers/japan-scholarship-program/main). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSTAR, 2010, AD ADH TREATM RET CA; Amiya RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090959; Armstrong WS, 2014, CLIN INFECT DIS, V59, P1480, DOI 10.1093/cid/ciu607; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS368, DOI 10.1097/QAI.0000000000000519; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Bhatta L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-604; Catz SL, 1999, AIDS CARE, V11, P361, DOI 10.1080/09540129947983; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; CBS, 2012, NAT POP HOUS CENS 20; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Daigle GT, 2015, AIDS CARE, V27, P836, DOI 10.1080/09540121.2015.1024098; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; Dyrehave C, 2015, J INT ASS PROVID AID; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hirnschall GW., 2015, LEARNING B IMPLICATI; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; IDRE, 2015, REGR STAT; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kalichman SC, 2000, AM J PREV MED, V18, P325, DOI 10.1016/S0749-3797(00)00121-5; Kalichman SC, 2000, J ACQ IMMUN DEF SYND, V25, P337, DOI 10.1097/00126334-200012010-00007; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Kohrt BA, 2009, POLITICAL VIOLENCE M; Kunutsor S, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/872396; Kunutsor S, 2011, AIDS BEHAV, V15, P1795, DOI 10.1007/s10461-011-9927-9; Ministry of Health and Population (MoHP) [Nepal] New ERA ICF International Inc., 2011, NEPAL DEMOGRAPHIC AN; Mitiku Habtamu, 2013, ISRN AIDS, V2013, P960954, DOI 10.1155/2013/960954; MoHSW, 2007, ART TREATM LITR COUR; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; Murray C. J. L., 2013, LANCET; National Center for AIDS and STDs Control (NCASC), 2011, INT BIOL BEH SURV IB; National Centre for AIDS and STD Control (NCASC) & Ministry of Health and Population, 2015, COUNTR PROGR REP NEP; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; NCASC, 2014, FACTSH 6 ANT THER CA; NCASC, 2012, NAT ANT THER GUID; NCASC, 2015, ART SERV SIT; NCASC, 2014, NAT CONS GUID TREAT; Nolan S, 2014, LANCET INFECT DIS, V14, P258, DOI 10.1016/S1473-3099(13)70329-3; O'Brien ME, 2003, JAIDS-J ACQ IMM DEF, V34, P407, DOI 10.1097/00126334-200312010-00008; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Poudel KC, 2015, INT Q COMMUNITY HLTH; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Rivero-Mendez M, 2015, P R HEALTH SCI J, V34, P31; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Sharma S, 2013, Kathmandu Univ Med J (KUMJ), V11, P50; Shigdel R, 2014, HIV AIDS-RES PALLIAT, V6, P109, DOI 10.2147/HIV.S55816; Shrestha Sadhana, 2014, J Int Assoc Provid AIDS Care, V13, P214, DOI 10.1177/1545109712456741; Simoni JA, 2006, HEALTH PSYCHOL, V25, P74, DOI 10.1037/0278-6133.25.1.74; Taiwo BO, 2010, JAIDS-J ACQ IMM DEF, V54, P85, DOI 10.1097/01.qai.0000371678.25873.1c; Talam N C, 2008, East Afr J Public Health, V5, P74; Tas U, 2007, BRIT J GEN PRACT, V57, P319; Thapa R, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0056-9; UNAIDS, 2015, 15 15 GLOB TARG ACH; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Wasti Sharada Prasad, 2009, Kathmandu Univ Med J (KUMJ), V7, P306; WHO, 2011, RET HIV PROGR DEF CH; WHO, 2011, ASS WHO HIV DRUG RES; World Health Organization, 2016, CONS GUID US ANT DRU; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; Yehia BR, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0990-0; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	63	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159382	10.1371/journal.pone.0159382	http://dx.doi.org/10.1371/journal.pone.0159382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438024	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100039
J	Smolinski, A; Howaniec, N				Smolinski, Adam; Howaniec, Natalia			Quantitative Modelling of Trace Elements in Hard Coal	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; MULTIVARIATE CALIBRATION; OUTLIER DETECTION; REGRESSION; GASIFICATION; ELIMINATION; COMPONENTS; BIOMASS	The significance of coal in the world economy remains unquestionable for decades. It is also expected to be the dominant fossil fuel in the foreseeable future. The increased awareness of sustainable development reflected in the relevant regulations implies, however, the need for the development and implementation of clean coal technologies on the one hand, and adequate analytical tools on the other. The paper presents the application of the quantitative Partial Least Squares method in modeling the concentrations of trace elements (As, Ba, Cd, Co, Cr, Cu, Mn, Ni, Pb, Rb, Sr, V and Zn) in hard coal based on the physical and chemical parameters of coal, and coal ash components. The study was focused on trace elements potentially hazardous to the environment when emitted from coal processing systems. The studied data included 24 parameters determined for 132 coal samples provided by 17 coal mines of the Upper Silesian Coal Basin, Poland. Since the data set contained outliers, the construction of robust Partial Least Squares models for contaminated data set and the correct identification of outlying objects based on the robust scales were required. These enabled the development of the correct Partial Least Squares models, characterized by good fit and prediction abilities. The root mean square error was below 10% for all except for one the final Partial Least Squares models constructed, and the prediction error (root mean square error of cross-validation) exceeded 10% only for three models constructed. The study is of both cognitive and applicative importance. It presents the unique application of the chemometric methods of data exploration in modeling the content of trace elements in coal. In this way it contributes to the development of useful tools of coal quality assessment.	[Smolinski, Adam; Howaniec, Natalia] Cent Min Inst, Dept Energy Saving & Air Protect, Katowice, Poland	Central Mining Institute (GIG)	Smolinski, A (corresponding author), Cent Min Inst, Dept Energy Saving & Air Protect, Katowice, Poland.	smolin@gig.katowice.pl	Smolinski, Adam/P-5333-2018	Smolinski, Adam/0000-0002-4901-7546; Howaniec, Natalia/0000-0003-4625-8464	Ministry of Science and Higher Education, Poland [11310046]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland, under Grant No. 11310046 (AS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeyo KH, 2010, APPL RADIAT ISOTOPES, V70, P2596; Bell DA, 2011, COAL GASIFICATION AND ITS APPLICATIONS, P1; Bridgwater AV, 1997, DEV THERMOCHEMICAL B; Centner V, 1996, ANAL CHEM, V68, P3851, DOI 10.1021/ac960321m; Chi QH, 2014, CONTROL ENG PRACT, V22, P181, DOI 10.1016/j.conengprac.2013.02.010; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Howaniec N, 2014, ENERGY, V78, P814, DOI 10.1016/j.energy.2014.10.076; Howaniec N, 2014, FUEL, V128, P442, DOI 10.1016/j.fuel.2014.03.036; Howaniec N, 2013, INT J HYDROGEN ENERG, V38, P16152, DOI 10.1016/j.ijhydene.2013.10.019; Joliffe IT, 1982, J ROYAL STAT SOC C, V31, P300; Jureczka J, 1995, PAPERS POLISH GEOLOG, P164; Koshoubu J, 2001, ANAL SCI, V17, P319, DOI 10.2116/analsci.17.319; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; Martens H., 1987, NEAR INFRARED TECHNO; Martens H., 1992, MULTIVARIATE CALIBRA; MASSART DL, 1986, ANAL CHIM ACTA, V187, P171, DOI 10.1016/S0003-2670(00)82910-4; Massart DL, 1997, HDB CHEMOMETRICS Q A; Mayfield DB, 2013, 2013 WORLD COAL ASH, P22; Michalewicz Z, 1992, GENETIC ALGORITHMS D; Peng J, 2010, J OPER MANAG, V30, P467; Peng JT, 2012, ANAL CHIM ACTA, V719, P24, DOI 10.1016/j.aca.2011.12.058; Rouhollah K, 2013, FOOD ANAL METHOD, V6, P386; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; RUPPERT D, 1980, J AM STAT ASSOC, V75, P828, DOI 10.2307/2287169; Seredin VV, 2012, INT J COAL GEOL, V94, P67, DOI 10.1016/j.coal.2011.11.001; SIEGEL AF, 1982, BIOMETRIKA, V69, P242, DOI 10.1093/biomet/69.1.242; Smolinski A, 2003, ANAL LETT, V36, P2317, DOI 10.1081/AL-120023722; Smolinski A., 2014, J SUST MIN, V13, P7; Smolinski A, 2014, THESCIENTIFICWORLDJO, V2014, DOI [10.1155/2014/234204, DOI 10.1155/2014/234204]; Smolinski A, 2009, CHEMOSPHERE, V76, P565, DOI 10.1016/j.chemosphere.2009.02.057; US Energy Information Administration, ANN EN OUTL 2015 PRO; WALCZAK B, 1995, CHEMOMETR INTELL LAB, V29, P63, DOI 10.1016/0169-7439(95)00009-L; WALCZAK B, 1995, CHEMOMETR INTELL LAB, V28, P259, DOI 10.1016/0169-7439(94)00077-V; WALCZAK B, 1995, CHEMOMETR INTELL LAB, V27, P41, DOI 10.1016/0169-7439(94)00059-R; Wold H., 1981, SYSTEMS INDIRECT OBS; Wold S, 1983, LECT NOTES MATH	38	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159265	10.1371/journal.pone.0159265	http://dx.doi.org/10.1371/journal.pone.0159265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438794	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100034
J	Zhu, LJ; Liu, JK; Cong, L; Ma, WM; Ma, W; Zhang, ZM				Zhu, Lijuan; Liu, Jiakai; Cong, Ling; Ma, Wenmei; Ma, Wu; Zhang, Zhenming			Spatiotemporal Characteristics of Particulate Matter and Dry Deposition Flux in the Cuihu Wetland of Beijing	PLOS ONE			English	Article							AIR-POLLUTION; ATMOSPHERIC AEROSOL; PM2.5; PARTICLES; URBAN; PM10; POLLUTANTS; SHANGHAI; FOREST; SITES	In recent years, the rapid development of industrialization and urbanization has caused serious environmental pollution, especially particulate pollution. As the "Earth's kidneys," wet-land plays a significant role in improving the environmental quality and adjusting the climate. To study how wetlands work in this aspect, from the early autumn of 2014 to 2015, we implemented a study to measure the PM concentration and chemical composition at three heights (1.5, 6, and 10 m) during different periods (dry, normal water, and wet periods) in the Cuihu wetland park in Beijing for analyzing the dry deposition flux and the effect of meteorological factors on the concentration. Results indicated that (1) the diurnal variations of the PM2.5 and PM10 concentrations at the three heights were similar in that the highest concentration occurred at night and the lowest occurred at noon, and the daytime concentration was lower than that at night; (2) the PM2.5 and PM10 concentrations also varied between different periods that wet period > normal water period > wet period, and the concentration at different heights during different periods varied. In general, the lowest concentration occurred at 10 m during the dry and normal water periods, and the highest concentration occurred at 1.5 m during the wet period. (3) SO42-, NO3-, and Cl- are the dominant constituents of PM2.5, accounting for 42.22, 12.6, and 21.56%, respectively; (4) the dry depositions of PM2.5 and PM10 at 10 m were higher than those at 6 m, and the deposition during the dry period was higher than those during the wet and normal water periods. In addition, the deposition during the night-time was higher than that during the daytime. Moreover, meteorological factors affected the deposition, the temperature and wind speed being negatively correlated with the deposition flux and the humidity being positively correlated. (5) The PM10 and PM2.5 concentrations were influenced by meteorological factors. The PM2.5 and PM10 concentrations were negatively correlated with temperature and wind speed but positively correlated with relative humidity.	[Zhu, Lijuan; Liu, Jiakai; Cong, Ling; Ma, Wenmei; Zhang, Zhenming] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China; [Ma, Wu] West Virginia Univ, Sch Nat Resources, Morgantown, WV USA	Beijing Forestry University; West Virginia University	Zhang, ZM (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	zhenmingzhang@bjfu.edu.cn	Liu, Jiakai/L-9946-2014; cong, ling/GQG-9582-2022	Liu, Jiakai/0000-0002-3337-1962; 	Fundamental Research Funds for the Central Universities [2016JX05]; Forestry Public Welfare Projects Special Fund of China [201304301]; Beijing Municipal Science and Technology Project [Z141100006014031]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Public Welfare Projects Special Fund of China; Beijing Municipal Science and Technology Project	This work was supported by the Fundamental Research Funds for the Central Universities (2016JX05), Forestry Public Welfare Projects Special Fund of China (201304301), and Beijing Municipal Science and Technology Project (Z141100006014031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Fundamental Research Funds for the Central Universities (2016JX05), Forestry Public Welfare Projects Special Fund of China (201304301), and Beijing Municipal Science and Technology Project (Z141100006014031). The authors acknowledge the constructive comments provided by both the reviewers and editors.	Aldrin M, 2005, ATMOS ENVIRON, V39, P2145, DOI 10.1016/j.atmosenv.2004.12.020; [Anonymous], 2002, MDHS143 HLTH SAF EX; Balestrini R, 2007, ATMOS ENVIRON, V41, P745, DOI 10.1016/j.atmosenv.2006.09.002; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Cao JJ, 2009, AEROSOL AIR QUAL RES, V9, P277; Chen JG, 2015, ATMOSPHERE-BASEL, V6, P650, DOI 10.3390/atmos6050650; Correia AW, 2013, EPIDEMIOLOGY, V24, P23, DOI 10.1097/EDE.0b013e3182770237; Dzierzanowski K, 2011, INT J PHYTOREMEDIAT, V13, P1037, DOI 10.1080/15226514.2011.552929; Eskeland GS, 1997, AM J AGR ECON, V79, P1636, DOI 10.2307/1244395; Fang GC, 2014, TOXICOL IND HEALTH, V30, P728, DOI 10.1177/0748233712462474; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; [郭建超 Guo Jianchao], 2014, [水土保持学报, Journal of Soil and Water Conservation], V28, P88; Guo S, 2012, ENVIRON SCI TECHNOL, V46, P9846, DOI [10.1021/es20425641, 10.1021/es2042564]; [郝立生 HAO Lisheng], 2008, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V31, P109; Harrison RM, 2001, ATMOS ENVIRON, V35, P3667, DOI 10.1016/S1352-2310(00)00526-4; He KB, 2001, ATMOS ENVIRON, V35, P4959, DOI 10.1016/S1352-2310(01)00301-6; Hu M, 2002, ATMOS ENVIRON, V36, P5853, DOI 10.1016/S1352-2310(02)00581-2; Jeremy A, 2001, NEW ENGL J MED, V344, P1251; Khan FI, 2000, ENVIRON MONIT ASSESS, V64, P457, DOI 10.1023/A:1006278000352; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu JK, 2016, ATMOS ENVIRON, V125, P178, DOI 10.1016/j.atmosenv.2015.11.023; [刘建华 Liu Jianhua], 2003, [物探与化探, Geophysical and Geochemical Exploration], V27, P490; Liu J, 2015, INFORM FUSION, V23, P1, DOI 10.1016/j.inffus.2014.08.001; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Park SS, 2004, ATMOS ENVIRON, V38, P1459, DOI 10.1016/j.atmosenv.2003.12.004; Pateraki S, 2012, SCI TOTAL ENVIRON, V419, P124, DOI 10.1016/j.scitotenv.2011.12.064; Peng GL, 2011, J ENVIRON MONITOR, V13, P1927, DOI 10.1039/c0em00776e; Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; Powe NA, 2004, J ENVIRON MANAGE, V70, P119, DOI 10.1016/j.jenvman.2003.11.003; Qiu DD, 2015, J ENVIRON SCI, V36, P93, DOI 10.1016/j.jes.2015.04.016; Shen ZX, 2008, J AIR WASTE MANAGE, V58, P1560, DOI 10.3155/1047-3289.58.12.1560; SLINN SA, 1980, ATMOS ENVIRON, V14, P1013, DOI 10.1016/0004-6981(80)90032-3; Spindler G, 2010, ATMOS ENVIRON, V44, P164, DOI 10.1016/j.atmosenv.2009.10.015; Sun FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097723; Nguyen T, 2015, J ENVIRON SCI, V27, P33, DOI 10.1016/j.jes.2014.04.019; Wang J, 2015, INT J ENV RES PUB HE, V12, P9089, DOI 10.3390/ijerph120809089; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Weinbruch S, 2014, ATMOS ENVIRON, V99, P175, DOI 10.1016/j.atmosenv.2014.09.075; Wu Z. P., 2007, J TSINGHUA U SCI TEC, V47, P2152; Yao XH, 2002, ATMOS ENVIRON, V36, P4223, DOI 10.1016/S1352-2310(02)00342-4; Ye BM, 2003, ATMOS ENVIRON, V37, P499, DOI 10.1016/S1352-2310(02)00918-4; Zhang LM, 2001, ATMOS ENVIRON, V35, P549, DOI 10.1016/S1352-2310(00)00326-5; Zhang XY, 2002, ATMOS ENVIRON, V36, P4189, DOI 10.1016/S1352-2310(02)00347-3; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	45	24	26	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158616	10.1371/journal.pone.0158616	http://dx.doi.org/10.1371/journal.pone.0158616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437688	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100015
J	Connan, M; Hofmeyr, GJG; Pistorius, PA				Connan, Maelle; Hofmeyr, G. J. Greg; Pistorius, Pierre A.			Reappraisal of the Trophic Ecology of One of the World's Most Threatened Spheniscids, the African Penguin	PLOS ONE			English	Article							CARBON STABLE-ISOTOPES; JACKASS PENGUINS; SOUTH-AFRICA; PRIOR INFORMATION; GENTOO PENGUIN; MIXING MODELS; CHOKKA SQUID; AVIAN BLOOD; BAY-REGION; ALGOA-BAY	Many species of seabirds, including the only penguin species breeding on the African continent, are threatened with extinction. The world population of the endangered African penguin Spheniscus demersus has decreased from more than 1.5 million individuals in the early 1900s to c.a. 23 000 pairs in 2013. Determining the trophic interactions of species, especially those of conservation concern, is important when declining numbers are thought to be driven by food limitation. By and large, African penguin dietary studies have relied on the identification of prey remains from stomach contents. Despite all the advantages of this method, it has well known biases. We therefore assessed the African penguin's diet, using stable isotopes, at two colonies in Algoa Bay (south-east coast of South Africa). These represent over 50% of the world population. Various samples (blood, feathers, egg membranes) were collected for carbon and nitrogen stable isotope analyses. Results indicate that the trophic ecology of African penguins is influenced by colony, season and age class, but not adult sex. Isotopic niches identified by standard Bayesian ellipse areas and convex hulls, highlighted differences among groups and variability among individual penguins. Using Bayesian mixing models it was for the first time shown that adults target chokka squid Loligo reynaudii for self-provisioning during particular stages of their annual cycle, while concurrently feeding their chicks primarily with small pelagic fish. This has important ramifications and means that not only pelagic fish, but also squid stocks, need to be carefully managed in order to allow population recovery of African penguin.	[Connan, Maelle; Pistorius, Pierre A.] Nelson Mandela Metropolitan Univ, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, Dept Zool, ZA-6031 Port Elizabeth, South Africa; [Hofmeyr, G. J. Greg] Nelson Mandela Metropolitan Univ, Dept Zool, ZA-6031 Port Elizabeth, South Africa; [Hofmeyr, G. J. Greg] Port Elizabeth Museum Bayworld, ZA-6013 Port Elizabeth, South Africa	National Research Foundation - South Africa; Nelson Mandela University; Nelson Mandela University	Connan, M (corresponding author), Nelson Mandela Metropolitan Univ, Percy Fitzpatrick Inst African Ornithol, DST NRF Ctr Excellence, Dept Zool, ZA-6031 Port Elizabeth, South Africa.	maelle.connan@gmail.com		Pistorius, Pierre/0000-0001-6561-7069; Connan, Maelle/0000-0002-1308-9118	Department of Science and Technology- National Research Foundation Centre of Excellence grant; Nelson Mandela Metropolitan University	Department of Science and Technology- National Research Foundation Centre of Excellence grant; Nelson Mandela Metropolitan University	This research was funded by the Department of Science and Technology- National Research Foundation Centre of Excellence grant to the Percy FitzPatrick Institute of African Ornithology at the University of Cape Town, http://www.fitzpatrick.uct.ac.za/. MC was supported by the Nelson Mandela Metropolitan University through a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALMELLI M, 1994, S AFR J MARINE SCI, V14, P151; Barange M, 1999, S AFR J MARINE SCI, V21, P367; Barham PJ, 2008, BIRD CONSERV INT, V18, P144, DOI 10.1017/S0959270908000142; Barquete V, 2012, USING STABLE ISOTOPE; Barquete V, 2013, J EXP MAR BIOL ECOL, V448, P121, DOI 10.1016/j.jembe.2013.06.021; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bearhop S, 2000, AUK, V117, P504, DOI 10.1642/0004-8038(2000)117[0504:IOLAUA]2.0.CO;2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; BirdLife International, 2015, SPHEN DEM IUCN RED L; Brinker DF, 2007, WATERBIRDS, V30, P93, DOI 10.1675/1524-4695(2007)030[0093:CSITCB]2.0.CO;2; Browne T, 2011, AUSTRAL ECOL, V36, P99, DOI 10.1111/j.1442-9993.2010.02125.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; COOPER J, 1977, Zoologica Africana, V12, P201; Cooper J., 1984, P217; Cooper J., 1978, International Zoo Yearbook, V18, P22, DOI 10.1111/j.1748-1090.1978.tb00211.x; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford R.J.M., 1981, P15; CRAWFORD RJM, 1995, IBIS, V137, P329, DOI 10.1111/j.1474-919X.1995.tb08029.x; Crawford RJM., 1985, S AFR J MARINE SCI, V3, P215, DOI [https://doi.org/10.2989/025776185784461252, DOI 10.2989/025776185784461252]; Crawford RJM., 2006, ACTA ZOOL SINICA, V52, P444; Crawford RJM, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00010; Crawford RJM, 2014, OSTRICH, V85, P111, DOI 10.2989/00306525.2014.955141; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; CROXALL JP, 1982, J ANIM ECOL, V51, P177, DOI 10.2307/4318; Davies DH, 1956, S AFRICAN PILCHARD S, V23, P1; Davies DH, 1955, INVESTIGATIONAL REPO, V18, P1; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; DUFFY DC, 1987, NATL GEOGR RES, V3, P480; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GHEBREMESKEL K, 1991, COMP BIOCHEM PHYS A, V99, P245, DOI 10.1016/0300-9629(91)90267-G; Green DB, 2015, ICES J MAR SCI, V72, P771, DOI 10.1093/icesjms/fsu203; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEATH RGM, 1985, J ZOOL, V205, P91; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; International BirdLife, IUCN RED LIST BIRDS; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jaquemet S, 2008, MAR BIOL, V155, P505, DOI 10.1007/s00227-008-1049-1; Jaquemet S, 2008, ESTUAR COAST SHELF S, V80, P374, DOI 10.1016/j.ecss.2008.08.019; Kohler SA, 2011, MAR ECOL PROG SER, V435, P235, DOI 10.3354/meps09215; LAUGKSCH RC, 1993, S AFR J MARINE SCI, V13, P295, DOI 10.2989/025776193784287275; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lescroel A, 2005, MAR ECOL PROG SER, V302, P245, DOI 10.3354/meps302245; Ludynia K, 2010, AFR J MAR SCI, V32, P563, DOI 10.2989/1814232X.2010.538151; Matthews JP, 1961, INVESTIGATIONAL REPO; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; Meijer T, 1999, IBIS, V141, P399, DOI 10.1111/j.1474-919X.1999.tb04409.x; Michalik A, 2010, RAPID COMMUN MASS SP, V24, P875, DOI 10.1002/rcm.4462; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; O'Brien JK, 2016, GEN COMP ENDOCR, V225, P81, DOI 10.1016/j.ygcen.2015.09.013; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P361, DOI 10.2989/1814232X.2010.502640; Ogden LJE, 2004, AUK, V121, P170, DOI 10.1642/0004-8038(2004)121[0170:BICANT]2.0.CO;2; Oppel S, 2009, J ORNITHOL, V150, P109, DOI 10.1007/s10336-008-0325-7; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Phillips DL, 2012, J MAMMAL, V93, P342, DOI 10.1644/11-MAMM-S-158.1; Pichegru L, 2013, ENDANGER SPECIES RES, V19, P255, DOI 10.3354/esr00477; Pichegru L, 2012, BIOL CONSERV, V156, P117, DOI 10.1016/j.biocon.2011.12.013; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Pichegru L, BIRD CONSERVATION IN; Polito MJ, 2009, J EXP MAR BIOL ECOL, V372, P106, DOI 10.1016/j.jembe.2009.02.014; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Quillfeldt P, 2015, RAPID COMMUN MASS SP, V29, P667, DOI 10.1002/rcm.7145; Quillfeldt P, 2009, RAPID COMMUN MASS SP, V23, P3632, DOI 10.1002/rcm.4286; Ralph M., 2008, THESIS N MANDELA MET; Ramirez F, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00297.1; Rand R. W., 1960, INVESTIGATIONAL REPO, V41, P1; RANDALL RM, 1986, BIOL CONSERV, V37, P119, DOI 10.1016/0006-3207(86)90087-X; RANDALL RM, 1981, S AFR J ZOOL, V16, P163; Randall RM, 1983, BIOL JACKASS PENGUIN; Ricklefs R. E., 1983, STUD AVIAN BIOL, V8, P84; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; Roberts MJ, 2012, ICES J MAR SCI, V69, P563, DOI 10.1093/icesjms/fss023; Roy C, 2007, AFR J MAR SCI, V29, P309, DOI 10.2989/AJMS.2007.29.3.1.331; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sears J, 2009, OECOLOGIA, V159, P41, DOI 10.1007/s00442-008-1199-3; SEDDON PJ, 1993, OSTRICH, V64, P8, DOI 10.1080/00306525.1993.9634188; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Shannon L. J., 1999, Marine Ornithology, V27, P119; Shelton PA, 1984, S AFRICAN J MARINE S, V2, P217, DOI DOI 10.2989/02577618409504370; Sherley RB, 2013, MAR ECOL PROG SER, V473, P291, DOI 10.3354/meps10070; Smale MJ, 2001, MAR BIOL, V139, P1095; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; Stock B., 2015, MIXSIAR USER MANUAL; Team RDC, 2015, LANG ENV STAT COMP; van der Lingen CD, 2010, AFR J MAR SCI, V32, P271, DOI 10.2989/1814232X.2010.501581; VANHEEZIK Y, 1989, J FIELD ORNITHOL, V60, P451; Voogt NM, 2014, DIETARY ASPECTS ESTA; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Weller F, 2016, ECOL MODEL, V327, P44, DOI 10.1016/j.ecolmodel.2016.01.011; Weller F, 2014, ECOL MODEL, V277, P38, DOI 10.1016/j.ecolmodel.2014.01.013; Williams CT, 2007, OECOLOGIA, V153, P11, DOI 10.1007/s00442-007-0717-z; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILSON RP, 1985, MAR ECOL PROG SER, V25, P219, DOI 10.3354/meps025219; WILSON RP, 1985, J ORNITHOL, V126, P53, DOI 10.1007/BF01640442; WILSON RP, 1985, ORNIS SCAND, V16, P77, DOI 10.2307/3676580	104	13	13	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159402	10.1371/journal.pone.0159402	http://dx.doi.org/10.1371/journal.pone.0159402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434061	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600052
J	Ponsuksili, S; Reyer, H; Trakooljul, N; Murani, E; Wimmers, K				Ponsuksili, Siriluck; Reyer, Henry; Trakooljul, Nares; Murani, Eduard; Wimmers, Klaus			Single- and Bayesian Multi-Marker Genome-Wide Association for Haematological Parameters in Pigs	PLOS ONE			English	Article							CLINICAL-CHEMICAL TRAITS; GROWTH-FACTOR SYSTEM; KOREAN NATIVE PIGS; BLOOD-CELL; BRANGUS HEIFERS; F-2 INTERCROSS; QTL ANALYSIS; COAT COLOR; POPULATION; HEMATOPOIESIS	Haematological traits are important traits that show associations with immune and metabolic status, as well as diseases in humans and animals. Mapping genome regions that affect the blood cell traits can contribute to the identification of genomic features useable as biomarkers for immune, disease and metabolic status. A genome-wide association study (GWAS) was conducted using PorcineSNP60 BeadChips. Single-marker and Bayesian multi-marker approaches were integrated to identify genomic regions and corresponding genes overlapping for both methods. GWAS was performed for haematological traits of 591 German Landrace pig. Heritability estimates for haematological traits were medium to high. In total 252 single SNPs associated with 12 haematological traits were identified (NegLog10 of p-value > 5). The Bayesian multi-marker approach revealed 102 QTL regions across the genome, indicated by 1-Mb windows with contribution to additive genetic variance above 0.5%. The integration of both methods resulted in 24 overlapping QTL regions. This study identified overlapping QTL regions from single-and multi-marker approaches for haematological traits. Identifying candidate genes that affect blood cell traits provides the first step towards the understanding of the molecular basis of haematological phenotypes.	[Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Unit Funct Genome Anal, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany; [Reyer, Henry; Trakooljul, Nares; Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Res Unit Genom, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Genom, Inst Genome Biol, Wilhelm Stahl Allee 2, D-18196 Dummerstorf, Germany.	wimmers@fbn-dummertorf.de	Wimmers, Klaus/AAF-9434-2020	Trakooljul, Nares/0000-0002-3214-2498; Wimmers, Klaus/0000-0002-9523-6790	project AgroClustEr PHAENOMICS [FKZ 0315536G]; German Federal Ministry of Education and Research; Leibniz Institute for Farm Animal Biology (FBN); Leibniz Association	project AgroClustEr PHAENOMICS; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Leibniz Institute for Farm Animal Biology (FBN); Leibniz Association	This study was part of the project AgroClustEr PHAENOMICS (FKZ 0315536G), which was funded by the German Federal Ministry of Education and Research. The Leibniz Institute for Farm Animal Biology (FBN) provided its own matched funding. The publication of this article was funded by the open access funds of the Leibniz Association and the Leibniz Institute for Farm Animal Biology (FBN).	Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Bustos RI, 2013, BIOCHEM BIOPH RES CO, V437, P426, DOI 10.1016/j.bbrc.2013.06.095; Chen YN, 2011, EXP BIOL MED, V236, P477, DOI 10.1258/ebm.2011.010283; Cho IC, 2011, ANIM GENET, V42, P621, DOI 10.1111/j.1365-2052.2011.02204.x; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Dayyani F, 2008, BLOOD, V111, P4338, DOI 10.1182/blood-2007-07-103291; El-Kordi A, 2013, BEHAV BRAIN RES, V251, P41, DOI 10.1016/j.bbr.2012.11.016; Evstatiev R, 2014, AM J HEMATOL, V89, P524, DOI 10.1002/ajh.23682; Fernando RL, 2008, GENSEL USER MANUAL P; Fesus L, 2005, J ANIM BREED GENET, V122, P127, DOI 10.1111/j.1439-0388.2005.00504.x; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Gong YF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-56; Haase B, 2010, VET J, V184, P315, DOI 10.1016/j.tvjl.2009.02.017; Johansson A, 2005, ANIM GENET, V36, P288, DOI 10.1111/j.1365-2052.2005.01320.x; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Lee S, 2011, BIOMETRICS, V67, P967, DOI 10.1111/j.1541-0420.2010.01520.x; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Moore SF, 2015, CARDIOVASC RES, V107, P9, DOI 10.1093/cvr/cvv132; Mpetile Z, 2015, J ANIM SCI, V93, P892, DOI 10.2527/jas.2014-8132; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Peters SO, 2013, J ANIM SCI, V91, P605, DOI 10.2527/jas.2012-5580; Peters SO, 2012, J ANIM SCI, V90, P3398, DOI [10.2527/jas.2011-4507, 10.2527/jas.2012-4507]; Pielberg G, 2002, GENETICS, V160, P305; Reiner G, 2009, ANIM GENET, V40, P57, DOI 10.1111/j.1365-2052.2008.01804.x; Reiner G, 2007, ANIM GENET, V38, P447, DOI 10.1111/j.1365-2052.2007.01629.x; Sandahl JD, 2014, HAEMATOLOGICA, V99, P865, DOI 10.3324/haematol.2013.098517; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Shi LL, 2013, HUM MOL GENET, V22, P3749, DOI 10.1093/hmg/ddt226; SHIMON I, 1995, LEUKEMIA RES, V19, P233, DOI 10.1016/0145-2126(94)00133-U; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Vong QP, 2014, BLOOD, V124, P3905, DOI 10.1182/blood-2014-06-582965; Wheat JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105557; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Yoo CK, 2012, PHYSIOL GENOMICS, V44, P657, DOI 10.1152/physiolgenomics.00172.2011; Yu G, 2004, J BIOL CHEM, V279, P55531, DOI 10.1074/jbc.M410814200; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-41; Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063665; Zhao HQ, 2009, GENET EPIDEMIOL, V33, P679, DOI 10.1002/gepi.20419; Zhu J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1240-y; Zumkeller W, 1999, BLOOD, V94, P3653, DOI 10.1182/blood.V94.11.3653.423k42_3653_3657	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159212	10.1371/journal.pone.0159212	http://dx.doi.org/10.1371/journal.pone.0159212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434032	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169600040
J	Sagata, K; Gibb, H				Sagata, Katayo; Gibb, Heloise			The Effect of Temperature Increases on an Ant-Hemiptera-Plant Interaction	PLOS ONE			English	Article							SCALE INSECTS; ELEVATED CO2; EUCALYPTUS-CAMALDULENSIS; ECOLOGICAL CONSEQUENCES; CLIMATE-CHANGE; WOOD DENSITY; HONEYDEW; GROWTH; NECTAR; RANGE	Global temperature increases are significantly altering species distributions and the structure of ecological communities. However, the impact of temperature increases on multi-species interactions is poorly understood. We used an ant-Hemiptera-plant interaction to examine the potential outcomes of predicted temperature increases for each partner and for the availability of honeydew, a keystone resource in many forest ecosystems. We re-created this interaction in growth cabinets using predicted mean summer temperatures for Melbourne, Australia, for the years 2011 (23 degrees C), 2050 (25 degrees C) and 2100 (29 degrees C), respectively, under an unmitigated greenhouse gas emission scenario. Plant growth and ant foraging activities increased, while scale insect growth, abundance and size, honeydew standing crop per tree and harvesting by ants decreased at 29 degrees C, relative to lower temperatures (23 and 25 degrees C). This led to decreased scale insect infestations of plants and reduced honeydew standing crop per tree at the highest temperature. At all temperatures, honeydew standing crop was lower when ants harvested the honeydew from scale insects, but the impact of ant harvesting was particularly significant at 29 degrees C, where combined effects of temperature and ants reduced honeydew standing crop to below detectable levels. Although temperature increases in the next 35 years will have limited effects on this system, by the end of this century, warmer temperatures may cause the availability of honeydew to decline. Decline of honeydew may have far-reaching trophic effects on honeydew and ant-mediated interactions. However, field-based studies that consider the full complexity of ecosystems may be required to elucidate these impacts.	[Sagata, Katayo; Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia; [Sagata, Katayo] Papua New Guinea Inst Biol Res, Goroka, Eastern Highlan, Papua N Guinea	La Trobe University	Sagata, K (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.; Sagata, K (corresponding author), Papua New Guinea Inst Biol Res, Goroka, Eastern Highlan, Papua N Guinea.	ksagata@students.latrobe.edu.au	Gibb, Heloise/B-8338-2013	Gibb, Heloise/0000-0001-7194-0620	La Trobe University Full Fee Research Scholarship; La Trobe University Postgraduate Research Scholarship; Australian Research Council Discovery Project [DP0985886, DP120100781]	La Trobe University Full Fee Research Scholarship; La Trobe University Postgraduate Research Scholarship; Australian Research Council Discovery Project(Australian Research Council)	The study was funded by a La Trobe University Full Fee Research Scholarship, a La Trobe University Postgraduate Research Scholarship and Australian Research Council Discovery Project grants DP0985886 to HG (and D. I. Warton and N. R. Andrew) and DP120100781 to HG (and C. L. Parr, N. J. Sanders, and R. R. Dunn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, beyond their initial decision to grant funding to the project.	Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; Beggs JR, 2005, NEW ZEAL J ECOL, V29, P105; Bernardo AL, 1998, FOREST ECOL MANAG, V104, P1, DOI 10.1016/S0378-1127(97)00199-0; Bluthgen N, 2004, AUSTRAL ECOL, V29, P418, DOI 10.1111/j.1442-9993.2004.01380.x; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; BRISTOW CM, 1991, OECOLOGIA, V87, P514, DOI 10.1007/BF00320414; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cotrufo MF, 1998, GLOBAL CHANGE BIOL, V4, P43, DOI 10.1046/j.1365-2486.1998.00101.x; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; CSIRO and Australian Bureau of Meteorology, 2007, CLIM CHANG AUSTR; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; DEGEN AA, 1986, INSECT SOC, V33, P211, DOI 10.1007/BF02224599; Diamond SE, 2013, INTEGR COMP BIOL, V53, P965, DOI 10.1093/icb/ict085; Dungan RJ, 2004, NEW ZEAL J ECOL, V28, P283; Dungan RJ, 2007, ECOL ENTOMOL, V32, P338, DOI 10.1111/j.1365-2311.2007.00871.x; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Flynn DFB, 2006, ENVIRON EXP BOT, V56, P10, DOI 10.1016/j.envexpbot.2004.12.001; Gibb H, 2009, INSECT SOC, V56, P405, DOI 10.1007/s00040-009-0038-9; Gough N, 1975, THESIS; GREENBERG R, 1993, OIKOS, V68, P519, DOI 10.2307/3544920; Gullan P. J., 1991, General and Applied Entomology, V23, P21; Hazell SP, 2010, J INSECT PHYSIOL, V56, P123, DOI 10.1016/j.jinsphys.2009.08.022; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Hellmann JJ, 2008, OECOLOGIA, V157, P583, DOI 10.1007/s00442-008-1112-0; Heterick BE, 2011, ZOOTAXA, P1; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Johns CV, 2002, GLOBAL CHANGE BIOL, V8, P142, DOI 10.1046/j.1365-2486.2002.00462.x; Kaspari M, 2015, GLOBAL CHANGE BIOL, V21, P1092, DOI 10.1111/gcb.12750; KISS A, 1981, OIKOS, V37, P382, DOI 10.2307/3544132; LARSEN KJ, 1992, J INSECT BEHAV, V5, P109, DOI 10.1007/BF01049162; LINCOLN DE, 1984, ENVIRON ENTOMOL, V13, P1527, DOI 10.1093/ee/13.6.1527; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Marquis M, 2014, ECOLOGY, V95, P9, DOI 10.1890/13-0760.1; Nano CEM, 2013, AUSTRAL ECOL, V38, P741, DOI 10.1111/aec.12036; PATEL J D, 1971, Journal of the Australian Entomological Society, V10, P43, DOI 10.1111/j.1440-6055.1971.tb00009.x; Piyaphongkul J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029409; R Core Team, 2012, R LANG ENV STAT COMP; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Roderick ML, 2001, NEW PHYTOL, V149, P473, DOI 10.1046/j.1469-8137.2001.00054.x; ROTH SK, 1995, GLOBAL CHANGE BIOL, V1, P173, DOI 10.1111/j.1365-2486.1995.tb00019.x; Salvucci ME, 1999, J INSECT PHYSIOL, V45, P21, DOI 10.1016/S0022-1910(98)00105-X; Seeger J, 2008, EUR J SOIL BIOL, V44, P483, DOI 10.1016/j.ejsobi.2008.07.008; Stadler B, 1998, ECOLOGY, V79, P1514, DOI 10.1890/0012-9658(1998)079[1514:LAEWNF]2.0.CO;2; Stiling P, 1999, ECOL APPL, V9, P240, DOI 10.1890/1051-0761(1999)009[0240:DLMAIE]2.0.CO;2; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Subchan W, 2002, THESIS; Thomas DS, 2004, FOREST ECOL MANAG, V193, P157, DOI 10.1016/j.foreco.2004.01.028; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Vranjic JA, 1997, J ECOL, V85, P143, DOI 10.2307/2960646; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Ward NL, 2007, GLOBAL CHANGE BIOL, V13, P1605, DOI 10.1111/j.1365-2486.2007.01399.x; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515	59	11	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0155131	10.1371/journal.pone.0155131	http://dx.doi.org/10.1371/journal.pone.0155131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434232	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600001
J	Waltman, PH; Guo, J; Reistetter, EN; Purvine, S; Ansong, CK; van Baren, MJ; Wong, CH; Wei, CL; Smith, RD; Callister, SJ; Stuart, JM; Worden, AZ				Waltman, Peter H.; Guo, Jian; Reistetter, Emily Nahas; Purvine, Samuel; Ansong, Charles K.; van Baren, Marijke J.; Wong, Chee-Hong; Wei, Chia-Lin; Smith, Richard D.; Callister, Stephen J.; Stuart, Joshua M.; Worden, Alexandra Z.			Identifying Aspects of the Post-Transcriptional Program Governing the Proteome of the Green Alga Micromonas pusilla	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; AU-RICH ELEMENTS; SACCHAROMYCES-CEREVISIAE; INTEGRATIVE ANALYSIS; UNTRANSLATED REGION; CIRCADIAN-RHYTHMS; SOFTWARE PACKAGE; GENE-FUNCTION; LAND PLANTS; EXPRESSION	Micromonas is a unicellular motile alga within the Prasinophyceae, a green algal group that is related to land plants. This picoeukaryote (<2 mu m diameter) is widespread in the marine environment but is not well understood at the cellular level. Here, we examine shifts in mRNA and protein expression over the course of the day-night cycle using triplicated mid-exponential, nutrient replete cultures of Micromonas pusilla CCMP1545. Samples were collected at key transition points during the diel cycle for evaluation using high-throughput LC-MS proteomics. In conjunction, matched mRNA samples from the same time points were sequenced using pair-ended directional Illumina RNA-Seq to investigate the dynamics and relationship between the mRNA and protein expression programs of M. pusilla. Similar to a prior study of the marine cyanobacterium Prochlorococcus, we found significant divergence in the mRNA and proteomics expression dynamics in response to the light: dark cycle. Additionally, expressional responses of genes and the proteins they encoded could also be variable within the same metabolic pathway, such as we observed in the oxygenic photosynthesis pathway. A regression framework was used to predict protein levels from both mRNA expression and gene-specific sequence-based features. Several features in the genome sequence were found to influence protein abundance including codon usage as well as 3' UTR length and structure. Collectively, our studies provide insights into the regulation of the proteome over a diel cycle as well as the relationships between transcriptional and translational programs in the widespread marine green alga Micromonas.	[Waltman, Peter H.; Stuart, Joshua M.] Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA; [Guo, Jian; Reistetter, Emily Nahas; van Baren, Marijke J.; Worden, Alexandra Z.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Purvine, Samuel; Ansong, Charles K.; Smith, Richard D.; Callister, Stephen J.] Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Wong, Chee-Hong; Wei, Chia-Lin] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Worden, Alexandra Z.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Worden, Alexandra Z.] Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON M5G 1Z8, Canada	University of California System; University of California Santa Cruz; Monterey Bay Aquarium Research Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Santa Cruz; Canadian Institute for Advanced Research (CIFAR)	Stuart, JM (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Santa Cruz, CA 95064 USA.; Worden, AZ (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.; Callister, SJ (corresponding author), Pacific Northwest Natl Lab, Div Biol Sci, Richland, WA 99352 USA.; Worden, AZ (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.; Worden, AZ (corresponding author), Canadian Inst Adv Res, Integrated Microbial Biodivers Program, Toronto, ON M5G 1Z8, Canada.	stephen.callister@pnnl.gov; jstuart@ucsc.edu; azworden@mbari.org	Worden, Alexandra Z./AAD-6567-2019; Smith, Richard D/J-3664-2012; Purvine, Samuel O/O-3358-2017	Smith, Richard D/0000-0002-2381-2349; Purvine, Samuel O/0000-0002-2257-2400; Stuart, Joshua/0000-0002-2171-565X; Worden, Alexandra/0000-0002-9888-9324; Wong, Chee Hong/0000-0003-4546-4979	DOE's Office of Biological and Environmental Research Pan-omics program; Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory for the DOE [DE-AC05-76RL01830]; David and Lucile Packard Foundation; U.S. DOE [DE-AC02-05CH11231]; U.S. Department of Energy (DOE) [DOE-DE-SC0004765]; GBMF Investigator Award [3788];  [NSF-IOS0843119]	DOE's Office of Biological and Environmental Research Pan-omics program; Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory for the DOE; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); U.S. DOE(United States Department of Energy (DOE)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); GBMF Investigator Award; 	Partial support for this research was provided by the DOE's Office of Biological and Environmental Research Pan-omics program, and the Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory operated by Battelle for the DOE under contract DE-AC05-76RL01830. Additional funds came from the David and Lucile Packard Foundation, a GBMF Investigator Award (3788) and NSF-IOS0843119 to AZW and for JGI under U.S. DOE Contract No. DE-AC02-05CH11231. Major funds for this research collaboration were from grant DOE-DE-SC0004765 from the U.S. Department of Energy (DOE) to RDS, SJC, JMS and AZW.	Aryal UK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-194; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Boudiere L, 2014, BBA-BIOENERGETICS, V1837, P470, DOI 10.1016/j.bbabio.2013.09.007; Bourquin F, 2010, STRUCTURE, V18, P1054, DOI 10.1016/j.str.2010.05.011; Breiman L., 1998, USING CONVEX PSEUDOD; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Callister SJ, 2010, ENVIRON SCI TECHNOL, V44, P8897, DOI 10.1021/es101029f; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Duanmu DQ, 2014, P NATL ACAD SCI USA, V111, P15827, DOI 10.1073/pnas.1416751111; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FONAGY A, 1993, J CELL PHYSIOL, V154, P16, DOI 10.1002/jcp.1041540104; Fonagy A, 1989, Cancer Commun, V1, P243; Foulon E, 2008, ENVIRON MICROBIOL, V10, P2433, DOI 10.1111/j.1462-2920.2008.01673.x; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Friedman J H, 1995, Stat Methods Med Res, V4, P197, DOI 10.1177/096228029500400303; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guerreiro ACL, 2014, MOL CELL PROTEOMICS, V13, P2042, DOI 10.1074/mcp.M113.035840; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hastie T., 2009, UNSUPERVISED LEARNIN; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kaufman L., 1987, CLUSTERING MEANS MED; Kim S., 2012, PPCOR PARTIAL SEMIPA; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kind B, 2009, BIOCHEM BIOPH RES CO, V390, P205, DOI 10.1016/j.bbrc.2009.09.080; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Li JJ, 2014, PEERJ, V2, DOI 10.7717/peerj.270; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Milborrow S., 2013, EARTH MULTIVARIATE A; Mitchell CJ, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0225-4; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakahara K, 2003, PLANT CELL PHYSIOL, V44, P326, DOI 10.1093/pcp/pcg044; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pillai B, 2009, J MOL BIOL, V385, P580, DOI 10.1016/j.jmb.2008.10.072; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Robidart J, 2013, ENVIRON SCI TECHNOL, V47, P4399, DOI 10.1021/es3037302; Schmid AK, 2007, GENOME RES, V17, P1399, DOI 10.1101/gr.6728007; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smyth R.D., 1982, Progress in Clinical and Biological Research, V80, P211; STAYTON MM, 1989, PLANT PHYSIOL, V89, P776, DOI 10.1104/pp.89.3.776; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanguay RL, 1996, MOL CELL BIOL, V16, P146; Martinez-Pastor MT, 2013, INT J MOL SCI, V14, P15785, DOI 10.3390/ijms140815785; Torres-Garcia W, 2009, BIOINFORMATICS, V25, P1905, DOI 10.1093/bioinformatics/btp325; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Baren MJ, BMC GENOMICS UNPUB; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Waldbauer JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043432; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wilkerson M., 2013, PACKAGE CONSENSUSCLU; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	93	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0155839	10.1371/journal.pone.0155839	http://dx.doi.org/10.1371/journal.pone.0155839			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434306	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000380169600002
J	Qi, LX; Fang, Q; Zhao, L; Xia, H; Zhou, YX; Xiao, JH; Li, K; Ye, GY				Qi, Lixing; Fang, Qi; Zhao, Lei; Xia, Hao; Zhou, Yuxun; Xiao, Junhua; Li, Kai; Ye, Gongyin			De Novo Assembly and Developmental Transcriptome Analysis of the Small White Butterfly Pieris rapae	PLOS ONE			English	Article							SHOCK-PROTEIN GENES; MANDUCA-SEXTA; EXPRESSION; EVOLUTIONARY; TOOL; PROPHENOLOXIDASE; RECOGNITION; GENERATION; ONTOLOGY; CLONING	The small white butterfly Pieris rapae is one of the most destructive pests of Brassicaceae. Yet little is understood about its genes involved in development. To facilitate research on P. rapae, we sequenced the transcriptome of P. rapae during six developmental stages, including the egg, three larval stages, the pupa, and the adult. In total, 240 million high-quality reads were obtained. De novo assembly generated 96,069 unigenes with an average length of 1353 nt. Of these, 31,629 unigenes had homologs as determined by a blastx search against the NR database with a cut-off e-value of 10(-5). Clusters of Orthologous Groups of proteins (COG), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted to functionally annotate those genes. Then, 849 genes involved in seven canonical development signaling pathway were identified, including dozens of key genes such as Hippo, Notch, and JAK2. A total of 21,883 differentially expressed (cut-off of 2-fold) unigenes were detected across the developmental stages, most of which were found between the egg and first larval stages. Interestingly, only 34 differentially expressed unigenes, most of which are cuticle protein related genes, were detected with a cut-off of 2(10)-fold. Furthermore, we identified 32 heat shock protein (Hsp) genes that were expressed with complete open reading frames. Based on phylogenetic trees of the Hsp genes, we found that Hsp genes with close evolutionary relationships had similar expression pattern. Additionally, partial pattern recognition receptors genes were found to be developmental regulated. This study provides comprehensive sequence resources for P. rapae and numerous differential expressed genes, and these findings will lay the foundation for future functional genomics studies on this species.	[Qi, Lixing; Zhao, Lei; Xia, Hao; Zhou, Yuxun; Xiao, Junhua; Li, Kai] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China; [Fang, Qi; Ye, Gongyin] Zhejiang Univ, Inst Insect Sci, Minist Agr, State Key Lab Rice Biol,Key Lab Mol Biol Crop Pat, Hangzhou, Zhejiang, Peoples R China	Donghua University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Li, K (corresponding author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.; Ye, GY (corresponding author), Zhejiang Univ, Inst Insect Sci, Minist Agr, State Key Lab Rice Biol,Key Lab Mol Biol Crop Pat, Hangzhou, Zhejiang, Peoples R China.	likai@dhu.edu.cn; chu@zju.edu.cn			Key Project of Science & Technology Commission of Shanghai Municipality [13140900300]; National Science Foundation of China [31171199]; Fundamental Research Funds for the Central Universities [2232013A3-06]; DHU Distinguished Young Professor Program [B201308]	Key Project of Science & Technology Commission of Shanghai Municipality; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); DHU Distinguished Young Professor Program	This work was supported by 1) National Science Foundation of China (No. 31171199, http://www.nsfc.gov.cn/): Data analysis; 2) Fundamental Research Funds for the Central Universities (No. 2232013A3-06, http://www.dhu.edu.cn/): sample collection and study design; 3) DHU Distinguished Young Professor Program (B201308, http://www.dhu.edu.cn/): data analysis, preparation of the manuscript; and 4) Key Project of Science & Technology Commission of Shanghai Municipality (No. 13140900300, http://www.stcsm.gov.cn/): sample collection.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chen SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015633; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gu J, 2013, INSECT BIOCHEM MOLEC, V43, P794, DOI 10.1016/j.ibmb.2013.06.001; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Heikkila JJ, 2004, J CELL BIOCHEM, V93, P672, DOI 10.1002/jcb.20237; Huang LH, 2009, J INSECT PHYSIOL, V55, P279, DOI 10.1016/j.jinsphys.2008.12.004; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073911; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; MacCallum RM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-620; Mao Zeng-Hui, 2010, Acta Entomologica Sinica, V53, P1295; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mun S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10484; Oppenheim SJ, 2015, INSECT MOL BIOL, V24, P139, DOI 10.1111/imb.12154; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Qi YX, 2014, J NEUROCHEM, V131, P767, DOI 10.1111/jnc.12940; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roxstrom-Lindquist K, 2005, INSECT MOL BIOL, V14, P645, DOI 10.1111/j.1365-2583.2005.00593.x; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu SF, 2013, DEV COMP IMMUNOL, V41, P1, DOI 10.1016/j.dci.2013.04.006; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin JianLi, 2010, Plant Diseases and Pests, V1, P21; Yu XQ, 1999, ARCH INSECT BIOCHEM, V42, P198, DOI 10.1002/(SICI)1520-6327(199911)42:3&lt;198::AID-ARCH4&gt;3.0.CO;2-G; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zhang XF, 2015, INSECT BIOCHEM MOLEC, V62, P38, DOI 10.1016/j.ibmb.2015.02.001; Zhu JY, 2013, INSECT SCI, V20, P183, DOI 10.1111/j.1744-7917.2011.01494.x; Zhu JY, 2011, J ZHEJIANG UNIV-SC B, V12, P103, DOI 10.1631/jzus.B1000275	49	21	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159258	10.1371/journal.pone.0159258	http://dx.doi.org/10.1371/journal.pone.0159258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428371	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300042
J	Zhang, L; Zhang, J; Han, W; Gao, J; He, L; Yang, YL; Yin, P; Xie, MX; Ge, SP				Zhang, Li; Zhang, Jing; Han, Wei; Gao, Jun; He, Lin; Yang, Yali; Yin, Ping; Xie, Mingxing; Ge, Shuping			Three-Dimensional Rotation, Twist and Torsion Analyses Using Real-Time 3D Speckle Tracking Imaging: Feasibility, Reproducibility, and Normal Ranges in Pediatric Population	PLOS ONE			English	Article							LEFT-VENTRICULAR TWIST; AGE-RELATED-CHANGES; APICAL ROTATION; ECHOCARDIOGRAPHY; MECHANICS; STRAIN; ASSOCIATION; GUIDELINES; STANDARDS; CHILDREN	Background and Objective The specific aim of this study was to evaluate the feasibility, reproducibility and maturational changes of LV rotation, twist and torsion variables by real-time 3D speckle-tracking echocardiography (RT3DSTE) in children. Methods A prospective study was conducted in 347 consecutive healthy subjects (181 males/156 females, mean age 7.12 +/- 5.3 years, and range from birth to 18-years) using RT 3D echocardiography (3DE). The LV rotation, twist and torsion measurements were made off-line using TomTec software. Manual landmark selection and endocardial border editing were performed in 3 planes (apical "2"-, "4"-, and "3"-chamber views) and semi-automated tracking yielded LV rotation, twist and torsion measurements. LV rotation, twist and torsion analysis by RT 3DSTE were feasible in 307 out of 347 subjects (88.5%). Results There was no correlation between rotation or twist and age, height, weight, BSA or heart rate, respectively. However, there was statistically significant, but very modest correlation between LV torsion and age (R-2 = 0.036, P<0.001). The normal ranges were defined for rotation and twist in this cohort, and for torsion for each age group. The intra-observer and inter-observer variabilities for apical and basal rotation, twist and torsion ranged from 7.3% +/- 3.8% to 12.3% +/- 8.8% and from 8.8% +/- 4.6% to 15.7% +/- 10.1%, respectively. Conclusions We conclude that analysis of LV rotation, twist and torsion by this new RT3D STE is feasible and reproducible in pediatric population. There is no maturational change in rotation and twist, but torsion decreases with age in this cohort. Further refinement is warranted to validate the utility of this new methodology in more sensitive and quantitative evaluation of congenital and acquired heart diseases in children.	[Zhang, Li; Zhang, Jing; Han, Wei; Gao, Jun; He, Lin; Yang, Yali; Xie, Mingxing] Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China; [Gao, Jun] Wuhan Women & Children Med Ctr, Dept Ultrasound, Wuhan, Peoples R China; [Yin, Ping] Huazhong Univ Sci & Technol, Epidemiol & Hlth Stat, Wuhan, Peoples R China; [Zhang, Li; Ge, Shuping] Drexel Univ, Coll Med, Ctr Heart, St Christophers Hosp Children, Philadelphia, PA 19104 USA; [Ge, Shuping] Deborah Heart & Lung Ctr, Browns Mills, NJ 08015 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Drexel University	Xie, MX (corresponding author), Huazhong Univ Sci & Technol, Dept Ultrasound, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China.; Ge, SP (corresponding author), Drexel Univ, Coll Med, Ctr Heart, St Christophers Hosp Children, Philadelphia, PA 19104 USA.; Ge, SP (corresponding author), Deborah Heart & Lung Ctr, Browns Mills, NJ 08015 USA.	xiemx64@126.com; shuping.ge@drexelmed.edu	Zhang, L/ABG-4378-2020; Lang, Ming/HIK-0758-2022; yang, yang/HGT-7999-2022; Yang, Ya-Li/GYU-4320-2022; Zhang, L/A-8465-2019	Zhang, L/0000-0003-1620-1512; Zhang, L/0000-0003-1620-1512				Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Ashraf M, 2012, J AM SOC ECHOCARDIOG, V25, P121, DOI 10.1016/j.echo.2011.09.001; Boissiere J, 2013, J AM SOC ECHOCARDIOG, V26, P1298, DOI 10.1016/j.echo.2013.07.007; Di Maria MV, 2014, J AM SOC ECHOCARDIOG, V27, P1336, DOI 10.1016/j.echo.2014.07.016; Dong LL, 2009, INT J CARDIOVAS IMAG, V25, P479, DOI 10.1007/s10554-009-9458-x; Forsey J, 2014, J AM SOC ECHOCARDIOG, V27, P215, DOI 10.1016/j.echo.2013.10.012; Gayat E, 2011, J AM SOC ECHOCARDIOG, V24, P878, DOI 10.1016/j.echo.2011.04.016; Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511; Hui L, 2007, J AM SOC ECHOCARDIOG, V20, P486, DOI 10.1016/j.echo.2006.10.012; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Laser KT, 2009, J AM SOC ECHOCARDIOG, V22, P1121, DOI 10.1016/j.echo.2009.06.014; Lorch SM, 2008, J AM SOC ECHOCARDIOG, V21, P1207, DOI 10.1016/j.echo.2008.08.011; Marcus KA, 2011, J AM SOC ECHOCARDIOG, V24, P625, DOI 10.1016/j.echo.2011.01.021; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Notomi Y, 2006, CIRCULATION, V113, P2534, DOI 10.1161/CIRCULATIONAHA.105.537639; Parikh NI, 2012, AM HEART J, V163, P470, DOI 10.1016/j.ahj.2011.12.011; Sengupta PP, 2007, J AM SOC ECHOCARDIOG, V20, P539, DOI 10.1016/j.echo.2006.10.013; Sengupta PP, 2006, J AM COLL CARDIOL, V48, P1988, DOI 10.1016/j.jacc.2006.08.030; Takahashi K, 2010, J AM SOC ECHOCARDIOG, V23, P286, DOI 10.1016/j.echo.2009.11.018; Tavakoli V, 2013, J ULTRAS MED, V32, P1435, DOI 10.7863/ultra.32.8.1435; Tejman-Yarden S, 2016, PEDIATR CARDIOL, V37, P106, DOI 10.1007/s00246-015-1246-x; van Dalen BM, 2009, HEART, V95, P657, DOI 10.1136/hrt.2008.152777; Wang JW, 2007, CIRCULATION, V116, P2580, DOI 10.1161/CIRCULATIONAHA.107.706770; Xie MX, 2013, INT J CARDIOL, V168, P4631, DOI 10.1016/j.ijcard.2013.07.194; Young AA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-49; Zhang L, 2007, J HUAZHONG U SCI-MED, V27, P691, DOI 10.1007/s11596-007-0619-7; Zhang L, 2013, J AM SOC ECHOCARDIOG, V26, P853, DOI 10.1016/j.echo.2013.05.002	32	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158679	10.1371/journal.pone.0158679	http://dx.doi.org/10.1371/journal.pone.0158679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427968	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300018
J	Matsumoto, Y; Yamagishi, T; Li, Y; Kiyonari, T				Matsumoto, Yoshie; Yamagishi, Toshio; Li, Yang; Kiyonari, Toko			Prosocial Behavior Increases with Age across Five Economic Games	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATION; UNFAIR OFFERS; COOPERATION; DILEMMAS; CHILDREN; ADOLESCENCE; RECIPROCITY; REJECTION; EXCHANGE; FAIRNESS	Ontogenic studies of human prosociality generally agree on that human prosociality increases from early childhood through early adulthood; however, it has not been established if prosociality increases beyond early adulthood. We examined a sample of 408 non-student residents from Tokyo, Japan, who were evenly distributed across age (20-59) and sex. Participants played five economic games each separated by a few months. We demonstrated that prosocial behavior increased with age beyond early adulthood and this effect was shown across all five economic games. A similar, but weaker, age-related trend was found in one of three social value orientation measures of prosocial preferences. We measured participants' belief that manipulating others is a wise strategy for social success, and found that this belief declined with age. Participants' satisfaction with the unilateral exploitation outcome of the prisoner's dilemma games also declined with age. These two factors-satisfaction with the DC outcome in the prisoner's dilemma games and belief in manipulation-mediated the age effect on both attitudinal and behavioral prosociality. Participants' age-related socio-demographic traits such as marriage, having children, and owning a house weakly mediated the age effect on prosociality through their relationships with satisfaction with the DC outcome and belief in manipulation.	[Matsumoto, Yoshie; Yamagishi, Toshio; Li, Yang] Tamagawa Univ, Brain Sci Inst, 6-1-1 Tamagawagakuen, Machida, Tokyo, Japan; [Yamagishi, Toshio] Hitotsubashi Univ, Grad Sch Int Corp Strategy, Tokyo, Japan; [Kiyonari, Toko] Aoyama Gakuin Univ, Sch Social Informat, Sagamihara, Kanagawa, Japan	Hitotsubashi University; Aoyama Gakuin University	Yamagishi, T (corresponding author), Tamagawa Univ, Brain Sci Inst, 6-1-1 Tamagawagakuen, Machida, Tokyo, Japan.; Yamagishi, T (corresponding author), Hitotsubashi Univ, Grad Sch Int Corp Strategy, Tokyo, Japan.	yamagishitoshio@gmail.com	Li, Yang/V-1465-2019	Li, Yang/0000-0002-8239-3279	Japan Society for the Promotion of Science [23223003, 15H05730]; Grants-in-Aid for Scientific Research [15H05730] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	23223003 and 15H05730, Japan Society for the Promotion of Science, https://www.jsps.go.jp/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balliet D, 2009, GROUP PROCESS INTERG, V12, P533, DOI 10.1177/1368430209105040; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2015, NATURE, V528, P258, DOI 10.1038/nature15703; Eisenberg N., 1991, PROSOCIAL BEHAV, P34; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gutierrez-Roig M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5362; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Kanacri BPL, 2013, J PERS, V81, P302, DOI 10.1111/jopy.12001; Kelley H. H, 1978, INTERPERSONAL RELATI; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; KNIGHT GP, 1984, J RES PERS, V18, P372, DOI 10.1016/0092-6566(84)90021-7; LIEBRAND WBG, 1985, J EXP SOC PSYCHOL, V21, P86, DOI 10.1016/0022-1031(85)90008-3; LIEBRAND WBG, 1984, EUR J SOC PSYCHOL, V14, P239, DOI 10.1002/ejsp.2420140302; McAuliffe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080966; McClintock CG, 1978, J RES DEV EDUC, V12, P121; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Murphy RO, 2014, PERS SOC PSYCHOL REV, V18, P13, DOI 10.1177/1088868313501745; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Nishina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137089; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; RUSHTON JP, 1975, J PERS SOC PSYCHOL, V31, P459, DOI 10.1037/h0076466; Skyrms B, 1987, STAG HUNT EVOLUTION; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Takagishi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108462; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Taylor M., 1987, POSSIBILITY COOPERAT; van den Assem MJ, 2012, MANAGE SCI, V58, P2, DOI 10.1287/mnsc.1110.1413; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Yamagishi T, 2007, RATION SOC, V19, P259, DOI 10.1177/1043463107080449; Yamagishi T, 2016, P NATL ACAD SCI USA, V113, P5582, DOI 10.1073/pnas.1523940113; Yamagishi T, 2015, SOC COGNITION, V33, P436, DOI 10.1521/soco.2015.33.5.436; Yamagishi T, 2014, PSYCHOL SCI, V25, P1699, DOI 10.1177/0956797614538065; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Yamagishi T, 2009, P NATL ACAD SCI USA, V106, P11520, DOI 10.1073/pnas.0900636106	36	41	42	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158671	10.1371/journal.pone.0158671	http://dx.doi.org/10.1371/journal.pone.0158671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27414803	Green Published, gold			2022-12-26	WOS:000379579500030
J	Kripke, K; Opuni, M; Schnure, M; Sgaier, S; Castor, D; Reed, J; Njeuhmeli, E; Stover, J				Kripke, Katharine; Opuni, Marjorie; Schnure, Melissa; Sgaier, Sema; Castor, Delivette; Reed, Jason; Njeuhmeli, Emmanuel; Stover, John			Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0	PLOS ONE			English	Article							HIV PREVENTION; PEOPLE; MEN	Background Despite considerable efforts to scale up voluntary medical male circumcision (VMMC) for HIV prevention in priority countries over the last five years, implementation has faced important challenges. Seeking to enhance the effect of VMMC programs for greatest and most immediate impact, the U. S. President's Plan for AIDS Relief (PEPFAR) supported the development and application of a model to inform national planning in five countries from 2013-2014. Methods and Findings The Decision Makers' Program Planning Toolkit (DMPPT) 2.0 is a simple compartmental model designed to analyze the effects of client age and geography on program impact and cost. The DMPPT 2.0 model was applied in Malawi, South Africa, Swaziland, Tanzania, and Uganda to assess the impact and cost of scaling up age-targeted VMMC coverage. The lowest number of VMMCs per HIV infection averted would be produced by circumcising males ages 20-34 in Malawi, South Africa, Tanzania, and Uganda and males ages 15-34 in Swaziland. The most immediate impact on HIV incidence would be generated by circumcising males ages 20-34 in Malawi, South Africa, Tanzania, and Uganda and males ages 20-29 in Swaziland. The greatest reductions in HIV incidence over a 15-year period would be achieved by strategies focused on males ages 10-19 in Uganda, 15-24 in Malawi and South Africa, 10-24 in Tanzania, and 15-29 in Swaziland. In all countries, the lowest cost per HIV infection averted would be achieved by circumcising males ages 15-34, although in Uganda this cost is the same as that attained by circumcising 15- to 49-year-olds. Conclusions The efficiency, immediacy of impact, magnitude of impact, and cost-effectiveness of VMMC scale-up are not uniform; there is important variation by age group of the males circumcised and countries should plan accordingly.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Opuni, Marjorie] United Nations Joint Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Schnure, Melissa] Futures Grp Inc, Hlth Policy Project, Washington, DC USA; [Sgaier, Sema] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sgaier, Sema] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Castor, Delivette; Reed, Jason] Off US Global AIDS Coordinator & Hlth Diplomacy, Washington, DC USA; [Njeuhmeli, Emmanuel] USAID, Washington, DC USA; [Stover, John] Avenir Hlth, Hlth Policy Project, Glastonbury, CT USA	UNAIDS; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577; Opuni, Marjorie/0000-0002-0939-7695	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project [AID-OAA-A-10-00067]; USAID	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) \ Health Policy Project(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID(United States Agency for International Development (USAID))	This work was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) vertical bar Health Policy Project, Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of USAID or the U.S. Government.; We would like acknowledge Laith J. Abu-Raddad and Susanne F. Awad of the Weill Cornell Medical College in Qatar for helpful discussions and for contributing to the analytical framework and model validation. Carel Pretorius, Xan Paxton, and Bernice Kuang from the USAID-funded Health Policy Project provided helpful consultation and assistance with the analyses. The PEPFAR VMMC Technical Working Group-including Naomi Bock, Carlos Toledo, Stephanie Marie Davis, and Dan Rutz from CDC; Anne Thomas from DoD; Jim Shelton, Adolfus Muyoti, Ramona Godbole, and Kim Ahanda from USAID; and Jason Reed from OGAC-contributed to the model framework and provided guidance regarding country model applications. Patrick Odawo and Maaya Sundaram from BMGF; Marelize Gorgens and Nicole Fraser-Hurt from the World Bank; Tin Tin Sint and Rene Ekpini from UNICEF; Julia Samuelson and Rachel Baggely from WHO; Karl Dehne and Celeste Sandoval from UNAIDS; Ade Fakoya from the Global Fund to Fight AIDS, Tuberculosis and Malaria; Mitchell Warren from AVAC; and Steven Forsythe from Avenir Health also contributed to the model framework. Timothy Hallett from Imperial College London reviewed and commented on the model in its early phases. We are also grateful to the publications staff of the Health Policy Project for their assistance with copyediting and formatting.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; Appleby J, 2000, BRIT MED J, V320, P1464, DOI 10.1136/bmj.320.7247.1464; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Awad S, 2016, PLOS ONE IN PRESS; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S4; Ghys PD, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000299404.99033.bf; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; Justman J, 2013, JAIDS-J ACQ IMM DEF, V63, pS140, DOI 10.1097/QAI.0b013e31829875cc; Kripke K, 2016, PLOS ONE IN PRESS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malawi National Statistical Office ICF Macro, 2011, MAL DEM HLTH SURV 20; Ministry of Health, 2012, SWAZ INC MEAS SURV S; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; PEPFAR, 2014, PEPFAR 3 0 CONTR EP; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Simbayi L, 2014, S AFRICAN NATL HIV P; Stover J, 2014, AIDS, V28, pS427, DOI 10.1097/QAD.0000000000000483; Swaziland Central Statistical Office Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) ICF International, 2013, TANZ HIV AIDS MAL IN, DOI Dares Salaam, Tanzania, and Calverton, Maryland, USA; U.S. President's Emergency Plan for AIDS Relief (PEFPAR), 2012, PEPFAR BLUEPR CREAT; Uganda Bureau of Statistics, 2012, UG DEM HLTH SURV 201; UNAIDS, 2015, AIDS CHANG EV MDG6 1; UNAIDS, 2014, LOC EP ISS BRIEF; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM	32	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0156909	10.1371/journal.pone.0156909	http://dx.doi.org/10.1371/journal.pone.0156909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410966	Green Published, gold			2022-12-26	WOS:000379508300004
J	Yang, G; Xu, HQ; Zhang, HP; Yu, Q; Wu, YH; Shi, JP; Rao, WW; You, YY; Kou, CG; Yu, YQ				Yang, Guang; Xu, Hongqin; Zhang, Huiping; Yu, Qiong; Wu, Yanhua; Shi, Jieping; Rao, Wenwang; You, Yueyue; Kou, Changgui; Yu, Yaqin			Association between PLA2G12A Polymorphisms and Schizophrenia in a Han Chinese Population from Northeast China	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE-A2 GENE; PTGS2/PLA2G4A LOCUS; COMMON VARIANTS; A(2) ACTIVITY; SAMPLES; CPLA2	Objective The purpose of this study was to explore the association between single nucleotide polymorphisms (SNPs) in the phospholipase A2 (PLA2), group XIIA gene (PLA2G12A) and schizophrenia. Methods This study included 1,063 schizophrenia patients and 1,103 healthy controls from a Han Chinese Population in Northeast China. Four tagSNPs (rs11728699 in intron 1, synonymous rs2285714 in exon 3, rs3087494 in the 3' UTR, and rs7694620 in the downstream region) in PLA2G12A were selected, and they were genotyped by the MALDI-TOF-MS technology. The Chi-square (chi(2)) test and haplotype analysis were performed to analyze the association of PLA2G12A SNPs and schizophrenia using the software packages SPSS 16.0 and Haploview 4.2. Results Among the four tagSNPs, only SNP rs3087494 in the 3' UTR of PLA2G12A showed significant differences in both allele frequencies (chi(2) = 20.136, P<0.001) compared to healthy controls. The minor allele G of SNP rs3087494 is potentially a predictive factor for schizophrenia (OR = 0.753, 95% CI: 0.665-0.882). The frequency distribution of haplotypes consisting of specific alleles of two SNPs (rs7694620-rs3087494 or rs3087494-rs2285714), three SNPs (rs7694620-rs3087494-rs2285714 or rs3087494-rs2285714-rs11728699), or all four SNPs (rs7694620-rs3087494-rs2285714-rs11728699) was significantly different between schizophrenia patients and control subjects (P<0.001). Conclusions Our study demonstrated that PLA2G12A SNPs or haplotypes might influence the susceptibility to schizophrenia in the Han Chinese population from Northeast China.	[Yang, Guang; Xu, Hongqin; Yu, Qiong; Shi, Jieping; Rao, Wenwang; You, Yueyue; Kou, Changgui; Yu, Yaqin] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China; [Xu, Hongqin] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130021, Jilin, Peoples R China; [Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Zhang, Huiping] VA Connecticut Healthcare Syst, VA Med Ctr, West Haven, CT USA; [Wu, Yanhua] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Jilin University	Kou, CG; Yu, YQ (corresponding author), Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, 1163 Xinmin St, Changchun 130021, Jilin Province, Peoples R China.	koucg@jlu.edu.cn; yuyq@jlu.edu.cn	Yu, Qiong/M-1175-2018; SHI, JIE/GXG-3394-2022	Rao, Wenwang/0000-0002-3514-3082; Zhang, Huiping/0000-0002-4902-0104; Yu, Qiong/0000-0003-1143-1749; Yang, Guang/0000-0002-4335-2618; Kou, Changgui/0000-0001-9544-4066	National Natural Science Foundation of China [30972536]; First Hospital of Jilin University; Sixth Hospital of Changchun	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First Hospital of Jilin University; Sixth Hospital of Changchun	This research was totally supported by the National Natural Science Foundation of China (30972536). The funding source had no role in the design of this study, the collection, analysis and interpretation of data, the writing of the paper, or the decision or submit the paper for publication.; We are grateful to the First Hospital of Jilin University and the Sixth Hospital of Changchun for supporting our project.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Arias B, 2002, NEUROTOX RES, V4, P523, DOI 10.1080/1029842021000022106; Chowdari KV, 2001, PSYCHIATR GENET, V11, P207, DOI 10.1097/00041444-200112000-00005; Eckert GP, 2011, PHARMACOPSYCHIATRY, V44, P161, DOI 10.1055/s-0031-1279731; Frieboes RM, 2001, AM J MED GENET, V105, P246, DOI 10.1002/ajmg.1262; GATTAZ WF, 1995, SCHIZOPHR RES, V16, P1, DOI 10.1016/0920-9964(94)00060-L; GATTAZ WF, 1990, BIOL PSYCHIAT, V28, P495; [寇长贵 KOU Changgui], 2006, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V32, P448; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Monti JM, 2013, PROG NEURO-PSYCHOPH, V43, P209, DOI 10.1016/j.pnpbp.2012.12.021; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Pae CU, 2004, PROG NEURO-PSYCHOPH, V28, P739, DOI 10.1016/j.pnpbp.2004.05.009; Price SA, 1997, PSYCHIATR GENET, V7, P111, DOI 10.1097/00041444-199723000-00004; Ross BM, 1997, ARCH GEN PSYCHIAT, V54, P487; Rybakowski JK, 2003, NEUROPSYCHOBIOLOGY, V47, P115, DOI 10.1159/000070578; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Smesny S, 2010, NEUROIMAGE, V52, P1314, DOI 10.1016/j.neuroimage.2010.05.009; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Talib LL, 2015, EUR ARCH PSY CLIN N, V265, P701, DOI 10.1007/s00406-015-0600-6; Tao R, 2005, AM J MED GENET B, V137B, P56, DOI 10.1002/ajmg.b.30210; Tao R, 2010, PSYCHIAT GENET, V20, P46, DOI 10.1097/YPG.0b013e328335117f; Tavares H, 2003, SCHIZOPHR RES, V61, P1, DOI 10.1016/S0920-9964(02)00281-5; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Wei J, 2004, PROSTAG LEUKOTR ESS, V70, P413, DOI 10.1016/j.plefa.2003.12.018; Wei J, 1998, MOL PSYCHIATR, V3, P480, DOI 10.1038/sj.mp.4000445; [俞琼 Yu Qiong], 2010, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V36, P938; Yu YQ, 2005, PROSTAG LEUKOTR ESS, V73, P351, DOI 10.1016/j.plefa.2005.07.003; Yu YQ, 2004, PROSTAG LEUKOTR ESS, V71, P405, DOI 10.1016/j.plefa.2004.09.001	28	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159584	10.1371/journal.pone.0159584	http://dx.doi.org/10.1371/journal.pone.0159584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434078	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600075
J	Zeiner, CA; Purvine, SO; Zink, EM; Pasa-Tolic, L; Chaput, DL; Haridas, S; Wu, S; LaButti, K; Grigoriev, IV; Henrissat, B; Santelli, CM; Hansel, CM				Zeiner, Carolyn A.; Purvine, Samuel O.; Zink, Erika M.; Pasa-Tolic, Ljiljana; Chaput, Dominique L.; Haridas, Sajeet; Wu, Si; LaButti, Kurt; Grigoriev, Igor V.; Henrissat, Bernard; Santelli, Cara M.; Hansel, Colleen M.			Comparative Analysis of Secretome Profiles of Manganese(II)-Oxidizing Ascomycete Fungi	PLOS ONE			English	Article							COAL-MINE DRAINAGE; ASPERGILLUS-NIGER; MN(II) OXIDATION; PHANEROCHAETE-CHRYSOSPORIUM; EXTRACELLULAR PROTEOME; TREATMENT SYSTEMS; PROTEINS; DATABASE; PEROXIDASE; DIVERSITY	Fungal secretomes contain a wide range of hydrolytic and oxidative enzymes, including cellulases, hemicellulases, pectinases, and lignin-degrading accessory enzymes, that synergistically drive litter decomposition in the environment. While secretome studies of model organisms such as Phanerochaete chrysosporium and Aspergillus species have greatly expanded our knowledge of these enzymes, few have extended secretome characterization to environmental isolates or conducted side-by-side comparisons of diverse species. Thus, the mechanisms of carbon degradation by many ubiquitous soil fungi remain poorly understood. Here we use a combination of LC-MS/MS, genomic, and bioinformatic analyses to characterize and compare the protein composition of the secretomes of four recently isolated, cosmopolitan, Mn(II)-oxidizing Ascomycetes (Alternaria alternata SRC1lrK2f, Stagonospora sp. SRC1lsM3a, Pyrenochaeta sp. DS3sAY3a, and Paraconiothyrium sporulosum AP3s5-JAC2a). We demonstrate that the organisms produce a rich yet functionally similar suite of extracellular enzymes, with species-specific differences in secretome composition arising from unique amino acid sequences rather than overall protein function. Furthermore, we identify not only a wide range of carbohydrate-active enzymes that can directly oxidize recalcitrant carbon, but also an impressive suite of redox-active accessory enzymes that suggests a role for Fenton-based hydroxyl radical formation in indirect, non-specific lignocellulose attack. Our findings highlight the diverse oxidative capacity of these environmental isolates and enhance our understanding of the role of filamentous Ascomycetes in carbon turnover in the environment.	[Zeiner, Carolyn A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Purvine, Samuel O.; Pasa-Tolic, Ljiljana; Wu, Si] Pacific Northwest Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Zink, Erika M.] Pacific Northwest Natl Lab, Biol Sci Lab, Richland, WA 99352 USA; [Chaput, Dominique L.] Smithsonian Inst, Dept Mineral Sci, Natl Museum Nat Hist, Washington, DC 20560 USA; [Haridas, Sajeet; LaButti, Kurt; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Henrissat, Bernard] CNRS, Architecture & Fonct Macromol Biol, UMR7257, F-13288 Marseille 9, France; [Henrissat, Bernard] Aix Marseille Univ, F-13288 Marseille 9, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, POB 80203, Jeddah 21589, Saudi Arabia; [Santelli, Cara M.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN USA; [Hansel, Colleen M.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Zeiner, Carolyn A.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Wu, Si] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Harvard University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; University of Minnesota System; University of Minnesota Twin Cities; Woods Hole Oceanographic Institution; Boston University; University of Oklahoma System; University of Oklahoma - Norman	Hansel, CM (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	chansel@whoi.edu	Santelli, Cara/AAG-2453-2019; Purvine, Samuel O/O-3358-2017; Henrissat, Bernard/J-2475-2012; Haridas, Sajeet/H-4018-2019	Santelli, Cara/0000-0001-8617-0008; Purvine, Samuel O/0000-0002-2257-2400; Henrissat, Bernard/0000-0002-3434-8588; Haridas, Sajeet/0000-0002-0229-0975; Chaput, Dominique/0000-0002-9736-2619; Grigoriev, Igor/0000-0002-3136-8903; Zeiner, Carolyn/0000-0002-4847-4673	National Science Foundation [EAR-1249489, CBET-1336496]; Office of Biological and Environmental Research [DE-AC02-05CH11231, DE-AC05-76RL01830]; Harvard University; Ford Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1743046] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Harvard University; Ford Foundation; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (www.nsf.gov), grant numbers EAR-1249489 and CBET-1336496, both awarded to CMH. Personal support for CAZ was also provided by Harvard University (www.harvard.edu) and by a Ford Foundation (www.fordfoundation.org) Predoctoral Fellowship administered by the National Academies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was performed under the Facilities Integrating Collaborations for User Science (FICUS) exploratory effort and used resources at the DOE Joint Genome Institute and the Environmental Molecular Sciences Laboratory, which are DOE Office of Science User Facilities. Both facilities are sponsored by the Office of Biological and Environmental Research and operated under Contract Nos. DE-AC02-05CH11231 (JGI) and DE-AC05-76RL01830 (EMSL). Part of this research was performed at the Bauer Core Facility of the FAS Center for Systems Biology at Harvard University. A portion of the bioinformatics analysis was performed at Harvard's FAS Research Computing facility.	Acumedia, 2011, YEAST EXTR 7184 PROD; Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Antelmann H, 2001, GENOME RES, V11, P1484, DOI 10.1101/gr.182801; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BERGBAUER M, 1992, BIOTECHNOL LETT, V14, P317, DOI 10.1007/BF01022331; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Dashtban Mehdi, 2010, Int J Biochem Mol Biol, V1, P36; Garcia-Molina MD, 2014, IUBMB LIFE, V66, P122, DOI 10.1002/iub.1250; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferrer C, 2009, J CLIN MICROBIOL, V47, P1596, DOI 10.1128/JCM.01912-08; Finch-Savage WE, 2003, EUR J PLANT PATHOL, V109, P615, DOI 10.1023/A:1024784831972; Girard V, 2013, PROTEOMICS, V13, P597, DOI 10.1002/pmic.201200282; GLENN JK, 1986, ARCH BIOCHEM BIOPHYS, V251, P688, DOI 10.1016/0003-9861(86)90378-4; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Grigoriev IV, 2006, APPL MYCOL BIOTECH, V6, P123; HAIDER K, 1969, ARCH MIKROBIOL, V64, P338, DOI 10.1007/BF00417015; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Hatakka A, 2010, MYCOTA, V10, P319; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hofer C, 1999, FEBS LETT, V451, P186, DOI 10.1016/S0014-5793(99)00566-9; Hori C, 2014, APPL ENVIRON MICROB, V80, P2062, DOI 10.1128/AEM.03652-13; HUDSON HJ, 1968, NEW PHYTOL, V67, P837, DOI 10.1111/j.1469-8137.1968.tb06399.x; Jensen KA, 2001, APPL ENVIRON MICROB, V67, P2705, DOI 10.1128/AEM.67.6.2705-2711.2001; Kelly RT, 2006, ANAL CHEM, V78, P7796, DOI 10.1021/ac061133r; Kersten P, 2014, FUNGAL GENET BIOL, V72, P124, DOI 10.1016/j.fgb.2014.05.011; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Krijger JJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-722; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levic J, 2012, ROM AGRIC RES, V29, P339; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang LM, 2013, APPL MICROBIOL BIOT, V97, P8683, DOI 10.1007/s00253-013-5178-1; Liu DY, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-149; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lu X, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-23; Luan FB, 2012, APPL GEOCHEM, V27, P1567, DOI 10.1016/j.apgeochem.2012.03.010; Maiolica A, 2005, PROTEOMICS, V5, P3847, DOI 10.1002/pmic.200402010; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Medina ML, 2004, FUNGAL GENET BIOL, V41, P327, DOI 10.1016/j.fgb.2003.11.014; Munoz-Gomez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112179; Nilsson T, 1973, STUD FOR SUEC, V104, P5; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phalip V, 2005, CURR GENET, V48, P366, DOI 10.1007/s00294-005-0040-3; Przybyl K, 2002, FOREST PATHOL, V32, P387, DOI 10.1046/j.1439-0329.2002.00301.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RIEBLE S, 1994, J BACTERIOL, V176, P4838, DOI 10.1128/jb.176.16.4838-4844.1994; Rohr CO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081033; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Santelli CM, 2014, GEOMICROBIOL J, V31, P605, DOI 10.1080/01490451.2013.875605; Santelli CM, 2010, APPL ENVIRON MICROB, V76, P4871, DOI 10.1128/AEM.03029-09; Saykhedkar S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-52; Schlosser D, 2002, APPL ENVIRON MICROB, V68, P3514, DOI 10.1128/AEM.68.7.3514-3521.2002; Schoch CL, 2015, MYCOTA COMPREHENSIVE, VVII; Shi JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085532; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solomon PS, 2006, MOL PLANT PATHOL, V7, P147, DOI [10.1111/j.1364-3703.2006.00326.x, 10.1111/J.1364-3703.2006.00326.X]; Timmer LW, 2000, COMPENDIUM CITRUS DI, P20; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; WARIISHI H, 1992, J BIOL CHEM, V267, P23688; Whittaker MM, 1996, J BIOL CHEM, V271, P681, DOI 10.1074/jbc.271.2.681; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	71	35	35	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0157844	10.1371/journal.pone.0157844	http://dx.doi.org/10.1371/journal.pone.0157844			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434633	Green Published, gold			2022-12-26	WOS:000380169600004
J	Helmfors, L; Bergkvist, L; Brorsson, AC				Helmfors, Linda; Bergkvist, Liza; Brorsson, Ann-Christin			Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ALZHEIMERS-DISEASE; MODEL; NEURODEGENERATION; APOPTOSIS; FAMILY; BETA	Lysozyme amyloidosis is a hereditary disease in which mutations in the gene coding for lysozyme leads to misfolding and consequently accumulation of amyloid material. To improve understanding of the processes involved we expressed human wild type (WT) lysozyme and the disease-associated variant F57I in the central nervous system (CNS) of a Drosophila melanogaster model of lysozyme amyloidosis, with and without co-expression of serum amyloid p component (SAP). SAP is known to be a universal constituent of amyloid deposits and to associate with lysozyme fibrils. There are clear indications that SAP may play an important role in lysozyme amyloidosis, which requires further elucidation. We found that flies expressing the amyloidogenic variant F57I in the CNS have a shorter lifespan than flies expressing WT lysozyme. We also identified apoptotic cells in the brains of F57I flies demonstrating that the flies' neurological functions are impaired when F57I is expressed in the nerve cells. However, co-expression of SAP in the CNS prevented cell death and restored the F57I flies' lifespan. Thus, SAP has the apparent ability to protect nerve cells from damage caused by F57I. Furthermore, it was found that co-expression of SAP prevented accumulation of insoluble forms of lysozyme in both WT- and F57I-expressing flies. Our findings suggest that the F57I mutation affects the aggregation process of lysozyme resulting in the formation of cytotoxic species and that SAP is able to prevent cell death in the F57I flies by preventing accumulation of toxic F57I structures.	[Helmfors, Linda; Bergkvist, Liza; Brorsson, Ann-Christin] Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, Linkoping, Sweden	Linkoping University	Brorsson, AC (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Mol Biotechnol, Linkoping, Sweden.	anki@ifm.liu.se		Bergkvist, Liza/0000-0001-7433-2647; Brorsson, Ann-Christin/0000-0001-7651-3556	Swedish Research Council; Soderberg foundation [M26/11]; Linkoping University Neurobiology Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg foundation; Linkoping University Neurobiology Center	This work was supported in part by the Swedish Research Council www.vr.se and the Soderberg foundation M26/11 www.torstensoderbergsstiftelse.se (A.-C.B.) and by the Linkoping University Neurobiology Center (L.H.). L.H. was enrolled in the multidisciplinary graduate school Forum Scientium at Linkoping University.	Andersson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055766; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; BRAND AH, 1993, DEVELOPMENT, V118, P401; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Coker AR, 2000, FEBS LETT, V473, P199, DOI 10.1016/S0014-5793(00)01530-1; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; de Haas CJC, 1999, FEMS IMMUNOL MED MIC, V26, P197, DOI 10.1016/S0928-8244(99)00148-0; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gillmore JD, 1999, NEPHROL DIAL TRANSPL, V14, P2639, DOI 10.1093/ndt/14.11.2639; Girnius S, 2012, AMYLOID, V19, P182, DOI 10.3109/13506129.2012.723074; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Jonson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133272; Kamada Y, 2015, BBA-GEN SUBJECTS, V1850, P1107, DOI 10.1016/j.bbagen.2015.01.018; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Kumita JR, 2012, FASEB J, V26, P192, DOI 10.1096/fj.11-185983; Loewen CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013084; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Nilsberth C, 2001, ARCTIC APP MUTATION, P18; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001	31	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159294	10.1371/journal.pone.0159294	http://dx.doi.org/10.1371/journal.pone.0159294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428539	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300043
J	Caballero, IC; Bates, JM; Hennen, M; Ashley, MV				Caballero, Isabel C.; Bates, John M.; Hennen, Mary; Ashley, Mary V.			Sex in the City: Breeding Behavior of Urban Peregrine Falcons in the Midwestern US	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; NEST-SITE FIDELITY; COMPUTER-PROGRAM; PARENTAL GENOTYPES; PROGENY ARRAYS; DISPERSAL; BIRDS; FERTILIZATIONS; RECONSTRUCTION; POPULATION	Peregrine falcons (Falco peregrinus) were extirpated from most of the continental United States by widespread use of the pesticide DDT in the 1960s. Populations have rebounded with banning of the pesticide and successful implementation of captive breeding and hacking programs. An essentially new population of Midwestern peregrines now exists that is comprised almost entirely of urban-nesting birds. The new population is considered to be of mixed ancestry, occurs at relatively high densities, and has nest sites in close proximity, factors that could influence breeding behaviors including mate fidelity, nest-site fidelity, extrapair paternity, and natal dispersal. We investigated these behaviors using a combination of field observations and DNA microsatellite genotyping. Data for eleven microsatellite DNA markers, including eight newly developed for the species, were analyzed from a total of 350 birds from nine Midwestern cities, representing 149 broods collected at 20 nest sites. To document breeding behavior, parentage was inferred by likelihood techniques when both parents were sampled and by parental genotype reconstruction when only one parent was sampled. In cases where neither parent was sampled, a sibship reconstruction approach was used. We found high mate fidelity and nest-site fidelity in urban peregrines; in 122 nesting attempts made by long-term breeders, only 12 (9.8%) mate changes and six (4.9%) nest-site changes occurred. Only one brood (of 35 tested) revealed extra-pair paternity and involved a male tending two offspring of a recently acquired mate. Natal dispersal patterns indicated that female peregrines dispersed on average 226 km, almost twice the distance of males (average 124 km). Despite the novel environment of cities, our results suggest that monogamous breeding, nest fidelity, and female natal dispersal are high in urban peregrines, not unlike other raptors living in non-urban habitats.	[Caballero, Isabel C.; Ashley, Mary V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Caballero, Isabel C.] Texas A&M Univ, Dept Biol, College Stn, TX USA; [Bates, John M.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL USA; [Hennen, Mary] Field Museum Nat Hist, Gantz Family Collect Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Texas A&M University System; Texas A&M University College Station; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago)	Caballero, IC (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.; Caballero, IC (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX USA.	icabal@tamu.edu		, Isabel/0000-0002-1373-3436	Donald L. Bleitz Award; Dean Amadon Grant; TIOF Grant; Pritzker Foundation; American Ornithologist's Union	Donald L. Bleitz Award; Dean Amadon Grant; TIOF Grant; Pritzker Foundation; American Ornithologist's Union	This work was supported by Donald L. Bleitz Award, American Ornithologist's Union (awarded to ICC) http://americanornithology.org/content/student-postdoctoral-research-awards, the Dean Amadon Grant (awarded to ICC) http://www.raptorresearchfoundation.org/grants-and-awards/grants/dean-amadon-grant, and the TIOF Grant (awarded to ICC) http://www.ospreys.com/styled-4/index.html. This work was completed in partial fulfillment of the requirements for the doctoral degree (to ICC) from the Graduate College, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Microsatellite development by ICC and laboratory work was carried out in the Ashley Laboratory at UIC and the Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. We thank Kevin A. Feldheim for helping in the development of microsatellites. We are grateful to the curators, collections managers, and their institutions that kindly provided materials for this study: David Willard, Field Museum of Natural History, Robert M. Zink and Mike Westberg, Bell Museum of Natural History. Special thanks go to the Chicago Peregrine Program members Matt Gies and Stephanie Ware. This work was supported by Donald L. Bleitz Award, American Ornithologist's Union (awarded to ICC) http://americanornithology.org/content/student-postdoctoral-research-awards, the Dean Amadon Grant (awarded to ICC) http://www.raptorresearchfoundation.org/grants-and-awards/grants/dean-amadon-grant, and the TIOF Grant (awarded to ICC) http://www.ospreys.com/styled-4/index.html. This work was completed in partial fulfillment of the requirements for the doctoral degree (to ICC) from the Graduate College, University of Illinois at Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2005, IBIS, V147, P608, DOI 10.1111/j.1474-919x.2005.00429.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berger DD, 1969, PEREGRINE FALCON POP; Booms TL, 2011, CONDOR, V113, P768, DOI 10.1525/cond.2011.100178; Burnham W, 2003, CONDOR, V105, P327, DOI 10.1650/0010-5422(2003)105[0327:PFEESH]2.0.CO;2; Dennhardt AJ, 2013, J RAPTOR RES, V47, P262; Faccio SD, 2013, J RAPTOR RES, V47, P246; Fuller MR, 1998, J AVIAN BIOL, V29, P433, DOI 10.2307/3677162; Gahbauer MA, 2015, J WILDLIFE MANAGE, V79, P10, DOI 10.1002/jwmg.803; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HICKEY JJ, 1968, SCIENCE, V162, P271, DOI 10.1126/science.162.3850.271; JENKINS JM, 1993, CONDOR, V95, P1053, DOI 10.2307/1369447; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jones AG, 2001, MOL ECOL NOTES, V1, P215, DOI 10.1046/j.1471-8278.2001.00062.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McKay C., 2006, USDI FISH WILDLIFE S, V71, P60563; Mougeot F, 2004, ANIM BEHAV, V67, P1067, DOI 10.1016/j.anbehav.2003.10.011; Negro JJ, 1996, ANIM BEHAV, V51, P935, DOI 10.1006/anbe.1996.0097; Nesje M, 2000, MOL ECOL, V9, P53, DOI 10.1046/j.1365-294x.2000.00834.x; R Core Team, 2021, R LANGUAGE ENV STAT; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Ratcliffe Derek A., 1980, PEREGRINE FALCON; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REDIG P. T., 1999, LOON, V71, P182; Redig PT, 2008, MIDWEST PEREGRINE FA; Redig PT, 2007, MIDWEST PEREGRINE FA; Rejt Lukasz, 2001, Acta Ornithologica (Warsaw), V36, P165; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenfield RN, 2015, J FIELD ORNITHOL, V86, P144, DOI 10.1111/jofo.12097; Rousset F, 1997, GENETICS, V145, P1219; Santure AW, 2009, GENETICS, V181, P259, DOI [10.1534/genetics.108.097998, 10.1534/genetics.108.100214]; SODHI NS, 1991, CONDOR, V93, P433, DOI 10.2307/1368960; Steenhof K, 2009, WILSON J ORNITHOL, V121, P12, DOI 10.1676/07-177.1; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Tordoff H.B., 1993, Loon, V65, P107; Tordoff HB, 1997, J RAPTOR RES, V31, P339; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x; Villarroel M, 1998, ANIM BEHAV, V56, P289, DOI 10.1006/anbe.1998.0788; Wakamiya SM, 2009, BIOL CONSERV, V142, P1767, DOI 10.1016/j.biocon.2009.03.015; WARKENTIN IG, 1994, MOL ECOL, V3, P229, DOI 10.1111/j.1365-294X.1994.tb00056.x; White C. M., 1994, HDB BIRDS WORLD, V2, P216; Zuberogoitia I, 2015, J ZOOL, V296, P6, DOI 10.1111/jzo.12221; Zuberogoitia I, 2009, J ORNITHOL, V150, P95, DOI 10.1007/s10336-008-0321-y	46	9	10	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159054	10.1371/journal.pone.0159054	http://dx.doi.org/10.1371/journal.pone.0159054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420915	Green Submitted, Green Published, gold			2022-12-26	WOS:000379662300008
J	Assaf, D; Amar, E; Marwan, N; Neuman, Y; Salai, M; Rath, E				Assaf, Dan; Amar, Eyal; Marwan, Norbert; Neuman, Yair; Salai, Moshe; Rath, Ehud			Dynamic Patterns of Expertise: The Case of Orthopedic Medical Diagnosis	PLOS ONE			English	Article							RECURRENCE PLOTS; EXPERIENCE; EDUCATION	The aim of this study was to analyze dynamic patterns for scanning femoroacetabular impingement (FAI) radiographs in orthopedics, in order to better understand the nature of expertise in radiography. Seven orthopedics residents with at least two years of expertise and seven board-certified orthopedists participated in the study. The participants were asked to diagnose 15 anteroposterior (AP) pelvis radiographs of 15 surgical patients, diagnosed with FAI syndrome. Eye tracking data were recorded using the SMI desk-mounted tracker and were analyzed using advanced measures and methodologies, mainly recurrence quantification analysis. The expert orthopedists presented a less predictable pattern of scanning the radiographs although there was no difference between experts and non-experts in the deterministic nature of their scan path. In addition, the experts presented a higher percentage of correct areas of focus and more quickly made their first comparison between symmetric regions of the pelvis. We contribute to the understanding of experts' process of diagnosis by showing that experts are qualitatively different from residents in their scanning patterns. The dynamic pattern of scanning that characterizes the experts was found to have a more complex and less predictable signature, meaning that experts' scanning is simultaneously both structured (i.e. deterministic) and unpredictable.	[Assaf, Dan; Amar, Eyal; Salai, Moshe; Rath, Ehud] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Amar, Eyal; Salai, Moshe; Rath, Ehud] Tel Aviv Sourasky Med Ctr, Orthoped Div, 6 Weizmann St, Tel Aviv, Israel; [Marwan, Norbert] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Neuman, Yair] Ben Gurion Univ Negev, Ctr Study Convers & Interreligious Encounters, Homeland Secur Inst, Dept Educ, Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Potsdam Institut fur Klimafolgenforschung; Ben Gurion University	Neuman, Y (corresponding author), Ben Gurion Univ Negev, Ctr Study Convers & Interreligious Encounters, Homeland Secur Inst, Dept Educ, Beer Sheva, Israel.	yneuman@bgu.ac.il	Amar, Eyal/ABF-1838-2020; Rath, Ehud/HDN-1358-2022; Marwan, Norbert/D-9576-2011	Marwan, Norbert/0000-0003-1437-7039				[Anonymous], 2005, TUTORIALS CONT NONLI; Avila GMR, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0623; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Eng J, 2000, AM J ROENTGENOL, V175, P1233, DOI 10.2214/ajr.175.5.1751233; Feldhoff JH, 2012, PHYS LETT A, V376, P3504, DOI 10.1016/j.physleta.2012.10.008; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20052; Gao ZK, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50004; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Leunig M, 2009, CLIN ORTHOP RELAT R, V467, P616, DOI 10.1007/s11999-008-0646-0; Litchfield D, 2010, J EXP PSYCHOL-APPL, V16, P251, DOI 10.1037/a0020082; Manning D, 2006, RADIOGRAPHY, V12, P134, DOI 10.1016/j.radi.2005.02.003; Marwan N, 2004, INT J BIFURCAT CHAOS, V14, P761, DOI 10.1142/S0218127404009454; Marwan N, 2008, EUR PHYS J-SPEC TOP, V164, P3, DOI 10.1140/epjst/e2008-00829-1; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Neuman Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101014; Nodine CF, 2001, RADIOLOGY, V221, P122, DOI 10.1148/radiol.2211001507; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x; Pusic M, 2011, ACAD MED, V86, P731, DOI 10.1097/ACM.0b013e3182178c3c; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; van Beek EJR, 2007, RADIOLOGY, V243, P633, DOI 10.1148/radiol.2433051098; Webber C., 2014, RECURRENCE QUANTIFIC; Webber CL, 2009, PHYS LETT A, V373, P3753, DOI 10.1016/j.physleta.2009.08.052; Zbilut JP, 2002, MED ENG PHYS, V24, P53, DOI 10.1016/S1350-4533(01)00112-6	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158820	10.1371/journal.pone.0158820	http://dx.doi.org/10.1371/journal.pone.0158820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414794	Green Published, gold			2022-12-26	WOS:000379579500042
J	Butler, JM; Field, KE; Maruska, KP				Butler, Julie M.; Field, Karen E.; Maruska, Karen P.			Cobalt Chloride Treatment Used to Ablate the Lateral Line System Also Impairs the Olfactory System in Three Freshwater Fishes	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; AFRICAN CICHLID FISH; RAINBOW-TROUT; MECHANOSENSORY SYSTEM; HAPLOCHROMIS-BURTONI; SPAWNING READINESS; SENSORY BASIS; CRYPT CELLS; TIME-COURSE; COPPER	Fishes use multimodal signals during both inter-and intra-sexual displays to convey information about their sex, reproductive state, and social status. These complex behavioral displays can include visual, auditory, olfactory, tactile, and hydrodynamic signals, and the relative role of each sensory channel in these complex multi-sensory interactions is a common focus of neuroethology. The mechanosensory lateral line system of fishes detects near-body water movements and is implicated in a variety of behaviors including schooling, rheotaxis, social communication, and prey detection. Cobalt chloride is commonly used to chemically ablate lateral line neuromasts, thereby eliminating water-movement cues to test for mechanosensory-mediated behavioral functions. However, cobalt acts as a nonspecific calcium channel antagonist and could potentially disrupt function of all superficially located sensory receptor cells, including those for chemosensing. Here, we examined whether CoCl2 treatment used to ablate the lateral line system also impairs olfaction in three freshwater fishes, the African cichlid fish Astatotilapia burtoni, goldfish Carassius auratus, and the Mexican blind cavefish Astyanax mexicanus. To examine the impact of CoCl2 on the activity of peripheral receptors, we quantified DASPEI fluorescence intensity of the olfactory epithelium from fish exposed to control and CoCl2 solutions. In addition, we examined brain activation in olfactory processing regions of A. burtoni immersed in either control or cobalt solutions. All three species exposed to CoCl2 had decreased DASPEI staining of the olfactory epithelium, and in A. burtoni, cobalt treatment caused reduced neural activation in olfactory processing regions of the brain. To our knowledge this is the first empirical evidence demonstrating that the same CoCl2 treatment used to ablate the lateral line system also impairs olfactory function. These data have important implications for the use of CoCl2 in future research and suggest that previous studies using CoCl2 should be reinterpreted in the context of both impaired mechanoreception and olfaction.	[Butler, Julie M.; Field, Karen E.; Maruska, Karen P.] Louisiana State Univ, Dept Biol Sci, 107 Life Sci Bldg, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Butler, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, 107 Life Sci Bldg, Baton Rouge, LA 70803 USA.	jbutl48@lsu.edu			College of Science and Department of Biological Sciences at Louisiana State University; Louisiana Board of Regents RCS Grant; Powe Faculty Enhancement Award from ORAU; National Science Foundation [IOS-1456004, IOS-1456558]; Louisiana Board of Regents Graduate Fellowship; National Science Foundation Graduate Research Fellowship	College of Science and Department of Biological Sciences at Louisiana State University; Louisiana Board of Regents RCS Grant; Powe Faculty Enhancement Award from ORAU; National Science Foundation(National Science Foundation (NSF)); Louisiana Board of Regents Graduate Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	Support was provided by startup funds from the College of Science and Department of Biological Sciences at Louisiana State University (KPM), Louisiana Board of Regents RCS Grant (KPM; http://www.regents.la.gov/), Powe Faculty Enhancement Award from ORAU (KPM; http://www.orau.org/university-partnership/faculty-studentprograms/powe/), and National Science Foundation (IOS-1456004 and IOS-1456558 to KPM; http://www.nsf.gov/div/index.jsp?div=IOS). JMB was supported by a Louisiana Board of Regents Graduate Fellowship and National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts J. R., 1976, MAMMALIAN OLFACTION, P67; Almeida OG, 2005, CHEM SENSES, V30, pI309, DOI 10.1093/chemse/bjh238; Gayoso JA, 2011, J COMP NEUROL, V519, P247, DOI 10.1002/cne.22518; Appelt CW, 2007, ANIM BEHAV, V74, P1329, DOI 10.1016/j.anbehav.2007.02.032; Appelt Christopher W., 1999, P247; Aronson LR, 1949, AN ANALYSIS OF REPRO; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Barata EN, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-54; Barata EN, 2008, J CHEM ECOL, V34, P438, DOI 10.1007/s10886-008-9458-7; Barata EN, 2008, ANIM BEHAV, V75, P379, DOI 10.1016/j.anbehav.2007.05.018; Barlow GW, 2002, CICHILD FISHES NATUR; Bazaes A, 2012, J EXP BIOL, V215, P1740, DOI 10.1242/jeb.067264; BECERRA M, 1994, J COMP NEUROL, V342, P131, DOI 10.1002/cne.903420112; BEREITERHAHN J, 1976, BIOCHIM BIOPHYS ACTA, V423, P1, DOI 10.1016/0005-2728(76)90096-7; Bireg WJ, 1980, OIL SHAL S SAMPL AN; BLAUSTEIN AR, 1981, AM NAT, V117, P1006, DOI 10.1086/283786; BLECKMANN H, 1991, J COMP PHYSIOL A, V168, P749; Brown AD, 2011, HEARING RES, V272, P1, DOI 10.1016/j.heares.2010.10.014; Brown SB, 1982, CHEMORECEPTION FISHE; Burghardt G. M., 1970, COMMUNICATION CHEM S, P241; Burghardt G.M., 1980, CHEM SIGNALS, P275; Butler JM, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00093; Butler JM, 2015, J EXP BIOL, V218, P3284, DOI 10.1242/jeb.125948; CAPRIO J, 1975, COMP BIOCHEM PHYS A, V52, P247, DOI 10.1016/S0300-9629(75)80160-5; Coffin AB, 2014, J EXP BIOL, V217, P2078, DOI 10.1242/jeb.093831; Coombs S, 1996, J COMP PHYSIOL A, V178, P359; COOMBS S, 1994, J EXP BIOL, V190, P109; Coombs S, 2009, J COMP PHYSIOL A, V195, P279, DOI 10.1007/s00359-008-0405-4; Corrado AP, 1988, ACTA PHYSL LAT AM, V39, P419; Curtis B, 1939, GILL B AMNH, V76; D'Aniello B, 2015, MICROSC RES TECHNIQ, V78, P268, DOI 10.1002/jemt.22471; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Doty R, 2012, MAMMALIAN OLFACTION; DULKA JG, 1987, NATURE, V325, P251, DOI 10.1038/325251a0; DULON D, 1989, J NEUROSCI RES, V24, P338, DOI 10.1002/jnr.490240226; Enger P.S., 1989, P575; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FERNALD RD, 1977, ANIM BEHAV, V25, P643, DOI 10.1016/0003-3472(77)90115-4; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Gerlach G, 2006, ANIM BEHAV, V72, P1119, DOI 10.1016/j.anbehav.2006.03.009; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Grone BP, 2015, J COMP NEUROL, V523, P1125, DOI 10.1002/cne.23729; GuevaraGuzman R, 1997, BRAIN RES BULL, V44, P141, DOI 10.1016/S0361-9230(97)00103-2; Hamdani EH, 2007, PROG NEUROBIOL, V82, P80, DOI 10.1016/j.pneurobio.2007.02.007; Hansen JA, 1999, ENVIRON TOXICOL CHEM, V18, P1979, DOI [10.1897/1551-5028(1999)018&lt;1979:CSOTAR&gt;2.3.CO;2, 10.1002/etc.5620180917]; Hansen JA, 1999, ENVIRON TOXICOL CHEM, V18, P1972, DOI [10.1897/1551-5028(1999)018&lt;1972:DINROC&gt;2.3.CO;2, 10.1002/etc.5620180916]; Hara TJ, 2006, J FISH BIOL, V68, P810, DOI 10.1111/j.1095.8649.2006.00967.x; HARA TJ, 1994, ACTA PHYSIOL SCAND, V152, P207, DOI 10.1111/j.1748-1716.1994.tb09800.x; Hara TJ, 1992, FISH CHEMORECEPTION, P199; Hiermes M, 2015, ANIM COGN, V18, P839, DOI 10.1007/s10071-015-0850-8; Janssen J, 2000, J COMP PHYSIOL A, V186, P957, DOI 10.1007/s003590000148; Julliard AK, 1996, TISSUE CELL, V28, P367, DOI 10.1016/S0040-8166(96)80023-1; KARLSEN HE, 1987, J EXP BIOL, V133, P249; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kermen F, 2014, FRONT NEURAL CIRCUIT; KOTRSCHAL K, 1992, ENVIRON BIOL FISH, V35, P273, DOI 10.1007/BF00001894; Kotrschal K, 2000, PFLUG ARCH EUR J PHY, V439, pR178, DOI 10.1007/s004240000137; Kulpa M, 2015, J EXP BIOL, V218, P1603, DOI 10.1242/jeb.119537; Lamb CF, 2000, FOOD INTAKE IN FISH, P108; Levy F, 2004, HORM BEHAV, V46, P284, DOI 10.1016/j.yhbeh.2004.02.005; Linbo TL, 2006, ENVIRON TOXICOL CHEM, V25, P597, DOI 10.1897/05-241R.1; MACKERETH RW, 1993, CAN J ZOOL, V71, P960, DOI 10.1139/z93-126; Marr JCA, 1998, AQUAT TOXICOL, V43, P225, DOI 10.1016/S0166-445X(98)00061-7; Medina LM, 2013, BEHAV PROCESS, V100, P163, DOI 10.1016/j.beproc.2013.09.007; Maruska KP, 2012, J COMP NEUROL, V520, P3471, DOI 10.1002/cne.23100; Maruska KP, 2012, J EXP BIOL, V215, P68, DOI 10.1242/jeb.062794; McHenry MJ, 2014, SPRINGER HANDB AUDIT, V48, P73, DOI 10.1007/2506_2013_13; Meyers JR, 2003, J NEUROSCI, V23, P4054; Michel William C., 2006, P471; Mirjany M, 2011, J EXP BIOL, V214, P3358, DOI 10.1242/jeb.052894; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Montgomery J, 2014, SPRINGER HANDB AUDIT, V48, P121, DOI 10.1007/2506_2013_17; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; MUNRO AD, 1985, HORM BEHAV, V19, P353, DOI 10.1016/0018-506X(85)90034-0; Oka Y, 1982, CHEMORECEPTION FISHE, P61; Olsen K. Hakan, 1992, Fish and Fisheries Series, V6, P229; PARADELIS AG, 1980, METHOD FIND EXP CLIN, V2, P45; Persson E, 2003, TOXICOL LETT, V145, P19, DOI 10.1016/S0378-4274(03)00266-2; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Pohlmann K, 2004, J EXP BIOL, V207, P2971, DOI 10.1242/jeb.01129; Repass JJ, 2001, HEARING RES, V154, P98, DOI 10.1016/S0378-5955(01)00226-X; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Rosenthal GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016994; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Ruschenbaum S, 2013, ETHOLOGY, V119, P368, DOI 10.1111/eth.12072; SAND O, 1975, J COMP PHYSIOL, V102, P27, DOI 10.1007/BF00657483; Sandahl JF, 2006, CAN J FISH AQUAT SCI, V63, P1840, DOI 10.1139/F06-074; SATOU M, 1994, J COMP PHYSIOL A, V174, P539; SAUCIER D, 1995, COMP BIOCHEM PHYS A, V112, P273, DOI 10.1016/0300-9629(95)00098-4; Schmachtenberg O, 2006, J COMP NEUROL, V495, P113, DOI 10.1002/cne.20847; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Schwalbe MAB, 2016, J EXP BIOL, V219, P1050, DOI 10.1242/jeb.136150; Schwalbe MAB, 2014, ZOOLOGY, V117, P112, DOI 10.1016/j.zool.2013.09.003; Schwalbe MAB, 2012, J EXP BIOL, V215, P2060, DOI 10.1242/jeb.065920; SORENSEN PW, 1992, BIOL BULL, V183, P173, DOI 10.2307/1542420; Stabell Ole B., 1992, Fish and Fisheries Series, V6, P249; Stacey N, 2015, FISH PHEROMONES AND RELATED CUES, P33; Stefansson SO., 2000, P 6 INT S REPR PHYS, P125; Stewart WJ, 2014, J EXP BIOL, V217, P4328, DOI 10.1242/jeb.111773; Stewart WJ, 2013, J EXP BIOL, V216, P388, DOI 10.1242/jeb.072751; STOVNER J, 1960, ACTA PHARMACOL TOX, V16, P235; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Stripling RMB, 1998, RESPONSE MODULATION; Sunderman FW, 2001, ANN CLIN LAB SCI, V31, P3; Tierney KB, 2010, AQUAT TOXICOL, V96, P2, DOI 10.1016/j.aquatox.2009.09.019; TONOSAKI K, 1985, COMP BIOCHEM PHYS C, V80, P361; TYRER NM, 1974, BRAIN RES, V73, P151, DOI 10.1016/0006-8993(74)91014-2; Webb JF, 2014, SPRINGER HANDB AUDIT, V48, P17, DOI 10.1007/2506_2013_12; WEBB JF, 1989, BRAIN BEHAV EVOLUT, V33, P34, DOI 10.1159/000115896; Wenzel B.M., 1971, P432; Whitear Mary, 1992, Fish and Fisheries Series, V6, P103; Yamamoto M., 1982, CHEMORECEPTION FISHE, P39; Yasuoka A, 2009, CHEMOSENSORY SYSTEMS, P97; YOSHII K, 1983, BRAIN RES, V274, P239, DOI 10.1016/0006-8993(83)90701-1; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017; Zeiske E., 1992, FISH CHEMORECEPTION, P13, DOI [10.1007/978-94-011-2332-7_2, DOI 10.1007/978-94-011-2332-7_2]	116	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159521	10.1371/journal.pone.0159521	http://dx.doi.org/10.1371/journal.pone.0159521			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416112	Green Published, gold			2022-12-26	WOS:000379579500134
J	Chen, CC; Lin, MW; Liang, CJ; Wang, SH				Chen, Chin-Chaun; Lin, Ming-Wei; Liang, Chan-Jung; Wang, Shu-Huei			The Anti-Inflammatory Effects and Mechanisms of Eupafolin in Lipopolysaccharide-Induced Inflammatory Responses in RAW264.7 Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; LUNG EPITHELIAL-CELLS; RAW 264.7 MACROPHAGES; NITRIC-OXIDE; SIGNALING PATHWAYS; GENE-EXPRESSION; ACTIVATION; MAPK; L.; NEUROTOXICITY	Eupafolin is a flavone isolated from Artemisia princeps Pampanini (family Asteraceae). The aim of this study was to examine the anti-inflammatory effects of eupafolin in lipopolysaccharide (LPS)-treated RAW264.7 macrophages and LPS-induced mouse skin and lung inflammation models and to identify the mechanism underlying these effects. Eupafolin decreased the LPS-induced release of inflammatory mediators (iNOS, COX-2 and NO) and proinflammatory cytokines (IL-6 and TNF-alpha) from the RAW264.7 macrophages. Eupafolin inhibited the LPS-induced phosphorylation of p38 MAPK, ERK1/2, JNK, AKT and p65 and the nuclear translocation of p65 and c-fos. These effects were mainly mediated by the inhibition of JNK. In the mouse paw and lung models, eupafolin effectively suppressed the LPS-induced edema formation and down-regulated iNOS and COX-2 expression. These results demonstrated that eupafolin exhibits anti-inflammatory properties and suggested that eupafolin can be developed as an anti-inflammatory agent.	[Chen, Chin-Chaun] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Chen, Chin-Chaun] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Chen, Chin-Chaun] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ, CLGR, Kaohsiung, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ Hosp, CLB, Kaohsiung, Taiwan; [Lin, Ming-Wei; Wang, Shu-Huei] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University	Wang, SH (corresponding author), Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan.	shwang@ntu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; WANG, SHU-HUEI/0000-0002-9208-3135	National Science Council [NSC103-2320-B-002-017]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC103-2320-B-002-017).	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Boje KMK, 2004, FRONT BIOSCI-LANDMRK, V9, P763, DOI 10.2741/1268; Boots AW, 2012, BBA-MOL CELL RES, V1823, P1151, DOI 10.1016/j.bbamcr.2012.04.012; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Choudhari AS, 2013, J ETHNOPHARMACOL, V150, P215, DOI 10.1016/j.jep.2013.08.025; Chung KS, 2010, MOL NUTR FOOD RES, V54, P1318, DOI 10.1002/mnfr.200900305; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Faffe DS, 2000, EUR RESPIR J, V15, P85, DOI 10.1183/09031936.00.15108500; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Ha VT, 2014, MEDIAT INFLAMM, V2014, DOI [10.1155/2014/354843, DOI 10.1155/2014/354843]; Hensel A, 2011, J ETHNOPHARMACOL, V138, P641, DOI 10.1016/j.jep.2011.10.002; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim HG, 2007, J ETHNOPHARMACOL, V114, P307, DOI 10.1016/j.jep.2007.08.011; Kim HR, 2015, MOL IMMUNOL, V63, P355, DOI 10.1016/j.molimm.2014.09.003; Ko HH, 2014, J ETHNOPHARMACOL, V151, P386, DOI 10.1016/j.jep.2013.10.054; Koyama S, 1999, EUR RESPIR J, V14, P545, DOI 10.1034/j.1399-3003.1999.14c11.x; Kwon DJ, 2014, BMB REP, V47, P318, DOI 10.5483/BMBRep.2014.47.6.200; Kwon DJ, 2013, FOOD CHEM TOXICOL, V58, P479, DOI 10.1016/j.fct.2013.05.031; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Ma CH, 2015, J ETHNOPHARMACOL, V168, P349, DOI 10.1016/j.jep.2015.03.068; Maas M, 2011, J ETHNOPHARMACOL, V137, P371, DOI 10.1016/j.jep.2011.05.040; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miura K, 2002, J AGR FOOD CHEM, V50, P1845, DOI 10.1021/jf011314o; Park HJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-7; Shi QH, 2014, INT IMMUNOPHARMACOL, V20, P298, DOI 10.1016/j.intimp.2014.04.004; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Sung HC, 2015, J ETHNOPHARMACOL, V170, P136, DOI 10.1016/j.jep.2015.04.058; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253	34	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158662	10.1371/journal.pone.0158662	http://dx.doi.org/10.1371/journal.pone.0158662			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414646	Green Submitted, gold, Green Published			2022-12-26	WOS:000379579500029
J	Czapla, J; Matuszczak, S; Wisniewska, E; Jarosz-Biej, M; Smolarczyk, R; Cichon, T; Glowala-Kosinska, M; Sliwka, J; Garbacz, M; Szczypior, M; Jazwiec, T; Langrzyk, A; Zembala, M; Szala, S				Czapla, Justyna; Matuszczak, Sybilla; Wisniewska, Ewa; Jarosz-Biej, Magdalena; Smolarczyk, Ryszard; Cichon, Tomasz; Glowala-Kosinska, Magdalena; Sliwka, Joanna; Garbacz, Marcin; Szczypior, Mateusz; Jazwiec, Tomasz; Langrzyk, Agnieszka; Zembala, Michal; Szala, Stanislaw			Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice	PLOS ONE			English	Article							STEM-CELLS; BONE-MARROW; STEM/STROMAL CELLS; THERAPY; REPAIR; INTERLEUKIN-6; ANGIOGENESIS; POLARIZATION; HYPERTROPHY; MEDIATE	Aims The aim of the present study was to isolate mesenchymal stromal cells (MSC) with CD105(+)CD34(-) phenotype from human hearts, and to investigate their therapeutic potential in a mouse model of hindlimb ischemia and myocardial infarction (MI). The study aimed also to investigate the feasibility of xenogeneic MSCs implantation. Methods and Results MSC isolated from human hearts were multipotent cells. Separation of MSC with CD105(+)CD34(-) phenotype limited the heterogeneity of the originally isolated cell population. MSC secreted a number of anti-inflammatory and proangiogenic cytokines (mainly IL-6, IL-8, and GRO). Human MSC were transplanted into C57Bl/6NCrl mice. Using the mouse model of hindlimb ischemia it was shown that human MSC treated mice demonstrated a higher capillary density 14 days after injury. It was also presented that MSC administrated into the ischemic muscle facilitated fast wound healing (functional recovery by ischemic limb). MSC transplanted into an infarcted myocardium reduced the post-infarction scar, fibrosis, and increased the number of blood vessels both in the border area, and within the post-infarction scar. The improvement of left ventricular ejection fraction was also observed. Conclusion In two murine models (hindlimb ischemia and MI) we did not observe the xenotransplant rejection. Indeed, we have shown that human cardiac mesenchymal stromal cells with CD105(+)CD34(-) phenotype exhibit therapeutic potential. It seems that M2 macrophages are essential for healing and repair of the post-infarcted heart.	[Czapla, Justyna; Matuszczak, Sybilla; Jarosz-Biej, Magdalena; Smolarczyk, Ryszard; Cichon, Tomasz; Glowala-Kosinska, Magdalena; Langrzyk, Agnieszka; Szala, Stanislaw] Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland; [Czapla, Justyna; Matuszczak, Sybilla; Jarosz-Biej, Magdalena; Smolarczyk, Ryszard; Cichon, Tomasz; Glowala-Kosinska, Magdalena; Langrzyk, Agnieszka; Szala, Stanislaw] Inst Oncol, Gliwice Branch, Gliwice, Poland; [Wisniewska, Ewa; Sliwka, Joanna; Garbacz, Marcin; Szczypior, Mateusz; Jazwiec, Tomasz; Zembala, Michal] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, Zabrze, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Silesian Center for Heart Diseases	Szala, S (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland.; Szala, S (corresponding author), Inst Oncol, Gliwice Branch, Gliwice, Poland.	sszala@io.gliwice.pl	Smolarczyk, Ryszard/AAL-8683-2021; Zembala, Michal/GNP-2971-2022; Jarosz-Biej, Magdalena/AAR-2783-2021; Sliwka, Joanna/HDM-3585-2022	Jarosz-Biej, Magdalena/0000-0003-4023-6782; Sliwka, Joanna/0000-0001-7231-0743; Smolarczyk, Ryszard/0000-0002-1131-289X; Matuszczak, Sybilla/0000-0001-6359-2582; Glowala-Kosinska, Magdalena/0000-0002-6455-7794; Czapla, Justyna/0000-0001-5402-8461; Cichon, Tomasz/0000-0002-3009-7080	Innovative Economy Operational Programme [POIG.01.03.01-00 169/09]; European Regional Development Fund within the framework of Innovative Economy Operational Programme (axis: Investments in Innovative Undertakings); European Regional Development Fund within the framework of Innovative Economy Operational Programme	Innovative Economy Operational Programme; European Regional Development Fund within the framework of Innovative Economy Operational Programme (axis: Investments in Innovative Undertakings); European Regional Development Fund within the framework of Innovative Economy Operational Programme	This work was supported by the Innovative Economy Operational Programme POIG.01.03.01-00 169/09. The study has been co-financed by European Regional Development Fund within the framework of Innovative Economy Operational Programme (axis: Investments in Innovative Undertakings). This work was supported by equipment bought for the purposes of the Project: "Silesian BIO-FARMA. Center for Biotechnology, Bioengineering, and Bioinformatics" cofinanced by European Regional Development Fund within the framework of Innovative Economy Operational Programme 2007-2013.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Ben-Mordechai T, 2013, J AM COLL CARDIOL, V62, P1890, DOI 10.1016/j.jacc.2013.07.057; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Brenes RA, 2012, J VASC SURG, V56, P1669, DOI 10.1016/j.jvs.2012.04.067; Caidahl K, 2010, ARTERIOSCL THROM VAS, V30, P1684, DOI 10.1161/ATVBAHA.110.208843; Chen PW, 2013, INT REV CEL MOL BIO, V301, P1, DOI 10.1016/B978-0-12-407704-1.00001-4; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12; Fredj S, 2005, J CELL PHYSIOL, V204, P428, DOI 10.1002/jcp.20307; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Gao S, 2014, EXP BIOL MED, V239, P366, DOI 10.1177/1535370213518169; GEISER T, 1993, J BIOL CHEM, V268, P15419; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Hoogduijn MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0596-3; Horwitz EM, 2008, CYTOTHERAPY, V10, P771, DOI 10.1080/14653240802618085; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; MacDonald DJ, 2005, J THORAC CARDIOV SUR, V130, P1114, DOI 10.1016/j.jtcvs.2005.04.033; Matuszczak S, 2014, CLIN RES CARDIOL, V103, P711, DOI 10.1007/s00392-014-0705-3; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Qazi BS, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/908468; Rahman MM, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00402; Rossini A, 2011, CARDIOVASC RES, V89, P650, DOI 10.1093/cvr/cvq290; Saito T, 2002, ANN THORAC SURG, V74, P19, DOI 10.1016/S0003-4975(02)03591-9; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Stoff A, 2009, EXP DERMATOL, V18, P362, DOI 10.1111/j.1600-0625.2008.00792.x; Uchibori R, 2014, INT J HEMATOL, V99, P377, DOI 10.1007/s12185-014-1537-7; Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Watt SM, 2013, BRIT MED BULL, V108, P25, DOI 10.1093/bmb/ldt031; Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zheng GP, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/989473	51	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158745	10.1371/journal.pone.0158745	http://dx.doi.org/10.1371/journal.pone.0158745			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415778	gold, Green Published, Green Submitted			2022-12-26	WOS:000379579500035
J	McDougall, C; Woodcroft, BJ; Degnan, BM				McDougall, Carmel; Woodcroft, Ben J.; Degnan, Bernard M.			The Widespread Prevalence and Functional Significance of Silk-Like Structural Proteins in Metazoan Biological Materials	PLOS ONE			English	Article							SPIDER DRAGLINE SILK; SEA-URCHIN; MATRIX PROTEIN; MECHANICAL-PROPERTIES; ORGANIC MATRIX; NACREOUS LAYER; MUSSEL BYSSUS; PEARL OYSTER; BOMBYX-MORI; GENE FAMILY	In nature, numerous mechanisms have evolved by which organisms fabricate biological structures with an impressive array of physical characteristics. Some examples of metazoan biological materials include the highly elastic byssal threads by which bivalves attach themselves to rocks, biomineralized structures that form the skeletons of various animals, and spider silks that are renowned for their exceptional strength and elasticity. The remarkable properties of silks, which are perhaps the best studied biological materials, are the result of the highly repetitive, modular, and biased amino acid composition of the proteins that compose them. Interestingly, similar levels of modularity/repetitiveness and similar bias in amino acid compositions have been reported in proteins that are components of structural materials in other organisms, however the exact nature and extent of this similarity, and its functional and evolutionary relevance, is unknown. Here, we investigate this similarity and use sequence features common to silks and other known structural proteins to develop a bioinformatics-based method to identify similar proteins from large-scale transcriptome and whole-genome datasets. We show that a large number of proteins identified using this method have roles in biological material formation throughout the animal kingdom. Despite the similarity in sequence characteristics, most of the silk-like structural proteins (SLSPs) identified in this study appear to have evolved independently and are restricted to a particular animal lineage. Although the exact function of many of these SLSPs is unknown, the apparent independent evolution of proteins with similar sequence characteristics in divergent lineages suggests that these features are important for the assembly of biological materials. The identification of these characteristics enable the generation of testable hypotheses regarding the mechanisms by which these proteins assemble and direct the construction of biological materials with diverse morphologies. The SilkSlider predictor software developed here is available at https://github.com/wwood/SilkSlider.	[McDougall, Carmel; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Woodcroft, Ben J.] Univ Queensland, Australian Ctr Ecogen, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Degnan, BM (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	b.degnan@uq.edu.au	McDougall, Carmel/G-3512-2010	McDougall, Carmel/0000-0002-2116-5651; Woodcroft, Ben/0000-0003-0670-7480; Degnan, Bernard/0000-0001-7573-8518	Australian Research Council [LP0990280]; BRAEMBL/NCISF in St Lucia, QLD, Australia	Australian Research Council(Australian Research Council); BRAEMBL/NCISF in St Lucia, QLD, Australia	This work was funded by Australian Research Council grant LP0990280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Fred Wilt for kindly providing S. purpuratus material, protocols and helpful advice, William Hatleberg for generating the line art in Fig 2, Felipe Aguilera, Selene Fernandez-Valverde and Marie E. A. Gauthier for bioinformatics assistance, and staff at Heron Island Research Station for assistance with animal maintenance. We acknowledge the support of the BRAEMBL/NCISF in St Lucia, QLD, Australia and the use of the High Performance Computing Cluster "Barrine" to complete this research.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; [Anonymous], 2014, R LANG ENV STAT COMP; Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Beckmann A, 2015, BMC BIOL, V13, DOI 10.1186/s12915-014-0113-1; Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043; Bonnal RJP, 2012, BIOINFORMATICS, V28, P1035, DOI 10.1093/bioinformatics/bts080; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron CB, 2012, P ROY SOC B-BIOL SCI, V279, P3041, DOI 10.1098/rspb.2012.0335; Cao QP, 1997, CURR BIOL, V7, pR677, DOI 10.1016/S0960-9822(06)00353-8; Chang YS, 2002, MOL REPROD DEV, V62, P397, DOI 10.1002/mrd.10125; Chen CM, 2013, BIOINFORMATICS, V29, P2808, DOI 10.1093/bioinformatics/btt484; Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130; Cheng SM, 2010, BIOPHYS J, V99, P3863, DOI 10.1016/j.bpj.2010.10.011; Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830; Craig CL, 2002, COMP BIOCHEM PHYS B, V133, P493, DOI 10.1016/S1096-4959(02)00095-7; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Degens E T, 1976, Top Curr Chem, V64, P1, DOI 10.1007/BFb0045698; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Evans JS, 2012, BIOINFORMATICS, V28, P3182, DOI 10.1093/bioinformatics/bts604; FANG RX, 1991, PLANT MOL BIOL, V17, P1255, DOI 10.1007/BF00028742; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GAGE LP, 1980, J BIOL CHEM, V255, P9444; Goto N, 2010, BIOINFORMATICS, V26, P2617, DOI 10.1093/bioinformatics/btq475; Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HIBNER BL, 1991, GENETICS, V128, P595; Hinman VF, 2000, DEV GENES EVOL, V210, P129, DOI 10.1007/s004270050019; HOHL D, 1991, J BIOL CHEM, V266, P6626; Hronska M, 2004, BIOMACROMOLECULES, V5, P834, DOI 10.1021/bm0343904; Huang XW, 2014, J BIOMED MATER RES B, V102, P1720, DOI 10.1002/jbm.b.33157; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang JS, 2010, P NATL ACAD SCI USA, V107, P18539, DOI 10.1073/pnas.1003256107; IATROU K, 1982, J MOL BIOL, V157, P417, DOI 10.1016/0022-2836(82)90469-7; Iconomidou VA, 2006, J STRUCT BIOL, V156, P480, DOI 10.1016/j.jsb.2006.08.011; Innamorati G, 2006, CELL SIGNAL, V18, P761, DOI 10.1016/j.cellsig.2005.11.004; Ioannidou ZS, 2014, INSECT BIOCHEM MOLEC, V52, P51, DOI 10.1016/j.ibmb.2014.06.004; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jackson D, 2005, MAR BIOL, V147, P681, DOI 10.1007/s00227-005-1603-z; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009; KELLER B, 1988, EMBO J, V7, P3625, DOI 10.1002/j.1460-2075.1988.tb03243.x; Killian CE, 2008, CHEM REV, V108, P4463, DOI 10.1021/cr0782630; Killian CE, 2010, GENE EXPR PATTERNS, V10, P135, DOI 10.1016/j.gep.2010.01.002; Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007; KUNZ W, 1987, NUCLEIC ACIDS RES, V15, P5894, DOI 10.1093/nar/15.14.5894; Liu XJ, 2015, GENE, V555, P217, DOI 10.1016/j.gene.2014.11.006; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Lucas JM, 2002, J EXP BIOL, V205, P1807; Mann K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-249; Mann K, 2010, PROTEOME SCI, V8, DOI [10.1186/1477-5956-8-6, 10.1186/1477-5956-8-33]; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-33; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2013, RECENT ADV PEARL RES; McDougall C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0041; McDougall C, 2011, CELLS TISSUES ORGANS, V194, P103, DOI 10.1159/000324213; MITA K, 1994, J MOL EVOL, V38, P583; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nudelman F, 2008, J STRUCT BIOL, V162, P290, DOI 10.1016/j.jsb.2008.01.008; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Ransick A, 2004, METHOD CELL BIOL, V74, P601; ROBSON P, 1993, J BIOL CHEM, V268, P1440; Rose MLH, 2009, CELL MOL LIFE SCI, V66, P2707, DOI 10.1007/s00018-009-0046-y; Ruangsittichai J, 2006, INT J PARASITOL, V36, P1329, DOI 10.1016/j.ijpara.2006.06.012; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Takahashi J, 2012, GENE, V499, P130, DOI 10.1016/j.gene.2011.11.057; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; WEINER S, 1980, FEBS LETT, V111, P311, DOI 10.1016/0014-5793(80)80817-9; Wilt F, 2013, J STRUCT BIOL, V183, P199, DOI 10.1016/j.jsb.2013.04.001; Woodcroft BJ, 2011, ORF FINDER RB; Woodcroft BJ, 2014, SILKSLIDER; Woodcroft BJ, 2012, GLY SLIDING WINDOW R; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yang YJ, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.19; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200; Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413	97	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159128	10.1371/journal.pone.0159128	http://dx.doi.org/10.1371/journal.pone.0159128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415783	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500083
J	Meehan, CL; Mench, JA; Carlstead, K; Hogan, JN				Meehan, Cheryl L.; Mench, Joy A.; Carlstead, Kathy; Hogan, Jennifer N.			Determining Connections between the Daily Lives of Zoo Elephants and Their Welfare: An Epidemiological Approach	PLOS ONE			English	Article							ANIMAL-WELFARE; BEHAVIOR	Concerns about animal welfare increasingly shape people's views about the acceptability of keeping animals for food production, biomedical research, and in zoos. The field of animal welfare science has developed over the past 50 years as a method of investigating these concerns via research that assesses how living in human-controlled environments influences the behavior, health and affective states of animals. Initially, animal welfare research focused on animals in agricultural settings, but the field has expanded to zoos because good animal welfare is essential to zoos' mission of promoting connections between animals and visitors and raising awareness of conservation issues. A particular challenge for zoos is ensuring good animal welfare for long-lived, highly social species like elephants. Our main goal in conducting an epidemiological study of African (Loxodonta africana) and Asian (Elephas maximus) elephant welfare in 68 accredited North American zoos was to understand the prevalence of welfare indicators in the population and determine the aspects of an elephant's zoo environment, social life and management that are most important to prevent and reduce a variety of welfare problems. In this overview, we provide a summary of the findings of the nine papers in the collection titled: Epidemiological Investigations of North American Zoo Elephant Welfare with a focus on the life history, social, housing, and management factors found to be associated with particular aspects of elephant welfare, including the performance of abnormal behavior, foot and joint problems, recumbence, walking rates, and reproductive health issues. Social and management factors were found to be important for multiple indicators of welfare, while exhibit space was found to be less influential than expected. This body of work results from the largest prospective zoo-based animal welfare study conducted to date and sets in motion the process of using science-based welfare benchmarks to optimize care of zoo elephants.	[Meehan, Cheryl L.; Hogan, Jennifer N.] AWARE Inst, Portland, OR USA; [Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA USA; [Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA USA; [Carlstead, Kathy] Honolulu Zoo Soc, Honolulu, HI USA	University of California System; University of California Davis; University of California System; University of California Davis	Meehan, CL (corresponding author), AWARE Inst, Portland, OR USA.	Cheryl.meehan@aware.institute			Institute of Museum and Library Services [LG-25-10-0033-10]; IMLS; AWARE Institute	Institute of Museum and Library Services; IMLS; AWARE Institute	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Employers provided financial support in the form of authors' salaries as follows: Honolulu Zoo (KC). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, REPORT TECHNICAL COM; Appleby M.C, 2011, ANIMAL WELFARE; Barber JCE, 2009, ELEPHANT ROOM SCI WE; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Botreau R, 2009, ANIM WELFARE, V18, P363; Brown JL, 2004, GEN COMP ENDOCR, V136, P360, DOI 10.1016/j.ygcen.2004.01.013; Brown JL, 2016, PLOS ONE; Carlstead K, 1999, ZOO BIOL, V18, P17, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;17::AID-ZOO4&gt;3.0.CO;2-K; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; CHAMOVE AS, 1988, ZOO BIOL, V7, P359, DOI 10.1002/zoo.1430070407; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Davey G, 2007, J APPL ANIM WELF SCI, V10, P169, DOI 10.1080/10888700701313595; de Silva Shermin, 2011, BMC Ecology, V11, P17, DOI 10.1186/1472-6785-11-17; Fowler M, 2006, BIOL MED SURG ELEPHA; Fraser D, 2011, UNDERSTANDING ANIMAL; Fraser D, 2013, VET J, V198, P19, DOI 10.1016/j.tvjl.2013.06.028; Galindo F., 2011, Animal welfare, P228, DOI 10.1079/9781845936594.0228; Gartner MC, 2013, APPL ANIM BEHAV SCI, V144, P1, DOI 10.1016/j.applanim.2012.11.010; Gosling SD, 2010, PSYCHOL BULL, V127, P54; Grandin T., 2010, IMPROVING ANIMAL WEL; Greco BJ, 2016, PLOS ONE; Harrison R., 1964, ANIMAL MACHINES; Holdgate MR, 2016, PLOS ONE; Hosey G, 2008, APPL ANIM BEHAV SCI, V109, P105, DOI 10.1016/j.applanim.2007.04.013; Hutchins M, 2008, ZOO BIOL, V27, P488, DOI 10.1002/zoo.20167; Mason G., 2008, STEREOTYPIC ANIMAL B; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Meehan CL, 2016, PLOS ONE; Melfi VA, 2009, ZOO BIOL, V28, P574, DOI 10.1002/zoo.20288; Mellor D, 2009, SCI ANIMAL WELFARE; Mench J., 2004, Measuring and auditing broiler welfare, P3, DOI 10.1079/9780851998053.0003; Mench JA, 2016, J ANIM SCI, V94, P1296, DOI 10.2527/jas.2015-9680; Mikota S.K., 1994, W BLOOMFIELD; Mikota SK, 2001, J ZOO WILDLIFE MED, V32, P1, DOI 10.1638/1042-7260(2001)032[0001:EADOMT]2.0.CO;2; Miller MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155223; Millman ST, 2009, J APPL ANIM WELF SCI, V12, P83, DOI 10.1080/10888700902719542; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Morfeld KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155146; Morfeld KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093802; Muller DWH, 2010, AM J VET RES, V71, P275, DOI 10.2460/ajvr.71.3.275; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Prado-Oviedo NA, 2016, PLOS ONE; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Ralph CR, 2016, J ANIM SCI, V94, P457, DOI 10.2527/jas.2015-9645; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Roberts M., 1989, P129; Rushen J, 2003, APPL ANIM BEHAV SCI, V81, P199, DOI 10.1016/S0168-1591(02)00281-2; Ryan SJ, 2001, ZOO BIOL, V20, P89, DOI 10.1002/zoo.1009; Shepherdson D, 2013, APPL ANIM BEHAV SCI, V147, P268, DOI 10.1016/j.applanim.2013.01.001; Shepherdson David, 2010, P62; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; van Keulen-Kromhout G., 1978, International Zoo Yearbook, V18, P177; Walker M., 2014, INT J COMP PSYCHOL, V27, P80, DOI [10.46867/ijcp.2014.27.01.03, DOI 10.46867/IJCP.2014.27.01.03]; Ward SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140237; Ward SJ, 2013, APPL ANIM BEHAV SCI, V147, P179, DOI 10.1016/j.applanim.2013.05.008; Watters JV, 2009, ZOO BIOL, V28, P501, DOI 10.1002/zoo.20287; Weiss A, 2011, BIOL LET        0715; Whitham JC, 2009, ZOO BIOL, V28, P545, DOI 10.1002/zoo.20281; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; Yeates JW, 2008, VET J, V175, P293, DOI 10.1016/j.tvjl.2007.05.009	65	40	43	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158124	10.1371/journal.pone.0158124	http://dx.doi.org/10.1371/journal.pone.0158124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414416	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500016
J	Zhu, WN; Drewes, J; Melcher, D				Zhu, Weina; Drewes, Jan; Melcher, David			Time for Awareness: The Influence of Temporal Properties of the Mask on Continuous Flash Suppression Effectiveness	PLOS ONE			English	Article							THRESHOLD TACTILE STIMULI; MOTION-INDUCED BLINDNESS; INTEROCULAR SUPPRESSION; VISUAL AWARENESS; BINOCULAR-RIVALRY; GLOBAL WORKSPACE; PHASE RESET; THETA-BAND; EEG ALPHA; LOW-LEVEL	Visual processing is not instantaneous, but instead our conscious perception depends on the integration of sensory input over time. In the case of Continuous Flash Suppression (CFS), masks are flashed to one eye, suppressing awareness of stimuli presented to the other eye. One potential explanation of CFS is that it depends, at least in part, on the flashing mask continually interrupting visual processing before the stimulus reaches awareness. We investigated the temporal features of masks in two ways. First, we measured the suppression effectiveness of a wide range of masking frequencies (0-32Hz), using both complex (faces/houses) and simple (closed/open geometric shapes) stimuli. Second, we varied whether the different frequencies were interleaved within blocks or separated in homogenous blocks, in order to see if suppression was stronger or weaker when the frequency remained constant across trials. We found that break-through contrast differed dramatically between masking frequencies, with mask effectiveness following a skewed-normal curve peaking around 6Hz and little or no masking for low and high temporal frequencies. Peak frequency was similar for trial-randomized and block randomized conditions. In terms of type of stimulus, we found no significant difference in peak frequency between the stimulus groups (complex/simple, face/house, closed/open). These findings suggest that temporal factors play a critical role in perceptual awareness, perhaps due to interactions between mask frequency and the time frame of visual processing.	[Zhu, Weina] Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China; [Zhu, Weina; Drewes, Jan; Melcher, David] Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy; [Zhu, Weina] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China	Yunnan University; University of Trento; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhu, WN (corresponding author), Yunnan Univ, Sch Informat Sci, Kunming, Peoples R China.; Zhu, WN (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy.; Zhu, WN (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China.	zhuweina.cn@gmail.com	Melcher, David/D-1775-2010	Melcher, David/0000-0003-0926-585X	European Research Council (ERC) grant [313658]; National Natural Science Foundation of China [61005087, 61263042, 61563056]; Key Science Project of the Department of Education, Yunnan Province, China [2015Z010]; High-level Foreign Expert Grant [GDT20155300084]	European Research Council (ERC) grant(European Research Council (ERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science Project of the Department of Education, Yunnan Province, China; High-level Foreign Expert Grant	This work was supported by a European Research Council (ERC) grant (Grant Agreement No. 313658), the National Natural Science Foundation of China (61005087, 61263042, 61563056), a Key Science Project of the Department of Education, Yunnan Province, China (2015Z010) and a High-level Foreign Expert Grant (GDT20155300084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Aller M, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00016; Alsius A, 2013, PSYCHOL SCI, V24, P423, DOI 10.1177/0956797612457378; Bahrami B, 2008, J VISION, V8, DOI 10.1167/8.3.12; BRADDICK OJ, 1980, PHILOS T ROY SOC B, V290, P137, DOI 10.1098/rstb.1980.0087; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brandt ME, 1997, INT J PSYCHOPHYSIOL, V26, P285, DOI 10.1016/S0167-8760(97)00771-X; Breitmeyer B., 2006, VISUAL MASKING; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Cohen MA, 2015, J COGNITIVE NEUROSCI, V27, P2240, DOI 10.1162/jocn_a_00855; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Drewes J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16290; Dugue L, 2015, P NATL ACAD SCI USA, V112, P15214, DOI 10.1073/pnas.1511331112; Dugue L, 2015, J COGNITIVE NEUROSCI, V27, P945, DOI 10.1162/jocn_a_00755; Enns James T, 2008, Adv Cogn Psychol, V3, P211, DOI 10.2478/v10053-008-0026-z; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fiebelkorn IC, 2013, CURR BIOL, V23, P2553, DOI 10.1016/j.cub.2013.10.063; Fiebelkorn IC, 2011, J NEUROSCI, V31, P9971, DOI 10.1523/JNEUROSCI.1338-11.2011; Fogelson SV, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00601; Gaillard R, 2006, P NATL ACAD SCI USA, V103, P7524, DOI 10.1073/pnas.0600584103; Goodhew SC, 2013, PSYCHON B REV, V20, P859, DOI 10.3758/s13423-013-0400-9; Hamada Y, 2001, CLIN NEUROPHYSIOL, V112, P1326, DOI 10.1016/S1388-2457(01)00542-9; Henry MJ, 2014, P NATL ACAD SCI USA, V111, P14935, DOI 10.1073/pnas.1408741111; Hong SW, 2015, EMOT SCI, V392, DOI [10.3389/fpsyq.2015.00392, DOI 10.3389/FPSYQ.2015.00392]; Huang Y, 2015, J NEUROSCI, V35, P2830, DOI 10.1523/JNEUROSCI.4294-14.2015; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; Kafaligonul H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00279; Kang MS, 2011, J NEUROSCI, V31, P13535, DOI 10.1523/JNEUROSCI.1691-11.2011; Kaunitz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060787; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Kaunitz LN, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00804; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Landau AN, 2012, CURR BIOL, V22, P1000, DOI 10.1016/j.cub.2012.03.054; Levelt JWM, 1965, BINOCULAR RIVALRY; Lin ZC, 2014, PSYCHOL SCI, V25, P296, DOI 10.1177/0956797613504964; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; Loffler G, 2005, VISION RES, V45, P2287, DOI 10.1016/j.visres.2005.02.009; Mach E., 1865, UNTERSUCHUNGEN ZEITS; Mathewson KE, 2012, J COGNITIVE NEUROSCI, V24, P2321, DOI 10.1162/jocn_a_00288; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Meng QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033053; MERZENICH MM, 1993, ANN NY ACAD SCI, V682, P1; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Mitroff SR, 2005, VISION RES, V45, P961, DOI 10.1016/j.visres.2004.09.044; Montaser-Kouhsari L, 2004, PERCEPTION, V33, P249, DOI 10.1068/p5174; Moors P, 2015, I-PERCEPTION, V6, P48, DOI 10.1068/i0678; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; Newman J, 1997, NEURAL NETWORKS, V10, P1195, DOI 10.1016/S0893-6080(97)00060-9; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; Occelli V, 2011, NEUROSCI BIOBEHAV R, V35, P589, DOI 10.1016/j.neubiorev.2010.07.004; OYAMA T, 1983, PSYCHOL RES-PSYCH FO, V45, P303, DOI 10.1007/BF00308709; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poppel E, 2009, PHILOS T R SOC B, V364, P1887, DOI 10.1098/rstb.2009.0015; Smith ML, 2012, CEREB CORTEX, V22, P1748, DOI 10.1093/cercor/bhr250; Smith ML, 2006, P NATL ACAD SCI USA, V103, P5626, DOI 10.1073/pnas.0508972103; Song K, 2014, J NEUROSCI, V34, P4837, DOI 10.1523/JNEUROSCI.4856-13.2014; Stein T, 2016, J EXP PSYCHOL HUMAN, V42, P788, DOI 10.1037/xhp0000188; Stein T, 2012, EMOTION, V12, P988, DOI 10.1037/a0026944; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Sterzer P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00453; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Sterzer P, 2009, NEUROIMAGE, V46, P803, DOI 10.1016/j.neuroimage.2009.02.046; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; VanRullen R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00060; VanRullen R, 2003, TRENDS COGN SCI, V7, P207, DOI 10.1016/S1364-6613(03)00095-0; WALTER WG, 1946, NATURE, V158, P540, DOI 10.1038/158540a0; Wertheimer Max, 1912, EXPT STUDIEN SEHEN B; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Wuhle A, 2011, EUR J NEUROSCI, V34, P641, DOI 10.1111/j.1460-9568.2011.07770.x; Wuhle A, 2010, PSYCHOPHYSIOLOGY, V47, P523, DOI 10.1111/j.1469-8986.2010.00964.x; Wutz A., 2014, J VISION, V14, P584, DOI DOI 10.1167/14.10.584; Wutz A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00952; Wutz A, 2014, J NEUROSCI, V34, P1554, DOI 10.1523/JNEUROSCI.3187-13.2014; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9; Yabe H, 1998, PSYCHOPHYSIOLOGY, V35, P615, DOI 10.1017/S0048577298000183; Yang E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00724; Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	94	28	28	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159206	10.1371/journal.pone.0159206	http://dx.doi.org/10.1371/journal.pone.0159206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416317	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500097
J	Apesteguia, S; Smith, ND; Valieri, RJ; Makovicky, PJ				Apesteguia, Sebastian; Smith, Nathan D.; Juarez Valieri, Ruben; Makovicky, Peter J.			An Unusual New Theropod with a Didactyl Manus from the Upper Cretaceous of Patagonia, Argentina	PLOS ONE			English	Article							MEGARAPTOR-NAMUNHUAIQUII; DINOSAURIA THEROPODA; PRINCIPAL COMPONENTS; BAHARIYA FORMATION; EVOLUTION; OSTEOLOGY; ORIGIN; DIVERSIFICATION; BIOGEOGRAPHY; PHYLOGENY	Background Late Cretaceous terrestrial strata of the Neuquen Basin, northern Patagonia, Argentina have yielded a rich fauna of dinosaurs and other vertebrates. The diversity of saurischian dinosaurs is particularly high, especially in the late Cenomanian-early Turonian Huincul Formation, which has yielded specimens of rebacchisaurid and titanosaurian sauropods, and abelisaurid and carcharodontosaurid theropods. Continued sampling is adding to the known vertebrate diversity of this unit. Methodology/Principal Findings A new, partially articulated mid-sized theropod was found in rocks from the Huincul Formation. It exhibits a unique combination of traits that distinguish it from other known theropods justifying erection of a new taxon, Gualicho shinyae gen. et sp. nov. Gualicho possesses a didactyl manus with the third digit reduced to a metacarpal splint reminiscent of tyrannosaurids, but both phylogenetic and multivariate analyses indicate that didactyly is convergent in these groups. Derived characters of the scapula, femur, and fibula supports the new theropod as the sister taxon of the nearly coeval African theropod Deltadromeus and as a neovenatorid carcharodontosaurian. A number of these features are independently present in ceratosaurs, and Gualicho exhibits an unusual mosaic of ceratosaurian and tetanuran synapomorphies distributed throughout the skeleton. Conclusions/Significance Gualicho shinyae gen. et sp. nov. increases the known theropod diversity of the Huincul Formation and also represents the first likely neovenatorid from this unit. It is the most basal tetatanuran to exhibit common patterns of digit III reduction that evolved independently in a number of other tetanuran lineages. A close relationship with Deltadromaeus from the Kem Kem beds of Niger adds to the already considerable biogeographic similarity between the Huincul Formation and coeval rock units in North Africa.	[Apesteguia, Sebastian] Univ Maimonides, CEBBAD, Area Paleontol, Fdn Hist Nat Felix Azara, Buenos Aires, DF, Argentina; [Smith, Nathan D.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA; [Juarez Valieri, Ruben] Gobierno Prov Rio Negro, Secretaria Cultura, Gen Roca, Argentina; [Makovicky, Peter J.] Field Museum Nat Hist, Integrat Res Ctr, Sect Earth Sci, Chicago, IL 60605 USA	Field Museum of Natural History (Chicago)	Makovicky, PJ (corresponding author), Field Museum Nat Hist, Integrat Res Ctr, Sect Earth Sci, Chicago, IL 60605 USA.	pmakovicky@fieldmuseum.org	Apesteguía, Sebastian/F-4034-2018	Apesteguía, Sebastian/0000-0002-0414-0524	Field Museum of Natural History; US National Science Foundation [EAR 0228607, ANT 0838925, PLR 1246379, EAR 1349554]; Consejo Nacional de Ciencia y Tecnologia; CONICET; Willi Hennig Society; Directorate For Geosciences [1246379] Funding Source: National Science Foundation	Field Museum of Natural History; US National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Willi Hennig Society; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Fieldwork was supported by funding from the Field Museum of Natural History to PJM. PJM and NDS were supported by grants from the US National Science Foundation over the course of this work (EAR 0228607; ANT 0838925; PLR 1246379; and EAR 1349554). SA was supported by the Consejo Nacional de Ciencia y Tecnologia.; We are grateful to Akiko Shinya, Alejandro Otero, Pablo Gallina, Jorge Gonzalez, and Attila Osi for assistance in the field, and to Juan Ignacio Canale and Alejandro Haluza for their assistance and hospitality in El Chocon. Rodolfo Coria, Philip Currie, and Hussam Zaher are thanked for discussions surrounding the provenance and history of excavation and preparation of the specimen. PJM and NDS are grateful to Pablo Chafrat for specimen access. Fieldwork that resulted in the discovery of the holotype of Gualicho shinyae was supported by a generous gift from Michael and Jacqueline Ferro through the Women's Board of The Field Museum. PJM and NDS were supported by grants from the US National Science Foundation over the course of this work (EAR 0228607; ANT 0838925; PLR 1246379; and EAR 1349554). SA was supported by CONICET. A single user copy of TNT used for this research was provided free through the generous support of the Willi Hennig Society. Diego Pol is thanked for his assistance in modifying the 'Term_length' script to include all taxa, and Sushma Reddy is thanked for assistance with R scripting.	Apestegufa S., 2007, 5 REUN ARG ICN 3 REU, P48; Apesteguia S., 2002, B 2 S CRETACIO AM, V6, P135; Azuma Y, 2000, CAN J EARTH SCI, V37, P1735, DOI 10.1139/e00-064; Baumel J.J., 1993, HDB AVIAN ANATOMY NO, P779; Bell MA, 2015, PALAEONTOLOGY, V58, P379, DOI 10.1111/pala.12142; Benson RBJ, 2008, GEOL MAG, V145, P778, DOI 10.1017/S0016756808005475; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Benson RBJ, 2013, PALAEOGEOGR PALAEOCL, V372, P88, DOI 10.1016/j.palaeo.2012.10.028; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Bonaparte JF, 1990, CONTRIB SCI NAT HIST; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Botelho JF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001957; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; BROCHU C. A., 2002, MEMOIR SOC VERTEBRAT, V22, P1; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Burch SH, 2014, J ANAT, V225, P271, DOI 10.1111/joa.12216; Calvo JO, 2004, AMEGHINIANA, V41, P555; Calvo JO, 2004, AMEGHINIANA, V41, P565; Canale J, 2009, NATURWISSENSCHAFTEN, V96, P409, DOI 10.1007/s00114-008-0487-4; Carpenter Kenneth, 2001, P90; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Carrano MT, 2007, J VERTEBR PALEONTOL, V27, P163, DOI 10.1671/0272-4634(2007)27[163:TASOMC]2.0.CO;2; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano Matthew T., 2011, Smithsonian Contributions to Paleobiology, P1; Carrano MT, 2002, J MORPHOL, V253, P207, DOI 10.1002/jmor.10018; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Casal Gabriel A, 2015, Rev. Asoc. Geol. Argent., V72, P77; Catuneanu O, 2006, SEDIMENT GEOL, V190, P121, DOI 10.1016/j.sedgeo.2006.05.010; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Chiarenza AA, 2016, PEERJ, V4, DOI 10.7717/peerj.1754; Chure DJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P283; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; Coria R., 2000, GAIA, V102, P89; Coria RA, 2006, GEODIVERSITAS, V28, P71; Currie Philip J., 2000, Geodiversitas, V22, P207; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; Gallina Pablo A., 2005, Revista del Museo Argentino de Ciencias Naturales, V7, P153; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanson M, 2014, HIST BIOL, V26, P775, DOI 10.1080/08912963.2013.853056; Harris J.D., 1998, B NEW MEXICO MUSEUM, V13, P1; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Lamanna MC, 2002, J VERTEBR PALEONTOL, V22, P58, DOI 10.1671/0272-4634(2002)022[0058:ADATDF]2.0.CO;2; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Carballido JL, 2012, HIST BIOL, V24, P631, DOI 10.1080/08912963.2012.672416; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Novas F.E., 2001, SPECIAL PUBLICATION, V7, P145; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2015, NATURE, V522, P331, DOI 10.1038/nature14307; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Pol D, 2016, REPTILES EXTINTOS VO, V15, P172; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Schweitzer CE, 2003, J PALEONTOL, V77, P888, DOI 10.1666/0022-3360(2003)077<0888:MCDBNA>2.0.CO;2; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Sereno PC, 2008, P ROY SOC LOND B BIO, V271, P1325; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Smith JB, 2006, J PALEONTOL, V80, P1179, DOI 10.1666/0022-3360(2006)80[1179:MOPSOA]2.0.CO;2; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Turner AH, 2004, P ROY SOC B-BIOL SCI, V271, P2003, DOI 10.1098/rspb.2004.2840; Turner AH, 2009, J BIOGEOGR, V36, P612, DOI 10.1111/j.1365-2699.2008.02020.x; Tykoski RS, 2004, DINOSAURIA, 2ND EDITION, P47; Uyeda JC, 2015, SYST BIOL, V64, P677, DOI 10.1093/sysbio/syv019; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; White MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039364; Xu X, 2011, P NATL ACAD SCI USA, V108, P2338, DOI 10.1073/pnas.1011052108; Xu X, 2009, NATURE, V459, P940, DOI 10.1038/nature08124; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108	88	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157793	10.1371/journal.pone.0157793	http://dx.doi.org/10.1371/journal.pone.0157793			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410683	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300012
J	Dening, KH; King, M; Jones, L; Vickestaff, V; Sampson, EL				Dening, Karen Harrison; King, Michael; Jones, Louise; Vickestaff, Victoria; Sampson, Elizabeth L.			Advance Care Planning in Dementia: Do Family Carers Know the Treatment Preferences of People with Early Dementia?	PLOS ONE			English	Article							SURROGATE DECISION-MAKING; OLDER-ADULTS; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; LIFE; SPOUSES; COMPETENCE; CAREGIVERS; EXPERIENCE; PHYSICIANS	Background and Aims When a person with dementia (PWD) has lost the ability to make treatment decisions, clinicians often rely on family carers to know and articulate these preferences with assumed accuracy. This study used the Life Support Preferences Questionnaire (LSPQ) to explore whether family carers' choices show agreement with the end of life care preferences of the person with dementia for whom they care and what factors influence this. Methods A cross-sectional study interviewing 60 dyads (a person with early dementia and preserved capacity and their family carer) each completing a modified LSPQ. We assessed how closely carers' choices resembled the PWD's preferences for treatment in three proposed health states: the here and now; severe stroke with coma; terminal cancer. Agreement between the PWD and their family carer responses was assessed using Kappa and Prevalence- Adjusted Bias-Adjusted Kappa (PABAK) statistics. We examined whether carer burden and distress, and relationship quality, influenced agreement. Results In interviews PWD were able to indicate their treatment preferences across all three scenarios. In the here-and-now most wanted antibiotics (98%), fewer cardio-pulmonary resuscitation (CPR) (50%) and tube feeding (47%). In severe stroke and coma antibiotics remained the more preferred treatment (88%), followed by CPR (57%) and tube feeding (30%). In advanced cancer PWD expressed lower preferences for all treatments (antibiotics 68%; CPR 50%; tube feeding 37%). Carers' choices were similar to the PWDs' preferences in the here-and-now (71%(k = 0.03; PABAK = 0.4) with less agreement for future hypothetical health states. In severe stroke and coma carers tended wrongly to suggest that the PWD preferred more intervention (antibiotic, 67%; k = -0.022; PABAK = -0.60; CPR, 73%; k = 0.20; PABAK = -0.20, tube feeding, 66%; k = 0.25; PABAK = -0.12). In advanced cancer the agreement between PWD and carers was low (antibiotics; k = -0.03; PABAK = -0.52; CPR, k = -0.07; PABAK = -0.45; tube feeding; k = 0.20; PABAK = -0.22). However, both PWD and carers showed marked uncertainty about their preferences for end of life treatment choices. Relationship quality, carer distress and burden had no influence on agreement. Conclusions This study is the first to have used the LSPQ with PWD in the UK to consider treatment options in hypothetical illness scenarios. Key finding are that family carers had a low to moderate agreement with PWD on preferences for end of life treatment. This underscores how planning for care at the end of life is beset with uncertainty, even when the carer and PWD perceive the care-giving/receiving relationship is good. Families affected by dementia may benefit from early and ongoing practical and emotional support to prepare for potential changes and aid decision making in the context of the realities of care towards the end of life.	[Dening, Karen Harrison] Dementia UK, Resource London, Second Floor, London, England; [Jones, Louise; Vickestaff, Victoria; Sampson, Elizabeth L.] UCL, Div Psychiat, Marie Curie Palliat Care Res Dept, 6th Floor,Maple House, London, England; [King, Michael] UCL, Fac Brain Sci, Div Psychiat, Maple House, London, England	University of London; University College London; University of London; University College London	Dening, KH (corresponding author), Dementia UK, Resource London, Second Floor, London, England.	Karen.harrison-dening@dementiauk.org	Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362; Vickerstaff, Victoria/0000-0002-3119-670X	Dementia UK; Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL; Marie Curie [MCCC-FPR-11-U] Funding Source: researchfish	Dementia UK; Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL; Marie Curie(European Commission)	This doctoral research study was supported by Dementia UK and the Marie Curie Palliative Care Research Department, Division of Psychiatry, UCL.	Alzheimer's Society, 2014, DEM 2014 OPP CHANG; Amjad H, 2014, J AM GERIATR SOC, V62, P1304, DOI 10.1111/jgs.12894; Ashton S, 2014, DEMENTIA-LONDON, DOI [10.1177/1471301214548521, DOI 10.1177/1471301214548521]; Ayalon L, 2012, INT PSYCHOGERIATR, V24, P1798, DOI 10.1017/S1041610212000877; Berger JT, 2005, J CLIN ETHIC, V16, P108; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Coppola KM, 1999, DEATH STUD, V23, P617, DOI 10.1080/074811899200803; Davies E, 2004, BETTER PALLIATIVE CA; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Denk CE, 1997, SOC SCI RES, V26, P95, DOI 10.1006/ssre.1996.0587; Department of Health (DH), 2012, PRIM MIN CHALL DEM D; Department of Health (DH), 2009, LIVING WELL DEMENTIA; DH, 2008, END LIF CAR STRAT; Digby R, 2014, COLLEGIAN, V21, P345, DOI 10.1016/j.colegn.2013.08.006; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2067; Fagerlin A, 2001, HEALTH PSYCHOL, V20, P166, DOI 10.1037/0278-6133.20.3.166; Fazel S, 1999, BRIT MED J, V318, P493, DOI 10.1136/bmj.318.7182.493; Fleiss J.L., 2013, STAT METHODS RATES P; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2013, OXFORD TXB OLD AGE P, P389; Gjerdingen DK, 1999, ARCH FAM MED, V8, P421, DOI 10.1001/archfami.8.5.421; Goodman C, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0040-0; Gregory R, 2007, AGE AGEING, V36, P527, DOI 10.1093/ageing/afm104; Hansen L, 2004, J NURS SCHOLARSHIP, V36, P233, DOI 10.1111/j.1547-5069.2004.04043.x; Herbert R., 2000, CANADIAN J AGING, V19, P494, DOI DOI 10.1017/S0714980800012484; HIGH DM, 1994, CLIN GERIATR MED, V10, P445, DOI 10.1016/S0749-0690(18)30332-X; Hirschman KB, 2006, AM J GERIAT PSYCHIAT, V14, P659, DOI 10.1097/01.JGP.0000203179.94036.69; Hughes R, 2002, J ADV NURS, V37, P382, DOI 10.1046/j.1365-2648.2002.02100.x; Huisman M, 2000, QUAL QUANT, V34, P331, DOI 10.1023/A:1004782230065; Jolley N, 1999, LOCKE HIS PHILOS THO; Karlawish JHT, 2000, J AM GERIATR SOC, V48, P1014, DOI 10.1111/j.1532-5415.2000.tb06904.x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kodadek Marie P, 2002, Pediatr Nurs, V28, P333; Livingston G, 2010, BMJ; Lord K, 2015, INT PSYCHOGERIATR, V27, P1301, DOI 10.1017/S1041610215000411; Low JA, 2003, INTERN MED J, V33, P345, DOI 10.1046/j.1445-5994.2003.00367.x; Mezey M, 1996, J AM GERIATR SOC, V44, P144, DOI 10.1111/j.1532-5415.1996.tb02430.x; Mishel M H, 1990, Image J Nurs Sch, V22, P256; Pearlman R A, 2000, J Palliat Med, V3, P37, DOI 10.1089/jpm.2000.3.37; Russ AJ, 2005, CULT MED PSYCHIAT, V29, P103, DOI 10.1007/s11013-005-4625-6; Sampson EL, 2006, AGE AGEING, V35, P187, DOI 10.1093/ageing/afj025; Scandrett KG, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-21; Schellinger S, 2011, J PALLIAT MED, V14, P1224, DOI 10.1089/jpm.2011.0105; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Spruytte N, 2002, PSYCHOL PSYCHOTHER-T, V75, P295, DOI 10.1348/147608302320365208; Sugarman J, 2001, J AM GERIATR SOC, V49, P1110, DOI 10.1046/j.1532-5415.2001.49218.x; Sulsamy DP, 1998, ANN INTERN MED, V128, P621; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; Vig EK, 2007, J GEN INTERN MED, V22, P1274, DOI 10.1007/s11606-007-0252-y; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; Whitlatch C. J., 2009, DEMENTIA-LONDON, V8, P223, DOI [DOI 10.1177/1471301209103259, 10.1177/1471301209103259]; WHO, 2004, PALL CAR OLD PEOPL B; Winter L, 2008, J PALLIAT MED, V11, P1109, DOI 10.1089/jpm.2008.0039; World Health Organization, 1992, ICD 10 INT STAT CLAS; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260	57	56	56	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159056	10.1371/journal.pone.0159056	http://dx.doi.org/10.1371/journal.pone.0159056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27410259	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300054
J	Daly, MC; Atkinson, SJ; Varisco, BM; Klingbeil, L; Hake, P; Lahni, P; Piraino, G; Wu, D; Hogan, SP; Zingarelli, B; Wong, HR				Daly, Meghan C.; Atkinson, Sarah J.; Varisco, Brian M.; Klingbeil, Lindsey; Hake, Paul; Lahni, Patrick; Piraino, Giovanna; Wu, David; Hogan, Simon P.; Zingarelli, Basilia; Wong, Hector R.			Role of matrix metalloproteinase-8 as a mediator of injury in intestinal ischemia and reperfusion	FASEB JOURNAL			English	Article						barrier function; tight junction; collagenase; epithelium; protease	ISCHEMIA/REPERFUSION INJURY; DRUG TARGETS; INFLAMMATION; DISEASE; MICE; INHIBITION; SEPSIS	Acute mesenteric ischemia is associated with high morbidity and mortality. In recent studies, we found that the intestine is an important source of matrix metalloproteinase (MMP)8 during intestinal injury. We hypothesized that genetic ablation or pharmacological inhibition of MMP8 would reduce intestinal injury in mice subjected to intestinal ischemia-reperfusion (I/R) injury. Male mice aged 8-12 wk were subjected to intestinal I/R injury by transient occlusion of the superior mesenteric artery for 30 min. MMP8 was inhibited by genetic and pharmacological approaches. In vivo study endpoints included several functional, histological, and biochemical assays. Intestinal sections were assessed for barrier function and expression of tight junction proteins. I/R injury led to increased intestinal and systemic expression of MMP8. This increase was associated with increased intestinal neutrophil infiltration, epithelial injury, and permeability. I/R injury was associated with increased systemic inflammation and weight loss. These parameters were ameliorated by inhibiting MMP8. I/R injury caused a loss of the tight junction protein claudin-3, which was ameliorated by genetic ablation of MMP8. MMP8 plays an important role in intestinal I/R injury through mechanisms involving increased inflammation and loss of claudin-3. Inhibition of MMP8 is a potential therapeutic strategy in this setting.	[Daly, Meghan C.; Atkinson, Sarah J.; Varisco, Brian M.; Klingbeil, Lindsey; Hake, Paul; Lahni, Patrick; Piraino, Giovanna; Zingarelli, Basilia; Wong, Hector R.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, MLC 2005,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wu, David; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Daly, Meghan C.] Cincinnati Childrens Res Fdn, Cincinnati, OH USA; [Daly, Meghan C.; Atkinson, Sarah J.; Klingbeil, Lindsey] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Varisco, Brian M.; Zingarelli, Basilia; Wong, Hector R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Cincinnati; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, MLC 2005,3333 Burnet Ave, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	, Basilia/AAV-7582-2021	Wong, Hector/0000-0001-7989-1173; Varisco, Brian/0000-0003-0180-2577	U.S. National Institutes of Health National Institute of General Medicine [T32GM008478, R01GM096994]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, R01GM096994] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of General Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by U.S. National Institutes of Health National Institute of General Medicine Grants T32GM008478 and R01GM096994. The authors declare no conflicts of interest.	Ackland G, 2000, CRIT CARE, V4, P269, DOI 10.1186/cc709; Atkinson SJ, 2014, SHOCK, V41, P67; Atkinson SJ, 2016, CRIT CARE MED, V44, pe200, DOI 10.1097/CCM.0000000000001374; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Gobbetti T, 2012, AM J PATHOL, V180, P141, DOI 10.1016/j.ajpath.2011.09.031; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Medina C, 2006, J PHARMACOL EXP THER, V318, P933, DOI 10.1124/jpet.106.103465; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; PATEL A, 1992, SURG CLIN N AM, V72, P31; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Rosario HS, 2004, AM J PATHOL, V164, P1707, DOI 10.1016/S0002-9440(10)63729-7; Solan PD, 2012, CRIT CARE MED, V40, P379, DOI 10.1097/CCM.0b013e318232e404; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Yabluchanskiy A, 2013, CURR DRUG TARGETS, V14, P276	25	11	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3453	3460		10.1096/fj.201600242R	http://dx.doi.org/10.1096/fj.201600242R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27435263	Green Published			2022-12-26	WOS:000384329800016
J	Mezawa, M; Pinto, VI; Kazembe, MP; Lee, WS; McCulloch, CA				Mezawa, Masaru; Pinto, Vanessa I.; Kazembe, Mwayi P.; Lee, Wilson S.; McCulloch, Christopher A.			Filamin A regulates the organization and remodeling of the pericellular collagen matrix	FASEB JOURNAL			English	Article						phagocytosis; matrix metalloproteinases; lysosomes; degradation	FORCE-INDUCED APOPTOSIS; EXTRACELLULAR-MATRIX; PERIODONTAL-LIGAMENT; CELL INVASION; ADHESION; PHAGOCYTOSIS; TURNOVER; TISSUES; PROTEIN; MECHANOTRANSDUCTION	Extracellular matrix remodeling by cell adhesion-related processes is critical for proliferation and tissue homeostasis, but how adhesions and the cytoskeleton interact to organize the pericellular matrix (PCM) is not understood. We examined the role of the actin-binding protein, filamin A (FLNa), in pericellular collagen remodeling. Compared with wild-type (WT), mice with fibroblast-specific deletion of FLNa exhibited higher density but reduced organization of collagen fibers after increased loading of the periodontal ligament for 2 wk. In cultured fibroblasts, FLNa knockdown (KD) did not affect collagen mRNA, but after 24 h of culture, FLNa WT cells exhibited similar to 2-fold higher cell-surface collagen KD cells and 13-fold higher levels of activated beta 1 integrins. In FLNa WT cells, there was 3-fold more colocalization of talin with pericellular cleaved collagen than in FLNa KD cells. MMP-9 mRNA and protein expression were >2-fold higher in FLNa KD cells than in WT cells. Cathepsin B, which is necessary for intracellular collagen digestion, was >3-fold higher in FLNa WT cells than in KD cells. FLNa WT cells exhibited 2-fold more collagen phagocytosis than KD cells, which involved the FLNa actin-binding domain. Evidently, FLNa regulates PCM remodeling through its effects on degradation pathways that affect the abundance and organization of collagen.	[Mezawa, Masaru] Nihon Univ, Dept Periodontol, Sch Dent Matsudo, Matsudo, Chiba, Japan; [Pinto, Vanessa I.; Kazembe, Mwayi P.; Lee, Wilson S.; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Fac Dent, Toronto, ON, Canada	Nihon University; University of Toronto	McCulloch, CA (corresponding author), Univ Toronto, Fitzgerald Bldg,Room 244,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca			Canada Research Chair (Tier 1) in Matrix Dynamics; Canadian Institutes of Health operating grant [MOP-11106]	Canada Research Chair (Tier 1) in Matrix Dynamics(Canada Research Chairs); Canadian Institutes of Health operating grant(Canadian Institutes of Health Research (CIHR))	Christopher McCulloch is supported by a Canada Research Chair (Tier 1) in Matrix Dynamics. The research was supported by a Canadian Institutes of Health operating grant, MOP-11106 (to C.M.). The authors declare no conflicts of interest.	Arora PD, 2013, MOL BIOL CELL, V24, P734, DOI 10.1091/mbc.E12-10-0754; Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Baldassarre M, 2012, J CELL SCI, V125, P3858, DOI 10.1242/jcs.104018; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; BURLEIGH MC, 1974, BIOCHEM J, V137, P387, DOI 10.1042/bj1370387; Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263; Carraher CL, 2013, J BIOL CHEM, V288, P14805, DOI 10.1074/jbc.M112.435271; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gasparski AN, 2015, ARCH BIOCHEM BIOPHYS, V586, P20, DOI 10.1016/j.abb.2015.07.017; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Jeon PD, 1999, AM J ORTHOD DENTOFAC, V115, P267, DOI 10.1016/S0889-5406(99)70328-8; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Klamer S, 2014, CELL ADHES MIGR, V8, P563, DOI 10.4161/19336918.2014.968501; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lee H, 2007, BIOCHEM SOC T, V35, P704, DOI 10.1042/BST0350704; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MELCHER AH, 1981, J ULTRA MOL STRUCT R, V77, P1, DOI 10.1016/S0022-5320(81)80064-0; Mohammad I, 2012, FASEB J, V26, P3260, DOI 10.1096/fj.11-202051; Mohammadi H, 2015, J INVEST DERMATOL, V135, P2852, DOI 10.1038/jid.2015.251; Monslow J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00231; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Navab R, 2016, ONCOGENE, V35, P1899, DOI 10.1038/onc.2015.254; Nazac A, 2015, MICROSC RES TECHNIQ, V78, P723, DOI 10.1002/jemt.22530; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; PERERA KAS, 1981, J ANAT, V133, P359; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Pinto VI, 2014, FASEB J, V28, P453, DOI 10.1096/fj.13-233759; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; RIPPIN JW, 1976, J PERIODONTAL RES, V11, P101, DOI 10.1111/j.1600-0765.1976.tb00057.x; Sardone F, 2014, J CELL PHYSIOL, V229, P878, DOI 10.1002/jcp.24518; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Shifrin Y, 2012, BIOCHEM J, V445, P57, DOI 10.1042/BJ20112119; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; SODEK J, 1977, ARCH ORAL BIOL, V22, P655, DOI 10.1016/0003-9969(77)90095-4; Staudinger LA, 2013, BIOL OPEN, V2, P1148, DOI 10.1242/bio.20135090; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SUGRUE SP, 1981, J CELL BIOL, V91, P45, DOI 10.1083/jcb.91.1.45; TENCATE AR, 1974, ARCH ORAL BIOL, V19, P339; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Vincent TL, 2013, CURR OPIN PHARMACOL, V13, P449, DOI 10.1016/j.coph.2013.01.010; von Nandelstadh P, 2014, MOL BIOL CELL, V25, P2556, DOI 10.1091/mbc.E13-11-0667; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Zhang ZJ, 2015, TISSUE ENG PART B-RE, V21, P267, DOI [10.1089/ten.teb.2014.0286, 10.1089/ten.TEB.2014.0286]; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	63	12	14	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3613	3627		10.1096/fj.201600354RR	http://dx.doi.org/10.1096/fj.201600354RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27407006				2022-12-26	WOS:000384329800029
J	Wang, Y; Zhang, KY; Shi, XC; Wang, C; Wang, F; Fan, JW; Shen, FG; Xu, JC; Bao, WG; Liu, MY; Yu, L				Wang, Yang; Zhang, Kaiyu; Shi, Xiaochen; Wang, Chao; Wang, Feng; Fan, Junwen; Shen, Fengge; Xu, Jiancheng; Bao, Wanguo; Liu, Mingyuan; Yu, Lu			Critical role of bacterial isochorismatase in the autophagic process induced by Acinetobacter baumannii in mammalian cells	FASEB JOURNAL			English	Article						bacteria clearance; septin; pathway	COLORIMETRIC DETERMINATION; PSEUDOMONAS-AERUGINOSA; SIGNALING PATHWAY; IRON ACQUISITION; RECEPTOR NDP52; PROTEIN; TARGET; SALMONELLA; KINASE; AMPK	A recent study reported that Acinetobacter baumannii could induce autophagy, but the recognition and clearance mechanism of intracytosolic A. baumannii in the autophagic process and the molecular mechanism of autophagy induced by the pathogen remains unknown. In this study, we first demonstrated that invading A. baumannii induced a complete, ubiquitin-mediated autophagic response that is dependent upon septins SEPT2 and SEPT9 in mammalian cells. We also demonstrated that autophagy induced by A. baumannii was Beclin-1 dependent via the AMPK/ERK/mammalian target of rapamycin pathway. Of interest, we found that the isochorismatase mutant strain had significantly decreased siderophore-mediated ferric iron acquisition ability and had a reduced the ability to induce autophagy. We verified that isochorismatase was required for the recognition of intracytosolic A. baumannii mediated by septin cages, ubiquitinated proteins, and ubiquitin-binding adaptor proteins p62 and NDP52 in autophagic response. We also confirmed that isochorismatase was required for the clearance of invading A. baumannii by autophagy in vitro and in the mouse model of infection. Together, these findings provide insight into the distinctive recognition and clearance of intracytosolic A. baumannii by autophagy in host cells, and that isochorismatase plays a critical role in the A. baumannii-induced autophagic process.	[Wang, Yang; Zhang, Kaiyu; Shi, Xiaochen; Wang, Chao; Wang, Feng; Shen, Fengge; Bao, Wanguo; Liu, Mingyuan; Yu, Lu] Jilin Univ, Key Lab Zoonosis Res, Minist Med Sci, Dept Infect Dis,Hosp 1,Inst Zoonosis, Changchun, Peoples R China; [Fan, Junwen] Acad Mil Med Sci, Lab Anim Ctr, Beijing, Peoples R China; [Xu, Jiancheng] Jilin Univ, Coll Vet Med & Anim Sci, Changchun, Peoples R China; [Liu, Mingyuan] Jilin Univ, Dept Clin Lab, Hosp 1, Changchun, Peoples R China; [Shen, Fengge; Yu, Lu] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Jilin University; Academy of Military Medical Sciences - China; Jilin University; Jilin University	Yu, L (corresponding author), Jilin Univ, Coll Vet Med, Xian Rd 5333, Changchun 130062, Peoples R China.	yu_lu@jlu.edu.cn		shen, fengge/0000-0001-8814-513X; Wang, Yang/0000-0001-8055-9522	National Nature Science Foundation of China [31172364, 31271951]; fund for Science and Technology Development of Jilin Province [20150101108JC]; Important National Science and Technology Specific Projects [2012ZX10003002]; Program for New Century Excellent Talents in University [NCET-09-0434, NCET-13-0245]; China Postdoctoral Science Foundation [2013M530142]; Fundamental Research Program of Shenzhen [JCYJ20130401172016183, ZDSY20120616141302982]; Shenzhen Science and Technology Research and Development funds [JCYJ20130401173155808]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund for Science and Technology Development of Jilin Province; Important National Science and Technology Specific Projects; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Program of Shenzhen; Shenzhen Science and Technology Research and Development funds	This work was supported by funds form the National Nature Science Foundation of China (31172364 and 31271951), fund for Science and Technology Development of Jilin Province (20150101108JC), the Important National Science and Technology Specific Projects (2012ZX10003002), the Program for New Century Excellent Talents in University (NCET-09-0434; NCET-13-0245), China Postdoctoral Science Foundation (2013M530142), Fundamental Research Program of Shenzhen (JCYJ20130401172016183 and ZDSY20120616141302982), and Shenzhen Science and Technology Research and Development funds (JCYJ20130401173155808). The authors thank Dr. Luis A. Actis (Miami University, Miami, FL, USA) for providing the pMU125 plasmid; Dr. Yoshimori Tamotsu (Research Institute for Microbial Diseases, Osaka University, Japan) for providing plasmids pmRFP-LC3, ptfLC3, and pEGFP-LC3; Dr. Philip N. Rather (Research Service Veterans Affairs Medical Center, Decatur, GA, USA) for providing strains M2 and abaI::Km M2'; and Dr. Paul M. Dunman (University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) for providing strain 98-37-09, ACJ6.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Arnow LE, 1937, J BIOL CHEM, V118, P531; Arroyo DS, 2013, FASEB J, V27, P299, DOI 10.1096/fj.12-214312; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Caruthers J, 2005, PROTEIN SCI, V14, P2887, DOI 10.1110/ps.051783005; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Dauphinee SM, 2014, GENES IMMUN, V15, P282, DOI 10.1038/gene.2014.17; Fiester SE, 2015, INFECT IMMUN, V83, P1354, DOI 10.1128/IAI.02925-14; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Goral Anna M., 2012, Journal of Structural and Functional Genomics, V13, P27, DOI 10.1007/s10969-012-9127-5; Hardie DG, 2011, EMBO J, V30, P634, DOI 10.1038/emboj.2011.12; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirienko NV, 2015, P NATL ACAD SCI USA, V112, P1821, DOI 10.1073/pnas.1424954112; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Li S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003730; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2013, AM J PHYSIOL-LUNG C, V305, pL93, DOI 10.1152/ajplung.00072.2013; NEILANDS JB, 1991, BIOL MET, V4, P1, DOI 10.1007/BF01135550; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ozpolat B, 2015, CANCER MANAG RES, V7, P291, DOI 10.2147/CMAR.S34859; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Qiu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040019; RIOUX C, 1983, ANAL BIOCHEM, V133, P163, DOI 10.1016/0003-2697(83)90238-5; Rumbo C, 2014, INFECT IMMUN, V82, P4666, DOI 10.1128/IAI.02034-14; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13; Tattoli I, 2012, AUTOPHAGY, V8, P1848, DOI 10.4161/auto.21863; Tayabali AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037024; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Wiedemann A, 2012, J BIOL CHEM, V287, P31148, DOI 10.1074/jbc.M112.392134; Yan Q., 2015, BIOPROTOC, V5, DOI [10.21769/bioprotoc.1406, DOI 10.21769/BIOPROTOC.1406]; Yu SW, 2008, MOL CANCER THER, V7, P2609, DOI 10.1158/1535-7163.MCT-07-2400; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	16	20	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3563	3577		10.1096/fj.201500019R	http://dx.doi.org/10.1096/fj.201500019R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27432399	Green Published, hybrid			2022-12-26	WOS:000384329800025
J	Ray, MK; Wiskow, O; King, MJ; Ismail, N; Ergun, A; Wang, YQ; Plys, AJ; Davis, CP; Kathrein, K; Sadreyev, R; Borowsky, ML; Eggan, K; Zon, L; Galloway, JL; Kingston, RE				Ray, Mridula K.; Wiskow, Ole; King, Matthew J.; Ismail, Nidha; Ergun, Ayla; Wang, Yanqun; Plys, Aaron J.; Davis, Christopher P.; Kathrein, Katie; Sadreyev, Ruslan; Borowsky, Mark L.; Eggan, Kevin; Zon, Leonard; Galloway, Jenna L.; Kingston, Robert E.			CAT7 and cat7l Long Non-coding RNAs Tune Polycomb Repressive Complex 1 Function during Human and Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin regulation; development; gene expression; long noncoding RNA (long ncRNA; lncRNA); mammal; polycomb; zebrafish; CsCl density gradient; PRC1	METHYLATED HISTONE H3; GENE-EXPRESSION; PRC2 RECRUITMENT; CHROMATIN; PROTEINS; DATABASE; TRANSCRIPTION; MECHANISMS; REGULATORS; COMPACTION	The essential functions of polycomb repressive complex 1 (PRC1) in development and gene silencing are thought to involve long non-coding RNAs (lncRNAs), but few specific lncRNAs that guide PRC1 activity are known. We screened for lncRNAs, which co-precipitate with PRC1 from chromatin and found candidates that impact polycomb group protein (PcG)-regulated gene expression in vivo. A novel lncRNA from this screen, CAT7, regulates expression and polycomb group binding at the MNX1 locus during early neuronal differentiation. CAT7 contains a unique tandem repeat domain that shares high sequence similarity to a non-syntenic zebrafish analog, cat7l. Defects caused by interference of cat7l RNA during zebrafish embryogenesis were rescued by human CAT7 RNA, enhanced by interference of a PRC1 component, and suppressed by interference of a known PRC1 target gene, demonstrating cat7l genetically interacts with a PRC1. We propose a model whereby PRC1 acts in concert with specific lncRNAs and that CAT7/cat7l represents convergent lncRNAs that independently evolved to tune PRC1 repression at individual loci.	[Ray, Mridula K.; Ergun, Ayla; Wang, Yanqun; Plys, Aaron J.; Davis, Christopher P.; Sadreyev, Ruslan; Borowsky, Mark L.; Kingston, Robert E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Ray, Mridula K.; Wang, Yanqun; Plys, Aaron J.; Davis, Christopher P.; Borowsky, Mark L.; Kingston, Robert E.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Wiskow, Ole; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wiskow, Ole; Eggan, Kevin] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02138 USA; [King, Matthew J.; Ismail, Nidha; Galloway, Jenna L.] Harvard Med Sch, Harvard Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med,Dept Orthopaed Surg, Boston, MA 02114 USA; [Ergun, Ayla; Sadreyev, Ruslan] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; [Kathrein, Katie; Zon, Leonard] Boston Childrens Hosp, Dana Farber Canc Inst, Harvard Stem Cell Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Eggan, Kevin] Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Kingston, RE (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Kingston, RE (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.; Galloway, JL (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med,Dept Orthopaed Surg, Boston, MA 02114 USA.	jenna_galloway@hms.harvard.edu; kingston@molbio.mgh.harvard.edu	Eggan, Kevin/P-7119-2018	Davis, Christopher/0000-0003-0112-9458	National Institutes of Health [RO1-GM043901]; ALS Association; Eunice Kennedy Shriver NICHD, National Institutes of Health [R00HD069533]; Harvard Stem Cell Institute (HSCI); National Research Service Award fellowship from the National Institutes of Health [F32GM109693]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048405, R01GM048405, R01GM043901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Association; Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Harvard Stem Cell Institute (HSCI); National Research Service Award fellowship from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-GM043901 (to R. E. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the ALS Association.; Supported by funding from the Eunice Kennedy Shriver NICHD, National Institutes of Health Grant R00HD069533 and the Harvard Stem Cell Institute (HSCI).; Supported by a National Research Service Award fellowship from the National Institutes of Health (F32GM109693).; Supported by a graduate research fellowship from the National Science Foundation.	Anderson E, 2014, DEVELOPMENT, V141, P3934, DOI 10.1242/dev.108480; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Blum M, 2015, DEV CELL, V35, P145, DOI 10.1016/j.devcel.2015.09.017; Bonnefond A, 2013, DIABETES METAB, V39, P276, DOI 10.1016/j.diabet.2013.02.007; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Chambers SM, 2016, METHODS MOL BIOL, V1307, P329, DOI 10.1007/7651_2013_59; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; He W, 2013, BBA-MOL BASIS DIS, V1832, P1528, DOI 10.1016/j.bbadis.2013.05.010; Head SR, 2011, BIOTECHNIQUES, V50, P177, DOI 10.2144/000113613; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Kaneko S, 2014, GENE DEV, V28, P1983, DOI 10.1101/gad.247940.114; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kochling J, 2001, EUR J HUM GENET, V9, P599, DOI 10.1038/sj.ejhg.5200683; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Nagano T, 2009, MAMM GENOME, V20, P557, DOI 10.1007/s00335-009-9218-1; Nie L, 2012, AM J TRANSL RES, V4, P127; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yang LM, 2011, C IND ELECT APPL, P2011, DOI 10.1109/ICIEA.2011.5975922; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	54	26	28	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19558	19572		10.1074/jbc.M116.730853	http://dx.doi.org/10.1074/jbc.M116.730853			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27405765	hybrid, Green Published			2022-12-26	WOS:000383242800031
J	Bordag, N; Janakiraman, V; Nachtigall, J; Maldonado, SG; Bethan, B; Laine, JP; Fux, E				Bordag, Natalie; Janakiraman, Vijay; Nachtigall, Jonny; Maldonado, Sandra Gonzlez; Bethan, Bianca; Laine, Jean-Philippe; Fux, Elie			Fast Filtration of Bacterial or Mammalian Suspension Cell Cultures for Optimal Metabolomics Results	PLOS ONE			English	Article							SAMPLE PREPARATION; MASS-SPECTROMETRY; STAPHYLOCOCCUS-AUREUS; METABOLISM; YEAST; ADENYLATE; APOPTOSIS; PROTOCOL	The metabolome offers real time detection of the adaptive, multi-parametric response of the organisms to environmental changes, pathophysiological stimuli or genetic modifications and thus rationalizes the optimization of cell cultures in bioprocessing. In bioprocessing the measurement of physiological intracellular metabolite levels is imperative for successful applications. However, a sampling method applicable to all cell types with little to no validation effort which simultaneously offers high recovery rates, high metabolite coverage and sufficient removal of extracellular contaminations is still missing. Here, quenching, centrifugation and fast filtration were compared and fast filtration in combination with a stabilizing washing solution was identified as the most promising sampling method. Different influencing factors such as filter type, vacuum pressure, washing solutions were comprehensively tested. The improved fast filtration method (MxP (R) FastQuench) followed by routine lipid/polar extraction delivers a broad metabolite coverage and recovery reflecting well physiological intracellular metabolite levels for different cell types, such as bacteria (Escherichia coli) as well as mammalian cells chinese hamster ovary (CHO) and mouse myeloma cells (NS0). The proposed MxP (R) FastQuench allows sampling, i.e. separation of cells from medium with washing and quenching, in less than 30 seconds and is robustly designed to be applicable to all cell types. The washing solution contains the carbon source respectively the C-13-labeled carbon source to avoid nutritional stress during sampling. This method is also compatible with automation which would further reduce sampling times and the variability of metabolite profiling data.	[Bordag, Natalie; Nachtigall, Jonny; Maldonado, Sandra Gonzlez; Bethan, Bianca; Fux, Elie] Metanomics GmbH, Berlin, Germany; [Janakiraman, Vijay] Biogen Idec Inc, Raleigh, NC USA; [Laine, Jean-Philippe] Metan Hlth GmbH, Berlin, Germany	Biogen	Fux, E (corresponding author), Metanomics GmbH, Berlin, Germany.	elie.fux@metanomics.de	Bordag, Natalie/M-7957-2013	Bordag, Natalie/0000-0002-9505-6271	Metanomics Health GmbH; metanomics GmbH; Biogen Idec Inc.	Metanomics Health GmbH; metanomics GmbH; Biogen Idec Inc.(Biogen)	The authors received no specific funding for this work. Natalie Bordag, Jonny Nachtigall, Sandra Gonzalez Maldonado, Bianca Bethan and Elie Fux are employed by metanomics GmbH. Vijay Janakiraman is employed by Biogen Idec Inc. Jean-Philippe Laine is employed by Metanomics Health GmbH. metanomics GmbH, Biogen Idec Inc. and Metanomics Health GmbH provided support in the form of salaries for authors Natalie Bordag, Jonny Nachtigall, Sandra Gonzalez Maldonado, Bianca Bethan, Elie Fux, Vijay Janakiraman and Jean-Philippe Laine and also materials, reagents and publication fees but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Balcke G, 2011, METHODS ANAL POLAR M; Balcke GU, 2011, TOXICOL LETT, V203, P200, DOI 10.1016/j.toxlet.2011.03.013; Bolten CJ, 2008, BIOTECHNOL LETT, V30, P1993, DOI 10.1007/s10529-008-9789-z; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; DROBNIS EZ, 1993, J EXP ZOOL, V265, P432, DOI 10.1002/jez.1402650413; Foley G, 2006, J MEMBRANE SCI, V274, P38, DOI 10.1016/j.memsci.2005.12.008; Grossmann K, 2010, WEED SCI, V58, P1, DOI 10.1614/WS-D-09-00004.1; Kamlage B, 2014, CLIN CHEM, V60, P399, DOI 10.1373/clinchem.2013.211979; Kim S, 2013, ANAL CHEM, V85, P2169, DOI 10.1021/ac302881e; Leon Z, 2013, ELECTROPHORESIS, V34, P2762, DOI 10.1002/elps.201200605; Liu X, 2012, BIOTECHNOL LETT, V34, P2275, DOI 10.1007/s10529-012-1030-4; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Ma NN, 2009, BIOTECHNOL PROGR, V25, P1353, DOI 10.1002/btpr.238; Mattes WB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/202497; Mellert W, 2011, TOXICOL LETT, V207, P173, DOI 10.1016/j.toxlet.2011.08.013; Meyer H, 2010, ANAL BIOCHEM, V401, P250, DOI 10.1016/j.ab.2010.03.003; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Padberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085082; Pinheiro J, R PACKAGE VERSION; R Development Core Team, 2014, R LANG ENV STAT COMP; ROTHMAN LB, 1969, BIOCHEMISTRY-US, V8, P3332, DOI 10.1021/bi00836a030; SAEZ MJ, 1976, MOL CELL BIOCHEM, V13, P73, DOI 10.1007/BF01837056; Sellick CA, 2011, BIOTECHNOL BIOENG, V108, P3025, DOI 10.1002/bit.23269; Sellick CA, 2009, ANAL CHEM, V81, P174, DOI 10.1021/ac8016899; Shin MH, 2010, ANAL CHEM, V82, P6660, DOI 10.1021/ac1012656; Singh D, 2013, INT J BIOL SCI, V9, P521, DOI 10.7150/ijbs.4962; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Thevissen K, 2006, MINI-REV MED CHEM, V6, P699, DOI 10.2174/138955706777435643; van Gulik WM, 2010, CURR OPIN BIOTECH, V21, P27, DOI 10.1016/j.copbio.2010.01.008; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; Volmer M, 2011, BIOTECHNOL LETT, V33, P495, DOI 10.1007/s10529-010-0466-7; Vuckovic D, 2012, ANAL BIOANAL CHEM, V403, P1523, DOI 10.1007/s00216-012-6039-y; Walk T. B., 2003, Patent Application, Patent No. [PCT/ EP2003/ 001274, WO2003073464, 2003001274]; Walk T.B., 2003, Mass spectrometry method for analysing mixtures of substances, Patent No. 2003073464; Walk TB, 2003, Patent No. [US7196323 B2, 71962323]; WEIBEL KE, 1974, ANAL BIOCHEM, V58, P208, DOI 10.1016/0003-2697(74)90459-X; WHITFORD W, 2003, BIOPROCESS INT   DEC, P36; Wittmann C, 2004, ANAL BIOCHEM, V327, P135, DOI 10.1016/j.ab.2004.01.002; Wu XH, 2010, BIOTECHNOL J, V5, P75, DOI 10.1002/biot.200900038; Xu YJ, 2014, TRAC-TREND ANAL CHEM, V56, P37, DOI 10.1016/j.trac.2013.12.009	45	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159389	10.1371/journal.pone.0159389	http://dx.doi.org/10.1371/journal.pone.0159389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438065	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100040
J	Kim, S; Feinberg, B; Kant, R; Chui, B; Goldman, K; Park, J; Moses, W; Blaha, C; Iqbal, Z; Chow, C; Wright, N; Fissell, WH; Zydney, A; Roy, S				Kim, Steven; Feinberg, Benjamin; Kant, Rishi; Chui, Benjamin; Goldman, Ken; Park, Jaehyun; Moses, Willieford; Blaha, Charles; Iqbal, Zohora; Chow, Clarence; Wright, Nathan; Fissell, William H.; Zydney, Andrew; Roy, Shuvo			Diffusive Silicon Nanopore Membranes for Hemodialysis Applications	PLOS ONE			English	Article							WEARABLE ARTIFICIAL-KIDNEY; QUALITY-OF-LIFE; HEMOFILTRATION MEMBRANES; PREDICT MORTALITY; DIALYSIS PATIENTS; TRANSPORT; ULTRAFILTRATION; PERFORMANCE; DISEASE; SYSTEMS	Hemodialysis using hollow-fiber membranes provides life-sustaining treatment for nearly 2 million patients worldwide with end stage renal disease (ESRD). However, patients on hemodialysis have worse long-term outcomes compared to kidney transplant or other chronic illnesses. Additionally, the underlying membrane technology of polymer hollow-fiber membranes has not fundamentally changed in over four decades. Therefore, we have proposed a fundamentally different approach using microelectromechanical systems (MEMS) fabrication techniques to create thin-flat sheets of silicon-based membranes for implantable or portable hemodialysis applications. The silicon nanopore membranes (SNM) have biomimetic slit-pore geometry and uniform pores size distribution that allow for exceptional permeability and selectivity. A quantitative diffusion model identified structural limits to diffusive solute transport and motivated a new microfabrication technique to create SNM with enhanced diffusive transport. We performed in vitro testing and extracorporeal testing in pigs on prototype membranes with an effective surface area of 2.52 cm(2) and 2.02 cm(2), respectively. The diffusive clearance was a two-fold improvement in with the new microfabrication technique and was consistent with our mathematical model. These results establish the feasibility of using SNM for hemodialysis applications with additional scale-up.	[Kim, Steven] Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; [Feinberg, Benjamin; Kant, Rishi; Park, Jaehyun; Blaha, Charles; Iqbal, Zohora; Chow, Clarence; Wright, Nathan; Roy, Shuvo] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Chui, Benjamin] Ben Chui Consulting, Sunnyvale, CA USA; [Goldman, Ken] H Cubed, Olmsted Falls, OH USA; [Moses, Willieford] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Blaha, Charles; Wright, Nathan; Fissell, William H.; Roy, Shuvo] Silicon Kidney LLC, San Francisco, CA 94122 USA; [Fissell, William H.] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Nashville, TN USA; [Zydney, Andrew] Penn State Univ, Dept Chem Engn, State Coll, PA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Roy, S (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Roy, S (corresponding author), Silicon Kidney LLC, San Francisco, CA 94122 USA.	Shuvo.roy@ucsf.edu		Fissell, William/0000-0002-3960-3998	American Society of Nephrology Ben J. Lipps Research Fellowship; National Institute of Diabetes, and Digestive, and Kidney Diseases of the National Institutes of Health [F32 DK103468]; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R01 EB014315, U01EB021214]; Wildwood Foundation; John and Marcia Goldman Foundation; H-Cubed; Ben Chui Consulting; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021214, R01EB014315] Funding Source: NIH RePORTER	American Society of Nephrology Ben J. Lipps Research Fellowship; National Institute of Diabetes, and Digestive, and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Wildwood Foundation; John and Marcia Goldman Foundation; H-Cubed; Ben Chui Consulting; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the American Society of Nephrology Ben J. Lipps Research Fellowship, National Institute of Diabetes, and Digestive, and Kidney Diseases of the National Institutes of Health under the Award Number F32 DK103468, National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under Award Numbers R01 EB014315 and U01EB021214, Wildwood Foundation and the John and Marcia Goldman Foundation. The funders, H-Cubed and Ben Chui Consulting, provided support in the form of salaries for authors BC and KG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, FRESENIUS OPTIFLUX D; Buoncristiani U, 1998, NEPHROL DIAL TRANSPL, V13, P148, DOI 10.1093/ndt/13.suppl_6.148; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; Conlisk AT, 2009, ANN BIOMED ENG, V37, P722, DOI 10.1007/s10439-009-9642-0; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Daugirdas JT, 2012, KIDNEY INT, V82, P147, DOI 10.1038/ki.2012.130; Daugirdas JT., 2007, HDB DIALYSIS; Dechadilok P, 2006, IND ENG CHEM RES, V45, P6953, DOI 10.1021/ie051387n; Del Vecchio L, 2011, SEMIN DIALYSIS, V24, P56, DOI 10.1111/j.1525-139X.2010.00819.x; Finkelstein FO, 2012, KIDNEY INT, V82, P561, DOI 10.1038/ki.2012.168; Fissell WH, 2006, ASAIO J, V52, P221, DOI 10.1097/01.mat.0000205228.30516.9c; Fissell WH, 2009, J MEMBRANE SCI, V326, P58, DOI 10.1016/j.memsci.2008.09.039; Gura V, 2009, CLIN J AM SOC NEPHRO, V4, P1441, DOI 10.2215/CJN.02790409; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Johnson DG, 2013, ADV CHRONIC KIDNEY D, V20, P508, DOI 10.1053/j.ackd.2013.08.001; Kanani DM, 2010, J MEMBRANE SCI, V349, P405, DOI 10.1016/j.memsci.2009.12.003; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Kim S, 2013, ADV CHRONIC KIDNEY D, V20, P516, DOI 10.1053/j.ackd.2013.08.006; Kimmel PL, 2000, KIDNEY INT, V57, P2093, DOI 10.1046/j.1523-1755.2000.00059.x; Langsdorf LJ, 1994, TRANSPORT PROPERTIES; Lee DBN, 2008, CLIN EXP NEPHROL, V12, P171, DOI 10.1007/s10157-008-0050-9; LI L, 2010, J BIOMATER SCI POLYM; Muthusubramaniam L, 2011, ANN BIOMED ENG, V39, P1296, DOI 10.1007/s10439-011-0256-y; OPONG WS, 1991, AICHE J, V37, P1497, DOI 10.1002/aic.690371007; Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d; Popat KC, 2004, BIOSENS BIOELECTRON, V19, P1037, DOI 10.1016/j.bios.2003.10.007; PORTER MC, 1972, IND ENG CHEM PROD RD, V11, P234, DOI 10.1021/i360043a002; Randoux C, 2001, KIDNEY INT, V60, P1571, DOI 10.1046/j.1523-1755.2001.00970.x; Ronco C, 2001, BLOOD PURIFICAT, V19, P347, DOI 10.1159/000046964; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Smith RA, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/4/045802; Twardowski ZJ, 2008, HEMODIAL INT, V12, P173, DOI 10.1111/j.1542-4758.2008.00253.x; Tzamaloukas AH, 1998, KIDNEY INT, V53, P1405, DOI 10.1046/j.1523-1755.1998.00896.x; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; US Department of Health and Human Services, 2013, OPTN DAT ORG PROC TR; Zhu JM, 2006, BIOMACROMOLECULES, V7, P1036, DOI 10.1021/bm050611p	37	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159526	10.1371/journal.pone.0159526	http://dx.doi.org/10.1371/journal.pone.0159526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438878	Green Published, gold			2022-12-26	WOS:000380170100053
J	Segev, A; Curtis, D; Jung, S; Chae, S				Segev, Aviv; Curtis, Dorothy; Jung, Sukhwan; Chae, Suhyun			Invisible Brain: Knowledge in Research Works and Neuron Activity	PLOS ONE			English	Article							DYNAMICS; CALCIUM; INTERNET; SYNCHRONIZATION; POPULATION; NETWORKS; SYSTEMS	If the market has an invisible hand, does knowledge creation and representation have an "invisible brain"? While knowledge is viewed as a product of neuron activity in the brain, can we identify knowledge that is outside the brain but reflects the activity of neurons in the brain? This work suggests that the patterns of neuron activity in the brain can be seen in the representation of knowledge-related activity. Here we show that the neuron activity mechanism seems to represent much of the knowledge learned in the past decades based on published articles, in what can be viewed as an "invisible brain" or collective hidden neural networks. Similar results appear when analyzing knowledge activity in patents. Our work also tries to characterize knowledge increase as neuron network activity growth. The results propose that knowledge-related activity can be seen outside of the neuron activity mechanism. Consequently, knowledge might exist as an independent mechanism.	[Segev, Aviv; Jung, Sukhwan; Chae, Suhyun] Korea Adv Inst Sci & Technol, Grad Sch Knowledge Serv Engn, 291 Daehak Ro, Daejeon, South Korea; [Segev, Aviv] Korea Adv Inst Sci & Technol, Sch Comp, 291 Daehak Ro, Taejon 305701, South Korea; [Curtis, Dorothy] MIT, CSAIL, 32 Vassar St, Cambridge, MA 02139 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Massachusetts Institute of Technology (MIT)	Segev, A (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Knowledge Serv Engn, 291 Daehak Ro, Daejeon, South Korea.; Segev, A (corresponding author), Korea Adv Inst Sci & Technol, Sch Comp, 291 Daehak Ro, Taejon 305701, South Korea.	aviv@kaist.edu	Segev, Aviv/C-2060-2011		IT R&D program of MSIP/KEIT [10044494]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2016R1A2B4011694]	IT R&D program of MSIP/KEIT; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the IT R&D program of MSIP/KEIT [10044494, WiseKB: Big data based self-evolving knowledge base and reasoning platform]. It was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) 2016R1A2B4011694.	Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Aggarwal C, 2014, ACM COMPUT SURV, V47, DOI 10.1145/2601412; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; [Anonymous], 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150467; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Battaglia D, 2013, PLOS COMPUTATIONAL B, V8, P1; Berger-Wolf TY, 2006, P 12 ACM SIGKDD INT, P523, DOI [10.1145/1150402.1150462, DOI 10.1145/1150402.1150462]; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Dal Maschio M, 2012, ADV EXP MED BIOL, V740, P83, DOI 10.1007/978-94-007-2888-2_4; Dayan P., 2005, THEORETICAL NEUROSCI; De Carlos JA, 2007, BRAIN RES REV, V55, P8, DOI 10.1016/j.brainresrev.2007.03.010; Dowdy S., 1983, STAT RES; Eckmann JP, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015011; Eppler Jochen Martin, 2008, Front Neuroinform, V2, P12, DOI 10.3389/neuro.11.012.2008; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fodor J. A, 2001, MIND DOESNT WORK WAY; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gewaltig MO, NEST NEURAL SIMULATI; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; HOLLAND PW, 1971, COMP GROUP STUD, V2, P107, DOI 10.1177/104649647100200201; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jowett Benjamin, 2008, THEAETETUS; Jung S, 2014, KNOWL-BASED SYST, V69, P34, DOI 10.1016/j.knosys.2014.04.036; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Leal B, 2010, INTERNET OF THINGS-BOOK, P3, DOI 10.1007/978-1-4419-1674-7_1; MacKay D. J. C., 2003, INFORM THEORY INFERE; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Orlandi JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098842; Plato, 2008, TIMAEUS; Ruan Y., 2013, WWW, P1089, DOI 10.1145/2488388.2488483; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Smith Adam, 1761, THEORY MORAL SENTIME; Song T, 2013, INFORM SCIENCES, V219, P197, DOI 10.1016/j.ins.2012.07.023; Steinmetz PN, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056019; Stetter O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002653; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0158590	10.1371/journal.pone.0158590	http://dx.doi.org/10.1371/journal.pone.0158590			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27439199	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100014
J	Van Acker, H; Gielis, J; Acke, M; Cools, F; Cos, P; Coenye, T				Van Acker, Heleen; Gielis, Jan; Acke, Marloes; Cools, Freya; Cos, Paul; Coenye, Tom			The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria	PLOS ONE			English	Article							OXIDATIVE STRESS; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; CIPROFLOXACIN; RESISTANCE; CEFTAZIDIME; INVOLVEMENT; MECHANISMS; BIOFILM	It was recently proposed that bactericidal antibiotics, besides through specific drug-target interactions, kill bacteria by a common mechanism involving the production of reactive oxygen species (ROS). However, this mechanism involving the production of hydroxyl radicals has become the subject of a lot of debate. Since the contribution of ROS to antibiotic mediated killing most likely depends on the conditions, differences in experimental procedures are expected to be at the basis of the conflicting results. In the present study different methods (ROS specific stainings, gene-expression analyses, electron paramagnetic resonance, genetic and phenotypic experiments, detection of protein carbonylation and DNA oxidation) to measure the production of ROS upon antibiotic treatment in Burkholderia cepacia complex (Bcc) bacteria were compared. Different classes of antibiotics (tobramycin, ciprofloxacin, meropenem) were included, and both planktonic and biofilm cultures were studied. Our results indicate that some of the methods investigated were not sensitive enough to measure antibiotic induced production of ROS, including the spectrophotometric detection of protein carbonylation. Secondly, other methods were found to be useful only in specific conditions. For example, an increase in the expression of OxyR was measured in Burkholderia cenocepacia K56-2 after treatment with ciprofloxacin or meropenem (both in biofilms and planktonic cultures) but not after treatment with tobramycin. In addition results vary with the experimental conditions and the species tested. Nevertheless our data strongly suggest that ROS contribute to antibiotic mediated killing in Bcc species and that enhancing ROS production or interfering with the protection against ROS may form a novel strategy to improve antibiotic treatment.	[Van Acker, Heleen; Acke, Marloes; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium; [Gielis, Jan] Univ Antwerp, Antwerp Surg Training & Anat Res Ctr, Dept Thorac Surg, Antwerp, Belgium; [Gielis, Jan; Cools, Freya; Cos, Paul] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium	Ghent University; University of Antwerp	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, Ghent, Belgium.	Tom.coenye@ugent.be	Cos, Paul/L-9717-2015; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; cos, paul/AAU-3896-2020	Cos, Paul/0000-0003-4361-8911; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; cos, paul/0000-0003-4361-8911; Cools, Freya/0000-0003-1891-4102	FWO-Vlaanderen	FWO-Vlaanderen(FWO)	This work was financially supported by FWO-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by FWO-Vlaanderen. We thank prof. Miguel Valvano for providing us with the B. cenocepacia K56-2 oxyR::lux fusion strain, B. cenocepacia C524 and the B. cenocepacia MDL2 mutant strain, prof. Giovanni Riccardi for the B. cenocepacia triple quorum sensing deletion mutant.	Aiassa V, 2010, BIOCHEM BIOPH RES CO, V393, P84, DOI 10.1016/j.bbrc.2010.01.083; Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; Battan PC, 2004, LUMINESCENCE, V19, P265, DOI 10.1002/bio.779; Cardona ST, 2006, APPL ENVIRON MICROB, V72, P2547, DOI 10.1128/AEM.72.4.2547-2555.2006; Dhamdhere G, 2010, ANTIMICROB AGENTS CH, V54, P5366, DOI 10.1128/AAC.00719-10; Dridi B, 2015, ANTIMICROB AGENTS CH; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; El-Halfawy OM, 2014, ANTIMICROB AGENTS CH, V58, P4162, DOI 10.1128/AAC.02649-14; EUCAST, 2003, CLIN MICROBIOL INFEC, V6, P509; Fang FC, 2013, NAT BIOTECHNOL, V31, P415, DOI 10.1038/nbt.2574; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gielis JF, 2015, EUR J CARDIO-THORAC, V48, P622, DOI 10.1093/ejcts/ezu518; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; IMLAY JA, 1991, FREE RADICAL RES COM, V12-3, P59, DOI 10.3109/10715769109145768; Imlay JA, 2015, CURR OPIN MICROBIOL, V24, P124, DOI 10.1016/j.mib.2015.01.004; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kolodkin-Gal I, 2008, PLOS BIOL, V6, P2774, DOI 10.1371/journal.pbio.0060319; Paez PL, 2010, FUND CLIN PHARMACOL, V24, P771, DOI 10.1111/j.1472-8206.2009.00806.x; Lefebre MD, 2005, MICROBIOL-SGM, V151, P1975, DOI 10.1099/mic.0.27704-0; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Paulander W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092231; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Tavernier S, 2015, PEERJ, V3, DOI 10.7717/peerj.787; Thomas VC, 2013, MBIO, V4, DOI 10.1128/mBio.00437-13; Udine C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055112; Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943; Wang JH, 2014, ANTIMICROB AGENTS CH, V58, P5964, DOI 10.1128/AAC.03683-14; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Wang Y, 2015, APPL ENVIRON MICROB, V81, P6393, DOI 10.1128/AEM.01199-15; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Wright GD, 2013, NAT MED, V19, P544, DOI 10.1038/nm.3198	39	50	52	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159837	10.1371/journal.pone.0159837	http://dx.doi.org/10.1371/journal.pone.0159837			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438061	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100077
J	Qin, XL; Zheng, HP; Xue, YH; Ren, XQ; Yang, B; Huang, JM; Huang, SJ; Wu, XZ; Zeng, WY; Ou, JL; Lan, YY; Tang, SM				Qin, Xiaolin; Zheng, Heping; Xue, Yaohua; Ren, Xuqi; Yang, Bin; Huang, Jinmei; Huang, Shujie; Wu, Xingzhong; Zeng, Weiying; Ou, Jiangli; Lan, Yinyuan; Tang, Sanmei			Prevalence of Chlamydia trachomatis Genotypes in Men Who Have Sex with Men and Men Who Have Sex with Women Using Multilocus VNTR Analysis-ompA Typing in Guangzhou, China	PLOS ONE			English	Article							INFECTION	Background Chlamydia trachomatis is one of the most prevalent bacterial sexually transmitted infection in China. Although C. trachomatis genotypes can be discriminated by outer membrane protein gene (ompA) sequencing, currently available methods have limited resolutions. This study used a high-resolution genotypingmethod, namely, multilocus variable number tandem-repeat analysis with ompA sequencing (MLVA)-ompA, to investigate the local epidemiology of C. trachomatis infections among men who have sex with men (MSM) and men who have sex with women (MSW) attending a sexually transmitted diseases (STD) clinic in Guangzhou, China. Methods Rectal specimens from MSM and urethral specimens from MSW were collected between January 2013 and July 2014 at the Guangdong Provincial Center STD clinic. The specimens were sent to the laboratory for analyses. All specimens that were tested positive for C. trachomatis by the commercial nucleic acid amplification tests were genotyped by MLVA-ompA. Results Fifty-one rectal specimens from MSM and 96 urethral specimens from MSW were identified with C. trachomatis. One hundred and forty-four of the 147 specimens were fully genotyped by MLVA-ompA. Rectal specimens from MSM were divided into four ompA genotypes and urethral specimens from MSW into nine genotypes. No mixed infections were found among all specimens. The most frequent genotypes were D, G, J, E and F. All specimens were further divided into 46 types after ompA genotyping was combined with MLVA. Genotypes D-8.7.1 and G-3.4a.3 were the most frequent among MSM, whereas genotypes D-3.4a.4, E-8.5.1, F-8.5.1, and J-3.4a.2 were the most frequent subtypes among MSW. The discriminatory index D was 0.90 for MLVA, 0.85 for ompA, and 0.95 for MLVA-ompA. Conclusions The most prevalent MLVA-ompA genotypes were significantly different between MSM and MSW from Guangzhou, China. Moreover, MLVA-ompA represented a more favorable degree of discrimination than ompA and could be a reliable complement for ompA for the routine subtypes of C. trachomatis.	[Qin, Xiaolin; Zheng, Heping; Xue, Yaohua; Ren, Xuqi; Yang, Bin; Huang, Jinmei; Huang, Shujie; Wu, Xingzhong; Zeng, Weiying; Ou, Jiangli; Lan, Yinyuan; Tang, Sanmei] Guangdong Prov Ctr Skin Dis & STIs Control & Prev, Guangzhou, Guangdong, Peoples R China; [Xue, Yaohua] Southern Med Univ, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Zheng, HP (corresponding author), Guangdong Prov Ctr Skin Dis & STIs Control & Prev, Guangzhou, Guangdong, Peoples R China.	zhhpf@hotmail.com	Ren, Xu-Qi/GRX-4131-2022		Medical Science and Technology Research Fundation of Guangdong Province [B2013050]; Guangdong Province Science Funds [2013B021800169]; Natural Science Foundation of Guangdong Province [2015A030313895]	Medical Science and Technology Research Fundation of Guangdong Province; Guangdong Province Science Funds; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the Medical Science and Technology Research Fundation of Guangdong Province (No. B2013050), Guangdong Province Science Funds (No. 2013B021800169), and the Natural Science Foundation of Guangdong Province (No. 2015A030313895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bom RJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053869; Bom RJ, 2011, J CLIN MICROBIOL; Chen L, 2015, MED IMAGE ANAL, V23, P1, DOI 10.1016/j.media.2015.03.004; Chen XS, 2013, LANCET INFECT DIS, V13, P13, DOI 10.1016/S1473-3099(12)70298-0; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Han Y, 2013, JPN J INFECT DIS, V66, P69, DOI 10.7883/yoken.66.69; Hong X., 2014, J DIAGN THER DERMATO, V21, P65, DOI 10.3969/j.issn.1674-8468.2014.01.023; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Klint M, 2006, J CLIN MICROBIOL, V44, P4066, DOI 10.1128/JCM.00574-06; Labiran C, 2015, SEXUALLY TRANSMITTED; Labiran C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00068; Li JH, 2011, JPN J INFECT DIS, V64, P143; Liu JJ, 2014, UROLOGY, V83, P795, DOI 10.1016/j.urology.2013.11.009; Marrazzo J, 2014, F1000PRIME REPORTS, V6; Mejuto P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002330; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Peuchant O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031538; Satoh M, 2014, J INFECT CHEMOTHER, V20, P656, DOI 10.1016/j.jiac.2014.06.010; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971; Yang B, 2010, JPN J INFECT DIS, V63, P342	23	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159658	10.1371/journal.pone.0159658	http://dx.doi.org/10.1371/journal.pone.0159658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434536	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600080
J	Rodriguez-Nieves, JA; Patalano, SC; Almanza, D; Gharaee-Kermani, M; Macoska, JA				Rodriguez-Nieves, Jose A.; Patalano, Susan C.; Almanza, Diego; Gharaee-Kermani, Mehrnaz; Macoska, Jill A.			CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; URINARY-TRACT SYMPTOMS; UP-REGULATING CXCR4; SURGICAL THERAPY; LUNG FIBROBLASTS; TISSUE-REPAIR; TGF-BETA; HYPERPLASIA; EXPRESSION; DISEASE	Benign prostate hyperplasia (BPH), an enlargement of the prostate common in aging in men, is associated with urinary voiding dysfunction manifest as Lower Urinary Tract Symptoms (LUTS). Although inflammation and abnormal smooth muscle contractions are known to play key roles in the development of LUTS, tissue fibrosis may also be an important and previously unrecognized contributing factor. Tissue fibrosis arises from the unregulated differentiation of fibroblasts or other precursor cell types into myofibroblasts, which is usually accomplished by activation of the TGF beta/TGF beta R axis. Previously we reported that the CXC-type chemokines, CXCL5, CXCL8 and CXCL12, which are up-regulated in the aging in the prostate, can drive this differentiation process as well in the absence of TGF beta. Based on this data we sought to elucidate the molecular mechanisms employed by CXCL12, and its receptor CXCR4, during prostate myofibroblast phenoconversion. The results of these studies suggest that CXCL12/CXCR4-mediated signaling events in prostate myofibroblast phenoconversion may proceed through non-canonical pathways that do not depend on TGF beta/TGF beta R axis activation or Smad signaling. Here we report that CXCL12/CXCR4 axis activation promotes signaling through the EGFR and downstream MEK/ERK and PI3K/A kappa t pathways during myofibroblast phenoconversion, but not through TGF beta/TGF beta R and downstream Smad signaling, in prostate fibroblasts undergoing myofibroblast phenoconversion. We document that EGFR transactivation is required for CXCL12-mediated signaling and expression of genes associate with myofibroblast phenoconversion (alpha-SMA, COL1a1). Our study successfully identified TGF beta/TGF beta R-independent molecular mechanisms that promote CXCL12/CXCR4-induced myofibroblast phenoconversion. This information may be crucial for the development of novel therapies and potential biomarkers for prostatic fibrosis.	[Macoska, Jill A.] Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA; Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Macoska, JA (corresponding author), Univ Massachusetts, Ctr Personalized Canc Therapy, Boston, MA 02125 USA.	Jill.Macoska@umb.edu		Almanza, Diego/0000-0003-1222-9366	National Institute of Diabetes and Digestive and Kidney Diseases [U54104310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R25GM076321] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases U54104310 to JAM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Bautista OM, 2003, CONTROL CLIN TRIALS, V24, P224, DOI 10.1016/S0197-2456(02)00263-5; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Begley LA, 2008, CYTOKINE, V43, P194, DOI 10.1016/j.cyto.2008.05.012; Chen S, 2005, IMMUNOLOGY, V114, P565, DOI 10.1111/j.1365-2567.2004.02110.x; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Dincses E, 2015, EUR J GASTROEN HEPAT, V27, P1149, DOI 10.1097/MEG.0000000000000409; Feng YF, 2014, MOL CELL BIOCHEM, V397, P131, DOI 10.1007/s11010-014-2180-6; Franitza S, 2002, EUR J IMMUNOL, V32, P193, DOI 10.1002/1521-4141(200201)32:1<193::AID-IMMU193>3.0.CO;2-H; Gharaee-Kermani M, 2014, AM J PATHOL, V184, P732, DOI 10.1016/j.ajpath.2013.11.024; Gharaee-Kermani M, 2013, CURR UROL REP, V14, P628, DOI 10.1007/s11934-013-0368-z; Gharaee-Kermani M, 2013, PROSTATE, V73, P1123, DOI 10.1002/pros.22662; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; GUESS HA, 1992, EPIDEMIOL REV, V14, P131, DOI 10.1093/oxfordjournals.epirev.a036083; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2013, PERIODONTOL 2000, V63, P14, DOI 10.1111/prd.12030; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V141, P467, DOI 10.1111/j.1365-2249.2005.02852.x; Kasabova M, 2014, J BIOL CHEM, V289, P16239, DOI 10.1074/jbc.M113.542407; Kasina S, 2009, CELL PROLIFERAT, V42, P799, DOI 10.1111/j.1365-2184.2009.00645.x; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Laborde Eric E, 2009, Rev Urol, V11, pS19; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Malaeb BS, 2012, UROLOGY, V79, P1111, DOI 10.1016/j.urology.2011.11.084; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; St Sauver Jennifer L, 2008, Curr Prostate Rep, V6, P67, DOI 10.1007/s11918-008-0011-5; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu XH, 2008, J UROLOGY, V180, P241, DOI 10.1016/j.juro.2008.03.039	38	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159490	10.1371/journal.pone.0159490	http://dx.doi.org/10.1371/journal.pone.0159490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434301	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600056
J	Ito, S; Murphy, CG; Doubrovina, E; Jasin, M; Moynahan, ME				Ito, Shuhei; Murphy, Conleth G.; Doubrovina, Ekaterina; Jasin, Maria; Moynahan, Mary Ellen			PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells	PLOS ONE			English	Article							SISTER-CHROMATID EXCHANGES; HOMOLOGY-DIRECTED REPAIR; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE; BLOOMS-SYNDROME; CHROMOSOME STABILITY; RECOMBINATION; MUTATION; CANCER; BRCA1	Poly(ADP-ribose) polymerases (PARPs) are the first proteins involved in cellular DNA repair pathways to be targeted by specific inhibitors for clinical benefit. Tumors harboring genetic defects in homologous recombination (HR), a DNA double-strand break (DSB) repair pathway, are hypersensitive to PARP inhibitors (PARPi). Early phase clinical trials with PARPi have been promising in patients with advanced BRCA1 or BRCA2-associated breast, ovary and prostate cancer and have led to limited approval for treatment of BRCA-deficient ovary cancer. Unlike HR-defective cells, HR-proficient cells manifest very low cytotoxicity when exposed to PARPi, although they mount a DNA damage response. However, the genotoxic effects on normal human cells when agents including PARPi disturb proficient cellular repair processes have not been substantially investigated. We quantified cytogenetic alterations of human cells, including primary lymphoid cells and non-tumorigenic and tumorigenic epithelial cell lines, exposed to PARPi at clinically relevant doses by both sister chromatid exchange (SCE) assays and chromosome spreading. As expected, both olaparib and veliparib effectively inhibited poly-ADP-ribosylation (PAR), and caused marked hypersensitivity in HR-deficient cells. Significant dose- dependent increases in SCEs were observed in normal and non-tumorigenic cells with minimal residual PAR activity. Clinically relevant doses of the FDA-approved olaparib led to a marked increase of SCEs (5-10-fold) and chromatid aberrations (2-6-fold). Furthermore, olaparib potentiated SCE induction by cisplatin in normal human cells. Our data have important implications for therapies with regard to sustained genotoxicity to normal cells. Genomic instability arising from PARPi warrants consideration, especially if these agents will be used in people with early stage cancers, in prevention strategies or for non-oncologic indications.	[Ito, Shuhei; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10021 USA; [Murphy, Conleth G.; Moynahan, Mary Ellen] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Doubrovina, Ekaterina] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Ito, Shuhei] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka, Japan; [Murphy, Conleth G.] Bon Secours Hosp, Dept Med Oncol, Cork, Ireland	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Kyushu University	Moynahan, ME (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	moynaham@mskcc.org			Hecksher Foundation for Children (MEM); National Institutes for Health [P01CA94060]; Memorial Sloan Kettering Cancer Center [P30 CA008748]; Sumitomo Life Social Welfare Services Foundation; Uehara Memorial Foundation; Fukuoka Foundation for Sound Health Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Hecksher Foundation for Children (MEM); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center; Sumitomo Life Social Welfare Services Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Fukuoka Foundation for Sound Health Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Hecksher Foundation for Children (MEM), National Institutes for Health grants P01CA94060 (MEM and MJ), The Memorial Sloan Kettering Cancer Center Support/CoreGrant (P30 CA008748), Sumitomo Life Social Welfare Services Foundation (SI), The Uehara Memorial Foundation (SI) and Fukuoka Foundation for Sound Health Cancer Research Fund (SI). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, ONCOLOGIC DRUGS ADVI; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Barker JN, 2010, BLOOD, V116, P5045, DOI 10.1182/blood-2010-04-281873; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; CARRANO AV, 1978, NATURE, V271, P551, DOI 10.1038/271551a0; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; De Soto JA, 2006, INT J BIOL SCI, V2, P179; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gallmeier E, 2005, CANCER BIOL THER, V4, P703, DOI 10.4161/cbt.4.7.1909; GERMAN J, 1977, AM J HUM GENET, V29, P248; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Haikarainen T, 2014, ACS MED CHEM LETT, V5, P18, DOI 10.1021/ml400292s; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; KATO H, 1974, NATURE, V251, P70, DOI 10.1038/251070a0; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; LANGLOIS RG, 1989, P NATL ACAD SCI USA, V86, P670, DOI 10.1073/pnas.86.2.670; LaRocque JR, 2011, P NATL ACAD SCI USA, V108, P11971, DOI 10.1073/pnas.1104421108; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Livraghi L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0425-1; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Masutani M, 1999, MOL CELL BIOCHEM, V193, P149; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Morimatsu M, 1998, CANCER RES, V58, P3441; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 2001, CANCER RES, V61, P4842; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neumann R, 2010, P NATL ACAD SCI USA, V107, P8304, DOI 10.1073/pnas.1003634107; NISHI Y, 1984, CANCER RES, V44, P3270; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; She QB, 2003, CLIN CANCER RES, V9, P4340; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Tentori L, 2002, CANCER CHEMOTH PHARM, V49, P217, DOI 10.1007/s00280-001-0409-z; Tong WM, 2007, ONCOGENE, V26, P3857, DOI 10.1038/sj.onc.1210156; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Westermark UK, 2003, MOL CELL BIOL, V23, P7926, DOI 10.1128/MCB.23.21.7926-7936.2003; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	53	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159341	10.1371/journal.pone.0159341	http://dx.doi.org/10.1371/journal.pone.0159341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428646	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300053
J	Yue, QX; Zhen, H; Huang, M; Zheng, X; Feng, LX; Jiang, BH; Yang, M; Wu, WY; Liu, X; Guo, D				Yue, Qingxi; Zhen, Hong; Huang, Ming; Zheng, Xi; Feng, Lixing; Jiang, Baohong; Yang, Min; Wu, Wanying; Liu, Xuan; Guo, Dean			Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells	PLOS ONE			English	Article							NA+/K+-ATPASE; HEPATOCELLULAR-CARCINOMA; CARDIAC-GLYCOSIDES; TOAD VENOM; CARDIOTONIC STEROIDS; GLIOBLASTOMA CELLS; CANCER-TREATMENT; CYCLE ARREST; LUNG-CANCER; APOPTOSIS	Although the possibility of developing cardiac steroids/ cardiac glycosides as novel cancer therapeutic agents has been recognized, the mechanism of their anticancer activity is still not clear enough. Toad venom extract containing bufadienolides, which belong to cardiac steroids, has actually long been used as traditional Chinese medicine in clinic for cancer therapy in China. The cytotoxicity of arenobufagin, a bufadienolide isolated from toad venom, on human cervical carcinoma HeLa cells was checked. And, the protein expression profile of control HeLa cells and HeLa cells treated with arenobufagin for 48 h was analyzed using two-dimensional electrophoresis, respectively. Differently expressed proteins in HeLa cells treated with arenobufagin were identified and the pathways related to these proteins were mapped from KEGG database. Computational molecular docking was performed to verify the binding of arenobufagin and Na, K-ATPase. The effects of arenobufagin on Na, K-ATPase activity and proteasome activity of HeLa cells were checked. The protein-protein interaction network between Na, K-ATPase and proteasome was constructed and the expression of possible intermediate proteins ataxin-1 and translationally-controlled tumor protein in HeLa cells treated with arenobufagin was then checked. Arenobufagin induced apoptosis and G2/M cell cycle arrest in HeLa cells. The cytotoxic effect of arenobufagin was associated with 25 differently expressed proteins including proteasome-related proteins, calcium ion binding-related proteins, oxidative stress-related proteins, metabolism-related enzymes and others. The results of computational molecular docking revealed that arenobufagin was bound in the cavity formed by the transmembrane alpha subunits of Na, K-ATPase, which blocked the pathway of extracellular Na+/K+ cation exchange and inhibited the function of ion exchange. Arenobufagin inhibited the activity of Na, K-ATPase and proteasome, decreased the expression of Na, K-ATPase alpha 1 and alpha 3 subunits and increased the expression of WEE1 in HeLa cells. Antibodies against Na, K-ATPase alpha 1 and alpha 3 subunits alone or combinated with arenobufagin also inhibited the activity of proteasome. Furthermore, the expression of the possible intermediate proteins ataxin-1 and translationally-controlled tumor protein was increased in HeLa cells treated with arenobufagin by flow cytometry analysis, respectively. These results indicated that arenobufagin might directly bind with Na, K-ATPase alpha 1 and alpha 3 subunits and the inhibitive effect of arenobufagin on proteasomal activity of HeLa cells might be related to its binding with Na, K-ATPase.	[Yue, Qingxi; Zhen, Hong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst Oncol, Shanghai 201999, Peoples R China; [Yue, Qingxi; Feng, Lixing; Jiang, Baohong; Yang, Min; Wu, Wanying; Liu, Xuan; Guo, Dean] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 201203, Peoples R China; [Huang, Ming] Rutgers State Univ, Ctr Integrat Prote Res, BioMaPS Inst, Piscataway, NJ 08854 USA; [Huang, Ming] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Zheng, Xi] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Yue, QX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst Oncol, Shanghai 201999, Peoples R China.; Yue, QX; Liu, X; Guo, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 201203, Peoples R China.	qxyue@sibs.ac.cn; xuanliu@simm.ac.cn; daguo@simm.ac.cn	zhou, ju/M-3255-2017; Liu, Xuan/AAR-5093-2020	Liu, Xuan/0000-0002-7356-7898	Twelfth Five-Year National Science & Technology Support Program [2012BAI29B06]; Shanghai Science & Technology Support Program [13431900401]; China Postdoctoral Science Foundation funded project [2012M510907]; Shanghai Postdoctoral Scientific Program [13R21417800]; Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP516]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program; National Nature Science Foundation [81302809, 81373964]; Research Program of Shanghai Municipal Commission of Health and Family Planning [20154Y0149]; grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University;  [syzrc2014-001];  [syz2014-005];  [YG2015MS24]	Twelfth Five-Year National Science & Technology Support Program; Shanghai Science & Technology Support Program; China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Shanghai Postdoctoral Scientific Program; Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Research Program of Shanghai Municipal Commission of Health and Family Planning; grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University; ; ; 	This work was supported in part by grants from the Twelfth Five-Year National Science & Technology Support Program (2012BAI29B06), Shanghai Science & Technology Support Program (13431900401), China Postdoctoral Science Foundation funded project (2012M510907), Shanghai Postdoctoral Scientific Program (13R21417800), the Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP516), the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program, the National Nature Science Foundation (81302809, 81373964), the Research Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0149), the fund (syzrc2014-001, syz2014-005, YG2015MS24) and the grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University. The authors would like to thank Scientific Creation (Shanghai) Bio-Tech Co. Limited for technology support and helpful advice.; This work was supported in part by grants from the Twelfth Five-Year National Science & Technology Support Program (2012BAI29B06), Shanghai Science & Technology Support Program (13431900401), China Postdoctoral Science Foundation funded project (2012M510907), Shanghai Postdoctoral Scientific Program (13R21417800), the Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2012KIP516), the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program, the National Nature Science Foundation (81302809, 81373964), the Research Program of Shanghai Municipal Commission of Health and Family Planning (20154Y0149), the fund (syzrc2014-001, syz2014-005, YG2015MS24) and the grant constructed multi-disciplinary team for oncology in No. 3 People's Hospital, School of Medicine, Shanghai Jiaotong University. We would like to thank Scientific Creation(Shanghai) Bio-Tech Co. Limited for technology support and helpful advice.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Adams J, 1999, CANCER RES, V59, P2615; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babula P, 2013, ANTI-CANCER AGENT ME, V13, P1069, DOI 10.2174/18715206113139990304; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Cerella C, 2013, MITOCHONDRION, V13, P225, DOI 10.1016/j.mito.2012.06.003; Chen AL, 2009, BIOTECHNOL LETT, V31, P487, DOI 10.1007/s10529-008-9888-x; Chen DD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-716; Chen Z, 2012, CHIN J INTEGR MED, V18, P339, DOI 10.1007/s11655-012-1083-1; Contreras RG, 1999, J CELL SCI, V112, P4223; CRUZ JD, 1994, EUR J PHARM-MOLEC PH, V266, P317; CRUZ JD, 1993, EUR J PHARMACOL, V239, P223; de Chiara C, 2014, TRENDS NEUROSCI, V37, P211, DOI 10.1016/j.tins.2014.02.003; de Pril R, 2007, MOL CELL NEUROSCI, V34, P10, DOI 10.1016/j.mcn.2006.09.006; Deng LJ, 2015, ONCOTARGET, V6, P34258, DOI 10.18632/oncotarget.5545; Dou QP, 1999, DRUG RESIST UPDATE, V2, P215, DOI 10.1054/drup.1999.0095; Durlacher CT, 2015, CLIN EXP PHARMACOL P, V42, P427, DOI 10.1111/1440-1681.12385; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Feng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.222; Forrest MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051169; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gomes A, 2010, INDIAN J EXP BIOL, V48, P93; Hashimoto O, 2003, MOL CARCINOGEN, V36, P171, DOI 10.1002/mc.10111; Jaitovich AA, 2006, SEMIN NEPHROL, V26, P386, DOI 10.1016/j.semnephrol.2006.07.002; JING YK, 1994, ANTICANCER RES, V14, P1193; Juel C, 2013, AM J PHYSIOL-REG I, V304, pR1161, DOI 10.1152/ajpregu.00591.2012; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lagalwar Sarita, 2013, Methods Mol Biol, V1010, P201, DOI 10.1007/978-1-62703-411-1_13; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee DY, 1996, LIFE SCI, V60, P127, DOI 10.1016/S0024-3205(96)00602-9; Lefranc F, 2008, NEUROSURGERY, V62, P211, DOI 10.1227/01.NEU.0000311080.43024.0E; Li D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141681; Li MM, 2012, BIOCHEM PHARMACOL, V83, P1251, DOI 10.1016/j.bcp.2012.01.023; Liu X, 1999, MOL BRAIN RES, V71, P210, DOI 10.1016/S0169-328X(99)00186-2; Lopez-Lazaro M, 2007, EXPERT OPIN THER TAR, V11, P1043, DOI 10.1517/14728222.11.8.1043; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Mijatovic T, 2012, CURR MED CHEM, V19, P627, DOI 10.2174/092986712798992075; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; N'Diaye EN, 2008, MOL BIOL CELL, V19, P1252, DOI 10.1091/mbc.E07-08-0775; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Paul D, 2014, J NEUROL SCI, V340, P139, DOI 10.1016/j.jns.2014.03.012; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Cordova WHP, 2016, TOXICON, V110, P27, DOI 10.1016/j.toxicon.2015.11.015; Piccioni F, 2004, HUM MOL GENET, V13, P437, DOI 10.1093/hmg/ddh045; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Qi FH, 2011, INT IMMUNOPHARMACOL, V11, P342, DOI 10.1016/j.intimp.2010.12.007; Qin TJ, 2008, WORLD J GASTROENTERO, V14, P5210, DOI 10.3748/wjg.14.5210; Qiu J, 2008, BBA-PROTEINS PROTEOM, V1784, P1857, DOI 10.1016/j.bbapap.2008.07.006; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; Sakai H, 2004, FEBS LETT, V563, P151, DOI 10.1016/S0014-5793(04)00292-3; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; Sun T, 2014, BIOSCI TRENDS, V8, P235, DOI 10.5582/bst.2014.01073; Sunol M, 2011, ANTICANCER RES, V31, P953; TANAHASHI N, 1993, ENZYME PROTEIN, V47, P241, DOI 10.1159/000468683; Tian J, 2003, MOL CELL BIOCHEM, V242, P181, DOI 10.1023/A:1021114501561; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Webster KA, 2012, FUTUR CARDIOL, V8, P863, DOI [10.2217/FCA.12.58, 10.2217/fca.12.58]; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Wu T, 2014, J CANCER RES THER, V10, P60, DOI 10.4103/0973-1482.139763; Xie XF, 2013, MED HYPOTHESES, V81, P243, DOI 10.1016/j.mehy.2013.04.038; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Ye M, 2006, J CHROMATOGR B, V838, P86, DOI 10.1016/j.jchromb.2006.04.042; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Yin JQ, 2007, ACTA PHARMACOL SIN, V28, P712, DOI 10.1111/j.1745-7254.2007.00559.x; Yu SP, 2003, BIOCHEM PHARMACOL, V66, P1601, DOI 10.1016/S0006-2952(03)00531-8; Yue QX, 2010, PHYTOMEDICINE, V17, P606, DOI 10.1016/j.phymed.2009.12.013; Yue QX, 2008, CANCER SCI, V99, P1461, DOI 10.1111/j.1349-7006.2008.00824.x; Yue QX, 2008, MOL CELL PROTEOMICS, V7, P949, DOI 10.1074/mcp.M700259-MCP200; Yue QX, 2012, J ETHNOPHARMACOL, V141, P659, DOI 10.1016/j.jep.2011.08.044; Yue QX, 2016, MOL CELL PROTEOMICS, V15, P26, DOI 10.1074/mcp.M115.053272; Zhang DW, 2009, J NEUROSCI, V29, P4498, DOI 10.1523/JNEUROSCI.6094-08.2009; Zhang DM, 2013, CARCINOGENESIS, V34, P1331, DOI 10.1093/carcin/bgt060; Zhao QF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/231351; Zhou B, 2015, EVID-BASED COMPL ALT, V2015	80	15	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159034	10.1371/journal.pone.0159034	http://dx.doi.org/10.1371/journal.pone.0159034			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428326	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300031
J	Barnard, S; Calderara, S; Pistocchi, S; Cucchiara, R; Podaliri-Vulpiani, M; Messori, S; Ferri, N				Barnard, Shanis; Calderara, Simone; Pistocchi, Simone; Cucchiara, Rita; Podaliri-Vulpiani, Michele; Messori, Stefano; Ferri, Nicola			Quick, Accurate, Smart: 3D Computer Vision Technology Helps Assessing Confined Animals' Behaviour	PLOS ONE			English	Article							VIDEO TRACKING SYSTEM; KENNELED DOGS; AUTOMATIC IDENTIFICATION; PHYSIOLOGICAL-RESPONSES; SHELTER; PIGS; TEMPERAMENT; VALIDATION; VALIDITY; STRESS	Mankind directly controls the environment and lifestyles of several domestic species for purposes ranging from production and research to conservation and companionship. These environments and lifestyles may not offer these animals the best quality of life. Behaviour is a direct reflection of how the animal is coping with its environment. Behavioural indicators are thus among the preferred parameters to assess welfare. However, behavioural recording (usually from video) can be very time consuming and the accuracy and reliability of the output rely on the experience and background of the observers. The outburst of new video technology and computer image processing gives the basis for promising solutions. In this pilot study, we present a new prototype software able to automatically infer the behaviour of dogs housed in kennels from 3D visual data and through structured machine learning frameworks. Depth information acquired through 3D features, body part detection and training are the key elements that allow the machine to recognise postures, trajectories inside the kennel and patterns of movement that can be later labelled at convenience. The main innovation of the software is its ability to automatically cluster frequently observed temporal patterns of movement without any pre-set ethogram. Conversely, when common patterns are defined through training, a deviation from normal behaviour in time or between individuals could be assessed. The software accuracy in correctly detecting the dogs' behaviour was checked through a validation process. An automatic behaviour recognition system, independent from human subjectivity, could add scientific knowledge on animals' quality of life in confinement as well as saving time and resources. This 3D framework was designed to be invariant to the dog's shape and size and could be extended to farm, laboratory and zoo quadrupeds in artificial housing. The computer vision technique applied to this software is innovative in non-human animal behaviour science. Further improvements and validation are needed, and future applications and limitations are discussed.	[Barnard, Shanis; Podaliri-Vulpiani, Michele; Messori, Stefano; Ferri, Nicola] Ist Zooprofilatt Sperimentale Abruzzo & Molise, Teramo, Italy; [Calderara, Simone; Pistocchi, Simone; Cucchiara, Rita] Univ Modena & Reggio Emilia, Engn Dept Enzo Ferrari, Modena, Italy; [Barnard, Shanis] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Universita di Modena e Reggio Emilia; Queens University Belfast	Barnard, S (corresponding author), Ist Zooprofilatt Sperimentale Abruzzo & Molise, Teramo, Italy.; Barnard, S (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland.	shanis.barnard@gmail.com	ferri, nicola/AAJ-8630-2021; Vulpiani, Michele Podaliri/P-6132-2015; Calderara, Simone/M-6932-2015; Cucchiara, Rita/L-3006-2015; Barnard, Shanis/J-7151-2012	ferri, nicola/0000-0003-1454-1687; Vulpiani, Michele Podaliri/0000-0001-8958-0424; Calderara, Simone/0000-0001-9056-1538; Cucchiara, Rita/0000-0002-2239-283X; Barnard, Shanis/0000-0001-9521-8122; Messori, Stefano/0000-0002-6988-7960	Italian Ministry of Health [IZS AM 01/11 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by the Italian Ministry of Health on the project IZS AM 01/11 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt P, 2011, COMPUT ELECTRON AGR, V76, P169, DOI 10.1016/j.compag.2011.01.011; Aydin A, 2013, T ASABE, V56, P1123; Barnard S, 2012, APPL ANIM BEHAV SCI, V138, P79, DOI 10.1016/j.applanim.2012.02.017; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Beerda B, 2000, ANIM WELFARE, V9, P49; Berckmans D, 2014, REV SCI TECH OIE, V33, P189, DOI 10.20506/rst.33.1.2273; Bertelli L., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2153, DOI 10.1109/CVPR.2011.5995597; Bordes A., 2007, P 24 INT C MACH LEAR, P89; Calderara S, 2011, COMPUT VIS IMAGE UND, V115, P1099, DOI 10.1016/j.cviu.2011.03.003; Calderara S, 2011, IEEE T CIRC SYST VID, V21, P457, DOI 10.1109/TCSVT.2011.2125550; Cangar O, 2008, COMPUT ELECTRON AGR, V64, P53, DOI 10.1016/j.compag.2008.05.014; Chen K, 2011, COMP VIS WORKSH ICCV, P846, DOI [. doi: 10.1109/ ICCVW. 2011.6130340, DOI 10.1109/ICCVW.2011.6130340]; Clarke N, 2016, APPL ANIM BEHAV SCI, V174, P99, DOI 10.1016/j.applanim.2015.11.019; Cucchiara R, 2008, MONDO DIGITALE, V3, P38; Dalla Villa P, 2010, PREV VET MED, V97, P58, DOI 10.1016/j.prevetmed.2010.07.001; Dalla Villa P, 2013, VET ITAL, V49, P231, DOI 10.12834/VetIt.2013.492.231.241; Dawkins MS, 2004, ANIM WELFARE, V13, pS3; Delcourt J, 2013, FISH FISH, V14, P186, DOI 10.1111/j.1467-2979.2012.00462.x; Diesel G, 2008, APPL ANIM BEHAV SCI, V115, P171, DOI 10.1016/j.applanim.2008.05.005; Eichner M., 2009, BRIT MACH VIS C, P5; Frost AR, 1997, COMPUT ELECTRON AGR, V17, P139, DOI 10.1016/S0168-1699(96)01301-4; Garde E., 2012, 1 INT C DOG POP MAN; Gerencser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077814; Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251; Hiby EF, 2006, PHYSIOL BEHAV, V89, P385, DOI 10.1016/j.physbeh.2006.07.012; HUBRECHT RC, 1992, APPL ANIM BEHAV SCI, V34, P365, DOI 10.1016/S0168-1591(05)80096-6; Kashiha M, 2013, COMPUT ELECTRON AGR, V93, P111, DOI 10.1016/j.compag.2013.01.013; Kiddie JL, 2014, APPL ANIM BEHAV SCI, V158, P57, DOI 10.1016/j.applanim.2014.05.008; Kulikov VA, 2014, J NEUROSCI METH, V235, P219, DOI 10.1016/j.jneumeth.2014.07.012; Leroy T, 2006, T ASABE, V49, P795, DOI 10.13031/2013.20462; Lind NM, 2005, J NEUROSCI METH, V143, P123, DOI 10.1016/j.jneumeth.2004.09.019; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Matsumoto J, 2014, BEHAV BRAIN RES, V272, P16, DOI 10.1016/j.bbr.2014.06.047; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Mertens PA, 1996, ANTHROZOOS, V9, P40, DOI 10.2752/089279396787001662; Natoli E, 2009, J VET BEHAV, V4, P79; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Oczak M, 2013, COMPUT ELECTRON AGR, V99, P209, DOI 10.1016/j.compag.2013.09.015; Ott S, 2014, LIVEST SCI, V160, P132, DOI 10.1016/j.livsci.2013.12.011; Park HS, 2009, EXPERT SYST APPL, V36, P3336, DOI 10.1016/j.eswa.2008.01.039; Pistocchi S, 2014, INT C PATT RECOG, P1993, DOI 10.1109/ICPR.2014.348; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Publicover NG, 2009, J NEUROSCI METH, V182, P34, DOI 10.1016/j.jneumeth.2009.05.016; Spangenberg EMF, 2006, APPL ANIM BEHAV SCI, V98, P260, DOI 10.1016/j.applanim.2005.09.004; Stephen JM, 2006, PHYSIOL BEHAV, V87, P911, DOI 10.1016/j.physbeh.2006.02.015; Tillett RD, 1997, COMPUT ELECTRON AGR, V17, P249, DOI 10.1016/S0168-1699(96)01308-7; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; Wathes CM, 2008, COMPUT ELECTRON AGR, V64, P2, DOI 10.1016/j.compag.2008.05.005; Wells DL, 2000, APPL ANIM BEHAV SCI, V68, P151, DOI 10.1016/S0168-1591(00)00100-3; Wells DL, 2002, ANIM WELFARE, V11, P317; Wu JH, 2004, COMPUT ELECTRON AGR, V44, P203, DOI 10.1016/j.compag.2004.05.003	52	18	18	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158748	10.1371/journal.pone.0158748	http://dx.doi.org/10.1371/journal.pone.0158748			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415814	Green Published, gold			2022-12-26	WOS:000379579500036
J	Greco, BJ; Meehan, CL; Hogan, JN; Leighty, KA; Mellen, J; Mason, GJ; Mench, JA				Greco, Brian J.; Meehan, Cheryl L.; Hogan, Jen N.; Leighty, Katherine A.; Mellen, Jill; Mason, Georgia J.; Mench, Joy A.			The Days and Nights of Zoo Elephants: Using Epidemiology to Better Understand Stereotypic Behavior of African Elephants (Loxodonta africana) and Asian Elephants (Elephas maximus) in North American Zoos	PLOS ONE			English	Article							ANIMAL-WELFARE; STRESS; CHOICE; POISSON; PARROTS	Stereotypic behavior is an important indicator of compromised welfare. Zoo elephants are documented to perform stereotypic behavior, but the factors that contribute to performance have not been systematically assessed. We collected behavioral data on 89 elephants (47 African [Loxodonta africana], 42 Asian [Elephas maximus]) at 39 North American zoos during the summer and winter. Elephants were videoed for a median of 12 daytime hours per season. A subset of 32 elephants (19 African, 13 Asian) was also observed live for a median of 10.5 nighttime hours. Percentages of visible behavior scans were calculated from five minute instantaneous samples. Stereotypic behavior was the second most commonly performed behavior (after feeding), making up 15.5% of observations during the daytime and 24.8% at nighttime. Negative binomial regression models fitted with generalized estimating equations were used to determine which social, housing, management, life history, and demographic variables were associated with daytime and nighttime stereotypic behavior rates. Species was a significant risk factor in both models, with Asian elephants at greater risk (daytime: p<0.001, Risk Ratio = 4.087; nighttime: p<0.001, Risk Ratio = 8.015). For both species, spending time housed separately (p<0.001, Risk Ratio = 1.009), and having experienced inter-zoo transfers (p<0.001, Risk Ratio = 1.175), increased the risk of performing higher rates of stereotypy during the day, while spending more time with juvenile elephants (p<0.001, Risk Ratio = 0.985), and engaging with zoo staff reduced this risk (p = 0.018, Risk Ratio = 0.988). At night, spending more time in environments with both indoor and outdoor areas (p = 0.013, Risk Ratio = 0.987) and in larger social groups (p = 0.039, Risk Ratio = 0.752) corresponded with reduced risk of performing higher rates of stereotypy, while having experienced inter-zoo transfers (p = 0.033, Risk Ratio = 1.115) increased this risk. Overall, our results indicate that factors related to the social environment are most influential in predicting elephant stereotypic behavior rates.	[Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA; [Greco, Brian J.; Mench, Joy A.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Greco, Brian J.; Meehan, Cheryl L.; Hogan, Jen N.] AWARE Inst, Portland, OR USA; [Leighty, Katherine A.; Mellen, Jill] Disneys Anim Kingdom, Lake Buena Vista, FL USA; [Mason, Georgia J.] Univ Guelph, Dept Anim Sci, Guelph, ON, Canada	University of California System; University of California Davis; University of California System; University of California Davis; Walt Disney Company; University of Guelph	Greco, BJ (corresponding author), Univ Calif Davis, Ctr Anim Welf, Davis, CA 95616 USA.; Greco, BJ (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Greco, BJ (corresponding author), AWARE Inst, Portland, OR USA.	bjgreco@ucdavis.edu			Institute of Museum and Library Services [LG-25-10-0033-10]; UC Davis' Jastro-Shields Research Scholarship; Disney's Animal Kingdom; IMLS	Institute of Museum and Library Services; UC Davis' Jastro-Shields Research Scholarship; Disney's Animal Kingdom; IMLS	Funding for this work was provided by a National Leadership Grant to the Honolulu Zoological Society from the Institute of Museum and Library Services (www.imls.gov) grant number: LG-25-10-0033-10. Funding was also provided by UC Davis' Jastro-Shields Research Scholarship (BJG). Employers provided financial support in the form of authors' salaries as follows: Disney's Animal Kingdom (KAL, JM). After the IMLS-funded period of performance (November 2010 - December 2013) AWARE Institute provided support in the form of salaries for author CM and JH. The specific roles of these authors are articulated in the 'author contributions' section. Neither the funders nor authors' employers had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquariums AoZa, 2011, STAND EL MAN CAR; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Birkett LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020101; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Carlstead K, 2013, J APPL ANIM WELF SCI, V16, P319, DOI 10.1080/10888705.2013.827915; CHAMOVE AS, 1988, ZOO BIOL, V7, P359, DOI 10.1002/zoo.1430070407; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Cohen J., 2003, APPL MULTIPLE REGRES; Coleman K, 2010, APPL ANIM BEHAV SCI, V124, P142, DOI 10.1016/j.applanim.2010.02.008; Cook RD, 1982, RESIDUALS INFLUENCE; Dehnhard M, 2007, GEN COMP ENDOCR, V151, P274, DOI 10.1016/j.ygcen.2007.01.001; Dembiec DP, 2004, ZOO BIOL, V23, P335, DOI 10.1002/zoo.20012; Friend TH, 1999, APPL ANIM BEHAV SCI, V64, P213, DOI 10.1016/S0168-1591(99)00039-8; Friend TH, 1999, APPL ANIM BEHAV SCI, V62, P73, DOI 10.1016/S0168-1591(98)00210-X; Garai Marion E., 2006, Zeitschrift des Koelner Zoo, V49, P85; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Garner JP, 2006, APPL ANIM BEHAV SCI, V96, P153, DOI 10.1016/j.applanim.2005.09.009; Garner JP, 2003, BEHAV BRAIN RES, V145, P125, DOI 10.1016/S0166-4328(03)00115-3; Gottlieb DH, 2013, AM J PRIMATOL, V75, P995, DOI 10.1002/ajp.22161; Greco BJ, 2016, PLOS ONE; Gruber TM, 2000, ZOO BIOL, V19, P209, DOI 10.1002/1098-2361(2000)19:3&lt;209::AID-ZOO4&gt;3.0.CO;2-7; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Harris M., 2008, WELFARE HOUSING HUSB; Haspeslagh M, 2013, ANIM WELFARE, V22, P437, DOI 10.7120/09627286.22.4.437; Hemsworth PH, 2003, APPL ANIM BEHAV SCI, V81, P185, DOI 10.1016/S0168-1591(02)00280-0; Hosey G, 2008, APPL ANIM BEHAV SCI, V109, P105, DOI 10.1016/j.applanim.2007.04.013; Hutchins Michael, 2008, P285; Kay R, 2009, APPL ANIM BEHAV SCI, V116, P237, DOI 10.1016/j.applanim.2008.08.013; KURT F, 2001, INT EL RHIN RES S VI; Kurtycz LM, 2014, J APPL ANIM WELF SCI, V17, P185, DOI 10.1080/10888705.2014.896213; Laule Gail E., 2003, Journal of Applied Animal Welfare Science, V6, P163, DOI 10.1207/S15327604JAWS0603_02; Laws N, 2007, J APPL ANIM WELF SCI, V10, P349, DOI 10.1080/10888700701555600; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mason G, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0000; Mason G., 2006, STEREOTYPIC ANIMAL B, P196; Mason GJ, 2010, TRENDS ECOL EVOL, V25, P713, DOI 10.1016/j.tree.2010.08.011; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; MASON GJ, 1993, BEHAVIOUR, V127, P191, DOI 10.1163/156853993X00029; Meehan CL, 2016, PLOS ONE; Millman ST, 2009, J APPL ANIM WELF SCI, V12, P83, DOI 10.1080/10888700902719542; Novak MA, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P153, DOI 10.1079/9780851990040.0153; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Owen MA, 2005, ZOO BIOL, V24, P475, DOI 10.1002/zoo.20064; Ozminkowski RJ, 2002, J OCCUP ENVIRON MED, V44, P21, DOI 10.1097/00043764-200201000-00005; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pomerantz O, 2009, AM J PRIMATOL, V71, P687, DOI 10.1002/ajp.20703; Poole JH, 2009, ELEPHANT ROOM SCI WE; Prado-Oviedo NA, 2016, PLOS ONE; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Rees PA, 2004, J THERM BIOL, V29, P37, DOI 10.1016/j.jtherbio.2003.10.004; Rees PA, 2009, ZOO BIOL, V28, P79, DOI 10.1002/Zoo.20200; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Ross SR, 2006, BEHAV PROCESS, V73, P117, DOI 10.1016/j.beproc.2006.04.003; Rushen J, 2003, APPL ANIM BEHAV SCI, V81, P199, DOI 10.1016/S0168-1591(02)00281-2; SCHMID J, 1995, ANIM WELFARE, V4, P87; Schmid J, 2001, ANIM WELFARE, V10, P357; Spinage C.A., 1994, ELEPHANTS; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889; Swaisgood R, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P256, DOI 10.1079/9780851990040.0256; Vickery S, 2004, ZOO BIOL, V23, P409, DOI 10.1002/zoo.20027; Wilson ML, 2006, ZOO BIOL, V25, P173, DOI 10.1002/zoo.20084; Wilson ML, 2004, ANIM WELFARE, V13, P39; Wurbel H, 1996, ETHOLOGY, V102, P371; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	66	49	51	4	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0144276	10.1371/journal.pone.0144276	http://dx.doi.org/10.1371/journal.pone.0144276			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416071	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500001
J	Maurel, DB; Duan, PP; Farr, J; Cheng, AL; Johnson, ML; Bonewald, LF				Maurel, Delphine B.; Duan, Peipei; Farr, Joshua; Cheng, An-Lin; Johnson, Mark L.; Bonewald, Lynda F.			Beta-Catenin Haplo Insufficient Male Mice Do Not Lose Bone in Response to Hindlimb Unloading	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; OSTEOCYTES; OSTEOPOROSIS; SPACEFLIGHT; OSTEOBLASTS; SCLEROSTIN; ACTIVATION; RELEASE; DENSITY; MASS	As the beta-catenin pathway has been shown to be involved in mechanotransduction, we sought to determine if haploinsufficiency would affect skeletal response to unloading. It has previously been shown that deletion of both alleles of beta-catenin in bone cells results in a fragile skeleton highly susceptible to fracture, but deletion of one allele using Dmp1-Cre (Ctnnb1(+/loxP); Dmp1-Cre, cKO HET) has little effect on the 2 mo old skeleton. We found that under normal housing conditions, trabecular bone volume was significantly less in 5 mo old male cKO HET mice compared to controls (Ctrl/HET: Tb. BV/TV = 13.96 +/- 2.71/8.92 +/- 0.95%, Tb.N. = 4.88 +/- 0.51/3.95 +/- 0.44/mm, Tb. Sp. = 0.20 +/- 0.02/0.26 +/- 0.03mm, a 36%, 19% and 30% change respectively) but not in females suggesting an age and gender related effect. Before performing suspension experiments and to control for the environmental effects, animals with the same tail attachment and housing conditions, but not suspended (NS), were compared to normally housed (NH) animals. Attachment and housing resulted in weight loss in both genders and phenotypes. Cortical bone loss was observed in the cKO HET males (NH/NS, Ct BV/TV: 90.45 +/- 0.72/89.12 +/- 0.56%) and both diaphyseal (0.19 +/- 0.01/0.17 +/- 0.01mm) and metaphyseal (0.10 +/- 0.01/0.08 +/- 0.01mm) thickness, but not in female cKO HET mice suggesting that male cKO HET mice are susceptible to attachment and housing conditions. These results with transgenic mice emphasizes the importance of proper controls when attributing skeletal responses to unloading. With suspension, cKO HET male mice did not lose bone unlike female cKO HET mice that had greater trabecular bone loss than controls (Ctrl 9%:cKO HET 21% decrease Tb. N; Ctrl 12%: cKO HET 27% increase Tb. Sp.). Suspended and non-suspended mice lost weight compared to normally housed animals. Taken together, the data suggest a protective effect of beta-catenin against the effects of stress in males and partial protection against unloading in females.	[Maurel, Delphine B.; Duan, Peipei; Farr, Joshua; Johnson, Mark L.; Bonewald, Lynda F.] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA; [Cheng, An-Lin] Univ Missouri, Sch Nursing & Hlth Studies, Kansas City, MO USA; [Maurel, Delphine B.] Univ Bordeaux Segalen, Unite INSERM U1026, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Duan, Peipei] Sichuan Univ, West China Hosp Stomatol, Dept Orthodont, State Key Lab Oral Dis, Chengdu, Peoples R China	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Sichuan University	Bonewald, LF (corresponding author), Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA.	bonewaldl@umkc.edu	Bonewald, Lynda/Q-3638-2019		National Institutes of Health (NIH), National Institute of Aging (NIA) [1PO1AG039355]; NIH NIA [1PO1AG039355]; NATIONAL INSTITUTE ON AGING [P01AG039355] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH), National Institute of Aging (NIA) grant 1PO1AG039355.; This work was funded by NIH NIA, grant 1PO1AG039355.	Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Borer KT, 2005, SPORTS MED, V35, P779, DOI 10.2165/00007256-200535090-00004; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Devlin M, 2014, J BONE MINER RES S1, V29; Ferreira JA, 2011, JOVE-J VIS EXP, DOI 10.3791/2467; Gaignier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092664; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grainger Michelle, 2011, Br J Nurs, V20, P171; Gupta S, 2012, AM J PHYSIOL-REG I, V303, pR159, DOI 10.1152/ajpregu.00499.2011; Henneicke H, 2014, J BONE MINER RES S1, V29; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Iwaniec U, 2012, J BONE MINER RES S1, V27; Javaheri B, 2014, J BONE MINER RES, V29, P705, DOI 10.1002/jbmr.2064; Johnson Mark L, 2012, Bonekey Rep, V1, P1, DOI 10.1038/bonekey.2012.1; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Kang KS, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00246; Kondoh S, 2014, BONE, V60, P68, DOI 10.1016/j.bone.2013.12.005; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Laine CM, 2011, EUR J HUM GENET, V19, P875, DOI 10.1038/ejhg.2011.42; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Nagaraja MP, 2013, J CELL BIOCHEM, V114, P1001, DOI 10.1002/jcb.24454; Ozcivici E, 2014, BONE, V67, P122, DOI 10.1016/j.bone.2014.05.009; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rikkonen T, 2006, EUR J APPL PHYSIOL, V97, P509, DOI 10.1007/s00421-006-0208-7; Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; WOLF JH, 1995, ORTHOPADE, V24, P378; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158381	10.1371/journal.pone.0158381	http://dx.doi.org/10.1371/journal.pone.0158381			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410430	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300022
J	Amrutkar, M; Chursa, U; Kern, M; Nunez-Duran, E; Stahlman, M; Sutt, S; Boren, J; Johansson, BR; Marschall, HU; Bluher, M; Mahlapuu, M				Amrutkar, Manoj; Chursa, Urszula; Kern, Matthias; Nunez-Duran, Esther; Stahlman, Marcus; Suett, Silva; Boren, Jan; Johansson, Bengt R.; Marschall, Hanns-Ulrich; Blueher, Matthias; Mahlapuu, Margit			STK25 is a critical determinant in nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						NAFLD; NASH; oxidative stress; inflammation; liver fibrosis	FATTY LIVER-DISEASE; HEPATIC STEATOSIS; ANIMAL-MODELS; LIPID-PEROXIDATION; IN-VITRO; PROGRESSION; NAFLD; MICE; INFLAMMATION; RECEPTOR	Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and 10-20% of patients with NAFLD progress to nonalcoholic steatohepatitis (NASH) with a high risk of cirrhosis, liver failure, and hepatocellular carcinoma. Despite its high medical importance, the molecular mechanisms controlling progression from simple liver steatosis to NASH remain elusive. We recently identified serine/threonine protein kinase (STK)25 as a critical regulator of ectopic lipid deposition, systemic glucose, and insulin homeostasis. To elucidate the role of STK25 in the development of NASH, we challenged Stk25-knockout and transgenic mice with a methionine and choline-deficient (MCD) diet. We show that Stk25(-/-) mice are protected against MCD-diet-induced NASH, as evidenced by repressed liver steatosis, oxidative damage, inflammation, and fibrosis, whereas Stk25 transgenic mice developed a more severe NASH phenotype, compared with corresponding wild-type littermates. Consistently, NASH features were suppressed in STK25-deficient human hepatocytes cultured in MCD medium, and reciprocally enhanced in STK25-overexpressing cells. We also found a significant positive correlation in human liver biopsies between STK25 expression and NASH development. The study provides evidence for multiple roles of STK25 in NASH pathogenesis and future investigations to address the potential therapeutic relevance of pharmacological STK25 inhibitors in prevention and treatment of NASH are warranted.	[Amrutkar, Manoj; Chursa, Urszula; Nunez-Duran, Esther; Suett, Silva; Mahlapuu, Margit] Univ Gothenburg, Sahlgrenska Univ Hosp, Lundberg Lab Diabet Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Stahlman, Marcus; Boren, Jan; Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Univ Hosp, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Johansson, Bengt R.] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Electron Microscopy Unit, Gothenburg, Sweden; [Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Leipzig University	Mahlapuu, M (corresponding author), Univ Gothenburg, Lundberg Lab Diabet Res, Dept Mol & Clin Med, Sahlgrenska Acad, Bla Straket 5, SE-41345 Gothenburg, Sweden.	margit.mahlapuu@gu.se	StÃhlman, Marcus/M-4597-2019; Amrutkar, Manoj/J-2848-2019; Marschall, Hanns-Ulrich/K-8842-2017	Amrutkar, Manoj/0000-0002-1868-0249; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Henricsson, Marcus/0000-0002-4202-0339; Mahlapuu, Margit/0000-0001-8740-8874	Swedish Research Council; European Foundation for the Study of Diabetes/Lilly Research; Novo Nordisk Foundation; Swedish Heart and Lung Foundation; Diabetes Wellness Network Sweden; Swedish Diabetes Foundation; P. and A. Hedlunds Foundation; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; West Sweden Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning; ALF) Program; F. Neubergh Foundation; Estonian Science Foundation; European Foundation for the Study of Diabetes/Novo Nordisk research grant; Novo Nordisk Fonden [NNF15OC0015842, NNF16OC0020802] Funding Source: researchfish; European Foundation for the Study of Diabetes [NN 2016_2] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes/Lilly Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Wellness Network Sweden; Swedish Diabetes Foundation; P. and A. Hedlunds Foundation; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; West Sweden Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning; ALF) Program; F. Neubergh Foundation; Estonian Science Foundation; European Foundation for the Study of Diabetes/Novo Nordisk research grant; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	This work was supported by grants from the Swedish Research Council, the European Foundation for the Study of Diabetes/Lilly Research, the Novo Nordisk Foundation, the Swedish Heart and Lung Foundation, the Diabetes Wellness Network Sweden, the Swedish Diabetes Foundation, the P. and A. Hedlunds Foundation, the A. Wiberg Foundation, the Adlerbert Research Foundation, the I. Hultman Foundation, the S. and E. Goljes Foundation, the West Sweden Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning; ALF) Program, the F. Neubergh Foundation, the Estonian Science Foundation, and a European Foundation for the Study of Diabetes/Novo Nordisk research grant. The authors declare no conflicts of interest.	Amrutkar M, 2016, DIABETOLOGIA, V59, P341, DOI 10.1007/s00125-015-3801-7; Amrutkar M, 2015, DIABETES, V64, P2791, DOI 10.2337/db15-0060; Amrutkar M, 2015, FASEB J, V29, P1564, DOI 10.1096/fj.14-264937; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Anstee QM, 2010, J HEPATOL, V53, P542, DOI 10.1016/j.jhep.2010.03.016; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Bellafante E, 2013, HEPATOLOGY, V57, P1343, DOI 10.1002/hep.26222; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Caldwell SH, 2009, HEPATOLOGY, V49, P1888, DOI 10.1002/hep.22851; Cansby E, 2013, FASEB J, V27, P3660, DOI 10.1096/fj.13-228494; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Coulon S, 2013, HEPATOLOGY, V57, P1793, DOI 10.1002/hep.26219; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dongiovanni P, 2013, WORLD J GASTROENTERO, V19, P6969, DOI 10.3748/wjg.v19.i41.6969; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Hatting M, 2013, HEPATOLOGY, V57, P2189, DOI 10.1002/hep.26271; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Heymann F, 2012, HEPATOLOGY, V55, P898, DOI 10.1002/hep.24764; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2011, J HEPATOL, V55, P941, DOI 10.1016/j.jhep.2011.04.010; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x; Matsuki T, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-21; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Ratziu V, 2012, HEPATOLOGY, V55, P419, DOI 10.1002/hep.24747; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Shen B, 2008, HEPATOLOGY, V47, P473, DOI 10.1002/hep.22039; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tariq Z, 2014, LIVER INT, V34, pE180, DOI 10.1111/liv.12523; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Xie L, 2012, J HEPATOL, V57, P1076, DOI 10.1016/j.jhep.2012.07.002; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655	46	34	35	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3628	3643		10.1096/fj.201600562R	http://dx.doi.org/10.1096/fj.201600562R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27421788				2022-12-26	WOS:000384329800030
J	Safa, L; Gueddouda, NM; Thiebaut, F; Delagoutte, E; Petruseva, I; Lavrik, O; Mendoza, O; Bourdoncle, A; Alberti, P; Riou, JF; Saintome, C				Safa, Layal; Gueddouda, Nassima Meriem; Thiebaut, Frederic; Delagoutte, Emmanuelle; Petruseva, Irina; Lavrik, Olga; Mendoza, Oscar; Bourdoncle, Anne; Alberti, Patrizia; Riou, Jean-Francois; Saintome, Carole			5 ' to 3 ' Unfolding Directionality of DNA Secondary Structures by Replication Protein A G-QUADRUPLEXES AND DUPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; TELOMERIC G-QUADRUPLEX; CHROMOSOME ENDS; MACROMOLECULAR MACHINES; HELICASE MECHANISMS; BINDING-PROTEINS; RPA; CELLS; POLARITY; LIGANDS	The replication protein A (RPA) is a single-stranded DNA-binding protein that plays an essential role in DNA metabolism. RPA is able to unfold G-quadruplex (G4) structures formed by telomeric DNA sequences, a function important for telomere maintenance. To elucidate the mechanism through which RPA unfolds telomeric G4s, we studied its interaction with oligonucleotides that adopt a G4 structure extended with a single-stranded tail on either side of the G4. Binding and unfolding was characterized using several biochemical and biophysical approaches and in the presence of specific G4 ligands, such as telomestatin and 360A. Our data show that RPA can bind on each side of the G4 but it unwinds the G4 only from 5' toward 3'. Weexplain the 5' to 3' unfolding directionality in terms of the 5' to 3' oriented laying out of hRPA subunits along single-stranded DNA. Furthermore, we demonstrate by kinetics experiments that RPA proceeds with the same directionality for duplex unfolding.	[Safa, Layal; Thiebaut, Frederic; Delagoutte, Emmanuelle; Alberti, Patrizia; Riou, Jean-Francois; Saintome, Carole] Sorbonne Univ, Museum Natl Hist Nat, Struct & Instabil Genomes, INSERM U1154,CNRS UMR 7196, CP26,57 Rue Cuvier, F-75005 Paris, France; [Safa, Layal; Thiebaut, Frederic; Saintome, Carole] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Gueddouda, Nassima Meriem; Mendoza, Oscar; Bourdoncle, Anne] Inst Europeen Chim & Biol, Lab ARNA INSERM U1212, UMR 5320, 2 Rue Robert Escarpit, F-33607 Pessac, France; [Thiebaut, Frederic] PSL Res Univ, Ecole Normale Super, Dept Chim, CNRS,UMR LBM 7203, 24 Rue Lhomond, F-75005 Paris, France; [Petruseva, Irina; Lavrik, Olga] Russian Acad Sci, Siberian Div, Novosibirsk Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Alberti, P (corresponding author), Sorbonne Univ, Museum Natl Hist Nat, Struct & Instabil Genomes, INSERM U1154,CNRS UMR 7196, CP26,57 Rue Cuvier, F-75005 Paris, France.; Saintome, C (corresponding author), Museum Natl Hist Nat, INSERM U1154, CNRS UMR 7196, F-75005 Paris, France.	alberti@mnhn.fr; carole.saintome@mnhn.fr	Petruseva, Irina/AAE-8923-2021; Lavrik, Olga I/G-4641-2013; saintome, carole/A-3703-2015	Alberti, Patrizia/0000-0002-5231-3768; saintome, carole/0000-0002-7609-6913; riou, jean-francois/0000-0002-0055-6506	Ligue Nationale contre le Cancer, Equipe Labelisee; Agence Nationale de la Recherche [ANR-09-BLAN-0355]; Institut National du Cancer [TP53-INTRON3]; Program on Molecular Cellular Biology RAS; Programme Doctoral Interfaces pour le Vivant, Sorbonne Universites, UPMC Univ Paris	Ligue Nationale contre le Cancer, Equipe Labelisee(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer(Institut National du Cancer (INCA) France); Program on Molecular Cellular Biology RAS; Programme Doctoral Interfaces pour le Vivant, Sorbonne Universites, UPMC Univ Paris	This work was supported in part by grants from the "Ligue Nationale contre le Cancer, Equipe Labelisee 2010," Agence Nationale de la Recherche Grant ANR-09-BLAN-0355, Institut National du Cancer Grant TP53-INTRON3 (to J. F. R., E. D., P. A., and C. S.), and a grant from the Program on Molecular Cellular Biology RAS (to O. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral fellowship from the "Ligue Nationale contre le Cancer."; Supported by a doctoral fellowship from the "Programme Doctoral Interfaces pour le Vivant 2014, Sorbonne Universites, UPMC Univ Paris 06."	Audry J, 2015, EMBO J, V34, P1942, DOI 10.15252/embj.201490773; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Boncina M, 2012, J AM CHEM SOC, V134, P9657, DOI 10.1021/ja300605n; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Brazda V, 2014, INT J MOL SCI, V15, P17493, DOI 10.3390/ijms151017493; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Cai LF, 2007, BIOCHEMISTRY-US, V46, P8226, DOI 10.1021/bi7004976; Cohen S, 2004, BBA-GENE STRUCT EXPR, V1679, P129, DOI 10.1016/j.bbaexp.2004.06.002; Davis JT, 2007, CHEM SOC REV, V36, P296, DOI 10.1039/b600282j; De Cian A, 2008, BIOCHIMIE, V90, P131, DOI 10.1016/j.biochi.2007.07.011; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; Favre A, 1998, J PHOTOCH PHOTOBIO B, V42, P109, DOI 10.1016/S1011-1344(97)00116-4; Favre A, 1990, BIOORG PHOTOCHEM, V1, P379; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P5586, DOI 10.1021/bi9526995; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gray RD, 2014, J MOL BIOL, V426, P1629, DOI 10.1016/j.jmb.2014.01.009; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Iftode C, 2000, BIOCHEMISTRY-US, V39, P11970, DOI 10.1021/bi0005761; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P382, DOI 10.1271/bbb.90496; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lavrik OI, 1998, FEBS LETT, V441, P186, DOI 10.1016/S0014-5793(98)01544-0; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Le DD, 2015, CHEM COMMUN, V51, P8048, DOI 10.1039/c5cc02252e; Li W, 2013, J AM CHEM SOC, V135, P6423, DOI 10.1021/ja4019176; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Luciano P, 2012, EMBO J, V31, P2034, DOI 10.1038/emboj.2012.40; Mendoza O, 2015, NUCLEIC ACIDS RES, V43, pE71, DOI 10.1093/nar/gkv193; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Nguyen B, 2014, J MOL BIOL, V426, P3246, DOI 10.1016/j.jmb.2014.07.014; Oakley GG, 2010, FRONT BIOSCI-LANDMRK, V15, P883, DOI 10.2741/3652; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Pennarun G, 2005, ONCOGENE, V24, P2917, DOI 10.1038/sj.onc.1208468; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Prakash A., 2011, J NUCL ACIDS, V2011, P896; Qureshi MH, 2012, J PHYS CHEM B, V116, P5588, DOI 10.1021/jp300546u; Ray S, 2013, BIOPHYS J, V104, P2235, DOI 10.1016/j.bpj.2013.04.004; Safa L, 2014, BIOCHIMIE, V103, P80, DOI 10.1016/j.biochi.2014.04.006; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; Salas TR, 2009, NUCLEIC ACIDS RES, V37, P38, DOI 10.1093/nar/gkn895; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Sidibe A, 2012, BIOCHIMIE, V94, P2559, DOI 10.1016/j.biochi.2012.07.003; Smith J, 2000, BIOCHIMIE, V82, P71, DOI 10.1016/S0300-9084(00)00183-8; Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu CG, 2013, ADV EXP MED BIOL, V973, P1, DOI 10.1007/978-1-4614-5037-5_1	56	30	30	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21246	21256		10.1074/jbc.M115.709667	http://dx.doi.org/10.1074/jbc.M115.709667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27440048	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000385406200037
J	Kreger, BT; Dougherty, AL; Greene, KS; Cerione, RA; Antonyak, MA				Kreger, Bridget T.; Dougherty, Andrew L.; Greene, Kai Su; Cerione, Richard A.; Antonyak, Marc A.			Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; exosome (vesicle); extracellular vesicles; microparticles; PTK2 protein tyrosine kinase 2 (PTK2); focal adhesion kinase (FAK); transformation; intercellular communication; microvesicles	FOCAL ADHESION KINASE; BREAST-CANCER CELLS; EXTRACELLULAR VESICLES; LARGE ONCOSOMES; FAK-SRC; GROWTH; GLIOBLASTOMA; APOPTOSIS; SURVIVAL; GTPASES	Extracellular vesicles (EVs), including exosomes and microvesicles (MVs), have emerged as a major form of intercellular communication, playing important roles in several physiological processes and diseases, including cancer. EVs generated by cancer cells contain a variety of proteins and RNA species that can be transferred between cancer cells as well as between cancer and non-transformed (normal) cells, thereby impacting a number of aspects of cancer progression. Here we show how oncogenic transformation influences the biogenesis and function of EVs using a mouse embryonic fibroblast (MEF) cell line that can be induced to express an oncogenic form of diffuse B cell lymphoma (Dbl). Although MEFs induced to express onco-Dbl generated a similar amount of MVs as uninduced control cells, we found that MVs isolated from onco-Dbl-transformed cells contain a unique signaling protein, the ubiquitously expressed non-receptor tyrosine kinase focal adhesion kinase. The addition of MVs isolated from MEFs expressing onco-Dbl to cultures of fibroblasts strongly promoted their survival and induced their ability to grow under anchorage-independent conditions, outcomes that could be reversed by knocking down focal adhesion kinase and depleting it from the MVs or by inhibiting its kinase activity using a specific inhibitor. We then showed the same to be true for MVs isolated from aggressive MDAMB231 breast cancer cells. Together, these findings demonstrate that the induction of oncogenic transformation gives rise to MVs, which uniquely contain a signaling protein kinase that helps propagate the transformed phenotype and thus may offer a specific diagnostic marker of malignant disease.	[Kreger, Bridget T.; Dougherty, Andrew L.; Greene, Kai Su; Cerione, Richard A.; Antonyak, Marc A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			National Science Foundation MRSEC Award [NSF DMR-1120296]; NATIONAL CANCER INSTITUTE [R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R35GM122575, R01GM040654, P41GM103485] Funding Source: NIH RePORTER	National Science Foundation MRSEC Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cindy Westmiller for help with preparing the manuscript. The FEI T12 Spirit 120-kV field emission TEM at the Cornell Center for Materials Research is supported by National Science Foundation MRSEC Award NSF DMR-1120296.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2014, METHODS MOL BIOL, V1165, P147, DOI 10.1007/978-1-4939-0856-1_11; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Bordeleau F, 2016, J BIOMECH, V49, P1272, DOI 10.1016/j.jbiomech.2015.10.003; Chatzizacharias NA, 2007, EXPERT OPIN THER TAR, V11, P1315, DOI 10.1517/14728222.11.10.1315; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fujita Y, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28388; Garces CA, 2006, CANCER RES, V66, P1446, DOI 10.1158/0008-5472.CAN-05-1661; Gercel-Taylor C., 2009, J CELL PHYSL, V218, P460; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Heneberg P, 2016, CRIT REV ONCOL HEMAT, V97, P303, DOI 10.1016/j.critrevonc.2015.09.008; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Liu YC, 2013, PROTEIN CELL, V4, P932, DOI 10.1007/s13238-013-3092-z; Liu Z, 2008, CELL MICROBIOL, V10, P1787, DOI 10.1111/j.1462-5822.2008.01165.x; Lo Cicero A, 2015, CURR OPIN CELL BIOL, V35, P69, DOI 10.1016/j.ceb.2015.04.013; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mahmoudi K, 2015, MOL ASPECTS MED, V45, P97, DOI 10.1016/j.mam.2015.06.008; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nickerson NK, 2012, ONCOL RES, V20, P303, DOI 10.3727/096504013X13639794277761; Olivo C, 2000, ONCOGENE, V19, P1428, DOI 10.1038/sj.onc.1203440; OWENS LV, 1995, CANCER RES, V55, P2752; Rak J, 2012, BIOESSAYS, V34, P489, DOI 10.1002/bies.201100169; Santana SM, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/065001; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Takahashi R, 2007, BBA-GEN SUBJECTS, V1770, P518, DOI 10.1016/j.bbagen.2006.11.011; Tomita N, 2013, BIOORG MED CHEM LETT, V23, P1779, DOI 10.1016/j.bmcl.2013.01.047; Ward KK, 2013, CLIN EXP METASTAS, V30, P579, DOI 10.1007/s10585-012-9562-5; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhao XP, 2015, CANCER LETT, V360, P125, DOI 10.1016/j.canlet.2015.01.032	44	32	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19774	19785		10.1074/jbc.M116.725705	http://dx.doi.org/10.1074/jbc.M116.725705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27440046	Green Published, hybrid			2022-12-26	WOS:000383243100005
J	Asano, R; Ito, K; Yoshida, T				Asano, Ryosuke; Ito, Kenichi; Yoshida, Toshikazu			Shared Relationship Efficacy of Dyad Can Increase Life Satisfaction in Close Relationships: Multilevel Study	PLOS ONE			English	Article							ROMANTIC RELATIONSHIPS; RELATIONSHIP SCIENCE; SELF-ESTEEM; PERSPECTIVE; ATTACHMENT; MODEL; COMMITMENT; SOCIOMETER; SUPPORT; PEOPLE	Characteristics of relationship itself play an important role in determining well-being of individuals who participate in the relationship. We used efficacy expectations mutually shared between close friends or romantic partners as a characteristic of relationship and investigated its impact on their life satisfaction. In Study 1, we conducted a cross-sectional study among 137 pairs of close same-sex friends to test whether the efficacy expectations shared between friends are associated with levels of life satisfaction. In Study 2, we conducted a longitudinal study among 114 heterosexual romantic couples to test predictive validity of the efficacy expectations shared between couples predict levels of life satisfaction 2 month later. In both studies we found a consistent result that as degrees of the efficacy expectations shared between individuals in a relationship increased, the degree of their life satisfaction also increased. Underlying mechanisms that explain how characteristics of relationship itself increase life satisfaction are discussed.	[Asano, Ryosuke] Kurume Univ, Dept Literature, Kurume, Fukuoka, Japan; [Ito, Kenichi] Nanyang Technol Univ, Div Psychol, Singapore, Singapore; [Ito, Kenichi] Inst Asian Consumer Insight, Singapore, Singapore; [Yoshida, Toshikazu] Gifu Shotoku Gakuen Univ, Dept Educ, Gifu, Japan	Kurume University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Asano, R (corresponding author), Kurume Univ, Dept Literature, Kurume, Fukuoka, Japan.	asano_ryousuke@kurume-u.ac.jp	Ito, Kenichi/A-5364-2019	Ito, Kenichi/0000-0001-6936-4468; Asano, Ryosuke/0000-0001-5812-5859	JSPS [23-2815]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by JSPS Research Fellowships for Young Scientists (23-2815) to RA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acitelli LK, 2000, SOCIAL PSYCHOL PERSO, P215; Agnew CR, 1998, J PERS SOC PSYCHOL, V74, P939, DOI 10.1037/0022-3514.74.4.939; Asano R, 2015, JAPANESE J PSYCHOL, V86, P481; Asano R, 2011, JAPANESE J SOC PSYCH, V27, P41; Asano R, 2011, JAPANESE J PSYCHOL, V82, P175; Asano R, 2009, JAPANESE J INTERPERS, V9, P121; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Ben-Ari A, 2005, AM J ORTHOPSYCHIAT, V75, P621, DOI 10.1037/0002-9432.75.4.621; BERSCHEID E, 1989, J PERS SOC PSYCHOL, V57, P792, DOI 10.1037/0022-3514.57.5.792; Berscheid E, 1999, AM PSYCHOL, V54, P260, DOI 10.1037/0003-066X.54.4.260; Bolger N, 2000, J PERS SOC PSYCHOL, V79, P953, DOI 10.1037//0022-3514.79.6.953; Campbell L, 2012, SCIENCE OF THE COUPLE: THE ONTARIO SYMPOSIUM, VOL 12, P1; CLARK MS, 1979, J PERS SOC PSYCHOL, V37, P12, DOI 10.1037/0022-3514.37.1.12; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Diener E, 2013, SOC INDIC RES, V112, P497, DOI 10.1007/s11205-012-0076-y; DOHERTY WJ, 1981, AM J FAM THER, V9, P35, DOI 10.1080/01926188108250395; Feeney BC, 2015, PERS SOC PSYCHOL REV, V19, P113, DOI 10.1177/1088868314544222; Fincham FD, 2000, J FAM PSYCHOL, V14, P267, DOI 10.1037/0893-3200.14.2.267; Gable SL, 2010, ADV EXP SOC PSYCHOL, V42, P195, DOI 10.1016/S0065-2601(10)42004-3; Gonzaga GC, 2007, J PERS SOC PSYCHOL, V93, P34, DOI 10.1037/0022-3514.93.1.34; Gonzalez R, 2000, SOCIAL PSYCHOL PERSO, P181; Huta V, 2014, J HAPPINESS STUD, V15, P1425, DOI 10.1007/s10902-013-9485-0; Ickes W, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P357; Kahneman D., 1999, WELL BEING FDN HEDON; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kenny D. A., 2006, DYADIC DATA ANAL; KENNY DA, 1985, J PERS SOC PSYCHOL, V48, P339, DOI 10.1037/0022-3514.48.2.339; Kubo M, 1993, JAPANESE J EXPT SOCI, V33, P1; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; Ledermann T, 2012, J FAM PSYCHOL, V26, P140, DOI 10.1037/a0026624; Lewin K, 1947, HUM RELAT, V1, P143, DOI 10.1177/001872674700100201; Ludtke O, 2008, PSYCHOL METHODS, V13, P203, DOI 10.1037/a0012869; Ludtke O, 2011, PSYCHOL METHODS, V16, P444, DOI 10.1037/a0024376; Murray SL, 2006, PSYCHOL BULL, V132, P641, DOI 10.1037/0033-2909.132.5.641; Murray SL, 2009, J EXP SOC PSYCHOL, V45, P1180, DOI 10.1016/j.jesp.2009.07.001; Murray SL, 1997, PERS SOC PSYCHOL B, V23, P586, DOI 10.1177/0146167297236003; Muthen B., 2011, HDB ADV MULTILEVEL A, P15, DOI DOI 10.4324/9780203848852.CH2; Muthen L.K., 2012, MPLUS USERS GUIDE ST, V7th; Oishi S., 2009, DOING SCI HAPPINESS; Oishi S, 2007, PERSPECT PSYCHOL SCI, V2, P346, DOI 10.1111/j.1745-6916.2007.00048.x; Oishi S, 2009, PERS SOC PSYCHOL REV, V13, P334, DOI 10.1177/1088868309347835; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Reis HT, 2013, PERSPECT PSYCHOL SCI, V8, P558, DOI 10.1177/1745691613497966; Reis HT, 2004, HANDBOOK OF CLOSENESS AND INTIMACY, P201; Rusbult CE, 2009, CURR DIR PSYCHOL SCI, V18, P305, DOI 10.1111/j.1467-8721.2009.01657.x; RUSBULT CE, 1983, J PERS SOC PSYCHOL, V45, P101, DOI 10.1037/0022-3514.45.1.101; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Schimmack U, 2003, J RES PERS, V37, P100, DOI 10.1016/S0092-6566(02)00532-9; Simpson JA, 2007, J PERS SOC PSYCHOL, V92, P355, DOI 10.1037/0022-3514.92.2.355; Srivastava S, 2005, J PERS SOC PSYCHOL, V89, P966, DOI 10.1037/0022-3514.89.6.966; Sternberg RJ, 1997, EUR J SOC PSYCHOL, V27, P313, DOI 10.1002/(SICI)1099-0992(199705)27:3<313::AID-EJSP824>3.3.CO;2-W; Watson CB, 2001, PERS SOC PSYCHOL B, V27, P1057, DOI 10.1177/0146167201278012; Zaccaro S., 1995, SELF EFFICACY ADAPTA, P305, DOI [DOI 10.1007/978-1-4419-6868-5_11, 10.1007/978-1-4419-6868-5_11]	57	3	3	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159822	10.1371/journal.pone.0159822	http://dx.doi.org/10.1371/journal.pone.0159822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27437946	gold, Green Published			2022-12-26	WOS:000380170100076
J	Walworth, K; Bodas, M; Campbell, RJ; Swanson, D; Sharma, A; Vij, N				Walworth, Kyla; Bodas, Manish; Campbell, Ryan John; Swanson, Doug; Sharma, Ajit; Vij, Neeraj			Dendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and Progression	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; CANCER-THERAPY; LUNG-CANCER; CELL-DEATH; ATPASE; P97; NANOPARTICLE; DEGRADATION; APOPTOSIS; FIBROSIS	Elevated valosin containing protein (VCP/p97) levels promote the progression of non-small cell lung carcinoma (NSCLC). Although many VCP inhibitors are available, most of these therapeutic compounds have low specificity for targeted tumor cell delivery. Hence, the primary aim of this study was to evaluate the in vitro efficacy of dendrimer-encapsulated potent VCP-inhibitor drug in controlling non-small cell lung carcinoma (NSCLC) progression. The VCP inhibitor(s) (either in their pure form or encapsulated in generation-4 PAMAM-dendrimer with hydroxyl surface) were tested for their in vitro efficacy in modulating H1299 (NSCLC cells) proliferation, migration, invasion, apoptosis and cell cycle progression. Our results show that VCP inhibition by DBeQ was significantly more potent than NMS-873 as evident by decreased cell proliferation (p<0.0001, MTT-assay) and migration (p<0.05; scratch-assay), and increased apoptosis (p<0.05; caspase-3/7-assay) as compared to untreated control cells. Next, we found that dendrimer-encapsulated DBeQ (DDNDBeQ) treatment increased ubiquitinated-protein accumulation in soluble protein-fraction (immunoblotting) of H1299 cells as compared to DDN-control, implying the effectiveness of DBeQ in proteostasis-inhibition. We verified by immunostaining that DDNDBeQ treatment increases accumulation of ubiquitinated-proteins that co-localizes with an ER-marker, KDEL. We observed that proteostasis-inhibition with DDNDBeQ, significantly decreased cell migration rate (scratch-assay and transwell-invasion) as compared to the control-DDN treatment (p<0.05). Moreover, DDNDBeQ treatment showed a significant decrease in cell proliferation (p<0.01, MTT-assay) and increased caspase-3/7 mediated apoptotic cell death (p<0.05) as compared to DDN-control. This was further verified by cell cycle analysis (propidium-iodide-staining) that demonstrated significant cell cycle arrest in the G2/M-phase (p<0.001) by DDNDBeQ treatment as compared to control-DDN. Moreover, we confirmed by clonogenic-assay that DDNDBeQ treatment significantly (p<0.001) inhibits H1299 colony-formation as compared to control/DDN. Overall, encapsulation of potent VCP-inhibitor DBeQ into a dendrimer allows selective VCP-mediated proteostasis-inhibition for controlling NSCLC-tumor growth and progression to allow tumor-targeted sustained drug delivery.	[Walworth, Kyla; Bodas, Manish; Campbell, Ryan John; Vij, Neeraj] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Vij, Neeraj] Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA; [Swanson, Doug; Sharma, Ajit] Cent Michigan Univ, Dept Chem & Biochem, Mt Pleasant, MI 48859 USA	Central Michigan University; Johns Hopkins University; Johns Hopkins Medicine; Central Michigan University	Vij, N (corresponding author), Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA.; Vij, N (corresponding author), Johns Hopkins Sch Med, Dept Pediat Resp Sci, Baltimore, MD 21205 USA.	neeraj.vij@cmich.edu	Bodas, Manish/AAE-4016-2020	Bodas, Manish/0000-0002-1046-9799	FAMRI [YCSA_082131]; NIH [U54CA141868]	FAMRI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by FAMRI (YCSA_082131) and NIH (U54CA141868) grants to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auner HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074415; Barthelme D, 2016, J MOL BIOL, V428, P1861, DOI 10.1016/j.jmb.2015.11.015; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Bodas M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015480; Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Duong HQ, 2012, INT J ONCOL, V41, P2227, DOI 10.3892/ijo.2012.1672; Fang CJ, 2015, CHEMMEDCHEM, V10, P52, DOI 10.1002/cmdc.201402420; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Gogineni VR, 2011, CANCER LETT, V313, P64, DOI 10.1016/j.canlet.2011.08.022; Kobes JE, 2016, PANCREAS, V45, P1158, DOI 10.1097/MPA.0000000000000607; Liu JF, 2011, INT J NANOMED, V6, P59, DOI 10.2147/IJN.S14601; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Parzych K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.373; Pourianazar NT, 2016, BIOMED PHARMACOTHER, V78, P81, DOI 10.1016/j.biopha.2016.01.002; Roy I, 2010, NANOMED-NANOTECHNOL, V6, P237, DOI 10.1016/j.nano.2009.07.001; Shah PP, 2015, ONCOTARGET, V6, P17725, DOI 10.18632/oncotarget.3918; Shivalingappa PC, 2016, ANTIOXID REDOX SIGN, V24, P186, DOI 10.1089/ars.2015.6367; Upadhaya SK, 2014, ANAL BIOANAL CHEM, V406, P455, DOI 10.1007/s00216-013-7458-0; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vij Neeraj, 2010, Journal of Nanobiotechnology, V8, P22, DOI 10.1186/1477-3155-8-22; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yang H, 2016, NANOMED-NANOTECHNOL, V12, P309, DOI 10.1016/j.nano.2015.11.012; Yoon AR, 2016, J CONTROL RELEASE, V231, P2, DOI 10.1016/j.jconrel.2016.02.046; Zheng YL, 2010, INT J CANCER, V126, P2199, DOI 10.1002/ijc.24771	32	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158507	10.1371/journal.pone.0158507	http://dx.doi.org/10.1371/journal.pone.0158507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434122	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600009
J	Zakostelska, Z; Malkova, J; Klimesova, K; Rossmann, P; Hornova, M; Novosadova, I; Stehlikova, Z; Kostovcik, M; Hudcovic, T; Stepankova, R; Juzlova, K; Hercogova, J; Tlaskalova-Hogenova, H; Kverka, M				Zakostelska, Zuzana; Malkova, Jana; Klimesova, Klara; Rossmann, Pavel; Hornova, Michaela; Novosadova, Iva; Stehlikova, Zuzana; Kostovcik, Martin; Hudcovic, Tomas; Stepankova, Renata; Juzlova, Katerina; Hercogova, Jana; Tlaskalova-Hogenova, Helena; Kverka, Miloslav			Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response	PLOS ONE			English	Article							ALTERED GUT MICROBIOTA; BACTERIAL OVERGROWTH; MUCOSAL BARRIER; GERM-FREE; T-CELLS; PROBIOTICS; DIET; MANIFESTATIONS; DISEASE; ROSACEA	Psoriasis is a chronic inflammatory skin disease in which Th17 cells play a crucial role. Since indigenous gut microbiota influences the development and reactivity of immune cells, we analyzed the link among microbiota, T cells and the formation of psoriatic lesions in the imiquimod-induced murine model of psoriasis. To explore the role of microbiota, we induced skin inflammation in germ-free (GF), broad-spectrum antibiotic (ATB)-treated or conventional (CV) BALB/c and C57BL/6 mice. We found that both mice reared in GF conditions for several generations and CV mice treated with ATB were more resistant to imiquimod-induced skin inflammation than CV mice. The ATB treatment dramatically changed the diversity of gut bacteria, which remained stable after subsequent imiquimod application; ATB treatment resulted in a substantial increase in the order Lactobacillales and a significant decrease in Coriobacteriales and Clostridiales. Moreover, as compared to CV mice, imiquimod induced a lower degree of local and systemic Th17 activation in both GF and ATB-treated mice. These findings suggest that gut microbiota control imiquimod-induced skin inflammation by altering the T cell response.	[Zakostelska, Zuzana; Malkova, Jana; Klimesova, Klara; Rossmann, Pavel; Hornova, Michaela; Novosadova, Iva; Stehlikova, Zuzana; Kostovcik, Martin; Tlaskalova-Hogenova, Helena; Kverka, Miloslav] Czech Acad Sci, Inst Microbiol, Vvi, Prague, Czech Republic; [Klimesova, Klara] Czech Acad Sci, Inst Mol Genet, Vvi, Prague, Czech Republic; [Hudcovic, Tomas; Stepankova, Renata] Czech Acad Sci, Inst Microbiol, Vvi, Novy Hradek, Czech Republic; [Juzlova, Katerina; Hercogova, Jana] Charles Univ Prague, Fac Med 2, Dept Dermatol, Prague, Czech Republic; [Juzlova, Katerina; Hercogova, Jana] Bulovka Hosp, Prague, Czech Republic; [Kverka, Miloslav] Czech Acad Sci, Inst Expt Med, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Bulovka University Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Kverka, M (corresponding author), Czech Acad Sci, Inst Microbiol, Vvi, Prague, Czech Republic.; Kverka, M (corresponding author), Czech Acad Sci, Inst Expt Med, Vvi, Prague, Czech Republic.	kverka@biomed.cas.cz	Hudcovic, Tomas/H-7917-2014; Zákostelská, Zuzana/ABB-9807-2021; stepankova, renata/J-9735-2014; Stehlikova, Zuzana/AAR-2775-2021; Kverka, Miloslav/H-2507-2014; Kostovcikova, Klara/J-6851-2014	Hudcovic, Tomas/0000-0002-4761-5040; stepankova, renata/0000-0001-7504-6300; Stehlikova, Zuzana/0000-0002-2420-3289; Kverka, Miloslav/0000-0002-1335-5252; Kostovcikova, Klara/0000-0003-1821-398X; Zakostelska, Zuzana/0000-0002-6695-8188	Ministry of Health of the Czech Republic [15-30782A]; Czech Science Foundation [P303/12/0535]; Institutional Research Concept [RVO: 61388971]; European Regional Development Fund BIOCEV [CZ.1.05/1.1.00/02.0109]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Institutional Research Concept; European Regional Development Fund BIOCEV	This work was supported by Ministry of Health of the Czech Republic (15-30782A; http://www.azvcr.cz/; JH), by Czech Science Foundation (P303/12/0535; https://gacr.cz/; MKv), by Institutional Research Concept (RVO: 61388971) and by European Regional Development Fund BIOCEV (CZ.1.05/1.1.00/02.0109; www.biocev.eu; MKo). All rights reserved. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Arck P, 2010, EXP DERMATOL, V19, P401, DOI 10.1111/j.1600-0625.2009.01060.x; Bhatia BK, 2014, J AM ACAD DERMATOL, V71, P350, DOI 10.1016/j.jaad.2014.03.017; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Bowe WP, 2014, BENEF MICROBES, V5, P185, DOI 10.3920/BM2012.0060; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardone M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114516; Chen LL, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909514; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Debbaneh M, 2014, J AM ACAD DERMATOL, V71, P133, DOI 10.1016/j.jaad.2014.02.012; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Fry L, 2013, BRIT J DERMATOL, V169, P47, DOI 10.1111/bjd.12322; Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huang BL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00013; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansen C, 2015, P NATL ACAD SCI USA, V112, pE5825, DOI 10.1073/pnas.1509971112; Klimesova K, 2013, INFLAMM BOWEL DIS, V19, P1266, DOI 10.1097/MIB.0b013e318281330a; Leffler DA, 2015, NAT REV GASTRO HEPAT, V12, P561, DOI 10.1038/nrgastro.2015.131; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; Majamaa H, 1996, J ALLERGY CLIN IMMUN, V97, P985, DOI 10.1016/S0091-6749(96)80074-1; McFadden JP, 2009, BRIT J DERMATOL, V160, P929, DOI 10.1111/j.1365-2133.2009.09102.x; Naldi L, 2001, J AM ACAD DERMATOL, V44, P433, DOI 10.1067/mjd.2001.110876; NOAH PW, 1990, SEMIN DERMATOL, V9, P269; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Parodi A, 2008, CLIN GASTROENTEROL H, V6, P759, DOI 10.1016/j.cgh.2008.02.054; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Viljanen M, 2005, ALLERGY, V60, P494, DOI 10.1111/j.1398-9995.2004.00514.x; Weinstock LB, 2013, J AM ACAD DERMATOL, V68, P875, DOI 10.1016/j.jaad.2012.11.038; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424	42	85	89	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159539	10.1371/journal.pone.0159539	http://dx.doi.org/10.1371/journal.pone.0159539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434104	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600065
J	Ashinsky, BG; Fishbein, KW; Carter, EM; Lin, PC; Pleshko, N; Raggio, CL; Spencer, RG				Ashinsky, Beth G.; Fishbein, Kenneth W.; Carter, Erin M.; Lin, Ping-Chang; Pleshko, Nancy; Raggio, Cathleen L.; Spencer, Richard G.			Multiparametric Classification of Skin from Osteogenesis Imperfecta Patients and Controls by Quantitative Magnetic Resonance Microimaging	PLOS ONE			English	Article							IN-VIVO; RELAXATION-TIMES; COLLAGEN; CARTILAGE; MRI; T2	The purpose of this study is to evaluate the ability of quantitative magnetic resonance imaging (MRI) to discriminate between skin biopsies from individuals with osteogenesis imperfecta (OI) and skin biopsies from individuals without OI. Skin biopsies from nine controls (unaffected) and nine OI patients were imaged to generate maps of five separate MR parameters, T-1, T-2, k(m), MTR and ADC. Parameter values were calculated over the dermal region and used for univariate and multiparametric classification analysis. A substantial degree of overlap of individual MR parameters was observed between control and OI groups, which limited the sensitivity and specificity of univariate classification. Classification accuracies ranging between 39% and 67% were found depending on the variable of investigation, with T-2 yielding the best accuracy of 67%. When several MR parameters were considered simultaneously in a multivariate analysis, the classification accuracies improved up to 89% for specific combinations, including the combination of T-2 and k(m). These results indicate that multiparametric classification by quantitative MRI is able to detect differences between the skin of OI patients and of unaffected individuals, which motivates further study of quantitative MRI for the clinical diagnosis of OI.	[Ashinsky, Beth G.; Fishbein, Kenneth W.; Spencer, Richard G.] NIA, Lab Clin Invest, Magnet Resonance Imaging & Spect Sect, NIH, Baltimore, MD 21224 USA; [Carter, Erin M.; Raggio, Cathleen L.] Hosp Special Surg, Kathryn O & Alan C Greenberg Ctr Skeletal Dysplas, 535 E 70th St, New York, NY 10021 USA; [Lin, Ping-Chang] Augusta Univ, GRU Canc Ctr, Core Imaging Facil Small Anim, Augusta, GA USA; [Pleshko, Nancy] Temple Univ, Coll Engn, Dept Bioengn, Philadelphia, PA 19122 USA; [Raggio, Cathleen L.] Hosp Special Surg, Dept Orthopaed, 535 E 70th St, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Spencer, RG (corresponding author), NIA, Lab Clin Invest, Magnet Resonance Imaging & Spect Sect, NIH, Baltimore, MD 21224 USA.	spencer@helix.nih.gov	Fishbein, Kenneth/AAN-2595-2021	Fishbein, Kenneth/0000-0002-6353-4603; Lin, Ping-Chang/0000-0003-0918-4072	Pediatric Society of North America; National Institute on Aging, National Institutes of Health, Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000922] Funding Source: NIH RePORTER	Pediatric Society of North America; National Institute on Aging, National Institutes of Health, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Pediatric Society of North America (https://posna.org/) Grant to CLR, "Identification of Skin Abnormalities in OI Patients by MR Imaging" and the National Institute on Aging, National Institutes of Health, Intramural Research Program (RGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin DS, 1997, PEDIATR RADIOL, V27, P111, DOI 10.1007/s002470050079; Adur J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069186; Balasubramanian M, 2015, CLIN DYSMORPHOL, V24, P45, DOI 10.1097/MCD.0000000000000066; BITTOUN J, 1990, RADIOLOGY, V176, P457, DOI 10.1148/radiology.176.2.2367660; Bittoun J, 2006, NMR BIOMED, V19, P723, DOI 10.1002/nbm.1101; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Braun Hillary J, 2011, Imaging Med, V3, P541; Burstein D, 2000, INVEST RADIOL, V35, P622, DOI 10.1097/00004424-200010000-00008; Canuto HC, 2012, NMR BIOMED, V25, P169, DOI 10.1002/nbm.1732; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheung MS, 2008, REV ENDOCR METAB DIS, V9, P153, DOI 10.1007/s11154-008-9074-4; Choi JA, 2011, MAGN RESON IMAGING C, V19, P249, DOI 10.1016/j.mric.2011.02.010; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; Dimitriadou E, 2008, R PACKAGE, V1, P5; Fishbein KW, 2007, MAGN RESON MED, V57, P1000, DOI 10.1002/mrm.21216; FRANCIS MJO, 1974, BRIT MED J, V1, P421, DOI 10.1136/bmj.1.5905.421; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P7, DOI 10.1097/00004728-199201000-00003; Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HOLBROOK KA, 1989, AM J MED GENET, V34, P105, DOI 10.1002/ajmg.1320340118; Laistler E, 2015, J MAGN RESON IMAGING, V41, P496, DOI 10.1002/jmri.24549; Lin PC, 2012, MAGN RESON MED, V67, P1815, DOI 10.1002/mrm.23189; Lin PC, 2009, MAGN RESON MED, V62, P1311, DOI 10.1002/mrm.22110; Lin PC, 2009, J MAGN RESON, V201, P61, DOI 10.1016/j.jmr.2009.08.001; Lukas VA, 2015, J ORTHOP RES, V33, P640, DOI 10.1002/jor.22810; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Mirrashed F, 2004, SKIN RES TECHNOL, V10, P149, DOI 10.1111/j.1600-0846.2004.00071.x; Mosher Timothy J, 2006, Magn Reson Imaging Clin N Am, V14, P63, DOI 10.1016/j.mric.2005.12.002; Mosher TJ, 2004, ARTHRITIS RHEUM-US, V50, P2820, DOI 10.1002/art.20473; RENOU JP, 1994, BIOPOLYMERS, V34, P1615, DOI 10.1002/bip.360341206; RICHARD S, 1993, J INVEST DERMATOL, V100, P705, DOI 10.1111/1523-1747.ep12472356; Schwenzer NF, 2009, J MAGN RESON IMAGING, V29, P1346, DOI 10.1002/jmri.21789; Shapiro L, 2012, J MAGN RESON IMAGING, V36, P775, DOI 10.1002/jmri.23629; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SMITH R, 1975, Q J MED, V44, P555; Song HK, 1997, MAGNET RESON MED, V37, P185, DOI 10.1002/mrm.1910370207; Spencer RG, 2013, J AM ACAD ORTHOP SUR, V21, P438, DOI 10.5435/JAAOS-21-07-438; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Wirth W, 2014, OSTEOARTHR CARTILAGE, V22, P1554, DOI 10.1016/j.joca.2014.06.003	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0157891	10.1371/journal.pone.0157891	http://dx.doi.org/10.1371/journal.pone.0157891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416032	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500014
J	Garcia-Lopez, R; de la Morena-Barrio, ME; Alsina, L; Perez-Duenas, B; Jaeken, J; Serrano, M; Casado, M; Hernandez-Caselles, T				Garcia-Lopez, Roberto; Eugenia de la Morena-Barrio, Maria; Alsina, Laia; Perez-Duenas, Belen; Jaeken, Jaak; Serrano, Mercedes; Casado, Mercedes; Hernandez-Caselles, Trinidad			Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG)	PLOS ONE			English	Article							NK-CELLS; CONGENITAL DISORDERS; GLYCOSYLATION; EXPRESSION; BINDING; ICAM-1; SUSCEPTIBILITY; IDENTIFICATION; DEGRANULATION; LYMPHOCYTES	Background PMM2-CDG is the most common N-glycosylation defect and shows an increased risk of recurrent and/or severe, sometimes fatal, infections in early life. We hypothesized that natural killer (NK) cells, as important mediators of the immune response against microbial pathogens and regulators of adaptive immunity, might be affected in this genetic disorder. Objective To evaluate possible defects on PMM2-CDG NK peripheral blood cell number, killing activity and expression of membrane receptors. Methods We studied fresh and activated NK cells from twelve PMM2-CDG cells. The number and expression of lymphoid surface receptors were studied by flow cytometry. The NK responsiveness (frequency of degranulated NK cells) and killing activity against K562 target cells was determined in the NK cytotoxicity assay. Results We found an increase of blood NK cells in three patients with a severe phenotype. Two of them, who had suffered from moderate/severe viral infections during their first year of life, also had reduced T lymphocyte numbers. Patient activated NK cells showed increased expression of CD54 adhesion molecule and NKG2D and NKp46 activating receptors. NKp46 and 2B4 expression was inversely correlated with the expression of NKG2D in activated PMM2-CDG cells. Maximal NK activity against K562 target cells was similar in control and PMM2-CDG cells. Interestingly, the NK cell responsiveness was higher in patient cells. NKG2D and specially CD54 increased surface expression significantly correlated with the increased NK cell cytolytic activity according to the modulation of the killer activity by expression of triggering receptors and adhesion molecules. Conclusions Our results indicate that hypoglycosylation in PMM2-CDG altered NK cell reactivity against target cells and the expression of CD54 and NKG2D, NKp46 and 2B4 activating receptors during NK cell activation. This suggests a defective control of NK cell killing activity and the overall anti-viral immune response in PMM2-CDG patients. The present work improves our understanding of the immunological functions in PMM2-CDG and possibly in other CDG-I types.	[Garcia-Lopez, Roberto; Hernandez-Caselles, Trinidad] IMIB Univ Murcia, Fac Med, Dept Bioquim Biol Mol & Inmunol B, Murcia, Spain; [Eugenia de la Morena-Barrio, Maria] Hosp Univ Morales Meseguer, IMIB Arrixaca, Serv Hematol & Oncol Med, Ctr Reg Hemodonac, Murcia, Spain; [Eugenia de la Morena-Barrio, Maria] CIBERER, Valencia, Spain; [Alsina, Laia] Hosp St Joan de Deu, Secc Alergia & Inmunol Clin, Barcelona, Spain; [Perez-Duenas, Belen; Serrano, Mercedes] Hosp St Joan de Deu, Dept Neurol Infantil, Barcelona, Spain; [Jaeken, Jaak] KULeuven, Univ Ziekenhuis Gasthuisberg, Ctr Metab Dis, Leuven, Belgium; [Casado, Mercedes] Hosp St Joan de Deu CIBERER ISCIII, Dept Bioquim Clin & Neuropediat, Barcelona, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Meseguer General University Hospital Morales; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; KU Leuven; University Hospital Leuven; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Hernandez-Caselles, T (corresponding author), IMIB Univ Murcia, Fac Med, Dept Bioquim Biol Mol & Inmunol B, Murcia, Spain.	trini@um.es	de la Morena-Barrio, ME/AAG-5103-2021; Perez-Duenas, Belen/AAG-9054-2019; Alsina, Laia/AID-4372-2022; Hernandez-Caselles, Trinidad/R-1065-2018; Alsina, Laia/GQI-3516-2022	de la Morena-Barrio, ME/0000-0001-7426-4947; Hernandez-Caselles, Trinidad/0000-0001-6727-8320; Alsina, Laia/0000-0002-3559-0018; Serrano, Mercedes/0000-0002-2056-2428	Ministerio de Economia y Competitividad	Ministerio de Economia y Competitividad(Spanish Government)	RG-L is a postgraduate student from the University of Murcia. MEM-B is a holder of a postdoctoral research grant from Ministerio de Economia y Competitividad.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Bergmann M, 1998, GLYCOBIOLOGY, V8, P963, DOI 10.1093/glycob/8.10.963; Blank C, 2006, J INHERIT METAB DIS, V29, P592, DOI 10.1007/s10545-006-0275-2; Bowles JA, 2005, J IMMUNOL METHODS, V304, P88, DOI 10.1016/j.jim.2005.06.018; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cohnen A, 2013, BLOOD, V122, P1411, DOI 10.1182/blood-2012-07-441832; Crome SQ, 2013, TRENDS IMMUNOL, V34, P342, DOI 10.1016/j.it.2013.03.002; de la Morena-Barrio ME, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-170; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Drescher B, 2003, IMMUNOLOGY, V110, P335, DOI 10.1046/j.1365-2567.2003.01743.x; Duske H, 2011, HUM IMMUNOL, V72, P1007, DOI 10.1016/j.humimm.2011.08.006; Enqvist M, 2015, J IMMUNOL, V194, P4518, DOI 10.4049/jimmunol.1401972; ERKELLERYUKSEL FM, 1992, J PEDIATR-US, V120, P216, DOI 10.1016/S0022-3476(05)80430-5; Freeze H. H., 2009, ESSENTIALS GLYCOBIOL; GALUSTIAN C, 1994, IMMUNOPHARMACOLOGY, V27, P165, DOI 10.1016/0162-3109(94)90051-5; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; He P, 2014, GLYCOBIOLOGY, V24, P392, DOI 10.1093/glycob/cwu006; He P, 2012, J BIOL CHEM, V287, P18210, DOI 10.1074/jbc.M112.355677; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Jaeken J, 2010, ANN NY ACAD SCI, V1214, P190, DOI 10.1111/j.1749-6632.2010.05840.x; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kjaergaard S, 2001, ARCH DIS CHILD, V85, P236, DOI 10.1136/adc.85.3.236; Konjevic G, 2007, CLIN EXP METASTAS, V24, P1, DOI 10.1007/s10585-006-9043-9; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Mason LH, 2003, J IMMUNOL, V171, P4235, DOI 10.4049/jimmunol.171.8.4235; Murugin VV, 2011, CLIN VACCINE IMMUNOL, V18, P1410, DOI 10.1128/CVI.05084-11; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P325, DOI 10.1080/17402520600578194; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; WANG P, 1990, CELL IMMUNOL, V131, P366, DOI 10.1016/0008-8749(90)90261-O; Watzl Carsten, 2014, F1000Prime Rep, V6, P87, DOI 10.12703/P6-87	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158863	10.1371/journal.pone.0158863	http://dx.doi.org/10.1371/journal.pone.0158863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415628	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500045
J	Haubrich, C; Czosnyka, M; Diehl, R; Smielewski, P; Czosnyka, Z				Haubrich, Christina; Czosnyka, Marek; Diehl, Rolf; Smielewski, Peter; Czosnyka, Zofia			Ventricular Volume Load Reveals the Mechanoelastic Impact of Communicating Hydrocephalus on Dynamic Cerebral Autoregulation	PLOS ONE			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; CEREBROSPINAL COMPENSATORY RESERVE; BLOOD-FLOW VELOCITY; INTRACRANIAL-PRESSURE; FLUID DYNAMICS; STENOSIS; DISEASE; CSF	Several studies have shown that the progression of communicating hydrocephalus is associated with diminished cerebral perfusion and microangiopathy. If communicating hydrocephalus similarly alters the cerebrospinal fluid circulation and cerebral blood flow, both may be related to intracranial mechanoelastic properties as, for instance, the volume pressure compliance. Twenty-three shunted patients with communicating hydrocephalus underwent intraventricular constant-flow infusion with Hartmann's solution. The monitoring included transcranial Doppler (TCD) flow velocities (FV) in the middle (MCA) and posterior cerebral arteries (PCA), intracranial pressure (ICP), and systemic arterial blood pressure (ABP). The analysis covered cerebral perfusion pressure (CPP), the index of pressure-volume compensatory reserve (RAP), and phase shift angles between Mayer waves (3 to 9 cpm) in ABP and MCA-FV or PCA-FV. Due to intraventricular infusion, the pressure-volume reserve was exhausted (RAP) 0.84+/-0.1 and ICP was increased from baseline 11.5+/-5.6 to plateau levels of 20.7+/-6.4 mmHg. The ratio dRAP/dICP distinguished patients with large 0.1+/-0.01, medium 0.05+/-0.02, and small 0.02+/-0.01 intracranial volume compliances. Both M wave phase shift angles (r = 0.64; p<0.01) and CPP (r = 0.36; p<0.05) displayed a gradual decline with decreasing dRAP/dICP gradients. This study showed that in communicating hydrocephalus, CPP and dynamic cerebral autoregulation in particular, depend on the volume-pressure compliance. The results suggested that the alteration of mechanoelastic characteristics contributes to a reduced cerebral perfusion and a loss of autonomy of cerebral blood flow regulation. Results warrant a prospective TCD follow-up to verify whether the alteration of dynamic cerebral autoregulation may indicate a progression of communicating hydrocephalus.	[Haubrich, Christina; Czosnyka, Marek; Smielewski, Peter; Czosnyka, Zofia] Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England; [Haubrich, Christina] Univ Hosp Aachen, Dept Neurol, Aachen, Germany; [Diehl, Rolf] Alfried Krupp Hosp, Dept Neurol, Essen, Germany	Addenbrooke's Hospital; University of Cambridge; RWTH Aachen University; RWTH Aachen University Hospital; Alfried Krupp Hospital	Haubrich, C (corresponding author), Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England.; Haubrich, C (corresponding author), Univ Hosp Aachen, Dept Neurol, Aachen, Germany.	ch723@cam.ac.uk		Smielewski, Peter/0000-0001-5096-3938	Alexander-von-Humboldt foundation; Cambridge Enterprise Ltd, UK	Alexander-von-Humboldt foundation(Alexander von Humboldt Foundation); Cambridge Enterprise Ltd, UK	CH received a research fellowship of the Alexander-von-Humboldt foundation. Cambridge Enterprise Ltd, UK, a commercial company, provided support in the form of ICM+ software licensing fees for authors PS and MC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; BRADLEY WG, 1991, AM J NEURORADIOL, V12, P31; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Czosnyka ZH, 2002, NEUROSURGERY, V50, P526, DOI 10.1097/00006123-200203000-00018; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; EKSTEDT J, 1984, HYDROCEPHALUS; Freimann FB, 2012, NEURORADIOLOGY, V54, P189, DOI 10.1007/s00234-011-0871-1; GREITZ TVB, 1969, J NEUROSURG, V31, P644, DOI 10.3171/jns.1969.31.6.0644; Hakim S, 1976, Surg Neurol, V5, P187; Haubrich C, 2004, ACTA NEUROL SCAND, V109, P210, DOI 10.1034/j.1600-0404.2003.00210.x; Haubrich C, 2003, STROKE, V34, P1881, DOI 10.1161/01.STR.0000080936.36601.34; Haubrich C, 2013, ULTRASOUND MED BIOL; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Haubrich C, 2015, MED ENG PHYS, V37, P175, DOI 10.1016/j.medengphy.2014.11.009; Hertel F, 2003, J NEUROL NEUROSUR PS, V74, P479, DOI 10.1136/jnnp.74.4.479; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Kim HG, 2015, ALTERNAT MED, P1, DOI DOI 10.3171/2014.11.JNS141382; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Mase M, 2005, ACT NEUR S, V95, P303; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Monro A, 1823, OBSERVATIONS STRUCTU, V5; Mori K, 2002, ACTA NEUROCHIR, V144, P255, DOI 10.1007/s007010200033; Owler BK, 2001, ACTA NEUROL SCAND, V104, P325, DOI 10.1034/j.1600-0404.2001.00092.x; Paulsen KD, 2011, P INT SOC MAG RESON, V19, P41; Pena A, 2002, ACT NEUR S, V81, P59; Piper IR, 1997, SEVERE CLOSED HEAD I, P102; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; Schuhmann MU, 2008, PEDIATR NEUROSURG, V44, P269, DOI 10.1159/000131675; Steiner LA, 2005, ACTA NEUROCHIR, V147, P477, DOI 10.1007/s00701-005-0510-x; Tisell M, 2004, EUR J NEUROL, V11, P17, DOI 10.1046/j.1351-5101.2003.00698.x; Tullberg M, 2001, AM J NEURORADIOL, V22, P1665	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158506	10.1371/journal.pone.0158506	http://dx.doi.org/10.1371/journal.pone.0158506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415784	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500023
J	Kurita, T; Sakurai, K; Takeda, Y; Horinouchi, T; Kusumi, I				Kurita, Tsugiko; Sakurai, Kotaro; Takeda, Youji; Horinouchi, Toru; Kusumi, Ichiro			Very Long-Term Outcome of Non-Surgically Treated Patients with Temporal Lobe Epilepsy with Hippocampal Sclerosis: A Retrospective Study	PLOS ONE			English	Article							PHARMACORESISTANT EPILEPSY; MRI EVIDENCE; SURGERY; PROGNOSIS; SEIZURES; TRIAL	Objective Surgical intervention can result in complete seizure remission rates of up to 80% in patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS). However, certain patients cannot be treated surgically for various reasons. We analyzed the very long-term clinical outcomes of patients with TLE-HS who could not be treated surgically. Methods Subjects were selected from among patients with TLE-HS who were actively followed up for > 10 years and treated with medication without surgical treatment. Patient medical records were used to retrospectively study seizure frequency, various clinical factors, and social adjustment. Patients who were seizure-free or had only aura were classified into Group 1; the others were classified into Group 2. Clinical factors including both patient and disease-specific factors were compared between the two groups. Current social adjustment, including the education, work, and economic status of each patient, was also investigated. Results Forty-one (41) subjects met the criteria for analysis, of which 12 (29%) were classified into Group 1. The average age of patients in Group 1 was higher than that of Group 2 (p = 0.0468). Group 2 included a significantly higher rate of patients who had more than one seizure per week at the onset (p = 0.0328), as well as a greater mean number of anti-epileptic drugs taken (p = 0.0024). Regarding social adjustment, Group 2 contained significantly fewer current jobholders than Group 1 (p = 0.0288). Conclusions After very long-term follow-up periods, 29% of patients with TLE-HS had a good outcome through treatment with anticonvulsant medications. Older patients tended to have fewer seizures, and seizure frequency at the onset was the only factor that predicted outcome.	[Kurita, Tsugiko; Sakurai, Kotaro; Takeda, Youji; Horinouchi, Toru; Kusumi, Ichiro] Hokkaido Univ, Grad Sch Med, Dept Psychiat & Neurol, Sapporo, Hokkaido, Japan	Hokkaido University	Kurita, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Psychiat & Neurol, Sapporo, Hokkaido, Japan.	tsugiko@med.hokudai.ac.jp						Aldenkamp AP, 2003, SEIZURE-EUR J EPILEP, V12, P101, DOI 10.1016/S1059131102002546; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Cohen-Gadol AA, 2005, J NEUROSURG, V102, P902, DOI 10.3171/jns.2005.102.5.0902; Elsharkawy AE, 2009, EPILEPSY RES, V86, P191, DOI 10.1016/j.eplepsyres.2009.06.008; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Kim WJ, 1999, EPILEPSIA, V40, P290, DOI 10.1111/j.1528-1157.1999.tb00706.x; Kumlien E, 2002, SEIZURE-EUR J EPILEP, V11, P413, DOI 10.1053/seiz.2001.0614; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Labate A, 2006, NEUROLOGY, V66, P562, DOI 10.1212/01.wnl.0000198208.59347.96; Loscher W, 2010, EPILEPSIA, V51, P89, DOI 10.1111/j.1528-1167.2009.02183.x; Olafsson E, 2005, LANCET NEUROL, V4, P627, DOI 10.1016/S1474-4422(05)70172-1; Raz N, 2007, ANN NY ACAD SCI, V1097, P84, DOI 10.1196/annals.1379.018; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Sandok EK, 2000, EPILEPSIA, V41, P1315, DOI 10.1111/j.1528-1157.2000.tb04611.x; Selwa LM, 2003, EPILEPSIA, V44, P1568, DOI 10.1111/j.0013-9580.2003.15003.x; Seymour N, 2012, EPILEPSIA, V53, P267, DOI 10.1111/j.1528-1167.2011.03343.x; Shackleton DP, 2003, NEUROLOGY, V61, P64, DOI 10.1212/01.WNL.0000073543.63457.0A; Spencer SS, 2002, LANCET NEUROL, V1, P375, DOI 10.1016/S1474-4422(02)00163-1; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Yasuda CL, 2006, SEIZURE-EUR J EPILEP, V15, P35, DOI 10.1016/j.seizure.2005.10.005; Yu AH, 2008, EUR J RADIOL, V65, P86, DOI 10.1016/j.ejrad.2007.04.011	23	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159464	10.1371/journal.pone.0159464	http://dx.doi.org/10.1371/journal.pone.0159464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415827	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500131
J	Vergara, PM; Soto, GE; Moreira-Arce, D; Rodewald, AD; Meneses, LO; Perez-Hernandez, CG				Vergara, Pablo M.; Soto, Gerardo E.; Moreira-Arce, Dario; Rodewald, Amanda D.; Meneses, Luis O.; Perez-Hernandez, Christian G.			Foraging Behaviour in Magellanic Woodpeckers Is Consistent with a Multi-Scale Assessment of Tree Quality	PLOS ONE			English	Article							BROWNIAN BRIDGE MOVEMENT; INDIVIDUAL-BASED MODEL; TIERRA-DEL-FUEGO; INCOMPLETE INFORMATION; HABITAT SELECTION; ANIMAL MOVEMENT; SPATIAL MEMORY; SPACE-USE; LANDSCAPES; ABUNDANCE	Theoretical models predict that animals should make foraging decisions after assessing the quality of available habitat, but most models fail to consider the spatio-temporal scales at which animals perceive habitat availability. We tested three foraging strategies that explain how Magellanic woodpeckers (Campephilus magellanicus) assess the relative quality of trees: 1) Woodpeckers with local knowledge select trees based on the available trees in the immediate vicinity. 2) Woodpeckers lacking local knowledge select trees based on their availability at previously visited locations. 3) Woodpeckers using information from long-term memory select trees based on knowledge about trees available within the entire landscape. We observed foraging woodpeckers and used a Brownian Bridge Movement Model to identify trees available to woodpeckers along foraging routes. Woodpeckers selected trees with a later decay stage than available trees. Selection models indicated that preferences of Magellanic woodpeckers were based on clusters of trees near the most recently visited trees, thus suggesting that woodpeckers use visual cues from neighboring trees. In a second analysis, Cox's proportional hazards models showed that woodpeckers used information consolidated across broader spatial scales to adjust tree residence times. Specifically, woodpeckers spent more time at trees with larger diameters and in a more advanced stage of decay than trees available along their routes. These results suggest that Magellanic woodpeckers make foraging decisions based on the relative quality of trees that they perceive and memorize information at different spatio-temporal scales.	[Vergara, Pablo M.; Soto, Gerardo E.; Meneses, Luis O.; Perez-Hernandez, Christian G.] Univ Santiago Chile, Lab Ecol & Conservac, Dept Gest Arg, Santiago 3363, Chile; [Soto, Gerardo E.; Rodewald, Amanda D.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY USA; [Soto, Gerardo E.; Rodewald, Amanda D.] Dept Nat Resources, Ithaca, NY USA; [Moreira-Arce, Dario] Univ Chile, Fac Ciencias, Lab Conservac, Dept Ciencias Ecol, Santiago, Chile	Universidad de Santiago de Chile; Cornell University; Universidad de Chile	Vergara, PM (corresponding author), Univ Santiago Chile, Lab Ecol & Conservac, Dept Gest Arg, Santiago 3363, Chile.	pablo.vergara@usach.cl	Rodewald, Amanda D/I-6308-2016; Vergara, Pablo M/F-2519-2010; Moreira-Arce, Dario/ABG-2898-2021	Rodewald, Amanda D/0000-0002-6719-6306; Vergara, Pablo M/0000-0002-0024-1678; Moreira-Arce, Dario/0000-0002-1188-496X; Soto, Gerardo/0000-0002-9706-6588	FONDECYT (Comision Nacional de Investigacion Cientifica y Tecnologica) [1131133]; FONDECYT [1131133]	FONDECYT (Comision Nacional de Investigacion Cientifica y Tecnologica); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was funded by FONDECYT (Comision Nacional de Investigacion Cientifica y Tecnologica) Grant #1131133, http://w1.conicyt.cl/bases/fondecyt/personas/4/0/40146.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by FONDECYT grant No1131133. We appreciate the help of Alejandro Canto, Daniela Cortes, Maria Donoso, Marlene Lizama, Ninoska Gajardo, Paola Diaz, and Ashley Smiley who helped in data collection. GES acknowledges Wesley Hochachka from the Cornell Lab of Ornithology and Mario Nazar for his technical support. We thank two anonymous reviewers for their helpful suggestions	Amano T, 2006, ECOL MONOGR, V76, P601, DOI 10.1890/0012-9615(2006)076[0601:DIGFWI]2.0.CO;2; Anderson CB, 2009, MAMMAL REV, V39, P33, DOI 10.1111/j.1365-2907.2008.00136.x; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Azevedo JCM, 2000, FOREST ECOL MANAG, V127, P271, DOI 10.1016/S0378-1127(99)00136-X; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Beauchesne D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077514; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Briscoe BK, 2002, B MATH BIOL, V64, P261, DOI 10.1006/bulm.2001.0273; Brooks RP, 1997, WILDLIFE SOC B, V25, P163; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Byrne ME, 2014, J ANIM ECOL, V83, P1234, DOI 10.1111/1365-2656.12205; Calenge C., 2011, HOME RANGE ESTIMATIO; Cardador L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092790; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chazarreta L, 2012, ORNITOL NEOTROP, V23, P529; COWIE RJ, 1977, NATURE, V268, P137, DOI 10.1038/268137a0; COX DR, 1972, J R STAT SOC B, V34, P187; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DAVIES NB, 1981, J ANIM ECOL, V50, P157, DOI 10.2307/4038; DUCHATEAU L, 2008, THE FRAILTY MODEL; Edwards W, 2006, J ECOL, V94, P687, DOI 10.1111/j.1365-2745.2006.01116.x; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Flaxman SM, 2009, J THEOR BIOL, V256, P187, DOI 10.1016/j.jtbi.2008.09.024; Fletcher RJ, 2007, J ANIM ECOL, V76, P598, DOI 10.1111/j.1365-2656.2007.01230.x; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; FRYXELL JM, 1991, CAN J ZOOL, V69, P1308, DOI 10.1139/z91-184; Gautestad AO, 2005, AM NAT, V165, P44, DOI 10.1086/426673; Gautestad AO, 2010, ECOL COMPLEX, V7, P458, DOI 10.1016/j.ecocom.2009.11.005; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hamel S, 2007, CAN J ZOOL, V85, P933, DOI 10.1139/Z07-080; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Houston AI, 2011, ECOL LETT, V14, P1101, DOI 10.1111/j.1461-0248.2011.01678.x; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Klaassen RHG, 2006, THEOR POPUL BIOL, V70, P452, DOI 10.1016/j.tpb.2006.04.002; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kristan WB, 2006, CONDOR, V108, P5, DOI 10.1650/0010-5422(2006)108[0005:SAEFHS]2.0.CO;2; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; LIMA SL, 1984, ECOLOGY, V65, P166, DOI 10.2307/1939468; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McKellar AE, 2015, ANIMAL CONSERVATION, DOI 10.111; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; MCNAMARA JM, 1987, J THEOR BIOL, V125, P385, DOI 10.1016/S0022-5193(87)80209-6; MCQUILLAN PB, 1993, BIOL J LINN SOC, V49, P317, DOI 10.1111/j.1095-8312.1993.tb00910.x; Meinel G., 2004, INT ARCH PHOTOGRAM B, V35, P1097, DOI DOI 10.3390/RS6042912; Merzlyak MN, 1999, PHYSIOL PLANTARUM, V106, P135, DOI 10.1034/j.1399-3054.1999.106119.x; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Morrissey CA, 2008, ECOL APPL, V18, P172, DOI 10.1890/07-0015.1; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Ohashi K, 2005, BEHAV ECOL, V16, P592, DOI 10.1093/beheco/ari031; Ojeda VS, 2006, WILSON J ORNITHOL, V118, P251, DOI 10.1676/05-014.1; Olsson O, 1999, OIKOS, V87, P264, DOI 10.2307/3546741; Olsson O, 2006, OIKOS, V112, P260, DOI 10.1111/j.0030-1299.2006.13548.x; Olsson O, 2001, OECOLOGIA, V127, P435, DOI 10.1007/s004420000596; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Pancel L, 2002, AGENTES DE DANO EN E; Patenaude-Monette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102162; Prevedello JA, 2010, J ANIM ECOL, V79, P1315, DOI 10.1111/j.1365-2656.2010.01736.x; Roman I, 2013, 98 ANN EC SOC AM M M; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Rota CT, 2014, FOREST ECOL MANAG, V313, P161, DOI 10.1016/j.foreco.2013.10.048; Santos MJ, 2010, REMOTE SENS ENVIRON, V114, P1242, DOI 10.1016/j.rse.2010.01.009; Schlatter RP, 2005, J ORNITHOL, V146, P188, DOI 10.1007/s10336-004-0069-y; SHORT LL, 1970, WILSON BULL, V82, P115; Soto GE, THE WILSON JOURNAL O; Soto GE, 2012, BOSQUE, V33, P271, DOI 10.4067/S0717-92002012000300007; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Stephens D.W., 1986, pi; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tingley MW, 2014, CONDOR, V116, P325, DOI 10.1650/CONDOR-13-140.1; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Vergara P, 2004, J ORNITHOL, V145, P343, DOI 10.1007/s10336-004-0052-7; Vergara PM, 2015, ECOL MODEL, V300, P114, DOI 10.1016/j.ecolmodel.2015.01.006; Wells AG, 2014, ECOL MODEL, V273, P242, DOI 10.1016/j.ecolmodel.2013.11.008; White G.C., 1990, ANAL WILDLIFE RADIO; Wiens J.A., 1991, FISH WILDLIFE RES, P1; Yang X, 2014, J GEOPHYS RES-BIOGEO, V119, P181, DOI 10.1002/2013JG002460; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zollner PA, 2000, LANDSCAPE ECOL, V15, P523, DOI 10.1023/A:1008154532512	88	22	22	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159096	10.1371/journal.pone.0159096	http://dx.doi.org/10.1371/journal.pone.0159096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416115	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500074
J	Zhao, C; Zhang, C; Chen, B; Shi, YH; Quan, YP; Nie, ZM; Zhang, YZ; Yu, W				Zhao, Cui; Zhang, Chen; Chen, Bin; Shi, Yanghui; Quan, Yanping; Nie, Zuoming; Zhang, Yaozhou; Yu, Wei			A DNA Binding Protein Is Required for Viral Replication and Transcription in Bombyx mori Nucleopolyhedrovirus	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; ESCHERICHIA-COLI; GENE; RECOMBINATION; SEQUENCE; GENOME; IDENTIFICATION; BACULOVIRUS; CLONING	A DNA-binding protein (DBP) [GenBank accession number: M63416] of Bombyx mori nuclear polyhedrosis virus (BmNPV) has been reported to be a regulatory factor in BmNPV, but its detailed functions remain unknown. In order to study the regulatory mechanism of DBP on viral proliferation, genome replication, and gene transcription, a BmNPV dbp gene knockout virus dbp-ko-Bacmid was generated by the means of Red recombination system. In addition, dbp-repaired virus dbp-re-Bacmid was constructed by the means of the Bac to Bac system. Then, the Bacmids were transfected into BmN cells. The results of this viral titer experiment revealed that the TCID50 of the dbp-ko-Bacmid was 0; however, the dbp-re-Bacmid was similar to the wtBacmid (p>0.05), indicating that the dbp-deficient would lead to failure in the assembly of virus particles. In the next step, Real-Time PCR was used to analyze the transcriptional phases of dbp gene in BmN cells, which had been infected with BmNPV. The results of the latter experiment revealed that the transcript of dbp gene was first detected at 3 h post-infection. Furthermore, the replication level of virus genome and the transcriptional level of virus early, late, and very late genes in BmN cells, which had been transfected with 3 kinds of Bacmids, were analyzed by Real-Time PCR. The demonstrating that the replication level of genome was lower than that of wtBacmid and dbp-re-Bacmid (p<0.01). The transcriptional level of dbp-ko-Bacmid early gene lef-3, ie-1, dnapol, late gene vp39 and very late gene p10 were statistically significantly lower than dbp-re-Bacmid and wtBacmid (p<0.01). The results presented are based on Western blot analysis, which indicated that the lack of dbp gene would lead to low expressions of lef3, vp39, and p10. In conclusion, dbp was not only essential for early viral replication, but also a viral gene that has a significant impact on transcription and expression during all periods of baculovirus life cycle.	[Zhao, Cui; Zhang, Chen; Chen, Bin; Shi, Yanghui; Quan, Yanping; Nie, Zuoming; Zhang, Yaozhou; Yu, Wei] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China; [Zhao, Cui; Zhang, Chen; Chen, Bin; Shi, Yanghui; Quan, Yanping; Nie, Zuoming; Zhang, Yaozhou; Yu, Wei] Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Yu, W (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China.; Yu, W (corresponding author), Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China.	mikkyu@163.com			National High-tech R&D program (863 Program) [2011AA100603]; Project Grants 521 Talents Cultivation of Zhejiang Sci-Tech University [11610132521506]	National High-tech R&D program (863 Program); Project Grants 521 Talents Cultivation of Zhejiang Sci-Tech University	This work was supported by the National High-tech R&D program (863 Program) (No. 2011AA100603) and the Project Grants 521 Talents Cultivation of Zhejiang Sci-Tech University (No. 11610132521506).	Argaud O, 1998, J GEN VIROL, V79, P931, DOI 10.1099/0022-1317-79-4-931; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Du MF, 2006, J BIOCHEM MOL BIOL, V39, P737; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Hamajima R, 2015, VIROLOGY, V485, P244, DOI 10.1016/j.virol.2015.08.008; Han YY, 2014, CURR MICROBIOL, V69, P56, DOI 10.1007/s00284-014-0551-6; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Innami K, 2016, J VIROL METHODS, V229, P24, DOI 10.1016/j.jviromet.2015.12.002; KOOL M, 1994, P NATL ACAD SCI USA, V91, P11212, DOI 10.1073/pnas.91.23.11212; Li A, 2015, J VIROL, V89, P7646, DOI 10.1128/JVI.00333-15; Lin GY, 2002, J VIROL, V76, P5503, DOI 10.1128/JVI.76.11.5503-5514.2002; MAEDA S, 1990, J GEN VIROL, V71, P1851, DOI 10.1099/0022-1317-71-8-1851; MAEDA S, 1993, J VIROL, V67, P6234, DOI 10.1128/JVI.67.10.6234-6238.1993; MAEDA S, 1991, VIROLOGY, V180, P807, DOI 10.1016/0042-6822(91)90096-T; MONTALVO EA, 1985, J VIROL, V53, P761, DOI 10.1128/JVI.53.3.761-770.1985; Pyne ME, 2015, APPL ENVIRON MICROB, V81, P5103, DOI 10.1128/AEM.01248-15; SUGAWARA K, 1986, VIRUS RES, V6, P27; Xiang XW, 2013, J GEN VIROL, V94, P1669, DOI 10.1099/vir.0.050583-0; Yamamoto Y, 2014, INFLAMMATION, V37, P1806, DOI 10.1007/s10753-014-9911-4; Yang JJ, 2015, BIOTECHNOL LETT, V37, P2011, DOI 10.1007/s10529-015-1878-1; Yang ZN, 2008, VIRUS RES, V135, P220, DOI 10.1016/j.virusres.2008.03.016; Yu W, 2013, VIRUS RES, V175, P45, DOI 10.1016/j.virusres.2013.03.022; Yu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-90; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	26	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159149	10.1371/journal.pone.0159149	http://dx.doi.org/10.1371/journal.pone.0159149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414795	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500090
J	Micheal, S; Siddiqui, SN; Zafar, SN; Iqbal, A; Khan, MI; den Hollander, AI				Micheal, Shazia; Siddiqui, Sorath Noorani; Zafar, Saemah Nuzhat; Iqbal, Aftab; Khan, Muhammad Imran; den Hollander, Anneke I.			Identification of Novel Variants in LTBP2 and PXDN Using Whole-Exome Sequencing in Developmental and Congenital Glaucoma	PLOS ONE			English	Article							ANTERIOR SEGMENT DYSGENESIS; BINDING-PROTEIN 2; CYTOCHROME P4501B1; MUTATIONS; GENE; CYP1B1; PEROXIDASIN; POPULATION; MOUSE; MYOC	Background Primary congenital glaucoma (PCG) is the most common form of glaucoma in children. PCG occurs due to the developmental defects in the trabecular meshwork and anterior chamber of the eye. The purpose of this study is to identify the causative genetic variants in three families with developmental and primary congenital glaucoma ( PCG) with a recessive inheritance pattern. Methods DNA samples were obtained from consanguineous families of Pakistani ancestry. The CYP1B1 gene was sequenced in the affected probands by conventional Sanger DNA sequencing. Whole exome sequencing (WES) was performed in DNA samples of four individuals belonging to three different CYP1B1-negative families. Variants identified by WES were validated by Sanger sequencing. Results WES identified potentially causative novel mutations in the latent transforming growth factor beta binding protein 2 (LTBP2) gene in two PCG families. In the first family a novel missense mutation (c.4934G>A; p.Arg1645Glu) co-segregates with the disease phenotype, and in the second family a novel frameshift mutation (c.4031_4032insA; p.Asp1345Glyfs*6) was identified. In a third family with developmental glaucoma a novel mutation (c.3496G>A; p.Gly1166Arg) was identified in the PXDN gene, which segregates with the disease. Conclusions We identified three novel mutations in glaucoma families using WES; two in the LTBP2 gene and one in the PXDN gene. The results will not only enhance our current understanding of the genetic basis of glaucoma, but may also contribute to a better understanding of the diverse phenotypic consequences caused by mutations in these genes.	[Micheal, Shazia; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; [Siddiqui, Sorath Noorani; Zafar, Saemah Nuzhat] Al Shifa Eye Trust Hosp, Dept Pediat Ophthalmol, Jhelum Rd, Rawalpindi, Pakistan; [Iqbal, Aftab] Univ Westminster, Sch Biosci, London, England; [Khan, Muhammad Imran; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; University of Westminster; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hollander, Anneke den/N-4911-2014; Siddiqui, Sorath Noorani/AAT-9861-2020	Khan, Muhammad Imran/0000-0003-0276-5480	Shaffer grant from the Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blindenhulp	Shaffer grant from the Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Blindenhulp	The authors thank the Stichting Blindenhulp, a Shaffer grant from the Glaucoma Research Foundation, the Glaucoomfonds, Oogfonds, and the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid for providing the financial support.; We thank the Stichting Blindenhulp, a Shaffer grant from the Glaucoma Research Foundation, the Glaucoomfonds, Oogfonds, and the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid for providing the financial support.	Abu-Amero KK, 2011, MOL VIS, V17, P2911; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Choi A, 2015, EUR J HUM GENET, V23, P337, DOI 10.1038/ejhg.2014.119; Dandona L, 1998, ARCH OPHTHALMOL-CHIC, V116, P545, DOI 10.1001/archopht.116.4.514; Desir J, 2010, EUR J HUM GENET, V18, P761, DOI 10.1038/ejhg.2010.11; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Haji-Seyed-Javadi R, 2012, HUM MUTAT, V33, P1182, DOI 10.1002/humu.22105; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kakiuchi-Matsumoto T, 2001, AM J OPHTHALMOL, V131, P345, DOI 10.1016/S0002-9394(00)00808-4; Khan K, 2011, AM J HUM GENET, V89, P464, DOI 10.1016/j.ajhg.2011.08.005; Kim HJ, 2011, MOL VIS, V17, P2093; Kumar A, 2010, HUM GENET, V128, P365, DOI 10.1007/s00439-010-0858-8; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim SH, 2013, AM J OPHTHALMOL, V155, P508, DOI 10.1016/j.ajo.2012.09.012; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MD S, 2005, SHIELDS TEXTBOOK OF; Mohanty K, 2013, MOL VIS, V19, P78; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; Sharafieh R, 2013, OPHTHALMIC GENET, V34, P14, DOI 10.3109/13816810.2012.716486; Shipley JM, 2000, MOL CELL BIOL, V20, P4879, DOI 10.1128/MCB.20.13.4879-4887.2000; Tanwar M, 2009, MOL VIS, V15, P2926; Vehvilainen P, 2009, J CELL PHYSIOL, V221, P586, DOI 10.1002/jcp.21888; Vranka JA, 2015, EXP EYE RES, V133, P112, DOI 10.1016/j.exer.2014.07.014; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yan XH, 2014, HUM MOL GENET, V23, P5597, DOI 10.1093/hmg/ddu274	29	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159259	10.1371/journal.pone.0159259	http://dx.doi.org/10.1371/journal.pone.0159259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409795	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300073
J	Bechir, N; Pecchi, E; Vilmen, C; Le Fur, Y; Amthor, H; Bernard, M; Bendahan, D; Giannesini, B				Bechir, Nelly; Pecchi, Emilie; Vilmen, Christophe; Le Fur, Yann; Amthor, Helge; Bernard, Monique; Bendahan, David; Giannesini, Benoit			ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo	FASEB JOURNAL			English	Article						skeletal muscle hypertrophy; myostatin inhibition; Duchenne muscular dystrophy; muscle fatigue	DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; MAGNETIC-RESONANCE-SPECTROSCOPY; MYOSTATIN-DEFICIENT MICE; IIB RECEPTOR; MECHANICAL PERFORMANCE; GASTROCNEMIUS-MUSCLE; INSULIN SENSITIVITY; GENE-EXPRESSION; ADIPOSE-TISSUE	Postnatal blockade of the activin type IIB receptor (ActRIIB) represents a promising therapeutic strategy for counteracting dystrophic muscle wasting. However, its impact on muscle function and bioenergetics remains poorly documented in physiologic conditions. We have investigated totally noninvasively the effect of 8-wk administration of either soluble ActRIIB signaling inhibitor (sActRIIB-Fc) or vehicle PBS (control) on gastrocnemius muscle force-generating capacity, energy metabolism, and anatomy in dystrophic mdx mice using magnetic resonance (MR) imaging and dynamic [P-31]-MR spectroscopy ([P-31]-MRS) in vivo. ActRIIB inhibition increased muscle volume (+33%) without changing fiber-type distribution, and increased basal animal oxygen consumption (+22%) and energy expenditure (+23%). During an in vivo standardized fatiguing exercise, maximum and total absolute contractile forces were larger (+40 and 24%, respectively) in sActRIIB-Fc treated animals, whereas specific force-generating capacity and fatigue resistance remained unaffected. Furthermore, sActRIIB-Fc administration did not alter metabolic fluxes, ATP homeostasis, or contractile efficiency during the fatiguing bout of exercise, although it dramatically reduced the intrinsic mitochondrial capacity for producing ATP. Overall, sActRIIB-Fc treatment increased muscle mass and strength without altering the fundamental weakness characteristic of dystrophic mdx muscle. These data support the clinical interest of ActRIIB blockade for reversing dystrophic muscle wasting.	[Bechir, Nelly; Pecchi, Emilie; Vilmen, Christophe; Le Fur, Yann; Bernard, Monique; Bendahan, David; Giannesini, Benoit] Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, UMR 7339, Marseille, France; [Amthor, Helge] Univ Versailles St Quentin En Yvelines, Unite Format Sci Sante, INSERM U1179,Cellules Soches Mesenchymateuses, St Quentin Yvelines Therapeut,Lab Int Associe,Bio, Montigny Le Bretonneux, France; [Amthor, Helge] Univ Versailles St Quentin En Yvelines, Unite Rech Sci Sante, INSERM U1179,Cellules Soches Mesenchymateuses, St Quentin Yvelines Therapeut,Lab Int Associe,Bio, Montigny Le Bretonneux, France; [Amthor, Helge] Univ Paris 05, Ctr Hosp Univ Necker Enfants Malad, Serv Genet Med, Paris, France; [Amthor, Helge] Ctr Hosp Univ CHU Raymond Poincare, Serv Pediat, Garches, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Giannesini, B (corresponding author), Aix Marseille Univ, CRMBM, UMR CNRS 7339, Fac Med Marseille, 27 Blvd Jean Moulin, F-13385 Marseille, France.	benoit.giannesini@univ-amu.fr	Bendahan, David/AAU-1420-2020; Bernard, Monique/Q-7254-2017	Bernard, Monique/0000-0002-3179-8698	French Muscular Dystrophy Association (AFM-Telethon)	French Muscular Dystrophy Association (AFM-Telethon)	The authors thank Acceleron Pharma, Inc. for the gift of sActRIIB-Fc, Ms. Laurence Louis (Aix-Marseille Universite) for helpful assistance with infrared imaging, and Drs. Delphine Bastelica and Marie-Christine Alessi (Aix-Marseille Universite) for sharing the indirect calorimetry system. This work was financially supported by the French Muscular Dystrophy Association (AFM-Telethon). The authors declare no conflicts of interest. Acceleron Pharma, Inc. did not influence data collection, analysis, interpretation and decision to publish the present study.	ADAMS GR, 1990, J APPL PHYSIOL, V69, P968, DOI 10.1152/jappl.1990.69.3.968; Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Amthor H, 2012, CURR GENE THER, V12, P245, DOI 10.2174/156652312800840577; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; ARNOLD DL, 1984, LANCET, V1, P1367; Attie KM, 2013, MUSCLE NERVE, V47, P416, DOI 10.1002/mus.23539; Baligand C, 2010, GENE THER, V17, P328, DOI 10.1038/gt.2009.141; Birot OJG, 2003, J PHYSIOL-LONDON, V552, P213, DOI 10.1113/jphysiol.2003.043026; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Carlson CG, 2011, MUSCLE NERVE, V43, P694, DOI 10.1002/mus.21944; Chiu CS, 2013, J GERONTOL A-BIOL, V68, P1181, DOI 10.1093/gerona/glt030; Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4; Conley KE, 1997, AM J PHYSIOL-CELL PH, V273, pC306, DOI 10.1152/ajpcell.1997.273.1.C306; Conley KE, 1998, J PHYSIOL-LONDON, V511, P935, DOI 10.1111/j.1469-7793.1998.935bg.x; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Dumonceaux Julie, 2009, Neuromuscul Disord, V19, P797, DOI 10.1016/j.nmd.2009.08.001; Erkintalo M, 1998, METABOLISM, V47, P769, DOI 10.1016/S0026-0495(98)90110-X; Farvid MS, 2005, DIABETES OBES METAB, V7, P406, DOI 10.1111/j.1463-1326.2004.00410.x; Giannesini B, 2001, J PHYSIOL-LONDON, V536, P905, DOI 10.1111/j.1469-7793.2001.00905.x; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; GYULAI L, 1985, J BIOL CHEM, V260, P3947; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kemp GJ, 2015, ACTA PHYSIOL, V213, P107, DOI 10.1111/apha.12307; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 1996, NMR BIOMED, V9, P261, DOI 10.1002/(SICI)1099-1492(199609)9:6<261::AID-NBM430>3.0.CO;2-B; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lanza IR, 2011, J MAGN RESON IMAGING, V34, P1143, DOI 10.1002/jmri.22733; Lawlor MW, 2011, AM J PATHOL, V178, P784, DOI 10.1016/j.ajpath.2010.10.035; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Macia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129579; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Morine KJ, 2010, MUSCLE NERVE, V42, P722, DOI 10.1002/mus.21743; Morrison BM, 2009, EXP NEUROL, V217, P258, DOI 10.1016/j.expneurol.2009.02.017; Mouisel E, 2014, AM J PHYSIOL-REG I, V307, pR444, DOI 10.1152/ajpregu.00377.2013; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Russ DW, 2009, MED SCI SPORT EXER, V41, P1504, DOI 10.1249/MSS.0b013e31819b3607; Rybalka E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115763; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; WOLFE CL, 1988, BIOCHIM BIOPHYS ACTA, V971, P9, DOI 10.1016/S0005-2728(88)80003-3; Zhao BP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-305; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	61	12	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3551	3562		10.1096/fj.201600271RR	http://dx.doi.org/10.1096/fj.201600271RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27416839	Green Submitted			2022-12-26	WOS:000384329800024
J	Goudarzi, S; Hassan, WH; Hashim, AHA; Soleymani, SA; Anisi, MH; Zakaria, OM				Goudarzi, Shidrokh; Hassan, Wan Haslina; Hashim, Aisha-Hassan Abdalla; Soleymani, Seyed Ahmad; Anisi, Mohammad Hossein; Zakaria, Omar M.			A Novel RSSI Prediction Using Imperialist Competition Algorithm (ICA), Radial Basis Function (RBF) and Firefly Algorithm (FFA) in Wireless Networks	PLOS ONE			English	Article							VERTICAL HANDOFF ALGORITHM; SERVICE; QUALITY; DESIGN	This study aims to design a vertical handover prediction method to minimize unnecessary handovers for a mobile node (MN) during the vertical handover process. This relies on a novel method for the prediction of a received signal strength indicator (RSSI) referred to as IRBF-FFA, which is designed by utilizing the imperialist competition algorithm (ICA) to train the radial basis function (RBF), and by hybridizing with the firefly algorithm (FFA) to predict the optimal solution. The prediction accuracy of the proposed IRBF-FFA model was validated by comparing it to support vector machines (SVMs) and multilayer perceptron (MLP) models. In order to assess the model's performance, we measured the coefficient of determination (R-2), correlation coefficient (r), root mean square error (RMSE) and mean absolute percentage error (MAPE). The achieved results indicate that the IRBF-FFA model provides more precise predictions compared to different ANNs, namely, support vector machines (SVMs) and multilayer perceptron (MLP). The performance of the proposed model is analyzed through simulated and real-time RSSI measurements. The results also suggest that the IRBF-FFA model can be applied as an efficient technique for the accurate prediction of vertical handover.	[Goudarzi, Shidrokh; Hassan, Wan Haslina; Zakaria, Omar M.] Univ Teknol Malaysia, MJIIT, Commun Syst & Network iKohza Res Grp, Jalan Semarak, Kuala Lumpur 54100, Malaysia; [Hashim, Aisha-Hassan Abdalla] Int Islamic Univ Malaysia Kuala Lumpur, Fac Elect & Comp Engn, Kuala Lumpur, Malaysia; [Soleymani, Seyed Ahmad] Univ Teknol Malaysia, Fac Comp, Utm Johor Bahru 81310, Johor, Malaysia; [Anisi, Mohammad Hossein] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur 50603, Malaysia	Universiti Teknologi Malaysia; International Islamic University Malaysia; Universiti Teknologi Malaysia; Universiti Malaya	Goudarzi, S (corresponding author), Univ Teknol Malaysia, MJIIT, Commun Syst & Network iKohza Res Grp, Jalan Semarak, Kuala Lumpur 54100, Malaysia.	gshidrokh2@live.utm.my	Hashim, Aisha/A-2921-2019; Hassan, Wan H/AAM-1570-2020; Goudarzi, Shidrokh/P-9642-2019; Anisi, Mohammad Hossein/L-3718-2016; Soleymani, Ahmad/AAN-1522-2021; Goudarzi, Shidrokh/AAH-3237-2019; Goudarzi, Shidrokh/AAA-4570-2021	Hashim, Aisha/0000-0001-6331-1373; Goudarzi, Shidrokh/0000-0003-0383-3553; Anisi, Mohammad Hossein/0000-0001-8414-2708; 	Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM)	Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM)	Authors acknowledge the support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge the support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM). Authors acknowledge support from Malaysia-Japan International Institute of Technology (MJIIT) center at Universiti Teknologi Malaysia, International Islamic University Malaysia (IIUM).	Ahmed A, 2014, IEEE COMMUN SURV TUT, V16, P776, DOI 10.1109/SURV.2013.082713.00141; Anisi MH, 2012, SENSORS-BASEL, V12, P3964, DOI 10.3390/s120403964; Ansong MO, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/376931; Atashpaz-Gargari E, 2007, IEEE C EVOL COMPUTAT, P4661, DOI 10.1109/CEC.2007.4425083; Becvar Z, 2011, COMPUT NETW, V55, P3759, DOI 10.1016/j.comnet.2011.03.020; Biabangard-Oskouyi A, 2009, INT J ENG SIMUL, V10, P11; Calhan A, 2013, WIRELESS PERS COMMUN, V71, P2399, DOI 10.1007/s11277-012-0944-4; Calhan A, 2013, COMPUT STAND INTER, V35, P170, DOI 10.1016/j.csi.2012.06.002; Chang BJ, 2008, IEEE T VEH TECHNOL, V57, P3679, DOI 10.1109/TVT.2008.921619; Chang BJ., 2009, WIR COMM NETW C WCNC, P1, DOI DOI 10.1109/WCNC.2009.4917802; Datta RS, 2010, ECON THEOR, V42, P55, DOI 10.1007/s00199-009-0447-z; Foody GM, 2004, INT J REMOTE SENS, V25, P3091, DOI 10.1080/01431160310001648019; Gargari EA, 2008, INT J INTELL COMPUT, V1, P337, DOI 10.1108/17563780810893446; Goudarzi S, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/620658; JORGENSEN M, 1995, IEEE T SOFTWARE ENG, V21, P674, DOI 10.1109/32.403791; Kordos M, 2004, Proceedings of the Eighth IASTED International Conference on Artificial Intelligence and Soft Computing, P215; Lam KF, 2001, COMPUT OPER RES, V28, P1141, DOI 10.1016/S0305-0548(00)00026-5; Lera G, 2002, IEEE T NEURAL NETWOR, V13, P1200, DOI 10.1109/TNN.2002.1031951; Lin CP, 2012, COMPUT ELECTR ENG, V38, P681, DOI 10.1016/j.compeleceng.2012.02.013; LITOVSKI VB, 1992, ELECTRON LETT, V28, P1766, DOI 10.1049/el:19921124; Liu Xia, 2008, 2008 International Conference on Neural Networks and Signal Processing, P550, DOI 10.1109/ICNNSP.2008.4590411; Liu Xia, 2012, Journal of Shanghai Jiaotong University (Science), V17, P25, DOI 10.1007/s12204-011-1137-0; Lukasik S, 2009, LECT NOTES ARTIF INT, V5796, P97; Mohanty S, 2006, IEEE T MOBILE COMPUT, V5, P1347, DOI 10.1109/TMC.2006.142; Movahedi Z, 2012, IEEE COMMUN SURV TUT, V14, P464, DOI 10.1109/SURV.2011.042711.00078; Pawar P, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P481; Perkins CE, 2001, IEEE PERS COMMUN, V8, P16, DOI 10.1109/98.904895; Rajabioun R, 2008, LECT NOTES COMPUT SC, V5073, P680; Rakovic V, 2010, NOVEL RAT SELECTION, P210; Rehan M, 2009, IFIP ADV INF COMM TE, V308, P359; Sadiq AS, 2014, INT J COMMUN SYST, V27, P969, DOI 10.1002/dac.2386; Salcic Z, 2000, WIRELESS PERS COMMUN, V14, P235, DOI 10.1023/A:1008917401129; Shabanzadeh P, 2015, J IND ENG CHEM, V24, P42, DOI 10.1016/j.jiec.2014.09.007; Shen XM, 2000, WIREL NETW, V6, P363, DOI 10.1023/A:1019166304306; Singhrova A, 2012, IET COMMUN, V6, P211, DOI 10.1049/iet-com.2010.0820; TalebiFard P, 2010, COMPUT NETW, V54, P545, DOI 10.1016/j.comnet.2009.08.017; Wang N, 2011, PROCEDIA ENVIRON SCI, V11, P55, DOI 10.1016/j.proenv.2011.12.010; Xia L, 2007, IEEE ICC, P5665, DOI 10.1109/ICC.2007.939; Yan XH, 2008, IEEE COMMUN LETT, V12, P14, DOI 10.1109/LCOMM.2008.071430; Yang XS, 2010, INT J BIO-INSPIR COM, V2, P78, DOI 10.1504/IJBIC.2010.032124; Ylianttila M, 2005, COMPUT NETW, V47, P185, DOI 10.1016/j.comnet.2004.07.004; Yu H, 2011, IEEE T IND ELECTRON, V58, P5438, DOI 10.1109/TIE.2011.2164773	42	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0151355	10.1371/journal.pone.0151355	http://dx.doi.org/10.1371/journal.pone.0151355			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438600	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000380170100001
J	Hu, HH; Hori, A; Nishiura, C; Sasaki, N; Okazaki, H; Nakagawa, T; Honda, T; Yamamoto, S; Tomita, K; Miyamoto, T; Nagahama, S; Uehara, A; Yamamoto, M; Murakami, T; Shimizu, C; Shimizu, M; Eguchi, M; Kochi, T; Imai, T; Okino, A; Kuwahara, K; Kashino, I; Akter, S; Kurotani, K; Nanri, A; Kabe, I; Mizoue, T; Kunugita, N; Dohi, S				Hu, Huanhuan; Hori, Ai; Nishiura, Chihiro; Sasaki, Naoko; Okazaki, Hiroko; Nakagawa, Tohru; Honda, Toru; Yamamoto, Shuichiro; Tomita, Kentaro; Miyamoto, Toshiaki; Nagahama, Satsue; Uehara, Akihiko; Yamamoto, Makoto; Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko; Eguchi, Masafumi; Kochi, Takeshi; Imai, Teppei; Okino, Akiko; Kuwahara, Keisuke; Kashino, Ikuko; Akter, Shamima; Kurotani, Kayo; Nanri, Akiko; Kabe, Isamu; Mizoue, Tetsuya; Kunugita, Naoki; Dohi, Seitaro		Japan Epidemiology Collaboration	Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study	PLOS ONE			English	Article							POORER GLYCEMIC CONTROL; MULTIFACTORIAL INTERVENTION; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; CIGARETTE-SMOKING; TYPE-2; RISK; ADULTS; CARE; COMPLICATIONS	Aims The control of blood glucose levels, blood pressure (BP), and low-density lipoprotein cholesterol (LDL-C) levels reduces the risk of diabetes complications; however, data are scarce on control status of these factors among workers with diabetes. The present study aimed to estimate the prevalence of participants with diabetes who meet glycated hemoglobin (HbA1c), BP, and LDL-C recommendations, and to investigate correlates of poor glycemic control in a large working population in Japan. Methods The Japan Epidemiology Collaboration on Occupational Health (J-ECOH) Study is an ongoing cohort investigation, consisting mainly of employees in large manufacturing companies. We conducted a cross-sectional analysis of 3,070 employees with diabetes (2,854 men and 216 women) aged 20-69 years who attended periodic health examinations. BP was measured and recorded using different company protocols. Risk factor targets were defined using both American Diabetes Association (ADA) guidelines (HbA1c < 7.0%, BP < 140/90 mmHg, and LDL-C < 100 mg/dL) and Japan Diabetes Society (JDS) guidelines (HbA1c < 7.0%, BP < 130/80 mmHg, and LDL-C < 120 mg/dL). Logistic regression models were used to explore correlates of poor glycemic control (defined as HbA1c >= 8.0%). Results The percentages of participants who met ADA (and JDS) targets were 44.9%(44.9%) for HbA1c, 76.6% (36.3%) for BP, 27.1%(56.2%) for LDL-C, and 11.2%(10.8%) for simultaneous control of all three risk factors. Younger age, obesity, smoking, and uncontrolled dyslipidemia were associated with poor glycemic control. The adjusted odds ratio of poor glycemic control was 0.58 (95% confidence interval, 0.46-0.73) for participants with treated but uncontrolled hypertension, and 0.47 (0.33-0.66) for participants with treated and controlled hypertension, as compared with participants without hypertension. There was no significant difference in HbA1c levels between participants with treated but uncontrolled hypertension and those with treated and controlled hypertension. Conclusion Data from a large working population, predominantly composed of men, suggest that achievement of HbA1c, BP, and LDL-C targets was less than optimal, especially in younger participants. Uncontrolled dyslipidemia was associated with poor glycemic control. Participants not receiving antihypertensive treatment had higher HbA1c levels.	[Hu, Huanhuan; Kuwahara, Keisuke; Kashino, Ikuko; Akter, Shamima; Kurotani, Kayo; Nanri, Akiko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Hori, Ai; Nishiura, Chihiro] Tokyo Gas Co Ltd, Tokyo, Japan; [Sasaki, Naoko] Mitsubishi Fuso Truck & Bus Corp, Kawasaki, Kanagawa, Japan; [Okazaki, Hiroko; Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan; [Nakagawa, Tohru; Honda, Toru; Yamamoto, Shuichiro] Hitachi Ltd, Ibaraki, Japan; [Tomita, Kentaro] Mitsubishi Plast Inc, Tokyo, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Nagahama, Satsue] All Japan Labour Welf Fdn, Tokyo, Japan; [Uehara, Akihiko; Yamamoto, Makoto] YAMAHA Corp, Shizuoka, Japan; [Murakami, Taizo; Shimizu, Chii; Shimizu, Makiko] Keihin Occupat Hlth Ctr, Mizue Med Clin, Kawasaki, Kanagawa, Japan; [Eguchi, Masafumi; Kochi, Takeshi; Kabe, Isamu] Furukawa Elect Corp Ltd, Tokyo, Japan; [Imai, Teppei; Okino, Akiko] Azbil Corp, Tokyo, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo, Japan; [Kunugita, Naoki] Natl Inst Publ Hlth, Saitama, Japan	National Center for Global Health & Medicine - Japan; Daimler AG; Mitsui Chemicals; Hitachi Limited; Nippon Steel & Sumitomo Metal Corporation; Yamaha; Furukawa Electric; Teikyo University; National Institute of Public Health - Japan	Hu, HH (corresponding author), Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan.	huhuanhuan@ri.ncgm.go.jp	Okino, Akitoshi/O-1804-2013; Nishiura, Chihiro/Q-7938-2019; Nishiura, Chihiro/C-4132-2017; Hori, Ai/G-5277-2019; KASHINO, IKUKO/AAS-4008-2020	Okino, Akitoshi/0000-0002-8949-294X; Nishiura, Chihiro/0000-0002-8850-5446; Nishiura, Chihiro/0000-0002-8850-5446; Hori, Ai/0000-0002-0191-5996; Kuwahara, Keisuke/0000-0002-7503-1333; Kochi, Takeshi/0000-0002-3411-1070; Kunugita, Naoki/0000-0002-6516-8379	Industrial Health Foundation; Industrial Disease Clinical Research Grants [140202-01, 150903-01]; Tokyo Gas Co., Ltd.; Mitsubishi Fuso Truck and Bus Corporation; Mitsui Chemicals, Inc.; Hitachi, Ltd.; Mitsubishi Plastics, Inc.; Nippon Steel & Sumitomo Metal Corporation Kimitsu Works; YAMAHA CORPORATION; Furukawa Electric Co., Ltd.; Azbil Corporation	Industrial Health Foundation; Industrial Disease Clinical Research Grants; Tokyo Gas Co., Ltd.; Mitsubishi Fuso Truck and Bus Corporation; Mitsui Chemicals, Inc.; Hitachi, Ltd.; Mitsubishi Plastics, Inc.; Nippon Steel & Sumitomo Metal Corporation Kimitsu Works; YAMAHA CORPORATION; Furukawa Electric Co., Ltd.; Azbil Corporation	This study was supported by the Industrial Health Foundation and Industrial Disease Clinical Research Grants (140202-01, 150903-01). "Tokyo Gas Co., Ltd.", "Mitsubishi Fuso Truck and Bus Corporation", "Mitsui Chemicals, Inc.", "Hitachi, Ltd.", "Mitsubishi Plastics, Inc.", "Nippon Steel & Sumitomo Metal Corporation Kimitsu Works", "YAMAHA CORPORATION", "Furukawa Electric Co., Ltd." and "Azbil Corporation" provided support in the form of salaries for authors [A. Hori, C. Nishiura, N. Sasaki, H. Okazaki, S. Dohi, T. Nakagawa, T. Honda, S. Yamamoto, K. Tomita, T. Miyamoto, A. Uehara, M. Yamamoto, M. Eguchi, T. Kochi, I. Kabe, T. Imai, and A. Okino], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali MK, 2014, ANN INTERN MED, V161, P681, DOI 10.7326/M14-0019; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Arai K, 2009, DIABETES RES CLIN PR, V83, P397, DOI 10.1016/j.diabres.2008.11.036; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Chan WB, 2005, DIABETES-METAB RES, V21, P183, DOI 10.1002/dmrr.497; Collins R, 2003, LANCET, V361, P2005; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gillespie EL, 2005, DIABETES CARE, V28, P2261, DOI 10.2337/diacare.28.9.2261; Guideline committee of the Japan Diabetes Society, 2013, TREATM GUID DIAB 201; Gunton JE, 2002, DIABETES CARE, V25, P796, DOI 10.2337/diacare.25.4.796-a; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holmes VA, 2011, DIABETES CARE, V34, P1683, DOI 10.2337/dc11-0244; Hori A, 2014, CIRC J, V78, P1160, DOI 10.1253/circj.CJ-13-1067; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Iso H, 2008, CIRCULATION, V118, P2725, DOI 10.1161/CIRCULATIONAHA.107.750117; Janghorbani M, 2015, J DIABETES INVEST, V6, P716, DOI 10.1111/jdi.12349; Juarez DT, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120065; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Liew SM, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-53; MacIsaac RJ, 2009, INTERN MED J, V39, P512, DOI 10.1111/j.1445-5994.2008.01821.x; Matsushita Y, 2010, OBESITY, V18, P2374, DOI 10.1038/oby.2010.33; Mullugeta Y, 2012, INDIAN J CLIN BIOCHE, V27, P363, DOI 10.1007/s12291-012-0225-8; Quah JHM, 2011, ANN ACAD MED SINGAP, V40, P276; Quah JHM, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-18; Rizos CV, 2014, WORLD J CARDIOL, V6, P517, DOI 10.4330/wjc.v6.i7.517; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; So WY, 2011, J DIABETES, V3, P109, DOI 10.1111/j.1753-0407.2011.00115.x; Spoelstra JA, 2003, THESIS; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Takahashi E, 2014, INTERNAL MED, V53, P1491, DOI 10.2169/internalmedicine.53.1876; Targher G, 1997, J CLIN ENDOCR METAB, V82, P3619, DOI 10.1210/jc.82.11.3619; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; The Ministry of Health Labour and Welfare Ministry of Education Culture Sports Science and Technology, 2002, ETH GUID EP RES; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Uehara A, 2014, DIABETES RES CLIN PR, V106, P118, DOI 10.1016/j.diabres.2014.07.013; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yokoyama H, 2007, DIABETES CARE, V30, P989, DOI 10.2337/dc06-1859; Yu SH, 2013, J DIABETES INVEST, V4, P460, DOI 10.1111/jdi.12077	43	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159071	10.1371/journal.pone.0159071	http://dx.doi.org/10.1371/journal.pone.0159071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27437997	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100027
J	Wu, J; Huang, Q; Meng, DD; Huang, MY; Li, CW; Qin, TZ				Wu, Jun; Huang, Qun; Meng, Dongdong; Huang, Minyu; Li, Chaowen; Qin, Tianzi			A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer	PLOS ONE			English	Article							MICRORNA-145; EXPRESSION; INVASION; SURVIVAL; SMOKING; GROWTH; CELLS; GENE	Background and Objectives MicroRNA (miR)-143/145, known as tumor suppressors, can promote cell apoptosis and differentiation, and suppress cell proliferation, invasion and migration. We performed a case-control study to investigate the association of rs353293 in the promoter region of miR-143/145 with bladder cancer risk. Methods In total, 869 subjects including 333 cases and 536 controls were enrolled in this study, and the rs353293 polymorphism was genotyped by using a Taqman assay. The promoter activity was measured by the Dual-Luciferase Assay System. Results We calculated an adjusted odds ratio of 0.64 for the presence of either AA/AG genotypes (95% CI 0.46-0.90) and 0.64 (95% CI 0.47-0.87) for carrying at least one A allele in bladder cancer. Stratified analyses showed that the AA/AG genotypes and the A allele were less prevalent in patients with low grade tumors, compared to those harboring higher grade bladder cancers (adjusted OR = 0.53, 95% CI, 0.30-0.94, P = 0.03 and adjusted OR = 0.54, 95% CI, 0.32-0.92, P = 0.02, respectively). In vitro luciferase reporter analysis showed that rs353293A allele had a lower activity compared with the rs353293G allele (P < 0.001). Conclusion These findings suggest that the functional rs353293 polymorphism may be a useful biomarker to predict the risk of bladder cancer.	[Wu, Jun; Huang, Qun; Meng, Dongdong; Huang, Minyu; Li, Chaowen; Qin, Tianzi] Youjiang Med Coll Nationalities, Affiliated Hosp, Dept Urinary Surg, Baise 533000, Guangxi, Peoples R China	Youjiang Medical University for Nationalities	Wu, J (corresponding author), Youjiang Med Coll Nationalities, Affiliated Hosp, Dept Urinary Surg, Baise 533000, Guangxi, Peoples R China.	984136322@qq.com			Health and Family Planning Commission of Guangxi [Z2015085]	Health and Family Planning Commission of Guangxi	This work was supported by Health and Family Planning Commission of Guangxi (No. Z2015085).	Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Avgeris M, 2015, CARCINOGENESIS, V36, P528, DOI 10.1093/carcin/bgv024; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Chu HY, 2016, ARCH TOXICOL, V90, P403, DOI 10.1007/s00204-014-1396-2; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Fujii T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1846-0; Gautam KA, 2016, CYTOKINE, V77, P152, DOI 10.1016/j.cyto.2015.11.008; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Inamoto T, 2015, ONCOTARGET, V6, P21628, DOI 10.18632/oncotarget.4129; Kou B, 2014, UROL ONCOL-SEMIN ORI, V32, P846, DOI 10.1016/j.urolonc.2014.01.003; Leppert JT, 2006, EUR UROL, V49, P226, DOI 10.1016/j.eururo.2005.12.011; Li LJ, 2013, HUM IMMUNOL, V74, P993, DOI 10.1016/j.humimm.2013.04.019; Li X, 2015, CANC BIOMARKERS A; Liang YD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001289; Liu LP, 2012, MOL MED REP, V5, P753, DOI 10.3892/mmr.2011.696; Michael MZ, 2003, MOL CANCER RES, V1, P882; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; Noguchi S, 2013, CANCER LETT, V328, P353, DOI 10.1016/j.canlet.2012.10.017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; Su JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114420; Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520; Volanisa D, 2010, TOXICOL LETT, V193, P131, DOI 10.1016/j.toxlet.2009.12.018; Wang Y, 2014, DNA CELL BIOL, V33, P205, DOI 10.1089/dna.2013.2100; Wu DY, 2013, MOL MED REP, V8, P626, DOI 10.3892/mmr.2013.1501; Yan X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-220; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zeegers MPA, 2002, CANCER CAUSE CONTROL, V13, P83, DOI 10.1023/A:1013954932343; Zhai L, 2015, MOL CARCINOG; Zhou H, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0167-0; Zhu ZW, 2014, FEBS LETT, V588, P3180, DOI 10.1016/j.febslet.2014.06.059	36	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159115	10.1371/journal.pone.0159115	http://dx.doi.org/10.1371/journal.pone.0159115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438131	Green Published, gold, Green Submitted			2022-12-26	WOS:000380170100029
J	Chen, L; Chu, C; Zhang, YH; Zhu, CM; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Zhang, Yu-Hang; Zhu, Changming; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Analysis of Gene Expression Profiles in the Human Brain Stem, Cerebellum and Cerebral Cortex	PLOS ONE			English	Article							AMINO-ACID OXIDASE; METABOLIC PATHWAY; SMO ALGORITHM; PREDICTION; EVOLUTION; DELETION; PROTEIN; CONVERGENCE; INFORMATION; DENSIN-180	The human brain is one of the most mysterious tissues in the body. Our knowledge of the human brain is limited due to the complexity of its structure and the microscopic nature of connections between brain regions and other tissues in the body. In this study, we analyzed the gene expression profiles of three brain regions-the brain stem, cerebellum and cerebral cortex-to identify genes that are differentially expressed among these different brain regions in humans and to obtain a list of robust, region-specific, differentially expressed genes by comparing the expression signatures from different individuals. Feature selection methods, specifically minimum redundancy maximum relevance and incremental feature selection, were employed to analyze the gene expression profiles. Sequential minimal optimization, a machine-learning algorithm, was employed to examine the utility of selected genes. We also performed a literature search, and we discuss the experimental evidence for the important physiological functions of several highly ranked genes, including NR2E1, DAO, and LRRC7, and we give our analyses on a gene (TFAP2B) that have not been investigated or experimentally validated. As a whole, the results of our study will improve our ability to predict and understand genes related to brain regionalization and function.	[Chen, Lei; Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China; [Chen, Lei; Zhu, Changming] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Chu, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zhang, Yu-Hang; Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China.; Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Chen, Lei/A-2275-2011; Chu, Chen/J-6527-2019; Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015	Chen, Lei/0000-0003-3068-1583; Chu, Chen/0000-0001-8084-0867; Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [61202021, 31371335]; Shanghai Natural Science Foundation [16ZR1414500]; Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) [2016245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Sailing Program; Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS)	This study was supported by the National Natural Science Foundation of China (61202021, 31371335), Shanghai Natural Science Foundation (16ZR1414500), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (61202021, 31371335), Shanghai Natural Science Foundation (16ZR1414500), Shanghai Sailing Program and The Youth Innovation Promotion Association of Chinese Academy of Sciences (CAS) (2016245).	[Anonymous], 2014, LANCET NEUROL, V13, P855, DOI 10.1016/S1474-4422(14)70181-4; Apperson ML, 1996, J NEUROSCI, V16, P6839; Bauernfeind AL, 2015, GENOME BIOL EVOL, V7, P2276, DOI 10.1093/gbe/evv132; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Chang CC, 2000, IEEE T NEURAL NETWOR, V11, P1003, DOI 10.1109/72.857780; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen L, 2015, PLOS ONE, V10, DOI [10.1371/ journal. pone. 0126492, DOI 10.1371/J0URNAL.P0NE.0126492]; Chen L, 2016, COMB CHEM HIGH T SCR, V19, P136, DOI 10.2174/1386207319666151110122453; Chen L, 2015, AMINO ACIDS, V47, P1485, DOI 10.1007/s00726-015-1974-5; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Christie BR, 2006, NEUROSCIENCE, V137, P1031, DOI 10.1016/j.neuroscience.2005.08.091; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fernandez-Irigoyen J, 2015, J PROTEOMICS, V127, P395, DOI 10.1016/j.jprot.2015.03.032; Foletta VC, 2002, MOL BRAIN RES, V107, P65, DOI 10.1016/S0169-328X(02)00448-5; Giger T, 2010, GENOME BIOL EVOL, V2, P284, DOI 10.1093/gbe/evq018; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Hastie T, 1998, ADV NEUR IN, V10, P507; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; Joven A, 2013, J COMP NEUROL, V521, P3913, DOI 10.1002/cne.23385; Keerthi SS, 2002, MACH LEARN, V46, P351, DOI 10.1023/A:1012431217818; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; KRUMLAUF R, 1987, DEVELOPMENT, V99, P603; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Lin CJ, 2001, IEEE T NEURAL NETWOR, V12, P1288, DOI 10.1109/72.963765; Lingaiah Kusuma, 2011, Indian J Med Res, V134, P621, DOI 10.4103/0971-5916.90986; Liu T, 2015, INT J SYST SCI, V46, P919, DOI 10.1080/00207721.2013.801096; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Mahfouz A, 2015, METHODS, V73, P79, DOI 10.1016/j.ymeth.2014.10.004; Matsunaga E, 2001, DEVELOPMENT, V128, P4069; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohn AR, 1997, MOL CELL NEUROSCI, V9, P63, DOI 10.1006/mcne.1997.0606; Moreno S, 1999, J NEUROCYTOL, V28, P169, DOI 10.1023/A:1007064504007; Myers EM, 2015, METHODS, V73, P54, DOI 10.1016/j.ymeth.2014.12.010; NAGATA Y, 1992, EXPERIENTIA, V48, P753, DOI 10.1007/BF02124295; O'Loghlen A, 2015, ONCOGENE, V34, P4069, DOI 10.1038/onc.2014.335; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Reichert H, 2010, ADV EXP MED BIOL, V689, P145; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Shen EH, 2012, TRENDS NEUROSCI, V35, P711, DOI 10.1016/j.tins.2012.09.005; Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328; Stenman JM, 2003, J NEUROSCI, V23, P10568; Strick CA, 2011, NEUROPHARMACOLOGY, V61, P1001, DOI 10.1016/j.neuropharm.2011.06.029; Torii Y, 2009, NEUROCOMPUTING, V72, P973, DOI 10.1016/j.neucom.2008.04.008; Witten I.H., 2005, DATA MINING PRACTICA; Wu H, 2007, DNA SEQUENCE, V18, P73, DOI 10.1080/10425170500511271; Xiong F, 2013, CARDIOVASC PATHOL, V22, P141, DOI 10.1016/j.carpath.2012.07.001; Xu ZB, 2009, IEEE T SYST MAN CY B, V39, P1292, DOI 10.1109/TSMCB.2009.2015672; Yamanaka M, 2012, AMINO ACIDS, V43, P1811, DOI 10.1007/s00726-012-1384-x; Young KA, 2002, BEHAV BRAIN RES, V132, P145, DOI 10.1016/S0166-4328(01)00413-2; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137	59	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159395	10.1371/journal.pone.0159395	http://dx.doi.org/10.1371/journal.pone.0159395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434030	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600051
J	Nunes, HEG; Goncalves, ECD; Vieira, JAJ; Silva, DAS				Gimenes Nunes, Heloyse Elaine; de Andrade Goncalves, Eliane Cristina; Jesus Vieira, Jessika Aparecida; Santos Silva, Diego Augusto			Clustering of Risk Factors for Non-Communicable Diseases among Adolescents from Southern Brazil	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BEHAVIORS; ASSOCIATIONS; PREVALENCE	Introduction The aim of this study was to investigate the simultaneous presence of risk factors for non-communicable diseases and the association of these risk factors with demographic and economic factors among adolescents from southern Brazil. Methods The study included 916 students (14-19 years old) enrolled in the 2014 school year at state schools in Sao Jose, Santa Catarina, Brazil. Risk factors related to lifestyle (i.e., physical inactivity, excessive alcohol consumption, smoking, sedentary behaviour and unhealthy diet), demographic variables (sex, age and skin colour) and economic variables (school shift and economic level) were assessed through a questionnaire. Simultaneous behaviours were assessed by the ratio between observed and expected prevalences of risk factors for non-communicable diseases. The clustering of risk factors was analysed by multinomial logistic regression. The clusters of risk factors that showed a higher prevalence were analysed by binary logistic regression. Results The clustering of two, three, four, and five risk factors were found in 22.2%, 49.3%, 21.7% and 3.1% of adolescents, respectively. Subgroups that were more likely to have both behaviours of physical inactivity and unhealthy diet simultaneously were mostly composed of girls (OR = 3.03, 95% CI = 1.57-5.85) and those with lower socioeconomic status (OR = 1.83, 95% CI = 1.05-3.21); simultaneous physical inactivity, excessive alcohol consumption, sedentary behaviour and unhealthy diet were mainly observed among older adolescents (OR = 1.49, 95% CI = 1.05-2.12). Subgroups less likely to have both behaviours of sedentary behaviour and unhealthy diet were mostly composed of girls (OR = 0.58, 95% CI = 0.38-0.89); simultaneous physical inactivity, sedentary behaviour and unhealthy diet were mainly observed among older individuals (OR = 0.66, 95% CI = 0.49-0.87) and those of the night shift (OR = 0.59, 95% CI = 0.43-0.82). Conclusion Adolescents had a high prevalence of simultaneous risk factors for NCDs. Demographic (gender and age) and economic (school shift) variables were associated with the most prevalent simultaneous behaviours among adolescents.	[Gimenes Nunes, Heloyse Elaine; de Andrade Goncalves, Eliane Cristina; Jesus Vieira, Jessika Aparecida; Santos Silva, Diego Augusto] Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Silva, DAS (corresponding author), Univ Fed Santa Catarina, Res Ctr Kinanthropometry & Human Performance, Florianopolis, SC, Brazil.	diegoaugustoss@yahoo.com.br	Silva, Diego/GRF-5446-2022; Silva, Diego Augusto Santos/AAB-9249-2020	Silva, Diego Augusto Santos/0000-0002-0489-7906	UNIEDU	UNIEDU	The author (HEGN) thanks the UNIEDU for the scholarship.	Alamian A, 2009, PREV MED, V48, P493, DOI 10.1016/j.ypmed.2009.02.015; [Anonymous], 2015, WHO REP GLOB TOB EP; Brazilian Association of Research Companies, 2012, EC CLASS CRIT BRAZ; Brazilian Institute of Geography and Statistics, 2013, POP CENS 2010; Brazilian Institute of Geography and Statistics, 2013, NAT HLTH SURV SCH 20; Busch V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1118; Council on Foreign Relations, 2011, POL DECL HIGH LEV M; Cureau FV, 2014, J PHYS ACT HEALTH, V11, P942, DOI 10.1123/jpah.2012-0247; Currie C, 2008, INEQUALITES YOUNG PE; da Silva KS, 2009, CAD SAUDE PUBLICA, V25, P2187, DOI 10.1590/S0102-311X2009001000010; Pedrosa AAD, 2011, CAD SAUDE PUBLICA, V27, P1611, DOI 10.1590/S0102-311X2011000800016; Drewnowski A, 2010, AM J CLIN NUTR, V92, P1181, DOI 10.3945/ajcn.2010.29300; Costa Filipe Ferreira da, 2013, Rev. bras. epidemiol., V16, P398, DOI 10.1590/S1415-790X2013000200015; de Moraes ACF, 2009, REV ASSOC MED BRAS, V55, P523, DOI 10.1590/S0104-42302009000500013; de Moraes ACF, 2009, CAD SAUDE PUBLICA, V25, P1195, DOI 10.1590/S0102-311X2009000600002; Goncalves EC, 2015, REV PAUL PEDIAT; Guedes Dartagnan Pinto, 2010, Rev. Saúde Pública, V44, P840, DOI 10.1590/S0034-89102010000500009; Pavon DJ, 2010, NUTR HOSP, V25, P311, DOI 10.3305/nh.2010.25.2.4596; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kuhnen Mirian, 2009, Rev. bras. epidemiol., V12, P615, DOI 10.1590/S1415-790X2009000400011; Kuntsche E, 2006, ADDICT BEHAV, V31, P1844, DOI 10.1016/j.addbeh.2005.12.028; Luiz R., 2000, CAD SAUDE COLET, V8, P9; Malta DC, 2013, EPIDEMIOL SERV SAUDE, V22; Ng C, 2010, PUBLIC HEALTH NUTR, V13, P1430, DOI 10.1017/S1368980010000832; Pechansky Flavio, 2004, Rev. Bras. Psiquiatr., V26, P14, DOI 10.1590/S1516-44462004000500005; Pronk NP, 2004, AM J PREV MED, V27; Rehm J, 2004, COMP QUANTIFICATION, P959; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Anez CRR, 2008, ARQ BRAS CARDIOL, V91, P102; Sanchez A, 2007, AM J PREV MED, V32, P124, DOI 10.1016/j.amepre.2006.10.012; Silva DAS, 2016, PEDIATR EXERC SCI, V28, P312, DOI 10.1123/pes.2015-0172; Silva DAS, 2012, J COMMUN HEALTH, V37, P591, DOI 10.1007/s10900-011-9489-9; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Silva K. S., 2012, REV PAUL PEDIATR, V30, P338, DOI DOI 10.1590/S0103-05822012000300006; Sousa SZ, 2008, EDUC REV-CURITIBA, P53, DOI 10.1590/S0104-40602008000100005; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Taylor RM, 2008, J CLIN NURS, V17, P3083, DOI 10.1111/j.1365-2702.2008.02629.x; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; WHO, 2015, GLOB STRAT DIET PHYS, P3	40	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159037	10.1371/journal.pone.0159037	http://dx.doi.org/10.1371/journal.pone.0159037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434023	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600029
J	Hoare, R; Thompson, KD; Herath, T; Collet, B; Bron, JE; Adams, A				Hoare, R.; Thompson, K. D.; Herath, T.; Collet, B.; Bron, J. E.; Adams, A.			Development, Characterisation and Application of Monoclonal Antibodies for the Detection and Quantification of Infectious Salmon Anaemia Virus in Plasma Samples Using Luminex Bead Array Technology	PLOS ONE			English	Article							MULTIPLEX FLOW IMMUNOASSAY; ATLANTIC SALMON; IDENTIFICATION; ASSAY; ISA; NUCLEOPROTEIN; CYTOKINES; PROTEINS; VACCINE; ELISA	Infectious salmon anaemia virus (ISAV) is an orthomyxovirus that has had a significant economic impact on Atlantic salmon farming in Europe, North America and Chile. Monoclonal antibodies (mAbs) were developed against Segment 3 (encoding the viral nucleoprotein, NP) of the virus. Six of the mAbs were shown to be specific to ISAV and recognised all isolates from Scotland, Norway and Canada. They reacted with ISAV in enzyme-linked immunosorbent assay (ELISA), indirect fluorescent antibody technique (IFAT) and western blotting. They were also used to develop a novel detection method based on Luminex (BioPlex) bead-based flow cytometric technology for the detection of ISAV in the plasma of Atlantic salmon (Salmo salar L.) smolts experimentally infected with ISAV. Fish were challenged by intraperitoneal (i.p.) injection of virus at 50% Tissue Culture Infective Dose (TCID50) = 2.8 x10(6) per animal. Virus present in plasma of infected fish, collected at 0, 4, 8, 12, 16, 21 and 28 days post infection using a non-lethal sampling method (n = 12 at each time point), was quantified using the optimised Bio-Plex assay. The results obtained with this assay were compared with absolute quantification of the virus by RT-qPCR using SYBR Green I and TaqMan chemistries. The Bio-Plex assay developed using the NP mAbs appears to be a rapid, sensitive method for detecting and quantifying ISAV in small volumes of fish plasma and has the potential to be multiplexed for the detection of other fish pathogens (e.g. during co-infections). To our knowledge this is the first report of the use of Luminex (Bio-Plex) technology for the detection of a fish pathogen.	[Hoare, R.; Thompson, K. D.; Bron, J. E.; Adams, A.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Thompson, K. D.] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Herath, T.] Harper Adams Univ, Dept Anim Prod Welf & Vet Sci, Newport TF10 8NB, Shrops, England; [Collet, B.] Marine Lab, Marine Scotland, 375 Victoria Rd, Aberdeen AB11 9PA, Scotland	University of Stirling; Moredun Research Institute; Marine Scotland Science (MSS)	Hoare, R (corresponding author), Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland.	rh30@stir.ac.uk	Thompson, Kim/GLU-8547-2022; Bron, James E/B-6231-2018; Thompson, Kim/O-7707-2015; Collet, Bertrand/C-1113-2012	Bron, James E/0000-0003-3544-0519; Hoare, Rowena/0000-0002-9298-4275; Thompson, Kim/0000-0003-3550-4842; Collet, Bertrand/0000-0003-2795-2653; Adams, Alexandra/0000-0002-2469-3310	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [G1100675]	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This work was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs, grant G1100675). The web page of the project is located at https://www.nc3rs.org.uk/development-non-lethalsampling-method-monitor-immune-response-anddisease-progression-salmonid-fish: BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2014, J FISH DIS, V37, P291, DOI 10.1111/jfd.12225; ADAMS A, 1995, FISH SHELLFISH IMMUN, V5, P537, DOI 10.1016/S1050-4648(95)80040-9; Ahn S.-B., 2014, EUPA OPEN PROTEOM, V3, P78; Aspehaug V, 2004, VIRUS RES, V106, P51, DOI 10.1016/j.virusres.2004.06.001; Binnicker MJ, 2008, CLIN VACCINE IMMUNOL, V15, P1410, DOI 10.1128/CVI.00082-08; Caraguel C, 2012, PREV VET MED, V104, P165, DOI 10.1016/j.prevetmed.2011.10.006; CASWELLRENO P, 1989, J CLIN MICROBIOL, V27, P1924, DOI 10.1128/JCM.27.9.1924-1929.1989; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Christopher-Hennings J, 2013, J VET DIAGN INVEST, V25, P671, DOI 10.1177/1040638713507256; Collet B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137767; Costa JZ, 2007, J FISH DIS, V30, P419, DOI 10.1111/j.1365-2761.2007.00824.x; DANNEVIG BH, 1995, J GEN VIROL, V76, P1353, DOI 10.1099/0022-1317-76-6-1353; DANNEVIG BH, 1995, VET RES, V26, P438; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Falk K, 1998, DIS AQUAT ORGAN, V34, P77, DOI 10.3354/dao034077; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Goic B, 2008, VIROLOGY, V379, P55, DOI 10.1016/j.virol.2008.05.036; Gomez E, 2010, CLIN VACCINE IMMUNOL, V17, P966, DOI 10.1128/CVI.00086-10; Gorgoglione B., 2013, DAFINET WORKSH 2013; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Kuller L, 2005, DIAGN MICR INFEC DIS, V53, P185, DOI 10.1016/j.diagmicrobio.2005.05.012; Lawson S, 2010, VACCINE, V28, P5356, DOI 10.1016/j.vaccine.2010.05.016; Mardones FO, 2014, PREV VET MED, V114, P37, DOI 10.1016/j.prevetmed.2014.01.012; Munir K, 2004, J VIROL METHODS, V117, P37, DOI 10.1016/j.jviromet.2003.11.020; Murray AG, 2002, EMERG INFECT DIS, V8, P1, DOI 10.3201/eid0801.010144; NEELAM B, 1995, DIS AQUAT ORGAN, V21, P201, DOI 10.3354/dao021201; OIE, 2014, AN OIE MAN DIAGN TES; Lhorente JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095397; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Tallent SM, 2013, APPL ENVIRON MICROB, V79, P1422, DOI 10.1128/AEM.02743-12; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; Valdes-Donoso P, 2013, J FISH DIS, V36, P353, DOI 10.1111/jfd.12070; Wolf A, 2014, FISH SHELLFISH IMMUN, V36, P383, DOI 10.1016/j.fsi.2013.12.018; Workenhe ST, 2008, J VIROL METHODS, V154, P128, DOI 10.1016/j.jviromet.2008.08.007; Zubach V, 2012, J CLIN MICROBIOL, V50, P460, DOI 10.1128/JCM.06090-11	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159155	10.1371/journal.pone.0159155	http://dx.doi.org/10.1371/journal.pone.0159155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434377	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000380169600036
J	Katsoulieris, EN; Drossopoulou, GI; Kotsopoulou, ES; Vlahakos, DV; Lianos, EA; Tsilibary, EC				Katsoulieris, Elias N.; Drossopoulou, Garyfalia I.; Kotsopoulou, Eleni S.; Vlahakos, Dimitrios V.; Lianos, Elias A.; Tsilibary, Effie C.			High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; SERINE/THREONINE PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; PODOCALYXIN EXPRESSION; ENDOPLASMIC-RETICULUM; NUTRIENT HOMEOSTASIS; SKELETAL-MUSCLE	Objective Chronic hyperglycaemia, as seen in type II diabetes, results in both morphological and functional impairments of podocytes in the kidney. We investigated the effects of high glucose (HG) on the insulin signaling pathway, focusing on cell survival and apoptotic markers, in immortalized human glomerular cells (HGEC; podocytes) and isolated glomeruli from healthy rats. Methods and Findings HGEC and isolated glomeruli were cultured for various time intervals under HG concentrations in the presence or absence of insulin. Our findings indicated that exposure of HGEC to HG led to downregulation of all insulin signaling markers tested (IR, p-IR, IRS-1, p-Akt, p-Fox01,03), as well as to increased sensitivity to apoptosis (as seen by increased PARP cleavage, Casp3 activation and DNA fragmentation). Short insulin pulse caused upregulation of insulin signaling markers (IR, p-IR, p-Akt, p-Fox01,03) in a greater extent in normoglycaemic cells compared to hyperglycaemic cells and for the case of p-Akt, in a PI3K-dependent manner. IRS-1 phosphorylation of HG-treated podocytes was negatively regulated, favoring serine versus tyrosine residues. Prolonged insulin treatment caused a significant decrease of IR levels, while alterations in glucose concentrations for various time intervals demonstrated changes of IR, p-IR and p-Akt levels, suggesting that the IR signaling pathway is regulated by glucose levels. Finally, HG exerted similar effects in isolated glomeruli. Conclusions These results suggest that HG compromises the insulin signaling pathway in the glomerulus, promoting a proapoptotic environment, with a possible critical step for this malfunction lying at the level of IRS-1 phosphorylation; thus we herein demonstrate glomerular insulin signaling as another target for investigation for the prevention and/or treatment of diabetic nephropathy.	[Katsoulieris, Elias N.; Drossopoulou, Garyfalia I.; Kotsopoulou, Eleni S.; Tsilibary, Effie C.] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece; [Vlahakos, Dimitrios V.] Attikon Univ Hosp, Dept Propaedeut Med 2, Athens, Greece; [Lianos, Elias A.] Univ Athens, Sch Med, Dept Pathol, Athens, Greece	National Centre of Scientific Research "Demokritos"; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens	Drossopoulou, GI; Tsilibary, EC (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	gdross@bio.demokritos.gr; effie@bio.demokritos.gr			European Social Fund NSRF EXCELLENCE (ARISTEIA) [DIABETAL-164]; Operational Programme Education and Lifelong learning, Ministry of Education Lifelong Learning and Religious Affiairs	European Social Fund NSRF EXCELLENCE (ARISTEIA); Operational Programme Education and Lifelong learning, Ministry of Education Lifelong Learning and Religious Affiairs	ENK's work was part of European Social Fund NSRF EXCELLENCE (ARISTEIA) DIABETAL-164 "Common Pathogenetic Mechanisms and Pathways of the Matrix-related Diseases of Diabetes and Alzheimer Resulting in Apoptotic Cell Death". The project was further supported by the Operational Programme Education and Lifelong learning, Ministry of Education Lifelong Learning and Religious Affiairs, and by receiving the honorary 1st award in the Panhellenic Medical Conference, 2014, Athens, Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catalano C, 1997, DIABETES, V46, P868, DOI 10.2337/diabetes.46.5.868; Chen C, 2009, NEPHRON EXP NEPHROL, V113, pE26, DOI 10.1159/000228080; Chuang PY, 2007, KIDNEY INT, V72, P965, DOI 10.1038/sj.ki.5002456; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Coward RJM, 2005, DIABETES, V54, P3095, DOI 10.2337/diabetes.54.11.3095; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; DELARUE F, 1991, KIDNEY INT, V40, P906, DOI 10.1038/ki.1991.292; Ding GH, 2002, AM J PHYSIOL-RENAL, V283, pF173, DOI 10.1152/ajprenal.00240.2001; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Drapeau N, 2013, AM J PHYSIOL-ENDOC M, V304, pE1188, DOI 10.1152/ajpendo.00560.2012; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Drossopoulou GI, 2009, AM J PHYSIOL-RENAL, V297, pF594, DOI 10.1152/ajprenal.00203.2009; Durvasula RV, 2008, AM J PHYSIOL-RENAL, V294, pF830, DOI 10.1152/ajprenal.00266.2007; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Gatica R, 2013, J CELL BIOCHEM, V114, P639, DOI 10.1002/jcb.24406; GROOP L, 1993, DIABETOLOGIA, V36, P642, DOI 10.1007/BF00404074; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Hilgers KF, 2005, J AM SOC NEPHROL, V16, P574, DOI 10.1681/ASN.2005010083; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; IDE R, 1994, BIOCHEM BIOPH RES CO, V201, P71, DOI 10.1006/bbrc.1994.1670; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; Katsoulieris E, 2010, FREE RADICAL BIO MED, V48, P1654, DOI 10.1016/j.freeradbiomed.2010.03.021; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Liu Y, 2014, J DIABETES COMPLICAT, V28, P265, DOI 10.1016/j.jdiacomp.2014.02.001; Meyer C, 2005, DIABETIC MED, V22, P453, DOI 10.1111/j.1464-5491.2005.01440.x; Meyer TW, 1999, DIABETOLOGIA, V42, P1341, DOI 10.1007/s001250051447; Mima A, 2011, KIDNEY INT, V79, P883, DOI 10.1038/ki.2010.526; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P91, DOI 10.3109/00365517109090667; Musso C, 2006, CLIN J AM SOC NEPHRO, V1, P616, DOI 10.2215/CJN.01271005; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Patari A, 2003, DIABETES, V52, P2969, DOI 10.2337/diabetes.52.12.2969; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pillay TS, 1996, J CLIN INVEST, V97, P613, DOI 10.1172/JCI118457; Qi YJ, 2013, DIABETES, V62, P3887, DOI 10.2337/db13-0095; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; ROTHENBERG PL, 1995, DIABETES, V44, P802, DOI 10.2337/diabetes.44.7.802; Sharma M, 2009, AM J PHYSIOL-RENAL, V296, pF1386, DOI 10.1152/ajprenal.90369.2008; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simon-Szabo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097868; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tang SG, 2001, DIABETES, V50, P83, DOI 10.2337/diabetes.50.1.83; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Tiwari S, 2007, J AM SOC NEPHROL, V18, P2661, DOI 10.1681/ASN.2006121410; Tsotakos NE, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-28; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Wu MS, 2014, MOL CARCINOGEN, V53, pE119, DOI 10.1002/mc.22053; Yu MS, 2006, INT J MOL MED, V17, P1157; Zdychova J, 2008, EXP BIOL MED, V233, P1231, DOI 10.3181/0801-RM-29	65	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158873	10.1371/journal.pone.0158873	http://dx.doi.org/10.1371/journal.pone.0158873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434075	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169600020
J	Zhao, Q; Zhu, Y; Best, LG; Umans, JG; Uppal, K; Tran, VT; Jones, DP; Lee, ET; Howard, BV; Zhao, JY				Zhao, Qi; Zhu, Yun; Best, Lyle G.; Umans, Jason G.; Uppal, Karan; Tran, ViLinh T.; Jones, Dean P.; Lee, Elisa T.; Howard, Barbara V.; Zhao, Jinying			Metabolic Profiles of Obesity in American Indians: The Strong Heart Family Study	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; PHYTANIC ACID; INSULIN-RESISTANCE; MASS-SPECTROMETRY; INFLAMMATORY CYTOKINES; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; LIPID-METABOLISM; PRISTANIC ACID; PPAR-ALPHA	Obesity is a typical metabolic disorder resulting from the imbalance between energy intake and expenditure. American Indians suffer disproportionately high rates of obesity and diabetes. The goal of this study is to identify metabolic profiles of obesity in 431 normoglycemic American Indians participating in the Strong Heart Family Study. Using an untargeted liquid chromatography-mass spectrometry, we detected 1,364 distinct m/z features matched to known compounds in the current metabolomics databases. We conducted multivariate analysis to identify metabolic profiles for obesity, adjusting for standard obesity indicators. After adjusting for covariates and multiple testing, five metabolites were associated with body mass index and seven were associated with waist circumference. Of them, three were associated with both. Majority of the obesity-related metabolites belongs to lipids, e.g., fatty amides, sphingolipids, prenol lipids, and steroid derivatives. Other identified metabolites are amino acids or peptides. Of the nine identified metabolites, five metabolites (oleoylethanolamide, mannosyl-diinositol-phosphorylceramide, pristanic acid, glutamate, and kynurenine) have been previously implicated in obesity or its related pathways. Future studies are warranted to replicate these findings in larger populations or other ethnic groups.	[Zhao, Qi; Zhu, Yun; Zhao, Jinying] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Best, Lyle G.] Missouri Breaks Ind Res Inc, Timber Lake, SD USA; [Umans, Jason G.] MedStar Hlth Res Inst, Hyattsville, MD USA; [Uppal, Karan; Tran, ViLinh T.; Jones, Dean P.] Emory Univ, Sch Med, Div Pulm Med, Atlanta, GA 30322 USA; [Lee, Elisa T.] Univ Oklahoma, Hlth Sci Ctr, Ctr Amer Indian Hlth Res, Oklahoma City, OK USA; [Howard, Barbara V.] Medstar Res Inst, Washington, DC USA; [Howard, Barbara V.] Georgetown & Howard Univ, Ctr Translat Sci, Washington, DC USA	Tulane University; MedStar Health Research Institute; Emory University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhao, JY (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	jzhao5@tulane.edu	Zhao, Qi/Y-9866-2019	Uppal, Karan/0000-0001-5985-1668	National Institute of Health (NIH) [R01DK091369, K01AG034259, R21HL092363, P20HL113451, R01AG038746, U01HL65520, U01HL41642, U01HL41652, U01HL41654, U01HL65521]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001409] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109319, R01HL109284] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institute of Health (NIH) grants R01DK091369, K01AG034259, R21HL092363, P20HL113451, R01AG038746 and cooperative agreement grants U01HL65520, U01HL41642, U01HL41652, U01HL41654, and U01HL65521. Dr. Qi Zhao is a Tulane University Building Interdisciplinary Research Careers in Women's Health (BIRCWH) scholar supported by Award K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institute of Health. The funder provided support in the form of salaries for authors [QZ, YZ, LGB, JGU, KU, VTT, DPJ, ETL, BVH, and JZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnes PM, 2010, 20 CDCP; Bogl LH, 2016, METABOLISM, V65, P111, DOI 10.1016/j.metabol.2015.10.027; Brandacher G, 2007, CURR DRUG METAB, V8, P289, DOI 10.2174/138920007780362590; BROWN PJ, 1993, J HUM NUTR DIET, V6, P295, DOI 10.1111/j.1365-277X.1993.tb00375.x; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Campbell BM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00012; Contreras AV, 2013, ADV NUTR, V4, P439, DOI 10.3945/an.113.003798; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Despres JP, 2006, EUR HEART J SUPPL, V8, pB4, DOI 10.1093/eurheartj/sul002; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Favennec M, 2015, OBESITY, V23, P2066, DOI 10.1002/oby.21199; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Go YM, 2015, TOXICOL SCI, V148, P531, DOI 10.1093/toxsci/kfv198; Grosshans M, 2014, JAMA PSYCHIAT, V71, P1254, DOI 10.1001/jamapsychiatry.2014.1215; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Hermanussen M, 2006, EUR J CLIN NUTR, V60, P25, DOI 10.1038/sj.ejcn.1602263; Hermanussen M, 2003, J PEDIATR ENDOCR MET, V16, P965; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Hughes G, 2014, BIOINFORMATICS, V30, P133, DOI 10.1093/bioinformatics/btt589; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim HY, 2014, NUTRITION, V30, P1433, DOI 10.1016/j.nut.2014.04.013; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Levian Candace, 2014, Yale Journal of Biology and Medicine, V87, P113; Mangge H, 2014, OBESITY, V22, P195, DOI 10.1002/oby.20491; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Morris C, 2012, P NUTR SOC, V71, P634, DOI 10.1017/S0029665112000699; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; North KE, 2003, AM J EPIDEMIOL, V157, P303, DOI 10.1093/aje/kwf208; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Panel N, 1998, 984083 NAT HEART LUN; Park YH, 2012, TOXICOLOGY, V295, P47, DOI 10.1016/j.tox.2012.02.007; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Proulx K, 2005, AM J PHYSIOL-REG I, V289, pR729, DOI 10.1152/ajpregu.00029.2005; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Services USDohaH, 2012, 256 CDCP SERV USDOHA; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y; Verhoeven NM, 2001, PROG LIPID RES, V40, P453, DOI 10.1016/S0163-7827(01)00011-X; Walker D.I., 2016, METABOLIC PHENOTYPIN; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wolowczuk I., 2012, AM J PHYSIOL-REG I, V303, pR135, DOI DOI 10.1152/ajpregu.00373.2011; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d; Zhao JY, 2015, DIABETES CARE, V38, P220, DOI 10.2337/dc14-2033; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zomer AWM, 2000, J LIPID RES, V41, P1801	65	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159548	10.1371/journal.pone.0159548	http://dx.doi.org/10.1371/journal.pone.0159548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434237	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600067
J	Jongwe, TI; Chapman, R; Douglass, N; Chetty, S; Chege, G; Williamson, AL				Jongwe, Tsungai Ivai; Chapman, Ros; Douglass, Nicola; Chetty, Shivan; Chege, Gerald; Williamson, Anna-Lise			HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MYCOBACTERIUM-BOVIS BCG; RECOMBINANT VACCINIA VIRUS; HIGHLY PATHOGENIC SIV; RHESUS-MONKEYS; DISCORDANT ASSOCIATIONS; INTRACELLULAR BACTERIA; PANTOTHENATE AUXOTROPH; LYMPHOCYTE RESPONSES; IMMUNE-RESPONSES	Over 90% of HIV/AIDS positive individuals in sub-Saharan Africa are infected with highly heterogeneous HIV-1 subtype C (HIV-1C) viruses. One of the best ways to reduce the burden of this disease is the development of an affordable and effective prophylactic vaccine. Mosaic immunogens are computationally designed to overcome the hurdle of HIV diversity by maximizing the expression of potential T cell epitopes. Mycobacterium bovis BCG Delta panCD auxotroph and modified vaccinia Ankara (MVA) vaccines expressing HIV-1C mosaic Gag (Gag(M)) were tested in a prime-boost regimen to demonstrate immunogenicity in a mouse study. The BCG-Gag(M) vaccine was stable and persisted 11.5 weeks post vaccination in BALB/c mice. Priming with BCG-Gag(M) and boosting with MVA-Gag(M) elicited higher Gag-specific IFN-gamma ELISPOT responses than the BCG-Gag(M) only and MVA-Gag(M) only homologous vaccination regimens. The heterologous vaccination also generated a more balanced and persistent CD4(+) and CD8(+) T cell Gag-specific IFN-gamma ELISPOT response with a predominant effector memory phenotype. A Th1 bias was induced by the vaccines as determined by the predominant secretion of IFN-gamma, TNF-alpha, and IL-2. This study shows that a low dose of MVA (10(4) pfu) can effectively boost a BCG prime expressing the same mosaic immunogen, generating strong, cellular immune responses against Gag in mice. Our data warrants further evaluation in non-human primates. A low dose vaccine would be an advantage in the resource limited countries of sub-Saharan Africa and India (where the predominating virus is HIV-1 subtype C).	[Jongwe, Tsungai Ivai; Chapman, Ros; Douglass, Nicola; Chetty, Shivan; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Jongwe, Tsungai Ivai; Chapman, Ros; Douglass, Nicola; Chetty, Shivan; Chege, Gerald; Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, Dept Pathol, Fac Hlth Sci, Cape Town, South Africa; [Williamson, Anna-Lise] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Chapman, R (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Chapman, R (corresponding author), Univ Cape Town, Div Med Virol, Dept Pathol, Fac Hlth Sci, Cape Town, South Africa.	Ros.Chapman@uct.ac.za	Chege, Gerald/HIK-1573-2022; Chapman, Rosamund/AAJ-6490-2020	Chege, Gerald/0000-0003-3986-9638; Chapman, Rosamund/0000-0001-9162-2099; Williamson, Anna-Lise/0000-0002-5467-1200; Douglass, Nicola/0000-0002-8929-6279	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Schlumberger Foundation; Oppenheimer Memorial Trust; Poliomyelitis Research Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Schlumberger Foundation(Schlumberger); Oppenheimer Memorial Trust; Poliomyelitis Research Foundation	This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. Tsungai Jongwe received bursaries from the Schlumberger Foundation, the Oppenheimer Memorial Trust and the Poliomyelitis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Alcalde R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-156; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Borsuk S, 2007, TUBERCULOSIS, V87, P474, DOI 10.1016/j.tube.2007.07.006; Boyle D.B., 2007, POXVIRUSES BIRKH USE; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Chapman R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103314; Chapman R, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071601, 10.1371/journal.pone.0076584]; Chapman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032769; Chapman R, 2010, CURR HIV RES, V8, P282, DOI 10.2174/157016210791208686; Chege GK, 2013, J VIROL, V87, P5151, DOI 10.1128/JVI.03178-12; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Esparza J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00124; Excler JL, 2015, VACCINE; Fenimore PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044769; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; GHEORGHIU M, 1988, J BIOL STAND, V16, P15, DOI 10.1016/0092-1157(88)90025-X; Goulder PJR, 1997, J EXP MED, V185, P1423, DOI 10.1084/jem.185.8.1423; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Guevara H, 2000, J ACQ IMMUN DEF SYND, V25, P390, DOI 10.1097/00126334-200012150-00002; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hatherill M, 2011, ARCH DIS CHILD, V96, P851, DOI 10.1136/adc.2011.214494; Haynes BF, 2015, CURR OPIN IMMUNOL, V35, P39, DOI 10.1016/j.coi.2015.05.007; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hess J, 2000, ADV IMMUNOL, V75, P1, DOI 10.1016/S0065-2776(00)75001-2; Hulot SL, 2015, J VIROL, V89, P6462, DOI 10.1128/JVI.00383-15; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Johansen P, 2004, EUR J IMMUNOL, V34, P91, DOI 10.1002/eji.200324231; Kemball CC, 2007, J IMMUNOL, V179, P1113, DOI 10.4049/jimmunol.179.2.1113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mann JK, 2015, VIROL J, V12; Matsuo Kazuhiro, 2011, Tuberc Res Treat, V2011, P574591, DOI 10.1155/2011/574591; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Murphy K. M., 2011, JANEWAYS IMMUNOBIOLO; Nkolola JP, 2014, J VIROL, V88, P9538, DOI 10.1128/JVI.01739-14; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Parish T, 2001, MYCOBACTERIA PROTOCO; Prendergast A, 2011, AIDS, V25, P1329, DOI 10.1097/QAD.0b013e3283478575; Price PJR, 2013, VACCINE, V31, P4231, DOI 10.1016/j.vaccine.2013.03.017; Ramsburg EA, 2007, J IMMUNOL, V178, P6350, DOI 10.4049/jimmunol.178.10.6350; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Santra S, 2012, VIROLOGY, V428, P121, DOI 10.1016/j.virol.2012.03.012; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Saubi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042559; Shedlock DJ, 2013, MOL THER, V21, P1432, DOI 10.1038/mt.2013.61; Shen Y. J., 2010, INVESTIGATION USE LU; Someya K, 2004, J VIROL, V78, P9842, DOI 10.1128/JVI.78.18.9842-9853.2004; Tatt ID, 2004, JAIDS-J ACQ IMM DEF, V36, P1092, DOI 10.1097/00126334-200408150-00013; Tongo M, 2014, VIRUSES-BASEL, V6, P3968, DOI 10.3390/v6103968; UNAIDS, GLOB FACT SHEET JUL; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; Van Harmelen JH, 1999, AIDS RES HUM RETROV, V15, P395; Wong YC, 2011, J VIROL METHODS, V171, P295, DOI 10.1016/j.jviromet.2010.11.003; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Zheng YQ, 2015, EXPERT REV VACCINES, V14, P1255, DOI 10.1586/14760584.2015.1068124; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	74	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159141	10.1371/journal.pone.0159141	http://dx.doi.org/10.1371/journal.pone.0159141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427967	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300037
J	Koli, K; Sutinen, E; Ronty, M; Rantakari, P; Fortino, V; Pulkkinen, V; Greco, D; Sipila, P; Myllarniemi, M				Koli, Katri; Sutinen, Eva; Ronty, Mikko; Rantakari, Pia; Fortino, Vittorio; Pulkkinen, Ville; Greco, Dario; Sipila, Petra; Myllarniemi, Marjukka			Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; MIGRATION INHIBITORY FACTOR; TO-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; TRANSGENIC MICE; IN-VIVO; ANTAGONIST; GROWTH; RECOMBINATION; INFLAMMATION	Idiopathic pulmonary fibrosis (IPF) is characterized by activation and injury of epithelial cells, the accumulation of connective tissue and changes in the inflammatory microenvironment. The bone morphogenetic protein (BMP) inhibitor protein gremlin-1 is associated with the progression of fibrosis both in human and mouse lung. We generated a transgenic mouse model expressing gremlin-1 in type II lung epithelial cells using the surfactant protein C (SPC) promoter and the Cre-LoxP system. Gremlin-1 protein expression was detected specifically in the lung after birth and did not result in any signs of respiratory insufficiency. Exposure to silicon dioxide resulted in reduced amounts of lymphocyte aggregates in transgenic lungs while no alteration in the fibrotic response was observed. Microarray gene expression profiling and analyses of bronchoalveolar lavage fluid cytokines indicated a reduced lymphocytic response and a downregulation of interferon-induced gene program. Consistent with reduced Th1 response, there was a downregulation of the mRNA and protein expression of the anti-fibrotic chemokine CXCL10, which has been linked to IPF. In human IPF patient samples we also established a strong negative correlation in the mRNA expression levels of gremlin-1 and CXCL10. Our results suggest that in addition to regulation of epithelial-mesenchymal crosstalk during tissue injury, gremlin-1 modulates inflammatory cell recruitment and anti-fibrotic chemokine production in the lung.	[Koli, Katri] Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland; [Koli, Katri; Sutinen, Eva; Myllarniemi, Marjukka] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Sutinen, Eva; Pulkkinen, Ville; Myllarniemi, Marjukka] Univ Helsinki, Helsinki, Finland; [Sutinen, Eva; Pulkkinen, Ville; Myllarniemi, Marjukka] Helsinki Univ Hosp, Heart & Lung Ctr, Dept Pulm Med, Helsinki, Finland; [Ronty, Mikko] Univ Helsinki, Dept Pathol, Tampere, Finland; [Ronty, Mikko] Fimlab Labs, Pathol, Tampere, Finland; [Rantakari, Pia] Univ Turku, MediCity Res Lab, Turku, Finland; [Fortino, Vittorio; Greco, Dario] FIOH, Unit Syst Toxicol, Helsinki, Finland; [Fortino, Vittorio; Greco, Dario] FIOH, Nanosafety Ctr, Helsinki, Finland; [Sipila, Petra] Univ Turku, Dept Physiol, Inst Biomed, Turku, Finland; [Sipila, Petra] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of Turku; University of Turku	Koli, K (corresponding author), Univ Helsinki, Translat Canc Biol, Res Programs Unit, Helsinki, Finland.; Koli, K (corresponding author), Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland.	katri.koli@helsinki.fi	Sipilä, Petra/GYE-3323-2022; Greco, Dario/T-7113-2019	Greco, Dario/0000-0001-9195-9003; Sipila, Petra/0000-0001-8187-7143; Myllarniemi, L Marjukka/0000-0001-9343-0867; Sutinen, Eva/0000-0002-9169-7178; Rantakari, Pia/0000-0003-1638-5075	Jane and Aatos Erkko foundation; Sigrid Juselius Foundation; University of Helsinki Research Fund; Magnus Ehrnrooth foundation; Helsinki University Hospital Research Fund; Academy of Finland [275151, 292307]; European Commission [FP7-309329]	Jane and Aatos Erkko foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Fund; Magnus Ehrnrooth foundation; Helsinki University Hospital Research Fund; Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre)	KK and MM are supported by the Jane and Aatos Erkko foundation, the Sigrid Juselius Foundation and the University of Helsinki Research Fund. KK is supported by the Magnus Ehrnrooth foundation. MM is supported by the Helsinki University Hospital Research Fund. VP is supported by the Sigrid Juselius Foundation. DG is supported by the Academy of Finland (grant number 275151 and 292307) and the European Commission, under grant agreement FP7-309329 (NANOSOLUTIONS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer CA, 2010, J LEUKOCYTE BIOL, V88, P547, DOI 10.1189/jlb.0210108; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Church RH, 2015, BIOCHEM J, V466, P55, DOI 10.1042/BJ20140771; Corsini M, 2014, ARTERIOSCL THROM VAS, V34, P136, DOI 10.1161/ATVBAHA.113.302517; D'Ambrosio D, 2001, AM J RESP CRIT CARE, V164, P1266, DOI 10.1164/ajrccm.164.7.2103011; Droguett A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101879; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC; Fortino V, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0477-4; Harari S, 2010, ALLERGY, V65, P537, DOI 10.1111/j.1398-9995.2009.02305.x; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; Kalderen C, 2014, INT IMMUNOPHARMACOL, V20, P66, DOI 10.1016/j.intimp.2014.02.020; Karagiannis GS, 2015, BIOL CHEM, V396, P163, DOI 10.1515/hsz-2014-0221; Keane MP, 1997, J IMMUNOL, V159, P1437; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lavoz C, 2015, J PATHOL, V236, P407, DOI 10.1002/path.4537; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lepparanta O, 2013, AM J RESP CELL MOL, V48, P448, DOI 10.1165/rcmb.2012-0201OC; Lepparanta O, 2012, CELL TISSUE RES, V348, P491, DOI 10.1007/s00441-012-1385-9; Lindahl GE, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-80; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Marchant V, 2015, AM J PHYSIOL-RENAL, V309, pF559, DOI 10.1152/ajprenal.00023.2015; Meyringer R, 2007, J RHEUMATOL, V34, P747; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Muller I, 2013, J BIOL CHEM, V288, P31635, DOI 10.1074/jbc.M113.477745; Muller II, 2014, INT J CARDIOL, V176, P923, DOI 10.1016/j.ijcard.2014.08.051; Mueller KAL, 2013, J CARD FAIL, V19, P678, DOI 10.1016/j.cardfail.2013.09.001; Mulvihill MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042264; Myllarniemi M, 2008, J PATHOL, V214, P456, DOI 10.1002/path.2300; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Myllarniemi M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-170; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; Pulkkinen V, 2010, FASEB J, V24, P1167, DOI 10.1096/fj.09-138545; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Sundar IK, 2015, AM J RESP CELL MOL B; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tamminen JA, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.29; Team RC, 2012, R LANG ENV STAT COMP; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; Yeung CYC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05183; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	53	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159010	10.1371/journal.pone.0159010	http://dx.doi.org/10.1371/journal.pone.0159010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428020	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300029
J	Mohammed, KA; Boakye, EA; Ismail, HA; Geneus, CJ; Tobo, BB; Buchanan, PM; Zelicoff, AP				Mohammed, Kahee A.; Boakye, Eric Adjei; Ismail, Honer A.; Geneus, Christian J.; Tobo, Betelihem B.; Buchanan, Paula M.; Zelicoff, Alan P.			Pineal Gland Calcification in Kurdistan: A Cross-Sectional Study of 480 Roentgenograms	PLOS ONE			English	Article							AGE-RELATED INCIDENCE; COMPUTED-TOMOGRAPHY; ALZHEIMERS-DISEASE; MELATONIN; PREVALENCE; CHILDREN; SYSTEM; RHYTHM; FILMS	Objective The goal of this study was to compare the incidence of Pineal Gland Calcification (PGC) by age group and gender among the populations living in the Kurdistan Region-Iraq. Methods This prospective study examined skull X-rays of 480 patients between the ages of 3 and 89 years who sought care at a large teaching public hospital in Duhok, Iraq from June 2014 to November 2014. Descriptive statistics and a binary logistic regression were used for analysis. Results The overall incidence rate of PGC among the study population was 26.9% with the 51-60 age group and males having the highest incidence. PGC incidence increased after the first decade and remained steady until the age of 60. Thereafter the incidence began to decrease. Logistic regression analysis revealed that both age and gender significantly affected the risk of PGC. After adjusting for age, males were 1.94 (95% CI, 1.26-2.99) times more likely to have PGC compared to females. In addition, a one year increase in age increases the odds of developing PGC by 1.02 (95% CI, 1.01-1.03) units after controlling for the effects of gender. Conclusion Our analysis demonstrated a close relationship between PGC and age and gender, supporting a link between the development of PGC and these factors. This study provides a basis for future researchers to further investigate the nature and mechanisms underlying pineal gland calcification.	[Mohammed, Kahee A.; Tobo, Betelihem B.] St Louis Univ, Dept Epidemiol, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA; [Boakye, Eric Adjei; Buchanan, Paula M.] St Louis Univ, Ctr Outcomes Res SLUCOR, St Louis, MO 63103 USA; [Mohammed, Kahee A.; Ismail, Honer A.] Univ Duhok, Sch Med, Dept Radiol, Duhok, Kurdistan, Iraq; [Geneus, Christian J.; Zelicoff, Alan P.] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Environm & Occupat Hlth, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University; University of Duhok; Saint Louis University	Boakye, EA (corresponding author), St Louis Univ, Ctr Outcomes Res SLUCOR, St Louis, MO 63103 USA.	adjeiboakyee@slu.edu	Adjei Boakye, Eric/D-4448-2015; Mohammed, Kahee/B-6344-2016	Adjei Boakye, Eric/0000-0001-9163-8103; Mohammed, Kahee/0000-0001-6765-3194				ADELOYE A, 1974, AM J ROENTGENOL, V122, P503, DOI 10.2214/ajr.122.3.503; Admassie Daniel, 2009, Ethiop Med J, V47, P55; Afgin AE, 2012, J ALZHEIMERS DIS, V29, P431, DOI 10.3233/JAD-2011-111667; Akano A, 2003, CLIN RADIOL, V58, P336, DOI 10.1016/S0009-9260(02)00510-X; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Bersani G, 1999, EUR PSYCHIAT, V14, P163, DOI 10.1016/S0924-9338(99)80735-4; Bhatti I H, 1977, J Pak Med Assoc, V27, P310; Butler P., 1999, APPL RADIOLOGICAL AN; Chiba M, 1948, PSYCHIAT CLIN NEUROS, V2; DARAMOLA GF, 1972, NEUROENDOCRINOLOGY, V9, P41, DOI 10.1159/000122036; Dyke CG, 1930, AM J ROENTGENOL, V23; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gurvit H, 2008, AM J ALZHEIMERS DIS, V23, P67, DOI 10.1177/1533317507310570; Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x; Khaleghipour S, 2012, SAO PAULO MED J, V130, P167, DOI 10.1590/S1516-31802012000300006; KOHLI N, 1992, INDIAN J MED RES-B, V96, P139; Korkmaz A, 2009, MOL MED, V15, P43, DOI 10.2119/molmed.2008.00117; Kunz D, 1998, PSYCHIAT RES-NEUROIM, V82, P187, DOI 10.1016/S0925-4927(98)00013-4; Macchi MM, 2004, FRONT NEUROENDOCRIN, V25, P177, DOI 10.1016/j.yfrne.2004.08.001; MACPHERSON P, 1979, NEURORADIOLOGY, V18, P67, DOI 10.1007/BF00344824; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Mahlberg R, 2008, NEUROBIOL AGING, V29, P203, DOI 10.1016/j.neurobiolaging.2006.10.003; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; Mayo JC, 2005, ENDOCRINE, V27, P169, DOI 10.1385/ENDO:27:2:169; MCKAY RT, 1973, T ROY SOC TROP MED H, V67, P214, DOI 10.1016/0035-9203(73)90147-8; MUGONDI SG, 1976, BRIT J RADIOL, V49, P594, DOI 10.1259/0007-1285-49-583-594; OON CL, 1964, AMER J ROENTGENOL RA, V92, P1242; Reiter RJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Ritzenthaler T, 2009, J PINEAL RES, V46, P349, DOI 10.1111/j.1600-079X.2009.00670.x; SANDYK R, 1994, INT J NEUROSCI, V79, P75, DOI 10.3109/00207459408986069; SANDYK R, 1992, INT J NEUROSCI, V62, P89; SILMAN RE, 1979, NATURE, V282, P301, DOI 10.1038/282301a0; Skene DJ, 2003, EXP GERONTOL, V38, P199, DOI 10.1016/S0531-5565(02)00198-5; Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137; Turgut Ahmet Tuncay, 2008, Pathophysiology, V15, P41, DOI 10.1016/j.pathophys.2008.02.001; Uberos J, 2011, J PINEAL RES, V50, P192, DOI 10.1111/j.1600-079X.2010.00828.x; Vastine JH, 1927, AM J ROENTGENOLOGY, V17; Vijayalaxmi, 2002, J CLIN ONCOL, V20, P2575, DOI 10.1200/JCO.2002.11.004; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; WINKLER P, 1987, J PINEAL RES, V4, P247, DOI 10.1111/j.1600-079X.1987.tb00862.x; WURTMAN RJ, 1964, J CLIN ENDOCR METAB, V24, P299, DOI 10.1210/jcem-24-3-299; Zhou JN, 2003, J PINEAL RES, V34, P11, DOI 10.1034/j.1600-079X.2003.01897.x; ZIMMERMAN RA, 1982, RADIOLOGY, V142, P659, DOI 10.1148/radiology.142.3.7063680	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159239	10.1371/journal.pone.0159239	http://dx.doi.org/10.1371/journal.pone.0159239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415622	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500105
J	Iandiorio, MJ; Fair, JM; Chatzipanagiotou, S; Ioannidis, A; Trikka-Graphakos, E; Charalampaki, N; Sereti, C; Tegos, GP; Hoogesteijn, AL; Rivas, AL				Iandiorio, Michelle J.; Fair, Jeanne M.; Chatzipanagiotou, Stylianos; Ioannidis, Anastasios; Trikka-Graphakos, Eleftheria; Charalampaki, Nikoletta; Sereti, Christina; Tegos, George P.; Hoogesteijn, Almira L.; Rivas, Ariel L.			Preventing Data Ambiguity in Infectious Diseases with Four-Dimensional and Personalized Evaluations	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SYSTEMS BIOLOGY; IN-VITRO; CHALLENGES; EMERGENCE; MODELS; HETEROGENEITY; HOMEOSTASIS; UNFOLDOMICS; COMPLEXITY	Background Diagnostic errors can occur, in infectious diseases, when anti-microbial immune responses involve several temporal scales. When responses span from nanosecond to week and larger temporal scales, any pre-selected temporal scale is likely to miss some (faster or slower) responses. Hoping to prevent diagnostic errors, a pilot study was conducted to evaluate a four-dimensional (4D) method that captures the complexity and dynamics of infectious diseases. Methods Leukocyte-microbial-temporal data were explored in canine and human (bacterial and/or viral) infections, with: (i) a non-structured approach, which measures leukocytes or microbes in isolation; and (ii) a structured method that assesses numerous combinations of interacting variables. Four alternatives of the structured method were tested: (i) a noise-reduction oriented version, which generates a single (one data point-wide) line of observations; (ii) a version that measures complex, three-dimensional (3D) data interactions; (iii) a non-numerical version that displays temporal data directionality (arrows that connect pairs of consecutive observations); and (iv) a full 4D (single line-, complexity-, directionality-based) version. Results In all studies, the non-structured approach revealed non-interpretable ( ambiguous) data: observations numerically similar expressed different biological conditions, such as recovery and lack of recovery from infections. Ambiguity was also found when the data were structured as single lines. In contrast, two or more data subsets were distinguished and ambiguity was avoided when the data were structured as complex, 3D, single lines and, in addition, temporal data directionality was determined. The 4D method detected, even within one day, changes in immune profiles that occurred after antibiotics were prescribed. Conclusions Infectious disease data may be ambiguous. Four-dimensional methods may prevent ambiguity, providing earlier, in vivo, dynamic, complex, and personalized information that facilitates both diagnostics and selection or evaluation of anti-microbial therapies.	[Iandiorio, Michelle J.; Rivas, Ariel L.] Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Fair, Jeanne M.] Los Alamos Natl Lab, Global Secur, Mailstop M888, Los Alamos, NM 87545 USA; [Chatzipanagiotou, Stylianos] Natl & Kapodistrian Univ Athens, Sch Med, Aeginition Hosp, Dept Biopathol & Clin Microbiol, Athens, Greece; [Ioannidis, Anastasios] Univ Peloponnese, Fac Human Movement & Qual Life Sci, Dept Nursing, Sparta, Greece; [Trikka-Graphakos, Eleftheria; Charalampaki, Nikoletta; Sereti, Christina] Thriasio Gen Hosp, Dept Clin Microbiol, Magoula, Greece; [Tegos, George P.] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Tegos, George P.] Harvard Med Sch, Dept Dermatol, Boston, MA USA; [Tegos, George P.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hoogesteijn, Almira L.] Ctr Invest Avanzadas, Dept Human Ecol, Merida, Mexico; [Rivas, Ariel L.] Univ New Mexico, Sch Med, Ctr Global Hlth, Div Infect Dis, Albuquerque, NM 87131 USA	University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; Athens Medical School; National & Kapodistrian University of Athens; University of Peloponnese; Torrey Pines Institute for Molecular Studies, Florida; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of New Mexico	Rivas, AL (corresponding author), Univ New Mexico, Sch Med, Dept Internal Med, Albuquerque, NM 87131 USA.; Rivas, AL (corresponding author), Univ New Mexico, Sch Med, Ctr Global Hlth, Div Infect Dis, Albuquerque, NM 87131 USA.	alrivas@unm.edu		Sereti, Christina/0000-0002-2258-9333				Akinnusi ME, 2011, CRIT CARE MED, V39, P1944, DOI 10.1097/CCM.0b013e31821bd79e; Amarasingham A, 2015, P NATL ACAD SCI USA, V112, P6455, DOI 10.1073/pnas.1506400112; Anuforom O, 2015, MED MICROBIOL IMMUN, V204, P151, DOI 10.1007/s00430-014-0355-0; Auffray C, 2008, PROG BIOPHYS MOL BIO, V97, P79, DOI 10.1016/j.pbiomolbio.2007.09.002; Azimian A, 2012, J CLIN MICROBIOL, V50, P3581, DOI 10.1128/JCM.01727-12; Balk RA, 2014, VIRULENCE, V5, P20, DOI 10.4161/viru.27135; Bannoehr J, 2012, VET DERMATOL, V23, P253, DOI 10.1111/j.1365-3164.2012.01046.x; Becker JM, 2013, MIS QUART, V37, P665, DOI 10.25300/MISQ/2013/37.3.01; Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.26516, 10.4161/viru.27794]; Bork P, 2005, CELL, V121, P507, DOI 10.1016/j.cell.2005.05.001; Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Chatzimoschou A, 2015, ANTIMICROB AGENTS CH, V59, P2198, DOI 10.1128/AAC.04934-14; D'Alessandro LA, 2015, PROG BIOPHYS MOL BIO, V117, P78, DOI 10.1016/j.pbiomolbio.2014.11.005; Davis JS, 2015, SEMIN RESP CRIT CARE, V36, P3, DOI 10.1055/s-0034-1396906; de Haan J, 2006, ECOL COMPLEX, V3, P293, DOI 10.1016/j.ecocom.2007.02.003; Decousser JW, 2015, INT J ANTIMICROB AG, V46, P622, DOI 10.1016/j.ijantimicag.2015.07.022; Fair JM, 2015, TRANSBOUND EMERG DIS, V62, P437, DOI 10.1111/tbed.12162; Firsov AA, 2013, ANTIMICROB AGENTS CH, V57, P4956, DOI 10.1128/AAC.00578-13; Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043; Groesser SN, 2012, SYST DYNAM REV, V28, P46, DOI 10.1002/sdr.476; Humphreys P, 2008, MIND MACH, V18, P431, DOI 10.1007/s11023-008-9125-3; Huneman P, 2012, SYNTHESE, V185, P195, DOI 10.1007/s11229-010-9721-7; Hutchinson JW, 2000, J CONSUM RES, V27, P324, DOI 10.1086/317588; Klinke DJ, 2009, ANN BIOMED ENG, V37, P1886, DOI 10.1007/s10439-009-9733-y; Knowlton ER, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00427; Lake K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.104031; Leitner G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123674; Ludewig B, 2012, EUR J IMMUNOL, V42, P3116, DOI 10.1002/eji.201242508; Moriarty TF, 2014, EUR CELLS MATER, V28, P112, DOI 10.22203/eCM.v028a09; Nadell CD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2770; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nielsen SN, 2013, ECOL INDIC, V28, P31, DOI 10.1016/j.ecolind.2012.12.015; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Osinga HM, 2012, DISCRETE CONT DYN-A, V32, P2853, DOI 10.3934/dcds.2012.32.2853; Pomorska-Mol M, 2012, POL J VET SCI, V15, P583, DOI 10.2478/v10181-012-0089-0; Qu ZL, 2011, PROG BIOPHYS MOL BIO, V107, P21, DOI 10.1016/j.pbiomolbio.2011.06.004; Raffatellu M, 2006, INFECT IMMUN, V74, P19, DOI 10.1128/IAI.74.1.19-27.2006; Ricca RL, 2009, MS A MOD SIMUL, V3, P167, DOI 10.1007/978-88-470-1122-9_12; Rivas AL, 2015, CURR PHARM DESIGN, V21, P2122, DOI 10.2174/1381612821666150310104053; Rivas AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053984; Rosslenbroich B, 2011, SEMIN CANCER BIOL, V21, P156, DOI 10.1016/j.semcancer.2011.06.001; San Miguel M, 2012, EUR PHYS J-SPEC TOP, V214, P245, DOI 10.1140/epjst/e2012-01694-y; Shima K, 2011, ANTIMICROB AGENTS CH, V55, P2319, DOI 10.1128/AAC.01655-10; Sidjabat HE, 2007, J MED MICROBIOL, V56, P426, DOI 10.1099/jmm.0.46888-0; Stephan A, 2006, SYNTHESE, V151, P485, DOI 10.1007/s11229-006-9019-y; Towhid ST, 2013, CELL PHYSIOL BIOCHEM, V31, P102, DOI 10.1159/000343353; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Valour F, 2014, CLIN MICROBIOL INFEC, V20, pO772, DOI 10.1111/1469-0691.12567; Van Regenmortel MHV, 2007, PROTEOMICS, V7, P965, DOI 10.1002/pmic.200600407; Vepsalainen K, 2000, BIOL PHILOS, V15, P211, DOI 10.1023/A:1006636918716; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004; Wolkenhauer O, 2013, FEBS J, V280, P5938, DOI 10.1111/febs.12311; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yip D, 2013, BIOCHEM BIOPH RES CO, V433, P327, DOI 10.1016/j.bbrc.2013.03.008; Zhang M, 2014, ANTIMICROB AGENTS CH, V58, P3217, DOI 10.1128/AAC.02410-14	58	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159001	10.1371/journal.pone.0159001	http://dx.doi.org/10.1371/journal.pone.0159001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CP	27411058	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300047
J	Maor, Y; Malnick, SDH; Melzer, E; Leshno, M				Maor, Yaakov; Malnick, Stephen D. H.; Melzer, Ehud; Leshno, Moshe			Treatment of Chronic Hepatitis C in the Aged - Does It Impact Life Expectancy? A Decision Analysis	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; LIVER FIBROSIS PROGRESSION; HCV-RELATED CIRRHOSIS; ALL-CAUSE MORTALITY; NATURAL-HISTORY; VIRUS; SOFOSBUVIR; LEDIPASVIR; INFECTION; RISK	Background and Aims Recent studies have demonstrated that the efficacy of interferon-free direct-acting antiviral agents (DAAs) in patients over 70 is similar to that of younger age groups. Evidence continues to mount that life expectancy (LE) increases with successful treatment of hepatitis C (HCV) patients with advanced fibrosis. The evidence in older people is more limited. Our aim was to estimate the life year (LY) and quality-adjusted life year (QALY) gained by treatment of naive patients with HCV as a function of patient's age and fibrosis stage. Methods We constructed a Markov model of HCV progression toward advanced liver disease. The primary outcome was LY and QALY saved. The model and the sustained virological response of HCV infected subjects treated with a fixed-dose combination of the NS5B polymerase inhibitor Sofosbuvir and the NS5A replication complex inhibitor Ledipasvir were based on the published literature and expert opinion. Results Generally, both the number of LY gained and QALY gained gradually decreased with advancing age but the rate of decline was slower with more advanced fibrosis stage. For patients with fibrosis stage F1, F2 and F3, LY gained dropped below six months if treated by the age of 55, 65 or 70 years, respectively, while for a patient with fibrosis stage F4, the gain was one LY if treated by the age of 75. The QALY gained for treated over untreated elderly were reasonably high even for those treated at early fibrosis stage. Conclusions There is a significant life expectancy benefit to HCV treatment in patients up to age 75 with advanced-stage fibrosis.	[Maor, Yaakov; Malnick, Stephen D. H.; Melzer, Ehud] Kaplan Med Ctr, Inst Gastroenterol & Hepatol, Rehovot, Israel; [Malnick, Stephen D. H.] Kaplan Med Ctr, Dept Internal Med C, Rehovot, Israel; [Leshno, Moshe] Tel Aviv Univ, Fac Management, Tel Aviv, Israel; [Leshno, Moshe] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Maor, Y (corresponding author), Kaplan Med Ctr, Inst Gastroenterol & Hepatol, Rehovot, Israel.	yaakovma1@clalit.org.il						Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; Centers for Disease Control and Prevention, MORTALITY TABLES; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Hezode C, 2013, HEPATOLOGY S, V58, p181A; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Ryder SD, 2004, GUT, V53, P451, DOI 10.1136/gut.2003.021691; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; van der Meer AJ, 2014, JAMA-J AM MED ASSOC, V312, P1927, DOI 10.1001/jama.2014.12627; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Gomez EV, 2013, J HEPATOL, V58, P434, DOI 10.1016/j.jhep.2012.10.023; Zhou K, 2014, GASTROENTEROLOGY, V146, pS969; Zipprich A, 2012, LIVER INT, V32, P1407, DOI 10.1111/j.1478-3231.2012.02830.x	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0157832	10.1371/journal.pone.0157832	http://dx.doi.org/10.1371/journal.pone.0157832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410963	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300013
J	Smith, D; Tikhonova, IG; Jewhurst, HL; Drysdale, OC; Dvorak, J; Robinson, MW; Cwiklinski, K; Dalton, JP				Smith, David; Tikhonova, Irina G.; Jewhurst, Heather L.; Drysdale, Orla C.; Dvorak, Jan; Robinson, Mark W.; Cwiklinski, Krystyna; Dalton, John P.			Unexpected Activity of a Novel Kunitz-type Inhibitor INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; enzyme inhibitor; enzyme kinetics; host-pathogen interaction; molecular modeling; parasite; protease inhibitor; protein-protein interaction; serine protease	FASCIOLA-HEPATICA; ELECTRON-MICROSCOPE; PROTEIN INHIBITORS; FUNCTIONAL-CHARACTERIZATION; HELMINTH PATHOGEN; TRYPSIN-INHIBITOR; LIVER FLUKE; PURIFICATION; ENVIRONMENT; EXPRESSION	Kunitz-type (KT) protease inhibitors are low molecular weight proteins classically defined as serine protease inhibitors. We identified a novel secreted KT inhibitor associated with the gut and parenchymal tissues of the infective juvenile stage of Fasciola hepatica, a helminth parasite of medical and veterinary importance. Unexpectedly, recombinant KT inhibitor (rFhKT1) exhibited no inhibitory activity toward serine proteases but was a potent inhibitor of the major secreted cathepsin L cysteine proteases of F. hepatica, FhCL1 and FhCL2, and of human cathepsins L and K (K-i = 0.4-27 nm). FhKT1 prevented the auto-catalytic activation of FhCL1 and FhCL2 and formed stable complexes with the mature enzymes. Pulldown experiments from adult parasite culture medium showed that rFhKT1 interacts specifically with native secreted FhCL1, FhCL2, and FhCL5. Substitution of the unusual P1 Leu(15) within the exposed reactive loop of FhKT1 for the more commonly found Arg (FhKT1Leu(15)/Arg(15)) had modest adverse effects on the cysteine protease inhibition but conferred potent activity against the serine protease trypsin (K-i = 1.5 nm). Computational docking and sequence analysis provided hypotheses for the exclusive binding of FhKT1 to cysteine proteases, the importance of the Leu(15) in anchoring the inhibitor into the S2 active site pocket, and the inhibitor's selectivity toward FhCL1, FhCL2, and human cathepsins L and K. FhKT1 represents a novel evolutionary adaptation of KT protease inhibitors by F. hepatica, with its prime purpose likely in the regulation of the major parasite-secreted proteases and/or cathepsin L-like proteases of its host.	[Smith, David; Jewhurst, Heather L.; Drysdale, Orla C.; Dvorak, Jan; Robinson, Mark W.; Cwiklinski, Krystyna; Dalton, John P.] Queens Univ Belfast, Sch Biol Sci, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Smith, D (corresponding author), Queens Univ Belfast, Sch Biol Sci, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	dsmith37@qub.ac.uk	Smith, David/AAH-4738-2020; Dvorak, Jan/AAJ-2426-2020	Robinson, Mark/0000-0001-7191-0034; Dvorak, Jan/0000-0002-6824-9000; Smith, David/0000-0002-5158-0522	Department for Employment and Learning (DEL), Northern Ireland grant; European Research Council Advanced Grant HELIVAC [European Research Council Advanced Grant HELIVAC 322725]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L019612/1]; BBSRC [BB/L019612/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L019612/1] Funding Source: researchfish	Department for Employment and Learning (DEL), Northern Ireland grant; European Research Council Advanced Grant HELIVAC; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a Department for Employment and Learning (DEL), Northern Ireland grant. To whom correspondence should be addressed: School of Biological Sciences, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Rd., Belfast BT9 7BL, Northern Ireland, United Kingdom. E-mail: dsmith37@qub.ac.uk.; Supported by European Research Council Advanced Grant HELIVAC 322725 (to J. P. D.).; Supported by Grant BB/L019612/1 from the Biotechnology and Biological Sciences Research Council (BBSRC).	Abreu PA, 2014, BIOCHEM BIOPH RES CO, V449, P69, DOI 10.1016/j.bbrc.2014.04.154; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Azzolini SS, 2005, EXP PARASITOL, V111, P30, DOI 10.1016/j.exppara.2005.03.013; Barrett A. J., 2012, HDB PROTEOLYTIC ENZY, P1097; BENNETT JL, 1977, INT J PARASITOL, V7, P221, DOI 10.1016/0020-7519(77)90051-0; Bozas SE, 1995, MOL BIOCHEM PARASIT, V74, P19, DOI 10.1016/0166-6851(95)02478-6; Ceraul SM, 2008, INFECT IMMUN, V76, P5429, DOI 10.1128/IAI.00866-08; CERWINSKY EW, 1967, BIOCHEMISTRY-US, V6, P3175, DOI 10.1021/bi00862a027; Chu D, 2004, INFECT IMMUN, V72, P2214, DOI 10.1128/IAI.72.4.2214-2221.2004; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; Cwiklinski K, 2015, MOL CELL PROTEOMICS, V14, P3258, DOI 10.1074/mcp.M115.053934; Cwiklinski K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0632-2; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; Delfin J, 1996, TOXICON, V34, P1367, DOI 10.1016/S0041-0101(96)00114-6; Eng W. S., 2015, VENOMOUS REPTILES TH, P281; Falcon CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114505; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Gil DF, 2011, FEMS YEAST RES, V11, P575, DOI 10.1111/j.1567-1364.2011.00749.x; Gonzalez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007009; HANNA REB, 1976, EXP PARASITOL, V39, P204, DOI 10.1016/0014-4894(76)90120-X; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Honey K, 2003, NAT REV IMMUNOL, V3, P472, DOI 10.1038/nri1110; Howell A, 2015, PREV VET MED, V121, P41, DOI 10.1016/j.prevetmed.2015.05.013; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Ishidoh K, 1998, BIOL CHEM, V379, P131; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jefferies JR, 2001, PROTEOMICS, V1, P1128, DOI 10.1002/1615-9861(200109)1:9<1128::AID-PROT1128>3.0.CO;2-0; Jin XA, 2011, PARASITOL RES, V108, P287, DOI 10.1007/s00436-010-2055-z; Kawamura K, 2011, ACTA CRYSTALLOGR D, V67, P140, DOI 10.1107/S0907444910053382; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Li B., 2013, AFRICAN J BIOTECHNOL, V10, P19464; Lowther J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000369; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mathews C. K., 2012, BIOCHEMISTRY-US, P192; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Molina-Hernandez V, 2015, VET PARASITOL, V208, P101, DOI 10.1016/j.vetpar.2015.01.004; Muino L, 2011, MOL BIOCHEM PARASIT, V179, P80, DOI 10.1016/j.molbiopara.2011.06.003; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; PERONA JJ, 1993, J MOL BIOL, V230, P919, DOI 10.1006/jmbi.1993.1210; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Ranasinghe SL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004268; Ranasinghe SL, 2015, PARASITOLOGY, V142, P1663, DOI 10.1017/S0031182015001328; Ranasinghe SL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1022-z; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Sasaki SD, 2006, BIOCHEM BIOPH RES CO, V341, P266, DOI 10.1016/j.bbrc.2005.12.178; Smooker PM, 2000, PROTEIN SCI, V9, P2567, DOI 10.1110/ps.9.12.2567; Soares TS, 2012, VET PARASITOL, V187, P521, DOI 10.1016/j.vetpar.2012.01.027; Stack CM, 2008, J BIOL CHEM, V283, P9896, DOI 10.1074/jbc.M708521200; THREADGOLD LT, 1966, PARASITOLOGY, V56, P299, DOI 10.1017/S0031182000070888; THREADGOLD LT, 1974, EXP PARASITOL, V35, P389, DOI 10.1016/0014-4894(74)90045-9; Torgerson P, 1999, FASCIOLOSIS, P113; Tsujimoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029964; Wan Hu, 2013, PLoS One, V8, pe53343, DOI 10.1371/journal.pone.0053343; Wang H, 2012, BIOCHIMIE, V94, P891, DOI 10.1016/j.biochi.2011.12.008; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zavasnik-Bergant T, 2008, FRONT BIOSCI-LANDMRK, V13, P4625, DOI 10.2741/3028	63	23	23	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19220	19234		10.1074/jbc.M116.724344	http://dx.doi.org/10.1074/jbc.M116.724344			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27422822	Green Published, hybrid			2022-12-26	WOS:000383242800002
J	Imae, K; Saito, Y; Kizaki, H; Ryuno, H; Mao, H; Miyashita, A; Suzuki, Y; Sekimizu, K; Kaito, C				Imae, Kenta; Saito, Yuki; Kizaki, Hayato; Ryuno, Hiroki; Mao, Han; Miyashita, Atsushi; Suzuki, Yutaka; Sekimizu, Kazuhisa; Kaito, Chikara			Novel Nucleoside Diphosphatase Contributes to Staphylococcus aureus Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROINVASIVE ESCHERICHIA-COLI; GENE REGULATOR AGR; EXOPROTEIN SYNTHESIS; CRYSTAL-STRUCTURE; SILKWORM MODEL; EXPRESSION; IDENTIFICATION; APYRASE; PROTEIN; SYSTEM	We identified SA1684 as a Staphylococcus aureus virulence gene using a silkworm infection model. The SA1684 gene product carried the DUF402 domain, which is found in RNA-binding proteins, and had amino acid sequence similarity with a nucleoside diphosphatase, Streptomyces coelicolor SC4828 protein. The SA1684-deletion mutant exhibited drastically decreased virulence, in which the LD50 against silkworms was more than 10 times that of the parent strain. The SA1684-deletion mutant also exhibited decreased exotoxin production and colony-spreading ability. Purified SA1684 protein had Mn2+ -or Co2+-dependent hydrolyzing activity against nucleoside diphosphates. Alanine substitutions of Tyr-88, Asp-106, and Asp-123/Glu-124, which are conserved between SA1684 and SC4828, diminished the nucleoside diphosphatase activity. Introduction of the wild-type SA1684 gene restored the hemolysin production of the SA1684-deletion mutant, whereas none of the alanine-substituted SA1684 mutant genes restored the hemolysin production. RNA sequence analysis revealed that SA1684 is required for the expression of the virulence regulatory genes agr, sarZ, and sarX, as well as metabolic genes involved in glycolysis and fermentation pathways. These findings suggest that the novel nucleoside diphosphatase SA1684 links metabolic-pathways and virulence gene expression and plays an important role in S. aureus virulence.	[Imae, Kenta; Saito, Yuki; Kizaki, Hayato; Ryuno, Hiroki; Mao, Han; Miyashita, Atsushi; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan	University of Tokyo; University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Ministry of Education, Culture, Sports, Science and Technology KAKENHI [22150002]; KANAE Foundation; Genome Pharmaceutical Institute;  [15H04727];  [15H05783]	Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KANAE Foundation; Genome Pharmaceutical Institute; ; 	This work was supported by Grants-in-aid for Scientific Research 15H04727 and 15H05783, Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grant 22150002, and in part by The KANAE Foundation and the Genome Pharmaceutical Institute. The authors declare that they have no conflicts of interest with the contents of this article.	AMANO T, 1993, J BIOCHEM-TOKYO, V114, P329, DOI 10.1093/oxfordjournals.jbchem.a124176; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Berlutti F, 1998, INFECT IMMUN, V66, P4957, DOI 10.1128/IAI.66.10.4957-4964.1998; Besier S, 2007, INT J MED MICROBIOL, V297, P217, DOI 10.1016/j.ijmm.2007.02.003; BHARGAVA T, 1995, CURR SCI INDIA, V68, P293; CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; Chatterjee I, 2008, J BACTERIOL, V190, P834, DOI 10.1128/JB.00912-07; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Geiger T, 2014, INT J MED MICROBIOL, V304, P150, DOI 10.1016/j.ijmm.2013.11.013; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hansen JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042645; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Ikuo M, 2010, MICROB PATHOGENESIS, V49, P1, DOI 10.1016/j.micpath.2010.03.010; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2012, ISJ-INVERT SURVIV J, V9, P163; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1016/S0378-1097(02)00603-1; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, MICROB PATHOGENESIS, V51, P142, DOI 10.1016/j.micpath.2011.04.007; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Khemici V, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005577, 10.1371/journal.pgen.1006320]; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kriegeskorte A, 2014, MBIO, V5, DOI 10.1128/mBio.01447-14; Kyuma T, 2015, BIOCHIMIE, V119, P166, DOI 10.1016/j.biochi.2015.10.027; Kyuma T, 2015, FEBS J, V282, P2570, DOI 10.1111/febs.13302; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; Li D, 2008, PROTEINS, V72, P1071, DOI 10.1002/prot.22093; Maierczyk C. D., 2008, J BACTERIOL, V190, P2257; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; Manna AC, 2006, J BACTERIOL, V188, P4288, DOI 10.1128/JB.00297-06; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Matsumoto Y, 2010, STRUCTURE, V18, P537, DOI 10.1016/j.str.2010.02.007; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Nagarajan V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-351; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Nasr F, 2000, NUCLEIC ACIDS RES, V28, P1676, DOI 10.1093/nar/28.8.1676; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Numata S, 2014, J BIOL CHEM, V289, P8420, DOI 10.1074/jbc.M114.554329; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Roux A, 2014, J BACTERIOL, V196, P1184, DOI 10.1128/JB.00128-13; Ryan RP, 2013, MICROBIOL-SGM, V159, P1286, DOI 10.1099/mic.0.068189-0; Sambrook J., 2001, MOL CLONING LAB MANU; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sarli S, 2005, MICROBIOL-SGM, V151, P2853, DOI 10.1099/mic.0.28142-0; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002	59	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18608	18619		10.1074/jbc.M116.721845	http://dx.doi.org/10.1074/jbc.M116.721845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27422825	Green Published, hybrid			2022-12-26	WOS:000383242300002
J	Ortega, E; Manso, JA; Buey, RM; Carballido, AM; Carabias, A; Sonnenberg, A; de Pereda, JM				Ortega, Esther; Manso, Jose A.; Buey, Ruben M.; Carballido, Ana M.; Carabias, Arturo; Sonnenberg, Arnoud; de Pereda, Jose M.			The Structure of the Plakin Domain of Plectin Reveals an Extended Rod-like Shape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; INTEGRIN BETA-4 SUBUNIT; RAY SOLUTION SCATTERING; ACTIN-BINDING DOMAIN; SPECTRIN-REPEATS; MACROMOLECULAR CRYSTALLOGRAPHY; BIOLOGICAL MACROMOLECULES; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURE; F-ACTIN	Plakins are large multi-domain proteins that interconnect cytoskeletal structures. Plectin is a prototypical plakin that tethers intermediate filaments to membrane-associated complexes. Most plakins contain a plakin domain formed by up to nine spectrin repeats (SR1-SR9) and an SH3 domain. The plakin domains of plectin and other plakins harbor binding sites for junctional proteins. We have combined x-ray crystallography with small angle x-ray scattering (SAXS) to elucidate the structure of the plakin domain of plectin, extending our previous analysis of the SR1 to SR5 region. Two crystal structures of the SR5-SR6 region allowed us to characterize its uniquely wide inter-repeat conformational variability. We also report the crystal structures of the SR7-SR8 region, refined to 1.8 angstrom, and the SR7-SR9 at lower resolution. The SR7-SR9 region, which is conserved in all other plakin domains, forms a rigid segment stabilized by uniquely extensive inter-repeat contacts mediated by unusually long helices in SR8 and SR9. Using SAXS we show that in solution the SR3-SR6 and SR7-SR9 regions are rod-like segments and that SR3-SR9 of plectin has an extended shape with a small central kink. Other plakins, such as bullous pemphigoid antigen 1 and microtubule and actin cross-linking factor 1, are likely to have similar extended plakin domains. In contrast, desmoplakin has a two-segment structure with a central flexible hinge. The continuous versus segmented structures of the plakin domains of plectin and desmoplakin give insight into how different plakins might respond to tension and transmit mechanical signals.	[Ortega, Esther; Manso, Jose A.; Buey, Ruben M.; Carballido, Ana M.; Carabias, Arturo; de Pereda, Jose M.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Unamuno, E-37007 Salamanca, Spain; [Buey, Ruben M.] Univ Salamanca, Dept Genet & Microbiol, Metab Engn Grp, E-37007 Salamanca, Spain; [Sonnenberg, Arnoud] Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Netherlands Cancer Institute	de Pereda, JM (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Campus Unamuno, E-37007 Salamanca, Spain.	pereda@usal.es	Manso, José/GWV-5180-2022; Martinez-Buey, Ruben/K-4296-2014; de Pereda, Jose M/AAE-5226-2022; del Rey, Arturo Carabias/A-4191-2019; Manso, José Antonio/S-3983-2019; Ortega, Esther/AAB-1836-2020; de Pereda, Jose M/F-1733-2010	Martinez-Buey, Ruben/0000-0003-1263-0221; de Pereda, Jose M/0000-0002-8912-6739; del Rey, Arturo Carabias/0000-0001-6286-2309; Manso, José Antonio/0000-0002-2565-6239; de Pereda, Jose M/0000-0002-8912-6739; Ortega Portero, Esther/0000-0003-1263-4409; Sonnenberg, Arnoud/0000-0001-9585-468X	Spanish Ministry of Economy and Competitiveness (MINECO); European Regional Development Fund [BFU2012-32847, BFU2015-69499-P]; Netherlands Science Foundation; Dutch Cancer Society; European Community under BioStruct-X Grant [283570]; MINECO [BES-2007-16463, BES-2010-038674, FPU14/ 06259]; MINECO	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); European Regional Development Fund(European Commission); Netherlands Science Foundation(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); European Community under BioStruct-X Grant; MINECO(Spanish Government); MINECO(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) and the European Regional Development Fund, Grants BFU2012-32847 and BFU2015-69499-P (to J. M. dP), as well as by the Netherlands Science Foundation and the Dutch Cancer Society (to A. S.). This work also was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X Grant Agreement 283570. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of Fellowships BES-2007-16463, BES-2010-038674, and FPU14/ 06259 from MINECO.; Supported by a "Ramon y Cajal" contract from MINECO.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ai-Jassar C, 2013, J MOL BIOL, V425, P4006, DOI 10.1016/j.jmb.2013.07.035; Al-Jassar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069767; Al-Jassar C, 2011, J MOL BIOL, V411, P1049, DOI 10.1016/j.jmb.2011.06.047; Alonso-Garcia N, 2009, ACTA CRYSTALLOGR D, V65, P858, DOI 10.1107/S0907444909018745; BABCOCK MS, 1994, J MOL BIOL, V237, P125, DOI 10.1006/jmbi.1994.1213; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; Boyden LM, 2016, HUM MOL GENET, V25, P348, DOI 10.1093/hmg/ddv481; Choi HJ, 2011, J MOL BIOL, V409, P800, DOI 10.1016/j.jmb.2011.04.046; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elliott P, 2010, CIRC-CARDIOVASC GENE, V3, P314, DOI 10.1161/CIRCGENETICS.110.937805; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fontao L, 2001, J CELL SCI, V114, P2065; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Alvarez B, 2003, STRUCTURE, V11, P615, DOI 10.1016/S0969-2126(03)00090-X; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; Jefferson JJ, 2007, J MOL BIOL, V366, P244, DOI 10.1016/j.jmb.2006.11.036; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapplinger JD, 2011, J AM COLL CARDIOL, V57, P2317, DOI 10.1016/j.jacc.2010.12.036; Ketema M, 2015, MOL BIOL CELL, V26, P2402, DOI 10.1091/mbc.E15-01-0043; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Manso JA, 2016, METHOD ENZYMOL, V569, P177, DOI 10.1016/bs.mie.2015.05.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Natsuga K, 2015, J DERMATOL SCI, V77, P139, DOI 10.1016/j.jdermsci.2014.11.005; Nikolic B, 1996, J CELL BIOL, V134, P1455, DOI 10.1083/jcb.134.6.1455; Ohno S, 2013, CIRC J, V77, P1534, DOI 10.1253/circj.CJ-12-1446; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Ortega E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197467; Osmani N, 2015, CURR OPIN CELL BIOL, V32, P30, DOI 10.1016/j.ceb.2014.10.004; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Quarta G, 2011, CIRCULATION, V123, P2701, DOI 10.1161/CIRCULATIONAHA.110.976936; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Samuelov L, 2015, CELL TISSUE RES, V360, P457, DOI 10.1007/s00441-014-2062-y; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sonnenberg A, 2007, J MOL BIOL, V368, P1379, DOI 10.1016/j.jmb.2007.02.090; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Theobald DL, 2012, BIOINFORMATICS, V28, P1972, DOI 10.1093/bioinformatics/bts243; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083	73	19	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18643	18662		10.1074/jbc.M116.732909	http://dx.doi.org/10.1074/jbc.M116.732909			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27413182	Green Published, hybrid			2022-12-26	WOS:000383242300005
J	Chen, X; Yang, YE; Shi, ZP; Gao, MQ; Zhang, Y				Chen, Xin; Yang, Yange; Shi, Zhaopeng; Gao, Ming-Qing; Zhang, Yong			Effects of Genetically Modified Milk Containing Human Beta-Defensin-3 on Gastrointestinal Health of Mice	PLOS ONE			English	Article							SAFETY ASSESSMENT; RISK-ASSESSMENT; FOOD ALLERGENS; CATTLE; DIGESTION; MEAT; STABILITY; ANIMALS; PEPTIDE; PROTEIN	This study was performed to investigate the effects of genetically modified (GM) milk containing human beta-defensin-3 (HBD3) on mice by a 90-day feeding study. The examined parameters included the digestibility of GM milk, general physical examination, gastric emptying function, intestinal permeability, intestinal microflora composition of mice, and the possibility of horizontal gene transfer (HGT). The emphasis was placed on the effects on gastrointestinal (GI) tract due to the fact that GI tract was the first site contacting with food and played crucial roles in metabolic reactions, nutrition absorption and immunity regulation in the host. However, the traditional methods for analyzing the potential toxicological risk of GM product pay little attention on GI health. In this study, the results showed GM milk was easy to be digested in simulated gastric fluid, and it did not have adverse effects on general and GI health compared to conventional milk. And there is little possibility of HGT. This study may enrich the safety assessment of GM product on GI health.	[Chen, Xin; Yang, Yange; Shi, Zhaopeng; Gao, Ming-Qing; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Gao, Ming-Qing; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Gao, MQ; Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.; Gao, MQ; Zhang, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China.	gaomingqing@nwsuaf.edu.cn; zhangyong1956@nwsuaf.edu.cn	chen, xiner/GVU-3933-2022		National Major Project for Production of Transgenic Breeding [2013ZX08007-004]	National Major Project for Production of Transgenic Breeding	This work was supported by the National Major Project for Production of Transgenic Breeding (No. 2013ZX08007-004), http://www.moa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaas H, 2006, INT DAIRY J, V16, P961, DOI 10.1016/j.idairyj.2005.10.029; Astwood JD, 1996, NAT BIOTECHNOL, V14, P1269, DOI 10.1038/nbt1096-1269; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cinova J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016169; Dhople V, 2006, BBA-BIOMEMBRANES, V1758, P1499, DOI 10.1016/j.bbamem.2006.07.007; Einspanier R, 2001, EUR FOOD RES TECHNOL, V212, P129, DOI 10.1007/s002170000248; Fu TJ, 2002, ANN NY ACAD SCI, V964, P99; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guillen I, 1999, MAR BIOTECHNOL, V1, P2, DOI 10.1007/PL00011746; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Hammond B, 2004, FOOD CHEM TOXICOL, V42, P1003, DOI 10.1016/j.fct.2004.02.013; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hu WP, 2012, BIOCHEM CELL BIOL, V90, P485, DOI [10.1139/o2012-003, 10.1139/O2012-003]; Kelly BG, 2009, FOOD CHEM TOXICOL, V47, P978, DOI 10.1016/j.fct.2008.06.012; Kleter GA, 2010, ANIM SCI PAP REP, V28, P105; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu S, 2013, FOOD CHEM TOXICOL, V57, P314, DOI 10.1016/j.fct.2013.04.003; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; Malatesta M, 2008, HISTOCHEM CELL BIOL, V130, P967, DOI 10.1007/s00418-008-0476-x; Mihara H, 2010, J NEUROSCI, V30, P16536, DOI 10.1523/JNEUROSCI.4426-10.2010; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tang MX, 2012, TRANSGENIC RES, V21, P499, DOI 10.1007/s11248-011-9550-6; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vantrappen G, 1986, DIG DIS SCI; Wheeler MB, 2010, TRANSGENIC RES, V19, P136; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Xu JX, 2011, TRANSGENIC RES, V20, P1043, DOI 10.1007/s11248-010-9477-3; Yamaguchi M, 2007, THERIOGENOLOGY, V67, P152, DOI 10.1016/j.theriogenology.2006.09.010; Yang XZ, 2007, NAT BIOTECHNOL, V25, P77, DOI 10.1038/nbt1276; Yu Y, 2013, PLOS ONE, V8; Yuan YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01962; Zhang Q, 2010, MICROB PATHOGENESIS, V48, P28, DOI 10.1016/j.micpath.2009.10.002; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049697; Zhou C, 2011, DRUG CHEM TOXICOL, V34, P359, DOI 10.3109/01480545.2010.542465	40	7	7	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159700	10.1371/journal.pone.0159700	http://dx.doi.org/10.1371/journal.pone.0159700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438026	Green Published, Green Submitted, gold			2022-12-26	WOS:000380170100069
J	Liu, L; Jiang, YD; Steinle, JJ				Liu, Li; Jiang, Youde; Steinle, Jena J.			Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion	PLOS ONE			English	Article							OXYGEN-INDUCED RETINOPATHY; ISCHEMIA-REPERFUSION INJURY; BETA-ADRENERGIC-RECEPTOR; VASCULAR-PERMEABILITY; CELL APOPTOSIS; MOUSE MODEL; HYPOXIA; IGFBP-3; EXPRESSION; GROWTH	We have recently reported that Compound 49b, a novel beta-adrenergic receptor agonist, can significantly reduce VEGF levels in retinal endothelial cells (REC) grown in diabetic-like conditions. In this study, we investigated whether Compound 49b could protect the retina under hypoxic conditions using the ischemia-reperfusion (I/R)-induced model in rats, as well REC cultured in hypoxic conditions. Some rats received 1mM topical Compound 49b for the 2 (5 rats each group) or 10 (4 rats in each group) days post-I/R. Analyses for retinal thickness and cell loss in the ganglion cell layer was done at 2 days post-I/R, while numbers of degenerate capillaries and pericyte ghosts were measured at 10 days post-I/R. Additionally, REC were cultured in normal oxygen or hypoxia (5% O-2) only or treated with 50 nM Compound 49b for 12 hours. Twelve hours after Compound 49b exposure, cells were collected and analyzed for protein levels of insulin-like growth factor binding protein 3 (IGFBP3), vascular endothelial cell growth factor (VEGF) and its receptor (KDR), angiopoietin 1 and its receptor Tie2 for Western blotting. Data indicate that exposure to I/R significantly decreased retinal thickness, with increasing numbers of degenerate capillaries and pericyte ghosts. Compound 49b treatment inhibited these retinal changes. In REC cultured in hypoxia, levels of IGFBP-3 were reduced, which were significantly increased by Compound 49b. Hypoxia significantly increased protein levels of VEGF, KDR, Angiopoiein 1, and Tie2, which were reduced following Compound 49b treatment. These data strongly suggested that Compound 49b protected the retina against I/R-induced injury. This provides additional support for a role of beta-adrenergic receptor actions in the retina.	[Liu, Li; Jiang, Youde; Steinle, Jena J.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Steinle, Jena J.] Wayne State Univ, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Steinle, JJ (corresponding author), Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Steinle, JJ (corresponding author), Wayne State Univ, Dept Ophthalmol, Detroit, MI 48201 USA.	jsteinle@med.wayne.edu		Steinle, Jena/0000-0002-7539-2892	Research to Prevent Blindness;  [R01EY022045];  [P30EY04068]; NATIONAL EYE INSTITUTE [P30EY004068, R01EY022045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01EY022045 (JJS), P30EY04068 (PI: Hazlett) and an Unrestricted Grant to the Department of Ophthalmology from Research to Prevent Blindness (Kresge Eye Institute).	Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Chang RL, 2015, GROWTH FACTORS, V33, P275, DOI 10.3109/08977194.2015.1077824; Chen J, 2012, INVEST OPHTH VIS SCI, V53, P2968, DOI 10.1167/iovs.12-9691; Dal Monte M, 2013, EXP EYE RES, V111, P27, DOI 10.1016/j.exer.2013.03.013; Dal Monte M, 2012, INVEST OPHTH VIS SCI, V53, P2181, DOI 10.1167/iovs.11-9408; Hsieh DJY, 2015, CELL PHYSIOL BIOCHEM, V36, P274, DOI 10.1159/000374070; Jiang YD, 2015, GROWTH FACTORS, V33, P192, DOI 10.3109/08977194.2015.1054990; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Kielczewski JL, 2011, AM J PATHOL, V178, P1517, DOI 10.1016/j.ajpath.2010.12.031; Kielczewski JL, 2009, CIRCULATION, P9022; Kociok N, 2007, GRAEF ARCH CLIN EXP, V245, P258, DOI 10.1007/s00417-006-0355-x; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Natsuizaka M, 2014, AM J CANCER RES, V4, P29; Park SY, 2011, INT J CANCER, V128, P2306, DOI 10.1002/ijc.25589; Park YS, 2003, MICROVASC RES, V65, P125, DOI 10.1016/S0026-2862(02)00035-3; Ristori C, 2011, INVEST OPHTH VIS SCI, V52, P155, DOI 10.1167/iovs.10-5536; Steinle JJ, 2009, EXP EYE RES, V88, P1014, DOI 10.1016/j.exer.2008.12.015; Veenstra Alexander, 2015, Curr Protoc Mouse Biol, V5, P247, DOI 10.1002/9780470942390.mo140190; Wiley LA, 2006, INVEST OPHTH VIS SCI, V47, P439, DOI 10.1167/iovs.05-0656; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	23	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159532	10.1371/journal.pone.0159532	http://dx.doi.org/10.1371/journal.pone.0159532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27439004	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100054
J	Tiadi, A; Seassau, M; Gerard, CL; Bucci, MP				Tiadi, Aime; Seassau, Magali; Gerard, Christophe-Loic; Bucci, Maria Pia			Differences between Dyslexic and Non-Dyslexic Children in the Performance of Phonological Visual-Auditory Recognition Tasks: An Eye-Tracking Study	PLOS ONE			English	Article							SPOKEN WORD RECOGNITION; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; SPEECH-PERCEPTION; PARIETAL CORTEX; MOVEMENTS; AWARENESS; SACCADES; DEFICIT; EYETRACKING	The object of this study was to explore further phonological visual-auditory recognition tasks in a group of fifty-six healthy children (mean age: 9.9 +/- 0.3) and to compare these data to those recorded in twenty-six age-matched dyslexic children (mean age: 9.8 +/- 0.2). Eye movements from both eyes were recorded using an infrared video-oculography system (MobileEBT (R) e(y)e BRAIN). The recognition task was performed under four conditions in which the target object was displayed either with phonologically unrelated objects (baseline condition), or with cohort or rhyme objects (cohort and rhyme conditions, respectively), or both together (rhyme + cohort condition). The percentage of the total time spent on the targets and the latency of the first saccade on the target were measured. Results in healthy children showed that the percentage of the total time spent in the baseline condition was significantly longer than in the other conditions, and that the latency of the first saccade in the cohort condition was significantly longer than in the other conditions; interestingly, the latency decreased significantly with the increasing age of the children. The developmental trend of phonological awareness was also observed in healthy children only. In contrast, we observed that for dyslexic children the total time spent on the target was similar in all four conditions tested, and also that they had similar latency values in both cohort and rhyme conditions. These findings suggest a different sensitivity to the phonological competitors between dyslexic and non-dyslexic children. Also, the eye-tracking technique provides online information about phonological awareness capabilities in children.	[Tiadi, Aime; Bucci, Maria Pia] Robert Debre Hosp, Inst Natl Sante & Rech Med Paris Diderot, UMR 1141, Paris, France; [Seassau, Magali] Eye Brain, Ivry, France; [Gerard, Christophe-Loic] Robert Debre Hosp, Child & Adolescent Psychiat Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Tiadi, A (corresponding author), Robert Debre Hosp, Inst Natl Sante & Rech Med Paris Diderot, UMR 1141, Paris, France.	bi-kuyami-guy-aime.tiadi@inserm.fr			e(ye)BRAIN company	e(ye)BRAIN company	These authors have no support or funding to report. The e(ye)BRAIN company provided support in the form of salaries for authors [Magali Seassau], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; BENTIN S, 1991, PSYCHOL SCI, V2, P271, DOI 10.1111/j.1467-9280.1991.tb00148.x; Berninger VW, 2010, J PSYCHOLINGUIST RES, V39, P141, DOI 10.1007/s10936-009-9130-6; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; BRUCK M, 1992, DEV PSYCHOL, V28, P874, DOI 10.1037/0012-1649.28.5.874; Bucci MP, 2014, RES DEV DISABIL, V35, P1292, DOI 10.1016/j.ridd.2014.03.029; Bucci MP, 2014, EXP BRAIN RES, V232, P927, DOI 10.1007/s00221-013-3805-9; Bucci MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077920; Bucci MP, 2013, RES DEV DISABIL, V34, P3727, DOI 10.1016/j.ridd.2013.07.032; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; CARRILLO M, 1994, READ WRIT, V6, P279, DOI 10.1007/BF01027086; Chevrie-Muller C, 1997, BATTERIE LANGAGE ORA; Clark KA, 2014, BRAIN, V137, P3136, DOI 10.1093/brain/awu229; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Demont E., 2004, ENFANCE, V3, P245; Desroches AS, 2006, COGNITION, V100, pB32, DOI 10.1016/j.cognition.2005.09.001; Ehri LC, 1991, DYSLEXIA INTEGRATING, P63; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Gorges F, 2013, ACTA PSYCHOL, V143, P168, DOI 10.1016/j.actpsy.2013.03.006; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gombert J.-E, 2007, ACQUISITION LANGAGE, P47; Goswami U, 2005, J EXP CHILD PSYCHOL, V92, P345, DOI 10.1016/j.jecp.2005.06.002; Goswami U, 2000, Dyslexia, V6, P133, DOI 10.1002/(SICI)1099-0909(200004/06)6:2<133::AID-DYS160>3.0.CO;2-A; Goswani U, 1990, PHONOLOGICAL SKILLS, P166; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Jones MW, 2010, COGNITION, V116, P56, DOI 10.1016/j.cognition.2010.03.015; Jones MW, 2008, COGNITION, V109, P389, DOI 10.1016/j.cognition.2008.10.005; KIRTLEY C, 1989, J EXP CHILD PSYCHOL, V48, P224, DOI 10.1016/0022-0965(89)90004-0; Lions C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083972; Lions C, 2013, INVEST OPHTH VIS SCI, V54, P620, DOI 10.1167/iovs.12-10526; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; McSorley E, 2012, VISION RES, V60, P61, DOI 10.1016/j.visres.2012.03.007; Meyer AS, 2007, PSYCHON B REV, V14, P710, DOI 10.3758/BF03196826; Miller B, 2013, SCHOOL PSYCHOL REV, V42, P123; Nystrom M, 2010, BEHAV RES METHODS, V42, P188, DOI 10.3758/BRM.42.1.188; O'Regan J K, 1990, Rev Oculomot Res, V4, P395; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Ruffino M, 2010, NEUROPSYCHOLOGIA, V48, P3793, DOI 10.1016/j.neuropsychologia.2010.09.002; Salman MS, 2006, VISION RES, V46, P1432, DOI 10.1016/j.visres.2005.06.011; Sekerina IA, 2007, J EXP CHILD PSYCHOL, V98, P20, DOI 10.1016/j.jecp.2007.04.005; Shaywitz SE, 2005, BIOL PSYCHIAT, V57, P1301, DOI 10.1016/j.biopsych.2005.01.043; Snowling M.J., 1995, J RES READ, V18, P132, DOI DOI 10.1111/J.1467-9817.1995.TB00079.X; Sprenger-Charolles L, 2003, J EXP CHILD PSYCHOL, V84, P194, DOI 10.1016/S0022-0965(03)00024-9; Sprenger-Charolles L, 2006, READING ACQUISITION; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; TALLAL P, 1980, TRENDS NEUROSCI, V3, P309; Tiadi A, 2014, RES DEV DISABIL, V35, P3175, DOI 10.1016/j.ridd.2014.07.057; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Wimmer H, 1996, J EXP CHILD PSYCHOL, V61, P80, DOI 10.1006/jecp.1996.0004; Zagar D, 1992, PSYCHOL COGNITIVE LE	57	7	7	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159190	10.1371/journal.pone.0159190	http://dx.doi.org/10.1371/journal.pone.0159190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TL	27438352	gold, Green Published, Green Submitted			2022-12-26	WOS:000380170100030
J	Aziz, SGG; Pashaei-Asl, F; Fardyazar, Z; Pashaiasl, M				Aziz, Shiva Gholizadeh-Ghaleh; Pashaei-Asl, Fatima; Fardyazar, Zahra; Pashaiasl, Maryam			Isolation, Characterization, Cryopreservation of Human Amniotic Stem Cells and Differentiation to Osteogenic and Adipogenic Cells	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; FETAL MEMBRANES; FLUID CELLS; IN-VITRO; MOUSE; MIR-302; CULTURE; LINES; PLURIPOTENCY; EXPRESSION	Human stem cells and progenitor cells can be used to treat cancer and replace dysfunctional cells within a tissue or organ. The objective of this study was to identify the appropriate cells type in regenerative medicine and targeted therapy. As an alternative to embryonic and bone marrow stem cells, we examined human amniotic fluid stem cells (hAFSCs), one of the potential source of multipotent stem cells isolated from both cell pellet (using single-stage method), and supernatant of human amniotic fluid. Source of isolation and unique property of the cells emphasize that these cells are one of the promising new tools in therapeutic field. Double sources for isolation and availability of the left over samples in diagnostic laboratory at the same time have less legal and ethical concerns compared with embryonic stem cell studies. Cells were isolated, cultured for 18th passage for 6 months and characterized using qPCR and flow cytometry. Cells showed good proliferative ability in culture condition. The cells successfully differentiated into the adipogenic and osteogenic lineages. Based on these findings, amniotic fluid can be considered as an appropriate and convenient source of human amniotic fluid stem cells. These cells provide potential tools for therapeutic applications in the field of regenerative medicine. To get a better understanding of crosstalk between Oct4/NANOG with osteogenesis and adipogenesis, we used network analysis based on Common Targets algorithm and Common Regulators algorithm as well as subnetwork discovery based on gene set enrichment. Network analysis highlighted the possible role of MIR 302A and MIR let-7g. We demonstrated the high expression of MIR 302A and low expression of MIR let7g in hAFSCs by qPCR.	[Aziz, Shiva Gholizadeh-Ghaleh; Fardyazar, Zahra; Pashaiasl, Maryam] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran; [Pashaei-Asl, Fatima] Tabriz Univ Med Sci, Mol Biol Lab, Biotechnol Res Ctr, Tabriz, Iran; [Aziz, Shiva Gholizadeh-Ghaleh; Fardyazar, Zahra] Tabriz Univ Med Sci, Sch Adv Med Sci, Dept Mol Med, Tabriz, Iran; [Pashaiasl, Maryam] Tabriz Univ Med Sci, Fac Med, Dept Anat Sci, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Pashaiasl, M (corresponding author), Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran.; Pashaiasl, M (corresponding author), Tabriz Univ Med Sci, Fac Med, Dept Anat Sci, Tabriz, Iran.	pashaim@tbzmed.ac.ir	Fardiazar, Zahra/M-5603-2017; az, Shiva Gholizadeh-Ghaleh/G-8254-2017; Pashaiasl, Maryam/M-4676-2017	az, Shiva Gholizadeh-Ghaleh/0000-0003-1949-4381; Pashaiasl, Maryam/0000-0002-4490-6627	Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran; Training Center-Al-Zahra Hospital of Tabriz University of Medical Sciences Grant [93/4-10/2]; Department of Molecular Medicine, Faculty of Advanced Medical Science of Tabriz University	Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran; Training Center-Al-Zahra Hospital of Tabriz University of Medical Sciences Grant; Department of Molecular Medicine, Faculty of Advanced Medical Science of Tabriz University	This work is funded by the 2015 Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran, Training Center-Al-Zahra Hospital of Tabriz University of Medical Sciences Grant (Study ID: 93/4-10/2).; The authors thank the Department of Molecular Medicine, Faculty of Advanced Medical Science of Tabriz University, for all support provided. This work is funded by the 2015 Women's Reproductive Health Research Center of Medical Sciences Tabriz, Iran, Training Center-AlZahra Hospital of Tabriz University of Medical Sciences Grant (Study ID: 93/4-10/2). We would like to thank Dr. Manijeh Mohammadidehcheshmeh, The University of Adelaide, for the assistance in network construction using Pathway Studio Web (version 11.0.5).	Alanazi I, 2013, APOPTOSIS, V18, P1291, DOI 10.1007/s10495-013-0887-6; Alanazi IO, 2016, MOL BIOTECHNOL, P1; Alisoltani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096320; Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bhatti I, 2009, J GASTROINTEST SURG, V13, P1379, DOI 10.1007/s11605-009-0887-6; Bossolasco P, 2006, CELL RES, V16, P329, DOI 10.1038/sj.cr.7310043; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Csermely P, 2015, SEMINARS CANC BIOL; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Diecke S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08081; Ebrahimie E, 2016, J ALZHEIMERS DIS, P1; Ebrahimie E, 2015, MOL BIOL REP, V42, P1377, DOI 10.1007/s11033-015-3916-4; Ebrahimie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090885; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fruzangohar M, 2014, BIORXIV; Fruzangohar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058759; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Gholizadeh-Ghalehaziz S, 2015, INT J STEM CELLS, V8, P115, DOI 10.15283/ijsc.2015.8.2.115; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; HOEHN H, 1982, METHOD CELL BIOL, V26, P11; Hosseinpour B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049931; Huskey NE, 2015, STEM CELL REP, V4, P374, DOI 10.1016/j.stemcr.2015.01.019; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Lee Young Jin, 2016, Cell Regen, V5, P2, DOI 10.1186/s13619-016-0028-0; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li L, 2015, CHARACTERISTICS HUMA; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ludlow J, 2015, FASEB J, V29; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Menasche P, 2015, EUROPEAN HEART J; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; NICOLAIDES K, 1994, LANCET, V344, P435, DOI 10.1016/S0140-6736(94)91769-8; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Pashaiasl M, 2016, GENE, V578, P194, DOI 10.1016/j.gene.2015.12.023; Pashaiasl M, 2013, REPROD FERT DEVELOP, V25, P707, DOI 10.1071/RD12018; Perin L, 2008, METHOD CELL BIOL, V86, P85, DOI 10.1016/S0091-679X(08)00005-8; Phermthai T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-79; POLGAR K, 1989, AM J HUM GENET, V45, P786; Pozzobon M, 2014, CELL TISSUE BANK, V15, P199, DOI 10.1007/s10561-014-9428-y; PRIEST RE, 1978, LAB INVEST, V39, P106; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Rossant J, 2015, DEVELOPMENT, V142, P9, DOI 10.1242/dev.115451; Rossi B, 2014, STEM CELL REV REP, V10, P712, DOI 10.1007/s12015-014-9525-0; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Sartore S, 2005, EUR J CARDIO-THORAC, V28, P677, DOI 10.1016/j.ejcts.2005.07.019; Stocum DL, 2001, WOUND REPAIR REGEN, V9, P429, DOI 10.1046/j.1524-475x.2001.00429.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi Kazutoshi, 2006, V329, P449; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Turner JD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09207; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Vidal DO, 2013, PEDIATR HEMAT ONCOL, V30, P367, DOI 10.3109/08880018.2013.783890; Wang BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002186; You Q, 2008, INT J GYNECOL OBSTET, V103, P149, DOI 10.1016/j.ijgo.2008.06.012; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	77	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158281	10.1371/journal.pone.0158281	http://dx.doi.org/10.1371/journal.pone.0158281			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434028	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600007
J	Colvin, RA; Jin, QL; Lai, B; Kiedrowski, L				Colvin, Robert A.; Jin, Qiaoling; Lai, Barry; Kiedrowski, Lech			Visualizing Metal Content and Intracellular Distribution in Primary Hippocampal Neurons with Synchrotron X-Ray Fluorescence	PLOS ONE			English	Article							PLASMA-MASS SPECTROMETRY; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CORTICAL-NEURONS; DOPAMINERGIC-NEURONS; SYNAPTIC VESICLES; SUBSTANTIA-NIGRA; IRON-METABOLISM; NERVOUS-SYSTEM; ZINC	Increasing evidence suggests that metal dyshomeostasis plays an important role in human neurodegenerative diseases. Although distinctive metal distributions are described for mature hippocampus and cortex, much less is known about metal levels and intracellular distribution in individual hippocampal neuronal somata. To solve this problem, we conducted quantitative metal analyses utilizing synchrotron radiation X-Ray fluorescence on frozen hydrated primary cultured neurons derived from rat embryonic cortex (CTX) and two regions of the hippocampus: dentate gyrus (DG) and CA1. Comparing average metal contents showed that the most abundant metals were calcium, iron, and zinc, whereas metals such as copper and manganese were less than 10% of zinc. Average metal contents were generally similar when compared across neurons cultured from CTX, DG, and CA1, except for manganese that was larger in CA1. However, each metal showed a characteristic spatial distribution in individual neuronal somata. Zinc was uniformly distributed throughout the cytosol, with no evidence for the existence of previously identified zinc-enriched organelles, zincosomes. Calcium showed a peri-nuclear distribution consistent with accumulation in endoplasmic reticulum and/or mitochondria. Iron showed 2-3 distinct highly concentrated puncta only in peri-nuclear locations. Notwithstanding the small sample size, these analyses demonstrate that primary cultured neurons show characteristic metal signatures. The iron puncta probably represent iron-accumulating organelles, siderosomes. Thus, the metal distributions observed in mature brain structures are likely the result of both intrinsic neuronal factors that control cellular metal content and extrinsic factors related to the synaptic organization, function, and contacts formed and maintained in each region.	[Colvin, Robert A.] Ohio Univ, Dept Biol Sci, Interdisciplinary Grad Program Mol & Cellular Bio, Neurosci Program, Athens, OH 45701 USA; [Jin, Qiaoling] Northwestern Univ, Dept Phys & Astron, Evanston, IL USA; [Lai, Barry] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Lemont, IL USA; [Kiedrowski, Lech] Univ Illinois, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA; [Kiedrowski, Lech] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University System of Ohio; Ohio University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colvin, RA (corresponding author), Ohio Univ, Dept Biol Sci, Interdisciplinary Grad Program Mol & Cellular Bio, Neurosci Program, Athens, OH 45701 USA.	colvin@ohio.edu			DOE Office of Science [DE-AC02-06CH11357]; National Institute of General Medical Sciences [1R01GM104530]; National Institutes of Health [1R21NS082786]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104530] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Photon Source (B.L.), a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Q. J. was supported by the National Institute of General Medical Sciences under Grant 1R01GM104530 awarded to Chris Jacobsen at Argonne National Laboratory and Northwestern University. L. K. was supported by National Institutes of Health Grant 1R21NS082786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The authors wish to thank Benjamin A. Colvin for art work.	ANDRASI E, 1995, ARCH GERONTOL GERIAT, V21, P89, DOI 10.1016/0167-4943(95)00643-Y; Antharam V, 2012, NEUROIMAGE, V59, P1249, DOI 10.1016/j.neuroimage.2011.08.019; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Bourassa MW, 2012, METALLOMICS, V4, P721, DOI 10.1039/c2mt20052j; Bozym R, 2008, METHOD ENZYMOL, V450, P287, DOI 10.1016/S0076-6879(08)03414-9; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Carmona A, 2010, ACS CHEM NEUROSCI, V1, P194, DOI 10.1021/cn900021z; CASSELL MD, 1984, J COMP NEUROL, V222, P461, DOI 10.1002/cne.902220311; Cerchiaro G, 2013, METALLOMICS, V5, P1336, DOI 10.1039/c3mt00136a; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chwiej J, 2014, J BIOL INORG CHEM, V19, P1209, DOI 10.1007/s00775-014-1177-7; Chwiej J, 2012, J BIOL INORG CHEM, V17, P731, DOI 10.1007/s00775-012-0892-1; Ciccotosto GD, 2014, METALLOMICS, V6, P1894, DOI 10.1039/c4mt00176a; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colvin R.A., 2012, METAL ION STROKE, P227, DOI [10.1007/978-1-4419-9663-3_10, DOI 10.1007/978-1-4419-9663-3_10]; Colvin RA, 2002, AM J PHYSIOL-CELL PH, V282, pC317, DOI 10.1152/ajpcell.00143.2001; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Colvin RA, 2015, METALLOMICS, V7, P1111, DOI 10.1039/c5mt00084j; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; Daoust A, 2014, HIPPOCAMPUS, V24, P598, DOI 10.1002/hipo.22252; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Ducic T, 2015, ACS CHEM NEUROSCI, V6, P1769, DOI 10.1021/acschemneuro.5b00093; Ducic T, 2013, J NEUROCHEM, V124, P250, DOI 10.1111/jnc.12073; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fahrni CJ, 2007, CURR OPIN CHEM BIOL, V11, P121, DOI 10.1016/j.cbpa.2007.02.039; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Ghadially FN, 1997, ULTRASTRUCT PATHOL, P668; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hare DJ, 2013, METALLOMICS, V5, P1656, DOI 10.1039/c3mt00227f; Hare DJ, 2012, ANAL CHEM, V84, P3990, DOI 10.1021/ac300374x; Hare DJ, 2010, METALLOMICS, V2, P745, DOI 10.1039/c0mt00039f; Haug F M, 1975, J Hirnforsch, V16, P151; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Jin QL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117437; KEMP K, 1979, HISTOCHEMISTRY, V59, P167, DOI 10.1007/BF00495664; Kiedrowski L, 2015, J NEUROCHEM, V135, P777, DOI 10.1111/jnc.13282; Kiedrowski L, 2014, J NEUROCHEM, V130, P87, DOI 10.1111/jnc.12712; Kosior E, 2012, J STRUCT BIOL, V177, P239, DOI 10.1016/j.jsb.2011.12.005; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Lane DJR, 2015, BBA-MOL CELL RES, V1853, P1130, DOI 10.1016/j.bbamcr.2015.01.021; Lavenex P, 2012, CLIN NEUROBIOLOGY HI, P10, DOI [DOI 10.1093/ACPROF:OSO/9780199592388.003.0002, DOI 10.1038/s41380-019-0392-6]; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Leskovjan AC, 2011, NEUROIMAGE, V55, P32, DOI 10.1016/j.neuroimage.2010.11.073; Maret Wolfgang, 2013, Met Ions Life Sci, V13, P389, DOI 10.1007/978-94-007-7500-8_12; de Lima MNM, 2008, NEUROBIOL AGING, V29, P1052, DOI 10.1016/j.neurobiolaging.2007.02.006; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Michaelis EK, 2012, CLIN NEUROBIOLOGY HI, P55; Ortega R, 2016, MOL NEUROBIOL, V53, P1925, DOI 10.1007/s12035-015-9146-x; Ortega R, 2009, J R SOC INTERFACE, V6, pS649, DOI 10.1098/rsif.2009.0166.focus; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Pivovarova NB, 2014, J NEUROCHEM, V128, P592, DOI 10.1111/jnc.12489; Prasad A, 1993, BIOCH ELEMENTS, V11, P149; Qin ZY, 2011, METALLOMICS, V3, P823, DOI 10.1039/c1mt00033k; Ranaldi G, 2002, AM J PHYSIOL-RENAL, V283, DOI DOI 10.1111/JNC.12073; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Robison G, 2015, METALLOMICS, V7, P748, DOI 10.1039/c5mt00023h; Robison G, 2013, METALLOMICS, V5, P1554, DOI 10.1039/c3mt00133d; Robison G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048899; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; SATO S, 1981, J INVEST DERMATOL, V77, P264, DOI 10.1111/1523-1747.ep12482449; Schroder N, 2013, J ALZHEIMERS DIS, V34, P797, DOI 10.3233/JAD-121996; Sekler I, 2012, GLIA, V60, P843, DOI 10.1002/glia.22286; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wegst-Uhrich SR, 2015, BIOMETALS, V28, P187, DOI 10.1007/s10534-014-9814-8; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676	72	15	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159582	10.1371/journal.pone.0159582	http://dx.doi.org/10.1371/journal.pone.0159582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434052	Green Published, gold			2022-12-26	WOS:000380169600074
J	Sieswerda, E; Font-Gonzalez, A; Reitsma, JB; Dijkgraaf, MGW; Heinen, RC; Jaspers, MW; van der Pal, HJ; van Leeuwen, FE; Caron, HN; Geskus, RB; Kremer, LC				Sieswerda, Elske; Font-Gonzalez, Anna; Reitsma, Johannes B.; Dijkgraaf, Marcel G. W.; Heinen, Richard C.; Jaspers, Monique W.; van der Pal, Helena J.; van Leeuwen, Flora E.; Caron, Huib N.; Geskus, Ronald B.; Kremer, Leontien C.			High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage	PLOS ONE			English	Article							LONG-TERM SURVIVORS; QUALITY-OF-LIFE; ADULT SURVIVORS; CARDIAC-FUNCTION; HEALTH OUTCOMES; HEART-FAILURE; BRAIN-TUMORS; COHORT; POPULATION; NEOPLASMS	Hospitalization rates over time of childhood cancer survivors (CCS) provide insight into the burden of unfavorable health conditions on CCS and health care resources. The objective of our study was to examine trends in hospitalizations of CCS and risk factors in comparison with the general population. We performed a medical record linkage study of a cohort of 1564 >= five-year CCS with national registers. We obtained a random sample of the general population matched on year of birth, gender and calendar year per CCS retrieved. We quantified and compared hospitalization rates of CCS and reference persons from 1995 until 2005, and we analyzed risk factors for hospitalization within the CCS cohort with multivariable Poisson models. We retrieved hospitalization information from 1382 CCS and 25583 reference persons. The overall relative hospitalization rate (RHR) was 2.2 (95% CI: 1.9-2.5) for CCS compared to reference persons. CCS with central nervous system and solid tumors had highest RHRs. Hospitalization rates in CCS were increased compared to reference persons up to at least 30 years after primary diagnosis, with highest rates 5-10 and 20-30 years after primary cancer. RHRs were highest for hospitalizations due to neoplasms (10.7; 95% CI: 7.1-16.3) and endocrine/nutritional/metabolic disorders (7.3; 95% CI: 4.6-11.7). Female gender (P<0.001), radiotherapy to head and/or neck (P<0.001) or thorax and/or abdomen (P = 0.03) and surgery (P = 0.01) were associated with higher hospitalization rates in CCS. In conclusion, CCS have increased hospitalization rates compared to the general population, up to at least 30 years after primary cancer treatment. These findings imply a high and long-term burden of unfavorable health conditions after childhood cancer on survivors and health care resources.	[Sieswerda, Elske; Font-Gonzalez, Anna; Heinen, Richard C.; van der Pal, Helena J.; Caron, Huib N.; Kremer, Leontien C.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Dijkgraaf, Marcel G. W.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Jaspers, Monique W.] Acad Med Ctr, Dept Med Informat, Ctr Human Factors Engn Hlth Informat Technol HITl, Amsterdam, Netherlands; [van der Pal, Helena J.] Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Geskus, Ronald B.] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam	Sieswerda, E (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands.	e.sieswerda@amc.uva.nl	Geskus, Ronald B/H-3684-2019	Geskus, Ronald B/0000-0002-2740-3155; Kremer, Leontien/0000-0001-7422-3248; kremer, leontien/0000-0002-7619-7845; Reitsma, Johannes/0000-0003-4026-4345	Stichting Kinderen Kankervrij (KiKa) [84]	Stichting Kinderen Kankervrij (KiKa)	This work was supported by Stichting Kinderen Kankervrij (KiKa), Project 84, https://www.kika.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, SURVIVORS CHILDHOOD; Armstrong GT, 2007, J CLIN ONCOL, V25, P4477, DOI 10.1200/JCO.2007.11.2003; Armstrong GT, 2010, RADIAT RES, V174, P840, DOI 10.1667/RR1903.1; Bradley NME, 2010, EUR J CANCER, V46, P2441, DOI 10.1016/j.ejca.2010.05.001; Brewster DH, 2013, EUR J CANCER, V110, P1342, DOI DOI 10.1038/BJC.2013.788; Cohen JW, 2003, HEALTH AFFAIR, V22, P129, DOI 10.1377/hlthaff.22.2.129; Curry HL, 2006, EUR J CANCER, V42, P501, DOI 10.1016/j.ejca.2005.11.003; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Dijkgraaf MGW, 1996, HEALTH POLICY, V35, P13, DOI 10.1016/0168-8510(95)00772-5; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gudmundsdottir T, 2015, INT J CANCER, V137, P1176, DOI 10.1002/ijc.29468; Gunn ME, 2015, NEURO-ONCOLOGY, V17, P747, DOI 10.1093/neuonc/nou321; Gurney JG, 2006, CANCER-AM CANCER SOC, V107, P1303, DOI 10.1002/cncr.22120; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Holmqvist AS, 2014, EUR J CANCER, V50, P1169, DOI 10.1016/j.ejca.2014.01.014; Howards PP, 2007, AM J EPIDEMIOL, V165, P444, DOI 10.1093/aje/kwk027; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Kilian R, 2001, CLIN PSYCHOL PSYCHOT, V8, P206, DOI 10.1002/cpp.277; Kirchhoff AC, 2014, CANCER EPIDEM BIOMAR, V23, P1280, DOI 10.1158/1055-9965.EPI-13-1090; Kurt BA, 2012, PEDIATR BLOOD CANCER, V59, P126, DOI 10.1002/pbc.24017; Licht SD, 2014, LANCET, V383, P1981, DOI 10.1016/S0140-6736(13)62564-7; Lorenzi MF, 2011, INT J CANCER, V128, P1624, DOI 10.1002/ijc.25751; Lund LW, 2013, LANCET ONCOL, V14, P971, DOI 10.1016/S1470-2045(13)70351-6; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Metcalfe C, 2003, EUR HEART J, V24, P105, DOI 10.1016/S0195-668X(02)00384-6; Mulder RL, 2009, CANCER TREAT REV, V35, P616, DOI 10.1016/j.ctrv.2009.06.004; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; Mulrooney DA, 2008, CURR TREAT OPTION ON, V9, P51, DOI 10.1007/s11864-008-0054-4; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2010, HEMATOL ONCOL CLIN N, V24, P129, DOI 10.1016/j.hoc.2009.11.013; Olsen M, 2014, AM J EPIDEMIOL, V180, P120, DOI 10.1093/aje/kwu144; Paas G, 2002, RES VALIDITY LMR; Poutanen T, 2003, J CLIN ONCOL, V21, P2349, DOI 10.1200/JCO.2003.08.050; Punyko JA, 2005, PEDIATR BLOOD CANCER, V44, P643, DOI 10.1002/pbc.20310; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Reynolds MR, 2010, AM HEART J, V160, P752, DOI 10.1016/j.ahj.2010.06.034; Ross L, 2003, NEW ENGL J MED, V349, P650, DOI 10.1056/NEJMoa022672; Sieswerda E, 2013, J CANCER SURVIV, V7, P439, DOI 10.1007/s11764-013-0283-9; Sieswerda E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132444; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stichting Medische Registratie, 1980, CLASS DIS 1980 BAS I; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJ, 2010, ARCH INTERN MED, V170, P1247, DOI 10.1001/archinternmed.2010.233; Wallace WH, 2004, LATE EFFECTS CHILDHO; Whelan KF, 2010, PEDIATR BLOOD CANCER, V54, P103, DOI 10.1002/pbc.22277	48	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159518	10.1371/journal.pone.0159518	http://dx.doi.org/10.1371/journal.pone.0159518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27433937	Green Submitted, gold, Green Published			2022-12-26	WOS:000380169600061
J	Zhao, J; Hakvoort, TBM; Willemsen, AM; Jongejan, A; Sokolovic, M; Bradley, EJ; de Boer, VCJ; Baas, F; van Kampen, AHC; Lamers, WH				Zhao, Jing; Hakvoort, Theodorus B. M.; Willemsen, A. Marcel; Jongejan, Aldo; Sokolovic, Milka; Bradley, Edward J.; de Boer, Vincent C. J.; Baas, Frank; van Kampen, Antoine H. C.; Lamers, Wouter H.			Effect of Hyperglycemia on Gene Expression during Early Organogenesis in Mice	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; GLUCOSE-TRANSPORTER EXPRESSION; DIABETES-MELLITUS; VISCEROATRIAL HETEROTAXY; EMBRYONIC MALFORMATIONS; ACTIN DYNAMICS; MOUSE EMBRYO; METABOLISM; PREGNANCY; STRESS	Background Cardiovascular and neural malformations are common sequels of diabetic pregnancies, but the underlying molecular mechanisms remain unknown. We hypothesized that maternal hyperglycemia would affect the embryos most shortly after the glucose-sensitive time window at embryonic day (ED) 7.5 in mice. Methods Mice were made diabetic with streptozotocin, treated with slow-release insulin implants and mated. Pregnancy aggravated hyperglycemia. Gene expression profiles were determined in ED8.5 and ED9.5 embryos from diabetic and control mice using Serial Analysis of Gene Expression and deep sequencing. Results Maternal hyperglycemia induced differential regulation of 1,024 and 2,148 unique functional genes on ED8.5 and ED9.5, respectively, mostly in downward direction. Pathway analysis showed that ED8.5 embryos suffered mainly from impaired cell proliferation, and ED9.5 embryos from impaired cytoskeletal remodeling and oxidative phosphorylation (all P <= E-5). A query of the Mouse Genome Database showed that 20-25% of the differentially expressed genes were caused by cardiovascular and/or neural malformations, if deficient. Despite high glucose levels in embryos with maternal hyperglycemia and a similar to 150-fold higher rate of ATP production from glycolysis than from oxidative phosphorylation on ED9.5, ATP production from both glycolysis and oxidative phosphorylation was reduced to similar to 70% of controls, implying a shortage of energy production in hyperglycemic embryos. Conclusion Maternal hyperglycemia suppressed cell proliferation during gastrulation and cytoskeletal remodeling during early organogenesis. 20-25% of the genes that were differentially regulated by hyperglycemia were associated with relevant congenital malformations. Unexpectedly, maternal hyperglycemia also endangered the energy supply of the embryo by suppressing its glycolytic capacity.	[Zhao, Jing; Hakvoort, Theodorus B. M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [Willemsen, A. Marcel; Jongejan, Aldo; van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Dept Bioinformat, Amsterdam, Netherlands; [Sokolovic, Milka] Univ Amsterdam, Acad Med Ctr, Dept Biochem, Amsterdam, Netherlands; [Bradley, Edward J.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [de Boer, Vincent C. J.] Univ Amsterdam, Acad Med Ctr, Dept Lab Genet Metab Dis, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Biosyst Data Anal Grp, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam	Lamers, WH (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.	w.h.lamers@amc.uva.nl	Sokolovic, Milka/AAY-1618-2020; de Boer, Vincent CJ/L-2196-2016; Lamers, Wouter H./D-2965-2012; Baas, Frank/F-9574-2010	Sokolovic, Milka/0000-0002-3957-4656; de Boer, Vincent CJ/0000-0001-9928-1698; Baas, Frank/0000-0003-3912-5428	EU Seventh Framework Programme [HEALTH-F2-2008-223040]	EU Seventh Framework Programme	The work was supported by EU Seventh Framework Programme (HEALTH-F2-2008-223040), http://ec.europa.eu/research/health/medical-research/cardiovasculardiseases/projects/chearted_en.html.	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; BECERRA JE, 1990, PEDIATRICS, V85, P1; Berkopec A, 2007, J DISCRETE ALGORITHM, P5; Bracero LA, 1996, GYNECOL OBSTET INVES, V41, P10, DOI 10.1159/000292026; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Charron MJ, 1998, MOL CELL BIOCHEM, V182, P143, DOI 10.1023/A:1006809611658; Cheng CH, 2009, CARDIOVASC RES, V81, P381, DOI 10.1093/cvr/cvn319; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; Christodoulou DC, 2011, CURR PROTOC MOL BIOL, p25B; CLOUGH JR, 1983, J EMBRYOL EXP MORPH, V74, P133; Dawson PA, 2001, MOL GENET METAB, V74, P186, DOI 10.1006/mgme.2001.3212; DEUCHAR EM, 1977, J EMBRYOL EXP MORPH, V41, P93; Di Ciano-Oliveira C, 2006, ACTA PHYSIOL, V187, P257, DOI 10.1111/j.1748-1716.2006.01535.x; Ekins S, 2005, DRUG METAB DISPOS, V33, P474, DOI 10.1124/dmd.104.002717; ELHAGE S, 1990, DEV GENET, V11, P149, DOI 10.1002/dvg.1020110205; ERIKSSON UJ, 1993, DIABETES, V42, P411, DOI 10.2337/diabetes.42.3.411; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Fine EL, 1999, DIABETES, V48, P2454, DOI 10.2337/diabetes.48.12.2454; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Fraseri RB, 2007, HUM REPROD, V22, P3059, DOI 10.1093/humrep/dem318; Fu J, 2006, DIABETOLOGIA, V49, P1027, DOI 10.1007/s00125-006-0153-3; GIAVINI E, 1986, TERATOLOGY, V34, P81, DOI 10.1002/tera.1420340111; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; GOODNER CJ, 1961, DIABETES, V10, P383, DOI 10.2337/diab.10.5.383; Harris MJ, 2005, BIRTH DEFECTS RES A, V73, P532, DOI 10.1002/bdra.20170; Horal M, 2004, BIRTH DEFECTS RES A, V70, P519, DOI 10.1002/bdra.20056; Houghton FD, 1996, MOL REPROD DEV, V44, P476, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;476::AID-MRD7&gt;3.0.CO;2-I; Innes KE, 1999, ACTA OBSTET GYN SCAN, V78, P263, DOI 10.1034/j.1600-0412.1999.780401.x; Ishibashi F, 2008, DIABETES RES CLIN PR, V80, P24, DOI 10.1016/j.diabres.2007.11.004; Jiang B, 2008, J NEUROSCI RES, V86, P3481, DOI 10.1002/jnr.21800; Jorstad TS, 2007, TRENDS PLANT SCI, V12, P46, DOI 10.1016/j.tplants.2007.01.001; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Kappen C, 2011, REPROD TOXICOL, V31, P41, DOI 10.1016/j.reprotox.2010.09.002; KARUNANAYAKE EH, 1976, DIABETOLOGIA, V12, P483, DOI 10.1007/BF01219512; Kaufman M.H., 1992, ATLAS MOUSE DEV; Korgun ET, 2001, BIOL REPROD, V65, P1364, DOI 10.1095/biolreprod65.5.1364; Kowluru A, 2010, ENDOCR REV, V31, P52, DOI 10.1210/er.2009-0022; Kucera J, 1965, Ger Med Mon, V10, P393; KUCERA J, 1971, J REPROD MED, V7, P73; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li R, 2007, DIABETOLOGIA, V50, P682, DOI 10.1007/s00125-006-0579-7; Lian QZ, 2004, J NEUROSCI RES, V75, P554, DOI 10.1002/jnr.20006; Loeken MR, 2005, AM J MED GENET C, V135C, P77, DOI 10.1002/ajmg.c.30056; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACKLER B, 1971, ARCH BIOCHEM BIOPHYS, V144, P603, DOI 10.1016/0003-9861(71)90367-5; MACKLER B, 1973, ARCH BIOCHEM BIOPHYS, V158, P662, DOI 10.1016/0003-9861(73)90558-4; Maksimovic-Ivanic D, 2002, CLIN EXP IMMUNOL, V129, P214, DOI 10.1046/j.1365-2249.2002.02001.x; Matsumura Hideo, 2012, Methods Mol Biol, V883, P1, DOI 10.1007/978-1-61779-839-9_1; Membrez M, 2006, MOL CELL BIOL, V26, P4268, DOI 10.1128/MCB.00081-06; Morgan SC, 2008, BIRTH DEFECTS RES A, V82, P453, DOI 10.1002/bdra.20457; MORISHIMA M, 1991, TERATOLOGY, V44, P91, DOI 10.1002/tera.1420440113; Morishima M, 1996, TERATOLOGY, V54, P183, DOI 10.1002/(SICI)1096-9926(199610)54:4<183::AID-TERA2>3.0.CO;2-2; MORITA Y, 1992, BIOCHEM BIOPH RES CO, V188, P8, DOI 10.1016/0006-291X(92)92342-U; MORITA Y, 1994, BIOCHEM BIOPH RES CO, V199, P1525, DOI 10.1006/bbrc.1994.1404; Narchi H, 2000, Images Paediatr Cardiol, V2, P17; Nikolsky Y, 2005, DRUG DISCOV TODAY, V10, P653, DOI 10.1016/S1359-6446(05)03420-3; PASSARGE E, 1966, PEDIATRICS, V37, P672; Pavlinkova G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-274; Phelan SA, 1997, DIABETES, V46, P1189, DOI 10.2337/diabetes.46.7.1189; Reed JC, 2015, NAT REV ENDOCRINOL, V11, P308, DOI 10.1038/nrendo.2014.236; Salbaum JM, 2010, BIRTH DEFECTS RES A, V88, P601, DOI 10.1002/bdra.20680; Savagner P, 2015, CURR TOP DEV BIOL, V112, P273, DOI 10.1016/bs.ctdb.2014.11.021; Schmidt S, 2009, J ENDOCRINOL, V200, P23, DOI 10.1677/JOE-08-0262; Scott-Drechsel DE, 2013, DIABETES, V62, P234, DOI 10.2337/db12-0161; Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1; Shen XH, 2009, J REPROD DEVELOP, V55, P534, DOI 10.1262/jrd.20231; Shepard TH, 1998, ANAT REC, V252, P383, DOI 10.1002/(SICI)1097-0185(199811)252:3<383::AID-AR6>3.0.CO;2-Z; SMITH DE, 1992, DEVELOPMENT, V116, P555; Solnica-Krezel L, 2012, ANNU REV CELL DEV BI, V28, P687, DOI 10.1146/annurev-cellbio-092910-154043; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; STYRUD J, 1995, PEDIATR RES, V37, P343, DOI 10.1203/00006450-199503000-00015; TAKAO Y, 1993, DIABETOLOGIA, V36, P696, DOI 10.1007/BF00401139; Teng Beina, 2012, Int J Cell Biol, V2012, P320531, DOI 10.1155/2012/320531; Thirone ACP, 2009, AM J PHYSIOL-CELL PH, V296, pC463, DOI 10.1152/ajpcell.00467.2008; TROCINO RA, 1994, ENDOCRINOLOGY, V134, P869, DOI 10.1210/en.134.2.869; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vannucci SJ, 2000, DEV NEUROSCI-BASEL, V22, P274, DOI 10.1159/000017451; Veld RAGHI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029002; Vijaya M, 2013, GENE, V516, P218, DOI 10.1016/j.gene.2012.12.071; Wu YQ, 2015, DIABETES, V64, P2526, DOI 10.2337/db14-1683; YANG XL, 1995, ANAT RECORD, V241, P255, DOI 10.1002/ar.1092410212	85	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158035	10.1371/journal.pone.0158035	http://dx.doi.org/10.1371/journal.pone.0158035			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27433804	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600005
J	Cartagena, CM; Mountney, A; Hwang, H; Swiercz, A; Rammelkamp, Z; Boutte, AM; Shear, DA; Tortella, FC; Schmid, KE				Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.			Subacute Changes in Cleavage Processing of Amyloid Precursor Protein and Tau following Penetrating Traumatic Brain Injury	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; BETA ACCUMULATION; CASPASE CLEAVAGE; PROGENITOR CELLS; HEAD-INJURY; PROLIFERATION; MITOCHONDRIA; AGGREGATION; FRAGMENT	Traumatic brain injury (TBI) is an established risk factor for the development of Alzheimer's disease (AD). Here the effects of severe penetrating TBI on APP and tau cleavage processing were investigated in a rodent model of penetrating ballistic-like brain injury (PBBI). PBBI was induced by stereotactically inserting a perforated steel probe through the right frontal cortex of the anesthetized rat and rapidly inflating/deflating the probe's elastic tubing into an elliptical shaped balloon to 10% of total rat brain volume causing temporary cavitation injury. Separate animals underwent probe injury (PrI) alone without balloon inflation. Shams underwent craniectomy. Brain tissue was collected acutely (4h, 24h, 3d) and subacutely (7d) post-injury and analyzed by immunoblot for full length APP (APP-FL) and APP beta c-terminal fragments (beta CTFs), full length tau (tau-FL) and tau truncation fragments and at 7d for cytotoxic Beta amyloid (A beta) peptides A beta 40 and A beta 42 analysis. APP-FL was significantly decreased at 3d and 7d following PBBI whereas APP beta CTFs were significantly elevated by 4h post-injury and remained elevated through 7d post-injury. Effects on beta CTFs were mirrored with PrI, albeit to a lesser extent. A beta 40 and A beta 42 were significantly elevated at 7d following PBBI and PrI. Tau-FL decreased substantially 3d and 7d post-PBBI and PrI. Importantly, a 22 kDa tau fragment (tau22), similar to that found in AD, was significantly elevated by 4h and remained elevated through 7d post-injury. Thus both APP and tau cleavage was dramatically altered in the acute and subacute periods post-injury. As cleavage of these proteins has also been implicated in AD, TBI pathology shown here may set the stage for the later development of AD or other tauopathies.	[Cartagena, Casandra M.; Mountney, Andrea; Hwang, Hye; Swiercz, Adam; Rammelkamp, Zoe; Boutte, Angela M.; Shear, Deborah A.; Tortella, Frank C.; Schmid, Kara E.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Cartagena, CM (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD 20910 USA.	casandra.m.cartagena@gmail.com			U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program	This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Rebecca Pedersen and Weihong Yang for their excellent technical assistance. This research was funded by the U.S. Army Medical Research and Material Command, Combat Casualty Care Research Program. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or reflecting true views of the Department of the Army or the Department of Defense.	Amadoro G, 2014, NEUROBIOL DIS, V62, P489, DOI 10.1016/j.nbd.2013.10.018; Amadoro G, 2014, J ALZHEIMERS DIS, V42, P211, DOI 10.3233/JAD-140267; Amadoro G, 2010, J ALZHEIMERS DIS, V21, P445, DOI 10.3233/JAD-2010-100120; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Baratchi S, 2012, HIPPOCAMPUS, V22, P1517, DOI 10.1002/hipo.20988; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Demars MP, 2013, NEUROBIOL AGING, V34, P2431, DOI 10.1016/j.neurobiolaging.2013.04.016; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hill T., 2006, STAT METHODS APPL CO; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Koike MA, 2011, NEUROSCI LETT, V495, P55, DOI 10.1016/j.neulet.2011.03.034; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Li RN, 2013, LIFE SCI, V92, P747, DOI 10.1016/j.lfs.2013.02.014; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Muller K. E., 2002, REGRESSION ANOVA INT; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Washington PM, 2014, J NEUROTRAUM, V31, P125, DOI 10.1089/neu.2013.3017; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015	44	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158576	10.1371/journal.pone.0158576	http://dx.doi.org/10.1371/journal.pone.0158576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428544	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300013
J	Eghdam, A; Bartfai, A; Oldenburg, C; Koch, S				Eghdam, Aboozar; Bartfai, Aniko; Oldenburg, Christian; Koch, Sabine			How Do Persons with Mild Acquired Cognitive Impairment Use Information and Communication Technology and E-Services? Results from a Swedish National Survey	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FAILURES QUESTIONNAIRE; PROFILE; HEALTH; DIMENSIONALITY; ASSOCIATION; DEFICITS; MEMORY; STROKE	Introduction Mild acquired cognitive impairment is a term used to describe a sub-group of persons with mild cognitive impairment who are expected to reach a stable cognitive level over time. One tactic that can be considered for further developing treatment for this group is the use of information and communication technology and e-services. The purpose of this study was to investigate the current use of regular e-services and social media by this group as well as their user experiences. Methods and Materials Data were collected through a self-administered survey and analyzed using quantitative methods. The questionnaire included questions regarding the participants' use of and experience with e-services. Categorization of e-services was based on and cross-validated with the International Classification of Functioning, Disability and Health (ICF). To estimate participants' degree and type of impairment, the Cognitive Failure Questionnaire (CFQ), measuring cognitive difficulties in performing everyday tasks, was added. Results In total, 282 persons with acquired brain injury participated in the survey. The participants' CFQ scores showed that they were suffering from mild to moderate cognitive impairments, most often acquired from traumatic brain injuries (40%). The majority (89%) used e-services in different categories whereof the most popular and essential ones were communication services (59%) and banking (39%) services. Participants with higher total CFQ scores (>58) used more e-services in most of the categories compared to participants with lower scores (<31). Although participants were interested in social media, they were annoyed by advertisements and the Internet speed in general. Some participants reported privacy concerns and addictive behavior. However, they mostly considered e-services to be trustworthy and supportive in different contexts. The usage of electronic devices decreased by age with the exception of electronic tablets that were used by older participants approximately as frequently as by other age groups. Conclusions Although persons with mild to moderate acquired brain injury used various e-services that are not customized for them, very few participants used self-care health services (apps) and readers (e-readers). Further studies are needed on utilizing these identified aspects for this group to support them with their chronic condition.	[Eghdam, Aboozar; Koch, Sabine] Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden; [Bartfai, Aniko; Oldenburg, Christian] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Div Rehabil Med, Stockholm, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet	Eghdam, A (corresponding author), Karolinska Inst, Hlth Informat Ctr, Dept Learning Informat Management & Eth LIME, Stockholm, Sweden.	aboozar.eghdam@ki.se	Koch, Sabine/F-8020-2010; Eghdam, Aboozar/D-8561-2013; Eqdam, James Abbott/H-5975-2016	Koch, Sabine/0000-0001-7144-8740; Oldenburg, Christian/0000-0003-4647-9136; Eqdam, James Abbott/0000-0001-8690-8594	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet through the Swedish Research Council; VINNOVA-Swedish Agency for Innovation Systems	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet through the Swedish Research Council; VINNOVA-Swedish Agency for Innovation Systems(Vinnova)	Strategic Research Area in Care Sciences (SFO-V) at Karolinska Institutet through the Swedish Research Council and VINNOVA-Swedish Agency for Innovation Systems supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballard C, 2003, DEMENT GERIATR COGN, V16, P52, DOI 10.1159/000069994; Bartfai A., 2014, TECHNOL DISABIL, V26, P11, DOI 10.3233/TAD-140400; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cotten SR, 2004, SOC SCI MED, V59, P1795, DOI 10.1016/j.socscimed.2004.02.020; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; DiMaggio P, 2001, ANNU REV SOCIOL, V27, P307, DOI 10.1146/annurev.soc.27.1.307; Dobransky K., 2006, Information Communication & Society, V9, P313, DOI 10.1080/13691180600751298; Eghdam A, 2012, J MED INTERNET RES, V14, P4, DOI 10.2196/jmir.2275; Eurostat, INF SOC STAT HOUS IN; HIRSCHHEIM R, 1988, COMPUT J, V31, P398, DOI 10.1093/comjnl/31.5.398; Hofer S, 2008, HDB COGNITIVE AGING; Jaillard A, 2009, STROKE, V40, P2473, DOI 10.1161/STROKEAHA.108.541144; Larson GE, 1997, BRIT J PSYCHOL, V88, P29, DOI 10.1111/j.2044-8295.1997.tb02618.x; Lazar J, 2011, ISSUES SCI TECHNOL, V27, P69; Lindberg B, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/461829; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Lundberg N, 2013, STUD HEALTH TECHNOL, V192, P687, DOI 10.3233/978-1-61499-289-9-687; MATTHEWS G, 1990, J PSYCHOPATHOL BEHAV, V12, P49, DOI 10.1007/BF00960453; Mayo Clinic Staff, 2012, MILD COGN IMP MAYO C; Meijer WJ, 2007, ST HEAL T, V127, P199; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; Ojo O, 2015, INT J ENV RES PUB HE, V12, P8281, DOI 10.3390/ijerph120708281; Petersen RC, 2009, CURR ALZHEIMER RES, V6, P324, DOI 10.2174/156720509788929237; POLLINA LK, 1992, BRIT J PSYCHOL, V83, P305, DOI 10.1111/j.2044-8295.1992.tb02443.x; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Rast P, 2009, ASSESSMENT, V16, P145, DOI 10.1177/1073191108324440; Rowley J, 2006, INTERNET RES, V16, P339, DOI 10.1108/10662240610673736; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Sandberg Karl W, 2005, Work, V24, P229; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; van Rijsbergen MWA, 2015, J STROKE CEREBROVASC, V24, P1823, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.017; Wallace JC, 2004, PERS INDIV DIFFER, V37, P307, DOI 10.1016/j.paid.2003.09.005; WHO, WHO GLOB STAT REP RO; Whyte E, 2011, PM&R, V3, pS45, DOI 10.1016/j.pmrj.2011.05.007; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; World Health Organization, WHO INT CLASS FUNCT; Zhu FX, 2002, INT J SERV IND MANAG, V13, P69, DOI 10.1108/09564230210421164; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015	41	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159362	10.1371/journal.pone.0159362	http://dx.doi.org/10.1371/journal.pone.0159362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TD	27427947	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300056
J	Jonas, BA; Johnson, C; Gratzinger, D; Majeti, R				Jonas, Brian A.; Johnson, Carl; Gratzinger, Dita; Majeti, Ravindra			Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity	PLOS ONE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; MYELODYSPLASTIC SYNDROMES; BETHESDA PROPOSALS; INITIATING CELLS; MICE; EXPRESSION; MUTATIONS; CLASSIFICATION; IDENTIFICATION; HETEROGENEITY	Acute myeloid leukemia (AML) is a heterogeneous group of aggressive bone marrow cancers arising from transformed hematopoietic stem and progenitor cells (HSPC). Therapy-related AML and MDS (t-AML/MDS) comprise a subset of AML cases occurring after exposure to alkylating chemotherapy and/or radiation and are associated with a very poor prognosis. Less is known about the pathogenesis and disease-initiating/leukemia stem cell (LSC) subpopulations of t-AML/MDS compared to their de novo counterparts. Here, we report the development of mouse models of t-AML/MDS. First, we modeled alkylator-induced t-AML/MDS by exposing wild type adult mice to N-ethyl-N-nitrosurea (ENU), resulting in several models of AML and MDS that have clinical and pathologic characteristics consistent with human t-AML/MDS including cytopenia, myelodysplasia, and shortened overall survival. These models were limited by their inability to transplant clinically aggressive disease. Second, we established three patient-derived xenograft models of human t-AML. These models led to rapidly fatal disease in recipient immunodeficient xenografted mice. LSC activity was identified in multiple HSPC subpopulations suggesting there is no canonical LSC immunophenotype in human t-AML. Overall, we report several new t-AML/MDS mouse models that could potentially be used to further define disease pathogenesis and test novel therapeutics.	[Jonas, Brian A.] Univ Calif Davis, Sch Med, Ctr Comprehens Canc, Dept Internal Med,Div Hematol & Oncol, Sacramento, CA 95817 USA; [Johnson, Carl; Majeti, Ravindra] Stanford Univ, Sch Med, Dept Med, Div Hematol,Canc Inst, Stanford, CA 94305 USA; [Johnson, Carl; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Gratzinger, Dita] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University; Stanford University	Majeti, R (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Hematol,Canc Inst, Stanford, CA 94305 USA.	rmajeti@stanford.edu	Jonas, Brian/AAS-3639-2020	Jonas, Brian/0000-0002-4921-5809; Majeti, Ravindra/0000-0002-5814-0984; Gratzinger, Dita/0000-0002-9182-8123	Leukemia & Lymphoma Society (LLS) [4698-13]; Stanford Training Program in Investigative Oncology [T32CA00927-35]; National Institutes of Health Paul Calabresi K12 Clinical Oncology Career Development Award [K12 CA138464]; California Institute for Regenerative Medicine Bridges Grant [TB1-01194]; Burroughs Welcome Fund; New York Stem Cell Foundation Robertson Investigator; Department of Defense (DOD) [CA093573]	Leukemia & Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Stanford Training Program in Investigative Oncology; National Institutes of Health Paul Calabresi K12 Clinical Oncology Career Development Award; California Institute for Regenerative Medicine Bridges Grant; Burroughs Welcome Fund(Burroughs Wellcome Fund); New York Stem Cell Foundation Robertson Investigator; Department of Defense (DOD)(United States Department of Defense)	This work was funded by a Special Fellow in Clinical Research award from the Leukemia & Lymphoma Society (LLS 4698-13; https://www.lls.org/research/career-development-program), Stanford Training Program in Investigative Oncology (T32CA00927-35; https://researchtraining.nih.gov/programs/training-grants/T32), and National Institutes of Health Paul Calabresi K12 Clinical Oncology Career Development Award (K12 CA138464; http://www.cancer.gov/grants-training/training/funding/K12) [BAJ]; California Institute for Regenerative Medicine Bridges Grant (TB1-01194; https://www.cirm.ca.gov/our-funding/research-rfas/bridges) [CJ]; and Career Award for Medical Scientists from the Burroughs Welcome Fund (http://www.bwfund.org/grantprograms/biomedicalsciences/career-awards-medical-scientists), New York Stem Cell Foundation Robertson Investigator (http://www.nyscf.org/grants/nyscf-robertson-prize), and Department of Defense (DOD CA093573; http://cdmrp.army.mil/funding/) [RM]. DG received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beachy SH, 2010, HEMATOL ONCOL CLIN N, V24, P361, DOI 10.1016/j.hoc.2010.02.002; Beurlet S, 2013, HAEMATOLOGICA, V98, P10, DOI 10.3324/haematol.2012.069385; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chao RC, 2005, CANCER CELL, V8, P337, DOI 10.1016/j.ccr.2005.08.011; Churpek JE, 2013, BEST PRACT RES CL HA, V26, P309, DOI 10.1016/j.beha.2013.09.001; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; Davis AP, 1998, GENETICS, V148, P7; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fenske TS, 2006, CANCER RES, V66, P5029, DOI 10.1158/0008-5472.CAN-05-3404; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Godley LA, 2008, SEMIN ONCOL, V35, P418, DOI 10.1053/j.seminoncol.2008.04.012; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Janke MR, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.59; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Lu EP, 2014, BLOOD, V124, P3887, DOI 10.1182/blood-2014-06-582551; Mahgoub N, 1999, BLOOD, V93, P3617, DOI 10.1182/blood.V93.11.3617.411a49_3617_3623; Majeti R, 2011, ONCOGENE, V30, P1009, DOI 10.1038/onc.2010.511; MAJOR IR, 1978, NATURE, V272, P455, DOI 10.1038/272455a0; Mallardo M, 2013, LEUKEMIA, V27, P2248, DOI 10.1038/leu.2013.114; Matsuura S, 2012, BLOOD, V120, P4028, DOI 10.1182/blood-2012-01-404533; Mc Cormack E, 2005, LEUKEMIA, V19, P687, DOI 10.1038/sj.leu.2403670; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Ok CY, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0139-z; Ok CY, 2015, LEUKEMIA RES, V39, P348, DOI 10.1016/j.leukres.2014.12.006; Olme CH, 2013, LEUKEMIA RES, V37, P1374, DOI 10.1016/j.leukres.2013.05.019; Ornstein MC, 2014, AM J HEMATOL, V89, P168, DOI 10.1002/ajh.23605; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schulz E, 2015, ANN HEMATOL, V94, P527, DOI 10.1007/s00277-014-2191-0; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wegrzyn J, 2011, LEUKEMIA RES, V35, P853, DOI 10.1016/j.leukres.2011.03.007; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Woll PS, 2014, CANCER CELL, V25, P794, DOI 10.1016/j.ccr.2014.03.036; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298	54	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159189	10.1371/journal.pone.0159189	http://dx.doi.org/10.1371/journal.pone.0159189			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428079	Green Published, gold			2022-12-26	WOS:000380169300040
J	Li, XH; Lu, J; Wang, Y; Huo, XY; Li, ZK; Zhang, SY; Li, CL; Guo, M; Du, XY; Chen, ZW				Li, Xiaohong; Lu, Jing; Wang, Ying; Huo, Xueyun; Li, Zhenkun; Zhang, Shuangyue; Li, Changlong; Guo, Meng; Du, Xiaoyan; Chen, Zhenwen			Establishment and Characterization of a Newly Established Diabetic Gerbil Line	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ANIMAL-MODELS; TYPE-2; OBESITY; MELLITUS; ASSOCIATION	Objectives We aimed to selectively breed a spontaneous diabetic gerbil when a sub-line of inbred gerbil showed increased blood glucose levels was found recently. Then we investigated the characteristics including the serum insulin, triglyceride, cholesterol, leptin, adiponectin and explored the underlying molecular mechanism for the diabetic phenotype. Methods The spontaneous diabetic line of gerbils was selectively inbreed the sub-line of gerbil by monitoring blood glucose of each animal. The serum insulin, adiponectin, and leptin levels were tested using an ELISA kit. The expression levels of GLUT4, Akt, leptin, adiponectin, and calpain 10 (CAPN10) were tested by western blot and Quantitative Real-time PCR (qPCR) in liver, skeletal muscle, and white adipose. Results Our results show that the percentages of animals with FPG >= 5.2 (mmol/l), PG2h >= 6.8 (mmol/l) and both FPG >= 5.2 and PG2h >= 6.8 (mmol/l) were increased with the number of breeding generations from F0 (21.33%) to F6 (38.46%). These diabetic gerbils exhibited insulin resistance and leptin resistance as well as decreased adiponectin level in the serum. We also observed decreased expression of adiponectin and increased expression of leptin in the skeletal muscle, respectively. Conclusions These results indicate that we have primarily established a spontaneous diabetic gerbil line, and the diabetic phenotypes may have been accounted for by altered expression of leptin and adiponectin.	[Li, Xiaohong; Lu, Jing; Wang, Ying; Huo, Xueyun; Li, Zhenkun; Zhang, Shuangyue; Li, Changlong; Guo, Meng; Du, Xiaoyan; Chen, Zhenwen] Capital Med Univ, Sch Basic Med Sci, Beijing Key Lab Canc Invas & Metastasis Res, Beijing 100069, Peoples R China	Capital Medical University	Du, XY; Chen, ZW (corresponding author), Capital Med Univ, Sch Basic Med Sci, Beijing Key Lab Canc Invas & Metastasis Res, Beijing 100069, Peoples R China.	duduyan@ccmu.edu.cn; czwen@ccmu.edu.cn	Du, Xiaoyan/ABD-3167-2021; li, xiao/GSN-6181-2022; Li, Changlong/AAJ-4483-2020	Du, Xiaoyan/0000-0002-4030-7299; 	National Science Foundation of China [31272393, 31572341]; Key Projects in the National Science & Technology Pillar Program [2015BAI09B01]; Beijing Natural Science Foundation [7141002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was funded by the National Science Foundation of China Nos. 31272393 and 31572341 Xiaoyan Du, the website is http://www.nsfc.gov.cn/Portal0/default152.htm, Key Projects in the National Science & Technology Pillar Program (No. 2015BAI09B01) and the Beijing Natural Science Foundation (No. 7141002), the website is http://www.bjnsf.org.	Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Black BL, 1998, METABOLISM, V47, P1354, DOI 10.1016/S0026-0495(98)90304-3; BOQUIST L, 1972, DIABETOLOGIA, V8, P274, DOI 10.1007/BF01225571; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Govers R, 2014, ADV CLIN CHEM, V66, P173, DOI 10.1016/B978-0-12-801401-1.00006-2; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Henry ML, 2008, BLOOD COAGUL FIBRIN, V19, P124, DOI 10.1097/MBC.0b013e3282f41e56; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Ikeda Y, 2001, DIABETES, V50, P584, DOI 10.2337/diabetes.50.3.584; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miura T, 2001, EUR J ENDOCRINOL, V145, P785, DOI 10.1530/eje.0.1450785; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; NAKAMA K, 1977, ENDOCRINOL JAPON, V24, P421; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Nishigaki R, 1999, Nihon Ika Daigaku Zasshi, V66, P166, DOI 10.1272/jnms.66.166; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Segre AV, 2015, DIABETES, V64, P1470, DOI 10.2337/db14-0703; Shafrir E, 2010, WORLD J DIABETES, V1, P137, DOI 10.4239/wjd.v1.i5.137; Shafrir E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1450, DOI 10.1152/ajpendo.00113.2009; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Swellam M, 2012, IUBMB LIFE, V64, P180, DOI 10.1002/iub.597; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/106206; Yang XL, 2001, MOL GENET METAB, V73, P111, DOI 10.1006/mgme.2001.3171	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159420	10.1371/journal.pone.0159420	http://dx.doi.org/10.1371/journal.pone.0159420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427908	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169300065
J	Paillamanque, J; Madrid, C; Carmona, EM; Osses, N; Moreno, RD; Oresti, GM; Pino, JA; Reyes, JG				Paillamanque, Joaquin; Madrid, Cristian; Carmona, Emerson M.; Osses, Nelson; Moreno, Ricardo D.; Oresti, Gerardo M.; Pino, Jose A.; Reyes, Juan G.			Effects of Fatty Acids on Intracellular [Ca2+], Mitochondrial Uncoupling and Apoptosis in Rat Pachytene Spermatocytes and Round Spermatids	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; MOUSE SPERMATOGENIC CELLS; SERTOLI-CELLS; GERM-CELLS; ARACHIDONIC-ACID; LACTATE PRODUCTION; SPECIES PRODUCTION; GENE-EXPRESSION; IN-VITRO; GLUCOSE	The aim of this work was to explore the ability of free arachidonic acid, palmitic acid and the unsaturated fatty acids oleic acid and docosahexaenoic acid to modify calcium homeostasis and mitochondrial function in rat pachytene spermatocytes and round spermatids. In contrast to palmitic acid, unsaturated fatty acids produced significant increases in intracellular calcium concentrations ([Ca2+](i)) in both cell types. Increases were fatty acid specific, dose-dependent and different for each cell type. The arachidonic acid effects on [Ca2+](i) were higher in spermatids than in spermatocytes and persisted when residual extracellular Ca2+ was chelated by EGTA, indicating that the increase in [Ca2+](i) originated from release of intracellular calcium stores. At the concentrations required for these increases, unsaturated fatty acids produced no significant changes in the plasma membrane potential of or nonspecific permeability in spermatogenic cells. For the case of arachidonic acid, the [Ca2+](i) increases were not caused by its metabolic conversion to eicosanoids or anandamide; thus we attribute this effect to the fatty acid itself. As estimated with fluorescent probes, unsaturated fatty acids did not affect the intracellular pH but were able to induce a progressive decrease in the mitochondrial membrane potential. The association of this decrease with reduced reactive oxygen species (ROS) production strongly suggests that unsaturated fatty acids induced mitochondrial uncoupling. This effect was stronger in spermatids than in spermatocytes. As a late event, arachidonic acid induced caspase 3 activation in a dose-dependent manner both in the absence and presence of external Ca2+. The concurrent but differential effects of unsaturated fatty acids on [Ca2+](i) and mitochondrial functions are additional manifestations of the metabolic changes that germ cells undergo during their differentiation.	[Paillamanque, Joaquin; Madrid, Cristian; Carmona, Emerson M.; Osses, Nelson; Pino, Jose A.; Reyes, Juan G.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Moreno, Ricardo D.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile; [Oresti, Gerardo M.] INIBIBB, Bahia Blanca, Buenos Aires, Argentina	Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Chile	Reyes, JG (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	juan.reyes@pucv.cl	Osses, Nelson/V-9065-2019; Pino, José/AAF-4359-2021	Osses, Nelson/0000-0003-0974-1051; Pino, José/0000-0002-1542-0660; Moreno, Ricardo/0000-0002-7499-5501; Carmona, Emerson/0000-0003-1332-0372	Fondo Nacional de Investigacion en Ciencia Y Tecnologia (Fondecyt) [1110267, 1140758]; Pontificia Universidad Catolica de Valparaiso (PUCV-VRIEA) grant [125.726]	Fondo Nacional de Investigacion en Ciencia Y Tecnologia (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Pontificia Universidad Catolica de Valparaiso (PUCV-VRIEA) grant	This work was supported by Fondo Nacional de Investigacion en Ciencia Y Tecnologia (Fondecyt) grant numbers 1110267 and 1140758 to JGR, and by the Pontificia Universidad Catolica de Valparaiso (PUCV-VRIEA) grant 125.726 to JGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artwohl M, 2009, ATHEROSCLEROSIS, V202, P351, DOI 10.1016/j.atherosclerosis.2008.05.030; Balnave CD, 2000, J PHYSIOL-LONDON, V528, P25, DOI 10.1111/j.1469-7793.2000.00025.x; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bustamante-Marin X, 2012, APOPTOSIS, V17, P539, DOI 10.1007/s10495-012-0709-2; Carrillo C, 2011, CELL PHYSIOL BIOCHEM, V28, P329, DOI 10.1159/000331749; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chiarella P, 2004, J CELL SCI, V117, P4127, DOI 10.1242/jcs.01283; CHO H, 1991, J MED CHEM, V34, P1503, DOI 10.1021/jm00108a039; Di PM, 2006, BIOCHIM BIOPHYS ACTA, V1757, P1330; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Glass R, 2001, CELLS TISSUES ORGANS, V169, P377, DOI 10.1159/000047905; GOETZL EJ, 1980, IMMUNOLOGY, V40, P709; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALL PF, 1984, BIOL REPROD, V31, P863, DOI 10.1095/biolreprod31.5.863; Herrera E, 2000, BIOL CELL, V92, P429, DOI 10.1016/S0248-4900(00)01082-0; Huleihel M, 2007, GROWTH FACTORS, V25, P236, DOI 10.1080/08977190701783400; JANNINI EA, 1994, BIOL REPROD, V51, P140, DOI 10.1095/biolreprod51.1.140; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; Konrad L, 2006, APOPTOSIS, V11, P739, DOI 10.1007/s10495-006-5542-z; LAPPIN DF, 1982, CLIN EXP IMMUNOL, V49, P623; Le GF, 1983, ARCH ANDROLOGY, V10, P149; Lee JH, 2006, ARCH ANDROLOGY, V52, P311, DOI 10.1080/01485010600664024; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Liu WH, 2009, TOXICOL LETT, V191, P140, DOI 10.1016/j.toxlet.2009.08.016; Lizama C, 2007, APOPTOSIS, V12, P499, DOI 10.1007/s10495-006-0012-1; LYMAN GE, 1967, ANAL BIOCHEM, V21, P435, DOI 10.1016/0003-2697(67)90318-1; MACDONALD ML, 1984, J NUTR, V114, P719, DOI 10.1093/jn/114.4.719; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Meinhardt A, 2000, MOL CELL ENDOCRINOL, V168, P111, DOI 10.1016/S0303-7207(00)00308-7; Meroni SB, 2003, INT J ANDROL, V26, P310, DOI 10.1046/j.1365-2605.2003.00432.x; Mishra DP, 2006, J BIOL CHEM, V281, P2133, DOI 10.1074/jbc.M508648200; MITA M, 1982, ENDOCRINOLOGY, V110, P1535, DOI 10.1210/endo-110-5-1535; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Oresti GM, 2010, J LIPID RES, V51, P2909, DOI 10.1194/jlr.M006429; Pino JA, 2013, REPRODUCTION, V145, P203, DOI 10.1530/REP-12-0330; Pointis Georges, 2011, Spermatogenesis, V1, P303; REYES J, 1984, MEMBRANE BIOCHEM, V5, P243, DOI 10.3109/09687688409150281; REYES JG, 1994, J REPROD FERTIL, V102, P313, DOI 10.1530/jrf.0.1020313; Reyes JG, 2002, REPRODUCTION, V123, P701, DOI 10.1530/reprod/123.5.701; Reyes JG, 1997, BIOL CELL, V89, P53, DOI 10.1016/S0248-4900(99)80081-1; Reyes JG, 2010, FEBS LETT, V584, P3111, DOI 10.1016/j.febslet.2010.05.051; Riera MF, 2001, GEN COMP ENDOCR, V122, P88, DOI 10.1006/gcen.2001.7619; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; ROUSSEAU E, 1990, PFLUG ARCH EUR J PHY, V415, P645, DOI 10.1007/BF02583520; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sofikitis N, 2008, J STEROID BIOCHEM, V109, P323, DOI 10.1016/j.jsbmb.2008.03.004; Sokal RR., 1979, BIOMETRIA PRINCIPIOS; TSURUTA JK, 1995, BIOL REPROD, V53, P1454, DOI 10.1095/biolreprod53.6.1454; Turmel P, 2011, MOL REPROD DEV, V78, P124, DOI 10.1002/mrd.21280; TURNER TT, 1983, FERTIL STERIL, V40, P530; Ulisse S, 2000, CELL DEATH DIFFER, V7, P916, DOI 10.1038/sj.cdd.4400716; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Yeung-Yam-Wah V, 2012, CELL CALCIUM, V51, P140, DOI 10.1016/j.ceca.2011.11.012; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0158518	10.1371/journal.pone.0158518	http://dx.doi.org/10.1371/journal.pone.0158518			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428262	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300010
J	Rowe, PC; Fontaine, KR; Lauver, M; Jasion, SE; Marden, CL; Moni, M; Thompson, CB; Violand, RL				Rowe, Peter C.; Fontaine, Kevin R.; Lauver, Megan; Jasion, Samantha E.; Marden, Colleen L.; Moni, Malini; Thompson, Carol B.; Violand, Richard L.			Neuromuscular Strain Increases Symptom Intensity in Chronic Fatigue Syndrome	PLOS ONE			English	Article							NEURALLY-MEDIATED HYPOTENSION; POSTURAL TACHYCARDIA SYNDROME; RANDOMIZED CONTROLLED-TRIAL; LEG RAISE TESTS; BLOOD-FLOW; SPINAL-CORD; FIBROMYALGIA SYNDROME; GENERAL-POPULATION; PERIPHERAL-NERVES; MAST-CELLS	Chronic fatigue syndrome (CFS) is a complex, multisystem disorder that can be disabling. CFS symptoms can be provoked by increased physical or cognitive activity, and by orthostatic stress. In preliminary work, we noted that CFS symptoms also could be provoked by application of longitudinal neural and soft tissue strain to the limbs and spine of affected individuals. In this study we measured the responses to a straight leg raise neuromuscular strain maneuver in individuals with CFS and healthy controls. We randomly assigned 60 individuals with CFS and 20 healthy controls to either a 15 minute period of passive supine straight leg raise (true neuromuscular strain) or a sham straight leg raise. The primary outcome measure was the symptom intensity difference between the scores during and 24 hours after the study maneuver compared to baseline. Fatigue, body pain, lightheadedness, concentration difficulties, and headache scores were measured individually on a 0-10 scale, and summed to create a composite symptom score. Compared to individuals with CFS in the sham strain group, those with CFS in the true strain group reported significantly increased body pain (P = 0.04) and concentration difficulties (P = 0.02) as well as increased composite symptom scores (all P = 0.03) during the maneuver. After 24 hours, the symptom intensity differences were significantly greater for the CFS true strain group for the individual symptom of lightheadedness (P = 0.001) and for the composite symptom score (P = 0.005). During and 24 hours after the exposure to the true strain maneuver, those with CFS had significantly higher individual and composite symptom intensity changes compared to the healthy controls. We conclude that a longitudinal strain applied to the nerves and soft tissues of the lower limb is capable of increasing symptom intensity in individuals with CFS for up to 24 hours. These findings support our preliminary observations that increased mechanical sensitivity may be a contributor to the provocation of symptoms in this disorder.	[Rowe, Peter C.; Lauver, Megan; Jasion, Samantha E.; Marden, Colleen L.; Moni, Malini] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Fontaine, Kevin R.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA; [Thompson, Carol B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Violand, Richard L.] Rick Violand PT LLC, Ellicott City, MD USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rowe, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	prowe@jhmi.edu	Moni, Mohammad Ali/ABG-3606-2020		Solve ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) Initiative; Blaustein Pain Foundation at the Johns Hopkins University School of Medicine; Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue and Related Disorders; Antoine Lavoisier Endowed Professor of Energetics and Health Lifestyles, School of Public Health, University of Alabama at Birmingham; National Center for Research Resources; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [1UL1TR001079]	Solve ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) Initiative; Blaustein Pain Foundation at the Johns Hopkins University School of Medicine; Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue and Related Disorders; Antoine Lavoisier Endowed Professor of Energetics and Health Lifestyles, School of Public Health, University of Alabama at Birmingham; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by Solve ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) Initiative, PCR, no grant number assigned [http://solvecfs.org/] and. Blaustein Pain Foundation at the Johns Hopkins University School of Medicine, KLF, no grant number assigned. Dr. Rowe's work is supported by the Sunshine Natural Wellbeing Foundation Professorship in Chronic Fatigue and Related Disorders. Dr. Fontaine is supported by the Antoine Lavoisier Endowed Professor of Energetics and Health Lifestyles, School of Public Health, University of Alabama at Birmingham. The authors would like to acknowledge partial support for the statistical analysis from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Number 1UL1TR001079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A., 1993, BECK ANXIETY INVENTO; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; BENTALL RP, 1993, BRIT J CLIN PSYCHOL, V32, P375, DOI 10.1111/j.2044-8260.1993.tb01070.x; Biswal B, 2011, J NEUROL SCI, V301, P9, DOI 10.1016/j.jns.2010.11.018; BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; BRIEG A, 1979, SPINE, V4, P242; Brieg A., 1978, ADVERSE MECH TENSION; Brown Molly M, 2007, Dyn Med, V6, P6, DOI 10.1186/1476-5918-6-6; Butler DS, 1999, MOBILISATION NERVOUS; Cockshell SJ, 2014, NEUROPSYCHOLOGY, V28, P394, DOI 10.1037/neu0000025; De-La-Llave-Rincon AI, 2009, J ORTHOP SPORT PHYS, V39, P658, DOI 10.2519/jospt.2009.3058; DOLAN EJ, 1980, J NEUROSURG, V53, P756, DOI 10.3171/jns.1980.53.6.0756; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Henderson FC, 2005, NEUROSURGERY, V56, P1101, DOI 10.1227/01.NEU.0000157929.85251.7C; Herrington L, 2008, MANUAL THER, V13, P289, DOI 10.1016/j.math.2007.01.013; Hu KK, 2014, IMMUNOL RES, V58, P211, DOI 10.1007/s12026-014-8510-7; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Keech A, 2015, J PSYCHOSOM RES, V79, P537, DOI 10.1016/j.jpsychores.2015.08.008; Kobayashi S, 2003, SPINE, V28, P1427, DOI 10.1097/00007632-200307010-00014; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Lamanca John J., 1998, American Journal of Medicine, V105, p59S, DOI 10.1016/S0002-9343(98)00171-5; Lew P. C., 1997, Man Ther, V2, P98, DOI 10.1054/math.1997.0291; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; LOUIS R, 1981, ANAT CLIN, V3, P1, DOI 10.1007/BF01557969; Lyons JJ, 2014, J ALLERGY CLIN IMMUN, V133, P1471, DOI 10.1016/j.jaci.2013.11.039; Murrough JW, 2010, NMR BIOMED, V23, P643, DOI 10.1002/nbm.1512; Nakatomi Y, 2014, J NUCL MED, V55, P945, DOI 10.2967/jnumed.113.131045; NATHAN H, 1987, SPINE, V12, P527, DOI 10.1097/00007632-198707000-00003; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Ocon AJ, 2012, CLIN SCI, V122, P227, DOI 10.1042/CS20110241; Rade M, 2015, SPINE, V40, P935, DOI 10.1097/BRS.0000000000000914; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rempel D, 1999, J BONE JOINT SURG AM, V81A, P1600, DOI 10.2106/00004623-199911000-00013; Torres JR, 2015, ARCH PHYS MED REHAB, V96, P1771, DOI 10.1016/j.apmr.2015.06.008; Rowe PC, 1999, J PEDIATR-US, V135, P494, DOI 10.1016/S0022-3476(99)70173-3; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; Rowe PC, 2014, J PEDIATR-US, V165, P360, DOI 10.1016/j.jpeds.2014.04.051; Rowe PC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00115; Shacklock M., 1995, NEURODYNAMICS PHYSIO, V81, P9, DOI [10.1016/S0031-9406(05)67024-1, DOI 10.1016/S0031-9406(05)67024-1]; Shibao C, 2005, HYPERTENSION, V45, P385, DOI 10.1161/01.HYP.0000158259.68614.40; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; SMITH CG, 1956, RADIOLOGY, V66, P259, DOI 10.1148/66.2.259; SMITH SA, 1993, SPINE, V18, P992, DOI 10.1097/00007632-199306150-00007; STRAUS SE, 1988, NEW ENGL J MED, V319, P1692, DOI 10.1056/NEJM198812293192602; Sunderland S., 1978, NERVES NERVE INJURIE; Tesarz J, 2011, NEUROSCIENCE, V194, P302, DOI 10.1016/j.neuroscience.2011.07.066; Theoharides TC, 2005, J CLIN PSYCHOPHARM, V25, P515, DOI 10.1097/01.jcp.0000193483.89260.a7; Topp KS, 2006, PHYS THER, V86, P92, DOI 10.1093/ptj/86.1.92; VanNess JM, 2010, J WOMENS HEALTH, V19, P239, DOI 10.1089/jwh.2009.1507; White KP, 2000, SCAND J RHEUMATOL, V29, P44; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wyller VB, 2015, TIDSSKR NORSKE LAEGE, V135, P2172, DOI 10.4045/tidsskr.15.1180; YAMADA S, 1981, J NEUROSURG, V54, P494, DOI 10.3171/jns.1981.54.4.0494; Yoshiuchi K, 2006, CLIN PHYSIOL FUNCT I, V26, P83, DOI 10.1111/j.1475-097X.2006.00649.x	55	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159386	10.1371/journal.pone.0159386	http://dx.doi.org/10.1371/journal.pone.0159386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428358	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169300060
J	Rieger, A; Kemter, E; Kumar, S; Popper, B; Aigner, B; Wolf, E; Wanke, R; Blutke, A				Rieger, Alexandra; Kemter, Elisabeth; Kumar, Sudhir; Popper, Bastian; Aigner, Bernhard; Wolf, Eckhard; Wanke, Ruediger; Blutke, Andreas			Missense Mutation of POU Domain Class 3 Transcription Factor 3 in Pou3f3(L423P) Mice Causes Reduced Nephron Number and Impaired Development of the Thick Ascending Limb of the Loop of Henle	PLOS ONE			English	Article							RENAL-DISEASE; GLOMERULAR HYPERTROPHY; KIDNEY-DISEASE; CRUCIAL ROLES; UROMODULIN; GROWTH; HYPERTENSION; PRESSURE; WEIGHT; EXCESS	During nephrogenesis, POU domain class 3 transcription factor 3 (POU3F3 aka BRN1) is critically involved in development of distinct nephron segments, including the thick ascending limb of the loop of Henle (TAL). Deficiency of POU3F3 in knock-out mice leads to underdevelopment of the TAL, lack of differentiation of TAL cells, and perinatal death due to renal failure. Pou3f3(L423P) mutant mice, which were established in the Munich ENU Mouse Mutagenesis Project, carry a recessive point mutation in the homeobox domain of POU3F3. Homozygous Pou3f3(L423P) mutants are viable and fertile. The present study used functional, as well as qualitative and quantitative morphological analyses to characterize the renal phenotype of juvenile (12 days) and aged (60 weeks) homo-and heterozygous Pou3f3(L423P) mutant mice and age-matched wild-type controls. In both age groups, homozygous mutants vs. control mice displayed significantly smaller kidney volumes, decreased nephron numbers and mean glomerular volumes, smaller TAL volumes, as well as lower volume densities of the TAL in the kidney. No histological or ultrastructural lesions of TAL cells or glomerular cells were observed in homozygous mutant mice. Aged homozygous mutants displayed increased serum urea concentrations and reduced specific urine gravity, but no evidence of glomerular dysfunction. These results confirm the role of POU3F3 in development and function of the TAL and provide new evidence for its involvement in regulation of the nephron number in the kidney. Therefore, Pou3f3(L423P) mutant mice represent a valuable research model for further analyses of POU3F3 functions, or for nephrological studies examining the role of congenital low nephron numbers.	[Rieger, Alexandra; Wanke, Ruediger; Blutke, Andreas] Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany; [Kemter, Elisabeth; Kumar, Sudhir; Aigner, Bernhard; Wolf, Eckhard] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Munich, Germany; [Kemter, Elisabeth; Kumar, Sudhir; Aigner, Bernhard; Wolf, Eckhard] Univ Munich, Gene Ctr, Lab Funct Genome Anal, Munich, Germany; [Popper, Bastian] Univ Munich, Biomed Ctr, Dept Anat & Cell Biol, Munich, Germany; [Wolf, Eckhard] Helmholtz Zentrum Munche, German Ctr Diabet Res DZD, Neuherberg, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Blutke, A (corresponding author), Univ Munich, Ctr Clin Vet Med, Inst Vet Pathol, Munich, Germany.	blutke@patho.vetmed.uni-muenchen.de	Wolf, Eckhard/AAT-7500-2021	Wolf, Eckhard/0000-0002-0430-9510; Popper, Bastian/0000-0003-1517-695X; Kemter, Elisabeth/0000-0001-7785-7502	Hanns-Seidel-Stiftung e. V., Munich, Germany	Hanns-Seidel-Stiftung e. V., Munich, Germany	AR recieved a PhD scholarship from the Hanns-Seidel-Stiftung e. V., Munich, Germany.	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; Albl B, 2016, TOXICOL PATHOL, V44, P414, DOI 10.1177/0192623316631023; Amann Kerstin, 2011, Klin Padiatr, V223 Suppl 1, pS18, DOI 10.1055/s-0030-1255880; [Anonymous], 1979, STEREOLOGICAL METHOD; Benz K, 2011, AM J PHYSIOL-RENAL, V300, pF521, DOI 10.1152/ajprenal.00490.2009; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Blutke A, 2014, MOL CELL ENDOCRINOL, V394, P88, DOI 10.1016/j.mce.2014.07.002; Blutke A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12709; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; BURG MB, 1982, KIDNEY INT, V22, P454, DOI 10.1038/ki.1982.198; Cohen CD, 2003, METH MOLEC MED, V86, P285; Cullen-McEwen L, 2016, HUMAN KIDNEY PARALLE, P27; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Douglas-Denton Rebecca N, 2006, Ethn Dis, V16, pS2; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; El-Dahr SS, 2008, AM J PHYSIOL-RENAL, V294, pF1273, DOI 10.1152/ajprenal.00562.2007; FOGO A, 1989, SEMIN NEPHROL, V9, P329; FOGO A, 1991, AM J KIDNEY DIS, V17, P666, DOI 10.1016/S0272-6386(12)80347-7; Fogo AB, 2000, KIDNEY INT, V57, pS15, DOI 10.1046/j.1523-1755.2000.07505.x; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Graham LA, 2014, HYPERTENSION, V63, P551, DOI 10.1161/HYPERTENSIONAHA.113.01423; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Herbach N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022814; Herbach N, 2009, AM J PHYSIOL-RENAL, V296, pF819, DOI 10.1152/ajprenal.90665.2008; HERMANNS W, 1981, HISTOCHEMISTRY, V73, P439, DOI 10.1007/BF00495658; Hoeflich A, 2002, FASEB J, V16, P1721, DOI 10.1096/fj.02-0349com; Howard V., 2004, UNBIASED STEREOLOGY; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; KRIZ W, 1974, Z ANAT ENTWICKLUNGS, V144, P137, DOI 10.1007/BF00519771; KRIZ W, 1988, ANAT EMBRYOL, V178, pN1; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150472; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Little MH, 2015, CURR OPIN GENET DEV, V32, P135, DOI 10.1016/j.gde.2015.03.001; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mount DB, 2014, CLIN J AM SOC NEPHRO, V9, P1974, DOI 10.2215/CJN.04480413; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; Ramage IJ, 2002, KIDNEY INT, V62, P895, DOI 10.1046/j.1523-1755.2002.00527.x; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song S, 2009, NEPHROL DIAL TRANSPL, V24, P1157, DOI 10.1093/ndt/gfn626; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108, DOI 10.3181/00379727-74-17825; Wang QR, 2005, DEV BIOL, V288, P582, DOI 10.1016/j.ydbio.2005.09.024; Wanke R, 2001, VERH DEUT G, V85, P250; Weiner ID, 2015, CLIN J AM SOC NEPHRO, V10, P1444, DOI 10.2215/CJN.10311013; Zhong JY, 2012, PEDIATR RES, V72, P241, DOI 10.1038/pr.2012.81	65	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158977	10.1371/journal.pone.0158977	http://dx.doi.org/10.1371/journal.pone.0158977			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420727	gold, Green Published, Green Submitted			2022-12-26	WOS:000379662300007
J	Wann, GT; Aldridge, CL; Braun, CE				Wann, Gregory T.; Aldridge, Cameron L.; Braun, Clait E.			Effects of Seasonal Weather on Breeding Phenology and Reproductive Success of Alpine Ptarmigan in Colorado	PLOS ONE			English	Article							WHITE-TAILED PTARMIGAN; CLIMATE-CHANGE; WILLOW PTARMIGAN; LAGOPUS-LEUCURUS; BODY-MASS; POPULATION; SELECTION; SURVIVAL; HISTORY; GROWTH	Animal populations occurring at high elevations are often assumed to be in peril of extinctions or local extirpations due to elevational-dispersal limitations and thermoregulatory constraints as habitats change and warm. However, long-term monitoring of high-elevation populations is uncommon relative to those occurring at lower elevations, and evidence supporting this assumption is limited. We analyzed 45 years of reproductive data for two Colorado populations of white-tailed ptarmigan (Lagopus leucura), an alpine-endemic species with restricted distribution in western North America. Seasonal temperatures measured by the number of growing degree days warmed significantly at our study sites for pre-nesting, nesting, and brood-rearing seasonal periods (mean advance of 8 growing degree days per decade), and both populations advanced their reproductive phenology over the study period based on median hatch dates (median advance of 3.7 and 1.9 days per decade for the northern and southern sites, respectively). Reproductive performance measured by the number of chicks per hen declined significantly at one study site but not the other, and differences between sites may have been due to habitat degradation at one study area. Annual variability in chicks per hen was large at both sites but only weakly related to seasonal weather. An index of precipitation and temperature during the brood-rearing period was the best predictor for reproductive success with warm and dry conditions relating positively to number of chicks per hen. Our results provide evidence for two alpine ptarmigan populations that are remarkably invariant to fluctuations in seasonal weather with respect to reproductive success as measured by number of chicks per hen in the breeding population. These results are surprising given the general perception of alpine animal populations as being highly sensitive to warming temperatures.	[Wann, Gregory T.] Colorado State Univ, Dept Ecosyst Sci, 1231 East Dr, Ft Collins, CO 80523 USA; [Wann, Gregory T.] Colorado State Univ, Nat Resource Ecol Lab, 1231 East Dr, Ft Collins, CO 80523 USA; [Aldridge, Cameron L.] Colorado State Univ, US Geol Survey, Ft Collins Sci Ctr, Dept Ecosyst Sci, 2150 Ctr Ave,Bldg C, Ft Collins, CO 80526 USA; [Aldridge, Cameron L.] Colorado State Univ, US Geol Survey, Ft Collins Sci Ctr, Nat Resource Ecol Lab, 2150 Ctr Ave,Bldg C, Ft Collins, CO 80526 USA; [Braun, Clait E.] Grouse Inc, 5572 North Ventana Vista Rd, Tucson, AZ 85750 USA	Colorado State University; Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; United States Department of the Interior; United States Geological Survey	Wann, GT (corresponding author), Colorado State Univ, Dept Ecosyst Sci, 1231 East Dr, Ft Collins, CO 80523 USA.; Wann, GT (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, 1231 East Dr, Ft Collins, CO 80523 USA.	greg.wann@colostate.edu	Aldridge, Cameron L/F-4025-2011	Aldridge, Cameron L/0000-0003-3926-6941	National Science Foundation; Colorado Division of Wildlife through Federal Aid in Wildlife Restoration Project [W-37-R]; Grouse Inc.; United States Geological Survey; Colorado State University; Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship; U.S. Geological Survey	National Science Foundation(National Science Foundation (NSF)); Colorado Division of Wildlife through Federal Aid in Wildlife Restoration Project; Grouse Inc.; United States Geological Survey(United States Geological Survey); Colorado State University; Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship; U.S. Geological Survey(United States Geological Survey)	This work was supported by the National Science Foundation (1966-1969; www.nsf.gov) through graduate support to CB through a NSF Traineeship, and also in the 1970s through the Tundra Biome Program. This work was also supported by the Colorado Division of Wildlife (1970-1999; http://cpw.state.co.us/) through Federal Aid in Wildlife Restoration Project W-37-R, Grouse Inc. (2000-2008), the United States Geological Survey (2007-2012; http://www.usgs.gov/), and Colorado State University (2008-2012; www.colostate.edu). GW was partially supported by the Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship. The U.S. Geological Survey and Colorado State University provided support in the form of salaries for authors GW and CA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The long-term studies benefited from field support provided by R Schmidt Jr., T May, B Poley, and R Ryder in the 1960s, K Giesen and R Hoffman in the late 1970s through the 1990s at RM, and K Martin in the late 1980s and early 1990s at ME. Early administrative support in RM was provided by Chief Naturalists T Thomas and G Gallison through housing and permits. Field work at ME was facilitated by housing provided courtesy of M Monahan of University of Denver. G Rogers and W Sandfort of the Colorado Division of Wildlife provided administrative and financial support to initiate the studies at both sites. The National Science Foundation provided graduate support to CEB through a NSF Traineeship during 1966-1969 and also in the 1970s through the Tundra Biome Program. Work at both sites was supported by the Colorado Division of Wildlife through Federal Aid in Wildlife Restoration Project W-37-R and the United States Geological Survey. GTW was partially supported by the Rocky Mountain Conservancy through the Leslie Bailey Charitable Trust Fellowship. Weather data were provided by the National Science Foundation supported Niwot Ridge Long-Term Ecological Research project and the University of Colorado Mountain Research Station. This manuscript was improved by an anonymous reviewer and academic editor. We thank all of those that were afield with us.	Aldridge CL, 2008, ISR J ECOL EVOL, V54, P389, DOI 10.1560/IJEE.54.3-4.389; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Barton K., 2014, MUMIN MULTIMODEL INF; BOAG DA, 1966, CAN J ZOOLOG, V44, P799, DOI 10.1139/z66-081; Bowman W. D., 2001, STRUCTURE FUNCTION A; BRAUN CE, 1973, J WILDLIFE MANAGE, V37, P90, DOI 10.2307/3799744; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Camfield AF, 2010, J AVIAN BIOL, V41, P273, DOI 10.1111/j.1600-048X.2009.04816.x; CaraDonna PJ, 2014, P NATL ACAD SCI USA, V111, P4916, DOI 10.1073/pnas.1323073111; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CLARKE JA, 1992, CONDOR, V94, P622, DOI 10.2307/1369247; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; ERIKSTAD KE, 1983, ORNIS SCAND, V14, P249, DOI 10.2307/3676311; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GIESEN KM, 1979, J WILDLIFE MANAGE, V43, P508, DOI 10.2307/3800362; GIESEN KM, 1980, WILSON BULL, V92, P188; Giraudoux P., 2013, PGIRMESS DATA ANAL E; Grayson DK, 2005, J BIOGEOGR, V32, P2103, DOI 10.1111/j.1365-2699.2005.01341.x; HANNON SJ, 1988, AUK, V105, P330, DOI 10.2307/4087498; HOFFMAN RW, 2006, WHITE TAILED PTARMIG; Hussell DJT, 2003, AUK, V120, P607, DOI 10.1642/0004-8038(2003)120[0607:CCSTAT]2.0.CO;2; Jackson MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142110; Keller F, 2003, ARCT ANTARCT ALP RES, V35, P361, DOI 10.1657/1523-0430(2003)035[0361:TROPIA]2.0.CO;2; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Marcstrom V., 1960, VILTREVY, V2, P1; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Martin K, 2000, CONDOR, V102, P503, DOI 10.1650/0010-5422(2000)102[0503:RDADRI]2.0.CO;2; Martin K, 2015, BIRDS N AM; Martin M, 2009, J FIELD ORNITHOL, V80, P253, DOI 10.1111/j.1557-9263.2009.00228.x; Mason THE, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0069-6; MAY TA, 1972, J WILDLIFE MANAGE, V36, P1180, DOI 10.2307/3799246; May TA, 1970, THESIS; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Moss R, 2001, J ANIM ECOL, V70, P47, DOI 10.1046/j.1365-2656.2001.00473.x; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEDERSEN HC, 1979, ORNIS SCAND, V10, P17, DOI 10.2307/3676339; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; R Core Team, 2021, R LANGUAGE ENV STAT; Sandercock BK, 2005, ECOLOGY, V86, P2176, DOI 10.1890/04-0563; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wang GM, 2002, CLIM RES, V23, P81, DOI 10.3354/cr023081; Wann GT, 2014, POPUL ECOL, V56, P555, DOI 10.1007/s10144-014-0452-3; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x; Wilkening JL, 2009, QUATERN INT, V235, P77; Wilson S, 2010, J AVIAN BIOL, V41, P319, DOI 10.1111/j.1600-048X.2009.04945.x; Wilson SD, 2009, GLOBAL CHANGE BIOL, V15, P1676, DOI 10.1111/j.1365-2486.2009.01896.x; Wong MML, 2009, WILSON J ORNITHOL, V121, P638, DOI 10.1676/08-029.1; Yee TW, 2010, J STAT SOFTW, V32, P1; Zeigenfuss LC, 2006, 20061122 US GEOL SUR; [No title captured]	63	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0158913	10.1371/journal.pone.0158913	http://dx.doi.org/10.1371/journal.pone.0158913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420478	Green Published, Green Submitted, gold			2022-12-26	WOS:000379662300006
J	Ahonen, L; Cowley, B; Torniainen, J; Ukkonen, A; Vihavainen, A; Puolamaki, K				Ahonen, Lauri; Cowley, Benjamin; Torniainen, Jari; Ukkonen, Antti; Vihavainen, Arto; Puolamaki, Kai			Cognitive Collaboration Found in Cardiac Physiology: Study in Classroom Environment	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MECHANISMS; INDEXES	It is known that periods of intense social interaction result in shared patterns in collaborators' physiological signals. However, applied quantitative research on collaboration is hindered due to scarcity of objective metrics of teamwork effectiveness. Indeed, especially in the domain of productive, ecologically-valid activity such as programming, there is a lack of evidence for the most effective, affordable and reliable measures of collaboration quality. In this study we investigate synchrony in physiological signals between collaborating computer science students performing pair-programming exercises in a class room environment. We recorded electrocardiography over the course of a 60 minute programming session, using lightweight physiological sensors. We employ correlation of heart-rate variability features to study social psychophysiological compliance of the collaborating students. We found evident physiological compliance in collaborating dyads' heart-rate variability signals. Furthermore, dyads' self-reported workload was associated with the physiological compliance. Our results show viability of a novel approach to field measurement using lightweight devices in an uncontrolled environment, and suggest that self-reported collaboration quality can be assessed via physiological signals.	[Ahonen, Lauri; Cowley, Benjamin; Torniainen, Jari; Ukkonen, Antti; Puolamaki, Kai] Finnish Inst Occupat Hlth, Helsinki, Finland; [Vihavainen, Arto] Univ Helsinki, Dept Comp Sci, Helsinki, Finland; [Cowley, Benjamin] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland	Finnish Institute of Occupational Health; University of Helsinki; University of Helsinki	Ahonen, L (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	lauri.ahonen@ttl.fi	Puolamäki, Kai/C-9016-2017; Cowley, Benjamin Ultan/A-6271-2019; Ukkonen, Antti/E-8512-2013	Puolamäki, Kai/0000-0003-1819-1047; Cowley, Benjamin Ultan/0000-0001-8828-2994; Ahonen, Lauri/0000-0001-9957-4263; Torniainen, Jari/0000-0003-4953-4508	Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project) [5159/31/2014]	Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project)	This work was supported by Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project), http://www.tekes.fi/en/funding/research_organisations/strategic-researchopenings/, 5159/31/2014.; Authors wish to thank Andreas Henelius, Jussi Korpela, and Kristian Lukander for technical contributions, and Tekes (The Finnish Funding Agency for Innovation, Revolution of Knowledge Work project) for funding.	Ackerman MS, 2000, HUM-COMPUT INTERACT, V15, P179, DOI 10.1207/S15327051HCI1523_5; Akgun AE, 2015, INFORM MANAGE-AMSTER, V52, P247, DOI 10.1016/j.im.2014.11.004; [Anonymous], 2016, GITHUB; Balocchi R, 2006, BIOMED TECH, V51, P190, DOI 10.1515/BMT.2006.034; Bani-Salameh H, 2014, INT J COMPUT APPL T, V49, P89, DOI 10.1504/IJCAT.2014.060520; Bartel CA, 2000, ADMIN SCI QUART, V45, P197, DOI 10.2307/2667070; Begel A, 2008, ESEM'08: PROCEEDINGS OF THE 2008 ACM-IEEE INTERNATIONAL SYMPOSIUM ON EMPIRICAL SOFTWARE ENGINEERING AND MEASUREMENT, P120; Call J., 1994, Human Evolution, V9, P297, DOI 10.1007/BF02435516; Camm AJ, 1996, EUR HEART J, V17, P354; Chanel G, 2012, INTERACT COMPUT, V24, P306, DOI 10.1016/j.intcom.2012.04.012; Chaparro Edgar Acosta, 2005, P 17 WORKSH PSYCH PR, P5; Chenes C., 2013, SOCIAL MEDIA RETRIEV, P217; Choi KS, 2008, INFORM SOFTWARE TECH, V50, P1114, DOI 10.1016/j.infsof.2007.11.002; Elkins AN, 2009, APPL ERGON, V40, P997, DOI 10.1016/j.apergo.2009.02.002; Goldberger JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1273, DOI 10.1152/ajpheart.1999.276.4.H1273; Good P, 2004, PERMUTATION TESTS PR; GOTTMAN JM, 1979, PSYCHOL BULL, V86, P338, DOI 10.1037/0033-2909.86.2.338; HART S G, 1988, P139; Henelius A, 2009, IEEE ENG MED BIO, P1836; Henning RA, 2009, APPL ERGON, V40, P1004, DOI 10.1016/j.apergo.2009.04.009; Henning RA, 2001, INT J PSYCHOPHYSIOL, V40, P221, DOI 10.1016/S0167-8760(00)00190-2; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Judd CM, 2000, HANDBOOK OF RESEARCH; Jung M., 2012, P SIGCHI C HUM FACT, P829, DOI [10.1145/2207676.2208523, DOI 10.1145/2207676.2208523]; Katira N., 2004, SIGCSE Bulletin, V36, P7, DOI 10.1145/1028174.971307; Kristiansen J, 2009, INT ARCH OCC ENV HEA, V82, P631, DOI 10.1007/s00420-008-0367-4; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; LEVENSON RW, 1983, J PERS SOC PSYCHOL, V45, P587, DOI 10.1037/0022-3514.45.3.587; Lovallo WR, 2005, INT J PSYCHOPHYSIOL, V58, P119, DOI 10.1016/j.ijpsycho.2004.11.007; Massen C, 2009, PHILOS T R SOC B, V364, P2349, DOI 10.1098/rstb.2009.0059; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Nagappan N., 2003, SIGCSE Bulletin, V35, P359, DOI 10.1145/792548.612006; R Core Team, 2016, R LANG ENV STAT COMP; Skibniewski FW, 2015, AEROSP MED HUM PERF, V86, P518, DOI 10.3357/AMHP.4087.2015; Smith AL, 2013, J CLIN MONIT COMPUT, V27, P569, DOI 10.1007/s10877-013-9471-4; Smith T.J., 1987, HDB HUMAN FACTORS, P251; Smith TJ, 1994, DESIGN WORK DEV PERS, P273; Spape MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078795; Suthers DD, 2005, CSCL 2005: COMPUTER SUPPORTED COLLABORATIVE LEARNING 2005: THE NEXT 10 YEARS, PROCEEDINGS, P662; Ter Horst GJ, 1999, EUR J MORPHOL, V37, P257, DOI 10.1076/ejom.37.4.257.4722; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; vanSchaik CP, 1996, NATURWISSENSCHAFTEN, V83, P186, DOI 10.1007/s001140050271; Vihavainen Arto, 2013, P 18 ACM C INNOVATIO, P117, DOI DOI 10.1145/2462476.2462501; Wang HM, 2012, MOD SIMUL ENG, V2012, DOI 10.1155/2012/931943; Williams L, 2000, IEEE SOFTWARE, V17, P19, DOI 10.1109/52.854064; Williams L., 2002, PAIR PROGRAMMING ILL; Zhang HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133148	48	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159178	10.1371/journal.pone.0159178	http://dx.doi.org/10.1371/journal.pone.0159178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR0DZ	27416036	Green Submitted, Green Published, gold			2022-12-26	WOS:000379579500095
J	Kazama, T; Toriyama, K				Kazama, Tomohiko; Toriyama, Kinya			Whole Mitochondrial Genome Sequencing and Re-Examination of a Cytoplasmic Male Sterility-Associated Gene in Boro-Taichung-Type Cytoplasmic Male Sterile Rice	PLOS ONE			English	Article							REPEAT-CONTAINING GENE; RESTORES FERTILITY; ATP6 RNA; PROTEIN; EVOLUTION; UNCOVER	Nuclear genome substitutions between subspecies can lead to cytoplasmic male sterility (CMS) through incompatibility between nuclear and mitochondrial genomes. Boro-Taichung (BT)-type CMS rice was obtained by substituting the nuclear genome of Oryza sativa subsp. indica cultivar Chinsurah Boro II with that of Oryza sativa subsp. japonica cultivar Taichung 65. In BT-type CMS rice, the mitochondrial gene orf79 is associated with male sterility. A complete sequence of the Boro-type mitochondrial genome responsible for BT-type CMS has not been determined to date. Here, we used pyrosequencing to construct the Boro-type mitochondrial genome. The contiguous sequences were assembled into five circular DNA molecules, four of which could be connected into a single circle. The two resulting subgenomic circles were unable to form a reliable master circle, as recombination between them was scarcely detected. We also found an unequal abundance of DNA molecules for the two loci of atp6. These results indicate the presence of multi-partite DNA molecules in the Borotype mitochondrial genome. Expression patterns were investigated for Boro-type mitochondria- specific orfs, which were not found in the mitochondria from the standard japonica cultivar Nipponbare. Restorer of fertility 1 (RF1)-dependent RNA processing has been observed in orf79-containing RNA but was not detected in other Boro-type mitochondria-specific orfs, supporting the conclusion that orf79 is a unique CMS-associated gene in Boro-type mitochondria.	[Kazama, Tomohiko; Toriyama, Kinya] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan	Tohoku University	Toriyama, K (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan.	torikin@m.tohoku.ac.jp		Kazama, Tomohiko/0000-0003-3808-3991	Ministry of Education, Culture, Sports, Science and Technology, Japan [24117502]; Japan Society for the Promotion of Science [23380002, 26292002, 16H06182]; Ministry of Agriculture Forestry and Fishery, Japan (Technology Research Promotion Program for the Agriculture, Forestry, Fisheries and Food Industry) [26010A]; Council for Science, Technology and Innovation (Cross-ministerial Strategic Innovation Promotion Program (SIP) "Technologies for creating next-generation agricult; Grants-in-Aid for Scientific Research [26292002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture Forestry and Fishery, Japan (Technology Research Promotion Program for the Agriculture, Forestry, Fisheries and Food Industry); Council for Science, Technology and Innovation (Cross-ministerial Strategic Innovation Promotion Program (SIP) "Technologies for creating next-generation agricult; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/, grant number 24117502 to K.T.), Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html, grant numbers 23380002, 26292002 to K.T. and 16H06182 to T.K.), the Ministry of Agriculture Forestry and Fishery, Japan (http://www.maff.go.jp/e/index.html, Technology Research Promotion Program for the Agriculture, Forestry, Fisheries and Food Industry, grant number 26010A to K.T.), and Council for Science, Technology and Innovation (http://www8.cao.go.jp/cstp/english/, Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO; http://www.naro.affrc.go.jp/english/brain/) to K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI H, 1994, CURR GENET, V25, P52, DOI 10.1007/BF00712968; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Bentolila S, 2012, PLANT PHYSIOL, V158, P996, DOI 10.1104/pp.111.190231; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Huang JZ, 2014, RICE, V7, DOI 10.1186/s12284-014-0013-6; Igarashi K, 2013, PLANT CELL PHYSIOL, V54, P237, DOI 10.1093/pcp/pcs177; Itabashi E, 2009, PLANT CELL REP, V28, P233, DOI 10.1007/s00299-008-0625-7; IWABUCHI M, 1993, EMBO J, V12, P1437, DOI 10.1002/j.1460-2075.1993.tb05787.x; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; Kazama T, 2008, PLANT J, V55, P619, DOI 10.1111/j.1365-313X.2008.03529.x; Kazama T, 2016, PLANT J, V85, P707, DOI 10.1111/tpj.13135; Koizuka N, 2003, PLANT J, V34, P407, DOI 10.1046/j.1365-313X.2003.01735.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Okazaki M, 2013, PLANT CELL PHYSIOL, V54, P1560, DOI 10.1093/pcp/pct102; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Tsushiya T, 2002, HYBRID RICE FOOD SEC, P53; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Yi P, 2002, CHINESE SCI BULL, V47, P744, DOI 10.1360/02tb9168; Zeltz P, 1996, PLANT MOL BIOL, V31, P647, DOI 10.1007/BF00042236; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042041	29	12	13	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159379	10.1371/journal.pone.0159379	http://dx.doi.org/10.1371/journal.pone.0159379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414645	Green Published, Green Submitted, gold			2022-12-26	WOS:000379579500125
J	Li, Z; An, XK; Liu, YD; Hou, ML				Li, Zhen; An, Xing-Kui; Liu, Yu-Di; Hou, Mao-Lin			Transcriptomic and Expression Analysis of the Salivary Glands in White-Backed Planthoppers, Sogatella furcifera	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; PROTEIN-KINASE-II; ALKALINE-PHOSPHATASE; MOLECULAR CHARACTERIZATION; BROWN PLANTHOPPER; NILAPARVATA-LUGENS; TREHALASE ACTIVITY; GENE-EXPRESSION; RUSSIAN WHEAT; RICE	The white-backed planthopper (WBPH), Sogatella furcifera (Horvath), is one of the serious rice pests because of its destructive feeding. The salivary glands of the WBPH play an important role in the feeding behaviour. Currently, however, very little is known about the salivary glands at the molecular level. We sequenced the salivary gland transcriptome (sialotranscripome) of adult WBPHs using the Illumina sequencing. A total of 65,595 transcripts and 51,842 unigenes were obtained from salivary glands. According to annotations against the Nr database, many of the unigenes identified were associated with the most studied enzymes in hemipteran saliva. In the present study, we identified 32 salivary protein genes from the WBPH sialotranscripome, which were categorized as those involved in sugar metabolism, detoxification, suppression of plant defense responses, immunity-related responses, general digestion, and other phytophagy processes. Tissue expression profiles analysis revealed that four of 32 salivary protein genes (multicopper oxidase 4, multicopper oxidase 6, carboxylesterase and uridine phosphorylase 1 isform X2) were primarily expressed in the salivary gland, suggesting that they played putative role in insect-rice interactions. 13 of 32 salivary protein genes were primarily expressed in gut, which might play putative role in digestive and detoxify mechanism. Development expression profiles analysis revealed that the expression level of 26 of 32 salivary protein genes had no significant difference, suggesting that they may play roles in every developmental stages of salivary gland of WBPH. The other six genes have a high expression level in the salivary gland of adult. 31 of 32 genes (except putative acetylcholinesterase 1) have no significant difference in male and female adult, suggesting that their expression level have no difference between sexes. This report analysis of the sialotranscripome for the WBPH, and the transcriptome provides a foundational list of the genes involved in feeding. Our data will be useful to investigate the mechanisms of interaction between the WBPH and the host plant.	[Li, Zhen; An, Xing-Kui; Liu, Yu-Di; Hou, Mao-Lin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 West Yuan Ming Yuan Rd, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, YD (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, 2 West Yuan Ming Yuan Rd, Beijing 100193, Peoples R China.	ydliu@ippcaas.cn	An, Xingkui/AAJ-7484-2020		National Natural Science Foundation of China [31370439]; EuropeAid project [DCIFood/2010/230-238]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EuropeAid project	This work was supported by the National Natural Science Foundation of China (31370439) and a EuropeAid project (DCIFood/2010/230-238).	An XK, 2016, J ECON ENTOMOL, V109, P879, DOI 10.1093/jee/tov333; Bansal R, 2013, B ENTOMOL RES, V103, P286, DOI 10.1017/S0007485312000697; Bao YY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-507; Bao YY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-160; Blanc S, 2011, CURR OPIN MICROBIOL, V14, P483, DOI 10.1016/j.mib.2011.07.008; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Burkert P, 2006, EUR J NEUROSCI, V23, P335, DOI 10.1111/j.1460-9568.2005.04562.x; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; CHANG WS, 1993, DEVELOPMENT, V118, P651; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010133; CLEGG JS, 1961, SCIENCE, V134, P54, DOI 10.1126/science.134.3471.54; COHEN P, 1978, FEBS LETT, V92, P287, DOI 10.1016/0014-5793(78)80772-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Dai LL, 2015, INSECT BIOCHEM MOLEC, V65, P35, DOI 10.1016/j.ibmb.2015.08.004; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; Fujita D, 2013, CRIT REV PLANT SCI, V32, P162, DOI 10.1080/07352689.2012.735986; Gasper Raphael, 2010, Small GTPases, V1, P133, DOI 10.4161/sgtp.1.3.14742; Ge LQ, 2011, PESTIC BIOCHEM PHYS, V100, P172, DOI 10.1016/j.pestbp.2011.03.007; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Inagaki S, 1998, COMP BIOCHEM PHYS C, V120, P225, DOI 10.1016/S0742-8413(98)00044-9; Isaac RE, 2007, PEPTIDES, V28, P153, DOI 10.1016/j.peptides.2006.08.029; Isaac RE, 1998, BIOCHEM J, V330, P61, DOI 10.1042/bj3300061; Ji R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079612; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; KUCERA M, 1974, ACTA ENTOMOL BOHEMOS, V71, P289; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; Lamango NS, 1997, PEPTIDES, V18, P47, DOI 10.1016/S0196-9781(96)00232-X; Lemeire E, 2008, INSECT BIOCHEM MOLEC, V38, P166, DOI 10.1016/j.ibmb.2007.10.004; Li BL, 2012, PESTIC BIOCHEM PHYS, V102, P198, DOI 10.1016/j.pestbp.2012.01.004; Liu S, 2015, PEST MANAG SCI, V71, P32, DOI 10.1002/ps.3760; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr C, 2007, CELL TISSUE RES, V327, P189, DOI 10.1007/s00441-006-0249-6; Marshall SDG, 2003, J MOL EVOL, V57, P487, DOI 10.1007/s00239-003-2492-8; Matsukura K, 2013, PHYTOPATHOLOGY, V103, P509, DOI 10.1094/PHYTO-10-12-0261-R; Matsumoto Y, 2014, J INSECT PHYSIOL, V71, P170, DOI 10.1016/j.jinsphys.2014.10.010; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Miao YG, 2002, J APPL ENTOMOL, V126, P138, DOI 10.1046/j.1439-0418.2002.00625.x; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MUTA T, 1993, J BIOL CHEM, V268, P21384; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; OHSAKO S, 1993, J BIOL CHEM, V268, P2052; Otuka A, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00309; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Peng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111344; Petrova A, 2014, INSECT MOL BIOL, V23, P13, DOI 10.1111/imb.12058; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao S, 2005, BBA-PROTEINS PROTEOM, V1752, P103, DOI 10.1016/j.bbapap.2005.05.008; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Ramzi S, 2010, J ASIA-PAC ENTOMOL, V13, P215, DOI 10.1016/j.aspen.2010.03.009; Sharma A, 2014, B ENTOMOL RES, V104, P117, DOI 10.1017/S0007485313000618; Silva MCP, 2009, INSECT MOL BIOL, V18, P769, DOI 10.1111/j.1365-2583.2009.00920.x; Siviter RJ, 2002, BIOCHEM J, V367, P187, DOI 10.1042/BJ20020567; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; SUJAK P, 1978, J INVERTEBR PATHOL, V31, P4, DOI 10.1016/0022-2011(78)90101-5; Sukhanova MZ, 1996, J INSECT PHYSIOL, V42, P161, DOI 10.1016/0022-1910(95)00070-4; Sun ZX, 2015, MOL ECOL, V24, P771, DOI 10.1111/mec.13069; Taillebois E, 2013, ARCH INSECT BIOCHEM, V83, P138, DOI 10.1002/arch.21102; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Wang J, 2014, ARCH INSECT BIOCHEM, V85, P216, DOI 10.1002/arch.21155; Wang ZX, 2011, ARCH INSECT BIOCHEM, V78, P30, DOI 10.1002/arch.20437; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; XU XM, 1994, J BIOL CHEM, V269, P23569; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye YX, 2015, INSECT BIOCHEM MOLEC, V63, P124, DOI 10.1016/j.ibmb.2015.06.010; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zhao W, 2016, INSECT BIOCHEM MOLEC, V70, P60, DOI 10.1016/j.ibmb.2015.11.009	74	15	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159393	10.1371/journal.pone.0159393	http://dx.doi.org/10.1371/journal.pone.0159393			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414796	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500126
J	Kripke, K; Okello, V; Maziya, V; Benzerga, W; Mirira, M; Gold, E; Schnure, M; Sgaier, S; Castor, D; Reed, J; Njeuhmeli, E				Kripke, Katharine; Okello, Velephi; Maziya, Vusi; Benzerga, Wendy; Mirira, Munamato; Gold, Elizabeth; Schnure, Melissa; Sgaier, Sema; Castor, Delivette; Reed, Jason; Njeuhmeli, Emmanuel			Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting	PLOS ONE			English	Article							TRIAL; MEN	Background Voluntary medical male circumcision (VMMC) for HIV prevention has been a priority for Swaziland since 2009. Initially focusing on men ages 15-49, the Ministry of Health reduced the minimum age for VMMC from 15 to 10 years in 2012, given the existing demand among 10- to 15-year-olds. To understand the implications of focusing VMMC service delivery on specific age groups, the MOH undertook a modeling exercise to inform policy and implementation in 2013-2014. Methods and Findings The impact and cost of circumcising specific age groups were assessed using the Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0), a simple compartmental model. We used age-specific HIV incidence from the Swaziland HIV Incidence Measurement Survey (SHIMS). Population, mortality, births, and HIV prevalence were imported from a national Spectrum/Goals model recently updated in consultation with country stakeholders. Baseline male circumcision prevalence was derived from the most recent Swaziland Demographic and Health Survey. The lowest numbers of VMMCs per HIV infection averted are achieved when males ages 15-19, 20-24, 25-29, and 30-34 are circumcised, although the uncertainty bounds for the estimates overlap. Circumcising males ages 25-29 and 20-24 provides the most immediate reduction in HIV incidence. Circumcising males ages 15-19, 20-24, and 25-29 provides the greatest magnitude incidence reduction within 15 years. The lowest cost per HIV infection averted is achieved by circumcising males ages 15-34: $870 U.S. dollars (USD). Conclusions The potential impact, cost, and cost-effectiveness of VMMC scale-up in Swaziland are not uniform. They vary by the age group of males circumcised. Based on the results of this modeling exercise, the Ministry of Health's Swaziland Male Circumcision Strategic and Operational Plan 2014-2018 adopted an implementation strategy that calls for circumcision to be scaled up to 50% coverage for neonates, 80% among males ages 10-29, and 55% among males ages 30-34.	[Kripke, Katharine] Avenir Hlth, Hlth Policy Project, Washington, DC USA; [Okello, Velephi; Maziya, Vusi] Minist Hlth, Mbabane, Swaziland; [Benzerga, Wendy; Mirira, Munamato] US Agcy Int Dev, Mbabane, Swaziland; [Gold, Elizabeth] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA; [Schnure, Melissa] Palladium Grp, Hlth Policy Project, Washington, DC USA; [Sgaier, Sema] Bill & Melinda Gates Fdn, Seattle, WA USA; [Sgaier, Sema] Univ Washington, Dept Global Hlth, Seattle, WA USA; [Castor, Delivette; Reed, Jason] Jhpiego, Baltimore, MD USA; [Njeuhmeli, Emmanuel] USAID, Washington, DC USA	United States Agency for International Development (USAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; University of Washington; University of Washington Seattle; Jhpiego; United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Hlth Policy Project, Washington, DC USA.	kkripke@avenirhealth.org	Kripke, Katharine/J-2146-2019	Kripke, Katharine/0000-0001-8228-4577	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) [AIDOAA-A-10-00067, AID-OAA-14-00026]	American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Health Policy Project, Agreement No. AIDOAA-A-10-00067, beginning September 30, 2010, and Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number AID-OAA-14-00026. The Health Policy Project is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (formerly Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). USAID was involved in study design, decision to publish, and preparation of the manuscript. The findings and conclusions in this paper do not necessarily represent the views or positions of PEPFAR, USAID, or the U.S. Government.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Futures Institute, 2011, GOALS MAN MOD EST EF; Government of the Kingdom of Swaziland, 2014, EXT NAT MULT HIV AID; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kripke K, 2015, EC EPIDEMIOLOG UNPUB; Kripke K, 2015, COST IMPACT VO UNPUB; Kripke K, 2015, VOLUNTARY MED UNPUB; Kripke K, 2015, MODELING IMPAC UNPUB; Kripke K., 2015, AGE TARGETING UNPUB; Ministry of Health, 2014, SWAZ MAL CIRC STRAT; Ministry of Health, 2012, SWAZ INC MEAS SURV S; Ministry of Health, 2009, POL SAF MAL CIRC HIV; NERCHA, 2015, SWAZ HIV INV CAS; Reed JB, 2012, 19 INT AIDS C JUL 22; Swaziland Central Statistical Office Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Swaziland Male Circumcision Task Force, 2009, STRAT IMPL PLAN SCAL; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM	19	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0156776	10.1371/journal.pone.0156776	http://dx.doi.org/10.1371/journal.pone.0156776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410687	Green Published, gold			2022-12-26	WOS:000379508300003
J	Martinez-Garcia, A; Martin-Vivaldi, M; Rodriguez-Ruano, SM; Peralta-Sanchez, JM; Valdivia, E; Soler, JJ				Martinez-Garcia, Angela; Martin-Vivaldi, Manuel; Rodriguez-Ruano, Sonia M.; Manuel Peralta-Sanchez, Juan; Valdivia, Eva; Soler, Juan J.			Nest Bacterial Environment Affects Microbiome of Hoopoe Eggshells, but Not That of the Uropygial Secretion	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; UPUPA-EPOPS; ANTIMICROBIAL PROPERTIES; GLAND; NESTEDNESS; COMMUNITY; LOADS; ANTIBACTERIAL; POLYMORPHISM; DIVERSITY	The study of associations between symbiotic bacterial communities of hosts and those of surrounding environments would help to understand how bacterial assemblages are acquired, and how they are transmitted from one to another location (i.e. symbiotic bacteria acquisition by hosts). Hoopoes (Upupa epops) smear their eggshells with uropygial secretion (oily secretion produced in their uropygial gland) that harbors antibiotic producing bacteria. Trying to elucidate a possible role of nest material and cloaca microbiota in determining the bacterial community of the uropygial gland and the eggshells of hoopoes, we characterized bacterial communities of nest material, cloaca, uropygial gland and eggshells by the ARISA fingerprinting. Further, by adding material with scarce bacteria and antimicrobial properties, we manipulated the bacterial community of nest material and thus tested experimentally its effects on the microbiomes of the uropygial secretion and of the eggshells. The experiment did not influence the microbiome of the uropygial secretion of females, but affected the community established on eggshells. This is the first experimental evidence indicating that nest material influences the bacterial community of the eggshells and, therefore, probability of embryo infection. Some of the bacterial strains detected in the secretion were also in the bacterial communities of the nest material and of cloaca, but their occurrence within nests was not associated, which suggests that bacterial environments of nest material and cloaca are not sources of symbiotic bacteria for the gland. These results do not support a role of nest environments of hoopoes as reservoirs of symbiotic bacteria. We discuss possible scenarios explaining bacterial acquisition by hoopoes that should be further explored.	[Martinez-Garcia, Angela; Soler, Juan J.] Estn Expt Zonas Aridas CSIC, E-04120 Almeria, Spain; [Martin-Vivaldi, Manuel] Univ Granada, Dept Zool, E-18071 Granada, Spain; [Rodriguez-Ruano, Sonia M.; Manuel Peralta-Sanchez, Juan; Valdivia, Eva] Univ Granada, Dept Microbiol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); University of Granada; University of Granada	Martinez-Garcia, A (corresponding author), Estn Expt Zonas Aridas CSIC, E-04120 Almeria, Spain.	angela@eeza.csic.es	Peralta-Sanchez, Juan M/L-3159-2017; Martín-Vivaldi, Manuel/F-8256-2016; Rodríguez-Ruano, Sonia María/AAA-9938-2020; Valdivia, Eva/R-9978-2018; Soler, J. J./H-2363-2011; Martínez, Manuel Martín-Vivaldi/AAJ-6736-2021	Peralta-Sanchez, Juan M/0000-0003-4648-7988; Martín-Vivaldi, Manuel/0000-0002-5432-425X; Rodríguez-Ruano, Sonia María/0000-0001-6863-717X; Valdivia, Eva/0000-0002-9429-9634; Soler, J. J./0000-0003-2990-1489; Martínez, Manuel Martín-Vivaldi/0000-0002-5432-425X	European funds (FEDER) [CGL2013-48193-C3-1-P, CGL2013-48193-C3-2-P]; Junta de Andalucia [P09-RNM-4557]; Spanish Ministerio de Economia y Competitividad	European funds (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Spanish Ministerio de Economia y Competitividad(Spanish Government)	Support by funding was provided by Spanish Ministerio de Economia y Competitividad, European funds (FEDER) (CGL2013-48193-C3-1-P, CGL2013-48193-C3-2-P) and Junta de Andalucia (P09-RNM-4557). AM-G had a predoctoral grant from the Junta de Andalucia (P09-RNM-4557).	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Aziz NH, 1998, MICROBIOS, V93, P43; Barbaro L, 2008, BIODIVERS CONSERV, V17, P1073, DOI 10.1007/s10531-007-9241-z; Barrow P. A., 1994, MICROBIOLOGY AVIAN E, P117; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; Brandl HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114861; Bruce J., 1994, P63; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Clark L., 1991, Oxford Ornithology Series, P205; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cramp S., 1998, THE COMPLETE BIRDS O; Cruz-Peragon F, 2006, GRASAS ACEITES, V57, P219; Danovaro R, 2006, APPL ENVIRON MICROB, V72, P5982, DOI 10.1128/AEM.01361-06; Ibanez-Alamo JD, 2014, J AVIAN BIOL, V45, P354, DOI 10.1111/jav.00353; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; FLEMING HP, 1973, APPL MICROBIOL, V26, P777, DOI 10.1128/AEM.26.5.777-782.1973; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horrocks NPC, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-49; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; Legendre P., 2012, NUMERICAL ECOLOGY; Loisel P, 2006, ENVIRON MICROBIOL, V8, P720, DOI 10.1111/j.1462-2920.2005.00950.x; Long RA, 2005, APPL ENVIRON MICROB, V71, P8531, DOI 10.1128/AEM.71.12.8531-8536.2005; Martin-Platero AM, 2010, ANAL BIOCHEM, V397, P253, DOI 10.1016/j.ab.2009.10.041; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Peralta-Sanchez JM, 2012, IBIS, V154, P725, DOI 10.1111/j.1474-919X.2012.01256.x; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Martin-Vivaldi M, 1999, BIRD STUDY, V46, P205, DOI 10.1080/00063659909461132; Martin-Vivaldi M, 2014, J ANIM ECOL, V83, P1289, DOI 10.1111/1365-2656.12243; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; Martin-Vivaldi M, 2009, J AVIAN BIOL, V40, P191, DOI 10.1111/j.1600-048X.2009.04393.x; Martinez-Garcia A, 2015, MICROB ECOL, V70, P1024, DOI 10.1007/s00248-015-0636-1; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mennerat A, 2009, OECOLOGIA, V161, P849, DOI 10.1007/s00442-009-1418-6; Moller AP, 2013, OECOLOGIA, V173, P169, DOI 10.1007/s00442-013-2600-4; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; Perez-Gutierrez RA, 2013, ISME J, V7, P487, DOI 10.1038/ismej.2012.119; Poisot T, 2011, BIOL LETTERS, V7, P201, DOI 10.1098/rsbl.2010.0774; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rehsteiner Ueli, 1996, Ornithologische Beobachter, V93, P277; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Ruiz-Castellano C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148894; Ruiz-de-Castaneda R, 2011, CONDOR, V113, P200, DOI 10.1525/cond.2011.100035; Ruiz-Rodriguez M, 2009, J EXP BIOL, V212, P3621, DOI 10.1242/jeb.031336; Ruiz-Rodriguez M, 2014, APPL ENVIRON MICROB, V80, P6714, DOI 10.1128/AEM.02242-14; Ruiz-Rodriguez M, 2013, FEMS MICROBIOL ECOL, V85, P495, DOI 10.1111/1574-6941.12138; Ruiz-Rodriguez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041843; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler JJ, 2016, BIOL J LINN SOC, V118, P763, DOI 10.1111/bij.12772; Soler JJ, 2014, NATURWISSENSCHAFTEN, V101, P697, DOI 10.1007/s00114-014-1201-3; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Strona G, 2014, J STAT SOFTW, V59, P1; Traveset A, 2014, J BIOGEOGR, V41, P823, DOI 10.1111/jbi.12243	60	24	24	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158158	10.1371/journal.pone.0158158	http://dx.doi.org/10.1371/journal.pone.0158158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409772	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508300018
J	Martfeld, AN; Greathouse, DV; Koeppe, RE				Martfeld, Ashley N.; Greathouse, Denise V.; Koeppe, Roger E., II			Ionization Properties of Histidine Residues in the Lipid Bilayer Membrane Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON LOADING SITE; M2 ION-CHANNEL; TRANSMEMBRANE PEPTIDE; AMINO-ACIDS; ARGININE RESIDUES; PK(A); MECHANISM; PROTEIN; DOMAIN; H-2	We address the critically important ionization properties of histidine side chains of membrane proteins, when exposed directly to lipid acyl chains within lipid bilayer membranes. The problem is important for addressing general principles that may underlie membrane protein function. To this end, we have employed a favorable host peptide framework provided by GWALP23 (acetyl-GGALW(5)LALALALALALALW(19)LAGA-amide). We inserted His residues into position 12 or 14 of GWALP23 (replacing either Leu(12) or Leu(14)) and incorporated specific [H-2] Ala labels within the helical core sequence. Solid-state H-2 NMR spectra report the folding and orientation of the core sequence, revealing marked differences in the histidinecontaining transmembrane helix behavior between acidic and neutral pH conditions. At neutral pH, the GWALP23-H12 and GWALP23-H14 helices exhibit well defined tilted transmembrane orientations in dioleoylphosphatidylcholine (DOPC) and dilauroylphosphatidylcholine (DLPC) bilayer membranes. Under acidic conditions, when His(12) is protonated and charged, the GWALP23-H12 helix exhibits a major population that moves to the DOPC bilayer surface and a minor population that occupies multiple transmembrane states. The response to protonation of His(14) is an increase in helix tilt, but GWALP23-H14 remains in a transmembrane orientation. The results suggest pK(a) values of less than 3 for His(12) and about 3-5 for His(14) in DOPC membranes. In the thinner DLPC bilayers, with increased water access, the helices are less responsive to changes in pH. The combined results enable us to compare the ionization properties of lipid-exposed His, Lys, and Arg side chains in lipid bilayer membranes.	[Martfeld, Ashley N.; Greathouse, Denise V.; Koeppe, Roger E., II] Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Koeppe, RE (corresponding author), Univ Arkansas, Dept Chem & Biochem, 119 Chem Bldg, Fayetteville, AR 72701 USA.	rk2@uark.edu		Koeppe, Roger/0000-0003-0676-6413	National Institutes of Health [GM103429, GM103450]; Div Of Molecular and Cellular Bioscience [1327611] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P30GM103450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The peptide, NMR, and mass spectrometry facilities were supported in part by National Institutes of Health Grants GM103429 and GM103450. We thank Vitaly Vostrikov for software for semi-static GALA and modified Gaussian methods for analysis of helix orientations and dynamics.	Achilonu I, 2012, BIOCHEMISTRY-US, V51, P995, DOI 10.1021/bi201541w; Baran KL, 2008, J MOL BIOL, V379, P1045, DOI 10.1016/j.jmb.2008.04.021; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; BENDER ML, 1964, J AM CHEM SOC, V86, P3704, DOI 10.1021/ja01072a020; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Chaloupka R, 2005, BIOCHEMISTRY-US, V44, P726, DOI 10.1021/bi048014v; Colvin MT, 2014, BIOCHEMISTRY-US, V53, P5987, DOI 10.1021/bi5005393; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; Fitch CA, 2015, PROTEIN SCI, V24, P752, DOI 10.1002/pro.2647; Gleason NJ, 2013, P NATL ACAD SCI USA, V110, P1692, DOI 10.1073/pnas.1215400110; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Larson CA, 2010, MOL PHARMACOL, V78, P333, DOI 10.1124/mol.110.064766; Li L, 2008, BIOPHYS J, V94, pL11, DOI 10.1529/biophysj.107.121566; Lu JX, 2014, P NATL ACAD SCI USA, V111, P12414, DOI 10.1073/pnas.1407187111; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MONCELLI MR, 1994, BIOPHYS J, V66, P1969, DOI 10.1016/S0006-3495(94)80990-7; Mortazavi A, 2016, CHEMBIOCHEM, V17, P462, DOI 10.1002/cbic.201500656; Nagai H, 2008, J CHEM ENG DATA, V53, P619, DOI 10.1021/je700067a; Nanga R. P. R., 2008, BIOCHEMISTRY-US, V47, P12689; Okada A, 2001, BIOCHEMISTRY-US, V40, P6053, DOI 10.1021/bi0028441; Paddock ML, 2003, BIOCHEMISTRY-US, V42, P9626, DOI 10.1021/bi0346648; Panahi A, 2015, J PHYS CHEM B, V119, P4601, DOI 10.1021/acs.jpcb.5b00289; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Plesniak LA, 1996, PROTEIN SCI, V5, P2319, DOI 10.1002/pro.5560051118; Rehwald M, 1999, FEBS LETT, V443, P357, DOI 10.1016/S0014-5793(99)00007-1; Reisser S, 2014, BIOPHYS J, V106, P2385, DOI 10.1016/j.bpj.2014.04.020; Rodnin MV, 2010, J MOL BIOL, V402, P1, DOI 10.1016/j.jmb.2010.07.024; Roux B, 2007, J GEN PHYSIOL, V130, P233, DOI 10.1085/jgp.200709819; SCHOELLMANN G, 1963, BIOCHEMISTRY-US, V2, P252, DOI 10.1021/bi00902a008; Sparks KA, 2014, BIOCHEMISTRY-US, V53, P3637, DOI 10.1021/bi500439x; Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402; Strandberg E, 2012, BBA-BIOMEMBRANES, V1818, P1242, DOI 10.1016/j.bbamem.2012.01.023; Thibado JK, 2015, BIOPHYS J, V108, p553A, DOI 10.1016/j.bpj.2014.11.3034; Tishmack PA, 1997, BIOCHEMISTRY-US, V36, P11984, DOI 10.1021/bi9712448; van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200; Vostrikov VV, 2008, J AM CHEM SOC, V130, P12584, DOI 10.1021/ja803734k; Vostrikov VV, 2012, J PHYS CHEM B, V116, P12980, DOI 10.1021/jp308182b; Vostrikov VV, 2011, BIOPHYS J, V101, P2939, DOI 10.1016/j.bpj.2011.11.008; Vostrikov VV, 2010, J BIOL CHEM, V285, P31723, DOI 10.1074/jbc.M110.152470; Vostrikov VV, 2010, J AM CHEM SOC, V132, P5803, DOI 10.1021/ja100598e; WANG C, 1995, BIOPHYS J, V69, P1363, DOI 10.1016/S0006-3495(95)80003-2; Yoo J, 2008, BIOPHYS J, V94, pL61, DOI 10.1529/biophysj.107.122945	50	20	20	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19146	19156		10.1074/jbc.M116.738583	http://dx.doi.org/10.1074/jbc.M116.738583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27440045	Green Published, hybrid			2022-12-26	WOS:000383242300046
J	Strenkert, D; Limso, CA; Fatihi, A; Schmollinger, S; Basset, GJ; Merchant, SS				Strenkert, Daniela; Limso, Clariss Ann; Fatihi, Abdelhak; Schmollinger, Stefan; Basset, Gilles J.; Merchant, Sabeeha S.			Genetically Programmed Changes in Photosynthetic Cofactor Metabolism in Copper-deficient Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; IRON-DEFICIENCY; HEAT-SHOCK; HIGH LIGHT; VITAMIN-E; PROTEIN; BIOSYNTHESIS; STRESS; SYNECHOCYSTIS; PLASTOCYANIN	Genetic and genomic studies indicate that copper deficiency triggers changes in the expression of genes encoding key enzymes in various chloroplast-localized lipid/pigment biosynthetic pathways. Among these are CGL78 involved in chlorophyll biosynthesis and HPPD1, encoding 4-hydroxyphenylpyruvate dioxygenase catalyzing the committed step of plastoquinone and tocopherol biosyntheses. Copper deficiency in wild-type cells does not change the chlorophyll content, but a survey of chlorophyll protein accumulation in this situation revealed increased accumulation of LHCSR3, which is blocked at the level of mRNA accumulation when either CGL78 expression is reduced or in the crd1 mutant, which has a copper-nutrition conditional defect at the same step in chlorophyll biosynthesis. Again, like copper-deficient crd1 strains, cgl78 knock-down lines also have reduced chlorophyll content concomitant with loss of PSI-LHCI super-complexes and reduced abundance of a chlorophyll binding subunit of PSI, PSAK, which connects LHCI to PSI. For HPPD1, increased mRNA results in increased abundance of the corresponding protein in copper-deficient cells concomitant with CRR1-dependent increased accumulation of gamma-tocopherols, but not plastoquinone-9 nor total tocopherols. In crr1 mutants, where increased HPPD1 expression is blocked, plastochromanol-8, derived from plastoquinone-9 and purported to also have an antioxidant function, is found instead. Although not previously found in algae, this metabolite may occur only in stress conditions.	[Strenkert, Daniela; Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Strenkert, Daniela; Limso, Clariss Ann; Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East,Box 951569, Los Angeles, CA 90095 USA; [Fatihi, Abdelhak] INRA AgroParisTech, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Basset, Gilles J.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; State University System of Florida; University of Florida	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East,Box 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu		Schmollinger, Stefan/0000-0002-7487-8014; Limso, Clariss Ann/0000-0002-7464-7865; Strenkert, Daniela/0000-0002-3420-1332; Basset, Gilles/0000-0001-5275-9797	National Institutes of Health [GM42143]; National Science Foundation [MCB-1148968]; European Molecular Biology Organization [ALTF 653-2013]; German Academic Exchange Service (DAAD); Div Of Molecular and Cellular Bioscience [1608088] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM042143, R01GM042143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42143 (to S. M.) and National Science Foundation Grant MCB-1148968 (to G. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by European Molecular Biology Organization Grant ALTF 653-2013.; Supported by a fellowship within the Postdoc-Program of the German Academic Exchange Service (DAAD).	Albus CA, 2012, PLANT PHYSIOL, V160, P1923, DOI 10.1104/pp.112.206045; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Bergner SV, 2015, PLANT PHYSIOL, V168, P615, DOI 10.1104/pp.15.00072; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Block A, 2013, J BIOL CHEM, V288, P27594, DOI 10.1074/jbc.M113.492769; Bollivar D, 2014, FEBS J, V281, P2377, DOI 10.1111/febs.12790; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Correa-Galvis V., 2016, J BIOL CHEM, DOI [10.1074/jbc.116.737312, DOI 10.1074/JBC.116.737312]; Fatihi A, 2015, PLANT CELL, V27, P1730, DOI 10.1105/tpc.15.00103; Formighieri C, 2012, MOL PLANT, V5, P1242, DOI 10.1093/mp/sss051; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hemschemeier A, 2013, PLANT CELL, V25, P3186, DOI 10.1105/tpc.113.115741; HILL KL, 1991, J BIOL CHEM, V266, P15060; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; Hussain N, 2013, J AGR FOOD CHEM, V61, P6137, DOI 10.1021/jf4010302; Jose Huertas Maria, 2014, Life-Basel, V4, P865, DOI 10.3390/life4040865; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kobayashi N, 2008, PLANT J, V55, P607, DOI 10.1111/j.1365-313X.2008.03539.x; Krieger-Liszkay A, 2006, J EXP BOT, V57, P1677, DOI 10.1093/jxb/erl002; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Kruk J, 2014, PHYTOCHEMISTRY, V108, P9, DOI 10.1016/j.phytochem.2014.09.011; Li ZR, 2012, PLANT PHYSIOL, V158, P313, DOI 10.1104/pp.111.181230; Maeda H, 2005, PLANT PHYSIOL, V138, P1422, DOI 10.1104/pp.105.061135; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Martinis J, 2013, PLANT PHYSIOL, V162, P652, DOI 10.1104/pp.113.218644; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1995, J CELL BIOCHEM, P241; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Pinnola A, 2015, PLANT CELL, V27, P3213, DOI 10.1105/tpc.15.00443; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; SANDMANN G, 1983, ARCH MICROBIOL, V134, P23, DOI 10.1007/BF00429401; Schmollinger S, 2010, CURR GENET, V56, P383, DOI 10.1007/s00294-010-0304-4; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Strenkert D, 2011, PLANT CELL, V23, P2285, DOI 10.1105/tpc.111.085266; Trebst A, 2002, FEBS LETT, V516, P156, DOI 10.1016/S0014-5793(02)02526-7; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; Williams RJP, 2003, CHEM COMMUN, P1109, DOI 10.1039/b211281g; WOLLMAN FA, 1982, BIOCHIM BIOPHYS ACTA, V680, P352, DOI 10.1016/0005-2728(82)90149-9; WOLLMAN FA, 1984, J CELL BIOL, V98, P1, DOI 10.1083/jcb.98.1.1; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Zingg JM, 2015, ANNU REV NUTR, V35, P135, DOI 10.1146/annurev-nutr-071714-034347	60	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19118	19131		10.1074/jbc.M116.717413	http://dx.doi.org/10.1074/jbc.M116.717413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27440043	Green Published, hybrid			2022-12-26	WOS:000383242300044
J	Reichard, EL; Chirico, GG; Dewey, WJ; Nassif, ND; Bard, KE; Millas, NE; Kraut, DA				Reichard, Eden L.; Chirico, Giavanna G.; Dewey, William J.; Nassif, Nicholas D.; Bard, Katelyn E.; Millas, Nickolas E.; Kraut, Daniel A.			Substrate Ubiquitination Controls the Unfolding Ability of the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; ATPases associated with diverse cellular activities (AAA); enzyme kinetics; enzyme mechanism; pre-steady-state kinetics; proteasome; protein degradation; protein unfolding	ATP-DEPENDENT PROTEASES; NF-KAPPA-B; FLUORESCENT PROTEIN TIMERS; 26S PROTEASOME; POLYUBIQUITIN CHAIN; ADAPTER PROTEIN; SINGLE-MOLECULE; DEGRADATION; PATHWAY; SYSTEM	In eukaryotic cells, proteins are targeted to the proteasome for degradation by polyubiquitination. These proteins bind to ubiquitin receptors, are engaged and unfolded by proteasomal ATPases, and are processively degraded. The factors determining to what extent the proteasome can successfully unfold and degrade a substrate are still poorly understood. We find that the architecture of polyubiquitin chains attached to a substrate affects the ability of the proteasome to unfold and degrade the substrate, with K48- or mixed-linkage chains leading to greater processivity than K63-linked chains. Ubiquitin-independent targeting of substrates to the proteasome gave substantially lower processivity of degradation than ubiquitin-dependent targeting. Thus, even though ubiquitin chains are removed early in degradation, during substrate engagement, remarkably they dramatically affect the later unfolding of a protein domain. Our work supports a model in which a polyubiquitin chain associated with a substrate switches the proteasome into an activated state that persists throughout the degradation process.	[Reichard, Eden L.; Chirico, Giavanna G.; Dewey, William J.; Nassif, Nicholas D.; Bard, Katelyn E.; Millas, Nickolas E.; Kraut, Daniel A.] Villanova Univ, Dept Chem, Villanova, PA 19085 USA	Villanova University	Kraut, DA (corresponding author), Mendel Hall 214D,800 Lancaster Ave, Villanova, PA 19085 USA.	daniel.kraut@villanova.edu		Kraut, Daniel/0000-0002-4428-5832	National Science Foundation [1515229]; Direct For Biological Sciences [1515229] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1515229. The authors declare that they have no conflicts of interest with the contents of this article.	Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Baird L, 2014, BIOTECHNOL ADV, V32, P1133, DOI 10.1016/j.biotechadv.2014.03.004; Baraibar MA, 2012, PROG MOL BIOL TRANSL, V109, P249, DOI 10.1016/B978-0-12-397863-9.00007-9; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Cannon JR, 2015, ANAL CHEM, V87, P1812, DOI 10.1021/ac5038363; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Gavrilov Y, 2015, PROTEIN SCI, V24, P1580, DOI 10.1002/pro.2688; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; Ha SW, 2012, BIOCHEM BIOPH RES CO, V419, P226, DOI 10.1016/j.bbrc.2012.01.152; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hospenthal MK, 2015, NAT PROTOC, V10, P349, DOI 10.1038/nprot.2015.018; Huang L, 2009, CURR MED CHEM, V16, P931, DOI 10.2174/092986709787581860; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Khmelinskii A, 2016, MOL BIOL CELL, V27, P360, DOI 10.1091/mbc.E15-07-0525; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Kraut DA, 2007, TRENDS CELL BIOL, V17, P419, DOI 10.1016/j.tcb.2007.06.008; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Nassif ND, 2014, IUBMB LIFE, V66, P309, DOI 10.1002/iub.1271; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Raasi Shahri, 2005, V301, P47; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schrader EK, 2011, J BIOL CHEM, V286, P39051, DOI 10.1074/jbc.M111.274993; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Small E, 2010, BIOCHEM BIOPH RES CO, V400, P471, DOI 10.1016/j.bbrc.2010.08.062; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takahashi K, 2015, ACS CHEM BIOL, V10, P2537, DOI 10.1021/acschembio.5b00554; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Vu ND, 2004, BIOCHEMISTRY-US, V43, P3346, DOI 10.1021/bi0362267; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	81	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18547	18561		10.1074/jbc.M116.720151	http://dx.doi.org/10.1074/jbc.M116.720151			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405762	Green Published, hybrid			2022-12-26	WOS:000383241800044
J	Mahjourimajd, S; Taylor, J; Rengel, Z; Khabaz-Saberi, H; Kuchel, H; Okamoto, M; Langridge, P				Mahjourimajd, Saba; Taylor, Julian; Rengel, Zed; Khabaz-Saberi, Hossein; Kuchel, Haydn; Okamoto, Mamoru; Langridge, Peter			The Genetic Control of Grain Protein Content under Variable Nitrogen Supply in an Australian Wheat Mapping Population	PLOS ONE			English	Article							USE EFFICIENCY; NEGATIVE RELATIONSHIP; BREAD WHEAT; YIELD; DISSECTION; PHOSPHORUS; DEVIATION; VARIETY; TRAITS; WEIGHT	Genetic variation has been observed in both protein concentration in wheat grain and total protein content (protein yield). Here we describe the genetic analysis of variation for grain protein in response to nitrogen (N) supply and locate significant genomic regions controlling grain protein components in a spring wheat population. In total, six N use efficiency (NUE) field trials were carried out for the target traits in a sub-population of doubled haploid lines derived from a cross between two Australian varieties, RAC875 and Kukri, in Southern and Western Australia from 2011 to 2013. Twenty-four putative Quantitative Trait Loci (QTL) for protein-related traits were identified at high and low N supply and ten QTL were identified for the response to N for the traits studied. These loci accounted for a significant proportion of the overall effect of N supply. Several of the regions were co-localised with grain yield QTL and are promising targets for further investigation and selection in breeding programs.	[Mahjourimajd, Saba; Okamoto, Mamoru] Univ Adelaide, Australian Ctr Plant Funct Genom, PMB1, Glen Osmond, SA 5064, Australia; [Kuchel, Haydn] Australian Grain Technol, PMB1, Glen Osmond, SA 5064, Australia; [Taylor, Julian; Kuchel, Haydn; Langridge, Peter] Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, PMB 1, Glen Osmond, SA 5064, Australia; [Rengel, Zed; Khabaz-Saberi, Hossein] Univ Western Australia, Sch Earth & Environm, Soil Sci & Plant Nutr M087, 35 Stirling Highway, Crawley, WA 6009, Australia	University of Adelaide; University of Adelaide; University of Western Australia	Okamoto, M (corresponding author), Univ Adelaide, Australian Ctr Plant Funct Genom, PMB1, Glen Osmond, SA 5064, Australia.; Langridge, P (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Waite Res Inst, PMB 1, Glen Osmond, SA 5064, Australia.	mamoru.okamoto@acpfg.com.au; peter.langridge@adelaide.edu.au	Okamoto, Mamoru/AAF-4265-2019; Langridge, Peter/G-5864-2010; Taylor, Julian/AAO-6302-2020	Okamoto, Mamoru/0000-0002-2989-607X; Langridge, Peter/0000-0001-9494-400X; Taylor, Julian/0000-0002-9145-052X	Australian Grain Technologies; University of Adelaide	Australian Grain Technologies; University of Adelaide	One of the authors, HK, is employed by the wheat breeding company, Australian Grain Technologies (AGT) and several questions were asked about the potential role of this commercial relationship. HK also holds the status as an affiliate of the University of Adelaide and his role in the project was as one of the supervisors of SM during her PhD studies. The authors can confirm that "Australian Grain Technologies provided support in the form of salaries for authors [HK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Butler D.G., 2009, TECHNICAL REPORT; Charmet G, 2005, THEOR APPL GENET, V111, P540, DOI 10.1007/s00122-005-2045-1; Cormier F, 2014, THEOR APPL GENET, V127, P2679, DOI 10.1007/s00122-014-2407-7; Cormier F, 2013, THEOR APPL GENET, V126, P3035, DOI 10.1007/s00122-013-2191-9; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Fontaine JX, 2009, THEOR APPL GENET, V119, P645, DOI 10.1007/s00122-009-1076-4; Gelli M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0696-x; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Laperche A, 2007, THEOR APPL GENET, V115, P399, DOI 10.1007/s00122-007-0575-4; Liu ZY, 2016, FUNCT INTEGR GENOMIC, V16, P323, DOI 10.1007/s10142-016-0486-z; Mahjourimajd S, 2015, THESIS; Maurer A, 2016, J EXP BOT, V67, P2507, DOI 10.1093/jxb/erw070; McDonald G, 2015, CROP PASTURE SCI, V66, P430, DOI 10.1071/CP14191; Monaghan JM, 2001, EUPHYTICA, V122, P309, DOI 10.1023/A:1012961703208; Oury FX, 2007, EUPHYTICA, V157, P45, DOI 10.1007/s10681-007-9395-5; Payne R.W., 2009, STAT, V1, P255, DOI DOI 10.1002/WICS.32; Smith A, 2001, BIOMETRICS, V57, P1138, DOI 10.1111/j.0006-341X.2001.01138.x; Smith AB, 2005, J AGR SCI-CAMBRIDGE, V143, P449, DOI 10.1017/S0021859605005587; SOSULSKI FW, 1990, J AGR FOOD CHEM, V38, P1351, DOI 10.1021/jf00096a011; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., 2007, WINDOWS QTL CARTOGRA; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y	27	14	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2016	11	7							e0159371	10.1371/journal.pone.0159371	http://dx.doi.org/10.1371/journal.pone.0159371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TL	27438012	gold, Green Submitted, Green Published			2022-12-26	WOS:000380170100038
J	Connelly, SJ; Stoeckel, JA; Gitzen, RA; Williamson, CE; Gonzalez, MJ				Connelly, Sandra J.; Stoeckel, James A.; Gitzen, Robert A.; Williamson, Craig E.; Gonzalez, Maria J.			Effect of Clonal Selection on Daphnia Tolerance to Dark Experimental Conditions	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ULTRAVIOLET-RADIATION; UV-RADIATION; LIFE-HISTORY; WATER; ZOOPLANKTON; COMPETITION; PREDATION; WINBUGS	Recent studies have demonstrated substantial effects of environmental stress that vary among clones. Exposure to ultraviolet radiation (UV) is an important abiotic stressor that is highly variable in aquatic ecosystems due to diel and seasonal variations in incident sunlight as well as to differences in the UV transparency of water among water bodies, the depth distribution of organisms, and the ability of organisms to detect and respond to UV. In contrast to the convention that all UV is damaging, evidence is accumulating for the beneficial effects of exposure to low levels of UV radiation. Whereas UV has been frequently observed as the primary light-related stressor, herein we present evidence that dark conditions may be similarly "stressful" (reduction of overall fitness), and stress responses vary among clones of the freshwater crustacean Daphnia parvula. We have identified a significant relationship between survivorship and reduced fecundity of clones maintained in dark conditions, but no correlation between tolerance of the clones to dark and UV radiation. Low tolerance to dark conditions can have negative effects not only on accumulated stresses in organisms (e.g. the repair of UV-induced damage in organisms with photolyase), but potentially on the overall physiology and fitness of organisms. Our results support recent evidence of the beneficial effects of low-level UV exposure for some organisms.	[Connelly, Sandra J.] Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA; [Stoeckel, James A.] Auburn Univ, Coll Agr, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Stoeckel, James A.; Williamson, Craig E.; Gonzalez, Maria J.] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Gitzen, Robert A.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA	Rochester Institute of Technology; Auburn University System; Auburn University; University System of Ohio; Miami University; Auburn University System; Auburn University	Connelly, SJ (corresponding author), Rochester Inst Technol, Thomas H Gosnell Sch Life Sci, Rochester, NY 14623 USA.	Sandra.Connelly@rit.edu		Gitzen, Robert/0000-0001-8507-8197				Agra AR, 2011, ECOTOXICOLOGY, V20, P552, DOI 10.1007/s10646-011-0621-5; Auld SKJR, 2014, AM NAT, V184, pS77, DOI 10.1086/676927; Barata C, 2002, ENVIRON TOXICOL CHEM, V21, P1058, DOI [10.1897/1551-5028(2002)021<1058:AAWPVI>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1058:AAWPVI&gt;2.0.CO;2]; Boeing WJ, 2006, ARCH HYDROBIOL, V166, P241, DOI 10.1127/0003-9136/2006/0166-0241; Connelly SJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P144, DOI 10.1111/j.1751-1097.2008.00408.x; Cooke SL, 2006, J PLANKTON RES, V28, P171, DOI 10.1093/plankt/fbi108; Dominoni DM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0015; Effertz C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3250; Fischer JM, 2006, HYDROBIOLOGIA, V563, P217, DOI 10.1007/s10750-005-0007-x; Fischer JM, 2006, PHOTOCHEM PHOTOBIOL, V82, P547, DOI 10.1562/2005-08-30-RA-664; Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253; Gerrish GA, 2003, FRESHWATER BIOL, V48, P1971, DOI 10.1046/j.1365-2427.2003.01136.x; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hader DP, 2015, PHOTOCH PHOTOBIO SCI, V14, P108, DOI 10.1039/c4pp90035a; Jansen M, 2013, ECOTOXICOLOGY, V22, P900, DOI 10.1007/s10646-013-1072-y; KARENTZ S, 1991, NATURE, V350, P28, DOI 10.1038/350028b0; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MACISAAC HJ, 1991, FRESHWATER BIOL, V25, P189, DOI 10.1111/j.1365-2427.1991.tb00484.x; Maguire SE, 2014, J BIOL RHYTHM, V29, P167, DOI 10.1177/0748730414537801; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; Meyer-Rochow V B, 2000, Int J Circumpolar Health, V59, P38; Miner BE, 2015, MOL ECOL, V24, P6177, DOI 10.1111/mec.13460; Mitchell David L., 1993, P345; Overholt EP, 2016, J PLANKTON RES, V38, P16, DOI 10.1093/plankt/fbv113; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Paull SH, 2014, ECOL LETT, V17, P445, DOI 10.1111/ele.12244; Riessen HP, 1999, CAN J FISH AQUAT SCI, V56, P2487, DOI 10.1139/cjfas-56-12-2487; SPITZE K, 1992, AM NAT, V139, P229, DOI 10.1086/285325; Stoeckel JA, 2008, ENVIRON TOXICOL CHEM, V27, P2352, DOI 10.1897/07-564.1; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; United States Environmental Protection Agency Office of Research and Development, 1990, METH MEAS AC TOX EFF; Williamson CE, 2001, ECOL APPL, V11, P1843, DOI 10.1890/1051-0761(2001)011[1843:BADEOU]2.0.CO;2; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603	35	3	3	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159628	10.1371/journal.pone.0159628	http://dx.doi.org/10.1371/journal.pone.0159628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434210	gold, Green Published, Green Submitted			2022-12-26	WOS:000380169600077
J	Gao, F; Liu, XX; Wang, XZ; Chen, SH; Shi, JH; Zhang, Y; Wu, SL; Cai, J				Gao, Fei; Liu, Xiaoxue; Wang, Xizhu; Chen, Shouhua; Shi, Jihong; Zhang, Ying; Wu, Shouling; Cai, Jun			Changes in Cardiovascular Health Status and the Risk of New-Onset Hypertension in Kailuan Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; URIC-ACID LEVELS; ASSOCIATION; PREVALENCE; INFLAMMATION; POPULATION; MORTALITY; METRICS; IMPACT	American Heart Association cardiovascular health metrics are intimately related to cardiovascular diseases. Acting as a key independent risk factor for high morbidity and mortality of cardiovascular diseases, hypertension and its relationship between health status get urgent attention. While the influence of individual health status changes and the future risk of new-onset hypertension is rarely understood, the present study applied this construct to assess the changes of cardiovascular health status and the morbidity of hypertension in Kailuan cohort study in north China. The Cardiovascular Health Score (CHS) was evaluated by the follow-ups of 2006-2007, 2008-2009, 2010-2011 and 2012-2013. The study population (n = 19381) was divided into 5 groups based on the changes in their CHS score between the first two follow-ups (Delta CHS) of 2006-2007 and 2008-2009 (<=-2, -1, 0, 1, >= 2). The morbidity of hypertension was collected during 2010-2011 and 2012-2013 follow-ups. Data analysis showed that during a median follow-up of 3.79 +/- 0.96 years, morbidity of hypertension had a graded relationship with Delta CHS. As Delta CHS scored from low to high, the standardized morbidity of hypertension for all participants were 81.40, 75.47, 68.37, 71.43 and 83.13 per 1000 person-year, respectively. An increased Delta CHS score of 1 was associated with a 10% decrease in the future risk of new-onset hypertension(HR: 0.90, 95% CI: 0.88-0.92). In conclusion, there was a strong inverse relationship between the incidence of new-onset hypertension and elevation of cardiovascular health metrics. Population-wide prevention, especially the promotion of lifestyle improvements, is critical to reducing the morbidity of new-onset hypertension.	[Gao, Fei] Univ Hong Kong, LKS Fac Med, Dept Opthalmol, Hong Kong, Hong Kong, Peoples R China; [Liu, Xiaoxue; Wang, Xizhu] North China Univ Sci & Technol, Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China; [Chen, Shouhua] North China Univ Sci & Technol, Kailuan Hosp, Dept Hlth Care Ctr, Tangshan, Peoples R China; [Shi, Jihong; Wu, Shouling] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Zhang, Ying] North China Univ Sci & Technol, Hosp, Dept Ultrasonog, Tangshan, Peoples R China; [Cai, Jun] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China; [Cai, Jun] Peking Union Med Coll, Beijing, Peoples R China	University of Hong Kong; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, SL (corresponding author), North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.; Cai, J (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Hyertens, Beijing, Peoples R China.; Cai, J (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	drwusl@163.com; caijun@fuwaihospital.org			National Basic Research Program of China [2014CB542302]; International S&T Cooperation Program of China [2013DFB30310]; Natural Science Foundation of China [811170244, 81222001, 81470541]	National Basic Research Program of China(National Basic Research Program of China); International S&T Cooperation Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Basic Research Program of China (2014CB542302) http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm, International S&T Cooperation Program of China (2013DFB30310), http://www.istcp.org.cn/, Natural Science Foundation of China (811170244, 81222001, 81470541) http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatola H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000532; Crichton GE, 2014, J HUM HYPERTENS, V28, P444, DOI 10.1038/jhh.2013.131; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Du TT, 2014, EUR J INTERN MED, V25, P388, DOI 10.1016/j.ejim.2014.03.004; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Gao JS, 2015, CLIN EXP HYPERTENS, V37, P650, DOI 10.3109/10641963.2015.1047938; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Huffman MD, 2013, CIRCULATION, V127, P2477, DOI 10.1161/CIRCULATIONAHA.112.000769; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Kim Ji Young, 2013, J Prev Med Public Health, V46, P319, DOI 10.3961/jpmph.2013.46.6.319; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Kulshreshtha A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000282; Lachman S, 2016, EUR J PREV CARDIOL, V23, P986, DOI 10.1177/2047487315602015; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Laitinen TT, 2012, CIRCULATION, V125, P1971, DOI 10.1161/CIRCULATIONAHA.111.073585; Li ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep11564; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu XF, 2014, HYPERTENS RES, V37, P685, DOI 10.1038/hr.2014.58; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Maclagan LC, 2015, CURR OPIN CARDIOL, V30, P518, DOI 10.1097/HCO.0000000000000210; Ogagarue ER, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000430; Pahkala K, 2013, CIRCULATION, V127, P2088, DOI 10.1161/CIRCULATIONAHA.112.000761; Qin L, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-26; Rasmussen-Torvik LJ, 2013, CIRCULATION, V127, P1270, DOI 10.1161/CIRCULATIONAHA.112.001183; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Still CH, 2015, J AM GERIATR SOC, V63, P2130, DOI 10.1111/jgs.13672; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Xue H, 2014, CLIN CHEM LAB MED, V52, P1379, DOI 10.1515/cclm-2013-0657; Xue H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081597; Yanes LL, 2011, CURR TOP MED CHEM, V11, P1736; Ye CL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1230; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]	40	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158869	10.1371/journal.pone.0158869	http://dx.doi.org/10.1371/journal.pone.0158869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434049	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169600019
J	Goldman, N; Glei, DA; Weinstein, M				Goldman, Noreen; Glei, Dana A.; Weinstein, Maxine			What Matters Most for Predicting Survival? A Multinational Population-Based Cohort Study	PLOS ONE			English	Article							MULTIPLE IMPUTATION; PHYSICIANS; HEALTH	Despite myriad efforts among social scientists, epidemiologists, and clinicians to identify variables with strong linkages to mortality, few researchers have evaluated statistically the relative strength of a comprehensive set of predictors of survival. Here, we determine the strongest predictors of five-year mortality in four national, prospective studies of older adults. We analyze nationally representative surveys of older adults in four countries with similar levels of life expectancy: England (n = 6113, ages 52+), the US (n = 2023, ages 50+), Costa Rica (n = 2694, ages 60+), and Taiwan (n = 1032, ages 53+). Each survey includes a broad set of demographic, social, health, and biological variables that have been shown previously to predict mortality. We rank 57 predictors, 25 of which are available in all four countries, net of age and sex. We use the area under the receiver operating characteristic curve and assess robustness with additional discrimination measures. We demonstrate consistent findings across four countries with different cultural traditions, levels of economic development, and epidemiological transitions. Self-reported measures of instrumental activities of daily living limitations, mobility limitations, and overall self-assessed health are among the top predictors in all four samples. C-reactive protein, additional inflammatory markers, homocysteine, serum albumin, three performance assessments (gait speed, grip strength, and chair stands), and exercise frequency also discriminate well between decedents and survivors when these measures are available. We identify several promising candidates that could improve mortality prediction for both population-based and clinical populations. Better prognostic tools are likely to provide researchers with new insights into the behavioral and biological pathways that underlie social stratification in health and may allow physicians to have more informed discussions with patients about end-of-life treatment and priorities.	[Goldman, Noreen] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; [Glei, Dana A.; Weinstein, Maxine] Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA	Princeton University; Georgetown University	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA.	dag77@georgetown.edu		Goldman, Noreen/0000-0003-2865-9491	National Institute on Aging [R01AG16790, R01AG16661]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P2CHD047879]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016790] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (www.nia.nih.gov) [grant numbers R01AG16790 (Princeton University, N.G. as PI), R01AG16661 (Georgetown University, M.W. as PI)] and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) [grant number P2CHD047879]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; [Anonymous], 1999, DEATH FORETOLD PROPH; Belloc NB, 1973, PREV MED, V2, P67; CALKINS DR, 1991, ANN INTERN MED, V114, P451, DOI 10.7326/0003-4819-114-6-451; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Crimmins E, 2010, DEMOGRAPHY, V47, pS41, DOI 10.1353/dem.2010.0005; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Hurd MD, 2001, THEMES EC AGING, P171; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; PARKES CM, 1972, BRIT MED J, V2, P29, DOI 10.1136/bmj.2.5804.29; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; The World Bank, LIF EXP BIRTH TOT YE; Todd MA, 2013, EPIDEMIOLOGY, V24, P913, DOI 10.1097/EDE.0b013e3182a713a8; University of California, HUMAN MORTALITY DATA; Weinstein M, 2007, BIOSOCIAL SURVEYS; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	22	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159273	10.1371/journal.pone.0159273	http://dx.doi.org/10.1371/journal.pone.0159273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434271	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169600045
J	Rodrigues-de-Souza, DP; Palacios-Cena, D; Moro-Gutierrez, L; Camargo, PR; Salvini, TF; Alburquerque-Sendin, F				Priscila Rodrigues-de-Souza, Daiana; Palacios-Cena, Domingo; Moro-Gutierrez, Lourdes; Camargo, Paula Rezende; Salvini, Tania Fatima; Alburquerque-Sendin, Francisco			Socio-Cultural Factors and Experience of Chronic Low Back Pain: a Spanish and Brazilian Patients' Perspective. A Qualitative Study	PLOS ONE			English	Article							PRIMARY-CARE; HEALTH; BELIEFS; MANAGEMENT; IMPACT; DISABILITY; NECK; POPULATIONS; PERCEPTIONS; INTERVIEWS	Background Low back pain (LBP) could be influenced by socio-cultural factors. Pain narratives are important to understand the influence of environment on patients with chronic LBP. There are few studies that have explored the experience of patients with chronic LBP in different socio-cultural environments. The aim of this study was to describe the experience of patients with chronic LBP in Spain and Brazil. Methods A qualitative phenomenology approach was implemented. Chronic LBP patients from the University Hospital of Salamanca (Spain), and/or Federal University of Sao Carlos (Brazil) were included, using purposeful sampling. Data were collected from 22 Spanish and 26 Brazilian patients during in-depth interviews and using researchers' field notes and patients' personal diaries and letters. A thematic analysis was performed and the guidelines for reporting qualitative research were applied. Results Forty-eight patients with a mean age of 50.7 years (SD: +/- 13.1 years) were included in the study. The themes identified included: a) ways of perceiving and expressing pain-the participants focused constantly on their pain and anything outside it was considered secondary; b) the socio-familial environment as a modulator of pain-most participants stated that no one was able to understand the pain they were experiencing; c) religion as a modulator of pain-all Brazilian patients stated that religious belief affected the experience of pain; and d) socio-economic and educational status as a modulator of pain-the study reported that economic factors influenced the experience of pain. Conclusions The influences of LBP can be determined based on the how a patient defines pain. Religion can be considered as a possible mechanism for patients to manage pain and as a form of solace.	[Priscila Rodrigues-de-Souza, Daiana] Catholic Univ Avila, Dept Phys Therapy, Avila, Spain; [Palacios-Cena, Domingo] Rey Juan Carlos Univ, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Madrid, Spain; [Moro-Gutierrez, Lourdes] Univ Salamanca, Dept Social Psychol & Anthropol, Salamanca, Spain; [Camargo, Paula Rezende; Salvini, Tania Fatima] Univ Fed Sao Carlos, Dept Phys Therapy, Sao Paulo, Brazil; [Alburquerque-Sendin, Francisco] Univ Salamanca, Dept Nursing & Phys Therapy, Biomed Res Inst Salamanca IBSAL, Salamanca, Spain	Santa Teresa Jesus Catholic University of Avila; Universidad Rey Juan Carlos; University of Salamanca; Universidade Federal de Sao Carlos; University of Salamanca	Alburquerque-Sendin, F (corresponding author), Univ Salamanca, Dept Nursing & Phys Therapy, Biomed Res Inst Salamanca IBSAL, Salamanca, Spain.	pacoalbu@usal.es	PALACIOS-CEÑA, DOMINGO/B-6944-2015; Salvini, Tania F/G-4349-2012; Rodrigues-de-Souza, Daiana Priscila/AAO-7843-2021; Camargo, Paula R/G-8782-2012; Moro, Lourdes/AAQ-7019-2021; Alburquerque-Sendín, Francisco/L-1539-2016	PALACIOS-CEÑA, DOMINGO/0000-0003-0669-6339; Salvini, Tania F/0000-0002-6353-6393; Rodrigues-de-Souza, Daiana Priscila/0000-0002-3651-3276; Camargo, Paula R/0000-0002-8961-4353; Alburquerque-Sendín, Francisco/0000-0002-3892-8440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) SP, Brazil [2015/50303-5]; University of Salamanca, Spain [8247/463AB08]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) SP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Salamanca, Spain	The study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP/Processes: 2015/50303-5) SP, Brazil and the University of Salamanca (process: 8247/463AB08), Spain.	Abasolo L, 2012, RHEUMATOL INT, V32, P3831, DOI 10.1007/s00296-011-2264-5; Arcanjo GN, 2007, CIENC SAUDE COLETIVA, V12, P389, DOI 10.1590/S1413-81232007000200015; Baetz M, 2008, PAIN RES MANAG, V13, P383, DOI 10.1155/2008/263751; Bailly F, 2015, JOINT BONE SPINE, V82, P437, DOI 10.1016/j.jbspin.2015.02.019; Montekio VB, 2011, SALUD PUBLICA MEXICO, V53, pS120; Bishop FL, 2015, SPINE, V40, P1842, DOI 10.1097/BRS.0000000000001215; Borrego PS, 2005, FISIOTERAPIA, V27, P250; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briggs AM, 2010, PAIN, V150, P275, DOI 10.1016/j.pain.2010.04.031; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Cano A, 2014, DISABIL REHABIL, V36, P1713, DOI 10.3109/09638288.2013.869625; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Cohen DJ, 2008, ANN FAM MED, V6, P331, DOI 10.1370/afm.818; Coyle N, 2007, PAIN MED, V8, P205, DOI 10.1111/j.1526-4637.2007.00303.x; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Darlow B, 2015, SPINE, V40, P842, DOI 10.1097/BRS.0000000000000901; Darlow B, 2014, FAM PRACT, V31, P723, DOI 10.1093/fampra/cmu051; De Souza L, 2011, DISABIL REHABIL, V33, P310, DOI 10.3109/09638288.2010.490865; Dean SG, 2011, J OCCUP REHABIL, V21, P395, DOI 10.1007/s10926-010-9275-z; Dezutter J, 2010, PAIN MED, V11, P765, DOI 10.1111/j.1526-4637.2010.00827.x; Dezutter J, 2009, INT J PSYCHIAT MED, V39, P393, DOI 10.2190/PM.39.4.d; Dima A, 2013, BRIT J GEN PRACT, V63, pE490, DOI 10.3399/bjgp13X669211; Duggleby Wendy, 2003, Home Healthc Nurse, V21, P174, DOI 10.1097/00004045-200303000-00013; Eaves ER, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0531-9; Fernandez-de-las-Penas C, 2013, SPINE J, V13, P1069, DOI 10.1016/j.spinee.2013.02.064; Fernandez-de-las-Penas C, 2011, SPINE, V36, pE213, DOI 10.1097/BRS.0b013e3181d952c2; Froud R, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-50; Haanstra TM, 2013, EUR SPINE J, V22, P1986, DOI 10.1007/s00586-013-2803-8; Hestbaek L, 2008, EUR SPINE J, V17, P1727, DOI 10.1007/s00586-008-0796-5; Heuch I, 2013, J PHYSIOTHER, V59, P127, DOI 10.1016/S1836-9553(13)70166-8; Holmberg SAC, 2010, ANN AGR ENV MED, V17, P251; Holt N, 2015, BRIT J GEN PRACT, V65, pE692, DOI 10.3399/bjgp15X686953; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jones RK, 2000, QUAL HEALTH RES, V10, P555, DOI 10.1177/104973200129118543; Kligler B, 2015, J ALTERN COMPLEM MED, V21, P713, DOI 10.1089/acm.2014.0376; Langridge N, 2015, MANUAL THER, V20, P745, DOI 10.1016/j.math.2015.01.005; Larsen EL, 2013, DISABIL REHABIL, V35, P819, DOI 10.3109/09638288.2012.709302; Lin IB, 2012, EUR J PAIN, V16, P1331, DOI 10.1002/j.1532-2149.2012.00128.x; MacNeela P, 2015, HEALTH PSYCHOL REV, V9, P63, DOI 10.1080/17437199.2013.840951; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Matthias MS, 2012, PAIN MED, V13, P1018, DOI 10.1111/j.1526-4637.2012.01433.x; Costa LDM, 2012, CAN MED ASSOC J, V184, pE613, DOI 10.1503/cmaj.111271; Meucci RD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-155; Ministerio de Sanidad Servicios Sociales e Igualdad, 2012, SIST NAC SAL; Mullersdorf M, 2011, SCAND J CARING SCI, V25, P637, DOI 10.1111/j.1471-6712.2011.00872.x; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; Myburgh C, 2015, J REHABIL MED, V47, P741, DOI 10.2340/16501977-1987; Perez-Agote A., 2012, CAMBIO RELIG ESPANA; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Rippentrop AE, 2005, PAIN, V116, P311, DOI 10.1016/j.pain.2005.05.008; Scheermesser M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-5; Shaw WS, 2013, BEST PRACT RES CL RH, V27, P637, DOI 10.1016/j.berh.2013.09.012; Shipton EA, 2013, NEW ZEAL MED J, V126, P7; Sloots M, 2010, J REHABIL MED, V42, P566, DOI 10.2340/16501977-0536; Snelgrove S, 2013, CHRONIC ILLN, V9, P283, DOI 10.1177/1742395313476901; Stisen DB, 2016, DISABIL REHABIL, V38, P307, DOI 10.3109/09638288.2015.1037465; Suto, 2008, QUALITATIVE RES OCCU; Tavafian SS, 2008, HEALTH CARE WOMEN IN, V29, P339, DOI 10.1080/07399330701876356; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Urquhart DM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-148; van Nes F, 2010, EUR J AGEING, V7, P313, DOI 10.1007/s10433-010-0168-y; Vianin M, 2008, J CHIROPR MED, V7, P161, DOI 10.1016/j.jcm.2008.07.001; Vigatto R, 2007, SPINE, V32, P481, DOI 10.1097/01.brs.0000255075.11496.47; Wachholtz AB, 2009, CURR PAIN HEADACHE R, V13, P127, DOI 10.1007/s11916-009-0022-0; Webster LR, 2013, PAIN MED, V14, P1811, DOI 10.1111/pme.12291	67	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159554	10.1371/journal.pone.0159554	http://dx.doi.org/10.1371/journal.pone.0159554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434594	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600070
J	Raggi, A; Corso, B; Minicuci, N; Quintas, R; Sattin, D; De Torres, L; Chatterji, S; Frisoni, GB; Haro, JM; Koskinen, S; Martinuzzi, A; Miret, M; Tobiasz-Adamczyk, B; Leonardi, M				Raggi, Alberto; Corso, Barbara; Minicuci, Nadia; Quintas, Rui; Sattin, Davide; De Torres, Laura; Chatterji, Somnath; Frisoni, Giovanni Battista; Haro, Josep Maria; Koskinen, Seppo; Martinuzzi, Andrea; Miret, Marta; Tobiasz-Adamczyk, Beata; Leonardi, Matilde			Determinants of Quality of Life in Ageing Populations: Results from a Cross-Sectional Study in Finland, Poland and Spain	PLOS ONE			English	Article							OLDER-ADULTS; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; COLLABORATIVE RESEARCH; ELDERLY POPULATION; VISUAL IMPAIRMENT; CHRONIC DISEASES; SOCIAL NETWORK; HEALTH-STATUS; IMPACT	Purpose To comprehensively identify the determinants of quality of life (QoL) in a population study sample of persons aged 18-50 and 50+. Methods In this observational, cross-sectional study, QoL was measured with the WHOQOL-AGE, a brief instrument designed to measure QoL in older adults. Eight hierarchical regression models were performed to identify determinants of QoL. Variables were entered in the following order: Sociodemographic; Health Habits; Chronic Conditions; Health State description; Vision and Hearing; Social Networks; Built Environment. In the final model, significant variables were retained. The final model was re-run using data from the three countries separately. Results Complete data were available for 5639 participants, mean age 46.3 (SD 18.4). The final model accounted for 45% of QoL variation and the most relevant contribution was given by sociodemographic data (particularly age, education level and living in Finland: 17.9% explained QoL variation), chronic conditions (particularly depression: 4.6%) and a wide and rich social network (4.6%). Other determinants were presence of disabling pain, learning difficulties and visual problems, and living in usable house that is perceived as non-risky. Some variables were specifically associated to QoL in single countries: age in Poland, alcohol consumption in Spain, angina in Finland, depression in Spain, and self-reported sadness both in Finland and Poland, but not in Spain. Other were commonly associated to QoL: smoking status, bodily aches, being emotionally affected by health problems, good social network and home characteristics. Conclusions Our results highlight the importance of modifiable determinants of QoL, and provide public health indications that could support concrete actions at country level. In particular, smoking cessation, increasing the level of physical activity, improving social network ties and applying universal design approach to houses and environmental infrastructures could potentially increase QoL of ageing population.	[Raggi, Alberto; Quintas, Rui; Sattin, Davide; De Torres, Laura; Leonardi, Matilde] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Corso, Barbara; Minicuci, Nadia] CNR, Inst Neurosci, Padua, Italy; [Chatterji, Somnath] WHO, Informat Evidence & Res Unit, Geneva, Switzerland; [Frisoni, Giovanni Battista] IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Lab Alzheimers Neuroimaging & Epidemiol, Brescia, Italy; [Frisoni, Giovanni Battista] Univ Hosp, Memory Clin, Geneva, Switzerland; [Frisoni, Giovanni Battista] Univ Hosp, LANVIE, Geneva, Switzerland; [Frisoni, Giovanni Battista] Univ Geneva, Geneva, Switzerland; [Haro, Josep Maria] Univ Barcelona, CIBERSAM, Parc Sanitari St Joan Deu, Barcelona, Spain; [Koskinen, Seppo] Natl Inst Hlth & Welf, Populat Hlth Res Unit, Helsinki, Finland; [Martinuzzi, Andrea] E Medea Sci Inst, Conegliano Pieve Soligo Res Ctr, Conegliano, Italy; [Miret, Marta] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Haro, Josep Maria; Miret, Marta] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain; [Miret, Marta] Hosp Univ Princesa, Inst Invest Sanitaria Princesa IP, Dept Psychiat, Madrid, Spain; [Tobiasz-Adamczyk, Beata] Jagiellonian Univ, Coll Med, Dept Med Sociol, Chair Epidemiol & Prevent Med, Krakow, Poland	Consiglio Nazionale delle Ricerche (CNR); World Health Organization; IRCCS Fatebenefratelli; University of Geneva; University of Geneva; University of Geneva; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Finland National Institute for Health & Welfare; IRCCS Eugenio Medea; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Jagiellonian University; Collegium Medicum Jagiellonian University	Raggi, A (corresponding author), Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Milan, Italy.	alberto.raggi@istituto-besta.it	Sattin, Davide/K-5963-2016; Haro, Josep Maria/D-1423-2011; Miret, Marta/C-6103-2019; leonardi, matilde/J-9997-2018; CHATTERJI, Somnath/ABE-6832-2020; MINICUCI, NADIA/D-5237-2016; Raggi, Alberto/K-5787-2016; Frisoni, Giovanni B./K-1360-2016; Corso, Barbara/P-1796-2018; Quintas, Rui/AAJ-6630-2021; Martinuzzi, Andrea/K-3887-2016	Sattin, Davide/0000-0001-7736-4337; Haro, Josep Maria/0000-0002-3984-277X; Miret, Marta/0000-0003-3252-854X; leonardi, matilde/0000-0003-0552-8923; MINICUCI, NADIA/0000-0002-0970-6531; Raggi, Alberto/0000-0002-7433-7779; Frisoni, Giovanni B./0000-0002-6419-1753; Corso, Barbara/0000-0002-0684-9078; Quintas, Rui/0000-0002-9985-334X; Martinuzzi, Andrea/0000-0002-0319-3579	European Commission [HEALTH-F2-2009-223071]; Commission's Seventh Framework Programme under REA grant [316795]	European Commission(European CommissionEuropean Commission Joint Research Centre); Commission's Seventh Framework Programme under REA grant	The authors acknowledge funding from the European Commission's Seventh Framework Programme, project no HEALTH-F2-2009-223071 (COURAGE in Europe), and from the Commission's Seventh Framework Programme under REA grant agreement no 316795 (MARATONE). AR takes full responsibility for the data, the analysis, the interpretation, and the conduct of the research. AR has full access to all of the data. All authors report no conflicts of interest. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors, and do not necessarily represent the views or policies of the World Health Organization.	Allen J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-140; Araya R, 2007, BRIT J PSYCHIAT, V190, P394, DOI 10.1192/bjp.bp.106.024596; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bernfort L, 2015, PAIN, V156, P521, DOI 10.1097/01.j.pain.0000460336.31600.01; Bookwala J, 2011, J GERONTOL B-PSYCHOL, V66, P605, DOI 10.1093/geronb/gbr091; Borglin G, 2006, HEALTH SOC CARE COMM, V14, P136, DOI 10.1111/j.1365-2524.2006.00603.x; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Carta Mauro Giovanni, 2012, Clin Pract Epidemiol Ment Health, V8, P169, DOI 10.2174/1745017901208010169; Cash SW, 2013, QUAL LIFE RES, V22, P2381, DOI 10.1007/s11136-013-0389-6; Chia EM, 2004, INVEST OPHTH VIS SCI, V45, P71, DOI 10.1167/iovs.03-0661; Dale CE, 2013, AGE AGEING, V42, P312, DOI 10.1093/ageing/aft029; Dey M, 2014, QUAL LIFE RES, V23, P1009, DOI 10.1007/s11136-013-0524-4; du Toit R, 2010, OPHTHALMOLOGY, V117, P2308, DOI 10.1016/j.ophtha.2010.03.041; Caballero FF, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-177; Fernandez-Martinez B, 2012, REV SAUDE PUBL, V46, P310, DOI 10.1590/S0034-89102012000200013; Finger RP, 2011, INVEST OPHTH VIS SCI, V52, P3613, DOI 10.1167/iovs.10-7127; Garcia EL, 2005, QUAL LIFE RES, V14, P511, DOI 10.1007/s11136-004-5329-z; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; Garin Noe, 2014, Clin Pract Epidemiol Ment Health, V10, P103, DOI 10.2174/1745017901410010103; Georgellis Y, 2009, SOC INDIC RES, V91, P329, DOI 10.1007/s11205-008-9344-2; Gill Diane L, 2013, J Prev Med Public Health, V46 Suppl 1, pS28, DOI 10.3961/jpmph.2013.46.S.S28; Goldenberg M, 2014, AM J ADDICTION, V23, P540, DOI 10.1111/j.1521-0391.2014.12148.x; Gureje O, 2007, CURR OPIN PSYCHIATR, V20, P42, DOI 10.1097/YCO.0b013e328010ddf4; Han KT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0109-0; Herman KM, 2012, MED SCI SPORT EXER, V44, P625, DOI 10.1249/MSS.0b013e31823a90ae; Hider SL, 2015, EUR SPINE J, V24, P444, DOI 10.1007/s00586-014-3355-2; Hunger M, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-53; Jespersen L, 2013, CLIN RES CARDIOL, V102, P571, DOI 10.1007/s00392-013-0568-z; Jivraj S, 2014, QUAL LIFE RES, V23, P2545, DOI 10.1007/s11136-014-0694-8; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Kim SY, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-68; Konnopka A, 2009, VALUE HEALTH, V12, P253, DOI 10.1111/j.1524-4733.2008.00444.x; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lacey RJ, 2014, RHEUMATOLOGY, V53, P2071, DOI 10.1093/rheumatology/keu240; Layte R, 2013, J AM GERIATR SOC, V61, pS299, DOI 10.1111/jgs.12198; Leonardi M, 2014, CLIN PSYCHOL PSYCHOT, V21, P193, DOI 10.1002/cpp.1856; Lin CH, 2014, J AFFECT DISORDERS, V166, P173, DOI 10.1016/j.jad.2014.03.039; Lopez D, 2011, MATURITAS, V69, P359, DOI 10.1016/j.maturitas.2011.05.006; Low G, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-146; Luthy C, 2015, QUAL LIFE RES, V24, P1687, DOI 10.1007/s11136-014-0894-2; Mielck A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-58; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Ohayon MM, 2010, J PSYCHIATR RES, V44, P454, DOI 10.1016/j.jpsychires.2009.10.013; Organization WH, 2015, SUMM WORLD REP AG HL; Parker L, 2014, FAM PRACT, V31, P557, DOI 10.1093/fampra/cmu035; Parra DC, 2010, SOC SCI MED, V70, P1070, DOI 10.1016/j.socscimed.2009.12.024; Perales F, 2014, QUAL LIFE RES, V23, P1921, DOI 10.1007/s11136-014-0645-4; Raggi A, 2014, CLIN PSYCHOL PSYCHOT, V21, P215, DOI 10.1002/cpp.1859; Raggi A, 2014, QUAL LIFE RES, V23, P1273, DOI 10.1007/s11136-013-0556-9; Renalds A, 2010, FAM COMMUNITY HEALTH, V33, P68, DOI 10.1097/FCH.0b013e3181c4e2e5; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Saatcioglu O, 2008, DRUG ALCOHOL REV, V27, P83, DOI 10.1080/09595230701711140; Seland JH, 2011, ACTA OPHTHALMOL, V89, P608, DOI 10.1111/j.1755-3768.2009.01794.x; Soulet D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053942; Strine TW, 2008, J COMMUN HEALTH, V33, P40, DOI 10.1007/s10900-007-9066-4; Subramanian SV, 2006, J GERONTOL B-PSYCHOL, V61, pS153, DOI 10.1093/geronb/61.3.S153; Switaj P, 2012, TRANSCULT PSYCHIATRY, V49, P51, DOI 10.1177/1363461511433143; Thompson WW, 2012, AM J PUBLIC HEALTH, V102, P496, DOI 10.2105/AJPH.2011.300500; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POPULATION AGE; Ustun T.B., 2005, HOUSEHOLD SAMPLE SUR, P199; Valencia-Martin JL, 2013, PREV MED, V57, P703, DOI 10.1016/j.ypmed.2013.09.007; Van Dijk AP, 2004, J STUD ALCOHOL, V65, P241, DOI 10.15288/jsa.2004.65.241; Vogl M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-203; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; *WHO, 2002, INT GUID MON ALC CON; World Health Organization, 2015, WHO GUID TRANSL AD I, P4; World Health Organization (WHO), 2015, PHYS ACTIVITY; World Health Organization (WHO), 2011, WAIST CIRCUMFERENCE; Zawisza K, 2014, CLIN PSYCHOL PSYCHOT, V21, P227, DOI 10.1002/cpp.1860	70	49	50	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0159293	10.1371/journal.pone.0159293	http://dx.doi.org/10.1371/journal.pone.0159293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR8TG	27434374	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169600046
J	Urbanek, K; De Angelis, A; Spaziano, G; Piegari, E; Matteis, M; Cappetta, D; Esposito, G; Russo, R; Tartaglione, G; De Palma, R; Rossi, F; D'Agostino, B				Urbanek, Konrad; De Angelis, Antonella; Spaziano, Giuseppe; Piegari, Elena; Matteis, Maria; Cappetta, Donato; Esposito, Grazia; Russo, Rosa; Tartaglione, Gioia; De Palma, Raffaele; Rossi, Francesco; D'Agostino, Bruno			Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model	PLOS ONE			English	Article							ACUTE LUNG INJURY; STROMAL CELLS; BONE-MARROW; RECEPTOR ANTAGONIST; INDUCED BRONCHOCONSTRICTION; ASTHMATIC-PATIENTS; ALLERGIC-ASTHMA; T-LYMPHOCYTES; MURINE MODEL; IFN-GAMMA	Background The need for new options for chronic lung diseases promotes the research on stem cells for lung repair. Bone marrow-derived mesenchymal stem cells (MSCs) can modulate lung inflammation, but the data on cellular processes involved in early airway remodeling and the potential involvement of neuropeptides are scarce. Objectives To elucidate the mechanisms by which local administration of MSCs interferes with pathophysiological features of airway hyperresponsiveness in an animal model. Methods GFP-tagged mouse MSCs were intratracheally delivered in the ovalbumin mouse model with subsequent functional tests, the analysis of cytokine levels, neuropeptide expression and histological evaluation of MSCs fate and airway pathology. Additionally, MSCs were exposed to pro-inflammatory factors in vitro. Results Functional improvement was observed after MSC administration. Although MSCs did not adopt lung cell phenotypes, cell therapy positively affected airway remodeling reducing the hyperplastic phase of the gain in bronchial smooth muscle mass, decreasing the proliferation of epithelium in which mucus metaplasia was also lowered. Decrease of interleukin-4, interleukin-5, interleukin-13 and increase of interleukin-10 in bronchoalveolar lavage was also observed. Exposed to pro-inflammatory cytokines, MSCs upregulated indoleamine 2,3-dioxygenase. Moreover, asthma-related in vivo upregulation of pro-inflammatory neurokinin 1 and neurokinin 2 receptors was counteracted by MSCs that also determined a partial restoration of VIP, a neuropeptide with anti-inflammatory properties. Conclusion Intratracheally administered MSCs positively modulate airway remodeling, reduce inflammation and improve function, demonstrating their ability to promote tissue homeostasis in the course of experimental allergic asthma. Because of a limited tissue retention, the functional impact of MSCs may be attributed to their immunomodulatory response combined with the interference of neuropeptide system activation and tissue remodeling.	[Urbanek, Konrad; De Angelis, Antonella; Spaziano, Giuseppe; Piegari, Elena; Matteis, Maria; Cappetta, Donato; Esposito, Grazia; Russo, Rosa; Tartaglione, Gioia; Rossi, Francesco; D'Agostino, Bruno] Univ Naples 2, Pharmacol Sect, Dept Expt Med, Naples, Italy; [De Palma, Raffaele] Univ Naples 2, Dept Clin & Expt Med, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	De Angelis, A; D'Agostino, B (corresponding author), Univ Naples 2, Pharmacol Sect, Dept Expt Med, Naples, Italy.	antonella.deangelis@unina2.it; bruno.dagostino@unina2.it	SPAZIANO, GIUSEPPE/H-9202-2016; Piegari, Elena/ABG-7510-2020	SPAZIANO, GIUSEPPE/0000-0002-1906-5109; D'AGOSTINO, Bruno/0000-0002-7220-7962	Scientific Publications Fund of SUN [5 14.06.16]	Scientific Publications Fund of SUN	This work was supported by Scientific Publications Fund of SUN n. 5 14.06.16.	Abreu SC, 2013, RESP PHYSIOL NEUROBI, V187, P190, DOI 10.1016/j.resp.2013.03.014; BAI TR, 1995, AM J PHYSIOL-LUNG C, V269, pL309, DOI 10.1152/ajplung.1995.269.3.L309; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Bonfield TL, 2010, AM J PHYSIOL-LUNG C, V299, pL760, DOI 10.1152/ajplung.00182.2009; Burian Bernhard, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P344; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; D'Agostino B, 2002, CLIN EXP ALLERGY, V32, P472, DOI 10.1046/j.1365-2222.2002.01328.x; D'Agostino B, 2010, EXPERT OPIN BIOL TH, V10, P681, DOI 10.1517/14712591003610614; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Duong KM, 2015, AM J RESP CELL MOL, V53, P615, DOI 10.1165/rcmb.2014-0431OC; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P879, DOI 10.1164/ajrccm.152.3.7663799; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Firinci F, 2011, INT IMMUNOPHARMACOL, V11, P1120, DOI 10.1016/j.intimp.2011.03.009; Gallelli L, 2003, LIFE SCI, V72, P1135, DOI 10.1016/S0024-3205(02)02372-X; Garbacki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016509; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Groneberg DA, 2004, ALLERGY, V59, P1139, DOI 10.1111/j.1398-9995.2004.00665.x; Guan CX, 2006, PEPTIDES, V27, P3107, DOI 10.1016/j.peptides.2006.08.004; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hoffman AM, 2011, STEM CELLS DEV, V20, P1779, DOI 10.1089/scd.2011.0105; Ichinose M, 1996, AM J RESP CRIT CARE, V153, P936, DOI 10.1164/ajrccm.153.3.8630576; ICHINOSE M, 1992, LANCET, V340, P1248, DOI 10.1016/0140-6736(92)92948-F; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; JAMES AL, 1988, AM REV RESPIR DIS, V138, P136, DOI 10.1164/ajrccm/138.1.136; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Kanki-Horimoto S, 2006, CIRCULATION, V114, pI181, DOI 10.1161/CIRCULATIONAHA.105.001487; Kobayashi M, 2012, EUR J IMMUNOL, V42, P393, DOI 10.1002/eji.201141845; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kraneveld AD, 2001, INT IMMUNOPHARMACOL, V1, P1629, DOI 10.1016/S1567-5769(01)00099-6; Lau AN, 2012, MOL THER, V20, P1116, DOI 10.1038/mt.2012.37; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Lynch EL, 2003, CYTOKINE GROWTH F R, V14, P489, DOI 10.1016/S1359-6101(03)00056-X; Mathias LJ, 2013, J IMMUNOL, V191, P5914, DOI 10.4049/jimmunol.1300667; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Oslund KL, 2009, TOXICOL PATHOL, V37, P805, DOI 10.1177/0192623309345691; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Ramalho R, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-41; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Raza K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109034; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Royce SG, 2015, STEM CELL RES, V15, P495, DOI 10.1016/j.scr.2015.09.007; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Shiomi T, 2014, FASEB J, V28, P5242, DOI 10.1096/fj.13-242735; Sinclair K, 2013, RESPIROLOGY, V18, P397, DOI 10.1111/resp.12050; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082367; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Squillaro T, 2015, CELL TRANSP IN PRESS; Sullo N, 2013, AM J PHYSIOL-LUNG C, V304, pL657, DOI 10.1152/ajplung.00358.2012; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Temelkovski J, 1998, THORAX, V53, P849, DOI 10.1136/thx.53.10.849; Trevor JL, 2014, ALLERGY, V69, P817, DOI 10.1111/all.12412; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Visweswaran M, 2015, INT J BIOCHEM CELL B, V68, P139, DOI 10.1016/j.biocel.2015.09.008; Walters MS, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-135; Weiss Daniel J, 2011, Proc Am Thorac Soc, V8, P223, DOI 10.1513/pats.201012-071DW; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Yao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129164; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504	76	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2016	11	7							e0158746	10.1371/journal.pone.0158746	http://dx.doi.org/10.1371/journal.pone.0158746			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TG	27434719	Green Published, gold, Green Submitted			2022-12-26	WOS:000380169600015
J	Fok, PW				Fok, Pak-Wing			Multi-Layer Mechanical Model of Glagov Remodeling in Coronary Arteries: Differences between In-Vivo and Ex-Vivo Measurements	PLOS ONE			English	Article							COMPENSATORY ENLARGEMENT; ATHEROSCLEROSIS; COLLAGEN; FLOW; WALL	When blood vessels undergo remodeling because of the buildup of atherosclerotic plaque, it is thought that they first undergo compensatory or outward remodeling, followed by inward remodeling: the lumen area stays roughly constant or increases slightly and then decreases rapidly. The second phase of remodeling is supposed to start after the plaque burden exceeds about 40%. These changes in the vessel were first observed by S. Glagov who examined cross-sections of coronary arteries at different stages of the disease. In this paper, we use a mathematical model based on growth and elasticity theory to verify the main aspects of Glagov's result. However, both our model and curve-fitting to the data suggest that the critical stenosis is around 20% rather than 40%. Our model and data from the PROSPECT trial also show that Glagov remodeling is qualitatively different depending on whether measurements are taken ex-vivo or in-vivo. Our results suggest that the first outward phase of "Glagov remodeling" is largely absent for in-vivo measurements: that is, the lumen area always decreases as plaque builds up. We advocate that care must be taken when infering how in-vivo vessels remodel from ex-vivo data.	[Fok, Pak-Wing] Univ Delaware, Dept Math Sci, Newark, DE 19716 USA	University of Delaware	Fok, PW (corresponding author), Univ Delaware, Dept Math Sci, Newark, DE 19716 USA.	pakwing@udel.edu			Simons Foundation [282579]	Simons Foundation	This work was supported by Simons Foundation Grant 282579 (https://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya RU, 2012, J MED SYST, V36, P1861, DOI 10.1007/s10916-010-9645-2; Akyildiz AC, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-25; Born G. V., 1990, PATHOBIOLOGY HUMAN A, P413; Fok PW, 2015, MATH MED BIOL; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Goriely A, 2009, LECT NOTES LES HOUCH, V92, P153, DOI [10.1093/acprof:oso/9780199605835.003.0006, DOI 10.1093/ACPROF:OSO/9780199605835.003.0006]; Hanke M, 2001, AM MATH MON, V108, P512, DOI 10.2307/2695705; Holzapfel GA, 2005, AM J PHYSIOL-HEART C, V289, pH2048, DOI 10.1152/ajpheart.00934.2004; Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P657, DOI 10.1115/1.1800557; Inaba S, 2014, CORONARY ARTERY DIS, V25, P98, DOI 10.1097/MCA.0000000000000074; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14, DOI 10.1152/ajpheart.1980.239.1.H14; Korshunov VA, 2004, CIRCULATION, V110, P220, DOI 10.1161/01.CIR.0000134958.88379.2E; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mulvany MJ, 2012, BASIC CLIN PHARMACOL, V110, P49, DOI 10.1111/j.1742-7843.2011.00758.x; Pijls NHJ, 2000, CIRCULATION, V102, P2371, DOI 10.1161/01.CIR.102.19.2371; SHEKHONIN BV, 1985, COLLAGEN REL RES, V5, P355; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Vandiver RM, 2015, J THEOR BIOL, V371, P1, DOI 10.1016/j.jtbi.2015.01.039; Vandiver RM., 2009, MORPHOELASTICITY MEC; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Ward MR, 2000, CIRCULATION, V102, P1186, DOI 10.1161/01.CIR.102.10.1186	23	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159304	10.1371/journal.pone.0159304	http://dx.doi.org/10.1371/journal.pone.0159304			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427954	Green Submitted, Green Published, gold			2022-12-26	WOS:000380169300046
J	Mendiratta, S; Bhatia, S; Jain, S; Kaur, T; Brahmachari, V				Mendiratta, Shweta; Bhatia, Shipra; Jain, Shruti; Kaur, Taniya; Brahmachari, Vani			Interaction of the Chromatin Remodeling Protein hINO80 with DNA	PLOS ONE			English	Article							ACTIN-RELATED PROTEINS; STRAND BREAK REPAIR; POLYCOMB RECRUITMENT; BINDING DOMAIN; INO80 COMPLEX; TRANSCRIPTION; DROSOPHILA; YY1; CHD1; CHROMODOMAIN	The presence of a highly conserved DNA binding domain in INO80 subfamily predicted that INO80 directly interacts with DNA and we demonstrated its DNA binding activity in vitro. Here we report the consensus motif recognized by the DBINO domain identified by SELEX method and demonstrate the specific interaction of INO80 with the consensus motif. We show that INO80 significantly down regulates the reporter gene expression through its binding motif, and the repression is dependent on the presence of INO80 but not YY1 in the cell. The interaction is lost if specific residues within the consensus motif are altered. We identify a large number of potential target sites of INO80 in the human genome through in silico analysis that can grouped into three classes; sites that contain the recognition sequence for INO80 and YY1, only YY1 and only INO80. We demonstrate the binding of INO80 to a representative set of sites in HEK cells and the correlated repressive histone modifications around the binding motif. In the light of the role of INO80 in homeotic gene regulation in Drosophila as an Enhancer of trithorax and polycomb protein (ETP) that can modify the effect of both repressive complexes like polycomb as well as the activating complex like trithorax, it remains to be seen if INO80 can act as a recruiter of chromatin modifying complexes.	[Mendiratta, Shweta; Bhatia, Shipra; Jain, Shruti; Kaur, Taniya; Brahmachari, Vani] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi, India; [Bhatia, Shipra] Univ Edinburgh, Inst Genet & Mol Med, Human Genet Unit, MRC, Edinburgh, Midlothian, Scotland	University of Delhi; University of Edinburgh	Brahmachari, V (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi, India.	vbrahmachari@acbr.du.ac.in		Kaur, Taniya/0000-0001-8061-0391	Council for Scientific and Industrial Research, Government of India (CSIR) [60(0102)/12/EMR-II, EpiHeD: BSC0118/2012-17]; CSIR	Council for Scientific and Industrial Research, Government of India (CSIR); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council for Scientific and Industrial Research, Government of India (CSIR, No. 60(0102)/12/EMR-II and EpiHeD: BSC0118/2012-17 to VB). SM, SB and SJ are supported by a fellowship from CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Debasis Das and Singh G.P. for help with bioinformatics, D. Bharadwaj for SELEX oligos and Animal Research facility at Dr. B.R. Ambedkar Centre for Biomedical Research, University of Delhi for help with antibody generation. VB thanks Council for Scientific and Industrial Research, Govt India (CSIR, No. 60(0102)/12/EMR-II) and (EpiHeD: BSC0118/2012-17) for financial support through research grant. SM, SB and SJ thank CSIR for fellowship.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bakshi R, 2006, BIOCHEM BIOPH RES CO, V339, P313, DOI 10.1016/j.bbrc.2005.10.206; Bakshi R, 2004, BIOCHEM BIOPH RES CO, V320, P197, DOI 10.1016/j.bbrc.2004.05.147; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhatia S, 2010, GENES CELLS, V15, P725, DOI 10.1111/j.1365-2443.2010.01416.x; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; DELMAS V, 1993, P NATL ACAD SCI USA, V90, P2414, DOI 10.1073/pnas.90.6.2414; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gerhold CB, 2014, TRENDS CELL BIOL; Ghasemi M, 2015, MECH DEV, V4; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Johnson CN, 2005, BIOCHEM CELL BIOL, V83, P405, DOI 10.1139/O05-115; Kato D, 2012, BIOCHEM BIOPH RES CO, V417, P433, DOI 10.1016/j.bbrc.2011.11.134; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Luo RX, 1999, J NATL CANCER I, V91, P1288, DOI 10.1093/jnci/91.15.1288; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Moshkin YM, 2012, MOL CELL BIOL, V32, P675, DOI 10.1128/MCB.06365-11; Neuman SD, 2014, DEV BIOL, V387, P229, DOI 10.1016/j.ydbio.2014.01.006; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Park EJ, 2010, BIOCHEM J, V431, P179, DOI 10.1042/BJ20100988; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Sharma A, 2011, J BIOL CHEM, V286, P42099, DOI 10.1074/jbc.C111.294462; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; STOKES DG, 1995, MOL CELL BIOL, V15, P2745; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Vassileva I, 2014, NUCLEIC ACIDS RES, V42, P9074, DOI 10.1093/nar/gku605; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xue Y, 2015, GENE DEV, V29, P350, DOI 10.1101/gad.256255.114	49	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159370	10.1371/journal.pone.0159370	http://dx.doi.org/10.1371/journal.pone.0159370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27428271	gold, Green Submitted, Green Published			2022-12-26	WOS:000380169300059
J	Now, H; Yoo, JY				Now, Hesung; Yoo, Joo-Yeon			AG490 and PF431396 Sensitive Tyrosine Kinase Control the Population Heterogeneity of Basal STAT1 Activity in Ube1l Deficient Cells	PLOS ONE			English	Article							PHENOTYPIC DIVERSITY; PROTEIN ISGYLATION; GENE-EXPRESSION; FOCAL ADHESION; GROWTH-FACTOR; CANCER-CELLS; STEM-CELLS; IDENTIFICATION; INHIBITOR; MIGRATION	A population often contains distinct sub-populations, thereby increasing the complexity of the overall heterogeneity. However, the cellular origin and biological relevance of sub-populations in cell population have not been clearly identified. Here we demonstrated the novel roles of ISGylation, which is an IFN-induced post-translational modification, controlling heterogeneity at the population level in cultured adherent cells. Without UBE1L, an E1 enzyme of ISGylation, mouse embryonic fibroblasts (MEF) exhibited low viral resistance despite high STAT1 and ISG expression compared with the wild-type MEF. We observe that Ube1l(-/-) MEF populations consist of two behaviorally distinguishable sub-populations with distinct basal STAT1 activity, while wild-type MEF populations are unimodal. This population heterogeneity in Ube1l knock-out cells was perturbed by tyrosine kinase inhibitors, AG490 and PF431396. In contrast, the neutralization of type I IFN did not affect population heterogeneity. Based on these results, we concluded that UBE1L functions to adjust basal immunological states with the regulation of population heterogeneity.	[Now, Hesung; Yoo, Joo-Yeon] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, South Korea	Pohang University of Science & Technology (POSTECH)	Yoo, JY (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, South Korea.	jyoo@postech.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012R1A4A1028200, NRF-2015R1A2A1A10054957]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. NRF-2012R1A4A1028200 and no. NRF-2015R1A2A1A10054957).	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GAZIT A, 1991, J MED CHEM, V34, P1896, DOI 10.1021/jm00110a022; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Hwang SY, 2013, J IMMUNOL, V190, P1192, DOI 10.4049/jimmunol.1202326; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Martin RA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-136; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Skinner MK, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0153-y; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Xie B, 2001, J BIOL CHEM, V276, P19512, DOI 10.1074/jbc.M009063200; Yoo HS, 2014, J IMMUNOL, V192, P1440, DOI 10.4049/jimmunol.1201952; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; ZAWATZKY R, 1985, P NATL ACAD SCI USA, V82, P1136, DOI 10.1073/pnas.82.4.1136; Zhang DX, 2011, J INTERF CYTOK RES, V31, P119, DOI 10.1089/jir.2010.0110; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	48	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2016	11	7							e0159453	10.1371/journal.pone.0159453	http://dx.doi.org/10.1371/journal.pone.0159453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR8TD	27427993	Green Published, Green Submitted, gold			2022-12-26	WOS:000380169300069
J	Chung, HS; Lee, S; Park, SJ				Chung, Hye-Shin; Lee, Sunbae; Park, Soon Jae			Oxidation Protection in Metal-Binding Peptide Motif and Its Application to Antibody for Site-Selective Conjugation	PLOS ONE			English	Article							DISULFIDE BOND; ZINC; COORDINATION; PROTEIN; IDENTIFICATION; MODULATION; REACTIVITY; STABILITY; CHEMISTRY; STRATEGY	Here, we demonstrate that a metal ion binding motif could serve as an efficient and robust tool for site-specific conjugation strategy. Cysteine-containing metal binding motifs were constructed as single repeat or tandem repeat peptides and their metal binding characteristics were investigated. The tandem repeats of the Cysteine-Glycine-Histidine (CGH) metal ion binding motif exhibited concerted binding to Co(II) ions, suggesting that conformational transition of peptide was triggered by the sequential metal ion binding. Evaluation of the free thiol content after reduction by reducing reagent showed that metal-ion binding elicited strong retardation of cysteine oxidation in the order of Zn(II)>Ni(II)>Co(II). The CGH metal ion binding motif was then introduced to the C-terminus of antibody heavy chain and the metal ion-dependent characteristics of oxidation kinetics were investigated. As in the case of peptides, CGH-motif-introduced antibody exhibited strong dependence on metal ion binding to protect against oxidation. Zn(II)-saturated antibody with tandem repeat of CGH motif retains the cysteine reactivity as long as 22 hour even with saturating O-2 condition. Metal-ion dependent fluorophore labeling clearly indicated that metal binding motifs could be employed as an efficient tool for site-specific conjugation. Whereas Trastuzumab without a metal ion binding site exhibited site-nonspecific dye conjugation, Zn(II) ion binding to antibody with a tandem repeat of CGH motif showed that fluorophores were site-specifically conjugated to the heavy chain of antibody. We believe that this strong metal ion dependence on oxidation protection and the resulting site-selective conjugation could be exploited further to develop a highly site-specific conjugation strategy for proteins that contain multiple intrinsic cysteine residues, including monoclonal antibodies.	[Chung, Hye-Shin] Hannam Univ, Coll Life Sci & Nano Technol, Dept Biol Sci & Biotechnol, 1646 Yuseong Daero, Daejeon, South Korea; [Chung, Hye-Shin; Lee, Sunbae; Park, Soon Jae] Alteogen Inc, Yuseong Daero 62, Daejeon, South Korea	Hannam University	Park, SJ (corresponding author), Alteogen Inc, Yuseong Daero 62, Daejeon, South Korea.	park@alteogen.com			Ministry of Trade, Industry and Energy, Republic of Korea [10040057]; Alteogen Inc.	Ministry of Trade, Industry and Energy, Republic of Korea; Alteogen Inc.	This work was supported by the Ministry of Trade, Industry and Energy, Republic of Korea (http://english.motie.go.kr/) Grant No.: 10040057. Alteogen Inc. provided support in the form of authors' salary [HSC, SL, and SJP] and research materials/instruments but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barok M, 2011, CANCER LETT, V306, P171, DOI 10.1016/j.canlet.2011.03.002; Brautigam L, 2013, BIOCHEM BIOPH RES CO, V436, P491, DOI 10.1016/j.bbrc.2013.05.132; Bullock TL, 2008, P NATL ACAD SCI USA, V105, P7428, DOI 10.1073/pnas.0711812105; Drake PM, 2014, BIOCONJUGATE CHEM, V25, P1331, DOI 10.1021/bc500189z; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Gasymov OK, 2014, BIOCHEM BIOPH RES CO, V452, P1004, DOI 10.1016/j.bbrc.2014.09.029; Griep MA, 1997, BIOCHEMISTRY-US, V36, P544, DOI 10.1021/bi9612778; HANAS JS, 1983, J BIOL CHEM, V258, P4120; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Ismail NF, 2016, SCI REP, V19, P1; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Kalia J, 2010, CURR ORG CHEM, V14, P138, DOI 10.2174/138527210790069839; Kassim R, 2013, J BIOL INORG CHEM, V18, P333, DOI 10.1007/s00775-013-0977-5; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lee S, 2006, J AM CHEM SOC, V128, P1937, DOI 10.1021/ja0546828; Lewis MR, 2001, BIOCONJUGATE CHEM, V12, P320, DOI 10.1021/bc0000886; Li L, 2002, BIOCONJUGATE CHEM, V13, P985, DOI 10.1021/bc025565u; Liu YJ, 2013, J NUCL MED, V54, P1135, DOI 10.2967/jnumed.112.114777; Lu HR, 2016, TALANTA, V146, P477, DOI 10.1016/j.talanta.2015.09.014; MCMILLIN DR, 1974, P NATL ACAD SCI USA, V71, P4760, DOI 10.1073/pnas.71.12.4760; Nies DH, 1997, CH MICROBIOL SER, P77; Ohrvik H, 2015, INT J MOL SCI, V16, P16728, DOI 10.3390/ijms160816728; Peacock AFA, 2009, DALTON T, P2271, DOI 10.1039/b818306f; Plegaria JS, 2015, BIOCHEMISTRY-US, V54, P2858, DOI 10.1021/acs.biochem.5b00064; Shein SA, 2015, B EXP BIOL MED+, V158, P371, DOI 10.1007/s10517-015-2765-4; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Singh VK, 1999, MOL MICROBIOL, V33, P200, DOI 10.1046/j.1365-2958.1999.01466.x; Smith MEB, 2010, J AM CHEM SOC, V132, P1960, DOI 10.1021/ja908610s; Stanyon HF, 2014, FEBS J, V281, P3945, DOI 10.1111/febs.12934; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Van Horn JD, 2003, J BIOL INORG CHEM, V8, P601, DOI 10.1007/s00775-003-0454-7; Wang H, 2008, BIOMACROMOLECULES, V9, P3223, DOI 10.1021/bm800801b; Wang L, 2014, BIOCONJUGATE CHEM, V25, P1252, DOI 10.1021/bc5000934; Watanabe M, 2015, FEBS LETT, V589, P1200, DOI 10.1016/j.febslet.2015.03.020; Wen B, 2006, ARCH BIOCHEM BIOPHYS, V454, P42, DOI 10.1016/j.abb.2006.08.003; Xie F, 2010, J INORG BIOCHEM, V104, P261, DOI 10.1016/j.jinorgbio.2009.12.005; Zhang ZW, 2003, BIOCHEMISTRY-US, V42, P6735, DOI 10.1021/bi0300231; Zinzani PL, 2015, ONCOLOGIST, V20, P1413, DOI 10.1634/theoncologist.2015-0227	40	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2016	11	7							e0159451	10.1371/journal.pone.0159451	http://dx.doi.org/10.1371/journal.pone.0159451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR1JR	27420328	Green Published, Green Submitted, gold			2022-12-26	WOS:000379662300013
J	Bai, YL; Zhu, WB; Hu, XC; Sun, CC; Li, YL; Wang, DD; Wang, QH; Pei, GL; Zhang, YF; Guo, AG; Zhao, HX; Lu, HB; Mu, XQ; Hu, JJ; Zhou, XN; Xie, CG				Bai, Yili; Zhu, Wenbo; Hu, Xiaochen; Sun, Congcong; Li, Yanlin; Wang, Dandan; Wang, Qinhu; Pei, Guoliang; Zhang, Yanfeng; Guo, Aiguang; Zhao, Huixian; Lu, Haibin; Mu, Xiaoqian; Hu, Jingjiang; Zhou, Xiaona; Xie, Chang Gen			Genome-Wide Analysis of the bZIP Gene Family Identifies Two ABI5-Like bZIP Transcription Factors, BrABI5a and BrABI5b, as Positive Modulators of ABA Signalling in Chinese Cabbage	PLOS ONE			English	Article							ALTERNATIVE SPLICING PRODUCTS; DROUGHT STRESS TOLERANCE; REGULATES ABSCISIC-ACID; BRASSICA-OLERACEA; SEED-GERMINATION; E3 LIGASE; EXPRESSION ANALYSIS; BINDING FACTOR; ABI5; ARABIDOPSIS	bZIP (basic leucine zipper) transcription factors coordinate plant growth and development and control responses to environmental stimuli. The genome of Chinese cabbage (Brassica rapa) encodes 136 putative bZIP transcription factors. The bZIP transcription factors in Brassica rapa (BrbZIP) are classified into 10 subfamilies. Phylogenetic relationship analysis reveals that subfamily A consists of 23 BrbZIPs. Two BrbZIPs within subfamily A, Bra005287 and Bra017251, display high similarity to ABI5 (ABA Insensitive 5). Expression of subfamily A BrbZIPs, like BrABI5a (Bra005287/BrbZIP14) and BrABI5b (Bra017251/BrbZIP13), are significantly induced by the plant hormone ABA. Subcellular localization assay reveal that both BrABI5a and BrABI5b have a nuclear localization. BrABI5a and BrABI5b could directly stimulate ABA Responsive Element-driven HIS (a HIS3 reporter gene, which confers His prototrophy) or LUC (LUCIFERASE) expression in yeast and Arabidopsis protoplast. Deletion of the bZIP motif abolished BrABI5a and BrABI5b transcriptional activity. The ABA insensitive phenotype of Arabidopsis abi5-1 is completely suppressed in transgenic lines expressing BrABI5a or BrABI5b. Overall, these results suggest that ABI5 orthologs, BrABI5a and BrABI5b, have key roles in ABA signalling in Chinese cabbage.	[Bai, Yili; Zhu, Wenbo; Hu, Xiaochen; Sun, Congcong; Li, Yanlin; Wang, Dandan; Wang, Qinhu; Pei, Guoliang; Guo, Aiguang; Zhao, Huixian; Mu, Xiaoqian; Hu, Jingjiang; Zhou, Xiaona; Xie, Chang Gen] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Yanfeng] Hybrid Rapeseed Res Ctr Shaanxi Prov, Yangling 712100, Shaanxi, Peoples R China; [Lu, Haibin] Northwest A&F Univ, Coll Agron, Yangling 712100, Shaanxi, Peoples R China; [Xie, Chang Gen] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Northwest A&F University - China; Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xie, CG (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Xie, CG (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	changen.xie@nwsuaf.edu.cn	Wang, Qinhu/AAD-4793-2021; Wang, Qinhu/I-6274-2012	Wang, Qinhu/0000-0003-1251-073X; Wang, Qinhu/0000-0003-1251-073X	National Natural Science Foundation of China [31201630]; China Scholarship Council [201506305025]; Young Faculty Study Abroad Program by Northwest AF University; Fundamental Research Funds for Science and Technology Innovation Program of the Central Universities by Northwest AF University [2452015216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Young Faculty Study Abroad Program by Northwest AF University; Fundamental Research Funds for Science and Technology Innovation Program of the Central Universities by Northwest AF University	This work was supported by grants from National Natural Science Foundation of China to Zhou Xiaona (31201630), grants from the State Scholarship Fund to Dr. Xie Chang Gen by China Scholarship Council (201506305025), and grants from the Young Faculty Study Abroad Program and the Fundamental Research Funds for Science and Technology Innovation Program of the Central Universities (2452015216) to Dr. Xie Chang Gen by Northwest A&F University.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Baloglu MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096014; Bensmihen S, 2005, J EXP BOT, V56, P597, DOI 10.1093/jxb/eri050; Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Casaretto J, 2003, PLANT CELL, V15, P271, DOI 10.1105/tpc.007096; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Dong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130451; Farinati S, 2010, NEW PHYTOL, V185, P964, DOI 10.1111/j.1469-8137.2009.03132.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hossain MA, 2010, J PLANT PHYSIOL, V167, P1512, DOI 10.1016/j.jplph.2010.05.008; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hwang I, 2014, GENOMICS, V104, P194, DOI 10.1016/j.ygeno.2014.07.008; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jin ZW, 2014, PLANTA, V239, P299, DOI 10.1007/s00425-013-1979-9; Kim S, 2004, PLANT J, V40, P75, DOI 10.1111/j.1365-313X.2004.02192.x; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Liu X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1457-9; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Miura K, 2009, P NATL ACAD SCI USA, V106, P5418, DOI 10.1073/pnas.0811088106; Nicolas P, 2014, PLANT PHYSIOL, V164, P365, DOI 10.1104/pp.113.231977; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Pourabed E, 2015, MOL BIOTECHNOL, V57, P12, DOI 10.1007/s12033-014-9797-2; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Waldmuller S, 1995, PLANT MOL BIOL, V29, P507, DOI 10.1007/BF00020981; Waldmuller S, 1996, PLANT MOL BIOL, V32, P631, DOI 10.1007/BF00020204; Wang JZ, 2011, J INTEGR PLANT BIOL, V53, P212, DOI 10.1111/j.1744-7909.2010.01017.x; Wang MY, 2013, BIOCHEM BIOPH RES CO, V442, P214, DOI 10.1016/j.bbrc.2013.11.032; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang YP, 2013, J EXP BOT, V64, P675, DOI 10.1093/jxb/ers361; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wycliffe P, 2005, PLANT J, V44, P1, DOI 10.1111/j.1365-313X.2005.02482.x; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yu JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-664; Yuan FF, 2013, BIOCHEM BIOPH RES CO, V442, P202, DOI 10.1016/j.bbrc.2013.11.035; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhou B, 2009, BIOTECHNOL LETT, V31, P1811, DOI 10.1007/s10529-009-0080-8; Zhou XN, 2015, PLANT PHYSIOL, V168, P659, DOI 10.1104/pp.114.255455; Zhou XN, 2013, BIOCHEM BIOPH RES CO, V430, P1140, DOI 10.1016/j.bbrc.2012.12.023; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4; Zou MJ, 2007, BIOCHEM BIOPH RES CO, V360, P307, DOI 10.1016/j.bbrc.2007.05.226	59	18	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158966	10.1371/journal.pone.0158966	http://dx.doi.org/10.1371/journal.pone.0158966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27414644	Green Submitted, gold, Green Published			2022-12-26	WOS:000379579500053
J	Davenport, EP; Harris, DF; Origanti, S; Antony, E				Davenport, Eric Parker; Harris, Derek F.; Origanti, Sofia; Antony, Edwin			Rad51 Nucleoprotein Filament Disassembly Captured Using Fluorescent Plasmodium falciparum SSB as a Reporter for Single-Stranded DNA	PLOS ONE			English	Article							PROTEIN-OLIGONUCLEOTIDE INTERACTIONS; C-TERMINAL TAILS; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; NEGATIVE COOPERATIVITY; LABELED NUCLEOTIDES; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; NUCLEIC-ACIDS; SRS2 HELICASE	Single-stranded DNA binding (SSB) proteins coordinate DNA replication, repair, and recombination and are critical for maintaining genomic integrity. SSB binds to single-stranded DNA (ssDNA) rapidly and with very high affinity making it a useful molecular tool to detect free ssDNA in solution. We have labeled SSB from Plasmodium falciparum (Pf-SSB) with the MDCC (7-diethylamino-3-((((2-maleimidyl) ethyl)amino)-carbonyl)coumarin) fluorophore which yields a four-fold increase in fluorescence upon binding to ssDNA. Pf-SSBMDCC binding to DNA is unaffected by NaCl or Mg2+ concentration and does not display salt-dependent changes in DNA binding modes or cooperative binding on long DNA substrates. These features are unique to Pf-SSB, making it an ideal tool to probe the presence of free ssDNA in any biochemical reaction. Using this Pf-SSBMDCC probe as a sensor for free ssDNA, we have investigated the clearing of preformed yeast Rad51 nucleoprotein filaments by the Srs2 helicase during HR. Our studies provide a rate for the disassembly of the Rad51 filament by full length Srs2 on long ssDNA substrates. Mutations in the conserved 2B domain in the homologous bacterial UvrD, Rep and PcrA helicases show an enhancement of DNA unwinding activity, but similar mutations in Srs2 do not affect its DNA unwinding or Rad51 clearing properties. These studies showcase the utility of the Pf-SSB probe in mechanistic investigation of enzymes that function in DNA metabolism.	[Davenport, Eric Parker; Harris, Derek F.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Davenport, Eric Parker; Origanti, Sofia; Antony, Edwin] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Utah System of Higher Education; Utah State University; Marquette University	Antony, E (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	edwin.antony@mu.edu	Antony, Edwin/AAA-3596-2021	Origanti, Sofia/0000-0002-6953-0160	NIH-NIGMS [R15GM110671]; Marquette University; Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110671] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marquette University; Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the NIH-NIGMS (R15GM110671) and start-up support from Marquette University to EA. EPD was supported by an Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a grant from the NIH-NIGMS (R15GM110671) and start-up support from Marquette University to EA. EPD was supported by an Undergraduate Research and Creative Opportunities (URCO) grant from Utah State University. We thank Tawny Moss for generation of the Srs2<SUP>DK-AA</SUP> mutation and undergraduate students-Mark Soffe, Cason Worley, Danny Morris and Jeff VonGermeten for their assistance with protein purification. We also acknowledge the members of the Antony Lab for critical reading of the manuscript and sharing ideas for using the Pf-SSB probe.	Antony E, 2013, J MOL BIOL, V425, P4802, DOI 10.1016/j.jmb.2013.08.021; Antony E, 2012, J MOL BIOL, V420, P284, DOI 10.1016/j.jmb.2012.04.022; Antony E, 2012, J MOL BIOL, V420, P269, DOI 10.1016/j.jmb.2012.04.021; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Balci H, 2011, BIOPHYS J, V101, P976, DOI 10.1016/j.bpj.2011.07.010; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bianco P R, 1998, Front Biosci, V3, pD570; Bianco Piero R, 2012, Methods Mol Biol, V922, P235, DOI 10.1007/978-1-62703-032-8_18; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; BUJALOWSKI W, 1989, J MOL BIOL, V207, P269, DOI 10.1016/0022-2836(89)90455-5; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1987, J MOL BIOL, V195, P897, DOI 10.1016/0022-2836(87)90493-1; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Daley JM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017954; EGGLESTON AK, 1991, BIOCHIMIE, V73, P163, DOI 10.1016/0300-9084(91)90199-B; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Green M, 2014, BIOSENS BIOELECTRON, V61, P579, DOI 10.1016/j.bios.2014.06.011; Heyer WD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016501; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Kozlov AG, 2015, J MOL BIOL, V427, P763, DOI 10.1016/j.jmb.2014.12.020; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Kunzelmann S, 2009, J BIOL CHEM, V284, P33130, DOI 10.1074/jbc.M109.047118; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1988, TRENDS BIOCHEM SCI, V13, P250; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lytle AK, 2014, J MOL BIOL, V426, P1883, DOI 10.1016/j.jmb.2014.02.014; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Meiners MJ, 2014, J BIOL CHEM, V289, P17100, DOI 10.1074/jbc.M114.565309; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Prusty D, 2010, NUCLEIC ACIDS RES, V38, P7037, DOI 10.1093/nar/gkq565; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; Ristic D, 2005, NUCLEIC ACIDS RES, V33, P3292, DOI 10.1093/nar/gki640; Robertson RB, 2009, J MOL BIOL, V388, P703, DOI 10.1016/j.jmb.2009.03.049; RONG L, 1993, J BIOL CHEM, V268, P1252; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tomko EJ, 2010, EMBO J, V29, P3826, DOI 10.1038/emboj.2010.242; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Walsh MT, 2015, BIOCHEMISTRY-US, V54, P4019, DOI 10.1021/acs.biochem.5b00269; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	69	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0159242	10.1371/journal.pone.0159242	http://dx.doi.org/10.1371/journal.pone.0159242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27416037	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500107
J	Lin, MV; Sise, ME; Pavlakis, M; Amundsen, BM; Chute, D; Rutherford, AE; Chung, RT; Curry, MP; Hanifi, JM; Gabardi, S; Chandraker, A; Heher, EC; Elias, N; Riella, LV				Lin, Ming V.; Sise, Meghan E.; Pavlakis, Martha; Amundsen, Beth M.; Chute, Donald; Rutherford, Anna E.; Chung, Raymond T.; Curry, Michael P.; Hanifi, Jasmine M.; Gabardi, Steve; Chandraker, Anil; Heher, Eliot C.; Elias, Nahel; Riella, Leonardo V.			Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							RENAL-REPLACEMENT THERAPY; GENOTYPE 1; DISEASE; IMPACT; SOFOSBUVIR; SURVIVAL; METAANALYSIS; SIMEPREVIR; HIV; HCV	The prevalence of Hepatitis C Virus (HCV) infection is significantly higher in patients with end-stage renal disease compared to the general population and poses important clinical challenges in patients who undergo kidney transplantation. Historically, interferon-based treatment options have been limited by low rates of efficacy and significant side effects, including risk of precipitating rejection. Limited data exist on the use of all-oral, interferon-free direct-acting antiviral (DAA) therapies in kidney transplant recipients. In this study, we performed a retrospective chart review with prospective clinical follow-up of post-kidney transplant patients treated with DAA therapies at three major hospitals in Boston, MA. A total of 24 kidney recipients with HCV infection received all-oral DAA therapy post-transplant. Patients were predominantly male (79%) with a median age of 60 years (range 34-70 years), median creatinine of 1.2 mg/dL (0.66-1.76), and 42% had advanced fibrosis or cirrhosis. The majority had HCV genotype 1a infection (58%). All patients received full-dose sofosbuvir; it was paired with simeprevir (9 patients without and 3 patients with ribavirin), ledipasvir (7 patients without and 1 patient with ribavirin) or ribavirin alone (4 patients). The overall sustained virologic response (SVR12) was 91% (21 out of 23 patients). One patient achieved SVR4 but demised prior to SVR12 check point due to treatment unrelated cause. Two treatment failures were successfully retreated with alternative DAA regimens and achieved SVR. Both initials failures occurred in patients with advanced fibrosis or cirrhosis, with genotype 1a infection, and prior HCV treatment failure. Adverse events were reported in 11 patients (46%) and were managed clinically without discontinuation of therapy. Calcineurin inhibitor trough levels did not significantly change during therapy. In this multi-center series of patients, all-oral DAA therapy appears to be safe and effective in post-kidney transplant patients with chronic HCV infection.	[Lin, Ming V.; Rutherford, Anna E.] Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Sise, Meghan E.; Heher, Eliot C.] Harvard Med Sch, Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA; [Pavlakis, Martha] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA USA; [Amundsen, Beth M.; Heher, Eliot C.; Elias, Nahel] Harvard Med Sch, Massachusetts Gen Hosp, Div Transplant Surg, Boston, MA USA; [Chute, Donald; Chung, Raymond T.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Liver, Div Gastroenterol, Boston, MA USA; [Curry, Michael P.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA USA; [Hanifi, Jasmine M.] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Boston, MA USA; [Gabardi, Steve; Chandraker, Anil; Riella, Leonardo V.] Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lin, MV (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.; Riella, LV (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Renal, Transplantat Res Ctr, Boston, MA USA.	mvlin@partners.org; lriella@bwh.harvard.edu	Riella, Leonardo V./AAD-5246-2019; Elias, Nahel/AAO-8344-2020; Chandraker, Anil/L-3908-2019; Riella, Leonardo V./AAC-8182-2019	Elias, Nahel/0000-0001-6466-7347; Riella, Leonardo V./0000-0002-7636-3196; Gabardi, Steven/0000-0001-8022-2751				Adinolfi LE, 2014, WORLD J GASTROENTERO, V20, P3410, DOI 10.3748/wjg.v20.i13.3410; Berdichevski RH, 2010, CLIN KIDNEY J, V3, P564, DOI 10.1093/ndtplus/sfq155; Bruchfeld A, 2004, TRANSPLANTATION, V78, P745, DOI 10.1097/01.TP.0000131948.29742.24; Burgess S, 2015, ANN PHARMACOTHER, V49, P674, DOI 10.1177/1060028015576180; Caillard S, 2006, TRANSPLANTATION, V81, P888, DOI 10.1097/01.tp.0000203554.54242.56; Caillard S, 2006, AM J TRANSPLANT, V6, P2735, DOI 10.1111/j.1600-6143.2006.01540.x; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P1413, DOI 10.1111/j.1365-2036.2006.03151.x; Fabrizi F, 2014, J VIRAL HEPATITIS, V21, P314, DOI 10.1111/jvh.12148; Fabrizi F, 2011, J VIRAL HEPATITIS, V18, pE263, DOI 10.1111/j.1365-2893.2010.01405.x; Fabrizi F, 2014, J MED VIROL, V86, P933, DOI 10.1002/jmv.23919; Fabrizi F, 2013, KIDNEY INT, V84, P874, DOI 10.1038/ki.2013.264; Gutierrez JA, 2015, LIVER TRANSPLANT, V21, P823, DOI 10.1002/lt.24126; Ingsathit A, 2013, TRANSPLANTATION, V95, P943, DOI 10.1097/TP.0b013e3182848de2; Kamar N, 2015, AM J TRANSPLANT; Kanungo S, 2010, INT UROL NEPHROL, V42, P219, DOI 10.1007/s11255-009-9594-1; Kidney Disease: Improving Global Outcomes (KDIGO), 2008, Kidney Int Suppl, pS1, DOI 10.1038/ki.2008.81; Lawitz E, 2015, HEPATOLOGY; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mahmoud IM, 2004, AM J KIDNEY DIS, V43, P131, DOI 10.1053/j.ajkd.2003.09.018; Markowitz GS, 2010, CLIN J AM SOC NEPHRO, V5, P607, DOI 10.2215/CJN.07311009; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007; Pungpapong S, 2015, HEPATOLOGY, V61, P1880, DOI 10.1002/hep.27770; Roth D, 1996, TRANSPLANTATION, V61, P886, DOI 10.1097/00007890-199603270-00007; Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9; Roth D, 2011, J AM SOC NEPHROL, V22, P1152, DOI 10.1681/ASN.2010060668; Santos L, 2009, TRANSPL P, V41, P880, DOI 10.1016/j.transproceed.2009.01.074; Sawinski D, 2015, AM J TRANSPLANT; Scott DR, 2010, TRANSPLANTATION, V90, P1165, DOI 10.1097/TP.0b013e3181f92548; Trotter JF, 2005, ALIMENT PHARM THERAP, V22, P37, DOI 10.1111/j.1365-2036.2005.02502.x; Wessler JD, 2013, J AM COLL CARDIOL, V61, P2495, DOI 10.1016/j.jacc.2013.02.058; Xia Y, 2014, AM J TRANSPLANT, V14, P2037, DOI 10.1111/ajt.12847; Yoshida EM, 2015, HEPATOLOGY, V61, P41, DOI 10.1002/hep.27366	33	85	91	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2016	11	7							e0158431	10.1371/journal.pone.0158431	http://dx.doi.org/10.1371/journal.pone.0158431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0DZ	27415632	Green Published, gold, Green Submitted			2022-12-26	WOS:000379579500021
J	Benson, JF; Sikich, JA; Riley, SPD				Benson, John F.; Sikich, Jeff A.; Riley, Seth P. D.			Individual and Population Level Resource Selection Patterns of Mountain Lions Preying on Mule Deer along an Urban-Wildland Gradient	PLOS ONE			English	Article							HABITAT SELECTION; PREDATION; COUGARS	Understanding population and individual-level behavioral responses of large carnivores to human disturbance is important for conserving top predators in fragmented landscapes. However, previous research has not investigated resource selection at predation sites of mountain lions in highly urbanized areas. We quantified selection of natural and anthropogenic landscape features by mountain lions at sites where they consumed their primary prey, mule deer (Odocoileus hemionus), in and adjacent to urban, suburban, and rural areas in greater Los Angeles. We documented intersexual and individual-level variation in the environmental conditions present at mule deer feeding sites relative to their availability across home ranges. Males selected riparian woodlands and areas closer to water more than females, whereas females selected developed areas marginally more than males. Females fed on mule deer closer to developed areas and farther from riparian woodlands than expected based on the availability of these features across their home ranges. We suggest that mortality risk for females and their offspring associated with encounters with males may have influenced the different resource selection patterns between sexes. Males appeared to select mule deer feeding sites mainly in response to natural landscape features, while females may have made kills closer to developed areas in part because these are alternative sites where deer are abundant. Individual mountain lions of both sexes selected developed areas more strongly within home ranges where development occurred less frequently. Thus, areas near development may represent a trade-off for mountain lions such that they may benefit from foraging near development because of abundant prey, but as the landscape becomes highly urbanized these benefits may be outweighed by human disturbance.	[Benson, John F.; Riley, Seth P. D.] Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA 90095 USA; [Benson, John F.; Sikich, Jeff A.; Riley, Seth P. D.] Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA 91360 USA	University of California System; University of California Los Angeles; United States Department of the Interior	Benson, JF (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA 90095 USA.; Benson, JF (corresponding author), Natl Pk Serv, Santa Monica Mt Natl Recreat Area, Thousand Oaks, CA 91360 USA.	benson.johnf@gmail.com			La Kretz Center for California Conservation at UCLA; California State Parks; Santa Monica Mountains Fund; Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority; Calabasas Landfill; National Park Service	La Kretz Center for California Conservation at UCLA; California State Parks; Santa Monica Mountains Fund; Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority; Calabasas Landfill; National Park Service	The authors received funding for this research from the La Kretz Center for California Conservation at UCLA, California State Parks, the Santa Monica Mountains Fund, Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority, and the Calabasas Landfill. The funding from the La Kretz Center for California Conservation came in the form of a postdoctoral fellowship for JFB made possible by an endowment from Morton La Kretz to UCLA through the Institute of the Environment and Sustainability. This fellowship was co-funded by the National Park Service. The other organizations noted above provided funding for mountain lion research that were not connected to specific grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the many NPS biologists and interns who assisted with fieldwork, including: J. Moriarty, J. Brown, E.C. York, C. Schoonmaker, E. Lara, C. Bromley, P. Roby, K. McCurdy, J. Fitzgerald, J. Golla, E. Bohling, and J. Dorcy. We thank B. Clarke, D. Kamradt, and L. Lee for assistance with GIS layers. We thank the La Kretz Center for California Conservation at UCLA, California State Parks, the Santa Monica Mountains Fund, Santa Monica Mountains Conservancy/Mountains Recreation and Conservation Authority, and the Calabasas Landfill for funding support.	Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Bank MS, 2002, J ZOOL, V258, P215, DOI 10.1017/S0952836902001334; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beier Paul, 2010, P141; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; BOWYER RT, 1986, CALIF FISH GAME, V72, P153; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARSON RG, 1987, J WILDLIFE MANAGE, V51, P46, DOI 10.2307/3801627; Conner L. Mike, 2001, P275, DOI 10.1016/B978-012497781-5/50011-6; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; DeStefano S, 2003, FRONT ECOL ENVIRON, V1, P95, DOI 10.1890/1540-9295(2003)001[0095:ETEOSW]2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Elbroch LM, 2012, MAMM BIOL, V77, P377, DOI 10.1016/j.mambio.2012.02.010; Elbroch ML, 2013, PLOS ONE, V8; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Knopff AA, 2014, BIOL CONSERV, V178, P136, DOI 10.1016/j.biocon.2014.07.017; KOEHLER GM, 1991, J MAMMAL, V72, P391, DOI 10.2307/1382112; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; Logan K. A., 2001, DESERT PUMA; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; Rotenberry JT, 1998, ECOLOGY, V79, P1160; Ruth TK, 2010, J WILDLIFE MANAGE, V74, P1122, DOI 10.2193/2009-058; Saether BE, 1998, AM NAT, V151, P441, DOI 10.1086/286131; Smith JA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2711; Soule ME, 1998, SCIENCE, V282, P1658, DOI 10.1126/science.282.5394.1658; STACEY PB, 1992, ECOL APPL, V2, P18, DOI 10.2307/1941886; Swenson J.E., 1983, Prairie Naturalist, V15, P97; Vickers WT, 2015, PLOS ONE, V10; Wilmers CC, PLOS ONE, V20138; Wood S., GEN ADDITIVE MODELS	43	29	31	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158006	10.1371/journal.pone.0158006	http://dx.doi.org/10.1371/journal.pone.0158006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411098	gold, Green Published			2022-12-26	WOS:000379508300015
J	Bilyk, O; Sekurova, ON; Zotchev, SB; Luzhetskyy, A				Bilyk, Oksana; Sekurova, Olga N.; Zotchev, Sergey B.; Luzhetskyy, Andriy			Cloning and Heterologous Expression of the Grecocycline Biosynthetic Gene Cluster	PLOS ONE			English	Article							STREPTOMYCES-GLOBISPORUS 1912; LANDOMYCIN-E PRODUCTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; JADOMYCIN BIOSYNTHESIS; RECOMBINATION CLONING; SELECTIVE ISOLATION; CYANOGENUS S136; COMPLEX GENOMES; TAR CLONING	Transformation-associated recombination (TAR) in yeast is a rapid and inexpensive method for cloning and assembly of large DNA fragments, which relies on natural homologous recombination. Two vectors, based on p15a and F-factor replicons that can be maintained in yeast, E. coli and streptomycetes have been constructed. These vectors have been successfully employed for assembly of the grecocycline biosynthetic gene cluster from Streptomyces sp. Acta 1362. Fragments of the cluster were obtained by PCR and transformed together with the "capture" vector into the yeast cells, yielding a construct carrying the entire gene cluster. The obtained construct was heterologously expressed in S. albus J1074, yielding several grecocycline congeners. Grecocyclines have unique structural moieties such as a dissacharide side chain, an additional amino sugar at the C-5 position and a thiol group. Enzymes from this pathway may be used for the derivatization of known active angucyclines in order to improve their desired biological properties.	[Bilyk, Oksana; Luzhetskyy, Andriy] Saarland Univ Campus, Helmholtz Inst Pharmaceut Res Saarland, Bldg C2-3, D-66123 Saarbrucken, Germany; [Sekurova, Olga N.; Zotchev, Sergey B.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Luzhetskyy, Andriy] Univ Saarland, Pharmazeut Biotechnol, Bldg C2-3, D-66123 Saarbrucken, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; University of Vienna; Saarland University	Luzhetskyy, A (corresponding author), Saarland Univ Campus, Helmholtz Inst Pharmaceut Res Saarland, Bldg C2-3, D-66123 Saarbrucken, Germany.; Luzhetskyy, A (corresponding author), Univ Saarland, Pharmazeut Biotechnol, Bldg C2-3, D-66123 Saarbrucken, Germany.	andriy.luzhetskyy@helmholtz-hzi.de		Zotchev, Sergey/0000-0002-9324-245X; Sekurova, Olga/0000-0001-5034-2015	ERC starting grant EXPLOGEN [281623]	ERC starting grant EXPLOGEN	This work was supported by the ERC starting grant EXPLOGEN No. 281623 to AL, https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the ERC starting grant EXPLOGEN No. 281623 to AL.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bonet B, 2015, J NAT PROD, V78, P539, DOI 10.1021/np500664q; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Demain AL, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P65; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; Erb A, 2009, CHEMBIOCHEM, V10, P1392, DOI 10.1002/cbic.200900054; Faust B, 2000, MICROBIOL-UK, V146, P147, DOI 10.1099/00221287-146-1-147; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Green M. R., 2012, MOLECULAR CLONING A; Gromyko O, 2004, J ANTIBIOT, V57, P383, DOI 10.7164/antibiotics.57.383; Han L, 2000, MICROBIOL-UK, V146, P903, DOI 10.1099/00221287-146-4-903; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Kharel MK, 2012, ORG BIOMOL CHEM, V10, P4256, DOI 10.1039/c2ob07171a; Kharel MK, 2012, CURR OPIN CHEM BIOL, V16, P150, DOI 10.1016/j.cbpa.2012.03.007; Kim JH, 2010, BIOPOLYMERS, V93, P833, DOI 10.1002/bip.21450; Kouprina N, 2008, NAT PROTOC, V3, P371, DOI 10.1038/nprot.2008.5; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Larionov V, 1996, P NATL ACAD SCI USA, V93, P13925, DOI 10.1073/pnas.93.24.13925; Lee NCO, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv112; Lombo F, 2009, CHEMBIOCHEM, V10, P296, DOI 10.1002/cbic.200800425; Luzhetskyy A, 2006, Genetika, V42, P595; Luzhetskyy A, 2005, CHEMBIOCHEM, V6, P1406, DOI 10.1002/cbic.200500018; Luzhetskyy A, 2005, CHEM BIOL, V12, P725, DOI 10.1016/j.chembiol.2005.05.008; Metsa-Ketela M, 2004, J ANTIBIOT, V57, P502, DOI 10.7164/antibiotics.57.502; OXENDER DL, 1980, P NATL ACAD SCI-BIOL, V77, P1412, DOI 10.1073/pnas.77.3.1412; Palmu K, 2007, CHEMBIOCHEM, V8, P1577, DOI 10.1002/cbic.200700140; Paululat T, 2010, EUR J ORG CHEM, V2010, P2344, DOI 10.1002/ejoc.201000054; PODKOVYROV SM, 1995, GENE, V156, P151, DOI 10.1016/0378-1119(95)00053-9; Rebets Y, 2003, FEMS MICROBIOL LETT, V222, P149, DOI 10.1016/S0378-1097(03)00258-1; Rebets YV, 2006, FEMS MICROBIOL LETT, V256, P30, DOI 10.1111/j.1574-6968.2005.00087.x; Rix U, 2005, CHEMBIOCHEM, V6, P838, DOI 10.1002/cbic.200400395; Ross A. C., 2014, ACS SYNTH BIOL, DOI [10.1021/sb500280q, DOI 10.1021/SB500280Q]; Sambrook J., 1989, MOLECULAR CLONING A; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; TODA S, 1993, J ANTIBIOT, V46, P875, DOI 10.7164/antibiotics.46.875; Trefzer A, 2000, CHEM BIOL, V7, P133, DOI 10.1016/S1074-5521(00)00079-X; Westrich L, 1999, FEMS MICROBIOL LETT, V170, P381, DOI 10.1111/j.1574-6968.1999.tb13398.x; Wexler M, 2005, ENVIRON MICROBIOL, V7, P1917, DOI 10.1111/j.1462-2920.2005.00854.x; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141; Zhang X, 2008, ANTIMICROB AGENTS CH, V52, P574, DOI 10.1128/AAC.00717-07; Zhu LL, 2005, J ORG CHEM, V70, P631, DOI 10.1021/jo0483623	49	45	47	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158682	10.1371/journal.pone.0158682	http://dx.doi.org/10.1371/journal.pone.0158682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410036	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508300030
J	Chiabotto, G; Bruno, S; Collino, F; Camussi, G				Chiabotto, Giulia; Bruno, Stefania; Collino, Federica; Camussi, Giovanni			Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles	PLOS ONE			English	Article							EXOSOME-MEDIATED TRANSFER; CYCLIN D1; MIR-200 FAMILY; AMINOPEPTIDASE-A; GENE-EXPRESSION; REPRESSORS ZEB1; MICRORNAS; MICROVESICLES; MIGRATION; KIDNEY	Mesenchymal-epithelial interactions play an important role in renal tubular morphogenesis and in maintaining the structure of the kidney. The aim of this study was to investigate whether extracellular vesicles (EVs) produced by human renal proximal tubular epithelial cells (RPTECs) may induce mesenchymal-epithelial transition of bone marrow-derived mesenchymal stromal cells (MSCs). To test this hypothesis, we characterized the phenotype and the RNA content of EVs and we evaluated the in vitro uptake and activity of EVs on MSCs. MicroRNA (miRNA) analysis suggested the possible implication of the miR-200 family carried by EVs in the epithelial commitment of MSCs. Bone marrow-derived MSCs were incubated with EVs, or RPTEC-derived total conditioned medium, or conditioned medium depleted of EVs. As a positive control, MSCs were co-cultured in a transwell system with RPTECs. Epithelial commitment of MSCs was assessed by real time PCR and by immunofluorescence analysis of cellular expression of specific mesenchymal and epithelial markers. After one week of incubation with EVs and total conditioned medium, we observed mesenchymal-epithelial transition in MSCs. Stimulation with conditioned medium depleted of EVs did not induce any change in mesenchymal and epithelial gene expression. Since EVs were found to contain the miR-200 family, we transfected MSCs using synthetic miR-200 mimics. After one week of transfection, mesenchymal-epithelial transition was induced in MSCs. In conclusion, miR-200 carrying EVs released from RPTECs induce the epithelial commitment of MSCs that may contribute to their regenerative potential. Based on experiments of MSC transfection with miR-200 mimics, we suggested that the miR-200 family may be involved in mesenchymal-epithelial transition of MSCs.	[Chiabotto, Giulia; Collino, Federica; Camussi, Giovanni] Univ Turin, Dept Med Sci, Sch Med, Turin, Italy; [Bruno, Stefania] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Camussi, G (corresponding author), Univ Turin, Dept Med Sci, Sch Med, Turin, Italy.	giovanni.camussi@unito.it	Collino, Federica/B-9956-2018; Camussi, Giovanni/J-7624-2016	Collino, Federica/0000-0002-3619-7701; BRUNO, Stefania/0000-0002-8879-9536; Camussi, Giovanni/0000-0003-2795-232X; Chiabotto, Giulia/0000-0002-1420-3517				Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Aliotta JM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26166; Aliotta JM, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18163; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Baer PC, 2009, CELL PROLIFERAT, V42, P29, DOI 10.1111/j.1365-2184.2008.00572.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Campanaro S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-383; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Collino F, 2015, J AM SOC NEPHROL, V26, P2349, DOI 10.1681/ASN.2014070710; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Del Tatto M, 2011, EXP HEMATOL, V39, P1072, DOI 10.1016/j.exphem.2011.08.008; Dimuccio V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104490; Eckes B, 1998, J CELL SCI, V111, P1897; Fanni D, 2011, J MATERN-FETAL NEO M, V24, P64, DOI 10.3109/14767058.2011.613159; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Hupkes M, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-1; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jiao J, 2013, ONCOTARGETS THER, V6, P667, DOI 10.2147/OTT.S44177; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanazawa T, 2011, J VET MED SCI, V73, P601, DOI 10.1292/jvms.10-0493; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618; Lipschutz JH, 1998, AM J KIDNEY DIS, V31, P383, DOI 10.1053/ajkd.1998.v31.pm9506676; Liu Xia, 2015, Asian Pac J Cancer Prev, V16, P6201; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Martin PJ, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0057-5; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Messai Y, 2010, INT J ONCOL, V36, P1145, DOI 10.3892/ijo_00000597; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Neviani P, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00047; Njock MS, 2015, BLOOD, V125, P3202, DOI 10.1182/blood-2014-11-611046; Nurwidya F, 2014, BIOCHEM BIOPH RES CO, V455, P332, DOI 10.1016/j.bbrc.2014.11.014; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Papadimou E, 2015, STEM CELL REP, V4, P685, DOI 10.1016/j.stemcr.2015.02.002; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Penfornis P, 2016, INT J CANCER, V138, P14, DOI 10.1002/ijc.29417; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Renzulli JF, 2010, J UROLOGY, V184, P2165, DOI 10.1016/j.juro.2010.06.119; Ridder K, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008371; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Singaravelu K, 2009, RENAL FAILURE, V31, P492, DOI 10.1080/08860220902928981; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Su HF, 2016, TUMOR BIOL, V37, P5355, DOI 10.1007/s13277-015-4393-z; Taliaferro-Smith L, 2015, ONCOTARGET, V6, P4757, DOI 10.18632/oncotarget.3023; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wan JX, 2012, CELL BIOCHEM FUNCT, V30, P129, DOI 10.1002/cbf.1826; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114627; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhou J, 2015, ONCOTARGET, V6, P44332, DOI 10.18632/oncotarget.6293	90	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0159163	10.1371/journal.pone.0159163	http://dx.doi.org/10.1371/journal.pone.0159163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27409796	Green Published, gold			2022-12-26	WOS:000379508300062
J	Emary, E; Zawbaa, HM				Emary, E.; Zawbaa, Hossam M.			Impact of Chaos Functions on Modern Swarm Optimizers	PLOS ONE			English	Article							OPTIMIZATION ALGORITHM; FEATURE-SELECTION	Exploration and exploitation are two essential components for any optimization algorithm. Much exploration leads to oscillation and premature convergence while too much exploitation slows down the optimization algorithm and the optimizer may be stuck in local minima. Therefore, balancing the rates of exploration and exploitation at the optimization lifetime is a challenge. This study evaluates the impact of using chaos-based control of exploration/exploitation rates against using the systematic native control. Three modern algorithms were used in the study namely grey wolf optimizer (GWO), antlion optimizer (ALO) and moth-flame optimizer (MFO) in the domain of machine learning for feature selection. Results on a set of standard machine learning data using a set of assessment indicators prove advance in optimization algorithm performance when using variational repeated periods of declined exploration rates over using systematically decreased exploration rates.	[Emary, E.] Cairo Univ, Fac Comp & Informat, Dept Informat Technol, Cairo, Egypt; [Emary, E.] Arab Open Univ, Fac Comp Studies, Dept Comp, Shrouq, Egypt; [Zawbaa, Hossam M.] Beni Suef Univ, Fac Comp & Informat, Dept Informat Technol, Bani Suwayf, Egypt; [Zawbaa, Hossam M.] Univ Babes Bolyai, Fac Math & Comp Sci, Dept Comp Sci, Cluj Napoca, Romania	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Beni Suef University; Babes Bolyai University from Cluj	Zawbaa, HM (corresponding author), Beni Suef Univ, Fac Comp & Informat, Dept Informat Technol, Bani Suwayf, Egypt.; Zawbaa, HM (corresponding author), Univ Babes Bolyai, Fac Math & Comp Sci, Dept Comp Sci, Cluj Napoca, Romania.	hossam.zawbaa@gmail.com	Emary, Eid M/C-6131-2017; Zawbaa, Hossam M./O-6203-2014	Emary, Eid M/0000-0002-9537-2530; Zawbaa, Hossam M./0000-0001-6548-2993	IPROCOM Marie Curie initial training network - People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/ under REA grant [316555]	IPROCOM Marie Curie initial training network - People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/ under REA grant	This work was partially supported by the IPROCOM Marie Curie initial training network, funded through the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no. 316555.	Aguirregabiria JM, 2009, CHAOS SOLITON FRACT, V42, P2531, DOI 10.1016/j.chaos.2009.03.196; Bingqun Ren, 2011, Information Technology Journal, V10, P1908, DOI 10.3923/itj.2011.1908.1916; Bucolo M., 2002, IEEE Circuits and Systems Magazine, V2, P4, DOI 10.1109/MCAS.2002.1167624; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chen H., 2013, MATHEMATICAL PROBLEM, V2013; Chizi B., 2009, SURVEY FEATURE SELEC, P1888; Chuang LY, 2011, EXPERT SYST APPL, V38, P12699, DOI 10.1016/j.eswa.2011.04.057; Emary E., 2014, 1ST INTERNATIONAL AF; Frank A., 2010, UCI MACHINE LEARNING; Gholipour A, 2006, NEURAL PROCESS LETT, V24, P217, DOI 10.1007/s11063-006-9021-x; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hassanien A.E., 2015, SWARM INTELLIGENCE P; Huang CL, 2009, NEUROCOMPUTING, V73, P438, DOI 10.1016/j.neucom.2009.07.014; Jun-Jie Yang, 2005, Proceedings of 2005 International Conference on Machine Learning and Cybernetics (IEEE Cat. No. 05EX1059), P2977; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Landassuri-Moreno V., 2011, ELECTRONICS ROBOTICS; Li B, 1998, CYBERNET SYST, V29, P409, DOI 10.1080/019697298125678; MARILL T, 1963, IEEE T INFORM THEORY, V9, P11, DOI 10.1109/TIT.1963.1057810; Mirjalili S, 2015, KNOWL-BASED SYST, V89, P228, DOI 10.1016/j.knosys.2015.07.006; Mirjalili S, 2015, ADV ENG SOFTW, V83, P80, DOI 10.1016/j.advengsoft.2015.01.010; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Rice J.A., 2006, MATHEMATICAL STATIST; Shoghian S., 2012, COMP WOLF PACK SEARC, V6; Tavazoei MS, 2007, J COMPUT APPL MATH, V206, P1070, DOI 10.1016/j.cam.2006.09.008; Vohra R, 2012, COMMUNICATION NETWOR, V1, P75; Wang D.F., 2002, FIRST INTERNATIONAL; WHITNEY AW, 1971, IEEE T COMPUT, VC 20, P1100, DOI 10.1109/T-C.1971.223410; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xin-She Yang, 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P240, DOI 10.1007/978-3-642-32894-7_27; Xue B, 2014, APPL SOFT COMPUT, V18, P261, DOI 10.1016/j.asoc.2013.09.018; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; [杨琛 YANG Chen], 2008, [仪表技术与传感器, Intstrument Technique and Sensor], P107; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2010, STUD COMPUT INTELL, V284, P65, DOI 10.1007/978-3-642-12538-6_6; Zawbaa HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150652	37	48	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158738	10.1371/journal.pone.0158738	http://dx.doi.org/10.1371/journal.pone.0158738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27410691	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300034
J	Ortega, RA; Carter, ES; Ortega, AE				Ortega, Ryan A.; Carter, Erin S.; Ortega, Albert E.			Nylon 6,6 Nonwoven Fabric Separates Oil Contaminates from Oil-in-Water Emulsions	PLOS ONE			English	Article							PERFORMANCE; POLYAMIDE	Industrial oil spills into aquatic environments can have catastrophic environmental effects. First responders to oil spills along the coast of the Gulf of Mexico in the southern United States have used spunbond nylon fabric bags and fences to separate spilled oil and oil waste from contaminated water. Low area mass density spunbond nylon is capable of sorbing more than 16 times its mass in low viscosity crude oil and more than 26 times its mass in higher viscosity gear lube oil. Nylon bags separated more than 95% of gear lube oil contaminate from a 4.5% oil-in-water emulsion. Field testing of spunbond nylon fences by oil spill first responders has demonstrated the ability of this material to contain the oily contaminate while allowing water to flow through. We hypothesize that the effectiveness of nylon as an oil filter is due to the fact that it is both more oleophilic and more hydrophilic than other commonly used oil separation materials. The nylon traps oil droplets within the fabric or on the surface, while water droplets are free to flow through the fabric to the water on the opposite side of the fabric.	[Ortega, Ryan A.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Carter, Erin S.; Ortega, Albert E.] Cerex Adv Fabr Inc, Pensacola, FL 32533 USA	Vanderbilt University	Ortega, AE (corresponding author), Cerex Adv Fabr Inc, Pensacola, FL 32533 USA.	AEOrtega@Cerex.com			Cerex Advanced Fabrics; Cerex Advanced Fabrics, Inc.	Cerex Advanced Fabrics; Cerex Advanced Fabrics, Inc.	This work was funded in part by a research budget from Cerex Advanced Fabrics, www.cerex.com. Authors EC and AO are research staff employed by Cerex Advanced Fabrics and participated in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors EC and AO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Bart Warner for donating Light Louisiana Sweet crude oil from a private well. This work was supported in part by funding from Cerex Advanced Fabrics, Inc.	Annunciado TR, 2005, MAR POLLUT BULL, V50, P1340, DOI 10.1016/j.marpolbul.2005.04.043; [Anonymous], 2009, SURFACE DESIGN APPL; [Anonymous], 2014, OLEOPHILIC FABRIC BE; [Anonymous], 2014, OLEPHILIC FABRIC FEN; [Anonymous], 2014, OLEOPHILIC FABRIC FE; Bachurova M, 2012, J ENG FIBER FABR, V7, P22; Briscoe BJ, 2000, COLLOID SURFACE A, V163, P151, DOI 10.1016/S0927-7757(99)00309-X; Broje V, 2007, J HAZARD MATER, V148, P136, DOI 10.1016/j.jhazmat.2007.02.017; Chen WJ, 2009, J MEMBRANE SCI, V337, P98, DOI 10.1016/j.memsci.2009.03.029; De Anda AR, 2011, POLYM ENG SCI, V51, P2129, DOI 10.1002/pen.22064; Goss B, 2010, PRACTICAL GUIDE ADHE; Hua FL, 2007, CHEM ENG J, V128, P169, DOI 10.1016/j.cej.2006.10.017; Kohan Melvin I., 1995, NYLON PLASTICS HDB; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; PARKER JP, 1977, J APPL POLYM SCI, V21, P821, DOI 10.1002/app.1977.070210322; PASTORE CM, 2001, SURFACE CHARACTERIST; Patel SU, 2014, SEP PURIF TECHNOL, V126, P62, DOI 10.1016/j.seppur.2014.02.009; Reed H, 2010, CITY GULF BREEZE DEE; SCHRADER EL, 1991, ENVIRON GEOL WATER S, V17, P157, DOI 10.1007/BF01701571; Telliard WA, 1999, 1664 US EPA; Wang H, 2014, ENVIRON SCI POLLUT R, V21, P1248, DOI 10.1007/s11356-013-2028-8; Wang QJ, 2007, APPL SURF SCI, V253, P9054, DOI 10.1016/j.apsusc.2007.05.030; Zhou JE, 2010, SEP PURIF TECHNOL, V75, P243, DOI 10.1016/j.seppur.2010.08.008	25	12	12	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158493	10.1371/journal.pone.0158493	http://dx.doi.org/10.1371/journal.pone.0158493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	27411088	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508300026
J	Perez-Cembranos, A; Leon, A; Perez-Mellado, V				Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin			Omnivory of an Insular Lizard: Sources of Variation in the Diet of Podarcis lilfordi (Squamata, Lacertidae)	PLOS ONE			English	Article							PLANT CONSUMPTION; FEEDING ECOLOGY; DRY-WEIGHT; EVOLUTION; SELECTION; ENERGETICS; DIVERSITY; BIOMASS; LENGTH	Through 17 years and from a sample of 7,790 faecal pellets and 26,346 prey items, we studied the diet of the Balearic lizard Podarcis lilfordi in Aire Island (Menorca, Balearic Islands, Spain). We analysed the diet in terms of prey frequencies, as well as by their volume and biomass contributions. The diet of the Balearic lizard was extremely variable through the years, months and areas under study. The dominance of small clumped prey, particularly ants, was confirmed. However, the main contribution by volume corresponded to beetles, with a relevant role for Diplopoda and terrestrial Isopoda during some months and at particular areas of the island. Several prey items were probably captured at the base of shrubs, under stones or inside rock crevices. Therefore, our estimations of electivity would only be reliable for epigeal and flying prey. The capacity of the Balearic lizard to include marine subsidies in its diet, such as coastal crustaceans, is noteworthy. Also, its consumption of carrion from carcasses of gulls and rabbits and leftovers from human visitors is remarkable. Juvenile conspecifics can also be a sporadic food resource, especially during the second half of summer, whereas the consumption of vegetal matter is constant for each whole year. The shifts of vegetal exploitation among areas of the island and months take place according to availability of different plant species at each area or during a given period. Thus, lizards are able to conduct a thorough monitoring of plant phenology, exploiting a large variety of plant species. Omnivory does not imply the indiscriminate inclusion of any edible food in its diet. Rather, the inclusion of several food items means the adoption of a wide range of foraging behaviours adapted to the exploitation of each food resource.	[Perez-Cembranos, Ana; Leon, Alicia; Perez-Mellado, Valentin] Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain	University of Salamanca	Perez-Mellado, V (corresponding author), Univ Salamanca, Dept Anim Biol, E-37008 Salamanca, Spain.	valentin@usal.es	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	Ministerio de Economia y Competitividad [CGL2012-39850-CO2-02]; FEDER funds from the European Union	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds from the European Union(European Commission)	The study was funded by the research project CGL2012-39850-CO2-02 from the Spanish Ministry of Science and Innovation (currently: Ministerio de Economia y Competitividad) co-funded by FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angelici FM, 1997, ITAL J ZOOL, V64, P267, DOI 10.1080/11250009709356207; BAUMGARTNER LUTHER L., 1939, JOUR WILDLIFE MANAGEMENT, V3, P266, DOI 10.2307/3796113; BEST TL, 1984, J HERPETOL, V18, P291, DOI 10.2307/1564083; Bowles E, 2011, MOL ECOL RESOUR, V11, P530, DOI 10.1111/j.1755-0998.2010.02974.x; Boyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075962; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; BROWN RP, 1992, OECOLOGIA, V91, P500, DOI 10.1007/BF00650322; BROWN RP, 1994, FUNCT ECOL, V8, P427, DOI 10.2307/2390065; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; CALVER MC, 1982, AUST WILDLIFE RES, V9, P293; Canyelles X, 2003, INSECTES ILLES BALEA; Capizzi Dario, 1999, Herpetozoa, V11, P117; Castilla AM, 1996, COPEIA, P991, DOI 10.2307/1447663; CASTILLA AM, 1991, J HERPETOL, V25, P30, DOI 10.2307/1564791; Civantos E, 2013, AFR J HERPETOL, V62, P78, DOI 10.1080/21564574.2013.799101; COLLINS PT, 1992, AM MIDL NAT, V128, P404, DOI 10.2307/2426474; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; Cronquist A., 1988, EVOLUTION CLASSIFICA; Diaz J.A., 1990, Donana Acta Vertebrata, V17, P67; Fialho RF, 2000, J HERPETOL, V34, P325, DOI 10.2307/1565437; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; Gillon Y, 1967, SECONDARY PRODUCTIVI, V2, P519; Hawlena D, 2009, OECOLOGIA, V161, P411, DOI 10.1007/s00442-009-1375-0; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hodar JA, 1996, ACTA OECOL, V17, P421; Hodar JA, 1997, MISC ZOOL, V20, P1; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Johnson MK, 1983, SAE831684 TECH PAP S, P1; Luiselli L, 2006, J TROP ECOL, V22, P91, DOI 10.1017/S0266467405002877; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Magnusson WE, 2003, COPEIA, P13, DOI 10.1643/0045-8511(2003)003[0013:UOGFTE]2.0.CO;2; Magurran A.E., 2004, MEASURING BIOL DIVER; Maragou P., 1996, Herpetozoa, V9, P105; MARTIN J, 1993, OIKOS, V66, P318, DOI 10.2307/3544820; Mateo JA, ZOOL ANZ IN PRESS; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Moore P.D., 1991, BLACKWELL SCI PUBLI; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ortmann Sylvia, 2006, P397; Ouboter MP, 1981, AMPHIB REPTIL, V2, P243; Pafilis P, 2009, NATURWISSENSCHAFTEN, V96, P1107, DOI 10.1007/s00114-009-0564-3; Pallmann P, 2012, MOL ECOL RESOUR, V12, P1068, DOI 10.1111/1755-0998.12004; Perera A, 2004, REV MENORCA, V86, P159; Perez-Cembranos A, 2015, SALAMANDRA, V51, P63; Perez-Cembranos A, 2015, ANIM COGN, V18, P629, DOI 10.1007/s10071-014-0831-3; Perez-Mellado V, HERPETOFAUNAS MEDITE; Perez-Mellado V., 1989, REV MENORCA, V80, P455; Perez-Mellado V., 1998, FAUNA IBERICA, P272; Perez-Mellado V., 2009, QUADERNS NATURA BALE; Perez-Mellado V., 2007, MAINLAND INSULAR LAC, P133; Perez-Mellado V, 2008, AMPHIBIA-REPTILIA, V29, P49, DOI 10.1163/156853808783431587; Perez-Mellado V, 2011, AMPHIBIA-REPTILIA, V32, P1, DOI 10.1163/017353710X530212; Perez-Mellado Valentin, 1993, Bonner Zoologische Beitraege, V44, P193; Pianka ER, 2003, WINDOWS EVOLUTION DI; POLIS GA, 1985, J HERPETOL, V19, P99, DOI 10.2307/1564425; Provenza Frederick D., 1993, P78; Punt W, 1980, NW EUROPEAN FLORA 2; Quayle A., 1983, British Journal of Herpetology, V6, P309; R Core Team, 2021, R LANGUAGE ENV STAT; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Roman P, 1971, TEJIDOS VEGETALES; SADEK RA, 1981, ZOOL J LINN SOC-LOND, V73, P313, DOI 10.1111/j.1096-3642.1981.tb01599.x; SAGE RD, 1982, AM MIDL NAT, V108, P407, DOI 10.2307/2425505; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; SALVADOR A., 1986, HDB REPTILIEN AMPHIB, P83; Scherer R., 2014, SIMBOOT SIMULTANEOUS; Stephens D.W., 1986, pi; Teerink B. J., 2003, HAIR W EUROPEAN MAMM; Valdes B., 1987, ATLAS POLINICO ANDAL; Van Damme R, 1999, J HERPETOL, V33, P663; VANDERPLOEG HA, 1979, ECOL MODEL, V7, P135, DOI 10.1016/0304-3800(79)90004-8; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	77	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0148947	10.1371/journal.pone.0148947	http://dx.doi.org/10.1371/journal.pone.0148947			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	26871439	Green Published, Green Submitted, gold			2022-12-26	WOS:000370054100078
J	Pereira, AGT; Utsunomiya, YT; Milanesi, M; Torrecilha, RBP; Carmo, AS; Neves, HHR; Carvalheiro, R; Ajmone-Marsan, P; Sonstegard, TS; Solkner, J; Contreras-Castillo, CJ; Garcia, JF				Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Neves, Haroldo H. R.; Carvalheiro, Roberto; Ajmone-Marsan, Paolo; Sonstegard, Tad S.; Solkner, Johann; Contreras-Castillo, Carmen J.; Garcia, Jose F.			Pleiotropic Genes Affecting Carcass Traits in Bos indicus (Nellore) Cattle Are Modulators of Growth	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-I CONCENTRATION; LINEAR MIXED MODELS; VISUAL SCORES; EXPRESSION; VARIANTS; ANGUS; PROOPIOMELANOCORTIN; MYOSTATIN; THICKNESS	Two complementary methods, namely Multi-Trait Meta-Analysis and Versatile Gene-Based Test for Genome-wide Association Studies (VEGAS), were used to identify putative pleiotropic genes affecting carcass traits in Bos indicus (Nellore) cattle. The genotypic data comprised over 777,000 single-nucleotide polymorphism markers scored in 995 bulls, and the phenotypic data included deregressed breeding values (dEBV) for weight measurements at birth, weaning and yearling, as well visual scores taken at weaning and yearling for carcass finishing precocity, conformation and muscling. Both analyses pointed to the pleomorphic adenoma gene 1 (PLAG1) as a major pleiotropic gene. VEGAS analysis revealed 224 additional candidates. From these, 57 participated, together with PLAG1, in a network involved in the modulation of the function and expression of IGF1 (insulin like growth factor 1), IGF2 (insulin like growth factor 2), GH1 (growth hormone 1), IGF1R (insulin like growth factor 1 receptor) and GHR (growth hormone receptor), suggesting that those pleiotropic genes operate as satellite regulators of the growth pathway.	[Pereira, Anirene G. T.; Contreras-Castillo, Carmen J.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Agroind Alimentos & Nutr, Piracicaba, Brazil; [Utsunomiya, Yuri T.; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Milanesi, Marco; Garcia, Jose F.] UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil; [Pereira, Anirene G. T.; Utsunomiya, Yuri T.; Milanesi, Marco; Torrecilha, Rafaela B. P.; Carmo, Adriana S.; Garcia, Jose F.] IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil; [Neves, Haroldo H. R.] GenSys Consultores Assoc, Porto Alegre, RS, Brazil; [Carvalheiro, Roberto] UNESP Univ Estadual Paulista, Dept Zootecnia, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil; [Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Piacenza, Italy; [Sonstegard, Tad S.] Recombinetics Inc, St Paul, MN USA; [Solkner, Johann] BOKU Univ Nat Resources & Life Sci, Dept Sustainable Agr Syst, Div Livestock Sci, Vienna, Austria	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Catholic University of the Sacred Heart; University of Natural Resources & Life Sciences, Vienna	Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Med Vet Prevent & Reprod Anim, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil.; Garcia, JF (corresponding author), UNESP Univ Estadual Paulista, Dept Apoio Prod & Saude Anim, Fac Med Vet & Aracatuba, Aracatuba, SP, Brazil.; Garcia, JF (corresponding author), IAEA, Collaborating Ctr Anim Genom & Bioinformat, Aracatuba, SP, Brazil.	jfgarcia@fmva.unesp.br	Carvalheiro, Roberto/I-2239-2013; Utsunomiya, Yuri Tani T/K-5214-2013; Carmo, Adriana S/E-4342-2016; Pérez-Cembranos, Ana/H-8542-2015; de Rezende Neves, Haroldo Henrique/F-9521-2012; León, Alicia/ABF-2086-2021; Carvalheiro, Roberto/AAG-2222-2020; MILANESI, Marco/P-7473-2015; Contreras-Castillo, Carmen Josefina/C-4696-2012; AJMONE MARSAN, Paolo/M-2466-2018	Carvalheiro, Roberto/0000-0002-4506-0555; Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Carmo, Adriana S/0000-0002-2712-4789; Pérez-Cembranos, Ana/0000-0002-8296-2283; León, Alicia/0000-0001-5919-1858; Carvalheiro, Roberto/0000-0002-4506-0555; MILANESI, Marco/0000-0001-6244-7455; Contreras Castillo, Carmen Josefina/0000-0002-0554-4694; Solkner, Johann/0000-0002-1517-5829; AJMONE MARSAN, Paolo/0000-0003-3165-4579	National Counsel of Technological and Scientific Development (CNPq) [560922/2010-8, 483590/2010-0]; Sao Paulo Research Foundation (FAPESP) [2014/01095-8, 2013/02552-0]; Gensys Consultores Associados; Recombinetics, Inc	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Gensys Consultores Associados; Recombinetics, Inc	This research was supported by: National Counsel of Technological and Scientific Development (CNPq-http://www.cnpq.br/) (process 560922/2010-8 and 483590/2010-0); and Sao Paulo Research Foundation (FAPESP-http://www.fapesp.br/) (process 2014/01095-8 and 2013/02552-0). Gensys Consultores Associados and Recombinetics, Inc provided support in the form of salaries for authors HHRN and TSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adoligbe C, 2012, MOL BIOL REP, V39, P4067, DOI 10.1007/s11033-011-1188-1; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Boligon AA, 2011, LIVEST SCI, V135, P238, DOI 10.1016/j.livsci.2010.07.011; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cancian PH, 2014, SCI AGR, V71, P17, DOI 10.1590/S0103-90162014000100002; Cao JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13950; Capomaccio S, 2015, BIOINFORMATICS, V31, P2380, DOI 10.1093/bioinformatics/btv144; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Davis ME, 2003, J ANIM SCI, V81, P2164; Davis ME, 1997, J ANIM SCI, V75, P317; DeAtley KL, 2011, J ANIM SCI, V89, P2031, DOI 10.2527/jas.2010-3293; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fortes M, 2013, EVIDENCE PLEIOTROPIS; Fortes M, 2012, BIOL; Fortes MRS, 2013, ANDROLOGY-US, V1, P644, DOI 10.1111/j.2047-2927.2013.00101.x; Fortes MRS, 2012, ANIM PROD SCI, V52, P143, DOI 10.1071/AN11165; Garrick DJ, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-17; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Hartati H, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0229-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Keady SM, 2013, J ANIM SCI, V91, P654, DOI 10.2527/jas.2012-5850; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Littlejohn M, 2012, GENETIC VARIATION PL; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Neto LRP, 2012, ANIM GENET, V43, P785, DOI 10.1111/j.1365-2052.2012.02330.x; Neves HHR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-17; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rimbault M, 2013, GENOME RES, V23, P1985, DOI 10.1101/gr.157339.113; Ronnegrard L, 2010, HGLM PACKAGE FITTING, V2; ROSIE R, 1992, J NEUROENDOCRINOL, V4, P625, DOI 10.1111/j.1365-2826.1992.tb00212.x; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taylor JA, 2007, BIOL REPROD, V76, P524, DOI 10.1095/biolreprod.106.055533; Taylor JF, 2014, AQUACULTURE, V420, pS8, DOI 10.1016/j.aquaculture.2013.02.017; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Utsunomiya YT, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-52; Velazquez MA, 2008, DOMEST ANIM ENDOCRIN, V35, P325, DOI 10.1016/j.domaniend.2008.07.002; Versteyhe Soetkin, 2013, Front Endocrinol (Lausanne), V4, P98, DOI 10.3389/fendo.2013.00098; Voz ML, 2000, CANCER RES, V60, P106; Xu Z Y, 2010, Animal, V4, P1541, DOI 10.1017/S1751731110000649; Xue M, 2011, INDIAN J ANIMAL SCI; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	55	42	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2016	11	7							e0158165	10.1371/journal.pone.0158165	http://dx.doi.org/10.1371/journal.pone.0158165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CP	26871439	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508300019
